{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\nThe gross benefit obligation for LMT’s non‑qualified defined‑benefit pension plans fell from roughly **$1.0 billion at the end of 2023 to $905 million at the end of 2024**.  At the same time, the pretax actuarial losses that were recorded in accumulated other comprehensive loss declined from **$347 million in 2023 to $303 million in 2024**.  This reflects a modest reduction in both the overall obligation and the unrecognized actuarial losses over the one‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. These values are reported correctly with acceptable formatting (e.g., $1.0 billion vs $1.0 billion). (2) The answer is complete, addressing both the gross benefit obligation and actuarial losses for both years as required by the question. (3) Entity accuracy is correct—LMT (Lockheed Martin) is properly identified, and the metric names (gross benefit obligation, actuarial losses) are used appropriately in context. (4) The reasoning is sound: the LLM correctly interprets the year-over-year decline and summarizes the trend as a reduction in both liability and actuarial losses, which aligns with the multi-hop synthesis required across two years and two financial metrics. (5) Semantic equivalence is achieved—the wording differs slightly (e.g., 'pretax actuarial losses recorded in accumulated other comprehensive loss' adds context not in the original but does not distort meaning), but the core information and implications are accurately conveyed. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 358,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\nGM lifted its weighted‑average long‑term return assumption on U.S. pension assets from roughly 5.4 % (the level used in the 2022 valuation) to 6.5 % by the end of 2024.  At the same time the plan’s strategic mix was re‑balanced: debt exposure fell from about 68 % of assets to ≈60 %, while allocations to private‑equity, real‑estate and other alternatives rose from roughly 23 % to ≈29 % of the portfolio.  This shift shows GM is deliberately reducing fixed‑income weighting and increasing higher‑return alternatives to improve the funded status of its pension plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces specific quantitative details not present or verifiable in the original answer. While the original answer states that the long-term rate of return decreased from 5.6% (2020) to 5.4% (2021) in the context of 2022 reporting, and then increased from 6.3% (2023) to 6.5% (2024) in the 2024 context, the LLM incorrectly frames the change as from '5.4% in 2022' to '6.5% in 2024'. This misrepresents the timeline: the 5.4% figure is from December 2021 (reported in 2022), not the assumption used throughout 2022, and the increase to 6.5% is from 6.3% in 2023, not from 5.4%. (2) The LLM introduces specific asset allocation figures—debt exposure falling from 68% to 60% and alternatives rising from 23% to 29%—which are not present in the original answer and cannot be verified from the provided ground truth. These numbers, while plausible, are hallucinated and significantly impact quantitative accuracy. (3) The multi-hop reasoning is sound in concept: the LLM correctly infers that an increase in expected return implies a strategic shift toward higher-return assets, which aligns with the original answer’s conclusion about a more optimistic projection reflecting strategic adjustments. However, the reasoning is based on fabricated data rather than the actual trend in return assumptions. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of return assumptions and strategic asset mix implications—and draws a logical conclusion. The qualitative accuracy is moderate because the entities (General Motors, U.S. pension plan assets, long-term return assumptions) and general direction of change are correct, but the reasoning is supported by incorrect specifics. The correctness score is 6 due to the right overall direction and interpretation but significant quantitative inaccuracies and unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 525,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\nBetween 2023 and 2024 the relationship moved from a pending acquisition in 2023 to full integration of PDC Energy as a subsidiary of Chevron.  The combined assets added roughly 250,000 barrels‑per‑day of net oil‑equivalent production (a 19 % rise) and contributed about $2.2 billion of sales volume, which drove a $3.5 billion increase in U.S. upstream earnings and lifted overall net income, while also allowing Chevron to exclude PDC from its internal‑control assessments after the 2023 acquisition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition and integration of PDC Energy by Chevron between 2023 and 2024, and notes the exclusion of PDC from internal control assessments in 2023, which aligns with the ground truth. However, there are significant quantitative inaccuracies: the $3.5 billion increase in U.S. upstream earnings is incorrect — the ground truth states a $2.2 billion increase, not $3.5 billion. Additionally, the LLM claims PDC contributed '$2.2 billion of sales volume', which is not mentioned in the original answer and misrepresents the $2.2 billion as sales volume rather than earnings. The 19% increase in net oil-equivalent production is correct, as is the ~250,000 barrels-per-day figure (implied from the 19% rise, though exact volume not in original, it's a reasonable inference). (2) The calculation errors are critical: attributing $3.5B earnings increase instead of $2.2B misstates financial impact. The conflation of 'sales volume' with 'earnings' shows a misunderstanding of financial metrics. (3) The multi-hop reasoning is partially sound — the model connects the acquisition in 2023 to integration in 2024 and links PDC to production and earnings growth. However, it introduces incorrect financial figures and misattributes the $2.2B, breaking the chain of accurate synthesis. (4) Scores reflect mostly correct structure and context (high contextual relevance), moderate qualitative accuracy due to correct entities and timeline, but low quantitative accuracy due to key number errors that distort the financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 432,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\nSouthern Company’s regulatory‑hedge unrealized gain on energy‑related derivatives rose sharply from about **$12 million in the 2021 comparative figures shown in the 2022 10‑K** to **$155 million in the 2024 balance‑sheet data (December 31 2023)**.  The 2024 filing now presents the gain (and the related liabilities) as separate **current and non‑current regulatory assets and liabilities**, net of offsetting amounts, whereas the 2022 filing aggregated the amounts in “Other regulatory assets/liabilities” without the detailed offset schedule.  As a result, the unrealized gains are recognized as regulatory assets/liabilities that flow into fuel expense or revenue through the rate‑recovery mechanism, rather than being recorded only in AOCI or as a single aggregate figure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces specific numerical values not present in the original answer or implied by the ground truth. (1) QUANTITATIVE INACCURACY: The claim that Southern Company's unrealized gains rose from $12 million (as of 2021) to $155 million (as of 2023) is not supported by the original answer, which does not provide any specific dollar amounts or trends in unrealized gains. These figures are fabricated or inferred without basis in the provided ground truth. (2) ENTITY AND TEMPORAL ISSUES: The LLM references 'December 31, 2023' data as part of the 2024 filing, but the original answer refers to changes in disclosure practices by 2024 without specifying data for 2023. Additionally, the original answer discusses disclosures as of 2020 and 2021 in the 2022 filing, not comparative 2021 figures labeled as '2022 10-K' with precise dollar amounts. (3) REASONING: While the LLM attempts multi-hop reasoning by comparing presentation differences between years, it incorrectly asserts a shift in accounting treatment based on invented numbers. The original answer notes a change in disclosure focus—from deferring unrealized gains under regulatory hedging to presenting fair values in balance sheets under specific line items—but does not state that this reflects a change in valuation approach or confirm the detailed offset schedule or net presentation introduced in 2024. (4) SEMANTIC MISMATCH: The core idea of evolving presentation is partially aligned, but the emphasis on regulatory assets/liabilities flowing into fuel expense via rate recovery is speculative and not in the original. The original does not mention AOCI, offsetting, or rate-recovery mechanisms. Thus, while the answer addresses the general topic of changing presentation, it fails on factual correctness, introduces unsupported specifics, and misrepresents the nature and extent of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 516,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron’s stake in Tengizchevroil expanded — the carrying value of the equity investment rose from roughly **$26.9 billion (2023)** to **$27.4 billion (2024)**, after having been about **$23 billion in 2022**.  At the same time, equity‑method earnings from TCO fell sharply, dropping from **≈ $4.4 billion in 2022** to **≈ $3.0 billion in 2024** (≈ $3.4 billion in 2023), reflecting lower net earnings from the partnership as oil‑price volatility and reduced production at the Tengiz and Korolev fields impacted the affiliate’s profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly the carrying value in 2022. The ground truth states that Chevron's investment and advances were $26,954 million in 2023 and $27,368 million in 2024, but the LLM incorrectly claims the 2022 carrying value was $23 billion, which is not supported by the original answer. The original does not provide the total carrying value for 2022 directly, only that it was about $100 higher than its equity in net assets and that a $4,500 million loan was part of the investment. The LLM fabricates a $23 billion figure for 2022 with no basis in the source. While the 2023 and 2024 figures are approximately correct ($26.9B and $27.4B vs actual $26,954M and $27,368M), the 2022 value is significantly off. (2) Equity earnings are mostly accurate: ≈$4.4B in 2022 and ≈$3.0B in 2024 align with the ground truth ($4,386M and $3,033M). The mention of $3.4B in 2023 is plausible but not confirmed in the original answer, which only provides 2022 and 2024 figures. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies the trend of rising investment value and declining earnings, and attempts to explain it with external factors like oil-price volatility and production issues. However, the original answer does not mention the Korolev field or specific production issues, so this addition, while contextually reasonable, is speculative and not grounded in the provided truth. (4) The qualitative reasoning is coherent and addresses the evolution of the financial relationship, but the incorrect 2022 carrying value undermines quantitative accuracy. Contextual relevance is high as all parts of the question are addressed. Correctness score is 6 due to significant error in 2022 investment value, despite correct trends and mostly accurate earnings data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 502,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s stake in Alert Innovation moved from a variable‑interest position to 100 % ownership after it completed a $0.4 billion acquisition in fiscal 2023; by the end of fiscal 2024 the company continued to hold a full 100 % interest, with no further transaction altering that relationship during the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and previously held a variable interest, it claims Walmart 'continued to hold a full 100% interest' in fiscal 2024. This directly contradicts the ground truth, which states that Walmart sold and deconsolidated Alert Innovation in fiscal 2024, resulting in a complete exit. The answer misses the critical second transaction entirely. (2) Quantitative accuracy is mostly correct: the $0.4 billion acquisition amount is accurate, and percentages (100%) are correctly used for the ownership post-acquisition. No calculation errors are present, but the failure to report the divestiture undermines the quantitative narrative. (3) The multi-hop reasoning is flawed. The question requires synthesizing two events across two fiscal years: acquisition in 2023 and divestiture in 2024. The LLM only captures the first hop and incorrectly asserts continued ownership, failing to recognize or report the deconsolidation. This breaks the logical chain and results in a fundamentally incorrect portrayal of the ownership evolution. (4) Correctness is severely impacted by the omission of the sale in fiscal 2024, making the answer mostly incorrect despite accurate initial facts. Quantitative accuracy is scored moderately high because the numbers cited are correct, but they are incomplete. Qualitative accuracy is low due to flawed reasoning and failure to identify the full sequence of events. Contextual relevance is medium because the answer addresses the right entities and timeframe but misses a key part of the relationship change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 463,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the fair‑value of Starbucks’ “foreign‑currency‑other” derivatives fell sharply: the asset position dropped from about **$115 million** (comprised of $39.9 m + $33.5 m designated plus $34.3 m + $7.3 m non‑designated) to roughly **$5.5 million**, while the liability rose from about **$6 million** to **$11 million**.  \n\nThis contraction shows that the company deliberately pared back its foreign‑currency derivative book, indicating a shift toward a more streamlined exposure‑management approach—relying less on extensive derivative hedges and more on operational or natural hedges to mitigate foreign‑currency risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, in fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in AOCI, with $32.5 million expected to be reclassified within 12 months. The LLM incorrectly states a total asset of about $115 million, breaking it down into designated and non-designated components not mentioned in the original answer. These figures do not align with the ground truth and appear to be fabricated or misattributed. In 2023, the correct figures are $1.9 million in current assets and $1.7 million in long-term assets (totaling $3.6 million in assets), and liabilities of $4.7 million (current) and $4.1 million (long-term) — totaling $8.8 million in liabilities. The LLM reports a total asset of $5.5 million and liabilities rising to $11 million, which is close to the liability total but overstates both assets and liabilities. (2) Calculations are not verifiable because the source numbers are incorrect. The LLM’s breakdown of $39.9M + $33.5M + $34.3M + $7.3M = ~$115M does not correspond to any data in the original answer and introduces granular categories absent from the truth. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that a reduction in derivative assets and increase in liabilities suggests a strategic shift in exposure management. The conclusion about moving toward a more streamlined or natural hedge strategy is plausible and aligns conceptually with the ground truth’s interpretation of reduced overall exposure. However, because the quantitative foundation is flawed, the reasoning is built on incorrect premises. (4) Contextual relevance is fair — the answer addresses both parts of the question (changes in positions and strategic implications) and uses appropriate financial terminology. However, due to severe quantitative inaccuracies, the correctness score is low. Minor flexibility is given for semantic interpretation of strategy, but numbers are critically off.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 555,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Medtronic went from having a small number of A Preferred Shares outstanding to none.  In the third quarter of fiscal 2022 the company redeemed the 1,872 A Preferred Shares that were still issued, paying $0.075 million and effectively retiring those shares; consequently, at the end of fiscal 2022 (and thereafter through fiscal 2024) no A Preferred Shares remained outstanding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in the third quarter of fiscal 2022, and no shares remained outstanding by the end of that fiscal year (specifically April 29, 2022, as per the original). The answer correctly notes that no A Preferred Shares were outstanding through fiscal 2024. (2) Quantitative accuracy is perfect: the number of shares (1,872) and dollar amount ($0.075 million) match exactly, with acceptable phrasing (e.g., 'paying $0.075 million'). (3) Multi-hop reasoning is sound—LLM correctly synthesizes the redemption event in 2022 with the continued absence of shares in 2024, concluding discontinuation. (4) The answer fully addresses both parts of the question: the evolution between 2022 and 2024, and the specific 2022 action. Wording differs slightly (e.g., 'retiring' vs 'redeeming') but is contextually appropriate and does not distort meaning. All entities—Medtronic, A Preferred Shares, fiscal years 2022 and 2024—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 316,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast’s equity‑method earnings from its Atairos investment flipped from a **$(434 million) loss** in 2022 to a **$1.1 billion gain** in 2023.  The swing was driven by favorable fair‑value adjustments on Atairos’s underlying investments, turning what had been a net loss in 2022 into a sizable equity‑income gain in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $(434 million) loss in 2022 and $1.1 billion gain in 2023 are correctly stated, with acceptable formatting (e.g., $1.1 billion = $1.1B). (2) Quantitative accuracy is perfect—both figures match the original answer exactly, and the directional change (loss to gain) is correctly emphasized. (3) The reasoning correctly identifies fair value adjustments on underlying investments as the driver, which aligns with the original explanation. (4) The answer addresses all parts of the question: the evolution of the financial relationship, the specific equity income/losses, and the role of fair value adjustments. Multi-hop synthesis between Comcast and Atairos across 2022 and 2023 is sound and concise. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 258,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the company’s reported natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped from roughly **305 billion cubic feet to 289 billion cubic feet** (about a 5 % decline). This reduction indicates that ConocoPhillips is **scaling back its proven gas base in that region**, shifting strategic focus and investment toward other areas such as North‑American onshore plays and LNG projects rather than expanding its reserve base in Asia‑Pacific/Middle‑East.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COP's natural gas reserves in the Asia Pacific/Middle East region were 312 billion cubic feet (Bcf) in 2023 and declined to 296 Bcf in 2024. The LLM incorrectly reports these figures as 305 Bcf and 289 Bcf, respectively. This results in an incorrect decline of about 5%, whereas the actual decline is from 312 to 296 Bcf—a decrease of 16 Bcf, or approximately 5.1%, which, while close in percentage, is based on wrong base numbers. (2) The calculation of the percentage decline is approximately correct (5% vs actual ~5.1%), but since it is derived from incorrect inputs, it fails the quantitative accuracy test. The actual values must match the ground truth for full credit. (3) The qualitative reasoning is partially sound: the LLM correctly infers that a decline in reserves may indicate a strategic reallocation or reduced focus on the region, which aligns with the ground truth’s interpretation of 'limited growth or strategic reallocation.' However, the LLM goes further by asserting a shift toward North American onshore plays and LNG projects—information not present in the original answer and thus unsupported by the provided ground truth. This introduces speculative content not justified by the source. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of reserves and strategic implications—and maintains focus on COP and the correct geographic region. However, due to incorrect core data and unsupported strategic claims, the correctness and accuracy scores are significantly reduced. Overall, the answer is directionally plausible but factually flawed in key numerical and inferential aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 480,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\nIn Canada, ENBREL sales fell sharply each year—from **$113 million in 2021 to $73 million in 2022 (‑35 %), $47 million in 2023 (‑36 % YoY), and $28 million in 2024 (‑40 % YoY)**.  This accelerating decline signals a continued erosion of the product’s Canadian market, driven by biosimilar competition, patent expirations and pricing pressure, indicating that ENBREL’s trajectory in Canada is decisively downward.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ($47 million) and 2024 ($28 million) revenue figures, which match the ground truth. However, it incorrectly states the 2022 revenue as $73 million, while the ground truth specifies $113 million for 2022. Additionally, the LLM introduces a 2021 figure ($113 million) not present in the original question or answer, likely misaligning the timeline. This leads to a significant quantitative error in the base year. (2) The percentage declines (-35%, -36%, -40% YoY) are based on incorrect year-over-year transitions (e.g., from 2021 to 2022), making the calculations inaccurate despite plausible math. The correct trend per ground truth is a drop from $113M (2022) to $47M (2023) (~58.4% decline), then to $28M (2024) (~40.4% decline), neither of which matches the LLM's reported percentages. (3) The multi-hop reasoning is sound in structure—recognizing a downward trend and attributing it to biosimilars, patent expiry, and pricing pressure—but these drivers are not present in the original answer, representing an addition rather than synthesis from the provided truth. While plausible, they go beyond the ground truth's scope. (4) Despite the incorrect 2022 number and fabricated 2021 data, the core trajectory (declining revenue from $113M to $47M to $28M) is partially correct except for misplacement of the $113M figure. The conclusion about a downward trajectory aligns with the original. Thus, the answer is mostly accurate in direction and qualitative interpretation but flawed in key quantitative details, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 439,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Qualcomm moved from a largely qualitative reference to human‑capital progress in its executive‑bonus discussion to a formal, quantitative performance modifier.  For fiscal 2024 the HR and Compensation Committee explicitly ties progress on human‑capital goals to a bonus‑adjustment multiplier of **0.9 to 1.1**, whereas in fiscal 2023 no such defined range was disclosed.  This evolution codifies human‑capital advancements as a direct, measurable factor that can raise or lower executive bonus payouts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution from fiscal 2023 to fiscal 2024: in 2023, human capital advancements were considered qualitatively, while in 2024 they became a formal, quantified performance modifier. (2) The specific performance modifier range of 0.9 to 1.1 is correctly stated and matches the ground truth exactly. (3) The multi-hop reasoning is sound—comparing Qualcomm's compensation approach across two fiscal years and identifying the shift from general consideration to a defined multiplier. (4) All entities (Qualcomm, fiscal years 2023 and 2024, executive compensation, HR and Compensation Committee) are accurate. The answer is complete, contextually relevant, and conveys the same information as the original with precise factual and quantitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 251,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s label expanded from the initial approvals for relapsed / refractory chronic‑lymphocytic leukemia/small‑lymphocyte lymphoma, follicular lymphoma and mantle‑cell lymphoma (2022 filing, p. 42) to multiple 2024 FDA accelerated approvals that require prior BTK‑inhibitor + BCL‑2‑inhibitor therapy and also add a Japan MHLW approval extending the follicular‑lymphoma indication to patients who have received only one prior line of treatment (2024 filings, pp. 44‑51). This widens both the disease spectrum and the line‑of‑therapy eligibility for the therapy.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Breyanzi had initial approvals in 2022 for chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and mantle-cell lymphoma (MCL), which contradicts the ground truth: in 2022, Breyanzi was still in late-stage trials (TRANSCEND-CLL-004 and TRANSCEND-FL) for 3L+ CLL and FL, not yet approved. The original answer confirms no approvals were in place in 2022—only expected timing in 2023/24. (2) The claim of 'multiple 2024 FDA accelerated approvals' requiring prior BTK + BCL-2 inhibitor therapy misrepresents the data: only the CLL/SLL indication (March 2024) required prior BTK and BCL-2 inhibitors; the FL approval (May 2024) required at least two prior lines of therapy but did not specify those drug classes. (3) The mention of a 'Japan MHLW approval' for FL after one prior line of treatment is not supported by the original answer, which only references U.S. FDA approvals and does not mention Japan or any international expansion. (4) The LLM incorrectly implies a broadening of the 'disease spectrum' by adding new diseases, but the ground truth shows approvals were in the same disease areas (CLL and FL) previously under investigation—so no new diseases were added, only regulatory progression from trials to approvals. (5) There are no numeric values (e.g., dates) that are outright miscalculated, but the use of '2022 filing, p. 42' and '2024 filings, pp. 44–51' introduces false precision not present in the ground truth, which does not reference page numbers or filings. While the answer attempts multi-hop reasoning by comparing 2022 status to 2024 developments, it fails in synthesis due to incorrect characterization of both time points. The contextual relevance is moderate because it addresses the evolution of indications, but the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 521,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024, revenue in Disney’s **Resorts & Vacations** business rose to **$8.38 billion**, a **5 % increase** over the prior year, driven by higher average ticket prices for cruise sailings, modest gains in hotel room rates and occupancy, and slightly higher DVC unit sales, while a 1 % dip in DVC unit volume offset some growth. This 5 % rise is essentially in line with the **overall Parks & Experiences segment**, which grew **5 %** to **$34.15 billion** in the same period. Thus, the Resorts & Vacations sub‑segment is performing in step with the broader segment’s revenue expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue growth for Disney's Resorts & Vacations segment as 5%, increasing from $7,949 million in 2023 to $8,375 million in 2024. The LLM reports $8.38 billion, which is a rounded but acceptable representation of $8,375 million. Similarly, the overall Parks & Experiences segment revenue is correctly stated as growing 5% to $34.15 billion, aligning with the ground truth of $34,151 million. The percentage growth (5%) is accurate for both segments. (2) Minor discrepancy: the LLM states Resorts & Vacations grew 'to $8.38 billion', which is a slight rounding up from $8,375 million ($8.375 billion), but this is within acceptable formatting variation. All calculations are correct—5% growth from $7,949M yields ~$8,346M, but actual reported $8,375M implies a ~5.3% increase; however, both the original and LLM answers cite 5%, suggesting rounding was applied consistently across sources. The Parks & Experiences growth from $32,549M to $34,151M is exactly 4.92%, which rounds to 5%—correctly reported. (3) Multi-hop reasoning is sound: the LLM correctly compares the sub-segment (Resorts & Vacations) performance to the broader Parks & Experiences segment, concluding they grew at similar rates, which matches the ground truth. (4) The answer is contextually complete and relevant, addressing both the evolution of Resorts & Vacations and its comparison to overall segment growth. The only minor issue is the slight rounding of $8.375B to $8.38B and the use of 'in line' versus 'slightly below' in growth characterization—ground truth notes 'slightly below', while LLM says 'in step'. However, given both are 5% after rounding, this is a negligible difference in interpretation. Overall, highly accurate with only negligible rounding and phrasing variance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 491,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s ASR‑related forward contracts grew in size and followed the same equity‑classification pattern. In 2023 the firm entered a $2.0 billion fixed‑dollar ASR with Citibank, recording an initial treasury‑stock purchase of roughly $1.6 billion and a forward contract of about $0.3 billion that was booked in capital surplus and later re‑classified to treasury stock when the remaining shares were received in February 2023. In 2024 the company executed a larger $3.0 billion ASR with Morgan Stanley, initially taking an $2.6 billion treasury‑stock position and a $0.4 billion forward contract—again classified as equity and subsequently re‑classified to treasury stock after the final share delivery in March 2024. Thus, the forward‑contract component expanded proportionally with the larger notional amount, but its accounting treatment (equity classification and later re‑classification) remained consistent.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. It states the 2023 forward contract was 'about $0.3 billion', but the ground truth specifies $0.4 billion. This is a significant error, especially since the key insight in the original answer is that the forward contract value remained constant at $0.4 billion across both years. The LLM incorrectly claims the 2023 forward was $0.3B and the 2024 was $0.4B, implying growth, which contradicts the ground truth. (2) The dates of final share receipt (February 2023 and March 2024) are correctly reported. The initial treasury stock and ASR totals are accurate: $1.6B/$2.0B in 2023 and $2.6B/$3.0B in 2024. However, the miscalculation of the 2023 forward contract undermines the quantitative accuracy. The claim that the forward contract 'expanded proportionally' is incorrect—the original answer emphasizes that despite the larger ASR, the forward value stayed the same at $0.4B, indicating a shift in allocation proportion. (3) The reasoning is partially sound: the LLM correctly identifies the accounting treatment (equity classification, recording in capital surplus, reclassification to treasury stock upon delivery) and recognizes the increase in overall ASR size. However, it fails to capture the key multi-hop insight that the forward contract value did not change year-over-year, which is central to understanding the structural evolution. (4) Contextual relevance is high—the response addresses the evolution of structure and value, uses correct entities (CVS, Citibank, Morgan Stanley, correct years), and discusses the right financial instruments. The qualitative reasoning is logical but based on incorrect numbers. Due to the critical error in the 2023 forward contract value and the resulting flawed conclusion about proportional expansion, the correctness score is reduced to 6—partially correct but with significant factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 525,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\nFrom 2023 to 2024 Duke Energy’s Master Retirement Trust disclosure became slightly more transparent about how its assets are valued under the fair‑value hierarchy.  In the 2023 table the fair‑value amounts were split as Level 1 $2,042 M, Level 2 $4,944 M, Level 3 $76 M and “Not Categorized” $179 M; by 2024 the same categories were $2,242 M (Level 1), $4,481 M (Level 2), $68 M (Level 3) and $178 M (Not Categorized).  The shift shows a modest increase in assets measured with observable market prices (Level 1) and a reduction in those relying on unobservable inputs (Level 2 and especially Level 3), accompanied by a concise reconciliation of the Level 3 balance, indicating clearer reporting of the valuation methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual errors not present in the ground truth. (1) The original answer states that Duke Energy did not categorize certain investments using the net asset value (NAV) practical expedient in the fair value hierarchy in 2023, and that in 2024 they added a Level 3 reconciliation for beginning and ending balances — this is the core evolution in transparency. However, the LLM answer fabricates specific dollar amounts for Level 1, Level 2, Level 3, and 'Not Categorized' assets for both years, which are not mentioned in the ground truth. There is no indication in the original answer that such a table or these values were disclosed, so their inclusion is a serious factual overreach. (2) The quantitative accuracy is very low because all the numbers ($2,042M, $4,944M, etc.) are invented and cannot be verified; they contradict the qualitative nature of the original disclosure. (3) The reasoning is flawed: the LLM infers trends like 'increase in Level 1 assets' and 'reduction in Level 3' based on made-up data, and incorrectly frames the addition of a Level 3 reconciliation as a 'modest increase in transparency' when the original answer identifies it as a 'significant increase'. (4) While the LLM correctly identifies that transparency improved and that Level 3 reconciliation was added, it misrepresents the nature and extent of the change by inventing numerical details. The contextual relevance is moderate because it addresses pension asset valuation and fair value hierarchy, but the fabricated data undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 437,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer moved from a cash‑based, government‑inventory model to a volume‑credit arrangement. In 2023 it recorded a $3.5 bn non‑cash revenue reversal tied to the expected return of roughly 6.5 million EUA‑labeled Paxlovid courses purchased by the U.S. government, and it began transitioning Paxlovid sales to commercial pricing as the government phased out free distribution. In 2024 the company recognized a $771 m favorable adjustment for 5.1 million courses returned through Feb 2024, created a U.S. Strategic National Stockpile of 1 million courses to be supplied at no cost (which will generate revenue only as the courses are later delivered), and reduced its Paxlovid‑related deferred‑revenue balance from $5.1 bn (2023) to $2.2 bn (2024), with future contracted revenue of about $1 bn expected through 2028.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to the expected return of 6.5 million Paxlovid courses and the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, which aligns with the ground truth. It also correctly notes the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses. However, it incorrectly states that the SNS courses were to be supplied 'at no cost' and that revenue would be recognized only upon delivery, which contradicts the ground truth that Pfizer recognized $442 million in revenue in 2024 in connection with the SNS. This is a significant factual error affecting quantitative and qualitative accuracy. Additionally, the LLM introduces new information not in the ground truth—such as the reduction in deferred revenue from $5.1B to $2.2B and future contracted revenue of $1B through 2028—which, while potentially accurate, is extraneous and not responsive to the question. (2) The numbers for the $3.5B reversal and $771M adjustment are correct. However, the $442M SNS revenue is omitted and replaced with an incorrect narrative about deferred recognition, which is a major quantitative inaccuracy. The 1 million SNS courses are correctly identified. (3) The multi-hop reasoning is generally sound—linking 2023 reversal to 2024 adjustment and stockpile formation—but the mischaracterization of revenue recognition for the SNS undermines the correctness of the synthesis. (4) The answer is contextually relevant and captures the shift from reversal to adjustment and stockpiling, but the omission of the $442M revenue and insertion of incorrect deferred recognition logic reduces factual correctness. Hence, a score of 7 is justified: core facts are present but with a significant error in revenue recognition treatment for the SNS.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 514,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\nERLEADA’s worldwide sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023** – an **≈27 % year‑over‑year increase** (26.9 % nominal, 27.5 % operational after adjusting for currency).  This strong growth helped lift total oncology sales by **10.5 %** and offset declines in legacy products such as Zytiga and Ibrutinib, underscoring ERLEADA’s emerging role as a **key growth engine within J&J’s oncology portfolio** as the Company navigates patent expiries and biosimilar competition for older agents.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key numbers match: $1.88 billion (2022) and $2.39 billion (2023) are correctly reported (equivalent to $1,881M and $2,387M in original); the 26.9% growth rate is accurately reflected (≈27% stated, with exact 26.9% noted); oncology segment growth of 10.5% is correct. Minor rounding ($2.387B → $2.39B) is acceptable. (2) Quantitative accuracy is excellent: all figures are either exact or appropriately rounded, and the operational growth note (27.5%) adds context without contradicting the ground truth. (3) Qualitative reasoning is sound: the answer correctly identifies ERLEADA’s role as a growth driver, contrasts its performance with declining products (Zytiga, Ibrutinib/IMBRUVICA), and situates it within J&J’s broader oncology portfolio challenges (patent expiries, biosimilars). (4) Contextual relevance is high—answer fully addresses both parts of the question: financial evolution (2022–2023 sales growth) and strategic role in J&J’s oncology portfolio. Multi-hop synthesis across products and years is accurate and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 319,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\nERLEADA’s worldwide sales surged from $760 million in 2022 to $1.29 billion in 2023—a roughly 70 % increase—driven by strong U.S. growth (up 39 % to $813 million) and a more than three‑fold rise in international sales (up to $478 million). This sharp expansion signals that ERLEADA is gaining rapid market acceptance and is on a clear upward trajectory, suggesting accelerating demand and a strengthening competitive position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in numbers and growth rates. According to the ground truth, ERLEADA had $1,291 million in sales in 2022 and $2,387 million in 2023, representing 26.9% growth. The LLM incorrectly states 2022 sales as $760 million and 2023 sales as $1.29 billion (which is actually the 2022 figure), reversing the years and misstating the figures. It also claims a 70% increase from 2022 to 2023, but the correct growth rate for that period is 26.9%; the 70% growth was from 2021 to 2022. Additionally, the breakdown into U.S. ($813M) and international ($478M) sales totaling $1.291B is accurate for 2022, but the LLM misattributes this to 2023. (2) Calculations are fundamentally flawed: the LLM implies $760M to $1.29B is ~70% growth, but this would actually be about a 69% increase, which matches the prior year’s growth, not 2022–2023. The correct 2022–2023 growth is ($2,387M - $1,291M) / $1,291M ≈ 84.9%, not 26.9% as stated in the original answer—wait, this reveals a critical discrepancy: the original answer claims 26.9% growth from $1,291M to $2,387M, but that math is incorrect. ($2,387 - $1,291) / $1,291 = 84.9%, not 26.9%. Therefore, the ground truth itself contains a calculation error. However, assuming the original answer is the ground truth regardless, the LLM still fails because it uses completely wrong base numbers and timeframes. (3) Multi-hop reasoning is poor: the model confuses the direction of growth, misassigns sales figures to years, and fails to correctly track the product's performance trajectory. It reports 2022 data as if it were 2023 results, leading to an inverted narrative. (4) Despite these severe quantitative inaccuracies, the LLM attempts to address the question’s intent—analyzing ERLEADA’s sales evolution and market trajectory—and provides a logically structured response with regional breakdowns, showing some qualitative understanding. Hence, low scores on correctness and quantitative accuracy due to wrong numbers and reversed timelines, slightly higher on qualitative for structure and relevance, and moderate on contextual relevance since it discusses the right topic with plausible framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 585,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 NVIDIA’s 0.584% Notes Due 2024 remained on the books at a $1.25 billion carrying amount with no issuance, refinancing or repayment—indicating the company’s strategy was simply to hold the low‑cost, short‑term note until its scheduled maturity. The notes were still classified as long‑term debt in the FY 2024 filing, and only in FY 2025 were they fully retired, showing a shift from maintaining the note to retiring it as part of NVIDIA’s broader debt‑management approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 0.584% Notes Due 2024 had a $1.25 billion carrying amount in both fiscal years 2023 and 2024, matching the ground truth value of $1,250 million. It accurately notes no repayment occurred in FY2023 or FY2024 and that the notes were retired in FY2025. The effective interest rate of 0.66% mentioned in the ground truth is omitted, which is a minor factual gap. (2) All numeric values—$1.25 billion (equivalent to $1,250 million)—and the note's coupon rate (0.584%) are correct. The timeline is accurate: the note remained outstanding in FY2024 and was repaid in FY2025. The only missing quantitative detail is the effective interest rate, which does not appear in the LLM answer. (3) The reasoning is sound: the model correctly infers that NVDA maintained the note through FY2024 and only retired it in FY2025, indicating a shift from holding to retiring. This aligns with the multi-hop synthesis required—comparing debt balances across two fiscal years and interpreting strategic intent. However, the LLM slightly mischaracterizes the note as 'short-term' while it was classified as long-term in FY2024, which affects nuance but not core accuracy. (4) The answer is highly relevant, directly addressing how NVDA’s debt management strategy evolved—holding initially, then retiring. The omission of the effective interest rate and slight misclassification of debt term prevent a perfect score, but the core facts, timeline, and strategic interpretation are correct. Hence, correctness is rated 8/10, with high marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 441,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\nHoneywell’s exposure to mortgage‑ and asset‑backed securities was trimmed sharply in the year‑over‑year comparison.  In the non‑U.S. pension portfolio the balance fell from **$31 million in 2022 to $10 million in 2023**, a reduction of **$21 million (≈ 68 %)**.  In the U.S. portfolio the amount dropped from **$1.119 billion to $676 million**, a decline of **about $443 million (≈ 40 %)**, meaning the company’s overall mortgage/asset‑backed securities holdings were cut by roughly **$464 million** between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell had $982 million in Mortgage/Asset-backed securities under U.S. Plans in 2022 and only $10 million under Non-U.S. Plans in 2023. However, the LLM claims $31 million in Non-U.S. Plans in 2022 and $10 million in 2023, and separately reports a drop from $1.119 billion to $676 million in the U.S. portfolio—none of which matches the ground truth. The total reduction is stated as $464 million, but the correct reduction is $972 million (from $982M to $10M), a discrepancy of over $500 million. (2) Calculations are internally consistent within the LLM's incorrect numbers (e.g., $31M to $10M is indeed ~68% drop; $1.119B to $676M is ~40%), but since the inputs are wrong, the outputs are factually incorrect. The ground truth shows a single-category shift (U.S. to Non-U.S.), not a split across both. (3) The multi-hop reasoning is flawed: the model incorrectly assumes data is available for both U.S. and Non-U.S. plans in both years and fabricates a breakdown not present in the original. It fails to recognize that the $982M (2022, U.S.) and $10M (2023, Non-U.S.) represent a complete strategic shift, not partial reductions across categories. (4) The contextual relevance is moderate—it addresses investment evolution and magnitude of change—but the qualitative and quantitative inaccuracies severely undermine correctness. The conclusion of a 'major shift' is directionally correct, but the magnitude and structure are wrong. Hence, low scores on correctness and quantitative accuracy; slightly higher for qualitative and contextual due to logical structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 460,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s securitized‑debt portfolio expanded modestly—carrying value rose from about **$16.9 billion** (2022) to **$18.0 billion** (2023)—as part of the company’s diversified wholesale‑funding strategy.  In both years these obligations were classified as **Level 2** fair‑value items (see the fair‑value hierarchy tables in the 2022 Notes to Consolidated Financial Statements, page 212, and the 2023 table on page 211), meaning their fair values were derived from observable market inputs rather than significant unobservable assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies that securitized debt obligations remained part of Capital One's diversified funding strategy and were classified under Level 2 of the fair value hierarchy in both years, which aligns with the original answer's emphasis on continued use and disclosure practices. However, the carrying value for 2022 is inaccurately stated as $16.9 billion, while the ground truth does not provide a 2022 carrying value—only noting the strategic role of securitized debt. Thus, the LLM introduces a specific number not present in the source, which undermines quantitative accuracy. The 2023 carrying value is correctly reported as $18.0 billion (rounded from $18,043 million), and the fair value of $18,067 million is omitted but approximated reasonably. (2) The calculation of growth from $16.9B to $18.0B implies a comparison not supported by the original answer, which only provides 2023 figures. This creates a false impression of year-over-year expansion without sufficient 2022 data. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the role of securitized debt in funding and its fair value classification across years. However, it overreaches by quantifying 2022's carrying value without evidence, reducing reliability. (4) Despite the numerical inaccuracy, the overall qualitative assessment—continued reliance, Level 2 classification, increased transparency—is consistent with the original. Contextual relevance is strong as all aspects of the question (funding mix role, fair value classification) are addressed appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 434,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\nJPMorgan’s CECL capital‑transition benefit fell from **$1.4 billion** in CET1 capital at the end of 2023 to **$720 million** at the end of 2024 — a **$680 million reduction** — as the benefit was fully phased‑in on 1 January 2025. This decline reflects the scheduled wind‑down of the transition provision under the U.S. capital rules, with the 2024 figure representing the remaining amount of the CECL benefit before it is completely phased out. (Pages 104 and 99)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.4 billion (2023) and $720 million (2024) are accurately reported. The reduction of $680 million ($1.4B - $720M = $680M) is correctly calculated. The date of full phase-in, January 1, 2025, is also accurate. (2) The answer addresses both parts of the question: the evolution of JPMorgan's treatment of CECL capital transition provisions (phased reduction under U.S. rules) and the quantitative change ($680 million decrease). (3) Entities are correct: JPMorgan, CET1 capital, CECL-related benefit, and the years 2023 and 2024. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the declining benefit to the regulatory phase-in schedule and correctly interprets the 2024 figure as the final step before full phase-in. The mention of specific pages (104 and 99) adds sourcing credibility. Semantic equivalence is maintained with the original answer, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 291,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the Revolving Loan Credit Agreement grew from a $3 billion unsecured revolving facility that was scheduled to mature in December 2025 (with no outstanding borrowings as of January 31 2023 and January 31 2024) to a $5 billion facility that matures in October 2029.  The 2024 amendment replaced the prior $3 billion agreement (originally entered in December 2020) with the larger, longer‑term $5 billion credit facility, while only minor administrative amendments were made in 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $3.0 billion facility in fiscal 2023 maturing in December 2025 was replaced by a $5.0 billion facility maturing in October 2029. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts and maturity dates are correct, and the mention of no outstanding borrowings as of January 31, 2023 and 2024 adds useful context not in the ground truth but does not contradict it. (3) The reasoning is sound: the LLM correctly identifies the replacement of the old agreement with a new, larger, longer-term facility, demonstrating proper multi-hop synthesis across fiscal years. It also correctly references the 2020 origin of the original agreement, which shows deeper contextual understanding. (4) The only minor shortcoming is the inclusion of administrative amendments in 2022 and 2023, which, while likely true, are not part of the original answer and slightly distract from the core evolution between 2023 and 2024. However, this does not reduce factual correctness. Overall, the answer is semantically equivalent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 338,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\nBetween 2022 and 2024 UPS’s relationship with Coyote shifted from a tightly‑integrated unit of its Supply‑Chain Solutions business—where Coyote’s truckload‑brokerage operations leveraged UPS’s own fleet, air‑freight, customs and global forwarding services—to a standalone asset that UPS sold in the third quarter of 2024.  The sale agreement generated a pre‑tax gain of **$156 million** (approximately **$152 million after tax**) that was recorded in “Other expenses” and is excluded from UPS’s ongoing operating performance metrics.  Consequently, while the divestiture removed Coyote’s recurring costs from UPS’s expense base, it produced a one‑time accounting gain that boosted 2024 earnings but did not affect the company’s core logistics profitability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the pre-tax gain of $156 million and after-tax gain of $152 million are accurately reported, with acceptable formatting (bolded but numerically correct). The timing of the sale in the third quarter of 2024 aligns with the broader 2024 divestiture timeline in the original answer. (2) The answer addresses both parts of the question: the evolution of the relationship (from integrated subsidiary to divested asset) and the financial impact in 2024 (one-time gain of $156M pre-tax). (3) Entities are correctly identified: UPS, Coyote, and the financial metrics (pre-tax and after-tax gains) are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the operational integration in 2022 with the strategic divestiture in 2024 and correctly interprets the financial statement impact, including the classification in 'Other expenses' and exclusion from core performance metrics. The answer adds contextual clarity by explaining that the gain is non-recurring and does not affect core profitability, which is consistent with but slightly more detailed than the original. Overall, the response is factually accurate, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 363,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 Union Pacific cut its chassis fleet dramatically – from **48,340 total chassis (30,635 owned + 17,705 leased)** in 2023 (page 19) to just **5,553 total chassis (4,356 owned + 1,197 leased)** in 2024 (page 20).  This sharp reduction reflects a downsizing of the chassis inventory and a shift toward a higher proportion of owned units, indicating a changed ownership structure in the chassis relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: 48,340 total chassis in 2023 (30,635 owned + 17,705 leased) and 5,553 total in 2024 (4,356 owned + 1,197 leased) match the original answer exactly. Calculations and totals are accurate. (2) The answer addresses both parts of the question—total units and ownership structure—showing a significant reduction in total chassis and a shift in composition. (3) The reasoning is sound: the model correctly synthesizes data across two years and identifies a strategic shift, particularly noting the increased proportion of owned units despite overall downsizing. (4) The only minor shortcoming is that it does not explicitly characterize the change as a 'transformation' or 'strategic shift in asset management' as in the original, slightly reducing qualitative depth. However, the core insight about changed ownership structure and reduced reliance is clearly conveyed. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—directly responsive to the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 318,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\nBoeing has continued to treat its aluminum purchase‑and‑sale agreements as derivative instruments that are **not designated for hedge accounting** – the 2024 10‑K (pages 111 and 109) explicitly lists them under “Derivatives not receiving hedge accounting treatment” and records their fair‑value changes directly in earnings.  The newer filing also **quantifies the horizon of these contracts**, stating that the commodity contracts hedge forecasted transactions **through 2028**, and provides a detailed table of notional amounts and fair values.  In contrast, the 2022 filing only described the agreements in general terms without specifying a forward‑looking time frame.  Thus, the evolution is one of greater transparency: the same classification (non‑hedge‑accounted derivatives) but with a clearly disclosed, multi‑year (to 2028) exposure and detailed quantitative disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in both 2022 and 2024, Boeing classified aluminum agreements as derivatives not designated for hedge accounting, with fair value changes recorded in earnings—this matches the original answer exactly. (2) The key evolution—disclosure of a defined time horizon through 2028 in the 2024 filing—is accurately reported, including the shift toward hedging forecasted transactions, which reflects the strategic evolution noted in the ground truth. (3) The LLM correctly identifies that the 2022 filing lacked a specific forward-looking time frame, while 2024 introduced quantitative disclosures and a multi-year horizon to 2028, demonstrating proper multi-hop reasoning across years and filings. (4) Minor deduction in qualitative accuracy due to framing the change primarily as 'greater transparency' rather than explicitly noting a strategic shift from 'strategic sourcing' to 'structured hedging'—though this nuance is implied, it is not directly articulated. All entities (Boeing, aluminum agreements, derivatives, 2022–2024), years, and financial treatments are correct. Number formats and dates (e.g., 'through 2028') are accurate. Contextual relevance is perfect—directly addresses classification and time horizon evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 371,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 P&G’s currency‑risk program showed essentially no change – it continues to manage exchange‑rate exposure primarily through short‑term forward contracts and currency swaps (typically < 18 months) that are layered onto a natural hedge across its global operations.  In both years the company states that, evaluated at a 95 % confidence level based on historical rate movements, a near‑term shift in foreign‑exchange rates would not materially affect its financial statements, reflecting unchanged confidence in its hedging approach.  (Pages 30‑33 of the 2024 Form 10‑K and the comparable discussion on pages 31‑35 of the 2023 filing.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: Procter & Gamble's currency risk exposure remained unchanged between FY2023 and FY2024; the company continues to use forward contracts and currency swaps with maturities under 18 months; and it maintains a 95% confidence level that near-term exchange rate fluctuations will not materially affect financial statements. (2) There are no numeric inaccuracies—percentages (95%), timeframes (<18 months), and fiscal years (2023 and 2024) match the ground truth exactly. Format variations (e.g., '95 %' vs '95%') are acceptable. (3) The multi-hop reasoning is sound: the answer correctly synthesizes information across two fiscal years and two types of hedging instruments, confirming consistency in strategy and risk assessment. (4) The answer is fully relevant, directly addressing the evolution (or lack thereof) in risk exposure, hedging instruments, and confidence in mitigation. Minor additions (e.g., reference to natural hedge, page numbers) enhance context without introducing error. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 324,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe expanded Frame.io from a standalone cloud‑collaboration service into a core, AI‑enhanced hub of its Creative Cloud ecosystem.  The 2024 10‑K notes that Frame.io now offers frame‑accurate commenting, Camera‑to‑Cloud upload and direct integration with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and it is bundled with Adobe Express and Firefly in GenStudio — signaling a broader functional scope and tighter product‑wide integration than in 2022.  (2022 10‑K lists Frame.io as a trademark; 2024 10‑K page 11 provides the detailed integration description.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that in 2022, Frame.io was only mentioned as a trademark in Adobe's 10-K, with no functional detail, and by 2024 it was described with expanded functionality and deep integration—this matches the original answer. (2) No numerical values (e.g., dollar amounts, percentages) are present, but the years (2022, 2024) and product names are correct and properly contextualized. The reference to '2024 10-K page 11' adds precise sourcing, which aligns with expected evidence standards. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2022 vs 2024), compares the evolution in functional scope (e.g., real-time upload, frame-accurate commenting, Camera to Cloud), and correctly identifies integration with specific Adobe products (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) and positioning within GenStudio, including bundling with Adobe Express and Firefly. (4) The answer fully addresses the question’s focus on positioning and integration evolution, functional scope expansion, and cross-product embedding. Wording differs slightly (e.g., 'AI-enhanced hub', 'bundled with Adobe Express and Firefly') but these are reasonable inferences consistent with the 'GenStudio' positioning in the ground truth. All key elements are present and correctly interpreted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 394,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\nAMD continued to account for its 15 % equity interest in the ATMP joint venture under the equity‑method both in FY 2022 and FY 2023, and the carrying amount of that investment showed no material change—it remained at the previously disclosed level of roughly $69 million (the most recent figure disclosed).  The related‑party footnote continued to disclose only the routine purchase‑and‑sale transactions, the associated receivable/payable balances, and the modest equity‑income earnings, with no new accounting policy or material‑value adjustments reported for the 2023 fiscal year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the carrying value of AMD's investment in the ATMP JV remained at roughly $69 million in FY 2023, but the ground truth states that the 2023 filing omitted any mention of the carrying value entirely—no updated or repeated figure was disclosed. This is a critical error. Additionally, the LLM incorrectly implies continuity in disclosure level, while the ground truth highlights a reduction in disclosure (specific transaction figures like $1.1B and $831M in purchases were reported in 2022 but omitted in 2023). (2) Quantitative inaccuracies include: (a) asserting the $69M figure was 'the most recent disclosed level' in 2023, when it was last disclosed in the 2022 filing for 2021; (b) failing to note that no carrying value was reported for 2023; and (c) omitting the specific transaction amounts ($1.1B in 2021, $831M in 2020) that were present in the 2022 filing but absent in 2023. (3) The reasoning is partially sound in recognizing the unchanged equity interest (15%) and accounting method (equity method), but fails the multi-hop synthesis by not contrasting the level of disclosure between the two years. The core of the question is about evolution in financial relationship and disclosure practices, which the model misunderstands. (4) Contextual relevance is high because the answer addresses AMD, ATMP JV, equity interest, and financial disclosures, but correctness and qualitative accuracy are low due to key factual and interpretive errors. The model misses the central point: reduced transparency in the 2023 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 442,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\nHoneywell’s Commercial Aviation Original‑Equipment revenue fell from **$2.397 billion in 2023 to $2.223 billion in 2024** (a decline of roughly 7 %). While this indicates a modest contraction in the OEM equipment market for commercial aviation, the broader Aerospace Technologies segment still posted strong growth—net aerospace sales rose from $13.6 billion in 2023 to $15.5 billion in 2024—showing that Honeywell’s overall aerospace business remains robust and diversified, even as its original‑equipment sales face slight pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Honeywell's Commercial Aviation Original Equipment revenue as $2.397 billion in 2023 and $2.223 billion in 2024, matching the ground truth of $2,397 million and $2,223 million (equivalent values, different units). The calculated decline of approximately 7% is accurate: (2,397 - 2,223) / 2,397 ≈ 7.26%. (2) The answer addresses both parts of the question: the revenue evolution and its implication for Honeywell’s position in the aerospace sector. It correctly notes the decline in OEM revenue while contextualizing it within broader aerospace growth, citing overall Aerospace Technologies sales rising from $13.6B to $15.5B, which aligns with external filing data (though this specific figure wasn't in the ground truth, it does not contradict it and supports valid reasoning). (3) All entities—Honeywell, Commercial Aviation Original Equipment, years 2023 and 2024—are correctly identified. The metric 'revenue' is accurately used. (4) The reasoning is sound: the model correctly infers that a decline in OEM revenue amid overall aerospace growth suggests relative weakness in that segment, possibly due to demand or supply factors, which matches the ground truth's interpretation of 'potential weakening or supply constraints.' The only minor shortcoming is that the LLM attributes the broader growth to 'net aerospace sales' without explicitly naming the Aerospace Technologies division as in the original, but the context and implication remain semantically equivalent. No factual errors; excellent quantitative and contextual accuracy with slightly less precise terminology in one phrase, warranting a 9/10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 460,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\nThe Heart‑Failure device business grew from **$1.161 billion in 2023 to $1.279 billion in 2024**.  That increase of $118 million represents a **≈10.2 % rise in total segment revenue** over the one‑year period.  (The 10.2 % change is reflected in the “Total %Change” column for Heart Failure in the 2024‑vs‑2023 comparison.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: 2023 revenue is correctly stated as $1.161 billion (equivalent to $1,161 million), and 2024 revenue is $1.279 billion ($1,279 million). The percentage change is accurately calculated and reported as ≈10.2%, matching the ground truth. (2) Quantitative accuracy is perfect: the dollar amounts are correctly converted between millions and billions, and the 10.2% increase is consistent with the calculation (1,279 - 1,161) / 1,161 ≈ 0.1016, or 10.2% when rounded. (3) The reasoning is sound—though the LLM references a 'Total %Change' column (likely from a source table), it does not contradict the ground truth and supports correct multi-hop synthesis of year-over-year revenue data. (4) While the LLM omits the additional context about U.S. and international market performance and exchange rate impacts, the core of the question—evolution of revenue and percentage change—is fully addressed with precise, correct figures. The omission of minor contextual details does not detract from factual correctness or completeness of the primary request. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 337,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\nIn the 2022 10‑K the 0.300 % Notes due 2028 were only noted in the Exhibits section (page 35), where IBM pointed to the original 2020 Form 8‑K that created the indenture. In the 2023 10‑K the same securities appear in the “Securities registered pursuant to Section 12(b)” table (listed as IBM 28B) and the exhibit reference is updated to a February 8, 2022 Form 8‑K, showing that IBM moved the notes from a peripheral exhibit citation to a primary registration disclosure and used a more recent governing document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, the 0.300% Notes due 2028 were referenced via incorporation by reference to a Form 8-K, and in 2023 they were explicitly listed in the Section 12(b) registration table with trading symbol IBM 28B. The shift from peripheral exhibit citation to formal registration is correctly interpreted. (2) Quantitative elements—interest rate (0.300%), maturity year (2028), and dates (February 10, 2020, in original; LLM says February 8, 2022, for updated exhibit)—are factually consistent with typical disclosure evolution, though the ground truth does not specify the 2022 Form 8-K date. This minor discrepancy (Feb 8 vs Feb 10, 2020) does not affect the core accuracy, as the focus is on the evolution in treatment, not the exact date of the original filing. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure location (from exhibits to registration table), increased prominence, and implications of formal exchange listing. (4) Semantic equivalence is strong—'peripheral exhibit citation to primary registration disclosure' captures the same evolution as 'general incorporation by reference to explicit disclosure and formal registration.' The only minor shortcoming is slightly less precise detail on the original exhibit reference date, but this does not undermine the overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 421,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023, net sales in Apple’s **Rest of Asia Pacific** segment edged up from **$29.38 billion to $29.62 billion** (≈ 0.8 % growth), while operating income rose more sharply from **$11.57 billion to $12.07 billion** (≈ 4.3 % growth). This indicates that the region’s revenue growth was modest, but profitability improved appreciably over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key financial figures are accurate: net sales increased from $29.38 billion (≈ $29,375 million) in 2022 to $29.62 billion (≈ $29,615 million) in 2023, reflecting a $240 million increase (0.8% growth); operating income rose from $11.57 billion (≈ $11,569 million) to $12.07 billion (≈ $12,066 million), a $497 million increase (4.3% growth). Minor rounding differences ($29.38B vs $29,375M) are acceptable and common in financial reporting. (2) Calculations are correct: 0.8% and 4.3% growth rates match the ground truth. (3) Multi-hop reasoning is sound—information from two years and two financial metrics (net sales and operating income) across the 'Rest of Asia Pacific' segment is correctly synthesized. (4) The answer addresses all parts of the question: evolution of financial performance, changes in both net sales and operating income, and the implied conclusion about modest revenue growth but stronger profitability improvement. Wording differs slightly but meaning is preserved. All entities (Apple, Rest of Asia Pacific, 2022–2023, net sales, operating income) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 333,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\nThe filings show a clear shift in the option‑vesting rule: options awarded **before 2022** under the 2007 Omnibus Incentive Plan were scheduled to vest **pro‑rata over a five‑year period** (with a ten‑year expiry), while **options awarded after December 31, 2021** (i.e., in 2022 and later) are set to vest **pro‑rata over a four‑year period** (also with a ten‑year expiry), subject to the same exceptions for executive officers and other specially‑treated employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitatively, all key details are accurate: stock options granted before 2022 (i.e., prior to January 1, 2022) vest pro rata over five years; those granted after December 31, 2021 (i.e., starting January 1, 2022) vest pro rata over four years. The mention of a ten-year expiry, while not in the original answer, is consistent with typical option terms and does not contradict the ground truth. (2) The core numbers—five-year vs. four-year vesting periods and the 2022 cutoff—are correct and match disclosures in both the 2022 and 2024 10-Ks. (3) The reasoning correctly synthesizes multi-hop information: it distinguishes between pre- and post-2021 grants, references the 2007 Omnibus Incentive Plan, and infers a structural change in vesting terms. (4) The only minor shortcoming is that the LLM does not explicitly cite the 2024 10-K confirmation (as the original answer does), but it correctly states the ongoing vesting terms, implying consistency through recent filings. The answer is semantically equivalent and highly relevant, with excellent contextual precision. Thus, the correctness score is 9 due to slight incompleteness in sourcing across both filings, though the factual content is fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 360,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\nFrom 2022 to 2023 CVS kept the same validation routine for its Level 2 debt securities.  The company continues to obtain a single external price for each security, performs a quarterly comparison of that price with a secondary source, flags any variance that exceeds a preset threshold, and only revises the price if the secondary source shows a material discrepancy.  CVS explicitly stated that it “did not adjust any of those prices” at the end of both 2022 and 2023, indicating that the methodology and the use of secondary‑source checks were unchanged over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that CVS obtained one price per Level 2 debt security and did not adjust any prices at year-end for both 2022 and 2023, which matches the original answer. The quarterly comparison to secondary sources and threshold-based variance review are accurately described. (2) All dates (2022, 2023) and factual claims (no price adjustments, use of single external price, secondary source checks) are factually correct and consistent with the ground truth. There are no numerical inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and validation steps, concluding that the methodology remained unchanged. The only minor shortcoming is that the LLM slightly overemphasizes the possibility of price revision 'if the secondary source shows a material discrepancy,' which is not explicitly confirmed in the original answer—though it's a reasonable inference. The original answer notes that no adjustments were made, but doesn't specify under what conditions they would be. (4) Despite this small interpretive leap, the answer is contextually precise, directly addressing the evolution (or lack thereof) in CVS's approach. Overall, the response is factually robust, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 378,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\nCVS continued to treat its privately‑placed equity securities as Level 3 in both 2022 and 2023, and the fair‑value approach remained an internal analysis of each investment’s financial statements and cash‑flow projections (page 181). The valuation still relied on significant unobservable inputs—principally earnings and revenue multiples, a discount for lack of marketability and comparability adjustments—so the methodology did not change materially; only the specific assumptions underlying those inputs varied from year to year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023, and correctly identifies the use of internal analysis of financial statements and cash flow projections for fair value determination. The significant unobservable inputs—earnings and revenue multiples, discount for lack of marketability, and comparability adjustments—are correctly listed. (2) There are no numeric values or calculations in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but all factual assertions about methodology are consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and identifies continuity in methodology. However, the LLM answer omits a key qualitative evolution noted in the original answer: in 2023, CVS placed 'added emphasis on the potential impact of changes in these inputs on fair value measurements,' indicating enhanced sensitivity analysis or scrutiny. This nuance is missing, which slightly weakens the qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and factually accurate in all other aspects, warranting high scores in contextual relevance and overall correctness. The absence of this detail prevents a perfect score, but the core facts and reasoning are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 400,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\nThe combined net revenue from Alphagan/Combigan fell from **$272 million in 2023 to $248 million in 2024**, a decline of about **8.8 %** (or 5.4 % at constant currency).  During the same period the **international portion edged up**, rising from **$151 million in 2023 to $153 million in 2024**—an increase of roughly **1.5 %** in actual terms (about **7.6 %** on a constant‑currency basis).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all core factual data: total net revenue decreased from $272 million in 2023 to $248 million in 2024 (8.8% decline), and international revenue increased from $151 million to $153 million (1.5% growth). These values match the ground truth exactly in actual terms.\n\n2) Quantitative accuracy is perfect for reported actual figures. The percentages (8.8% and 1.5%) are correctly calculated: (272-248)/272 ≈ 8.8%, and (153-151)/151 ≈ 1.5%. The additional constant-currency figures (5.4% and 7.6%) are not present in the ground truth but are plausible supplementary data that do not contradict the primary facts.\n\n3) The multi-hop reasoning is sound—LLM correctly synthesizes revenue trends across two years and two geographies (total vs. international). The inclusion of constant-currency metrics suggests deeper financial reporting context, which enhances rather than detracts from accuracy, as long as actual results are preserved (which they are).\n\n4) Semantic equivalence is maintained. The core answer fully addresses both parts of the question: total revenue change and international revenue trend. The extra detail on constant currency is common in financial reporting and does not mislead.\n\nJustification: Score is 9 instead of 10 because the LLM introduces constant-currency figures not present in the ground truth, which, while likely accurate, go beyond the verified data. However, since the primary metrics (actual-dollar amounts and growth rates) are exactly correct and clearly presented, the answer remains highly accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 434,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\nChevron’s ties with PDC Energy shifted from the completion of the acquisition in 2023 to a fully integrated component of its 2024 operations, with Chevron treating PDC’s Permian assets as a core growth engine.  The integration delivered an estimated 405 k bbl/d of crude and 1.6 bcf/d of gas from the Permian, drove a 7 % rise in worldwide oil‑equivalent production to 3.3 million bbl/d, and added roughly 70 million BOE of purchased undeveloped locations and other reserve extensions, directly boosting overall production performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Chevron's relationship with PDC Energy from acquisition in 2023 to integration in 2024 and links it to production growth, which aligns with the ground truth. The 7% increase in worldwide oil-equivalent production is accurately cited and matches the original answer. However, the LLM introduces specific quantitative figures not present in the ground truth: '405 k bbl/d of crude', '1.6 bcf/d of gas', '3.3 million bbl/d', and '70 million BOE of purchased undeveloped locations'. These numbers, while plausible, are not supported by the original answer and represent over-specificity or potential hallucination. (2) The percentage (7%) and year references (2023 acquisition, 2024 integration) are correct. The production increase is correctly attributed to PDC’s full-year contribution, but the additional metrics (daily production volumes, reserve additions) lack corroboration in the ground truth and reduce quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers that the acquisition led to integration, which in turn drove production growth. It synthesizes the timeline and operational impact logically, showing PDC as a growth engine—consistent with the 'integral operational component' described in the original. (4) Despite the unsupported specifics, the core facts—acquisition in 2023, integration in 2024, and contribution to 7% production growth—are correct. The answer is contextually excellent and semantically aligned in intent, but the inclusion of unverified granular data prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 451,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved from building cold‑chain capacity to integrating it, primarily by acquiring **Bomi Group** and **MNX Global Logistics** in 2023—both specialists in temperature‑controlled healthcare and time‑critical logistics—and then using those assets to expand its cold‑chain network within Supply Chain Solutions.  In 2024 the company continued to integrate those businesses and announced the **planned acquisition of Frigo‑Trans and Biotech & Pharma Logistics** (signed in January 2025) to further strengthen its international cold‑chain capabilities.  Thus, the key acquisitions that drove the evolution are **Bomi Group, MNX Global Logistics, and the forthcoming Frigo‑Trans/Biotech & Pharma Logistics deal**.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key acquisitions driving UPS's cold-chain evolution—Bomi Group and MNX Global Logistics in 2023, and Frigo-Trans and Biotech & Pharma Logistics in 2024. However, it inaccurately states that the Frigo-Trans and Biotech & Pharma Logistics acquisition was 'signed in January 2025,' which contradicts the original answer implying the deal occurred in 2024. This misstatement of the date reduces quantitative accuracy. Additionally, the original answer specifies the $440 million price tag for the German acquisitions, which the LLM omits, representing a missing quantitative detail. (2) While the $440 million figure is absent and the 2025 date is incorrect, no incorrect calculations are made—only factual omissions and a date error. Other dates (2023 acquisitions) are correctly attributed. (3) The multi-hop reasoning is strong: the LLM synthesizes the strategic shift from 2023 to 2024, correctly framing the evolution from building capacity to integrating and expanding internationally. It accurately links the acquisitions to enhanced cold-chain logistics, particularly in healthcare, and recognizes the international expansion focus in 2024. (4) Despite the date error and missing dollar amount, the core facts and strategic narrative align with the ground truth, warranting a high correctness score. The answer is contextually fully relevant, addressing both the evolution and the contributing acquisitions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 403,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\nBetween 2022 and 2024 Linde formalised its non‑employee director equity program by moving from the generic RSU language in the 2021 LTIP (Exhibit 10.0e) to a dedicated, Board‑approved **Non‑employee Director Deferral Program** (adopted 30 July 2024, Exhibit 10.16) and a **second amendment to the Compensation Deferral Program** that took effect 1 January 2024 (Exhibit 10.08b).  The new structure, overseen by the Compensation Committee, adds explicit deferral periods, performance‑linked vesting triggers and longer holding requirements for director awards, thereby tightening governance oversight and aligning director compensation with long‑term shareholder value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and overstatements. (1) Quantitatively, the key date of July 30, 2024, for the adoption of the Non-employee Director Deferral Program is accurate. However, the LLM references a 'second amendment to the Compensation Deferral Program' effective January 1, 2024 (Exhibit 10.08b), which is not mentioned in the ground truth and may conflate employee and non-employee programs—this introduces a factual overreach. (2) The original answer confirms the 2022 introduction under the 2021 LTIP and the 2024 deferral program adoption, both of which are correctly identified. The LLM correctly notes enhanced governance and long-term alignment, but adds specifics like 'performance-linked vesting triggers' and 'longer holding requirements' not explicitly stated in the ground truth, which only mentions deferral of receipt. These additions, while plausible, are not supported by the provided truth and represent an extrapolation. (3) The reasoning is multi-hop and logically sound—connecting the evolution from basic RSUs to a deferral mechanism to strengthen governance and shareholder alignment—but slightly over-interprets the sophistication of the 2024 changes. (4) Despite minor embellishments, the core evolution is accurately captured: a move toward stronger governance and long-term alignment via deferral. Wording differs but semantic meaning is largely equivalent. The answer is highly relevant and addresses both governance structure and shareholder alignment as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 429,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\nBetween 2022 and 2024 the only remaining financial link between GM and Stellantis is the indemnification clause that GM assumed in the 2017 sale of Opel/Vauxhall to PSA (now Stellantis).  Under that agreement GM continues to indemnify Stellantis for certain breach‑of‑representation, emissions‑related and recall liabilities, but the obligations are capped, time‑limited and, as of the 2024 filing, have produced only immaterial payments (e.g., for Takata‑related recalls); GM cannot quantify any additional exposure and therefore records no material loss or gain from these indemnities.  Consequently, GM’s relationship with Stellantis has not generated any material investment‑related earnings during the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misses a key fact from the original answer, leading to a partially incorrect synthesis. (1) Quantitatively, the LLM correctly states that indemnification obligations are capped, time-limited, and have resulted in immaterial payments as of 2024, which aligns with the ground truth. However, it fails to mention the $0.2 billion gain GM reported in 2022 from Stellantis warrants—a critical financial event explicitly highlighted in the original answer. This omission undermines the multi-hop comparison between 2022 (positive gain) and 2024 (legal risks). (2) The LLM incorrectly claims that 'the only remaining financial link' is indemnification, contradicting the 2022 warrant gain, which represents a direct investment-related financial relationship. (3) While the LLM accurately describes the indemnification terms and their limited impact as of 2024, it does not acknowledge the evolution from financial benefit (2022 gain) to legal risk (2024 disclosures), which is the core of the question’s multi-hop reasoning. (4) The answer is contextually relevant and uses accurate terminology (e.g., 'indemnify,' 'emissions-related liabilities'), but the failure to incorporate the 2022 gain results in an incomplete and misleading narrative about the evolution of the relationship. Thus, while factually sound on the indemnification aspect, the LLM misses a pivotal element of the financial evolution, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 408,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\nFrom 2022 to 2024 Southern Company shifted from a brief, narrative description of hedge accounting (see 2022 10‑K pages 326‑327, which only noted cash‑flow and fair‑value hedge impacts on income) to a full, quantitative footnote that separates energy‑related derivatives into three distinct categories—regulatory hedges, cash‑flow/fair‑value hedges, and non‑designated contracts—and presents each at fair value with Level‑1/2/3 classifications, current‑vs‑non‑current balances, and explicit volume and longest‑hedge‑date disclosures (2024 pages 278, 281, 283). The 2024 filing also explicitly links regulatory‑hedge gains/losses to regulatory assets and liabilities and states that cash‑flow hedge reclassifications to earnings are immaterial, providing far richer financial‑statement presentation and categorization than the earlier, more limited disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, correct evolution of Southern Company's treatment and disclosure of energy-related derivatives from 2022 to 2024. It correctly identifies the shift from income statement-focused disclosures in 2022 (mentioning hedge impacts on income) to a more comprehensive, balance sheet-oriented presentation in 2024, including fair value categorization, current vs. non-current breakdowns, and Level 1/2/3 classifications. The specific mention of 'regulatory hedges' being linked to regulatory assets/liabilities aligns with the ground truth's emphasis on categorization under 'Risk Management Activities'. The LLM adds granular detail not in the original answer—such as footnote locations (pages 278, 281, 283), volume disclosures, and immaterial reclassifications—which is consistent with a deeper analysis of the filings and enhances accuracy without contradicting the ground truth. All entities (Southern Company, years 2022 and 2024, energy-related derivatives) are correct. There are no calculation errors (no numerical computations required), and the reasoning reflects sound multi-hop synthesis across years and disclosure types. The only reason for not scoring a 10 is that the original answer emphasizes the shift from 'income statement' to 'balance sheet' focus as a high-level theme, which the LLM supports but does not explicitly summarize in those exact terms—though the content is semantically equivalent. Wording differences are acceptable under semantic equivalence. All information is contextually relevant and directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 438,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\nBetween the end of 2023 and January 2024 Gilead’s stake in Arcus Biosciences rose from roughly 19.9 % (about 14.8 million shares) to approximately 33 % after a $320 million equity investment, thereby deepening its economic exposure.  The amendment to the collaboration agreement also increased Gilead’s board representation at Arcus from two to three designees and kept in place the right to purchase up to 35 % of Arcus’s voting stock over the next five years, enhancing Gilead’s governance influence over the partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in GILD's ownership from 19.9% to 33% following a $320 million equity investment in January 2024, and accurately notes the expansion of board representation from two to three designees. These facts align perfectly with the ground truth. The mention of the right to purchase up to 35% over five years is an additional detail not present in the original answer but does not contradict it and may reflect forward-looking provisions in the agreement. (2) All numeric values—19.9%, 33%, $320 million, two to three designees—are factually correct and match the ground truth. The reference to 14.8 million shares is a precise detail not in the original but does not conflict and may be derived from public filings; it does not detract from accuracy. (3) The multi-hop reasoning is sound: the model connects equity ownership, governance changes, and timing (end of 2023 to January 2024) correctly, synthesizing financial and governance dimensions across time. (4) The answer is semantically equivalent to the ground truth, with slightly more detail. The only minor gap is that the original emphasizes the 'significant increase in financial commitment and governance influence,' which the LLM implies but does not explicitly characterize—hence a 9 instead of 10 on qualitative accuracy. Otherwise, all key facts are present, accurate, and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 391,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\nThe 2021 Multicurrency Credit Facility’s maturity was extended – it moved from a June 30 2025 maturity (the date in effect through 2022 after the Dec 8 2021 amendment) to a July 1 2026 maturity following the June 29 2023 amendment.  At the same time the total commitment stayed at **$6.0 billion** (with a $3.5 billion multicurrency sub‑limit, $200 million letter‑of‑credit sub‑limit and $50 million swingline sub‑limit), so borrowing capacity remained $6 bn but the loan’s maturity was pushed out an additional year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the maturity date correctly shifts from June 30, 2025 (as in effect in 2022) to July 1, 2026 (after the June 29, 2023 amendment), and the borrowing capacity remains at $6.0 billion, which aligns with the original answer. Sub-limit details ($3.5B multicurrency, $200M letter of credit, $50M swingline) are additional but accurate and do not contradict the core $6.0B total commitment. (2) The answer is complete, addressing both parts of the question—evolution of maturity date and borrowing capacity—between 2022 and 2023. (3) Entity accuracy is correct: the facility name, years (2022 vs 2023), and financial terms are properly identified. (4) Reasoning is sound: the LLM correctly infers a one-year extension in maturity while noting unchanged capacity, demonstrating proper multi-hop synthesis across time points and amendments. (5) Semantic equivalence is strong—the wording differs slightly but conveys the same core facts and implications as the original answer. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 325,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\nChevron kept the share of imported crude in its U.S. refinery feedstock essentially unchanged – about 60 percent of the crude processed in both 2023 and 2024.  At the same time, overall refinery utilization slipped: U.S. crude‑unit capacity utilisation fell from roughly 90.8 percent in 2023 to 86.6 percent in 2024 (and total system utilisation dropped from 89.8 percent to 87.9 percent), reflecting a modest reduction in operating rates despite the steady imported‑crude mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron's use of imported crude oil remained at ~60% in both 2023 and 2024, and U.S. crude unit capacity utilization decreased from 90.8% in 2023 to 86.6% in 2024—matching the original answer exactly. The LLM also adds supplementary detail about total system utilization (89.8% to 87.9%), which is consistent with the trend and adds context without contradicting the ground truth. (2) Quantitative accuracy is perfect: all percentages and years are correctly reported, and no calculation errors are present. (3) The multi-hop reasoning is sound—correctly linking stable imported crude input with declining refinery utilization across two years. (4) The only minor deviation is the inclusion of total system utilization, which was not in the original answer, but this does not detract from correctness and may enhance completeness. The core entities (Chevron, U.S. refining operations, crude oil, years) are correctly identified. Semantic equivalence is maintained, with slightly more detail in the LLM response. Thus, a high score of 9 is warranted—excellent accuracy with a small addition beyond the ground truth that doesn't affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 349,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\nUPS reduced its explicit British‑Pound‑sterling hedge from **$856 million in 2022 to $663 million in 2023 and further to $536 million in 2024** (pages 130 & 137).  This downward trend shows the company is scaling back its GBP‑focused derivative coverage, indicating a strategic shift toward relying more on natural currency exposure management (e.g., revenue‑based hedges) and a reassessment of foreign‑exchange risk rather than maintaining large notional hedge positions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2023 and 2024 GBP hedge positions as $663 million and $536 million, matching the ground truth. The reduction of 127 million units (19.15%) is accurate. However, the LLM introduces a 2022 figure ($856 million) not present in the original question or ground truth, which, while possibly factual, is extraneous and not requested. 2) Quantitative accuracy is high: the 2023 and 2024 values are correct, and the implied decrease is accurate. No calculation errors are present, though the added 2022 data could mislead if not properly contextualized. 3) The reasoning is sound: the answer correctly infers a strategic shift in currency risk management, aligning with the ground truth's interpretation of reduced exposure and reassessment of GBP risk. It adds value by suggesting a move toward natural hedges, which is a plausible and insightful extension of the data. 4) The answer is highly relevant, addressing both the evolution of the hedge position and the strategic implication. The extra 2022 data slightly detracts from precision but does not undermine correctness. Overall, the answer is factually accurate on the required years and provides valid qualitative insight, warranting a high score with minor deduction for introducing unrequested data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 359,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\nThe fair‑value of Bank of America’s money‑market holdings rose from **$868 million at the end of 2023 to $1.3 billion at the end of 2024** (≈ 50 % growth).  This increase reflects a deliberate shift toward a larger, more liquid cash‑equivalent position—likely to preserve liquidity, capture higher short‑term yields in a rising‑rate environment, and reduce exposure to longer‑duration interest‑rate risk in the bank’s short‑term investment strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the 2023 value: it reports $868 million instead of the correct $1.2 billion from the ground truth. The 2024 value is correct at $1.3 billion. This leads to an incorrect 50% growth calculation; the actual increase is from $1.2B to $1.3B, which is approximately an 8.3% increase, not 50%. (2) Quantitative accuracy is low due to the incorrect base value and resulting miscalculation of growth. While $1.3 billion in 2024 matches the ground truth, the $868 million figure for 2023 is unsupported and materially understates the original amount. (3) The qualitative reasoning is sound—the interpretation that the increase reflects a strategic shift toward greater liquidity and yield capture in a rising rate environment is plausible and aligns with typical financial logic. The model correctly identifies the implication of such a move on short-term investment strategy, showing appropriate multi-hop synthesis between observed financial changes and strategic intent. (4) Contextual relevance is high because the answer addresses both parts of the question: the evolution of fair value and its strategic implication. Despite incorrect numbers, the structure, intent, and direction of reasoning are appropriate. However, the major numerical inaccuracy in the starting value severely undermines overall correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 385,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\nThe “maximum expected volume” of natural‑gas supply contracts with a sell‑back feature fell sharply – from roughly **26 million mmBtu** in the 2022 filing (which reports the 2021 levels) to about **15 million mmBtu** in the 2024 filing.  Accordingly, each subsidiary’s share dropped from **6 mmBtu (Alabama Power), 8 mmBtu (Georgia Power), 4 mmBtu (Mississippi Power) and 8 mmBtu (Southern Power)** in 2022 to **4 mmBtu, 6 mmBtu, 2 mmBtu and 3 mmBtu**, respectively, in 2024.  (Pages 319 of SO_10k_2022.pdf and 281 of SO_10k_2024.pdf.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: the total volume decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024, with subsidiary volumes matching exactly—Alabama Power (6 to 4), Georgia Power (8 to 6), Mississippi Power (4 to 2), and Southern Power (8 to 3). Minor formatting variation (e.g., 'mmBtu' vs 'million mmBtu') is acceptable and does not affect meaning. (2) Calculations are accurate: totals sum correctly (6+8+4+8=26; 4+6+2+3=15), and the direction of change (decrease) is correctly stated. (3) Multi-hop reasoning is sound—the model correctly synthesized data across Southern Company’s subsidiaries and across years, demonstrating proper cross-entity and cross-time analysis. (4) The only minor issue is a potentially confusing parenthetical note stating 'the 2022 filing (which reports the 2021 levels)', which is not supported in the ground truth and could mislead about the time period; otherwise, entity names, years, and metrics are correctly identified. Despite this small clarification issue, the answer remains factually aligned with the ground truth in all key aspects. Hence, a score of 9 is warranted—excellent accuracy with a minor qualification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 354,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe moved the Firefly Vector Model from a single experimental feature in Illustrator (2023 – Generative Recolor and text‑to‑vector generation) to a broadly embedded capability across the Creative Cloud suite.  In 2023 it appeared in Illustrator, Fresco and Adobe Express, delivering editable vectors with Content Credentials; by 2024 the model powered vector generation in additional apps (e.g., Acrobat, Stock, and the web‑based Firefly Editor), was packaged with enterprise‑focused Firefly Services and Custom Models (including indemnification), and was monetised through a paid Generative‑Credits subscription plan, markedly expanding both the breadth of integration and the commercial‑ready AI workflow.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the evolution of the Firefly Vector Model. (1) The ORIGINAL ANSWER states that in 2023, the Firefly Vector Model was integrated into Adobe Express, enabling text-to-image and text effects in over 100 languages. However, the LLM claims it was first used in Illustrator in 2023 for Generative Recolor and text-to-vector generation—this is incorrect. According to ground truth, the integration into Illustrator occurred in 2024, not 2023. (2) The LLM incorrectly asserts that the model was present in Illustrator, Fresco, and Adobe Express in 2023, which contradicts the ground truth stating a 2023 launch only in Adobe Express. (3) The mention of Acrobat, Stock, and the web-based Firefly Editor in 2024 is not supported by the original answer, which only confirms expansion to Illustrator in 2024. (4) While the original answer highlights a meaningful functional expansion (e.g., Generative Recolor in Illustrator), the LLM introduces unverified details like 'Content Credentials', 'enterprise-focused Firefly Services', 'Custom Models with indemnification', and 'Generative-Credits subscription plan'—none of which are in the ground truth. (5) Quantitatively, there are no explicit numbers to verify (e.g., dollar amounts, percentages), so the score is based on correct use of years and app names—partially accurate but with key misplacements. (6) The reasoning is structured logically (evolution over time, broadening scope), but the multi-hop synthesis fails because it misattributes features and timelines across products. (7) Contextual relevance is high as the response attempts to trace integration across years and products, aligning with the question's intent. However, due to major factual errors in entity, year, and feature mapping, the overall correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 506,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\nBiktarvy’s sales grew from $10.4 billion in fiscal 2023 ( $8.5 bn U.S., $1.1 bn Europe, $0.8 bn other – page 65, 2023 10‑K) to $11.9 billion in fiscal 2024 ( $9.7 bn U.S., $1.3 bn Europe, $0.9 bn other – page 21, 2024 10‑K), a roughly 14 % increase and now representing the bulk of Gilead’s HIV product revenue.  This continued expansion reinforces Gilead’s HIV‑focused strategy of protecting the franchise through price‑management and rebate‑optimization while investing in next‑generation HIV therapies to sustain long‑term growth amid pricing‑pressure and competition risks (pages 18, 69, 88).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states Biktarvy sales grew from $10.4 billion in 2023 to $11.9 billion in 2024, but the ground truth reports $11,850 million ($11.85 billion) in 2023, not $10.4 billion. The $10.4 billion figure actually corresponds to 2022 sales, not 2023. This misalignment leads to an incorrect growth narrative: the LLM implies growth from 2023 to 2024, but the ground truth shows growth from 2022 to 2023, with no 2024 sales data provided in the original answer. The 14% growth calculation is therefore based on incorrect year assignments and is factually wrong. (2) The LLM fabricates a 2024 sales figure of $11.9 billion, while the original answer does not provide 2024 sales—only a qualitative note about increased risks. This is a major factual error. (3) On qualitative reasoning, the LLM correctly identifies Biktarvy as central to GILD’s HIV business and references strategic efforts like price management and investment in next-gen therapies, which aligns with the original answer’s implication of strategic pressure. However, it misses the key point in the ground truth that GILD highlighted increased risks due to generic competition and shifting treatment paradigms in 2024, which is central to the strategic implication. Instead, it downplays risks by emphasizing continued sales growth. (4) Contextually, the answer is well-structured and relevant, addressing both commercial significance and strategy. However, due to the critical error in reversing the years and inventing a 2024 sales number, the correctness score is significantly reduced. Quantitative accuracy is low due to incorrect figures and misattributed years. Qualitative accuracy is moderate as reasoning is sound but based on flawed data. Contextual relevance is high as the response stays on topic and attempts multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 508,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\nThe Series 2018‑1A Securities continued to carry a fixed interest rate of **3.652 %** and an anticipated repayment date of **15 March 2028**.  At the end of 2022 the outstanding principal was **$496.1 million**, and by the end of 2023 it had risen slightly to **$496.8 million**—a modest increase that reflects only minimal amortization and no change in the coupon.  (2023 10‑K, p. 108; 2022 10‑K, p. 117)",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative values. According to the ground truth, the 2022 outstanding principal was $500.0 million, but the LLM incorrectly states it was $496.1 million. This is a material discrepancy of nearly $4 million. Additionally, while the 2023 principal of $496.8 million matches the ground truth, the LLM interprets the change as an increase, when in fact it should reflect a decrease from a higher 2022 value. The interest rate of 3.652% is correctly reported. (2) The numbers are not accurate: the 2022 principal is wrong, and the direction of change (increase vs. decrease) is incorrect, undermining the financial interpretation. The cited documents (2023 and 2022 10-Ks) may be correct, but the data extracted is inconsistent with the ground truth. (3) The multi-hop reasoning is partially sound in that the model attempts to compare two years and draw a conclusion about amortization, but the flawed input data leads to an incorrect conclusion. The model fails to correctly synthesize the evolution of the principal, misrepresenting a reduction as a slight increase. (4) Contextual relevance is high because the answer addresses the required elements—principal, interest rate, and time evolution—and includes appropriate context like the maturity date. However, due to major quantitative inaccuracies and the resulting flawed interpretation, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 402,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved Coyote from a core, growth‑focused acquisition (bought in 2022) to a non‑strategic unit that was impairing and then sold.  In 2023 the company recorded a $111 million impairment to the Coyote trade‑name and $119 million of goodwill/asset write‑downs, while the business still contributed roughly $800 million of revenue and $950 million of operating expenses.  In September 2024 UPS divested Coyote, recognizing a $156 million gain on the sale and eliminating the $806 million of revenue and $949 million of expenses that had dragged down its Supply‑Chain Solutions segment, thereby reshaping the business toward higher‑margin logistics and forwarding operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in financial figures not present in the ground truth. While the $111 million impairment charge for the Coyote trade name in 2023 is correct, the additional claim of $119 million in goodwill/asset write-downs is not supported by the original answer and introduces unverified data. The original answer does not mention Coyote's revenue ($800M) or operating expenses ($950M) in 2023, nor does it state a $156 million gain on sale in 2024—these figures are absent from the ground truth. The $806 million revenue elimination is close to the implied $800M but presented with false precision and unsupported context. (2) The date of divestiture (September 2024) is correctly identified and aligns with the original answer. However, the financial impact of the divestiture is overstated with speculative numbers. The original answer only states that Coyote's exit contributed to a decrease in Supply Chain Solutions revenue, not specific revenue or expense figures or a gain on sale. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift from impairment in 2023 to divestiture in 2024, which is consistent with the original answer. It correctly identifies the evolution in strategic direction. However, the reasoning is undermined by the inclusion of fabricated financial details, weakening the overall factual synthesis. (4) The contextual relevance is high—the answer directly addresses the evolution of the relationship in both financial and strategic terms. The qualitative reasoning about shifting toward higher-margin logistics is a reasonable inference, though not explicitly stated. Due to significant quantitative inaccuracies despite correct timeline and strategic interpretation, the correctness score is 6—partially correct but with major factual overreach in financial details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 509,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\nFrom 2019 onward Linde’s Performance Share Unit awards were tied to two distinct performance metrics—Return on Capital (ROC) for one tranche and Total Shareholder Return (TSR) for the other. Between 2022 and 2024 the company made only procedural updates (the 2020 amendment and the January 2024 third amendment to the 2009 Long‑Term Incentive Plan) that refined the award language but left the underlying ROC and TSR metrics unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Linde plc maintained two performance metrics for Performance Share Unit Awards from 2019 through 2024: Return on Capital (ROC) and Total Shareholder Return (TSR). This matches the original answer's claim about the dual structure being preserved. (2) The dates and amendments referenced (2020 amendment, January 2024 third amendment) are consistent with procedural updates and do not contradict the ground truth; while the original answer focuses on exhibit numbers (e.g., 10.11k, 10.10l), the LLM emphasizes the continuity of metrics despite plan refinements—this is semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly links the 2019 grant structure to its persistence in 2022–2024, synthesizing across years and plan updates. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly reference the exhibit numbers or directly tie the 2024 structure to the same forms as the 2019 grants using document evidence (e.g., exhibit correspondence), which was a key supporting detail in the original. However, the conclusion about no change in metrics is correct. Overall, the answer is contextually relevant, quantitatively precise, and substantively aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 375,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\nBetween 2023 and 2024 the FDA moved Trodelvy from an accelerated‑approval setting into a broader, full approval for HR⁺/HER2⁻ metastatic breast cancer (including EC approval), and granted it a Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer, while also extending its label in Europe. These regulatory advances reflect a clear development trajectory toward expanding Trodelvy’s indications and reinforcing confidence in its clinical benefit across multiple oncology markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the key regulatory advancement in 2024—Breakthrough Therapy designation for extensive-stage small cell lung cancer—which aligns with the ground truth and correctly reflects the expansion into new oncology indications. However, it introduces information not present in the original answer: specifically, the claim that Trodelvy moved from accelerated approval to full approval for HR+/HER2- metastatic breast cancer in 2023–2024 and received European approval. While plausible, these details are not supported by the provided ground truth, which only states the existing indications in 2023 without specifying approval type or region (beyond implying U.S. FDA context), and does not mention European regulatory actions. The core facts about 2024 designation are correct (dates, disease indication, regulatory status), and the interpretation about development trajectory—expansion into high-need oncology areas—is semantically equivalent and well-reasoned. There are no numerical inaccuracies (quantitative accuracy is high), but the qualitative accuracy is slightly reduced due to unsupported elaboration on approval status and geography. Contextual relevance is strong as the response directly addresses the evolution and strategic implications. Thus, the answer is mostly correct but includes unverified details beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 376,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\nBetween 2023 and 2024, Vertex AI transitioned from a nascent developer platform for generative AI to the core engine of Google Cloud’s AI suite, now tightly coupled with the Gemini family of multimodal models and enriched with pre‑packaged AI agents (e.g., Duet AI for Cloud) and services such as vector search, grounding and model distillation. This deeper integration gave customers a more seamless, end‑to‑end workflow for training, tuning, deploying and scaling generative‑AI applications, helping drive a 31 % year‑over‑year increase in Google Cloud revenue in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Vertex AI from 2023 to 2024 in terms of expanded capabilities and deeper integration with generative AI, particularly Gemini, and mentions key new services like vector search, grounding, and model distillation, which aligns with the ground truth. It also correctly notes enhanced developer workflows for training, tuning, and deploying generative AI applications. However, it introduces a specific quantitative claim—'31% year-over-year increase in Google Cloud revenue in 2024'—that is not present in the original answer and cannot be verified from the provided ground truth, making it factually unsupported. (2) The 31% revenue increase is a significant quantitative inaccuracy because it is not mentioned or implied in the original answer, and no financial performance data was part of the ground truth. This undermines the quantitative accuracy despite the rest of the content being qualitative. (3) The multi-hop reasoning is sound: the model correctly infers a progression in Vertex AI’s role and integrates the introduction of Gemini and new AI services as a strategic evolution. The synthesis of capabilities across time (2023 vs 2024) is logically structured and semantically consistent with the original. (4) The correctness score is 7 because the core qualitative information is accurate and comprehensive, but the inclusion of an unverified financial figure reduces factual reliability. Quantitative accuracy is low due to the unsupported 31% claim. Qualitative accuracy is high due to correct entity identification and reasoning. Contextual relevance is perfect—the answer directly addresses the question’s focus on evolution, capabilities, and integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 473,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\nBoth the 2022 filing (p. 123) and the 2024 filing (p. 285) expressly state that the premium and intrinsic value of weather‑related derivatives are deemed immaterial and are therefore excluded from the recorded fair‑value of those derivatives. As a result, the balance‑sheet derivative amounts for 2022 and 2024 omit these insignificant items, showing no material change in the treatment or valuation of weather derivatives between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that SO consistently treated weather derivative premiums and intrinsic values as immaterial in both 2022 and 2024, and that these were excluded from derivative valuations—this aligns with the ground truth. It also accurately reflects that there was no material change in the treatment of weather derivatives between the two years. However, the LLM answer fails to mention a key development in the 2024 disclosure: the specific reporting of cash collateral held in broker margin accounts ($17 million at end of 2024 and $62 million at end of 2023), which indicates a more detailed disclosure framework despite the immateriality of weather derivatives. This omission reduces completeness and weakens the qualitative accuracy, as the evolution in disclosure granularity is a central part of the question. While the LLM correctly synthesizes the consistent immateriality treatment (correct reasoning), it misses the multi-hop nuance that broader derivative disclosures became more structured over time. Quantitative accuracy is high because no incorrect numbers are stated—the LLM simply omits the collateral figures rather than misstating them. Contextual relevance is strong as the response stays focused on the question, but the missing detail limits full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 361,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\nBased on Gilead’s 2024 filings, the FDA granted Biktarvy a new expanded indication—covering HIV‑infected patients with the M184V/I resistance mutation and pregnant women with suppressed viral load— and updated its label to reflect these uses, strengthening its therapeutic positioning.  At the same time, the company’s patent exclusivity for Biktarvy remains in force through 2033 (U.S. and EU), preserving market protection, although it cautions that pricing pressures from insurers, rebates and emerging competition could limit net price growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Biktarvy's U.S. patent expiration in 2033 is accurately noted, and the 2024 FDA expanded indication for patients with M184V/I resistance and updated labeling for use in pregnant people with HIV are correctly reported. The LLM combines both regulatory and market positioning elements as required by the question. (2) Quantitative accuracy is perfect: the patent year 2033 is correct, and no other numerical data (e.g., financials) are misstated. The mention of 'U.S. and EU' patent protection slightly extends beyond the ground truth, which only specifies the U.S., but this is a minor addition rather than an error. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2023 vs 2024) and domains (patent protection vs regulatory expansion), correctly identifying the evolution in positioning. (4) The answer captures the core shift from exclusivity-based positioning in 2023 to broader therapeutic application in 2024, though it could have more explicitly contrasted the two years as a 'shift' to fully mirror the original answer’s structure. However, the semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the evolution in regulatory and market positioning based on GILD’s disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 380,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\nBetween 2022 and 2023 the company moved from a net draw on the 2021 Multicurrency Credit Facility to a net repayment.  In 2022 it borrowed roughly $1.2 bn under the facility, whereas in 2023 it drew $3.0 bn but repaid $6.1 bn (including €842.6 m of revolving debt), leaving a net reduction of about $3.1 bn in outstanding borrowings.  The facility was also amended on June 29 2023 (page 52 of the 2023 10‑K) to extend its maturity to July 1 2026 and to replace LIBOR with SOFR, preserving the $6.0 bn commitment but changing its structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift from net borrowing in 2022 to net repayment in 2023, the $3.0 billion drawn and $6.1 billion repaid in 2023, the inclusion of €842.6 million ($919.1 million) repayment, the June 29, 2023 amendment, the extension of maturity to July 1, 2026, the replacement of LIBOR with SOFR, and the maintained $6.0 billion commitment—all of which are factually accurate and contextually relevant. However, the LLM incorrectly states that AMT borrowed 'roughly $1.2 bn' in 2022, whereas the ground truth specifies 'additional net borrowings of $850.0 million'. This is a significant quantitative error (~41% overstatement). Additionally, while the net reduction of $3.1 billion in 2023 is correctly calculated ($3.0B drawn - $6.1B repaid), the 2022 figure is not properly aligned with the source. (2) Number verification: $3.0B drawn (correct), $6.1B repaid (correct), €842.6M = $919.1M (correctly reflected), maturity date (correct), SOFR replacement (correct), facility size (correct). Only the 2022 borrowing amount is incorrect. (3) Multi-hop reasoning is sound: the model synthesizes data across years, identifies changes in utilization pattern, and incorporates facility amendments. It correctly infers a net reduction trend and links the structural changes. (4) The correctness score is 7 because the core facts about 2023 and the amendments are accurate, but the incorrect 2022 borrowing amount undermines quantitative precision. The qualitative and contextual accuracy remain high due to proper entity identification and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 436,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\nBetween 2023 and 2024 Alphabet continued to treat Google Ad Manager as the platform through which advertisers buy inventory on Google Network properties and to record the resulting advertising revenue on a **gross basis when it is the principal** (i.e., before any payments to network partners are booked as cost of revenue).  However, the 2024 filing sharpened the integration of Ad Manager into the company’s revenue‑recognition model by explicitly tying Ad Manager transactions to the **multiple‑performance‑obligation allocation and variable‑consideration guidance**, thereby providing a clearer mapping of gross billings to revenue line items and a more explicit separation of those billings from partner payouts.  The underlying gross‑versus‑net policy did not change, but the 2024 disclosures show a more detailed, obligation‑based treatment of Ad Manager‑generated advertising revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) There are no numeric values to verify (e.g., dollar amounts, percentages), but dates (2023 and 2024) are correct and consistently used. (2) The answer correctly identifies that Google Ad Manager remained central to Alphabet's gross revenue recognition in both years, with no change in the gross-versus-net policy—this matches the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes the continuity of gross reporting with the evolution in disclosure emphasis, noting that 2024 introduced a more detailed, obligation-based framework tied to ASC 606 elements (performance obligations, variable consideration), which reflects a deeper integration into revenue reporting models. This aligns with the ground truth’s point about a shift toward control-based justification. (4) The only minor gap is that the LLM does not explicitly mention 'control' as the conceptual foundation (e.g., control of inventory, pricing discretion), instead focusing on performance obligations and variable consideration. While these are related aspects of ASC 606, the emphasis differs slightly from the original answer’s focus on control as the principle justifying gross reporting. However, the substance is consistent, and the explanation enhances the original with technical accounting context. Thus, the answer is factually correct, complete, and contextually precise, warranting a high score with a small deduction in qualitative accuracy for slight misalignment in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 425,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\nBetween 2023 and 2024 UPS moved from recording a $56 million goodwill impairment on Roadie (and a full $61 million impairment on the related Delivery Solutions unit) to concluding in its 2024 annual test that Roadie’s fair value still exceeds its carrying value but only by a thin margin—placing it among three reporting units with “limited excess” and $1.1 billion of the company’s total goodwill.  Management now flags Roadie as a higher‑risk unit, noting that a modest 100‑basis‑point rise in the cost of capital or a 10 % dip in projected cash flows could trigger future impairment, so the company’s financial exposure to Roadie remains present but is being monitored more closely.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states the $56 million goodwill impairment related to Roadie in 2023, matching the original answer. While it adds that the Delivery Solutions unit had a $61 million total impairment, this is contextually accurate and consistent with SEC filings, though not in the ground truth—this is a minor addition, not an error. (2) For 2024, it accurately notes no new impairment but correctly identifies Roadie as having 'limited excess' fair value over carrying value, which matches the original answer’s 'ongoing financial risk' characterization. The mention of Roadie being among three reporting units with limited excess and holding $1.1 billion of total goodwill is factually correct and adds context without contradicting the ground truth. (3) The reasoning is sound: it captures the shift from active impairment to heightened monitoring, and correctly explains the sensitivity to cost of capital (100 bps increase) and cash flow projections (10% dip) as triggers for future impairment—this reflects the multi-hop synthesis of risk assessment evolution. (4) All entities (UPS, Roadie, goodwill, impairment, 2023–2024 timeline) are correct. The only minor deviation is the inclusion of the $61 million Delivery Solutions figure, which, while accurate, slightly extends beyond the scope of the original answer but does not reduce correctness. Overall, the semantic meaning, quantitative accuracy, and strategic interpretation are excellent, warranting a 9/10 due to the slight over-elaboration without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 435,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\nLinde’s helium business has continued to shrink – the volume of helium sold fell enough that the “Other” segment’s sales were $32 million (about 2 %) lower in 2024 than in 2023, a trend that extends the decline seen in 2022.  At the same time, operating profit in that segment rose $19 million (≈ 44 %) in 2024 versus 2023, because insurance recoveries and other cost‑savings more than offset the higher helium‑related expenses, underscoring a modest profitability gain despite the ongoing sales reduction.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual and reasoning errors. It correctly identifies that helium had a negative impact on Linde's 'Other' segment sales in 2024, citing a 2% decrease, which aligns with the ground truth. However, it incorrectly attributes this sales decline to a comparison between 2024 and 2023, while the original answer does not specify 2023 as a reference point—instead, it describes a shift from 2022 to 2024. More critically, the LLM claims operating profit in the 'Other' segment rose by $19 million (~44%) in 2024 due to insurance recoveries offsetting helium costs. This contradicts the ground truth, which states that operating profit was negatively affected by increased helium-related costs, with only a partial offset from insurance recovery—implying profit pressure, not a gain. Thus, the direction of the operating profit impact is misrepresented. (2) Quantitatively, the $32 million (2%) sales decrease is consistent with the original answer’s mention of a 2% underlying sales decline, though the exact dollar figure is not in the ground truth and cannot be verified. However, the $19 million (44%) operating profit increase is not supported by the original answer and appears fabricated or misinterpreted. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from 2022 (helium as a supply component) to 2024 (helium as a cost pressure), instead focusing on 2023–2024 trends not mentioned in the ground truth. It also mischaracterizes the net effect on profitability. (4) Scores reflect partial credit for identifying the sales impact and segment, but major deductions for incorrect profit trend, unsupported numbers, and flawed temporal reasoning. Contextual relevance is high as the answer addresses the right company, segment, and general theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 505,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\nThe amount of loans covered by the Corporation’s long‑term credit‑protection agreements with FNMA and FHLMC fell from **$8.7 billion at the end of 2023 to $8.0 billion at the end of 2024** – a decline of roughly $0.7 billion (about 8 %).  This reduction shows that fewer residential‑mortgage loans are now fully guaranteed by these government‑sponsored enterprises, meaning the Corporation’s direct credit‑risk exposure on the remaining unprotected residential‑mortgage portfolio is relatively larger, even though the overall protected exposure has shrunk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the loan values: $8.7 billion in 2023 and $8.0 billion in 2024, matching the ground truth exactly. The calculated decrease of $0.7 billion (~8%) is accurate. 2) Quantitatively, all numbers and calculations are correct. The dollar amounts and time periods (end of 2023 and end of 2024) are precise and consistent with the original answer. 3) The reasoning is largely sound: the decline in protected loans is correctly interpreted as a reduction in full credit protection coverage. The LLM correctly infers increased direct credit risk on the unprotected portion, which aligns with the implication in the ground truth. However, the original answer adds a key nuance: these agreements cover loans that become severely delinquent, and no allowance for credit losses is recorded on them. This detail about loss allowance policy and delinquency severity is missing in the LLM response, slightly weakening the qualitative depth. 4) Despite this omission, the LLM captures the core multi-hop logic—linking the decrease in protected loans to higher relative exposure on unprotected loans—and remains contextually focused on the evolution and risk implications. The answer is semantically very close to the original, with only minor contextual nuance missing. Thus, high scores across all dimensions, with a 9 on correctness due to the missing detail about delinquency and loss allowance policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 391,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\nAdobe shifted Firefly from a set of generative‑AI features embedded in Photoshop, Illustrator and Premiere (introduced in fiscal 2023 with a monthly “Generative Credits” allocation) to a broader, standalone Firefly web app and deeper, native integration across the Creative Cloud, Document Cloud and Experience Cloud suites by fiscal 2024 [page 20; 21].  This expansion differentiates Adobe by offering a unified, commercially‑safe AI layer that can be accessed directly from Acrobat and other Adobe apps, while also exposing the company to heightened regulatory risk as it must navigate newly enacted AI‑specific rules such as the EU AI Act and other emerging global frameworks [page 36; 21].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Adobe Firefly's evolution from 2023 to 2024: starting as generative AI features within core creative apps (Photoshop, Illustrator, Premiere) with a 'Generative Credits' model in 2023, then expanding into a broader, standalone web app with deeper integration across Creative Cloud, Document Cloud, and Experience Cloud by 2024. This reflects the strategic expansion and competitive differentiation through native integration and commercial safety. (2) The answer accurately captures the shift in strategic positioning by noting increased regulatory risks, specifically mentioning the EU AI Act and other global frameworks, which matches the ground truth's emphasis on newly adopted regulations in 2024 (e.g., EU AI Act) that could impose compliance costs or development delays. (3) Multi-hop reasoning is sound: the model synthesizes information about product evolution (from embedded features to standalone platform), competitive differentiation (commercially safe AI across Adobe’s ecosystem), and regulatory risk escalation (due to new AI regulations), all of which are required for the question. (4) Minor deduction in qualitative accuracy due to slightly more granular detail than the original (e.g., 'Generative Credits', 'page 20; 21' references), but this does not detract from correctness—rather, it adds precision. No numeric inaccuracies; dates (fiscal 2023/2024) and regulatory developments are correctly framed. Semantic equivalence is strong, and all parts of the question (competitive differentiation, regulatory risks, evolution over time) are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 455,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\nBetween 2023 and 2024, Trodelvy’s product sales jumped 24 % to $1.3 billion, propelled by stronger demand across all geographies (U.S., Europe and other international markets).  At the same time, the FDA awarded Trodelvy a second Breakthrough‑Therapy designation—this time for extensive‑stage small‑cell lung cancer after platinum‑based chemotherapy—highlighting a continued upward regulatory trajectory for the asset.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key qualitative developments: Trodelvy received a second Breakthrough Therapy designation from the FDA in 2024 for extensive-stage small cell lung cancer after platinum-based chemotherapy, which aligns with the ground truth. This reflects accurate entity and regulatory event identification. However, the financial figures are incorrect. The LLM states that product sales increased 24% to $1.3 billion in 2024, but the ground truth reports $1,063 million in 2023 (a 56% increase from 2022), with no data provided for 2024 sales. Thus, the LLM fabricates a 2024 sales figure and growth rate not present in the original answer. 2) Quantitatively, the error is significant: $1.3 billion (i.e., $1,300 million) exceeds the actual 2023 sales of $1,063 million, implying unrealistic growth without basis. The claimed 24% increase is also inconsistent with the 56% year-over-year growth already reported for 2023. There is no support for projecting or asserting 2024 sales performance. 3) The reasoning is partially sound—linking increased demand across geographies to sales growth and pairing it with regulatory progress shows logical synthesis—but it fails the multi-hop requirement because it invents financial data rather than accurately reporting or inferring based on available information. 4) Despite the factual inaccuracy in numbers, the answer remains contextually relevant and captures the intended narrative of strong commercial performance and regulatory momentum. Hence, high marks for qualitative accuracy and contextual relevance, but a moderate correctness score due to major quantitative inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 450,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\nChevron has held a steady 36.4 percent equity interest in Angola LNG Limited since at least 2022, but the size of that stake and the capital it is deploying have risen markedly.  In the 2024 filing the company reports an investment balance of roughly $2.3 billion in Angola LNG (up from about $2.2 billion in 2022) and discloses a $4.5 billion loan to fund the Wellhead‑Pressure‑Management and Future‑Growth projects, while also earmarking roughly $0.8 billion of African‑region capital for offshore gas development in Angola.  These disclosures show a deepening financial commitment—larger equity exposure, expanded loan facilities, and targeted development spending—that positions Angola LNG as a core strategic pillar of Chevron’s upstream growth and LNG expansion strategy through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron's 36.4% stake in Angola LNG Limited was specifically disclosed in 2024, but the LLM claims this stake has been held 'since at least 2022'—a claim not supported by the original answer and contradicted by the implication that the stake was only clearly quantified in 2024. Additionally, the LLM introduces specific dollar figures—$2.3 billion investment in 2024 (up from $2.2 billion in 2022), a $4.5 billion loan, and $0.8 billion in capital spending—that are entirely absent from the original answer and not supported by the provided ground truth. These numbers are fabricated or hallucinated. (2) Quantitative accuracy is very low: none of the financial figures in the LLM answer ($2.3B, $2.2B, $4.5B, $0.8B) appear in the original answer. The only numeric data in the ground truth is the $5,657 million income from equity affiliates in 2022 and the 36.4% ownership in 2024. The LLM invents investment balances and loans with no basis in the source. (3) Multi-hop reasoning is flawed. The original answer traces a qualitative evolution from 2022 (general earnings contribution from Angola LNG) to 2024 (specific ownership stake disclosed), indicating increased strategic clarity. The LLM instead constructs a narrative of increasing financial commitment based on invented metrics, failing to accurately reflect the actual progression of disclosures. It misrepresents the nature of the evolution by emphasizing capital deployment and loans not mentioned in the ground truth. (4) Contextual relevance is moderate—the answer addresses Chevron’s strategic positioning in Angola LNG and attempts to show evolution over time, which is relevant. However, due to severe factual and quantitative errors, the answer misleads rather than informs. The conclusion about Angola LNG being a 'core strategic pillar' is plausible but unsupported by the evidence provided in the original answer. Overall, the LLM answer fabricates key details and fails to represent the actual disclosures, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 568,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 Meta’s fixed‑rate senior unsecured notes grew sharply, with total outstanding principal rising from **$18.5 billion** (as of Dec 31 2023) to **$29.0 billion** (as of Dec 31 2024).  The increase was driven by a **$8.46 billion issuance in May 2023** and a subsequent **$10.5 billion issuance in August 2024**, which together lifted the note portfolio by roughly **$10.5 billion** in 2024 alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key figures: $18.5 billion outstanding at end of 2023, $29.0 billion at end of 2024, $8.46 billion issued in May 2023, and $10.5 billion issued in August 2024. These match the ground truth exactly. (2) The calculation of the increase in total value is accurate: $29.0B - $18.5B = $10.5B, which aligns with the August 2024 issuance. However, the phrasing 'lifted the note portfolio by roughly $10.5 billion in 2024 alone' is slightly misleading because the net increase in outstanding value during 2024 was $10.5B, but this was due entirely to the new issuance—there was no repayment mentioned. The original answer clarifies that the total increased from $18.5B to $29.0B with a $10.5B issuance, which is precise. The LLM implies the $8.46B issuance in 2023 contributed to the 2024 increase, which is factually correct as it sets the base, but the wording could suggest it occurred in 2024. (3) Multi-hop reasoning is sound: the model synthesizes data across two years and two issuance events, correctly tracking the evolution of the debt instrument. (4) Scores reflect high accuracy in numbers and entities, minor deduction in quantitative accuracy due to potential misinterpretation of timing impact, and excellent qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 366,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\nIn the 2023 Form 10‑K (page 62) helium is listed only as part of the $614 million “Rawmaterials and supplies” inventory, presented as a routine purchased supply. The 2024 filing (page 62) still reports helium under the same line item, but the ending balance has fallen to $529 million and the accompanying disclosure notes that helium is now a “critical dependency” sourced from a limited number of vendors and has experienced a modest price increase, signalling a shift from a generic supply to a strategically important raw material.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and omits key quantitative details from the ground truth. (1) Quantitative Accuracy: The ground truth specifies that helium costs were 4.2% of total raw material expenses in 2023 and rose to 6.8% in 2024, reflecting increased exposure. The LLM answer does not mention these percentages at all. Instead, it refers to inventory balances of $614M and $529M for 'Raw materials and supplies'—a broader category—not helium-specific costs. These figures are not equivalent to the percentage of raw material expenses and misrepresent the metric being assessed. There is no evidence that the $85M decrease in inventory relates directly to helium, so using this as a proxy for helium cost exposure is incorrect. (2) Completeness: The question asks specifically about changes in financial exposure based on cost or sourcing disclosures. The LLM mentions a 'modest price increase' and 'limited number of vendors', which aligns with increased dependency, but fails to report the critical cost percentages that quantify the exposure change. (3) Entity Accuracy: The company (LIN), years (2023, 2024), and material (helium) are correctly identified. The reference to Form 10-K page 62 for both years appears consistent, though not verifiable without source access. (4) Reasoning: The qualitative shift from 'supply' to 'dependency' is correctly inferred from sourcing constraints and strategic language ('critical dependency'), showing some valid multi-hop reasoning. However, the failure to incorporate the actual cost percentages undermines the financial analysis required. (5) Semantic Equivalence: While the direction of change (increased importance) is correct, the lack of precise cost metrics and substitution of inventory totals for expense percentages results in a materially incomplete and misleading answer. The core financial exposure change—rising from 4.2% to 6.8%—is entirely missing, which is the central fact in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 530,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\nPayPal’s ability to earmark European customer balances for credit purposes fell in absolute terms: the amount of balances that management could designate for credit activities dropped from **$3.8 billion in 2022 to $3.0 billion in 2023**.  This represents a **≈21 % decrease** in the approved dollar amount ( ($3.0 bn – $3.8 bn) / $3.8 bn ≈ ‑0.21 ).  (The share of European customer balances that could be used actually rose slightly, from about 37 % to 39 % of the total, but the approved capital itself was lower.)  [Source: PYPL_10k_2023.pdf page 75]",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.8 billion in 2022 and $3.0 billion in 2023 are correctly reported. The percentage of European customer balances used increased from 37% to 39%, which aligns with the original answer. The calculated percentage change of approximately 21% decrease is correct: (3.0 - 3.8) / 3.8 = -0.2105, or -21.05%, which rounds to ≈21% decrease. (2) The answer addresses both parts of the multi-part question: it describes how PayPal's utilization evolved (decrease in absolute approved amount despite a slight rise in percentage share) and provides the percentage change in the approved amount. (3) Entity accuracy is perfect: PayPal (PYPL), European customer balances, credit activities, and the years 2022 and 2023 are all correctly identified and contextualized. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly interprets that while the proportion of balances approved increased slightly (37% to 39%), the absolute dollar amount decreased, indicating a more conservative funding approach. The conclusion about reduced capital approval despite higher relative utilization is logically consistent with the data. (5) Semantic equivalence is achieved: the LLM conveys the same core insight as the ground truth, using slightly different phrasing but preserving factual and conceptual accuracy. The inclusion of a source reference (PYPL_10k_2023.pdf page 75) adds contextual support. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 428,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the “foreign‑currency‑other” component of Starbucks’ AOCI fell sharply—from an unrealized gain of **$39.6 million** as of Oct 1 2023 to **$11.5 million** as of Sep 29 2024— and the amount projected to be re‑classified to earnings over the next 12 months dropped from **$39.6 million** to **$9.5 million**.  Consequently, the realized gain/(loss) on these derivatives that flowed into earnings was essentially flat (a **$0.1 million** gain in 2024 versus a **$3.6 million** loss in 2023), indicating that the company’s foreign‑currency exposure and the related earnings impact have both receded markedly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in the net gain in AOCI from $39.6 million in 2023 to $11.5 million in 2024 and the drop in the amount expected to be reclassified to earnings from $55.3 million to $9.5 million. However, it incorrectly states that the projected reclassification amount in 2023 was $39.6 million instead of the correct $55.3 million, which is a significant factual error. This misstatement undermines the quantitative accuracy. Additionally, the LLM introduces new data not present in the original answer—specifically, the realized gain/loss in earnings ($0.1 million gain in 2024 vs $3.6 million loss in 2023)—which was not part of the ground truth and cannot be verified from the provided information. (2) The fair values of the instruments ($1,164 million in 2023 and $920 million in 2024) are completely omitted, which is a major omission since the question explicitly asks about fair value evolution. This missing data reduces completeness and correctness. (3) The reasoning about reduced foreign currency exposure and earnings impact is logically consistent with the trends, but the synthesis is flawed due to incorrect numbers and missing fair value data. The multi-hop aspect—linking fair value, AOCI gains, and reclassification impact—is partially addressed but incomplete. (4) Despite the errors, the answer remains contextually relevant, discussing the right concepts and direction of change. The qualitative reasoning is sound where data is correct, but the quantitative inaccuracies—especially the wrong reclassification figure and missing fair values—prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 447,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\nThe reported fair‑value of the energy‑related derivatives held by Alabama Power and Georgia Power was essentially flat from 2022 to 2023 (about $15 million of assets and roughly $110–$124 million of liabilities for the two utilities).  However, the accounting classification changed – in 2022 the derivatives were shown only as liabilities, while in 2023 they appear as both assets (positive $15 million for Alabama Power and $13 million for Georgia Power) and liabilities, indicating a directional shift from a net‑liability position to a mixed asset‑liability position (i.e., from liability to asset).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the fair value of derivatives was 'essentially flat' from 2022 to 2023, which contradicts the ground truth showing major changes. In 2022, Alabama Power had $55M in assets and $11M in liabilities, and Georgia Power had $75M in assets and $8M in liabilities—totaling $130M in assets and $19M in liabilities. By 2023, assets dropped to $28M ($15M + $13M) while liabilities surged to $234M ($110M + $124M). The LLM misrepresents this dramatic shift as 'flat', which is factually wrong. (2) The LLM incorrectly claims that in 2022 the derivatives were shown 'only as liabilities', but the ground truth clearly shows both asset and liability positions for both companies in 2022. This is a critical error in entity and metric interpretation. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the directional change, which is a shift from net asset/low liability positions in 2022 to high liability/low asset positions in 2023—indicating increased liability exposure, not a shift from liability to asset. The conclusion that there was a shift 'from liability to asset' is the opposite of the truth. (4) While the 2023 liability figures are in the correct range ($110–$124M), the LLM aggregates across companies without distinguishing them, losing entity-specific accuracy. The contextual relevance is moderate because it addresses derivatives and the time frame, but the reasoning and facts are largely incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 431,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\nFrom 2022 to 2023 the U.S. Retiree Health Care Plan shifted its asset mix toward a higher fixed‑income allocation and a lower equity allocation.  In 2022 the plan’s assets were roughly 65 % fixed‑income and 35 % equity, whereas by the end of 2023 they were about 80 % fixed‑income and 20 % equity—moving the portfolio into the plan’s target range of 65‑80 % fixed income and 15‑25 % equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all percentages and years are correct: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. These match the original answer exactly, and no calculation errors are present. (2) The answer is complete, addressing the evolution of asset allocation between the two years and correctly identifying the shift toward a more conservative strategy. (3) Entity accuracy is strong—'U.S. Retiree Health Care Plan' is correctly named, and the time periods (2022 to 2023) are accurate. (4) The reasoning is sound: the LLM correctly infers a strategic shift and adds contextual value by noting the 2023 allocation falls within the plan’s target range (65–80% fixed income, 15–25% equity), which is consistent with the knowledge graph and enhances the explanation without contradicting it. The only minor point preventing a perfect 10 is that the original answer explicitly characterizes the change as a 'more conservative investment strategy,' while the LLM implies it through context but doesn't use that exact qualitative framing. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 355,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s approvals remained accelerated for its original metastatic TNBC and urothelial‑cancer indications (granted under the accelerated‑approval pathway in 2022; see page 8), but in 2023 the FDA granted a new, non‑accelerated indication: full approval for adult patients with unresectable locally advanced or metastatic HR⁺/HER2‑ breast cancer who have previously received endocrine therapy and at least two systemic therapies (see page 39). Thus, while the drug kept its earlier accelerated approvals, the 2023 approval expanded its use to a distinct breast‑cancer population.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Trodelvy's regulatory approval status between 2022 and 2023. It correctly identifies that in 2022, Trodelvy had accelerated approvals for metastatic triple-negative breast cancer (TNBC) and urothelial cancer. It also accurately states that in 2023, a new indication was granted for HR+/HER2-negative breast cancer, specifying the correct patient population (previously treated with endocrine therapy and at least two systemic therapies). The answer correctly characterizes this 2023 approval as a full (non-accelerated) approval, which aligns with the significance of the expansion. However, the LLM omits mention of the EC (European Commission) approval also being granted in 2023, which is included in the ground truth and represents a key part of the global regulatory evolution. While the FDA approval is correctly detailed, the absence of the EC approval reduces completeness. There are no numerical inaccuracies (dates and therapy counts are correct), so quantitative accuracy is high. The reasoning is sound in connecting the 2022 status to the 2023 expansion, though the multi-jurisdictional aspect (U.S. and EU) is not fully synthesized. Wording differs from the original but maintains semantic equivalence on the FDA approval and patient indication. Contextual relevance is excellent, directly addressing the question’s focus on regulatory evolution and new indications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 398,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\nIn the 2023 10‑K the “user‑perception” risk was framed narrowly: if people no longer view Meta’s products as useful, reliable or trustworthy, the company could lose users, engagement and ultimately revenue. The 2024 filing keeps that core concern but expands it into a systemic exposure— inaccurate or poorly‑perceived metrics can damage Meta’s reputation, deter marketers and developers from allocating budget or resources, and intersect with broader operational risks such as scaling, international regulation and potential liability. Consequently, user perception in 2024 is presented not just as a threat to user growth but as a material risk that can affect advertising revenue, partner relationships and the overall financial condition of the business.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and entity synthesis compared to the ground truth. (1) Correct elements: The answer correctly identifies that user perception was a risk factor in both 2023 and 2024, and that it could impact user engagement, reputation, and revenue. It also appropriately links user perception to advertising and partner relationships, which aligns with the broader implications mentioned in the original answer. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in either the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM incorrectly frames the evolution as an expansion of the user-perception risk into systemic exposure, whereas the ground truth indicates a strategic *reduction* in emphasis on user perception in 2024, with a shift toward operational and financial risks like acquisition integration and tax liabilities. The LLM suggests continuity and broadening of user-perception risk, while the original answer states that explicit mention of user perception as a direct risk was reduced. This is a critical reversal of the actual trend. (4) Justification for scores: The correctness score is 5 due to this major contradiction in the core claim about risk disclosure evolution—LLM says user perception became more central and systemic, while truth shows it became less prominent. Qualitative accuracy is 5 because the reasoning and synthesis are flawed despite some accurate contextual details. Quantitative accuracy is 10 by default (no numbers involved). Contextual relevance is 8 because the response stays on topic and discusses relevant business impacts, even if the directional change is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 484,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\nThe notional amount of Lockheed Martin’s outstanding variable‑interest‑rate swaps grew from **$0.5 billion at the end of 2021** (as reported in the 2022 filing) to **$1.3 billion at the end of 2024** (the 2024 filing notes the same $1.3 billion figure for both 2024 and 2023). This roughly 2½‑fold increase shows that the company has markedly expanded its use of variable‑rate swaps to hedge the interest‑rate exposure of its fixed‑rate debt and to stabilize cash‑flow earnings as rates rose, indicating a more aggressive and broader interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts for 2021 ($0.5 billion) and 2024 ($1.3 billion), matching the ground truth exactly (with acceptable format variation: $0.5 billion = $500 million). It also accurately notes that the 2024 filing reports $1.3 billion for both 2023 and 2024, which is consistent with available data. (2) Quantitative accuracy is perfect: the values are correct, and the '2½-fold increase' is a reasonable approximation of the actual increase (from $500M to $1.3B is a 160% increase, or 2.6x, so '2½-fold' is acceptably close). (3) The reasoning is sound: the LLM correctly infers that the increase in variable-rate swaps indicates a strategic shift in interest rate risk management, specifically to hedge fixed-rate debt and stabilize cash flows amid rising rates. This aligns with the ground truth's interpretation of a growing emphasis on converting fixed to variable-rate borrowings. (4) The only minor shortcoming is that the LLM slightly reframes the strategy as 'hedging fixed-rate debt' rather than explicitly stating the company is converting fixed to variable-rate borrowings, which is a subtle but relevant distinction in financial strategy. However, the semantic meaning and strategic implication are sufficiently aligned. All parts of the question are addressed: evolution over time and strategic interpretation. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 402,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\nPayPal continued to record a specific allowance for the losses that arise from its Seller‑Protection programs, but the reserve was trimmed slightly—from **$66 million at the end of 2022 to $64 million at the end of 2023**—showing a modest reduction in the estimated transaction‑loss exposure.  At the same time the allowance for negative customer balances grew from **$212 million to $218 million**, reflecting the company’s ongoing adjustment of provisions as actual charge‑offs and recoveries changed.  (Pages 113 & 114).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the allowance decreased from $66 million in 2022 to $64 million in 2023, matching the original answer. The additional detail about negative customer balances increasing from $212M to $218M is factually consistent with PayPal's disclosures and adds context without distorting the response. (2) The core of the question—how PayPal’s approach evolved financially—is addressed: the shift from a more qualitative risk discussion in 2022 to a specific, quantified allowance in 2023 is implied by citing exact figures for both years. (3) Entity accuracy is correct: PayPal, Seller Protection Programs, and the relevant financial provisions are properly identified. (4) Reasoning is sound: the answer correctly infers a modest reduction in estimated loss exposure, reflecting a more structured financial approach. The only minor shortcoming is that the LLM does not explicitly contrast the qualitative nature of 2022 disclosures (mentioning historical loss rates of 0.09%–0.15% of TPV and macroeconomic risks) with the 2023 quantitative allowance, which was a key nuance in the original answer. However, the numerical comparison still supports the same conclusion. Thus, the answer is semantically equivalent in financial evolution, though slightly less comprehensive in framing the shift in disclosure style.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 392,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\nThe foreign‑currency‑other derivative asset fell from $54.9 million at the end of fiscal 2023 to $3.6 million at the end of fiscal 2024—a decline of $51.3 million—while the related derivative liability rose modestly from $2.3 million to $2.6 million (an increase of $0.3 million).  Thus the net balance‑sheet exposure to foreign‑currency‑other derivatives was reduced by roughly $51 million between the two fiscal years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative accuracy. According to the ground truth, Starbucks' derivative asset for 'Foreign currency - other' decreased from $1,164 million in fiscal year 2023 to $1.9 million in 2024, a massive drop of approximately $1,162.1 million. However, the LLM reports this asset as $54.9 million in 2023 and $3.6 million in 2024, which is off by over $1.1 billion. This represents a fundamental factual error in the core data. Similarly, the derivative liability increased from $2.0 million in 2023 to $4.7 million in 2024 per the ground truth, but the LLM states it rose from $2.3 million to $2.6 million—again, incorrect values. The LLM's calculated change in asset ($51.3 million decrease) and liability ($0.3 million increase) are therefore also wrong. While the LLM attempts the correct type of analysis—calculating changes in asset and liability positions and assessing net balance sheet impact—the actual numbers are completely inaccurate, likely due to hallucination or referencing incorrect data. The reasoning structure is sound (assessing change in assets, liabilities, and net exposure), and the question is relevantly addressed in scope, but the factual foundation is entirely flawed. Hence, the correctness and quantitative accuracy scores are very low. Qualitative accuracy is slightly higher because the model understands the required financial interpretation, but it fails on entity-level accuracy (numbers tied to the correct metric and year). Contextual relevance is moderate because the response addresses the right topic and structure, but with false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 443,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\nIn 2022 the non‑designated energy derivatives produced a roughly **$117 million loss** on natural‑gas revenue hedging and a **$65 million loss** on the cost of natural gas, but by 2023 those positions flipped to a **$11 million loss** on revenue and a **$59 million gain** on cost—an improvement of about **$100 million** in the overall hedging result from 2022 to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, the cost of natural gas was negatively impacted by $27 million, but the LLM states a $65 million loss—this is a major discrepancy. Additionally, the LLM claims a $11 million loss on revenue in 2023, whereas the ground truth reports a neutral $0 impact. The only correct number is the $59 million gain on cost in 2023. The claimed 'improvement of about $100 million' is based on incorrect inputs and thus invalid. (2) Correct numbers: 2022 revenue impact ($117M loss) and 2023 cost impact ($59M gain) are accurate. Incorrect: 2022 cost impact ($65M vs. true $27M), 2023 revenue impact ($11M loss vs. true $0), and overall improvement calculation. The actual net change in cost impact is from -$27M to +$59M, a $86M improvement; revenue improved from -$117M to $0, a $117M improvement—total improvement is ~$203M, not $100M. (3) The reasoning correctly identifies a shift in derivative impact from negative to positive, and attempts multi-hop synthesis across years and categories (revenue vs. cost). However, due to incorrect data, the conclusion about the magnitude of improvement is flawed. (4) Contextually, the answer addresses the evolution of financial impact over time and discusses both cost and revenue hedging, which is relevant. Despite incorrect numbers, the directional shift (from loss to gain in cost, improvement in revenue) is partially aligned, but factual errors severely limit correctness. Hence, correctness score is 5—partially correct but with major factual and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 438,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Deferred Compensation Matching Plan was only referenced in its prior form (effective Nov 8 2022) and was not highlighted as a newly restated document. The 2024 filing revises the disclosure to note the plan as “amended and restated effective Nov 8 2023” and lists it as Exhibit 10.1, thereby documenting the amendment and moving the plan’s effective date forward to late 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents key aspects of the Deferred Compensation Matching Plan's treatment in the 2023 and 2024 10-K filings. (1) Quantitatively, it incorrectly states that the 2023 10-K referenced a version of the plan effective November 8, 2022—this date does not appear in the ground truth; instead, the 2023 filing introduced the plan as amended and restated effective November 8, 2023. The LLM also falsely claims the effective date was changed in the 2024 filing, when the ground truth explicitly states the effective date remained unchanged. (2) The answer incorrectly asserts that the 2023 filing did not highlight the plan as newly restated, when in fact it did. Conversely, it claims the 2024 filing 'revises the disclosure' and documents the amendment as Exhibit 10.1, which contradicts the ground truth stating that by 2024 the plan was no longer labeled as newly introduced and was instead incorporated by reference—indicating normalization, not new documentation. (3) The multi-hop reasoning is flawed: the model fails to recognize the evolution from 'newly introduced' in 2023 to 'established and incorporated by reference' in 2024, instead inventing a narrative of amendment and effective date shift that is unsupported. (4) While the answer addresses the general topic and attempts to compare two years’ disclosures, its core claims are factually inverted or fabricated, leading to a very low correctness score. Contextual relevance is moderate because it engages with the right document types and plan name, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 436,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\nThe 2024 filing again describes LTIP units as “potentially dilutive securities” but, like the 2023 filing, explicitly states that they had **no material dilutive effect** for 2024, 2023 or 2022. Consequently, the company does **not adjust net income attributable to common stockholders or the weighted‑average share/unit count** for income allocable to those units, and it continues to **accrue dividends on the LTIP units when they are declared**—a policy that is unchanged between 2023 and 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that LTIP Units are described as 'potentially dilutive securities' in both 2023 and 2024 filings, with no material dilutive effect reported for 2024, 2023, and 2022—matching the original answer exactly. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts), but the years and time periods (2024, 2023, 2022) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of disclosures, noting consistency in both dilutive effect assessment and accrual policy. (4) The accrual policy—'distributions are accrued when declared'—is correctly reflected as unchanged, with the LLM accurately stating dividends are accrued when declared. No factual inaccuracies, omissions, or misinterpretations are present. The answer is concise, complete, and contextually precise, fully addressing the evolution (or lack thereof) in disclosure, dilutive effect, and accrual policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 307,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\nBetween 2023 and 2024 Meta shifted from merely adopting the new EU‑U.S Data Privacy Framework to actively reshaping how it transfers and uses European users’ data in response to regulator pressure.  After the Irish Data‑Protection Committee imposed a €1.2 bn fine and issued corrective orders (now under an interim stay), the European Commission opened formal DMA proceedings in March 2024 and, in July 2024, issued preliminary findings that Meta’s “subscription‑for‑no‑ads” model does not comply with the DMA’s consent requirements—prompting Meta to move behavioral advertising from “legitimate interests” to explicit consent and to offer a less‑personalized ad tier for users who remain on the free service.  These steps illustrate a clear evolution toward stricter consent‑based mechanisms, greater transparency, and structural changes to its ad‑targeting and data‑transfer practices to meet EU privacy and competition rules.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Meta's compliance approach between 2023 and 2024, with accurate qualitative reasoning and strong contextual relevance. (1) Correct elements include: the €1.2 billion fine by the Irish Data Protection Commission (IDPC), the implementation of corrective orders, the introduction of the 'subscription-for-no-ads' model in late 2023, and the European Commission's July 2024 preliminary findings of non-compliance under the DMA. The shift toward explicit consent and less personalized ads is also correctly framed. (2) Quantitative accuracy is mostly sound: the €1.2 billion fine is correct, and the July 2024 date for preliminary findings matches the ground truth. However, the LLM incorrectly states that the European Commission opened formal DMA proceedings in March 2024; the original answer specifies that these proceedings were opened in 2024 but does not confirm March, and public records indicate the formal opening was later (closer to May–June 2024). This minor date inaccuracy affects precision. Additionally, the LLM claims Meta moved behavioral advertising from 'legitimate interests' to 'explicit consent'—a plausible inference but not explicitly stated in the ground truth, making it a slight overreach. (3) Multi-hop reasoning is strong: the answer synthesizes information across regulatory bodies (IDPC, European Commission), legal frameworks (SCCs, EU-U.S. DPF, DMA), and business model changes, correctly linking enforcement actions to Meta’s strategic shifts. (4) Despite minor factual overprecision and one unsupported inference, the answer conveys the essential evolution in Meta’s compliance posture and aligns well with the ground truth in meaning and scope, warranting a high correctness score with room for improvement in strict factual adherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 495,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\nBetween 2023 and 2024 Linde moved from a general description of “green” hydrogen as an emerging clean‑energy option to a concrete, renewable‑energy‑focused production strategy.  In the 2024 filing (pages 5‑6) the company details that green hydrogen is now produced *exclusively* by electrolysis powered by renewable electricity (wind, solar, hydro) and that it is expanding commercial‑scale electrolyzer projects and partnerships to secure dedicated renewable power, whereas the 2023 filing (page 4) only mentioned green hydrogen as one of several “clean‑energy” pathways without emphasizing the renewable‑energy source or the scale of deployment.  Consequently, Linde’s 2024 approach places a far greater emphasis on renewable‑energy‑driven electrolysis as the primary method for delivering green hydrogen.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Linde's approach to green hydrogen between 2023 and 2024. It accurately captures the shift toward a stronger emphasis on renewable energy-powered electrolysis as the primary method for green hydrogen production in 2024, compared to a more general mention in 2023. The answer correctly identifies that in 2024, Linde focused on electrolysis using renewable electricity (wind, solar, hydro) and highlighted commercial-scale projects and partnerships—details consistent with a more strategic and refined framing. However, the LLM answer states that green hydrogen is produced *exclusively* by electrolysis in 2024, which slightly overstates the case; the ground truth notes that Linde also referenced steam methane reforming of biomethane as a method in 2023, but does not confirm exclusivity in 2024—only a stronger emphasis on electrolysis. Additionally, the LLM omits the 2024 introduction of carbon intensity as a key metric for differentiating production methods (e.g., green vs. blue hydrogen), which is a significant qualitative refinement mentioned in the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound, though not fully complete in capturing all nuances. The contextual relevance is excellent, as the response directly addresses the question’s focus on production methods and renewable energy emphasis. Minor omissions and slight overstatement prevent a top score, but the core facts and direction of evolution are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 439,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\nSouthern Company completed the sale of Sequent in July 2021, and by 2022 the wholesale‑gas services business—including Sequent—was removed from its segment reporting, leaving only the after‑tax gain of $92 million that had been recorded in 2021. In 2023 there were no further earnings or expenses from Sequent; the only financial impact was the residual tax effect of the transaction (an $85 million additional tax expense recognized in 2021 that continued to flow through subsequent periods).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the sale of Sequent occurred in July 2021, but the ground truth states the sale was completed in 2022. This misalignment in timing undermines the entire narrative. The LLM correctly mentions an $85 million additional tax expense, which matches the ground truth, but attributes it to 2021, whereas the original answer does not specify the year of recognition for the tax expense—only that it resulted from the sale. However, the LLM incorrectly states the after-tax gain as $92 million, while the ground truth reports a pre-tax gain of $121 million. There is no mention of the $159 million sale price in the LLM answer, which is a key financial figure. (2) Quantitative accuracy is low: the dates (2021 vs 2022), the nature of the gain ($92M after-tax vs $121M pre-tax), and the absence of the $159M sale price are all incorrect or missing. The $85M tax expense is the only correct number, but its timing is misattributed. (3) The multi-hop reasoning is flawed—the LLM fails to correctly link the 2022 sale to its financial implications in 2022 and 2023. Instead, it frames all major financial impacts as occurring in 2021, which contradicts the ground truth. The evolution of the relationship from ownership in 2022 to divestiture in 2023 is completely misrepresented, as the LLM suggests the divestiture was already complete by 2022. (4) Contextual relevance is moderate because the answer addresses the right entities (Southern Company, Sequent, financial impacts) and touches on the divestiture and tax effects, but the incorrect timeline and financial figures severely limit its usefulness. The core of the question—how the relationship evolved between 2022 and 2023—is answered incorrectly, as the LLM implies no relationship existed during that period due to a 2021 sale.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 503,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart continued to list “Allswell” among its stable of private‑brand labels and highlighted it as part of the strategic merchandise units that underpin the company’s omni‑channel offering.  The filings show no shift away from the brand; instead, its inclusion alongside other private‑label lines (e.g., “Equate,” “Free Assembly”) underscores Walmart’s intent to leverage Allswell to broaden its differentiated, higher‑margin product assortment while reinforcing the value‑price promise that drives customer traffic.  This steady positioning reflects a deliberate strategy to deepen the role of private‑brand assets—like Allswell—within Walmart’s overall portfolio to enhance profitability and competitive differentiation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy, timeline, and strategic interpretation. It correctly identifies that Allswell was retained from 2023 to 2024 and positioned among other private brands, indicating ongoing strategic importance. The answer accurately reflects that there was no discontinuation and that Allswell remains part of Walmart’s private brand portfolio. However, the original answer emphasizes a key evolution: Allswell transitioned from a newly introduced brand in 2023 to being grouped with mature brands in 2024, signaling progression in its lifecycle. The LLM answer does not explicitly highlight this developmental shift—from new to established—which is a core element of the original answer’s reasoning. While the LLM correctly infers strategic intent (e.g., higher-margin products, value positioning), it misses the nuance of brand maturation explicitly stated in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and all entities (Walmart, Allswell, Equate, Free Assembly) are correctly referenced. The reasoning is sound and contextually relevant, but the lack of emphasis on the brand’s progression from introduction to maturity slightly weakens the qualitative accuracy. Overall, the answer captures the strategic significance but omits a key inferential step in the brand’s evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 394,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s total revenue fell 12.5 % to $17.5 billion, but the decline was “primarily due to lower revenue from Analog, partially offset by higher revenue from Embedded Processing.” This is the first explicit indication that Embedded Processing is now a growth‑offsetting segment, and the firm’s strategic narrative repeatedly stresses “designing and selling our products into the industrial and automotive markets, which we believe represent the best long‑term growth opportunities,” a focus that aligns directly with Embedded Processing’s role. Consequently, while Analog remains a core revenue source, Embedded Processing’s contribution has risen in strategic importance—it is now the primary engine propping up overall sales and a key pillar of the company’s long‑term growth plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12.5% revenue decline to $17.5 billion in 2023, aligning with the ground truth total revenue of $17.52 billion (rounding to $17.5 billion is acceptable). It accurately notes that the decline was primarily due to Analog revenue and partially offset by Embedded Processing, which matches the ground truth. The only minor quantitative imprecision is the lack of explicit mention that no revenue figures were disclosed for Embedded Processing in 2022, though this is a subtle point and does not undermine the overall accuracy. (2) The dollar amount ($17.5 billion vs. $17.52 billion) is acceptably close, and the percentage decline (12.5%) is consistent with the context of a revenue drop, even if not explicitly stated in the original answer—this inference is reasonable given the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Embedded Processing played a compensatory role in 2023 and infers increased strategic importance based on its offsetting effect and alignment with industrial and automotive markets emphasized in strategy. This goes beyond repetition and shows logical inference supported by the ground truth. (4) The answer captures the evolution in strategic importance—maintaining core status while gaining a more pronounced role—thus achieving semantic equivalence. The slight deduction in scores reflects the absence of explicit mention that Embedded Processing was already a core segment in 2022 (though implied), and the use of 'primary engine' may slightly overstate relative to 'partially offsetting,' but not egregiously. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 465,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept its 36.4 % stake in Angola LNG and directed roughly $0.8 billion of capital into offshore development and liquefaction projects in Angola, while still meeting long‑term delivery commitments for that gas.  The continued investment and the inclusion of Angola’s gas volumes in the company’s reserve and production outlooks show that Chevron is using Angola LNG as a core pillar of its LNG growth strategy—expanding lower‑carbon gas supplies to offset declining oil volumes and strengthen its position in the global LNG market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies. While it correctly states Chevron's 36.4% stake in Angola LNG, this stake is presented as continuous from 2022 to 2024, whereas the ground truth indicates that in 2022, Chevron's involvement was only referenced in terms of production volumes, not an explicitly defined stake. The explicit 36.4% ownership is only confirmed in 2024 per the original answer, so asserting it was held throughout 2022–2024 is unsupported. Additionally, the LLM introduces a $0.8 billion capital investment in offshore and liquefaction projects in Angola, which is not mentioned or verifiable from the ground truth and appears fabricated. (2) Quantitative accuracy is low: the 36.4% figure is correct but misapplied in time; the $0.8 billion figure has no basis in the provided truth and cannot be verified, making it a serious error. (3) The reasoning is partially sound in interpreting Chevron’s strategic intent—linking LNG investments to long-term positioning and lower-carbon growth—but this is speculative and overreaches the evidence. The multi-hop synthesis fails because it assumes continuity and additional investments not present in the source data. (4) Contextual relevance is high as the answer addresses Chevron’s evolving role in Angola LNG and strategic positioning in the LNG market. However, due to key factual errors—especially the unverified capital expenditure and misrepresentation of stake timeline—the correctness score is limited to 4, reflecting partial accuracy with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 424,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\nFrom 2021 through 2024 the CH‑53K heavy‑lift helicopter was a clear growth driver for RMS: in 2021 it accounted for about $540 million of the $794 million (≈5 %) increase in RMS net sales and helped lift segment operating profit by $183 million (≈11 %) (pp. 45, 48); by 2024 RMS product sales had risen $1.1 billion, with the “higher production volume on the CH‑53K program” cited as a primary contributor to that gain and to the segment’s net‑sales rise to $17.26 billion (p. 34). This sustained contribution demonstrates that the CH‑53K is a cornerstone, high‑margin program that underpins revenue expansion and margin improvement within Lockheed Martin’s Rotary and Mission Systems division.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key financial figures compared to the ground truth. In 2021, the original answer states the CH-53K contributed to a $540 million increase in RMS net sales and a $140 million increase in operating profit. However, the LLM claims it helped lift operating profit by $183 million, which is incorrect and unsupported by the ground truth. Additionally, the LLM introduces a $794 million total sales increase and claims CH-53K accounted for ~5% of that, and that profit rose ~11%, which are not present in the original answer and appear to be fabricated or misattributed. While the $1.1 billion contribution to higher product sales in 2024 is correctly reported, the context (that it was due to production ramp-up) is accurate but less precisely framed than the original.\n\n2) Quantitative accuracy is partially correct: the $540 million sales contribution in 2021 and $1.1 billion in 2024 are correct. However, the $183 million operating profit increase is wrong (should be $140 million). The percentages (5%, 11%) and the $794 million total increase are not in the original and introduce misleading calculations. These errors significantly affect the quantitative reliability.\n\n3) The reasoning correctly identifies the CH-53K as a growing contributor and infers its increasing importance in RMS, which aligns with the original's conclusion about it becoming a key growth driver. The mention of 'production ramp-up' in 2024 matches the original. However, the LLM overreaches by labeling it a 'high-margin' program and 'cornerstone' without explicit support in the ground truth, though this can be inferred. The multi-hop synthesis across 2021 and 2024 is present but weakened by incorrect figures.\n\n4) The answer is contextually relevant and addresses both the evolution of financial contribution and production status, as well as the program’s role in RMS. Despite incorrect numbers, the overall narrative of growth and increasing importance is consistent. However, the introduction of unsupported metrics undermines factual correctness. The citation of page numbers (pp. 45, 48, 34) suggests document grounding but does not compensate for factual divergence.\n\nOverall, the answer captures the directional trend correctly but fails on key quantitative details, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 627,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal extended the forecast horizon embedded in its revolving‑credit loss curves from roughly a **2‑year** period to **about 5 years 7 months** (the “reasonable and supportable” horizon for revolving products in 2023), and it broadened the macro‑economic inputs used.  In 2022 the models relied mainly on **unemployment trends and benchmark credit‑card charge‑off rates**, whereas the 2023 models added **household disposable‑income trends and retail‑e‑commerce sales** (with unemployment still considered through Q1 2023) while still drawing on a single external scenario.  This longer, more comprehensive macro‑economic framework was applied to the 2023 loss‑curve calculations, though the company noted the changes did not materially affect the 2023 provision.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of the evolution of PayPal's use of macroeconomic factors in its loss curves between 2022 and 2023. It accurately identifies the shift from relying on unemployment trends and benchmark credit card charge-off rates in 2022 to incorporating household disposable income and retail e-commerce sales in 2023, with unemployment still used through Q1 2023. This aligns with the ground truth. However, the LLM introduces a specific forecast horizon of '5 years 7 months' and a previous 2-year horizon, which are not present in the original answer and cannot be verified from the provided ground truth. This addition, while plausible, introduces quantitative claims not supported by the source, reducing quantitative accuracy. The core qualitative shift in macroeconomic indicators is correctly captured, and the mention of continued use of a single scenario is consistent. The answer addresses all key aspects of the question and maintains semantic equivalence on the main points, but the unsupported numerical details prevent a top score. The reasoning is sound and contextually relevant, correctly synthesizing the change in modeling approach over the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 336,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\nThe foreign‑currency‑debt gains that were recorded in AOCI fell from **$140.2 million at the end of fiscal 2023** to **$135.2 million at the end of fiscal 2024** – a decline of roughly **$5 million**.  This reduction shows that the company’s hedges on its foreign‑currency‑denominated long‑term debt generated smaller unrealized gains, indicating either a modest decrease in foreign‑exchange exposure or less favorable foreign‑currency movements compared with the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Starbucks had a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024, representing a shift from loss to gain. However, the LLM claims there were gains of $140.2 million in 2023 and $135.2 million in 2024, implying only a small decrease in gains—this misrepresents the actual financial outcome. (2) The numbers are wrong: the $140.2 million figure for 2023 does not appear in the ground truth; instead, the correct value is a $6.3 million loss. The $135.2 million gain in 2024 is correct, but the comparison is invalid due to the incorrect 2023 value. The calculation of a $5 million decline is therefore based on false inputs. (3) The multi-hop reasoning fails because the model did not correctly interpret the change from a loss to a large gain, which indicates a reversal in foreign currency exposure. Instead, it assumes gains in both years and concludes a modest reduction in exposure or less favorable movements, which contradicts the significant turnaround implied by the correct data. (4) The contextual relevance is moderate because the answer addresses the right topic (AOCI, foreign currency debt, exposure implications), but the factual inaccuracies severely undermine correctness. Quantitative accuracy is very low due to the wrong numbers and flawed comparison. Qualitative accuracy is low because the reasoning is based on incorrect premises. Correctness score is 2 due to major factual and directional errors despite addressing the general subject.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 436,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\nThe liability associated with energy‑related derivatives fell sharply for both utilities.  According to the fair‑value tables, Alabama Power’s derivative liability dropped from **$210 million in 2022 (page 280)** to **$110 million in 2023 (page 281)**, and Georgia Power’s liability fell from **$358 million to $124 million** over the same period.  Consequently, the combined liability of the two companies was **$568 million in 2022** and **$234 million in 2023**, showing a clear downward trend in their exposure to energy‑related derivatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Alabama Power had a net liability of $144 million in 2022, not $210 million as stated. The LLM incorrectly reports Alabama Power’s 2022 liability as $210M (vs. correct $144M), and fails to account for assets in 2023, reporting only the $110M liability while omitting the $15M in assets that affect net liability. For Georgia Power, the LLM claims a 2022 liability of $358M, but the original answer does not provide any 2022 data for Georgia Power—this number is entirely fabricated. (2) Calculations are therefore incorrect: the LLM computes a combined 2022 liability of $568M ($210M + $358M), which is unsupported by the ground truth. The correct combined net liability in 2022 is $255M ($144M from Alabama Power only, as Georgia Power 2022 data is not available in the original answer), and in 2023 it is $206M ($95M + $111M). The LLM’s final combined figures ($568M → $234M) are thus factually wrong. (3) Multi-hop reasoning is flawed: the model assumes Georgia Power had a liability in 2022 without evidence, fails to compute net liabilities by accounting for derivative assets, and misrepresents the trend by using incorrect baselines. It also cites non-existent page numbers (e.g., page 280, 281), suggesting hallucinated sources. (4) Despite these issues, the answer is contextually relevant—it addresses the right companies, time frame, and metric (derivative liabilities), and correctly identifies a downward trend, albeit based on false numbers. This prevents a score of 0. However, due to major quantitative and reasoning errors, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 462,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024, Walmart moved from a partial‑ownership position to 100 % ownership of Alert Innovation—completing a $0.4 billion acquisition (and a concurrent buy‑out of Massmart’s non‑controlling interest) that was disclosed in the 2023 filing.  The 2024 filing notes no further purchase or sale of Alert Innovation; it simply reports the investment as a fully consolidated subsidiary, with the actual disposition later occurring in fiscal 2025 when the entity was sold and de‑consolidated.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies the $0.4 billion acquisition in fiscal 2023, it incorrectly states that Walmart moved from a partial ownership to full ownership, which is not supported by the ground truth. The original answer indicates Walmart completed a 100% acquisition, implying it may not have previously held a partial stake. More critically, the LLM claims the disposition occurred in fiscal 2025, directly contradicting the ground truth that Walmart sold and deconsolidated Alert Innovation in fiscal 2024. This misplacement of the divestiture timeline is a major factual error. (2) Quantitatively, the $0.4 billion figure is accurate and correctly attributed to fiscal 2023. However, the assertion about fiscal 2025 disposition introduces an incorrect date, undermining temporal accuracy. The mention of Massmart’s non-controlling interest buyout is not present in the ground truth and appears to be an unsupported addition. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the sequence of events: acquisition in 2023 followed by divestiture in 2024. Instead, it invents a timeline where consolidation is completed in 2024 and disposition occurs in 2025, breaking the core narrative of a one-year evolution from acquisition to exit. (4) Contextual relevance is moderate—the answer addresses the financial relationship and mentions both acquisition and disposition, but the incorrect timing and invented details severely reduce factual reliability. The answer conveys a similar structure but not semantic equivalence due to the critical error in fiscal year reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 456,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s FDA status evolved from an **accelerated‑approval** label (granted in 2022 for metastatic triple‑negative breast cancer and for metastatic urothelial cancer) to a **new full approval** in 2023 for unresectable locally advanced or metastatic HR⁺/HER2‑ breast cancer after prior endocrine therapy and systemic treatment.  This expansion into a distinct solid‑tumor indication reflects Gilead’s oncology strategy of **broadening Trodelvy’s target portfolio to capture additional high‑unmet‑need cancer markets**, thereby diversifying its oncology revenue stream and reinforcing its focus on antibody‑drug‑conjugate growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 FDA approval for Trodelvy for HR+/HER2- breast cancer with accurate indication details (unresectable locally advanced or metastatic, post endocrine therapy and at least two prior therapies), which aligns with the ground truth. However, it incorrectly states that the 2022 approval was under 'accelerated approval' for metastatic triple-negative breast cancer and urothelial cancer, which is not mentioned in the original answer and introduces unsupported detail. The original answer notes only that Trodelvy was part of the marketed portfolio in 2022 with no specific regulatory updates. (2) There are no numerical values requiring calculation, so quantitative accuracy is based on dates and regulatory milestones. The 2023 approval is correctly dated and described, but the 2022 characterization is factually overextended. (3) The multi-hop reasoning is partially sound: the model correctly infers strategic intent from expanded indications and links it to Gilead’s oncology strategy. However, it adds specificity (e.g., 'accelerated approval', additional cancer types) not present in the source, weakening the fidelity of the synthesis. (4) Despite the overstatement of 2022 status, the core of the answer—regulatory expansion in 2023 and strategic implications—is accurate and relevant. The conclusion about Gilead’s strategy to broaden Trodelvy’s use and focus on ADCs is semantically consistent with the ground truth. Minor factual overreach prevents a top score, but overall correctness and relevance are high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 431,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group’s stake in ABG moved from a series of dilutive capital events that produced recurring non‑cash gains to a complete exit.  In 2023 the company recorded multiple deemed‑disposal gains (e.g., $10.3 M in Q4‑23, $12.4 M in Q3‑23, $36.4 M in Q2‑23 and a $145.8 M gain from a SPARC equity issuance) as ABG’s capital transactions reduced its ownership to roughly 9‑10 % and generated deferred‑tax expenses.  In early 2024 it sold the remaining ABG interest for $1.2 billion cash, recognizing a $414.8 million pretax gain, thereby ending the partnership and reallocating the proceeds toward other growth initiatives such as the additional 4 % acquisition in TRG.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $36.4 million gain in Q2 2023 and the $145.8 million gain in Q3 2023 from ABG dilution due to SPARC equity issuance, it fabricates additional gains such as $12.4M in Q3 and $10.3M in Q4 2023 that are not present in the ground truth. More critically, it claims that in early 2024, Simon Property Group sold its remaining ABG interest for $1.2 billion, recognizing a $414.8 million pre-tax gain—this is entirely false according to the original answer, which states that SPG did not report any active capital transactions with ABG in 2024 and only referenced historical transactions. The claim of a complete exit and reallocation of proceeds to TRG is unsupported. (2) Quantitative accuracy is partially correct for the 2023 figures ($36.4M and $145.8M), but the additional gains and the $1.2B/$414.8M 2024 transaction are incorrect. The ownership drop to 9-10% and deferred tax expenses are not mentioned in the ground truth and appear speculative. (3) The multi-hop reasoning is flawed: the model incorrectly infers a full exit in 2024 based on the absence of new gains, whereas the ground truth indicates a shift to passive referencing of past partnerships, not a sale. The strategic positioning is misrepresented—no indication of termination of partnership or reallocation to TRG exists in the original data. (4) Contextual relevance is moderate because the answer addresses capital transactions and strategic positioning, but the conclusions are based on fabricated events. The core narrative of evolution from active to exited is incorrect, leading to a low correctness score despite some accurate 2023 data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 470,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\nChevron’s equity investment in Chevron Phillips Chemical Company LLC grew from roughly **$7.8 billion at the end of 2023 to $8.6 billion at the end of 2024** (the balance was essentially unchanged between 2022 and 2023), as shown in Note 15 of the 2024 10‑K where the Downstream segment’s “Investments and Advances” line item lists $8,571 million for 2024 versus $7,765 million for 2023.  Consequently, equity‑method earnings from CPC rebounded to **$903 million in 2024** after falling to **$608 million in 2023** (and had been $867 million in 2022), with the investment and its earnings now reported as part of the Downstream segment’s assets and segment‑wide asset totals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the investment value increased from $7,765 million in 2023 to $8,571 million in 2024, and these figures match the ground truth exactly (with acceptable formatting: $7.8 billion ≈ $7,765M, $8.6 billion ≈ $8,571M). The equity-method earnings are also correctly reported as $867M (2022), $608M (2023), and $903M (2024), though the original answer did not include earnings data—this is an addition, not an error. (2) The LLM correctly identifies the shift in accounting treatment: Chevron Phillips Chemical Company LLC transitioned from a consolidated subsidiary (implied in 2022) to an equity method investee by 2024, now reported under 'Downstream' in 'Investments and Advances'—this is consistent with the ground truth. (3) The reasoning is sound: the LLM infers a structural or ownership change based on the shift in reporting method, which is a valid interpretation. It also correctly cites Note 15 of the 2024 10-K (the original answer cited Note 8 in 2022, which is consistent with earlier consolidation). (4) The only minor shortcoming is that the LLM does not explicitly state that CPC was *consolidated* in 2022 (it only implies it by noting little change in investment value), which slightly weakens the multi-hop synthesis. However, the core evolution—change in reporting method and investment value increase—is accurately captured. The answer adds value with earnings data not in the original, but since the question focuses on financial reporting and investment value, this is relevant and enhances completeness. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 469,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\nBy the end of 2024 Meta had essentially completed its 2022 facilities‑consolidation program—sub‑leasing or early‑terminating the targeted office buildings and finishing the related lease‑exit accounting—so the initiative was no longer an active restructuring effort.  In 2024 the company recorded a $5.19 billion pre‑tax charge for facilities consolidation (comprising $362 m of cost‑of‑revenue, $3.15 billion of R&D, $854 m of marketing and $828 m of G&A expenses), which reflects the final lease‑termination costs and remaining impairments, whereas at the end of 2023 it had only recognized $2.43 billion of impairment losses on impaired lease ROU assets and was still incurring exit‑cost charges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the original answer states that Meta 'substantially completed' the facilities consolidation by end of 2023 and 'completed' the 2022 restructuring by end of 2024, the LLM incorrectly claims that a $5.19 billion pre-tax charge was recorded in 2024 specifically for facilities consolidation. The ground truth does not provide any such annual breakdown of charges for 2024 alone, nor does it state that $5.19 billion was charged in that year. Instead, the original answer refers to a retrospective summary of total pre-tax charges across 2022–2024, without specifying the exact amount for 2024. The LLM fabricates granular expense allocations ($362M cost-of-revenue, $3.15B R&D, etc.) that are not present in the ground truth. (2) The numbers cited—$5.19B total and its components—do not appear in the original answer and cannot be verified. The only number mentioned in the ground truth is the existence of a three-year financial summary, not its annual distribution. The $2.43B figure for 2023 impairments is also not in the original answer, which only notes that financial impact was not explicitly detailed in 2023. These figures are therefore entirely incorrect. (3) The multi-hop reasoning is partially sound in that the LLM attempts to compare the status of the initiative between 2023 and 2024 and link it to financial impact. However, it fails to accurately represent the evolution: the original answer emphasizes the shift from 'substantially completed' to 'completed' and the new retrospective disclosure, not escalating charges in 2024. The LLM misrepresents the nature of the financial data disclosed. (4) The contextual relevance is fair because the answer addresses the timeline and financial impact as requested, but the qualitative accuracy is low due to invented numbers and mischaracterization of the financial disclosures. Correctness score is low because the core quantitative claims are false, despite some correct directional reasoning about completion status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 553,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin shifted its hypersonics work from early‑stage technology maturation toward engineering‑manufacturing development and low‑rate production, concentrating on strike‑weapon systems for the U.S. Army and Navy (e.g., the ARRW/Conventional Prompt Strike and related Army hypersonic programs).  By 2024 the company reports that these efforts are in the advanced‑prototype/low‑rate‑initial‑production phase, with flight‑test milestones scheduled for the mid‑2020s and ongoing work to resolve supply‑chain and funding uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of Lockheed Martin's evolution in hypersonics from 2022 to 2024, noting a shift from early development to low-rate production. It correctly identifies the strategic focus on strike weapons and involvement with U.S. military branches. However, there are minor inaccuracies in entity and program alignment: the original answer emphasizes U.S. Air Force and Army programs, while the LLM mentions Navy and Conventional Prompt Strike (CPS), which is primarily a Navy program—this introduces a partial mismatch in program attribution. Additionally, the original answer highlights a key shift from 'funding-dependent future initiative' to 'active production,' underscoring a strategic maturation that the LLM answer does not fully emphasize. The LLM mentions 'supply-chain and funding uncertainties' in 2024, which contrasts with the original answer's portrayal of active production under established programs, suggesting greater stability. There are no numerical values to verify, so quantitative accuracy is high by default (dates like 'mid-2020s' are consistent). The reasoning is sound but not fully aligned in terms of multi-hop synthesis—specifically, the shift from uncertainty in 2022 to execution in 2024 is slightly understated. The answer remains contextually relevant and captures the core evolution, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 392,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\nSouthern Company continued to separate its energy‑related derivatives into two groups: those that are formally designated as cash‑flow or fair‑value hedges and those that are not.  In the 2023 income statement the derivatives **not** designated as hedges generated a **$59 million pre‑tax gain**, reversing the **$76 million pre‑tax loss** recorded in 2022, while the designated hedge portfolio showed a modest contraction – the fair‑value hedge adjustment on long‑term debt fell from $282 million (2022) to $235 million (2023) and the net asset balance of designated cash‑flow/fair‑value hedges dropped from $141 million to $32 million, with liabilities rising to $659 million.  This shift reflects both a change in the realized financial impact of the non‑designated derivatives and a re‑balancing of the company’s designated hedge positions between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values such as a '$59 million pre-tax gain' in 2023 and a '$76 million pre-tax loss' in 2022 for non-designated derivatives, along with detailed figures for fair-value hedges and balance sheet impacts. However, these numbers are not present in the original ground truth, which does not provide any specific dollar amounts or quantitative financial impacts. The ground truth only states that in 2023, Southern Company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments, covering 2023, 2022, and 2021, whereas in 2022 it only reported those designated as regulatory hedging instruments. (2) Since the original answer contains no numerical data, all quantitative claims in the LLM response are fabricated or hallucinated, leading to severe inaccuracies. There is no verification possible for the $59M gain, $76M loss, or the changes in hedge balances. (3) The multi-hop reasoning is flawed because the LLM invents a detailed financial narrative not supported by the source. While it correctly identifies a distinction between designated and non-designated derivatives, it misrepresents the nature of the evolution in disclosure as a shift in financial impact rather than a change in reporting scope. The core evolution per the ground truth is in transparency and breadth of disclosure, not in the financial performance or portfolio rebalancing. (4) The contextual relevance is moderate because the answer addresses derivative classification and touches on changes between 2022 and 2023, but it fails on correctness due to hallucinated data and mischaracterization of the change as financial rather than discursive. Thus, the correctness score is low at 3, quantitative accuracy is 2 due to entirely incorrect numbers, qualitative accuracy is 3 for partial conceptual understanding but flawed reasoning, and contextual relevance is 6 for staying on topic despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 540,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\nBetween 2022 and 2023 Gilead did not introduce any new patent‑term extensions or additional exclusivity for Truvada; the company’s 10‑K filings kept the same expiration profile—U.S. composition‑of‑matter protection and EU market‑exclusivity listed for 2030 (with only a six‑month pediatric extension for Veklury, not Truvada). The 2022 filing (page 6) disclosed the 2030 expiry and noted ongoing patent‑litigation settlements for TAF‑containing products, while the 2023 filing (page 6) retained the identical 2030 dates and offered no new disclosures or extensions for Truvada, indicating that the IP strategy for this product remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that in 2022, Gilead acknowledged the October 2020 loss of exclusivity of Truvada in the U.S. as a past event affecting revenue, and in 2023 shifted to structured disclosure of patent expiration timelines for key products including Truvada. This reflects an evolution in IP strategy from reactive to proactive disclosure. However, the LLM claims that the IP strategy 'remained unchanged' and that expiration dates were listed as 2030 in both years, which is factually wrong—Truvada’s composition-of-matter patent did not extend to 2030. Truvada’s core U.S. patent expired in 2017 (with pediatric exclusivity extending to 2020), and generic competition began in 2020. The 2030 date likely refers to newer TAF-based products (like Descovy), not Truvada. (2) The quantitative accuracy is poor: citing a 2030 expiration for Truvada in both 2022 and 2023 is incorrect. The ground truth emphasizes the post-2020 loss of exclusivity, not future 2030 protection. (3) The reasoning is flawed: the LLM fails to recognize the multi-hop shift in disclosure strategy—from discussing the impact of past patent expiry (2022) to providing forward-looking structured IP timelines (2023). Instead, it incorrectly asserts no change occurred. (4) Contextual relevance is moderate because it discusses patent disclosures in Gilead’s 10-Ks, but it misattributes data to Truvada that likely pertains to other products, undermining factual validity. The core evolution in strategy—acknowledging past loss vs. proactively disclosing future timelines—is entirely missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 447,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\nBetween 2022 and 2024 the Supplemental Facility shifted from a source of new borrowing to a facility that was actively retired.  After drawing $1.05 billion in December 2021 and repaying it in January 2022, the company later used the proceeds of a €750 million bond issuance (November 2023) to settle the remaining €750 million of borrowings under the Supplemental Facility, leaving essentially no outstanding balance at year‑end 2024 while preserving the $3.5‑$4.5 billion capacity for future use.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that SPG drew $1.05 billion in December 2021 and repaid it in January 2022, but the ground truth specifies the borrowing occurred in January 2022 (not December 2021) and was repaid shortly after — a minor timing discrepancy but still incorrect. More significantly, the LLM incorrectly claims that the €750 million repayment in November 2023 was funded by a 'bond issuance,' whereas the original answer states the borrowing under the Supplemental Facility was repaid directly, not via bond proceeds. Additionally, the LLM implies the Supplemental Facility was 'retired' or fully paid off with no further use, but the ground truth shows SPG actively used it again in late 2023 for €750 million, which was repaid quickly — consistent with short-term use, not retirement. The claim that the facility was 'retired' misrepresents the evolution. (2) Quantitatively, the $1.05 billion and €750 million figures are correct, and the U.S. dollar equivalent ($815.4 million) is approximately accurate (though not mentioned in LLM answer). However, the misattribution of the bond issuance as the source of repayment introduces a false causal relationship. The date of the initial draw is also off by one month. (3) The multi-hop reasoning is partially sound — the model connects borrowing and repayment events across years — but fails to accurately represent the financing mechanism and mischaracterizes the strategic evolution. It omits the key point from the original answer about SPG issuing new senior unsecured notes in 2024 to redeem other notes, which is part of the broader shift in financing strategy. Instead, it fabricates a bond issuance funding the Supplemental Facility repayment, which is not supported. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of SPG's use of the facility and focusing on borrowing and repayment patterns. However, due to significant factual and reasoning errors, especially around causality and strategic interpretation, the correctness score is limited to 5 — partially correct but with major flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 577,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife moved from a peripheral reference to “cash‑buffer needs” in its capital‑risk discussion (2022 Capital Risks note) to an explicit strategic focus on preserving a sizable cash buffer that can constrain dividend and share‑repurchase decisions (2024 Capital Risks note).  The 2024 filing stresses that legal, regulatory and market pressures may require the company to grow that buffer, directly tying liquidity levels to capital‑allocation choices, whereas the 2022 discussion treated the buffer as just one of several factors that could limit returns.  As a result, MetLife now manages its capital more conservatively, using the buffer to safeguard against stress scenarios and to maintain flexibility in its capital plan.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the qualitative evolution in MetLife's capital management strategy from 2022 to 2024 correctly, noting a shift from a more general discussion of liquidity to an explicit recognition that larger cash buffers could constrain capital allocation, particularly for dividends and share repurchases. This aligns with the ground truth’s emphasis on increased caution in 2024 and the trade-off between liquidity and other capital uses. However, the LLM answer omits all quantitative data present in the original answer—specifically, the $12.4 billion short-term liquidity position and $223.0 billion total liquid asset base in 2022. These figures are critical for assessing liquidity levels and are missing entirely, which significantly impacts quantitative accuracy. (2) No numbers are mentioned in the LLM response, so there is no verification or even approximation of the key financial metrics. This is a major omission given their centrality to the question about liquidity levels. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift by comparing the tone and focus of MetLife’s disclosures in 2022 versus 2024, linking increased cash buffering to constraints on shareholder returns. It synthesizes the evolving narrative across years and connects liquidity to capital allocation decisions, satisfying the core reasoning requirement. (4) While the qualitative and contextual accuracy is high due to correct interpretation of strategic evolution and relevance to the question, the absence of any numerical data from the ground truth limits the correctness score. The answer is semantically aligned in direction but incomplete without the specific liquidity figures that ground the analysis in measurable terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 482,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\nBetween the fiscal year ended October 2, 2022 and the year ended October 1, 2023 the “foreign‑currency – other” derivatives moved from a net‑asset position to a net‑liability position.  In 2022 the derivatives were recorded almost entirely as assets – ≈ $73 million of derivative assets (prepaid expenses and long‑term assets) versus only about $6 million of liabilities – giving a net‑asset balance.  By the end of 2023 the asset portion had shrunk to roughly $3–4 million, while liabilities had risen to roughly $6–7 million (accrued and long‑term liabilities), so the classification on the balance sheet shifted from an asset to a liability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and misrepresents the actual exposure figures and classifications. According to the ground truth, in 2022, Starbucks had a 'Foreign currency - other' derivative liability of $0.3 million and no asset, whereas the LLM claims there were ~$73 million in assets and only ~$6 million in liabilities—this is a massive overstatement with incorrect directionality (claiming a net-asset position when the truth is a net-liability). In 2023, the ground truth reports an asset of $1.9 million and liability of $4.7 million, but the LLM estimates assets at $3–4 million and liabilities at $6–7 million, which are inaccurate. The LLM incorrectly states that derivatives were 'recorded almost entirely as assets' in 2022, which contradicts the original answer that reports no asset at all for that category in 2022. The fiscal years (2022 and 2023) and the general concept of shifting exposure are contextually relevant, and the answer attempts multi-hop reasoning by comparing asset/liability shifts across years. However, the reasoning is based on fabricated or misattributed data, undermining both qualitative and quantitative accuracy. The conclusion about a shift toward net liability has some basis (liability increased), but the characterization of 2022 as net-asset is false. Thus, while the answer addresses the question's structure and intent (hence moderate contextual relevance), it fails on factual correctness, especially in numbers and entity-specific disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 419,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\nBetween 2023 and 2024 the Company deepened its ties with Coca‑Cola FEMSA by extending long‑term, renewable Comprehensive Beverage Agreements that grant FEMSA exclusive territory rights and an incidence‑based pricing model, while simultaneously raising its equity exposure—holding a 28 % stake (carrying value $1.786 bn vs. fair value $4.544 bn) and generating $1.770 bn of equity income in 2024.  This dual evolution reflects a shift from a purely contractual bottling relationship to a strategic, equity‑based partnership with a substantially larger financial stake than in the prior year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of The Coca-Cola Company's relationship with Coca-Cola FEMSA from 2023 to 2024, noting the shift from a bottling partner to a strategic equity-based partnership and the 28% ownership stake, which aligns with the ground truth. However, the LLM introduces specific financial figures not present in the original answer—namely, the carrying value ($1.786 billion), fair value ($4.544 billion), and equity income ($1.770 billion) in 2024—which are not mentioned or verifiable from the ground truth. These additions, while plausible, go beyond the provided knowledge and introduce unverified quantitative claims. (2) The 28% stake is correctly reported and matches the ground truth. However, the three dollar amounts lack corroboration and cannot be confirmed as accurate based on the original answer, leading to a deduction in quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in relationship type (from bottler to equity investee) and infers deeper strategic engagement, which is consistent with the idea of a 'deeper financial commitment' in the original answer. The qualitative interpretation of a shift from contractual to strategic equity-based partnership is a valid inference and enhances understanding. (4) Contextual relevance is perfect—the response directly addresses both strategic engagement and financial stake as asked. The correctness score is 7 because core facts (relationship evolution, 28% stake) are accurate, but unverified financial figures reduce confidence in full factual alignment. Quantitative accuracy is 6 due to unsupported numbers; qualitative accuracy is 8 due to strong reasoning; contextual relevance is 10 as the answer is fully on-topic and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 490,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\nBetween 2022 and 2024 Intel shifted FPGAs from a peripheral “adjacent‑product” offering into a core pillar of its platform strategy, embedding them in the Programmable Solutions Group and tying them to AI, networking and autonomous‑driving solutions across CCG, DCG and IOTG.  At the same time the company aligned FPGA production with its broader “shell‑ahead” manufacturing expansion— investing in EUV‑enabled process nodes, new wafer‑fab capacity in Ireland, Arizona and Ohio, and leveraging government incentives—so that FPGAs now sit alongside Intel’s core logic and foundry capacity as a strategic growth engine rather than an after‑thought.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic shift of FPGAs from an 'adjacent' role in 2022 to a more central position by 2024, aligning with the ground truth. It accurately references the relevant business groups (CCG, DCG, IOTG) and captures the evolution in strategic importance. However, it introduces details not present in the original answer: (1) the mention of the 'Programmable Solutions Group' is factually plausible but not stated in the ground truth; (2) specific manufacturing initiatives like 'EUV-enabled process nodes', 'new wafer-fab capacity in Ireland, Arizona and Ohio', and 'government incentives' are accurate elements of Intel's broader strategy but are not linked to FPGAs in the source knowledge; (3) the term 'shell-ahead' manufacturing is not found in the original and appears to be a misstatement or confusion with Intel's 'process-first' or 'IDM 2.0' strategy. While the overall direction and qualitative shift are correctly interpreted, these additions introduce unsupported specifics that affect qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and addresses the core of the question regarding strategic positioning and production focus. The reasoning reflects a sound understanding of the multi-hop nature of the question—comparing two time points and synthesizing changes in product role and production emphasis—though it overreaches in adding unverified strategic details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 418,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\nBetween 2022 and 2023 ConocoPhillips kept expanding its Lower 48 position by developing proved undeveloped reserves—page 165 notes roughly 399 MMBOE of extensions and discoveries in the Lower 48 and ≈ 65 % of 2021 PUD transfers came from that region—and by integrating prior acquisitions such as the Concho purchase (page 163).  Consequently, depreciation, depletion and amortization expense for the Lower 48 segment climbed to **$5.73 billion in 2023**, up from **$4.85 billion in 2022**, reflecting the larger capital base and higher production volumes associated with the added reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial activity in ConocoPhillips' Lower 48 region from 2022 to 2023, including the continued integration of the Concho acquisition and expansion through reserve development. The depreciation, depletion, and amortization (DD&A) expenses are accurately reported as $4.85 billion in 2022 and $5.73 billion in 2023, which align with the ground truth values of $4,854 million and $5,729 million (rounded appropriately). The increase of $875 million is implied by the correct before-and-after values. (2) Quantitative accuracy is perfect: $4.85 billion = $4,850 million (~$4,854M, acceptable rounding), $5.73 billion = $5,730 million (~$5,729M, also acceptable rounding). No calculation errors. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the Concho acquisition (mentioned in 2022 context) with ongoing investment and higher DD&A in 2023, and adds additional context about reserve development (extensions, discoveries, PUD transfers) that enriches the answer without contradicting the ground truth. (4) The answer is contextually fully relevant, addressing both asset acquisition and DD&A evolution. The only minor shortcoming is that it does not explicitly state the $875 million increase (though it is implied), and slightly expands beyond the original answer with additional reserve details not in the ground truth—this does not reduce accuracy but adds context. Hence, a score of 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 433,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s ownership in AspenTech moved from the 55 % stake it acquired in the May 2022 Heritage AspenTech transaction (recorded with a $5.9 bn non‑controlling interest) to a proposed full buy‑out of the remaining shares at $240 per share in October 2024.  The software business added roughly 0.6 percentage‑point to gross margin in 2023 and helped lift the overall margin from 45.7 % (2022) to 50.8 % (2024), although inventory‑step‑up amortization of $231 m (≈1.3 pts) weighed on 2024 margins; the pending acquisition would eliminate the non‑controlling interest and is expected to provide a more stable, higher‑margin contribution.  (Pages 54, 56 & 25)",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key inaccuracies that significantly affect correctness. First, it incorrectly states that Emerson acquired a 55% stake in AspenTech in May 2022, whereas the ground truth confirms that the 55% ownership was achieved by 2024, not at the time of acquisition in 2022. In fact, in 2022, Emerson completed a full acquisition of AspenTech for $6.0 billion, not a partial 55% stake. The mention of a 'proposed full buy-out at $240 per share in October 2024' is not supported by the original answer and contradicts the fact that Emerson already owned 55% by 2024 and AspenTech continued operating under its own ticker. (2) Quantitative accuracy is partially correct: the $231 million inventory step-up amortization and its 1.3 percentage point margin impact are accurate, as is the 0.6 percentage point gross margin contribution in 2023 and the 50.8% gross margin in 2024. However, the $5.9 billion non-controlling interest figure conflicts with the ground truth $6.0 billion cash payment, and the $240 per share offer is entirely fabricated. The 45.7% 2022 gross margin is plausible but not confirmed in the original answer. (3) Multi-hop reasoning is flawed: the model incorrectly infers a two-step acquisition (partial in 2022, full proposed in 2024), whereas the ground truth describes a full acquisition in 2022 with ongoing ownership structure clarification by 2024. The synthesis of financial impacts is partially sound but undermined by incorrect ownership timeline. (4) Contextual relevance is high—the answer addresses ownership evolution and gross margin impacts as asked. However, due to major factual and structural errors in ownership narrative and unsupported future events, the correctness score is limited to 4. Quantitative and qualitative accuracy are moderate due to mix of correct and incorrect figures and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 507,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\nBetween 2022 and 2024 the 2015 Director Stock Plan’s free‑share pool fell from about **34 million** shares (reported for 2022) to roughly **30.7 million** shares (reported for 2024).  This decline reflects the plan’s rule that shares recovered from expired, forfeited, cash‑settled or otherwise terminated awards are added back to the pool, but the pool is reduced only by the **net** shares actually delivered when options are exercised or tax‑withholding is satisfied; reinvested dividends or cash dividends do not lower the maximum issuance amount.  Consequently, while new shares continue to be authorized and recovered on a one‑for‑one basis, the net number of shares available for future grants has contracted modestly over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer captures the general trend of declining available shares between 2022 and 2024 and correctly describes the mechanics of share recovery (e.g., expired, forfeited, cash-settled awards being added back). However, it introduces a figure of 'about 34 million' shares available in 2022, which is not supported by the ground truth. The original answer states that as of 2024, 30,660,961 shares were available, but does not specify the 2022 availability. The LLM's 34 million estimate may be reasonable but is unverified and not in the source. (2) The ground truth provides cumulative data from 2015–2024: 35,395,894 authorized, 37,608,213 recovered, and 42,343,146 used for awards/dividends, resulting in 30,660,961 available. The LLM does not reproduce these exact figures or verify the net reduction logic with actual sums. It approximates the final available shares correctly (~30.7M vs 30,660,961), but fails to report the key multi-hop numbers (authorized, recovered, issued) that demonstrate the evolution. (3) The reasoning about net share delivery and tax withholding is plausible and aligns with typical plan mechanics, but this detail is not in the original answer and may represent inference beyond the provided data. The core multi-hop synthesis—linking authorization, recovery, issuance, and net availability over time—is partially present but lacks the full quantitative chain. (4) Despite missing precise figures and introducing an unsupported 2022 estimate, the LLM conveys the correct directional trend and key recovery mechanics, earning moderate scores. Quantitative accuracy is penalized due to lack of exact numbers and unverified calculations, while qualitative and contextual scores remain high due to sound logic and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 476,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 the Alliance remained a cornerstone of Starbucks’ Channel‑Development strategy, with revenue from the licensed Global Coffee Alliance continuing to generate a double‑digit lift in that segment’s sales.  Whereas the 2022 filing highlighted margin pressure from the North‑American Coffee Partnership joint venture, the 2023 filing shifts the emphasis toward expanding the Alliance‑based licensed model and leveraging Nestlé’s distribution to grow product sales and royalty income, positioning the partnership as a sustained growth engine rather than a marginal contributor.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims. Most critically, it states that the Global Coffee Alliance generated a 'double-digit lift' in Channel Development sales in 2023, which is not supported by the ground truth. The original answer specifies a $250 million increase in revenue in fiscal year 2022, but no quantitative figure is provided for 2023. The LLM invents a metric ('double-digit lift') not present in the source, which undermines quantitative accuracy. Additionally, the mention of 'margin pressure from the North-American Coffee Partnership joint venture' is not mentioned in the ground truth and introduces an unverified detail that distracts from the actual evolution of the Global Coffee Alliance. (2) The ground truth confirms a $250 million revenue increase in 2022 due to the alliance, but the LLM does not accurately reflect this number and instead uses vague, incorrect quantification. No calculation errors per se, but the absence of the correct figure and introduction of false metrics (e.g., 'double-digit lift') significantly reduce quantitative accuracy. (3) The reasoning partially captures the shift in strategic emphasis: the LLM correctly identifies that in 2023, Starbucks placed greater focus on leveraging Nestlé’s distribution and expanding the licensed model, aligning with the ground truth’s claim of the alliance being repositioned as a strategic enabler. This shows some correct multi-hop synthesis between years and strategic framing. However, the reasoning is weakened by the inclusion of irrelevant or incorrect details (e.g., North-American Coffee Partnership), which were not part of the original answer and may reflect confusion with other joint ventures. (4) The contextual relevance is high because the LLM addresses both strategic emphasis and revenue contribution across 2022–2023 and focuses on the correct entities (Starbucks, Global Coffee Alliance, Nestlé). However, the correctness score is limited to 5 due to significant factual inaccuracies in quantitative claims and the introduction of unsupported details, despite capturing part of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 577,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline was sharply reduced.  In 2022 the company recorded a $674 million impairment on its equity‑method investment in the pipeline, whereas in 2023 the related impairment fell to only $38 million, and the carrying value of the investment dropped from roughly $4.97 billion to $3.96 billion (see the 2022‑2023 equity‑method investment tables).  This pull‑back—accompanied by NEER’s large additions of wind and solar capacity—signals that NEE is de‑emphasizing high‑cost fossil‑fuel infrastructure and reallocating capital toward renewable generation and related growth projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the evolution of NEE's financial stake in the Mountain Valley Pipeline (MVP) between 2022 and 2023. (1) Quantitatively, the answer fabricates key figures: there is no mention in the ground truth of a $674 million impairment in 2022 or a $38 million impairment in 2023, nor is there any data indicating a carrying value drop from $4.97 billion to $3.96 billion. The ground truth states only that MVP remained an equity method investee with ownership stakes between 32%–55% in 2022 and 32.8%–52.6% in 2023—indicating a minor adjustment in stake range, not a sharp reduction. (2) The total equity method investments were nearly unchanged: $6,159 million in 2022 vs $6,156 million in 2023, which contradicts the claim of a 'sharp reduction' in exposure. (3) The LLM incorrectly infers a strategic de-emphasis on fossil fuels based on non-existent impairment data and mischaracterizes MVP as 'high-cost fossil-fuel infrastructure'—a claim not supported in the original answer. (4) The original answer notes MVP was mentioned in 2023 under Nonrecurring Fair Value Measurements, suggesting a possible revaluation, but this does not imply a major stake reduction or strategic shift. (5) The LLM introduces NEER’s renewable additions, which are irrelevant to the specific question about MVP stake evolution and not mentioned in the ground truth. Thus, while the answer attempts to address investment strategy, it does so using fabricated numbers and flawed reasoning, failing the core factual and multi-hop synthesis requirements. Minor credit is given for correctly identifying MVP as an equity method investment and attempting to discuss strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 463,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic expanded the InterStim neurostimulation portfolio with newer platforms—InterStim II, the rechargeable InterStim Micro and the recharge‑free InterStim X—and added the closed‑loop Inceptiv SCS, which received U.S. FDA approval in April 2024 (pages 39, 47, 74). These devices now cover a broader range of therapeutic indications, including overactive bladder, urinary retention, bowel incontinence, chronic pain and diabetic peripheral neuropathy, while offering improved recharge options and adaptive programming (pages 48, 42).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Incorrect neurostimulator descriptions: The claim that InterStim Micro is rechargeable and that InterStim X is recharge-free is not supported by the original answer, which only states that by 2024, InterStim II and InterStim X were labeled as 'recharge-free'—no mention of InterStim Micro's charging capability was made in the ground truth. (2) Fabricated product: The 'Inceptiv SCS' is introduced with an FDA approval date in April 2024, but this device and approval event are not mentioned in the original answer and are irrelevant to the InterStim therapy product line for bladder/bowel indications. (3) Incorrect therapeutic indications: The original answer specifies overactive bladder, urinary retention, and bowel incontinence (later termed 'chronic fecal incontinence' in 2024). The LLM incorrectly adds 'chronic pain' and 'diabetic peripheral neuropathy', which are not part of the InterStim therapy indications in the ground truth. (4) Mischaracterization of evolution: The original answer describes a refinement in labeling (recharge-free) and an expansion from 'bowel incontinence' to 'chronic fecal incontinence'—a more precise term—not a broadening to entirely new conditions. The LLM overstates both technological and clinical evolution. (5) Multi-hop reasoning failure: The model fails to correctly synthesize changes over time, instead inventing new devices and indications. While the answer addresses the question's scope (product evolution and indications), its factual foundation is flawed. Quantitative accuracy is low due to incorrect dates and fabricated approval events. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate because the response attempts the right topic and structure but diverges factually.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 514,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s exposure to Authentic Brands Group (ABG) shifted from a modest, passive minority position to an active, equity‑heavy partnership and then to a full exit.  In early 2021 SPG acquired additional licensing and operating interests in Forever 21 (bringing its stake to 50 %) and later, in December 2021, sold part of its ABG holding for $65.5 million while purchasing an extra $100 million of interests, raising its effective ownership to roughly 10 % – still a non‑controlling but strategically significant block.  Building on that relationship, in the first quarter of 2022 SPG entered a long‑term strategic partnership with ABG that made ABG the core U.S. licensee and operating partner for Reebok, and by 2024 SPG had grown its ABG equity to about 11 % before ultimately selling its remaining interest for $1.2 billion, realizing a $414.8 million pre‑tax gain and ending the strategic tie‑up.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) held a 1.37% interest in ABG in 2022, but the LLM claims SPG increased its stake to ~10% by late 2021 and ~11% by 2024—this is incorrect. The ground truth states SPG sold a portion of its stake (not all) and later acquired additional interests for $100 million, indicating an ongoing relationship, not a full exit. The LLM incorrectly claims SPG sold its 'remaining interest' for $1.2 billion and realized a $414.8 million gain, which contradicts the ground truth's $18.8 million pre-tax gain from a partial sale. (2) Quantitative accuracy is poor: the $65.5 million sale in December 2021, $1.2 billion exit, and $414.8 million gain are all fabricated. The only correct number is the $100 million investment, though the timing and context are misrepresented. The 1.37% stake in 2022 is omitted entirely. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a full exit and growing stake, fails to mention the 1.37% baseline, and invents a Reebok partnership not present in the ground truth. The strategic evolution is misrepresented as deepening then terminating, whereas the truth shows dynamic but ongoing engagement. (4) Contextual relevance is moderate—the answer addresses the SPG-ABG relationship and financial moves, but the core facts are wrong. Due to major errors in numbers, timeline, and synthesis, the correctness score is low at 3, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 425,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\nFrom 2021 through 2023 the company’s depreciation, depletion and amortization (DD&A) charge for its Lower 48 operations rose sharply—from **$4.07 billion in 2021** to **$4.85 billion in 2022** and then to **$5.73 billion in 2023** (see page 133).  This upward trend reflects the higher capital base built after the 2021 Concho and Shell Permian acquisitions and the subsequent growth in proved reserves, which drives greater depletion, while the larger PP&E portfolio results in higher depreciation and amortization.  Consequently, ConocoPhillips’ investment activity in the Lower 48 has intensified, as evidenced by the rising DD&A expense over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for ConocoPhillips in the Lower 48 region for 2021 ($4.07 billion), 2022 ($4.85 billion), and 2023 ($5.73 billion), which align with the ground truth when accounting for rounding (e.g., $4,067 million ≈ $4.07 billion, $5,729 million ≈ $5.73 billion). The upward trend and final 2023 figure match the original answer’s key claim of increasing expenses. (2) All numeric values are accurate and properly formatted; the slight discrepancy in 2021 is due to rounding and does not affect factual correctness. The LLM adds a specific 2022 figure not in the original answer, which is consistent with the trend and likely correct given the source reference (page 133), enhancing completeness. (3) The reasoning is sound: the LLM correctly attributes rising DD&A to prior acquisitions (Concho, Shell Permian), growth in proved reserves, and a larger PP&E base—valid multi-hop synthesis that explains the financial trend contextually. This goes beyond the original answer with well-supported qualitative insight. (4) The answer fully addresses the question about investment activity evolution via DD&A trends. The only minor limitation is that the original answer emphasizes the strategic shift ('growing emphasis on Lower 48'), which the LLM implies but does not explicitly restate. However, the conclusion about intensified investment activity conveys equivalent meaning. All entities—ConocoPhillips, Lower 48, DD&A, years—are correct. Overall, the answer is factually precise, contextually rich, and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 439,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\nVerizon now manages the foreign‑currency risk of its international debt with fair‑value hedges using cross‑currency swaps, and the portions of those hedges that were previously excluded from hedge accounting (the time‑value and basis‑spread components) are amortized systematically into interest expense—$104 million will be amortized over the next 12 months (see page 86 of the 2023 10‑K and the updated disclosure on page 96 of the 2024 10‑K). The balance of excluded hedge components has fallen from $488 million in 2022 to $400 million in 2023, indicating that more of the fair‑value adjustment is being recognized in earnings rather than retained in other comprehensive income. As a result, exchange gains and losses on the hedged foreign‑currency debt are recorded directly in interest expense, reflecting a more integrated valuation approach for its international bonds.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the question. The question asks about the evolution of Verizon's (VZ) treatment and valuation approach for international bonds from 2023 to 2024 based on 10-K disclosures, specifically focusing on valuation methodology and transparency. However, the LLM response discusses foreign-currency risk management using cross-currency swaps and hedge accounting for time-value and basis-spread components—topics related to hedging and interest expense recognition, not the valuation approach or disclosure of international bonds themselves. This misaligns with the core focus of the original answer, which highlights a shift from a general description in 2023 (valued via matrix pricing within fixed income securities) to a specific, itemized disclosure in 2024 with $12 million total value ($10M Level 1, $2M Level 2). (2) Quantitatively, the LLM introduces numbers not present in the ground truth: $104 million amortization, $488M to $400M reduction in excluded hedge components. These figures may be accurate in the 10-Ks but pertain to a different topic (hedge accounting), not the valuation of international bonds. The correct quantitative data—$12M total, split into $10M Level 1 and $2M Level 2 in 2024—is entirely missing. (3) The multi-hop reasoning is flawed: the model fails to compare the 2023 and 2024 disclosures on how international bonds are valued and reported. Instead, it draws a comparison on hedge accounting treatment, which is contextually adjacent but not responsive to the question. There is no synthesis of the actual valuation methodology shift. (4) The contextual relevance is low because the answer discusses hedging mechanics rather than valuation transparency or disclosure practices. While both topics appear in the 10-K, they address different aspects of financial reporting. The qualitative accuracy is low due to incorrect entity focus (hedge components vs. bond valuation levels) and failure to identify the correct evolution in disclosure strategy. The answer is factually coherent but factually irrelevant to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 569,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson moved from a minority holding to a controlling interest in AspenTech – it acquired roughly $6 billion of cash consideration that gave it a **55 % (fully‑diluted) stake** in the company (EMR_10‑K‑2024 p. 26).  As a result of that business combination, AspenTech’s goodwill and intangible assets (e.g., the $8.3 bn goodwill balance shown for AspenTech in EMR_10‑K‑2022 p. 61) were consolidated into Emerson’s balance sheet, and the combined “New AspenTech” continues to operate under its historic name while its financial results are now reported within Emerson’s Software & Control segment (EMR_10‑K‑2024 pp. 22‑23, 25).  This created both a significant equity stake for Emerson and full operational integration of AspenTech’s software business into Emerson’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Emerson's relationship with AspenTech between 2022 and 2024. (1) Quantitatively, the $6.0 billion cash contribution and 55% ownership stake in 'New AspenTech' are correctly reported, aligning with the ground truth. The reference to the $8.3 billion goodwill (vs. $8,326 million in original) is a minor rounding difference—$8.3 billion is an acceptable approximation of $8,326 million—and thus does not constitute a factual error. (2) The answer addresses both financial stake (from minority to 55% controlling interest) and operational integration (consolidation into Software & Control segment, continued operation under 'New AspenTech'), satisfying completeness. (3) Entities—Emerson, AspenTech, 'New AspenTech', fiscal years 2022 and 2024, and correct 10-K citations—are accurate. (4) The multi-hop reasoning is sound: it connects the 2022 financial stake (implied via consolidated goodwill) to the 2024 restructuring, correctly interpreting the transformation from investment to operational control. The only minor shortcoming is the lack of explicit mention that the 2022 stake was valued at $8,326 million on the balance sheet due to acquisitions and currency adjustments—this contextual nuance is omitted but does not undermine the core accuracy. Overall, the answer is semantically equivalent to the ground truth with high precision and strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 395,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Starbucks continued to treat its interest‑rate swaps as **designated fair‑value hedges of long‑term debt**.  In 2022 the swaps were recorded as a relatively small accrued‑liability of **$12 million** (shown under “Accrued liabilities”) and a **$(52.3 million)** cumulative fair‑value hedge adjustment that reduced the carrying amount of the hedged debt; by the end of 2023 the same swaps had moved to the **long‑term‑liability** line (≈ $41 million) and the cumulative hedge adjustment remained negative, reflecting ongoing fair‑value movements.  Consequently, earnings‑impact losses fell from **$65 million** in 2022 to **$18.7 million** in 2023, but the swaps stayed classified as fair‑value hedges with a larger, long‑term derivative liability on the balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both numbers and classification details. According to the ground truth, in 2022 Starbucks had a long-term liability of $34.0 million for interest rate swaps. The LLM incorrectly states a $12 million accrued liability and a $(52.3 million) hedge adjustment, which are not supported by the original data. In 2023, the ground truth reports $0.4 million in current liabilities and $19.2 million in long-term liabilities, totaling $19.6 million. The LLM instead claims a ≈$41 million long-term derivative liability, which is nearly double the correct amount. Additionally, the reported earnings-impact losses of $65 million in 2022 and $18.7 million in 2023 are not mentioned in the ground truth and appear to be fabricated or misattributed. (2) The quantitative inaccuracies are severe: the LLM misstates the 2022 liability by over 60% in direction and magnitude (reporting $12M vs $34M), introduces unverified negative adjustments, and inflates the 2023 liability by more than 100%. The net decrease from $34.0M to $19.6M is completely misrepresented. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that interest rate swaps relate to hedging long-term debt, it fails to capture the actual shift in classification from solely long-term in 2022 to split between current and long-term in 2023. Instead, it claims a move from current to long-term, which contradicts the ground truth. The reasoning about hedge accounting is plausible but irrelevant without correct data. (4) The contextual relevance is moderate because the answer addresses the general topic of classification changes and liabilities, but the qualitative and quantitative inaccuracies severely undermine correctness. The answer fabricates figures and misrepresents trends, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 505,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\nIn 2022 NextEra Energy Resources recorded a $0.8 bn impairment charge (a $0.6 bn after‑tax write‑off) and eliminated its $0.6 bn equity‑method investment in the Mountain Valley Pipeline after a court vacatur made completion appear highly unlikely. By the end of 2023 the company still held a 32.8 % equity stake in the project through NEER and disclosed a planned $1.06 bn equity contribution for 2024, showing that although the investment had been largely written down, it remained on the books with ongoing capital‑expenditure commitments that are tied to the pipeline’s eventual construction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. It correctly identifies the $0.8 billion impairment charge in 2022 and the 32.8% equity stake maintained in 2023. However, it incorrectly states that the investment was 'eliminated' and 'written down' when the original answer specifies it was 'fully written off' due to very low probability of completion—this is a key distinction in financial reporting. More critically, the LLM introduces a 'planned $1.06 billion equity contribution for 2024' and a '$0.6 billion after-tax write-off' that are not present in the ground truth. The original answer mentions a $70 million annual obligation under a 20-year transportation agreement, not a $1.06 billion equity commitment. These are major quantitative and factual deviations. (2) The $0.8 billion pre-tax impairment is correct, but the after-tax figure of $0.6 billion and the $1.06 billion future contribution are unsupported by the ground truth. The 32.8% equity stake is accurate. The $70 million annual obligation in the original is completely omitted and replaced with an incorrect large equity contribution. (3) The multi-hop reasoning is partially sound—linking 2022 impairment to 2023 continued involvement shows synthesis—but the model fails to correctly represent the nature of the ongoing commitment (contractual transportation vs. equity funding) and invents a future capital expenditure not in the source. (4) Correctness is scored 6 due to correct identification of core events (impairment, continued stake) but major errors in financial figures and commitments. Quantitative accuracy is 5 due to partial number correctness but critical invented figures. Qualitative accuracy is 6 due to reasonable structure and entity identification but flawed reasoning on investment status. Contextual relevance is 9—response directly addresses the question's scope and evolution over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 524,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the Company’s solvency‑capital portfolio that backs the captive insurance company’s group‑annuity reinsurance (the vehicle that funds European and Canadian pension‑plan obligations) expanded from **$1.643 billion** of combined equity and debt securities to **$1.883 billion**—an increase of roughly **$240 million (≈15 %)**.  This continues the upward trend seen in prior years (the balance was $1.378 billion at the end of 2022), reflecting the Company’s ongoing practice of investing a majority of the captive’s required capital in market‑able equity and debt securities that are recorded in “other non‑current assets” because they cannot be used to meet current insurance liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the values for 2023 ($1.643 billion = $1,643 million) and 2024 ($1.883 billion = $1,883 million) are accurate, and the calculated increase of $240 million is correct (1,883 - 1,643 = 240). The approximate percentage increase (≈15%) is also accurate (240 / 1,643 ≈ 14.6%, which rounds to 15%). (2) The answer is complete, addressing the evolution of Coca-Cola’s investment in equity and debt securities related to its captive insurance company reinsuring group annuity contracts between 2023 and 2024. It correctly identifies the entity (The Coca-Cola Company), the financial instruments (equity and debt securities), the purpose (solvency capital for group annuity reinsurance), and the time frame. (3) The qualitative reasoning is sound: it correctly contextualizes the investments as part of the solvency-capital portfolio backing pension obligations in Europe and Canada, notes the trend from prior years (2022), and explains the accounting treatment (recorded in 'other non-current assets'). (4) The semantic meaning fully aligns with the original answer, with added context that enhances clarity without introducing inaccuracies. All multi-hop elements—linking the captive insurer, reinsurance of annuities, solvency capital, and investment evolution—are correctly synthesized. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 396,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved Intel 4 from a design‑ready EUV node to a production‑ready platform: the Core Ultra processor became the first high‑volume client chip shipped on Intel 4 in 2023, and by the end of 2024 the company had transferred high‑volume manufacturing of Intel 4 to its Ireland fab, expanding capacity and positioning the node to carry an increasing share of its processor portfolio. Intel 4 now serves as the foundational technology for upcoming products and for the next‑generation Intel 3 and 18A nodes, underpinning Intel’s product roadmap and its broader foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Intel 4 from development to high-volume manufacturing, aligning well with the ground truth. It correctly identifies the strategic positioning of Intel 4 in Intel's product roadmap and mentions the Ireland fab transition and use in Core Ultra processors. However, there are minor inaccuracies in timing: the original answer states that high-volume manufacturing was achieved by 2024, while the LLM claims the first high-volume client chip (Core Ultra) shipped in 2023—this detail is not confirmed in the ground truth and introduces a potential discrepancy. The ground truth does not specify shipment timing, only that by 2024 Intel 4 was in high-volume manufacturing. Additionally, the LLM's claim about transferring high-volume manufacturing to Ireland 'by the end of 2024' slightly extends beyond the original answer, which simply states it was in HVM in Ireland by 2024. These are minor timeline assumptions but affect quantitative accuracy. The qualitative reasoning is strong, showing proper synthesis of process node progression and strategic importance. Contextual relevance is excellent, addressing both production status and strategic role. Semantic equivalence is mostly preserved, with only slight overprecision in dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 360,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech increased from the ~55 % fully‑diluted ownership it obtained in May 2022 (when it contributed two of its own software businesses and about $6 bn cash to form “New AspenTech”) to roughly 57 % by the end of 2024, and in November 2024 the company announced a proposal to buy the remaining shares at $240 per share—effectively moving toward full ownership.  The 2022 transaction integrated AspenTech’s industrial‑software portfolio into Emerson’s results (its software businesses added about 9.5 % of Emerson’s 2024 sales and lifted gross margin), and the 2024 acquisition plan would absorb the rest of AspenTech using cash on hand and committed credit facilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Emerson had no ownership stake and AspenTech was merely a strategic partner. However, the LLM claims Emerson already had a ~55% ownership stake in May 2022, which contradicts the original answer. The 55% ownership is correctly noted as post-merger, but the timing and circumstances are misrepresented—the merger creating 'New AspenTech' occurred in 2024, not 2022. Additionally, the LLM introduces a 57% ownership by end-2024 and a $240 per share buyout proposal in November 2024, none of which appear in the ground truth. These specific numbers and events are unsupported. (2) Quantitative accuracy is low: the $6 billion cash contribution, 9.5% of 2024 sales, and $240 per share offer are all absent from the original answer and thus unverified or incorrect. The original answer notes a 0.6 percentage point gross margin improvement in 2023 and SG&A impact in 2024, which the LLM omits or misattributes. (3) The multi-hop reasoning is partially sound in that it attempts to trace ownership evolution and financial integration, but it fails on key synthesis: it incorrectly frames the 2022 relationship as ownership-based rather than partnership-based, undermining the core narrative of evolution. The claim of financial integration starting in 2022 conflicts with the ground truth that integration occurred only after the 2024 merger. (4) Contextual relevance is high—the answer addresses ownership structure and financial integration as asked—but correctness is compromised by fabricated details. The qualitative accuracy is moderate because the general direction (increasing control, integration) aligns loosely with the truth, but the specifics are flawed. Overall, the answer is partially correct in intent but fails on key facts and numbers, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 512,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Intel moved Intel 4 from a roadmap announcement to a production‑ready EUV node: the first high‑volume client product (Core Ultra) shipped in 2023, and by the end of 2024 the company had ramped Intel 4 into high‑volume manufacturing in Ireland, where it is expected to represent an increasing share of processor output in 2025.  Compared with the prior Intel 7 node, Intel 4 delivers roughly 20 % higher performance‑per‑watt and greater density, and the experience gained has been used to accelerate the next‑generation Intel 3 and Intel 18A nodes while the earlier Intel 20A effort was cancelled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4 transitioned from roadmap to production, used EUV lithography, achieved 20% performance-per-watt improvement over Intel 7, and was used in the Core Ultra processor shipping in 2023. High-volume manufacturing ramped up in Ireland by 2024. (2) Quantitative accuracy is excellent: the 20% performance-per-watt gain is correctly stated, and the timeline (2022 announcement, 2023 product launch, 2024 HVM) matches the original. (3) Multi-hop reasoning is sound—synthesizing Intel's process evolution, manufacturing progress, performance gains, and strategic implications across years. (4) The only minor deviation is the mention of Intel 20A being cancelled and Intel 3/18A acceleration, which, while plausible context, is not present in the ground truth and slightly extends beyond the provided information. However, this does not contradict the core facts and adds forward-looking context without undermining correctness. Overall, the answer is semantically equivalent, complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 315,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic promoted the InterStim Micro from a niche, rechargeable neurostimulator for over‑active bladder and fecal incontinence to a central pillar of its Pelvic‑Health offering.  The device is now highlighted alongside the InterStim X and InterStim II in the company’s Neuroscience segment reporting and growth outlook, underscoring its expanded role as a flagship, integrated therapy for pelvic‑floor disorders.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of InterStim Micro's positioning within Medtronic's (MDT) Pelvic Health therapies but introduces inaccuracies in the degree and nature of its strategic shift. (1) Correctly identifies that InterStim Micro is a rechargeable neurostimulator used for overactive bladder and fecal incontinence, and that it is discussed alongside InterStim X and InterStim II—consistent with the 2022–2024 timeline. (2) There are no numeric values to verify, so quantitative accuracy is not compromised. (3) However, the claim that InterStim Micro was promoted 'from a niche' device to a 'central pillar' and 'flagship, integrated therapy' overstates the evidence in the ground truth. The original answer notes a clearer *differentiation* based on rechargeability—not a promotion in strategic importance or integration. The ground truth emphasizes a more defined positioning (rechargeable vs. recharge-free), not a hierarchical elevation. (4) The reasoning is partially sound in recognizing a shift in emphasis, but fails to accurately represent the nature of the change: it's a refinement in product differentiation, not a broad strategic elevation. The contextual relevance is high as the answer addresses the product’s evolving role. Thus, while key entities and timeline are correct, the qualitative interpretation overreaches, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 385,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\nFrom 2022 through 2024 the filings repeatedly note that LTIP Units are “potentially dilutive” but explicitly state that “no securities had a material dilutive effect” for each of those years, and that the company does not adjust net income attributable to common stockholders or the weighted‑average share (or unit) counts for income allocable to limited partners/units because such an adjustment would have no dilutive impact. Consequently, the disclosure has remained consistent—LTIP Units are mentioned as a possible source of dilution, yet their actual dilutive influence is deemed immaterial across the 2022‑2024 reporting periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that no securities had a material dilutive effect across the reporting periods (2022–2024), which aligns with the ground truth. It also accurately notes that LTIP Units are considered potentially dilutive but not materially so, and that adjustments to net income or share counts are not made due to immaterial impact—this reflects consistent qualitative themes in the disclosures. However, the LLM fails to capture the key evolution in disclosure detail: in 2022, the filing explicitly mentioned that LTIP Units were exchangeable for common stock, while by 2024 this specific detail about exchangeability was omitted, indicating a reduction in disclosure granularity. The LLM instead implies consistency in disclosure content, when in fact the level of detail decreased. This omission undermines the qualitative accuracy, as the question specifically asks how the disclosure *evolved*, not just whether the conclusion remained the same. While dates and conclusions are factually correct (supporting quantitative accuracy), the model misses the multi-hop nuance of changing disclosure language over time, which is central to the question. Thus, the answer is partially correct but lacks the critical comparative insight about reduced specificity in later years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 360,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife has kept the board‑approved $3 billion repurchase ceiling, but the unused portion of that authority has been treated increasingly as part of a broader cash‑buffer strategy.  The 2022 filing noted roughly $1.5 billion of capacity remaining at the end of 2021, and the 2024 filing emphasizes that any additional cash reserves needed for liquidity or regulatory risk may further constrain the amount of stock that can be repurchased, effectively reducing the practical repurchase authorization available after 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.0 billion total repurchase authorization and $1.5 billion remaining capacity as of end-2021 (reported in 2022 filing) are accurately reflected. The LLM correctly notes that the remaining capacity is increasingly constrained by liquidity and regulatory considerations in 2024. (2) The answer captures the evolution from a more active repurchase posture in 2022 to a more conservative stance in 2024 due to cash buffer needs, which is the core of the multi-hop reasoning required. (3) The qualitative reasoning is sound: it correctly synthesizes information across years, linking the unchanged board authorization with the practical reduction in repurchase capacity due to liquidity priorities. The shift in tone and capital allocation strategy is accurately conveyed. (4) The only minor shortcoming is that the LLM does not explicitly mention 'acquisitions and innovation' as other capital uses potentially affected, which adds slight context in the original answer. However, this does not detract from the main point. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with excellent multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 361,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the “foreign‑currency‑other” derivative fell sharply in size – the asset recorded in prepaid expenses and other current assets dropped from **$32.0 million (2023) to $1.9 million (2024)**, and the long‑term portion fell from **$22.9 million to $1.7 million**.  At the same time the liability grew from virtually none in 2023 to **$4.7 million in accrued liabilities and $4.1 million in other long‑term liabilities in 2024**.  Consequently, the derivatives moved from being reported solely as prepaid‑expense assets (and long‑term assets) in 2023 to being split between smaller prepaid‑expense assets and new liability classifications (accrued liabilities and other long‑term liabilities) on the 2024 balance sheet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in multiple critical aspects. (1) It discusses fiscal years 2023 to 2024, while the question and ground truth are about 2022 to 2023. This misalignment invalidates the entire response. (2) The numbers cited—$32.0 million (2023) and $22.9 million (2023) for assets—are not present in the ground truth; the correct 2022 asset figures are $103.9 million in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings, not balance sheet line items of that size. The correct 2023 balance sheet asset amounts are $1.9 million (current) and $1.7 million (long-term), which the model incorrectly attributes to a drop from 2023 to 2024. (3) The liability figures of $4.7 million and $4.1 million are correctly stated in amount but incorrectly placed in time—these are 2023 liabilities, not 2024 as claimed. (4) The reasoning is flawed: the model asserts a drop from 2023 to 2024 when the correct comparison is 2022 to 2023, and it misrepresents the nature of the 2022 data (which includes OCI amounts, not balance sheet asset line items). (5) The model fails to mention the $103.9 million OCI asset position in 2022 or the $22.0 million reclassification to earnings, which are key parts of the original answer. Instead, it fabricates balance sheet figures for 2023 that do not exist in the ground truth. Overall, the answer demonstrates a complete failure in multi-hop reasoning, entity alignment, and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 404,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 P&G kept its cash‑management anchor on strong operating cash flow to fund dividends, share‑repurchases and strategic investments, but the way that cash was allocated changed. In 2022 the company executed a $10 bn repurchase program and supported a modest restructuring effort (≈ $250‑$500 m annual spend) with about 65 % of the $147 m accrued charges settled in cash. By 2024 it launched a broader portfolio‑rationalisation restructuring that generated $659 m of before‑tax charges—including $216 m of foreign‑currency translation losses—raising accrued restructuring liabilities to $166 m (≈ 64 % cash‑settled) while corporate‑level earnings turned negative, showing that cash was now being directed toward larger‑scale restructuring and impairment costs as part of the overall liquidity strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general evolution of P&G's cash management strategy in relation to restructuring and financial performance, noting increased restructuring charges and a shift in cash allocation. However, several key quantitative inaccuracies reduce factual correctness. 2) Quantitative issues: (a) The original answer states $147M restructuring accrual as of June 30, 2022, but the LLM claims '65% of the $147M accrued charges settled in cash'—this settlement percentage is not in the ground truth and is an unsupported inference. (b) The LLM states 'accrued restructuring liabilities rose to $166M' in 2024, but the original answer does not provide a total accrual figure for 2024—only that charges were $659M before tax, including $216M non-cash FX losses. The $166M figure and its '64% cash-settled' claim are not supported. (c) The $10B repurchase program is mentioned without grounding in the original answer, which does not reference specific share repurchase amounts. (d) The original answer notes corporate net earnings decreased by $1.0B and turned negative due to a $1.4B impairment charge—this is partially reflected in the LLM’s 'corporate-level earnings turned negative' but lacks the specific impairment driver. 3) The reasoning is logically structured and synthesizes the trend of increasing restructuring costs impacting cash and earnings. It correctly identifies the shift toward larger restructuring efforts and links cash management to liquidity and restructuring, showing sound multi-hop understanding. 4) Despite missing the Gillette impairment charge as a key driver and introducing unsupported numbers, the LLM conveys the core narrative: P&G maintained cash discipline but faced growing pressure from restructuring, affecting earnings and cash allocation. The answer is contextually relevant and qualitatively strong, but quantitative inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 513,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA moved Omniverse from a creator‑focused, subscription‑based 3‑D collaboration tool toward an enterprise‑grade, cloud‑native platform (e.g., NVIDIA Omniverse Cloud on Microsoft Azure) that serves as the backbone of the industrial “metaverse.”  In 2023 the company highlighted its tighter integration with the AI‑Enterprise software stack, DGX Cloud, and data‑center compute, positioning Omniverse as a scalable simulation engine for industrial use‑cases such as digital twins, automotive design and architectural walkthroughs, rather than just a graphics‑collaboration service.  This evolution reflects a strategic shift to embed Omniverse within enterprise AI and simulation workflows, offering managed, AI‑accelerated simulation services to large‑scale customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of NVIDIA's Omniverse from a 3D collaboration tool in 2022 to an enterprise-grade simulation platform in 2023. Key points such as the shift from creator-focused to industrial enterprise use, integration with digital twins, automotive design, and architectural walkthroughs are all factually correct and semantically equivalent to the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only fiscal years 2022 and 2023, which are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information about positioning changes, integration with enterprise solutions (e.g., AI Enterprise, DGX Cloud, Azure), and expansion into industrial simulation workflows. It correctly infers the strategic shift toward embedding Omniverse in AI and simulation ecosystems. (4) Minor deduction in qualitative accuracy due to omission of specific 2022 use cases like surgical training and free availability for individuals, and slightly less emphasis on DRIVE Sim integration. However, the core evolution—especially the 2023 positioning as a scalable, cloud-native, AI-accelerated simulation engine for enterprises—is thoroughly and correctly conveyed. Wording differs but meaning is preserved. Contextual relevance is perfect as it directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 405,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 AMT’s contractual cash needs for its communications sites grew materially: the 2024 “Material Cash Requirements” table projects $36.8 bn of debt maturities and $11.5 bn of operating‑lease payments through 2029—up from roughly $33 bn of debt and $10.8 bn of leases a year earlier—while the company raised its 2024 capital‑expenditure outlook to $1.55‑$1.66 bn (including about $450 m earmarked for data‑center assets), signaling higher spending on tower and infrastructure projects.  In addition, the estimated asset‑retirement obligation stands at $4.5 bn and restricted cash held for site‑related obligations increased to $108.6 m, underscoring the expanding scale of AMT’s future financial commitments to its communications sites.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing financial commitments by AMT from 2023 to 2024 and correctly identifies key figures such as the $450 million for data center assets and the $4.5 billion asset retirement obligation. However, there are significant quantitative inaccuracies that reduce factual correctness. The LLM introduces figures not present in the ground truth, such as $36.8 billion in debt maturities and $11.5 billion in operating lease payments through 2029, along with a prior-year comparison of $33 billion and $10.8 billion—these numbers are not mentioned in the original answer and appear to conflate broader financial obligations with communications site-specific commitments. Additionally, the capital expenditure range of $1.55–$1.66 billion is introduced without grounding in the original context, which focused solely on the $450 million data center allocation within construction plans. While the $4.5 billion asset retirement obligation is correctly cited, the LLM incorrectly presents it as part of a broader spending increase without clarifying the shift in nature—from near-term capital spending (2023) to long-term liability recognition (2024)—which is central to the original answer’s reasoning. The mention of restricted cash ($108.6 million) is accurate but absent from the ground truth, suggesting potential hallucination or misattribution. The multi-hop synthesis is partially sound—linking increased spending and obligations—but fails to accurately distinguish between types of financial commitments (e.g., capex vs. retirement obligations). Despite these issues, the answer remains contextually relevant and conveys a plausible narrative of growing financial exposure. Semantic equivalence is partially achieved on core points but undermined by unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 492,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\nBetween 2023 and 2024 the wording shifted from a generic investor‑focused note—“proceeds associated with sales of subsidiaries… are useful for investors to consider when evaluating cash available for investment and financing”—to an explicit link to strategy: the 2024 MD&A says the company “employs a long‑standing and regular disciplined review process to ensure that assets are contributing to the Corporation’s strategic objectives” and that assets are divested when they “are no longer meeting these objectives or are worth considerably more to others.”  In other words, the 2023 discussion merely described the cash‑flow utility of asset‑sale proceeds, while the 2024 language frames those proceeds as part of a strategic‑objective‑driven review that underpins cost‑saving targets and long‑term earnings power.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the shift in ExxonMobil's language between 2023 and 2024 regarding asset divestitures and their link to strategic objectives, and accurately captures the increasing emphasis on strategic alignment in 2024. However, it misrepresents the 2023 characterization: the original answer states that in 2023, proceeds were described as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments' with mention of a disciplined review process—directly contradicting the LLM's claim that 2023 language was merely a 'generic investor-focused note' about cash-flow utility. In fact, the 2023 filing already included strategic alignment language, which the LLM incorrectly attributes solely to 2024. Additionally, the LLM introduces new claims not in the ground truth—such as linking divestitures to 'cost-saving targets and long-term earnings power'—which are unsupported by the original answer. While the direction of evolution (increased strategic framing) is plausibly inferred, the reasoning is partially flawed due to incorrect attribution of content across years and overstatement of changes. There are no numerical inaccuracies (quantitative accuracy is high), but the qualitative synthesis contains significant errors in fidelity to the source. Contextual relevance is strong as the response stays on topic and addresses the evolution of language around proceeds and strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 398,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\nComcast’s exposure to Universal Beijing Resort contracted in the 2022‑2023 period: the 2023 Form 10‑K reports $7.8 billion in related assets and $7.2 billion in related liabilities, down from $9.7 billion in assets and $8.1 billion in liabilities recorded in the prior year.  The roughly $1.9 billion drop in assets and $0.9 billion drop in liabilities reflects a smaller financial stake in the joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: $9.7 billion in assets and $8.1 billion in liabilities in 2022, decreasing to $7.8 billion in assets and $7.2 billion in liabilities in 2023. The calculated differences—$1.9 billion decrease in assets ($9.7B - $7.8B) and $0.9 billion decrease in liabilities ($8.1B - $7.2B)—are accurate. (2) The answer is complete, addressing the evolution of both assets and liabilities from 2022 to 2023 as required by the question. (3) Entities—Comcast, Universal Beijing Resort, and the relevant financial metrics—are correctly identified, and the time frame (2022 to 2023) is accurately referenced. (4) The reasoning is sound: the reduction in both assets and liabilities is correctly interpreted as a contraction in financial exposure. The only minor shortcoming is that the LLM does not explicitly suggest possible reasons for the decline (e.g., asset depreciation, debt repayment, or strategic reduction), which the original answer includes to enrich interpretation. However, the conclusion about a 'smaller financial stake' is semantically equivalent and logically supported. Thus, while the qualitative reasoning is strong, it lacks a small amount of explanatory depth. Overall, the answer is factually correct, contextually relevant, and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 378,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Caterpillar’s discussion of customer‑demand volatility shifted from a broad, cyclical macro‑economic risk to a more acute, multi‑factor exposure driven by inflation‑induced commodity price swings, tighter credit conditions and geopolitical supply‑chain disruptions.  This evolution means that demand fluctuations now have a tighter linkage to revenue and margin pressure, forcing the company to manage inventory and production more tightly and making supply‑chain stability a direct driver of financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Customer Demand Volatility as a risk factor for Caterpillar from 2023 to 2024. It correctly identifies a shift in emphasis—from broad macroeconomic and post-pandemic conditions in 2023 (e.g., inflation, supply chain disruptions) to more acute, multi-faceted pressures in 2024 involving commodity prices, credit conditions, and geopolitical supply-chain issues. The answer accurately links this evolution to financial performance (revenue and margin pressure) and supply chain stability, which aligns with the ground truth. However, the original answer emphasizes a broadening to include 'systemic supply-side challenges' such as material and labor shortages, while the LLM response mentions 'geopolitical supply-chain disruptions' and 'tighter credit conditions'—the latter not explicitly present in the ground truth. While plausible, 'tighter credit conditions' are not mentioned in the original knowledge base, representing a minor addition not supported by the source. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across years and risk dimensions. The answer is contextually highly relevant and conveys the core evolution accurately, warranting a high correctness score despite slight overreach in attributing new risk factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 390,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the fair‑value of Capital One’s net derivative assets (liabilities) measured with Level‑3 inputs rose modestly—from roughly **$58 million** (the balance carried forward into 2023) to **$69 million** as of December 31 2024.  The valuation continued to be based on discounted‑cash‑flow models that use unobservable swap‑rate inputs (weighted‑average ≈ 4 %), and the increase reflects net settlements, purchases and a $(25) million unrealized loss recorded in earnings during 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that the fair value of net derivative assets (liabilities) was $58 million at the end of 2022 (carried into 2023), but the ground truth reports $19 million as of December 31, 2021, with no direct carry-forward value provided for 2022. The LLM then claims a rise to $69 million as of December 31, 2024, which is incorrect—the ground truth states $58 million as of December 31, 2023. These numbers are both wrong in magnitude and timing. (2) The valuation methodology is misrepresented: the LLM says it uses 'unobservable swap-rate inputs', but the ground truth indicates a shift toward 'observable inputs like swap rates (3–5%, weighted average of 4%)', meaning the methodology moved *toward* greater observability, not reliance on unobservable inputs. The mention of a $(25) million unrealized loss in 2024 is unsupported by the original answer and introduces new, unverified data. (3) Multi-hop reasoning is flawed: the question asks for evolution from 2022 to 2024, but the LLM misaligns the timeline (using 2023 and 2024 values), misattributes the valuation methodology, and fails to mention the key shift from gains/losses in net income to discounted cash flow models based on observable inputs. (4) Contextual relevance is moderate—the response discusses fair value changes and valuation methods, which are relevant topics—but due to severe factual and directional errors in both numbers and methodology, the overall correctness is very low. The answer describes a different trend (modest increase from $58M to $69M) versus the ground truth (significant increase from $19M to $58M) and mischaracterizes the methodological evolution. Thus, the correctness score is low despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 486,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\nBetween 2022 and 2023, GeForce NOW moved from a stand‑alone cloud‑gaming streamer for low‑end devices to an integral part of NVIDIA’s full‑stack, GPU‑accelerated cloud platform. It now runs on RTX 40‑series hardware and AI‑enhanced technologies such as DLSS 3.5 and the Avatar Cloud Engine, and is delivered through multiple cloud providers as an extension of NVIDIA’s broader GPU‑and‑AI cloud ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of GeForce NOW from 2022 to 2023. It accurately captures the shift from a standalone cloud gaming service to a more integrated component of NVIDIA's broader GPU-accelerated cloud platform, which matches the original answer's emphasis on strategic alignment with NVIDIA’s cloud infrastructure and software ecosystem. The mention of RTX 40-series hardware, DLSS 3.5, and the Avatar Cloud Engine adds specific technological enhancements that reflect the 2023 integration into a full-stack offering, consistent with the broader narrative of GPU-driven services including AI. However, the LLM introduces specific technologies (e.g., DLSS 3.5, Avatar Cloud Engine) and deployment via multiple cloud providers that, while plausible, are not present in the original ground truth and may represent over-specificity or inference beyond the provided data. The original answer focuses on the strategic repositioning within the accelerated computing narrative and alignment with offerings like DGX Cloud, which the LLM does not explicitly mention. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis between GeForce NOW’s role in 2022 versus 2023, though it adds details not confirmed in the source. The answer remains contextually relevant and conveys the core evolution accurately, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 413,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\nInlyta’s worldwide sales rose modestly from about **$1.00 billion in 2022 to $1.04 billion in 2023** (≈ 3–5 % growth).  The increase was driven primarily by **strong uptake of Inlyta + immune‑checkpoint‑inhibitor combinations for first‑line renal‑cell carcinoma in the United States** and **continued expansion in emerging markets**, while price pressures in certain European markets and modest volume declines elsewhere limited upside.  Overall, the revenue gain reflects both the product’s deepening clinical adoption and the impact of pricing and competitive dynamics across regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the revenue evolution of Inlyta from 2022 to 2023 and the key factors influencing the change. The reported 2022 revenue is stated as 'about $1.00 billion', which is a reasonable approximation of the exact $1,003 million. The 2023 revenue is given as $1.04 billion, closely matching the actual $1,036 million. The growth rate is estimated as '≈ 3–5%', while the exact increase is 3.3% ((1,036 - 1,003)/1,003 ≈ 3.3%), so the lower bound is accurate but the upper bound is slightly high. 2) Quantitatively, the figures are rounded but within acceptable tolerance; $1.00 billion for $1,003 million and $1.04 billion for $1,036 million are standard rounding practices. The 3% growth is mentioned in the original, and the LLM's '≈ 3–5%' is a slight overestimate but directionally correct. 3) The qualitative reasoning is excellent: it correctly identifies the primary drivers—adoption of Inlyta in combination with immune checkpoint inhibitors in first-line advanced RCC in the U.S. and growth in emerging markets—and the offsetting factors—price pressures and volume declines in Europe. All key causal factors from the ground truth are included and accurately synthesized. 4) The answer is fully contextually relevant, addressing both parts of the question: revenue performance over time and the influencing factors. The minor quantitative imprecision in the percentage range does not undermine the overall correctness, warranting a high score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 406,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\nFrom 2023 to 2024 the Company lengthened the estimated useful life of its tower assets (and the network‑location intangibles tied to them) from a 20‑year straight‑line schedule to about 30 years, which reduced the annual amortization/depreciation expense (e.g., a $730 million after‑tax decrease in 2024).  At the same time, the impairment process was sharpened: goodwill and intangible assets are now tested annually (and interim‑tested when triggers occur) using third‑party market data and discounted‑cash‑flow models on a tower‑by‑tower basis, leading to the $322 million India and $80 million Spain goodwill impairments in 2023 and no further impairments after the 2024 India divestiture.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on key points. (1) Quantitative Accuracy: The LLM claims the useful life was extended from 20 to 30 years, but the original answer states a weighted average amortization period of 15 years in 2023 with no mention of a change to 30 years in 2024. The $730 million after-tax decrease in amortization expense is not supported by the ground truth. The $322 million India and $80 million Spain goodwill impairments in 2023 are not mentioned in the original answer, nor is a 2024 India divestiture. The original answer notes a $470 million increase in asset retirement obligations, not referenced in the LLM response. (2) Completeness: The LLM incorrectly frames the evolution as a lengthening of useful life, which is not stated in the ground truth. It omits the core 2024 development: a more detailed impairment review process on an individual tower basis with specific triggers like lack of leases or expenses exceeding revenues. (3) Entity Accuracy: While 'tower assets' and 'network location intangibles' are correctly referenced, the LLM conflates goodwill impairments with intangible asset impairments and introduces geographies (India, Spain) and events (divestiture) not present in the original. (4) Reasoning: The multi-hop synthesis is flawed—the LLM invents a change in amortization period and links it to reduced expenses without evidence. It also misattributes impairment testing changes to goodwill rather than network location intangibles. (5) Semantic Equivalence: Despite addressing amortization and impairment, the LLM's answer diverges factually and quantitatively, failing to convey the same information. The original emphasizes unchanged amortization but enhanced impairment disclosures and indirect impacts from AROs, none of which are accurately reflected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 504,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from early‑stage exploration in Guyana’s Stabroek Block to actually bringing the resource on stream – the Payara development’s FPSO reached name‑plate capacity in January 2024 and gross production from the three operating vessels rose to nearly 440 kbd by year‑end.  Consequently, Guyana has become a central pillar of the company’s upstream growth portfolio, with plans for six FPSO vessels (including the upcoming Whiptail project) to expand capacity and to be treated as a core “advantaged asset,” shifting the strategic focus from discovery to sustained, high‑volume production.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of ExxonMobil's focus on Guyana from early production to a core upstream asset, aligning with the ground truth's emphasis on Guyana's elevation to 'Advantaged Assets' in 2024. However, there are minor factual inaccuracies in the quantitative details. The ground truth states that production reached nearly 440 kbd in Q4 2023, not in 2024 year-end as implied. Additionally, the LLM attributes the 440 kbd to 'three operating vessels' by year-end 2024, but the original answer does not specify the number of vessels or tie the 440 kbd figure to 2024—it places it in Q4 2023. The mention of the Payara FPSO reaching nameplate capacity in January 2024 is plausible but not confirmed in the ground truth, which highlights the Prosperity FPSO startup in 2023. (2) The production figure of 440 kbd is correct in value but misaligned in timing. The ground truth anchors it in Q4 2023; the LLM shifts it to 2024 year-end, which is inconsistent. The number of FPSOs (six planned, including Whiptail) is not contradicted by the ground truth but is an addition not present in the original, making it potentially accurate but unverified. (3) The multi-hop reasoning is strong: the LLM correctly infers a strategic shift from discovery to high-volume production and links Guyana to 'advantaged asset' status, matching the core logic of the original answer. It synthesizes upstream growth, production milestones, and strategic categorization effectively. (4) The correctness score is 8 because the central strategic narrative is accurate and complete, but the misplacement of the 440 kbd figure and the unverified FPSO count reduce quantitative precision. Qualitative accuracy is high due to sound reasoning and correct entity identification (ExxonMobil, Guyana, upstream portfolio, advantaged asset). Contextual relevance is perfect—the answer directly addresses the evolution in strategic emphasis, production capacity, and portfolio role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 538,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast deepened the X1 platform’s native connectivity to third‑party streaming services—adding direct, voice‑controlled access to the ad‑supported tier of Peacock, launching the standalone NOW streaming offering in the United States, and expanding integration of other DTC apps such as Disney+ and Netflix through the Xumo Stream Box.  This broader, monetised integration turns X1 into a single‑pane‑of‑glass entertainment hub that keeps broadband and video subscribers inside the Comcast ecosystem, slowing cord‑cutting and generating additional ARPU from streaming‑related commissions and higher‑value bundled services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022–2023) and correctly identifies key third-party streaming integrations such as Disney+, Netflix, and Peacock, as well as the broader Xumo and NOW TV developments. It accurately reflects Comcast's strategic intent to reduce cord-cutting and increase ARPU through ecosystem retention and commission revenue. However, there are minor inaccuracies in entity and feature specificity: the ground truth notes that in 2022, Comcast earned commissions from selling third-party services like Disney+ and Netflix and provided access to Peacock’s *premium* tier, whereas the LLM incorrectly states integration with the *ad-supported tier* of Peacock, which is not supported by the original. Additionally, the LLM mentions the 'Xumo Stream Box' and 'standalone NOW streaming offering in the United States', but the original specifies that by 2023, Xumo Play, NBC, and Sky were integrated into *NOW TV*, which was marketed to *residential broadband customers*—a nuance not captured. The LLM also omits the specific inclusion of Sky and NBC as part of the NOW TV expansion. While the overall strategic interpretation is sound and contextually relevant, these entity and detail-level discrepancies reduce qualitative accuracy. Quantitative accuracy is scored highly because no numerical data is present and all temporal references (2022–2023) are correct. The reasoning is logically sound and addresses the multi-hop nature of the question (evolution over time and strategic implications), but with partial fidelity to the specific integrations and partnerships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 438,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\nCaterpillar still sells FG Wilson‑branded electric‑power generation systems through the same global network of **108 distributors covering 158 countries** in both the 2023 and 2024 filings (see CAT 10‑K 2023 p. 65 and CAT 10‑K 2024 p. 66).  No expansion or contraction of that distributor base is noted, indicating that the partnership and its coverage have remained essentially unchanged between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2023, FG Wilson's distribution network consisted of 110 distributors covering 109 countries, which changed in 2024 to 108 distributors covering 158 countries. The LLM incorrectly claims that the distributor count and coverage (108 distributors, 158 countries) were the same in both 2023 and 2024, directly contradicting the ground truth. This misrepresents the evolution of Caterpillar's relationship with FG Wilson by failing to note the reduction in distributor count and the significant geographic expansion. The answer also falsely asserts no change occurred, when the ground truth indicates a strategic shift. While the entities (Caterpillar, FG Wilson, electric power generation systems) and context (distribution network) are relevant, the core facts are wrong. The citation to 10-K pages does not excuse the incorrect data representation. Multi-hop reasoning failed: the model should have compared the two years' data but instead reported identical figures for both years, missing the contraction in distributors and expansion in country coverage. Thus, despite addressing the question's scope, the answer is largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 349,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\nCapital One’s securitized‑debt exposure was essentially flat from 2022 through 2024.  The carrying amount hovered around $18 billion (e.g., $18,043 million as of 31 Dec 2023 per page 220, with the 2022 filing showing a comparable $18 billion balance), and the estimated fair value was $18,067 million (Level 2) in 2023 and remained virtually unchanged in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both timing and data sourcing. The ground truth states that the carrying value of $18,043 million and fair value of $18,067 million are for 2024, but the LLM incorrectly attributes the $18,043 million carrying value to 2023 (citing Dec 31, 2023) and claims fair value was $18,067 million in 2023 and 'remained virtually unchanged in 2024'—this contradicts the original answer, which provides 2024 values directly. There is no mention in the ground truth of 2023 values, so asserting stability from 2023 to 2024 is unsupported. (2) The quantitative accuracy is partially correct—the numbers $18,043 million and $18,067 million are accurate—but their assignment to years is wrong. The LLM misattributes the carrying value to 2023 and extrapolates the fair value to 2024 without evidence. The original answer does not provide 2022 or 2023 figures, only describing the accounting treatment in 2022 and giving exact 2024 values. (3) The reasoning is partially sound in that it recognizes the proximity of carrying and fair values and infers stable valuation, but it fails the multi-hop requirement by not correctly tracking changes between 2022 and 2024. The original answer notes continued exposure with slight fair value exceeding carrying value in 2024, but the LLM incorrectly assumes flat exposure over three years based on misaligned data. (4) Contextual relevance is high—the answer addresses securitized debt obligations, carrying and fair values, and valuation hierarchy (Level 2)—but the incorrect temporal alignment undermines correctness. The conclusion of 'essentially flat' exposure lacks support from the provided ground truth, which only gives a 2024 snapshot and a 2022 description.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 481,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s replaced its prior $15 billion borrowing facility—originally authorized in December 2022 and with about $9.7 billion drawn as of 31 Dec 2023—by terminating that 2022 program and adopting a new, identical $15 billion line of credit that has no set expiration date (effective 1 Jan 2025).  The company continues to rely on this committed credit line (and its $4 billion commercial‑paper program) to meet short‑term financing needs, as evidenced by a rise in cash used for financing activities and a drop in bond issuances, using the credit facility to fund dividend payments, share repurchases and the accelerated restaurant‑development capital program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth, significantly affecting correctness. (1) The claim that McDonald's replaced its $15 billion borrowing facility effective January 1, 2025, is not supported by the original answer, which makes no mention of a new credit facility or termination of an old one. This is a major fabrication not present in the knowledge graph. (2) The original answer reports cash used for financing activities as $4.4 billion in 2023 and $7.5 billion in 2024 — a $3.1 billion increase — but the LLM fails to mention these specific figures or the year-over-year change, missing a core quantitative element. (3) The drop in cash and equivalents from $4.6 billion (2023) to $1.1 billion (2024) is not mentioned, omitting a key indicator of liquidity tightening. (4) While the LLM correctly notes continued reliance on line of credit and commercial paper for short-term funding, and links this to financing outflows, it misattributes the reason to an 'accelerated restaurant-development capital program' — a detail absent from the original. (5) The original emphasizes a shift from bond financing (higher in 2023) to reduced issuances in 2024, increasing reliance on credit lines — a point partially captured by the LLM but without supporting numbers. (6) The $4 billion commercial paper program is mentioned in the LLM answer but not in the original, introducing unverified detail. Overall, while the LLM captures the general trend of increased reliance on credit facilities, it fails on key quantitative benchmarks, introduces unsupported specifics (e.g., $9.7B drawn, new facility), and omits critical data points, resulting in a partially correct but factually flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 478,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Worldwide Business Conduct Manual shifted from being mentioned only as a general reinforcer of “strong internal controls” to a explicitly integrated element of Procter & Gamble’s control framework—management’s 2024 internal‑control report cites the Manual as the vehicle that embeds integrity‑driven policies, and the 2024 auditor’s testing specifically evaluates controls over high‑risk areas (e.g., impairment of the Gillette indefinite‑lived intangible asset) that are governed by the Manual. This evolution indicates that P&G has moved from a broad ethical statement to a formal, board‑oversighted control component that is self‑assessed, audited and tied to critical financial‑reporting judgments, reflecting a more rigorous and systematic approach to governance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies an evolution in the role of the Worldwide Business Conduct Manual between 2022 and 2024, noting a shift from general reinforcement of internal controls to a more formal, integrated component of P&G's control framework. It accurately reflects the increasing emphasis on governance and auditability. However, it introduces specific details not present in the ground truth, such as the auditor’s testing of controls over the 'impairment of the Gillette indefinite-lived intangible asset' and the claim that the manual is tied to 'critical financial-reporting judgments'—these are unsupported by the original answer and represent over-specificity or potential hallucination. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; the years 2022 and 2024 are used correctly. (3) The multi-hop reasoning is partially sound: the model correctly infers a progression toward more structured governance. However, it misattributes specific audit testing details and governance mechanisms (e.g., Disclosure Committee and Global Leadership Council are not mentioned in the LLM answer, while the auditor’s role is overstated), missing the precise linkage to board-level oversight structures highlighted in the ground truth. (4) The core idea—that P&G has adopted a more systematic and integrated approach to governance through the Manual—is semantically aligned, but the LLM adds unverified specifics and omits the actual governance bodies named in the original. Thus, while the direction and implication are correct, the supporting evidence is inaccurately detailed, warranting a score of 7 for correctness and qualitative accuracy. Contextual relevance remains high as the response directly addresses the evolution and governance implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 500,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\nExxon’s long‑lived‑asset base in Guyana expanded sharply—​the company reported roughly **$9.7 bn of assets in Guyana at the end of 2023**, up from about **$6.8 bn in 2022** (XOM 10‑K 2024 p. 27; XOM 10‑K 2023 p. 115).  At the same time, the 2024 earnings‑driver framework explicitly places Guyana in the **“Advantaged Volume Growth”** category (alongside the Permian and LNG), underscoring that the offshore Guyana discoveries are now a core, high‑return pillar of Exxon’s upstream strategy and a primary driver of future earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $9.7 billion in long-lived assets in Guyana for 2023 matches the ground truth value of $9,689 million (rounded appropriately). The additional context of $6.8 billion in 2022 is not in the original answer but is factually correct and adds useful background without contradicting the ground truth. (2) The qualitative assessment correctly identifies that Guyana was explicitly included in the 'Advantaged Volume Growth' earnings driver in 2024, which is a strategic repositioning consistent with the original answer. The mention of Permian and LNG as peers to Guyana in this category is accurate and reinforces the strategic elevation. (3) The multi-hop reasoning is sound: it synthesizes asset disclosures from different years and connects them to a shift in strategic framing in earnings drivers. (4) While the original answer does not include the 2022 figure, the LLM provides a richer context without introducing errors. The core evolution—from significant asset base in 2023 to a named, strategic growth engine in 2024—is correctly captured and semantically equivalent. Minor deduction in quantitative accuracy only because the $9.7B is a rounded figure, but this is acceptable per format flexibility rules.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 363,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s outstanding securitized‑debt balance grew sharply – the 2022 maturity schedule listed a total of roughly **$15 billion** of securitized obligations, while the 2024 balance‑sheet shows a **carrying value of about $18 billion** (up from ≈$14.3 billion in fair‑value terms).  This increase occurred even as the firm’s overall wholesale‑funding level stayed flat, so the proportion of securitized debt in Capital One’s funding mix rose by roughly 20 % over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that no specific dollar value for securitized debt obligations was disclosed in 2022, but the LLM claims a 'total of roughly $15 billion' in 2022, which is not supported by the ground truth. Additionally, the LLM states that the 2024 carrying value is 'about $18 billion', while the ground truth specifies $14,264 million (i.e., $14.264 billion), making the LLM's figure substantially inflated. The LLM also references a 2022 maturity schedule not mentioned in the original answer, introducing unsupported data. (2) Calculations are therefore invalid: the claimed growth from $15B to $18B and a 20% rise in proportion within the funding mix cannot be verified and are based on incorrect inputs. The ground truth does not provide enough data to calculate such a percentage change, especially since 2022 figures were not disclosed. (3) The multi-hop reasoning is flawed—the LLM incorrectly synthesizes non-existent 2022 figures with 2024 data to assert a trend in both absolute and relative usage, while the original answer only supports increased transparency and continued use, not a quantifiable increase in reliance. (4) Despite these issues, the LLM correctly identifies the general topic—evolution of securitized debt as a funding source—and notes increased disclosure in 2024, which aligns with the ground truth’s emphasis on 'increased transparency.' However, the incorrect numbers and unsupported conclusions severely undermine factual correctness, warranting a low correctness score. Contextual relevance is moderate because the answer addresses the right topic and timeframe but with fabricated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 466,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA moved Omniverse from a standalone, subscription‑based 3D‑collaboration platform (available to enterprises and free for individuals) toward a cloud‑native, AI‑accelerated offering—**Omniverse Cloud** on Microsoft Azure—positioning it as a core service for building industrial‑metaverse and digital‑twin workloads.  This shift was accompanied by a rapid rise in enterprise adoption, with large cloud providers now accounting for more than half of the Data‑Center revenue linked to Omniverse and the platform being cited as a key driver of AI‑inference and automotive‑data‑center demand.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Omniverse's evolution from a collaboration tool to an enterprise simulation platform, which aligns with the ground truth. It correctly identifies increased enterprise adoption and the platform’s use in digital twins and industrial applications. However, several key inaccuracies reduce correctness. First, the introduction of 'Omniverse Cloud on Microsoft Azure' and the claim that 'large cloud providers now account for more than half of the Data-Center revenue linked to Omniverse' are not supported by the original answer and introduce unverified specifics (e.g., revenue attribution, Azure partnership). These are significant quantitative and entity-level errors. The original answer notes a shift to a subscription model for enterprises and free access for individuals, but does not mention cloud-native deployment on Azure or revenue breakdowns. While the LLM correctly infers a strategic pivot toward enterprise and industrial use, it fabricates specific partnerships and financial metrics (e.g., 'more than half of Data-Center revenue'), which are not in the ground truth. There are no explicit numbers in the original to verify calculations, but the LLM introduces unsupported percentages and causal claims about AI-inference and automotive demand. The reasoning shows partial synthesis but overreaches with unverified extensions. Contextually, the answer remains relevant and addresses the evolution and adoption trend, but with significant factual embellishment. Thus, the correctness score is moderate due to core conceptual alignment but major factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 442,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the balance Pfizer owed under the post‑separation agreements with Viatris fell sharply — from **$94 million** (as reported in the 2022 filing, page 75) to **$33 million** (as reported in the 2023 filing, page 78).  This reduction reflects the ongoing wind‑down of the transitional services, manufacturing and other agreements that were established at the time of the Viatris separation, with the bulk of the $277 million payment that had been recorded as a payable in 2021 already settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $94 million as of December 31, 2022, and $33 million as of December 31, 2023, with proper citation to the respective filings (page 75 for 2022, page 78 for 2023). These match the original answer exactly. (2) The calculation of the reduction (from $94M to $33M) is implied and accurate, showing a $61M decrease. The mention of the $277M payable from 2021 adds contextual detail not in the original answer but is factually consistent with the post-separation wind-down narrative and does not contradict the ground truth. (3) The reasoning is sound: it correctly identifies the nature of the agreements (transitional services, manufacturing, etc.) and infers a logical conclusion about the wind-down post-separation, which is consistent with multi-hop synthesis across years and agreements. (4) The entities (Pfizer, Viatris, post-separation agreements) and time periods (2022 to 2023) are correctly identified. The only minor limitation is that the original answer emphasizes 'net amounts due to Viatris' while the LLM says 'balance Pfizer owed', which could be misinterpreted as Pfizer being the debtor, whereas the original clarifies Viatris is the recipient. However, given that the direction of the amount (due to Viatris) and the reduction are correctly presented, this is a nuance in phrasing rather than a factual error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 418,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved Guyana from being described only as a developing offshore resource in its “Other Americas” activities (2023 10‑K, pp. 19‑20 – net acreage ≈ 4.6 million offshore acres, 12.6 net exploratory/development wells, Payara development start‑up, Uaru project funded) to being explicitly classified as an **“Advantaged Asset”** in the 2024 earnings‑driver definitions (2024 10‑K, p. 37 – “Advantaged Assets (Advantaged growth projects) … Includes Permian, Guyana and LNG”).  This re‑classification signals that Guyana is now treated as a high‑return, low‑cost source of volume growth and is grouped with the Permian and LNG projects in the company’s strategic narrative.  The 2024 filing therefore reflects a strategic evolution: Guyana’s projects are no longer just “ongoing activities” but are positioned as core, advantaged growth drivers in ExxonMobil’s portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of net exploratory and development wells (12.6) is correctly cited from the 2023 10-K, and the classification shift in 2024 is accurately tied to the 'Advantaged Assets' category on page 37 of the 2024 10-K. No calculations are required, but the factual numbers are precise. (2) Completeness: The answer addresses both parts of the question—how the strategic emphasis evolved (from operational development to strategic prioritization) and what specific changes reflect this (reclassification as an 'Advantaged Asset' alongside Permian and LNG). (3) Entity accuracy: ExxonMobil, Guyana, Payara, Uaru, Permian Basin, and LNG are all correctly identified with accurate project statuses. The years 2023 and 2024 are properly attributed to their respective disclosures. (4) Reasoning: The multi-hop synthesis is sound—linking the operational details in 2023 to the strategic reclassification in 2024 demonstrates clear understanding of the evolution. The conclusion that Guyana shifted from 'ongoing activities' to 'core growth driver' aligns exactly with the ground truth's emphasis on strategic elevation. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer, using slightly expanded context (e.g., mentioning 'Other Americas' and acreage) without introducing inaccuracies. The core insight—that Guyana is now grouped with Permian and LNG as a high-priority growth asset—is preserved and well-supported. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 433,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\nFrom 2022 to 2023 the weighted‑average interest rate on Comcast’s senior notes that mature after 10 years stayed essentially flat at **3.8 %** in both years.  At the same time, the face‑value amount of those long‑dated notes edged up slightly from **$52.8 billion** (as of 2022) to **$53.4 billion** (as of 2023).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8%, and the face value was $54.536 billion, not $52.8 billion. The 2023 values reported by the LLM ($53.4 billion face value and 3.8% rate) match the ground truth, but the 2022 figures are incorrect. 2) Quantitative accuracy is low: the 2022 interest rate is misrepresented (3.67% vs 3.8%), overstating the initial rate, and the 2022 face value is off by over $1.7 billion ($52.8B vs $54.536B). These are material errors in financial reporting. 3) The reasoning is partially sound—correctly identifying that the interest rate remained stable and attempting to compare face value changes—but fails on multi-hop synthesis because it uses incorrect source data for 2022. The conclusion that face value increased is incorrect (it actually decreased), reversing the true trend. 4) Contextual relevance is high as the answer addresses both parts of the question (interest rate and face value evolution) and focuses on the correct instrument (senior notes with maturities >10 years) and time frame (2022 to 2023). However, due to major quantitative errors and resulting flawed synthesis, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 359,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\nBetween 2023 and 2024 the nuclear decommissioning trusts of Alabama Power and Georgia Power moved a larger share of their domestic‑equity holdings into Level 2 valuation, with Alabama Power’s Level 2 domestic‑equity balance increasing to $443 million (up from $396 million) and Georgia Power’s to $321 million (up from $255 million); Level 3 balances stayed essentially flat ($208 million and $1 million, respectively). This reflects a shift toward using observable market‑based inputs (Level 2) for valuation and a reduced reliance on Level 1 or Level 3 classifications.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the allocation shifts and classification assignments. It incorrectly states that Alabama Power and Georgia Power shifted domestic equity investments into Level 2, when in fact both companies increased their Level 1 allocations. The LLM misattributes Alabama Power’s 2024 Level 1 amount ($443 million) as a Level 2 amount, and similarly misassigns Georgia Power’s $321 million (Level 1) as Level 2. It also falsely claims Level 3 balances were $208 million and $1 million, but the original answer does not mention Level 3 at all, making this an unsupported addition. (2) Quantitative inaccuracies are severe: Alabama Power’s Level 1 increased from $396M to $443M (correct values), but LLM says Level 2 rose to $443M from $396M — conflating Level 1 and Level 2. Georgia Power’s Level 1 rose from $255M to $321M, but LLM incorrectly presents this as a Level 2 increase. The LLM also fabricates Level 3 figures not present in the original. (3) Multi-hop reasoning is fundamentally flawed: instead of identifying a shift toward more Level 1 (actively traded, transparent) instruments, the LLM incorrectly infers a move toward Level 2, reversing the actual trend. It fails to correctly synthesize the data across years and entities, and introduces non-existent information (Level 3 balances). (4) Contextual relevance is moderate — the answer addresses nuclear decommissioning trusts, domestic equity, and valuation levels, so the general topic is correct. However, due to severe factual and classification errors, the conclusion is misleading. Correctness and quantitative accuracy are very low due to swapped classifications and fabricated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 467,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA expanded CUDA from a stand‑alone parallel‑programming model into the central software layer of a full‑stack computing platform that now spans GPUs, DPUs, the new Grace CPU, networking, storage and a growing suite of domain‑specific libraries (CUDA‑X), AI‑Enterprise software and cloud services.  This unified CUDA‑based stack lets the same software ecosystem be deployed across disparate end‑markets—AI data‑center workloads, automotive (DRIVE), industrial digital twins (Omniverse) and gaming—providing a common development foundation and enabling NVIDIA to deliver its “platform strategy” across gaming, data‑center, professional visualization and automotive with a single underlying architecture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of CUDA's strategic positioning from 2022 to 2023 as described in the ground truth. It correctly identifies that CUDA evolved from a programming model into the central software layer of a full-stack computing platform, which aligns with the ground truth's description of CUDA becoming the 'foundational programming model' within NVIDIA's full-stack infrastructure. The integration across end markets—gaming, data center, automotive (DRIVE), and industrial digital twins (Omniverse)—is consistent with the original answer's emphasis on expanded vertical integration into healthcare, telecom, automotive, and manufacturing. The mention of CUDA-X, AI Enterprise, and domain-specific libraries reflects the ground truth's point about CUDA supporting hundreds of domain-specific SDKs and APIs by 2023. The reference to Grace CPU, DPUs, networking, and storage adds contextual detail not explicitly in the original but is factually accurate and supports the full-stack narrative. The only minor gap is that the original emphasizes a shift in emphasis from 'fundamental building block' (2022) to 'core enabler of a vertically integrated software stack' (2023), which the LLM captures conceptually but doesn't explicitly contrast in framing. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and all entities (CUDA, Omniverse, DRIVE, Grace CPU) are correctly used. The reasoning is sound, synthesizing multi-hop elements across architecture, software stack, and market expansion. The answer is fully contextually relevant and addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 456,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\nFrom 2022 to 2023 the balance of money Pfizer owed Viatris under the post‑spin‑off transition agreements fell sharply—from about **$94 million** outstanding as of 31 Dec 2022 to roughly **$33 million** by the end of 2023.  The interim **transition‑service agreements (TSAs)** that had supported the Upjohn‑Viatris separation were largely completed by 31 Dec 2023, and only minimal amounts remained under the related manufacturing‑supply and MSA arrangements, indicating that Pfizer’s contractual and financial obligations to Viatris had essentially wound down.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the net amounts owed decreased from $94 million in 2022 to $33 million in 2023, which matches the original answer exactly. The completion of transitional service agreements (TSAs) by the end of 2023 is also correctly stated. (2) Quantitative accuracy is perfect—both dollar amounts and the time frame (end of 2022 to end of 2023) are precise and consistent with the source. The phrasing 'about $94 million' and 'roughly $33 million' is acceptable as it reflects typical reporting language and does not distort the figures. (3) The reasoning is sound: the LLM correctly infers that the decline in amounts owed and completion of TSAs indicate a winding down of contractual and financial obligations, linking this back to the 2020 spin-off context (implied understanding of the Upjohn-Viatris separation). While the original answer explicitly mentions the spin-off, the LLM references it via 'post-spin-off transition agreements' and 'Upjohn-Viatris separation', showing correct entity and event linkage. (4) The only minor shortcoming is that the LLM omits the 2022 detail that TSA services were 'largely completed by the end of 2022', instead implying full completion occurred by 2023. However, this is nuanced and does not contradict the overall timeline, as full completion is confirmed for 2023. The answer remains semantically equivalent in substance and captures the evolution accurately. Contextual relevance is excellent, addressing both financial obligations and contractual relationships as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 439,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\nFrom 2022 to 2023 the filings show that deregulation is still presented as a risk that could generate unrecovered “stranded” costs and impair assets, but the 2023 10‑K (pages 26‑27) links that risk more directly to the company’s environmental‑compliance burden.  The 2022 filing (page 28) treats environmental‑regulation costs as a separate, potentially material expense that may or may not be recovered through rates, while the 2023 filing emphasizes that any future deregulatory or restructuring changes could make it harder to recover the capital and operating costs required to meet EPA and state climate‑related rules (pages 26‑27).  Consequently, the relationship has tightened: deregulation pressures now are portrayed as a factor that could exacerbate the financial impact of environmental compliance costs and limit the company’s ability to recover those expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: the 2022 and 2023 filings are accurately characterized in terms of how Duke Energy views the relationship between retail deregulation and environmental compliance costs. The LLM correctly identifies that in 2022, environmental regulation costs were treated as a separate risk, while in 2023, deregulation was more directly linked to impairing recovery of environmental compliance costs. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in a numerical sense, but the temporal references (2022, 2023) and page numbers (26–27, 28) are correct and consistent with the source context, supporting accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly infers the evolving relationship, and identifies the tightening linkage between deregulation risks and environmental cost recovery. The mention of EPA and state climate rules reflects accurate entity and regulatory context. (4) The semantic meaning fully matches the original answer—while the wording differs, the core conclusion that deregulation pressures compound the challenge of recovering rising environmental costs under competitive market conditions is preserved. The only minor shortcoming is that the LLM does not explicitly mention PURPA or qualifying facilities (QFs), which are part of the original 2022 risk description, slightly reducing completeness in entity coverage. However, the omission does not undermine the central thesis. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy (as no numbers were misstated).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 499,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\nThe retail share of Skoal fell from **9.3 % in 2023 to 7.6 % in 2024** – a decline of roughly 1.7 percentage points.  This drop occurred despite Altria’s 2023 pricing moves that raised Skoal’s list price several times (by about **$0.09–$0.10 per can**), indicating that the brand’s higher prices did not halt share loss.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: Skoal's retail share decreased from 9.3% in 2023 to 7.6% in 2024, which is accurate. However, the dollar amount of the 2023 pricing increase is slightly off—the ground truth specifies a $0.11 per can increase announced in 2023 and effective January 23, 2024, while the LLM states '$0.09–$0.10 per can', which underrepresents the final increase. Earlier increases in 2022 are not required for the 2023 pricing strategy context, so their omission is acceptable. (2) The calculation of the share decline (1.7 percentage points) is correct (9.3 - 7.6 = 1.7). The pricing figures, however, are approximated and do not reflect the exact $0.11 figure specified in the ground truth, leading to a minor quantitative inaccuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts declining market share with price increases, inferring that higher prices did not prevent share loss. It synthesizes market performance and pricing strategy appropriately, though it lacks mention of the cumulative effect of past increases noted in the original answer. (4) The answer is contextually relevant and addresses both parts of the question—change in retail share and contrast with 2023 pricing strategy. Due to minor inaccuracy in pricing figures but correct core facts and reasoning, the scores reflect high accuracy with room for improvement in quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 396,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\nAmgen’s “Other short‑term interest‑bearing securities” fell modestly from **$138 million (amortized cost) as of December 31 2023** to **$135 million (amortized cost) as of December 31 2024** – a drop of about $3 million (≈2 %).  The fair‑value column shows the same amounts, indicating no material unrealized gains or losses.  \n\nThis small contraction signals that Amgen is maintaining a **highly conservative, liquidity‑focused short‑term investment stance**, keeping the bulk of its short‑term cash in safe, investment‑grade instruments while only modestly adjusting the allocation.  The move is consistent with the company’s stated policy of preserving principal, ensuring prudent liquidity and limiting risk in its interest‑bearing portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's investment in 'Other short-term interest-bearing securities' decreased from $138 million in 2023 to $135 million in 2024. The ground truth confirms the amount remained unchanged at $138 million in both years. This is a critical factual error. (2) The calculation of a $3 million drop (≈2%) is therefore incorrect, as there was no change. The mention of amortized cost and fair value being the same may be plausible contextually, but it does not compensate for the core inaccuracy. (3) The reasoning about a 'conservative, liquidity-focused stance' is logically sound and contextually appropriate, but it is based on a false premise (a decline that did not occur). The multi-hop synthesis fails because the model misrepresents the primary data point. (4) While the answer addresses both parts of the question (evolution and strategic implication), the quantitative inaccuracy severely undermines the correctness. The contextual relevance is high because the structure and intent align with the question, but the factual foundation is flawed. Correctness score is low due to the central error in financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 331,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics moved the Abrams upgrade effort from a relatively narrow, U.S.–only contract—around a $360 million award for tank upgrades, mission‑control units and technical support (as reflected in the 2021‑2022 Combat Systems backlog)—to a far broader, multi‑year program that now includes engineering, logistics and sustainment support and extends to foreign production.  In 2024 the company received a $350 million Army contract for Abrams upgrades plus a $285 million SEPv3 production package for Romania, pushing the total estimated contract value for the program toward $1 billion and signaling a substantial expansion in both scope and value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in General Dynamics' involvement in Abrams tank upgrades from 2022 to 2024. (1) Quantitatively, the $360 million 2022 contract and the 2024 contracts of $350 million and $285 million are correctly reported, with only a minor permissible variation in phrasing (e.g., 'toward $1 billion' as an estimate of total value is reasonable given the sum is $995 million). (2) The answer correctly identifies the shift in scope from upgrades and technical support in 2022 to include engineering, logistics, sustainment, and foreign production (Romania SEPv3) in 2024, aligning with the ground truth. (3) Multi-hop reasoning is sound: it synthesizes contract scope changes across years and entities (U.S. Army, Romania), correctly infers broader program expansion, and supports the conclusion with specific contract values. (4) Minor deduction in quantitative accuracy due to the phrasing 'toward $1 billion'—while semantically acceptable and close—the exact sum ($995M) is not explicitly acknowledged, though not required for full credit. Wording differences (e.g., 'mission-control units' vs 'mission control units') are stylistic and do not affect meaning. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 357,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\nFrom 2023 to 2024 AIG moved Corebridge from a fully‑consolidated subsidiary to a partially retained investment; Corebridge continued to carry its own debt—including a $250 million DDTL facility and $7.7 billion of senior unsecured notes—while AIG provided a guarantee with a reimbursement and collateral arrangement that could be triggered on a rating downgrade.  As a result, AIG no longer records Corebridge’s earnings directly but instead recognizes equity‑method income (a $601 million loss in 2024) and the fair‑value changes of its retained $8.5 billion stake, and it records the related interest expense and any gains/losses on debt‑related transactions in its cash‑flow statements.  The deconsolidation also generated a $4.754 billion after‑tax loss on sale, after which only the equity‑method results and the financing obligations tied to Corebridge’s borrowings affect AIG’s income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative details not present in the ground truth, though it correctly identifies the high-level shift in AIG's relationship with Corebridge. (1) The ground truth states that in 2023, Corebridge had borrowing ability through February 25, 2025, and in 2024, AIG began recognizing equity method income tied to stock price changes and dividends starting June 9, 2024. The LLM answer fabricates specific financial figures such as a $250 million DDTL facility, $7.7 billion in senior unsecured notes, a $601 million loss in 2024, a retained $8.5 billion stake, and a $4.754 billion after-tax loss on sale—none of which appear in the original answer or are implied by it. These numbers cannot be verified and contradict the more general, qualitative nature of the ground truth. (2) The dates mentioned in the LLM answer (e.g., June 9, 2024) are partially correct—this date aligns with the start of equity income recognition—but the extensive financial data around it lacks support. (3) The reasoning correctly captures the multi-hop evolution: from a borrowing-based arrangement in 2023 to equity-method income recognition in 2024, indicating deconsolidation. However, the model overextends by inferring detailed debt structures, guarantees, and exact losses without basis. (4) While the conceptual shift is accurately framed (from consolidation to equity method), the inclusion of unverified dollar amounts and financial mechanisms severely undermines factual correctness. The contextual relevance is high because the answer addresses the core transformation, but quantitative accuracy is low due to invented figures. Thus, the correctness score is limited to 4—partially correct but with major factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 484,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Solar Roof from a niche, pilot‑scale offering toward a higher‑volume, integrated energy‑product line, but it continued to wrestle with the same production bottlenecks that have plagued its broader manufacturing.  The company now relies on a tightly coordinated supply chain of specialty glass, solar‑inverter and Powerwall components—and on its new Gigafactory‑scale facilities (e.g., Texas and Shanghai) to mass‑produce the roof tiles—while also depending on external partners for installation and on its own battery‑cell development to meet the energy‑storage performance targets that underpin the product’s economics.  Consequently, any delay or cost‑inflation in these supplier or manufacturing dependencies directly threatens the Roof’s ramp‑up and profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but does not fully align with the ground truth from the knowledge graph in key qualitative aspects. (1) Correct elements: The answer correctly identifies ongoing production challenges (bottlenecks, supply chain dependencies) and strategic shifts toward scaling, which aligns with the 2024 10-K emphasis on production ramp challenges. It appropriately highlights dependencies on suppliers, Gigafactory-scale production, and integration with Powerwall and inverter components. There are no numeric values in either answer, so quantitative accuracy is not an issue—scored 10 by default. (2) Inconsistencies: The claim that Solar Roof moved 'from a niche, pilot-scale offering' in 2022 is not supported by the original answer, which states Tesla was already actively selling the product and collaborating with real estate developers—indicating more than pilot-scale deployment. The original emphasizes a shift in narrative from sales and installation efficiency to production dependency risks, not a scaling trajectory. (3) Multi-hop reasoning: The LLM synthesizes plausible strategic dependencies but overemphasizes progress in scaling that isn't reflected in the ground truth. The original answer stresses continuity in challenges rather than movement toward higher-volume success. The LLM implies advancement in integration and manufacturing scale that isn't confirmed in the source. (4) Despite strong contextual relevance and logical structure, the answer misrepresents the evolution as more progress-oriented, whereas the truth reflects increased caution and dependency risks. Thus, correctness and qualitative accuracy are reduced to 7 due to mischaracterization of strategic evolution, though core themes of production challenges and dependencies are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 496,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\nSkoal’s U.S. oral‑tobacco retail share slipped from **9.3 % in 2023 to 7.6 % in 2024**, a decline of roughly **1.7 percentage points (about an 18 % drop)**.  This loss coincides with the segment’s overall retail‑share contraction (from 42.5 % to 37.5 %) and is underscored by rivals such as **on! (8.3 % in 2024)** now out‑selling Skoal, indicating that Skoal’s competitive positioning is weakening in the U.S. oral‑tobacco market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Skoal's retail share as 9.3% in 2023 and 7.6% in 2024, matching the ground truth exactly. The calculated decline of 1.7 percentage points and approximate 18% relative drop (1.7 / 9.3 ≈ 18.3%) are accurate. It correctly references on!'s 8.3% share in 2024, aligning with the original answer. 2) All numbers are factually correct: percentages, years, and implied calculations (difference in share, relative decline) are precise. The mention of the overall segment contraction (42.5% to 37.5%) is an additional but plausible contextual detail not in the ground truth, but does not contradict it. 3) The multi-hop reasoning is sound: the model correctly infers that Skoal’s declining share, especially in comparison to on!’s growth, indicates weakening competitive positioning. It synthesizes Skoal's performance relative to a competitor, which is central to assessing competitive dynamics. 4) The answer is semantically equivalent to the ground truth in all key aspects—core data, trend direction, competitor comparison, and strategic implication—though it adds minor contextual detail (overall segment decline) not in the original. This does not detract from accuracy. The only reason for not scoring a 10 is that the original answer explicitly notes on!’s increase from 6.8% to 8.3%, which provides stronger comparative context; the LLM mentions on!’s 2024 share but not its growth, slightly reducing completeness in multi-hop synthesis. However, the conclusion remains valid and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 419,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\nThe 2023 filing first warned that the mobile industry’s premium‑tier concentration gave a handful of OEMs (Apple, Samsung, Xiaomi) enough purchasing power to pressure Qualcomm on price and to make revenue “fluctuate” with each customer’s product cycle. In the 2024 filing that risk has deepened – the company now stresses that the same concentration, combined with OEMs’ push to design their own chips (e.g., Apple, Samsung) and with China‑driven self‑sufficiency policies, is eroding Qualcomm’s pricing power and heightening the volatility of the revenue stream that depends on those few premium customers. Thus, the concentration risk has become more pronounced between 2023 and 2024, directly threatening both pricing leverage and revenue stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: the risk of premium-tier concentration affecting Qualcomm's pricing power and revenue stability is properly described for both 2023 and 2024. The 2023 emphasis on pricing pressure and revenue fluctuation due to a few large OEMs is accurately captured, as is the 2024 evolution highlighting intensified risk due to in-house chip development (e.g., Apple, Samsung) and China's self-sufficiency trends. (2) There are no numeric values in the question or answer requiring verification—dates (2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of risk over time, connects concentration to pricing and revenue impacts, and incorporates additional factors like vertical integration by OEMs. The mention of Chinese OEMs in the original is generalized to 'China-driven self-sufficiency policies' in the LLM answer, which is a reasonable interpretation and adds contextual depth without distorting the truth. (4) The only minor shortcoming is that the original emphasizes 'Chinese OEMs' more centrally in the revenue concentration, while the LLM broadens to Apple and Samsung—though these are also correct examples, the shift slightly downplays the specific Chinese OEM focus in 2023. However, this does not undermine the overall correctness. The answer is contextually excellent, directly addressing the evolution of risk, its impact on pricing power, and revenue stability. Thus, the correctness score is 9 due to this slight nuance loss, but quantitative accuracy is perfect, qualitative reasoning is strong, and relevance is full.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 466,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\nAmgen’s short‑term liquidity is managed through a portfolio of investment‑grade debt and money‑market instruments, with a particular emphasis on money‑market mutual funds.  At the end of 2023 the fund held $10,266 million in such funds, and by the end of 2024 that amount had risen modestly to $10,354 million—a gain of about $88 million (≈0.9 %).  This slight increase reflects the company’s ongoing effort to preserve principal safety and maintain adequate liquidity while adhering to its investment‑policy limits on issuer concentration and maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased from $10,266 million in 2023 to $10,354 million in 2024. The ground truth confirms that the allocation remained unchanged at $10,266 million in both years. This is a critical factual error that undermines the core of the response. (2) The quantitative inaccuracies are significant: the reported 2024 value ($10,354 million) is wrong, and the claimed increase of $88 million (≈0.9%) is therefore also incorrect. No such change occurred. While the 2023 figure is accurate, the 2024 figure and all derived calculations (difference, percentage change) are false. (3) The reasoning is flawed in its synthesis: the model incorrectly infers a strategic shift or modest reallocation, whereas the ground truth explicitly states there was no change, indicating stability in Amgen’s short-term investment strategy. The multi-hop requirement—comparing disclosed values across two years—was not fulfilled correctly. (4) Despite the factual errors, the answer is contextually relevant, correctly identifying Amgen’s general approach to short-term liquidity (use of money market funds, investment-grade debt, focus on liquidity and principal preservation). However, the incorrect data and resulting faulty conclusion severely reduce correctness and quantitative accuracy. The qualitative reasoning would be higher if based on accurate data, but as it stands, it reflects a plausible but incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 418,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\nGeneral Dynamics’ U.S. government accounts receivable pledged to the Capital Construction Fund increased from roughly $315 million at the end of 2022 (and again in 2023) to $333 million at the end of 2024 – an increase of about $18 million, or 5–6 %. This reflects a modest upward evolution in the company’s participation in the CCF over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the pledged amount was $295 million as of December 31, 2021 (reported in 2022), $315 million as of December 31, 2023 (reported in 2024), and $333 million as of December 31, 2024 (also reported in 2024). The LLM incorrectly states that the amount was $315 million at the end of 2022, which is not supported by the data. The correct figure for the end of 2022 (i.e., December 31, 2022) is not provided in the original answer, so the LLM should not have assumed it was $315 million. The $315 million figure corresponds to December 31, 2023, not 2022. (2) The calculation of an $18 million increase is correct ($333M - $315M), and the percentage increase (~5.7%) is approximately accurate, but it's based on incorrect starting points. The actual increase from 2021 to 2024 is $38 million ($333M - $295M), which the LLM fails to capture. (3) The reasoning is partially sound in identifying a trend of increasing participation, which aligns with the ground truth, but the multi-hop synthesis is flawed because the LLM misaligns the time periods and reported figures. It conflates reporting year with fiscal year-end data. (4) The contextual relevance is high because the answer addresses the evolution of GD's CCF participation and interprets the trend correctly in broad terms. However, due to the incorrect assignment of values to years, the quantitative accuracy is only partial, warranting a moderate correctness score of 5. The qualitative accuracy is slightly higher because the overall direction and interpretation of growth are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 450,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge moved from consolidation to an equity‑method holding after the 2022 IPO reduced its ownership below 80 %, triggering a tax deconsolidation that separated Corebridge’s U.S. federal tax group from AIG’s consolidated return for five years and required separate realizability testing of AIG’s deferred‑tax assets.  The deconsolidation produced a $4.75 bn after‑tax loss in 2024 (largely a write‑down of the retained Corebridge investment), while Corebridge’s own pre‑tax earnings of $1.57 bn in the second half of 2024 generated $601 m of equity‑method income for AIG, which is recorded in other income and net investment income and reflects dividends plus changes in the Corebridge stock price.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's financial relationship with Corebridge—deconsolidation due to ownership falling below 80% post-IPO, tax deconsolidation, and shift to equity method accounting. However, it introduces specific financial figures not present in the ground truth: a $4.75 billion after-tax loss in 2024 and $601 million in equity-method income based on Corebridge’s $1.57 billion pre-tax earnings. These numbers are not supported by the original answer, which only states 'X' as a placeholder for the equity method income and does not mention any loss or specific earnings figures. (2) Quantitative accuracy is low because the LLM fabricates precise dollar amounts and calculations (e.g., $601M income from $1.57B earnings implies a ~38.3% attribution, which is not justified or verified). The original answer does not provide any of these figures, making them factually unverifiable and likely incorrect. (3) The multi-hop reasoning is generally sound: the model correctly infers that dropping below 80% ownership triggers tax deconsolidation and a shift to equity method accounting, and it appropriately links equity income to dividends and stock price changes. However, it overreaches by inventing financial data to illustrate the impact, undermining factual reliability. (4) Contextual relevance is high—the answer directly addresses tax implications, investment income, IPO timing, and deconsolidation effects. The structure and focus align well with the question. The qualitative accuracy is moderate because while the conceptual framework is correct, the inclusion of unsupported numbers reduces trust in the response. The correctness score is 6 due to accurate reasoning and structure but significant factual overreach in numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 487,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\nFrom 2022 to 2024 Tesla moved Solar‑Roof production from a largely “scale‑by‑training‑installers and partner‑with‑builders” model toward a more formalized talent‑and‑engineering pipeline.  In the 2022 filing (p. 34) the company highlighted onboarding new installers and collaborating with developers to cut installation time, while warning that success depended on battery‑cell supply and hiring skilled electricians.  By the 2024 filing (pp. 13‑18, 15‑16) Tesla had launched dedicated engineering‑development and apprenticeship programs, an Education‑Assistance program for early‑career engineers, and a broader “Engineering Development Program” aimed at building the skilled workforce needed for Solar‑Roof and other energy products, signaling a shift from ad‑hoc installer training to a structured talent strategy—still constrained by global component shortages but now supported by a pipeline of trained engineers and technicians to improve cost efficiency and installation speed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant inaccuracies in qualitative details and reasoning, despite correct dates and no numeric errors. (1) Correct elements: The 2022 focus on onboarding installers, collaborating with developers, and concerns about battery cell supply and electrician hiring align with the ground truth. The shift in focus by 2024 toward broader systemic challenges is contextually relevant. (2) Quantitative accuracy is perfect—no numbers, dates, or financial figures are present, so no errors occur; references to filing pages are plausible but not verifiable from the ground truth and do not contradict it. (3) Multi-hop reasoning is flawed: The LLM incorrectly claims Tesla launched 'dedicated engineering-development and apprenticeship programs,' an 'Education-Assistance program for early-career engineers,' and a 'Engineering Development Program' by 2024. These specific programs are not mentioned in the ground truth, which instead emphasizes supply chain risks like global component procurement, supplier failures, and inflationary pressures—topics the LLM omits or underrepresents. The evolution described in the LLM answer centers on talent development pipeline improvements, while the ground truth highlights a shift from localized labor challenges to systemic supply chain and production scalability risks. This misrepresents the core of Tesla’s strategic evolution. (4) Contextual relevance is high because the answer addresses both years and the general theme of strategic evolution in Solar Roof production. However, the qualitative inaccuracy in depicting Tesla’s 2024 strategy as talent-program-driven rather than supply-chain-risk-focused undermines the correctness. Thus, while the framing is reasonable, the factual synthesis is significantly off, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 499,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\nIn the 2022 filing (page 71) Duke Energy estimated that permanently closing all of the coal‑ash basins in North Carolina and South Carolina would cost **about $8 billion – $9 billion**, with roughly **$3.1 billion already spent through 2021**. By the 2023 filing (page 194) the company refined that outlook to **approximately $7 billion – $8 billion**, noting that **about $4 billion had been spent through 2023**. The modest downward revision in the cost ceiling, together with the nearly $1 billion increase in cumulative spending, shows that Duke Energy is making tangible progress on the Coal Ash Act‑mandated closures—executing the settlement‑driven excavation and landfill disposal plan and achieving cost‑efficiency gains as the work advances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2022 cost estimate of $8 billion–$9 billion, the 2023 revised estimate of $7 billion–$8 billion, the $3.1 billion spent through 2021 (as reported in 2022), and the $4 billion spent through 2023 are all correctly reported. The nearly $1 billion increase in spending is consistent with the data. (2) The answer addresses all parts of the question: it traces the evolution of cost estimates from 2022 to 2023 and interprets what this indicates about progress under the Coal Ash Act. (3) Entity accuracy is perfect—Duke Energy, North Carolina, South Carolina, and the Coal Ash Act are correctly identified and contextualized. (4) The reasoning is sound: the downward revision in cost estimates combined with increased spending indicates progress, cost refinement, and execution efficiency, which aligns with the multi-hop synthesis required. The LLM correctly infers that tangible progress has been made, supported by both financial outlays and updated projections. Minor wording differences (e.g., 'modest downward revision' vs. 'decreased') do not affect semantic equivalence—meaning is preserved and factually aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 348,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\nThe “on!” oral tobacco product’s retail‑share grew from **6.8 % in 2023 to 8.3 % in 2024** – an increase of about 1.5 percentage points.  This rise occurred while the overall oral‑tobacco segment’s retail‑share slipped from **42.5 % to 37.5 %**, meaning that “on!” is gaining ground within a contracting market and is becoming a more notable contributor to the segment, even though it still represents only a modest share of the total oral‑tobacco category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for 'on!' oral tobacco retail share (6.8% in 2023 and 8.3% in 2024) and the overall oral tobacco segment (42.5% to 37.5%) are accurately reported. The implied increase of 1.5 percentage points is correct (8.3 - 6.8 = 1.5). (2) The answer addresses both parts of the question: the evolution of 'on!' retail share and its market position relative to the broader segment. (3) All entities—'on!' product, oral tobacco segment, correct years—are accurately identified. (4) The reasoning is sound: the LLM correctly infers that 'on!' is gaining market share during a period of overall segment contraction, indicating relative strength and improved positioning. The conclusion that 'on!' is becoming a more notable contributor despite its modest absolute share aligns semantically with the ground truth's interpretation of strengthened market position. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 290,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2024 Qualcomm still derived a large share of its sales from Chinese OEMs—Xiaomi alone accounted for 10 % or more of total revenue (page 14)—so its reliance on that market remained pronounced.  However, the company repeatedly flags that many Chinese OEMs are now developing their own integrated‑circuit products under policies such as “Made in China 2025” and amid U.S./China trade tensions (pages 18‑19), meaning the concentration is beginning to erode and could sharply reduce Qualcomm’s revenue stream if those OEMs shift away from its chips.  This growing concentration risk makes the business more vulnerable to policy changes, competitive pressure and revenue volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's continued reliance on Chinese OEMs from 2023 to 2024, aligning with the ground truth. However, it introduces a specific claim not present in the original answer—that Xiaomi alone accounted for 10% or more of total revenue—with a citation to 'page 14'. This quantitative detail is absent from the ground truth and cannot be verified against it; thus, it introduces a potentially inaccurate specific percentage not supported by the provided knowledge graph. The original answer states a 'significant portion' and 'small number of Chinese OEMs' but does not quantify Xiaomi’s share. (2) While the fiscal years (2023–2024) are correctly referenced, the inclusion of a precise 10% figure for Xiaomi constitutes a quantitative overreach, lowering the quantitative accuracy. There are no calculation errors per se, but the introduction of unsourced specifics reduces factual reliability. (3) The reasoning is strong: the LLM correctly synthesizes the risk of U.S./China tensions, mentions 'Made in China 2025' as a factor in OEMs developing in-house chips, and concludes that this poses a threat to Qualcomm’s revenue stability—this reflects valid multi-hop reasoning and aligns with the original answer’s implications about business risk. (4) Contextual relevance is high, as the answer directly addresses both parts of the question: evolution of reliance (persistent) and implications (increased vulnerability). Despite the unsupported percentage, the overall qualitative assessment remains strong due to accurate framing of risks and continuity in reliance. The answer adds contextual detail (e.g., policy name) not in the original but consistent with it, which is acceptable. However, the unverified numeric claim prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 491,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\nBetween 2022 and 2023 Amgen’s available‑for‑sale (AFS) portfolio shifted dramatically from a mixed holdings of Treasury securities and money‑market funds to a near‑pure money‑market fund position. In 2022 the AFS balance of $4.3 bn consisted of about $1.7 bn of U.S. Treasury bills and $2.7 bn of money‑market mutual funds, with essentially no other short‑term securities. By the end of 2023 the portfolio had grown to $10.4 bn, Treasury‑bill holdings were eliminated, money‑market funds accounted for roughly $10.3 bn (≈99 % of the total), and a small $138 m of other short‑term interest‑bearing securities appeared. This evolution reflects a move toward larger cash‑equivalent holdings and a reliance on money‑market instruments as the primary AFS security type.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 available-for-sale investments. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities (which may include U.S. Treasury bills) and $2,659 million in cash and cash equivalents — not $1.7 billion in U.S. Treasury bills and $2.7 billion in money-market mutual funds as claimed. The LLM incorrectly states that money-market funds were a major component in 2022, when in fact they were not reported as a category until 2023. Additionally, the LLM misrepresents the 2022 breakdown by omitting the actual categories (marketable securities and cash/cash equivalents) and replacing them with U.S. Treasury bills and money-market funds, which distorts the factual evolution. (2) Quantitatively, the 2023 figures are mostly accurate: $10.4 billion total, $10.3 billion in money-market funds (approximating $10,266 million), and $138 million in other short-term securities. However, the 2022 totals are misrepresented: the LLM reports $4.3 billion (correct total) but misallocates it as $1.7B + $2.7B between Treasury bills and money-market funds, whereas the ground truth shows no money-market funds in 2022 and instead $1,676M marketable securities and $2,659M cash and cash equivalents. This is a critical error in composition. (3) The multi-hop reasoning is partially sound — the model correctly identifies a strategic shift toward more liquid instruments in 2023 and notes the elimination of Treasury securities and growth in money-market funds. However, because it fabricates the presence of money-market funds in 2022, the comparative analysis is flawed. The conclusion about a 'dramatic shift' is valid, but the baseline (2022) is incorrect, undermining the reasoning. (4) Contextual relevance is high — the answer addresses the evolution of investment composition and attempts to explain the strategic shift. However, due to major quantitative and entity-level inaccuracies in the 2022 breakdown, the correctness score is low. The answer conveys a plausible narrative but with incorrect underlying facts, especially regarding the 2022 portfolio composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 588,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\nShake Shack’s presence was unchanged between 2022 and 2023 – it remained a tenant at the same premium‑outlet properties (notably the Las Vegas Outlets and Woodbury Common Premium Outlets), with no new or removed locations across SPG’s premium‑outlet portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Shake Shack's presence was unchanged between 2022 and 2023. According to the ground truth, Shake Shack was only present at Woodbury Common Premium Outlets in 2022. In 2023, it expanded to a new location at Las Vegas Outlets North Premium, indicating growth in SPG's portfolio. The LLM incorrectly states that Shake Shack was present at both locations in both years, which contradicts the documented evolution. Specifically, the LLM claims Shake Shack was at Las Vegas Outlets in 2022, but the original answer confirms it was not present there until 2023. This is a critical factual error affecting both entity accuracy and temporal reasoning. While the answer correctly identifies the two outlet locations involved and addresses the question’s focus on SPG’s premium outlets, the incorrect assertion of no change undermines the quantitative and qualitative accuracy. The reasoning fails the multi-hop requirement to compare tenant presence across years and properties. However, the response is contextually relevant, as it attempts to address the evolution of Shake Shack’s footprint within SPG’s portfolio using appropriate entities and timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 338,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\nBetween 2022 and 2024 the retirement‑annuity contracts stayed in **Level 3** of the fair‑value hierarchy, but their reported fair value fell from **$35 million (as of 31 Dec 2021)** to **$22 million (as of 31 Dec 2024)**.  This decline reflects a smaller portfolio and/or changes in the unobservable inputs used to value the contracts, showing that General Dynamics continues to apply internally‑derived, non‑market‑based assumptions for these assets, though the reduced balance and continued Level 3 classification indicate the company is refining its methodology—relying more on observable inputs where possible and treating the remaining exposure as a relatively immaterial, internally‑valued component.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that retirement annuity contracts remained in Level 3 from 2022 to 2024, it introduces specific dollar amounts ($35 million as of 2021 and $22 million as of 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These figures are likely fabricated or misattributed, as the ground truth does not mention any monetary values for these contracts. Additionally, the reference to '31 Dec 2021' is outside the requested 2022–2024 timeframe and irrelevant to the question. (2) The quantitative inaccuracies are severe—there are no numbers in the original answer to support the claimed values or trends, and no calculation or comparison based on real data can be validated. The inclusion of precise figures undermines credibility and misleads the reader. (3) The multi-hop reasoning is partially sound in recognizing that Level 3 classification persisted, indicating continued use of unobservable inputs. However, the LLM fails to capture the key qualitative insight from the original answer: the change in disclosure practice regarding NAV as a practical expedient being included in reconciliation tables in 2024 but not explicitly in 2022. This omission misses the core evolution in reporting transparency. Instead, the model incorrectly infers a methodological refinement toward more observable inputs, which is not supported by the ground truth. (4) The contextual relevance is moderate because the answer addresses the fair value hierarchy and valuation methodology, but the introduction of false quantitative data and incorrect reasoning about methodology shifts severely compromises accuracy. The qualitative accuracy is low due to incorrect inferences and missing key disclosure-related insights. Correctness score is low due to major factual and inferential errors despite partial recognition of Level 3 continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 530,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s exposure to Corebridge shifted from a consolidated subsidiary to an equity‑method investment.  In 2023 AIG owned roughly 52 % of Corebridge (after the 2023 share‑repurchase and secondary‑offering activity disclosed in the Non‑controlling‑interest note), and its stake was only modestly adjusted by those transactions.  In the second quarter of 2024 AIG de‑consolidated Corebridge, recording a $4.8 bn after‑tax loss on the de‑consolidation (see the loss‑on‑deconsolidation table on page 110), and thereafter accounted for its remaining interest under the equity method, recognizing $601 m of equity‑method income—comprised of dividends received and the change in the fair value of its retained Corebridge shares— for the June‑December 2024 period (page 109).  The only dilutionary effect was the normal market‑driven fluctuation in Corebridge’s share count; there were no new issuances that materially diluted AIG’s ownership percentage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly regarding key dates, mechanisms, and the nature of AIG's financial relationship with Corebridge. (1) The original answer states that the potential equity dilution mechanism—tied to Blackstone’s right to exchange its interest in Corebridge for AIG shares—was terminated due to Corebridge’s IPO on September 19, 2022, not in 2023 or 2024. The LLM incorrectly implies this mechanism was still relevant in 2023, failing to note it had already been terminated pre-2023. This is a major factual error in timeline and mechanism. (2) The LLM claims AIG de-consolidated Corebridge in Q2 2024 and began equity-method accounting from then, but the original answer specifies that income recognition under the new model began on June 9, 2024—this partial alignment gives some credit. (3) The $4.8 billion after-tax loss and $601 million equity-method income are specific figures not present in the original answer, suggesting the LLM is drawing from a different or more detailed source; however, since these numbers are not in the ground truth, they cannot be verified and may conflict with the known timeline. (4) The original answer emphasizes a shift from a potential dilution scenario (that no longer applied post-IPO) to an equity income model; the LLM misrepresents this by suggesting dilution was still a consideration in 2023 and incorrectly frames the transition. (5) The LLM correctly identifies the shift to equity-method accounting and income recognition based on dividends and fair value changes, aligning semantically with the post-divestiture model. However, it omits any mention of Blackstone’s exchange right or the historical context of the 24.1 million (2022) and 4.4 million (2023) potential shares, which are central to the 'potential equity dilution' part of the question. Overall, while the answer captures the directional shift in accounting treatment, it fails on critical multi-hop elements: the timing of the IPO, the termination of the dilution mechanism, and the correct causal logic. Quantitative accuracy is low due to unverified figures and incorrect temporal attribution. Qualitative accuracy is moderate due to correct use of accounting terminology and recognition of the investment shift. Contextual relevance is high as it addresses the core theme of the evolving financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 639,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\nComcast’s recorded debt tied to Universal Beijing Resort slipped only slightly—from roughly $3.5 billion of outstanding debt (including a $3.1 billion term loan) as of the end of 2023 to about $3.4 billion (including a $3.0 billion term loan) by the end of 2024—reflecting scheduled repayments on the resort’s ¥29.7 billion (≈$4.2 bn) financing.  The resort continues to be fully consolidated as a variable‑interest entity, so Comcast’s financial exposure is now limited to its 30 % equity interest and the remaining debt of the VIE, which has been modestly reduced but remains on the consolidated balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly identifies the $3.4 billion debt figure for Universal Beijing Resort as of December 31, 2024, matching the ground truth. However, it incorrectly states $3.5 billion as of the end of 2023, which is accurate, but fails to mention the earlier disclosed figures for 2020 ($2.5B) and 2021 ($3.6B) from the 2022 filing—critical for showing the evolution from 2022 to 2024. Instead, it fabricates a 'slipped only slightly' narrative between 2023 and 2024, ignoring the full trend. (2) The LLM introduces a $3.1 billion term loan and ¥29.7 billion (≈$4.2B) financing not present in the original answer, which lacks support from the ground truth. These specific loan details and conversions are unverified and appear invented. Additionally, the answer omits the key consolidation data: $7.3B in assets and $7.0B in liabilities as of 2024, which are central to Comcast’s financial exposure. (3) The reasoning partially captures the consolidation treatment—correctly noting that the resort is a VIE and fully consolidated—but incorrectly implies Comcast’s exposure is 'limited to its 30% equity interest,' which contradicts the full consolidation principle where 100% of assets and liabilities are on the balance sheet. This misrepresents the nature of financial exposure. (4) Despite these issues, the answer is contextually relevant, addressing debt trends and consolidation, and gets the most recent two debt figures approximately right. Hence, quantitative accuracy is medium due to some correct numbers but unsupported additions; qualitative accuracy is moderate due to correct identification of VIE status but flawed reasoning on exposure; contextual relevance is high as it stays on topic and attempts multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 496,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\nBetween 2022 and 2023 the company’s aircraft‑trade‑in arrangements kept the same basic mechanics—options that let customers trade in an aircraft for a set fair‑market value (usually ≤ 45 days before delivery) or that guarantee a pre‑determined trade‑in price, with any shortfall treated as a revenue reduction—but the eligibility narrowed.  In the 2022 filing the commitments were described generally as “some customers” having such options, whereas the 2023 filing specifies that “some Gulfstream customers” hold the options, indicating a more limited pool of eligible customers.  The risk profile (exposure to adverse market‑value changes) remains, but the company continues to regard the potential financial impact as not material in either year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the narrowing of customer eligibility from 'some customers' in 2022 to 'some Gulfstream customers' in 2023, capturing the key structural change in trade-in commitments. The risk exposure related to adverse market-value changes is accurately noted as present in both years, with the financial impact deemed 'not material'—a critical factual point correctly preserved. (2) There are no numeric values (e.g., dollar amounts, percentages, timeframes like '≤ 45 days') in the original answer, but the LLM introduces a specific detail—'usually ≤ 45 days before delivery'—that is not present in the ground truth. However, this detail does not contradict the original and may reflect accurate knowledge from the filing; since it doesn’t impair correctness and is plausibly consistent, it doesn’t warrant a major deduction. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in eligibility and risk framing across two years and segments the information appropriately between structural mechanics (unchanged) and eligibility (narrowed). (4) The answer is contextually relevant and fully addresses both parts of the question: changes in customer eligibility and risk exposure. The only minor gap is the slightly more detailed risk framing in the original answer—highlighting Gulfstream as a key business jet brand for strategic focus—which the LLM implies but doesn’t explicitly interpret. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 440,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\nTesla first introduced the Semi in its 2022 business overview as a planned commercial‑vehicle model that would be built on a next‑generation platform and rely on the company’s new battery‑cell and autonomous‑driving technologies. By 2024 the Semi had progressed to pilot‑production status at the Nevada Gigafactory (as shown in the 2024 segment table), but full‑scale manufacturing was still limited; the truck is now positioned as part of Tesla’s strategy to expand into commercial‑vehicle sales, leverage its advancing battery and Full‑Self‑Driving capabilities, and support profitable growth across its broader product lineup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2022, the Tesla Semi was in the planning/development phase, and by 2024 it had entered 'pilot production' at the Nevada facility—matching the key evolution in production status. The strategic positioning as part of Tesla's expansion into commercial vehicles and leveraging battery and Full-Self-Driving technology is consistent with the ground truth's emphasis on market entry and strategic shift. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2024) and production status milestones are factually correct. (3) The multi-hop reasoning—connecting Tesla's initial announcement in 2022 to the 2024 pilot production and inferring strategic intent—is sound and well-synthesized across time points. (4) The only minor shortcoming is that the LLM adds detail not present in the ground truth (e.g., 'next-generation platform', 'Full-Self-Driving capabilities') which, while plausible, are not confirmed in the original answer; however, they do not contradict it. Overall, the answer is semantically equivalent, factually correct, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 341,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\nAltria’s valuation allowance for the deferred‑tax assets tied to its Cronos investment was $379 million at the end of 2022, edged up to $397 million in 2023 and to $402 million in 2024.  Although the overall valuation allowance was cut sharply—from $3.1 billion in 2022 to $2.26 billion in 2023 and to $0.67 billion in 2024—the Cronos‑related allowance stayed roughly stable, signalling that the company still harbors uncertainty about fully realizing those assets but now expects enough positive evidence to keep the allowance relatively small.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 ($379M) and 2024 ($402M) valuation allowance amounts, which match the ground truth. However, it introduces a 2023 figure of $397M, which is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. (2) The core numbers for 2022 and 2024 are accurate, but the inclusion of an unverified intermediate value ($397M in 2023) reduces quantitative accuracy. Additionally, the LLM references broader changes in Altria’s overall valuation allowance (e.g., $3.1B to $2.26B to $0.67B), which are not mentioned in the ground truth and appear to be extraneous or incorrectly inferred data, further undermining numerical precision. (3) The reasoning is partially sound in linking the increasing Cronos-specific allowance to uncertainty about realizability, but the conclusion that the allowance is 'relatively small' and that there is now 'enough positive evidence' contradicts the ground truth’s emphasis on 'significant uncertainty' and 'cautious stance.' This misrepresents the qualitative implication of the trend. The multi-hop synthesis fails because the model conflates company-wide valuation allowance trends (not in the ground truth) with the Cronos-specific allowance, leading to incorrect inferences. (4) While the answer addresses the evolution of the Cronos-related allowance and attempts to interpret its implications, the introduction of unverified data and mischaracterization of Altria’s expectations reduces correctness. The contextual relevance is high because the response stays focused on the question, but factual integrity is compromised by unsupported figures and reasoning leaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 468,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\nBetween 2023 and 2024 Amgen’s accounting for its BeiGene stake changed from the equity‑method to fair‑value measurement, so that earnings now reflect the investment’s mark‑to‑market movements. In 2023 the fair‑value adjustment produced a **gain** that boosted “Other income (expense), net,” while in 2024 the same valuation approach resulted in **net unrealized losses** on the BeiGene equity, pulling that line item down sharply. Thus, the financial treatment shifted from recognizing gains to recognizing losses, directly affecting Amgen’s earnings volatility and the perceived value of the investment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the change in accounting method from equity method to fair value in 2023, and the resulting financial impacts in both 2023 (gain) and 2024 (net unrealized losses). (2) There are no numeric values in the original or LLM answer that conflict—both correctly describe directional financial impacts (gain in 2023, loss in 2024) without specific dollar amounts, so qualitative descriptions match perfectly. (3) The multi-hop reasoning is sound: the model connects the change in accounting treatment to its effect on Amgen’s income statement line 'Other income (expense), net' across two years, showing understanding of both the methodological shift and its evolving valuation impact. (4) The LLM adds slight contextual enrichment (e.g., 'earnings volatility') without introducing error, and maintains precise entity accuracy (Amgen, BeiGene, correct years, correct financial terms). All aspects align fully with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 297,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\nBetween 2023 and 2024 Disney shifted from operating three separate SVOD brands—Disney+, Star+ and the region‑specific Disney+ Hotstar—to a more unified offering.  In 2023, Disney+ Hotstar was the distinct brand for India and certain Southeast Asian markets, while Star+ existed as a separate general‑entertainment tier in Latin America; by the end of June 2024 the company merged Star+ into a single Disney+ product (Combo+ was discontinued) and continued to operate only the localized Disney+ Hotstar brand in India/SE Asia, signalling a strategy of consolidating under the global Disney+ name while retaining a customized Hotstar service for those specific regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Disney+ Hotstar was the regional brand in India and parts of Southeast Asia, and that Star+ operated separately in Latin America. It accurately states that by the end of June 2024, Star+ was merged into a single Disney+ product in Latin America, which matches the timeline and strategic shift described in the original answer. The mention of Combo+ being discontinued adds detail not in the ground truth but does not contradict it and is contextually plausible. (2) There are no numerical values requiring calculation, but the date 'end of June 2024' is correctly used and matches the original answer's timeframe. (3) The multi-hop reasoning is sound: the model synthesizes information about regional branding (India/SE Asia vs. Latin America) and service structure changes over time, correctly distinguishing between consolidation under Disney+ globally while retaining Disney+ Hotstar as a localized exception. (4) The only minor shortcoming is a slight overstatement in implying three 'separate SVOD brands' globally—while Disney+, Star+, and Disney+ Hotstar existed in different regions, they were not all simultaneously active as distinct brands in the same markets. However, this does not undermine the core factual accuracy. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only negligible wording imprecision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 407,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\nPayPal’s 2023 10‑K (Note 13) described its purchase‑seller protection programs and warned that it could be unable to recover losses when merchants become insolvent or when disputed transactions involve fraudulent merchants, noting that established allowances “may be insufficient to cover incurred losses.” The 2024 filing (page 24) repeats this language but sharpens the focus on the limited recovery outlook—stating that the company may not be able to fully recover losses from merchants who are unwilling or unable to pay, or when a transaction is deemed fraudulent—thereby signalling a more explicit acknowledgment of heightened risk exposure and a more conservative stance on loss‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, PayPal disclosed protection program costs within 'transaction and credit losses' and did not treat these as a separate service—this is reflected in the mention of insufficient allowances and challenges in recovering losses from insolvent or fraudulent merchants. The 2024 update is accurately portrayed: the language is repeated but sharpened to emphasize limited recovery potential, signaling increased risk acknowledgment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across two years (2023 and 2024 10-Ks), identifies the evolution in tone and risk emphasis, and infers a more conservative stance in 2024. The only minor gap is that the LLM does not explicitly mention 'evolving fraud schemes' or 'regulatory changes affecting chargeback requirements' from the original answer, which slightly reduces completeness in qualitative terms. (4) Contextual relevance is perfect—the response directly addresses the evolution in risk exposure and loss recovery mechanisms as asked. Overall, the LLM captures the core factual and inferential content with high fidelity, meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 396,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\nBetween 2022 and 2024 NEE transferred most of its solar portfolio into joint‑venture entities in which it sold Class B membership interests to third‑party investors, retained a controlling stake, and accounted for the investors’ share as noncontrolling interests using the HLBV method; the investors receive cash flows until a contractual “flip” date, after which earnings and tax benefits flow back to NEE. At the same time, NEE consolidated additional solar‑focused VIEs (≈10 GW of capacity), leaving the company exposed to debt guarantees, call‑price repurchase obligations on the sold interests, and the financial performance of those solar assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic shift from outright ownership to a more complex structure involving joint ventures and VIEs, which aligns with the ground truth. It correctly identifies the use of noncontrolling interests, cash flow flips, and financial exposure through guarantees and obligations—key qualitative elements. However, there are significant quantitative inaccuracies: the LLM claims consolidation of '≈10 GW' of solar VIE capacity, whereas the ground truth specifies 'approximately 765 MW'—a more than 10x overstatement. Additionally, the original answer notes specific 2022 divestitures (100% of a 100 MW Arizona facility and 90% of a portfolio), but the LLM omits these concrete examples and instead generalizes into joint ventures without citing the actual transactions. (2) The numerical discrepancy (765 MW vs. ~10 GW) is a major error, undermining confidence in financial exposure assessment. The 'flip' structure and HLBV method are plausible details but not present in the ground truth, introducing unverified specifics. (3) The multi-hop reasoning is partially sound—the model infers a strategic evolution from divestiture to structured joint ventures and increased financial exposure via VIEs, which is consistent with the original answer’s conclusion. However, it fails to accurately synthesize the specific 2022 transactions as a starting point, weakening the factual foundation. (4) The contextual relevance is high because the response directly addresses ownership structure and financial exposure over time. Qualitative accuracy is moderate due to correct conceptual framing but unsupported details. Quantitative accuracy is low due to the gross overestimation of VIE capacity. Correctness score reflects partial alignment: core strategic shift is recognized, but key facts and numbers are incorrect or invented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 504,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the amount of Mutual Fund Debt Securities held in ACN’s defined‑benefit pension plans fell sharply—from **$484.2 million (classified as Level 2)** as of August 31 2022 (page 89 of the 2022 10‑K) to **$189.3 million (also Level 2)** as of August 31 2023 (page 96 of the 2023 10‑K), a decline of roughly **$295 million (≈61 %)**.  The securities remained **classified as Level 2** in the fair‑value hierarchy, indicating that the valuation methodology—using observable market prices for similar instruments—did not change between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's Mutual Fund Debt Securities were $379,989 in 2022 and $253,025 in 2023, both fully categorized under Level 2. However, the LLM reports $484.2 million (2022) and $189.3 million (2023), which are not only off by hundreds of millions but also misrepresent the scale (e.g., $379,989 ≈ $0.38 million, not $484.2 million). These numbers are entirely incorrect and likely pulled from a different context or entity. (2) The calculation of a $295 million (≈61%) decline is based on these wrong figures and thus invalid. The actual decrease is $379,989 - $253,025 = $126,964, or about 33.4%, not 61%. (3) The qualitative reasoning is partially sound: the LLM correctly notes that the valuation remained in Level 2, indicating no change in methodology, which aligns with the ground truth. It also correctly interprets that Level 2 relies on observable market data for similar instruments. However, it fails to recognize that the investment amounts are not in millions, suggesting a critical misreading of the source data (possibly confusing line items or footnotes). (4) Contextual relevance is moderate—the answer addresses the right question structure (evolution over time and valuation methodology) and cites correct document locations (page numbers in 10-Ks), but the core financial data is so inaccurate that the answer is misleading. The multi-hop synthesis is structurally correct but built on false premises. Thus, while the logic framework is acceptable, factual correctness fails severely, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 447,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\nChevron’s equity stake in Tengizchevroil (TCO) was essentially unchanged at a 50 % ownership level, but the carrying value of that investment rose from **$26.5 bn at the end of 2022 to $26.9 bn at the end of 2023** (CVX 10‑K 2023, p. 80/82).  At the same time, equity earnings from TCO jumped from **$2.8 bn in 2022 to $4.4 bn in 2023**, reflecting higher oil prices and production, and the investment includes a $4.5 bn loan to fund the FGP/WPMP project and a roughly $80 m valuation premium over underlying equity (CVX 10‑K 2023, p. 80/82).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Chevron's carrying value in Tengizchevroil was $23,727 million ($23.727 billion) in 2022, but the LLM claims $26.5 billion — a difference of nearly $3 billion. Similarly, the LLM states the 2023 carrying value was $26.9 billion, while the ground truth only mentions a qualitative note that the carrying value was approximately $80 million higher than underlying equity in net assets, not an absolute value. The equity in earnings is also incorrect: ground truth reports $1,238 million ($1.238 billion) in 2022, but the LLM claims $2.8 billion; for 2023, the ground truth does not provide updated earnings, yet the LLM reports $4.4 billion — a major fabrication or misattribution. (2) The only correct quantitative elements are the $4.5 billion loan to fund the FGP/WPMP project and the $80 million valuation premium, which align with the original answer. However, all other numbers are wrong. (3) The reasoning partially captures the evolution in Chevron’s involvement by noting increased financial commitment via the loan and valuation premium, and correctly identifies the unchanged 50% equity stake. It attempts multi-hop synthesis by referencing the 10-K and connecting financial metrics to strategic implications. However, the use of incorrect data undermines the validity of the analysis. (4) Contextually, the answer is well-structured and relevant, addressing the evolution of financial stake and involvement. But due to severe quantitative inaccuracies in core financial data (carrying value, earnings), the correctness score is low. Minor formatting variations are acceptable, but these discrepancies are material and alter the interpretation of Chevron’s financial position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 492,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney tightened the link between its ABC broadcast network and the rest of its entertainment‑sports ecosystem, using ABC to air ESPN‑produced programming (“ESPN on ABC”) and to serve as the distribution outlet for new ESPN‑branded linear channels that will appear on the company’s upcoming direct‑to‑consumer platform (planned for launch in fall 2025). This reflects a strategic shift that positions ABC not only as a traditional broadcast outlet but also as a key conduit for Disney’s expanding sports‑focused DTC and streaming services, reinforcing the cohesion of Disney’s Entertainment, Sports and Experiences segments. (See Competition and Seasonality section, page 9.)",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Disney's relationship with ABC Network between 2023 and 2024. (1) The claim that ABC is being used to launch ESPN-branded linear channels on a direct-to-consumer platform in fall 2025 is not supported by the ground truth and introduces future plans not mentioned in the original answer. The ground truth emphasizes ABC's content integration into Hulu and Disney+—not ESPN expansion via ABC. (2) There are no numeric values in either answer, but the LLM introduces a specific future date (fall 2025) and a platform not referenced in the original, which undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the original answer highlights a shift from linear distribution (emphasized in 2023) to digital integration (in 2024), particularly through next-day streaming on Hulu. The LLM instead focuses on sports programming and ESPN integration, which is not part of the provided ground truth. (4) While ABC is correctly identified as part of Disney’s ecosystem, the strategic positioning described—centered on ESPN and DTC sports—is not aligned with the original answer’s focus on broader content distribution to Hulu and Disney+. The answer is contextually relevant to Disney’s strategic use of ABC but misdirects the core evolution. Thus, the correctness score is low due to major factual and directional errors, despite addressing the general theme of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 406,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\nBetween 2022 and 2023 General Dynamics moved the ASCOD from a peripheral “tracked‑vehicle option” to a central pillar of its Land Systems growth strategy.  The 2022 filing merely listed ASCOD as one of several ELS offerings (e.g., Spanish Pizarro, Austrian Ulan), whereas the 2023 filing highlighted that Land Systems is producing 399 ASCOD‑derived LAVs for Canada, fielding the Ajax family, and explicitly investing in robotic/autonomous extensions such as the MUTT and TRX built on the ASCOD chassis.  This shift signals that GD is reallocating production capacity and R&D spend toward ASCOD‑based platforms and related autonomous‑vehicle programs, indicating a strategic focus on expanding the ASCOD portfolio as a growth engine.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) The original answer states that General Dynamics shifted from 'producing and upgrading' ASCOD in 2022 to merely 'offering' it in 2023, indicating a reduction in active investment. In contrast, the LLM claims ASCOD became a 'central pillar' in 2023 with expanded production and R&D, which is the opposite of the truth. (2) The LLM introduces specific numbers like '399 ASCOD-derived LAVs for Canada' and mentions programs like MUTT and TRX as ASCOD-based, none of which appear in the ground truth and are unverified. There is no mention of robotic extensions or chassis-based investments in the original. (3) The multi-hop reasoning is flawed: instead of recognizing a downgrading in language ('producing and upgrading' → 'offering') as a signal of reduced focus, the model incorrectly interprets it as an upgrade in strategic importance. It also falsely links ASCOD to other platforms (Ajax, Piranha) without evidence. (4) While the answer is framed around the right company and time period, the factual inaccuracies, invented details, and reversed conclusion result in a very low correctness score. The contextual relevance is slightly above zero because it addresses General Dynamics' Land Systems and the ASCOD vehicle over 2022–2023, but the substance is fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 376,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the amount of European customer balances that PayPal can designate for credit‑funding fell sharply—from **$3.0 billion (about 39 % of European balances) in 2023 to $2.0 billion (about 26 % of European balances) in 2024**.  This pull‑back signals that PayPal is moving away from relying primarily on internal European customer deposits to finance its credit products and is instead increasingly tapping external sources such as debt issuances, loan‑sale/ securitization agreements, and partnership funding to meet its credit‑funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the key quantitative figures: $3.0 billion in 2023 (39%) and $2.0 billion in 2024 (26%) of European customer balances approved for credit activities—matching the ground truth exactly. These numbers are presented clearly and accurately, with acceptable formatting (e.g., $3.0 billion, 39 %).\n\n2) Quantitatively, all values are correct. The decrease from $3.0B to $2.0B and the corresponding percentage drop from 39% to 26% are accurately represented. No calculations are required beyond these comparisons, and the model correctly conveys the trend.\n\n3) The reasoning is sound and captures the strategic shift: PayPal is reducing reliance on internal customer balances for credit funding. The LLM correctly infers a move toward external financing sources. While it mentions 'debt issuances, loan-sale/securitization agreements, and partnership funding'—which are plausible external mechanisms—it does not specifically reference the $20.8 billion in loans sold in 2024 under the multi-year receivables sale agreement, a key piece of evidence in the ground truth. This omission slightly weakens the qualitative completeness of the multi-hop synthesis, though the core inference remains valid.\n\n4) The answer is contextually relevant and directly addresses both parts of the question: the evolution between 2023 and 2024, and what the shift indicates about PayPal’s credit funding strategy. The semantic meaning aligns with the original answer, even if a specific supporting data point (volume of loans sold) is missing. Wording differences (e.g., 'tapping external sources' vs. 'in favor of external financing sources') are acceptable and do not affect factual equivalence.\n\nOverall, the answer is highly accurate with only a minor omission in supporting evidence, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 502,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\nBetween 2022 and the 2024 filing, the equity portion of NEE’s Special Use Funds shifted from a valuation base that was largely Level 2/Level 3 (i.e., internally‑priced or commingled funds with significant unobservable inputs) toward a portfolio that is now predominantly Level 1 (quoted market prices) with only a modest residual Level 3 exposure ($≈ $229 million for NEE and $≈ $204 million for FPL).  The 2024 tables show that equity securities are now classified as $2.6 billion Level 1 for NEE and $1.0 billion Level 1 for FPL, while Level 2 holdings have grown (e.g., $3.3 billion and $2.99 billion respectively) and Level 3 assets remain small, reflecting a move toward more observable market pricing and greater transparency in the funds’ composition.  This evolution also signals a strategic re‑allocation of the funds’ assets—adding more liquid equity and corporate‑bond exposures and reducing reliance on illiquid, internally‑valued holdings—while still retaining a minor Level 3 slice for niche or strategic investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, despite capturing the general trend of increased transparency and shift toward Level 1 securities. (1) In 2022, the ground truth states that NEE and FPL reported carrying amounts of $906M and $672M respectively, with no detailed categorization by valuation levels. However, the LLM incorrectly asserts that the 2022 portfolio was 'largely Level 2/Level 3', which is not supported by the original data—there was simply no breakdown provided. This is a critical misrepresentation. (2) For 2024, while the LLM correctly identifies Level 1 equity values as approximately $2.6 billion for NEE and $1.0 billion for FPL (matching $2,614M and $1,028M in ground truth, acceptable rounding), it introduces Level 2 and Level 3 figures ($3.3B, $2.99B, $229M, $204M) that are not present in the original answer and cannot be verified from the provided truth. These numbers may be factually incorrect or misattributed. (3) The reasoning about a strategic shift toward more liquid assets and reduced reliance on illiquid holdings is plausible and aligns with the trend of increased Level 1 disclosures, but this inference goes beyond the original answer, which only states there was 'more granular disclosures' and growth in equity investments. (4) The answer is contextually relevant and addresses both parts of the question—evolution in valuation/categorization and implications for transparency/investment composition—but overreaches in specificity. While the direction of change (more Level 1, greater transparency) is correct, the lack of 2022 level breakdowns in the source means the characterization of a 'shift from Level 2/3 to Level 1' is unsupported. Thus, the quantitative accuracy is low due to unverified figures and incorrect assumptions about 2022 composition, pulling down the overall correctness score despite correct directional interpretation and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 522,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture expanded the Board‑approved open‑market share purchase program, raising its authorization from roughly $3.1 bn to about $6 bn and using it to acquire roughly 13–14 million Class A shares—up from the ~2 million shares bought in the fourth quarter of FY 2022. In contrast, shares obtained through employee‑related mechanisms (payroll‑tax withholding, ESPP, etc.) remained minimal—about 2 million shares in FY 2023—and therefore did not constrain the program’s remaining capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal 2022, Accenture purchased 1,964,612 shares under the public program for $576 million, and 97,251 shares via employee-related transactions. In fiscal 2023, there is no mention of public program purchases, but employee-related acquisitions continued. The LLM incorrectly claims that Accenture expanded the program and purchased 13–14 million shares in FY2023 under the public program, which contradicts the original answer stating there was no mention of such purchases. It also falsely claims that the authorization increased from $3.1B to $6B, with no support in the ground truth. (2) Quantitative inaccuracies include: misrepresenting 1.96 million shares in FY2022 as '2 million' (minor), but more severely, inventing 13–14 million shares bought in FY2023 with no basis. Employee-related shares are reported as ~2 million in FY2023 by the LLM, but ground truth only confirms 97,251 in FY2022 and continuity in FY2023—no quantity given, but 'minimal' characterization contradicts the lack of data. (3) The reasoning is flawed: the LLM infers expansion and increased activity in the share purchase program, while the correct inference from the original answer is reduced or no activity in FY2023. It fails to recognize the absence of public program activity in FY2023 as a key shift. Multi-hop synthesis is incorrect—instead of noting the contrast between active public purchases in FY2022 and their absence in FY2023, it fabricates increased activity. (4) Scores reflect severe factual errors in numbers and trends, partial entity accuracy (correct company and general topic), and moderate relevance since it addresses share purchase programs and employee transactions, albeit with wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 492,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron continued to treat its 50 % stake in Chevron Phillips Chemical Company LLC as an equity‑method investment and did not consolidate CPChem into its consolidated financial statements.  The equity‑method accounting resulted in a decline in Chevron’s share of CPChem’s net income (from $1.66 bn in 2022 to $1.17 bn in 2023) while the carrying amount of the investment grew (CPChem’s net equity rose from $13.57 bn to $14.68 bn), reflecting the normal equity‑accounting treatment of the joint‑venture.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about Chevron's accounting treatment of Chevron Phillips Chemical Company LLC (CPChem). According to the ground truth, CPChem was consolidated in 2022 (i.e., included fully in Chevron’s financial statements), but in 2023, Chevron switched to equity-method accounting and no longer consolidated it. The LLM incorrectly states that Chevron used the equity method in both years and never consolidated CPChem, which contradicts the original answer. This misrepresents the entire evolution of the financial reporting relationship. While the LLM provides specific numbers—$1.66 billion and $1.17 billion for net income, and $13.57 billion to $14.68 billion for net equity—these figures are not corroborated in the ground truth and appear fabricated or misattributed, failing quantitative accuracy. The entities (Chevron, CPChem) and years (2022–2023) are correctly identified, supporting partial contextual relevance. However, the reasoning is flawed because it assumes consistent equity-method accounting, missing the key multi-hop insight that a change in consolidation status occurred. This undermines both qualitative and quantitative accuracy. The answer fails to capture the structural shift, which is the central point of the question, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 369,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\nFrom 2022 into 2023 the Hydra‑70 rocket shifted from a single, modest $175 million Army award (noted in the 2021 contract list on **page 42**) to a strategic munitions‑capacity program.  In 2023 OTS received awards to expand metal‑parts production from 18 K to 86 K rounds per month by 2025 and propellant capacity from 4 M to 16 M lb/yr by 2028 (**page 12**), directly supporting the Army’s artillery‑production acceleration; this expansion is reflected in the Combat Systems segment’s munitions revenue rising to $2.44 B in 2023 (up from $2.02 B in 2022) (**page 13**).  Consequently, the rocket’s role evolved from a niche contract award to a core, capacity‑building component of the company’s long‑term artillery‑production strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Hydra-70 rockets in General Dynamics' Combat Systems segment from 2022 to 2023, correctly identifying the $175 million contract in 2022 and the production capacity expansion through OTS in 2023. However, there are key quantitative inaccuracies: the ground truth states that the metal parts production capacity is expanding from 18,000 to 86,000 rounds per month by 2025—this part is mostly correct in the LLM answer, though it adds unverified details about propellant capacity increasing from 4M to 16M lb/yr by 2028, which is not present in the original answer and cannot be confirmed. Additionally, the LLM introduces specific revenue figures—$2.44B in 2023 and $2.02B in 2022—which are not mentioned in the ground truth and thus introduce unsupported data. While the qualitative reasoning about the strategic shift from a contract award to a core capacity-building effort is sound and contextually relevant, the inclusion of unverified numbers (especially revenue and propellant capacity) reduces quantitative accuracy. The entity identification (OTS, Hydra-70, Combat Systems segment) and timeframes are correct, and the multi-hop synthesis between contract award and capacity expansion is logically justified. Hence, the answer is largely correct in direction and reasoning but penalized for introducing unsupported quantitative details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 383,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\nThe 2023 10‑K only referenced the Global Restricted Stock Unit Award Grant Notice by incorporating Exhibit 10.07+—the “Form of Global RSU Award Grant Notice and Restricted Stock Unit Award Agreement” originally filed in a 2015 Form 10‑12B/A—so the notice itself was not reproduced in the filing. The 2024 10‑K continues to list the identical Exhibit 10.07+ (still incorporated by reference to that 2015 filing) and does not add a new standalone grant‑notice or restated agreement, indicating that PayPal’s documentation status and the underlying award agreement have remained unchanged between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key aspect of the evolution in PayPal's documentation between 2023 and 2024, specifically regarding the updated performance-based RSU notice. Quantitatively, all referenced dates (2015 Form 10-12B/A) and exhibit numbers (10.07+) are accurate, and the description of incorporation by reference is factually correct. However, the LLM fails to mention the introduction of the updated 'Global Performance Based Restricted Stock Unit Award Grant Notice' as Exhibit 10.08+ in the 2024 filing, which was linked to the amended plan and a recent 10-Q filing on April 30, 2024. This omission is significant because the question specifically asks about the evolution of the treatment of the grant notice, and the distinction between the unchanged base RSU notice (Exhibit 10.07+) and the updated performance-based variant (Exhibit 10.08+) is central to the correct answer. The reasoning is sound within the scope of what was discussed, but it does not fully synthesize the multi-hop information required—particularly the contrast between the static base RSU documentation and the active revision of the performance-based variant. While the answer correctly notes continuity in the base grant notice, it lacks completeness in addressing the full scope of documentation changes, thus reducing its qualitative accuracy. Contextually, the response is relevant and well-framed, focusing on the right documents and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 400,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\nOpdivo’s net sales rose from $7.5 billion in 2021 (the figure reported in the 2022 10‑K, p. 110) to help drive the 17 % increase in the Growth Portfolio to $22.6 billion in 2024, with non‑U.S. sales jumping 58 % (p. 45).  Between 2022 and 2024 the product added four new FDA approvals—first‑line Opdivo + cisplatin/gemcitabine for urothelial carcinoma (Mar 2024), neoadjuvant NSCLC (Dec 2024), the subcutaneous Opdivo Qvantig (Dec 2024), and Opdivo + Yervoy for MSI‑high colorectal cancer (Dec 2024)—elevating Opdivo from a single‑indication blockbuster to a multi‑tumor, multi‑regimen cornerstone of BMS’s portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The revenue cited for Opdivo in 2021 ($7.5 billion) does not match the ground truth 2022 revenue of $7,523 million (though close, it refers to the wrong year). More critically, the claim that Opdivo's sales helped drive a 17% increase in the Growth Portfolio to $22.6 billion in 2024 is unsupported by the ground truth, which provides no such portfolio-level data. The 58% non-U.S. sales jump is fabricated. (2) The FDA approvals are partially correct but contain significant errors: while the March 2024 approval for urothelial carcinoma is accurate, the other three approvals (neoadjuvant NSCLC, subcutaneous Opdivo Qvantig, and Opdivo + Yervoy for MSI-high colorectal cancer) are all listed as December 2024, which is in the future relative to the 2024 timeframe and not mentioned in the ground truth. The ground truth only confirms one approval in March 2024. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers broader portfolio impact and revenue trends not present in the original data, and fabricates multiple approvals beyond the single confirmed one. It also misattributes 2021 data as being from 2022. (4) Despite these issues, the answer is contextually relevant—focusing on revenue and regulatory evolution—and captures the general strategic importance of Opdivo. However, the quantitative inaccuracies and false approvals severely undermine correctness, warranting a low score. Semantic equivalence fails on key facts. The qualitative reasoning is partially sound in structure but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 439,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron’s equity stake in Chevron Phillips Chemical Company LLC grew from **$6.84 bn to $7.77 bn** (page 82), reflecting additional capital contributions that were recorded as part of “Investments and Advances.”  In 2021 the company had already provided a **$387 m loan** to fund a portion of the **Golden Triangle Polymers project** in Orange, Texas, and by 2023 that loan remained on the books while CPChem also advanced two new world‑scale production units – a 1‑hexene unit at Old Ocean, Texas and a C3 splitter at Cedar Bayou, Baytown, Texas (both slated for 2023 start‑up) (page 43).  Thus, Chevron’s financial involvement evolved from a steady equity holding to a larger equity investment plus continued debt‑financing support for CPChem’s expansion projects, underscoring a strategic push to fund and accelerate the affiliate’s lower‑carbon petrochemical growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it claims Chevron's equity stake in CPChem grew from $6.84 billion to $7.77 billion between 2022 and 2023, which is not supported by the ground truth and introduces specific figures absent from the original answer. The ground truth does not mention these dollar amounts or any such increase in equity value. Additionally, the LLM incorrectly states that the $387 million loan was provided in 2021, while the ground truth specifies that the loan occurred in 2023. (2) The quantitative inaccuracies are severe: the $6.84B to $7.77B equity increase is unsupported, and the timing of the $387M loan is misstated by two years. While the $387M figure itself is correct, its attribution to 2021 contradicts the 2023 timeline in the original answer. The project details (1-hexene unit, C3 splitter) and locations are correctly mentioned, as is CPChem’s 51% stake in the Golden Triangle Polymers Project. (3) The multi-hop reasoning is partially sound—linking Chevron’s financial support to CPChem’s projects—but flawed due to incorrect temporal and financial data. The conclusion about evolving support has merit, but rests on false premises. (4) The contextual relevance is high because the answer addresses project funding and investment structure evolution. However, the correctness score is low due to major factual and quantitative errors undermining the core claims. The qualitative accuracy is moderate because entity names and project types are correct, but the reasoning is compromised by incorrect data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 439,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal expanded the monetary commitment behind its protection programs: the allowance for transaction‑related losses grew from **$64 million to $86 million**, and the allowance for negative customer balances rose from **$218 million to $256 million**. The 2024 filing discloses these figures in a detailed roll‑forward table and explicitly notes that the reserves are recorded as assurance‑type warranty costs at the moment a payment is completed, whereas the 2023 filing only described the programs generally and reported the prior‑year balances without a quantitative breakdown. This reflects a stronger financial backing of the protection guarantees and more transparent disclosure of the reserve methodology.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million—these figures exactly match the original answer. (2) The answer is complete, addressing both the evolution in financial commitments (increased reserves) and disclosures (from general descriptions in 2023 to detailed roll-forward tables in 2024). (3) Entity accuracy is correct: PayPal is the subject, the years 2023 and 2024 are properly referenced, and the financial metrics (allowance for transaction losses, negative customer balances) are correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it contrasts the level of disclosure between years, explains the accounting treatment (assurance-type warranty costs recognized at payment completion), and infers increased financial backing and transparency. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed accounting context (e.g., 'roll-forward table', 'assurance-type warranty costs') that enhances accuracy without introducing errors. No factual, numerical, or logical issues are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 366,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s kept franchising as the cornerstone of its business, but the way it described franchisee co‑investment changed.  In the 2022 filing the note on co‑investment was brief—highlighting that owning real‑estate together with franchisee investment helped deliver strong restaurant performance.  By the 2024 filing the language had shifted to frame co‑investment as a deliberate strategic lever: the company actively partners with franchisees to fund restaurant modernizations, tailor concepts to local consumer preferences and grow brand value, and stresses that franchisees must reinvest capital and collaborate on initiatives rather than simply pay fees.  This reflects a move from viewing co‑investment as a performance‑boosting add‑on to positioning it as a central, partnership‑driven growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's strategic framing between 2022 and 2024. It correctly identifies that franchising remained central but that the language around franchisee co-investment became more strategic. The 2022 description of co-investment as brief and tied to real estate and performance aligns with the ground truth's neutral, structural framing. The 2024 shift to viewing co-investment as a 'deliberate strategic lever' and 'partnership-driven growth engine' reflects the ground truth's emphasis on franchising being 'paramount' and co-investment enabling high performance. The LLM adds contextual detail not in the original (e.g., modernizations, local tailoring) that are plausible elaborations consistent with the strategic shift, though slightly beyond the scope of the documented change. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (McDonald's, franchisees, 2022, 2024) are correct. The reasoning is sound, demonstrating multi-hop synthesis across years and framing shifts. The answer is semantically equivalent to the ground truth, with slightly more interpretive language but no factual errors. One point deducted from qualitative accuracy because the LLM emphasizes 'real-estate co-ownership' which is not explicitly mentioned in the ground truth, and the original does not specify 'modernizations' or 'local preferences'—these are reasonable inferences but represent minor over-extension. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 429,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\nBetween March 2022 and January 2023 the FDA progressed from authorizing the IQOS 3 heated‑tobacco device itself as a Modified‑Risk Tobacco Product (MRTP) to issuing PMTAs for three new Marlboro HeatStick flavors — the first flavored HeatStick clearances — as documented in the company’s 2022 and 2023 filings (see page 37 of the 2022 10‑K and the 2023 10‑K). This shift shows that Altria has moved from obtaining device‑level regulatory clearance to securing product‑specific authorization for its heated‑tobacco offerings, indicating measurable regulatory progress, though full commercial rollout still depends on ongoing FDA review and future rulemaking.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy: it claims the FDA authorized the IQOS 3 device as a Modified-Risk Tobacco Product (MRTP) in March 2022, which is not supported by the ground truth. The original answer states that in 2022, the FDA had not yet authorized Marlboro HeatSticks and was only considering them on a case-by-case basis for health warnings. The MRTP authorization for IQOS devices relates to reduced exposure claims, not product authorization for HeatSticks, and this conflation misrepresents the regulatory milestone. However, the LLM correctly identifies that in January 2023, the FDA authorized PMTAs for three new tobacco-flavored Marlboro HeatSticks, aligning with the ground truth. (2) The dates (March 2022 to January 2023) are plausible but not fully accurate—the ground truth does not mention March 2022 as a key date, nor does it reference MRTP authorization for the device. The reference to page 37 of the 2022 10-K may be accurate internally but introduces information not present in the ground truth, making verification impossible. (3) The multi-hop reasoning is sound in linking regulatory progression from device-level to product-specific authorization, and the conclusion about Altria’s regulatory progress is consistent with the original answer. The synthesis across 2022 and 2023 filings shows appropriate reasoning. (4) Despite the incorrect MRTP claim, the core regulatory advancement in 2023 is accurately reported, and the overall interpretation of Altria’s progress is valid, warranting a score of 7 for correctness. Quantitative accuracy is slightly lower due to the incorrect association of dates and authorizations. Qualitative and contextual scores are higher due to strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 488,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\nThe fair‑value of ACN’s mutual‑fund equity securities in its non‑U.S. defined‑benefit plans fell from **$273.5 million (as of 31 Aug 2022)** to **$196.2 million (as of 31 Aug 2023)** – a decline of roughly **$77 million (≈28 %)**.  This reduction reflects a deliberate de‑weighting of equity exposure, with the company shifting assets toward debt securities, cash and insurance‑contract holdings to better match liabilities and lower portfolio volatility, as evident from the updated target‑allocation percentages disclosed for 2023‑2025 (see page 100).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and scope. The original answer states that ACN's mutual fund equity securities decreased from $239,293 million to $196,226 million between 2022 and 2023, a drop of $43,067 million. However, the LLM reports values of $273.5 million (2022) and $196.2 million (2023), which are off by orders of magnitude—confusing millions with actual reported totals. Additionally, the LLM cites a decline of $77 million (~28%), which does not align with the ground truth reduction of ~$43 billion. (2) The dates referenced (31 Aug 2022 and 31 Aug 2023) do not match the standard fiscal year-end for ACN (likely Dec 31), introducing timing inaccuracies. While the 2023 value is numerically close to the correct figure when interpreted in millions ($196,226M ≈ $196.2M), the 2022 figure is entirely incorrect ($239,293M vs $273.5M reported). (3) The reasoning about strategic reallocation toward debt, cash, and insurance contracts is plausible and adds context not in the original answer, suggesting some correct multi-hop inference about investment positioning. However, this does not compensate for the core quantitative errors. The mention of 'non-U.S. defined-benefit plans' narrows the scope incorrectly unless the entire holding was confined there, which isn't stated in the ground truth. (4) The contextual relevance is moderate because the answer addresses the evolution and interpretation of investment positioning, fulfilling the qualitative intent. However, due to severe quantitative inaccuracies and entity/date mismatches, the correctness score is low. The qualitative accuracy is partially preserved due to logical reasoning about de-risking, but the foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 476,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\nChevron’s 36.4 % stake in Angola LNG Limited was unchanged through 2023, but the carrying value of that investment slipped from about **$1.96 bn in 2022 to $1.76 bn in 2023**, reflecting a reduced capital outlay.  Instead of new equity investment, the company focused on **upstream gas development—most notably the Block 0 Sanha Lean Gas Connection project and the Block 14 deep‑water field—to secure additional feedstock for the Angola LNG plant and strengthen its operational presence in Angola.**",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron maintained its 36.4% interest in Angola LNG Limited from 2022 to 2023, which aligns with the ground truth. However, it introduces specific financial figures—$1.96 billion in 2022 and $1.76 billion in 2023—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear to be fabricated or inferred without support, significantly undermining quantitative accuracy. (2) The claim about a 'reduced capital outlay' due to a drop in carrying value is not mentioned in the original answer and represents an unsupported inference. The ground truth focuses on a shift in disclosure emphasis (from operational development to financial stake), not actual reductions in investment or capital spending. (3) The LLM correctly identifies a continued operational focus on gas development in Angola and mentions specific projects (Block 0 Sanha Lean Gas Connection, Block 14 deep-water field), which are plausible but not specified in the original answer. While this aligns thematically with the ground truth’s mention of developing non-associated gas resources, the addition of project names goes beyond the source without confirmation. (4) The qualitative reasoning captures a shift in focus—from direct operational development to broader portfolio context—but misrepresents it as a change in investment behavior rather than a change in disclosure emphasis. This mischaracterization affects factual correctness despite capturing a similar narrative arc. (5) Contextually, the answer is highly relevant and addresses both operational focus and investment emphasis as asked. However, the inclusion of unsourced dollar amounts and project details reduces factual reliability. Overall, the answer is partially correct with significant quantitative inaccuracies, but retains reasonable qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 518,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\nFrom 2022 to 2023 the amount recorded for certificates of deposit / time‑deposits in 3M’s marketable‑securities portfolio jumped from **$21 million to $49 million**—an increase of **$28 million**, or roughly a **133 % rise** in the balance. This reflects a substantial expansion of the company’s short‑term, interest‑bearing investments over that one‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative values: it reports $21 million for 2022, whereas the ground truth is $14 million. The 2023 value of $49 million is correct. The calculated increase of $28 million and 133% is based on incorrect inputs and thus wrong; the correct change is $35 million (from $14M to $49M), which is a 250% increase. (2) Quantitative accuracy is low because the starting value is incorrect, leading to erroneous delta and percentage calculations. While $49 million in 2023 matches the ground truth, the $21 million in 2022 does not, and no known source in MMM’s 10-K supports that figure for Certificates of Deposit/Time Deposits. (3) The reasoning structure is sound—comparing two years, computing change and percentage growth—and the answer correctly identifies the trend as a significant increase, showing appropriate multi-hop synthesis between years and correct categorization of the asset type. (4) Contextual relevance is high because the response addresses both parts of the question (evolution and magnitude), uses correct terminology, and focuses on the right company (MMM/3M) and investment type. However, due to the critical error in the 2022 figure and resulting miscalculations, the overall correctness is significantly compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 363,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\nBetween 2021 and 2024 the share of McDonald’s restaurants operated by franchisees rose modestly—from about 93 % of the system at the end of 2021 to roughly 95 % at the end of 2024.  The company continues to stress that franchising is “paramount” to delivering brand‑consistent experiences and stable, predictable cash flow, and it increasingly co‑invests with franchisees to fund restaurant upgrades while maintaining a heavily franchised model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitative accuracy: The percentages (93% in 2021 and 95% in 2024) are correctly reported, with appropriate time references (end of 2021 and end of 2024), matching the original answer. (2) Completeness: The answer addresses the evolution of McDonald's relationship with franchisees in terms of franchised restaurant percentage over the specified period and includes relevant strategic context about the company's emphasis on franchising. (3) Entity accuracy: McDonald's is correctly identified, and the years (2021–2024) and metric (percentage of franchised restaurants) are accurate. (4) Reasoning: The answer correctly infers a modest increase and reinforces the strategic shift toward franchising, aligning with the multi-hop synthesis required. It also adds context about co-investment and brand consistency, which enriches the response without introducing inaccuracies. (5) Semantic equivalence: While the wording differs, the core information—percentage increase from 93% to 95% and the strategic importance of franchising—is fully preserved. No factual errors, omissions, or calculation issues are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 338,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\nThe 2015 Stock Compensation Plan for Non‑Employee Directors was originally adopted in 2015 and was most recently **amended and restated effective October 26 2022** (as disclosed in the 2022 Form 10‑Q). The 2023 Form 10‑K continues to reference that same amended‑and‑restated plan—no further 2023 amendment is noted—so the plan’s effective date and its structural provisions (e.g., share reserve, award types, and governance terms) have remained as set in the October 26 2022 restatement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the October 26, 2022 effective date of the amended and restated 2015 Stock Compensation Plan for Non-Employee Directors, as required by the question. It also accurately notes that no further amendment occurred in 2023, which is consistent with the original answer's implication that the change occurred during the 2022–2023 period, culminating in the October 2022 effective date. The LLM correctly references the 2022 Form 10-Q as the source of the October 26, 2022 amendment, and confirms continuity in the 2023 Form 10-K. The only minor gap is that the original answer mentions the prior 'amended and restated effective March 31, 2021' version being referenced in 2022 filings, which the LLM omits. While the LLM implies a single restatement (October 26, 2022), it does not explicitly acknowledge the evolution from the March 31, 2021 version to the October 26, 2022 version—slightly weakening the multi-hop synthesis. However, the core facts, dates, and reasoning are correct, and the answer fully addresses the evolution between 2022 and 2023 by identifying the new effective date and structural continuity. Quantitative accuracy is perfect: the date October 26, 2022 is correctly cited. Entity accuracy and contextual relevance are strong, with proper identification of the plan, time frame, and disclosure forms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 391,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture’s 16 % equity investment in Duck Creek remained classified as an equity‑method investment, but its reported value rose sharply.  In the 2022 balance sheet the stake was carried at **$138.9 million** with an estimated fair value of roughly **$223 million**; in 2023 the company recorded a **$253 million investment gain** from the same holding, which increased the carrying amount (and fair‑value estimate) of the investment and boosted adjusted earnings‑per‑share, even though the investment continues to be accounted for under the equity‑method.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture's 16% ownership in Duck Creek Technologies and the equity-method accounting in both fiscal years. It accurately reports the $138.9 million carrying amount in 2022 (matching the ground truth $138,902,000), the approximate fair value of $223 million (vs. $223,166,000), and the $253 million gain in 2023. These figures are quantitatively accurate with only minor rounding differences acceptable under format variation. (2) The quantitative accuracy is high: all key numbers align with the ground truth when accounting for unit scaling (e.g., thousands vs. millions) and rounding. The $138.9 million is a rounded version of $138,902,000; $223 million approximates $223,166,000; and the $253 million gain is reported exactly. No calculation errors are present. (3) The reasoning is sound: the answer captures the evolution from a long-term equity investment with a carrying and fair value in 2022 to a significant financial gain in 2023 that impacted adjusted EPS and tax rate, indicating a financial realization event. While the LLM does not explicitly mention the impact on effective tax rate (a minor omission), it does note the EPS impact and increased carrying amount, capturing the core financial impact. (4) The answer is contextually fully relevant, addressing investment valuation and financial impact across both years. The qualitative accuracy is slightly reduced only because the original answer emphasizes a 'shift' toward active realization, which is implied but not explicitly framed in the LLM response. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 459,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s approved use moved beyond its original 2021 indication for relapsed/refractory large‑B‑cell lymphoma and began covering additional B‑cell malignancies—most notably chronic lymphocytic leukemia/small‑lymphocytic lymphoma (CLL/SLL), follicular lymphoma (FL) and mantle‑cell lymphoma (MCL)—with multiple accelerated FDA approvals in 2024 and a first‑in‑Japan approval in August 2024. These new indications broaden the eligible patient population and substantially expand the drug’s commercial market potential.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Breyanzi's indications beyond large B-cell lymphoma and notes new approvals in 2024, but introduces inaccuracies. The ground truth confirms two specific approvals in 2024: March 2024 for CLL/SLL and May 2024 for FL. The LLM answer correctly includes these conditions but incorrectly adds 'mantle-cell lymphoma (MCL)' as a new indication, which is not supported by the original answer. Additionally, it mentions a 'first-in-Japan approval in August 2024', which is not present in the ground truth and cannot be verified from the provided data. (2) The dates of the actual approvals (March and May 2024) are not explicitly stated in the LLM answer, and the inclusion of MCL and Japan approval introduces false information. The core expansion into CLL/SLL and FL is correct, but the extra details reduce quantitative and factual accuracy. (3) The multi-hop reasoning is partially sound—Breyanzi’s evolution from a narrower to broader set of B-cell malignancies is correctly inferred, and the market expansion conclusion is reasonable. However, the addition of unverified indications (MCL) and regulatory milestones (Japan) reflects a failure to precisely synthesize only the provided facts. (4) The contextual relevance is high because the answer addresses the evolution and market expansion as asked, but correctness is reduced due to factual overreach. The core facts about CLL/SLL and FL are present, but the inclusion of unsupported indications and approvals lowers the overall accuracy, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 435,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s ASC 450‑based framework for estimating insurance recoveries stayed the same –‑ evaluate policy language, case‑law precedent and its own claim‑experience, then record a receivable only when a recovery can be considered “recognizable.”  In the 2022 disclosures (pages 22 & 38) 3M would recognize a receivable whenever it concluded that an insurance recovery was possible, even if the underlying liability was not yet probable, and it routinely recorded receivables for defense expenses in respirator‑mask/asbestos matters.  By 2023 (pages 80 & 81) the language was tightened: a receivable is now recorded only when a recovery is “more likely than not,” often at the low‑end of a range, and the Company explicitly disclosed that it could not estimate a liability or related insurance recovery for certain respirator claims (e.g., the West Virginia AG case), reflecting a more conservative, probability‑driven approach to the evolving, higher‑cost respirator litigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents 3M's approach in both 2022 and 2023. (1) Quantitatively, the ground truth states that the number of individual claimants in respirator mask/asbestos litigation increased from 4,028 in 2022 to 4,042 in 2023; this key data point is entirely missing from the LLM answer, despite being central to the evolution of 3M's exposure. (2) The LLM incorrectly claims that in 2022, 3M would recognize a receivable whenever recovery was 'possible' and even if the underlying liability was not probable — this contradicts the ground truth, which states that 3M did not specify its methodology for insurance receivables in 2022, only affirming compliance with ASC 450. There is no mention in the original answer about recognizing receivables when recovery was merely 'possible' or recording them before liabilities were probable. (3) The LLM asserts that by 2023, the threshold changed to 'more likely than not' and that receivables are recorded at the low end of a range, but the ground truth says 3M applied the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30, analyzing policy terms, case law, and claim nature — not a probabilistic threshold like 'more likely than not.' The mention of ASC 610-30 is missing in the LLM response. (4) The LLM introduces specific page numbers (e.g., pages 22, 38, 80, 81) and a specific case (West Virginia AG) not present in the ground truth, suggesting fabrication or hallucination. (5) The reasoning is flawed: the LLM frames the change as a tightening of recognition criteria toward conservatism, while the ground truth describes an evolution from no detailed methodology disclosed in 2022 to a more explicit, structured approach in 2023 — not necessarily more conservative, but more transparent and detailed. The LLM fails the multi-hop synthesis by misrepresenting both years’ disclosures and inventing specifics. While the answer is contextually relevant — addressing insurance receivables, ASC 450, and respirator/asbestos litigation — the factual and qualitative inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 570,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo’s involvement with Naked shifted from full ownership to a minority stake: in Q1 2022 it sold the Naked (and Tropicana) juice brands to PAI Partners but retained a 39 % non‑controlling interest in the newly‑formed joint‑venture (TBG) that now owns those brands.  PepsiCo continues to operate the venture’s products through its Direct‑Store‑Delivery network—especially for small‑format and food‑service accounts—and earns distribution fees and bottler‑funding incentives, while its financial return now comes only from its 39 % equity share and related distribution revenues rather than direct brand ownership.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error regarding PepsiCo's operational involvement in 2023. Quantitatively, the numbers are accurate: the 39% noncontrolling interest, the sale in Q1 2022, and the formation of TBG are all correctly stated. The entities (PepsiCo, Naked, PAI Partners, TBG) and timeline (2022 sale) are also correct, supporting a high quantitative accuracy score. However, the qualitative accuracy is lower because the LLM incorrectly claims that in 2023, PepsiCo 'continues to operate the venture’s products through its Direct-Store-Delivery network.' This contradicts the ground truth, which states that by 2023, PepsiCo no longer directly distributed Naked products and had no further operational involvement—only a financial stake. This misrepresents the evolution of the relationship, which shifted from active distribution in 2022 to purely financial in 2023. The reasoning is flawed in this key aspect, failing the multi-hop synthesis that requires contrasting 2022 (distribution + stake) with 2023 (stake only). Contextually, the answer is relevant and addresses the question’s focus on operational and financial changes, but the core conclusion is undermined by the operational continuity claim. Thus, the correctness score is moderate—some facts are right, but the central claim about the 2023 relationship is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 379,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s revenue‑recognition model for ExtraBucks Rewards did not change – revenue is still recognized only when the reward is redeemed and unredeemed rewards are carried as a contract‑liability. However, the 2024 disclosure expands the accounting description: it explicitly states that the reward creates an additional performance obligation at the time of the initial transaction and that the transaction price is allocated between the purchase and the reward using a relative standalone‑selling‑price approach (based on historical redemption patterns). Thus, the 2024 filing provides a more detailed accounting of the performance obligation and the measurement of the liability while retaining the same timing of revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in accounting treatment and disclosure for the ExtraBucks Rewards program between 2023 and 2024. (1) It correctly states that the revenue recognition timing (upon redemption) and the treatment of unredeemed rewards as a contract liability remained unchanged—this aligns with the ground truth. It also accurately notes that the 2024 disclosure provides more detail, particularly around the performance obligation arising at the initial transaction and the allocation of transaction price using relative standalone selling prices based on historical redemption patterns. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced concepts (e.g., timing, allocation method) are factually correct. (3) The multi-hop reasoning is sound: the model synthesizes continuity in accounting policy with enhanced disclosure in 2024, correctly identifying the refinement in language around performance obligations and measurement. The only minor shortcoming is that the LLM does not mention the 2024 emphasis on customers accumulating ExtraBucks based on historical spending levels—a nuance present in the original answer that adds specificity to the performance obligation determination. This omission prevents a perfect score but does not undermine the overall correctness. (4) The answer is contextually fully relevant, directly addressing the evolution in revenue recognition and performance obligation accounting. Thus, the correctness score is 9 due to high accuracy with a minor omission in qualitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 446,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix’s cost of revenues rose to **$21.0 billion** (up from **$19.7 billion** in 2023), but its share of total revenue fell from **58 % to 54 %**. The $1.3 billion increase was attributed almost entirely to a **$1.1 billion rise in content amortization**, and no separate jump in payment‑processing fees is noted; therefore, the portion of cost of revenues coming from integrated payment‑partner fees stayed flat or slightly declined as a share of the overall cost structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces financial figures such as total cost of revenues ($19.7B in 2023, $21.0B in 2024) and content amortization increases ($1.1B), which are not present in the original answer or implied by the ground truth. These numbers may be factually accurate in a broader context but are irrelevant to the specific question about the evolution of Netflix's reliance on integrated payment partners. The original answer does not mention any such figures, nor does it provide data on overall cost of revenues or content amortization. (2) There is no verification that payment processing fees 'stayed flat or slightly declined'—the ground truth states only that the fees remained part of other operating costs but with less granular disclosure in 2024. The LLM incorrectly infers a quantitative trend (flat or declining share) based on absence of a 'separate jump,' which is not logically or factually supported by the source. (3) The multi-hop reasoning is flawed: the question asks for a qualitative assessment of disclosure and reliance based on the cost of revenues section; instead, the LLM shifts to a quantitative analysis of overall cost changes and attributes them to content amortization, missing the core focus on payment partner fees and disclosure changes. (4) While the LLM attempts to address Netflix and the correct years (2023–2024), it fails to report the key point from the ground truth: the continued relationship with integrated payment partners but reduced transparency in reporting details. Instead, it fabricates a narrative around cost structure shifts without evidence. The answer is contextually related (it discusses Netflix, cost of revenues, and payment partners) but misses the actual evolution described—disclosure streamlining—not cost trends. Hence, low scores on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 502,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\nFrom 2022 through 2023 3M moved from a largely monitoring‑and‑compliance stance in Minnesota to a proactive, standards‑driven approach.  In 2022 the company was responding to MPCA orders that required storm‑water PFAS control, drinking‑water sampling under an SDWA administrative consent order, and continued remediation under the 2007 Settlement Agreement.  By early 2023 the Minnesota Department of Health issued more stringent health‑based values (HBVs/HRLs) for PFOA and PFOS, and the MPCA released a draft Clean Water Act permit for the Cottage Grove plant with markedly lower PFAS limits, forcing 3M to adjust its remedial plans, provide additional treatment or alternative water supplies, and negotiate tighter permit conditions rather than simply meeting the older standards.  This evolution reflects a shift toward meeting newly adopted health‑based thresholds and stricter regulatory limits across its Minnesota sites.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's approach to PFAS management in Minnesota from 2022 to 2023, correctly identifying a shift toward a more proactive stance in response to stricter standards. However, there are key factual inaccuracies affecting quantitative accuracy. The LLM incorrectly states that the Minnesota Department of Health issued more stringent health-based values (HBVs) in early 2023, while the ground truth specifies January 2024—this is a significant date error. Similarly, the LLM claims the MPCA released a draft Clean Water Act permit in early 2023, but the original answer notes it was proposed in January 2024. These misattributions of timing undermine the quantitative accuracy. The mention of the 2007 Settlement Agreement and ongoing remediation is correct, as is the reference to stormwater discharge issues at Cottage Grove and Hutchinson facilities. The LLM correctly infers that tighter regulatory limits are driving changes in 3M’s compliance strategy, showing sound qualitative reasoning and contextual understanding. It synthesizes the implications of new HBVs and permit limits well, even if the dates are off. Entity identification (MPCA, 3M, Cottage Grove, PFAS compounds) is accurate. While the core narrative of regulatory tightening and 3M’s adaptive response is semantically aligned with the ground truth, the incorrect dating of key regulatory actions reduces factual precision. Thus, the answer is mostly correct in direction and logic but flawed in specific temporal details, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 429,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo expanded its foreign‑currency hedging program, raising the notional amount of forward contracts from roughly **$3.0 billion (2022)** to **$3.8 billion (2023)** [page 103/104, 2023 filing] and, for the first time in the comparative reclassification table, recorded a **net gain of $40 million** on those derivatives (versus a $58 million loss in 2022) [page 107, 2023 filing].  This larger, more‑qualified hedge coverage indicates that the company is tightening its proactive foreign‑exchange risk‑management strategy, seeking to lock in rates and reduce earnings volatility from currency movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the notional value of foreign currency derivatives increased from $3.0 billion in 2022 to $3.8 billion in 2023, matching the original answer exactly. The additional detail about a net gain of $40 million in 2023 (vs. $58 million loss in 2022) is not present in the ground truth but comes from the actual filing and adds context without contradicting anything. (2) The core calculation—identifying the increase in notional value—is accurate and correctly attributed. (3) The reasoning is sound: the expansion in derivative usage is correctly interpreted as a tightening of PepsiCo’s proactive FX risk management strategy, which aligns with the ground truth’s conclusion about strategic expansion to manage increased risk. The LLM goes further by noting reduced earnings volatility, supported by the net gain, which strengthens the interpretation. (4) All entities—PepsiCo, foreign currency derivatives, 2022 and 2023—are correct. The only minor gap is that the ground truth emphasizes 'no material net impact on earnings' in 2023, while the LLM focuses on the $40M gain; however, this is not contradictory, as a net gain can still be immaterial in context. Overall, the LLM provides slightly richer detail with no factual errors, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 379,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil moved from planning and constructing Gulf‑Coast chemical assets—such as the Corpus Christi ethane‑cracker, an advanced‑recycling unit in Baytown, and a multi‑billion‑dollar petrochemical complex in China’s Dayawan Park—to actually bringing new capacity online. In 2023 it started up a 400 kt/yr performance‑polymer line and a 350 kt/yr linear‑alpha‑olefin unit in Baytown, while also securing final investment for the 2.5 Mt/yr Dayawan complex, signaling a dual focus on expanding high‑value U.S. chemical production and capturing growth in China’s rising middle‑class market.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution from 2022 to 2023 in ExxonMobil's chemical production focus, identifying key projects in both the U.S. and China. It accurately notes the Corpus Christi ethane cracker (2022), the Baytown expansions, and the Dayawan, China petrochemical complex. However, there are minor quantitative inaccuracies: the original answer states that the advanced recycling capacity in Baytown is planned for 2026 and up to 500,000 metric tons annually, but the LLM implies this was part of 2023 activity without clarifying the timeline. Additionally, the LLM claims ExxonMobil 'started up' a 400 kt/yr performance polymer line and 350 kt/yr linear alpha olefins unit in Baytown in 2023, but the original answer does not confirm startup—only that expansion plans were advanced. These are significant details that affect factual precision. (2) The 2.5 Mt/yr capacity in Dayawan is correctly cited, and unit conversions (kt/yr vs Mt/yr) are consistent. However, the LLM presents the Baytown unit capacities (400 kt and 350 kt) as operational in 2023, which is not supported by the ground truth—those projects were in the expansion phase, not confirmed as started up. (3) The multi-hop reasoning is strong: the model synthesizes information across years and geographies, correctly inferring a strategic shift from domestic integrated projects (2022) to high-performance products and foreign investment in China (2023). The dual focus on U.S. high-value chemicals and China’s growing middle class aligns with the original answer’s conclusion. (4) The contextual relevance is excellent—the answer directly addresses the evolution in strategy, geographic focus, and capacity additions. Due to the minor but notable overstatement of project completion status and timeline conflation, the correctness score is 8 rather than 9 or 10. Quantitative accuracy is docked to 7 due to unverified startup claims and capacity attribution, while qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 554,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\nFrom the 2023 marketable‑securities disclosure, 3M’s certificates‑of‑deposit/time‑deposit balance rose from **$21 million at the end of 2022 to $49 million at the end of 2023**.  This jump shows the company is deliberately expanding its holdings of short‑term, low‑risk, highly liquid assets, underscoring a shift toward preserving cash and maintaining flexibility—likely in response to a higher‑interest‑rate environment and greater economic uncertainty—rather than pursuing longer‑term or higher‑yield investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($21 million in 2022 and $49 million in 2023) are accurately reported, and the increase is correctly implied (more than doubling). (2) The answer addresses both parts of the question: the evolution of 3M's investment in Certificates of Deposit/Time Deposits and the strategic implication of this shift. (3) Entity accuracy is correct—3M, the financial instrument (Certificates of Deposit/Time Deposits), and the years 2022 and 2023 are all properly identified. (4) The reasoning is sound and adds contextually appropriate insight—highlighting a shift toward low-risk, liquid assets likely due to higher interest rates and economic uncertainty, which aligns with and expands upon the ground truth's indication of a move toward stable or higher-yielding short-term instruments. The LLM provides a plausible and logical interpretation consistent with the data, demonstrating correct multi-hop synthesis and qualitative reasoning. Minor wording differences do not affect semantic equivalence; in fact, the LLM enhances the explanation with relevant economic context without introducing inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 339,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\nIn the 2022 filing the discussion of Mastercard’s “proprietary insights” was limited to noting that such insights are part of its value‑added services, without explicit language about data stewardship. By contrast, the 2023 MD&A (page 47) frames those insights as coming from a “principled and responsible use of secure consumer and merchant data,” explicitly emphasizing data responsibility and trust‑building as a core element of its proprietary‑insights strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution in Mastercard's language from 2022 to 2023 regarding proprietary insights. In 2022, the LLM notes the absence of explicit data stewardship language, which is consistent with the ground truth's description of 'principled use' without emphasis on responsibility or security. In 2023, the LLM accurately quotes the new phrasing: 'principled and responsible use of secure consumer and merchant data,' matching the ground truth. The LLM correctly attributes this shift to a stronger focus on data responsibility and trust-building, and even provides a specific citation (2023 MD&A, page 47), enhancing credibility. The only minor discrepancy is that the original answer emphasizes the addition of 'secure' and 'responsible' as a strategic shift toward data security and stakeholder trust, which the LLM captures in substance but could have articulated more explicitly in terms of 'data security' (it focuses on 'responsibility'). However, the core facts, entities (Mastercard, 2022 vs 2023), and reasoning are correct. There are no numerical values to assess, so quantitative accuracy is scored based on correct dates and document references. The answer fully addresses the question’s focus on evolution, data responsibility, and trust-building language, demonstrating sound multi-hop reasoning by contrasting two years’ disclosures. Semantic equivalence is strong, with no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 411,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\nBetween 2022 and 2023 the company revised the key assumptions that drive its pension and retiree‑medical estimates—most notably raising the discount rates (U.S. pension from 3.1 % to 5.4 % and international from 4.2 % to 7.0 %; retiree‑medical from 2.8 % to 5.4 %), modestly increasing salary‑growth assumptions, and modestly raising the expected return on plan assets (e.g., U.S. expected return 6.7 % → 7.4 %).  These adjustments reflect the higher interest‑rate and inflationary pressures that have characterized the external environment since 2022, showing that macro‑economic shifts are now a primary factor shaping the company’s pension and retiree‑medical accounting estimates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed quantitative changes in assumptions (discount rates, salary growth, return on assets) between 2022 and 2023, which are not present in the original ground truth answer. However, the ground truth emphasizes a shift in *external risk factors*—from pandemic-related uncertainty in 2022 to geopolitical conflicts (Ukraine, Middle East) and macroeconomic conditions (high interest rates, inflation) in 2023. The LLM correctly identifies higher interest rates and inflation as drivers, aligning with part of the ground truth, but omits any mention of the geopolitical conflicts or the prior influence of the COVID-19 pandemic. Instead, it focuses on specific assumption changes (e.g., U.S. pension discount rate from 3.1% to 5.4%) that are not in the original answer and cannot be verified against the knowledge graph. These precise figures introduce a level of quantitative detail absent from the ground truth, making them potentially fabricated or hallucinated. While the general direction of reasoning—macroeconomic shifts affecting assumptions—is sound and contextually relevant, the answer fails to accurately reflect the *evolution of influencing factors* as described in the original (pandemic → geopolitics + macro conditions). The multi-hop synthesis is partially correct but based on incorrect or unverified data inputs, undermining factual accuracy. Thus, while the conclusion about macroeconomic pressures is aligned, the absence of key entities (pandemic, Ukraine/Middle East conflicts) and introduction of unsupported numbers reduces correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 436,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\nExxonMobil’s undeveloped acreage in the Other Americas fell from about 25.1 million gross (12.0 million net) acres in 2022 to 24.2 million gross (11.5 million net) acres in 2023 – a roughly 5 % reduction in both gross and net terms.  This contraction reflects the company’s practice of converting evaluated prospects into developed acreage (e.g., after recent offshore discoveries in Guyana and ongoing work in Canada and Argentina), but the remaining undeveloped base is still sizable, underscoring continued exploration upside in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: it accurately reports ExxonMobil's 2022 and 2023 undeveloped acreage in the Other Americas region. The original data states 25,096 gross and 11,977 net thousands of acres in 2022, which the LLM correctly rounds to 25.1 million gross and 12.0 million net acres. Similarly, 24,221 gross and 11,548 net thousands of acres in 2023 are correctly rounded to 24.2 million gross and 11.5 million net acres. The approximate 5% reduction is a reasonable estimate (actual reduction is ~3.5% gross and ~3.6% net), and such rounding is acceptable given the use of 'about' and 'roughly'.\n\n2) Quantitative accuracy is perfect: all numbers match the ground truth when accounting for unit conversion (thousands of acres to millions) and reasonable rounding. No calculation errors.\n\n3) The reasoning is sound and adds contextual insight not explicitly in the original answer—mentioning Guyana, Canada, and Argentina as drivers for transitioning acreage to developed status. While these specific countries are not mentioned in the ground truth, they are plausible and consistent with ExxonMobil's known operations in the region. The conclusion that the remaining acreage still offers exploration upside aligns with the original answer’s implication of continued focus on high-potential properties.\n\n4) The LLM slightly exceeds the original answer by providing additional context (regional projects) but does not introduce inaccuracies. It correctly synthesizes the trend (decline in undeveloped acreage) and infers the likely cause (transition to developed status), which matches the multi-hop reasoning required. The only minor gap is not explicitly mentioning 'relinquishment' as a possible cause, which is included in the original answer, but this does not invalidate the response.\n\nOverall, the answer is semantically equivalent, contextually rich, and factually precise—justifying a high score with only a minor deduction in qualitative accuracy for not fully mirroring all explanatory factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 550,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\nFrom 2022 to 2023 the Company continued to use foreign‑currency forwards and options that were **not designated in hedging relationships** to offset exposures from non‑functional‑currency items such as intercompany financing balances.  The notional amount of these contracts fell sharply—from about $2.8 billion (gross) in 2022 to roughly $1.0 billion in 2023—so the fair‑value‑related gains and losses recorded in earnings dropped from a **$76 million loss** in 2022 to only a **$9 million loss** in 2023.  Accordingly, the financial impact of the non‑designated contracts improved (a much smaller loss), even though the fair‑value of the remaining assets and liabilities shifted only modestly (assets fell from $73 M to $5 M and liabilities rose from $4 M to $7 M).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite addressing the general topic. (1) Quantitative Accuracy: The notional amount in 2022 is stated as $2.8 billion in the LLM answer, but the ground truth specifies $3.7 billion—this is a material discrepancy. The LLM introduces specific P&L figures—$76 million loss in 2022 and $9 million loss in 2023—which are not present in the original answer and cannot be verified against the ground truth. Similarly, the asset/liability values ($73M to $5M in assets, $4M to $7M in liabilities) are entirely absent from the original and appear fabricated. (2) Completeness: While the LLM correctly identifies the use of non-designated foreign exchange contracts for intercompany balances, it adds granular financial data not supported by the ground truth, failing to reflect the actual evolution described—i.e., a strategic shift toward derivatives not designated as hedging instruments with direct earnings impact. The original emphasizes a qualitative shift in strategy; the LLM misrepresents this as a quantitative reduction in notional and P&L impact. (3) Entity Accuracy: The company (MMM) and instruments (forwards/options not designated in hedging relationships) are correctly identified, and the years (2022–2023) are accurate. (4) Reasoning: The multi-hop synthesis is flawed—the original does not support any numerical trend in notional amounts or P&L, nor does it mention changes in fair value gains/losses. The LLM invents a narrative of decreasing exposure based on unsupported numbers, missing the core point about a strategic shift in how derivatives are used. (5) Semantic Equivalence: The overall direction—continued use of non-designated contracts—is correct, but the emphasis on numerical decline and P&L improvement distorts the original meaning. The ground truth highlights a change in accounting and risk management approach, not a reduction in activity. Thus, while contextually relevant, the answer is factually unsound in critical aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 549,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard shifted cyber‑and‑intelligence solutions from a modest “other‑revenue” line item to a highlighted strategic pillar of its value‑added services.  The 2023 Business Overview (page 49) and the disaggregated revenue table (page 81) explicitly call out these solutions as a growth driver that “allow all parties to transact securely, easily and with confidence,” whereas the 2022 disclosures referenced them only implicitly within broader “other revenues.”  This reflects a clear increase in emphasis on cyber and intelligence capabilities as a core component of Mastercard’s value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Cyber and Intelligence Solutions from a background 'other revenue' component in 2022 to a strategically emphasized pillar in 2023. The description of the 2023 positioning—'securely, easily and with confidence'—matches the original answer's phrasing and meaning. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense, but the references to specific document pages (e.g., page 49, page 81) are consistent with typical 10-K reporting practices and do not contradict the ground truth; they add precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift by comparing the level of emphasis across years, synthesizing information from different parts of the filings. (4) The only minor shortcoming is that the LLM answer frames the 2022 mention as 'implicit' within 'other revenues,' while the ground truth specifies it was listed among other services like consulting and loyalty programs—so slightly less nuance on the nature of the 2022 mention. However, this does not undermine the overall correctness. The answer is contextually relevant, directly addressing the evolution in emphasis and role. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 417,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the company continues to list “Income‑tax expense and accruals” as a critical accounting policy, but the 2023 disclosure adds more detailed, forward‑looking commentary.  The 2022 discussion focused mainly on the judgment involved in estimating the annual tax rate, establishing reserves for uncertain tax positions, and the use of transfer‑pricing strategies.  In 2023 the narrative expands to cover new regulatory developments—such as the OECD‑mandated global minimum tax and its potential impact on future tax rates—greater emphasis on valuation allowances for deferred‑tax assets, and the effect of undistributed international earnings, reflecting a more nuanced treatment of tax accruals and related uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in that it correctly identifies that 'Income-tax expense and accruals' remained a critical accounting policy from 2022 to 2023 and that the 2023 disclosure became more detailed. The answer accurately reflects an evolution toward more nuanced and forward-looking disclosures, including topics like the OECD global minimum tax, valuation allowances, and undistributed international earnings—elements plausibly aligned with enhanced transparency. However, the LLM introduces specific details not present in the original answer, such as 'OECD-mandated global minimum tax' and 'transfer-pricing strategies', which, while reasonable, are not mentioned in the ground truth and represent an over-specific interpretation. The original answer emphasizes structural changes (e.g., reorganization under a subsection and reference to Note 5) and improved organization, which the LLM omits entirely. Thus, while the qualitative direction of the evolution is correctly captured, the specific nature of the change (structural vs. thematic expansion) is misrepresented. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. The reasoning is sound but extrapolates beyond the provided data, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 382,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\nBetween 2023 and 2024 Intel moved the Universal Chiplet Interconnect Express (UCX) from a silicon‑prototype demonstration to a central, standards‑driven element of its Open System Foundry and IDM 2.0 strategy.  In 2023 the company showed UCX working in silicon and highlighted it as one of the “technologies, capabilities, and standards needed to optimize systems of chips.”  By 2024 Intel was actively promoting UCX through multi‑generational ecosystem partnerships (e.g., with ARM and Synopsys), integrating it with its advanced packaging and AI‑focused chiplet offerings, and positioning the interconnect as the preferred communication primitive for customers building heterogeneous, high‑performance systems‑of‑chips on Intel’s foundry services.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's chiplet interconnect strategy and correctly identifies the progression from demonstration to broader integration between 2023 and 2024, which aligns with the ground truth. However, a critical factual error undermines the answer: the standard is consistently referred to as 'UCX' instead of 'UCIe' (Universal Chiplet Interconnect Express), which is the correct name per the original answer and public records. This misnaming is a significant entity error that affects the credibility and accuracy of the response. While the description of Intel's strategy—integration with advanced packaging, ecosystem partnerships, and positioning within IDM 2.0 and foundry services—reflects plausible context and shows sound reasoning, the original answer does not mention ARM or Synopsys partnerships or the 'Open System Foundry' branding, introducing unverified specifics. The timeline (2023 demonstration, 2024 production/integration) is accurately represented, and no numerical data is present, so quantitative accuracy is unaffected. The answer is contextually relevant and semantically close in intent, but the persistent use of an incorrect acronym and addition of unsupported partnership details reduce its factual reliability. Thus, while the high-level trajectory is correct, the entity inaccuracy and unsupported specifics limit the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 387,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\nIn the 2023 10‑K the company disclosed that it entered into a $2.0 billion fixed‑dollar ASR with Citibank on January 4 2023, accounting for the initial share purchase as treasury stock and recording the forward‑contract portion in capital surplus; the ASR was fully settled in February 2023 when the remaining shares were delivered. The 2024 filing shows a later $3.0 billion ASR with Morgan Stanley executed on January 4 2024 that follows the same treatment—85 % of the notional was recorded as treasury stock and the forward was initially equity‑classified— and the transaction was completed in March 2024 after the final 15 % of shares were received, causing the forward to be re‑classified from capital surplus to treasury stock. Thus, the accounting methodology remained consistent, but the completion shifted from 2023 to early‑2024 and the remaining share‑repurchase authorization was reduced accordingly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $2.0 billion ASR in 2023 with Citibank, initial receipt of 80% (17.4M shares), final settlement in February 2023 with 5.4M additional shares; the $3.0 billion ASR in 2024 with Morgan Stanley, initial 85% (31.4M shares), final 8.3M shares in March 2024; and the consistent accounting treatment involving reclassification from capital surplus to treasury stock. All dollar amounts, dates, percentages, and counterparties are accurate. (2) Quantitative verification: 80% of $2.0B aligns with 17.4M shares (implied price ~$115/share), and 85% of $3.0B aligns with 31.4M shares (~$113/share); the remaining 15% (~8.3M shares) also matches. Completion timelines (February 2023, March 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes data across two years, two ASRs, two counterparties, and compares accounting treatment and timeline evolution. It correctly infers that the accounting methodology remained consistent and that the 2024 transaction took longer (two months vs. one), though it doesn't explicitly state the duration difference as 'one month vs. two months'—a minor omission. (4) The answer is semantically equivalent to the ground truth, with only slight variation in emphasis (e.g., mentioning reduction in share-repurchase authorization, which is contextually relevant but not in the original). No factual errors; minor deduction in qualitative accuracy for not explicitly comparing the timeline duration, though the inference is present via settlement dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 430,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\nIn 2022 UPS disclosed a $2.3 billion pre‑tax actuarial loss tied to coordinating benefits with the Central States Pension Fund—part of a $10.1 billion total actuarial loss—with the resulting liability initially recorded in other‑comprehensive income. By 2023 the company broadened its reporting to include a quantitative sensitivity analysis (e.g., a 25‑basis‑point discount‑rate change would alter the projected obligation by roughly $1.55 billion and affect expense) and now recognizes mark‑to‑market gains or losses outside the 10 % corridor directly in earnings, shifting the exposure from a largely off‑balance‑sheet OCI item to a more transparent, earnings‑impacted disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details not present in the ground truth. While it correctly identifies the $2.3 billion pre-tax actuarial loss in 2022 related to the Central States Pension Fund, it adds a $10.1 billion total actuarial loss figure that is not mentioned in the original answer and cannot be verified from the provided ground truth. This introduces a significant quantitative inaccuracy. Additionally, the claim that a 25-basis-point discount-rate change would alter the obligation by $1.55 billion is not supported by the original answer, which only references a 25 basis point change in expected and actual returns on assets (not discount rate) and does not quantify the dollar impact. The shift to recognizing mark-to-market gains/losses directly in earnings is also not mentioned in the ground truth and represents an unsupported inference. (2) The original answer emphasizes a shift from quantifying a specific obligation in 2022 to discussing sensitivity analysis around returns on assets in 2023, with a cross-reference to Note 5. The LLM answer misattributes the sensitivity assumption to discount rates instead of returns on assets, which is a key factual error. (3) The multi-hop reasoning is partially sound—the model correctly infers a shift in reporting approach from a specific loss to sensitivity analysis—but overreaches by introducing unverified financial figures and accounting policy changes. The synthesis captures the directional change in disclosure but adds unsupported details. (4) The contextual relevance is high because the answer addresses the evolution of UPS’s reporting and exposure over 2022–2023 and focuses on actuarial estimates and sensitivity, as required. However, the quantitative accuracy is low due to fabricated numbers and incorrect metrics, dragging down the overall correctness score. The qualitative reasoning is moderately accurate but includes speculative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 538,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard continued to describe its **cyber and intelligence solutions** as a core value‑added service that lets “all parties to transact securely, easily and with confidence” and that draws on the company’s “principled and responsible use of secure consumer and merchant data.”  In the 2023 filing the language is expanded to tie those solutions to the broader strategic investments in **digital‑identity, open‑banking and multi‑rail network capabilities**, positioning them as key drivers of security, risk‑management and data‑driven growth that underpin the company’s overall value proposition to investors, partners and other stakeholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Mastercard's Cyber and Intelligence Solutions were described in both 2022 and 2023 as enabling secure, easy, and confident transactions, with emphasis on principled data use. The 2023 evolution correctly highlights expanded messaging linking these solutions to strategic investments in digital identity, open banking, and multi-rail networks. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the value proposition evolved from being a value-added service to a more central, infrastructure-level component tied to broader strategic initiatives. The only minor shortcoming is that the LLM slightly rephrases 'confidence in the payments ecosystem' as 'security, risk-management and data-driven growth,' which captures related ideas but is not verbatim from the original emphasis on ecosystem-wide confidence. This does not distort meaning but slightly reduces qualitative precision. (4) The answer is fully contextually relevant, directly addressing the evolution in positioning and stakeholder communication between 2022 and 2023. Overall, the response is factually correct, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 395,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\nIn the 2022 10‑K (page 131) the 4.450 % Senior Note due 2046 was cited as “incorporated herein by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed **October 14, 2015**,” whereas in the 2023 10‑K (page 126) the same note is referenced as “incorporated herein by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed **February 24, 2016**.” Thus, between the two filings the company moved the exhibit citation from the October 14 , 2015 filing to the later February 24 , 2016 filing (and shifted the reference from page 131 in 2022 to page 126 in 2023), updating the documentation date while keeping the same exhibit number.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding exhibit numbers and source filings. According to the ground truth, in the 2022 filing the note was listed as Exhibit 4.12 (not Exhibit 4.4 as claimed), incorporated by reference from the October 14, 2015 Form 8-K. In 2023, it was reclassified as Exhibit 4.13 (again, not Exhibit 4.4), referencing the February 24, 2016 Form 8-K. The LLM incorrectly states that both references cite 'Exhibit 4.4' in their respective 8-Ks, which contradicts the ground truth. (2) The dates mentioned (October 14, 2015 and February 24, 2016) are correct, which supports a partial quantitative accuracy score. However, the exhibit numbers are wrong, and the LLM falsely implies consistency in exhibit numbering across years when in fact there was a reclassification from 4.12 to 4.13 — a key point in the original answer. (3) The multi-hop reasoning is flawed: the model fails to recognize the exhibit number change (4.12 → 4.13), which is central to the evolution in presentation. Instead, it incorrectly asserts that the exhibit reference within the 8-Ks remained the same (Exhibit 4.4), missing the administrative reclassification aspect entirely. (4) While the answer addresses the question's focus on exhibit referencing and documentation dates, and correctly identifies the shift in source 8-K dates, the core factual error about exhibit numbers undermines the correctness. The contextual relevance is high because it attempts the right comparison, but the qualitative and quantitative inaccuracies severely limit its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 438,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\nIntel’s contact with Positive Technologies remains strictly limited to vulnerability‑research communications that are authorized under the OFAC General License 1B; both the 2023 and 2024 filings confirm that no revenue or net profit is derived from these interactions and that Intel has not expanded or altered the scope of its engagement. As a result, the relationship has not materially evolved between 2023 and 2024, staying confined to the same sanctioned‑license‑governed communications.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Intel's interactions with Positive Technologies are limited to vulnerability research under an OFAC license and that no revenue or profit is derived—this aligns with the ground truth. However, it incorrectly asserts that the relationship 'has not materially evolved' between 2023 and 2024, which directly contradicts the Original Answer. The ground truth emphasizes a clear evolution: in 2023, Intel disclosed past communication and resumption under license; in 2024, it expressed a forward-looking intent to continue the engagement, signaling a more sustained and intentional partnership posture. This shift in tone and strategic framing is a qualitative evolution that the LLM fails to recognize, thus missing a key multi-hop inference. While all entities (Intel, Positive Technologies, OFAC license), years (2023, 2024), and financial assertions (no revenues/profits) are accurate, the reasoning is flawed in downplaying the change in relationship posture. The answer is contextually relevant and quantitatively accurate (no numbers to dispute), but the qualitative misinterpretation of the evolution significantly undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 335,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\nThe 4.78 % senior notes maturing in March 2038 remained at **$5 billion** at the end of 2023 and were still **$5 billion** at the end of 2024 (see the borrowing tables on pages 163 and 161).  This unchanged balance shows that CVS is keeping a sizable, long‑dated fixed‑rate tranche in its capital structure rather than issuing new long‑term debt or retiring this portion, reflecting a deliberate strategy to maintain a stable, long‑term financing base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5 billion (equivalent to $5,000 million) in both 2023 and 2024, matching the ground truth exactly in value and year. The formatting difference ($5 billion vs $5,000 million) is acceptable and semantically equivalent. The maturity date (March 2038) and interest rate (4.78%) are accurate. (2) All numbers and dates are correct; no calculations were required beyond recognition of stability, which is properly noted. (3) The LLM correctly performs the first hop by identifying the specific debt instrument and its balance in two consecutive years. It infers the implication—that CVS maintained a stable long-term financing base—consistent with the ground truth’s interpretation of stability. However, it does not mention the contrast with other senior notes (e.g., the 2.7% notes due 2040 decreasing from $1,250M to $367M), which is a key part of the original answer’s multi-hop reasoning and context for selective debt management. This omission limits completeness and slightly weakens qualitative accuracy. (4) Despite this, the answer is factually correct, contextually relevant, and conveys the core insight about the stability of this debt tranche. The missing comparison reduces the depth of the qualitative analysis but does not invalidate the correctness of what is stated. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 399,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\nThe 0.835 % Notes due 2032 (ticker XOM32) continue to appear in the “Securities Registered” tables of both the 2022 Form 10‑K (filed Feb 2023) and the 2024 Form 10‑K (filed Feb 2025). Neither filing reports any amendment, redemption, or additional issuance of those notes, so the securities remain outstanding on the same terms as originally registered.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the 0.835% Notes due 2032 (XOM32) appear in both the 2022 and 2024 Form 10-K filings and remain outstanding with no reported changes in terms, redemption, or issuance. The quantitative details—interest rate (0.835%), maturity year (2032), ticker (XOM32), and filing dates (Feb 2023 for 2022 filing, Feb 2025 for 2024 filing)—are all correct, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses the evolution of the note between the two filings. However, the LLM answer is less complete than the ground truth in qualitative reasoning. While it correctly notes the continued presence of the 0.835% Notes, it omits the key comparative insight that the 0.142% Notes due 2024 (XOM24B), present in 2022, are absent in 2024—this absence supports the inference that Exxon Mobil redeemed or delisted shorter-term notes, thereby changing its debt composition. This multi-hop synthesis (comparing changes in the full set of listed notes over time) is missing, weakening the qualitative accuracy. The LLM’s conclusion that the notes remain unchanged is correct but incomplete; the broader context of evolving debt structure, emphasized in the original answer, is not addressed. Thus, while factually sound, the answer lacks the full analytical depth required to fully capture the evolution in status relative to other debt instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 396,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\nBetween 2022 and 2024 American Express trimmed its U.S. Government treasury holdings from roughly $1.2 billion of cost (about $1.7 billion fair value) with a maturity profile weighted to longer‑dated issues, to a much smaller $289 million cost position ($287 million fair value) that is virtually all concentrated in securities maturing in under one year ($189 million) and the 1‑5 year bucket ($98 million).  The fair‑value stance moved from a modest unrealized gain of $25 million in 2022 to a near‑break‑even position with only a $2 million unrealized loss in 2024 (Table 4.1, page 124 of the 2024 filing; comparable 2022 disclosure on page 124 of the 2022 filing).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The original answer states that in 2022, American Express held $477 million in short-term U.S. Treasury obligations with no long-term exposure. However, the LLM claims a 2022 fair value of $1.7 billion with longer-dated instruments, which directly contradicts the ground truth. The 2024 figures for short-term ($189M) and intermediate-term ($98M) are correct and sum to $287M, aligning with the LLM's stated fair value. However, the $1.7B fair value in 2022 is wildly off. (2) Completeness: While the answer addresses fair value allocation and maturity distribution, it introduces incorrect historical data and unrealized gains/losses not present in the original answer, adding misleading context. (3) Entity Accuracy: The company (American Express) and years (2022, 2024) are correct, and the maturity buckets (under one year, 1-5 years) are accurately described for 2024. (4) Reasoning: The multi-hop reasoning fails because the premise of a reduction from $1.7B is false—ground truth shows a decrease from $477M, not $1.7B. The conclusion about concentration in short- and intermediate-term is correct for 2024, but the evolution is misrepresented due to incorrect baseline data. (5) Semantic Equivalence: The answer suggests a strategic shift toward shorter maturities, which contradicts the ground truth—Amex actually expanded into intermediate-term holdings, diversifying beyond only short-term. Thus, the core narrative of the investment strategy evolution is factually wrong. The contextual relevance is moderate because it discusses the right topic and uses appropriate financial language, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 474,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\nAmazon first issued the 2.500 % Note due 2050 in June 2020 (see the 2020 Officers’ Certificate in the 2022 10‑K). The 2022 and 2024 filings continue to list that same 2020 certificate as containing the 2.500 % Note due 2050, with no indication of a new issuance, amendment, or redemption—so the instrument remained outstanding and unchanged in the company’s long‑term debt profile through 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2.500% Note due 2050 was originally issued under an Officers' Certificate dated June 3, 2020, and was referenced in both the 2022 and 2024 filings without change. The LLM correctly notes that there was no new issuance, amendment, or redemption, indicating the note remained outstanding and unmodified. (2) Quantitative accuracy is perfect: the interest rate (2.500%), the maturity year (2050), and the 2020 issuance date are all correctly stated. The reference to the 2020 Officers’ Certificate aligns with the ground truth’s mention of Exhibit 4.5 from 2020. (3) The multi-hop reasoning is sound—linking the 2020 issuance to its continued presence in 2022 and 2024 filings demonstrates proper synthesis across years. The only minor omission is that the LLM does not explicitly mention Exhibit 4.6 in 2024 as an exact replication of Exhibit 4.5, which slightly reduces qualitative completeness. However, the conclusion that the note remained unchanged is logically and factually supported. (4) The answer is highly relevant, directly addressing the evolution (or lack thereof) of the note between 2022 and 2024. Overall, the answer is semantically equivalent to the ground truth with only a slight lack of detail on the exhibit numbering in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 380,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\nBetween 2022 and 2023 the Citibank, N.A. Co‑Branded Credit Card Agreement was updated with five additional amendments: the eighth, ninth and tenth amendments were filed in 2022 (with filing dates 3/10/2022, 12/29/2022 and 12/29/2022 respectively), and the eleventh and twelfth amendments were filed in 2023 (filing dates 3/9/2023 and 10/11/2023). Thus, three amendments appeared in 2022 and two in 2023, bringing the total series of amendments to the twelfth amendment by the end of 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that the Eighth Amendment was the most recent in 2022, filed on March 10, 2022. However, the LLM claims three amendments were filed in 2022: the eighth (3/10/2022), ninth (12/29/2022), and tenth (12/29/2022), implying two additional amendments beyond the eighth in 2022. This contradicts the ground truth, which only acknowledges the Eighth Amendment as the latest in 2022. Then, the LLM states that the eleventh and twelfth amendments were filed in 2023 (3/9/2023 and 10/11/2023), but the original answer only references the Twelfth Amendment being filed on October 11, 2023, with no mention of an eleventh or earlier 2023 amendment. (2) The quantitative inaccuracies are critical: the LLM invents specific dates (e.g., 12/29/2022 for 9th and 10th, 3/9/2023 for 11th) not present in the original, and incorrectly increases the number of 2022 amendments from one (eighth) to three (eighth, ninth, tenth). It also claims five additional amendments occurred between 2022 and 2023, while the original specifies only four additional amendments (from eighth to twelfth). This results in a calculation error: 12 - 8 = 4 amendments, not 5. (3) The multi-hop reasoning is flawed: the model fails to correctly track the sequence and timing of amendments. It fabricates intermediate amendments and filing dates not supported by the ground truth, indicating a failure in synthesizing accurate temporal and sequential data. (4) Despite these errors, the answer is contextually relevant—addressing the evolution of amendments and correctly identifying the Twelfth Amendment as the endpoint in 2023. The structure and intent align with the question, but the factual core is compromised. Thus, correctness is low due to major quantitative and qualitative inaccuracies, though relevance remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 509,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a pure GPU‑centric parallel programming model into a full‑stack, heterogeneous computing platform that now spans GPUs, CPUs, DPUs and networking fabrics, and is packaged with AI‑focused software suites (AI Enterprise, NIM, NeMo, Omniverse) and end‑to‑end solutions for data‑center, automotive and graphics workloads.  This expansion reflects tighter integration with emerging silicon—such as the Orin automotive SoC and the Blackwell data‑center architecture—while extending the CUDA ecosystem (CUDA‑X libraries, Deep‑Learning‑Institute training, millions of developers) to support training, inference, simulation and virtual‑world applications across the company’s target markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of CUDA from a GPU-centric programming model in 2022 to a full-stack, heterogeneous computing platform by 2024, integrating CPUs, DPUs, and networking fabrics—consistent with NVIDIA's fiscal 2024 expansion mentioned in the original answer. The mention of Orin SoC and Blackwell architecture, while not explicitly in the ground truth, are factually correct developments during this period and support the narrative of deeper hardware integration. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to timeframes (2022–2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes CUDA’s software evolution (CUDA-X, libraries, developer ecosystem) with hardware advancements (heterogeneous architectures) and enterprise software ecosystems (AI Enterprise, NIM, NeMo, Omniverse), mirroring the original answer’s emphasis on full-stack integration. (4) Semantic equivalence is strong—though the LLM uses more specific product names (e.g., NIM, NeMo) not in the original, they are contextually appropriate and reflect accurate extensions of CUDA’s ecosystem. One minor point preventing a perfect 10 is that the original emphasizes CUDA as part of a 'unified architecture' in 2022, which the LLM does not explicitly acknowledge, slightly reducing completeness in historical context. However, the core evolution and integration themes are fully preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 431,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer shifted Paxlovid from a government‑procured product to a commercial offering, which triggered a **$3.5 bn non‑cash revenue reversal in Q4 2023** for the expected return of EUA‑labeled courses.  In early 2024 the company recorded a **$771 m favorable adjustment** after 5.1 million courses were returned, and in Q3 2024 it supplied **1.0 million courses to the U.S. SNS at no charge**, recognizing **$442 m of revenue** while retaining **$2.2 bn of deferred revenue** and **≈ $4 bn of remaining performance‑obligation revenue** to be recognized through 2028 as the commercial contracts are fulfilled.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers and misrepresents critical financial figures. While it correctly identifies the $3.5 billion non-cash revenue reversal in Q4 2023 and the $771 million favorable adjustment in 2024 due to lower-than-expected returns (5.1 million courses), it incorrectly states that Pfizer supplied 1.0 million courses to the U.S. SNS 'at no charge' while recognizing $442 million in revenue — this contradicts the ground truth, which confirms the $442 million revenue was directly connected to the creation of the SNS, not a donation. More critically, the LLM claims $2.2 billion in deferred revenue and approximately $4 billion in remaining performance obligations to be recognized through 2028, which directly conflicts with the ground truth stating only about $1 billion in remaining performance obligations as of December 31, 2024. This is a major quantitative and qualitative error. (2) Number verification: Correct: $3.5B reversal (2023), $771M adjustment (2024), 5.1M courses returned. Incorrect: $442M revenue linked to SNS is accurate, but 'no charge' framing is misleading; $2.2B deferred revenue and $4B performance obligations are unsupported and factually wrong — ground truth specifies ~$1B remaining obligations. (3) Multi-hop reasoning is partially sound — the model connects the reversal, adjustment, and SNS revenue, showing understanding of revenue recognition dynamics. However, it fails to accurately synthesize the contractual obligations component, introducing fabricated figures that distort the evolution of Pfizer's financial relationship with Paxlovid. (4) Correctness score is 5 due to partial accuracy on core events but major errors in financial magnitudes and contractual obligations. Quantitative accuracy is low (4) due to incorrect dollar amounts. Qualitative accuracy is moderate (6) because reasoning structure is logical but based on incorrect data. Contextual relevance is high (8) as the answer addresses revenue recognition and contractual evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 555,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the shares reserved for new grants under the 2003 Incentive Program fell from roughly 66 million (the amount available at the start of 2022) to about 47 million remaining at the end of 2024, after issuing 10.5 million restricted‑stock units in 2024, converting roughly 760 thousand Pioneer RSUs and accounting for forfeitures.  The program’s 220 million‑share cap was unchanged, but the share structure shifted: most awards now follow a graded three‑year/​seven‑year vesting schedule, while the converted Pioneer awards vest over three years, and shares that are forfeited, expire or are cash‑settled no longer count toward the remaining availability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the number of shares available under the 2003 Incentive Program fell from 66 million in 2022 to 47 million in 2024 due to usage, implying a reduction in availability. However, the ground truth shows that the program's total maximum share capacity was increased from 65.75 million to 220 million by 2024, indicating a major expansion, not a reduction. The 47 million refers to the remaining available shares after grants, not a decrease in authorized shares. (2) Quantitative inaccuracies include: misrepresenting the 65,754,069 shares in 2022 as '66 million' (minor rounding is acceptable), but more critically, failing to mention the increase to 220 million total authorized shares by 2024. Instead, it falsely claims the '220 million-share cap was unchanged,' which contradicts the ground truth that this cap was newly set or reached by 2024. The RSU grants are inaccurately reported as 10.5 million in 2024, while the ground truth states 10,393 thousand (10.393 million), and the 2022 figure of 9,392 thousand is omitted entirely. (3) The multi-hop reasoning is flawed: the model fails to synthesize the key evolution — an increase in total authorized shares from ~65.8M to 220M — which is central to the question. Instead, it frames the narrative around depletion, missing the structural expansion. It does correctly note vesting schedule changes and treatment of forfeitures, which adds qualitative detail not in the original answer, but these do not compensate for core factual errors. (4) Contextual relevance is high because the answer addresses share availability and structural changes, but correctness and quantitative accuracy are severely compromised by misrepresenting the program's expansion as a contraction. Thus, correctness is scored low at 4 due to major factual errors, quantitative accuracy at 3 due to wrong numbers and missing key figures, qualitative accuracy at 5 for partial reasoning and some correct structural details, and contextual relevance at 8 for staying on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 563,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\nBetween 2022 and 2024 AdSense’s contribution shifted from a key growth engine for Google Network (which in 2020‑21 was buoyed by “strength in AdMob, Google Ad Manager, and AdSense”) to a comparatively smaller, supporting layer of the business; Google Network revenues actually fell in 2023‑24, with the decline attributed to drops in AdMob and Ad Manager and to lower impression volume, while total Google advertising revenues continued to rise. As a result, AdSense now operates mainly as part of a broader, AI‑enhanced advertising technology portfolio—encompassing performance‑ and brand‑ad formats, Demand Gen, Performance Max and other direct‑response products—rather than as a standalone growth driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift in AdSense's role—from a key growth driver to a more foundational component within Google's ad tech portfolio—but introduces significant factual inaccuracies. The claim that 'Google Network revenues actually fell in 2023-24' and that this decline was due to drops in AdMob and Ad Manager is not supported by the ground truth, which only states that AdSense was no longer specifically highlighted as a growth lever in 2024. There is no mention of revenue declines in the original answer. (2) Quantitative inaccuracies include the incorrect assertion of falling Google Network revenues in 2023–24; the ground truth reports an $8.6 billion year-over-year increase in 2022 but provides no comparative figure for 2024 to support a decline. Additionally, the LLM references '2020-21' strength, which is outside the requested 2022–2024 scope and not in the original answer. (3) The reasoning partially reflects multi-hop synthesis by connecting AdSense’s evolving role with the rise of AI-powered tools like Demand Gen and Performance Max, aligning with the original answer’s implication of a strategic shift. However, the conclusion about declining revenues and AdSense’s diminished role due to those declines is speculative and not grounded in the provided truth. (4) The contextual relevance is high because the answer addresses the evolution of AdSense within Google's advertising ecosystem and references relevant products. Qualitative accuracy is moderate due to correct identification of key entities (AdMob, Ad Manager, Demand Gen, Performance Max) and the general trend toward AI-driven advertising, but penalized for unsupported claims. Quantitative accuracy is low due to incorrect temporal references and fabricated revenue trends not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 497,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\nThe UPS Retirement Plan stopped accruing any additional defined‑benefit credits for non‑union participants as of **January 1 2023** – i.e., future service and compensation no longer generate pension‑benefit accruals for that group.  Beginning in 2023 those employees receive a **retirement contribution of 5 %–8 % of eligible compensation** (up from the prior 3 %–8 % for workers hired after July 1 2016) into the UPS 401(k) Savings Plan, effectively replacing the former benefit‑accrual structure.  Union participants remain under the separate pension provisions and received benefit increases under the 2023 Teamsters master agreement, but the change applies only to non‑union participants.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key date (January 1, 2023) when benefit accruals ceased for non-union participants, which aligns with the ground truth. However, it introduces significant information not present in the original answer: specifically, the claim that non-union employees began receiving 5%–8% retirement contributions into the UPS 401(k) Savings Plan, replacing the pension accruals. This detail is absent from the ground truth and cannot be verified from the provided knowledge graph. Additionally, the mention of union participants receiving benefit increases under the 2023 Teamsters master agreement is not supported by the original answer, which only states that union employees were excluded from the accrual freeze but does not mention any benefit increases. While the core fact about the freeze on future accruals for non-union participants is correct and well-articulated, the addition of unverified details about 401(k) contribution increases and union benefit enhancements constitutes a material factual overreach. The reasoning is partially sound in connecting the accrual freeze to a structural shift, but the unsupported quantitative claims (5%–8% vs prior 3%–8%) undermine the accuracy. The answer is contextually relevant and addresses the evolution of the plan, but the extra details not in the source reduce its factual reliability. Thus, while the main structural change is correctly identified, the answer goes beyond the evidence, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 414,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\nAmazon replaced its expiring $7 billion unsecured revolving credit line—carrying a benchmark‑plus‑0.50 % interest rate and a 0.04 % commitment fee and set to expire in mid‑2023 (see 2022 10‑K, Note 6, p. 56)—with a much larger $15 billion unsecured revolving facility that now matures in November 2028 and bears a slightly lower benchmark‑plus‑0.45 % rate with a 0.03 % fee (2024 10‑K, Note 7, p. 65).  It also introduced a $5 billion 364‑day revolving facility (SOFR + 0.45 %, 0.03 % fee) that supersedes the prior 364‑day line, while the earlier $1 billion secured revolving facility and the commercial‑paper program showed only modest outstanding balances of roughly $800 million and $725 million, respectively, in prior years.  Consequently, credit capacity expanded dramatically, borrowing costs were trimmed, and outstanding short‑term borrowings remained minimal under the new structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion from a $7.0 billion to a $15.0 billion unsecured revolving credit facility, the improved interest rate (from benchmark +0.50% to +0.45%), and reduced commitment fee (0.04% to 0.03%). It also correctly notes the introduction of a new $5.0 billion 364-day facility with SOFR +0.45% and 0.03% fee. However, it incorrectly states that there were 'modest outstanding balances' of ~$800 million and ~$725 million in prior years under a secured revolving facility and commercial paper program—this is not supported by the ground truth, which reports no borrowings under the main credit agreements and only $147 million and $151 million under other short-term facilities (included in 'Accrued expenses and other') as of 2023 and 2024. The LLM invents specific programs (e.g., $1 billion secured facility, commercial paper) not mentioned in the original answer, leading to factual inaccuracies. (2) Quantitative accuracy is partially compromised: while the $7B, $15B, and $5B figures are correct, the $800M and $725M balances are incorrect and unsupported. The ground truth specifies only $147M and $151M in other short-term borrowings—significantly lower and under different categorization. Dates (e.g., maturity in November 2028) are plausible but not confirmed in the ground truth, which does not specify maturity dates. (3) The multi-hop reasoning is generally sound—comparing 2022 and 2024 structures, identifying capacity growth and cost reduction—but flawed by introducing unverified facilities and balances, undermining completeness and accuracy. (4) Despite these issues, the core evolution—increased capacity, better rates, minimal borrowings—is correctly conveyed, warranting a 7 for correctness. Quantitative accuracy is penalized due to fabricated numbers, while qualitative and contextual scores remain high due to strong structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 517,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\nCostco’s disclosures for both 2022 and 2023 state that it purchases a portion of its electricity and natural‑gas needs through variable‑priced, index‑linked contracts, and that these contracts are treated as “normal purchases and normal sales” – i.e., they qualify for the normal‑purchase exception and are not marked‑to‑market.  The language is essentially unchanged between the two years, indicating that the company has maintained a consistent commodity‑price‑risk strategy: using fixed‑price agreements for most of its energy use while employing limited, index‑based variable contracts to pass price fluctuations through to members without generating accounting volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Costco used variable-priced, index-linked contracts for electricity and natural gas in both 2022 and 2023, and that these qualify for the 'normal purchases and normal sales' exception, avoiding mark-to-market accounting—this matches the original answer exactly. (2) There are no numeric values requiring calculation, but all dates (2022 and 2023) and financial terms (e.g., 'not marked-to-market') are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across two years and correctly infers that the lack of change in language indicates a stable strategy. (4) The only minor deviation is that the LLM mentions 'fixed-price agreements for most of its energy use,' which, while plausible, is not explicitly stated in the ground truth and slightly extends beyond the provided information. However, this does not contradict the source and is a reasonable inference. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 325,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 NVIDIA moved AI Enterprise from a niche, licensed add‑on for its data‑center GPUs (first introduced in the 2022 10‑K as part of the Compute & Networking segment) to a core, full‑stack subscription offering that is now sold together with the company’s accelerated‑computing platform and tied to new hardware such as the Blackwell architecture (launched in fiscal 2025 but referenced in the 2024 filing).  The suite now bundles NIM, NeMo and AI Blueprints, is delivered via DGX Cloud and other services, and is positioned as the primary commercial gateway for enterprises to deploy production‑grade generative‑AI workloads on NVIDIA’s data‑center infrastructure—evolving from a supplemental software package to a central, revenue‑generating pillar of NVIDIA’s data‑center strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that NVIDIA AI Enterprise was introduced in 2022 as part of the Compute & Networking segment and evolved into a core commercial offering by 2024. The description of it becoming a 'full-stack subscription offering' and being integrated with DGX Cloud and new hardware (e.g., Blackwell, referenced in 2024 filings despite 2025 launch) matches the strategic evolution in the original answer. (2) There are no numeric values to verify, but all dates (fiscal 2022, 2024, and reference to 2025 launch) are used appropriately and contextually accurate based on SEC filing timelines. (3) The multi-hop reasoning is sound: the model synthesizes information about product positioning, software bundling (NIM, NeMo, AI Blueprints), delivery mechanisms (DGX Cloud), and strategic role shifts—correctly inferring the move from a foundational initiative to a monetization pillar. (4) Minor deduction in qualitative accuracy because the original answer emphasizes the shift to a 'key monetization vehicle' and 'enterprise-grade AI software' more explicitly, while the LLM focuses on 'subscription offering' and 'revenue-generating pillar'—semantically close but slightly different framing. However, the core facts, entities, and evolution are correctly captured. The answer is fully contextually relevant and addresses all aspects of the strategic and commercial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 401,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer shifted Paxlovid from a government‑procurement model (EUA‑labeled supply and large‑scale revenue reversals in 2023) to a commercial‑market regime, recording a $3.5 bn non‑cash reversal in Q4 2023, a $771 m favorable adjustment in Q1 2024 for returned courses, and only $1 bn of remaining contracted revenue expected from long‑term orders through 2028. This decline in remaining performance‑obligation value signals that Pfizer no longer expects significant future sales growth from Paxlovid, forecasting only modest, limited revenue from the product in the coming years.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. The $3.5 billion non-cash revenue reversal in Q4 2023 is correctly stated and aligns with the ground truth. However, the LLM introduces a $771 million favorable adjustment in Q1 2024 for returned courses, which is not mentioned in the original answer and cannot be verified from the provided ground truth. Additionally, the remaining performance obligations are stated as $1 billion as of December 31, 2024, in the ground truth, but the LLM extends this to 'long-term orders through 2028', adding unverified temporal scope. (2) The quantitative accuracy is partially correct: $3.5 billion reversal is accurate, $1 billion remaining obligation is close but lacks precise context (no mention of 2024 year-end date), and the $771 million figure is extraneous and unsupported. The original answer does not mention any favorable adjustment in Q1 2024. (3) The reasoning is partially sound—there is a shift from EUA-based government procurement to commercial sales, and reduced obligations suggest lower future revenue expectations. However, the conclusion that Pfizer expects only 'modest, limited revenue' contradicts the ground truth's interpretation of 'stabilization' and 'more stable outlook'. The LLM interprets the decline in obligations more pessimistically than the original, missing the positive implication of contractual stabilization after prior uncertainty. (4) Contextual relevance is high—the answer addresses the evolution of contractual obligations and attempts to infer revenue expectations. However, due to incorrect figures and misinterpretation of the trend (decline vs. stabilization), the qualitative and correctness scores are reduced. The multi-hop synthesis is attempted but flawed in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 488,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 the nature of Google’s exposure to international regulatory costs shifted from a broad, generic warning about “an evolving foreign‑policy landscape” that could bring new compliance expenses (mainly centered on data‑transfer issues between the EU and the UK) to a detailed, multi‑jurisdictional list of concrete obligations.  The 2024 filing specifically cites new regulatory regimes such as the EU Digital Markets Act, the EU Data Act, AI‑related liability and data‑portability rules, heightened competition‑law enforcement, and stricter privacy/encryption requirements—expanding both the scope of potential costs and the variety of regulatory challenges the company faces.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 vs 2024) and correctly identifies the evolution in Google's regulatory exposure over time. It accurately notes that in 2022, Google's concerns were centered on data transfers between the EU and UK, aligning with the ground truth. The 2024 expansion in regulatory scope is also correctly described with references to new regimes like the EU Digital Markets Act, Data Act, AI liability, and privacy rules, which reflect real developments. However, the LLM answer introduces specific regulatory frameworks (e.g., Digital Markets Act, Data Act, AI liability) that are plausible but not explicitly mentioned in the original ground truth. Instead, the ground truth emphasizes a broader shift toward 'uncertainty regarding regulatory outcomes' and risks under 'local laws that may not offer due process or clear legal precedent'—a more general and legally systemic concern than the specific EU regulations cited by the model. While these EU regulations are relevant and likely contributors to the increased uncertainty, the LLM substitutes concrete examples not present in the source answer, potentially over-specifying the nature of the regulatory changes. This affects qualitative accuracy, as the reasoning, while logical, does not fully mirror the original emphasis on unpredictability and due process risks. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. The core evolution—broadening scope and increasing complexity of regulatory challenges—is correctly conveyed, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the projected cash outflows for UPS’s post‑retirement medical benefits slipped modestly—from about **$229 million in 2022 to $219 million in 2023**.  The company continues to fund those payments from the plan’s trust assets, but the 2023 filing makes clear that benefit payments will be drawn **from “plan trusts and corporate assets,”** reflecting a greater reliance on the corporation’s balance‑sheet resources (especially after the 2023 actuarial loss driven by lower discount rates).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies. The ground truth states there was no change in the funding approach between 2022 and 2023—both years used 'plan trusts and corporate assets'—but the LLM incorrectly implies a shift or increased reliance on corporate assets in 2023. This misrepresents the continuity emphasized in the original answer. (2) The dollar amounts cited ($229 million in 2022, $219 million in 2023) are not present in the ground truth and are therefore unverified; the original answer does not mention specific payment amounts, so these figures are extraneous and potentially misleading. There is no indication in the ground truth that actuarial losses or discount rate changes affected funding sources. (3) The multi-hop reasoning is flawed: the LLM infers a change in funding strategy based on unspecified '2023 filing' language and financial events, but the ground truth explicitly states the language remained unchanged. The model fails to recognize that consistent disclosure implies no evolution in approach. (4) While the mention of 'plan trusts and corporate assets' aligns with the source, the interpretation of increased reliance on corporate assets is unsupported, leading to a low correctness score. Quantitative accuracy is partially preserved due to plausible formatting but incorrect values. Qualitative reasoning is weak due to incorrect inference. Contextual relevance is moderate as the topic and entities are appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 405,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\nNVIDIA AI Enterprise launched in 2022 as a dedicated software suite for enterprise‑AI workloads that sat atop the company’s accelerated‑computing platform. By 2024 the offering had expanded into a full‑stack, cloud‑ready AI platform—delivered on DGX systems and via DGX Cloud, pre‑installed on GPUs, CPUs and DPUs, and tightly integrated with tools such as NIM, NeMo and AI Blueprints—as a broadly supplied, end‑to‑end AI software solution rather than a niche add‑on. This evolution reflects a shift from a focused enterprise‑AI product to a widely distributed, hardware‑software ecosystem that is embedded across NVIDIA’s hardware, cloud services and partner network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 as a software suite for enterprise AI, and by 2024 evolved into a full-stack, integrated platform. The inclusion of NIM, NeMo, and AI Blueprints is correctly identified. (2) There are no numeric values in the original answer beyond '2.5x increase in token throughput', which the LLM does not mention—this is the only minor omission. However, no incorrect numbers are presented, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution from a software suite to a broader hardware-software ecosystem across time (2022 to 2024), captures the expansion in deployment options (DGX systems, DGX Cloud, pre-installation on GPUs/CPUs/DPUs), and identifies the shift in strategic positioning. (4) Semantic equivalence is strong—the LLM conveys the same core evolution: from a foundational offering to a comprehensive, widely distributed AI platform. The only reason for not scoring a 10 is the omission of the specific performance metric (2.5x throughput improvement), which was part of the 2024 enhancement in the original answer. Otherwise, the answer is complete, contextually relevant, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 364,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\nExxonMobil’s proved reserves that are reported through equity companies grew from roughly **2.5 billion barrels of oil‑equivalent (boe) in 2022 to about 3.0 billion boe by the end of 2024** (developed reserves rose from ~1.35 bn boe to 1.48 bn boe and undeveloped reserves from ~1.21 bn boe to 1.51 bn boe).  The increase is driven primarily by additions in **Asia (e.g., Iraq, Kazakhstan) and Africa (e.g., Mozambique, Nigeria)**, while the company’s holdings in other regions remained relatively stable.  This pattern shows that ExxonMobil is strategically concentrating its upstream growth in high‑potential, emerging basins outside the United States, using equity partnerships to expand its resource base in those regions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative data. According to the ground truth, ExxonMobil's proved reserves through equity companies were 14 million barrels gross (1 million net) in 2022, not 2.5 billion boe as claimed. By 2024, the actual reserves are reported as 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas—nowhere near the 3.0 billion boe stated by the LLM. These figures are off by orders of magnitude and conflate oil-equivalent units with actual component breakdowns not present in the original. (2) The LLM invents a detailed breakdown into developed and undeveloped reserves (1.35 bn boe, etc.) that does not appear in the ground truth and is factually unsupported. Additionally, the original answer emphasizes a dramatic increase concentrated in Asia, but the LLM spreads the growth across Asia and Africa with specific country mentions (Iraq, Kazakhstan, Mozambique, Nigeria) that are not in the source. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a strategic upstream shift via equity partnerships, it misattributes regional focus and scale. The original indicates a major pivot specifically to Asia, whereas the LLM dilutes this with multiple regions and fabricated data. (4) Despite incorrect numbers and entities, the answer is contextually relevant—it addresses the evolution of reserves and attempts to interpret strategic positioning. However, due to severe quantitative inaccuracies and invented details, the correctness and qualitative scores are low. Minor credit is given for attempting the right type of analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 457,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\nBetween 2022 and 2024 the amount Google pays to its Network Partners (the “TAC” – traffic‑acquisition‑costs) grew from roughly **$45 billion in 2022** (2022 10‑K, p. 55) to **$50.9 billion in 2023** and **$54.9 billion in 2024** (2024 10‑K, p. 42).  At the same time the **TAC rate fell from about 21 % of revenue in 2022 to 20.7 % in 2024** (2024 10‑K, p. 42), reflecting a strategic shift toward higher‑margin Google Search and other owned‑inventory and away from lower‑margin Google Network properties.  Thus, while Network Partners continue to supply a large share of ad inventory and are still billed on a gross‑basis (so they remain a key revenue source), their contribution to total cost of revenues has declined modestly, and their relative importance in the overall revenue mix has been eclipsed by Search‑driven growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides accurate quantitative data: TAC amounts of $45B in 2022, $50.9B in 2023, and $54.9B in 2024 are factually correct per the cited 10-Ks, and the TAC rate decline from ~21% to 20.7% is also accurate. These numbers reflect proper extraction and citation from source documents, supporting a high quantitative accuracy score. However, the qualitative reasoning misrepresents the evolution of the financial relationship. The LLM emphasizes a strategic shift away from Google Network Partners due to margin pressures and declining TAC rate, framing the relationship as diminishing in importance. In contrast, the ground truth highlights a shift in financial reporting emphasis—from gross revenue recognition (2022) to highlighting cash flow impact of partner payments (2024)—not a strategic de-emphasis of Network Partners. The LLM incorrectly infers business strategy from cost trends without supporting evidence from the original answer, which focuses on reporting and accounting framing, not inventory mix or margin strategy. While the LLM correctly notes that Google continues to report ads on a gross basis (aligning with 2022 practice), it fails to mention the key 2024 shift in narrative toward treating partner payments as a primary use of operating cash flow, which is central to the ground truth. Thus, despite strong number accuracy and relevance, the multi-hop synthesis is flawed—the model substitutes its own strategic interpretation for the actual reporting evolution, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 421,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\nUPS’s use of non‑designated foreign‑currency forward contracts shifted markedly between 2022 and 2023, moving from a $69 million loss recorded in earnings in 2022 to only a $7 million loss in 2023 (see the “Derivative Instruments Not Designated in Hedging Relationships” table on page 135).  By periodically terminating the original forwards and entering offsetting swap or currency positions, the company now neutralizes most market movements, which has reduced the volatility of earnings attributable to these undesignated contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that UPS recorded a $69 million loss in 2022 and a $7 million loss in 2023 from undesignated foreign currency forward contracts is not supported by the original answer (ground truth), which does not provide specific dollar amounts or losses for either year. This introduces false precision and incorrect data, failing the quantitative accuracy check. There is no mention in the ground truth of strategies involving 'terminating the original forwards and entering offsetting swap or currency positions' or that such actions 'neutralized most market movements'—this represents an unsupported inference or fabrication not present in the source. While the LLM correctly identifies that undesignated contracts affect earnings volatility and that their fair value impacts earnings directly, it misrepresents the evolution as a quantitative reduction in losses rather than a qualitative shift in disclosure and transparency. The original answer emphasizes improved disclosure structure, side-by-side reporting, and clearer linkage to earnings volatility in 2023—not a change in strategy that reduced financial impact. Thus, while the LLM addresses the general topic of earnings volatility and undesignated forwards, it fails on core factual correctness and mischaracterizes the nature of the evolution. The reasoning is flawed due to reliance on non-existent numerical data and incorrect causal mechanisms. However, the response is contextually relevant, focusing on the right instruments and earnings impact, which supports a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 451,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\nBetween 2022 and 2023 the membership format shifted from a primarily loyalty‑maintaining program to a direct profit driver: the 2023 filing (p. 24) highlights that growth in the overall member base and especially in Executive‑tier memberships, coupled with high renewal rates, generated additional fee revenue that helped offset lower merchandise margins and contributed to a 77‑basis‑point decline in SG&A as a share of sales. In contrast, the 2022 filing (p. 23) emphasized sustaining the existing membership base and renewal rates, with the fee revenue described more as a stable contributor rather than a growth lever. Thus, by 2023 the membership model was explicitly tied to fee‑revenue expansion and profitability, reinforcing member loyalty as a strategic engine for earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Costco's membership format as increasingly central to profitability and correctly identifies the emphasis on Executive membership growth and renewal rates. However, it introduces significant quantitative inaccuracies not present in the ground truth: specifically, the claim that membership growth 'contributed to a 77-basis-point decline in SG&A as a share of sales' is not supported by the original answer and appears to be fabricated or misattributed. The original answer does not mention any such metric or calculation. Additionally, the LLM cites specific page numbers (p. 23, p. 24) and makes a distinction in tone about fee revenue being a 'growth lever' in 2023 versus 'stable contributor' in 2022, which, while plausible, goes beyond the documented shift in language provided in the ground truth. The original answer focuses on the slight strengthening of language from 'significant effect on profitability' in 2022 to 'integral part of... profitability' in 2023, and introduces a new concern about renewal rates in newer markets affecting worldwide rates—a key point entirely missing in the LLM response. Thus, while the LLM correctly identifies the membership model’s growing strategic importance, it fails to mention this critical emerging risk and introduces unsupported numerical claims, reducing its factual accuracy. The reasoning is logically coherent and contextually relevant, but the inclusion of unverified metrics undermines quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 415,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA transformed CUDA from a GPU‑only programming model into a full‑stack data‑center platform that spans GPUs, DPUs and CPUs, and ties them together with a unified software stack (CUDA‑X libraries, AI Enterprise, NIM, NeMo, AI Blueprints, and DGX Cloud).  The company also broadened the ecosystem—now over 3 million developers use CUDA, and its AI‑Enterprise suite delivers end‑to‑end generative‑AI tools and over‑the‑air updates—so that CUDA is no longer just a compute API but the core software layer that orchestrates compute, networking, storage and cloud services across the entire data‑center workload.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the claim of 'over 3 million developers' using CUDA matches the original answer's 'nearly 3 million developers'—this is semantically equivalent and factually consistent. No other numerical values (dates, dollar amounts, etc.) are present, and the years 2022 and 2024 are correctly referenced. (2) The answer addresses the evolution of CUDA between 2022 and 2024, capturing the shift from a GPU-centric programming model to a full-stack data center platform. It correctly identifies CUDA’s deeper integration into NVIDIA’s broader software ecosystem, including references to CUDA-X, AI Enterprise, and cloud integration (DGX Cloud), which reflects the 'end-to-end optimized computing' and enterprise-scale focus noted in the ground truth. (3) The multi-hop reasoning is sound: it synthesizes CUDA’s role expansion across hardware (GPUs, CPUs, DPUs) and software (libraries, SDKs, cloud services), correctly inferring a strategic shift from developer tool to infrastructure layer. (4) Minor deduction in qualitative accuracy because the LLM introduces specific product names (NIM, NeMo, AI Blueprints) not mentioned in the ground truth, which, while plausible, go beyond the provided evidence. However, these do not contradict the core evolution narrative. Overall, the answer is factually correct, contextually precise, and captures the essence of CUDA’s strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 403,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\nFrom 2023 through 2024 Pfizer moved Paxlovid out of the free‑government EUA program and into commercial markets—recording a $3.5 bn revenue reversal in Q4 2023 and then a $771 m favorable adjustment in Q1 2024, while also generating $442 m from a U.S. SNS delivery of 1 million courses in Q3 2024.  The company now expects roughly $1 bn of remaining contracted revenue from Paxlovid, with firm shipments scheduled for 2025‑2028, and the $2.2 bn of deferred revenue will be recognized proportionally as those later‑year deliveries are made.  In short, Pfizer’s Paxlovid commitments have shifted from large‑scale government purchases to a commercial‑revenue model with future sales spread over the next few years.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Pfizer's Paxlovid financial commitments from 2023 to 2024, including the $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of EUA-labeled product from U.S. government inventory, and the shift toward commercialization with future revenue recognition. It also correctly identifies the $1 billion of remaining performance obligations with delivery timelines extending from 2025 to 2028. However, the LLM introduces specific figures not present in the ground truth: a $771 million favorable adjustment in Q1 2024 and $442 million from a U.S. Strategic National Stockpile (SNS) delivery in Q3 2024. These numbers, while plausible, are not supported by the original answer and represent over-specificity or potential hallucination. Additionally, the mention of '$2.2 billion of deferred revenue' is not in the ground truth and lacks corroboration, introducing a significant quantitative discrepancy. (2) The $3.5 billion reversal and $1 billion remaining obligation match the ground truth exactly. However, the $771M, $442M, and $2.2B figures cannot be verified and appear to be fabricated or misattributed, reducing quantitative accuracy. The timeline (2025–2028) is consistent. (3) The multi-hop reasoning is sound: the model correctly infers a transition from government EUA-based distribution to commercial contracting, and links remaining obligations to future revenue recognition. The synthesis of shifting financial models and delivery timelines is logically coherent and aligns with the original answer’s intent. (4) Despite the addition of unsupported figures, the overall narrative and strategic shift are accurately conveyed, making the answer contextually relevant and qualitatively strong. The correctness score is reduced due to unverified financial data, but not severely, as the central facts and directional insight remain valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 522,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil elevated Guyana from a newly discovered offshore prospect to a core “advantaged asset” in its strategic narrative, explicitly placing it in the “Advantaged Assets (Advantaged growth projects)” category alongside the Permian and LNG. The company’s disclosures now treat Guyana’s reserve development as a primary driver of future volume growth and a focal point of its capital‑allocation and earnings‑driver strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in ExxonMobil's strategic emphasis on Guyana between 2022 and 2024. (1) Quantitatively, while the LLM does not repeat the specific 1.3 billion oil-equivalent barrels (GOEB) figure from 2022, it does not contradict it either—this omission is minor given the focus on strategic framing rather than numerical detail. All other entities (ExxonMobil, Guyana, 'advantaged assets', Permian, LNG) and timeframes (2022–2024) are correct. (2) The qualitative assessment is strong: the LLM correctly identifies the shift from Guyana being a reserves growth story to a core 'advantaged asset' explicitly tied to earnings and volume growth, which aligns with the ground truth. It appropriately contextualizes Guyana alongside Permian and LNG as part of a strategic capital allocation framework. (3) The multi-hop reasoning is sound—synthesizing disclosures across years to show an evolution in strategic narrative from reserves additions to advantaged production and earnings visibility. (4) Semantic equivalence is maintained: though the LLM uses slightly different phrasing (e.g., 'elevated from a newly discovered offshore prospect'), the overall meaning matches the ground truth. The only minor shortcoming is the lack of the 1.3 GOEB figure, which slightly reduces completeness but does not impair the core correctness. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 389,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\nThe 2022 commitment called for 24 ATR 72‑600F aircraft (11 in 2023, 6 in 2024, 6 in 2025 and 1 in 2026), but the 2024 schedule reduces the total to only 10 aircraft—7 slated for delivery in 2025 and 3 in 2026, with no further deliveries thereafter. This cutback signals that FedEx is de‑emphasizing the ATR 72‑600F in its fleet strategy, shifting focus toward larger freighter models (B767F/B777F) and the Cessna SkyCourier for regional cargo rather than expanding its turboprop fleet.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and projections. According to the ground truth, in 2022 the plan was for 11 units in 2023 declining to 1 by 2026, but the LLM incorrectly states 24 total aircraft with 11 in 2023, 6 in 2024, 6 in 2025, and 1 in 2026—adding up to 24, which is not supported. The 2024 update in the ground truth shows 7 units in 2025 and 3 in 2026, which the LLM correctly reports, but it mischaracterizes this as a 'cutback' from 24 to 10, which is factually wrong. (2) The quantitative accuracy is low: the 2022 plan did not include 6 units in 2024 or 6 in 2025—those numbers are fabricated. The correct trajectory is 11 (2023) → ? (no 2024 number given) → 1 (2026) in the 2022 plan, versus 7 (2025) → 3 (2026) in the 2024 plan. The LLM invents intermediate years and totals not present in the original. (3) The reasoning is partially sound in identifying a strategic shift, but misinterprets the nature of the evolution: the ground truth describes a *less rapid* phaseout (i.e., sustained role), while the LLM claims a 'de-emphasizing' and 'cutback', which contradicts the more stable 2024 projection. This misrepresents the strategic implication. (4) Contextual relevance is high—the answer addresses fleet strategy, timelines, and aircraft role—but the incorrect data and flawed synthesis undermine correctness. The mention of FedEx, B767F/B777F, and Cessna SkyCourier is extraneous and not in the ground truth, introducing unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 417,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA transformed Omniverse from a standalone 3‑D design‑collaboration and simulation tool into the central hub of its AI‑driven simulation ecosystem.  In the 2022 filing (pages 4, 9) Omniverse was described mainly as a real‑time 3‑D platform for digital‑twin and design workflows, but by 2024 the company was embedding it within the NVIDIA AI Enterprise stack—linking it to AI services such as NIM, NeMo, AI Blueprints and DGX Cloud and exposing APIs that let synthetic‑data generators, autonomous‑driving simulators (e.g., Isaac Sim, DRIVE Sim) and generative‑AI models run natively inside the platform (pages 8, 11).  This evolution reflects a shift from offering Omniverse as a discrete SaaS product to positioning it as an integrated, AI‑accelerated simulation layer that unifies graphics, physics and large‑scale AI across cloud, data‑center and edge environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of NVIDIA's Omniverse from a 3D collaboration and simulation platform in 2022 to a more integrated, AI-driven simulation ecosystem by 2024. The answer captures the key shift from a standalone tool to a central component of NVIDIA's AI Enterprise stack, which matches the ground truth's emphasis on Omniverse becoming a development platform and operating system for digital twins and enterprise simulation. The LLM adds specific technical details not in the original answer—such as integration with NIM, NeMo, AI Blueprints, DGX Cloud, Isaac Sim, and DRIVE Sim—which are plausible enhancements based on NVIDIA's known product trajectory and consistent with the direction described in the ground truth. These additions do not contradict but rather enrich the core narrative. All dates (2022 to 2024) and product names are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited). The reasoning is sound, demonstrating multi-hop synthesis by connecting Omniverse’s evolution with broader AI and simulation platforms. The only reason for not scoring a 10 is that the original answer emphasizes the shift toward on-premises and cloud accelerated computing infrastructure for industrial digital twins, which the LLM mentions implicitly via 'data-center and edge environments' but could have stated more explicitly. Overall, the answer is semantically equivalent and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 424,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the way Google Play is reported changed from being a vague part of the “non‑advertising revenues” bucket in the 2022 MD&A (2022 10‑K, p. 29) to a distinct line‑item within the “Google Subscriptions, Platforms and Devices” category and under “Google other revenues” in the 2023 filing (2023 10‑K, pp. 18, 33).  This explicit separation shows that Google Play’s contribution to non‑advertising revenue has grown and is now tracked as a separate, material revenue stream rather than being bundled together with other sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the evolution of Google Play's role in non-advertising revenue between 2022 and 2023 based on changes in financial reporting structure. Quantitatively, no specific numerical values (e.g., dollar amounts or percentages) are mentioned in either the original or LLM answer, so accuracy is not compromised—this is consistent with the source information. The LLM correctly notes that in 2022, Google Play was part of a broader 'non-advertising revenues' category (citing the 2022 10-K, p.29), while in 2023 it became a more explicitly separated component under 'Google Subscriptions, Platforms and Devices' and 'Google other revenues' (citing 2023 10-K, pp.18,33). This reflects the same strategic shift described in the original answer: a move toward clearer categorization and recognition as a material, standalone revenue stream. The reasoning is sound and demonstrates multi-hop synthesis across two years of SEC filings. The only minor shortcoming is that the LLM does not explicitly mention the strategic intent behind the change (e.g., 'monetization platform', 'revenue stability') emphasized in the original answer, which slightly reduces qualitative depth. However, the core factual evolution—structural reporting change indicating growing importance—is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the evolution of Google Play’s role in non-ad revenue reporting and implies increased significance through disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 441,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept using expected‑loss‑ratio techniques for workers‑compensation reserves but refined how they are applied.  For guaranteed‑cost business the company continues to give such ratios significant weight only in the most recent accident year, while for excess‑of‑deductible (large‑deductible) business it now systematically assigns weight to the most recent five accident years and adjusts the ratios for inflation, rate changes and market trends.  The 2023 filing also stresses that the growing share of large‑deductible policies slows claim reporting, so the expected‑loss‑ratio model is used more deliberately and with trend‑adjusted assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core facts and captures the key evolution in AIG's use of expected loss ratio methods between 2022 and 2023. It correctly states that for guaranteed cost business, significant weight is given only to the most recent accident year, and for excess of deductible (large deductible) business, weight is given to the most recent five accident years—consistent with the 2022 practice described in the ground truth. The mention of trend adjustments (inflation, rate changes, market trends) in 2023 is plausible but not explicitly confirmed in the original answer; the ground truth does not state that such adjustments are new or systematically applied in 2023, so this represents an unsupported elaboration. The LLM correctly identifies the continued impact of large deductible business on slowing claim reporting. However, it omits a key point from the original answer: the 2023 filing's change in presentation of incurred and paid losses net of reinsurance and undiscounted, which reflects a reporting refinement. This omission reduces completeness and affects qualitative accuracy. The answer also implies a methodological refinement ('now systematically assigns weight') that isn't clearly supported—the ground truth states the methodology remained 'broadly consistent.' Quantitatively, there are no errors: no incorrect numbers, dates, or metrics. Contextually, the response is highly relevant and addresses the evolution in reserving methods for both business lines. The reasoning is sound but slightly overreaches in suggesting methodological changes not confirmed in the source. Thus, the answer earns a 7 for correctness—core facts are accurate, but with minor overstatement of changes and omission of a key reporting update.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 477,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco reshaped its product‑category reporting, moving from the six‑category model disclosed in the FY 2022 filing (Secure & Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; Other Products) to a four‑category structure introduced in FY 2024 – Networking, Security, Collaboration and Observability – while retaining Collaboration as a separate segment but redefining its scope.  The Collaboration category, which generated roughly $4.5 billion of product revenue in FY 2022, slipped to about $4.05 billion in FY 2023 before edging up to $4.11 billion in FY 2024, reflecting a modest recovery after a year‑over‑year decline.  This evolution shows Collaboration’s continued presence but a reduced relative weight as the new Networking and Observability categories grew.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in Cisco's product category segmentation from six categories in fiscal 2022 to four in fiscal 2024, and accurately notes that 'Collaboration' was retained while new categories like 'Observability' were introduced. It also correctly highlights the consolidation and realignment, including the removal of 'Optimized Application Experiences' and 'Internet for the Future', which aligns with the ground truth. However, the LLM introduces specific financial figures—$4.5 billion (FY2022), $4.05 billion (FY2023), and $4.11 billion (FY2024) for Collaboration revenue—that are not present in the original answer or implied by the knowledge graph. Since the ground truth does not include any revenue numbers, the inclusion of precise dollar amounts constitutes a hallucination, severely impacting quantitative accuracy. While the qualitative reasoning about the restructuring and the continued presence of Collaboration is sound and contextually relevant, the unsupported numerical claims undermine factual correctness. The model also implies a 'modest recovery' and 'relative weight reduction', which are interpretive and not confirmed by the ground truth. Thus, while the structural and categorical changes are correctly synthesized, the addition of unverified financial data lowers the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 375,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\nIn the 2022 filing the 3.125% 2025 Notes were disclosed simply as a fixed‑rate tranche with a $1 billion aggregate principal and a 3.125% coupon, listed in the debt schedule together with other long‑term borrowings and fair‑value adjustments. By the 2023 filing the same tranche is presented as part of a hedged portfolio: the company reports an **effective interest rate of SOFR + 2.1%** (based on a $1 billion interest‑rate swap) and includes the swap notional in a table of outstanding swaps, shifting the disclosure from a static coupon description to a dynamic effective‑rate framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) QUANTITATIVE ACCURACY: The $1 billion principal amount and 3.125% coupon are correctly stated and align with the ground truth. However, the claim that the 2023 filing reports an 'effective interest rate of SOFR + 2.1%' due to a $1 billion interest-rate swap is not supported by the original answer. The ground truth states that in 2023, Amgen disclosed the interest rate mechanism as SOFR + 2.1%, but does not mention an interest-rate swap or that this is an 'effective' rate due to hedging. This introduces a significant factual inaccuracy regarding the source and nature of the rate framework. (2) COMPLETENESS: The answer addresses the evolution in disclosure from 2022 to 2023 and attempts to describe the change in presentation, but misrepresents the reason for the new rate framework by introducing derivative instruments not mentioned in the ground truth. (3) ENTITY ACCURACY: The company (Amgen), note (3.125% 2025 Notes), and years (2022, 2023) are correct. (4) REASONING: The multi-hop synthesis is partially sound—comparing disclosure formats across years—but incorrectly infers that the SOFR + 2.1% rate is the result of a swap, which is not stated in the original. This undermines the reasoning. (5) SEMANTIC EQUIVALENCE: While the direction of change (from simple to more detailed) is correctly noted, the explanation of the 2023 framework is factually different due to the unsupported reference to hedging and swaps. Thus, the core financial presentation evolution is partially misrepresented. The answer is contextually relevant and well-structured, but contains key factual errors in the qualitative interpretation of the interest rate framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 469,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\nFrom the reserve tables in the 2022 and 2024 10‑K filings, Asia‑Pacific/Middle‑East natural‑gas reserves fell from **326 billion cubic feet (BCF) at the end of 2022 to 296 BCF at the end of 2024**—a roughly 9 % decline.  The drop reflects production that outpaced modest additions (≈67 BCF of extensions/discoveries in 2024) and only small positive revisions, indicating that the company’s resource base in that region is shrinking.  Consequently, the trend signals that ConocoPhillips is **scaling back its strategic emphasis on the Asia‑Pacific/Middle‑East gas portfolio** and is likely reallocating capital toward higher‑return assets elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 326 BCF in 2022 and 296 BCF in 2024, matching the ground truth exactly. The 9% decline is accurately calculated: (326 - 296) / 326 ≈ 0.0914 or 9.14%, which rounds to 'roughly 9%', an acceptable approximation. The mention of ~67 BCF of extensions/discoveries in 2024 aligns with plausible supporting data from the filings (though not in the ground truth, it does not contradict and adds context). (2) All numbers, dates, and calculations are correct. The format (BCF, billion cubic feet) is consistent and equivalent. (3) The multi-hop reasoning is sound: the model synthesizes reserve changes over time, infers production outpacing additions, and concludes a shrinking resource base. It correctly links this trend to strategic positioning, noting a likely capital reallocation—consistent with the ground truth's implication of a strategic shift or divestment. (4) The LLM answer goes slightly beyond the original answer by providing context on production dynamics and capital allocation, but this enhances rather than distorts the conclusion. The only minor gap is that the original answer frames the change more neutrally ('potential strategic shift or divestment'), while the LLM asserts a 'scaling back' with more confidence. However, this is a reasonable interpretation and does not constitute a factual error. Thus, the answer is factually excellent, with full quantitative accuracy and strong qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 427,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 Alphabet’s dollar outlay for Class C share repurchases stayed roughly flat—$52.6 billion in 2022 versus $52.9 billion in 2023—while the number of shares bought fell slightly (469 million to 450 million).  Overall repurchase activity rose modestly, from $59.3 billion in 2022 to $62.2 billion in 2023, and the Board subsequently expanded the authorized buyback to an additional $70 billion, leaving $36.3 billion of capacity as of Dec 31 2023.  This reflects a continued emphasis on returning excess cash to shareholders through equity buybacks, using the program to manage capital allocation while preserving flexibility for future investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Alphabet repurchased $52.6 billion of Class C shares in 2022 and $52.9 billion in 2023, but the ground truth does not provide a breakdown between Class A and Class C repurchases—only a combined total of $59.3 billion in 2022 and $62.2 billion in 2023 for both classes. The LLM incorrectly splits these totals into Class C-specific figures, which are not supported by the original data. This is a major factual error. (2) The overall repurchase totals ($59.3B in 2022, $62.2B in 2023) and the $70.0B additional authorization with $36.3B remaining are correctly reported, showing partial quantitative accuracy. However, the introduction of unsupported Class C-specific dollar amounts and share counts (469M to 450M) is fabricated or misattributed, as the ground truth does not provide such granular data. (3) The reasoning about capital allocation strategy—continued emphasis on shareholder returns via buybacks and strategic flexibility—is logically sound and aligns with the ground truth. The multi-hop synthesis of increased buybacks and expanded authorization is correctly interpreted. (4) Despite correct high-level interpretation and strategic inference, the inclusion of incorrect, specific financial figures undermines factual reliability. The answer appears more precise than the data allows, leading to a misleading impression of granularity. Thus, while contextually relevant and reasonably reasoned, the answer is partially incorrect due to unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 432,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept frequency/severity reserving methods confined to short‑tail, low‑frequency lines—principally U.S. Property and the property‑class portions of its program‑business (and related liability lines)—and continued to exclude them from high‑severity, longer‑tail lines such as aviation. The 2023 filing added a clearer rationale, stating that these methods are used because they are well‑suited to low‑frequency, high‑severity exposures and are combined with loss‑development and IBNR‑factor techniques to reflect portfolio shifts and produce more precise loss‑reserve estimates.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies regarding AIG's evolution in the use of frequency/severity methods between 2022 and 2023. While it correctly states that in 2022 AIG used these methods for short-tail lines like U.S. Property and excluded aviation due to high severity, it fails to mention the key development in 2023: the expansion of frequency/severity methods to U.S. Workers' Compensation, a long-tail line. Instead, the LLM claims AIG 'kept' these methods confined to short-tail lines, which contradicts the ground truth. This omission represents a failure in multi-hop reasoning and misrepresents the strategic shift. (2) There are no numeric values in the response or ground truth, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The qualitative accuracy is low because the model mischaracterizes the evolution of method usage. It incorrectly implies continuity rather than change, and although it adds a detail about rationale (combination with other methods), it applies this to the wrong context—portraying it as a 2023 clarification rather than part of a broader methodological expansion. The synthesis across years is flawed. (4) Contextual relevance is moderate: the answer discusses the right company, time frame, and general methodology, and addresses the lines of business and reasoning to some extent, but misses the core evolution the question asks about. The focus on rationale and method combination is relevant but does not compensate for the failure to report the actual expansion into Workers' Compensation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 437,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen’s net cost recoveries from BeiGene fell sharply to **$109 million** (down from **$199 million** in 2022), while product sales to BeiGene rose to **$125 million** (up from **$64 million**).  Accordingly, profit‑and‑loss sharing expenses declined to **$40 million** (from **$53 million**), indicating a shift toward higher revenue from sales and reduced shared‑cost outflows.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all figures are accurate: $199 million to $109 million in cost recovery, $64 million to $125 million in product sales, and $53 million to $40 million in profit and loss sharing expenses—all match the original answer. Minor formatting differences (e.g., use of en dash, bolding) do not affect accuracy. (2) The answer addresses all components of the multi-part question: cost recovery, product sales, and profit and loss sharing across 2022 and 2023. (3) Entities—Amgen, BeiGene, and the relevant financial metrics—are correctly identified and attributed. (4) The reasoning is sound: the LLM correctly infers a shift in the collaboration dynamics, noting reduced cost recovery and shared expenses alongside increased product sales, which aligns with the original conclusion about maturation of the partnership. The synthesis across years and financial categories demonstrates accurate multi-hop reasoning. Semantic equivalence is maintained despite more concise wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 303,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\nConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East segment fell from 326 billion cubic feet at year‑end 2022 to 296 billion cubic feet by year‑end 2024. The decline persisted even though the company recorded only modest upward revisions (6 BCF in 2022 and 9 BCF in 2023 and 2024) and production remained roughly flat at about 24–25 BCF per year, with no purchases of reserves in that region during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the starting and ending reserve volumes (326 BCF in 2022 and 296 BCF in 2024), matching the ground truth. It accurately reports the 9 BCF upward revision in 2023, which is correct. However, it incorrectly states that there was a 9 BCF revision in 2024 and a 6 BCF revision in 2022, which are not mentioned in the original answer and contradict the provided data—only the 2023 revision of 9 BCF is noted in the ground truth. Additionally, while the original answer specifies that 25 BCF was subtracted due to production in 2024, the LLM claims 'production remained roughly flat at about 24–25 BCF per year' across the period, implying multi-year production data not present in the source. The original only confirms 2024 production subtraction, not 2022 or 2023. The LLM also generalizes 'no purchases... during the period' (2022–2024), while the original only confirms no purchases in 2024, leaving 2022–2023 unspecified. (2) Key numbers like the 326 → 296 BCF decline and 9 BCF 2023 revision are correct, but the addition of unverified revisions in 2022 and 2024 and assumed annual production figures reduces quantitative accuracy. (3) The reasoning is mostly sound—recognizing that revisions and production contributed to the decline—but overextends by inferring multi-year trends not supported in the source. The synthesis is partially correct but includes unsupported extrapolations. (4) The answer remains highly relevant, addressing all aspects of reserve evolution, though with minor inaccuracies in scope and attribution. The core message of a slight decline due to production outweighing limited revisions is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 457,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx’s B767F purchase schedule was trimmed sharply.  In the 2022 filing the company was committed to take delivery of 38 B767Fs (14 in 2023, 14 in 2024 and 10 in 2025); by the 2024 filing it had already received about 24 of those aircraft and the remaining order had been reshaped to 11 deliveries in 2025 and only three in 2026.  This reduction and the shift of later deliveries to 2026 signal that FedEx is deliberately scaling back its B767F expansion, focusing instead on newer wide‑body types (e.g., B777F, A300) and using the B767F only for specific medium‑range, high‑density routes—an indication that fleet planning is being driven by capacity‑demand alignment, fuel‑efficiency goals, and a broader fleet‑mix strategy rather than a straight‑line increase in B767F numbers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the directional shift in FedEx's B767F usage plans—showing a reduction from earlier projections and an accelerated drawdown by 2026. However, there are significant quantitative inaccuracies. The original answer states that in 2022, FedEx projected using 14 B767Fs in 2023 and 2024, and 10 in 2025. The LLM misrepresents this as a 'purchase' or 'delivery' schedule, claiming 38 total B767Fs were committed (14+14+10), but the ground truth refers to planned usage, not deliveries or purchases. This is a critical error because usage does not equate to new deliveries—many could be existing or leased aircraft. The 2024 update correctly notes a reduction to 11 in 2025 and 3 in 2026, aligning with the ground truth. However, the claim that '24 had already been received' is unsupported by the original answer and introduces fabricated data. (2) The numbers for 2025 (11) and 2026 (3) are accurate per the updated projection, but the earlier characterization of 14 in 2023 and 2024 as 'deliveries' is incorrect—these were usage projections, not purchase commitments. The sum of 38 is therefore misleading. (3) The multi-hop reasoning is partially sound: the model correctly identifies a strategic shift and infers a move toward newer wide-body types like B777F and A300 (though A300 is outdated and likely a mistake—FedEx uses A300s but is retiring them, not expanding). The inference about fuel efficiency and route-specific use adds reasonable qualitative context not in the original but does not contradict it. However, introducing 'purchase schedule' and 'deliveries' distorts the core data. (4) The correctness score is 7 because the key strategic conclusion—accelerated reduction in B767F reliance—is correct. Quantitative accuracy is 6 due to misrepresentation of usage as deliveries and fabrication of receipt numbers. Qualitative accuracy is 8 due to sound reasoning and strategic interpretation despite some incorrect assumptions. Contextual relevance is 10—fully addresses the question's intent and provides relevant strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 561,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG continued to apply Expected Loss Ratio methods to the latest accident year for its short‑tail lines—especially U.S. Property, program business and certain liability classes—using them to translate recent premiums into ultimate loss estimates. In 2023 the company increasingly supplemented these estimates with ground‑up claim projections and adjusted for inflation, emerging severity trends and climate‑related catastrophe risk, reflecting a more targeted, premium‑driven reserving approach aligned with updated underwriting standards and heightened catastrophe uncertainty.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly diverges from the ground truth in key aspects. (1) Correctly identifies that AIG used Expected Loss Ratio (ELR) methods for the latest accident year and in short-tail lines, which aligns with the 2022 practice. However, it fails to mention the specific 2022 application in aviation exposures, a key detail in the original answer. (2) The LLM introduces new elements not present in the ground truth—such as 'ground-up claim projections,' 'inflation adjustments,' 'emerging severity trends,' and 'climate-related catastrophe risk'—as drivers for changes in 2023, whereas the original answer emphasizes the expansion of ELR into U.S. Workers' Compensation, a long-tail line, due to extended loss emergence and complex policy features. (3) The shift described in the LLM answer is from premium-driven reserving to a more adjusted approach, but the ground truth describes a structural shift from short-tail, high-severity contexts (like aviation) to long-tail, structurally complex lines (like Workers' Compensation). This misrepresents the nature of the evolution. (4) The LLM does not mention U.S. Workers' Compensation at all, which is central to the 2023 change. While the years (2022–2023) and the general use of ELR methods are correctly framed, the reasoning and business lines cited are inaccurate or incomplete. (5) Quantitative accuracy is high because there are no explicit numbers or calculations that are incorrect—only qualitative misalignment. (6) Contextual relevance is moderate because the answer discusses ELR methods and reserving practices, but misses the core evolution described in the original. (7) Multi-hop reasoning is weak: the model fails to connect AIG’s methodological shift to specific lines of business and their actuarial characteristics as required. Overall, partially correct but with significant factual and conceptual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 516,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\nBetween 2022 and 2024 Cisco continued to frame Enterprise Data‑Center Transformation as the convergence of compute, networking, storage and software, but the emphasis evolved from “alliances = growth” to “alliances = risk.”  In the 2022 filing the company highlighted that partners were building end‑to‑end data‑center solutions and warned that some alliance partners could become competitors, while the 2024 filing repeats this warning and stresses that the competitive set is widening—traditional rivals, new entrants from Asia, and former alliance partners are all moving toward integrated, end‑to‑end offerings.  As a result, Cisco’s positioning now stresses tighter management of its strategic‑partner ecosystem and differentiation through broader ecosystem integration, even as the competitive landscape becomes more crowded and overlapping.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Cisco's evolving positioning from 2022 to 2024 around Enterprise Data Center Transformation, noting the ongoing convergence of computing, networking, storage, and software. It accurately reflects the shift in tone regarding strategic alliances—from growth enablers in 2022 to potential risks in 2024 due to partners becoming competitors. The mention of a broadening competitive landscape, including traditional rivals, new Asian entrants, and former partners, aligns with the ground truth’s emphasis on new entrants like Nvidia and shifting alliance dynamics. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all timeframes (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and themes (strategic alliances, competition, ecosystem strategy), correctly inferring Cisco’s adaptive positioning. The only minor gap is that the original answer specifically names Nvidia Corporation as a new entrant, while the LLM generalizes to 'new entrants from Asia'—this is a slight deviation in entity specificity but does not invalidate the overall correctness. (4) The answer is contextually excellent, directly addressing the evolution in Cisco’s strategy, alliances, and competitive environment. The qualitative accuracy is marked down slightly for the lack of specific mention of Nvidia, which is a key detail in the ground truth, but the broader trend is accurately captured. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 459,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the 3.125% 2025 Notes kept the same $1 billion (1,000 million) notional amount.  However, the effective interest rate shifted from the prior LIBOR + 1.8% structure (reported for 2022) to a SOFR + 2.1% structure (reported for 2023), reflecting the industry move from LIBOR to SOFR and a modest increase in the spread.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but has significant errors in quantitative details and incomplete representation of the evolution of the notional amount. (1) Quantitatively, the LLM incorrectly states that the notional amount was $1 billion in both 2022 and 2023. According to the ground truth, in 2022 the notional amount was part of a $5.2 billion principal, not $1 billion. Only in 2023 did it decrease to $1.0 billion. This is a major factual error affecting the core of the question about how the notional evolved. (2) The effective interest rate shift from LIBOR + 1.8% to SOFR + 2.1% is plausible and aligns with the broader transition from LIBOR to SOFR, but the original answer does not specify the 2022 rate as LIBOR + 1.8%; instead, it implies new swaps were entered without stating the prior rate. Thus, this detail is unsupported and potentially fabricated. (3) Qualitatively, the reasoning about a shift in interest rate benchmark and environment is reasonable and reflects correct synthesis of financial trends, but the model fails to capture the key dynamic: a reduction in hedged exposure from $5.2B to $1.0B, which indicates a strategic de-hedging or rebalancing. (4) Contextually, the answer addresses the right question and uses appropriate financial terminology, but the incorrect baseline notional undermines the multi-hop analysis. The answer would be stronger if it acknowledged the $5.2B starting point and explained the reduction. Overall, the answer gets credit for directionally correct interest rate benchmark shift but is significantly flawed in key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 439,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Cisco has shifted AppDynamics from a highlighted “best‑of‑breed” application‑performance‑monitoring tool in its full‑stack observability narrative (page 5 of the 2022 filing) to an integrated pillar of a broader Observability product category.  The 2023‑2024 disclosures treat Observability as a distinct revenue line—showing 27 % growth in FY 2024 driven by ThousandEyes and the Splunk‑based Observability Suite (page 42)—indicating that AppDynamics is now positioned alongside ThousandEyes and the Splunk offering as part of a consolidated observability portfolio rather than as a separate growth emphasis.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of AppDynamics' strategic positioning from 2022 to 2024: initially as a highlighted component of full-stack observability in 2022, then integrated into a formal 'Observability' revenue category by 2024. The mention of ThousandEyes and Splunk-based offerings aligns with Cisco's broader observability consolidation. (2) Quantitatively, the 27% growth in FY2024 for the Observability category is correctly cited, and fiscal year references (FY2022–FY2024) match the context. While the ground truth does not mention Splunk or the 27% growth, these details are consistent with Cisco’s 2024 disclosures and do not contradict the original answer—they add context supported by external knowledge. (3) The multi-hop reasoning is sound: the model synthesizes changes in product categorization, reporting structure, and strategic emphasis across years. The integration of AppDynamics into a consolidated observability pillar alongside ThousandEyes is correctly inferred and articulated. (4) Minor deduction in correctness and quantitative accuracy is due to the introduction of Splunk-based Observability Suite, which is accurate in context but not present in the ground truth; however, it does not distort the answer. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 386,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\nFrom 2022 to 2023 the 4.663 % 2051 Notes kept the same outstanding notional amount of **$1.5 billion**.  However, the effective interest rate on that tranche shifted from the prior LIBOR‑plus‑4.1 % structure (which translated to roughly 5.6 % in 2022) to a SOFR‑plus‑4.3 % structure in 2023 (approximately 5.8‑6 % depending on the prevailing SOFR).  In other words, the notional stayed flat at $1.5 bn while the benchmark‑based effective rate increased slightly.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies. The notional amount of $1.5 billion in 2023 matches the ground truth, which is correct. However, the claim that the notional amount was the same in 2022 ($1.5 billion) is incorrect — the original answer states that in 2022, the 4.663% 2051 Notes were part of a larger $5.2 billion hedged portfolio, not that the 2051 Notes alone had a $1.5 billion notional. This misrepresents the structure and magnitude of the debt in 2022. (2) Regarding interest rates, the LLM claims the 2022 effective rate was LIBOR + 4.1% (~5.6%), but this figure is not supported by the ground truth, which does not specify the prior effective rate or benchmark (LIBOR) for 2022 — it only states that swaps were terminated and replaced. The 2023 rate of SOFR + 4.3% is correctly reported. The approximate range of 5.8–6.0% in 2023 is a reasonable estimate given SOFR levels, but this is an inference not in the original. (3) Multi-hop reasoning is flawed: the model incorrectly assumes continuity of notional amount and constructs a narrative about rate changes without evidence for the 2022 rate structure. The original answer emphasizes a restructuring (termination and replacement of swaps), not a simple benchmark shift. (4) The contextual relevance is high because the answer addresses the evolution of rate and notional, but factual inaccuracies in key quantitative and qualitative aspects reduce correctness. The model fabricates specifics (LIBOR + 4.1%, $1.5B in 2022) not present in the ground truth, leading to a low qualitative and quantitative accuracy score despite some correct elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 457,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG moved from a more general use of expected‑loss‑ratio estimates—applying a premium‑percentage to short‑tail lines and projecting ultimate loss ratios for long‑tail lines with only modest trend adjustments—to a more structured, segmentation‑driven approach.  In 2023 the company gave the expected‑loss‑ratio method explicit weight for business written in excess of a deductible, using the five most recent accident years and adjusting the ratios for loss‑cost trends, rate changes and reinsurance (including ADC) impacts, and it segmented reserves by profit‑center‑coded lines of business (e.g., Excess Casualty, Financial Lines, Workers’ Compensation, etc.) rather than by the broader short‑/long‑tail categories used previously.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's use of expected loss ratio methods from a broad to a more structured approach between 2022 and 2023, which aligns with the ground truth. However, there are significant factual discrepancies. The original answer states that in 2022, AIG used the expected loss ratio method only in a general sensitivity analysis without specifying lines of business or segmentation—this is accurate. The LLM answer incorrectly claims that in 2022, AIG applied the method to short-tail lines using premium percentages and projected ultimate loss ratios for long-tail lines with trend adjustments, which is not supported by the ground truth and adds unsupported detail. Additionally, while the original answer highlights U.S. Workers' Compensation as a specifically named long-tail line in 2023 with segmentation by state, industry, deductible size, and claim handling entities, the LLM mentions segmentation by 'profit-center-coded lines' (e.g., Workers’ Compensation) and business written over deductibles, but does not accurately reflect the specific segmentation criteria (state, industry, deductible size) emphasized in the ground truth. The mention of 'five most recent accident years', 'ADC reinsurance', and adjustments for rate changes and loss-cost trends introduces details not present in the original answer, suggesting over-inference or hallucination. While the directional shift—increased structure and segmentation in 2023—is correct, the specific lines of business and segmentation criteria are inaccurately represented. Quantitative accuracy is moderate: no explicit numbers (percentages, dollar amounts) are present in either answer, but the LLM fabricates procedural details (e.g., five accident years, adjustment methodology) absent in the source. Qualitative accuracy is partially correct in reasoning but flawed in entity and method attribution. Contextual relevance is high as the response directly addresses the evolution of the method across years and lines of business.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 543,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo kept its original 2.850 % Senior Notes due 2026—first issued in 2016 and re‑authorized in the 2024 Board resolutions (page 129 of the 2024 10‑K).  At the same time the company broadened its issuance program, authorizing a suite of new unsecured senior notes in 2024 (e.g., a 5.125 % note due 2026, a floating‑rate note due 2026, and several longer‑dated fixed‑rate issues from 2028‑2034).  This reflects a staggered‑maturity strategy that diversifies funding sources, extends the average debt profile, and takes advantage of favorable market conditions while retaining the existing 2.850 % 2026 tranche as part of the laddered structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo maintained the 2.850% Senior Notes due 2026 and expanded its debt issuance in 2024 with new senior notes, which aligns with the ground truth's emphasis on a broader, diversified debt strategy. However, there are discrepancies in the specific notes cited: the LLM mentions a '5.125% note due 2026', 'floating-rate note due 2026', and 'issues from 2028–2034', while the ground truth references '7.00% Senior Notes due 2029' and '5.50% Senior Notes due 2035'. These specific instruments do not match, indicating a failure in precise quantitative recall. (2) The dates and percentages are partially accurate but not fully consistent with the ground truth; the 2.850% note is correctly referenced, but the newly introduced notes differ in rate and maturity. The mention of Board resolutions on page 129 of the 2024 10-K adds detail not contradicted by the ground truth but not verifiable from it. (3) The multi-hop reasoning is sound: the model correctly infers that maintaining existing notes while issuing new ones reflects a laddered, diversified debt strategy, which is consistent with the ground truth’s interpretation of a long-term, risk-diverse capital structure. (4) The answer is contextually excellent—directly addressing the evolution of PepsiCo’s engagement and strategic intent. Due to the mismatch in specific new notes issued (critical quantitative details), the quantitative accuracy is reduced to 7, pulling the overall correctness to 8 despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 431,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\nCisco’s guarantee liability fell from roughly **$1.4 billion at the end of fiscal 2022 to $1.7 billion in fiscal 2023, then declined to about $1.2 billion by the end of fiscal 2024**.  The reduction reflects a deliberate pull‑back from extensive third‑party financing guarantees, shifting most of the credit risk to external lenders and tightening underwriting standards.  This trend demonstrates Cisco’s effort to **lower contingent cash‑outflows and preserve balance‑sheet strength**, using guarantees only where they provide clear strategic benefit rather than as a broad financing tool.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Cisco reported a balance of financing subject to guarantees of $1.4 billion as of July 30, 2022 (fiscal year 2022), but no specific figures were disclosed for fiscal years 2023 or 2024. The LLM incorrectly states that the liability rose to $1.7 billion in 2023 and then fell to $1.2 billion in 2024—these numbers are not supported by the original data and contradict the absence of updated disclosures. (2) The quantitative inaccuracies are severe: the LLM fabricates figures for 2023 and 2024 that do not appear in the source, including a false increase and subsequent decrease in guarantee liabilities. There is no mention in the ground truth of any such trend. (3) The reasoning is flawed because it assumes a downward trend in risk exposure based on made-up numbers, while the original answer emphasizes that the lack of disclosure prevents definitive conclusions. The LLM fails the multi-hop requirement by not recognizing that the key evolution is reduced transparency, not a measurable change in exposure. (4) While the LLM attempts to interpret Cisco's strategy around risk management, its conclusions about 'tightening underwriting standards' and 'shifting risk to external lenders' are speculative and not grounded in the provided data. The contextual relevance is moderate because it addresses the right topic and frames it in terms of financial risk management, but the factual foundation is entirely incorrect, severely undermining the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 429,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\nBetween 2022 and 2023 the 2.45 % 2030 Notes remained outstanding with a $1.25 billion principal amount on the balance sheet (see page 130).  The fixed‑coupon notes were hedged with interest‑rate swaps that convert the 2.45 % coupon into a floating SOFR‑plus‑1.3 % rate; this swap structure, originally entered in 2021, was still in place at year‑end 2023, as shown by the $1 billion notional and “SOFR + 1.3 %” effective rate listed for the 2030 Notes (page 144).  No redemption or new issuance of the 2030 Notes occurred during 2022‑2023, so the only evolution was the continued use of the same swap‑based floating‑rate structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative details. The original answer states that the notional amount of the interest rate swaps related to the 2.45% 2030 Notes was $1.0 billion in 2022, and the same notional ($1.0 billion) remained in 2023. However, the LLM claims a $1.25 billion principal amount outstanding, which contradicts the ground truth. This is a significant error in a core financial figure. Additionally, the LLM incorrectly states that the swap was originally entered in 2021, while the ground truth specifies 2022 as the disclosure year. (2) The interest rate structure transition is partially correct: the LLM correctly identifies the current floating rate as SOFR + 1.3%, aligning with the 2023 update in the original answer. However, it fails to mention the shift from LIBOR to SOFR as an evolution between 2022 and 2023, instead implying the SOFR-based swap was in place since 2021. This misrepresents the timeline and nature of the rate benchmark transition. (3) The multi-hop reasoning is partially sound—the model recognizes that the notes remained outstanding and that swaps affect the interest structure—but it synthesizes incorrect temporal and numerical data. It also conflates the timing of the swap initiation, undermining the evolution narrative. (4) Despite these errors, the answer is contextually relevant and captures the general idea that the fixed-rate note is synthetically converted to floating via swaps, with no redemption. Thus, while the conceptual framework is present, the factual backbone—especially on amounts and timing—is flawed, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 458,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 FedEx’s exposure to the pass‑through trusts shifted from a direct, unconditional guarantee to a more arms‑length lease‑based structure. In the 2022 filing the $970 million of Series 2020‑1AA certificates were described as “fully and unconditionally guaranteed by FedEx,” with FedEx Express using the proceeds for general corporate purposes. By the 2023 filing the same certificates are noted only as “leveraged operating leases” where the pass‑through trusts—not FedEx or FedEx Express—are the obligors, and FedEx’s maximum exposure is limited to the future minimum lease payments disclosed in the lease‑payment schedule. Consequently, the financial guarantees and obligations that once backed the certificates were removed, leaving the trusts to bear the payment risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $970 million Pass-Through Certificates, Series 2020-1AA, were indeed fully and unconditionally guaranteed by FedEx in 2022, and in 2023, FedEx clarified that these were not direct obligations or guarantees of FedEx or FedEx Express. The shift in financial obligation is correctly characterized. (2) Quantitative accuracy is perfect: the $970 million amount is correctly cited, and no other numerical values (e.g., aircraft count or net book value) are misrepresented—though the LLM omits the detail about 19 Boeing aircraft with a $1.8 billion net book value, which is present in the original answer. This omission is minor and does not affect the core financial or obligation-related claims. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2023 filings to show a shift from direct guarantee to limited exposure via lease payments. It accurately identifies the change in obligor (from FedEx to the trusts) and the risk transfer. (4) Semantic equivalence is strong—the LLM conveys the same conclusion: FedEx no longer has direct financial guarantees on these certificates in 2023. The only minor shortcoming is the omission of the collateral detail (aircraft and their value), which slightly reduces completeness but does not impair the central accuracy of the financial obligation analysis. Hence, a 9/10 on correctness and qualitative accuracy is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 433,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard’s gross settlement exposure grew modestly—from about **$75 bn to $78.4 bn**—and the company applied a larger amount of risk‑mitigation collateral and guarantees—**$12.2 bn to $13.5 bn**—to offset that exposure.  Consequently, net settlement exposure rose only slightly, from **$62.9 bn to $64.9 bn**, reflecting a deliberate scaling of mitigation measures in step with higher transaction volumes and a continuous refinement of its risk‑assessment methodology.  This shows that Mastercard’s risk‑management strategy is proactive and data‑driven: it expands collateral and credit‑enhancement requirements as exposure rises, while regularly reviewing and updating its risk standards to keep potential losses low.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: it accurately reports the increase in gross settlement exposure from $75,023 million (rounded to $75 bn) in 2023 to $78,385 million (rounded to $78.4 bn) in 2024, and the increase in risk mitigation from $12,167 million ($12.2 bn) to $13,466 million ($13.5 bn). These rounded figures are acceptable and semantically equivalent to the original values. The derived net exposure (gross minus mitigated) is correctly implied: ~$62.9 bn in 2023 ($75.023 - $12.167) and ~$64.9 bn in 2024 ($78.385 - $13.466), showing only a modest increase in net risk.\n\n2) Quantitative accuracy is high. All numbers are correctly rounded and consistent with the source. The LLM correctly infers net exposure, which is not explicitly stated in the original answer but is logically derived and supports the reasoning. No calculation errors are present.\n\n3) The multi-hop reasoning is sound: the model synthesizes data across two years, compares gross exposure and mitigation levels, and draws a valid conclusion about the evolution of risk management strategy. It adds value by interpreting the slight rise in net exposure and linking mitigation scaling to transaction volume growth and methodology refinement—insights consistent with, and expanding upon, the original answer.\n\n4) The entity accuracy is correct: Mastercard, 2023–2024 time frame, gross settlement exposure, and risk mitigation arrangements are all properly identified. The qualitative interpretation—that the strategy is proactive and data-driven—is a reasonable extension of the original conclusion that the strategy became 'more robust.'\n\n5) The answer is fully contextually relevant, addressing both parts of the question: the evolution of risk mitigation use and what it indicates about strategy. The only reason for not scoring 10 is that the original answer did not mention 'net exposure' or 'transaction volumes' explicitly, so those inferences, while correct and logical, slightly extend beyond the provided ground truth. However, they do not introduce error, so the correctness score remains high at 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 566,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the liability for foreign‑exchange forwards and options that are designated as hedging instruments rose from roughly **$48 million** (reported in the 2022 balance sheet) to about **$146 million** in 2024 – an increase of roughly **$98 million**.  This jump shows that Nike deliberately expanded its hedge book, locking in exchange rates for a larger share of its cross‑border sales and cost structure, indicating a proactive strategy to manage heightened foreign‑currency volatility and protect earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative errors. According to the ground truth, total liabilities increased from $48 million in 2022 to $115 million in 2024, not $146 million as stated by the LLM. The LLM incorrectly reports the 2024 liability as $146 million, which does not match either the component values or the total provided in the original answer. The correct increase is $67 million ($115M - $48M), not $98 million. (2) The ground truth specifies that in 2022, liabilities were split into $37M under accrued liabilities and $11M under deferred income taxes and other liabilities, totaling $48M. In 2024, it was $110M under accrued liabilities and $5M under deferred income taxes and other liabilities, totaling $115M. The LLM fails to report these components accurately and instead gives a single incorrect aggregate figure for 2024. (3) While the LLM correctly identifies the general trend—an increase in liabilities related to foreign exchange hedging instruments—and infers a plausible strategic rationale (increased hedging due to currency volatility), this reasoning is based on incorrect data. The multi-hop synthesis across years and balance sheet categories is incomplete and inaccurate. (4) Despite the factual inaccuracies, the answer remains contextually relevant by addressing both the change in liabilities and its implication for Nike's risk management strategy. However, the substantial numerical errors severely undermine the correctness and reliability of the response, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 428,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\nIn the 2022 filing Bounty is listed explicitly as a major brand within the Baby, Feminine & Family Care segment, highlighting its prominence in P&G’s brand portfolio. By the 2023 filing the brand is no longer presented as a stand‑alone marquee—its mention is folded under broader brand groupings and its standalone emphasis is removed—signaling a deliberate reduction in the brand’s visibility and strategic focus.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claims. According to the ground truth, in the 2022 10-K, Bounty was part of the Family Care business but was *not* explicitly listed as a key brand, whereas in the 2023 10-K, it *was* explicitly included among the major brands—indicating an increase in visibility. The LLM answer reverses this: it claims Bounty was explicitly listed in 2022 and then de-emphasized in 2023, which is the opposite of the truth. There are no numeric values in the question or answer, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. However, the qualitative reasoning is fundamentally flawed—the multi-hop synthesis is incorrect because the model misrepresents the direction of change in brand visibility. The answer also introduces a claim of 'deliberate reduction in strategic focus' that contradicts the evidence. Contextual relevance is low because the answer addresses the general topic but with incorrect factual premises, leading to a misleading conclusion. The semantic meaning is not equivalent to the original answer; it conveys the opposite interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 325,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\nOracle continues to recognize hardware product revenue at the moment the Engineered System and its software are delivered, and to recognize hardware‑support revenue ratably over the support term in both the 2022 and 2023 filings.  However, the 2023 filing stresses that hardware now makes up only about 6 % of total revenue and carries lower operating margins, highlighting its volatility, dependence on indirect channels and the need for ongoing R&D investment, whereas the 2022 filing presented hardware as a slightly larger, growing segment ($3.18 B in fiscal 2022) but still emphasized its low‑margin, indirect‑channel nature.  Consequently, the strategic emphasis shifted from a modest growth narrative to a clearer focus on hardware’s small, low‑margin, unpredictable role within the broader cloud‑centric business.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly notes that Oracle recognizes hardware revenue upon delivery and support revenue ratably, which aligns with the general revenue recognition principle mentioned in the ground truth, it introduces specific quantitative claims not present in the original answer. For example, the claim that hardware made up 'about 6%' of total revenue and that fiscal 2022 hardware revenue was $3.18B is not supported by the ground truth, which does not provide specific revenue figures or percentages. These numbers may be factually accurate but are not part of the verified knowledge graph answer, making their inclusion problematic in a truthfulness evaluation. (2) The calculation and comparison of revenue figures and margins are not verifiable from the ground truth, so their accuracy cannot be confirmed—this introduces risk of hallucination. The ground truth does not mention margin levels, revenue share, or growth narratives, so these are additions not grounded in the provided evidence. (3) The multi-hop reasoning is partially sound—LLM attempts to compare 2022 and 2023 strategic emphasis and revenue recognition—but diverges from the actual evolution described. The ground truth emphasizes a shift in accounting treatment (combined performance obligation) and increased emphasis on R&D for innovation and integration, which the LLM answer only partially captures. Instead, the LLM focuses on hardware's declining strategic role and volatility, which is a plausible interpretation but not the one supported by the ground truth. (4) The contextual relevance is high because the answer addresses revenue recognition and strategic emphasis over the two years. However, correctness is reduced due to unsupported quantitative claims and misalignment with the actual strategic shift described (integration and R&D focus vs. narrative of decline). Thus, while the answer is coherent and relevant, it is not fully factually aligned with the ground truth, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 556,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\nERLEADA’s sales jumped from roughly **$1.88 billion in 2022 to $2.39 billion in 2023**, a **≈27 % increase** (as shown in the 2023 vs. 2022 oncology sales table on page 31). This growth, driven by continued share gains and broader market adoption in metastatic castration‑resistant prostate cancer, signals a **strong, upward market trajectory** for the product.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the sales figures are accurate: $1.88 billion in 2022 (matches $1,881 million) and $2.39 billion in 2023 (approximates $2,387 million); the ≈27% growth is correctly calculated (actual: (2387 - 1881) / 1881 ≈ 26.9%). Minor rounding is acceptable. (2) The answer addresses both parts of the question: the sales evolution (increase from 2022 to 2023) and the market trajectory (upward, strong growth). (3) Entities are correct: product name ERLEADA, correct years (2022, 2023), and financial metric (sales). (4) The reasoning is sound—citing continued market adoption and share gains supports the conclusion of a strong upward trajectory, aligning with the ground truth. The reference to page 31 adds contextual support. All aspects are factually accurate, complete, and logically synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 259,
        "total_tokens": 1419
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\nFrom 2023 to 2024 the relationship shifted from a relatively straightforward affiliation model to one that is increasingly driven by negotiated retransmission‑consent fees and higher leverage points for local stations.  The 2023 filing describes the need to secure affiliations with independent broadcast stations, while the 2024 filing emphasizes that programming costs now include payments to those stations for consent to carry their signals and that industry consolidation is intensifying their demands—making Comcast’s distribution of broadcast network content more competitive and more dependent on each station’s pricing and carriage terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in CMCSA's relationship with local broadcast television stations from 2023 to 2024, aligning closely with the ground truth. It accurately identifies the shift from a competitive or affiliation-based model in 2023 to a more dependent, negotiation-driven relationship in 2024 centered on retransmission-consent fees. The answer reflects the increased leverage of local stations and the rising cost pressures due to industry consolidation, which matches the qualitative shift described in the original answer. There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across the two years’ filings, correctly interpreting the strategic shift from competition to dependency. The only minor shortcoming is that the LLM does not explicitly state that CMCSA previously *competed* with local stations for advertising and viewership in 2023, instead framing it as an 'affiliation model'—slightly underemphasizing the competitive aspect noted in the original. However, the core factual progression and dependency shift are accurately conveyed. Wording differs but semantic meaning is substantially equivalent, satisfying completeness and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 379,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\nThe Company’s held‑to‑maturity portfolio fell dramatically — from **$306 million at the end of 2023** to only **$38 million at the end of 2024** (a decline of roughly 87 %).  This sharp reduction shows that Mastercard is deliberately shrinking its short‑term, low‑yield time‑deposit holdings and reallocating the cash to more flexible, higher‑return assets such as available‑for‑sale securities and equity investments, reflecting a strategic shift toward greater liquidity and potentially better risk‑adjusted returns in the current interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the HTM securities values for MA (Mastercard) as $306 million in 2023 and $38 million in 2024, matching the ground truth exactly. The calculated decline of approximately 87% is accurate: (306 - 38) / 306 ≈ 0.876, or 87.6%, which rounds to 'roughly 87%', so this is acceptable. 2) All numeric values, years, and entities (MA = Mastercard, HTM securities) are correct. The use of 'the Company' is contextually appropriate given that the question and answer both refer to MA. 3) The reasoning is sound and goes beyond the ground truth by elaborating on the strategic rationale—reallocating to available-for-sale securities and equity investments for greater liquidity and better risk-adjusted returns. While the original answer does not specify the destination assets (e.g., AFS or equity), this extension is plausible and consistent with the idea of increased liquidity; it does not contradict the ground truth but enriches it. However, the LLM characterizes HTM securities as 'short-term, low-yield time-deposit holdings', which may be misleading—HTM securities can include various fixed-income instruments and are defined by intent to hold, not necessarily short duration. This is a minor inaccuracy in qualitative classification but doesn't undermine the overall correctness. 4) The answer fully addresses both parts of the question: the quantitative evolution and the strategic implication. The synthesis across years is correct, and the conclusion aligns with the ground truth’s interpretation of a shift toward liquidity. Thus, the answer is factually correct, complete, and contextually relevant, meriting a high score with only minor room for refinement in terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 464,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\nBetween 2022 and 2023 the Always brand did **not** move to a different segment or product group – it remained classified under **Feminine Care**, the sub‑category that covers both **menstrual care** (e.g., Tampax) and **adult incontinence** (Always Discreet).  The 2023 filing lists Always alongside Always Discreet and Tampax within the “Feminine Care (Adult Incontinence, Menstrual Care)” grouping, and the segment’s flat net sales with a 13 % rise in earnings indicate that the brand’s positioning stayed the same but shifted toward higher‑margin, premium offerings rather than a change in categorisation.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a key factual inaccuracy regarding the evolution of Always's categorization. While it correctly states that Always remained within the Feminine Care sub-category of the Baby, Feminine & Family Care segment, it fails to acknowledge the strategic repositioning highlighted in the ground truth: the shift from a general 'Feminine Care' classification to a more specific alignment with 'Menstrual Care' in 2023. Instead, the LLM incorrectly implies no change in categorization, stating that Always remained grouped under 'Feminine Care (Adult Incontinence, Menstrual Care)' without recognizing the refinement in sub-category labeling and strategic emphasis. The mention of Always Discreet (adult incontinence) and Tampax as co-brands is accurate and contextually relevant, and the financial data (flat net sales, 13% rise in earnings) is plausible and consistent with P&G’s reporting trends, though not directly tied to Always alone—this adds contextual insight but does not address the core question about product categorization evolution. Quantitatively, there are no errors in numbers or dates; the 13% earnings increase is not contradicted by the ground truth (which omits financials), so it does not count as incorrect. However, the reasoning is flawed in concluding that 'positioning stayed the same' when the ground truth explicitly describes a strategic shift in categorization to emphasize menstrual care. This reflects a failure in multi-hop synthesis: the model conflates segment stability with lack of repositioning, missing the nuance of internal sub-category refinement. Thus, while contextually relevant and factually plausible in parts, the answer misses the central point of reclassification within the segment, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 489,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Oracle’s Engineered‑Systems hardware remained a modest, roughly 6 %‑of‑total‑revenue line item, and its revenue is recognized at the point in time when the hardware (and any bundled software) is delivered and ownership transfers to the customer.  The company continues to treat hardware support contracts as a percentage‑of‑net‑hardware‑fee that is then recognized ratably over the support term, but it explicitly notes that the hardware business carries lower operating margins than its cloud‑and‑license operations and that its future investments will be directed toward “developing, marketing, selling and delivering our cloud‑based offerings.”  Consequently, while the recognition timing has not changed, the strategic emphasis has shifted away from growing the hardware segment toward expanding cloud services, with hardware now serving mainly as a complementary, low‑margin complement to the broader cloud‑and‑license strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the quantitative contribution of Oracle Engineered Systems in 2022. The original answer states that no specific percentage of total revenue was provided for hardware (including Engineered Systems) in 2022, but the LLM claims it was 'roughly 6% of total revenue' in both 2022 and 2023. This misrepresents the evolution, as the 6% figure was only explicitly disclosed starting in 2023. This is a critical error in quantitative accuracy. (2) The revenue recognition timing — at the point of delivery for hardware and bundled software — is correctly stated and matches the ground truth. The treatment of support contracts as ratably recognized over the term is also accurate, though not directly asked, it adds relevant context. (3) The qualitative reasoning about strategic shift is partially correct: Oracle did emphasize cloud growth over hardware, and hardware has lower margins. However, the original answer highlights that in 2023, Oracle increased R&D investment in hardware and provided more detailed factors affecting hardware revenue predictability (e.g., manufacturing partners, competition with cloud infrastructure), indicating ongoing strategic attention rather than a simple de-emphasis. The LLM overstates the strategic downgrading by framing hardware as merely a 'complementary, low-margin complement' without acknowledging the continued investment and expanded disclosure, which suggests a more nuanced strategic role. (4) Contextually, the answer is highly relevant and addresses both revenue recognition and strategic emphasis. It synthesizes information appropriately but fails on a key multi-hop point: the evolution from undisclosed percentage in 2022 to 6% disclosure in 2023. This undermines the correctness score despite otherwise strong structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 505,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\nComcast’s advertising‑sales model with representation firms has stayed essentially unchanged from 2023 to 2024: the company still treats these firms as an extension of its own sales force, selling a portion of the advertising inventory that is allocated to it and recording the net amount after agency commissions.  Both the 2023 and 2024 Form 10‑K filings describe the same practice—recognizing advertising revenue on a gross basis and then offsetting the fees paid to representation firms in other operating expenses—indicating no substantive shift in strategy, only a consistent continuation of the approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Comcast's relationship with representation firms remained unchanged between 2023 and 2024. The ground truth states that in 2023, Comcast used representation firms as an extension of its sales force, recognizing revenue net of commissions (a co-selling model), but by 2024, it had transitioned to formal representation agreements where it sells advertising on behalf of third parties—indicating a strategic shift to a more formalized structure. The LLM incorrectly asserts that the model stayed the same and mischaracterizes the accounting treatment, claiming revenue is recognized on a gross basis and commissions offset in expenses, which contradicts the ground truth that revenue was recorded net of agency commissions in 2023. There are no numeric values in the question to verify, so quantitative accuracy is not applicable—scored as 10 by default for absence of numerical errors. However, the qualitative accuracy is very low due to failure in multi-hop reasoning: the model did not correctly synthesize the evolution in strategy across the two years. Contextual relevance is moderate because the answer addresses the right topic and entities (Comcast, representation firms, advertising sales) but draws the wrong conclusion about strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 365,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\nOracle’s accounting for its industry‑specific hardware remained the same: product sales are recognized at the point in time when the hardware (and its embedded software) is delivered, while hardware‑support fees are recorded ratably over the contractual term.  The 2023 filing shows the same revenue‑recognition pattern as 2022, but the company’s strategic focus on hardware was unchanged – it still describes hardware as a modest (~6 % of total revenue) yet strategically important component of its broader cloud‑and‑infrastructure portfolio, emphasizing continued R&D investment and the need to manage volatile quarterly sales and lower margins relative to its cloud and license businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative distinctions in Oracle's evolving strategic emphasis between fiscal 2022 and 2023. (1) Quantitatively, the answer correctly notes that hardware contributes approximately 6% of total revenue and accurately describes the revenue recognition policy—point-in-time for product sales and ratable for support fees. These details align with typical disclosures and are consistent across years, so the numerical and accounting treatment accuracy is high. (2) However, the qualitative analysis is flawed: the LLM claims Oracle’s strategic focus on hardware was 'unchanged,' which contradicts the ground truth. In fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition and explicitly emphasized ongoing R&D investments to improve and innovate hardware offerings—signaling a heightened strategic focus. In contrast, the 2022 description was more general, focusing on the breadth of offerings rather than innovation. This evolution in strategic emphasis is a critical multi-hop insight that the LLM fails to capture. (3) The reasoning is sound in terms of revenue recognition consistency but incorrect in concluding no strategic change. The model does not synthesize the shift in narrative tone and focus between the two years, which is central to the question. (4) Therefore, while the answer is contextually relevant and quantitatively accurate, it lacks completeness and reasoning depth on the strategic evolution, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 419,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\nIMBRUVICA (ibrutinib) sales fell sharply – from roughly **$3.78 billion in fiscal 2022 to about $3.26 billion in fiscal 2023**, a decline of **≈13–14 %**.  The drop was attributed to **global competitive pressures on the BTK‑inhibitor franchise**, including newer oral agents and pricing pressure that eroded market share, even as the company’s overall oncology portfolio grew modestly thanks to other products such as DARZALEX, CARVYKTI and ERLEADA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the sales figures for IMBRUVICA in 2022 ($3.78 billion) and 2023 ($3.26 billion), which match the ground truth of $3.784 billion and $3.264 billion (rounded appropriately). The calculated decline of '≈13–14%' is accurate, as the exact drop is (3.784 - 3.264)/3.784 ≈ 13.7%, so the approximation is acceptable. 2) Quantitatively, all numbers and calculations are correct, with only minor rounding differences that do not affect accuracy. The use of 'fiscal year' is appropriate and consistent with SEC reporting. 3) The reasoning correctly identifies competitive pressures from newer oral agents as a key factor, aligning with the ground truth. It adds 'pricing pressure' and 'eroded market share', which are reasonable inferences from 'competitive pressures' and 'market dynamics' mentioned in the original. The mention of other oncology products (DARZALEX, CARVYKTI, ERLEADA) is contextually relevant and supports the broader portfolio trend, though not directly part of the IMBRUVICA performance explanation—this adds context without detracting from accuracy. 4) The answer fully addresses both parts of the question: the sales evolution (quantitative change) and contributing factors (competitive pressures). The synthesis across time periods and market dynamics is sound. The only minor shortcoming is the omission of pandemic-related delays in new patient starts mentioned in the 2022 context in the original, which slightly reduces qualitative completeness. However, the core reasoning remains robust. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 449,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\nFrom 2023 to 2024 Comcast’s stake in Universal Beijing Resort remained at 30 percent and the resort continued to be consolidated as a variable‑interest entity because Comcast controls the activities that most affect its economic performance.  The resort’s outstanding debt fell slightly, from about $3.5 billion (including a $3.1 billion term loan) at the end of 2023 to roughly $3.4 billion (with a $3.0 billion term loan) by the end of 2024, and there were no new liquidity guarantees or other financial commitments linking Comcast to the debt.  Consequently, Comcast’s financial risk exposure stayed limited to its 30 percent equity interest (and any remaining unfunded capital commitments), with no additional guarantees or contingent liabilities introduced between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Comcast maintains a 30% ownership stake, Universal Beijing Resort's debt decreased from $3.5 billion to $3.4 billion, the term loan reduced from $3.1 billion to $3.0 billion, and Comcast continues to consolidate the resort as a VIE. The financial risk exposure remains limited to its equity interest, with no new guarantees. (2) Quantitative accuracy is perfect—dollar amounts and percentages match exactly, with acceptable phrasing like 'about' and 'roughly' not affecting factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across ownership, debt levels, consolidation, and risk exposure across two years. (4) The only minor shortcoming is the slight omission of explicitly stating that the risk profile is 'stable' due to no structural changes, a nuance present in the original answer. However, this is implied in the conclusion. Wording differs slightly but maintains semantic equivalence. All parts of the question—debt levels, ownership, and financial risk—are fully addressed with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 329,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\nIn the 2022 disclosure (page 58) FedEx noted that it had signed additional build‑to‑suit leases with undiscounted future payments of roughly **$3.4 billion**, most slated to commence in 2023‑2024. By the 2023‑2024 footnote (page 98) the remaining undiscounted commitment for those build‑to‑suit facilities and equipment had fallen to about **$0.9 billion**, with commencement now pushed to 2025‑2027. This decline indicates that many of the planned off‑balance‑sheet projects either came online or were cancelled, and FedEx is scaling back its large‑scale build‑to‑suit expansion in favor of more controlled, longer‑term lease arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key financial figures: $3.4 billion in 2022 and $0.9 billion in 2023 for future undiscounted lease payments related to build-to-suit facilities and equipment. These numbers match the ground truth exactly, and the expected commencement periods (2023–2024 in 2022, shifting to 2025–2027 in 2023) are accurately reported. The wording differs slightly (e.g., 'build-to-suit facilities and equipment' in 2023 vs. only 'facilities' in 2022 in the original), but this is semantically acceptable as the 2023 disclosure includes both. 2) Quantitatively, all numbers and timeframes are correct. The reduction from $3.4B to $0.9B is accurately portrayed, and no calculations are required beyond this comparison. 3) The reasoning is sound: the LLM correctly infers a strategic shift, noting the decline indicates scaling back of large-scale build-to-suit expansion. It adds a plausible interpretation — that projects either came online or were cancelled — which is consistent with the data but slightly extends beyond the ground truth's more conservative 'strategic shift' conclusion. This is a reasonable inference but introduces a minor assumption not explicitly in the original. 4) The answer fully addresses both parts of the question: the evolution of financial commitments and the implication for FedEx's leasing strategy. The contextual relevance is excellent, with accurate citations (page numbers) and appropriate financial terminology. The only reason for not scoring a 10 is the slight interpretive addition about cancellations, which, while logical, is not explicitly confirmed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 446,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard did not make any additional investment in or acquire more of Dynamic Yield LTD – the company’s 2022 purchase remained the only exposure – and the business was fully integrated into Mastercard’s “value‑added services and solutions” portfolio.  The continued contribution of Dynamic Yield’s technology helped lift revenue from value‑added services to $9.274 bn in 2023 (up from $7.879 bn in 2022), underscoring Mastercard’s strategic shift toward data‑driven, cybersecurity and intelligence‑focused offerings rather than pure payment‑network fees.  This reflects a broader strategic focus on expanding high‑margin, analytics‑rich services that can be sold alongside its core payment‑network platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that Mastercard acquired Dynamic Yield in April 2022 for $325 million with $200 million attributed to goodwill, but the LLM omits these specific figures entirely. Instead, it introduces revenue numbers for 'value-added services'—$9.274 billion in 2023 and $7.879 billion in 2022—which are not present in the original answer and cannot be verified from the provided ground truth. There is no mention in the ground truth about Dynamic Yield's direct contribution to revenue or specific financial performance post-acquisition. (2) The calculation of revenue growth from $7.879B to $9.274B is accurate if those numbers were correct, but they are not supported by the ground truth, making this a hallucination. The date of acquisition (2022) is correctly implied, but the lack of specific disclosure about the $325M purchase price and $200M goodwill in the LLM response misses key facts from 2023 disclosures. (3) The reasoning about strategic focus has partial alignment: the LLM correctly infers a shift toward data-driven and intelligence-based services, which is consistent with the ground truth’s mention of a pivot to cybersecurity via the Recorded Future acquisition in 2024. However, the LLM fails to mention Recorded Future at all, missing a critical multi-hop element—comparing the post-integration phase of Dynamic Yield with a new strategic direction signaled by a different acquisition. Instead, it overattributes strategic meaning to unverified revenue growth. (4) Despite the incorrect numbers, the LLM captures the qualitative evolution—integration completed, no new activity in 2023–2024, and strategic movement beyond payments—giving it moderate qualitative accuracy and high contextual relevance. The core idea of a strategic shift is preserved, but the absence of key facts and insertion of unsupported figures reduces overall correctness to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 541,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\nThe Senior Officer Severance Plan was most recently restated on **May 26 2022** (Exhibit 10.28), filed as an exhibit to a **Form 10‑Q** (filed November 27 2024). The only prior amendment was a **May 29 2020** restatement (Exhibit 10.29) that appeared in a Form 10‑Q filed on **August 26 2020**; no further amendments have been disclosed through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key dates, amendment details, and filing information. The most recent amendment date (May 26, 2022), exhibit number (10.28), and filing date (November 27, 2024) match the ground truth. The prior amendment on May 29, 2020, with Exhibit 10.29 filed on August 26, 2020, is also accurately reported. (2) All numeric values—dates and exhibit numbers—are factually correct. There are no calculation errors, and the formatting (e.g., May 26 2022 vs May 26, 2022) is acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two filings (2020 and 2024) to show the evolution of the plan between 2022 and 2024. It correctly infers that no additional amendments were disclosed beyond the 2022 restatement, which aligns with the ground truth. (4) The only minor shortcoming is that the LLM states 'no further amendments have been disclosed through 2024,' which, while technically accurate based on available data, slightly overreaches by implying completeness of the record, whereas the ground truth cautiously states the plan was 'further amended and restated on May 26, 2022' without asserting no others exist. This is a subtle difference in tone but does not affect factual correctness. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 385,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\nThe 6.375 % Senior Notes were quoted at a fair value of **$830 million on December 31 2021** and rose to **$872 million on December 31 2023**—an increase of about **$42 million (≈5 %)**, moving the bonds slightly above their $800 million par amount.  \nThis upward movement in market‑derived fair value indicates that investors grew more confident in Netflix’s debt, pricing the notes at a premium and signaling a perceived improvement in the company’s creditworthiness and financial outlook over the two‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the fair value of Netflix's 6.375% Senior Notes decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023. However, the LLM incorrectly states the 2021 fair value as $830 million and claims an increase to $872 million, which is the opposite of the actual trend. This misrepresents both the starting value and the direction of change. (2) The calculation of a $42 million (≈5%) increase is based on incorrect inputs and is therefore invalid. The actual change is a decrease of $127 million (≈12.7%), which the model fails to report. The par amount of $800 million is mentioned without confirmation from the ground truth and introduces unsupported detail. (3) The multi-hop reasoning is flawed: the model incorrectly infers improved market confidence due to a rise in fair value, when in fact the fair value declined, which typically indicates reduced market confidence or higher perceived credit risk. The conclusion about improved creditworthiness contradicts the evidence in the ground truth. (4) While the answer addresses the structure of the question (change in fair value and market perception), the severe inaccuracies in numbers and resulting misinterpretation of market signals drastically reduce correctness. Contextual relevance is moderate because the response engages with the right concepts (fair value, market perception, creditworthiness) but applies them to incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 417,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\nIMBRUVICA’s worldwide sales fell from **$3.78 billion in 2022 to $3.26 billion in 2023**, a decline of roughly **13–14 %**.  The drop is attributed in the filing to “global competitive pressures,” reflecting loss of market share as newer oncology therapies and biosimilar/next‑generation BTK inhibitors erode its dominance.  Consequently, while the overall oncology segment grew double‑digit (10.5 % to $17.7 billion), IMBRUVICA’s performance indicates that its once‑leading market position is now being challenged and is no longer a primary growth driver for the company.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, IMBRUVICA's sales were $4,369 million in 2022, but the LLM reports $3.78 billion, which is off by over $500 million. The 2023 sales figure ($3.26 billion) is correct and matches the ground truth of $3,264 million. The calculated decline is therefore incorrect: the LLM states a 13–14% drop, but the actual decline is (4,369 - 3,264) / 4,369 ≈ 25.2%, as correctly stated in the original answer. This major miscalculation undermines the quantitative accuracy. (2) Number verification: 2022 sales: LLM $3.78B vs actual $4.369B — incorrect; 2023 sales: $3.26B vs $3.264B — acceptable rounding; percentage change: ~13.5% decline claimed vs actual 25.2% — significantly underestimates the drop. (3) Multi-hop reasoning is partially sound: the LLM correctly infers competitive pressures and weakening market position, and contextualizes IMBRUVICA’s performance against overall oncology growth, which shows good qualitative synthesis. It also correctly identifies that newer therapies are eroding its dominance, aligning with the broader trend implied in the ground truth. However, it fails to mention the comparative growth of specific competitors like DARZALEX and ERLEADA, which are key to the original conclusion about market position. (4) Despite strong contextual relevance and reasonable interpretation of implications, the severe quantitative errors — especially the incorrect baseline sales figure and resulting flawed percentage decline — severely compromise the correctness score. The answer conveys a less severe decline than reality, potentially leading to incorrect business conclusions. Hence, correctness is rated 4 (partially correct with major errors), quantitative accuracy 3 (major number errors), qualitative accuracy 6 (sound reasoning but based on wrong inputs), and contextual relevance 8 (well-structured and relevant discussion).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 532,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\nThe LCNRV (lower‑of‑cost‑or‑net‑realizable‑value) reserve grew from about **$168 million at the end of fiscal 2021** (the figure disclosed in the 2022 filing) to roughly **$222 million at the end of fiscal 2024**, while the inventory‑shrink reserve rose from roughly **$414 million to $427 million** over the same period.  Because these reserves are recorded as additional cost of sales, the higher balances added non‑cash expense that reduced net earnings; the company estimates that a 10 % change in either reserve would shift net income by roughly **$13–$17 million**, implying that the reserve increases between 2022 and 2024 subtracted several tens of millions of dollars from earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor error in the starting year for the LCNRV reserve. The original answer states the LCNRV reserve was $168 million in 2022, while the LLM claims it was disclosed at the end of fiscal 2021 (in the 2022 filing). This is a subtle but important distinction: the ground truth uses 2022 as the starting point, so referencing fiscal 2021 introduces a misalignment in the time period, even if the number itself is accurate. The shrink reserve values ($414M to $427M) are correctly reported. 2) Quantitatively, the dollar amounts for both reserves are accurate, and the impact on net earnings is mostly correct—the original specifies a $17M impact for a 10% change in LCNRV-related assumptions and $32M for shrink, while the LLM reports a combined range of $13–$17M, which underrepresents the $32M sensitivity to shrink. This omission or conflation of the two distinct sensitivities reduces quantitative accuracy. 3) The reasoning is sound in linking reserve increases to cost of sales and thus lower net earnings, and the conclusion about growing reserve needs is supported. However, the model fails to separately highlight the differing earnings sensitivity between the two reserves, which is a key implication in the original answer. 4) Contextually, the response is highly relevant, addressing both the evolution of reserves and their earnings implications. Despite minor inaccuracies in time framing and earnings impact quantification, the core facts and synthesis are present, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 427,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\nQulipta moved from essentially no sales in 2021 to $158 million of U.S. revenue in 2022 and $405 million in 2023 – a >150 % increase – showing that the drug progressed from its 2021 regulatory approval to full commercial launch and is now a growing contributor to AbbVie’s “other” net‑revenue segment.  The 2021 re‑classification of $1 billion of indefinite‑lived IPR&D to definite‑lived developed‑product rights for Qulipta (see Note 100) confirms that its development was completed and the asset began amortizing, and the steep revenue jump reported in 2023 (page 98) reflects the successful commercialization and expanding market uptake of the product.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qulipta's transition from development to commercialization and its growing revenue, which aligns with the ground truth. However, there are key quantitative inaccuracies: the ground truth does not mention $158 million in U.S. revenue for 2022, nor does it reference 2021 sales or a >150% increase. The $1.0 billion reclassification is correctly tied to regulatory approval and asset reclassification, but the LLM incorrectly attributes this specifically to 2021 (ground truth states it occurred in 2022). (2) The 2023 U.S. revenue of $405 million is accurate, and the international revenue of $3 million is missing from the LLM answer, making it incomplete. The $158 million figure for 2022 is unsupported by the original answer and appears to be fabricated or misattributed. (3) The reasoning about the reclassification of IPR&D to developed product rights is sound and reflects correct multi-hop synthesis between regulatory approval and accounting treatment. The conclusion about successful commercialization in 2023 is valid based on the revenue jump, though the comparison relies on incorrect prior-year data. (4) The contextual relevance is high as the answer addresses both development and commercialization progress. Qualitative accuracy is strong due to correct use of financial terminology and logical inference, but quantitative accuracy is reduced due to unsupported numbers and incorrect timing of events. Correctness score is 7 because the core narrative of transition to commercialization is accurate, but significant numerical and temporal errors prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 448,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the amount Honeywell can recover from Resideo under the indemnification‑reimbursement agreement grew—recorded receivables rose from $157 million to $187 million, and the total outstanding receivable (short‑ plus long‑term) increased from roughly $614 million to $661 million—while cash collections stayed at the $140 million annual cap. This shows that Honeywell is increasingly dependent on Resideo to offset its environmental spending, but the cap and the 2043 termination date mean that any future environmental liabilities that exceed the capped reimbursements or that arise after the agreement ends could expose Honeywell to additional cash‑flow risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Resideo's subsidiary is obligated to pay 90% of Honeywell's annual net spending on environmental matters up to $140 million per year, and this arrangement remained consistent between 2022 and 2023. However, the LLM claims that receivables increased from $157M to $187M and total outstanding receivables rose from $614M to $661M—specific figures not present in the original answer or supported by the knowledge graph. These numbers contradict the cap of $140M per year and suggest growing dependency, which is not confirmed in the ground truth. (2) The quantitative inaccuracies are severe: the LLM fabricates specific receivable balances and trends not found in the original answer. While the $140 million annual cap is correctly referenced, the claim about rising receivables and increasing dependency is unsupported. The original answer emphasizes consistency, not growth, in the financial dependency. (3) The reasoning is partially sound in interpreting risk exposure related to the cap and termination in 2043, but it fails the multi-hop synthesis because it misrepresents the evolution of dependency. The core of the question—how dependency evolved—is answered incorrectly: the truth is 'no change,' while the LLM implies 'increasing.' (4) Scores reflect major factual errors in numbers and conclusions (correctness 4/10, quantitative 3/10), moderate qualitative reasoning where logic follows but from false premises (5/10), and high contextual relevance as the answer addresses the right topic and structure (8/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 444,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\nTarget’s 2022 and 2024 10‑K filings use the same wording for cash equivalents – “highly liquid investments with an original maturity of **three months or less from the time of purchase**” – and no alternate definition is introduced in the intervening years.  Consequently, there has been no material evolution in how Target classifies the “original maturity” of its cash‑equivalent holdings; the company continues to treat only instruments that mature within three months as cash equivalents.  The modest changes observed in the composition of those equivalents (e.g., a slight shift toward shorter‑dated short‑term investments and a lower overall cash‑equivalent balance) reflect routine liquidity‑management adjustments, but the underlying cash‑management strategy—maintaining a large, highly liquid buffer of short‑term assets—remains consistent.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Target maintained the same three-month threshold for cash equivalents between 2022 and 2024, which aligns with the ground truth. There are no numeric inaccuracies, and the entity (Target), time frame (2022–2024), and financial definition (original maturity of three months or less) are correctly identified—supporting a high quantitative accuracy score. However, the LLM contradicts the ground truth by asserting there was 'no material evolution' in the definition or treatment, while the original answer notes that although the threshold remained unchanged, Target expanded its discussion around fair value measurements for short-term assets and liabilities in 2024, indicating a broader, more comprehensive financial reporting approach. This omission represents a significant qualitative inaccuracy: the model fails to recognize that evolution in disclosure and contextual treatment—beyond just the definition—constitutes a shift in how the company manages or reports on cash equivalents. The reasoning is therefore incomplete, as it does not synthesize the multi-hop insight that unchanged classification criteria can coexist with strategic refinements in financial management and disclosure. While the answer is relevant and addresses the core question about maturity definition, it misses the nuanced evolution in treatment that the ground truth identifies, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 400,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\nThe $1 billion 3.50% Notes Due 2040 continued to be reported as an **unsecured senior long‑term obligation** (classified as Level 2 in the fair‑value hierarchy) in both fiscal 2023 and 2024.  Its **carrying amount remained $1 billion**, but the disclosed fair value slipped from **$870 million (Jan 29 2023)** to **$851 million (Jan 28 2024)**, reflecting the modest decline in market price as interest rates rose.  This stable, multi‑decade issuance shows NVIDIA’s strategy of financing growth with low‑coupon, long‑dated senior debt while managing interest‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 the carrying value was $851 million as of January 28, 2024, not $1 billion. The LLM incorrectly states the carrying amount remained $1 billion, while the ground truth shows it increased to $1,000 million (i.e., $1 billion) only by 2024 (as of January 26, 2025). The LLM also misreports fair values as $870 million (2023) and $851 million (2024), but the original answer does not mention fair value changes or market price declines due to interest rates—this is an unsupported interpretation. The ground truth emphasizes an increase in valuation from $851M to $1,000M, which the LLM completely reverses. (2) The dates are close but misaligned: Jan 29, 2023 vs. Jan 28, 2024 in the LLM answer do not match the reporting periods in the original (which are as of the end of fiscal years 2023 and 2024). The effective interest rate of 3.54% and remaining term of 15.2 years—key details in the original—are missing in the LLM response. (3) The multi-hop reasoning is flawed: instead of showing an increase in carrying value and enhanced disclosure indicating a long-term debt strategy, the LLM suggests stability and a decline in fair value, contradicting the ground truth. It fails to capture the evolution in valuation and classification detail. (4) While the LLM correctly identifies the notes as unsecured senior long-term obligations and Level 2 classification, and generally frames NVIDIA’s use of long-term debt, the core quantitative narrative is inverted. Thus, despite some contextual relevance and partial entity accuracy, the answer is largely incorrect on key facts and trends, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 471,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\nVenclexta’s global net sales rose from **$2.009 billion in 2022 to $2.288 billion in 2023**, an increase of **13.9 %** at actual currency rates (roughly **15 %** on a constant‑currency basis). The growth was broad‑based, with double‑digit gains in both U.S. and international markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Venclexta's global revenue as $2.009 billion in 2022 and $2.288 billion in 2023, matching the ground truth of $2,009 million and $2,288 million (equivalent values, different units). The growth rate of 13.9% in 2023 is accurately stated. However, the ground truth also includes the 2022 growth rate of 10.4%, which the LLM omits. This is a minor omission affecting completeness but not the core quantitative accuracy. (2) All numeric values are correct: $2.009 billion = $2,009 million, $2.288 billion = $2,288 million, and the year-over-year growth from 2022 to 2023 is correctly calculated as (2,288 - 2,009) / 2,009 ≈ 13.9%. The mention of '15% on a constant-currency basis' is additional context not in the ground truth but does not contradict it and may reflect supplementary data. (3) The reasoning is sound: the LLM identifies the correct drug (Venclexta), correct years (2022–2023), and correctly computes the growth rate. It synthesizes revenue figures across years and draws a valid conclusion about growth. The only missing multi-hop element is the 2022 growth rate, which was part of the original answer. (4) The answer is highly relevant, accurately addressing the evolution of financial performance with correct figures and clear trend interpretation. The omission of the 2022 growth rate prevents a perfect score, but all provided information is factually correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 398,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Netflix replaced its prior “Executive Severance and Retention Incentive Plan”—which had been adopted and filed as an amended‑and‑restated plan effective September 10 2021 in the 2022 Form 10‑K—with a newly amended and restated version that will become effective on January 1 2024 (Exhibit 10.16 in the 2023 filing) and, at the same time, introduced a separate “Executive Officer Severance Plan” that took effect on December 8 2023 (Exhibit 10.15). These moves signal a deliberate update to the company’s executive‑compensation framework, adjusting severance and retention triggers and shifting the operative dates of the plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. Correctly identifies the 2023 filing date (December 8, 2023) and the forward-looking effective date of January 1, 2024, for the amended plan, which aligns with the ground truth. It also correctly references the evolution of the plan name and the general intent to update executive compensation. However, it introduces a significant factual error by claiming Netflix introduced a separate 'Executive Officer Severance Plan' effective December 8, 2023 (Exhibit 10.15), which is not mentioned or supported in the original answer or implied knowledge graph. The original answer only references a single plan with an amendment effective January 1, 2024, filed on December 8, 2023. The LLM incorrectly splits this into two plans and misattributes the December 8 date as an effective date rather than a filing date. While the September 10, 2021, date is correctly referenced, the LLM mischaracterizes it as the effective date of the prior plan in the 2022 filing, whereas the original answer treats it as the filing date of the amended version. Quantitative accuracy is partially correct but flawed in interpretation of dates and entities. The reasoning shows an attempt at multi-hop synthesis (comparing 2022 and 2023 filings) but fails due to hallucination of a second plan. Contextually, the answer is relevant and addresses the evolution question, but the factual errors undermine correctness. Semantic equivalence is not achieved due to the addition of unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 420,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\nFrom the 2022 filing (see NOTE 12 in the 2022 10‑K, pages 67‑71) the Benefit Restoration Plan was presented only as a supplemental defined‑contribution arrangement that provides matching contributions to employees whose 401(k) benefits are limited by IRS caps.  In the 2024 filing the plan was formally amended and restated, effective January 1 2025, and appears as Exhibit 10.3 in the 2024 10‑K (page 78), with revised eligibility language, updated matching formulas and integration with the newly restated 401(k) and cash‑deferral amendments.  This evolution shows that Lowe’s is actively refining and modernizing its retirement‑benefit structure to remain competitive, comply with regulatory changes, and clarify how supplemental benefits are administered.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Benefit Restoration Plan in 2022 was a supplemental defined-contribution plan providing matching contributions for employees affected by IRS limits, as noted in NOTE 12 of the 2022 10-K. In 2024, Lowe's filed an amended and restated version of the plan (Exhibit 10.3) effective January 1, 2025, which matches the original answer. (2) Quantitative elements—dates (January 1, 2025), exhibit number (10.3), document type (10-K), and years (2022, 2024)—are all factually correct. No numerical calculations were required, but all referenced details are precise. (3) The reasoning is sound: the LLM correctly infers that the formal restatement and integration with updated 401(k) and deferral plans indicate active refinement and modernization, reflecting a strategic approach to retirement benefits. This constitutes valid multi-hop synthesis across years and filings. (4) The LLM adds slightly more detail than the ground truth (e.g., 'revised eligibility language', 'updated matching formulas'), which are plausible based on the restatement but not explicitly confirmed in the original answer. However, these do not contradict the ground truth and are reasonable inferences. The only minor gap is that the original emphasizes 'documentation and structure' evolution more explicitly, while the LLM focuses on competitiveness and compliance—still valid, but slightly less focused on the 'indicative' aspect of formalization. Overall, the answer is factually excellent, contextually appropriate, and semantically equivalent with minor stylistic expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 451,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\nBetween the end of fiscal 2023 (January 28 2024) and the end of fiscal 2024 (January 26 2025), NVIDIA’s 0.584 % Notes Due 2024 fell from **$1.25 billion**—recorded as a short‑term liability of $1,250 million on page 72 of the 2023 10‑K—to **$0**—the same line shows “$‑” on page 72 of the 2024 10‑K, indicating the notes were fully retired (the company repurchased/repaid them in fiscal 2025). Thus the obligation evolved from a $1.25 bn short‑term debt to no outstanding balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported liability amount. The original answer (ground truth) states that NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024 in fiscal year 2023, but the LLM claims it was $1,250 million (or $1.25 billion), which is incorrect. This discrepancy is material and affects quantitative accuracy. (2) The LLM correctly identifies that the obligation was fully repaid by fiscal year 2024, aligning with the ground truth that the debt was fully repaid as per the 2024 10-K. However, it incorrectly states that repayment occurred in 'fiscal 2025', which is outside the scope of the question and factually misleading—fiscal 2024 ends in January 2025, but the repayment is reported in the 2024 filing and pertains to the resolution of the obligation by the end of fiscal 2024. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes data from two 10-K filings (2023 and 2024) and interprets the '$-' notation as indicating zero balance, showing understanding of financial reporting conventions. However, the use of an incorrect initial value ($1,250M vs $1,185M) undermines the accuracy of the synthesis. (4) Contextual relevance is high—the answer addresses the evolution of the debt obligation over the two fiscal years and cites specific document locations (page 72 of both 10-Ks), though these page references cannot be verified here. The conclusion that the notes were fully retired is correct, but the incorrect dollar figure and misstated repayment timing reduce overall correctness. Quantitative accuracy is low due to the large numerical error; qualitative accuracy is moderate due to correct logic but flawed input data; contextual relevance remains high as the structure and intent match the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 494,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\nMavyret’s worldwide net sales fell 12.7 % from 2022 to 2023, dropping from **$1.54 billion** to **$1.43 billion**. The decline was led by the U.S. market, where revenue slipped 12.7 % (from $755 M to $659 M), while international sales also fell modestly 1.9 % (from $786 M to $771 M).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values match: 2022 global revenue of $1.541 billion (reported as $1.54 billion, an acceptable rounding), 2023 revenue of $1.43 billion, U.S. revenue dropping from $755M to $659M (12.7% decline), and international revenue declining from $786M to $771M (1.9% decline). (2) Calculations are accurate: the 12.7% drop in U.S. revenue ((755-659)/755 ≈ 12.7%) and 1.9% international decline ((786-771)/786 ≈ 1.9%) are correctly reflected. The total global decline from $1,541M to $1,430M is also correctly stated as 12.7%. (3) Multi-hop reasoning is sound: the answer synthesizes data across U.S. and international markets for two years, correctly identifying trends in each region and their combined impact on global revenue. (4) Entities (Mavyret, U.S., international markets, years 2022–2023) are accurately referenced. The answer is concise but complete, addressing all parts of the question with precise, factually correct information. Minor formatting differences (e.g., $1.54 billion vs $1,541 million) do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 317,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\nNetflix continued to meet the same covenant package that governs its senior unsecured notes – the language restricting additional indebtedness, mergers, sale‑lease‑back transactions and the creation of liens was materially identical in the 2022 and 2024 filings, and the company affirmed compliance as of 31 Dec 2023 and 31 Dec 2024 【54】【56】.  The only evolution was the repayment at maturity in 2024 of the $400 million 5.750 % senior note, which removed that $400 million from short‑term debt, while the scope of the covenants themselves did not change.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a key factual inaccuracy regarding the evolution of covenant scope. Quantitatively, the repayment of the $400 million 5.750% Senior Notes in 2024 is accurately reported, and the compliance status as of year-end 2023 and 2024 aligns with the ground truth. However, the LLM incorrectly states that the covenant language was 'materially identical' and that 'the scope of the covenants themselves did not change,' which contradicts the ground truth: by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions, indicating a narrowing of covenant scope. This omission or misrepresentation of a key qualitative evolution in the covenants significantly undermines the correctness of the answer. The multi-hop reasoning is sound in linking compliance status and debt repayment, but fails in synthesizing changes in covenant language across years. While the answer addresses repayment obligations correctly, it misses the nuanced change in restriction scope, which was a central part of the question. Wording and structure are relevant and clear, hence high contextual relevance, but the qualitative inaccuracy reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 340,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell moved its Safety and Retail offering out of a stand‑alone “Safety and Retail” unit and began bundling it with its Advanced Sensing Technologies business to deliver a more integrated safety‑and‑sensing portfolio. In 2023 the company formalized this shift by realigning the Safety and Retail business unit with Advanced Sensing Technologies, renaming the combined unit “Sensing and Safety Technologies,” and recasting prior‑period results to reflect the new reporting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the Safety and Retail unit was standalone in 2022 and merged with Advanced Sensing Technologies to form Sensing and Safety Technologies in 2023. The structural change is correctly described, including the renaming and integration rationale. (2) Quantitative accuracy is perfect: while the $2,387 million revenue figure is omitted, this is a minor omission and not critical to the question’s focus on structural evolution. No incorrect numbers or dates are presented. The timing of the change (effective July 2022, reported in 2023) is implied via 'formalized in 2023' and 'recasting prior-period results,' which aligns with the knowledge graph. (3) Multi-hop reasoning is sound: the model correctly synthesizes the organizational shift across years and units, identifying the strategic intent behind the merger. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor shortcoming is the lack of explicit mention of the $2.387B revenue figure and the July 2022 effective date, which slightly reduces completeness but does not impair the overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 347,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\nBetween 2023 and 2024 Visa created Class B‑2 common stock for the first time by exchanging tendered Class B‑1 shares in its May 2024 exchange offer; the new B‑2 shares remain subject to the same transfer restriction that makes them non‑convertible and non‑voting until all U.S. covered litigation is finally resolved, and their conversion‑rate adjustments are double those of the existing B‑1 shares. Consequently, once the restriction lifts the B‑2 shares can be converted into Class A common stock (or, after a later date, into Series A preferred stock), diluting existing Class A shareholders and giving the B‑series holders limited but strategically important voting power on matters that require the affirmative vote of the B‑classes, such as major mergers or exits from Visa’s core payments business.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, no shares of Class B-2 Common Stock were outstanding in 2024 prior to the Class B-1 exchange offer, indicating it was no longer active. However, the LLM claims Visa 'created' Class B-2 stock in May 2024 via an exchange offer, which directly conflicts with the ground truth that B-2 shares were not outstanding—implying they were either eliminated or not issued. (2) The LLM states B-2 shares were newly created from B-1 shares and remain non-convertible until U.S. litigation resolves, with future conversion into Class A or Series A preferred stock. This detailed timeline and conversion mechanism are absent from the ground truth and introduce unsupported specifics (e.g., double conversion-rate adjustments, Series A preferred stock), which are not mentioned in the original. (3) The original emphasizes that Class B-2 stock transitioned from having governance influence in 2023 to being non-outstanding in 2024, thus losing influence. The LLM instead portrays B-2 as newly created and gaining future governance power, reversing the actual trajectory. (4) There are no numeric values (dates, percentages, dollar amounts) to verify for quantitative accuracy, but the use of 'May 2024' as a specific creation date is unsupported in the ground truth, which only notes the absence of B-2 shares before the B-1 exchange. (5) Multi-hop reasoning fails: the model does not synthesize the key evolution—disappearance of B-2 stock—but instead fabricates a new narrative around its creation and future role. While the answer is framed around corporate governance and convertibility (relevant topics), it misrepresents the direction and nature of change. Thus, despite addressing the general themes, the factual core is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 502,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot moved from initial store‑level upgrades—such as refreshed layouts, electronic shelf‑labels, expanded self‑checkout and curb‑side pickup—to a systematic, omnichannel “interconnected shopping” strategy.  In 2024 the retailer deepened its digital investments by enhancing mobile‑first navigation, boosting the “shopability” of product pages with richer content and AI‑driven personalization, and scaling same‑day delivery and curb‑side options, while continuing to refine in‑store tools (e.g., way‑finding signage, self‑service lockers, associate‑enabled mobile maps) to make the entire journey—from inspiration to post‑purchase support—seamless across stores, online and on‑the‑job sites.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original answer. It correctly identifies the evolution from 2023 to 2024 in The Home Depot's shopping experience strategy. In 2023, the focus was on in-store improvements such as electronic shelf labels, self-checkout, and store layouts—accurately reflected in the LLM response with terms like 'electronic shelf-labels,' 'expanded self-checkout,' and 'refreshed layouts.' The original answer also mentions mobile app-enabled navigation and reconfigured service desks, which are partially captured in the LLM’s mention of 'associate-enabled mobile maps' and 'way-finding signage,' though not explicitly tied to the mobile app. In 2024, the original answer emphasizes personalized digital experiences, customer review summaries, enhanced product content, and data-driven personalization. The LLM correctly captures this shift with 'AI-driven personalization,' 'richer content,' and 'mobile-first navigation,' indicating a deeper integration of digital and data tools. The concept of 'interconnected shopping' and 'omnichannel' strategy reflects the broader synthesis goal of seamless experience across channels, which is consistent with the original's emphasis on digital platform integration. All dates (2023–2024) are correct, no numeric inaccuracies exist, and the reasoning across years is sound. The only minor gap is the absence of explicit mention of 'customer product review summaries' and 'service desk reconfiguration,' which are specific elements from the original. However, the LLM compensates with semantically related concepts (e.g., AI personalization likely encompasses review-based insights). Thus, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across time periods and capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 489,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\nFrom 2022 to 2024 the LTIP stayed under the 2020 plan but became more granular: the 2022 filing (Exhibit 10.4 * and related ** exhibits on page 68 of the 2022 10‑K) listed separate “Cliff‑Vested Restricted Stock Unit Agreement” and “Performance Award Performance Share Unit Agreement,” while the 2024 filing (Exhibit 10.4 * and ** exhibits on page 73 of the 2024 10‑K) retained those categories and added a dedicated “Target Corporation Officer EDCP (2025 Plan Statement)” as a new long‑term incentive vehicle.  Consequently, the plan evolved from a generic RSU/performance‑unit mix to a structured set of award types with distinct cliff‑vesting and performance‑award mechanics, plus an officer‑specific deferred compensation component.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the existence of the Long-Term Incentive Plan (LTIP) under the 2020 plan framework, it incorrectly states that the 'Cliff-Vested Restricted Stock Unit Agreement' and 'Performance Award Performance Share Unit Agreement' were already present in the 2022 filing. According to the ground truth, these were introduced by 2024, not present in 2022. This misrepresents the evolution timeline. Additionally, the LLM introduces a 'Target Corporation Officer EDCP (2025 Plan Statement)' as a new long-term incentive vehicle in 2024, which is not mentioned in the original answer and appears to be fabricated or misattributed. The original answer notes only the addition of two new equity award forms—Cliff-Vested RSUs and Performance Award PSUs—without reference to an officer-specific deferred compensation plan. While the LLM captures the general direction of increased granularity in award types, the specific entities and their timing are incorrect. The reasoning is partially sound in that it attempts to trace changes across filings, but the multi-hop synthesis fails due to incorrect attribution of documents and award types to the wrong years. The contextual relevance is fair because the response addresses the evolution of equity awards, but the core factual claims about what existed when are flawed. Number formats and dates (2022, 2024) are correctly used, but the content associated with those years is not accurate, leading to a moderate penalty in quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 438,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\nQulipta generated virtually no sales immediately after its September 2021 FDA approval, posting $158 million of U.S. revenue (with only modest international sales) in 2022.  In 2023 the product’s U.S. sales more than doubled to $405 million and added roughly $3 million abroad, driving total worldwide revenue up by over 100 % year‑over‑year and signalling accelerating market uptake through 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qulipta was approved in September 2021, had $158 million in U.S. revenue in 2022, and reached $405 million in U.S. revenue and $3 million internationally in 2023, totaling $408 million. These figures match the original answer exactly. (2) Quantitative accuracy is perfect: the numbers for each year and region are correct, and the statement that sales 'more than doubled' from $158M to $405M is accurate (a 156% increase). The claim of 'over 100% year-over-year growth' is also correct given the total revenue increase from ~$158M to $408M. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across years and geographies, inferring accelerating market uptake based on revenue trends. (4) The only minor limitation is that the original answer notes Qulipta had 'no revenue in 2021', which the LLM slightly softens to 'virtually no sales', which is slightly less precise but still reasonable given the timing of approval late in the year. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 329,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\nBetween the 2022 and 2024 filings Netflix retained the same high‑level description of the 2020 Stock Plan but markedly deepened its quantitative disclosures.  The 2024 filing adds a full‑year stock‑option activity table that shows balances, grants, exercises, expirations and vested/exercisable amounts through 2024, includes a separate RSU/PSU schedule with unvested share counts and grant‑date fair values, reports $46 million of unrecognized compensation cost, and notes the recent $10 billion and $15 billion share‑repurchase authorizations.  These updates provide far more granular, forward‑looking detail on the plan’s structure and the company’s equity‑compensation activity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The ground truth states that in 2022, the 2020 Stock Plan was only referenced in the exhibit list with no detailed description, while in 2024 it was explicitly described and linked to specific equity compensation activities. The LLM incorrectly claims that Netflix 'retained the same high-level description' between 2022 and 2024, which contradicts the ground truth showing a shift from no description to detailed disclosure. (2) The LLM introduces specific quantitative details not present in the ground truth: a 'full-year stock-option activity table', 'RSU/PSU schedule', '$46 million of unrecognized compensation cost', and '$10 billion and $15 billion share-repurchase authorizations'. These numbers and disclosures are not mentioned in the original answer and cannot be verified against the provided ground truth, making them potentially fabricated or misattributed. There is no mention of repurchase authorizations or exact cost figures in the ground truth. (3) The multi-hop reasoning is partially sound in that it attempts to compare disclosure depth across years and identify changes in equity compensation reporting, but it fails to accurately represent the nature of the evolution—shifting from mere documentation to operational disclosure—instead focusing on added quantitative tables not referenced in the ground truth. (4) While the LLM addresses the question's focus on structural description and equity compensation activities, it does so with incorrect specifics, inflating the level of quantitative detail added. The contextual relevance is moderate because it discusses the right topic and direction of change (increased disclosure), but the factual foundation is flawed. Overall, the answer is partially correct in direction but incorrect in key facts and specifics, warranting a low-to-mid score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 513,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\nBetween 2022 and 2023 the company kept its aluminum purchase agreements classified as **derivatives that do not receive hedge accounting treatment** – they are still recorded as “commodity contracts” in the “Derivatives not receiving hedge accounting treatment” table (page 103).  However, the **notional amount of those aluminum contracts fell dramatically**, from **$412 million in 2022 to $115 million in 2023** (page 103), indicating a more selective, strategic use of the instruments to support long‑term sourcing for its non‑U.S. operations rather than broad price‑risk hedging.  The company continues to disclose the fair‑value of these contracts in its Consolidated Statements of Financial Position (page 104) and notes that they are used to address long‑term sourcing objectives and non‑U.S. business requirements (page 103).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer. The original answer does not mention specific dollar amounts ($412 million in 2022, $115 million in 2023), nor does it reference a dramatic reduction in notional value or specific page numbers (103, 104). These figures and citations are fabrications or hallucinations, severely undermining quantitative accuracy. While the LLM correctly identifies that aluminum purchase agreements are classified as derivatives without hedge accounting and are used for long-term sourcing and non-U.S. business needs—consistent with the 2022 description—the evolution described in the original answer focuses on the clarification of offsetting quantities and pricing at prevailing market rates in 2023, not a reduction in notional value. The LLM fails to mention this key strategic refinement: the offsetting nature of the contracts and alignment with market pricing. This omission represents a failure in multi-hop synthesis, as the evolution in strategy is misrepresented. However, the answer is contextually relevant and captures part of the correct classification and purpose of the instruments. The reasoning is partially sound but based on incorrect data. Semantic equivalence is partially achieved on the role and classification of the agreements, but not on the evolution between years due to invented metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 390,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\nThe 2024 filing updates the public posting link for the Directors’ Code of Conduct—from an “inv relations” folder to the more prominent “investor‑relations” directory—while retaining the same language that the code applies to all directors. It also re‑emphasizes the company’s intent to post any future amendments or waivers of the Directors’ Code on its website, reinforcing a clearer, more transparent disclosure practice, though the substantive scope of the code remains unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the change in URL structure between 2023 and 2024, noting the shift from 'inv relations' to 'investor-relations', which aligns with the ground truth regarding accessibility improvements. It also accurately mentions the continued public posting of the Directors' Code of Conduct and the company's commitment to disclose amendments or waivers, supporting transparency. However, the LLM answer misses a key factual update from the ground truth: the addition of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES' in 2024, which was not present in 2023. This omission is significant because it reflects an expansion in the document's scope and compliance focus, directly addressing the question about evolution in 'scope'. While the LLM claims the 'substantive scope remains unchanged', this contradicts the ground truth, which indicates an expanded focus. Thus, while the accessibility aspect is correctly addressed and all referenced details (like URL changes and disclosure practices) are factually accurate, the answer fails to capture a critical change in content scope, leading to a partially incorrect assessment of the overall evolution. Quantitative accuracy is perfect—no numbers, dates, or URLs are misstated. Contextual relevance is high as the response stays focused on the question. Qualitative accuracy is reduced due to the incorrect conclusion about unchanged scope, undermining the multi-hop synthesis required to compare both years' documents for both accessibility and content changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 423,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\nBetween the end of fiscal 2023 and the end of fiscal 2024 the existing 4.95 % senior notes due September 2026 grew only modestly – their carrying amount rose from $745 million to $747 million – while a new $1.75 billion series of 4.95 % notes maturing in June 2034 was issued in June 2024 (discount of $16.7 million).  This adds a longer‑dated, fixed‑rate tranche to the debt profile and signals Home Depot’s strategy of extending maturity, diversifying funding sources and locking in low‑cost long‑term financing to support growth initiatives such as the SRS acquisition while keeping overall leverage in check.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HD issued $750 million of 4.95% senior notes due September 30, 2026, in 2023 at a discount of $1.6 million, and by 2024, the carrying amount was $747 million. The LLM incorrectly states the 2023 carrying amount as $745 million (should be $748.4 million after discount: $750M - $1.6M), and falsely claims a new $1.75 billion series of 4.95% notes maturing in June 2034 was issued in June 2024. In reality, the new issuance was $980 million of 4.95% notes due 2052, not 2034, and no mention of a $16.7 million discount exists in the ground truth. (2) Quantitative accuracy is severely compromised: the amounts ($1.75B vs $980M), maturity dates (June 2034 vs September 2052), and original carrying value are all incorrect. The only correct number is the $747 million carrying amount in 2024 for the 2026 notes. (3) Multi-hop reasoning is flawed: the LLM invents a new bond issuance not present in the truth data and misrepresents the long-term strategy. While the general idea of extending maturities is directionally plausible, it is based on fabricated data. The actual strategy involves a leap to a 2052 maturity, indicating a much longer-term rate lock, which the LLM fails to capture. (4) Contextual relevance is moderate because the answer addresses debt strategy and maturity extension, but the incorrect entities and numbers undermine the validity. Correctness is very low due to core factual errors in amounts, dates, and issuances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 424,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\nBetween 2021 and 2023 Intel recorded a one‑time $471 million observable‑price adjustment to the carrying amount of its equity stake in Beijing Unisoc Technology Ltd. in the first quarter of 2021, and by the end of 2022 the investment’s net book value had risen to $1.1 billion (the same figure reported as of December 30 2023).  Subsequent observable‑price adjustments for the broader non‑marketable equity portfolio fell sharply—from $750 million in 2021 to $17 million in 2023—so after the 2021 bump the Unisoc stake was carried at roughly $1.1 billion with only immaterial further re‑valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $471 million observable-price adjustment in 2021 and the $1.1 billion net book value as of both December 30, 2023, and December 31, 2022 (aligned with ground truth). The statement that the value was the same in 2023 as in 2022 matches the original answer’s claim of stable valuation. (2) All numeric values are accurate: $471 million in 2021, $1.1 billion book value, and the broader portfolio adjustments ($750M in 2021 to $17M in 2023) are factually correct and consistent with Intel’s filings, though the latter is contextual and not part of the core truth. No calculation errors. (3) The multi-hop reasoning is sound—LLM connects the 2021 adjustment to the subsequent stable carrying value, infers lack of significant revaluation, and correctly frames Unisoc as part of the non-marketable equity portfolio. Minor deduction in qualitative accuracy because the original answer emphasizes the lack of marketability and stable valuation post-2021, while the LLM adds contextual data about the broader portfolio (not incorrect, but slightly beyond the scope). (4) The answer is semantically equivalent to the ground truth, with precise numbers, correct entities (Intel, Beijing Unisoc Technology Ltd.), and accurate timeframes. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses evolution of financial treatment and valuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 394,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\nFrom 2022 into 2023 AbbVie moved Qulipta from a newly‑launched acute‑migraine option toward its first preventive indication.  In April 2023 the FDA approved Qulipta for the preventive treatment of chronic migraine in adults, and in August 2023 the European Commission followed with approval of Aquipta (Qulipta) for the same preventive use, allowing the company to begin commercial rollout of the preventive indication in both the United States and the EU.  This regulatory expansion marked the key evolution of Qulipta’s commercial development between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory milestones for Qulipta in 2023—FDA approval in April 2023 for preventive treatment of chronic migraine in adults and EC approval in August 2023. These dates and events match the ground truth. However, the LLM omits the 2022 context about the reclassification of $1.0 billion in indefinite-lived R&D intangible assets to developed product rights, which is a significant part of the 'evolution' asked in the question. This omission reduces completeness. (2) Quantitatively, all dates and approvals are accurate. The mention of 'Aquipta (Qulipta)' appears to be a typo but is likely intended as Qulipta, and the context makes the identity clear. No numerical inaccuracies are present. (3) The reasoning correctly traces the regulatory progression from 2022 to 2023, but fails to incorporate the 2022 financial/accounting impact (the $1.0 billion reclassification), which represents a multi-hop element between financial reporting and product development status. This weakens the full synthesis required. (4) Despite the omission, the answer captures the core regulatory and commercial evolution in 2023 and is highly relevant to the question. The phrasing 'moved Qulipta from a newly-launched acute-migraine option' is not fully supported in the ground truth, which does not describe Qulipta as an 'acute-migraine option'—it was approved for preventive use. This is a minor factual overreach. Overall, the answer is strong on regulatory development but incomplete on the full 2022–2023 evolution including financial reclassification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 439,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\nBoeing’s 2022 Form 10‑K (page 5) and the 2023 Form 10‑K (page 3) both describe the Global Services segment with virtually the same wording – “upgrades and conversions” are listed together with maintenance, spare parts, training and digital analytics as a core offering for sustaining commercial and defense aircraft. The 2023 filing does not add new language or shift the strategic emphasis; it simply reiterates the same framing, underscoring that upgrades and conversions remain a key, recurring‑revenue driver within Global Services.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no shift in strategic emphasis between 2022 and 2023. The ground truth states that while 'upgrades and conversions' were mentioned as part of a broader, general list of services in 2022, in 2023 they were repositioned within a more structured narrative emphasizing the full spectrum of sustaining aerospace platforms—indicating a more integrated and strategic role. The LLM incorrectly asserts that the wording and framing are 'virtually the same' and that there is no strategic shift, which contradicts the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct citation of document pages (which the LLM got right: 2022 10-K page 5, 2023 10-K page 3), hence a score of 10. However, the qualitative accuracy is low because the model fails to detect the nuanced but meaningful evolution in language and strategic framing, which is the central point of the question. The reasoning is flawed as it misses the multi-hop requirement to compare not just presence but positioning and context of 'upgrades and conversions' across years. Contextual relevance is moderate because the answer discusses the right segment and service offerings but fails to capture the evolution in strategic emphasis, thus missing the core intent of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 380,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\nIntel classifies its stake in Beijing Unisoc Technology Ltd. as a non‑marketable equity security and adjusts its carrying amount only for observable price changes and impairment testing.  In 2021 the company recorded $471 million of observable‑price adjustments, bringing the investment’s net book value to $1.1 billion—a level that remained unchanged through 2022 and 2023, even though only $299 million and $17 million of additional observable adjustments were recognized in 2022 and 2023, respectively, and a $214 million impairment was taken in 2023, leaving the carrying amount at $1.1 billion as of Dec 30 2023.  (INTC 10‑K 2023 pages 58, 96; INTC 10‑K 2022 page 96).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Intel's net book value of its investment in Beijing Unisoc was $1.1 billion in both 2021 and 2023, with a $471 million observable price adjustment recognized in 2021. However, the LLM claims that only $299 million and $17 million in additional observable adjustments were recognized in 2022 and 2023, respectively, and that a $214 million impairment was taken in 2023—none of which are supported by the original answer or implied by the knowledge graph. These figures are entirely fabricated or misattributed, leading to a false narrative of ongoing adjustments and an impairment. (2) The quantitative inaccuracies are severe: the LLM invents numbers not present in the ground truth (e.g., $299M, $17M, $214M) and incorrectly suggests that the $1.1 billion value was maintained despite these changes, which contradicts the original claim that no such adjustments were reported in 2023. The only correct numbers are the $471 million adjustment in 2021 and the $1.1 billion net book value in 2021 and 2023. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the classification of the investment and the concept of observable price adjustments, it fails to accurately synthesize the evolution over time. It incorrectly implies continued valuation activity in 2022 and 2023, whereas the ground truth states that such adjustments were not explicitly mentioned in the 2023 filing, suggesting stability. (4) Contextual relevance is moderate—the answer addresses the right topic (Intel's investment in Unisoc, valuation methods, and book value) and cites plausible document locations, but the inclusion of false data severely undermines its accuracy. The core conclusion about the $1.1 billion value being maintained is correct, but the path to that point is factually wrong, making the overall assessment highly misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 524,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot deepened the integration of self‑service lockers into its omnichannel journey, using them as a core node for online‑order storage and curb‑side pickup and expanding their presence in newly opened and remodeled stores. The lockers now work hand‑in‑hand with the mobile‑app navigation and real‑time inventory tools that guide customers to items, enabling faster, guaranteed pickup options and reinforcing the retailer’s “interconnected shopping experience” that blends digital convenience with the physical store environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolving role of Self-Service Lockers within Home Depot's interconnected shopping experience between 2023 and 2024, noting deeper integration into the omnichannel strategy and their use for online order storage and pickup. It accurately reflects the strategic shift toward operational integration and mentions relevant context like mobile app navigation and real-time inventory tools. However, it omits key quantitative and programmatic details from the ground truth: specifically, the 2024 statistic that approximately 50% of U.S. online orders were fulfilled through stores, and the explicit linkage of lockers to fulfillment programs like BOSS, BOPIS, BODFS, and BORIS. While the LLM mentions 'curb-side pickup,' the original answer emphasizes the broader role of stores as 'pickup, return, and delivery fulfillment locations,' which the LLM does not fully convey. There are no numerical inaccuracies (hence a perfect quantitative score), but the qualitative accuracy is reduced due to incomplete synthesis of the multi-hop elements—particularly the evolution from a convenience feature in 2023 to a core fulfillment component in 2024 supported by specific data and program names. The answer remains contextually relevant and semantically aligned in direction, but lacks full completeness on the strategic depth and evidence presented in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 384,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\nThe 2023 filing (page 46) only brief‑ly noted that retained‑risk insurance liabilities “are not discounted and are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions,” without elaborating on the drivers of those assumptions or the potential impact of external factors. In contrast, the 2024 filing (page 31) expands the description: it explicitly states that the estimates rely on historical claims data, demographic and severity factors, and other actuarial inputs, and it highlights that claim costs can fluctuate due to inflation, regulatory or legal changes, and unforeseen developments, while also noting that historical adjustments have been immaterial. This added detail provides a clearer, more specific picture of how Costco develops its insurance/self‑insurance liability estimates.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy that undermines its overall correctness. (1) The 2023 filing is incorrectly described as including the specific factors used in estimating liabilities—namely, 'historical claims experience, demographic factors, severity factors, and other actuarial assumptions.' However, according to the ground truth, the 2023 disclosure did *not* specify these factors; it only provided a general description of self-insurance practices, including the use of a captive insurance subsidiary and reinsurance program, without detailing the estimation methodology. This is a critical error because the core of the question is about the *evolution* in specificity, and the LLM falsely attributes 2024-level detail to the 2023 filing. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not heavily applicable—minor credit given for correct reference to page numbers (31 and 46), though these were not in the ground truth and cannot be verified. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies an increase in detail in 2024, including the mention of external factors like inflation and legal changes, and notes the immateriality of historical adjustments, which aligns with increased transparency. However, because it misrepresents the 2023 disclosure as already containing detailed actuarial factors, the comparison is flawed, and the evolution is misrepresented. (4) Contextual relevance is high—the answer addresses the question directly and discusses the right topic with appropriate financial terminology. Due to the major factual error in attributing 2024-level detail to 2023, the correctness and qualitative accuracy scores are reduced to 6, reflecting partial correctness with significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 507,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\nThe inventory‑related cost impact of the Aldevron acquisition fell to $0 in 2022—after the one‑time $59 million fair‑value inventory uplift that was recorded in 2021—so there was no recurring charge that year. In 2023 the company reversed course and booked an $87 million write‑down of excess inventory in the Biotechnology segment, creating a new, larger inventory‑related cost headwind compared with the prior year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the $59 million fair value adjustment occurred in 2021 and that there was no charge in 2022. The ground truth confirms the $59 million increase in cost of sales due to Aldevron's inventory fair value adjustment occurred in 2022, not 2021. Additionally, the LLM claims the impact was $0 in 2022, which directly contradicts the original answer. The $87 million charge in 2023 is correctly identified in amount and timing, though the LLM mischaracterizes it as a reversal of course rather than a separate operational issue. (2) Quantitative accuracy is low: the $59 million figure is misplaced by a year, and the absence of the charge in 2022 is factually wrong. The $87 million figure is accurate. (3) Multi-hop reasoning is partially sound—the model recognizes a shift in inventory-related costs between years and attempts to contrast acquisition-related charges with later operational write-downs—but the incorrect timeline undermines the logic. The synthesis fails because it misattributes the year of the Aldevron-related cost. (4) Contextual relevance is high as the answer addresses inventory-related costs, the Aldevron acquisition, and year-over-year evolution. However, due to the critical error in timing and misrepresentation of the 2022 cost impact, the overall correctness score is low despite relevant structure and partial factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 400,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\nBoth the 2023 filing (page 47) and the 2024 filing (page 48) state that Costco records shop‑card revenue only when the card is redeemed and that the unredeemed balance is carried as a “shop‑card liability,” net of an estimated breakage amount that is based on historical redemption data. The 2024 text adds a clearer description of the breakage estimation and notes that the liability is presented in “other current liabilities,” but the underlying accounting treatment is unchanged. This consistent policy shows Costco’s conservative approach to unclaimed balances—recognizing revenue only upon use and reserving for the portion that is expected to remain unredeemed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costco recognizes shop card revenue upon redemption, carries unredeemed balances as a liability net of estimated breakage based on historical redemption data, and this treatment is consistent between 2023 and 2024. The LLM correctly notes that the 2024 filing provides a clearer description of breakage estimation and specifies that the liability is included in 'other current liabilities'—a detail not emphasized in 2023, which matches the ground truth's claim of increased emphasis and refinement. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not compromised; all references to page numbers (47 in 2023, 48 in 2024) are consistent with source documents. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies consistency in accounting policy, and infers a more refined approach in 2024 based on enhanced disclosure. (4) The LLM slightly underemphasizes the implication that this evolution reflects an improvement in estimation techniques over time, instead framing it as a 'consistent policy' which, while true, downplays the progression toward a more formalized method noted in the ground truth. However, the conclusion about Costco’s conservative approach is valid and contextually appropriate. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 417,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 Intel moved the IDM 2.0 foundry concept into a commercial reality: it announced the ARM‑ and Synopsys‑based design‑win framework in 2022 and, by 2023, the IFS Accelerator ecosystem had doubled to > 40 partners, secured multiple design wins on the advanced 18A node, and signed a commercial foundry agreement with Tower for capacity in New Mexico (plus expanded RAMP‑C ties with Nvidia, IBM, Microsoft, Boeing, Northrop Grumman). These partnerships and the resulting design‑win momentum drove a $483 million rise in foundry‑related revenue and positioned Intel’s advanced packaging and AI‑PC capabilities as the primary customer‑engagement differentiators.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies the evolution of Intel's Foundry Services from strategic intent to customer engagement, several key facts are inaccurate or unsupported by the ground truth. The claim of a $483 million rise in foundry-related revenue is not mentioned in the original answer and cannot be verified from the provided data, making this a significant factual error. The announcement of an agreement with Tower Semiconductor for capacity in New Mexico is also not present in the ground truth and appears to be fabricated or misattributed. Similarly, the mention of expanded RAMP-C ties with Nvidia, IBM, Microsoft, Boeing, and Northrop Grumman is not supported by the original answer. (2) Quantitatively, the $483 million revenue increase is entirely unsupported. The original answer mentions four design wins on Intel 18A and five in advanced packaging, which the LLM partially captures by referencing 'multiple design wins,' but does not specify the correct numbers. The IFS Accelerator Ecosystem reaching over 40 partners is correctly noted (phrased as '> 40 partners'). However, the claim that it 'doubled' lacks support, as no 2022 baseline is given in the ground truth. (3) The multi-hop reasoning is partially sound—Intel did move from strategy in 2022 to execution in 2023—but the LLM introduces entities (Tower, RAMP-C, multiple tech firms) and financial impacts not present in the source, indicating flawed synthesis. The correct identification of ARM and Synopsys multigenerational agreements is accurate and aligns with the original answer. (4) The contextual relevance is high because the response addresses the evolution of partnerships and customer engagement. However, due to significant factual inaccuracies—especially the unverified revenue figure and fabricated partnerships—the correctness score is limited to 5. The qualitative accuracy is moderate due to correct framing but flawed details, and quantitative accuracy is low due to the unsupported $483M figure and missing specific design win counts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 566,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\nDuring 2022‑2023 Danaher recorded no new goodwill from Aldevron – the roughly $6.1 billion of goodwill recognized at the 2021 acquisition remained unchanged – and it did not make any additional cash payments beyond the original $9.6 billion cash purchase price (net of non‑cash consideration of about $9.5 billion) that was funded in 2021.  Only minor measurement‑period adjustments were made, which did not materially affect the goodwill balance or require further cash outflows.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims that the $6.1 billion goodwill was recognized in 2021 and remained unchanged through 2022–2023, but the ground truth states that DHR *preliminarily recorded* $6.1 billion of goodwill related to Aldevron in 2022 — a critical discrepancy in timing and context. Additionally, the LLM asserts that the net cash consideration was $9.6 billion funded in 2021, while the original answer states that net cash consideration *increased to $9.561 billion in 2023*, implying a later or updated payment or adjustment. The LLM incorrectly frames the entire acquisition as completed in 2021, which contradicts the evolution described between 2022 and 2023. (2) The numbers cited ($6.1B goodwill, ~$9.6B cash) are close in magnitude but misattributed to the wrong years and contexts; no mention is made of the 2023 increase to $9.561B as a development from 2022. (3) Qualitatively, the reasoning fails the multi-hop requirement: the question asks how the financial impact *evolved* between 2022 and 2023, but the LLM denies any change occurred, claiming all amounts were settled in 2021. This misses the core point of the question — the evolution and increased financial commitment. (4) Contextual relevance is low because the answer discusses a 2021 acquisition closure that isn't in the ground truth and ignores the 2022–2023 developments entirely. The mention of 'minor measurement-period adjustments' is speculative and unsupported by the provided truth. Overall, the answer contradicts the ground truth on timing, magnitude, and direction of financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 453,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\nThe 1.800 % Global Notes are listed as maturing on **September 14, 2039** in both the 2022 and the 2024 Form 10‑K filings, so the maturity date has not changed between the two filings. This continuity indicates that AT&T is keeping a long‑dated, low‑coupon debt tranche on its balance sheet and has not needed to refinance or extend this portion of its obligations, reflecting a stable, long‑term debt structure with limited near‑term refinancing pressure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) According to the ground truth, the maturity date of the AT&T 1.800% Global Notes changed from September 5, 2026 (2022 filing) to September 14, 2039 (2024 filing), but the LLM claims the maturity date was September 14, 2039 in both filings—this is false. (2) The quantitative error is severe: the LLM misstates a key date in both years, failing to detect a 13-year extension. This undermines all subsequent analysis. (3) The reasoning is flawed because it assumes no change and concludes stability, when the actual data shows a major refinancing or extension event, indicating a strategic shift in debt management. The multi-hop synthesis failed—comparing the same instrument across two filings is the core task, and the model did not perform it correctly. (4) Contextual relevance is low but not zero because the answer discusses debt structure implications, which is relevant, but the incorrect premise invalidates the conclusion. Minor formatting of percentages (1.800%) is acceptable, but incorrect dates are critical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 304,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\nTarget continued to satisfy its debt‑leverage covenant in both fiscal years, with the leverage metric actually improving modestly from 2023 to 2024 even though total long‑term debt rose slightly (from $13.467 billion to $14.151 billion, page 50).  The company’s credit‑facility overhaul—terminating the prior $1 billion 364‑day revolving line and replacing it with a new $1 billion 364‑day facility and a $3 billion, five‑year revolving facility that now runs to October 2028 ( page 35 – financing discussion) —provided a larger, longer‑term liquidity backstop and eliminated near‑term maturities, giving Target greater flexibility to meet the covenant while maintaining strong cash positions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly states that Target remained compliant with its debt leverage covenant in both 2023 and 2024, it introduces specific financial figures not present in the ground truth—namely, long-term debt increasing from $13.467 billion to $14.151 billion—and claims the leverage metric improved. These numbers and the assertion of improvement are not supported by the original answer and cannot be verified from the provided ground truth, making them potentially hallucinated. (2) The credit facility structure is partially correct: the LLM correctly identifies the $1 billion 364-day facility and the $3 billion five-year facility extending to October 2028. However, it inaccurately describes the 2024 change as a 'credit-facility overhaul' involving termination and replacement, whereas the ground truth states the 364-day facility was simply renewed with an extension from October 2024 to October 2025—no termination or structural overhaul occurred. The original five-year facility was unchanged. (3) The multi-hop reasoning is sound in linking facility renewal to covenant compliance and liquidity flexibility, and the synthesis between covenant compliance and credit structure is logically coherent. The conclusion that renewal supports compliance aligns with the original answer. (4) Despite incorrect numbers and some mischaracterization of the facility renewal as a structural overhaul, the core qualitative point—continued compliance supported by renewed credit facilities—is correct. The answer is contextually relevant and well-structured, but the inclusion of unsupported quantitative data significantly undermines factual accuracy, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 488,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\nFrom 2022 to 2023 Intel shifted from launching the Alliance for Global Inclusion and developing its Inclusion Index (2022) to actively participating in the third‑annual global inclusion‑index survey, earning a spot on the index and using the RISE framework to broaden external partnerships that accelerate digital‑readiness initiatives for millions of people.  The company deepened collaboration by reporting progress in its Corporate‑Responsibility Report, linking diversity‑and‑inclusion metrics to executive compensation, and scaling joint programs with other technology firms to expand inclusive, technology‑driven access worldwide.  (Pages 15 (2022) & 18 (2023)).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's digital readiness efforts from 2022 to 2023 in relation to its RISE strategy and external collaborations. It accurately notes the launch of the Alliance for Global Inclusion and development of the Inclusion Index in 2022, and the participation in the third-annual survey in 2023. The recognition of Intel as one of the 18 organizations scoring 50% or higher is implied by 'earning a spot on the index,' though the specific benchmark (50%) and respondent count (27) are omitted. (2) Quantitatively, no incorrect numbers are stated; the LLM avoids making false claims about percentages, counts, or financials. The absence of the 50% threshold and the exact number of respondents (18 out of 27) is a minor omission but does not introduce inaccuracy. (3) The multi-hop reasoning is sound: the answer connects Intel’s RISE strategy with external collaboration via the Alliance, tracks progress across years, and links inclusion metrics to broader digital readiness goals. It also adds contextual detail not in the original—such as linking D&I metrics to executive compensation and reporting in the Corporate Responsibility Report—which is plausible and consistent with Intel’s practices but not explicitly confirmed in the ground truth. (4) The answer is contextually excellent, directly addressing the question’s focus on evolution, strategy, and collaboration. The slight deduction in correctness and qualitative accuracy is due to incomplete benchmarking details, but overall, the response is factually aligned, well-reasoned, and semantically equivalent in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 451,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\nBetween early 2023 and mid‑2023 Emerson (AspenTech) moved from actively pursuing the purchase of Micromine—using foreign‑currency forwards to hedge the deal—to terminating that agreement on August 1 2023 after the Russian‑regulatory approval proved uncertain. The termination ended any planned acquisition, eliminated the associated integration‑related expenses, and resulted in a modest $24 million mark‑to‑market gain on the unwound derivatives that was recorded in 2023; thereafter no further Micromine‑related financial activity or costs appeared in the 2024 results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential facts from the ground truth. (1) All key information is correct: Emerson (via AspenTech) pursued the Micromine acquisition in 2023, terminated it on August 1, 2023 due to Russian regulatory uncertainty, recognized a $24 million mark-to-market gain from unwinding foreign currency forward contracts in 2023, and had no further financial activity related to Micromine in 2024. (2) Quantitative accuracy is excellent: the $24 million gain is correctly stated (matches ground truth), and the August 1, 2023 termination date aligns with known facts. The AU$900 million / ~$623 million purchase price is omitted but not required for answering the specific question about the evolution and financial implications of the relationship. (3) Multi-hop reasoning is sound—correctly linking AspenTech (Emerson) to the deal initiation, termination cause, derivative gain, and absence of 2024 exposure. (4) The answer is contextually complete and relevant, focusing on the shift in relationship and associated financial effects. The only minor omission is the explicit mention of the full termination of the foreign currency contracts in 2024, though the absence of further financial activity implies this. Wording differences (e.g., 'modest gain' vs 'mark-to-market gain') do not affect factual accuracy. Overall, the answer matches the ground truth in substance and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 392,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\nThe U.S. ESPP had roughly 17 million shares available at the start of fiscal 2022, but only about 15 million shares were available at the start of fiscal 2023.  At the same time, the average price paid for shares under the plan fell from approximately $305 per share in fiscal 2022 to about $277 per share in fiscal 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the number of shares available decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price dropped from $305.14 to $277.19. The LLM correctly rounds these to $305 and $277, which is acceptable under semantic equivalence. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers match the original data within acceptable rounding. (3) The reasoning is sound: the model correctly identifies the trend of decreasing share availability and lower average price, synthesizing data across the two fiscal years. However, the LLM omits the detail that approximately one million shares were purchased in each year, which is part of the original answer and relevant to understanding the context of the average price. While not the focus of the question, this omission slightly weakens completeness. (4) The response is fully relevant, directly addressing how both share availability and average purchase price changed from 2022 to 2023. The minor omission prevents a perfect 10, but the core facts and trends are accurately communicated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 336,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\nIn 2022 DHR recorded **no impairment charges** for intangible assets, but in 2023 it identified impairment triggers in the second quarter (Biotechnology) and fourth quarter (Biotechnology and Diagnostics), resulting in **$77 million of impairment charges** (up from $10 million in 2021 and none in 2022). This shift shows that the company is increasingly exposing its acquired technology and customer‑related intangibles—particularly in the high‑growth, volatile biotech and diagnostics segments—to potential write‑downs, signaling heightened risk and possible overvaluation in its intangible‑asset portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $77 million impairment charge in 2023 and references the $10 million charge in 2021, which aligns with the ground truth. It accurately notes impairment triggers in the Biotechnology segment in Q2 2023 and in both Biotechnology and Diagnostics in Q4 2023. However, it incorrectly states that DHR recorded 'no impairment charges' in 2022, which contradicts the ground truth: the 2022 filing did report a $10 million charge related to the Diagnostics segment in Q1 2021 (disclosed in the 2022 filing for that year). The LLM misattributes the absence of 2022 charges when the issue is the timing of reporting versus occurrence. (2) Quantitative accuracy is partially compromised: while $77 million (2023) and $10 million (2021) are correct, the claim of 'none in 2022' is factually wrong because the 2022 filing did include an impairment charge (from 2021). The comparison 'up from $10 million in 2021 and none in 2022' introduces a false baseline. (3) The multi-hop reasoning is mostly sound—LLM synthesizes segment-level triggers across years and infers increasing risk in intangible assets, especially in Biotechnology, which is consistent with the ground truth. It correctly identifies the expansion of impairment activity beyond Diagnostics. However, it omits the nuance that the 2021 Diagnostics charge was carried forward in the 2023 filing for comparability, which weakens completeness. (4) Contextual relevance is strong: the answer directly addresses the evolution of impairment triggers and interprets the implications for intangible asset risk. Despite the factual error on 2022 charges, the overall trend interpretation is reasonable. Correctness score is 7 due to accurate core numbers and trend analysis but penalized for a significant factual error in the 2022 charge status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 499,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\nThe company’s outstanding letters of credit that are tied to trade contracts grew from **$362 million at the end of fiscal 2022** to **$598 million at the end of fiscal 2023**—an increase of about **$236 million (≈ 65 %)**.  \nThis jump shows that the firm’s commitments related to trade‑contract transactions expanded markedly, indicating a larger role for the company in business dealings that require such credit guarantees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $362 million in 2022 and $598 million in 2023 are accurately reported. The increase of $236 million is correct (598 - 362 = 236), and the calculated percentage increase of approximately 65% is accurate (236 / 362 ≈ 0.6519, or 65.19%). Minor formatting such as using '≈ 65%' is acceptable and does not affect correctness. (2) The answer addresses both parts of the question: the change in value between 2022 and 2023, and the implication regarding the company's involvement in trade-related transactions. (3) Entities are correct—'letters of credit related to trade contracts' is the precise metric, and the fiscal years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the increase in letters of credit is correctly interpreted as indicating expanded business commitments and a growing role in trade-contract transactions, which aligns with the inference in the original answer. The LLM provides additional clarity by quantifying the percentage increase, enhancing the response without introducing error. Overall, the answer demonstrates accurate multi-hop synthesis of financial data across years and correct qualitative interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 353,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\nIn the 2023 filing the 0.300 % Notes due 2028 were only referenced generically in the “Exhibits defining the rights of holders” table, without a separate line in the securities‑registration table. By the 2024 filing the same notes appear as a distinct registered security (listed as IBM28B with its ticker and exchange) in the “Securities registered pursuant to Section 12(b)” table. This evolution shows that IBM now provides explicit, stand‑alone disclosure of the 0.300 % Notes due 2028 in its periodic reports, enhancing the transparency of its financial‑instrument disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.300% Notes due 2028 were referenced in the 2023 filing under exhibit disclosures (specifically Exhibit 4.1, though not explicitly named in the LLM answer, the reference to 'Exhibits defining the rights of holders' is accurate), and in the 2024 filing they appear as a registered security with ticker IBM28B on the NYSE. The LLM correctly identifies the shift in disclosure practice. (2) Quantitative elements—interest rate (0.300%), maturity year (2028), ticker (IBM28B)—are all accurate. No calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings and infers an improvement in disclosure transparency. The only minor omission is that the original answer notes the exhibit was filed on February 10, 2020—a detail absent in the LLM response—but this is not central to the evolution described. (4) The conclusion about increased transparency and explicit disclosure is semantically equivalent to the ground truth's interpretation of increased market engagement or liquidity, though the LLM emphasizes transparency over market activity. This is a valid interpretation, but slightly less comprehensive in financial implication, justifying a 9 instead of 10 on qualitative accuracy. Overall, the response is factually correct, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 397,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\nBetween 2023 and 2024 IBM moved from merely referencing the 1.750 % Notes due 2031 in the “Instruments defining the rights” paragraph of a 2019 Form 8‑K (as seen in the 2023 filing) to giving the securities an explicit entry in the 2024 Form 10‑K registration table. In the 2024 filing the notes are listed with the ticker **IBM31** and confirmed as registered on the New York Stock Exchange, showing a clear, standalone disclosure of their registration and exchange listing that was absent in the prior year’s filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: the 1.750% Notes due 2031 were referenced in 2023 via incorporation by reference (from the 2019 Form 8-K, filed Jan 30, 2019), and in 2024 they were explicitly registered with ticker IBM31 on the NYSE. The percentages, years, and ticker symbol are all accurate. (2) Quantitative elements—interest rate (1.750%), maturity year (2031), and ticker (IBM31)—are correctly reported. The date of the original exhibit (January 30, 2019) is not mentioned in the LLM answer, which is a minor omission but does not affect the core correctness. (3) The multi-hop reasoning is sound: the model correctly infers an evolution from passive disclosure (via incorporation) in 2023 to active, standalone registration and listing in 2024. The shift in disclosure treatment is logically and accurately portrayed. (4) The answer is contextually fully relevant, directly addressing the evolution in disclosure and exchange registration. The only reason for not scoring a 10 is the omission of the specific 2019 Form 8-K filing date, which was included in the ground truth and adds minor contextual precision. However, this does not detract from the overall correctness of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 355,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\nBetween 2023 and 2024 Eli Lilly essentially exited the traditional product‑sale model for Zyprexa.  In 2023 the company sold the worldwide rights to the olanzapine portfolio (which includes Zyprexa) and recorded a one‑time net gain of $1.45 billion on that transaction (page 75), recognizing revenue from the upfront sale and from the $579 million gain on the Baqsimi rights sale (page 75).  Thereafter, any remaining Zyprexa‑related cash flows are generated only through a supply agreement in which Lilly manufactures the product for the new owner and recognizes revenue over time as the product is produced, rather than through direct product sales or upfront licensing fees (pages 47 and 75).  This shift reflects a move from recognizing Zyprexa as a conventional product revenue stream to a collaboration/licensing model with deferred, performance‑based revenue recognition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core shift in Eli Lilly's financial relationship with Zyprexa—from direct product sales to a post-sale collaboration model. It accurately notes the $1.45 billion gain from the sale of the olanzapine portfolio rights in 2023, which aligns with the ground truth. However, it incorrectly frames this as a 'net gain' and conflates it with the $579 million gain from the Baqsimi rights sale, implying both are part of Zyprexa-related revenue, which is not supported by the original answer. The ground truth does not mention Baqsimi in connection with Zyprexa, nor does it describe the $1.45 billion as a 'net gain'—it is presented as revenue from the sale of rights. (2) The $1.45 billion figure is correct and matches the ground truth, but the inclusion of the $579 million Baqsimi gain introduces a factual inaccuracy, reducing quantitative accuracy. The LLM also correctly identifies the shift to a supply agreement for revenue recognition in 2024, which is consistent with the collaboration/licensing model described in the ground truth. (3) The multi-hop reasoning is largely sound: the model connects the 2023 sale to a change in 2024 revenue recognition, inferring a strategic shift in business model. However, it overreaches by combining unrelated financial events (Baqsimi sale), weakening the logical synthesis. (4) The contextual relevance is high—the answer directly addresses the evolution of the financial relationship, revenue recognition, and business model. The qualitative reasoning is strong despite the quantitative error. Correctness score is 7 because the core transformation is accurately captured, but the inclusion of extraneous and misleading financial data reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 476,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\nBy the end of 2023 AT&T had repurchased all of its Mobility Preferred Interests, eliminating any remaining redemption obligations; therefore, from 2024 onward these interests no longer appear as dilutive securities and have no effect on diluted earnings‑per‑share calculations. Before the repurchase, the interests were redeemable at the holder’s option at a price based on market value plus accrued distributions (payable in cash, AT&T stock, or a mix), and their potential settlement in stock was reflected in diluted EPS for 2023 but not for 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timing and financial treatment of the Mobility Preferred Interests. While it correctly states that AT&T repurchased the interests and eliminated redemption obligations, it fails to mention the key 2023 reclassification from equity to liability — a central part of the financial impact — and omits the specific liability split ($2,670 million current and $2,670 million noncurrent). The repurchase amount of $5,414 million (including accrued distributions) is entirely missing, which is a major quantitative omission. (2) The date of repurchase is partially correct — April 2023 is accurate — but the LLM implies the repurchase occurred by 'the end of 2023' without specifying April, which is less precise. More critically, the LLM incorrectly claims that the interests have 'no effect on diluted EPS calculations' in 2024. According to the ground truth, the impact in 2024 is retrospective: under ASU 2020-06, the ability to settle in stock was reflected in diluted EPS for periods *prior* to repurchase, meaning there is still an accounting effect in 2024 when reporting comparative prior-period EPS. The LLM incorrectly frames this as a complete removal of EPS impact, which misrepresents the ongoing accounting treatment. (3) The reasoning is partially sound in connecting redemption obligations to EPS treatment and recognizing the shift post-repurchase, but it fails the multi-hop synthesis by not linking the 2023 reclassification (equity to liability) to the change in EPS methodology and the retrospective application in 2024. The model treats the issue as a simple removal of dilution, missing the nuanced accounting standard (ASU 2020-06) and its implications. (4) The contextual relevance is high because the answer addresses both redemption obligations and EPS impact across 2023–2024. However, due to missing key financial figures, incorrect EPS interpretation, and omission of the reclassification event, the correctness score is reduced to 6. Quantitative accuracy is low (4) due to missing dollar amounts and lack of verification of the $5,414 repurchase cost and $2,670 liability splits. Qualitative accuracy is moderate (7) as the logic is coherent but misses critical accounting nuances. Contextual relevance is strong (9) as the structure and focus align well with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 634,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\nBetween 2023 and 2024 IBM moved from merely referencing the 0.875 % Notes due 2030 in the 2023 filing (where they were only incorporated by reference to a 2022 Form 8‑K describing the indenture) to explicitly listing and registering them in the 2024 Form 10‑K.  The 2024 cover page now shows the notes as “0.875 % Notes due 2030 – IBM30A – New York Stock Exchange,” and they appear in the “Securities registered pursuant to Section 12(b)” table, confirming that the issue is formally listed on the NYSE and registered for public trading.  This represents a shift from a passive disclosure to a full, listed‑security disclosure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: in 2023, the 0.875% Notes due 2030 were incorporated by reference to the February 8, 2022 Form 8-K (Exhibit 4.1), not explicitly listed; by 2024, they were formally registered and listed on the NYSE with the trading symbol IBM30A. (2) Quantitative elements—interest rate (0.875%), maturity year (2030), exchange (New York Stock Exchange), and ticker (IBM30A)—are all correct. No calculations are required, but the temporal comparison across 2023 and 2024 is accurately framed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two annual filings (2023 and 2024 Form 10-Ks) and references prior disclosure mechanisms (Form 8-K) to infer an evolution in disclosure status. (4) The answer captures the shift from passive incorporation by reference to active registration and listing, which is the core of the question. Wording differs slightly but meaning is preserved and complete. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 313,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T kept the same basic structure for its Telco LLC preferred interests—cumulative, non‑convertible units with a 4.25 % annual distribution for Class A‑1 and a 6.85 % distribution for Classes A‑2/A‑3, each reset on a seven‑year schedule and callable after seven years.  The 2024 filing (pages 85 & 91) merely added clearer language about redemption‑upon‑default and call rights, but did not change the underlying distribution terms.  This demonstrates that AT&T is relying on preferred equity as a flexible, low‑leverage financing tool that can be retired on demand while preserving cash for other strategic uses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the distribution terms (4.25% for Class A-1 and 6.85% for Classes A-2/A-3) and the seven-year reset/call schedule, which aligns with the ground truth. However, it omits key quantitative details: the $2,000 and $5,250 issuance amounts in 2023 and the total growth to $7,250 in 2024. These dollar amounts are critical to assessing the evolution of the structure and are missing entirely, representing a significant omission. (2) While percentages and structural features are accurate, the absence of dollar figures undermines quantitative accuracy. The claim that the 2024 filing 'added clearer language about redemption-upon-default and call rights' is not fully supported by the ground truth, which emphasizes instead the clarification that failure to pay distributions does not restrict dividends or share repurchases—a key point about financial flexibility that the LLM mischaracterizes. (3) The reasoning is generally sound: the model correctly infers that AT&T is using preferred equity as a flexible financing tool. However, it fails to explicitly connect the expansion in total value ($7,250M) to continued reliance on preferred equity, which is a central conclusion in the original answer. The multi-hop synthesis is partial—correct in logic but incomplete in data support. (4) Despite missing key numbers, the answer remains contextually relevant and captures the strategic implication about financing. Wording differences are acceptable, but missing core financial figures reduces correctness. Quantitative accuracy is penalized due to omitted dollar amounts; qualitative and contextual scores remain higher due to correct interpretation of terms and strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 470,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\nCapital One continued to originate multifamily commercial‑real‑estate loans that it sells to government‑sponsored enterprises and to enter into loss‑sharing agreements with those GSEs.  The 2023 10‑K (Note 18) shows the liability recorded for those loss‑sharing arrangements rising from **$82 million at the end of 2022 to $137 million at the end of 2023**, a result of both a larger volume of originations and the firm’s election to record new agreements at fair value, which now pushes unrealized gains and losses into earnings.  Consequently, while the credit risk is still mitigated by the GSEs, the firm’s exposure to potential losses under the loss‑sharing arrangements has increased materially between 2022 and 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($82 million in 2022 and $137 million in 2023) are accurately reported, with proper context on the increase in liability. The figures match the original answer exactly, and the format variation (using 'million' vs numerical representation) is acceptable. (2) The answer is complete, addressing both years, the nature of the loss sharing agreements with GSEs, the increase in liability, and the underlying reasons—specifically citing higher origination volume and the change in accounting treatment (fair value election impacting earnings). (3) Entity accuracy is correct: Capital One, multifamily commercial real estate loans, government-sponsored enterprises (GSEs), and reference to Note 18 of the 2023 10-K are all accurate and contextually appropriate. (4) The reasoning is sound and reflects multi-hop synthesis: it connects loan origination practices, sale to GSEs, loss sharing agreements, liability recognition, and accounting policy impact on financial statements. The conclusion that risk exposure has increased materially aligns with the ground truth’s interpretation of growing involvement and rising obligations. The LLM adds valuable context (fair value accounting impact) not in the original but consistent with plausible 10-K disclosures, enhancing rather than distorting accuracy. Overall, the answer is factually precise, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 416,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\nIn 2022 Amazon treated its co‑branded credit‑card programs as a modest ancillary revenue source, warning only that renewal on less‑favorable terms or termination could adversely affect operating results and that the main compliance concerns were standard payment‑card rules, interchange fees and reliance on third‑party processors. By 2023 the disclosures emphasized that the programs now sit under heightened regulatory scrutiny—new authentication and data‑security mandates, expanded consumer‑protection and antitrust investigations, and broader “gatekeeper” obligations—creating additional compliance costs and the risk of curtailed or renegotiated agreements that could materially dent operating results.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall assessment of increased regulatory scrutiny and potential impact on operating results from Amazon's co-branded credit card programs between 2022 and 2023. It correctly identifies that in 2022, the primary risks were related to renewal/termination and standard payment card compliance (e.g., interchange fees, third-party processors), which aligns with the ground truth. The 2023 shift toward heightened regulatory scrutiny is also accurately portrayed, including new compliance demands and risks to operating results.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so no discrepancies exist—this earns a perfect score.\n\nHowever, the qualitative accuracy is slightly lower because the LLM introduces concepts not present in the ground truth, such as 'antitrust investigations,' 'gatekeeper obligations,' and 'authentication mandates,' while omitting the specific new compliance obligation highlighted in the original answer: data localization rules, particularly in international jurisdictions and their impact on cross-border data transfers. These are key differentiators in the actual shift in regulatory risk. While 'heightened scrutiny' and 'expanded consumer-protection' are plausible interpretations, they are not the specific risks documented in the knowledge graph.\n\nThe reasoning is sound in structure—comparing 2022 to 2023 and assessing evolving risk—but the synthesis does not accurately reflect the precise nature of the new regulatory obligations (data localization) that marked the strategic shift. Instead, it generalizes into broader regulatory themes that may not be directly supported by the source data.\n\nContextual relevance is high, as the answer directly addresses the question’s focus on strategic significance and regulatory risks over time, and correctly infers increasing compliance costs and operational impact. However, the substitution of actual new obligations (data localization) with speculative ones (antitrust, gatekeeper rules) reduces factual precision.\n\nIn summary: core facts about increased regulatory burden and impact on operations are correct, but the specific nature of the new compliance obligations is misrepresented, leading to a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 621,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\nBetween 2022 and 2024 PMI continues to treat RBH as an **equity‑method investment** rather than a consolidated subsidiary – RBH was de‑consolidated from PMI’s financial statements in March 2019 (and remains excluded in the 2024 balance sheet).  The only financial link is the 23 % equity stake and the related foreign‑currency translation adjustments (≈ $1.6 bn of cumulative translation losses recorded in OCI as of 2024), which are reflected in PMI’s accumulated other‑comprehensive‑losses.  Because the investment is not consolidated, PMI must test it for impairment using significant judgments—discount rates, projected sales volumes and operating margins for RBH’s combustible‑tobacco business, and the deductibility of settlement payments—procedures that auditors highlighted as a critical audit matter in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in PM's financial relationship with RBH between 2022 and 2024, particularly the shift from deconsolidation to equity-method accounting and the need for impairment testing. However, there are minor quantitative and entity-related inaccuracies. First, the LLM refers to 'PMI' (Philip Morris International), but the correct entity is 'PM' (Philip Morris Inc., a subsidiary of Altria), which is a critical distinction in the context of RBH and U.S. financial reporting. Second, the $1.6 billion cumulative translation loss is not present in the ground truth and appears to be fabricated or misattributed; the original answer does not mention any specific OCI amounts. The deconsolidation date is correctly tied to 2019 (CCAA proceedings), though the LLM cites March 2019 without confirmation from the ground truth. The qualitative reasoning is strong: it correctly identifies the equity-method treatment, the exclusion from consolidation, the use of significant judgment in impairment analysis, and auditor focus in 2024. It also accurately reflects the key assumptions (discount rates, sales volumes, operating margins, tax treatment of settlements). While the core financial evolution is correctly synthesized, the incorrect entity (PMI vs PM) and unsupported $1.6B figure reduce quantitative and overall correctness. Semantic equivalence is mostly maintained, and the answer is highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 405,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\nBetween 2023 and 2024 Baqsimi’s direct product sales collapsed – the company recorded $677.6 million of total Baqsimi revenue in 2023 (up from $139.3 million in 2022) but, after selling the rights to Amphastar in June 2023, essentially no product‑sale revenue appears in 2024.  Instead, LLY now earns only royalty and contingent milestone payments (up to $450 million) and recognizes a small, over‑time net‑product revenue stream from the supply agreement under which it manufactures the drug for Amphastar.  This shift re‑positions Baqsimi from a core revenue‑generating product to a licensing asset that contributes only modest, future‑oriented income to LLY’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $677.6 million in total Baqsimi revenue in 2023 matches the original answer ($645.7M U.S. + $31.9M ex-U.S. = $677.6M total). The mention of $139.3M in 2022, while not in the original answer, is factually accurate and adds context without contradicting the ground truth. The $450 million milestone cap is correctly stated. (2) The June 2023 sale date is consistent with the 2023 divestiture referenced in the original. (3) The qualitative reasoning is sound: the shift from direct product sales to a licensing/supply arrangement is correctly interpreted, and the strategic repositioning of Baqsimi as a non-core, future-income asset is logically derived. (4) The only minor gap is that the LLM does not explicitly state that Baqsimi was 'no longer reported as a direct revenue contributor' in 2024 filings—instead, it infers this from the absence of sales and presence of supply/royalty income. However, this inference is valid and consistent with the knowledge graph. The addition of Amphastar as the buyer (not in original) is accurate and enhances clarity. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth with excellent multi-hop synthesis between financial performance and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 382,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\nFrom 2022 (which is reflected in the 2021 baseline figures) through 2024, Union Pacific moved sharply toward greater ownership of its highway‑revenue equipment.  Owned containers rose from roughly 96 % of the fleet in 2021 to about 99 % in 2024 (leased containers fell from 1,856 to 288), and owned chassis increased from roughly 68 % to 78 % of the chassis fleet (leased chassis dropped from 14,148 to 1,197).  Consequently, the proportion of equipment that is owned has expanded markedly, while the leased share has contracted over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the trend in Union Pacific's Total Highway Revenue Equipment from 2022 to 2024. (1) Quantitative inaccuracies: The LLM claims that 'owned containers rose from roughly 96% of the fleet in 2021 to about 99% in 2024' and references a 2021 baseline, but the question asks about 2022–2024, and the ground truth does not provide percentage breakdowns by ownership share of the total fleet in those terms. More critically, the LLM states that 'owned chassis increased from roughly 68% to 78%' and that 'leased chassis dropped from 14,148 to 1,197'. However, the ground truth does not mention leased chassis numbers directly, but does state that total leased units dropped from 16,004 in 2022 to 1,485 in 2024, and that owned chassis decreased from 29,875 to 4,356—directly contradicting the LLM's claim of an increase in owned chassis. (2) The LLM incorrectly asserts that Union Pacific moved toward 'greater ownership' and that owned chassis increased, when in fact both owned and leased equipment were drastically reduced, especially owned chassis (down from 29,875 to 4,356). This misrepresents the strategic shift: the company reduced both ownership and leasing, not increased ownership. (3) The only correct data point is the drop in leased containers from 1,856 to 288, which matches the ground truth. However, the LLM fails to mention the overall reduction in owned units from 78,837 to 50,731 and leased units from 16,004 to 1,485, omitting key context. (4) The reasoning is flawed: the LLM infers increasing ownership based on rising ownership percentages, but this is not supported by the absolute numbers, which show large reductions in owned assets. The synthesis across years and equipment types is incorrect, and the conclusion contradicts the ground truth. While the answer addresses the topic and attempts multi-hop reasoning, the factual and directional errors severely undermine accuracy. Contextual relevance is moderate as it discusses the right company and equipment types, but with incorrect trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 556,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\nBetween the end of 2021 and the end of 2023 Capital One’s outstanding securitized‑debt balance grew from about **$15 billion** (Table 6, 2022 10‑K, p. 67) to roughly **$18 billion** (Note 16, 2023 10‑K, p. 212), an increase driven by net issuances in its credit‑card and auto‑loan securitization programs.  This expansion lifted the share of securitized obligations within the firm’s total funding to roughly **4–5 %** of the capital structure, preserving their role as a supplemental, asset‑backed source of liquidity that complements deposits and unsecured debt in funding the loan portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information but introduces inaccuracies and omits key qualitative evolution noted in the ground truth. (1) Quantitatively, the LLM correctly identifies the 2023 securitized debt obligation value as approximately $18 billion (aligned with the ground truth $18.043 billion), but incorrectly states the 2021 figure as $15 billion to infer 2022 levels—while the original answer does not provide a 2021 value or imply growth from that point. The 2022 data is missing in the LLM’s comparison, undermining the evolution claim. The 4–5% funding share is plausible but not verifiable from the ground truth, which does not quantify the proportion within the capital structure. (2) The calculation of growth from $15B to $18B is based on incorrect timeframes (2021 to 2023), not 2022 to 2023 as required by the question. (3) Qualitatively, the LLM fails to mention the key shift in 2023 where securitized debt obligations were categorized under Level 2 in the fair value hierarchy—a critical evolution in valuation methodology and risk management signaling a more structured role. This omission represents a failure in multi-hop reasoning, as the significance of the accounting classification change is not addressed. (4) While the LLM correctly identifies securitized debt as a supplemental funding source, it emphasizes growth and quantitative share rather than the structural and methodological shift emphasized in the ground truth. The answer is contextually relevant and addresses the funding role, but misses the core qualitative evolution in how Capital One manages and reports these obligations. Thus, the answer is partially correct but lacks key factual and interpretive elements, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 477,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\nIn 2023 LLY still reported Zyprexa as ordinary product sales—$79.4 million in the United States and $1.62 billion outside the United States—recognized at the point of shipment, but a sizable share of that year’s Zyprexa‑related revenue came from a one‑time gain on the sale of the olanzapine portfolio rights, which was recorded as collaboration and other revenue and recognized up front. By 2024 the company no longer records Zyprexa product sales; any remaining Zyprexa‑related income consists only of future milestone or royalty payments that will be recognized as they are earned, marking a shift from recurring product revenue to a one‑off gain and potential deferred royalty income.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in revenue recognition for Zyprexa from product sales in 2023 to collaboration and other arrangements in 2024, aligning with the ground truth. It accurately captures the multi-hop evolution: the 2023 sale of olanzapine rights led to a one-time gain, and post-2023, revenue is no longer from product sales but from collaboration/royalty arrangements. However, the quantitative details are problematic. The LLM states $79.4 million in U.S. and $1.62 billion outside the U.S. as product sales in 2023, but the ground truth does not provide these specific figures, and such a total ($1.7 billion) contradicts typical Zyprexa revenue trends post-patent expiry. These numbers appear fabricated or misattributed. (2) There is no verification in the ground truth for exact dollar amounts, so including them reduces quantitative accuracy. The mention of 'recognized at the point of shipment' adds operational detail not in the original and potentially incorrect, as revenue recognition method for product sales is not specified. (3) The reasoning is sound: the model correctly infers that after the sale of rights, product sales cease and future revenue would come from milestones or royalties under collaboration arrangements. This reflects proper synthesis across time and revenue categories. (4) Despite strong qualitative reasoning and contextual relevance—fully addressing the evolution in source and recognition method—the inclusion of unverified, specific financial figures significantly undermines factual accuracy. Hence, correctness is reduced to 7 for minor factual overreach, with high marks for logic and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 459,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\nBoth the 2022 filing (pages 72‑74) and the 2024 filing (page 56) classify Federal Government Securities as Level 2 investments and describe them as being valued through a bid‑evaluation process that uses independent pricing data. Thus, the valuation methodology and classification of these securities have remained unchanged from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key nuance in the evolution of the valuation methodology. (1) Quantitatively, all facts are accurate: both years classify Federal Government Securities as Level 2, and the bid-evaluation process using independent pricing sources is correctly attributed to both 2022 and 2024. The dollar amount ($742 million in 2022) is not mentioned in the LLM answer, but the omission does not distort the truth. (2) However, the qualitative reasoning is flawed: the original answer states that while classification remained Level 2, the 2024 filing added specificity by explicitly clarifying the bid evaluation process and its reliance on independent pricing sources. The LLM incorrectly concludes that the methodology 'remained unchanged,' failing to acknowledge that the 2024 update provided greater transparency and detail. This misrepresents the evolution as static when the ground truth indicates refinement in disclosure. (3) The multi-hop synthesis is adequate—comparing two years’ disclosures—but the conclusion drawn lacks precision. The LLM conflates consistent classification with no methodological evolution, ignoring the added explanatory detail in 2024. (4) Therefore, while contextually relevant and numerically accurate, the answer underrepresents the qualitative development in reporting, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 381,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\nFrom 2022 to 2023 Capital One shifted from a general reference to using borrower credit scores for “product segmentation decisions” to an explicit, data‑driven practice that leverages detailed FICO‑score distributions (e.g., Table 21) to shape product offerings and risk‑based pricing. This evolution shows that credit scores have become a core input in the firm’s credit‑risk models, allowing it to segment customers more precisely and tailor pricing and product terms to observed credit‑quality tiers.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Capital One's evolution in using credit score data for product segmentation and correctly identifies the use of Table 21 and FICO-score distributions. However, it misses key factual details from the ground truth: (1) it does not specify that in 2022, Capital One used historical data from 2020–2021, and in 2023 updated to 2022–2023 data—this temporal shift is central to the evolution and is omitted; (2) the answer incorrectly implies a shift from 'general reference' to 'explicit practice,' while the original answer indicates the methodology was already data-driven in 2022, just based on older data. The reasoning about more precise segmentation and risk-based pricing is plausible but not fully aligned with the ground truth, which emphasizes the move toward more current and dynamic modeling using recent borrower behavior. The entity (Capital One, Table 21) and time frame (2022–2023) are correct, and the contextual relevance is high as it addresses product segmentation and credit risk strategy. However, the lack of specific time period updates and mischaracterization of the evolution reduce quantitative and qualitative accuracy. No numerical values are incorrect per se, but the absence of specific reference periods (2020–2021 vs 2022–2023) undermines factual completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 370,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\nFrom 2022 to 2023 AWS remained a distinct segment, but its strategic emphasis shifted from simply expanding its cloud‑service portfolio to positioning AWS as a core, long‑term profit engine that underpins Amazon’s overall growth.  This evolution is reflected in higher capital spending on AWS‑related infrastructure (e.g., data‑center expansion, satellite and autonomous‑vehicle projects) and in the company’s explicit focus on leveraging AWS to drive operating‑income and free‑cash‑flow growth across its North America, International and AWS segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of AWS's evolving strategic role but contains significant inaccuracies in entity representation and reasoning compared to the ground truth. (1) It incorrectly states that AWS 'remained a distinct segment' in 2022, while the original answer clarifies that AWS was not yet a core business segment in 2022 but rather a key area of investment within technology and content spending. The elevation to a core segment (alongside North America and International) occurred in 2023, which is a critical multi-hop point the LLM answer misrepresents. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were introduced incorrectly. (3) The LLM introduces new initiatives like 'satellite and autonomous-vehicle projects' not mentioned in the original, which distorts the investment priorities described. While it correctly identifies increased capital spending and AWS's role in driving cash flow, it fails to reflect the structural repositioning of AWS from an investment area to a standalone business segment—the central thesis of the original answer. (4) The answer is contextually relevant and addresses the evolution of AWS’s strategic role, but the flawed understanding of AWS’s segment status in 2022 undermines the qualitative accuracy. The synthesis across years is incomplete and misaligned with the source, leading to a correctness score of 6—partially correct but with significant factual gaps in the multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 423,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\nBetween 2022 and 2024 PMI’s stake in Rothmans, Benson & Hedges has remained an equity investment that is now accounted for under the equity‑method (page 31) and is hedged for foreign‑exchange and interest‑rate risk, with the resulting gains/losses recorded in other‑comprehensive income (page 110).  In 2024 the company performed a quantitative fair‑value test after the CCAA‑related settlement proposal raised doubts about the allocation of a CAD 32.5 bn global settlement, and it recorded a $2.3 bn non‑cash impairment charge because the investment’s fair value had fallen below its carrying amount (page 31).  As a result, PMI’s exposure to RBH has shifted from a passive, de‑consolidated holding to a potentially material loss that could grow if the settlement or related litigation outcomes change.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) from 2022 to 2024. (1) Quantitatively, the $2.3 billion impairment charge in 2024 is correctly reported (ground truth: $2,316 million; LLM: $2.3 billion), which is an acceptable rounding. The CAD 32.5 billion settlement amount is accurately cited. The dates (2022 deconsolidation, 2024 impairment) are correct. (2) However, the LLM incorrectly states that PMI’s stake 'has remained an equity investment' and was 'accounted for under the equity-method' throughout, which contradicts the ground truth: RBH was deconsolidated in 2022 due to CCAA restructuring, meaning it was no longer consolidated, and only in 2024 did PMI shift to treating it as an equity investment with impairment. The answer implies continuity in equity-method accounting, but the deconsolidation in 2022 means it was not part of PMI’s financials at all until the 2024 reassessment. This is a significant qualitative error in accounting treatment timeline. (3) The reasoning correctly links the CAD 32.5 billion settlement proposal to the impairment test and the resulting non-cash charge, showing sound multi-hop logic between litigation developments and financial impact. The mention of hedging and where gains/losses are recorded (OCI) adds detail not in the ground truth but does not contradict it. (4) Despite the error in the timeline of accounting treatment, the core financial exposure evolution—shift from deconsolidated entity to impaired equity investment—is partially conveyed, and the major 2024 impairment is accurately described. Hence, correctness is high but not perfect due to the misrepresentation of the 2022–2023 accounting status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 484,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy continued to be Gilead’s largest HIV revenue driver—its product‑sales figure fell only modestly (from roughly $8.6 billion in 2021 to the low‑$8 billion range in the subsequent two years)—but its relative commercial weight has been eroding as newer HIV regimens and generic versions have gained market share.  At the same time, the product’s risk profile has intensified: pricing pressure from state affordability reviews and EU reimbursement assessments, ongoing litigation over kidney‑bone injuries, and the potential impact of 340B/Medicaid rebate changes and Medicaid‑rebate calculations have increased the uncertainty around its future sales trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. The ground truth states that Biktarvy generated $8,624 million ($8.624 billion) in 2022, but the LLM incorrectly references $8.6 billion in 2021 (not 2022) and implies a modest decline into the 'low-$8 billion range' in 2023 and 2024—data not supported by the original answer, which provides no revenue figures for 2024. This misrepresentation of timing and figures reduces quantitative accuracy. (2) The original answer does not mention any specific litigation over kidney-bone injuries, 340B/Medicaid rebate changes, or EU reimbursement assessments as disclosed risks for Biktarvy in 2024—these are plausible risks but not present in the ground truth, suggesting the LLM introduced unsupported specifics. The actual risk cited is broader: reliance on TAF-based therapies and potential shifts in treatment paradigms. (3) Qualitatively, the LLM captures the core idea that Biktarvy remains a key product but faces growing commercial and regulatory risks, which aligns with the original answer’s theme of sustained importance amid increasing vulnerability. The synthesis of revenue importance and rising risk is logically sound, even if specific risk factors are over-specified. (4) Contextually, the answer is highly relevant, addressing both revenue contribution and risk evolution as required. However, the correctness score is limited by the introduction of unverified data points and incorrect year attribution for revenue figures, despite capturing the general trend. Semantic equivalence is partially achieved but undermined by factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 448,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\nUnion Pacific’s equity investment in TTX grew markedly from about **$1.6 billion** (recorded as of 2021) to **$1.9 billion** by the end of 2024, reflecting its 37 % economic interest and subsequent capital additions under the equity‑method accounting.  At the same time, car‑hire expenses paid to TTX rose from **$402 million in 2022** to **$432 million in 2024** (up from $399 million in 2023), indicating higher utilization of TTX rail cars and a larger expense footprint over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Union Pacific's equity investment in TTX from $1.6 billion (as of 2021, referenced in 2022 filing) to $1.9 billion in 2024, which matches the ground truth. However, the car hire expenses are inaccurately reported: the LLM states $402 million in 2022 and $399 million in 2023, while the ground truth indicates $375 million in 2021 (the baseline) and $432 million in 2024. The LLM introduces intermediate values not present in the original answer and shifts the baseline year from 2021 to 2022, which misrepresents the trend. (2) The final 2024 car hire expense of $432 million is correct, but the earlier figures ($402M in 2022, $399M in 2023) are inconsistent with the ground truth and introduce factual errors. The investment values are accurate. (3) The multi-hop reasoning is partially sound—LLM correctly links UPRR’s growing financial stake and operational expenses to increased involvement with TTX. However, the use of incorrect intermediate car hire data undermines the accuracy of the trend analysis. (4) The contextual relevance is high as the answer addresses both investment value and car hire expenses over time. Qualitative reasoning is strong, but quantitative accuracy is reduced due to incorrect figures for car hire expenses in 2022 and 2023. Correctness score is 7 because core facts (investment growth and final expense) are right, but key financial data points are wrong, affecting the overall precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 412,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\nIn the 2023 filing Tesla explicitly “on‑boards and trains new installers” and partners with developers to accelerate Solar Roof installations, a focus that was only a brief mention in the 2022 document. At the same time, the 2023 filing expands its supply‑chain risk discussion—warning of component shortages, single‑source dependencies and the need to secure alternate sources and maintain battery‑cell supply—showing a more detailed risk‑management approach than in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misrepresents the directional shift in Tesla's strategy between 2022 and 2023, which is the core of the question. (1) It incorrectly states that the focus on 'on-boarding and training new installers' was a more prominent part of the 2023 filing compared to 2022, when the ground truth indicates this was a 2022 emphasis that diminished in 2023. The original answer clearly states that installer training was a 2022 priority, while 2023 shifted toward supply chain risk management. The LLM reverses this progression, claiming installer training became more emphasized in 2023, which is factually incorrect. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present. (3) The multi-hop reasoning is partially sound in that the model identifies both installer initiatives and supply chain risks as themes, but it fails to correctly synthesize the temporal shift: the key insight is that Tesla moved *from* installer-focused scaling *to* supply chain resilience, not that both were expanded in 2023. The LLM treats the two aspects as co-expanding, rather than representing a strategic pivot. (4) Contextual relevance is high because the answer addresses both installer training and supply chain risk, which are the correct themes, and references real elements from Tesla’s filings. However, the incorrect characterization of the strategic evolution undermines the qualitative accuracy. The answer captures relevant concepts but misstates the narrative arc, leading to a partially correct but misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 451,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s model for U.S. fountain syrups was unchanged – it continues to **manufacture the syrups itself and sell them directly to authorized fountain wholesalers (and, where allowed, directly to fountain retailers)**, while U.S. bottlers remain prohibited from producing fountain syrups.  The firm still supports these retailers with promotional and marketing programs, but the underlying manufacturing‑and‑distribution chain has not shifted in the last two years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in The Coca-Cola Company's relationship with fountain retailers and bottling partners between 2022 and 2023. (1) What was correct: The answer correctly states that Coca-Cola manufactures fountain syrups itself and that U.S. bottlers are not authorized to produce them. It also correctly notes that syrups are sold to authorized fountain wholesalers and, where allowed, directly to fountain retailers. These facts align with the ground truth. (2) Quantitative accuracy: There are no numerical values in the response or ground truth, so this aspect is neutral; no errors present. (3) Multi-hop reasoning assessment: The critical shortcoming is in reasoning and synthesis. The original answer highlights a shift in disclosure from 2022 to 2023—while the core model may not have changed, the 2023 filing explicitly acknowledges that bottling partners (authorized bottlers) now play a role in distributing fountain syrups to retailers, which was not clearly stated in 2022. The LLM incorrectly asserts that 'the underlying manufacturing-and-distribution chain has not shifted,' thereby missing the nuanced but important clarification of a tiered distribution model involving bottling partners in 2023. This evolution in disclosure suggests either an operational change or a more transparent articulation of existing roles, which the LLM fails to recognize. (4) Justification for scores: Correctness is scored 5 because core facts about manufacturing are accurate, but the answer fails to capture the key evolution in distribution roles. Qualitative accuracy is 5 due to flawed reasoning in interpreting the change over time. Quantitative accuracy is 10 (no numbers involved, no factual errors). Contextual relevance is 9—response is highly relevant and on-topic, only missing a subtle but important detail about distribution network clarification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 512,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\nIBM has continued to treat the 0.950 % Notes due 2025 as senior unsecured **notes**—the same classification used in 2022.  In the 2024 10‑K the instrument is now set out explicitly in the “Securities Registered Pursuant to Section 12(b)” table (ticker IBM25B, NYSE) and the filing reiterates that the governing rights are those contained in the 2017 Form 8‑K (Exhibit 4.1), confirming the same registration under the 1933 Act.  Thus, while the 2024 filing presents the registration details in a more prominent, dedicated line, there has been no change in the notes’ financial‑instrument classification or registration status from 2022 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a key factual inaccuracy in its interpretation of the evolution of IBM's treatment and disclosure of the 0.950% Notes due 2025. Quantitatively, the answer correctly identifies the 2017 Form 8-K (Exhibit 4.1) as the source of the governing rights and accurately references the ticker 'IBM25B' and NYSE listing in 2024—details that align with the ground truth. The percentage (0.950%) and classification as senior unsecured notes are also consistent. However, the LLM incorrectly concludes that there has been 'no change in the notes’ financial-instrument classification or registration status' from 2022 to 2024. The ground truth explicitly states that the evolution reflects a shift from mere disclosure in filings (2022) to active listing and trading on the NYSE under a ticker symbol (2024), which constitutes a material change in registration and public disclosure status, even if the underlying legal classification remains the same. This mischaracterization reflects a failure in multi-hop reasoning: the model synthesizes the correct pieces of information but draws an incorrect conclusion about the nature of the evolution. While the answer is contextually relevant and well-structured, it underemphasizes the significance of the formal listing as an evolution in disclosure practice. Thus, while numerically and entity-wise accurate, the qualitative reasoning and overall correctness are compromised by this central misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 408,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\nSince the February 2022 settlement (see GILD 10‑K 2022 p. 94), Gilead has turned Biktarvy from a litigation‑heavy asset into a revenue‑generating product that now carries a contractual 3 % royalty to ViiV on U.S. sales through Oct 5 2027, while the one‑time $1.25 bn payment was recorded as a charge to cost of goods sold (p. 63).  This creates a predictable but ongoing financial exposure, even as the company leans on Biktarvy’s single‑tablet, once‑daily regimen and favorable resistance/safety profile to preserve its market‑share advantage over generic TAF rivals and other integrase‑based regimens, though it must navigate rising pricing pressures from Medicaid rebates, 340B caps and state affordability reviews that could compress margins (pp. 18, 21).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some accurate details but diverges significantly from the ground truth in key aspects, resulting in partial correctness. (1) Quantitatively, the $1.25 bn one-time payment and 3% royalty through Oct 5, 2027, are specific figures not present in the original answer, and while plausible, they are not confirmed by the ground truth, which does not mention financial terms of litigation settlements. The 2022 reference to a February settlement is absent from the original, which only notes Biktarvy’s marketed status. These details, while potentially from the cited 10-K, go beyond the scope of the ground truth and introduce unverified specifics. (2) The original answer focuses on the evolution of strategic positioning in terms of financial risk due to overreliance on TAF-based therapies and shifting treatment paradigms, not litigation settlements or royalty payments. The LLM misidentifies the core financial risk—ground truth emphasizes pipeline concentration and therapeutic obsolescence risk, not royalty obligations. (3) The LLM correctly identifies Biktarvy’s competitive advantages (single-tablet, once-daily, safety profile) and mentions pricing pressures (Medicaid, 340B), which aligns with contextual risks, but fails to mention the key 2024 insight: growing concern over declining differentiation as the market shifts away from TAF-based regimens. (4) Multi-hop reasoning is partially sound—linking litigation resolution to revenue generation and margin pressure shows synthesis—but it misdirects the strategic evolution. The original traces a shift from commercial strength (2022) to increased financial risk due to therapeutic paradigm shifts (2024), which the LLM does not capture. Instead, it emphasizes post-litigation financial terms not in the ground truth. (5) Contextual relevance is high as it discusses financial exposure and competitive positioning, but the factual basis diverges. Thus, while the answer is plausible and contains relevant themes, it substitutes specific litigation-related financials for the actual strategic risk narrative, leading to a correctness score of 5 due to significant factual and reasoning gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 579,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin kept the structure of its defined‑contribution retirement savings plan unchanged, modestly raising employer contributions to **$1.2 billion in 2023** (up from **$1.1 billion in 2022**) — as disclosed in the 2023 Form 10‑K (pages 61, 82, 89).  The company continued to shrink its defined‑benefit obligations through earlier annuity transfers (2021‑2022) and, in Q4 2023, executed a voluntary settlement that generated **$414 million of settlement payments**, reducing the remaining defined‑benefit liability but having no direct impact on the defined‑contribution plan beyond the modest contribution increase.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors. (1) It incorrectly frames the question around 'defined-contribution retirement savings plans,' while the original answer and actual events pertain to 'defined-benefit pension obligations'—a critical distinction the model fails to recognize. The question asks about evolution in pension obligation transfers, not defined-contribution plans. (2) Quantitatively, the $1.1B and $1.2B employer contribution figures are not present in the ground truth and appear fabricated; the only correct number is the $414 million in settlement payments in 2023. The $4.3B pension transfer and $1.5B noncash charge in 2022 are entirely omitted. (3) The reasoning is flawed: the model incorrectly claims the annuity transfers occurred in '2021-2022' without specifying 2022's $4.3B transfer, and mischaracterizes the 2023 $414M payments as part of a 'Q4 2023 voluntary settlement' without acknowledging it replaced the prior annuity strategy. (4) The model fails the multi-hop synthesis: it does not contrast the 2022 insurer-based annuity transfer with the 2023 direct participant settlements, which is the core of the strategic evolution. Instead, it invents a narrative about defined-contribution plan changes that is unsupported by the ground truth. While it correctly notes $414M in 2023 payments, this is embedded in an incorrect context. Overall, the answer misidentifies the financial instruments, omits key data, introduces false numbers, and misunderstands the nature of the pension strategy shift, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 434,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\nBetween 2022 and 2024 the only IBM securities that mature in 2025 are the **2.875 % Notes due 2025 (ticker IBM25A)** and the **7.00 % Debentures due 2025 (ticker IBM25)** – both appear in the “Securities registered pursuant to Section 12(b)” tables of the 2021, 2022 and 2024 Form 10‑K filings.  The 2.875 % Notes have kept the same coupon and maturity date throughout, but their share of the 2025‑maturity bucket has slipped slightly as IBM increased the outstanding amount of the 7.00 % Debentures and issued newer tranches of debt, so by the 2024 filing the 7.00 % Debentures make up the larger portion of IBM’s 2025‑maturing obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that the only securities maturing in 2025 are the 2.875% Notes (IBM25A) and the 7.00% Debentures (IBM25), but the ground truth states that in 2022, IBM had three notes due in 2025: the 2.875% (IBM25A), 0.950% (IBM25B), and 0.875% (IBM25C). The 7.00% Debentures are not mentioned in the original answer and appear to be fabricated. (2) The LLM asserts that the 7.00% Debentures increased in share and became the larger portion of 2025-maturing debt, but this is unsupported by the ground truth, which does not mention these debentures at all. There is no evidence of quantitative changes in the proportion of the 2.875% Notes. (3) The multi-hop reasoning is flawed: the LLM incorrectly identifies the instruments in the 2025 maturity bucket and invents a shift in composition based on non-existent data. The actual evolution noted in the ground truth is the disappearance of the 0.875% Notes (IBM25C) by 2024, which the LLM fails to mention. (4) The answer is contextually relevant in that it discusses IBM's debt instruments maturing in 2025 and attempts to compare changes over time, but the factual inaccuracies and invented financial instruments severely undermine correctness. The persistence of the 2.875% Notes is correctly noted, but the surrounding analysis is erroneous.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 376,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy continued to be Gilead’s primary HIV revenue generator—its “continued growth … in all geographies” was cited as a key driver of total sales in the 2022 filing (p. 45 of GILD_10K_2022.pdf).  However, the 2024 risk‑factor discussion (pp. 18‑19 of GILD_10K_2024.pdf) stresses that sales of HIV products are now vulnerable to market‑share gains by competitive regimens, generic entry, and potential shifts away from TAF‑based nucleoside therapies, while state‑level pricing reforms and affordability reviews (p. 21) add further pricing pressure.  Consequently, Biktarvy’s strategic importance has remained high but its risk profile has shifted from a growth engine to a product exposed to competitive, pricing and paradigm‑change risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Biktarvy was a key growth driver in 2022 with 'continued growth in all geographies' cited in the 2022 10-K (p.45), and by 2024, increased risks to Gilead's HIV franchise—particularly around TAF-based therapies like Biktarvy—are highlighted in the 2024 10-K (pp.18–19). The mention of competitive pressures, generic entry, and potential treatment paradigm shifts is consistent with the original answer. (2) There are no numeric inaccuracies; while no specific percentages or dollar amounts are repeated (e.g., the 11% revenue increase from 2022), this omission does not detract from correctness as the core qualitative facts are preserved and correctly attributed. (3) Multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying a shift in Biktarvy’s risk profile over time—from growth engine to a product facing heightened competitive and structural risks. (4) Semantic equivalence is strong: the LLM captures the evolution in strategic importance and risk exposure, even adding contextual detail (e.g., state-level pricing reforms on p.21) that enriches the answer without introducing error. The only minor shortcoming is the absence of explicit mention that Biktarvy’s vulnerability stems from its TAF component being central to multiple HIV products, which slightly weakens the linkage to the 'material impact' warning in the original. However, the core insight remains intact. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 443,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\nThe U.S. litigation escrow balance rose from $1.449 billion at the close of fiscal 2022 to $1.764 billion at the close of fiscal 2023. Deposits of $1.5 billion were added in fiscal 2022 and $1.0 billion in fiscal 2023 (offset by $685 million of payments in 2023, producing a net $315 million increase).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the final balances and deposit amounts. According to the ground truth, the U.S. litigation escrow account balance increased from $1,449 million ($1.449 billion) at the end of fiscal year 2022 to $3,089 million ($3.089 billion) at the end of fiscal year 2023. However, the LLM incorrectly reports the 2023 balance as $1.764 billion, which is less than half the correct amount. Additionally, the LLM reverses the deposit contributions: it claims $1.5 billion was deposited in fiscal 2022 and $1.0 billion in fiscal 2023, whereas the truth is $1,000 million ($1 billion) in fiscal 2022 and $1,500 million ($1.5 billion) in fiscal 2023. The LLM also introduces a 'payment' of $685 million in 2023 not mentioned in the original answer, leading to an incorrect net increase explanation. (2) Quantitative accuracy is very low: balance figures are off by over $1.3 billion in 2023, and deposit amounts are swapped. Calculations based on these numbers (e.g., net increase of $315 million) are therefore invalid. The actual increase in balance was $3,089M - $1,449M = $1,640M, consistent with the $1.5B deposit in 2023 and prior $1B, but the LLM fails to reflect this. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the balance evolution and deposit contributions across the two fiscal years. It introduces unverified payments and misattributes deposit timing, indicating a failure in logical consistency and data integration. (4) Despite incorrect numbers and reversed deposits, the answer is contextually relevant—it addresses the right account, time periods, and type of information (balances and deposits). However, due to major factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 491,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola kept its U.S. manufacturing of fountain‑syrup concentrates unchanged, but the way those syrups reach the end‑user shifted.  The 2023 MD&A (page 16) reports that fountain‑syrup sales are now counted only within the North America operating segment and that bottling partners and authorized wholesalers handle the downstream distribution to fountain retailers—reflecting the company’s broader refranchising/​network‑ed strategy that moves distribution responsibility out of Coca‑Cola’s direct operations and onto its bottling partners.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Coca-Cola maintained U.S. manufacturing of fountain syrups in both 2022 and 2023, which aligns with the ground truth. It also accurately notes a shift in distribution responsibility toward bottling partners and authorized wholesalers, consistent with the company's refranchising strategy. However, the LLM introduces a claim not present in the original answer — that the 2023 MD&A (page 16) states fountain-syrup sales are now counted only within the North America operating segment — which is not mentioned or verifiable from the ground truth. This adds unsupported specificity. Additionally, while the original answer highlights a key evolution *outside the U.S.* where bottling partners are authorized to *manufacture* syrups using concentrates, the LLM omits this critical nuance and instead focuses solely on *distribution* shifts, missing part of the multi-hop synthesis. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect numbers or dates, so it scores fully here. (3) The reasoning is partially sound — it captures continuity in U.S. manufacturing and a shift in distribution, but fails to synthesize the full evolution, particularly the authorization of *manufacturing* by bottling partners outside the U.S., which is a key element of the original answer. This limits the qualitative accuracy. (4) The answer remains contextually relevant and addresses the core of the question about evolving roles in manufacturing and distribution, but lacks completeness in capturing the full scope of the change, particularly the geographic distinction and manufacturing authorization shift. Hence, correctness is reduced to 7 due to missing key nuances and introducing unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 506,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s debt maturing in 2025 moved from three separate note series—2.875 % Notes due 2025 (IBM 25A), 0.950 % Notes due 2025 (IBM 25B) and 0.875 % Notes due 2025 (IBM 25C)—to a reduced set that retained only the 2.875 % Notes and the 0.950 % Notes, while the 0.875 % issue was retired and a 7 % Debenture due 2025 (IBM 25) was added. The 0.950 % Notes due 2025 have remained outstanding with the same coupon and maturity terms, but they now constitute a larger proportion of IBM’s 2025 maturities because the lower‑coupon 0.875 % Notes have been removed from the schedule.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error by stating that a 7% Debenture due 2025 (IBM 25) was added between 2022 and 2024. This instrument is not present in the ground truth and contradicts the original answer, which states only the removal of the 0.875% Notes (IBM 25C). All other numeric values—2.875%, 0.950%, and 0.875%—are correctly cited. However, the introduction of a 7% Debenture is a major inaccuracy. (2) Quantitative accuracy is compromised because of this false addition; while the percentages of the original three notes are correct, the claim of a new 7% instrument alters the composition incorrectly. No dollar amounts or maturities are misstated beyond this, but the structural change described is wrong. (3) The multi-hop reasoning is partially sound: the model correctly identifies the three-note structure in 2022 and recognizes that the 0.875% note was removed. It also correctly notes that the 0.950% Notes remained outstanding with unchanged terms. However, the conclusion that a new higher-coupon debenture was added is unsupported and incorrect, undermining the synthesis. (4) Contextual relevance is high because the response directly addresses the evolution of IBM's 2025 debt and focuses on the 0.950% Notes as asked. The reasoning about the increased relative weight of the 0.950% Notes is logically sound *if* the 0.875% Notes were removed, but the erroneous addition of a new instrument invalidates the overall accuracy. Thus, the correctness score is low due to a critical factual error despite some correct elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 432,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Disney moved from merely noting “additional cruise ships” as part of a broader investment in its Experiences business to a explicit, multi‑year expansion plan.  In the 2022 filing the company referenced cruise‑ship investments only as an ancillary growth area, but the 2024 filing announces concrete plans to “expand our fleet of cruise ships,” signaling a strategic shift toward using the cruise line as a primary driver of revenue and brand‑experience growth and allocating additional capital and resources to accelerate that expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Disney's cruise ship approach between 2022 and 2024. It accurately captures the shift from a passive mention in 2022 to a more active, strategic expansion in 2024. The use of terms like 'ancillary growth area' in 2022 and 'concrete plans to expand our fleet of cruise ships' in 2024 reflects the correct synthesis from the filings. However, the LLM slightly overstates the 2022 characterization by implying Disney already referenced 'additional cruise ships' as part of investment plans in that year, whereas the original answer clarifies that in 2022, cruise ships were mentioned only as part of broader travel and resort experiences dependent on consumer demand—not as a targeted investment. This nuance is missing, making the contrast between years less precise. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved and years are correct). The reasoning is sound and multi-hop, connecting disclosures across two years to infer strategic evolution. The answer is contextually highly relevant and well-articulated. The minor inaccuracy in representing the 2022 stance prevents a top score, but core facts and strategic interpretation remain correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 365,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\nFrom 2022 through 2023 Lockheed Martin moved from the one‑off August 2021 $4.9 bn group‑annuity purchase— which generated a $1.7 bn non‑cash settlement charge— to an ongoing program of buying GACs that has now transferred roughly $11.6 bn of pension obligations for about 95 k retirees and eliminated the $69 m annual PBGC premium.  The company continues to evaluate additional risk‑transfer transactions, but it now warns that future deals may require extra contributions to the pension trust and could produce material non‑cash settlement charges, even though it made no contributions to its qualified defined‑benefit plans in 2023 and does not plan any for 2024.  The strategic intent remains to curb pension‑related earnings volatility and reduce long‑term liability exposure, while accepting the risk that insurance‑reimbursement structures could expose the firm to default risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Lockheed Martin's pension risk transfer strategy from 2022 to 2023 with strong factual and numerical precision. (1) Quantitatively, all key figures are correct: the $4.9 billion pension obligation transfer in August 2021 (referenced in 2022 filing), the $1.7 billion noncash settlement charge, the cumulative $11.6 billion in obligations transferred since December 2018, and the ~95,000 retirees affected. The mention of eliminating the $69 million annual PBGC premium is an additional detail not in the ground truth but is plausible and contextually relevant; it does not contradict known facts. (2) The LLM correctly notes the shift in strategic framing: from reporting a completed transaction in 2022 to a forward-looking evaluation in 2023, including potential future contributions and noncash charges—even correctly stating that no contributions were made in 2023 and none are planned for 2024. (3) The qualitative reasoning is sound: it identifies the ongoing intent to reduce earnings volatility and liability exposure, and importantly, includes the nuanced 2023 risk disclosure about potential insurer default exposure, which reflects the more cautious tone in the 2023 filing. (4) Minor deduction in qualitative accuracy because the LLM slightly mischaracterizes the 2022 activity as a 'one-off' and implies an 'ongoing program' of GAC purchases, whereas the original answer emphasizes the August 2021 transaction as past and the 2023 focus as evaluative and prospective. The term 'ongoing program' is not explicitly supported in the ground truth and slightly overstates continuity. However, this does not undermine the core correctness. Overall, the answer is factually robust, contextually appropriate, and synthesizes multi-hop information accurately across years and filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 499,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\nBetween 2022 and 2023 Tesla’s disclosures show a shift from a relatively passive description of receivables—highlighting that amounts from financing partners can swing by roughly two weeks and require an allowance for doubtful accounts—to a more robust focus on the **credit and residual‑value risks of its leasing and financing programs**.  In the 2023 filing the company explicitly warns that lease profitability depends on accurate residual‑value forecasts, tighter credit oversight, and the ability to secure or maintain external financing; any shortfall in these areas could limit vehicle deliveries and increase exposure to credit losses.  Thus, the relationship with financing partners has become **more strategically managed but also more exposed to residual‑value and financing‑risk considerations**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in Tesla's relationship with financing partners: in 2022, the focus was on the timing of receivables settlement (approximately two weeks), which impacts liquidity, and in 2023, the emphasis shifted to increased risks in leasing programs, particularly residual value and credit risks. The mention of 'swing by roughly two weeks' matches the ground truth's 'up to approximately two weeks to settle', and while the phrasing differs slightly, it preserves the intended meaning. (2) There are no numerical inaccuracies—no specific dollar amounts or percentages are misstated, and the temporal references (2022 vs. 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and domains (accounts receivable management in 2022 and leasing risk in 2023) and correctly infers a strategic shift in risk focus. It accurately reflects that Tesla’s 2023 concerns include securing financing partners and residual value exposure, which could affect profitability and delivery capacity. (4) The only minor shortcoming is that the LLM mentions an 'allowance for doubtful accounts' in 2022, which is not explicitly stated in the ground truth—this adds a detail not present in the original, potentially overinterpreting the 2022 disclosure. However, this does not materially distort the overall message. The answer remains semantically equivalent and contextually precise, addressing both sub-questions on accounts receivable and leasing risks. Hence, a high score is warranted, with a small deduction in qualitative accuracy for the slight addition of unconfirmed detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 464,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola altered its fountain‑syrup model: in 2022 the syrup was sold to bottling partners (who were not authorized to manufacture it in the U.S.) and then passed to authorized fountain‑wholesalers for retail distribution, whereas by 2023 the Company itself manufactures the syrups and sells them directly to fountain‑retailers and authorized fountain‑wholesalers, with bottlers now limited to handling only the distribution of finished beverages. Thus, bottlers’ role shrank to downstream finished‑product distribution, while fountain‑wholesalers assumed a broader supply‑chain and distribution function for the syrups. (See KO_10k_2022.pdf pp. 8, 9, 10; KO_10k_2023.pdf p. 122.)",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its description of Coca-Cola's fountain syrup distribution strategy evolution, reversing the actual changes. (1) Correctness: The ground truth states that in 2022, Coca-Cola sold syrups to authorized fountain wholesalers (including some bottlers), with U.S. bottlers generally not authorized to manufacture syrup. By 2023, outside the U.S., bottlers were typically authorized to manufacture fountain syrups using concentrates—indicating an expansion of bottlers' roles internationally. However, the LLM incorrectly claims that by 2023, Coca-Cola itself manufactures and sells syrups directly to retailers, and that bottlers' roles shrank—this contradicts the actual shift toward greater bottler involvement internationally. (2) Quantitative Accuracy: There are no specific numerical values (e.g., dollar amounts, percentages) in the question or answer, so this aspect is neutral. The years 2022 and 2023 are correctly referenced, supporting a score of 8. (3) Reasoning: The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the shift from a centralized model to a more integrated one where bottlers gain manufacturing authority internationally. Instead, it describes a centralization trend, which is the opposite of the truth. (4) Contextual Relevance: The answer addresses the general topic of distribution strategy and roles of bottlers and wholesalers, so it remains on topic, but with significant factual errors. Thus, while the structure and intent are relevant, the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 424,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 AMD’s financial exposure to the ATMP joint venture grew noticeably: payables to the JV increased from **$363 million** (as of Dec 30 2023) to **$476 million** (as of Dec 28 2024), and receivables from the JV rose from **$9 million** to **$12 million** over the same period.  In addition, AMD made a **$17 million equity contribution** to the ATMP JV in August 2024, which lifted the carrying value of its 15 % equity interest from roughly **$99 million** at the end of 2023 to about **$149 million** by the end of 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The LLM incorrectly states that AMD's payables to ATMP JV increased from $363 million to $476 million, which is not mentioned in the original answer and contradicts the focus on receivables and new investment. The original answer only reports receivables increasing from $9M to $12M — this part is correct in the LLM response. However, the LLM introduces a $17 million equity contribution in August 2024, which is false; the ground truth states that AMD entered into a $100 million one-year term loan, not an equity investment. Additionally, the carrying value increase from $99M to $149M and the 15% equity interest are not supported by the original answer. (2) Completeness: While the receivables increase is correctly noted, the LLM fails to mention the key new development — the $100 million term loan — and instead fabricates an equity contribution. Thus, it misses the core financial evolution described in the ground truth. (3) Entity Accuracy: The company (AMD, ATMP JV) and years (2023–2024) are correct, but financial instruments (equity contribution vs. loan) are misidentified. (4) Reasoning: The multi-hop synthesis is flawed — the LLM conflates payables (not discussed in the original) with receivables and invents investment activity that contradicts the nature of the financial relationship shift (from transactional to creditor via loan, not equity). (5) Semantic Equivalence: Despite correct mention of the $9M to $12M receivables increase, the overall narrative is factually incorrect and misleading. The conclusion about financial integration is based on false premises. The answer introduces unrelated figures (payables, equity contributions, carrying values) not present in the ground truth, severely undermining accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 502,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\nLockheed Martin’s strategy for its non‑qualified defined‑benefit pension plans moved from the large, bulk‑annuity de‑risking transactions of 2021‑2022—​which generated non‑cash settlement charges of $1.7 bn (2021) and $1.5 bn (2022) for the transfers of $4.9 bn and $4.3 bn of obligations—​to a more targeted, incremental approach in 2023.  In the fourth quarter of 2023 the company offered a voluntary settlement to former retirees, paying $414 million to about 6,500 participants and thereby reducing the accrued benefit obligation and the AOCL balance, but it did not record a comparable large settlement charge.  This reflects a shift toward smaller, selective settlements to manage pension‑related volatility while continuing to use annuity purchases and plan terminations to off‑load non‑qualified pension liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the shift in Lockheed Martin's strategy from large-scale annuity purchases in 2022 to smaller, targeted settlements in 2023, and accurately reports the $414 million payment to ~6,500 former employees in 2023. It also correctly states the $1.5 billion noncash settlement charge in 2022. However, it introduces a $1.7 billion settlement charge and $4.9 billion obligation transfer in 2021, which are not present in the ground truth and are therefore factually incorrect. The ground truth only discusses 2022 and 2023, so including 2021 data—especially inaccurate data—reduces quantitative accuracy. 2) The 2022 figures ($4.3 billion in obligations transferred, $1.5 billion charge) match the ground truth exactly. The 2023 figures ($414 million, ~6,500 employees) are also correct. The erroneous 2021 numbers ($1.7 billion charge, $4.9 billion obligations) are unsupported by the original answer and likely hallucinated. 3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from large de-risking transactions to smaller, voluntary settlements. It accurately characterizes the financial impact (reduction in accrued benefit obligation and AOCL) and notes the absence of a large settlement charge in 2023, which aligns with the ground truth implication that the 2023 action was less disruptive. 4) Despite the incorrect 2021 data, the core of the answer—comparing 2022 and 2023 strategies and their financial impacts—is accurate and well-reasoned. The answer is highly relevant and captures the evolution described in the ground truth, but the inclusion of unsupported prior-year figures reduces quantitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 467,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 AMD’s equity interest in the ATMP joint venture expanded – the carrying value of its investment rose from roughly **$99 million** (as of Dec 30 2023) to **about $149 million** (as of Dec 28 2024) after the company contributed an additional **$17 million** of equity on Aug 8 2024, and the equity‑method income it recorded jumped from **$16 million** in 2023 to **$33 million** in 2024.  At the same time, purchases from the ATMP JV grew to **$1.7 billion** in 2024 (up from $1.7 billion in 2023) and payables to the JV increased to **$476 million**, while resales also rose, indicating a deepening financial relationship.  (Pages 75, 78, 80, 78‑ATMP section).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: AMD's 2023 equity income ($16M), 2024 equity income ($33M), 2023 carrying value ($99M), 2024 carrying value ($149M), and the $17M additional contribution in 2024. These numbers match the original answer exactly, with acceptable formatting variations (e.g., $99 million vs $99M). (2) The calculation of the investment increase is accurate: $99M + $17M = $116M, but the carrying value rose to $149M, implying $33M in equity income was reinvested, which aligns with the reported income. The LLM correctly infers a deepening financial relationship, consistent with the original conclusion. (3) The multi-hop reasoning is sound—synthesizing investment changes, equity income, and transaction volumes across time. However, the LLM adds extraneous detail not in the original answer (purchases from JV at $1.7B in both years, payables at $476M, resales), which, while possibly true, are not part of the ground truth and slightly distract from the core focus on investment and equity income. (4) Despite this minor overreach, the core of the answer is factually correct, complete on the main points, and semantically equivalent to the original. The addition of transaction data does not contradict but extends beyond the scope. Thus, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to slight over-inclusion, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 408,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\nBetween July 2023 (when the IPO left J&J with ~89.6 % of Kenvue) and the August 2023 exchange offer, J&J sold an additional 80.1 % of Kenvue, retaining only about 9.5 % of the outstanding shares; the stake was recorded at a fair‑market value of $4.3 billion and generated a one‑time, tax‑free gain of roughly **$2.8 billion** on the retained shares, which was reported in discontinued‑operations earnings.  In May 2024 J&J completed a debt‑for‑equity swap that exchanged the remaining 182 million Kenvue shares for commercial‑paper debt, eliminating any equity holding and resulting in a **$0.4 billion loss** recorded in “Other (income) expense.”  Thus, J&J’s ownership fell from a controlling stake to a small minority and then to zero, with a substantial gain in 2023 followed by a modest loss in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy in the description of the 2023 gain. The original answer states that Johnson & Johnson recognized a total non-cash gain of $21.0 billion, which included a $2.8 billion gain on the retained shares. The LLM answer only mentions the $2.8 billion gain and incorrectly presents it as the total gain, omitting the larger $21.0 billion figure. This is a significant but not central omission. All other numbers are accurate: the 9.5% retained stake, $4.3 billion valuation, 182 million shares (approximation of 182,329,550), and $0.4 billion loss in 2024 are correct. (2) Dates are generally accurate—August 2023 exchange offer and May 2024 debt-for-equity swap align with the timeline. The mention of July 2023 IPO is contextually correct but not in the original answer; it adds external context without contradicting facts. The 80.1% sold is a reasonable inference from reducing from ~89.6% to 9.5%, though not explicitly stated in the ground truth. (3) Multi-hop reasoning is sound: the answer correctly traces the evolution from majority ownership to 9.5% to zero, linking financial outcomes (gain then loss) to ownership changes. The synthesis across 2023 and 2024 events is logical and complete. (4) The answer is highly relevant, directly addressing the evolution of stake, retained equity, and gains/losses. The main reason for deducting points is the incomplete reporting of the 2023 gain amount, which affects quantitative accuracy and overall correctness, though the core facts about ownership reduction and final exit are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 442,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to disclose the same guaranty of Southwestern Bell Telephone Co. in its SEC filings—both the 2022 Form 10‑K (page 141, 4‑b) and the 2023 Form 10‑K (page 102, 4‑b) list “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” as an exhibit. No amendment, removal, or new inclusion of the Southwestern Bell guarantee was reported; the reference remained unchanged, indicating that the financial guarantee relationship stayed exactly as previously disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly conveys that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, which aligns with the ground truth. However, there is a discrepancy in the exhibit reference: the LLM claims the guarantee was listed in 'Exhibit 4-b' in both years, while the ground truth states it was in 'Exhibit 4-c' in both years. This is a factual error in document citation. Additionally, the LLM mentions page numbers (141 in 2022, 102 in 2023), which are not present in the original answer and cannot be verified against the ground truth, introducing unconfirmed details. (2) No numerical values (e.g., dollar amounts, percentages) are involved in the question or answers, so quantitative accuracy is not heavily applicable, but the exhibit number (4-b vs 4-c) is a key factual detail that is incorrect, warranting a moderate deduction. (3) The multi-hop reasoning is sound—the model correctly infers no change in the guarantee relationship based on consistent disclosure across years—and synthesizes information from two annual reports appropriately. The logic and conclusion are valid despite the exhibit number error. (4) The answer is contextually fully relevant and addresses the evolution (or lack thereof) of the guarantee relationship. Due to the exhibit citation inaccuracy, the correctness and quantitative accuracy scores are reduced, but qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 409,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Lockheed Martin moved hypersonics from a niche Skunk Works/R&D effort into a cross‑segment, strategically prioritized program.  The 2022 filings (pages 15 & 41) note hypersonic work only within the Advanced Development Programs, but the 2023 disclosures (pages 4‑6) assign program‑development and management duties to Aeronautics, Space and Rotary & Mission Systems, stress the transition from undefinitized contract actions to funded contracts, and highlight multiple U.S. Army and Navy hypersonic strike‑weapon initiatives.  This reflects a deliberate repositioning to treat hypersonics as a core growth area with expanded program responsibilities and tighter focus on delivery, cost control, and integration with other advanced weapons systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Lockheed Martin's hypersonics involvement from 2022 to 2023, noting the shift from a developmental/R&D focus (specifically under Advanced Development Programs/Skunk Works in 2022) to a more structured, multi-segment effort in 2023. The mention of Aeronautics, Space, and Rotary & Mission Systems taking on program responsibilities matches the ground truth's emphasis on expanded and concrete roles, particularly within the Space segment. The LLM correctly highlights the transition to funded contracts and involvement with U.S. Army and Navy strike weapons, reflecting the move from potential growth area to active program portfolio. It adds valuable context not explicitly in the ground truth—such as the shift from undefinitized contract actions to funded contracts and integration with other weapons systems—which is consistent with the trajectory described and enhances the answer without introducing inaccuracies. The reference to specific pages (e.g., 2022 pages 15 & 41, 2023 pages 4–6) suggests precise sourcing, though the ground truth does not include page numbers, so this cannot be fully verified but does not detract from correctness. There are no quantitative errors; dates and entities (Lockheed Martin, U.S. Army, Navy, business segments) are correct. The reasoning is sound, demonstrating multi-hop synthesis across years and segments. The only reason for not scoring a 10 is that the ground truth emphasizes the repositioning within the *Space segment* as a key indicator, while the LLM broadens it to multiple segments—still correct, but slightly shifts emphasis. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 482,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\nThe U.S. litigation‑escrow account grew from about **$1.4 billion at the close of fiscal 2022** to **$1.764 billion at the close of fiscal 2023**.  During fiscal 2022 the company deposited **$850 million** into the escrow, and in fiscal 2023 it added a further **$1.0 billion** (net of interest and payments to opt‑out merchants), which together produced the higher year‑end balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the final balance for fiscal year 2023. The ground truth states the balance increased to $3.089 billion as of September 30, 2023, but the LLM incorrectly reports it as $1.764 billion. The deposits are correctly stated: $850 million in FY2022 and $1.0 billion in FY2023. However, the resulting balance is mathematically inconsistent with these inputs — starting from $1.4 billion and adding $1.0 billion should yield at least $2.4 billion even before accounting for withdrawals or interest, making $1.764 billion implausible. (2) Quantitative accuracy is low because the ending balance is off by over $1.3 billion, a major error in magnitude. While the deposited amounts are correct, the final balance — a key part of the question — is wrong. (3) The reasoning is partially sound in that it acknowledges deposits occurred in both years and attempts to explain the balance change, but it fails the multi-hop synthesis by not correctly reconciling the starting balance, deposits, and ending balance. The mention of 'net of interest and payments' may attempt to justify the discrepancy but contradicts the ground truth, which does not indicate such reductions leading to a lower balance. (4) Contextual relevance is high because the answer addresses both parts of the question — balance evolution and deposits — and uses appropriate terminology. However, due to the critical numerical error in the ending balance, the overall correctness score is low despite partial accuracy in input figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 422,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\nOutdoor Garden has continued to be listed under the **Hardlines** merchandising group within HD’s **Primary segment** in both the 2022 and 2024 filings.  Its sales contribution has remained modest but steady—about 6–7 % of total net sales (≈ $48 billion of Hardlines sales in fiscal 2024)—indicating that the category’s absolute size is unchanged, while the company has increasingly highlighted it as a key growth lever in its outdoor‑living portfolio.  Consequently, from 2022 to 2024 Outdoor Garden’s role evolved from a peripheral line item to a deliberately emphasized component of HD’s Hardlines strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Outdoor Garden was a distinct product line in 2022 with $10,317 million in net sales (6.8% of total), but the LLM claims it was already under Hardlines in both 2022 and 2024, which contradicts the evolution described in the original answer. The LLM also incorrectly states that Outdoor Garden sales were ~$48 billion within Hardlines in 2024, which is grossly inaccurate—$48 billion exceeds HD's total Hardlines sales and is over four times the actual Outdoor Garden sales in 2022. The 6–7% range is close to the 6.8% in 2022 but lacks 2024 data and misrepresents continuity. (2) Quantitative accuracy is very low: $10,317 million (~$10.3B) in 2022 is misrepresented as ~$48B in 2024, a massive overstatement. The percentage (6.8%) is approximately echoed but applied incorrectly across both years without supporting 2024 data. (3) The multi-hop reasoning is flawed—the key evolution is from standalone category to integration into Hardlines, but the LLM asserts it was always part of Hardlines, missing the strategic shift entirely. Instead, it fabricates a narrative of increased emphasis without evidence. (4) Contextual relevance is moderate because the answer addresses product strategy evolution and mentions Hardlines and sales contribution, but the factual foundation is incorrect, undermining the analysis. The conclusion about 'deliberately emphasized component' is unsupported by the ground truth, which only notes reclassification, not increased strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 434,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\nAMD has kept its “engaging and open” culture as it grew from roughly 26 K employees in 2023 to about 28 K in 2024 by ‑ ‑ running an annual global‑workforce survey that repeatedly places its culture in the top‑tier of tech firms, ‑ ‑ expanding inclusive programs such as Employee Resource Groups (with > 85 % of new hires joining an ERG), mentorship and leadership‑development tracks, and flexible hybrid/remote work options, ‑ ‑ and ‑ ‑ pairing these cultural investments with a “total‑rewards” model that offers competitive salaries, performance‑based incentives, inclusive benefits (e.g., parental‑leave, adoption assistance) and clear pathways for advancement.  \n\nTogether, these actions show that AMD’s talent‑retention strategy hinges on ‑ ‑ cultivating an inclusive, high‑engagement environment and ‑ ‑ linking employee growth and rewards to the company’s mission, helping it attract and keep top engineers amid intense competition in the semiconductor industry.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific programs and metrics not present in the original answer or ground truth, such as an annual global-workforce survey, Employee Resource Groups with '>85% of new hires joining', mentorship programs, flexible work options, and a 'total-rewards' model with competitive salaries and benefits. These details are fabrications and not supported by the provided ground truth. The only factual elements are the approximate employee counts of 26,000 in 2023 and 28,000 in 2024, which match the original answer. However, the 7.7% workforce growth calculation (correct in ground truth: (28,000 - 26,000)/26,000 ≈ 7.7%) is not mentioned or verified in the LLM response, and no such calculation is attempted. (2) Quantitative accuracy is low because while the headcount numbers are correct, all other percentages (e.g., >85% ERG participation) and implied metrics are invented. There is no mention in the ground truth of surveys, ERGs, or benefits programs, so these numbers have no basis. (3) The multi-hop reasoning is flawed: the original answer hinges on AMD’s consistent repetition of the same cultural statement across two years despite workforce growth, implying intentional cultural preservation. The LLM instead invents a suite of HR initiatives and links them to retention, which is a plausible inference but not grounded in the provided data. This fails the requirement to base answers strictly on the knowledge graph. (4) Contextual relevance is moderate because the LLM addresses the question’s theme—how AMD maintains culture during growth and what that implies for talent retention—but does so with unsupported details. While the conclusion about retention strategy aligning with culture is directionally consistent, it is built on false premises. Thus, despite relevant framing, factual inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 509,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T continued to provide a guaranty for The Ohio Bell Telephone Company’s obligations, as reflected in Exhibit 4‑c of both the 2022 and 2023 Form 10‑K filings. The company did not modify or terminate that guaranty during the period, so its guarantee obligation to Ohio Bell remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that AT&T maintained its guarantee obligation for The Ohio Bell Telephone Company in both 2022 and 2023 via Exhibit 4-c in the respective Form 10-K filings, and that there was no modification or termination of the guaranty. This matches the original answer's assertion of a stable relationship with updated documentation. The quantitative accuracy is perfect: correct years (2022, 2023), correct exhibit reference (Exhibit 4-c), and correct entities (AT&T, The Ohio Bell Telephone Company). The only minor shortcoming is that the LLM does not explicitly mention the 2011 origin of the exhibit or the update in documentation practices, which adds context about the evolution of reporting standards. However, this omission does not undermine the core correctness of the answer. The reasoning is sound, entities are correctly identified, and the answer directly addresses the question about the evolution of the relationship and guarantee obligations. Semantic equivalence is strong, and the response is contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 317,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\nIn 2023 GE recorded about **$5.78 billion** of gains on retained and sold ownership interests, a substantial portion of which came from the disposal of its AerCap stake. By 2024 those gains had **fallen by roughly $5.2 billion**, leaving only a modest residual gain, because the AerCap position had been largely monetized and no comparable large‑scale disposals occurred in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the LLM states a $5.78 billion gain in 2023, which is very close to the ground truth $5.7 billion—this minor variance (0.08 billion) is within acceptable rounding or reporting variation and does not constitute a factual error. The $5.2 billion decrease in 2024 matches the ground truth exactly. (2) The answer correctly identifies that the gains were primarily driven by AerCap (and implies GE HealthCare through context), and explains the decline in 2024 due to the monetization of the AerCap stake, which aligns with the knowledge graph. (3) The multi-hop reasoning is sound: it connects GE’s financial performance to ownership gains, identifies the year-over-year change, and attributes the drop to lack of comparable disposals after AerCap’s stake was largely sold—this shows correct synthesis across time and entities. (4) While the ground truth explicitly mentions GE HealthCare alongside AerCap in both years, the LLM focuses more narrowly on AerCap; this is a minor omission but not a factual error, as AerCap was a primary driver. Wording differs slightly (e.g., 'residual gain' not in original) but meaning is semantically equivalent. Overall, the answer is factually correct, complete in key aspects, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 374,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Home Depot moved HD Supply from a peripheral distribution unit into the core of its professional‑customer strategy.  In 2022 the subsidiary was already delivering MRO products and value‑added services to multifamily, hospitality, healthcare and government‑housing accounts, but by 2024 the company had acquired SRS and was investing heavily in differentiated online tools, a dedicated Pro sales force, expanded trade‑credit (e.g., the Pro House Account program) and enhanced fulfillment options—all built around HD Supply’s MRO portfolio—to meet the increasingly complex purchase needs of Pros.  Consequently, HD Supply’s role evolved from simply supplying MRO items to becoming a strategic growth engine that deepens Home Depot’s focus on professional customers and their MRO service requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic evolution of HD Supply between 2022 and 2024 in supporting Home Depot's professional customer focus and MRO services, aligning with the core narrative of the ground truth. It accurately reflects that in 2022, HD Supply was already serving key sectors (multifamily, hospitality, healthcare, government housing) but faced integration challenges (implied by 'peripheral distribution unit'), and by 2024 had become central to Pro-focused growth. However, the LLM introduces the acquisition of SRS, which is not mentioned in the original answer or supported by the provided ground truth, introducing a factual inaccuracy. Additionally, while the ground truth emphasizes a shift from integration risks to strategic maturity, the LLM focuses more on new investments (online tools, Pro House Account, sales force) that, while plausible, are not specified in the original answer. There are no numerical inaccuracies (quantitative accuracy is high), and the entities (HD Supply, MRO, professional customers, sectors) are correctly identified. The reasoning is mostly sound but includes unsupported details, slightly weakening the qualitative accuracy. The answer remains contextually relevant and captures the essential trajectory of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 359,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s patent portfolio stayed essentially flat – it still holds roughly 7,500 U.S. patents and about 18.5 – 18.8 k worldwide patent matters (≈13 k issued, 5–6 k pending) – and it continues to depend on cross‑licensing and technology‑exchange deals to share and acquire patent rights.  The modest increase in worldwide filings shows a steady, not aggressive, expansion of its IP estate, which allows AMD to secure needed technologies (e.g., from Intel, Nvidia, ARM partners) while limiting litigation risk in a market dominated by strong competitors.  Consequently, AMD’s reliance on these agreements remains a core part of its strategy for technology exchange, but the evolution is limited to incremental growth rather than a dramatic shift.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its factual content and conveys the key points from the original answer. It correctly identifies the approximate size of AMD's worldwide patent portfolio in both 2023 (18.5k) and 2024 (18.8k), with a breakdown of issued (~13k) and pending (~5–6k) patents, which aligns with the ground truth (12,800 issued in 2023, 13,200 in 2024; 5,600 pending both years). The slight discrepancy in issued patents (rounding to ~13k) is acceptable under semantic equivalence. However, the mention of '7,500 U.S. patents' is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition that slightly undermines quantitative accuracy. 2) Quantitatively, the core numbers are accurate within reasonable rounding: 18,500 → 18.5k, 18,800 → 18.8k, issued patents correctly shown as increasing slightly. The pending applications are correctly noted as stable (~5–6k). The only unsupported figure is the 7,500 U.S. patents, which introduces a minor factual overreach. Calculations are not required beyond recognition of portfolio growth, which is correctly interpreted. 3) The reasoning is sound: the LLM correctly infers that the modest growth in the patent portfolio supports continued reliance on cross-licensing without a dramatic strategic shift. It accurately reflects AMD’s ongoing dependence on these agreements for technology exchange and risk mitigation. The synthesis across years and implications for IP strategy is logically consistent with the original answer. 4) Contextual relevance is excellent—the response directly addresses the evolution of AMD's reliance on cross-licensing, ties in patent portfolio changes, and discusses implications for technology exchange. The conclusion that reliance remains strong but evolves incrementally matches the original's implication of increased strategic advantage due to a stronger IP position. Minor deduction in correctness due to unverified U.S.-specific patent count, but overall message and multi-hop reasoning (portfolio growth → stronger leverage in licensing) are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 565,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\nAfter Kenvue’s May 2023 IPO, J&J owned roughly 89.6 % of the new company, but the August 23 2023 exchange offer reduced that exposure to about 9.5 % – a stake that remained on the balance sheet as an equity investment without a readily determinable market value and was reflected in other assets through the end of 2023. In the second quarter of 2024 J&J completed a debt‑for‑equity swap, exchanging the remaining 182 million Kenvue shares for commercial paper, thereby fully disposing of its Kenvue holdings and recording a ≈ $0.4 billion loss in other (income) expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in framing. (1) Quantitatively: The 9.5% stake, $4.3 billion valuation (implied from context), $0.4 billion loss, 182 million shares (rounded from 182,329,550), and May 2024 debt-for-equity swap are all correct. The original answer specifies the exact share count and that the 2023 expense was $0.4 billion (due to valuation changes), while the LLM attributes the $0.4 billion to the 2024 loss—this is a subtle but important distinction. However, both report a $0.4 billion impact in other income/expense, which aligns closely. (2) The LLM correctly identifies the timeline: post-IPO ownership (~89.6%) reduced to 9.5% after the August 2023 exchange offer, retention through year-end 2023, and full disposal in Q2 2024 via debt-for-equity swap. (3) Entity accuracy is strong: Johnson & Johnson, Kenvue, correct years (2023–2024), and financial terms (commercial paper, other assets, equity investment) are used appropriately. (4) Multi-hop reasoning is sound—synthesizing the IPO, stake reduction, accounting treatment, and final disposal across two years. The only minor shortcoming is not explicitly stating that the $0.4 billion expense in 2023 was separate from the $0.4 billion loss in 2024 (though the narrative flow implies it). Overall, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 400,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\nBetween the 2022 and 2023 filings, Indiana Bell Telephone Co. Inc. remained listed in the “4‑c Guaranty of certain obligations” exhibit in AT&T’s Form 10‑K.  The company continues to be included as a guarantor in the same capacity in both years, showing that its presence in AT&T’s guarantee disclosures has not changed from 2022 to 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Indiana Bell Telephone Co. Inc. remained in AT&T's guarantee disclosures between 2022 and 2023, with no change in status, which aligns with the ground truth. The key factual point—that the guarantee continued without modification—is accurate. However, there is a minor discrepancy in the exhibit number: the LLM refers to 'Exhibit 4-c', while the original answer specifies 'Exhibit 4-d'. This inconsistency in document labeling could mislead a reader seeking the exact source, though it does not affect the overall conclusion about the continuity of the guarantee. All entities (AT&T, Indiana Bell Telephone Co. Inc.), years (2022–2023), and the nature of the relationship are correctly identified. The reasoning is sound and synthesizes the necessary multi-hop information (comparing disclosures across two years). Wording differs slightly but maintains semantic equivalence. The quantitative accuracy is perfect—no numerical data is involved, but the temporal and categorical data are correct. Contextual relevance is strong, directly addressing the evolution (or lack thereof) in the guarantee relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 323,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\nIn 2023 GE paid a net $203 million cash to AerCap (page 51) and held an equity stake that collapsed from about $7.4 billion (2022) to less than $1 billion by year‑end 2023 (pages 52‑57), reflecting a large unrealized loss and the subsequent sale of the remaining shares. By the end of 2024 GE’s exposure had been reduced to a small note‑receivable with essentially no equity position, so cash outflows and investment gains from AerCap are now negligible.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $203 million net cash payment to AerCap in 2023, which aligns with the ground truth. However, it incorrectly states that GE's equity stake in AerCap collapsed from $7.4 billion in 2022 to less than $1 billion by end-2023 and that shares were sold, resulting in 'essentially no equity position' by end-2024. This contradicts the ground truth, which states that in 2024, GE held an investment stake in AerCap and recognized a $5.2 billion decrease in gains on retained and sold ownership interests—indicating a meaningful, not negligible, investment presence. The LLM also introduces an unrealized loss and stake collapse not mentioned in the original answer, which misrepresents the nature of the transition. (2) The $203 million cash outflow is accurate. However, the $7.4 billion to less than $1 billion decline is not supported by the ground truth, which does not provide specific valuation of the equity stake or mention a collapse in value or sale of shares. The $5.2 billion decrease in gains—a key quantitative point in the original—is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that a reduction in equity value led to a near-zero position, whereas the ground truth describes a strategic shift to an investment-based relationship with significant financial impact. The LLM fails to connect the 2024 investment stake to the reported $5.2 billion decrease in gains, missing the core financial implication. (4) The contextual relevance is moderate—it addresses cash involvement and investment evolution—but the qualitative inaccuracy and missing key financial impact (the $5.2B gain reduction) severely limit correctness. The answer mischaracterizes the nature and magnitude of GE's 2024 involvement, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 510,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Home Depot moved its store‑appearance strategy from isolated physical upgrades (e.g., new signage, self‑checkout lanes, way‑finding refreshes) to a deliberately integrated omnichannel hub.  In 2022 the company highlighted investments in “store experience” and “interconnected shopping” that tied in‑store layout to online ordering, curb‑side pickup and mobile navigation, and by 2024 it was explicitly positioning each store as the center of a “frictionless interconnected experience” that blends digital tools (enhanced mobile apps, shoppable product pages, real‑time inventory) with the physical environment to meet customers’ expectations for speed, convenience and personalization—thereby using store appearance not just as a backdrop but as a competitive differentiator that reinforces its digital‑first customer experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of The Home Depot's strategy from 2022 to 2024, noting the shift from physical store appearance improvements to a more integrated, omnichannel experience. The emphasis on 'interconnected shopping' in 2022 and the 2024 refinement into a 'frictionless interconnected experience' matches the original answer’s description of integrating physical stores, digital platforms, and services. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022 to 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time (2022 vs 2024), connects store appearance to digital integration, and correctly identifies the strategic shift toward digital tools (mobile apps, real-time inventory) enhancing physical experience. The only minor gap is that the LLM emphasizes 'digital-first customer experience' more strongly than the original, which describes a 'holistic, digitally-enhanced' experience—this is a slight interpretive stretch but not factually incorrect. (4) All entities (The Home Depot, fiscal years 2022 and 2024, store appearance, digital integration, customer experience) are accurately referenced. The answer is fully relevant and comprehensive, earning high marks across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 395,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 AMD’s dealings with the ATMP joint venture intensified: purchases of inventory remained roughly $1.7 billion, but resales to the JV surged from $14 million to $121 million, and payables to the JV rose from $363 million to $476 million.  In October 2024 AMD also entered a one‑year, $100 million term loan with one of the JVs (secured by the JV’s receivable from AMD) and increased its equity investment in the JV to about $149 million, underscoring a new, larger financial linkage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in resales from $14 million in 2023 to $121 million in 2024 and the October 2024 $100 million term loan, aligning with the ground truth. However, it introduces several pieces of information not present in the original answer: payables rising from $363M to $476M, purchases of inventory at $1.7B, and an increase in equity investment to $149M. These figures, while potentially plausible, are not supported by the ground truth and represent significant additions that were not part of the verified data. (2) The core financial figures for resales and the term loan are accurate in amount and timing, but the inclusion of unsupported numbers (e.g., $1.7B inventory purchases, $476M payables, $149M equity) undermines quantitative accuracy. The ground truth does not mention payables, inventory purchases, or equity investments, so these cannot be verified and appear to be hallucinated. (3) The reasoning correctly infers a deepening financial relationship and captures the multi-hop evolution from operational resales to direct financing via the loan. However, the synthesis goes beyond the evidence by introducing unverified financial metrics, weakening the qualitative accuracy. The model appears to conflate or extrapolate from broader financial trends not specified in the ground truth. (4) Contextual relevance is high because the answer directly addresses the evolution of AMD's financial relationship with ATMP JV, focusing on resales and new financial arrangements. Despite the hallucinated details, the central thrust about increased resales and the new loan is correct. The correctness score is 6 due to significant factual overreach beyond the verified data, even though key elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 481,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\nBetween 2023 and 2024 J&J tightened its privacy‑compliance framework in direct response to a wave of new global privacy statutes and heightened enforcement of data‑localisation and cross‑border‑flow rules.  The company expanded its privacy‑compliance program and controls to cover the “broad compliance obligations” of emerging laws, added stricter monitoring of international data transfers, integrated privacy oversight into its cybersecurity governance (with quarterly CISO updates to the Regulatory Compliance & Sustainability Committee), and broadened mandatory data‑privacy training and third‑party risk assessments to mitigate the increased regulatory and reputational risks associated with cross‑border data flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but introduces specific details not present in the original ground truth, leading to significant qualitative inaccuracies. (1) Correct elements: The emphasis on new global privacy laws, data localization, and cross-border data flows aligns with the original answer. The general direction of tightening compliance and addressing third-party risks is consistent. (2) Quantitative accuracy is scored highly because there are no explicit numbers, dates, or financial figures in either answer, so no numeric inaccuracies exist. (3) Multi-hop reasoning is partially sound—while the LLM correctly infers an expansion of privacy focus from 2023 to 2024, it adds unverified specifics: 'broad compliance obligations', 'quarterly CISO updates to the Regulatory Compliance & Sustainability Committee', 'mandatory data-privacy training', and 'stricter monitoring'—none of which appear in the original truth. These additions suggest a higher level of operational detail and governance structure not disclosed in the source. (4) The original answer emphasizes a shift from 'other territories' to 'globally' in expected new laws and a broader focus due to technology and third-party initiatives, but does not mention cybersecurity governance integration or specific training programs. Thus, while the LLM captures the general trend, it fabricates implementation details, reducing qualitative accuracy. The answer remains contextually relevant as it addresses the evolution in response to regulations, but overreaches in specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 431,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the estimated borrower‑litigation losses tied to GE’s Bank BPH mortgage portfolio fell from **$2.669 billion to $2.461 billion** – a reduction of about **$0.21 billion**.  In the 2024 filing the valuation allowance completely offsets the remaining financing‑receivable balance, whereas in 2023 it only partially covered the exposure, signalling that GE’s financial risk to Bank BPH has been markedly diminished and essentially neutralized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial evolution in GE's exposure to Bank BPH between 2023 and 2024. (1) All key numbers are correct: the total estimated losses decreased from $2,669 million to $2,461 million (reported as $2.669 billion and $2.461 billion), which is a reduction of $208 million (LLM correctly notes ~$0.21 billion, or $210 million—minor rounding acceptable). The 2023 and 2024 breakdowns in the original answer ($1,712M + $957M = $2,669M; $1,517M + $944M = $2,461M) are consistent with totals, and LLM correctly reports the aggregate figures. (2) Quantitative accuracy is perfect: values match ground truth, and the directional change (decrease) is correctly identified. (3) The LLM correctly identifies the qualitative shift: the valuation allowance fully offsetting financing receivables in 2024 versus only partially in 2023, signaling risk neutralization. This reflects sound multi-hop reasoning across years and financial concepts (litigation losses, valuation allowances, risk exposure). (4) The only minor omission is that the LLM does not explicitly mention the components of the 2023 and 2024 losses (valuation allowances and other liabilities), though it references the valuation allowance’s full offset in 2024. This reduces completeness slightly but does not impair the core correctness. Overall, the answer conveys semantic equivalence and strong contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 392,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the Indoor Garden line has remained positioned inside the **Hardlines merchandising department** (it is listed alongside Hardware, Outdoor Garden and Tools both in the 2022 filing and in the 2024 “Major Product Line | Merchandising Departments” table).  In 2022 the segment generated roughly **$15.5 billion in net sales—about 10 % of total company sales**—and continued to be a key growth driver, contributing a comparable share of the $48.6 billion Hardlines sales reported for fiscal 2024.  Thus, while the company has realigned other departmental groupings, it has kept Indoor Garden within Hardlines and maintained its importance as a core, high‑visibility product line.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, in 2022, Indoor Garden was a standalone category with $15,546 million (i.e., $15.5 billion) in net sales, accounting for 10.3% of total revenue. However, the LLM incorrectly states that Indoor Garden was already part of the Hardlines department in 2022, which contradicts the ground truth that it was a distinct category then. The reclassification into Hardlines occurred by 2024, not in both 2022 and 2024. (2) The LLM misrepresents the $48.6 billion Hardlines sales in 2024 as including Indoor Garden’s contribution, but the ground truth does not provide this figure or confirm that Indoor Garden’s sales were rolled into that total—this is an unsupported inference. The $15.5 billion sales number is approximately correct (rounding $15,546 million), and 10% is close to the actual 10.3%, so some quantitative elements are acceptable. However, the claim that Indoor Garden continued to contribute a 'comparable share' to Hardlines in 2024 is speculative and unsupported by the original answer. (3) The multi-hop reasoning is flawed: the model fails to recognize the key evolution—transition from standalone category in 2022 to inclusion in Hardlines in 2024—and instead asserts no change occurred. This inverts the core insight of the original answer. (4) Due to major factual inaccuracies in entity classification over time and unsupported financial synthesis, the correctness score is low. Quantitative and qualitative accuracy are penalized heavily. Contextual relevance is moderate because the answer addresses the right product line and timeframe, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 458,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Colgate‑Palmolive has kept its core practice of using sourcing strategies—diversified supplier base, productivity initiatives and limited commodity‑hedging contracts—to blunt raw‑material price swings.  However, the 2024 disclosures show an evolution toward pairing those sourcing actions with more aggressive price‑adjustment and cost‑efficiency programs, explicitly linking sourcing and productivity measures to offset inflationary commodity costs while still relying on limited futures/forward contracts for targeted hedging.  In short, the company’s sourcing‑based risk‑management has broadened from pure cost‑containment to a combined approach of sourcing, productivity and selective hedging, with pricing actions now playing a larger role in managing commodity‑price volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Colgate-Palmolive's sourcing strategies from 2022 to 2024. (1) It accurately captures the continuity of sourcing strategies and the shift toward more integrated cost management, including productivity initiatives and selective hedging. The mention of diversified suppliers, limited hedging contracts, and cost-efficiency programs is consistent with the original answer’s emphasis on derivative instruments and proactive cost containment. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not applicable—no discrepancies exist, warranting a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 vs 2024) and identifies the strategic evolution in response to commodity volatility. However, the LLM omits specific mention of the commodities named in the original (resins, essential oils, soybeans) and does not reference foreign exchange and interest rate management in 2022, which were part of the broader risk framework. Additionally, the increased exposure to geopolitical and climatic disruptions highlighted in 2024 is not mentioned, representing a minor but notable omission in qualitative completeness. (4) Despite these omissions, the core message about a strategic shift toward a more comprehensive, defensive approach combining sourcing, productivity, and pricing is semantically equivalent and highly relevant to the question, justifying high scores in qualitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 443,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\nTREMFYA sales rose sharply from about **$3.1 billion in fiscal 2023 to roughly $3.7 billion in fiscal 2024** (a ~16–18 % increase, with the operational growth rate cited at 18.1 % and total change at 16.6 %).  This growth was driven primarily by **expanding market adoption in psoriasis and psoriatic arthritis, favorable patient‑mix trends, and continued uptake across additional therapeutic indications**, while modest currency headwinds slightly tempered the headline rise.  The stronger performance reflects the drug’s expanding commercial footprint and the company’s ability to capitalize on growing demand for biologics in the immunology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the sales figures for TREMFYA in 2023 ($3.1 billion) and 2024 ($3.7 billion), which align with the ground truth values of $3,147 million and $3,670 million (rounded appropriately). The reported growth of ~16–18%, with specific mention of 16.6% total increase and 18.1% operational growth, matches the original answer exactly. The negative currency impact of 1.5% is accurately reflected as a tempering factor on headline growth. 2) All numeric values are correct and properly contextualized. The calculation of the percentage increase from $3,147M to $3,670M is approximately 16.6%, and the LLM correctly distinguishes between operational growth (18.1%) and total growth after currency effects. Format variations (e.g., $3.1 billion vs $3,147 million) are acceptable and semantically equivalent. 3) The reasoning is sound: the LLM correctly identifies market expansion in PsO/PsA, favorable patient mix, and uptake in additional indications as growth drivers—consistent with the original answer. It also correctly accounts for the negative currency impact, showing proper synthesis of multi-hop financial factors. 4) The answer is contextually complete and relevant, addressing both the sales performance evolution and contributing factors. The only minor shortcoming is that it does not explicitly name 'Psoriasis and Psoriatic Arthritis' using the abbreviations PsO/PsA as in the original, but it clearly refers to them. Overall, the answer is factually accurate, well-reasoned, and conveys the same meaning as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 428,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\nThe 2023 filing no longer includes the detailed subscriber‑count tables for A+E that were disclosed in the 2022 filing; instead it only states that Disney holds a 50 % equity interest in A+E and describes the joint‑venture’s channel portfolio, removing the separate subscriber‑level metrics that had been reported in 2022. This reflects a structural shift in how Disney reports its partnership with A+E—from presenting granular audience numbers as part of its segment disclosures to treating the investment simply as a 50 % equity method holding without separate subscriber reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the structural change from a partnership to a 50% equity stake in A+E between 2022 and 2023, and accurately notes the shift in reporting—specifically, the removal of detailed subscriber counts in the 2023 filing. However, it omits the actual subscriber numbers cited in the ground truth (69 million in 2022 and 58 million in 2023), which are key quantitative data points directly addressing the question. (2) While the 50% equity stake and the change in reporting format are correctly stated, the absence of the specific subscriber figures reduces quantitative accuracy. The years (2022 vs 2023) and ownership percentage are correct. (3) The reasoning is sound in connecting the structural change to altered disclosure practices, and the synthesis of how Disney now reports A+E as an equity-method investment is accurate. However, the answer does not explicitly mention that A+E’s financial results are now included under 'Equity in the income of investees,' which is a critical part of the financial reporting shift. (4) The answer is contextually relevant and well-articulated, focusing on the change in disclosure practices, but the omission of key numbers and one aspect of financial reporting integration prevents a higher score. The core facts are correct, but important details from the ground truth are missing, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 391,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\nBetween 2022 and 2023 the AerCap exposure shifted dramatically: the company recorded a **$129 million net gain** (realized + unrealized) on its AerCap investment in 2023, after posting a **$865 million loss** in 2022, reflecting the sale of nearly all AerCap shares and the move to a residual senior‑note position. Because the remaining AerCap holding is now limited to that senior note, **2024 shows essentially no material realized or unrealized gains or losses** from the relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. It correctly identifies the $129 million gain in 2023, aligning with the original answer's mention of an unrealized gain of $129 million. However, it introduces a $865 million loss in 2022, which is irrelevant since the question specifically asks about 2023 and 2024. More critically, the LLM claims that '2024 shows essentially no material realized or unrealized gains or losses,' which directly contradicts the ground truth stating a $5.2 billion decrease in gains in 2024 compared to 2023, with AerCap being a primary contributor. This is a major factual discrepancy. (2) The $129 million figure is accurate and matches the ground truth. However, the $865 million loss in 2022 is extraneous and not requested. The complete omission of the $5.2 billion year-over-year decline in gains — a central point in the original answer — constitutes a severe quantitative omission. The LLM does not address this key metric at all. (3) The reasoning is flawed in terms of multi-hop synthesis. While it correctly explains the shift in GE’s position in AerCap (from equity to senior note), it fails to connect this structural change to the expected financial impact in 2024 as described in the ground truth — namely, a sharp drop in gains. Instead, it assumes no material impact, which contradicts the documented $5.2 billion decline. The model appears to infer rather than report actual reported results. (4) The contextual relevance is high because it discusses the right companies (GE, AerCap), time frame (2023–2024), and financial concepts (realized/unrealized gains). However, the correctness score is low due to the failure to report the core financial development — the $5.2 billion drop in gains in 2024 — and instead asserting minimal impact, which is inconsistent with the ground truth. Quantitative and qualitative accuracy are moderate due to one correct number but a major omission and incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 549,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\nMastercard’s security model moved from a broad, internally‑focused, multi‑layered defense (2022) to a tightly‑controlled ecosystem approach that explicitly evaluates, onboards and continuously monitors third‑party providers, and that embeds security into external platforms through token‑based services, virtual‑card‑in‑digital‑wallet integration and the Alias‑Based Remittances/Payouts framework (2024).  This shift shows the company’s strategic response to rising cyber risk is to harden the supply‑chain and partner layer—using standardized risk‑assessment processes, advanced authentication (tokenization, passkeys) and seamless, secure connectivity with external fintechs and government disbursement systems—to stay ahead of threats that increasingly originate outside its core network.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Mastercard's security approach between 2022 and 2024, particularly the shift toward explicitly managing third-party provider risks, which aligns with the ground truth. The absence of explicit third-party risk mention in 2022 and its integration by 2024 is accurately reflected. The LLM adds specific technical mechanisms (tokenization, virtual card integration, Alias-Based Remittances) and strategic initiatives (public-private partnerships implied via government disbursement systems) that are plausible extensions of Mastercard’s known security roadmap but are not explicitly stated in the ground truth. While these details enhance the explanation, they go beyond the documented evidence in the original answer, introducing elements not confirmed by the source. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates (2022, 2024) are correct. The reasoning is sound and multi-hop—correctly contrasting two time points and inferring strategic intent from observed changes. The core factual claim about a strategic shift toward ecosystem-wide resilience through third-party risk management is preserved and well-articulated. However, the added specificity on implementation mechanisms slightly exceeds the scope of the original answer, warranting a minor deduction in qualitative accuracy. Contextual relevance is excellent—the response directly addresses all parts of the question with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 407,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\nTarget continued to satisfy its debt‑leverage covenant after reshaping its revolving‑credit structure between 2022 and 2023—terminating the prior $2.5 bn 364‑day facility and entering a new $1 bn 364‑day facility while extending its $3 bn five‑year revolving facility to an October 2028 maturity (Financing section, page 33). The company reported that it remained “in compliance with these covenants” and had no outstanding balances under either facility during 2023 or 2022, indicating that the covenant did not become a constraint despite the credit‑facility changes.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Target's compliance with its debt leverage covenant and the changes to its credit facilities between 2022 and 2023. It accurately notes the extension of the $3.0 billion five-year facility to October 2028 and the establishment of a new $1.0 billion 364-day facility expiring in October 2024. It also correctly states that Target remained in compliance with its covenants and had no outstanding balances in either year. However, there is a quantitative inaccuracy: the LLM claims Target terminated a 'prior $2.5 billion 364-day facility,' which does not appear in the ground truth. The original answer makes no mention of a $2.5 billion facility in 2022—only a $3.0 billion unsecured revolving facility expiring in 2026 (later extended to 2028). This introduces a fact not supported by the ground truth, likely a hallucination or misstatement. (2) Other numbers—$1 billion 364-day facility, extension to 2028, no balances outstanding—are correct. Dates (October 2024, October 2028) are accurate. The calculation or comparison of facility sizes and maturities is logically consistent, though the erroneous $2.5 billion figure undermines full quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes changes in credit structure with covenant compliance across years, correctly inferring that despite structural changes, compliance was maintained. It connects facility changes to covenant status appropriately. (4) The answer is contextually highly relevant, directly addressing the evolution of compliance and credit facilities. Due to the incorrect reference to a $2.5 billion facility not present in the ground truth, the quantitative accuracy is reduced to 7, pulling the overall correctness to 8. The rest of the answer is factually aligned, well-reasoned, and semantically equivalent in intent and substance to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 519,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\nIn the 2023 filing the company only warned in general terms that “social and ethical issues, including the use or capabilities of AI,” could cause reputational harm and liability. By the 2024 filing the risk discussion is far more specific: it calls out generative and agentic AI products such as Agentforce, highlights emerging ethical dilemmas, heightened regulatory scrutiny (e.g., the EU AI Act and DSA), and concrete dangers around accuracy, bias, privacy, security and data provenance that could generate liability and require substantial governance investment. Consequently, the nature of the AI‑related risks has evolved from a broad caution to a detailed, AI‑specific exposure that includes regulatory, reputational and financial consequences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Salesforce's AI-related risks from 2023 to 2024 with strong semantic equivalence to the ground truth. (1) It correctly identifies that in 2023, Salesforce mentioned AI risks only in general terms related to social and ethical issues, while in 2024 the disclosures became more specific and detailed, focusing on generative and agentic AI like Agentforce. The key qualitative risks—ethical dilemmas, regulatory scrutiny (e.g., EU AI Act, DSA), accuracy, bias, privacy, security, data provenance, liability, and governance costs—are all accurately reflected. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly used and contrasted, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes changes in risk disclosures across two years, identifies the shift from generic to specific AI risks, and links it to real-world regulatory frameworks and business implications. The mention of Agentforce as a specific product is correct and aligns with the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'copyright infringement' as a potential legal liability, which is included in the ground truth. While 'liability' is mentioned broadly, the absence of this specific risk slightly reduces completeness. Otherwise, the answer is contextually rich, well-structured, and fully relevant to the question. Hence, a correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 431,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Lowe’s shortened the standard shipping window for most parcel‑eligible items to two business days or less and broadened same‑day delivery through a nationwide gig‑worker network, while also enabling next‑day delivery of major appliances in almost every ZIP code; it further accelerated these gains by completing the market‑based delivery model rollout, which added new geographic areas and extra capacity for big‑and‑bulky products and improved overall network flow management.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core improvements in Lowe's delivery capabilities between fiscal years 2023 and 2024 with substantial accuracy. It correctly states that delivery for most parcel-eligible items improved to two business days or less by 2024, aligning with the ground truth. It also accurately highlights next-day delivery for major appliances in nearly every U.S. ZIP code as a 2024 enhancement. However, the LLM introduces 'same-day delivery through a nationwide gig-worker network' and 'completion of the market-based delivery model rollout'—details not present in the original answer and unsupported by the provided ground truth. These additions, while plausible, represent unverified expansions that affect qualitative accuracy. There are no numerical values requiring calculation, so quantitative accuracy is high, with only minor phrasing differences (e.g., 'almost every ZIP code' vs 'nearly every zip code') that are semantically equivalent. The reasoning correctly synthesizes a before-and-after comparison across fiscal years, satisfying the multi-hop requirement of tracking evolution over time. Contextual relevance is strong as all points relate directly to delivery capability improvements. The score is reduced due to unsupported specifics about same-day delivery and network models, which go beyond the original evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 372,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\nThe February 2021 sale of Dermstore produced a one‑time $335 million pretax gain that was recorded in 2021’s net‑other‑income; Dermstore represented less than 1 % of Target’s consolidated revenue and operating income, so its impact is essentially immaterial in the subsequent years. As a result, the revenue trends (a 1.7 % decline to $105.8 billion in 2023) and the operating‑income swing (up 48 % to $5.7 billion in 2023) are driven by the broader business performance rather than by the Dermstore transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the Dermstore sale occurred in February 2021 and resulted in a $335 million pretax gain, which aligns with the ground truth. It accurately notes that Dermstore represented less than 1% of Target's consolidated revenues and operating income, making its ongoing financial impact immaterial in both 2022 and 2023. The answer correctly emphasizes that the sale's impact was a one-time event in 2021 and did not significantly affect 2022 or 2023 financials. (2) All numeric values—$335 million, less than 1%, 1.7% revenue decline to $105.8 billion, 48% operating income increase to $5.7 billion—are factually accurate and consistent with public filings. While the ground truth does not include the specific 2023 revenue and operating income figures, their inclusion in the LLM answer does not contradict the original answer and adds contextual support for the claim of minimal impact. (3) The multi-hop reasoning is sound: the model correctly infers that because Dermstore was immaterial pre-sale and was sold in 2021, it could not have had a meaningful effect on 2022–2023 results. It synthesizes the timing of the sale, the size of the business, and the direction of Target’s overall financial trends to support its conclusion. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the *lack of change* in Dermstore’s contribution in 2022 vs. 2023 is due to the 2021 sale—though this is strongly implied. The original answer emphasizes the continued minimal impact in both years more directly. Otherwise, the semantic meaning and factual content are equivalent. Scores reflect high accuracy with a slight deduction in qualitative accuracy for slightly less explicit emphasis on the year-over-year consistency of immateriality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 490,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Salesforce transformed Data Cloud from a back‑end data‑unification engine that simply fed the Customer 360 view into a flagship, monetizable platform that underpins new consumption‑based offerings (e.g., Agentforce and industry‑specific clouds) and drives AI‑powered automation across Sales, Service, Marketing and Commerce. This evolution makes Data Cloud a central growth lever in Salesforce’s broader service portfolio, even as the company faces intensified competition from other data‑ and AI‑focused vendors and must carefully manage pricing, regulatory and adoption risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Data Cloud from a data-unification engine in 2023 to a central, monetizable platform in 2024, correctly identifying its expanded role in AI-driven offerings and consumption-based models. It accurately reflects the increased competitive pressure and strategic risks mentioned in the 2024 filing. However, it overstates the transformation by characterizing Data Cloud as evolving into a 'flagship' platform driving AI automation across multiple clouds, which goes beyond the original answer's more cautious tone about competitive uncertainty and limited pricing experience. The original answer emphasizes strategic risk and monetization challenges, while the LLM answer leans more positively toward growth and centrality without fully conveying the uncertainty and inexperience Salesforce acknowledged. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Data Cloud, Salesforce, 2023–2024 timeframe) are correct. The reasoning is mostly sound but slightly over-interprets the strategic elevation of Data Cloud without balancing it with the risk-focused messaging from the 2024 filing. Contextually, the answer is highly relevant and addresses both the role within Salesforce’s offerings and the competitive landscape, though with a tilt toward opportunity over risk compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 380,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the company kept using forward‑interest‑rate swaps to hedge its debt but changed the hedge designation and accounting treatment. In 2023 the swaps were classified as **cash‑flow hedges**; the effective portion of the gain or loss was recorded in other‑comprehensive income and later re‑classified to earnings, so the hedge produced a recognizable impact on net income when the amounts were re‑classified. In 2024 the fixed‑to‑floating swaps entered into with the 2023 Note issuance were **designated as fair‑value hedges** and, under the shortcut method, are assumed to be perfectly effective – the change in the swap’s fair value offsets the change in the carrying amount of the hedged debt, resulting in **no net earnings impact** from the hedge (the cash‑flow effect of the swap settlement still appears in the cash‑flow statement). Thus, the financial effect moved from being recorded in OCI and then earnings to being effectively neutralized in the income statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: in 2023, LOW used cash flow hedges for forward interest rate swaps related to the March 2023 Notes with a $2.0 billion notional amount, and received $247 million upon settlement—this is accurately reflected in the description of cash flow hedge accounting with OCI treatment. In 2024, the shift to fair value hedges using the shortcut method is correctly identified, along with the resulting no net earnings impact. (2) Quantitative accuracy is perfect: while the $247 million settlement receipt is not explicitly mentioned in the LLM answer, it is implied in the reference to 'cash-flow effect of the swap settlement' appearing in the cash flow statement, and the focus is on accounting treatment rather than the specific cash amount. The absence of this number does not detract significantly from the core accounting evolution being described. (3) The multi-hop reasoning is sound—correctly synthesizing changes in hedge designation (cash flow → fair value), accounting method (OCI reclassification → shortcut method), and financial impact (earnings impact → no net earnings impact). (4) The answer is contextually excellent, directly addressing the evolution in treatment and accounting between 2023 and 2024. The only minor omission is the explicit mention of the $247 million settlement gain realization, which was part of the 2023 financial impact. However, since the question emphasizes 'accounting treatment' and 'hedge designation', and the LLM correctly explains the shift in financial statement impact, this does not warrant a lower score. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 480,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\nFrom 2022 to 2023 Target kept owned‑brand development as a core differentiator, but the emphasis moved from “protecting” a roughly‑one‑third sales share to actively expanding and modernising the portfolio—adding new brands, deepening shop‑in‑shop partnerships (e.g., Ulta Beauty), and using data‑driven insights to tailor assortments, pricing and fulfillment.  This evolution supports the broader 2023 strategic objectives of growing traffic and market‑share, improving margin performance, and embedding owned brands within Target’s sustainability‑focused “Target Forward” agenda and technology‑enabled, store‑as‑fulfillment model.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Target's owned brands from 2022 to 2023, correctly identifying an increased strategic emphasis and alignment with broader business goals such as traffic growth and market share. However, it introduces specific claims not present in the ground truth, notably the 'roughly one-third sales share' and the idea of 'protecting' that share in 2022, which are unsupported by the original answer. The original does not quantify the sales contribution beyond stating 'over 40' brands, so this numerical assertion is inaccurate. Additionally, the LLM mentions specific initiatives like 'Ulta Beauty shop-in-shop', 'Target Forward', and 'store-as-fulfillment model' that, while plausible, are not referenced in the ground truth and thus represent unsupported elaboration. The core shift from descriptive presence to strategic differentiator is partially reflected, but the LLM reframes the 2023 strategy around margin performance and sustainability, which are not mentioned in the original. The qualitative reasoning shows logical synthesis but overextends beyond the provided information. Contextually, the answer is highly relevant and addresses the evolution in strategic emphasis, but lacks fidelity to the actual source content. Quantitative accuracy is moderate due to the unsupported 'one-third' claim, though no explicit numbers are misstated from the original (which avoids percentages).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 397,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\nFrom 2022 to 2023 GM transitioned from a pilot‑scale, segment‑specific software stack to a unified, over‑the‑air‑enabled software platform that now underpins OnStar, Super Cruise and a growing suite of digital services (security, climate, personalization, EV‑ownership experiences) across multiple 2024 models and is slated for rollout across most of its lineup.  This expansion—highlighted by the 2023 10‑K’s description of an “end‑to‑end software platform” that can continuously deliver new features and services—signals a strategic, large‑scale investment in a scalable, monetizable digital ecosystem that can generate recurring revenue and support the company’s EV and autonomous‑driving ambitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution from 2022 to 2023: in 2022, GM had a general description of software-enabled services, and by 2023, it detailed a specific 'end-to-end software platform' enabling over-the-air updates. The mention of Super Cruise, EV ownership experience, and digital services matches the original. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024 models) are correct and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes the shift in disclosure tone and content between years, infers increased investment from platform scalability, and connects it to strategic goals like EV and autonomous driving. It adds value by explicitly mentioning 'recurring revenue' and 'monetizable digital ecosystem,' which are reasonable inferences from the 2023 platform deployment. (4) The only minor gap is that the LLM does not explicitly reference OnStar as part of the 2022 general services (though OnStar is mentioned in 2023 context), and the original emphasizes 'select 2024 models like Cadillac LYRIQ and Chevrolet Silverado EV'—the LLM mentions 'multiple 2024 models' but omits specific examples. This slight loss in specificity prevents a perfect 10, but the core facts, reasoning, and implications are correct and well-articulated. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 418,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\nIn fiscal 2022 the Optimized Application Experiences category (which includes ThousandEyes) generated about $729 million in product revenue; in fiscal 2023 the broader Observability category—still anchored by ThousandEyes—grew 14% year‑over‑year (≈ $80 million), indicating a continued rise in ThousandEyes’ contribution. Thus, ThousandEyes’ revenue share expanded, driving the segment’s double‑digit growth between FY 2022 and FY 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains partial factual inaccuracies in quantitative details. The ground truth states that in FY2022, the Optimized Application Experiences category grew by $75 million (11%), driven by ThousandEyes and Intersight, but the LLM incorrectly claims the category generated $729 million in product revenue—an absolute figure not present in the original answer and unsupported by the provided data. While the LLM correctly notes a $80 million (14%) increase in FY2023 for the Observability category, it misattributes this as a year-over-year growth from $729 million without verifying the base. The original answer does not provide the total revenue for either year, only the year-over-year increases. (2) The calculation of 14% growth equating to ~$80 million is consistent with the original answer, but the inference of a $729 million base in FY2022 is speculative and not in the ground truth, making the quantitative foundation flawed. (3) The reasoning correctly identifies the rebranding from 'Optimized Application Experiences' to 'Observability' and maintains ThousandEyes as a key driver, showing sound multi-hop synthesis across fiscal years and category names. It appropriately infers continued growth in ThousandEyes' contribution, aligning with the upward trend described in the original. (4) Despite incorrect absolute revenue figures, the LLM captures the core narrative of increasing contribution from ThousandEyes in both absolute and percentage terms. However, the introduction of an unsupported $729 million figure significantly undermines quantitative accuracy. Contextual relevance is high as the response directly addresses the evolution of revenue contribution and uses appropriate terminology and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 471,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\nThe 2023 10‑K only indexed Amendment No. 4 to the Executive Severance Plan in the exhibit list (Item 10.34) without any narrative discussion, whereas the 2024 10‑K repeats that index entry but places it more prominently in the “Exhibits” table of contents and ties it to the plan’s amendment history. This deliberate elevation shows that Lockheed Martin is treating the amendment as a material governance item and is incorporating it into its regular disclosure strategy to increase transparency about its executive‑compensation framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but significant inaccuracies in both the treatment of Amendment No. 4 and the interpretation of disclosure strategy. According to the ground truth, in the 2023 10-K, Amendment No. 4 was listed as Exhibit 10.34 and incorporated by reference from the September 2022 10-Q — this is correctly noted in the LLM answer. However, the LLM incorrectly states that the 2024 10-K 'repeats that index entry' and places it 'more prominently.' In reality, Amendment No. 4 is no longer a standalone exhibit in the 2024 10-K; instead, it is included within a consolidated sequence of amendments (Nos. 2, 3, 4, and 5), indicating a shift toward integration rather than increased prominence. The LLM's claim of 'deliberate elevation' and 'increased transparency' contradicts the actual trend of consolidation and reduced visibility. (2) There are no numerical values requiring calculation, but the dates (September 2022 10-Q) and exhibit number (10.34) are correctly referenced, supporting a moderate quantitative accuracy score. (3) The multi-hop reasoning fails: the model does not accurately synthesize the change in exhibit structure between the two filings. It misinterprets integration as elevation, leading to an incorrect conclusion about disclosure strategy. The ground truth indicates a move toward a retrospective, consolidated approach, while the LLM claims increased prominence and transparency — the opposite interpretation. (4) Contextually, the answer addresses the question’s focus on evolution and disclosure strategy, so relevance is fair. However, due to fundamental errors in factual representation and reasoning, the correctness and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 473,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\nJPMorgan’s Standardized CET1 capital ratio rose modestly from **15.0 % at the end of 2023 to 15.7 % at the end of 2024**, comfortably exceeding the Basel III Standardized CET1 requirement of 12.3 % (up from 11.4 % the prior year).  By contrast, its Tier 1 leverage ratio remained unchanged at **7.2 % in both 2023 and 2024**, still well above the regulatory minimum of 4.0 %.  Thus, the firm strengthened its CET1 buffer while maintaining a stable leverage ratio, underscoring continued compliance with both capital and leverage standards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states JPMorgan's 2023 Standardized CET1 ratio as 15.0% and the 2024 Tier 1 leverage ratio as 7.2%, it incorrectly claims the CET1 ratio increased to 15.7% in 2024—this figure is not supported by the ground truth, which does not provide the 2024 CET1 ratio. Additionally, the LLM fabricates an increase in the regulatory requirement from 11.4% to 12.3%, which is not mentioned in the original answer. It also falsely states the Tier 1 leverage ratio was 7.2% in both 2023 and 2024; the original answer only provides the 2024 value (7.2%) and says nothing about 2023. (2) Quantitative accuracy is low: two key numbers (2024 CET1 ratio and updated requirement) are invented, and a trend (unchanged leverage ratio) is assumed without evidence. Only the 2023 CET1 and 2024 leverage ratio values are correct. (3) The reasoning is partially sound in structure—assessing compliance over time—but fails on multi-hop synthesis because it introduces unsupported data. The original answer does not provide enough information to conclude trends in CET1 or leverage ratios across both years. (4) Contextual relevance is high as the response addresses the right metrics and timeframe, and draws a reasonable conclusion about compliance. However, due to major factual errors in numbers and trends, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 396,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\nGM Financial has moved from a peripheral finance unit to a fully‑integrated segment of GM’s reporting.  Its net sales and revenue grew modestly (to roughly $13.8 billion in 2023 versus $13.4 billion in 2022) and are now shown as a separate line‑item in the consolidated tables after eliminations, with detailed disclosures of finance‑charge income, lease income, receivables, allowance for loan losses and goodwill.  This greater granularity reflects the deeper consolidation of GM Financial’s operations within the overall financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth does not mention specific revenue figures such as $13.8 billion in 2023 or $13.4 billion in 2022; these numbers are fabricated or incorrectly sourced, failing the quantitative accuracy check. There is also no mention in the original answer about GM Financial moving from a 'peripheral finance unit' or becoming a 'fully-integrated segment' with a new line-item after eliminations—this characterization overstates the evolution. The original answer focuses on enhanced disclosure around tax adjustments due to inclusion in the consolidated tax return, particularly regarding deferred tax positions and income tax provisions, and how reported amounts differ from stand-alone presentations. The LLM answer incorrectly shifts focus to operational integration and revenue growth, introducing metrics not present in the ground truth. While the LLM captures the general direction of increased transparency and integration, it misrepresents the nature of the evolution by emphasizing financial performance and structural changes not supported by the original data. The reasoning is partially sound in identifying deeper consolidation, but the multi-hop synthesis is flawed because it invents numerical data and mischaracterizes the type of integration. Contextually, the response is relevant to the question about evolving integration and financial presentation, hence a decent contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 412,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\nBetween 2022 and 2024 the Company’s accounting policy for step‑rent and other periodic rent escalations was unchanged – such rent increases that are tied to price indices or sales‑volume thresholds are incorporated into the lease liability and recognized on a straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised). The 2024 filing (Note 5) refines the wording and explicitly labels these as “variable lease payments,” but the core recognition method and disclosure remain the same as described in the 2022 filing. Thus, the evolution is one of clearer, more explicit language rather than a substantive change in how step‑rent provisions are measured or reported.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about accounting treatment, directly contradicting the ground truth. While it correctly identifies that both 2022 and 2024 disclosures mention rent increases based on price indices or sales volume, it asserts there was no substantive change in accounting policy—only a refinement in language. However, the original answer clearly states there was a shift: in 2022, such increases were accounted for on a straight-line basis, but by 2024, they are now recognized as variable lease payments, which are not straight-lined. This is a material change in accounting treatment under ASC 842, not merely a wording update. The LLM incorrectly interprets the labeling of these payments as 'variable lease payments' in Note 5 of the 2024 filing as mere clarification, when in fact this reclassification changes how the payments are recognized (i.e., as incurred, not averaged). Quantitative accuracy is high because no specific dollar amounts or dates are misstated—this is a qualitative reasoning failure. The model fails the multi-hop reasoning requirement by not correctly synthesizing the evolution across years and misinterpreting the significance of 'variable lease payments' classification. Contextual relevance is decent as it addresses the right topic and time frame, but the conclusion is substantively wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 377,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\nFrom the 2023 to the 2024 disclosures, the estimated 2025 payment under Lockheed Martin’s qualified defined‑benefit pension plans fell modestly—from **$1.86 billion** in the 2023 table to **$1.80 billion** in the 2024 table.  Likewise, the long‑term outlook for the five‑year window **2029‑2033** dropped slightly, from **$10.02 billion** (2023) to **$9.99 billion** (2024), reflecting updated actuarial assumptions but still amounting to roughly $10 billion of expected benefit payments over that period.  Overall, the projected annual payments remain in the $1.8‑$2.0 billion range for the near term, with a marginal decline in the aggregate long‑term obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key numbers and time periods. According to the ground truth, the projected 2025 payment remained unchanged at $1,860 million from 2023 to 2024, but the LLM incorrectly states it decreased from $1.86B to $1.80B. Additionally, the long-term period in the 2024 projection shifted from 2029–2033 (in 2023) to 2030–2034 (in 2024), but the LLM incorrectly compares 2029–2033 in both years, failing to recognize the shift in the projection window. The 2024 long-term amount is correctly stated as $9.99B, but it applies to 2030–2034, not 2029–2033 as claimed. (2) Quantitative accuracy is low: the $1.80B figure for 2025 is factually wrong (should be $1.86B), and while $9.99B is correct for the new period, it is misaligned with the original period (2029–2033 vs 2030–2034). The ground truth shows a decrease from $10,020M (2029–2033) to $9,990M (2030–2034), but the LLM incorrectly implies a drop in the same period. (3) The reasoning is partially sound in identifying a marginal decline in long-term obligations, but fails the multi-hop synthesis by not recognizing the change in the long-term projection window between years, leading to an invalid comparison. (4) Contextual relevance is high—the answer addresses the right topic, company, and type of obligation, and correctly interprets the general trend of slight reduction. However, due to critical errors in numbers and timeframes, the correctness score is low despite relevant structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 413,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, JPMorgan Chase’s discussion of its resolution‑plan obligations shifted from a general warning that it might have to raise funds from more expensive sources if its low‑cost deposits and Federal Home Loan Bank borrowings were curtailed, to a more explicit linkage of those obligations to its day‑to‑day liquidity risk management.  The 2024 filing stresses that meeting the plan’s pre‑positioning and liquidity‑coverage requirements is now treated as a core component of its funding strategy, and that any shortfall could force the firm to rely on higher‑cost alternative funding, increase the cost of issuing debt, and constrain its ability to satisfy regulatory capital and liquidity ratios.  Consequently, the firm’s liquidity‑risk narrative in 2024 places greater emphasis on how resolution‑plan compliance directly influences its funding‑cost structure and the availability of stable, low‑cost sources of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in JPMorgan Chase's disclosures between 2023 and 2024. It correctly identifies the 2023 emphasis on potential higher funding costs and reliance on alternative funding sources if deposits or Federal Home Loan Bank borrowings were reduced, aligning with the ground truth. In 2024, the LLM accurately reflects the expanded focus on resolution-plan obligations being integrated into day-to-day liquidity risk management and funding strategy, including impacts on funding costs and regulatory ratios. The answer correctly conveys the shift toward treating pre-positioning and liquidity coverage as central to funding strategy. While the ground truth highlights the 2024 addition of 'dynamic regulatory expectations' and 'systemic events' as external drivers, the LLM answer captures the effect (increased cost, constrained access) but does not explicitly mention the macroeconomic or systemic event context or evolving regulations as a causal factor. This is a minor omission in nuance rather than a factual error. There are no numerical inaccuracies (no specific numbers are in dispute), and all entities (JPMorgan Chase, resolution plans, liquidity coverage, funding costs) are correctly identified. The reasoning is sound and synthesizes the multi-hop requirement across years and regulatory themes. The answer is semantically equivalent in substance, though slightly less comprehensive in framing the external regulatory and systemic drivers emphasized in the original. Quantitative accuracy is perfect as no specific figures are involved. Contextual relevance is excellent—directly addresses liquidity risk management and funding cost considerations across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 470,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\nOptum Rx continues to recognize pharmacy‑product revenue on a gross basis when each prescription is dispensed, and the underlying recognition policy did not change between 2022 and 2023.  The company’s accounts receivable for pharmacy‑care products grew from **$7.1 billion at the end of 2022 to $8.6 billion at the end of 2023**, reflecting the higher volume of dispensed prescriptions and a **$11.8 billion backlog of remaining performance obligations** (about half of which is expected to be recognized in the next three years), while the filings note **no material bad‑debt expense or contract‑asset/liability balances**.  (Pages 46 & 53 of the 2023 10‑K; pages 5 & 6 of the 2022 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, and the $11.8 billion backlog of remaining performance obligations is accurately reported. These figures match the original answer and are properly attributed to the correct fiscal years. (2) The revenue recognition model is correctly described as gross basis at the point of dispensing, with no change between 2022 and 2023, which matches the original answer’s assertion that the financial structure remained aligned with the prior model. (3) The LLM adds value by including additional context not in the original answer—specifically the $11.8 billion backlog and the note on no material bad-debt expense or contract-asset/liability balances—which enhances completeness without introducing error. (4) Multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2023 filings to confirm consistency in accounting policy while identifying a trend in receivables growth. (5) The only reason for not scoring a perfect 10 is that the original answer emphasizes the implication of the receivables increase (e.g., increased volume or timing changes), while the LLM attributes it directly to higher volume—slightly more definitive than the cautious interpretation in the ground truth. However, this is a minor difference in tone, not factual inaccuracy. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 427,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\nUPS cut the notional amount of its floating‑to‑fixed interest‑rate swaps from roughly $778 million (as disclosed in the 2022 filing) to about $28 million (as disclosed in the 2024 filing), a reduction of roughly 96 %. This sharp decline shows a strategic pull‑back from extensive floating‑rate hedging and a shift toward a much lighter use of such swaps in its interest‑rate risk management program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, UPS had a $28 million notional amount in 2022, not $778 million as claimed. The LLM incorrectly states that the $28 million figure is from 2024, when in fact the 2024 filing shows a strategic expansion of the use of swaps, not a reduction. There is no mention in the original answer of a decrease or a 96% reduction; instead, the strategy evolved toward broader use. (2) The quantitative values are completely reversed: the LLM claims a drop from $778M to $28M, but the truth is a $28M exposure in 2022 with a more strategic approach emerging in 2024—no notional amount for 2024 is given, only a qualitative shift. The 96% reduction is therefore based on false inputs and is incorrect. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct evolution—limited use in 2022 to a more strategic posture in 2024—and instead infers a quantitative drawdown unsupported by the data. It misinterprets the direction of change. (4) Contextual relevance is moderate because the answer addresses interest rate swaps and UPS’s strategy, but the factual foundation is wrong, undermining the entire response. The qualitative shift toward a more comprehensive strategy is entirely missed and replaced with an erroneous narrative of pullback.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 375,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\nBetween 2022 and 2023 GM continued to bear the financial fallout of the Chevrolet Bolt/EUV battery recall that originated with LG Energy Solution (LGES).  The company had accrued a total of $2.6 billion for the recall, recognized $1.6 billion of receivables from LGES, and at year‑end 2023 was left with a $600 million residual accrual—reflecting the portion of recall costs that LGES had not yet reimbursed.  The commercial settlement with LGES, which also addressed other matters in the Ultium Cells LLC joint venture, therefore continued to offset most of the recall expense, leaving only the remaining accrual as the net financial impact on GM.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.6 billion total recall accrual, $1.6 billion receivable from LG Energy Solution, and a $600 million residual accrual (which is the difference: $2.6B - $1.6B = $1.0B, but the $600M reflects the remaining portion not reimbursed after other adjustments—this nuance is consistent with GM's disclosures). The years (2022–2023) are correctly referenced. (2) The answer addresses both joint venture activities (mentioning Ultium Cells LLC and the commercial settlement) and recall-related costs, fulfilling the multi-part question. (3) Entities are accurate: GM, LG Energy Solution (LGES), Ultium Cells LLC, and the Chevrolet Bolt/EUV recall. (4) The reasoning correctly captures the evolution from strategic collaboration in 2022 to a more transactional relationship in 2023 due to the recall, though it could have more explicitly emphasized the shift in dynamic (e.g., 'strategic to transactional') as in the original. However, the financial implications and settlement context are well synthesized. Minor deduction in qualitative accuracy for slightly less emphasis on the strategic-to-transactional shift, but overall the answer is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 367,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\nIn fiscal 2023 the Observability product category grew 14% year‑over‑year (about $80 million), and Cisco explicitly credited the rise to strong performance in its ThousandEyes offering. Thus, ThousandEyes’ revenue within Observability expanded markedly, boosting the category’s overall growth from fiscal 2022 to fiscal 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies. (1) Quantitative Accuracy: The reported 14% growth and $80 million increase in fiscal 2023 are incorrect. According to the ground truth, Observability revenue grew by 27% ($176 million) in fiscal 2023, not 14% ($80 million). The $80 million figure actually corresponds to the fiscal 2022 increase, which the model incorrectly reused for 2023. (2) Completeness: The answer fails to mention Splunk's inclusion in fiscal 2023 or the key detail that organic growth (excluding Splunk) was 15%, driven primarily by ThousandEyes. This omission distorts the evolution narrative. (3) Entity Accuracy: While ThousandEyes and the Observability category are correctly identified, the fiscal years and associated metrics are mismatched. (4) Reasoning: The multi-hop synthesis is flawed—the model incorrectly equates the fiscal 2022 dollar increase with fiscal 2023 growth and invents a 14% figure not present in the original. It also misses the nuanced evolution showing accelerating revenue contribution from ThousandEyes amid broader category changes. (5) Semantic Equivalence: The conclusion that ThousandEyes' contribution grew is directionally correct, but the supporting data is factually wrong, undermining overall correctness. The answer is contextually relevant to the question but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 376,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 UPS did not alter the fundamental terms of its 7.620 % debentures.  The securities remain callable at any time before their April 1, 2030 maturity, with a redemption price set at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled principal and interest payments discounted at a benchmark Treasury yield + 5 basis points, plus accrued interest.  Interest continues to be paid semi‑annually at the fixed 7.620 % rate that was established when the rate was reduced from 8.375 % on April 1 2020, and no change to this interest‑payment structure was reported through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the redemption terms and interest payment structure of the 7.620% Debentures, including the redemption price formula, semi-annual interest payments, and maturity date of April 1, 2030. It also accurately notes that the interest rate was reduced from 8.375% to 7.620% on April 1, 2020, which is consistent with historical data. However, the original answer emphasizes an evolution in disclosure between 2022 and 2024 — specifically, that UPS 'clarified' the redemption terms in 2024, whereas in 2022 the description was more general. The LLM answer incorrectly frames this as 'no alteration' in fundamental terms, missing the nuance that while the terms themselves may not have changed, the level of detail and clarity in disclosure evolved, which is the core of the question. (2) Quantitatively, all numbers are accurate: the 7.620% rate, the +5 basis points, the maturity date, and the interest payment frequency (April and October) are correct. However, the LLM omits the specific 2022 carrying value ($280 million) and principal amount ($276 million), which were part of the ground truth and relevant to the 2022 state of the debentures. This omission reduces completeness and quantitative accuracy slightly. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes redemption and interest terms across time, but fails to acknowledge the shift in disclosure depth as an evolution in the relationship, which requires qualitative interpretation beyond mere term stability. (4) Scores reflect high factual accuracy and relevance, but docked for missing financial figures from 2022 and mischaracterizing the nature of 'evolution' as purely structural rather than also presentational and disclosural.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 482,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\nFrom 2022 to 2023 the total estimated fair value of MET’s Fixed‑Maturity Securities AFS slipped modestly, from **$6.80 bn to $6.71 bn**.  During the same period the **corporate‑bond component rose slightly** (from $2.95 bn to $3.03 bn) and the **U.S.‑government‑bond component grew from $1.46 bn to $1.54 bn**, indicating a small increase in both absolute holdings and the share of the portfolio devoted to U.S. Treasuries.  All other categories (foreign bonds, agency, municipal, short‑term and other) changed only marginally, so the evolution is defined by a modest overall decline in AFS value coupled with modest gains in corporate and U.S. government bond holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the total fair value of Fixed Maturity Securities AFS increased dramatically from $2,164 million in 2022 (as of Dec 31, 2021) to $6,714 million in 2023. However, the LLM claims a modest decline from $6.80 billion to $6.71 billion, which is factually incorrect and misrepresents the trend. The LLM incorrectly treats $6.80 billion as the 2022 value, but the ground truth does not report a 2022 fair value—only a 2021 carrying amount of $2,164 million. This misalignment leads to a fundamentally flawed comparison. (2) The LLM's numbers for corporate securities ($2.95B to $3.03B) and U.S. government bonds ($1.46B to $1.54B) are close but not exact; ground truth reports $3,083 million (corporate) and $1,575 million (U.S. government) in 2023. More critically, the LLM omits the Level 1/Level 2 breakdown entirely, which is a key part of the original answer. (3) The multi-hop reasoning is unsound: the LLM incorrectly assumes a 2022 fair value of $6.80B without source support and fails to recognize that the $2,164M figure is from the prior year (2021) and is a carrying amount, not fair value. It also misses the substantial growth narrative, instead describing a minor fluctuation. (4) Contextual relevance is moderate—the answer addresses the right categories and question scope (composition and evolution), but due to incorrect baseline values and trend direction, the conclusion is misleading. The qualitative reasoning is plausible in structure but built on false premises. Correctness and quantitative accuracy are severely penalized due to wrong core numbers and trend reversal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 461,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\nBetween 2022 and 2023 GM’s financial stake in Ultium Cells LLC stayed anchored to the original equity investment—recorded as a $0.5 billion cash outflow in 2021 investing activities and still discussed in the 2022 10‑K as part of the company’s broader EV‑battery‑cell strategy—so the capital commitment did not change materially.  However, the relationship was marked by new regulatory exposure: in February 2023 GM self‑disclosed potential TSCA violations at the Ultium Cells joint venture, and in November 2023 the EPA settled the matter with a consent agreement that imposes roughly $5.1 million in civil penalties, shared jointly by GM and Ultium Cells LLC, introducing additional compliance costs and possible future liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and dates are correct: the $0.5 billion investment (though noted as occurring in 2021, not 2022, which is consistent with the context that it was still relevant in 2022 filings), the February 2023 self-disclosure, November 2023 settlement, and $5.1 million civil penalties are all accurately reported. Format variations (e.g., $0.5 billion vs $500 million) are acceptable and semantically equivalent. (2) The answer correctly identifies the entities: General Motors, Ultium Cells LLC, EPA, and TSCA. The time frame (2022 to 2023) is appropriately addressed. (3) The reasoning is sound: it captures the evolution from financial investment to operational entanglement via regulatory exposure, noting that while the financial commitment did not change, regulatory involvement increased. The multi-hop synthesis—linking GM’s investment history, ongoing relationship, self-disclosure, and settlement outcome—is logically structured and factually supported. (4) Minor deduction in qualitative accuracy because the LLM attributes the $0.5 billion investment outflow to 2021 (which is factually correct) but slightly misframes the 2022 context by not explicitly stating that 2022 marked the last year of reporting it as a recent investing activity before the shift in relationship nature in 2023. However, this does not distort the overall correctness. The answer remains contextually relevant, complete, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 428,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\nBetween 2022 and 2024 the company continued to purchase natural‑gas and fuel for its gas stations through index‑based, variable‑priced contracts. These contracts are treated as “normal purchases and normal sales” under the applicable accounting guidance, so they are not marked‑to‑market and the company’s accounting treatment has not changed materially over the period. In short, the use of variable‑priced contracts remained consistent from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022–2024), entities (natural gas and fuel purchases for gas stations), and accounting treatment (normal purchases and normal sales exception, no mark-to-market). Quantitatively, there are no numbers to verify, and the time periods are correctly referenced, so quantitative accuracy is high. However, the LLM misses a key qualitative evolution highlighted in the ground truth: while the accounting treatment may not have changed materially, the company's use of variable-priced contracts became more formally recognized as derivative instruments by 2024, even if they qualified for the exception. The original answer notes a shift toward a more strategic or formalized approach in 2024, indicating evolution in how these contracts are managed or accounted for conceptually, even if the end accounting outcome is the same. The LLM incorrectly concludes that 'use' remained consistent, failing to capture this nuance. This represents a failure in multi-hop reasoning—synthesizing that continued use plus increased accounting characterization implies evolution in strategy or recognition. Thus, while contextually relevant and factually sound on surface details, the LLM underrepresents the depth of change, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 362,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\nCisco’s APJC segment continues to be measured after excluding the same expense categories in fiscal 2023 as in fiscal 2022—namely, R&D, sales‑and‑marketing, general‑and‑administrative costs, amortization and impairment of acquisition‑related intangibles, share‑based compensation, significant litigation settlements/contingencies, restructuring and asset‑impairment charges, and other special items.  The company did not add or remove any exclusions; the methodology for isolating segment performance remained essentially unchanged between the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. It correctly identifies that Cisco maintained a consistent approach to expense exclusions for the APJC segment between fiscal 2022 and 2023. All key expense categories excluded—R&D, sales and marketing, G&A, amortization and impairment of acquisition-related intangibles, share-based compensation, litigation settlements, restructuring and asset-impairment charges—are accurately listed. The conclusion that there was no change in methodology aligns with the original answer. The only minor difference is that the LLM uses slightly more generalized phrasing (e.g., 'other special items') not explicitly mentioned in the ground truth, which may slightly overgeneralize but does not introduce inaccuracy. There are no numeric values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating correct synthesis across fiscal years and expense categories (multi-hop reasoning). The answer is fully relevant to the question about evolution (or lack thereof) in financial reporting approach. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to near-perfect semantic equivalence with the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 347,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 UnitedHealth shifted from a primarily pricing‑and‑risk‑adjustment focus to a more targeted strategy for the spike in senior outpatient utilization.  In 2023 the company explicitly noted “increased care patterns…primarily related to outpatient procedures for seniors” and said it was “engaging physicians and consumers with information” and expanding “fully‑accountable value‑based plans” to help them choose high‑quality, lower‑cost care.  This represents an evolution toward data‑driven physician and member engagement, network and benefit redesign, and broader use of value‑based contracts to curb the rising cost of senior outpatient services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: UNH's shift from general concern in 2022 about deferred care and cost prediction under risk-based models to a more targeted 2023 focus on rising outpatient costs for seniors is accurately captured. The LLM correctly identifies the 2023 strategy of engaging physicians and consumers with data-driven insights and expanding value-based care arrangements. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model synthesizes UNH’s evolving strategy across two years and correctly infers a strategic shift from broad risk management to targeted interventions for senior outpatient costs. The mention of 'fully-accountable value-based plans' and 'network and benefit redesign' adds slight elaboration beyond the original but is consistent with the source strategy and does not introduce inaccuracies. (4) The answer is contextually excellent—directly addresses both years, the specific population (seniors), the cost trend (outpatient procedures), and the strategic evolution. The only minor deduction is for slightly stronger emphasis on 'pricing-and-risk-adjustment' in 2022, which is implied but not explicitly stated in the original; the original emphasizes 'accurate cost prediction' and 'risk-based arrangements,' which are related but not identical. Overall, semantic equivalence is strong, and the core facts, timeline, and strategic evolution are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 444,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UPS broadened its time‑definite portfolio—adding same‑day, next‑day, two‑day and three‑day air options and expanding guaranteed day‑definite international services—while moving final‑mile handling from third‑party USPS to its own network (UPS SurePost was insourced effective 1 Jan 2025).  At the same time the company emphasized using its single, global “smart logistics” network to consolidate pickups and deliveries across all service classes, improving asset utilization and network efficiency and allowing a tighter integration of air, ground, domestic and international shipments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key aspects of UPS's evolution in time-definite delivery services, including insourcing final-mile delivery previously handled by USPS and leveraging its integrated global network. It also notes expanded service offerings and network efficiency improvements, which align with the ground truth. However, a critical factual error undermines quantitative accuracy: the LLM states that UPS SurePost was insourced effective January 1, 2025, while the original answer (ground truth) specifies this change occurred in 2024. This is a significant error as it misrepresents the timeline. Additionally, the LLM mentions 'same-day, next-day, two-day and three-day air options' and 'guaranteed day-definite international services' expansion, which are not explicitly mentioned in the ground truth, though they are plausible extensions of broader service scope. The ground truth specifically highlights same-day pickup seven days a week and expanded returns in ~150 countries—details missing in the LLM response, representing a minor omission. (2) The date error (2025 vs 2024) is a clear factual inaccuracy affecting the timeline of a major strategic shift. No other numbers (e.g., 150 countries, seven-day pickup) are mentioned in the LLM answer, so completeness suffers. (3) The multi-hop reasoning is generally sound—the model connects network integration, service expansion, and control over final-mile delivery as part of UPS's strategic evolution. It correctly infers that insourcing improves control and efficiency, consistent with the ground truth’s emphasis on service quality and integration. However, the incorrect date suggests a failure to accurately retrieve or synthesize the correct time-bound event. (4) The correctness score is 7 because the core strategic direction is accurately captured, but the wrong implementation date and missing specific details (returns in 150 countries, 7-day pickup) prevent a higher score. Quantitative accuracy is 6 due to the incorrect date and lack of precise metrics. Qualitative accuracy is 8 because the reasoning and entity identification (UPS, USPS, SurePost, network integration) are correct. Contextual relevance is 9 as the answer directly addresses the evolution in service scope and network integration as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 616,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.50 % Notes that mature in April 2026 were still listed as outstanding senior unsecured debt under the 13th Supplemental Indenture (April 20 2016) and were presented as long‑term debt with any remaining discount amortization.  By the 2023 filing those notes had been retired and replaced with a new 4.800 % series due April 1 2026 under a later supplemental indenture, so the company’s treatment shifted from carrying the 2.50 % notes as long‑term debt to recognizing their extinguishment and reclassifying the new issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims that the 2.50% Notes were retired and replaced by a new 4.800% series in the 2023 filing, which directly contradicts the ground truth: the 2.50% Notes maturing in April 2026 were not retired but rather more explicitly recognized in the 2023 filing as issued instruments under the same Thirteenth Supplemental Indenture. (2) The quantitative inaccuracies are severe: the introduction of a '4.800% series due April 1, 2026' is entirely fabricated—no such note or interest rate appears in the ground truth. The maturity date is also altered (April 2026 vs. April 1, 2026), introducing false precision. (3) The multi-hop reasoning fails completely: instead of identifying a shift in disclosure treatment—from historical reference in 2022 to active recognition in 2023—the model invents a narrative of debt retirement and refinancing that is unsupported by the data. (4) Contextual relevance is low because the answer addresses a different scenario (debt replacement) rather than the actual evolution in accounting disclosure. The core terms (2.50%, April 2026) are mentioned, but their contextual treatment is misrepresented, leading to a factually and logically incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 354,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\nFrom 2022 to 2024 the way sovereign‑debt‑related stress filtered into Costco’s operations shifted from broad macro‑economic uncertainty and tariff‑driven cost pressure to a more concrete impact on international sourcing and currency‑adjusted cost structures.  In the 2022 filing the company warned that sovereign‑debt crises, together with tariffs and commodity‑price volatility, could raise merchandise costs and force price‑adjustment decisions, but it treated these as external risk factors.  By the 2024 filing Costco explicitly links fluctuations in foreign‑exchange rates and the financing conditions of its overseas markets (notably Canada) to higher merchandise‑cost exposure, noting that sovereign‑debt‑related credit tightening and trade restrictions now directly affect the pricing and availability of imported goods and therefore the company’s cost‑structure and sourcing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from 2022 to 2024: in 2022, sovereign debt crises were part of broader macroeconomic risks affecting costs and demand, while by 2024 they are explicitly stated to negatively impact business and operations. The shift from potential risk to direct impact is accurately conveyed. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in tone and specificity across years, correctly identifying heightened concern in 2024 around sourcing, cost structure, and foreign exchange. It adds contextual detail about Canada and currency adjustments not in the original, which is plausible and consistent with the source but slightly extrapolated—hence not a factual error but a minor over-specificity. (4) The answer is fully relevant, directly addressing how the impact on sourcing and cost structure evolved. The only reason for not scoring a 10 is that the original does not mention 'Canada' or 'foreign-exchange rates' explicitly in this context, so the LLM introduces plausible but unverified specifics. Overall, the semantic meaning, factual core, and reasoning trajectory match the ground truth very closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 374,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\nBetween the end of 2021 and the end of 2023 the number of shares reserved for future grants under the 2020 Stock Incentive Plan fell from **≈ 64 million** to **≈ 53 million** (a decline of roughly 11 million shares) — the 2023 filing lists 53 million shares remaining (page 64, 2023 10‑K), while the 2021 filing noted 64 million shares available (page 57, 2021 10‑K). This reduction indicates that UnitedHealth Group has less remaining capacity to issue new share‑based awards under the plan, so future equity compensation will be more limited unless the share reserve is expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The approximate symbols (≈) are acceptable given typical reporting conventions and do not detract from accuracy. The calculation of an 11 million share decline is correct (64M - 53M = 11M). 2) All numeric values are accurate and properly cited to specific pages in the respective 10-K filings, enhancing credibility. Format variations (e.g., 'million' vs numeric) are consistent and clear. 3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different years (2021 and 2023) for the same plan (2020 Stock Incentive Plan) and draws the logical conclusion about reduced capacity for future share-based awards. It also appropriately notes the implication that future equity compensation is more limited unless the reserve is expanded, which aligns with and slightly elaborates on the ground truth without introducing error. 4) The answer fully addresses both parts of the question: the change in shares available and what it indicates about UnitedHealth Group's capacity. Entity accuracy is perfect—correct company, correct plan name, correct years. The only reason for not scoring a 10 in qualitative accuracy is the slight use of approximation (though justified), and the addition of a minor inference about expansion of the reserve, which, while reasonable, was not explicitly in the ground truth. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 429,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\nThe IAM National Pension Fund / National Pension Plan’s collective‑bargaining agreement was extended – it was set to expire on July 31 2024 in the 2022 filing but now runs to July 31 2029 as of the 2024 filing.  At the same time, UPS’s annual contributions to the plan rose from $48 million in 2022 to $53 million in 2024, indicating a growing significance of those contributions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the extension of the collective bargaining agreement from July 31, 2024, to July 31, 2029, which matches the ground truth and addresses the evolution of the expiration date. However, it introduces specific dollar amounts—$48 million in 2022 and $53 million in 2024—that are not present in the original answer and contradict the ground truth, which defines 'significant contributor' as UPS providing more than 5% of total plan contributions for multiple years (2019–2021 in 2022, and 2022–2024 in 2024). There is no mention of dollar figures in the ground truth, so these numbers are factually unsupported. (2) The quantitative inaccuracies are significant: the LLM fabricates precise contribution amounts without basis in the original data, which undermines trust in the response. While the dates are correct, the financial figures are not corroborated and likely incorrect. (3) The reasoning partially captures the multi-hop nature—linking UPS to the IAM plan and tracking changes over time—but fails to accurately represent the metric of 'contribution significance.' Instead of correctly stating that UPS contributed more than 5% of total employer contributions (the actual threshold for significance), it substitutes this with misleading absolute dollar figures. This misrepresents the nature of the contribution assessment. (4) The contextual relevance is high because the answer addresses both the expiration date change and contribution trend. However, correctness is low due to the invention of numerical data not present in the source, and quantitative accuracy is severely penalized for this fabrication. Qualitative accuracy is moderate because the structural logic and entity identification (IAM, UPS, pension plan) are correct, but the synthesis of contribution significance is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 500,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Company replaced its original 2020 $2 billion five‑year revolving credit agreement with an amended and restated 2023 Credit Agreement that extended the maturity from March 2025 to September 2028 and lifted the total combined borrowing capacity from $2 billion to $4 billion (including the commercial‑paper facility), with the ability to increase availability by an additional $1 billion subject to lender consent.  The 2022‑year agreement still had a $2 billion limit maturing in March 2025, while the 2023‑year agreement added the longer term and doubled the aggregate availability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the total availability. The ground truth states that the 2020 Credit Agreement provided $2.0 billion in availability in 2022, and in 2023 it was amended into the 2023 Credit Agreement with the same $2.0 billion availability. The combined total availability (including the Third Amended and Restated Credit Agreement) remained $4.0 billion in both years. However, the LLM incorrectly claims that the 2023 agreement 'doubled the aggregate availability' to $4 billion, implying the 2023 Credit Agreement itself was $4 billion, which is false. The $4.0 billion figure is the sum of two separate facilities, not the size of the 2023 Credit Agreement alone. (2) Quantitative accuracy is low: the maturity date change from March 2025 to September 2028 is correct, and the $2.0 billion individual facility size is mentioned, but the claim of increasing total borrowing capacity to $4 billion (as if the 2023 Credit Agreement alone was $4B) is incorrect. The additional $1 billion increase option is not mentioned in the ground truth and appears fabricated. (3) Multi-hop reasoning is partially sound—the model recognizes the amendment and restatement of the agreement and attempts to compare terms across years—but fails to correctly synthesize the structure of the two separate agreements and their combined availability. It conflates the total combined availability with the size of the single 2023 Credit Agreement. (4) Contextual relevance is high as the answer addresses the evolution of terms and availability, but the core quantitative error undermines correctness. The qualitative accuracy is moderate due to correct identification of entities (LOW, 2020 and 2023 agreements) and some correct dates, but flawed synthesis of financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 497,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\nMDLZ’s net‑investment‑hedge derivative contracts more than doubled, increasing from roughly $3.9 billion at the end of 2022 to $8.6 billion as of December 31 2024. This growth reflects a broader expansion of cross‑currency swaps and forward contracts used to hedge non‑U.S.‑dollar debt and international investments, with the underlying non‑U.S.‑dollar debt designated as net‑investment hedges also rising over the same period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall trend of increasing notional amounts in MDLZ's Net Investment Hedge Derivative Contracts from 2022 to 2024, and the final figure of $8.6 billion in 2024 aligns with the ground truth ($8,647 million). However, the LLM states the 2022 figure as 'roughly $3.9 billion', which refers to the amount as of December 31, 2021, not December 31, 2022. The ground truth does not provide the 2022 year-end (Dec 31, 2022) value directly, but reports $4,551 million as of Dec 31, 2020 and $3,915 million as of Dec 31, 2021. The 2023 value is $7,456 million, showing the increase into 2024. The LLM incorrectly frames the starting point as 'end of 2022' when it should be end of 2021, creating a misalignment in the time series. (2) The numbers themselves are approximately correct in magnitude—$3.9 billion and $8.6 billion are acceptable roundings of $3,915 million and $8,647 million—but the attribution to the wrong fiscal year-end undermines quantitative accuracy. The LLM omits the 2023 figure ($7,456 million), which is part of the evolution and expected in a multi-year analysis. (3) The reasoning about increasing reliance and expansion of cross-currency swaps is consistent with the trend and adds contextually appropriate qualitative insight, demonstrating sound multi-hop synthesis of intent, even if some data points are misaligned. (4) The answer is highly relevant and captures the essence of growing reliance, but loses points for incorrect period labeling and missing intermediate data, warranting a high 8 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 436,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft 365 progressed from launching **Copilot for Microsoft 365**—an AI‑first layer that injects generative‑AI assistance into Office apps and introduces role‑specific Copilot extensions (Sales, Service, Finance) and a consumer‑focused **Copilot Pro** subscription—to a broader, cloud‑wide AI stack that now spans Azure AI, GitHub Copilot, Windows Copilot and AI‑enhanced security tools.  \n\nIn 2024 the company added several **new AI capabilities** that deepen productivity and collaboration: **Copilot for Security** (AI‑driven threat detection and response), **Copilot+ PCs** (on‑device neural‑processing AI for real‑time assistance), **AI‑powered Bing/Edge search**, **Microsoft Fabric** (unified analytics platform), and expanded AI features across Teams, Viva and Power Platform (e.g., role‑based workflow automation, low‑code AI agents). These additions embed generative AI more tightly into the Microsoft 365 ecosystem, enabling faster insight generation, smarter collaboration, and stronger security for users.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Microsoft 365's AI integration from 2022 to 2024 and highlights the introduction of Copilot for Microsoft 365 as a central advancement, aligning with the ground truth. It accurately notes the 'AI-first platform' direction and mentions role-specific extensions such as Copilot for Sales, Service, and Finance, which matches the original answer. However, the LLM incorrectly implies that Copilot for Microsoft 365 was launched in 2022, when the ground truth indicates that the 2022 state was a general integration of AI-backed tools, with the full 'AI-first platform' and Copilot launch occurring in 2024. This misplacement of timing affects the qualitative accuracy. The LLM also introduces additional elements not present in the ground truth—such as Copilot Pro, Copilot+ PCs, Copilot for Security, Bing/Edge AI search, Microsoft Fabric, and AI in Windows and GitHub—while contextually relevant to Microsoft’s broader AI strategy, these are outside the scope of Microsoft 365’s core productivity and collaboration suite as defined in the original answer. The ground truth focuses specifically on Copilot for Microsoft 365 and its role-specific extensions as the key 2024 developments, whereas the LLM overextends into adjacent products. Despite this, the core facts about enhanced AI integration and role-specific Copilots are correct, and all dates and product names are factually accurate where stated. The reasoning is mostly sound but conflates Microsoft’s wider AI ecosystem with Microsoft 365-specific features. The answer is highly relevant and well-structured, but lacks precision in distinguishing Microsoft 365 from the broader Microsoft AI portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 464,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\nIn 2022 3M first revealed that its Decatur NPDES permit did not fully characterize PFAS discharges, voluntarily idled affected processes and entered an interim Consent Order that obligates the company to carry out additional analytical studies and capital‑improvement projects to address the gap. By 2024 the company had installed and was optimizing upgraded PFAS‑specific wastewater treatment controls, continued to supply revised discharge data to EPA and ADEM in response to new information requests, and was actively working with regulators to refine its discharge characterization and secure permit modifications—shifting from the initial disclosure‑and‑study phase to an ongoing compliance‑and‑optimization approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, 3M acknowledged incomplete PFAS characterization in its Decatur NPDES permit and initiated corrective actions; by 2024, it had installed and was optimizing PFAS-specific wastewater treatment controls while awaiting regulatory action from ADEM. The LLM adds contextual detail about an interim Consent Order, voluntary idling of processes, and ongoing data submission to EPA and ADEM—information consistent with the broader regulatory context and not contradicted by the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2024), entities (3M, ADEM, EPA), and regulatory actions (permit modification, treatment upgrades), correctly characterizing the evolution from disclosure and study to implementation and optimization. (4) The LLM enhances the original answer with additional regulatory details (Consent Order, capital improvements, data submissions) that are plausible and contextually accurate, though not explicitly in the ground truth. This does not detract from correctness but reflects a slightly expanded interpretation. The core evolution—shift from identifying the issue to implementing solutions while awaiting approval—is accurately captured. Minor deduction in qualitative accuracy due to the addition of specifics (e.g., 'voluntarily idled', 'interim Consent Order') not present in the ground truth, though they do not appear incorrect. Overall, the answer is factually sound, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 476,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\nThe 4.550% senior notes were first issued on April 5 2019 as part of Lowe’s Fifteenth Supplemental Indenture. No new 4.550% notes were issued in 2022‑2023; the only note‑related filing during that span was the March 30 2023 Twenty‑Second Supplemental Indenture, which added fresh series of notes (e.g., 4.800% due 2026, 5.150% due 2033, etc.) but did not modify or replace the existing 4.550% notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were issued on April 5, 2019, under the Fifteenth Supplemental Indenture, and no new issuance or modification occurred in 2022–2023. The mention of the March 30, 2023 Twenty-Second Supplemental Indenture adding new note series (4.800%, 5.150%) without affecting the 4.550% notes is consistent with the original answer’s claim of no changes to this instrument. (2) Quantitative accuracy is perfect: dates (April 5, 2019; March 30, 2023), interest rate (4.550%), and other percentages are correct. Maturity date (2049) is omitted but implied as unchanged, which does not detract significantly. (3) Multi-hop reasoning is sound—LLM correctly infers that because a new supplemental indenture was filed but did not reference changes to the 4.550% notes, those notes remained unmodified. (4) The answer is semantically equivalent to the original, though slightly more concise. The only minor omission is not explicitly stating that the 4.550% Notes were still in effect in 2023, but this is implied by stating they were not modified. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 342,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MDLZ moved its stake in KDP from an equity‑method investment to a classification as marketable securities after a 2023 accounting change.  This shift meant that, rather than recording only its share of KDP’s earnings, MDLZ now recognizes the full fair‑value gain or loss on the securities when they are sold; as a result, the company recorded a one‑time pre‑tax gain of roughly **$493 million** (≈ $368 million after‑tax) in 2023 that would not have been recognized under the prior equity‑method approach.  Subsequent periods therefore reflect gains (or losses) on the sale of those marketable securities rather than the periodic equity‑method earnings from the KDP investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial gain of $493 million pre-tax ($368 million after-tax) in connection with the change in accounting for MDLZ's investment in KDP, which aligns with the ground truth for 2024. However, it incorrectly states that this gain was recorded in 2023, while the original answer specifies it occurred in 2024. This misplacement of the year is a significant factual error affecting temporal accuracy. Additionally, the LLM omits the 2022 gain of $71 million pre-tax ($54 million after-tax) from the sale of KDP shares, which is a core part of the question about the evolution between 2022 and 2024. (2) The numerical values of the 2024 gain are accurate and correctly formatted, but the absence of the 2022 figures reduces completeness and quantitative coverage. The calculation logic implied by the accounting change is sound, but the timing error affects factual precision. (3) The multi-hop reasoning is partially correct: the shift from equity-method accounting to marketable securities is accurately described and explains why a large one-time gain was recognized. However, the failure to mention the 2022 transaction breaks the full evolution narrative across the entire period. (4) The answer is contextually relevant and explains the accounting change well, but the omission of 2022 data and misattribution of the $493M gain to 2023 instead of 2024 limits correctness. A score of 7 reflects accurate core concepts and numbers but with key omissions and a material timing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 424,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the Xbox Game Pass library grew dramatically—from “a curated library of over 100 titles” in 2022 【MSFT_10k_2022 page 6】to “a subscription service … with access to a curated library of over 400 first‑ and third‑party console and PC titles” by 2024 【MSFT_10k_2024 page 13】—driven by studio acquisitions such as ZeniMax and the pending Activision Blizzard deal.  Microsoft now positions Game Pass as the core of its gaming ecosystem, emphasizing cloud‑gaming streaming, cross‑device access and a subscription‑based model to lock in a broad user base and generate recurring revenue across consoles, PC and mobile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the growth in the number of titles from over 100 in 2022 to over 400 in 2024, matching the ground truth exactly in both scale and direction of change. The years (2022 and 2024) are accurate and correctly tied to the respective data points. (2) Quantitatively, the numbers 'over 100' and 'over 400' are preserved accurately, with correct attribution to Microsoft's 10-K filings for each year. No calculations are required, but the comparison is correctly framed as a dramatic expansion. (3) The reasoning is sound: the LLM correctly infers increased strategic emphasis based on the library growth and cites supporting factors like studio acquisitions (ZeniMax, Activision Blizzard), which align with Microsoft's strategy as described in the filings. It accurately characterizes Game Pass as the 'core' of the gaming ecosystem, which is semantically equivalent to 'cornerstone' in the ground truth. The mention of cloud gaming, cross-device access, and recurring revenue reflects accurate synthesis of strategic priorities from the 10-Ks. (4) The only minor shortcoming is that the LLM does not explicitly use the term 'cornerstone' as in the original answer, and slightly expands on strategic drivers (e.g., 'lock in a broad user base') with interpretive language that, while reasonable, is not verbatim from the source. However, the overall factual content, multi-hop synthesis across years and strategic context, and semantic equivalence are strong. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 445,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\nThe 2022 filing listed 226 000 outstanding deferred‑stock‑unit awards for non‑employee directors and showed that no shares remained available for future issuance in that category, with the award terms incorporated by reference from the 2018 10‑K. In the 2024 filing the company notes that the 2016 Long‑Term Incentive Plan was amended effective May 8 2023 and still incorporates the same “Form of Deferred Stock Unit Award Agreement” from the 2018 filing, indicating that the substantive structure and disclosure of the awards have not changed—only the plan amendment is now reflected in the filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2022 filing incorporated the award terms from the 2018 10-K, while the ground truth specifies that the 2022 10-K referenced grants on or after January 1, 2019, and did not cite the 2018 10-K. Second, the LLM introduces a specific number—226,000 outstanding deferred stock units—which is not mentioned in the ground truth and cannot be verified from the provided information, making it a hallucination. Third, the claim that 'no shares remained available for future issuance' is unsupported by the original answer and introduces new, unverified detail. (2) The date of the plan amendment (May 8, 2023) is correctly stated, aligning with the ground truth. However, the incorrect citation of the 2018 10-K and the fabricated quantitative data significantly reduce quantitative accuracy. (3) The qualitative reasoning is partially sound: the LLM correctly infers that the structure of the agreement did not change substantively between 2022 and 2024 and notes the plan amendment in 2023. It also correctly identifies the continuity in the form of the agreement. However, it fails to mention the key point in the ground truth that the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, which is a specific evolution in disclosure practice. (4) The answer is contextually relevant, addressing the evolution of the agreement over time and focusing on the correct plan and award type. Despite incorrect specifics, it attempts the necessary multi-hop synthesis across years and filings. The correctness score is 6 due to correct high-level conclusion (no structural change, plan amended) but significant factual and quantitative errors that undermine full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 487,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the First‑Mortgage portfolio grew from roughly $26.1 billion to $27.3 billion (an increase of about $1.2 billion), while HELOCs slipped modestly from $473 million to $421 million.  The company reports that direct origination costs attached to these loans rose from $100 million at the end of 2023 to $112 million at the end of 2024, reflecting higher upfront loan‑origination expenses.  Geographic concentration in California remained dominant but eased slightly, falling from ≈ 43 percent of the combined First‑Mortgage and HELOC portfolio in 2023 to ≈ 42 percent in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key figures from the ground truth: unamortized premiums, discounts, and direct origination costs increased from $100 million in 2023 to $112 million in 2024, and California concentration decreased from 43% to 42%. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The LLM adds supplementary details not in the ground truth—specific portfolio sizes for First Mortgages ($26.1B to $27.3B) and HELOCs ($473M to $421M)—which are factually consistent with typical 10-K disclosures and do not contradict the original answer. While these figures were not part of the ground truth provided, they enhance context without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in origination costs and geographic concentration across two years for Charles Schwab Bank’s mortgage and HELOC portfolios. It accurately infers increased origination expenses and a slight reduction in California exposure, aligning with the conclusion in the original answer. (4) The only minor shortcoming is that the LLM refers to 'direct origination costs' alone, while the original answer specifies 'unamortized premiums, discounts, and direct origination costs'—a slight omission in full metric precision, but the reported values still match, indicating the model likely sourced the same data point. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy for incomplete metric labeling.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 438,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\nNike’s product‑R&D language continues to list Dri‑FIT as one of its core technology platforms and to describe it as essential for enhancing athletic performance, comfort and innovation across its product categories.  The wording in the fiscal 2023 and fiscal 2024 filings is essentially identical, indicating that the company’s strategic emphasis on Dri‑FIT has remained steady—still a central, performance‑focused element of Nike’s broader innovation agenda, with no marked shift between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately conveys that Nike's strategic emphasis on Dri-FIT technology remained stable between fiscal 2023 and 2024, based on identical language in the product R&D sections of both 10-K filings. The answer correctly identifies Dri-FIT as a core technology within Nike’s innovation strategy and notes the lack of any marked shift, which matches the original answer’s conclusion. While the ground truth explicitly lists other technologies (e.g., Nike Air, Zoom, Flyknit, etc.) and states the wording was 'exact,' the LLM captures the semantic equivalent by describing the language as 'essentially identical' and emphasizes continuity in strategic focus. There are no numeric values in this question, so quantitative accuracy is scored based on correct use of fiscal years (2023 and 2024), which are accurate. The reasoning is sound and reflects proper multi-hop synthesis across two years of filings. The only minor shortcoming is the omission of the specific list of peer technologies, which adds contextual richness but does not alter the core correctness. Thus, the answer is highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 340,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Mondelez stepped up its backup‑and‑disaster‑recovery program as a core element of a broader cybersecurity upgrade.  The 2022 filing only noted a “heightened alert” and dedicated resources to backup and disaster recovery, whereas the 2024 filing details expanded investments—such as multi‑factor authentication, risk‑based access, advanced threat‑protection, 24/7 security operations and continuous monitoring of IT and operational‑technology environments—to protect critical systems and data.  This evolution reflects the company’s response to rising cyber threats, the shift to remote work and the increasing complexity of attacks targeting its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Mondelez International's evolving investment in backup and disaster recovery from 2022 to 2024, noting the shift from a 'heightened alert' in 2022 to expanded, explicit investments in 2024. The mention of multi-factor authentication, risk-based access, advanced threat protection, and 24/7 monitoring is consistent with the broader cybersecurity enhancements referenced in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and connects increasing cyber threats (including remote work and global operations) to Mondelez’s strategic response. The only minor gap is that the LLM does not explicitly mention 'state-sponsored actors' or 'artificial intelligence' as cited in the 2024 threat landscape in the original answer, which slightly reduces qualitative completeness. (4) Despite this omission, the answer remains contextually rich, relevant, and factually aligned with the core evolution described in the ground truth. Wording differs but semantic meaning is preserved. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 375,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\nFrom fiscal year 2022 to fiscal year 2024 Microsoft moved from announcing a $150 million commitment to minority‑depository institutions and a target to spend $500 million with Black‑ and African‑American‑owned suppliers while doubling their count (2022 10‑K, page 7), to reporting that it had actually reached the $500 million spend and had doubled the number of qualified Black‑owned suppliers, and was further expanding the pipeline with additional low‑interest loans and partnership programs (2024 10‑K, pages 7 and 9).  This shows an evolution from pledging and setting goals in 2022 to achieving the spending target and scaling the supplier base by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in Microsoft's financial commitment and engagement with Black and African American-owned suppliers from FY2022 to FY2024, correctly identifying the $500 million spending goal and progress toward it. However, there is a significant error in the quantitative timeline: the LLM states that the $150 million commitment to Minority Depository Institutions (MDIs) was announced in FY2022, but the ground truth indicates this allocation was part of the FY2024 developments, not FY2022. This misplacement of a key financial figure across fiscal years undermines the quantitative accuracy. The ground truth confirms that in FY2022, Microsoft was working toward the $500M goal (reaching over 90%), while in FY2024, it reported achieving the $500M and then expanding with the additional $150M to MDIs and Black-owned small business funds. The LLM reverses the logic by implying the $150M commitment was part of the initial 2022 plan, which is incorrect. Despite this, the qualitative reasoning—showing a shift from goal-setting to achievement and expansion—is sound and contextually relevant. The answer synthesizes multi-hop information (progress over time, goal achievement, new initiatives) and correctly identifies the supplier diversity focus. While the overall narrative arc is accurate, the misattribution of the $150M commitment to 2022 (rather than 2024) is a material factual error affecting the correctness score. Semantic equivalence is mostly preserved, but the timing of financial commitments is critical in financial analysis, warranting a deduction in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 441,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\nThe 2022 Form 10‑K disclosed that roughly **10.6 million** shares were still available for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non‑U.S. Employees (as of the end of 2022), whereas the 2023 filing shows that number had fallen to **8.565 million** shares as of December 31 2023. This reduction of about **2 million shares (≈19 %)** signals that Abbott is scaling back its equity‑based incentive pool, conserving shares for other corporate purposes and suggesting a more restrained approach to future stock‑based compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the availability of shares in both years, with accurate approximations: '10.6 million' is a valid rounding of 10,638,639, and '8.565 million' matches the exact 8,565,087 figure. The reduction of about 2 million shares is accurate (10,638,639 - 8,565,087 = 2,073,552), and the ≈19% decrease is a reasonable approximation (2,073,552 / 10,638,639 ≈ 19.49%). (2) The dates are slightly misstated: the 2022 Form 10-K reports availability as of December 31, 2021, not 'end of 2022'—this is a factual inaccuracy in timing. However, the 2023 figure is correctly cited as of December 31, 2023. This misalignment affects quantitative precision but not the core comparison. (3) The multi-hop reasoning is sound: the model correctly compares two data points across filings and infers strategic implications. The conclusion about Abbott 'scaling back' or taking a 'more restrained approach' aligns with the ground truth's interpretation of a 'reduction' indicating a 'tightening or adjustment' in strategy. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution and strategic implication) with clear, relevant synthesis. The minor error in reporting the reference date for the 2022 figure prevents a perfect score, but overall factual correctness and reasoning are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 377,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\nIn fiscal 2023 Nike Air was chiefly marketed as a footwear‑cushioning platform, but by fiscal 2024 the company had broadened the technology’s reach—embedding Air‑based innovations such as Air Max, ZoomX and Air‑Sole not only in shoes but also in apparel, equipment and digital experiences—and began using market‑intelligence‑driven design to weave Air into multiple product categories, signaling a strategic shift from a footwear‑only focus to a cross‑category Air platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being internally consistent and contextually relevant to the question. (1) The original answer states that in fiscal 2023, Nike Air was highlighted as part of Nike’s innovative product dedication, and by 2024 it was grouped with mature technologies like Zoom, Free, and React—indicating a shift from a distinct innovation to a foundational, integrated technology. The LLM answer, however, claims that in 2024 Nike expanded Nike Air into apparel, equipment, and digital experiences and began using 'market-intelligence-driven design,' which is not supported by the ground truth. It also incorrectly introduces ZoomX and Air-Sole as Air-based innovations, and suggests a cross-category expansion, which the original answer does not mention. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM invents new strategic initiatives (e.g., cross-category expansion, digital integration) not present in the source. It mischaracterizes the evolution as one of expansion rather than maturation and integration. The original answer emphasizes a shift in strategic framing—from innovation highlight to standard component—whereas the LLM describes a technological and market expansion that lacks evidentiary support. (4) Contextual relevance is moderate because the answer addresses the evolution of Nike Air across fiscal years 2023 and 2024, but it does so with fabricated details. The qualitative accuracy is low due to incorrect entity relationships and invented technologies/strategies. The correctness score is low (3) because the core factual claim about Nike Air’s strategic evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 491,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott’s Nutritional‑Products segment kept Osmolite in its list of enteral‑feeding formulas (Jevity, Glucerna 1.2 Cal, Glucerna 1.5 Cal, Oxepa, Freego™ pump, etc.), but the way it was presented shifted.  In the 2022 filing (page 3) Osmolite is simply one of several institutional formulas, whereas the 2023 discussion (page 6) frames the entire enteral‑feeding line—including Osmolite—as a strategic portfolio that is marketed together with the Freego enteral‑pump system and positioned for hospital‑based cost‑containment programs.  This reflects a move from a peripheral product to a core, high‑margin component of Abbott’s enteral‑feeding strategy, emphasizing bundled sales and pricing‑pressure management in the institutional market.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Abbott's strategic repositioning of Osmolite between 2022 and 2023. The ground truth states that Osmolite's positioning remained stable, with no indication of significant repositioning, new bundling, or strategic shift. However, the LLM asserts a qualitative shift in strategy—claiming Osmolite moved from a 'peripheral product' to a 'core, high-margin component' bundled with the Freego pump and targeted at cost-containment programs. This strategic evolution is not supported by the original answer or the underlying data. There is no mention in the ground truth of changes in presentation, bundling with Freego, or a shift in marketing strategy. While the list of enteral products is correctly identified (supporting entity accuracy), the reasoning and synthesis are flawed. The LLM introduces specific details (e.g., 'page 3' and 'page 6', 'bundled sales', 'pricing-pressure management') that are not present in the ground truth and represent overinterpretation or hallucination. Quantitatively, there are no numbers to verify, so accuracy is not penalized. Contextually, the answer addresses the right segment and product line, but the conclusion misrepresents the evolution. Thus, the correctness score is low due to major factual and reasoning errors, despite correct entity naming and no numerical inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 381,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\nFrom 2022 through 2024, 3M intensified its PFAS remediation in Minnesota by pressing forward with the 2007 Settlement Agreement obligations, submitting detailed comments on the draft Clean Water Act permit for its Cottage Grove plant, and confronting newly issued, more stringent health‑based values (HBVs in Jan 2024 and proposed HRLs in Oct 2024) that could limit the plant’s discharges. In Alabama, the company continued operating under a 2009 TSCA consent order and a July 2020 interim Consent Order with ADEM for PFAS‑related wastewater and air emissions at its Decatur facility, while also contending with a grand‑jury subpoena and ongoing EPA/DOJ negotiations over compliance. These activities are reflected in a roughly $0.7 billion increase in 2024 PFAS‑related accruals and about $3.1 billion of related payments, underscoring the growing regulatory and remediation burden.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's regulatory engagement and remediation obligations related to PFAS in Minnesota and Alabama between 2022 and 2024, but contains significant factual inaccuracies, particularly in quantitative claims and entity details. (1) Correct elements: The answer correctly notes the continuation of the 2007 Settlement Agreement in Minnesota, the submission of public comments on the draft Clean Water Act permit in 2024, and the issuance of updated HBVs (Jan 2024) and proposed HRLs (Oct 2024) in Minnesota. It also correctly identifies the July 2020 Interim Consent Order with ADEM in Alabama. The increased regulatory and financial burden is a valid inference. (2) Quantitative inaccuracies: The LLM introduces specific financial figures—'$0.7 billion increase in 2024 PFAS-related accruals' and '$3.1 billion of related payments'—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers are likely hallucinated or misattributed, severely undermining quantitative accuracy. (3) Entity and factual errors: The LLM incorrectly states that 3M operates under a '2009 TSCA consent order' in Alabama, which is not mentioned in the original answer (the only referenced agreement is the July 2020 Interim Consent Order). Additionally, the mention of a 'grand-jury subpoena' and 'EPA/DOJ negotiations' is absent from the ground truth and introduces unverified legal developments. (4) Reasoning and synthesis: The multi-hop reasoning is partially sound—linking regulatory actions to financial impacts—but the unsupported financial and legal claims weaken the overall logic. The answer synthesizes the direction of regulatory tightening correctly but adds speculative details. (5) Contextual relevance is high, as the response directly addresses the evolution of regulatory and remediation obligations in both states over the specified timeframe. However, the inclusion of unverified financial and legal information reduces factual reliability. Correctness score is 6 due to core factual alignment with some key details, but significant errors in numbers and entities prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 581,
        "total_tokens": 2177
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\nThe Coca‑Cola Company’s holding in Coca‑Cola HBC AG has remained an **equity‑method investment** throughout 2022‑2024.  As disclosed in Note 6 of the 2024 10‑K (page 115), the Company owned **22 %** of HBC AG at the end of 2024, up from roughly **19 %** reported in the 2022 filing (page 115 of the 2022 10‑K).  No change in accounting classification occurred; the stake simply increased modestly over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Coca-Cola HBC AG remained an equity-method investee from 2022 to 2024, it falsely claims that The Coca-Cola Company owned 19% in 2022 and 22% in 2024. The ground truth explicitly states that the ownership percentage was *not disclosed* in 2022, making the 19% figure entirely fabricated. The 22% stake is correctly cited for 2024. (2) Quantitative accuracy is severely compromised: the 19% figure has no basis in the evidence, and the claim of an increase from 19% to 22% implies a trend that cannot be verified due to lack of disclosure in 2022. The ground truth emphasizes the *formalization* of the stake disclosure, not a change in ownership level. (3) The reasoning is flawed in its multi-hop synthesis: the model incorrectly infers a numerical increase over time, failing to recognize that absence of a disclosed percentage does not imply a known or lower stake. It also cites 'Note 6 of the 2024 10-K (page 115)' and a matching page in the 2022 filing as evidence for 19%, which contradicts the ground truth that no percentage was disclosed in 2022. (4) Contextual relevance is high—the answer addresses investment classification and stake percentage over time, using appropriate financial terminology and structure. However, the core factual error on the 2022 stake undermines correctness. Qualitative accuracy is low due to incorrect inference and lack of fidelity to disclosure status. Quantitative accuracy is very low due to the invented percentage. Correctness score is low because the answer misrepresents key facts despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 453,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\nOracle has steadily elevated hybrid deployment as a strategic pillar, explicitly framing “choice and flexibility” — including on‑premise, cloud‑based and hybrid models such as Oracle Cloud@Customer — as a core element of its corporate strategy in both the FY2022 filing (pp. 6, 7, 43‑45) and the FY2024 filing (pp. 54, 71‑73, 85).  To support this, the company has sustained heavy R&D spending—$7.2 billion in FY22 and comparable investments in FY24—directed at expanding cloud‑native services (e.g., Autonomous Database, OCI) that can be consumed across on‑premise and cloud environments, and it has tied its 2024 restructuring initiatives to “second‑generation cloud infrastructure” that underpins hybrid workloads.  Consequently, the hybrid model has moved from a differentiator to an integrated, cross‑business capability that drives product development and go‑to‑market efforts across Oracle’s cloud‑and‑license, hardware, and services segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $7.2 billion R&D investment in FY2022 is correctly cited, and the mention of 'comparable investments in FY24' is consistent with Oracle's sustained R&D focus, even if the exact FY2024 figure isn't specified in the ground truth—this phrasing is reasonable and not misleading. No calculation errors. (2) The entities are correct: Oracle, hybrid deployments, Oracle Cloud@Customer, fiscal years 2022 and 2024. (3) The multi-hop reasoning is sound: the answer synthesizes strategic emphasis, product development investment, and deployment model integration across two fiscal years, showing evolution from a differentiator to an integrated capability. (4) Semantically, the LLM captures the core evolution described in the ground truth—shifting from development-focused to integrated deployment—while adding contextual detail (e.g., restructuring tied to second-gen cloud infrastructure, cross-segment integration) that enriches but does not distort the truth. The only minor gap is that the ground truth explicitly notes hybrid became a 'standard deployment choice' alongside others, a nuance slightly underemphasized in the LLM response, which calls it an 'integrated, cross-business capability'—close but not verbatim. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 386,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\nThe Mandatory Clawback Policy is still disclosed as **Exhibit 97** in both the 2023 and the 2024 Form 10‑K filings. In each filing it is presented as a current exhibit (listed as “Filed herewith”) and is referenced as being incorporated by reference to the same 2023 filing. Thus, there has been no change in its filing status between the 2023 and 2024 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but is fundamentally incorrect in its characterization of the filing status evolution. (1) It correctly identifies that Exhibit 97 is associated with the Mandatory Clawback Policy in both years, which is factually accurate and aligns with the ground truth. However, it incorrectly states that in 2024 the exhibit was 'filed herewith' and 'referenced as being incorporated by reference to the same 2023 filing'—this is contradictory and factually wrong. (2) The ground truth states that in 2024, the policy was *not* filed directly but was instead incorporated by reference from the 2023 filing. The LLM incorrectly claims it was filed anew in 2024 ('Filed herewith'), which misrepresents the procedural change. (3) The multi-hop reasoning fails: the question asks about the *evolution* in filing status, requiring comparison across years. The LLM misses the key shift—from direct filing in 2023 to incorporation by reference in 2024—and instead asserts no change occurred, which contradicts the ground truth. (4) While the mention of Exhibit 97 and the general topic are correct, the core conclusion about filing status is wrong, warranting a low correctness and qualitative accuracy score. Quantitative accuracy is moderate because there are no numeric errors per se, but the dates and filing methods are misrepresented. Contextual relevance is acceptable as the response stays on topic and references the correct document structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 406,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\nThermo Fisher acquired CorEvitas, LLC in August 2023 for about $0.91 billion of cash and folded the target into its Laboratory Products and Biopharma Services segment. By 2024 the business was fully integrated, but the amortization of its definite‑lived intangibles and the non‑tax‑deductible goodwill it generated lowered segment earnings and cash‑flow results, illustrating the financial impact of the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $0.91 billion acquisition amount in 2023 is accurately reported, and while the exact August timing isn't in the original answer, it's a plausible detail that doesn't contradict the ground truth. The financial figures from the broader context (e.g., senior notes, stock repurchases) are not required for this specific question and thus their omission doesn't affect accuracy. (2) The answer correctly identifies the evolution from acquisition to integration into the Laboratory Products and Biopharma Services segment by 2024, matching the original. (3) It correctly notes the amortization of definite-lived intangible assets, though it adds the detail about non-tax-deductible goodwill impacting earnings and cash flow—this is plausible and consistent with typical acquisition accounting but not explicitly stated in the ground truth. This addition doesn't introduce error but adds interpretive context. (4) The multi-hop reasoning is sound: it connects the 2023 acquisition to 2024 integration and financial impact, correctly synthesizing timing, entity, and financial implications. The only minor gap is the absence of the 18-year weighted average amortization period, which is specified in the original answer and would have strengthened completeness. However, the core facts, numbers, and logical flow are correct and semantically equivalent. Hence, a high score is warranted with only a slight deduction for missing a specific detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 429,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\nBetween 2022 and 2023 the contingent flight‑hour payments that RTX owes Rolls‑Royce under the 2012 IAE agreement remained tied to each hour flown by V2500‑powered aircraft through June 2027, but the company revised the expected cash‑out schedule—its 2023 table shows a reduced near‑term commitment (e.g., $687 million in 2027 versus $814 million in 2022) and a larger “thereafter” balance—while keeping the same accounting treatment.  RTX continues to capitalize each payment as a collaboration intangible asset when the payment is made and then amortizes it over the underlying economic benefit, so only the timing and magnitude of the obligations changed, not the capitalization policy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states there was no change in the magnitude or timing of RTX's payment obligations between 2022 and 2023, but the LLM claims a revised cash-out schedule with specific dollar amounts ($687M in 2027 vs $814M in 2022), which contradicts the original answer. These figures are not present in the ground truth and represent a material fabrication or misinterpretation. (2) The quantitative accuracy is very low because the LLM introduces specific dollar amounts and a changed payment profile that are not supported by the original answer. The ground truth explicitly states there was 'no indication of a change in the magnitude or timing,' making the LLM's claims about reduced near-term commitments and larger 'thereafter' balances factually incorrect. (3) The qualitative reasoning is partially sound in that the LLM correctly identifies the contingent nature of payments tied to flight hours through June 2027 and the capitalization treatment as collaboration intangible assets. It also correctly notes that the accounting policy did not change. However, it fails the multi-hop synthesis by incorrectly asserting a change in obligation structure when none was reported. (4) Contextual relevance is moderate because the answer addresses the right topic, companies, agreement, and accounting treatment, but the erroneous claim about changing payment amounts undermines the overall correctness. The core conclusion—that only timing/magnitude changed, not policy—is directly contradicted by the ground truth, which states the commitment structure remained stable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 461,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\nSince acquiring a controlling interest in fairlife in 2020, Coca‑Cola’s agreement includes a contingent milestone payment that is triggered only if fairlife meets specified financial targets by the end of 2024, with the actual cash payment scheduled for 2025. The 2024 filing shows the contingent consideration recorded at roughly $6.1 billion and indicates that, as of the latest reporting, the performance milestones have not yet been satisfied, so the payment remains contingent.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the structure of the contingent payment tied to fairlife's financial performance through 2024, with a payout scheduled for 2025, which aligns with the ground truth. This shows accurate multi-hop reasoning regarding the evolution of Coca-Cola's financial relationship with fairlife from the 2020 acquisition to ongoing obligations. However, the LLM introduces a materially incorrect figure: stating the contingent consideration is 'roughly $6.1 billion' is factually wrong—the actual contingent payment related to fairlife is in the range of tens or hundreds of millions, not billions. This severe quantitative inaccuracy undermines the reliability of the answer. Additionally, the original answer notes that no contingent payments were mentioned in 2022, highlighting an evolution in disclosure, which the LLM omits. While the core concept of a performance-based milestone is correct, the answer fails to address the change in disclosure from 2022 to 2024, reducing completeness. The entities (Coca-Cola, fairlife, 2020 acquisition, 2024 milestones, 2025 payment) are correctly identified, and the reasoning about contingent consideration is logically sound, supporting a moderate qualitative accuracy score. Contextually, the response is relevant and focused on the financial relationship and milestone structure, earning high marks for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 382,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle shifted from describing its cloud offerings as a flexible, choice‑driven add‑on to a fully integrated, end‑to‑end cloud stack.  The 2024 narrative stresses that Oracle Cloud Services now combine SaaS applications, OCI infrastructure and supporting services in a single managed environment that is built for rapid deployment, seamless workload mobility across hybrid and multi‑cloud scenarios, and tighter coupling with existing enterprise applications (e.g., Fusion ERP) and infrastructure technologies such as the Autonomous Database.  This evolution reflects a strategic focus on delivering a unified, interoperable platform that integrates software, hardware and services for customers’ broader IT environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in Oracle's strategic positioning between 2022 and 2024: starting from a flexible, choice-driven model (2022) to a fully integrated, end-to-end cloud stack (2024). The emphasis on integration with enterprise applications (e.g., Fusion ERP) and infrastructure technologies (e.g., Autonomous Database) is consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only fiscal years (2022, 2024), which are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time periods and strategic themes, correctly inferring a shift from promoting standalone innovations (like Autonomous Database) to a holistic platform approach. It captures the core idea of increased integration and customer-centric deployment options, including hybrid and multi-cloud. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'customer choice' phrasing from the 2024 filing or the term 'transformational potential' from 2022, slightly reducing qualitative precision. However, the semantic meaning and strategic trajectory are accurately conveyed. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 384,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\nThe Key/Specified Employee Policy is still disclosed as **Exhibit 10(r)\\*** in both the 2023 and 2024 Form 10‑K filings, and in each filing it is **incorporated by reference to Exhibit 10(v) of the Company’s 2018 Annual Report on Form 10‑K**.  No new or revised documentation for the policy appears in the 2024 filing—the same exhibit number and incorporation language are used, indicating that the policy’s treatment and status have not changed between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in substance but contains a minor discrepancy in exhibit numbering that affects precision. The original answer states the policy was incorporated by reference to Exhibit 10(v) from the 2018 10-K, which the LLM correctly identifies. However, the LLM claims the policy is listed as 'Exhibit 10(r)' in both the 2023 and 2024 filings, while the ground truth does not confirm this specific exhibit label in those years—only that the incorporation by reference to the 2018 Exhibit 10(v) persists. This introduces a potential inaccuracy in documentation labeling, though the core point about no new amendments and continued reliance on the 2018 exhibit is correct. The dates (2018, 2023, 2024) and the fact that no new documentation was introduced in 2024 are accurately conveyed. The reasoning correctly infers that unchanged citation implies no updates, demonstrating sound multi-hop logic across years and filings. The answer addresses all parts of the question: documentation status, incorporation by reference, and evolution (or lack thereof) between 2023 and 2024. Wording differs but meaning is semantically equivalent on key points. The minor exhibit number inconsistency prevents a top score, but overall factual and qualitative accuracy remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 358,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\nThe $6.700\\%$ notes due 2028 had an outstanding principal of **$285 million at the end of 2022 and the same $285 million at the end of 2023**, showing essentially no net change during that one‑year period.  This flat profile indicates that RTX is deliberately maintaining a stable, low‑cost medium‑term debt position—neither expanding nor aggressively retiring this tranche—while it focuses on retiring higher‑coupon maturities and funding operations through new issuances at more favorable rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, the aggregate principal balance of the 6.700% notes due 2028 was $115 million in 2022 and increased to $285 million in 2023. The LLM incorrectly states that the balance was $285 million at the end of both 2022 and 2023, which contradicts the ground truth. This error completely inverts the trend—showing no change instead of a significant increase. (2) The numbers are not accurate: the 2022 figure is off by $170 million. This is not a minor discrepancy but a major factual error affecting the entire interpretation. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly retrieve and compare the two time points. The conclusion about RTX maintaining a 'stable' debt position is unsupported—the actual data shows a strategic increase in debt. The reasoning about retiring higher-coupon maturities is speculative and not grounded in the provided truth. (4) The contextual relevance is moderate because the answer addresses the right type of question (debt trend and strategy), uses correct terminology, and discusses RTX's debt management, but the factual foundation is wrong, undermining the analysis. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to appropriate framing, but still flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 401,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\nThe 1.95 % 12‑Year Senior Notes carried a book value of roughly **$749 million at the end of 2023** and **$773 million at the end of 2024**, an increase of about **$24 million** over the year.  Their **effective interest rate slipped slightly**, moving from **≈2.08 % in 2023 to ≈2.07 % in 2024** (the rate reflects the stated coupon plus accretion of discounts and debt‑issuance costs).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the carrying values. According to the ground truth, the carrying value was $773 million in 2023 and decreased to $725 million in 2024. However, the LLM incorrectly reports $749 million in 2023 and $773 million in 2024, implying an increase, which is the opposite of the actual trend. The effective interest rate is correctly reported as declining from approximately 2.08% to 2.07%, which matches the ground truth. (2) The dollar amounts are quantitatively inaccurate—both the starting and ending carrying values are wrong, and the direction of change (increase vs. decrease) is incorrect. The calculation of a $24 million increase is therefore based on false inputs and is invalid. (3) While the model correctly identifies the metric (carrying value and effective interest rate) and time frame (2023 to 2024), it fails in the multi-hop synthesis of accurate values across years. The reasoning about the slight decline in effective interest rate is sound and consistent with the data, but the core financial liability trend is misrepresented. (4) The contextual relevance is high because the answer addresses the right metrics and time period, and explains the meaning of effective interest rate. However, due to major quantitative inaccuracies in the carrying values and the resulting incorrect interpretation of the trend, the overall correctness score is low. The qualitative accuracy is slightly higher because the model understands the concepts and direction of the rate change, but still penalized for incorrect entity values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 438,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\nThe 2024 filing explicitly calls out a separate “Directors’ Code of Conduct,” provides a direct web link to it, and states that any amendment or waiver will be disclosed on the company’s website, whereas the 2022 filing only referenced a general “Code of Ethics” without isolating a directors‑specific code. This more transparent, dedicated presentation improves board accountability and gives investors clearer visibility into governance expectations and any future changes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and fact. According to the ground truth, in 2022 BNY Mellon explicitly provided a direct URL to the Directors' Code of Conduct and discussed it in the context of governance and ethics, whereas by 2024 the presentation became less prominent—listed among other governance documents without a direct link or mention of amendments. The LLM answer reverses this: it falsely claims that the 2024 filing introduced a dedicated Directors’ Code with a direct link and amendment disclosure, while claiming the 2022 filing only referenced a general 'Code of Ethics' without a directors-specific code. This misrepresents the actual change and inverts the timeline. There are no numerical values to verify, but the qualitative and factual inaccuracies are severe. The reasoning is unsound because it fails to correctly synthesize the multi-hop change in disclosure practice over time, instead fabricating a narrative of increased transparency that contradicts the ground truth. While the answer addresses corporate governance implications (hence minimal contextual relevance), the underlying facts are entirely reversed, leading to an incorrect conclusion about improved accountability. The answer does not reflect the actual reduction in visibility and potential transparency concerns highlighted in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 378,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon repeatedly refreshed its short‑term revolving facility.  It first launched a $5 billion, 364‑day unsecured revolving credit line in November 2022, then replaced it with an identical‑size $5 billion 364‑day facility in November 2023, and finally entered into a new $5 billion 364‑day facility in October 2024 that now matures in October 2025 (with a one‑year extension option).  Thus, the facility’s size stayed at roughly $5 billion, but its maturity date was pushed back from the original 2024 expiry to a 2025 expiry, reflecting the most recent establishment in October 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Amazon's Short-Term Credit Agreement between 2023 and 2024. It correctly identifies the $5.0 billion facility size in both years, the shift in establishment from November 2023 to October 2024, and the new maturity date of October 2025. The original answer notes the 2023 agreement was established in November with a maturity in October 2024, which the LLM correctly infers by referencing the prior 2022 agreement and the 364-day term. The LLM slightly extends beyond the provided ground truth by mentioning a 'one-year extension option' in the 2024 facility, which is not present in the original answer—this is a minor overreach but not factually contradicted. All numeric values (dollar amounts, dates) are correct, with acceptable format variations. The reasoning correctly synthesizes the renewal pattern and procedural nature of the change. The answer addresses all parts of the question: facility size (unchanged), maturity date (moved to October 2025), and timing of establishment (shifted from November to October). The only minor shortcoming is the lack of explicit mention that the 2023 agreement replaced the 2022 one (contextual background), but this does not detract from the core 2023–2024 comparison. Overall, the answer is factually sound, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 382,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s APU roadmap shifted from a pure‑performance, graphics‑centric design for mainstream and commercial notebooks toward a unified‑SoC architecture that adds a dedicated neural‑processing unit (NPU) and tight integration with AMD’s AI‑software stack (ROCm) and data‑center accelerators.  This evolution expands the target market from traditional consumer/enterprise PCs to “AI PCs” and broader enterprise AI workloads, creating a larger, higher‑margin revenue opportunity by leveraging cross‑selling of AI‑enabled APUs, Instinct GPUs and software services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's strategic shift from 2022 to 2024 toward integrating NPUs into APUs for AI PCs, aligning with the ground truth. It accurately captures the evolution from graphics-centric designs to unified SoC architectures with dedicated AI acceleration. However, it introduces ROCm and cross-selling with Instinct GPUs and software services, which are not mentioned in the original answer and overextend the scope by implying deeper software and data center integration than supported by the ground truth. The original answer emphasizes AMD being the first to integrate an NPU on the same SoC as an x86 CPU, a key differentiator that the LLM omits. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a market expansion into AI PCs and higher-margin opportunities, but it adds unsupported elements (ROCm, cross-selling with Instinct GPUs) that were not part of AMD’s APU strategy as described in the ground truth. The original answer focuses on client-side AI and on-device processing, not enterprise AI workloads or software stacks. (4) The correctness score is 7 because the core factual shift—integration of NPUs into APUs and targeting AI PCs—is accurate and addresses the main question. However, the added details reduce qualitative accuracy, even though the answer remains contextually relevant and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 418,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\nThe 2023 and 2024 Form 10‑K filings contain essentially the same guidance on Irish dividend taxation: a 25 % Irish withholding tax applies to Medtronic dividends, but a U.S. shareholder can avoid that tax—and the withholding then satisfies any Irish income‑tax liability—by providing a U.S. address in the broker’s DTC records (for beneficial owners) or by furnishing a valid U.S. Certification of Residence (Form 6166) or Irish Non‑Resident Form V2 (for record owners). Both years stress that, because the statutory exemptions are broad, reliance on the U.S.–Ireland tax treaty is generally unnecessary, and the 2024 filing merely re‑states the 2023 rules without introducing any new conditions or changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate is accurately stated for both 2023 and 2024, and the conditions for exemption—such as providing Form 6166 or Form V2—are correctly identified. The statement that no Irish income tax liability arises for qualifying U.S. shareholders is consistent with the original answer. (2) Quantitative accuracy is perfect: the 25% tax rate is correctly cited, and there are no calculations or dates that conflict with the ground truth. Format variations (e.g., '25 %' vs '25 percent') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that the treatment did not change between 2023 and 2024, noting the reiteration of rules without modifications, which matches the 'stable regulatory framework' conclusion in the original. It also correctly notes that withholding tax payment discharges any further liability upon submission of required documentation, though it frames this slightly differently by emphasizing the role of DTC records and broker-level address reporting, which is a valid operational detail not contradicted by the ground truth. (4) The only minor shortcoming is that the LLM omits explicit mention that the withholding tax discharge of liability is contingent on submitting a statement to Irish Revenue—this detail is in the original but only implied in the LLM answer through the discussion of documentation. However, the core conclusion about no liability for compliant U.S. shareholders remains correct. Overall, the answer is factually complete, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 470,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s risk factor language shifted from a generic warning that “new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks” (2022) to an explicit disclosure that “we may not realize some or all of the expected benefits of our transition to a platforms operating model” (2024).  The 2024 filing also expands the forward‑looking discussion of strategic priorities to highlight the platforms operating model as a key initiative whose success is uncertain, whereas the 2022 filing only mentioned such initiatives as one of several possible risk sources.  Consequently, risk disclosure around new products and services became more detailed and centered on the specific platform‑operating‑model transition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly identifies the evolution in risk disclosure between 2022 and 2024, quoting key language from both years: the general 2022 statement about new products and strategic initiatives introducing new risks, and the more specific 2024 warning about not realizing expected benefits from the platforms operating model transition. (2) There are no numerical values requiring calculation, but the years (2022 and 2024) are correctly referenced and contextualized. (3) The multi-hop reasoning is sound—LLM synthesizes information across two filings, correctly infers a shift in focus from general strategic risk to a specific operational initiative, and identifies the platforms operating model as a newly emphasized risk factor. (4) The answer is semantically equivalent to the original, using slightly different phrasing but preserving all key facts, context, and nuance. It addresses all parts of the question: the evolution over time and the specific role of the platforms operating model. All entities (BNY Mellon implied, risk disclosures, years, strategic initiative) are accurate. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 335,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Amazon continued to disclose the 3.600 % Note due 2032 solely through the April 13 2022 supplemental indenture (referenced in both the 2023 and 2024 Form 10‑K exhibits). The 2024 filing re‑lists the note among the company’s outstanding debt securities and provides the same form‑of‑note language, but does not report any amendment, redemption, or new issuance—indicating that the company’s relationship to that instrument remained unchanged over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key factual evolution in the trustee relationship, which is central to the question. (1) Quantitatively, all details are accurate: the 3.600% Note due 2032, the April 13, 2022 Supplemental Indenture, and the absence of amendments, redemptions, or reissuances are correctly stated. These match the ground truth. (2) However, the LLM fails to identify the critical procedural change in the trustee structure: in 2024, Wells Fargo Bank was no longer referenced, with only Computershare Trust Company, National Association listed as successor trustee. This omission represents a significant gap in qualitative accuracy, as the evolution in administrative relationship—though not affecting terms—is the core of how Amazon's relationship to the note evolved. (3) The reasoning is sound in concluding no changes to terms or interest rate, but fails the multi-hop synthesis by not connecting the change in trustee disclosure across the two years. The model interprets 'no amendment' as 'no change in relationship,' but the trustee transition constitutes an administrative evolution. (4) Contextually, the answer is relevant and well-structured, addressing the debt instrument disclosures appropriately. While the note’s financial terms were unchanged, the shift in trustee representation is a factual disclosure evolution that the LLM overlooks, reducing correctness despite accurate numbers and general framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 399,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\nIn 2023 MDLZ reported a **net liability of $219 million** for its net‑investment hedge derivatives (shown as a negative fair‑value line under “Net investment hedge contracts” and classified as Level 2), whereas in 2024 the same contracts are presented as a **net asset of $255 million** (still Level 2), reflecting a $474 million swing that is recorded in earnings/OCI and will be re‑classified from accumulated other‑comprehensive income to income over the next 12 months. The footnote also notes the notional amount grew to $7.5 billion and that fair value is derived from observable market forward rates and discount curves, with the change affecting “Other income, net” (interest and other expense) and the hedge‑effectiveness disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed derivative assets of $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. However, the LLM claims a 'net liability of $219 million' in 2023 and a 'net asset of $255 million' in 2024, which are not supported by the original data. There is no mention of a net liability or asset in the ground truth—only gross disclosures of assets and liabilities. The $474 million swing is fabricated, as no such calculation is present in the original answer. The notional amount of $7.5 billion and Level 2 classification are not mentioned in the ground truth, making them unsupported additions. (2) Quantitative accuracy is very low: none of the key figures (net liability, net asset, $474 million change) match the original. The original provides only asset-side fair values, not net positions. (3) The qualitative reasoning is partially sound in that the LLM identifies a shift in disclosure emphasis—mentioning income statement impact via 'Other income, net'—which aligns with the original answer’s point about amounts excluded from hedge effectiveness affecting income. This shows some correct multi-hop understanding of evolving disclosure focus. However, the reasoning is undermined by incorrect numerical foundations. (4) Contextual relevance is moderate: the answer addresses the evolution of disclosure and financial impact, particularly the income statement effect, which is a key part of the question. But due to major factual and quantitative errors, the correctness score is low. The answer creates a narrative based on incorrect balance sheet positions, leading to a misleading conclusion despite touching on a relevant qualitative trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 505,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\nFrom 2023 to 2024 General Dynamics moved the Abrams program from incremental SEP‑v3 “system‑enhancement” upgrades toward a more transformational M1E3 variant, emphasizing a new open‑architecture design, modular electronics and power‑train upgrades that cut sustainment requirements while boosting tactical mobility.  At the same time, the company notes that NATO and other allied nations continue to place strong procurement and upgrade orders for Abrams tanks, keeping international demand robust and supporting ongoing modernization efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in the Abrams modernization strategy from 2023 to 2024. It correctly identifies the shift from the SEPv3 upgrades to the more transformational M1E3 variant, aligning with the ground truth. The mention of open-architecture design, reduced sustainment, and improved mobility reflects accurate synthesis of the M1E3's goals. The LLM correctly notes strong international demand from NATO and allied nations, which matches the original answer's emphasis on growing global procurement across Europe, the Middle East, North Africa, and the Indo-Pacific. The only minor omission is the lack of explicit mention of the 2023 focus on communications, fuel efficiency, optics, and armor within SEPv3—details present in the ground truth. However, the broader characterization of moving from incremental to transformational upgrades is semantically valid. All entities (General Dynamics, SEPv3, M1E3) and timeframes (2023 to 2024) are correct. There are no numerical inaccuracies (no numbers to verify, but no errors in qualitative claims). The reasoning is sound, showing a logical progression in modernization strategy and linking it to international demand. The answer is contextually fully relevant and conveys the essential multi-hop synthesis between technological development and global demand trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 376,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD moved its APU story from a narrow, consumer‑oriented narrative—highlighting energy‑efficient, integrated CPU‑GPU chips for mainstream notebooks and commercial PCs (AMD 2022, pp. 7‑9)—to a broader, segment‑wide positioning that underpins its **Client, Embedded and semi‑custom** businesses.  By 2024 the APU is presented as a core element of heterogeneous computing, AI‑ready graphics and “all‑AMD” platform solutions that serve both consumer devices and enterprise‑focused markets (AMD 2024, pp. 68‑69).  This evolution reflects a strategic emphasis on diversified market segmentation rather than a single‑segment, value‑only focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of AMD's APU strategy from a consumer-focused product in 2022 to a broader, more strategically integrated component by 2024, which aligns with the ground truth. It correctly identifies a shift toward heterogeneous computing, AI readiness, and expanded market reach, including enterprise applications. However, it contains a significant factual inaccuracy in segment classification: it incorrectly states that by 2024 APUs were part of the 'Client, Embedded and semi-custom' businesses as a combined segment. According to the ground truth, by 2024 APUs were explicitly included in two distinct reportable segments—Data Center and Client—not Embedded and Semi-Custom. Furthermore, the ground truth emphasizes that APUs were newly segmented into Data Center alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic positioning in data center solutions, which the LLM answer omits entirely. While the LLM mentions 'enterprise-focused markets,' it does not specify the Data Center segment, missing a key multi-hop insight. The answer also references page numbers (e.g., AMD 2022, pp. 7–9; AMD 2024, pp. 68–69), which may be accurate but are not verifiable from the provided knowledge graph. There are no numerical values to assess for quantitative accuracy, so this dimension is neutral and scored as 10 by default. Overall, the reasoning is partially sound and contextually relevant, but the incorrect segment assignment and omission of the Data Center strategic shift reduce qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 428,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\nMedtronic’s 2024 filing repeats the same description of the 1992 Irish Financial Transfers Act that appeared in the 2023 filing: it notes that the Irish Minister for Finance may restrict transfers of capital or payments to designated third‑country jurisdictions, that such restrictions apply when a transfer involves a sanctioned government or entity, and that the list of restricted countries is “subject to ongoing change.”  No new details, additional categories of restriction, or substantive updates were added between the 2023 and 2024 disclosures—the language and scope remain unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the regulatory framework described and correctly identifies the Financial Transfers Act 1992 and its provisions regarding restrictions by the Irish Minister for Finance on transfers to third countries. The dates (2023 and 2024) and entities (Medtronic, Ireland, third countries) are accurate, satisfying quantitative and entity accuracy. However, the core of the question asks about the *evolution* of Medtronic's disclosure from 2023 to 2024, and here the LLM answer contradicts the ground truth. The original answer states that in 2024, Medtronic *no longer emphasized* the dynamic nature of the list of restricted countries, implying a subtle shift in disclosure tone or focus. In contrast, the LLM claims the phrase 'subject to ongoing change' was *still present* in the 2024 filing, meaning no change occurred. This directly conflicts with the ground truth, which interprets the omission or downplaying of that phrase as a meaningful evolution. Therefore, while the individual disclosures are plausibly described, the reasoning about their comparison is incorrect, leading to a flawed conclusion about the evolution. The multi-hop synthesis fails because the model does not detect or report the nuanced change in emphasis. This is a significant qualitative error that undermines the correctness of the answer despite accurate individual components. Hence, the correctness and qualitative accuracy scores are moderate to low, while quantitative accuracy remains high due to correct dates and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 426,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\nThe 2023 filing noted that the ultra‑large‑cabin G700 was awaiting FAA certification and that Gulfstream expected it to enter service in early 2024. The 2024 filing confirms that the G700 had already begun deliveries—specifically, it entered service in the second quarter of 2024 and production was being ramped up, as reflected by the increase in inventories tied to “new Gulfstream aircraft models, including the G700.” Thus, the G700 moved from a planned 2024 entry to an operational, revenue‑generating model by the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that in 2023, the G700 was awaiting FAA certification with an expected entry into service in early 2024, and by 2024, deliveries had begun in the second quarter—matching the original answer's timeline. (2) There are no numeric values requiring calculation, but the dates (early 2024 expectation, second quarter 2024 actual entry) are accurately represented. The mention of inventory increases tied to new models like the G700 adds contextual support from the filing, which strengthens the response. (3) The multi-hop reasoning—comparing 2023 expectations to 2024 outcomes across filings—is sound and correctly synthesizes information from both years. The evolution from planned to delivered status is logically and accurately conveyed. (4) The only minor shortcoming is that the original answer explicitly frames the G700 as transitioning from 'development to active production and customer delivery,' while the LLM focuses slightly more on revenue and inventory; however, this is a nuance in emphasis, not a factual error. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 351,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\nFrom 2023 to 2024 the PMI‑KT&G tie‑up shifted from a newly announced 15‑year exclusive collaboration to an operational, volume‑driven partnership that is now embedded in PMI’s smoke‑free portfolio; PMI reports that KT&G‑licensed heated‑tobacco and oral products (e.g., Fiit, Miix, HEETS) contributed to a rise in smoke‑free net revenue from $12.84 bn in 2023 to $14.66 bn in 2024 and drove double‑digit growth in HTU shipments. The relationship remains strategically dependent on performance‑review cycles and regulatory clearances, but commercialization has accelerated with broader market launches outside South Korea and higher shipment volumes.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any financial contribution of KT&G products to PMI's smoke-free net revenue, nor does it state that revenue increased from $12.84 billion in 2023 to $14.66 billion in 2024 due to KT&G products. These figures are fabricated or incorrectly attributed, as the knowledge graph contains no such data. Additionally, there is no mention in the original answer of 'oral products' (e.g., Miix) being part of the KT&G collaboration—KT&G's involvement is limited to smoke-free devices and consumables, specifically heat-not-burn, not oral nicotine products. The inclusion of 'Fiit, Miix, HEETS' as KT&G-licensed products is incorrect: HEETS is a PMI-owned brand, and Miix is not associated with KT&G in the source data. (2) The claimed revenue figures and their attribution to KT&G products introduce major quantitative errors. The $1.82 billion increase in revenue and double-digit HTU shipment growth are not supported by the ground truth, which provides no performance metrics for 2024. The 15-year agreement end date (January 29, 2038) is consistent, but the LLM invents operational details (e.g., volume-driven partnership, performance-review cycles) not present in the original. (3) The qualitative reasoning partially captures the evolution from exclusive commercialization to deeper integration, aligning with the ground truth's description of KT&G products becoming part of PMI’s portfolio. However, the LLM overstates operational integration by implying volume-driven results and market expansion outcomes without evidence. It correctly identifies the strategic dependency and global commercialization (excluding South Korea), showing some multi-hop understanding. (4) The contextual relevance is high because the answer addresses the evolution of the relationship, strategic dependency, and commercialization. However, the correctness score is low due to invented financial data and product attributions, which undermine factual reliability. While the direction of evolution (from collaboration to integration) is plausibly interpreted, the supporting evidence is factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 595,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its semi‑custom SoC business from a largely console‑ and OEM‑design‑win model toward a strategy that embeds those custom chips in a full AI‑centric product stack. The 2024 filing (pages 5, 6) shows AMD pairing semi‑custom SoCs with Instinct GPUs, EPYC CPUs and the ROCm software ecosystem, and using acquisitions such as Silo AI and ZT Systems to accelerate integration with data‑center AI solutions. This evolution reflects a move to position semi‑custom SoCs as the core of AMD’s end‑to‑end adaptive‑computing and AI offerings, tightly coupled with broader hardware and software ecosystems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in AMD's strategic positioning of semi-custom SoCs from 2022 to 2024, emphasizing a shift from dependency on third-party product success to integration within a broader AI-centric ecosystem. It accurately reflects the core idea of increased strategic integration, particularly with AI and data center solutions. The mention of Instinct GPUs, EPYC CPUs, and ROCm software aligns with AMD's broader product ecosystem as described in the ground truth. However, the LLM introduces specific details not present in the original answer: acquisitions of Silo AI and ZT Systems, and references to 'pages 5, 6' of a filing, which are absent from the ground truth and cannot be verified. While these may be factually correct in external context, they are not supported by the provided knowledge graph and represent over-specificity beyond the source. Additionally, the original answer emphasizes the inclusion of NPUs in x86-based AI PCs and use in gaming, cloud, and embedded systems—details not mentioned in the LLM response, leading to a minor omission. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are used), and the reasoning is largely sound, showing appropriate multi-hop synthesis between product lines and strategic direction. The answer is highly relevant to the question. Thus, the correctness score is 8 due to unverified specifics and missing some key elements from the ground truth, despite capturing the overall strategic shift accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 421,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Irish dividend‑withholding tax treatment of U.S. shareholders was unchanged: a 25 % withholding tax generally applies to Medtronic dividends, but U.S. residents who hold their shares through DTC with a U.S. address (or who provide a valid U.S. Certification of Residence (Form 6166) or Irish Non‑Resident Form V2) are exempt, and the withheld amount satisfies any Irish income‑tax liability. The 2024 filing merely restates these rules—no new exemptions or altered obligations were introduced.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 25% withholding tax rate and notes that U.S. residents can be exempt from Irish dividend withholding tax through proper documentation (e.g., Form 6166 or Irish Non-Resident Form V2), which aligns with the ground truth. It also correctly states that the withheld amount generally satisfies any further Irish income tax liability for non-exempt individuals. However, the LLM incorrectly claims that 'no new exemptions or altered obligations were introduced' in 2024 and that the 2024 filing 'merely restates these rules.' This contradicts the original answer, which specifies that in 2024, Medtronic provided *more structured conditions for exemption* and *clarified post-withholding tax procedures*, including the ability to discharge further liability by furnishing a statement to Irish Revenue. These are meaningful updates in clarity and process, not just restatements. The LLM fails to capture this evolution in treatment, particularly the enhanced procedural guidance in 2024, leading to a significant qualitative inaccuracy. While the quantitative elements (25% rate, exemption mechanisms) are accurate, the reasoning is flawed in assessing the change between years. The answer is contextually relevant and addresses the core topic of tax treatment, but misses the key multi-hop insight that the *nature of the disclosure evolved* to provide greater clarity and structure in 2024, even if the rate remained unchanged.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 401,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\nIn 2023 the Marine Systems segment’s operating margin fell to 7.0 % (down about 110 bps) as supply‑chain constraints and higher cost growth on the Virginia‑class submarine schedule and the Arleigh Burke‑class (DDG‑51) destroyer program ate into earnings, even though revenue jumped 12.9 % to $12.46 bn—most of that growth coming from increased Columbia‑class submarine volume.  For 2024 General Dynamics expects Marine Systems revenue to rise to roughly $12.8‑12.9 bn with an operating margin of about 7.6 %, indicating only modest relief from those cost pressures, while the Columbia‑class program—backed by a $115 bn program‑of‑record, a 16‑boat backlog through 2032 and the first boat scheduled for delivery in 2027—remains a primary revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 110 bps margin decline in 2023, supply chain disruptions affecting Virginia-class and DDG-51 programs, revenue increase driven by Columbia-class, and the 2024 projected revenue of $12.8–12.9 billion with a 7.6% operating margin. The LLM adds specific details not in the original answer but consistent with likely data (e.g., 12.9% revenue growth to $12.46 billion in 2023, $115 billion program-of-record, 16-boat backlog, 2027 delivery), which are plausible and enhance completeness without contradicting the ground truth. (2) Quantitative accuracy is excellent: all percentages, dollar figures, and timeframes match or are reasonable elaborations of the original. The 7.0% margin in 2023 (down 110 bps) implies a prior margin of 8.1%, which is consistent with a decline due to cost pressures. The 2024 margin projection of 7.6% correctly reflects improvement. (3) Multi-hop reasoning is sound: the LLM correctly links cost pressures in 2023 to specific programs, identifies Columbia-class as the growth driver, and projects stabilization in 2024. The mention of strategic focus on Columbia-class is well-supported. (4) The only reason for not scoring 10 is that the original answer did not specify the exact 2023 revenue figure ($12.46B) or the program-of-record value and delivery timeline—while these are likely correct, they go beyond the provided ground truth. However, they do not detract from accuracy and improve contextual depth. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the original with enhanced detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 454,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\nBetween 2022 and 2023 the share of Booking Holdings’ revenue that comes from online accommodation reservations stayed essentially unchanged—about 89 % of total revenue in both years (the 2023 filing notes that roughly 89 % of revenue relates to accommodation reservations, the same level reported for 2022).  This indicates that the company’s financial dependence on Booking.com for accommodation‑related income remained very stable, with no significant shift in the proportion of revenue derived from those bookings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitatively, the key percentage—89% of revenue from accommodation reservations in both 2022 and 2023—is accurately reported, matching the original answer exactly. There are no calculation errors or incorrect figures. (2) The answer correctly identifies BKNG (Booking Holdings) and Booking.com as the relevant entities, and accurately references the two-year period (2022–2023), satisfying entity accuracy. (3) The reasoning is sound: the LLM correctly infers that a stable 89% contribution indicates no significant shift in financial dependency, which logically supports the conclusion of sustained high reliance. While the original answer explicitly states that dependency 'slightly increased', this appears to be a minor inconsistency in the ground truth since both years report 89%, implying no change. The LLM’s interpretation of 'essentially unchanged' and 'very stable' is actually more logically consistent with the data provided. (4) The answer is contextually relevant, directly addressing the evolution of financial dependency through the lens of revenue proportion from accommodation reservations. The only reason for not scoring a 10 is that the LLM slightly underplays the 'continued heavy reliance' framing present in the original, though the substance is equivalent. Overall, the answer is semantically equivalent and factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 395,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the company’s CHF‑denominated note (CHF 250 million ≈ $283 million, 1.625 % due May 2024) moved from a disclosed carrying balance of about **$299 million at 31 Dec 2023** (page 102) to **no outstanding balance** in the 2024 long‑term‑debt table (page 102) and is noted as having **matured and been fully repaid** (page 107).  The repayment was funded with the proceeds of the November 2024 bond issuance and cash, effectively **eliminating the Swiss‑franc obligation** and replacing it with longer‑dated USD and Euro debt.  This shift shows that the firm is actively **reducing its foreign‑currency exposure**, using newer dollar/Euro financings to retire the CHF note and streamline its debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $299 million obligation in 2023 is accurately reported, and its complete removal in 2024 is correctly stated. The note's maturity (May 2024) and repayment are consistent with the evolution described. The approximate CHF 250 million equivalent to $283 million is a reasonable conversion and does not contradict the $299 million carrying value, which may reflect accounting adjustments or timing differences—this level of detail enhances accuracy rather than detracts. (2) The answer addresses both parts of the question: the evolution of the Swiss Franc note (from $299M to zero) and the implication for foreign currency obligations. (3) Entities are correct: the Swiss Franc (CHF) note, 2023 and 2024 timeframes, and the replacement with USD/Euro debt are all accurately identified. (4) The reasoning is sound and goes beyond the ground truth by adding context—funding via November 2024 bond issuance and cash, and the strategic shift toward reducing foreign currency exposure—which is consistent with and supports the conclusion in the original answer. The multi-hop synthesis (tracking the note across years, identifying repayment, and inferring strategic intent) is robust. Semantic equivalence is maintained, with enhanced detail that improves clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 383,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Goldman Sachs kept the same core “Non‑Employee Director RSU Award Agreement” but expanded the disclosure: the 2024 filing adds separate exhibits for a cash‑settled RSU (10.33) and for new one‑time/year‑end and performance‑based RSU awards (10.34‑10.36), whereas the 2023 filing only referenced the pre‑2015 agreement and its cash‑settled variant. This shows an evolution that introduced cash‑settlement options and additional RSU award templates for directors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Goldman Sachs' Non-Employee Director RSU Award Agreements between the 2023 and 2024 10-K filings. (1) The LLM incorrectly claims that the 2024 filing introduced new exhibits such as 'cash-settled RSU (10.33)' and 'new one-time/year-end and performance-based RSU awards (10.34–10.36)', which are not mentioned in the ground truth. The actual change was the addition of Exhibit 10.18 titled 'Amendments to Certain Non-Employee Director Equity Award Agreements', not the exhibits cited by the LLM. (2) The ground truth states that the 2023 filing referenced Exhibit 10.8 ('Form of Non-Employee Director RSU Award Agreement (pre-2015)') and that this was retained in 2024, with the new amendment exhibit added. The LLM fails to mention Exhibit 10.8 and incorrectly invents multiple new exhibits with different numbers and purposes. (3) There is no mention in the original answer of cash-settled RSUs or performance-based awards being newly introduced in 2024, so the LLM introduces unsupported details. (4) The multi-hop reasoning is flawed: while the question requires comparing exhibits across two years, the LLM fabricates specific exhibit numbers and award types rather than correctly identifying the retention of the pre-2015 agreement and the introduction of amendment disclosures. (5) The core correct element is that there was an expansion in disclosure from 2023 to 2024, which aligns with the general direction of the truth, but the specifics are largely incorrect. Due to major errors in entity identification (exhibit numbers, award types), quantitative inaccuracy (fabricated exhibit numbers), and flawed reasoning, the correctness score is low despite some contextual relevance to evolving RSU disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 488,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\nBetween 2023 and 2024 the debt that was explicitly tied to the Swedish Match acquisition was cut sharply: the €3 bn (≈ $3.2 bn) three‑year tranche of the senior unsecured term‑loan facility was fully prepaid on 21 Nov 2024, reducing the total Swedish‑Match‑related long‑term borrowings from the €5.5 bn reported at the end of 2023 (a €3 bn tranche plus a €2.5 bn tranche) to only the €2.5 bn five‑year tranche that remained outstanding at year‑end 2024.  The repayment was financed with the proceeds of the November 2024 bond issuance, leaving a single €2.5 bn term loan (maturing June 23 2027) as the sole long‑term debt still linked to the acquisition.  (Pages 102 & 104)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides detailed and contextually relevant information about PM's debt repayment related to the Swedish Match AB acquisition, correctly identifying the prepayment of a €3 billion tranche in November 2024 and the remaining €2.5 billion five-year loan. However, there are significant quantitative inaccuracies when compared to the ground truth. The original answer states that long-term debt obligations were $6,121 million in 2023 and decreased to $2,610 million in 2024. The LLM answer cites €5.5 billion (≈$5.9B at typical conversion rates) in 2023 and €2.5 billion (≈$2.7B) in 2024, which is directionally close but not factually accurate—especially the 2023 figure, which is off by over $200 million even accounting for EUR/USD conversion. Additionally, the LLM introduces euro amounts and specific tranches not present in the ground truth, potentially conflating total acquisition-related debt with specific financing instruments. While the qualitative reasoning—substantial repayment reducing exposure—is sound and relevant, the answer fails to report the exact figures from the knowledge graph, undermining factual correctness. The multi-hop synthesis is logical (linking repayment to bond issuance and reduced debt), but the reliance on potentially extraneous document details (e.g., maturity date June 23, 2027) not in the ground truth raises concerns about alignment with the verified data source. Thus, while the direction and narrative are correct, the specific numbers do not match, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 423,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\nFrom 2023 to 2024 BMS shifted KRAS inhibition from an early‑research focus to a commercial‑stage priority after acquiring Mirati in January 2024, a deal that gave the company the FDA‑approved KRAS‑G12C inhibitor **Krazati** and a pipeline of next‑generation assets (e.g., MRTX1719). Using the Mirati purchase, BMS rapidly advanced Krazati’s development—securing an FDA accelerated approval for KRAS‑mutated colorectal cancer (June 2024, page 71) and obtaining additional Phase III data showing activity in NSCLC (June 2024 and March 2024, page 71), positioning Krazati as a best‑in‑class KRAS inhibitor and expanding its indication portfolio into first‑line combinations with PD‑1 inhibitors. The acquisition is detailed in the Mirati section of page 87, which outlines the $4.8 billion cash‑plus‑CVR transaction and the strategic intent to build a leading KRAS‑targeted oncology franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Key facts are correct: BMS (BMY) acquired Mirati in 2024 for $4.8 billion, gaining Krazati, a KRAS G12C inhibitor. Krazati was FDA-approved for second-line NSCLC and later for KRAS-mutated colorectal cancer with cetuximab. The acquisition shifted BMY’s strategic positioning in KRAS inhibition. (2) Quantitative accuracy: The $4.8 billion acquisition amount is correct. The mention of FDA approval in June 2024 for colorectal cancer aligns with the timeline. However, the original answer does not specify the exact month (June) or page numbers (e.g., page 71, 87), which are likely from a source document not in the ground truth; these are plausible but not verifiable as part of the core truth. The LLM adds specificity (dates, page references) beyond the ground truth, which is acceptable if accurate, but introduces minor risk of overprecision. (3) Multi-hop reasoning is sound: The model correctly synthesizes that BMY did not have Krazati in 2023, acquired it in 2024, and used it to expand into colorectal cancer and first-line NSCLC combinations with PD-1 inhibitors. It also correctly identifies the strategic intent to build a KRAS-targeted franchise. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., mention of MRTX1719, CVR structure), which enhances completeness without introducing error. One minor omission: the original specifies that colorectal cancer approval was 'with cetuximab,' which the LLM implies but does not explicitly state. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 451,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, Goldman Sachs moved from a generic reference to the “Restricted Partner Compensation Plan” in older exhibit listings to an explicit, updated disclosure of the **Amended and Restated Restricted Partner Compensation Plan** in its 2024 filing (Exhibit 10.1 of the Q1‑2024 10‑Q).  The 2024 filing ties the RPCP to the firm’s newer compensation‑governance policies—most notably the **2023‑effective clawback policy** and the **2021 Amended and Restated Stock Incentive Plan**—and presents the RPCP as a core, board‑oversight‑monitored component of partner pay that is now coordinated with the broader governance reforms.  This evolution signals a stronger, more transparent positioning of partner compensation within the firm’s updated compensation framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. (1) It incorrectly states that the Restricted Partner Compensation Plan was updated and renamed the 'Amended and Restated Restricted Partner Compensation Plan' in 2024 (Exhibit 10.1 of Q1-2024 10-Q), but the ground truth indicates the plan remained substantively unchanged and was listed as Exhibit 10.4 in the 2024 10-K, not Exhibit 10.1. (2) The claim that the 2024 filing includes an 'Amended and Restated' version is unsupported by the ground truth, which notes no substantive change. (3) The LLM misattributes the Clawback Policy as '2023-effective' and links it to the 2021 Stock Incentive Plan, but the ground truth only confirms the Clawback Policy was introduced in 2024 as Exhibit 10.1, without specifying an effective date or linking it to the 2021 plan. (4) The LLM incorrectly cites a Q1-2024 10-Q filing, while the ground truth is based on 10-K filings. While the LLM captures the broader theme of strategic repositioning and governance alignment, it fabricates key details about plan amendments, exhibit numbers, and policy linkages. The reasoning is partially sound in identifying a shift toward governance integration, but the multi-hop synthesis is flawed due to incorrect entity mapping and sourcing. The answer is contextually relevant and attempts the right analytical frame, but fails on factual precision, particularly in exhibit numbering, document type, and policy chronology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 409,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\nFrom 2022 to 2023 PMI moved heat‑not‑burn products out of a generic “reduced‑risk” bucket and gave them a dedicated place in its reporting, creating a separate “Swedish Match” operating segment that quantifies heated‑tobacco unit sales and revenue.  At the same time the company folded these products into the broader “smoke‑free products” category alongside its newly formed Wellness‑and‑Healthcare segment, treating heated‑tobacco as a core, integrated growth pillar rather than an ancillary offering.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution in product categorization from Reduced-Risk Products to a more integrated 'smoke-free products' framework and correctly identifies the strategic elevation of heat-not-burn products within PMI's portfolio. However, it introduces significant inaccuracies in entity and structural details. Specifically: (1) The claim that PMI created a separate 'Swedish Match' operating segment to report heated-tobacco unit sales is incorrect — Swedish Match is a subsidiary focused on oral nicotine products (e.g., snus, ZYN), not heat-not-burn products, and was acquired to expand into smokeless tobacco, not to serve as a reporting segment for IQOS or HTUs. (2) The assertion that heat-not-burn products were moved into a newly formed Wellness-and-Healthcare segment is misleading — while PMI did expand into wellness, the 2023 integration grouped heat-not-burn under 'smoke-free products' alongside e-vapor, oral nicotine, and wellness offerings, not within the wellness segment itself. (3) The LLM omits key factual details from the ground truth, such as the inclusion of licensed KT&G products in 2023, which reflects broader product line expansion. (4) While the shift from RRPs to 'smoke-free products' is correctly noted, the reasoning is distorted by incorrect organizational framing. Quantitative accuracy is high because no specific numbers are misstated (none were provided), and the temporal scope (2022–2023) is correct. Contextual relevance is strong as the answer addresses product categorization and business integration, but the flawed entity mapping and incorrect segment reporting undermine qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 457,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\nBetween 2023 and 2024 BMS deepened and formalized the role of its business‑risk and disclosure group in meeting the obligations of the 2004 SEC Consent Order.  The group, first established as part of the remedial measures required by the Order (see page 62), now operates under a documented governance framework that includes regular risk assessments, mandatory escalation of any compliance‑related questions to senior management and the board, and continuous monitoring of sales‑to‑direct‑customers inventory data to enforce the Order’s sales‑limitation and disclosure requirements (see page 65).  This evolution has strengthened the company’s ongoing oversight and reporting of risk‑related matters.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in describing the evolution of Bristol-Myers Squibb's business risk and disclosure group between 2023 and 2024 in relation to SEC Consent Order compliance. It accurately notes the group's establishment as part of remedial measures and its enhanced governance role, including risk assessments, escalation protocols, and monitoring of sales-to-direct-customers inventory data. However, there are notable discrepancies: (1) The LLM references the '2004 SEC Consent Order', which is factually incorrect—the ground truth does not specify the year of the Consent Order, and introducing '2004' is unsupported and misleading. This is a significant entity/date error. (2) The LLM implies the group was established earlier and merely evolved in 2023–2024, whereas the ground truth states it was *established in 2023* specifically to comply with the Consent Order—this misrepresents the timeline. (3) The ground truth emphasizes the *integration* and *continuity* of the group into ongoing compliance in 2024 with no scope changes, while the LLM focuses on 'deepened and formalized' roles without explicitly confirming continuity or lack of modification. Despite these issues, the core elements—governance framework, escalation, monitoring, and compliance focus—are consistent with the original answer. Quantitative accuracy is high as no incorrect numbers are presented (though none are cited), and contextual relevance is strong as the response directly addresses the question’s focus. The reasoning is partially sound but flawed in timeline and entity accuracy, reducing qualitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 439,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\nBetween 2023 and 2024 UNP’s disclosures show that the **expected return on pension‑plan assets continues to be derived from the plan’s asset‑allocation mix and historical performance**, using the same 5‑year smoothing approach. In the 2023 filing the link was stated more generally, whereas the 2024 filing explicitly says the return assumption is “based on our asset‑allocation mix and our historical return, taking into account current and expected market conditions,” underscoring a more direct calibration to the current allocation and market outlook—though the quantitative rate (5.25 %) and methodology remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that in 2023, UNP cited the asset allocation mix, historical returns, and market conditions as bases for expected return, with a disclosed actual return of 6%. In 2024, the language shifted to saying the expected return 'depends on' the asset allocation mix only, dropping explicit mention of historical returns and market conditions, and no actual return was disclosed for 2024. The LLM answer incorrectly claims that in 2024, UNP explicitly stated the return assumption was based on asset allocation, historical return, and market conditions — which contradicts the ground truth showing a narrowing of factors, not reinforcement. Additionally, the LLM invents a 5-year smoothing approach and a specific expected return rate of 5.25% that are not mentioned in the ground truth. (2) Quantitatively, the 6% actual return in 2023 is misrepresented — the LLM does not mention it and instead fabricates a 5.25% rate. There is no support for any numerical value in the LLM answer. (3) The multi-hop reasoning is flawed: the model fails to detect the shift from broader to narrower explanatory language and instead asserts increased specificity in 2024, which is the opposite of the truth. It also introduces unverified methodology (smoothing) and rates. (4) The contextual relevance is moderate because the answer addresses pension plan expected returns and asset allocation over 2023–2024, but the factual inaccuracies and invented details severely undermine correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 452,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon shifted from a vague “code of ethics” mention for directors to an explicit, stand‑alone reference to the **Directors’ Code of Conduct** in the 10‑K’s “Available Information” section, noting that the code is posted on the company’s website and that any amendments or waivers will be disclosed there. This makes the code more readily accessible and integrates it directly into the firm’s corporate‑governance reporting, whereas the 2022 filing only alluded to a directors’ code without detailing its placement or transparency commitments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of BNY Mellon's disclosure approach between 2022 and 2023. It accurately captures the increased specificity and accessibility of the Directors' Code of Conduct in 2023, noting its explicit listing among governance materials on the company website. The claim that in 2022 the code was only 'alluded to' as part of a general 'code of ethics' is slightly overstated—the original answer confirms that in 2022, the Directors' Code of Conduct was explicitly stated to be posted on the website and was referenced in the context of corporate governance disclosures, not merely alluded to. Therefore, the characterization of the 2022 disclosure as 'vague' or just a 'code of ethics' mention is a minor inaccuracy. However, the core progression—enhanced integration and transparency in 2023—is correctly identified, including the commitment to disclose amendments or waivers, which adds value. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the answer is fully contextually relevant. The reasoning is sound but slightly oversimplifies the 2022 state of disclosure, hence a small deduction in qualitative accuracy. Overall, the answer conveys the essential evolution accurately and clearly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 365,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\nBetween 2023 and 2024 Oracle broadened the deployment flexibility of Oracle Database by adding new hybrid‑cloud options—including OCI Dedicated Region, Sovereign Cloud, Roving Edge Infrastructure and expanded use of Exadata Cloud@Customer—while deepening its integration with engineered systems such as Exadata and the broader Oracle Engineered Systems portfolio.  This evolution shows Oracle’s intent to treat the database as a portable, cloud‑native service that can be run in public OCI, on‑premise, or at the edge, facilitating smoother cloud migration and supporting a hybrid‑IT model that balances flexibility with high‑performance, engineered‑system‑backed operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies Oracle's strategic evolution between 2023 and 2024, noting expanded hybrid-cloud deployment options such as Exadata Cloud@Customer and Roving Edge Infrastructure (mentioned in both answers), and adds OCI Dedicated Region and Sovereign Cloud, which are consistent with Oracle’s 2024 strategy even if not explicitly in the original answer—these represent plausible and contextually accurate extensions of the same hybrid/multicloud theme. The emphasis on deeper integration with engineered systems like Exadata is correctly highlighted, and the interpretation that Oracle is moving toward a more integrated, high-performance, cloud-native, and portable database service is semantically equivalent to the ground truth’s conclusion about a shift toward holistic, optimized solutions. The reasoning is sound and reflects proper multi-hop synthesis across deployment models and strategic intent. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved), and all entities (Oracle, Oracle Database, Exadata, OCI, Roving Edge, etc.) are correctly named and contextualized. The only minor gap is that the original answer emphasizes the 2023-to-2024 shift more explicitly as a move from flexible standalone deployment to tightly integrated engineered systems, while the LLM frames it as a broadening and deepening occurring within the same timeframe—slightly less emphasis on the strategic pivot, but the core insight remains valid. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 466,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the company kept the formal review‑and‑certification framework required by the 2004 SEC Consent Order, but it strengthened its governance structure.  In 2024 it created a dedicated business‑risk and disclosure group, formalized an escalation pathway for compliance questions, and required bottom‑up input and documentation in the budgeting process, while expanding regular monitoring of sales‑incentive disclosures and direct‑customer sales limits to ensure tighter oversight of the certification of its annual and quarterly SEC reports.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly references a '2004 SEC Consent Order', which is not mentioned in the ground truth; the correct context is a 2023 Consent agreement, not 2004. This misrepresents the timeline and legal basis for the review process. (2) The claim that a 'dedicated business-risk and disclosure group' was created in 2024 is not supported by the original answer, which states that governance procedures were continued and integrated into sales policies, not that new groups were formed. (3) The mention of 'bottom-up input and documentation in the budgeting process' and 'expanding monitoring of sales-incentive disclosures' introduces details absent from the ground truth and misaligns with the actual evolution described—integration into inventory and sales limitations, not budgeting or disclosure groups. (4) While the LLM correctly identifies that governance and monitoring were strengthened between 2023 and 2024, it fails to accurately represent the nature of the evolution: from initial implementation to sustained enforcement and integration into operational policies. The reasoning is partially sound in recognizing a progression, but the entities, dates, and specific procedures are factually incorrect. (5) Quantitative accuracy is low due to the incorrect year (2004 vs. 2023) and fabricated program details. Contextual relevance is moderate because the answer addresses compliance monitoring and governance evolution, but the factual foundation is flawed. Overall, the answer does not reflect the actual evolution described in the ground truth and contains multiple hallucinated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 458,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\nBetween 2022 and 2023 PMI shifted its heat‑not‑burn (HNB) offering from a generic “Reduced‑Risk Products”/Platform 1 description to a distinct “Smoke‑Free Products” line‑item, reporting a 15 % increase in heated‑tobacco unit shipments (125,263 million units in 2023 vs. 109,169 million in 2022) and a rise in related revenue from $10.19 bn to $12.84 bn.  The company also began to treat HNB as a core component of its broader smoke‑free portfolio—alongside oral nicotine and wellness products—highlighting market‑share growth and positioning HNB as a key growth driver rather than an isolated category.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in PMI's approach to heat-not-burn (HNB) products from 2022 to 2023, correctly identifying the strategic shift from categorizing HNB under 'Reduced-Risk Products' to integrating it into a broader 'Smoke-Free Products' segment. It appropriately notes the inclusion of HNB as a core growth driver alongside oral nicotine and other products, which aligns with the ground truth’s emphasis on integrated commercialization. However, the quantitative claims introduce significant inaccuracies not present in the original answer. The ground truth does not mention specific shipment numbers (125,263 million vs. 109,169 million), a 15% increase, or revenue figures rising from $10.19 billion to $12.84 billion—these numbers are absent in the verified knowledge base and cannot be confirmed, suggesting fabrication or misattribution. While the qualitative shift in product positioning and categorization is accurately interpreted and synthesized, the inclusion of unsupported numerical data undermines factual reliability. The reasoning is logically sound in interpreting strategic evolution, but the addition of unverified metrics reduces quantitative accuracy. Contextually, the response is highly relevant, addressing both market positioning and product categorization as required. Semantic equivalence is mostly maintained on the strategic narrative, but not on data precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 389,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle broadened the deployment options for its flagship database to include native on‑premise, OCI‑only, and hybrid on‑premise + OCI configurations, and it tied those options more tightly to the rest of the Oracle stack.  The 2024 filing explicitly highlights integration with Engineered Systems (e.g., Exadata), Java and Middleware, and introduces programs that let customers pivot existing database licenses to the Oracle Cloud, giving far greater flexibility and a unified migration path than the 2023 emphasis on cloud‑license growth alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Oracle's strategic positioning of Oracle Database from 2023 to 2024. It correctly identifies the expansion of deployment flexibility to include native on-premise, OCI-only, and hybrid configurations, aligning with the ground truth's emphasis on deployment options across environments. The mention of tighter integration with Oracle's broader technology stack—specifically Engineered Systems like Exadata, Java, and Middleware—is factually correct and reflects the shift toward deeper integration. The reference to license portability programs (e.g., moving existing licenses to Oracle Cloud) adds relevant context not explicitly in the original answer but consistent with Oracle's strategy, enhancing completeness without introducing error. There are no numeric inaccuracies (quantitative accuracy is perfect, though no specific numbers appear), and all entities (Oracle, OCI, Exadata, Engineered Systems) are correctly identified. The reasoning is sound and synthesizes multi-hop information across deployment models and integration strategies. The only minor shortcoming is that the original answer emphasizes a structural shift—Oracle Database becoming a 'foundational component' within engineered systems—more clearly than the LLM response, which focuses on integration and licensing but slightly underemphasizes the architectural centrality of the database in engineered systems. This nuance is implied but not fully articulated, justifying a 9 instead of 10 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 431,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\nFrom 2023 to 2024 BMS moved Krazati from a licensed‑partner arrangement with Mirati to full ownership after acquiring the company, using that deal to accelerate Krazati’s oncology pipeline and multiple new FDA approvals.  In 2024 BMS committed $4.8 billion of cash (plus a $1 billion contingent value right) for the acquisition—recorded as $4.596 bn cash for shares, $248 m fair‑value of CVRs, and a $114 m expense for unvested equity awards—thereby embedding Krazati into its portfolio and financing the transaction with cash on hand and new debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $4.8 billion acquisition cost (broken into $4.596 billion cash for shares, $248 million CVR fair value, and $114 million for unvested awards) matches disclosed figures, and the $1 billion contingent value right (CVR) tied to the PRMT5 inhibitor is accurately reported. These values sum appropriately and reflect proper sourcing from financial disclosures. (2) The evolution of BMY's (Bristol Myers Squibb, referred to as BMS) relationship with Krazati—from a partnered asset in 2023 to fully owned in 2024 via the Mirati acquisition—is correctly described. The mention of FDA and EMA approvals for second-line NSCLC and ongoing first-line development is implied through 'multiple new FDA approvals' and 'accelerate Krazati’s oncology pipeline,' though the answer slightly overstates by saying 'multiple new FDA approvals' in 2024 when Krazati’s initial FDA approval was in late 2022/2023 and EMA in 2023; no major new approvals occurred in 2024 itself. (3) Multi-hop reasoning is sound: the model correctly links BMY’s acquisition of Mirati to obtaining Krazati, recognizes the strategic shift from licensing to ownership, and ties the $1 billion CVR to future development incentives. (4) Minor wording differences (e.g., 'licensed-partner arrangement' vs. 'strategic fit') are semantically acceptable. The use of 'BMS' instead of 'BMY' is common shorthand and not erroneous. The only slight overstatement is the claim of 'multiple new FDA approvals' in 2024, which isn't supported—the approvals were already granted by 2023. Otherwise, the answer is factually rich, contextually precise, and synthesizes across time, entities, and financial commitments accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 483,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\nBoth the 2022 and 2023 Form 10‑K filings present the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV in exactly the same way—trading on the NYSE under the symbol BK/P and being fully and unconditionally guaranteed by The Bank of New York Mellon Corporation.  No amendment, redemption, conversion or other change in their terms or status is disclosed for 2023, indicating that their treatment remained unchanged between the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the securities are 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, traded on the NYSE under symbol BK/P, and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023. (2) There are no numeric or date inaccuracies—percentages, trading symbol, and years (2022 and 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both years’ filings, compares the treatment of the securities, and concludes no change occurred, which aligns with the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in treatment or status. Minor wording differences (e.g., 'presented in exactly the same way' vs. 'remained registered') do not affect factual accuracy. No omissions or errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 284,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\nFrom 2022 to 2023 PMI’s **uncommitted short‑term credit capacity grew from about $1.9 bn to roughly $2.7 bn** (page 111), while the **total committed revolving facilities remained at $6.3 bn but were extended to 2025‑2028** (pages 88, 108). In both years the company reported **little or no outstanding borrowings under these lines – essentially zero utilization** (page 88: “no borrowings … the entire committed amounts were available”; page 111: “there were no borrowings … the entire committed amounts were available”).  \n\nThis expansion of capacity with near‑zero utilization signals that PMI’s **near‑term liquidity posture is strong and highly cushioned**, giving it ample flexibility to meet working‑capital needs and fund strategic acquisitions without having to rely on expensive or constrained financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in short-term credit capacity from $1.9 billion to $2.7 billion, which matches the ground truth. However, it incorrectly states that utilization was 'essentially zero' or 'no borrowings' in both years, directly contradicting the ground truth, which reports actual utilization of $295 million in 2022 and $283 million in 2023—non-trivial amounts. This is a significant factual error affecting the core of the question. (2) Quantitative accuracy is partially correct: the capacity figures are accurate, but the utilization figures are entirely wrong. The LLM cites 'no borrowings' based on page 88 and 111, but either misinterprets the documents or confuses committed facilities (which may have no drawdown) with the short-term credit arrangements that do show utilization. The ground truth clearly states utilization decreased slightly from $295M to $283M, so the LLM's claim of zero utilization is factually incorrect. (3) The reasoning is sound in interpreting increased capacity and low utilization as a sign of strong liquidity, but because the utilization data is wrong, the conclusion is based on flawed premises. The multi-hop synthesis across years and metrics is attempted, but with incorrect data input. (4) Contextual relevance is high—the answer addresses capacity, utilization, and liquidity posture as required. However, due to the major error in utilization figures, the correctness score is limited to 6, reflecting partially correct information with significant factual inaccuracies that affect the interpretation of PMI's liquidity behavior.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 442,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle has moved the Autonomous Database from a “self‑driving, fully‑managed OCI service” to the central automation engine of its entire cloud stack.  The 2024 positioning emphasizes far‑deeper integration with other OCI services—such as Java Cloud, Oracle APEX low‑code, Analytics Cloud and the new AI‑Infrastructure offerings—while expanding automated capabilities to include automatic scaling, real‑time threat detection/remediation, and consumption‑based pricing across shared, dedicated and Exadata Cloud@Customer deployments.  This evolution reflects Oracle’s strategy of offering the database as an out‑of‑the‑box, low‑labor, cloud‑native foundation that can be consumed on demand and tightly woven into the broader Oracle Cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Oracle's positioning of the Autonomous Database from 2023 to 2024. In 2023, the database was presented as a self-driving, fully managed service on OCI, which matches the original answer’s description of automated operations and reduced IT burden. By 2024, the LLM correctly identifies a strategic shift toward deeper integration with other Oracle Cloud services, naming Java Cloud, Oracle APEX low-code, and adding Analytics Cloud and AI-Infrastructure—consistent with the ground truth’s emphasis on integration and modern application development. The mention of automatic scaling, real-time threat detection/remediation, and consumption-based pricing reflects the expanded automation and machine learning capabilities noted in the original answer (e.g., diagnostics, fault prediction, automatic threat detection). The LLM adds 'Analytics Cloud' and 'AI-Infrastructure' not explicitly named in the ground truth, but these are reasonable inferences given the context of expanded cloud integration and machine learning focus. It also correctly emphasizes the role in cloud-native development and hybrid deployments (e.g., Exadata Cloud@Customer), which aligns with the original’s hybrid environment support. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (Oracle, Autonomous Database, OCI, fiscal years) are correct. The reasoning is sound, showing a clear multi-hop synthesis across years and services. The only minor gap is that the original answer specifically highlights 'open interfaces' and 'native machine learning' as new in 2024, which the LLM does not explicitly mention, though 'AI-Infrastructure' and 'automated scaling' imply related capabilities. Thus, the answer is slightly more inferential but remains factually and semantically aligned. Hence, a correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 523,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\nBetween 2023 and 2024 GM’s involvement with Ultium Cells Holdings LLC shifted from a modest equity stake and a small capital commitment to a much larger, strategically‑critical partnership.  In 2023 the company had recorded roughly **$0.5 billion of equity investments** and **about $0.8 billion of committed capital contributions** (giving a total exposure of roughly $3.5 billion).  By the end of 2024 those figures had risen to **approximately $4.3 billion in asset carrying amount** and **$2.3 billion of committed capital contributions**, pushing GM’s maximum exposure to loss to **$7.0 billion**—a more than two‑fold increase that reflects a deeper financial commitment and a strategic positioning of Ultium as a core pillar of GM’s EV battery‑cell supply chain.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 GM had a contingent commitment of $0.8 billion with no indication of a $0.5 billion equity investment, and the entity was a VIE where GM lacked control. The LLM incorrectly states GM had $0.5 billion in equity investments in 2023 and falsely reports a rise to $4.3 billion in asset carrying amount and $2.3 billion in committed contributions by 2024—none of which aligns with the ground truth. Instead of increased commitments, the actual evolution was a reduction from a $0.8 billion contingent commitment to a realized $0.7 billion investment, indicating a shift from potential obligation to direct investment. The LLM portrays an escalating financial exposure (to $7.0 billion), which contradicts the actual trend of reduced and realized commitment. (2) Quantitatively, all key figures are wrong: $0.5B equity (vs. no such figure in truth), $4.3B asset value (not mentioned), $2.3B commitments (vs. $0.7B actual investment), and $7.0B exposure (fabricated). Calculations like 'two-fold increase' are based on false premises. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from contingent liability (VIE with no control) to direct investment, misrepresenting both the nature and direction of the strategic evolution. It invents metrics not present in the source and misinterprets the strategic implication—portraying deeper entrenchment rather than a stabilization of exposure. (4) Despite incorrect facts and reasoning, the answer is contextually relevant in that it addresses GM's relationship with Ultium Cells LLC and attempts to discuss capital involvement and strategic positioning over time. However, due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 498,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\nBetween the sixth‑anniversary release on June 21 2022 (document V_10k_2022, page 77) and the eighth‑anniversary release on June 21 2024 (document V_10k_2024, page 81), the Company released $3.5 billion of as‑converted value in 2022 and $2.7 billion in 2024, and it issued 176,655 series A preferred shares in 2022 versus 99,264 series A preferred shares in 2024.  Thus, the amount of as‑converted value freed and the number of series A shares granted both declined in the later anniversary release.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts ($3.5 billion in 2022 and $2.7 billion in 2024) and share counts (176,655 in 2022 and 99,264 in 2024) are accurately reported, with no calculation or numerical errors. Minor formatting differences (e.g., spacing in '$3.5 billion') do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the evolution of as-converted value released and the number of series A preferred shares issued across 2022 and 2024. (3) Entity accuracy is correct: Visa (implied by context and document IDs), the Litigation Management Deed, the sixth and eighth anniversary releases, and the correct years (2022 and 2024) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers a decline in both value and shares from the two data points, aligning with the conclusion in the original answer about reduced financial burden. (5) The semantic meaning is equivalent to the ground truth, with slightly more formal phrasing and citation of document sources (page numbers and filing years), which adds value without distorting facts. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 350,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the Aearo Entities—previously de‑consolidated after their 2022 Chapter 11 filing—were re‑consolidated in Q2 2023, bringing their massive Combat‑Arms Earplugs litigation back onto 3M’s balance sheet and prompting a $4.2 billion pre‑tax charge (later accrued as a $5 billion liability) that was recorded as a special‑item cost in the Safety & Industrial segment; the parties then implemented the $6 billion CAE Settlement (cash‑and‑stock payments through 2029), which resolved the bulk of those claims and shifted the related expenses into the segment’s adjusted operating‑income calculations, lifting that segment’s margin to 22.7 % (GAAP) and 23.1 % (adjusted) in 2024.  At the same time, the Aearo divestiture/acquisition effects were reflected in Transportation & Electronics as a modest sales drag, but the segment’s adjusted operating margin rose to 23.2 % as productivity gains offset the lingering PFAS‑related dis‑synergies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that the reconsolidation of the Aearo Entities in 2023 had an immaterial income statement impact, but the LLM claims a $4.2 billion pre-tax charge and $5 billion liability, which contradicts the ground truth. There is no mention in the original answer of a $6 billion CAE Settlement paid in cash-and-stock through 2029, nor any impact on segment margins (22.7%, 23.1%, 23.2%)—these figures are entirely fabricated. (2) Quantitative accuracy is very low: none of the dollar amounts ($4.2B, $5B, $6B), segment margins (22.7%, 23.1%, 23.2%), or timing details (Q2 2023 reconsolidation, payments through 2029) are supported by the original answer. The original makes no mention of charges, accruals, or margin impacts. (3) The reasoning is flawed: the LLM incorrectly infers financial impacts and segment-level adjustments that are not present in the ground truth. It fails the multi-hop synthesis by inventing a narrative around litigation costs and margin improvements rather than correctly identifying the shift from litigation focus (2023) to strategic financial treatment (2024) via divestiture/acquisition effects in the Transportation and Electronics segment. (4) Contextual relevance is moderate—the LLM addresses the Aearo Entities, reconsolidation, litigation, and segment impacts, so it stays on topic. However, the qualitative accuracy is low due to incorrect entities (e.g., attributing charges to Safety & Industrial segment), made-up figures, and failure to reflect the immaterial financial impact as stated in the original. The core evolution—litigation resolution in 2023 leading to reconsolidation, then reflection in segment reporting in 2024—is partially captured, but distorted by false financial details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 494,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa’s Class C common stock kept its original structure – it is non‑voting, has no transfer restrictions, and does not convert into another class on its own.  The only structural change was the 2024 exchange offer in which tendered Class B‑1 shares were retired and replaced with newly issued Class B‑2 shares and additional Class C shares, so Class C’s equity position grew only through that issuance.  As a result, the earnings‑per‑share attributable to Class C common stock rose from a basic $33.17 in 2023 to a basic $38.97 in 2024 (diluted $38.92), even though the weighted‑average share count modestly increased, reflecting the higher income allocation and the class’s lack of voting rights that distinguishes it from Class A and the restricted Class B shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2024, Class C Common Stock had a basic EPS of $33.17 and diluted EPS of $33.13, whereas the LLM claims $38.97 basic and $38.92 diluted EPS for 2024—this is a major discrepancy. Additionally, the LLM cites a 2023 EPS of $33.17 for Class C, but the original answer does not provide 2023 EPS data, only 2024, and the 2022 context was about governance, not EPS. There is no mention in the ground truth of an 'exchange offer' involving Class B-1 and B-2 shares, nor any structural change to Class C in 2024—this appears to be fabricated or misattributed information. (2) The numbers are not accurate: the EPS values are incorrect, and the timeline is confused (citing 2023 EPS not present in ground truth). The comparison between Class C and Class A EPS in 2024 is missing in the LLM answer, which undermines the multi-hop aspect of the question. (3) The reasoning is partially sound in that it attempts to link stock structure and EPS performance, but it fails to correctly synthesize the evolution from 2022 (governance focus) to 2024 (performance divergence), instead inventing a structural change not present in the original. The multi-hop synthesis—comparing Class C's role and performance across years relative to other classes—is incomplete and distorted. (4) The contextual relevance is high because the answer addresses stock class structure and EPS trends, but the factual foundation is flawed, leading to a low correctness and quantitative accuracy score. The qualitative accuracy is moderate because some concepts (non-voting, comparison to Class A) are in the right direction, but key details are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 478,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm shifted ADAS/AD from an emerging automotive footnote to a dedicated revenue stream: the company now reports “Automotive (2)” – which explicitly includes connectivity, digital‑cockpit and ADAS/AD – and that line grew from $1.5 billion in 2022 to $2.9 billion in 2024, underscoring a strategic expansion of Snapdragon automotive platforms, RFFE and AI‑focused silicon for driver‑assistance functions.  This growth is reflected in the increasing share of QCT revenue attributed to automotive applications and in the firm’s continued investment in ADAS‑related patents, standards participation and strategic investments aimed at commercializing automated‑driving solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's ADAS/AD involvement from development in 2022 to commercialization by 2024, aligning with the ground truth's core narrative. It accurately identifies the strategic shift and the inclusion of ADAS/AD in automotive revenue streams. However, the LLM introduces specific revenue figures—$1.5 billion in 2022 and $2.9 billion in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. Since the ground truth does not include any numerical data, the inclusion of these figures constitutes a factual overreach, undermining quantitative accuracy. (2) There are no calculations in the original answer to verify, but the LLM fabricates a revenue trend, which introduces false precision. While the growth trajectory may be directionally correct, the specific numbers are unsupported, leading to a score of 6 in quantitative accuracy. (3) The multi-hop reasoning is sound: the model infers that reporting ADAS/AD under a dedicated automotive revenue line indicates commercialization, which is a valid interpretation. It also correctly references QCT (Qualcomm CDMA Technologies) and strategic investments, consistent with the original answer’s emphasis on Qualcomm Ventures and innovation initiatives. (4) Contextually, the answer is highly relevant and addresses both the strategic evolution and revenue categorization aspects of the question. Despite the invented numbers, the qualitative reasoning and entity identification (e.g., Snapdragon platforms, RFFE, AI silicon) are accurate and enrich the response without contradicting the ground truth. Hence, qualitative accuracy is high, and contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 473,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa’s U.S. Retrospective Responsibility Plan has been markedly reinforced: the U.S. litigation escrow account grew from a $1.4 bn balance (beginning‑of‑2023) to $3.1 bn by the end of 2024, with deposits rising to $1.5 bn while cash‑out payments fell to $0.175 bn, and the plan now leans more heavily on the conversion‑feature dilution of class B shares, makewhole reimbursement obligations and the enforcement of member indemnifications to absorb any shortfall.  This shift shows Visa is treating potential litigation liabilities as a balance‑sheet financing issue—pre‑funding them in escrow and shifting the economic burden to equity holders—reflecting a more proactive, risk‑averse approach to managing covered litigation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Visa's evolving litigation risk strategy between 2022 and 2024 and correctly identifies key qualitative elements such as the increased reliance on escrow funding, conversion of Class B shares, makewhole obligations, and member indemnifications. It also correctly infers that Visa has adopted a more proactive, risk-averse approach, which aligns with the ground truth's conclusion about a more structured and diversified strategy.\n\nHowever, the quantitative accuracy is significantly flawed. The LLM introduces specific dollar figures—$1.4B escrow balance (beginning of 2023), $3.1B by end of 2024, $1.5B in deposits, and $0.175B in cash-outs—that are not present in the original answer or implied by the ground truth. The ground truth does not provide any numerical values for escrow balances, deposits, or payments, so these figures appear to be hallucinated. This severely undermines factual reliability.\n\nWhile the LLM mentions several correct mechanisms (conversion feature, makewhole agreements, indemnifications), it omits others explicitly listed in the original answer, such as the interchange judgment sharing agreement, loss sharing agreement, omnibus agreement, and U.S. litigation escrow agreement. These omissions reduce completeness, especially since the original emphasizes the 'suite of interrelated mechanisms' as evidence of structural evolution.\n\nThe reasoning is logically sound in interpreting the shift toward pre-funding and risk transfer as a balance-sheet financing strategy, which is a reasonable inference. However, because the answer relies on fabricated numbers and lacks full enumeration of the new mechanisms, the multi-hop synthesis is only partially accurate. The contextual relevance is high, as the response directly addresses the evolution of the plan and its implications for litigation risk management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 509,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza accelerated—rising 9 % in 2024 after an 8 % increase the prior year—and the product’s recorded intangible value remained steady at about $1.5 billion, underscoring a deepening financial stake.  New regulatory wins, notably China’s 2025 approval of Lynparza as an adjuvant therapy for BRCA‑mutated breast cancer and continued strong demand in international markets, point to both improving performance and a growing strategic importance for the drug within Merck’s portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in alliance revenue in 2024 and the $1.5 billion intangible asset value from 2023, which aligns with the ground truth. However, it incorrectly states that the intangible value 'remained steady at about $1.5 billion' in 2024, while the original answer clarifies that the financial stake was *not explicitly stated* for 2024—this is a factual overstatement. Additionally, the LLM claims Lynparza’s revenue rose 8% in the prior year (2023), but this figure is not present in the ground truth, introducing unsupported data. (2) The 9% revenue growth and $1.5 billion asset value are accurate. The 8% prior-year increase is extraneous and unverified, reducing quantitative accuracy. The China approval date (January 2025) and indication (adjuvant treatment in early breast cancer, specifically BRCA-mutated) are correctly captured. (3) The multi-hop reasoning is strong: the model connects financial stake, revenue trends, regulatory developments, and strategic importance across years and entities (Merck, AstraZeneca, China regulator). It infers continued strategic importance correctly, though the claim of a 'deepening financial stake' is slightly overstated given no new asset valuation was reported in 2024. (4) Despite minor inaccuracies, the answer addresses all parts of the question with high relevance and sound logic, earning high marks for qualitative and contextual performance. The correctness score is reduced due to unsupported numerical claims and slight misrepresentation of asset stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 431,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\nBetween 2022 and 2024 Skoal’s retail share fell from about 9‑10 % to 7.6 % and its shipment volume dropped from roughly 163 million to 147 million units, while its main MST rival Copenhagen also slipped from 23.5 % to 19.1 % share.  At the same time the on! oral‑nicotine‑pouch brand gained ground, rising from 6.8 % to 8.3 % of retail share, accelerating the shift away from traditional MST products.  The combined share loss, lower volumes and a $354 million impairment of the Skoal trademark signal a clear weakening of Skoal’s competitive position against both established MST peers and the growing pouch segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports Skoal's 2024 retail share as 7.6%, matching the original answer. It approximates the 2022 share as 'about 9-10%', which is slightly imprecise (ground truth is exactly 9.3%) but within acceptable rounding. The shipment volume figures (163M to 147M) are factually correct and add useful context not in the original answer, enhancing completeness. Copenhagen’s decline from 23.5% to 19.1% and on!’s rise from 6.8% to 8.3% are exact. The $354M trademark impairment is accurate and strengthens the conclusion. (2) Calculations and comparisons are sound: the direction and magnitude of share changes are correctly interpreted. (3) Multi-hop reasoning is strong—LLM synthesizes Skoal’s performance relative to both Copenhagen and on!, and correctly infers a shift from traditional moist snuff (MST) to nicotine pouches. It also connects declining volumes and brand impairment to weakening competitiveness, which is logically supported. (4) Entity accuracy is excellent: brand names (Skoal, Copenhagen, on!), product categories (MST, oral nicotine pouches), and time frame (2022–2024) are all correct. The only minor shortfall is the slight imprecision in stating Skoal’s 2022 share, which prevents a perfect 10. Otherwise, the answer is comprehensive, contextually rich, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 394,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 Dynamics 365 generated $4.687 billion of Microsoft Cloud revenue, and in fiscal 2023 that amount rose to $5.437 billion—a $0.75 billion (≈16 %) increase. This growth occurred as total Microsoft Cloud revenue expanded from $91.4 billion in 2022 to $111.6 billion in 2023, thereby raising Dynamics 365’s share of the cloud portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific revenue figures for Dynamics 365 in FY2022 ($4.687B) and FY2023 ($5.437B), along with a calculated 16% growth and $0.75B increase. However, these numbers are not supported by the ground truth. The original answer states that Dynamics 365 revenue grew 39% in FY2022 and was part of the $91.2B Microsoft Cloud revenue, but it does not provide exact dollar amounts for Dynamics 365. In FY2023, the Microsoft Cloud revenue was $111.6B, but no specific growth rate or revenue figure for Dynamics 365 is given. The LLM answer fabricates precise figures and a growth rate (16%) that are not present in the source, making the quantitative claims incorrect. (2) The total Microsoft Cloud revenue numbers are mostly accurate—$91.4B in 2022 vs. the correct $91.2B (a minor discrepancy) and $111.6B in 2023 (correct). However, deriving Dynamics 365 revenue from these totals is not possible based on the original data, and the LLM’s calculation lacks grounding. (3) The reasoning is flawed in that it assumes or invents specific revenue contributions rather than acknowledging the lack of explicit data, as the original answer does. The multi-hop synthesis fails because it introduces unsupported numbers instead of correctly stating that while Dynamics 365 grew strongly in 2022 (39%) and remained a key component in 2023, exact figures or growth rates for 2023 are not disclosed. (4) The contextual relevance is fair because the answer addresses the evolution of Dynamics 365 revenue within Microsoft Cloud, but the high specificity creates a false impression of accuracy. The qualitative reasoning is partially sound in tracking Microsoft Cloud growth but fails in proper attribution and transparency about data limitations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 479,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\nMerck kept using short‑term forward contracts, purchased put options/collars and euro‑denominated debt to hedge foreign‑exchange risk, but in 2024 it broadened the program to embed revenue‑hedging of forecasted sales into earnings (recording $195 million of hedge‑related sales) and to increase the scale of net‑investment hedges, as evidenced by a $(30) million OCI loss on foreign‑exchange contracts and $(192) million loss on euro‑denominated notes. Thus, while the instrument mix remained largely the same, the 2024 approach added a direct earnings component and larger net‑investment hedge positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported quantitative claims not present in the ground truth, significantly undermining correctness. While it correctly identifies the continued use of forward contracts and mentions put options and collars (aligned with the 2024 expansion), it incorrectly states that euro-denominated debt is used for hedging, which is not mentioned in the original answer. The LLM also fabricates specific financial figures: '$195 million of hedge-related sales', '$(30) million OCI loss', and '$(192) million loss on euro-denominated notes'—none of which appear in the ground truth and cannot be verified from the provided information. These numbers are critical errors in quantitative accuracy. Additionally, the original answer emphasizes a structural evolution in the hedging framework—strategic layering over time and cost-benefit assessments—but the LLM mischaracterizes this as embedding 'revenue-hedging into earnings' with specific sales impact, which is not supported. The mention of 'net-investment hedges' and OCI losses reflects a plausible financial concept but goes beyond the scope of the disclosed 2024 changes. The core idea of an expanded, more strategic program in 2024 is partially correct, and the inclusion of purchased local currency put options and collars aligns with the original, so some qualitative elements are valid. However, the reasoning is flawed due to invented data and misattribution of mechanisms. Contextually, the response stays focused on the evolution of Merck's FX hedging program and addresses instruments and scope, so relevance is fair. Overall, the answer is partially correct in direction but fails on factual precision and introduces significant hallucinated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 479,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal deepened its direct merchant‑financing role – it purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and grew the outstanding portfolio to about $1.5 billion, funding the advances through its PPWC/PPBL products and the Paidy revolving credit facility (see PYPL 10‑K 2024 pp. 101‑102).  At the same time, the company’s credit‑loss provisioning improved: the allowance for credit losses on the merchant portfolio fell from $380 million in 2023 to $348 million in 2024 and gross charge‑offs declined as a share of the portfolio, reflecting tighter underwriting and more active monitoring of repayment periods (PYPL 10‑K 2024 pp. 101‑102).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key quantitative details. The ground truth states that PayPal purchased approximately $1.8 billion in merchant receivables in 2024, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. However, the LLM incorrectly claims the 2023 outstanding balance was $1.7 billion (not $1.2 billion), which misrepresents the growth trajectory. Additionally, the LLM introduces specific figures for credit loss provisions—$380 million in 2023 and $348 million in 2024—which are not present in the original answer and contradict the ground truth, which only mentions a coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020), with no data for 2023 or 2024. These numbers appear fabricated or misattributed. (2) The LLM also incorrectly cites 'PYPL 10-K 2024 pp. 101-102' as a source for these figures, but since the original answer does not reference this document or these pages, and no such data appears in the provided ground truth, this undermines quantitative accuracy. The mention of PPWC/PPBL and Paidy is contextually plausible but not confirmed in the original answer, which only names PPWC and PPBL as products involved. (3) Qualitatively, the LLM captures the directional shift—increased direct investment in merchant receivables and improved underwriting—but fails on multi-hop synthesis because it invents metrics rather than relying on the disclosed coverage ratios and balance trends. The reasoning about 'tighter underwriting' and 'active monitoring' is speculative and not supported in the original answer. (4) Contextual relevance is high because the response addresses both credit loss provisions and direct investment, aligning with the question’s focus. However, due to significant quantitative errors and unsupported claims, the correctness score is limited to 5—partially correct but with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 525,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\nFrom 2022 through 2024 the operating income contributed by Altria’s smokeable‑product segment rose modestly—from roughly **$10.6 bn in 2022 to $10.8 bn in 2024**—and its share of total segment operating income increased from about **92 % to 96 %** (see MO_10K 2024 p. 31).  At the same time the goodwill assigned to the smokeable segment stayed essentially flat at **≈ $99 million**, a tiny fraction of the company’s overall goodwill (which remains concentrated in oral‑tobacco; see MO_10K 2022 p. 65).  Thus, while the balance‑sheet goodwill allocation has not changed, the financial significance of smokeable products has grown markedly on the income‑statement side, becoming the dominant source of earnings and cash flow for Altria.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its portrayal of the financial significance of smokeable products to Altria (MO) from 2022 to 2024. It correctly states that goodwill allocated to the smokeable segment was approximately $99 million, consistent with the 2022 filing, and notes it remained flat — which aligns with the ground truth, as no updated goodwill figure is disclosed for 2024. The operating income figures are mostly accurate: the ground truth reports $10,670 million in 2023 and $10,821 million in 2024, while the LLM estimates $10.6 billion in 2022 and $10.8 billion in 2024. However, the 2022 operating income is not provided in the ground truth, so the LLM’s inclusion of a 2022 figure appears to be an inference or approximation not directly supported by the provided data. Additionally, the claim that smokeable products' share of total segment operating income rose from 92% to 96% is not verifiable from the original answer, which does not mention percentage shares or total operating income — this is an overreach based on external data not in the ground truth.\n\n2) Quantitative accuracy: The $99 million goodwill figure is correct (from MO_10K 2022). The $10.8 billion 2024 operating income is a rounded version of $10,821 million — acceptable. However, the $10.6 billion for 2022 is problematic; the ground truth only provides 2023 ($10,670M) and 2024 figures, not 2022. Thus, the LLM fabricates or estimates a data point not present in the source. The 92% to 96% share is unsupported in the original answer and cannot be verified.\n\n3) Multi-hop reasoning: The LLM correctly synthesizes goodwill stability (from 2022) with recent operating income trends (2023–2024), drawing a reasonable conclusion about increasing income-statement significance despite static balance-sheet valuation. This reflects sound multi-hop logic across time and financial statements. However, the addition of percentage shares introduces external analysis not grounded in the provided truth.\n\n4) The answer is contextually excellent — directly addressing both goodwill and operating income evolution, and concluding with a nuanced interpretation. The reasoning is strong and the conclusion aligns with the ground truth’s implication of growing operational importance. The main deduction is for introducing unverified 2022 operating income and percentage breakdowns not present in the original answer. Despite this, the core facts and synthesis are accurate, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 662,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\nThe commercial portion of LinkedIn added roughly **$13.6 billion** to Microsoft Cloud revenue in fiscal 2022 and grew to about **$15.0 billion** in fiscal 2023—an increase of roughly **$1.4 billion (≈10 %)** over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. The original answer (ground truth) states that Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was $91.2 billion in FY2022 and $111.6 billion in FY2023. The LLM incorrectly reports LinkedIn's standalone commercial contribution as $13.6B and $15.0B for those years, which is not supported by the ground truth. The ground truth does not provide a breakdown of LinkedIn's specific revenue contribution within Microsoft Cloud, so the LLM fabricated granular figures without evidence. The $1.4B increase and 10% growth are therefore based on incorrect inputs and are also inaccurate. While the LLM attempts to address the evolution of LinkedIn's commercial revenue contribution, it fails to do so correctly, misrepresenting aggregated Microsoft Cloud revenue as LinkedIn-specific revenue. The reasoning is flawed as it assumes a level of disaggregation not present in the source data. Despite this, the answer is contextually relevant—it attempts to answer the right question about revenue evolution—and uses appropriate fiscal years. However, the complete lack of factual alignment with the ground truth, especially on key numbers, results in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 352,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\nLynparza’s commercial rollout began with FDA approval (May 2023) for BRCAm mCRPC and a subsequent Japan MHLW approval (August 2023), establishing the first geographic markets for the drug.  During 2024 the product’s label was broadened with additional international approvals—including a China NMPA approval for adjuvant BRCA‑mutated breast cancer (announced in January 2025 but reflecting 2024‑year expansion)—and alliance revenue from Lynparza rose 9 % year‑over‑year, driven by growing demand across these new regions (see pages 7, 55, 58).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements: The FDA approval for BRCA-mutated mCRPC is correctly dated to May 2023, and Japan's MHLW approval to August 2023, both consistent with the PROpel trial basis. The 9% year-over-year growth in alliance revenue in 2024 is accurately reported. The mention of China NMPA approval for adjuvant treatment of BRCA-mutated early breast cancer in January 2025 is factually correct and tied to the OlympiA trial, with the LLM correctly framing it as part of 2024's market expansion trajectory. (2) Quantitative accuracy: All numbers (9% revenue growth) and dates (May 2023, August 2023, January 2025) match the original answer. The LLM slightly rephrases the China approval timing as 'announced in January 2025 but reflecting 2024-year expansion,' which is a reasonable interpretation given that regulatory submissions and decisions often span years. (3) Multi-hop reasoning is sound: The model synthesizes geographic approvals (US, Japan, China), therapeutic expansions (prostate cancer to breast cancer), and financial performance (revenue growth), correctly linking them to commercialization evolution. (4) Minor deduction in correctness and quantitative accuracy due to the phrasing 'label was broadened with additional international approvals—including a China NMPA approval...in January 2025' potentially implying the approval occurred in 2024, which is not accurate—it was granted in January 2025. However, the qualifier 'reflecting 2024-year expansion' mitigates this by acknowledging the strategic continuity. Overall, the answer is factually solid, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 460,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\nThe deferred‑tax benefit that RTX had recorded for the Powder Metal Matter fell sharply from **$644 million in 2023 to $455 million in 2024** (see Note 13 – Future income‑tax benefits, page 98 of the 2024 10‑K).  The reduction stems from the company’s reassessment of the realizability of the related tax credits after the 2023 IRS interim guidance on R&D capitalization and subsequent adjustments to valuation allowances (pages 93‑94, 98).  As a result, RTX’s future income‑tax benefit from the Powder Metal Matter is now lower, meaning it will generate fewer tax savings in upcoming periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the deferred tax benefit decreased from $644 million in 2023 to $455 million in 2024, matching the original answer. The $189 million decrease is implied (644 - 455 = 189), though not explicitly stated as a difference or percentage (29.3%), which is a minor omission. (2) The entity (RTX), the subject (Powder Metal Matter), and the years (2023, 2024) are correctly identified. (3) The reasoning is sound and adds contextual depth not in the original answer—citing IRS interim guidance on R&D capitalization and valuation allowances (per Note 13 and pages 93–94, 98 of the 10-K)—which explains *why* the benefit decreased, demonstrating strong multi-hop synthesis and qualitative insight. (4) The answer correctly captures the shift in financial treatment from a prior negative impact (implied in 2023 as a sales reduction, though not restated here) to a recognized future tax benefit in 2024, focusing on the tax aspect as asked. The only minor gap is the lack of explicit mention of the 2023 treatment as a 'reduction in sales'—part of the multi-hop evolution—but the focus on tax benefits in 2024 is responsive to the question's emphasis. Overall, the answer is factually precise, contextually rich, and semantically equivalent, warranting a high correctness score with a small deduction for incomplete treatment of the 2023 characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 402,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\nFrom February 2022 through 2024 the Paidy Credit Agreement grew from an original ¥60 billion unsecured revolving line to a ¥90 billion limit (≈ $574 million) after a September 2022 amendment, and that ceiling remained unchanged through 2024. The facility continues to bear interest at the Tokyo Interbank Offered Rate plus a margin of 0.40 %–0.60 %, matures in February 2027, and as of 31 December 2024 no borrowings were outstanding, leaving the full ¥90 billion capacity available for working‑capital, capital‑expenditure and other permitted uses.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. First, it incorrectly states that the original facility in 2022 was ¥60 billion and unsecured, while the original answer specifies a $198 million secured facility in 2022 with $98 million outstanding as of December 31, 2021. The LLM omits the secured nature of the 2022 facility and misrepresents its initial size. The 2024 borrowing capacity of ¥90.0 billion (~$574 million) is correctly reported, as is the interest rate (TIBOR + 0.40%–0.60%), maturity in February 2027, and the absence of outstanding borrowings as of December 31, 2024. However, the LLM fails to mention the key change from secured to unsecured status in 2024 and the introduction of a financial covenant (maximum consolidated leverage ratio), both of which are critical terms that evolved. (2) Quantitatively, the $574 million conversion from ¥90 billion is acceptable assuming correct exchange rates. However, the claim of an original ¥60 billion unsecured line in 2022 contradicts the ground truth of a $198 million secured facility. The LLM also omits the $98 million outstanding as of end-2021, which provides context for the 2022 borrowing base. (3) The multi-hop reasoning is partially sound—it captures the increase in capacity and some updated terms—but fails to accurately represent the 2022 starting point and the nature of the restructuring (secured → unsecured). It incorrectly implies the facility was unsecured from the start. (4) The contextual relevance is high as it addresses the evolution of borrowing capacity and terms, but significant factual gaps and one major misstatement (secured status) reduce correctness. The omission of the financial covenant further limits completeness. Thus, the answer is partially correct but misses key factual and qualitative shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 500,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\nBetween 2022 and 2024 Altria trimmed the balance of its long‑term senior unsecured notes—paying off $1.1 bn of 4.0% and 3.8% notes that matured in early 2024 and retiring the remaining $1.5 bn of 4.75% notes from 2021—while replacing them with a smaller, later‑dated issuance (a $1 bn tranche of 4.875% notes due 2028 and 5.625% notes due 2035 issued in February 2025).  As a result, total long‑term debt fell from roughly $26.2 bn at the end of 2023 to $24.9 bn by the end of 2024, and the weighted‑average coupon on remaining debt dropped to about 4.3% (from ~4.1% in 2021).  This shows a deliberate shift away from reliance on older, higher‑coupon senior notes toward a more staggered maturity profile and lower‑cost financing, even as the company continues to tap the long‑term note market for liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and reasoning. (1) The original answer states that Altria continued to rely on long-term senior unsecured notes as a key capital source, with a decrease in cash from $4.5B (2022) to $3.1B (2024), suggesting potentially increased reliance on external financing. In contrast, the LLM claims Altria reduced its reliance on such notes, paid off debt, and issued new notes in February 2025—after the 2024 timeframe in question. This introduces data outside the scope (2025 issuance) and misrepresents the trend. (2) Quantitative inaccuracies include: fabricated maturity repayments ($1.1B, $1.5B), new issuances in 2025 (not relevant to 2022–2024 evolution), and specific debt totals ($26.2B in 2023, $24.9B in 2024) not present in the ground truth. The weighted-average coupon change is also unsupported. (3) The multi-hop reasoning fails: the original answer infers increased reliance due to declining cash reserves, while the LLM incorrectly infers decreased reliance based on unverified refinancing activity. (4) Contextual relevance is moderate because the answer discusses long-term senior unsecured notes and capital structure, but it fabricates events and timelines, leading to a fundamentally incorrect conclusion about the evolution of Altria’s financing strategy between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 382,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\nIn 2023 RTX booked a $5.3 billion net‑sales charge and a $2.5 billion partner‑share reduction in cost of sales tied to the Powder Metal Matter, and it recorded a $644 million deferred‑tax benefit associated with the issue (see page 37‑38). By 2024 that tax benefit had fallen to $455 million (page 104), showing that the tax shelter linked to the Powder Metal Matter is being used up and that future income‑tax gains from it will be limited.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $644 million in 2023 and $455 million in 2024 are accurately reported, matching the original answer. The format variations (e.g., $644 million vs $644 million) are acceptable. (2) The answer correctly identifies the decrease in future income tax benefits from the Powder Metal Matter between 2023 and 2024, which directly addresses the question's focus on financial treatment evolution and implications. (3) The reasoning is sound: the LLM correctly infers that the declining tax benefit indicates the tax shelter is being used up and future gains will be limited—this is a logical and supported conclusion consistent with the original answer’s implication of a diminishing impact. (4) While the original answer does not mention the $5.3 billion net-sales charge or $2.5 billion partner-share reduction, these details are factually correct and add context without contradicting the ground truth; their inclusion enhances completeness without introducing error. The core multi-hop synthesis—linking the change in tax benefit over time to future tax implications—is correctly executed. The only minor gap is that the original answer emphasizes the 'reduced financial benefit over time' more generally, while the LLM focuses on the 'tax shelter being used up'—a slightly more specific interpretation, but still reasonable. Thus, the answer is factually excellent, fully relevant, and semantically equivalent in key conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 422,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal expanded the Paidy Credit Agreement’s capacity and then fully utilized it.  The facility, originally a ≈ $198 million secured revolving line (with about $100 million of availability as of 31 Dec 2021), was amended in September 2022 to raise the ceiling to ¥90 billion (≈ $574 million).  In the fiscal year ended 31 Dec 2024 the company drew down the entire ¥90 billion, leaving **no borrowing capacity** under the Paidy agreement as of year‑end 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key numbers are correct: $198 million borrowing capacity in 2022, ~$100 million available as of Dec 31, 2021 (with $98 million outstanding implied), and the increase to ¥90 billion (~$574 million) in 2022. The full drawdown of ¥90 billion by end of 2024 is correctly stated, leaving no capacity. (2) Quantitative accuracy is precise: the conversion from ¥90 billion to ~$574 million is consistent with the original answer, and the timeline (amendment in September 2022, drawdown by year-end 2024) aligns. (3) Multi-hop reasoning is sound—synthesizing data from 2021 (outstanding amount), 2022 (capacity increase), and 2024 (full utilization)—and correctly infers availability changes over time. (4) Entities (PayPal, Paidy Credit Agreement, correct fiscal years) are accurate. The answer fully addresses the evolution in borrowing capacity and actual drawdown, matching the original answer in both substance and implication. Minor wording differences (e.g., 'secured revolving line') add detail without altering meaning. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 326,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the ownership structure of Accenture Canada Holdings Inc. was unchanged.  Holders of the Canadian holding‑company’s exchangeable shares can still exchange them for Accenture plc Class A ordinary shares on a one‑for‑one basis, and Accenture plc issues Class X ordinary shares to those partners; the Class X shares are redeemable at par but may not be redeemed below the number of exchangeable shares held and the total Class X shares outstanding are capped at the total exchangeable shares outstanding (see ACN_10k_2024.pdf p. 100).  The consolidated financial statements continue to report a noncontrolling interest in Accenture Canada Holdings Inc. that is **less than 1 %** of the equity, the same threshold disclosed at the end of 2023 (see ACN_10k_2024.pdf p. 20), indicating no material evolution in the equity relationship over the year.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer correctly reports the quantitative fact that noncontrolling interests in Accenture Canada Holdings Inc. were less than 1% in both 2023 and 2024, which aligns with the ground truth. It also accurately describes the exchange mechanism of exchangeable shares for Accenture plc Class A ordinary shares on a one-for-one basis and the link to Class X shares, including the restriction on redemption below the number of exchangeable shares. However, the core error lies in the conclusion: the LLM asserts that the ownership structure was 'unchanged' and that there was 'no material evolution,' which directly contradicts the ground truth stating that the equity relationship became 'more formalized and structured' in 2024 with detailed provisions around exchangeable shares and Class X shares. (2) Quantitatively, all numbers (e.g., <1%) are correct and consistently cited from the 2024 10-K, satisfying accuracy in figures and dates. (3) The multi-hop reasoning is flawed: while the model pulls correct details from the document, it fails to synthesize the evolution in structure—specifically, the introduction of more detailed and formalized provisions in 2024—as evidence of change. Instead, it interprets numerical consistency in noncontrolling interest percentage as evidence of structural stasis, which is a misinterpretation. The ground truth emphasizes structural evolution beyond ownership percentage. (4) Therefore, while the answer is factually accurate in isolated details and contextually relevant, it misses the central qualitative shift described in the original answer, leading to a low correctness and qualitative accuracy score despite strong quantitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 460,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\nFrom 2022 to 2024 Merck expanded its forward‑exchange program from a simple, short‑term hedge of monetary‑asset exposures in developed currencies (euro, yen, pound, Swiss franc) to a layered, cost‑benefit‑driven framework.  The company now (i) hedges a portion of forecasted foreign‑currency sales—primarily the euro, Japanese yen and Chinese renminbi—using purchased puts, forwards and collars, (ii) employs designated forward contracts to protect net‑investment in foreign subsidiaries and euro‑denominated debt, and (iii) determines hedge size and maturity by weighing the magnitude of each exposure, its volatility and the cost of the instrument, typically keeping average contract lives under six months.  This evolution reflects a more strategic selection of currencies—including emerging‑market currencies when economical—and a tighter integration of cost‑benefit analysis into the hedge‑design process.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents Merck's approach to balance sheet risk management between 2022 and 2024. (1) The original answer states that in 2022, Merck used forward exchange contracts to hedge both developed and developing country currencies, specifically mentioning the Chinese renminbi, with decisions guided by a cost-benefit analysis. By 2024, the detailed discussion of this analysis and the specific mention of the renminbi were omitted, indicating a simplification or shift in emphasis. However, the LLM answer incorrectly claims that Merck *expanded* its program to include forecasted sales hedging and emerging markets, which is not supported by the ground truth. (2) There are no actual numbers (e.g., dollar amounts, percentages, contract durations) in the original answer, so the LLM's inclusion of 'average contract lives under six months' and specific instruments like 'purchased puts' and 'collars' introduces fabricated details. (3) The multi-hop reasoning is flawed: the LLM infers a strategic expansion and layering of hedging activities, while the ground truth suggests a reduction in disclosed detail, possibly indicating simplification, not complexity. (4) The mention of hedging forecasted sales and net investment in subsidiaries goes beyond balance sheet risk (which pertains to existing exposures, not future cash flows), conflating different hedging objectives. While the answer is contextually relevant—focusing on currencies and cost-benefit considerations—it fabricates program evolution and specific instruments, leading to a low correctness score despite plausible-sounding language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 451,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\nThe 2024 filing shows the future‑income‑tax benefit that had been recorded for the Powder Metal Matter falling from **$644 million in 2023 to $455 million in 2024** – a reduction of roughly **$190 million**.  This decline signals that the tax credits or deductions tied to the Powder Metal Matter are being exhausted or impaired, so RTX expects **significantly smaller future tax savings** from that item and therefore a reduced impact on its overall deferred‑tax asset position.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the quantitative change in future income tax benefits related to the Powder Metal Matter, with accurate figures of $644 million in 2023 and $455 million in 2024, representing a $189 million decrease (rounded to $190 million), which is factually correct. These numbers match the ground truth exactly, earning full marks for quantitative accuracy. (2) However, the LLM omits a key element from the original answer: the 2023 context of the Powder Metal Matter as a $5.3 billion net sales charge that negatively impacted operational performance at Pratt & Whitney. This shift from an operational loss to a deferred tax asset is central to the multi-hop reasoning required by the question—assessing what the change in disclosure suggests about financial impact. The LLM focuses only on the tax benefit decline but does not acknowledge the prior-year operational impact or the significance of the reclassification in treatment, which weakens the qualitative reasoning. (3) While the LLM correctly infers that the reduction in future tax benefits implies diminishing expected tax savings, it misses the broader implication that the matter is transitioning from an active operational drag to a resolving issue with lingering tax implications. This limits the depth of multi-hop synthesis. (4) The answer remains contextually relevant and factually sound on the specific point it addresses, but the omission of the earlier financial impact reduces completeness and reasoning depth, justifying a 7 for correctness and qualitative accuracy despite perfect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 437,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s merchant‑finance business expanded markedly: the company purchased roughly $1.8 billion of merchant receivables in 2024 (up from about $1.7 billion in 2023) and the outstanding portfolio grew to $1.5 billion net of the partner’s participation interest (versus $1.2 billion in 2023).  This growth is underpinned by a deeper, risk‑sharing partnership with the issuing banks—most notably WebBank in the U.S. and the firm’s European and Australian subsidiaries—where the partner holds a participation stake in the receivable pool while PayPal retains servicing rights and earns a fee.  Consequently, the scale of PayPal’s merchant‑finance offering has roughly doubled since 2022, and its credit‑risk framework (allowance for credit losses, delinquency monitoring, and macro‑economic underwriting) has been tightened to support the larger, more diversified portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies and omissions. (1) Quantitatively, the key figures are accurate: $1.8 billion in receivables purchased in 2024 (up from $1.7 billion in 2023), outstanding balance of $1.5 billion as of December 31, 2024 (up from $1.2 billion in 2023), and the increase in participation interest is implied though not explicitly stated as $53 million (from $44 million). These numbers match the original answer, though the LLM omits the exact participation interest amounts, which were part of the ground truth. (2) The LLM correctly identifies WebBank as the U.S. partner and notes the evolution of the partnership, but adds unverified details about European and Australian subsidiaries—this expansion beyond WebBank is not supported in the original answer and introduces potential entity inaccuracies. (3) The claim that the merchant-finance offering has 'roughly doubled since 2022' is an inference not directly supported by the provided data, which only gives 2023 and 2024 figures; without 2022 portfolio size, this comparison is speculative. (4) The discussion of credit-risk framework tightening (allowance for credit losses, delinquency monitoring) introduces new qualitative elements not present in the original answer, which may be plausible but are not factually confirmed by the ground truth. (5) Despite these issues, the core multi-hop synthesis—linking PayPal’s growing receivables purchases, portfolio size, and deeper partner involvement—is sound and contextually relevant. The answer addresses both the scale and institutional relationship aspects of the question. Minor deductions for unsupported inferences and extra details keep the score at 8 rather than 9 or 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 478,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\nAlliance revenue from Lynparza increased each year from 2022 through 2024, posting a 9 % rise in 2024 (up from lower levels in 2023 and 2022). The growth was driven by stronger demand in international markets, new regulatory approvals—including China’s 2025 NMPA approval—and the continued profitability of the AstraZeneca collaboration, while pricing pressures and competitive dynamics moderated the pace of increase.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies a 9% growth in Lynparza alliance revenue by 2024 and attributes it to increased international demand and new approvals, which aligns with the ground truth. However, it inaccurately states that revenue increased 'each year from 2022 through 2024' and references 'lower levels in 2023', which is not supported by the original answer—no 2023 data is provided, so year-over-year trends cannot be confirmed. Additionally, the LLM mentions a '2025 NMPA approval' occurring during the 2024 analysis period, which is chronologically inconsistent; while the original answer notes the January 2025 approval, it does so as a forward-looking indicator of continued growth, not as a contributor to 2024 revenue. (2) The 9% growth figure is accurate, and the $989 million 2022 baseline is implied (though not explicitly restated in the LLM answer). However, the LLM does not mention the exact 2022 figure, which reduces quantitative completeness. The reference to 'up from lower levels in 2023 and 2022' introduces a misleading trend implication not present in the original. (3) The multi-hop reasoning is partially sound—correctly linking international demand, regulatory approvals, and collaboration profitability to revenue growth. However, it incorrectly treats the 2025 China approval as a past event contributing to 2024 growth, when the original positions it as a future development consistent with momentum. (4) Despite these issues, the core message—9% growth driven by international demand and regulatory momentum—is preserved, and the answer remains contextually relevant and largely aligned with the key drivers. Hence, a score of 7 is justified: factually mostly correct but with notable chronological and trend inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 480,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\nBetween 2022 and the end of 2024 PayPal shifted from simply purchasing merchant receivables from a partner bank to **originating and servicing its own merchant‑finance products (PPWC and PPBL)**, growing the outstanding portfolio to roughly **$1.5 billion of merchant loans, advances and interest receivable** as of 31 Dec 2024 (see Note 101 & the delinquency tables in Note 102).  The company now records a **$348 million allowance for credit losses** on these receivables and reports modestly higher gross charge‑offs, reflecting an expanding financial exposure, while operationally it monitors delinquency by days‑past‑due, recalculates repayment rates each month, and must comply with regulator‑mandated reporting and remediation processes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in PayPal's involvement in merchant receivables from 2022 to 2024, correctly identifying the shift from indirect exposure to direct origination and servicing through PPWC and PPBL, which aligns with the ground truth. It appropriately highlights increased financial exposure and deeper operational engagement, including servicing responsibilities and regulatory compliance, satisfying the qualitative and contextual aspects of the question.\n\nHowever, there are key quantitative inaccuracies. The ground truth states that PayPal purchased $1.8 billion in receivables in 2024 (up from $1.7 billion in 2023) and reported an outstanding balance of $1.5 billion (up from $1.2 billion). The LLM answer mentions a $1.5 billion outstanding portfolio as of Dec 31, 2024, which matches, but fails to report the $1.8 billion purchase volume in 2024 or the 2023 comparison. Instead, it introduces a $348 million allowance for credit losses and references gross charge-offs and delinquency monitoring—details not present in the ground truth. While plausible, these specifics are not supported by the provided answer and may reflect hallucination or over-inference.\n\nThe LLM also references 'Note 101 & Note 102' without grounding in the original answer, suggesting a source-level detail not required but potentially misleading. While the shift in operational role is correctly inferred, the financial exposure is partially misrepresented due to the introduction of unverified figures. The reasoning is logically sound in structure—showing progression from risk management to active involvement—but the synthesis includes unsupported metrics.\n\nThus, while the overall direction and qualitative transformation are accurately conveyed (justifying a 7 for correctness), the quantitative accuracy is compromised by missing key figures and introducing unverified ones, warranting a 6. Qualitative accuracy is strong at 8 due to correct entity identification (PPWC, PPBL, servicing role), and contextual relevance is high at 9 as the response directly addresses the evolution in financial and operational roles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 570,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\nFrom 2022 through 2024 Merck pushed Lynparza through a series of regulatory milestones: the FDA gave the drug a priority‑review designation in early 2022 for an adjuvant treatment of BRCA‑mutated, HER2‑negative high‑risk early‑stage breast cancer (page 22), the EU was reviewing a similar indication for metastatic castration‑resistant prostate cancer (page 23), and in January 2025 (announced in the 2024 filing) China’s NMPA approved Lynparza for that adjuvant breast‑cancer setting (page 55).  Consequently, alliance revenue from Lynparza rose about 9 % in 2024, driven by stronger demand in international markets and the impact of these new approvals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 FDA priority review for adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer (PDUFA date in Q1 2022, mentioned as priority review in early 2022), the January 2025 China NMPA approval (correctly noted as announced in the 2024 filing), and the 9% alliance revenue growth in 2024 due to international demand. (2) Quantitative accuracy is perfect: the 9% revenue increase and January 2025 approval date match the ground truth; the mention of 'January 2025' is correctly contextualized as part of 2024 disclosures. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory progress across years and geographies (US, EU, China) and links it to commercial performance. One minor issue: the EU review for metastatic castration-resistant prostate cancer is not mentioned in the original answer, so its inclusion introduces a detail not supported by the ground truth, slightly reducing qualitative accuracy. However, this does not contradict the core narrative. (4) The answer is contextually relevant, directly addressing both regulatory evolution and revenue growth as asked. Wording differs but meaning is semantically equivalent. Overall, a very strong response with only a minor addition beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 377,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\nBoeing has lengthened the horizon of its commodity‑price hedges, moving from short‑term fixes to multi‑year contracts that now run out to 2031 and expanding the use of commodity swaps and purchase contracts to lock in input prices.  This broader, longer‑dated coverage has increased the company’s financial exposure to commodity‑price volatility, which is reflected in a growing unrealized‑loss position in accumulated other comprehensive income – the derivative‑related balance rose from about ($24) million in 2022 to roughly ($211) million by the end of 2024, and a 10 % price move would still generate roughly $46 million of unrealized loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly notes Boeing's extension of hedging through 2031, it incorrectly states that financial exposure has increased due to a growing unrealized loss position, claiming derivative-related balances rose from ($24) million in 2022 to ($211) million in 2024. This contradicts the ground truth, which reports that in 2022, a 10% price change would impact unrealized losses by $46 million — not $24 million — and there is no mention of a $211 million unrealized loss by 2024 in the original answer. The $46 million sensitivity figure is correctly repeated in the LLM answer, but the supporting balance sheet figures are fabricated or misattributed. (2) The original answer does not mention accumulated other comprehensive income (AOCI) or specific derivative balances for 2022 or 2024, so the LLM introduces unsupported data. The claim of increased financial exposure is also misleading: the ground truth emphasizes risk *reduction* via hedging, not increased exposure. (3) The multi-hop reasoning is partially sound — the LLM identifies a strategic shift toward longer-term contracts and connects it to production planning — but misinterprets the effect on financial exposure. It fails to recognize that hedging is used to *neutralize* market risk, not increase exposure. (4) The contextual relevance is high because the answer addresses the evolution of Boeing’s strategy, time horizon, and financial implications. However, due to major quantitative errors and a flawed interpretation of risk management outcomes, the correctness score is low. The qualitative accuracy is moderate because the direction of strategy change is correct, but reasoning about financial impact is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 490,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\nBetween 2021 and 2024 Schwab’s pledged‑asset line (PAL) portfolio grew from roughly $12.7 bn to about $17 bn, yet the lines have remained fully collateralized by securities whose fair value exceeds the outstanding balances, so no allowance for credit losses is recorded for PALs in either year.  The overall allowance for credit losses on the bank‑loan portfolio fell from 0.09 % of total loans in 2023 to 0.05 % in 2024 (and the allowance‑to‑nonaccrual ratio dropped from 253 % to 60 %), reflecting a lower projected loss rate and improved credit quality even as the absolute size of the PAL exposure increased.  Consequently, while exposure to PALs has risen, the credit risk associated with them stays minimal because they are continuously over‑collateralized and are excluded from the allowance calculation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly around the allowance for credit losses and collateralization status in 2024. (1) The ground truth states that in 2021, PALs were fully collateralized and no allowance was required — this is correctly reflected. However, by 2024, the original answer notes a decrease in the allowance for credit losses due to improved credit quality and lower projected loss rates, implying that an allowance *is now being recorded*, suggesting a shift in risk assessment methodology. In contrast, the LLM claims that 'no allowance for credit losses is recorded for PALs in either year' and that they are 'continuously over-collateralized and excluded from the allowance calculation' — this contradicts the ground truth, which implies that credit risk is now being assessed more broadly, including through allowance modeling. (2) The LLM introduces specific dollar figures ($12.7B to $17B) and percentages (0.09% to 0.05%, 253% to 60%) not present in the original answer; these lack verification and appear fabricated or misattributed, failing quantitative accuracy. (3) While the LLM correctly identifies the trend of increasing PAL exposure and improved credit metrics, it misrepresents the evolution of Schwab's risk management approach — the key multi-hop insight in the original answer is that the firm shifted from relying solely on collateralization (2021) to incorporating forward-looking credit loss projections (2024). The LLM instead asserts that PALs remain fully collateralized and excluded from allowance, which contradicts the notion of an evolving risk framework. (4) Despite these errors, the answer is contextually relevant and captures some qualitative trends (e.g., lower projected losses, improved credit quality), earning moderate scores in qualitative accuracy and relevance. However, the incorrect treatment of the allowance for credit losses — a central element of the question — severely undermines factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 544,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\nBoeing’s exposure to the 777X deepened sharply through 2022‑2024: the forward‑loss recognition recorded for the program rose to **$7.6 bn in 2024** (up from $4.7 bn in 2023 and from earlier years), which pushed cost‑of‑sales as a share of revenue higher and added to overall cost‑of‑sales reductions (‑$1.56 bn in 2024).  At the same time, the company’s **R&D spend jumped to $3.812 bn in 2024**, with a **$435 m increase attributed specifically to the 777X program** and other enterprise product‑development investments, underscoring a continued strategic commitment to the aircraft despite delivery delays.  These cost impacts and heightened R&D spending reflect Boeing’s effort to manage the program’s financial risk while preserving its long‑term market position.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not mention specific forward-loss amounts such as $7.6B in 2024 or $4.7B in 2023, nor does it state a -$1.56B impact on cost-of-sales in 2024. These figures are fabricated or misattributed and are not supported by the original answer. While the $435M increase in R&D spending in 2024 is correctly cited, the LLM adds a specific total R&D figure of $3.812B in 2024, which is not present in the ground truth and cannot be verified. (2) The original answer confirms a $435M increase in R&D in 2024 vs 2023 and a $525M increase in 2023 vs 2022 — the LLM omits the 2022–2023 increase, breaking the multi-year trend essential to the evolution narrative. The absence of this data point undermines the completeness of the financial evolution analysis. (3) The qualitative reasoning partially captures the shift from cost burden to strategic investment, aligning with the ground truth’s theme. However, it overemphasizes ongoing losses without acknowledging the conceptual shift from 'cost impact' in 2022 to 'strategic investment' in 2024. The LLM frames continued losses and rising R&D as concurrent burdens, whereas the original answer positions the R&D increases as evidence of strategic repositioning. This misrepresents the evolution in financial treatment. (4) Contextually, the answer is relevant and addresses Boeing and the 777X program across 2022–2024, discussing both cost impacts and R&D — fulfilling the question's scope. However, due to major numerical inaccuracies and incomplete trend data, the correctness score is limited to 5. Quantitative accuracy is low due to unsupported figures; qualitative accuracy is moderate due to correct directionality but flawed synthesis; contextual relevance is high as the structure and focus match the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 502,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\nSchwab’s Portfolio‑Against‑Loans (PALs) portfolio expanded modestly—average PAL balances rose from roughly $13.7 bn in 2022 to $14.9 bn in 2024—yet the credit‑loss allowance for this segment remained essentially $0, because the loans are over‑collateralized and Schwab applies a practical‑expedient that waives a formal allowance. Consequently, the overall bank‑loan allowance‑to‑loan ratio fell from 0.09 % in 2023 to 0.05 % in 2024, reflecting improved credit quality, while the PAL risk‑management methodology has stayed unchanged: losses are only recognized if collateral falls below prescribed thresholds, which is rare.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in Schwab's PALs risk management and portfolio growth between 2022 and 2024, aligning well with the ground truth in qualitative reasoning and context. However, there are significant quantitative inaccuracies that reduce confidence in the numerical claims. The ground truth does not specify exact average PAL balances of $13.7B in 2022 or $14.9B in 2024, nor does it mention the overall bank-loan allowance-to-loan ratio decreasing from 0.09% in 2023 to 0.05% in 2024—these precise figures are absent from the original answer. While the original confirms the allowance remained negligible due to the practical expedient and over-collateralization, it does not state the allowance was exactly $0 or provide the ratios cited. The claim about the allowance-to-loan ratio is a plausible inference but not directly supported, making it an over-precision. The qualitative reasoning is strong: the LLM correctly identifies the continued use of the practical expedient, daily collateral monitoring, and the reduced risk profile despite portfolio growth. It also correctly notes that losses are only recognized upon collateral shortfall, which matches the original's emphasis on strict maintenance levels. The answer addresses all parts of the question—evolution in exposure (portfolio growth), risk management (methodology continuity), and allowance methodology—making it contextually complete and relevant. However, the unsupported specific numbers and ratios reduce quantitative accuracy. Multi-hop synthesis is sound: the model connects PALs' structure to allowance policy and infers implications for overall credit loss trends. In summary: correct in direction and logic, but overstates precision with unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 476,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\nThe after‑tax gain on British‑pound‑denominated net‑investment hedges fell sharply from **$45 million in 2022 to essentially $0 (a $45 million decline) in 2023** (MDLZ 10‑K 2023, p. 98).  This drop shows that the company either reduced its GBP‑hedge position or allowed the hedge to become less effective, signaling a more conservative or re‑calibrated foreign‑exchange risk‑management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023, indicating growing exposure or hedging. However, the LLM claims an after-tax gain dropped from $45 million to $0, which is the opposite trend and refers to a different financial metric (gain on hedges vs. value of notes). (2) The numbers are mismatched: $45 million is cited as the 2022 value in the LLM answer but it is actually the 2023 value of the notes themselves, not gains. The $3 million 2022 figure is omitted entirely. The calculation of a $45 million decline is therefore incorrect. (3) The multi-hop reasoning fails because the LLM confuses the value of pound-denominated notes with gains on hedging instruments. It draws conclusions about risk management strategy based on the wrong data point, leading to an invalid inference (conservative strategy) when the truth suggests increased exposure. (4) Scores reflect major factual errors in numbers and metrics (quantitative accuracy), flawed reasoning and entity confusion (qualitative accuracy), partial relevance to FX strategy (contextual relevance), and overall low correctness due to inversion of the actual trend and use of incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 371,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\nThe 2022 filing lists the 3.125% 2025 Notes as a straight‑fixed‑rate tranche (3.125% coupon, $1 billion outstanding) with no reference to any hedging or floating‑rate structure. In the 2024 filing the same series appears in a table of notes that are covered by interest‑rate swaps, showing a current “interest rate = SOFR + 2.1%” and a $1 billion swap notional, indicating that the notes are now effectively a synthetic floating‑rate debt. This shift shows that Amgen has moved from a pure fixed‑rate financing for the 2025 notes to a hedged, floating‑rate profile, using swaps to align the cost of the 2025 debt with its broader interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fixed interest rate of 3.125% in the 2022 filing and the shift to SOFR + 2.1% in the 2024 filing, aligning with the ground truth. The $1 billion notional amount is consistent and accurate. (2) All numeric values—3.125%, SOFR + 2.1%, $1 billion—are factually correct and match the expected data. No calculations are required, but the reference to interest rate swaps is supported by the context and plausibly explains the floating-rate disclosure. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two filings (2022 vs 2024) for the same debt instrument and infers the use of interest rate swaps to convert fixed to floating exposure. While the ground truth attributes the floating rate to a refinancing or repricing, the LLM attributes it to hedging via swaps—this is a plausible alternative interpretation that does not contradict the data and reflects sophisticated financial reasoning. (4) The answer is highly relevant, complete, and factually accurate. The slight difference in explanation (hedging vs. refinancing) does not undermine correctness, as both mechanisms can lead to the same disclosure. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this interpretive difference, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 381,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s dependence on its Commercial Paper Issuance Program receded as a primary source of liquidity.  In the 2022 filing the CP program was listed alongside bank lines and a shelf‑registration, but the company warned that market disruptions and the rapid rise in short‑term rates could limit CP access and forced it to supplement funding with higher‑cost sources such as FHLB advances, repurchase‑agreement borrowings and brokered CDs.  By the 2024 filing the CP program is still noted as one of several backup financing options, but the narrative stresses a broader, more diversified funding mix—indicating that CP issuance now serves mainly as a contingency rather than a core reliance.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of Schwab's reliance on the Commercial Paper (CP) Issuance Program. The original answer states that Schwab's reliance on the CP program *increased* by 2024 as a complement to other funding mechanisms, due to rising interest rates and client cash outflows outpacing internal cash generation. In contrast, the LLM claims that dependence on the CP program *receded* and that it became more of a contingency tool, which directly contradicts the ground truth. This is a major factual and reasoning error. While the LLM correctly identifies the existence of the CP program in 2022, mentions alternative funding sources (FHLB advances, repurchase agreements, brokered CDs), and references market disruptions and rising rates, these elements are woven into an incorrect narrative. The qualitative inaccuracy undermines the answer despite some correct contextual elements. There are no explicit numerical values in the question or answer, so quantitative accuracy is not heavily applicable—however, the temporal references (2022, 2024) and event sequencing are accurate, warranting a moderate score there. Contextual relevance is fair because the answer discusses the right instruments and market conditions, but it fails to correctly synthesize the evolution of reliance over time, which is the central requirement of the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 389,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\nThe 3.625 % fixed‑rate notes were largely eliminated between 2022 and 2024.  In 2022 the company still had 3.625 % 2022 notes on its balance sheet, but those were redeemed in 2021‑2022 (see the 2021 redemption discussion in the 10‑K).  By the end of 2023 the only remaining 3.625 % issue was the 3.625 % 2024 notes, which had a $1.4 bn notional amount and, as shown in the 2023 interest‑rate‑swap table, were effectively converted to a floating‑rate of **SOFR + 3.4 %** through interest‑rate swaps.  In 2024 those notes were fully retired (their notional balance fell to $‑), leaving zero 3.625 % debt outstanding.  \n\nThis evolution shows Amgen’s debt‑management strategy of **pruning legacy fixed‑rate obligations, refinancing with longer‑dated floating‑rate debt, and using swaps to hedge interest‑rate exposure**, thereby reducing refinancing risk and aligning the debt profile with its cash‑flow and liquidity objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of the 3.625% Notes from 2022 to 2024—namely, that they were fully retired by 2024 and replaced with floating-rate debt via SOFR. However, there are factual inaccuracies in the timeline and details. It incorrectly states that the 3.625% 2022 notes were redeemed in 2021–2022, which contradicts the ground truth focusing on the 2024 notes. The ground truth does not mention interest rate swaps converting the fixed rate to SOFR + 3.4%, nor does it specify that the conversion occurred by end of 2023. This detail is unsupported in the original answer and introduces a specific spread (3.4%) not present in the truth. (2) Quantitatively, the $1.4 billion notional amount (equivalent to $1,400 million) is accurate and matches the ground truth. However, the introduction of SOFR + 3.4% is a fabricated precision—while the shift to floating rates is correct, the exact spread and use of swaps are not mentioned in the original, making this a significant quantitative overreach. (3) The multi-hop reasoning is generally sound: the model connects the retirement of fixed-rate debt with a strategic shift toward floating rates and interprets this as part of a broader debt management strategy. The conclusion about pruning legacy debt and using swaps aligns conceptually with the ground truth’s interpretation, though the original does not mention swaps. (4) The answer is contextually relevant and addresses both parts of the question—evolution of the notes and implications for debt strategy. Despite incorrect specifics on swaps and redemption timing, the core message about strategic refinancing and rate environment adaptation is consistent. Hence, correctness is reduced due to unsupported quantitative claims, but qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 505,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\nSchwab’s VIE funding continues to be tied to the same contractual triggers and is projected to be paid down through 2025; in the 2022 filing the company expressly said it would not provide support unless it was contractually required, but the 2024 filing softens that stance by noting it may offer credit or liquidity support to related funds for competitive reasons—still only when such support is deemed necessary and subject to the existing conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Schwab's approach to VIE support between 2022 and 2024. It correctly identifies the 2022 stance—no support unless contractually required—and notes a softening in the 2024 disclosure, acknowledging potential discretionary support. The use of phrases like 'may offer credit or liquidity support' and 'for competitive reasons' captures the essence of a more proactive, though still conditional, stance. However, the LLM answer introduces the detail about funding being 'projected to be paid down through 2025' and 'tied to the same contractual triggers,' which are not present in the original answer and not supported by the provided ground truth. This adds extraneous information that cannot be verified from the source, slightly undermining qualitative accuracy. There are no numerical figures or dates in dispute (quantitative accuracy is perfect), and the response is fully relevant to the question. The multi-hop reasoning—comparing disclosures across years and inferring a shift in intent—is sound, though the added detail about repayment through 2025 suggests possible conflation with another part of the filing not reflected in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 349,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\nBetween 2022 and 2023 the equity‑method investment in JDE Peet’s was unchanged in nature – MDLZ continues to record its share of JDE Peet’s earnings and related costs in non‑GAAP adjustments while relying on cash from operations, revolving credit and short‑term borrowings for funding.  As noted on page 54 of the 2023 10‑K, the investment “provides us additional flexibility” and the company does not expect any material adverse effect on its liquidity or capital structure, a stance that reflects the same approach taken in the 2022 filing (page 44, discussion of “Costs associated with JDE Peet’s transaction”).  Consequently, the partnership has not materially altered MDLZ’s debt levels or financing mix; it simply adds a flexible, equity‑method exposure that is reflected in earnings and non‑GAAP measures but does not impact the company’s overall liquidity or capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in the characterization of MDLZ's relationship with JDE Peet's between 2022 and 2023, which undermines the core of the multi-hop reasoning. The ground truth states that the relationship evolved from 'Has_Stake_In' in 2022 to 'Invests_In' in 2023, indicating a reclassification and strategic shift that enhanced MDLZ's financial flexibility within its capital structure. However, the LLM claims the nature of the investment was 'unchanged,' directly contradicting the ground truth. This misrepresents the evolution of the financial relationship. While the LLM correctly notes that the investment provides 'additional flexibility' (citing the 2023 10-K) and does not materially affect liquidity, it fails to acknowledge the reclassification and its implications for capital planning. There are no numerical values in the question or answer, so quantitative accuracy is not applicable—no numbers are present to be wrong or right, but no errors in dates or document references (e.g., page 54, 2023 10-K) are noted. The answer is contextually relevant and cites appropriate sections of the filings, showing awareness of how the investment affects non-GAAP measures and funding sources. However, the failure to recognize the change in relationship type—a key qualitative shift—means the synthesis across years is flawed. Thus, while the answer is well-structured and contextually grounded, it misses the central evolution in the financial relationship, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 425,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\nThe 3.125% 2025 Notes were originally hedged with a swap that converted the fixed 3.125% coupon into a floating rate of **LIBOR + 1.8 %** (see AMGN 10‑K 2022, page 132). By the end of 2024 the company had rolled/terminated that arrangement and entered a new swap with a notional of roughly **$1 billion** that now applies a **SOFR + 2.1 %** floating rate to the note (see AMGN 10‑K 2024, page 149). Thus, between 2022 and 2024 the hedging strategy evolved from a LIBOR‑based 1.8 % spread to a SOFR‑based 2.1 % spread, reflecting the industry transition away from LIBOR and the firm’s updated swap terms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of the hedging strategy from a LIBOR-based to a SOFR-based rate and accurately reports the 2024 swap terms (SOFR + 2.1%, $1 billion notional). However, the original answer (ground truth) does not mention the specific 2022 rate of LIBOR + 1.8%, only stating that swaps were terminated and reentered at then-current rates without disclosing the exact rate. Thus, the LLM introduces a specific figure (LIBOR + 1.8%) not present in the ground truth, which is a factual overclaim. (2) The notional amount ($1 billion) and 2024 rate (SOFR + 2.1%) are correct and match the ground truth. The use of 'roughly $1 billion' is acceptable as it aligns with the exact $1,000 million stated. However, the 2022 rate is inaccurately specified—while the transition from old to new swaps is correctly described, the precise spread (LIBOR + 1.8%) is not supported by the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time, recognizes the shift from LIBOR to SOFR as part of broader market trends, and links updated terms to the 2024 filing. The logic connecting termination, reentry, and rate change is coherent and contextually appropriate. (4) The correctness score is 7 because the core evolution and 2024 terms are accurate, but the unsupported 2022 rate reduces quantitative accuracy. Qualitative accuracy is high due to strong reasoning and correct entity identification (AMGN, 3.125% 2025 Notes, correct years). Contextual relevance is perfect—the answer directly addresses the question’s focus on the strategy’s evolution and swap terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 449,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\nWalmart’s equity investments measured with Level 2 inputs fell from **$5.819 billion** as of January 31 2022 (fiscal 2022) to **$5.570 billion** as of January 31 2023 (fiscal 2023).  This represents a **decrease of $0.249 billion (≈ $249 million)** over the one‑year period.  (Source: Note 8 – Fair Value Measurements, pages 72 and 73.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Walmart's fair value of equity investments using Level 2 inputs decreased from $5,819 million (or $5.819 billion) in fiscal year 2022 to $5,570 million ($5.570 billion) in fiscal year 2023. The magnitude of change is correctly calculated as a $249 million (or $0.249 billion) decrease. (2) Quantitative accuracy is perfect—numbers match exactly (allowing for unit formatting: billion vs million), and the difference (5,819 - 5,570 = 249) is correct. (3) Multi-hop reasoning is sound: the model correctly identified the metric, extracted values for two consecutive fiscal years, computed the change, and contextualized the trend (decline). (4) Entity accuracy is confirmed: Walmart, Level 2 inputs, correct fiscal years (ending January 31), and the financial metric are all correctly referenced. The inclusion of a source (Note 8, pages 72–73) adds contextual credibility. The answer fully addresses both parts of the question: the evolution (decrease) and the magnitude ($249 million).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 311,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\nApple’s 2023 filing listed “marketing and distribution capability” as one of the principal competitive factors that support the launch of new products, placing it alongside design innovation, ecosystem strength and price/performance considerations. In the 2024 filing the same language is retained but is embedded in a broader discussion of the highly competitive, rapidly evolving markets that demand continual product introductions and aggressive pricing, again emphasizing marketing and distribution as essential to sustaining demand. Thus, Apple’s characterization of its reliance on marketing abilities did not undergo a substantive change—it remained a consistent, though context‑expanded, element of its competitive strategy across the two filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Apple's characterization of marketing abilities between the 2023 and 2024 10-K filings. The original answer (ground truth) states that Apple shifted its language from 'relies primarily' on innovative skills, technical competence, and marketing abilities in 2023, to 'depends heavily' on these same factors in 2024, with an added emphasis on their role in ensuring a timely flow of competitive products amid rising rivalry. This indicates a qualitative evolution in tone and strategic framing, particularly elevating marketing abilities as part of a broader competitiveness imperative. In contrast, the LLM claims there was 'no substantive change' and mischaracterizes the 2023 and 2024 disclosures as merely embedding 'marketing and distribution capability' in a broader context. Worse, the LLM introduces a term—'marketing and distribution capability'—that does not appear in the original answer and misrepresents the actual language used ('innovative skills, technical competence, and marketing abilities'). While there are no numerical inaccuracies (hence a high quantitative accuracy score), the qualitative analysis fails on entity accuracy (wrong phrasing/construct), reasoning (fails to detect linguistic shift indicating strategic emphasis), and completeness (misses the evolution in strategic framing). The answer is contextually relevant to Apple’s competitive factors but fundamentally incorrect in assessing the evolution of its reliance on marketing abilities, which is the central question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 427,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Amgen’s 3.625 % 2024 Notes, which had a $1.4 billion notional amount in 2022, were completely redeemed, and the associated interest‑rate swaps that had turned the fixed 3.625 % coupon into a floating SOFR + ≈3.2 % rate matured at the same time, leaving the notes with a $0 notional balance by 2024.  This unwind shows Amgen’s proactive hedging approach—using swaps to manage fixed‑rate exposure and then refinancing or retiring that debt to adjust its mix of fixed‑ and floating‑rate liabilities in response to market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key quantitative details. According to the ground truth, in 2022 Amgen terminated swaps on a total notional of $5.2 billion covering multiple notes, not just the 3.625% 2024 Notes. The LLM incorrectly states that the 3.625% 2024 Notes had a $1.4 billion notional in 2022, but the ground truth shows the $1,400 million (i.e., $1.4B) notional was as of December 2023, not 2022. Additionally, the LLM claims the floating rate was SOFR + ~3.2%, but the ground truth specifies SOFR + 3.4% in 2023—this discrepancy, while small, is material in financial contexts. The LLM also omits the fact that new swaps were reentered at current rates in 2022, which is a key part of the hedging strategy evolution. (2) The calculation of the notional dropping to $0 by 2024 is correct and aligns with the ground truth, but the timeline and attribution of the $1.4B amount are off. The redemption and unwind are correctly framed, but the sequencing and scope of the 2022 swap termination are misrepresented. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that unwinding the hedge near maturity reflects a proactive hedging strategy and connects the swap termination to debt refinancing or retirement. However, it fails to fully synthesize the two-step process in 2022 (termination and reentering of swaps) and incorrectly narrows the $5.2B swap activity to only the 2024 Notes. (4) Despite these errors, the answer is contextually relevant and captures the general intent of Amgen’s hedging behavior—managing fixed-rate exposure and adjusting liability structure. The conclusion about strategic hedging is reasonable, but the factual foundation is partially flawed, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 482,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\nFrom 2022 through 2023 Schwab shifted iRebal from a retained TD Ameritrade Institutional capability to a fully integrated component of its Advisor Services platform—embedding the customizable rebalancing engine within Schwab’s own technology stack and promoting it as a differentiator for the independent‑advisor clients that were migrating from TD Ameritrade.  This evolution, highlighted in the 2023 integration updates (e.g., the rollout of “Schwab Trading Powered by Ameritrade™” and the explicit note that iRebal is now part of Schwab’s offering for RIAs), demonstrates that Schwab is leveraging iRebal to strengthen its value proposition and competitive positioning in the RIA market, offering a differentiated, end‑to‑end portfolio‑construction solution that rivals stand‑alone RIA technology providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, iRebal was retained as part of TD Ameritrade Institutional's offering for independent advisors, and by 2023 it became a fully integrated component of Schwab’s platform—this matches the original answer’s timeline and progression. (2) There are no numeric values in the question or answer that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes Schwab’s integration of TD Ameritrade assets with the specific evolution of the iRebal tool, correctly inferring that its promotion within the Advisor Services platform reflects a strategic enhancement of Schwab’s competitive positioning in the RIA market. The mention of 'Schwab Trading Powered by Ameritrade™' adds contextual detail consistent with broader integration efforts. (4) While the original answer includes additional context about $1.6 trillion in assets and 15 million accounts transitioning—specific metrics that the LLM omits—the core evolution and strategic implication are accurately conveyed. The LLM emphasizes differentiation against standalone RIA tech providers, which is a reasonable interpretation of Schwab’s intent. The omission of the exact scale of integration (asset and account numbers) prevents a perfect score, but the qualitative and contextual accuracy remains high. Semantic equivalence is maintained, and the answer fully addresses both parts of the question: the evolution of iRebal and its implications for competitive positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 459,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\nApple introduced a new iMac model in the first quarter of fiscal 2024—something that was not highlighted as a distinct product launch in the 2023 filing—signaling a refresh of the iMac line after a year‑long hiatus.  The 2024 Form 10‑K notes that this product‑mix shift, together with broader cost‑saving initiatives, helped lift Products gross margin (from 36.5 % in 2023 to 37.2 % in 2024), indicating that the updated iMac (based on Apple’s newer silicon) played a measurable role in the company’s improved margin performance between 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific claims not present in the ground truth, particularly regarding a 'new iMac model in the first quarter of fiscal 2024' and a 'year-long hiatus,' which are not supported by the original answer. The ground truth does not mention timing, product launches, or a hiatus—only a change in disclosure prominence. (2) The quantitative claim that Products gross margin increased from 36.5% in 2023 to 37.2% in 2024 is not verifiable from the original answer, which does not include any margin data. This is a significant factual addition with no support in the ground truth, reducing quantitative accuracy. (3) The reasoning partially aligns with the multi-hop requirement: the LLM correctly infers increased strategic importance of the iMac in 2024 based on disclosure changes, and attempts to link it to financial performance. However, it overreaches by attributing margin improvement specifically to the iMac refresh, which is not stated or implied in the original answer. (4) While the LLM captures the elevated strategic emphasis on iMac in 2024, it adds unsupported specifics (timing, financial impact, product hiatus) that reduce factual correctness. The core idea of increased importance is accurate, but the added detail lowers the correctness and quantitative accuracy scores. Contextual relevance remains high as the response directly addresses the evolution of Apple's iMac strategy across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 402,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the $1 billion 2.820% Notes due 2051 remained on RTX’s balance sheet with no indication of repayment or retirement— the same $1 billion principal that was issued in 2021 to fund the 2022 note retirements (see the issuance table on page 94 of the 2022 filing and the long‑term‑debt tables for 2023‑2024 on pages 89, 98 and 108 of the 2024 filing).  This shows that RTX is deliberately extending its maturity profile by using low‑cost, long‑dated fixed‑rate debt to replace shorter‑term obligations, thereby reducing near‑term refinancing risk and shaping a more stable, laddered long‑term debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies that the $1 billion 2.820% Notes Due 2051 remained on RTX's balance sheet from 2022 to 2024 with no repayment or retirement, matching the ground truth's core quantitative facts (principal amount, stability of the note). The dollar amount ($1 billion = $1,000 million) and interest rate (2.820%) are accurate. However, the LLM incorrectly states the notes were 'issued in 2021'—the ground truth and SEC filings confirm they were issued in 2022. This is a factual error in entity timing. 2) Quantitatively, all numbers are correct: $1 billion principal, consistent across years. No calculations were required, but the LLM accurately reports the static nature of the note. Format variation ($1 billion vs $1,000 million) is acceptable. 3) The reasoning partially aligns with the ground truth: the LLM correctly infers that maintaining long-dated debt contributes to a stable maturity profile and reduces refinancing risk. However, it omits the key point from the original answer that RTX’s *overall* long-term debt increased from $40,078 million to $41,146 million during this period, which is critical context showing the 2051 notes were stable *within a growing debt portfolio*. This missing synthesis weakens the multi-hop reasoning. 4) The answer is contextually relevant and addresses the evolution of the debt instrument and its implication for long-term structure. But it fails to incorporate the broader debt trend, leading to an incomplete picture. The conclusion about 'laddered debt structure' is reasonable but not directly supported by the provided ground truth data. Thus, while the core fact about the 2051 notes is correct, the absence of total debt growth and the incorrect issuance year reduce the qualitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 483,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab’s IDA agreement was first amended in 2022 to reduce the service fee on client‑cash deposits at TD depository institutions from 25 basis points to 15 basis points (as disclosed in the 2022 pro‑forma footnote). In 2023 the company completed the migration of the agreement’s reference rate from LIBOR to alternative benchmark rates (e.g., SOFR), but the fee level remained at the 15‑basis‑point rate established the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the reduction in service fee from 25 to 15 basis points in 2022 is accurately reported, and the 2023 transition from LIBOR to alternative rates (e.g., SOFR) matches the original answer. No calculation errors are present. (2) The answer is complete, addressing both parts of the question—evolution of service fees and reference rate adjustments—and correctly identifies the relevant entities: Schwab, IDA agreement, TD depository institutions, and the timeline (2022–2023). (3) The multi-hop reasoning is sound: it synthesizes changes across two years, correctly distinguishing between fee structure changes in 2022 and reference rate updates in 2023. (4) Semantically, the LLM conveys the same core information as the original answer, though it adds specificity by naming SOFR as the alternative benchmark, which is a reasonable inference given market practices and does not contradict the ground truth. The only minor limitation is that the original answer frames the shift as part of a broader LIBOR phase-out preparation, providing slightly more contextual framing, while the LLM focuses on the completion of migration. This does not affect factual accuracy but slightly reduces qualitative depth. Overall, the answer is factually correct, well-structured, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 389,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\nThe 2024 filing no longer presents Filorga as a stand‑alone reporting unit with $221 million of goodwill; instead it is rolled into the broader “trademarks” group within the Oral, Personal & Home‑Care segments.  This consolidation signals that the company now views Filorga’s value as part of an aggregated brand portfolio rather than as a distinct growth engine, using a combined market‑based valuation (e.g., royalty‑rate and discount‑rate assumptions applied to the whole trademark suite) instead of a separate goodwill impairment test.  Consequently, Filorga’s strategic importance appears to have been down‑weighted, and its financial contribution is assessed collectively with other trademarks rather than in isolation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Filorga's financial treatment from 2023 to 2024, accurately stating that in 2023 it was a standalone reporting unit with $221 million in goodwill and that in 2024 it was grouped into broader trademark categories within the Oral, Personal & Home-Care segments. All factual elements—such as the $221 million goodwill amount and the shift in reporting structure—are consistent with the ground truth. (2) Quantitative accuracy is perfect: the dollar amount ($221 million) and years (2023 to 2024) are correct, with no calculation errors. Format is slightly different (use of thin space: $221 million), but this is acceptable variation. (3) The multi-hop reasoning is sound: the model correctly infers that the removal of standalone goodwill implies a shift in valuation approach (from individual to portfolio-level impairment testing) and interprets the strategic implication—reduced emphasis on Filorga as a distinct growth engine. This aligns with the ground truth’s interpretation of potential shifts in strategic focus or brand management. (4) The only minor shortcoming is that the LLM does not explicitly mention the Europe segment (where Filorga was previously reported), nor does it reference how this change affects future strategic decisions like divestiture or investment as directly as the original answer. However, the core implications about valuation and strategic down-weighting are clearly conveyed. Thus, while highly accurate and contextually relevant, it misses a small nuance in completeness, justifying a 9 instead of a 10 in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 451,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\nThe 2024 10‑K adds a dedicated bullet in the “Product, Service and Software Announcements” section that explicitly names the iPhone 16 Pro and iPhone 16 Pro Max as part of the Q4 2024 launch, and it links those devices to new software features such as Apple Intelligence. In contrast, the 2023 filing only referred to “upcoming iPhone generations” in generic terms and did not tie them to specific software or service extensions. This more granular, forward‑looking disclosure reflects Apple’s evolution toward integrating new hardware releases with ecosystem‑wide software and services, giving investors clearer visibility into its product‑development pipeline and the revenue drivers that will accompany it.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The 2023 10-K filing does not merely refer to 'upcoming iPhone generations' in generic terms—it specifically announces the iPhone 16 Pro as part of the Fourth Quarter 2024 product lineup, contrary to the LLM's claim of generic language. (2) The 2024 10-K does not 'add a dedicated bullet' naming the iPhone 16 Pro as a new announcement—by that time, the device has already launched and should be reported as an existing product, consistent with the ground truth that it transitions from forward-looking to retrospective classification. Instead, the LLM incorrectly frames the 2024 filing as containing a new forward-looking announcement, which misrepresents the timeline and disclosure evolution. (3) The mention of 'Apple Intelligence' and linking hardware to software features is speculative and not supported by the ground truth, which makes no reference to software integration in the disclosure shift. (4) The core multi-hop reasoning is flawed: the evolution is from planning/launch phase (2023) to established product status (2024), but the LLM reverses the logic by suggesting increased forward-looking detail in 2024, when the actual shift is toward maturity and inclusion in the base product portfolio. While the answer is contextually relevant and attempts to interpret strategic reporting changes, it fails on key factual points—especially regarding the nature and direction of disclosure change—resulting in a partially correct but fundamentally misleading response. Quantitative accuracy is moderate because no explicit numbers are wrong (no dollar amounts or dates are misstated), but the temporal framing (Q4 2024 launch in both filings) is inconsistently interpreted. Qualitative accuracy suffers due to incorrect entity-state mapping (planned vs. active product) and flawed reasoning about disclosure trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 515,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab refined its EVE framework by updating deposit‑beta assumptions and incorporating more granular balance‑sheet dynamics—such as larger margin‑loan and cash balances, greater use of FHLB borrowings, and revised prepayment and rate‑floor projections—into its instantaneous‑shift calculations.  These changes heightened the measured sensitivity of net‑interest revenue to rate moves (e.g., a 100‑bp rise now produces a 10.8 % impact versus 3.6 % in 2022), reflecting a more nuanced modeling of asset‑liability behavior.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative impacts (e.g., 10.8% vs 3.6% change in net interest revenue from a 100-bp rate rise) and detailed balance sheet items (margin loans, FHLB borrowings) that are not present in the original answer and cannot be verified from the ground truth. These numbers and specifics are likely fabricated or hallucinated, as the original answer does not mention any such percentages, comparisons, or granular balance sheet components. (2) The original answer highlights that in 2023, the company expanded EVE simulations to include client cash allocation changes and updated deposit beta assumptions in a declining rate environment. While the LLM correctly notes updated deposit beta assumptions, it misrepresents the context (does not specify declining rate environment) and adds unverified quantitative outcomes. The claim about 'instantaneous-shift calculations' and specific sensitivity percentages lacks support. (3) The multi-hop reasoning is partially sound in that it attempts to compare modeling changes across years and link assumptions to sensitivity outcomes, but it fails to accurately reflect the evolution described in the ground truth—particularly the new inclusion of client cash allocation dynamics, which is a key 2023 update omitted in the LLM response. (4) The contextual relevance is high because the answer addresses the evolution of EVE modeling and interest rate risk, but correctness is low due to unsupported numerical claims and missing key qualitative shifts. The entity 'Schwab' is introduced without being in the original, which may be correct but is unverified. Overall, the answer contains plausible-sounding but unverified details that undermine factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 475,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\nQualcomm’s 2023 move from only enabling—through standards, IP licensing and chip‑set supply—wireless access‑point technology to actually shipping its own AP platforms gave the company a direct presence in the edge‑networking market.  By leveraging its QCT portfolio that now includes Wi‑Fi 6/6E/7 access‑point chips, network processors and integrated RFFE, the firm broadened its product lineup beyond semiconductors and licensing, offering end‑to‑end, 5G‑ready, AI‑accelerated AP solutions that compete more head‑to‑head with traditional networking vendors and expand its addressable market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Qualcomm's strategic shift from enabling wireless access point technologies in 2022 (via chipsets, IP licensing) to directly producing access point platforms in 2023. The key entities—Qualcomm, Broadcom, Intel (implied through 'traditional networking vendors'), and the timeframes (2022–2023)—are accurate. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2023) match the original. (3) The multi-hop reasoning is sound: the model synthesizes Qualcomm’s evolution from component supplier to full-system solution provider, leveraging its QCT portfolio (Wi-Fi 6/6E/7 chips, RFFE, network processors), which reflects accurate understanding across product lines and strategic positioning. (4) The answer captures the core implications: expanded product portfolio breadth, direct competition with established networking vendors, and increased market reach. The only minor shortcoming is that it does not explicitly name competitors like Broadcom and Intel as in the original, instead using the general term 'traditional networking vendors,' which slightly reduces qualitative precision. However, this does not detract significantly from factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 397,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\nFrom the 2022 10‑K (page 94) Schwab disclosed that roughly **28 %** of its adjustable‑rate mortgage portfolio had interest‑only payment terms, and about **89 %** of those interest‑only loans were not scheduled to reset for three or more years. In the 2023 filing (page 93/100) the figures shifted to **≈27 %** of the adjustable‑rate portfolio with interest‑only terms, and **≈86 %** of those loans are not slated to reset within three years. Thus, between 2022 and 2023 the share of interest‑only HELOC‑eligible mortgages slipped modestly, and a slightly smaller share of those loans are locked into longer non‑reset periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: 28% to 27% for interest-only adjustable-rate mortgages and 89% to 86% for those not scheduled to reset for three or more years, matching the ground truth exactly. Minor formatting variations (e.g., ≈27% vs 27%) are acceptable and do not affect factual accuracy. (2) All numbers are quantitatively accurate and consistent with the original answer. The percentages are correctly cited, and no calculation errors are present. (3) The reasoning is sound: the model correctly synthesizes data from Schwab’s 2022 and 2023 10-K filings, compares the two years, and draws a logical conclusion about a modest shift in the HELOC product’s structure. The mention of 'HELOC-eligible mortgages' is a slight generalization (the original refers to adjustable-rate mortgages within the HELOC context), but the multi-hop synthesis across years and metrics is accurate. (4) The answer is contextually fully relevant, directly addressing the evolution of the interest-only structure using the two specified metrics. The only minor deduction is for slightly less precise terminology around 'HELOC-eligible mortgages' versus the more precise 'adjustable-rate mortgages with interest-only terms,' which slightly affects qualitative accuracy but not overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 367,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Qualcomm moved XR from a stand‑alone growth narrative to a component of its broader IoT business.  In the 2022 filing (pages 13‑14) the company highlighted XR as a target for its QSI strategic‑investment arm and noted that Snapdragon platforms power XR devices.  By the 2023 filing (page 74) XR revenue is aggregated under the IoT segment, which slipped from $7.35 billion in 2022 to $5.94 billion in 2023, showing that despite continued investment in XR‑related technologies, the company’s product‑revenue exposure to XR declined sharply over that period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies Qualcomm's strategic investments in XR via Qualcomm Ventures (QSI) in 2022 and references to Snapdragon platforms powering XR devices. However, it incorrectly claims that XR revenue declined sharply due to a drop in the broader IoT segment from $7.35B to $5.94B. The ground truth does not support any assertion of declining XR revenue, nor does it state that XR revenue is explicitly broken out or quantified within IoT. In fact, the ground truth emphasizes a qualitative shift from investment to commercialization, not a decline in exposure. (2) The numbers cited ($7.35B and $5.94B) may be accurate representations of IoT segment revenue for 2022 and 2023, but the LLM incorrectly attributes this decline to XR performance, which is not supported by the original answer. There is no evidence in the ground truth that XR-specific revenue declined, or that it was ever reported separately. (3) The multi-hop reasoning is flawed: while the model synthesizes information across years and mentions strategic investments and product disclosures, it draws an unsupported conclusion about declining XR revenue based on aggregated IoT data. The original answer highlights a shift in business model (investment → revenue-generating), not a contraction in market involvement. The LLM misinterprets aggregation under IoT as evidence of reduced focus, when the ground truth interprets explicit product sales as increased commercialization. (4) The contextual relevance is high because the answer addresses both years, strategic investments, and product revenue. However, correctness and qualitative accuracy are low due to the significant factual misrepresentation of the trend in XR involvement. The answer contradicts the ground truth’s core claim of evolution toward commercialization by asserting a decline in revenue exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 520,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.030 % Notes due 2052 held a steady aggregate principal balance of **$1.1 billion** in 2022, and the same $1.1 billion figure is reported for both 2023 and 2024 (see RTX 10‑K 2024, page 89; RTX 10‑K 2022, page 93). No repayments or reductions of this tranche are disclosed, indicating that RTX is preserving a large, long‑dated, low‑coupon debt issuance as a core component of its long‑term capital structure while managing nearer‑term maturities through other debt actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the aggregate principal balance of the 3.030% Notes Due 2052 as $1.1 billion (equivalent to $1,100 million) in both 2022 and 2024, matching the ground truth. The mention of $1.1 billion for 2023 is an addition not contradicted by the ground truth, and since no change occurred between 2022 and 2024, its inclusion is reasonable and consistent. (2) All numeric values are accurate: $1.1 billion = $1,100 million, and the interest rate (3.030%) and maturity year (2052) are correct. Format variation ($1.1 billion vs $1,100 million) is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across RTX’s 2022 and 2024 10-K filings, correctly infers stability in the principal balance, and draws a logical conclusion about RTX’s long-term debt strategy. It appropriately notes the absence of repayments or issuances, aligning with the ground truth’s implication of strategic consistency. (4) The LLM answer is contextually fully relevant, addressing both the evolution of the debt balance and its implication for RTX’s capital structure. The only minor shortcoming is that it slightly expands on 2023 without explicit grounding in the original answer, but this does not introduce inaccuracy. Overall, the answer is factually correct, well-reasoned, and conveys the same core information as the ground truth with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 393,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\nBetween 2023 and 2024 AXP’s language on corporate‑card initiatives shifted from a general intent to “evolve our card‑value propositions and further differentiate our corporate‑card and expense‑management solutions” (2023 10‑K, p. 8) to a more explicit articulation that these efforts are part of building “a full suite of financing, banking and payment solutions for our business customers” and thereby strengthening its overall commercial‑payments platform (2024 10‑K, p. 8).  This progression shows that AXP is moving beyond simply expanding its corporate‑card portfolio and is now positioning corporate‑card products as the cornerstone of a broader, integrated commercial‑payments strategy that bundles financing, banking and other value‑added services for enterprise clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and expense management solutions is accurately represented, as is the 2024 shift toward integrated 'financing, banking and payment solutions.' The citations to the 2023 and 2024 10-Ks (p.8) add precision. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the years 2023 and 2024 are correctly attributed and contextualized. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings and infers a strategic evolution—from product differentiation to an integrated suite approach. The conclusion that the corporate card is becoming a 'cornerstone' of a broader strategy is a valid interpretation of the shift. (4) The LLM answer conveys the same core insight as the original: AXP is expanding beyond standalone corporate card products to embed them in a holistic commercial payments platform. The only minor difference is that the LLM uses 'cornerstone' and 'full suite,' which are slightly stronger than the original's 'expanding beyond just product differentiation,' but this is a nuance in emphasis, not a factual error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 413,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\nBetween 2023 and 2024 PCA SKIN remained positioned as a premium skin‑health brand inside Colgate‑Palmolive’s Oral, Personal and Home Care segment, with its products sold chiefly through skin‑health professionals and direct‑to‑consumer channels. The filings do not indicate any shift in these distribution channels, suggesting the brand’s strategic placement and sales approach stayed consistent over the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that PCA SKIN was sold chiefly through skin-health professionals and direct-to-consumer channels in both 2023 and 2024. The ground truth states that in 2023, PCA SKIN was distributed primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists, with no mention of skin health professionals. Only in 2024 did the filing explicitly expand distribution to include skin health professionals in some geographies. The LLM incorrectly asserts no change occurred, when in fact there was a documented refinement in distribution strategy. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is flawed: the model failed to detect the evolution in distribution channels between the two years, which is the central point of the question. Instead, it incorrectly concludes no shift occurred, missing the key update in the 2024 filing. (4) While the answer is contextually relevant—focusing on PCA SKIN’s positioning and distribution—the significant factual inaccuracy regarding the evolution of distribution channels severely undermines correctness. The answer contradicts the ground truth rather than reflecting it, warranting a low correctness and qualitative accuracy score despite correct use of years and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 404,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s strategy shifted Opdivo from a “stand‑alone” immunotherapy to a broader, earlier‑line engine: the 2023 10‑K explicitly calls for “expanding the use of Opdivo … into additional indications and tumor types both as a monotherapy and in combination with Yervoy and other anti‑cancer agents” and notes progress on a subcutaneous formulation (p. 43).  This commercial repositioning—adding new tumor indications such as earlier‑stage NSCLC, gastric/esophageal cancers and expanded melanoma use, and pairing Opdivo with Yervoy, Cabometyx and other agents—creates multiple growth levers that the firm expects to translate into double‑digit contribution to total sales, helping to offset declines in legacy LOE products and sustain an upward revenue trajectory for Opdivo (pp. 70‑71, 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Opdivo’s strategic focus from 2022 to 2023, noting the shift toward earlier lines of therapy, expanded tumor indications, and increased use in combination regimens, including with Yervoy and other agents like Cabometyx. The mention of the subcutaneous formulation as a growth driver is consistent with the original answer. (2) There are no explicit numerical values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the reference to 'double-digit contribution to total sales' is a reasonable inference from the 2023 10-K and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information about new indications (e.g., earlier-stage NSCLC, gastric/esophageal, melanoma), combination therapies, and formulation improvements to support a coherent narrative about revenue growth trajectory. The only minor gap is that the original answer provides a more comprehensive list of approved indications in 2022 (e.g., bladder, blood, CRC, HCC, MPM), which the LLM omits, though it does reference key ones. (4) The answer is contextually excellent—directly addressing all parts of the question: strategic focus, commercial positioning, new indications, combinations, and revenue implications. Wording differs but semantic meaning matches. Minor deduction in qualitative accuracy for slightly less completeness in listing 2022 indications, but core facts and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 436,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the fair‑value of American Express’s holdings of foreign‑government bonds fell only modestly—from roughly **$770 million** (cost $770 million, no unrealized gain or loss) to **$765 million** (cost $765 million, also no unrealized gain or loss).  The maturity profile remained overwhelmingly short‑term: about **99 %** of the position matures within one year (≈$764 million in 2024 versus $768 million in 2023), with only a trivial amount (≈$1 million) maturing after one year but within five years and nothing maturing beyond five years.  Thus, the exposure stayed essentially unchanged in size and remained almost entirely a near‑term, low‑duration holding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key numbers. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated by the LLM. Additionally, the LLM claims there was no unrealized gain or loss in 2023, but the original answer specifies a gross unrealized loss of $1 million. The 2024 fair value of $765 million is correct, as is the split of $764 million maturing within one year and $1 million maturing after one year but within five years. However, the LLM incorrectly states that the investment 'fell modestly' when in fact it increased significantly from $549M to $765M. (2) Quantitative accuracy is severely compromised: the 2023 value is off by over $220 million, and the characterization of the change as a 'modest fall' is incorrect—it was a substantial increase (~39%). The maturity distribution for 2023 is also wrong; the LLM claims $768 million matured within one year, but the truth is all $549 million matured in 12 months or more (i.e., long-term), which is the opposite of short-term concentration. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of both fair value and maturity distribution. It incorrectly assumes the portfolio was already short-term in 2023, when in fact it was entirely long-term, and misses the strategic shift toward short-term maturities in 2024. This undermines the core insight about changing investment strategy. (4) Despite these serious errors, the answer is contextually relevant—it addresses the right company, time frame, asset class, and metrics (fair value, maturity). The 2024 numbers are mostly accurate, and the conclusion about short-term concentration in 2024 is valid, though the comparison to 2023 is entirely incorrect. Hence, partial credit is given for structure and relevance, but not for factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 516,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the portion of cash that cannot be moved freely to the United States fell modestly—from roughly **$4.3 billion** of cash‑equivalents that were subject to local legal or regulatory restrictions (and, for about $2.2 billion of that amount, could only be accessed through dividends or intercompany financing that required approval of Flipkart’s minority shareholders) to **about $3.5 billion** as of the end of fiscal 2024.  The underlying mechanics have remained the same: Walmart uses intercompany financing to shift cash to the jurisdictions where it is needed at the lowest cost, and earnings can be repatriated to the U.S. generally free of U.S. federal tax but may still incur withholding or state taxes; however, any such repatriations are still contingent on local laws, potential contractual or shareholder approvals, and the Company does not expect these restrictions to have a material impact on its overall liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its factual content and addresses the evolution of Walmart's intercompany financing arrangements between 2022 and 2024. It correctly identifies the $4.3 billion figure for 2022 and notes the $2.2 billion subset tied to Flipkart minority shareholder approval. However, the 2024 amount is reported as 'about $3.5 billion,' whereas the ground truth specifies $3.3 billion—a notable but not critical deviation. This minor inaccuracy affects quantitative precision but does not distort the overall trend (a modest decrease). 2) The numbers for 2022 are accurate: $4.3 billion total restricted cash, $2.2 billion requiring Flipkart minority approval. The 2024 figure should be $3.3 billion, not $3.5 billion. While 'about $3.5 billion' may reflect rounding or approximation, it diverges from the exact value in the ground truth, which is specific. No calculations are required beyond comparison, and the direction of change (decrease) is correctly noted. 3) The reasoning is sound: the LLM correctly observes that the mechanics of intercompany financing remain largely unchanged, with repatriation subject to local laws, shareholder approvals, and tax considerations. It appropriately generalizes the 2024 condition to broader noncontrolling interest approvals rather than Flipkart-specific ones, aligning with the ground truth's observation of a 'broader framing.' The synthesis across years and entities (Walmart, Flipkart, noncontrolling interests) is accurate and logically presented. 4) The answer is contextually excellent—directly responsive to both parts of the question: the change in amount of cash not freely transferable and the evolving conditions for transfer. The slight numerical discrepancy prevents a top score, but the qualitative and contextual accuracy is strong, with appropriate nuance on tax implications and liquidity impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 507,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the U.S. Retiree Health Care Plan’s asset base shrank modestly—from $264 million to $248 million—with fixed‑income securities (cash and cash‑equivalents) falling from $210 million to $198 million and equity securities from $54 million to $50 million. As a result, the fixed‑income portion stayed roughly 80 % of the portfolio (about 79.5 % in 2023 and 79.8 % in 2024), while the equity portion slipped slightly from ~20.5 % to ~20.2 % of total assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that Texas Instruments' U.S. Retiree Health Care Plan assets remained unchanged between 2023 and 2024, with fixed income securities at $210 million and equity securities at $54 million in both years, totaling $264 million. The LLM incorrectly reports a decline in total assets to $248 million, fixed income falling to $198 million, and equity to $50 million—none of which are supported by the data. Percentages are also miscalculated based on these false totals: claiming 79.8% and ~20.2% in 2024 is incorrect because the actual allocation remained static at 79.5% and 20.5%. (2) Completeness: While the LLM addresses the question's structure (discussing fixed income and equity allocations across years), it fails to correctly convey the core fact—no change occurred. (3) Entity Accuracy: The company (Texas Instruments) and plan name are correct, and years (2023–2024) are accurate. (4) Reasoning: The multi-hop synthesis is flawed—the model invents changes in asset values and misrepresents stability as modest evolution, contradicting the ground truth of identical figures across filings. (5) Semantic Equivalence: The answer does not match the original; it asserts change where there was none. The only partial credit is for addressing the relevant asset categories and attempting percentage breakdowns, but all numerical inputs are false. Thus, the correctness score is very low due to pervasive factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 425,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\nBetween 2022 and 2024 the 2006 Stock Plan for Non‑Employee Directors remained governed by the 2021 omnibus amendment, with awards issued under the “Form of Option Agreement” and “Form of Restricted Unit Agreement.” By the 2024 filing the company had shifted to the 2016 Stock Plan for Directors, referencing “Form of Stock Option Award Agreement” and “Form of Restricted Stock Unit Agreement (Form 1/2)”, indicating a move toward a broader, more structured equity‑based compensation program that includes RSUs and performance‑linked awards for its non‑employee directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents key facts from the ground truth. (1) It falsely claims that by 2024, Honeywell had shifted to the '2016 Stock Plan for Directors', which contradicts the original answer stating that the 2006 Stock Plan for Non-Employee Directors was still referenced in 2024 filings. There is no mention of a transition to a new plan in the ground truth. (2) The LLM incorrectly states that both 'Form of Option Agreement' and 'Form of Restricted Unit Agreement' were still in use under the 2006 plan in 2022, but the key point in the original answer is that while both were present in 2022 (Exhibits 10.30 and 10.32), by 2024 the 'Form of Restricted Unit Agreement' was no longer listed—indicating a removal or discontinuation. The LLM instead suggests a continuation and expansion into RSUs and performance awards under a new plan, which is unsupported. (3) The multi-hop reasoning is flawed: the question asks about the evolution *within* the 2006 plan between 2022 and 2024, but the LLM incorrectly infers a shift to a different plan altogether, failing to track the specific exhibit-level changes in the same plan over time. (4) The suggestion of a 'broader, more structured equity-based compensation program' with performance-linked awards is speculative and not supported by the original data, which only notes the absence of the restricted unit agreement form. The contextual relevance is moderate because the answer addresses director compensation and equity forms, but the factual inaccuracies severely undermine correctness. Quantitative and qualitative accuracy are low due to wrong years, plans, and documents referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 453,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Walmart’s Flipkart stake fell from ~83 % to ~75 % after a 2022 equity raise that brought in $3.2 bn of cash, then rose to about 85 % in 2024 when it paid $3.5 bn to acquire the remaining non‑controlling shares and settle a $0.9 bn liability to former PhonePe holders, thereby gaining full control and eliminating that accrued liability.  The cash‑intensive transactions reshaped the consolidation of Flipkart’s results, but they also expose Walmart to ongoing Indian foreign‑direct‑investment scrutiny and potential antitrust or enforcement actions that could affect its ownership structure and future cash flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Walmart reduced its ownership from ~83% to ~75% in 2022 due to a $3.2 billion equity raise, it falsely claims that Walmart increased its stake to ~85% in 2024 by acquiring remaining shares for $3.5 billion and settling a $0.9 billion liability to former PhonePe holders. This is incorrect—there is no evidence in the ground truth or public filings that Walmart increased its stake in Flipkart in 2024; instead, the focus was on regulatory risks. The $3.5 billion transaction and liability settlement are entirely fabricated. (2) Quantitative accuracy is poor: the $3.5 billion payment and $0.9 billion liability are not supported by the original answer or known public data. The only correct numbers are the $3.2 billion equity funding and the ownership drop from 83% to 75%. The claim of rising to 85% contradicts the ground truth, which states Walmart remained at 75% and was dealing with regulatory exposure, not expanding ownership. (3) Multi-hop reasoning fails: the model incorrectly infers a reverse ownership increase and invents transactions, failing to connect the actual evolution—partial exit in 2022 followed by ongoing regulatory scrutiny in 2024. It misses the key point that regulatory risks stem from Flipkart’s pre-2018 history, not post-acquisition actions, and that Walmart cannot estimate potential losses or indemnification outcomes. (4) Contextual relevance is moderate because the answer addresses financial implications and regulatory risks, but the reasoning is based on false premises. The mention of Indian FDI scrutiny is partially correct but lacks the specific context of the 2021 show cause notice and the 2009–2015 violation period. Overall, major factual and quantitative errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 500,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 Honeywell’s cash pool expanded sharply—from roughly **$9.6 billion** of cash and cash equivalents at the close of 2022 to **$8.1 billion** in 2023 and then to **$11.0 billion** in 2024 (cash‑flow tables, HON_10K‑2022 p. 43; HON_10K‑2024 p. 41).  The company continued to keep the bulk of that cash abroad, reporting that **about $8 billion (≈73 %) of the 2024 balance was held in non‑U.S. subsidiaries**, leaving only roughly **$3 billion of U.S.–based cash** (the remainder of the $11 billion total).  This evolution underscores a strategic emphasis on maintaining a sizable offshore cash base to fund global operations and acquisitions while relying on a more modest U.S. cash buffer for domestic liquidity needs and dividend commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. It states that HON had $9.6 billion in cash at the end of 2022, but the ground truth reports $11.5 billion as of December 31, 2021 (reported in the 2022 10-K), with no explicit figure provided for end-of-2022 cash in the original answer. The LLM incorrectly infers a decline to $8.1 billion in 2023 and then an increase to $11.0 billion in 2024, which is not supported by the ground truth. The only correct quantitative figure is the $11.0 billion total cash as of December 31, 2024, and the $8.0 billion held in non-U.S. subsidiaries in 2024. However, the percentage calculation (≈73%) is approximately correct but not mentioned in the original answer, so it's an unsupported addition. (2) The ground truth emphasizes a shift in geographic distribution from an unspecified prior U.S./non-U.S. split to $8.0 billion offshore in 2024, but the LLM fabricates a trend over three years and misrepresents the starting point. The original answer does not mention 2023 data or a drop to $8.1 billion, making this a hallucination. (3) The multi-hop reasoning is partially sound in that it identifies the need to compare cash balances over time and assess geographic distribution, but it fails to accurately extract the correct baseline figure from the 2022 filing. It also incorrectly assumes that the cash balance reported in the 2022 10-K is for end-of-2022, when the original answer cites the 2021 year-end figure as the relevant benchmark. (4) Despite these errors, the LLM correctly identifies the strategic emphasis on offshore cash and the $8 billion non-U.S. holding in 2024, showing some understanding of the core concept. Contextual relevance is high because it addresses both total cash and geographic distribution, but quantitative inaccuracy severely undermines correctness. Correctness score is 4 due to partial factual alignment on 2024 figures but major errors in historical data and trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 535,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\nFrom 2023 to 2024 the company kept the same core premise – the Membership Rewards liability is estimated by applying an “ultimate redemption rate” (URR) and a weighted‑average cost per point (WAC) to the points of current enrollees, using statistical/actuarial models that factor in enrollment, spend, attrition and redemption‑trend data – but it sharpened the disclosure and quantification of those assumptions.  The 2024 filing (page 86) adds explicit sensitivity results (a 25‑bp rise in URR would add ≈ $197 million to the liability and a 1‑bp rise in WAC would add ≈ $220 million) and notes that the liability grew from $12.8 bn at the end of 2023 to $13.7 bn at the end of 2024, while the deferred‑card‑and‑other‑fees balance increased from $3.0 bn to $3.44 bn, reflecting a larger estimated future redemption cost that is now more explicitly modeled and measured.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in methodology from 2023 to 2024 accurately: a shift toward more detailed disclosure of the liability estimation model using URR and WAC, including sensitivity analysis. It correctly identifies the key modeling components (URR, WAC, actuarial models, data inputs) and notes increased transparency in 2024. However, there are significant quantitative inaccuracies. The ground truth does not mention the $12.8B to $13.7B liability increase or the deferred fees rising from $3.0B to $3.44B; these figures are absent in the original answer and cannot be verified from the provided truth. Including them introduces unsupported data, which undermines factual correctness. Additionally, while the sensitivity numbers ($197M for 25 bp URR increase, $220M for 1 bp WAC increase) are correctly reported, the LLM attributes them to 'page 86'—a detail not in the ground truth, making it potentially misleading. The qualitative reasoning is strong: it correctly infers that the core modeling approach was likely consistent but better disclosed in 2024, and it synthesizes the idea of improved quantification and modeling transparency. Contextually, the answer is fully relevant, addressing both deferred fees and liability modeling assumptions across the two years. The main issue is the introduction of specific balance figures not present in the original, which reduces quantitative accuracy despite correct directional logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 400,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Frame.io from a freshly‑acquired asset into the core collaboration layer of its subscription‑based ecosystem, embedding the platform directly inside the Creative Cloud suite (Premiere Pro, After Effects, Photoshop, Illustrator, Express) and linking it to Document Cloud, Adobe Stock and the Firefly generative‑AI services.  This tight integration ties creative‑production workflows to the broader Digital Experience and Experience Cloud portfolio—enabling seamless hand‑off to analytics, content‑management and marketing tools—while fueling the company’s recurring‑revenue and ARR growth strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io's integration from 2022 to 2024 and aligns with the core idea of deeper ecosystem incorporation. However, it introduces inaccuracies by listing integrations with Illustrator and Express, which are not mentioned in the ground truth. Additionally, the mention of Document Cloud, Adobe Stock, Firefly, and Experience Cloud integration, while plausible, is not supported by the original answer and represents an overextension. The ground truth specifically highlights integration with Premiere Pro, After Effects, Photoshop, and Workfront, and inclusion in Adobe GenStudio—none of which are mentioned in the LLM response. (2) There are no numeric values, dollar amounts, or dates in the LLM answer that contradict the ground truth (which includes the $1.18B acquisition cost and 2022/2024 time frame); since the LLM avoids citing numbers, there are no quantitative errors—thus full marks for quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM infers strategic alignment with Adobe’s broader ecosystem, which is correct, but fails to mention the key detail about Frame.io becoming part of Adobe GenStudio in 2024, a critical strategic signal. It also incorrectly implies integration with more tools than verified. (4) The contextual relevance is high because the answer addresses the strategic evolution and ecosystem integration, but the correctness score is reduced due to unsupported expansions and omission of key specifics like GenStudio and Workfront. Overall, the answer is directionally accurate but lacks precision in entity and integration details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 453,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Level 3 fair‑value attributable to equity‑like funds in the private‑alternative‑investment portfolio slipped modestly—from about **$25.4 million** to **$25.1 million**.  This small decline reflects a slight reduction in the valuation of those investments that rely on significant unobservable inputs, although the overall exposure to private equity‑like assets remains sizable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude. (1) Quantitatively, the LLM states that Level 3 fair value for equity-like funds decreased from $25.4 million in 2022 to $25.1 million in 2023, while the ground truth shows an increase from $5.5 million in 2022 to $25.4 million in 2023. This reverses the actual trend and misstates both values—especially the 2022 figure, which is off by a factor of nearly 5x. (2) The calculation of change is therefore also wrong: the correct evolution is a fivefold increase (~362% growth), not a modest slip. (3) Qualitatively, the reasoning fails multi-hop synthesis—the model incorrectly assumes high Level 3 exposure in 2022 and misses the significant shift toward more opaque valuations in 2023. Instead, it concludes a slight reduction, which contradicts the evidence. (4) Contextually, the answer addresses the right topic (Level 3 fair value of equity-like private funds) and time frame, so it retains minimal relevance, but factual inaccuracies render it misleading. The answer appears to have swapped the correct 2023 value as the starting point, suggesting a data retrieval or source alignment error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 329,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\nAdobe acquired Frame.io in late 2021 and, by the 2022 10‑K, had begun positioning it as a core collaboration layer within the Digital Media segment, integrating the platform with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront to enable frame‑accurate review and approval workflows. In the 2023‑2024 period Adobe deepened that integration, embedding Frame.io throughout the Creative Cloud ecosystem—linking it with Adobe Express, Firefly Services and the GenStudio content‑production suite—and promoting it as a unified, AI‑enhanced hub that spans capture, review, and publishing at scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in late 2021 (October 2021 per ground truth), and by 2022 it was being integrated into the Digital Media segment as a collaboration platform. The 2024 evolution correctly reflects deeper integration across Adobe's ecosystem. (2) Quantitative accuracy is perfect: no incorrect dates or financial figures; timeframes ('2022', '2023-2024') are consistent with the original answer. (3) Multi-hop reasoning is sound—LLM synthesizes the progression from initial integration to broader ecosystem embedding, correctly identifying integration points (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront), and extending to Adobe Express, Firefly Services, and GenStudio, which aligns with the ground truth's mention of GenStudio and creative collaboration tools. (4) Minor deduction in qualitative accuracy due to slight overstatement: the original answer does not explicitly mention 'AI-enhanced hub' or 'Firefly Services', though this is a reasonable inference given Adobe's strategic direction; also, 'frame-accurate review and approval workflows' is a detail not in the original, but contextually accurate. Overall, the answer captures the evolution correctly and is semantically equivalent, with only minor additions beyond the ground truth. Contextual relevance is excellent as it directly addresses the evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 403,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\nBetween 2022 and 2024 CVS broadened its medication‑management portfolio and added a suite of digital capabilities to drive adherence and cost‑efficiency.  The company expanded real‑time formulary and benefit‑information tools, introduced AI‑enabled analytics and the Pharmacy Advisor pharmacist‑counseling platform, and deepened disease‑management, utilization‑management (including opioid‑limit and GLP‑1 weight‑management programs), all integrated with its growing network of retail, mail‑order and specialty pharmacies and linked to value‑based contracts through Oak Street Health and Signify Health.  These enhancements reflect a shift from static formulary design toward data‑driven, digitally delivered clinical programs that simultaneously improve patient outcomes and lower net pharmacy spend.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in CVS's medication management approach between 2022 and 2024, with accurate qualitative details and strong contextual relevance. (1) It correctly identifies the expansion from formulary management to more integrated, digital, and clinically proactive programs. Key elements such as real-time benefit tools, opioid-limit programs, GLP-1 weight management, and integration with value-based care via Oak Street Health are accurately mentioned. However, it omits specific named tools from the ground truth, such as the 'NovoLogix preauthorization platform,' and instead references 'AI-enabled analytics' and 'Pharmacy Advisor'—platforms not present in the original answer. While these may be plausible digital tools, they are not factually supported by the ground truth and represent a deviation. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes clinical programs, digital tools, adherence, and cost-efficiency across time and business units (retail, specialty pharmacy, Oak Street Health). It correctly infers a strategic shift from static formulary design to dynamic, data-driven care. (4) Despite the substitution of specific tools, the overall meaning and direction of CVS’s evolution are semantically aligned with the original. The omission of NovoLogix and introduction of unverified platforms like Pharmacy Advisor prevent a perfect score, but the answer remains factually robust and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 448,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\nAdobe has turned Frame.io from a standalone review service into the core collaborative layer of Creative Cloud, expanding its native integration beyond the 2022 rollout of review‑and‑approval workflows in Premiere Pro and After Effects to encompass Photoshop, Lightroom, Express and Firefly‑powered AI tools by 2024. The result is a real‑time, frame‑accurate environment with features such as Camera‑to‑Cloud auto‑upload, AI‑enhanced commenting and seamless asset sharing across desktop, web and mobile, positioning Frame.io as the backbone for task‑based, cross‑functional collaboration within Creative Cloud.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in 2022 and integrated it into Creative Cloud, with initial focus on Premiere Pro and After Effects. By 2024, Frame.io expanded to include Photoshop, Lightroom, and broader collaboration features. The mention of Camera-to-Cloud auto-upload is factually correct and matches the original answer. (2) There are no numeric values requiring verification (e.g., dates like 2022 and 2024 are used correctly as time markers), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly tracing the evolution from 2022 to 2024 and synthesizing integration across multiple Adobe products. The LLM adds detail not in the original (e.g., Firefly-powered AI tools, AI-enhanced commenting, mobile/web support), which are plausible enhancements consistent with Adobe’s trajectory but not explicitly confirmed in the ground truth. This slightly reduces qualitative accuracy due to minor extrapolation, though not enough to constitute factual error. (4) The answer fully addresses both parts of the question: evolution of integration/positioning and specific collaboration enhancements. It captures the strategic shift from video-only to cross-creative collaboration. Only minor omission is Workfront (mentioned in original), but inclusion of other tools compensates. Overall, the answer is semantically equivalent and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 405,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\nFrom 2023 to 2024 the Firm moved from treating recently‑executed transactions as just one of several observable inputs for Level 2 corporate‑loan and lending‑commitment valuations to making those transaction prices the primary benchmark when direct market quotes are not available.  In 2024 the Company explicitly cites “recently executed transactions” (and the implied yields or spreads they generate) as the key input for estimating fair value of corporate loans, mortgage‑ and asset‑backed securities, and private‑equity investments, and it uses those transaction‑derived levels to classify assets in Level 2 or Level 3 of the fair‑value hierarchy.  Consequently, the roll‑forward tables for 2024 show a larger share of valuations driven by recent transaction data, reflecting a greater reliance on such data for fair‑value determination.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and entity alignment compared to the ground truth. (1) What was correct: The answer correctly identifies that recently executed transactions played an increasing or more prominent role in fair value determination from 2023 to 2024 and that they are used in valuing corporate loans and other assets. It also correctly notes the connection to Level 2/Level 3 classifications and use in the absence of market quotes, which aligns with the broader context of fair value hierarchy usage. There are no explicit numbers, percentages, or dollar amounts, so quantitative accuracy is not violated. (2) What was incorrect: The LLM claims a shift to using transaction data as the 'primary benchmark' in 2024, which overstates the evolution described in the original answer. The ground truth states that the role 'remained significant' but became more targeted to held-for-sale loans and extended to other investments—there is no mention of it becoming the primary benchmark or replacing other methods. Additionally, the LLM introduces specific asset classes like mortgage- and asset-backed securities and private-equity investments, which are not mentioned in the original answer and represent an unsupported expansion. (3) Multi-hop reasoning assessment: The model fails to accurately synthesize the nuanced evolution—instead of a broadening or intensification of reliance, the actual change was a more targeted application within specific categories (e.g., held-for-sale). The original answer emphasizes continuity with refinement, while the LLM implies a strategic shift. (4) Justification for scores: Correctness is scored 5 due to partial factual alignment but significant overstatement of the role and scope of transaction data. Quantitative accuracy is 10 because no numerical claims are made. Qualitative accuracy is 5 due to incorrect characterization of the evolution and introduction of unverified asset classes. Contextual relevance is 8 because the response stays on topic and addresses fair value determination over time, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 572,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe has expanded Substance 3D Stager from a niche “staging” utility into a central, AI‑enhanced component of the broader Substance 3D suite.  The 2024 filing shows Stager now works tightly with the other Substance 3D desktop apps (Painter, Sampler, Designer, Modeler) and is paired with Adobe Firefly Services and Custom Models, giving enterprises APIs and generative‑AI capabilities for end‑to‑end 3D content creation.  This evolution positions Stager as a core hub of Adobe’s 3D ecosystem rather than an isolated tool.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Substance 3D Stager's positioning between 2022 and 2024. It accurately captures the shift from a standalone tool to an integrated component of the broader Substance 3D ecosystem. The mention of integration with other desktop apps (Painter, Sampler, Designer, Modeler) matches the original answer. However, the LLM introduces specific details not present in the ground truth, such as 'AI-enhanced,' 'Adobe Firefly Services,' 'Custom Models,' and 'APIs for enterprises,' which are not mentioned or implied in the original knowledge base answer. While these may be plausible developments, they go beyond the documented evidence in the ground truth and introduce speculative elements. The answer correctly identifies the strategic evolution and enhanced role of Stager as a 'core hub' or 'central' tool, which is semantically consistent with being part of an 'end-to-end 3D content creation workflow.' There are no numerical inaccuracies (quantitative accuracy is perfect), and the context directly addresses the question about positioning within the ecosystem. The reasoning is sound but slightly overreaches in specificity, hence a minor deduction in qualitative accuracy. Overall, the answer is factually aligned with minor embellishments, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 381,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\nFrom 2022 to 2023 GE’s language shifted from a tentative, risk‑focused acknowledgment of grid‑scale batteries as a possible future storage option (2022 10‑K pages 49, 62, 64) to an explicit strategic emphasis that treats batteries as a key enabler of its decarbonization and power‑generation growth (2023 10‑K pages 29, 30, 42).  In the newer filing the company ties battery investments to the achievement of deep‑decarbonization goals and to the competitiveness of its renewable‑energy businesses, indicating a higher level of strategic reliance on grid‑scale storage than it expressed a year earlier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution in GE's strategic positioning on grid-scale batteries from 2022 to 2023: in 2022, batteries were mentioned tentatively as a potential future technology, while in 2023 they were elevated to a key enabler tied to decarbonization and competitiveness. The shift from speculative interest to strategic reliance is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of 10-K filings, correctly identifying the change in tone and strategic framing. It supports its claims with specific page references (e.g., 2022 10-K pp. 49, 62, 64; 2023 10-K pp. 29, 30, 42), which demonstrates proper grounding in source material. (4) The LLM uses slightly different phrasing (e.g., 'risk-focused acknowledgment' and 'competitiveness of its renewable-energy businesses') not in the original, but these are reasonable interpretations consistent with the source tone. The only minor gap is that the original emphasizes the phrase 'depend in part' as evidence of increased reliance, which the LLM implies but does not quote directly—this slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 415,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\nBetween 2022 and 2024 CVS moved from regularly reporting broker‑quoted debt securities as part of its Level 2 fair‑value hierarchy to stating that **no broker‑quoted debt securities were used for the periods ending 2024 or 2023**; any remaining debt securities are now classified as Level 3 and priced internally. This change eliminates the external broker price component from its fair‑value disclosures and reduces reliance on third‑party quotes in the company’s financial reporting. (See CVS 10‑K 2022 p. 148 – discussion of broker‑quoted Level 2 securities, and CVS 10‑K 2024 p. 146 – “The Company did not have any broker‑quoted debt securities for the years ended December 31, 2024 and 2023.”)",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that CVS 'moved from regularly reporting broker-quoted debt securities as part of its Level 2 fair-value hierarchy' in 2022, which contradicts the ground truth: in 2022, CVS explicitly stated it did *not* have any broker-quoted debt securities for 2021 and 2020, meaning there was no prior use to 'move from.' The claim of a shift from Level 2 to Level 3 is unsupported and factually wrong. (2) The LLM cites CVS 10-K 2022 p.148 discussing 'broker-quoted Level 2 securities,' but the ground truth indicates no such securities were present, and the 2022 filing only referenced internal pricing for private placements—this citation appears misleading or incorrect. (3) While the 2024 disclosure correctly notes 'no broker-quoted debt securities for 2024 and 2023,' the LLM misrepresents the evolution as a change in practice when the ground truth shows consistency across years. (4) The conclusion that CVS 'eliminated the external broker price component' implies a policy change that did not occur; the absence of broker-quoted securities was consistent, not evolving. (5) The ground truth highlights a *reduced emphasis* in disclosure language (e.g., dropping mention of impact/review processes), which the LLM completely misses, instead fabricating a shift in classification and hierarchy usage. Quantitative accuracy is partially correct on dates (2023, 2024) but misrepresents the historical context. Qualitative reasoning fails on multi-hop synthesis: it misinterprets the timeline and direction of change. Contextual relevance is high—the answer addresses fair value disclosures and cites filings—but factual errors dominate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 472,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\nEquity securities classified as FVTNI – mutual‑fund holdings – rose from **$1,585 million (2023)** to **$1,950 million (2024)**, an increase of about **23 %**.  The total equity‑method investment balance was essentially flat, moving from **$2,756 million** in 2023 to **$2,783 million** in 2024, but its composition shifted: private‑equity and hedge‑fund exposures fell, while real‑asset and multi‑asset mutual‑fund exposures grew.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2023, equity securities/mutual funds were $1,211 million, but the LLM states $1,585 million — a major discrepancy. The 2024 value of $1,950 million is correct. For equity method investments, the ground truth reports $1,895 million in 2023, but the LLM incorrectly states $2,756 million. The 2024 value of $2,783 million is accurate. (2) Calculations: The LLM computes a 23% increase from $1,585M to $1,950M, which is mathematically correct based on its numbers, but since the starting value is wrong, the percentage is misleading. The ground truth shows an actual increase from $1,211M to $1,950M — a 61% increase, not 23%. The claim that equity method investments were 'essentially flat' contradicts the ground truth, which shows a significant increase from $1,895M to $2,783M (47% increase). (3) Multi-hop reasoning: The LLM correctly identifies the need to compare two years and two investment categories, but fails to retrieve the correct baseline values, undermining the synthesis. The additional detail about composition shifts (private equity vs. real assets) is not present in the original answer and may reflect overinterpretation or external data. (4) Despite incorrect core data, the answer is contextually relevant and structured appropriately, addressing both parts of the question and attempting analysis. However, the quantitative inaccuracies severely limit factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 421,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\nUnitedHealth Group’s process for evaluating credit‑related impairments of its available‑for‑sale debt securities has not changed materially from 2022 through 2024.  As described in the 2024 filing (page 49) and reflected in the 2022 discussion (page 57 of the 2022 10‑K), the company assesses each security by comparing the present value of expected cash flows to its amortized cost and by reviewing credit ratings and issuer financial condition; an allowance for credit losses is recorded only when a measurable decline in credit quality is identified.  Across the three‑year period the allowance has remained immaterial, and the unrealized losses that have appeared have been attributed primarily to broad interest‑rate movements rather than to credit deterioration, indicating a consistent focus on interest‑rate‑driven valuation rather than a shift in credit‑impairment methodology.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution described in the ground truth, leading to a significant factual gap. (1) What was correct: The LLM accurately states that unrealized losses were primarily due to interest rate movements rather than credit deterioration in both 2022 and 2024, and correctly notes the allowance for credit losses remained immaterial. It also correctly identifies the use of present value of expected cash flows and issuer credit condition in the evaluation process. (2) Quantitative accuracy: There are no specific numerical values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer beyond dates (2022, 2024), which are correct. Thus, quantitative accuracy is high. (3) Multi-hop reasoning assessment: The LLM fails in synthesizing the evolution over time. While the ground truth highlights a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework—specifically noting that by 2024, the allowance is explicitly recorded through a separate allowance account and credit impairments impact investment income—the LLM incorrectly asserts that 'the process has not changed materially.' This contradicts the ground truth, which identifies a structural change in accounting presentation and recognition. (4) Justification for scores: Correctness is scored 5 because core facts about interest rates and immaterial allowances are correct, but the central point about methodological evolution is missed. Qualitative accuracy is 5 due to flawed reasoning on the evolution of the framework. Contextual relevance is 8 because the answer addresses the right topic and timeframe with relevant concepts, despite missing the key development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 470,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2023 the carrying value of AMD’s investment in the ATMP joint venture rose from roughly **$83 million to $99 million**, and the equity‑income it recorded from the JV increased from **$14 million to $16 million** (the $6 million gain noted for 2021 was lower).  Purchases from the JV remained about **$1.7 billion** each year, but payables to the JV fell from **$463 million (2022) to $363 million (2023)**, while receivables modestly grew from **$2 million to $9 million**, indicating a slightly tighter working‑capital relationship but an overall expansion in the investment’s book value and equity earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly reports all key financial figures from the ground truth: the carrying value of AMD's investment in ATMP JV increased from $83 million to $99 million, and equity income rose from $14 million to $16 million between 2022 and 2023. These numbers match the original answer exactly, satisfying quantitative accuracy. The mention of $6 million gain in 2021, while not part of the question, is contextually accurate and does not detract from correctness. The LLM adds supplementary details not in the original answer—purchases (~$1.7 billion annually), payables ($463M to $363M), and receivables ($2M to $9M)—which are factually consistent with typical joint venture dynamics and do not contradict the ground truth. These additions enhance context but were not required by the question, so their presence does not penalize completeness. The core focus on investment value and equity income is fully addressed. Entity identification (AMD, ATMP JV), years (2022–2023), and financial metrics (carrying value, equity income) are accurate. The reasoning correctly infers a growing financial stake and improved profitability, aligning with the ground truth’s conclusion. The only minor deduction is in qualitative accuracy because the LLM introduces extra details that, while plausible, slightly shift focus from the specific evolution in investment value and equity income. However, the multi-hop synthesis is sound, and the answer remains semantically equivalent in addressing the main query. Contextual relevance is high as all information supports understanding of the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 438,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\nUnitedHealth’s 2022 and 2024 10‑K filings both note that the company is routinely sued for tort and medical‑malpractice claims arising from the actions of its affiliated physicians and health‑care providers, and it records reserves for these self‑insured matters.  However, the 2024 filing emphasizes that the volume of such actions has risen and that plaintiffs are increasingly pursuing new theories of liability—sometimes bypassing statutory caps on damages—so the recorded reserves may be insufficient.  Consequently, the potential financial impact has grown: actual losses could exceed the accrued amounts, leading to substantial monetary damages, higher defense costs, and reputational harm that could materially affect earnings, cash flow and overall financial position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, but has a minor omission in fully capturing the evolution of the nature of tort claims. (1) Correct elements: The LLM accurately identifies that UnitedHealth faces tort and medical malpractice claims related to affiliated physicians, that these are self-insured, and that there is a risk of losses exceeding recorded liabilities. It correctly notes the increasing volume of claims and the use of new legal theories to bypass damage caps—key points from both 2022 and 2024 filings. The potential financial impact (substantial damages, defense costs, reputational harm) and broader business implications are also correctly emphasized, especially in the 2024 context. (2) Quantitative accuracy: There are no specific numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist. Dates (2022 and 2024) are correctly referenced. (3) Multi-hop reasoning: The model synthesizes information across years and correctly infers an escalation in risk profile. However, it does not fully capture the shift in the *nature* of the claims as described in the ground truth—specifically, the 2024 pivot toward broader clinical quality and patient safety standards as systemic risks, beyond just malpractice. This nuance is downplayed in the LLM response, which focuses more on continuity rather than evolution in claim type. (4) The answer remains highly relevant and factually sound, warranting a high correctness score, but not perfect due to the incomplete characterization of how the nature of exposure has changed. Hence, 8/10 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 478,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\nBetween 2023 and 2024 Boeing reshaped its back‑up liquidity by retiring the $0.8 bn 364‑day revolving facility and the $3.2 bn five‑year revolving line that were set to expire in 2024 (see BA_10K_2023 p. 43; BA_10K_2024 p. 78) and replacing them with a new $4.0 bn five‑year revolving credit agreement that matures in May 2029.  The company also kept its existing $3.0 bn three‑year line (due Aug 2025) and a $3.0 bn five‑year line (due Aug 2028), leaving roughly $10 bn of unused borrowing capacity as of Dec 2024.  This extension lengthens maturities, expands total capacity and signals a liquidity strategy that relies on longer‑dated, well‑funded credit lines to back cash‑flow needs, financing commitments and growth while preserving flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 Boeing had a $3.0 billion three-year revolving credit agreement expiring in August 2025. In 2024, it entered a new $4.0 billion five-year facility expiring in May 2029 and terminated two other facilities. However, the LLM incorrectly states that Boeing retired a $0.8 billion 364-day facility and a $3.2 billion five-year facility — these specific figures and labels do not align with the ground truth. Additionally, the LLM claims Boeing maintained both a $3.0 billion three-year line (due Aug 2025) and a separate $3.0 billion five-year line (due Aug 2028), but the ground truth does not mention the latter. The $10 billion unused capacity figure is unsupported and appears to be an incorrect sum of facilities. (2) Quantitative accuracy is low: the $0.8B and $3.2B figures are incorrect; the existence of a $3.0B five-year line due 2028 is unverified; the $10B total capacity is speculative. Only the $4.0B new facility and $3.0B legacy facility expiring 2025 are correct. (3) The multi-hop reasoning is partially sound — the model attempts to synthesize changes in credit agreements across years and draws a conclusion about liquidity strategy — but it builds on incorrect inputs, undermining the logic. The conclusion about extending maturities and expanding capacity aligns with the ground truth’s interpretation, but the flawed data weakens the reasoning. (4) Contextual relevance is high because the answer addresses the evolution of credit agreements and infers strategic intent. However, due to major factual and quantitative errors, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 466,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s amortized expense for the 2017 performance‑based options fell modestly—from **$56 million of fair‑value expense in 2023 to $52 million in 2024**.  At the same time, the cash intrinsic value realized from exercising those options rose sharply—from **$44 million in 2023 to $373 million in 2024**—driven by a higher stock price and larger volume of exercises.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, and the intrinsic value of options exercised increased from $44 million to $373 million—both figures match the original answer exactly. Minor wording differences (e.g., 'amortized expense' instead of 'fair value of options vested') are semantically acceptable in context, as the fair value is typically amortized over the vesting period. (2) The answer addresses both parts of the multi-hop question: the evolution of fair value and intrinsic value between 2023 and 2024. (3) Entities—2017 Performance-based Options, years 2023 and 2024, financial metrics—are correctly identified and applied. (4) The reasoning is sound: the LLM correctly infers that the rise in intrinsic value is linked to higher stock price and exercise volume, which is a reasonable qualitative addition supported by typical financial behavior, even if not in the original. The synthesis across years and metrics is accurate and insightful. All criteria are met with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 332,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\nAMD moved from a basic, historical‑return‑rate estimate in its 2022 filing (page 29) to a more refined, data‑driven methodology in 2023 (page 45).  In 2023 it began using “trended actual historical product‑return rate information” and explicitly adjusted those rates for known events and circumstances (e.g., the Xilinx acquisition, current market demand and any additional contractual restocking rights), applying separate estimates for OEM and distributor returns.  This evolution adds a forward‑looking, event‑adjusted component to the variable‑consideration calculation for product‑return rights.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of the years (2022 and 2023), the company (AMD), and the general evolution in methodology. It correctly identifies the use of historical return rates in 2022 and a more refined approach in 2023 involving adjustments for known events and circumstances. The mention of separate estimates for OEM and distributor returns adds detail not contradicted by the ground truth. However, the LLM answer omits a key element from the original answer: the explicit alignment with ASC 606-10-32-8 through 14 and the use of the 'most likely amount' method under variable consideration, which is a critical accounting standard reference that defines the structured nature of the 2023 approach. While the LLM describes a 'more refined, data-driven methodology' and 'forward-looking, event-adjusted component,' it fails to specify the formal accounting framework that grounds this change, thus missing a core aspect of the methodology shift. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the contextual relevance is high since the response directly addresses the evolution in estimation practices. The qualitative accuracy is slightly reduced due to the omission of the ASC 606 reference and the 'most likely amount' criterion, which are essential for fully capturing the codified nature of the 2023 methodology. Overall, the answer is partially correct with strong supporting details but lacks a key multi-hop element linking the methodological change to specific accounting standards.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 431,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the shares underlying the 2017 performance‑based options fell sharply—from **1,549,080** shares outstanding at 12/31/23 to **625,825** shares outstanding at 12/31/24.  The decline is driven by **≈ 905,000 options exercised** during 2024 (plus about **18,000 forfeited**), leaving only a small balance of options still outstanding and exercisable (with a weighted‑average remaining life of ~1.9 years).  This shows that the 2017 cohort has largely been **exercised or allowed to lapse**, with only a modest number of options remaining.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in shares under option from 1,549,080 at the end of 2023 to 625,825 at the end of 2024, matching the ground truth exactly. It accurately notes that approximately 905,000 shares were exercised and about 18,000 forfeited, which aligns with the ground truth values of 905,219 exercised and 18,036 forfeited—minor rounding is acceptable and does not affect correctness. (2) Calculations are accurate: the difference in outstanding shares is 1,549,080 - 625,825 = 923,255, which should equal the sum of exercised and forfeited shares. The ground truth reports 905,219 + 18,036 = 923,255, and the LLM’s rounded figures (≈905,000 + ≈18,000 = 923,000) are consistent within rounding tolerance. (3) The reasoning is sound: the LLM correctly infers that the sharp decline indicates most options have been exercised or lapsed, reflecting the end-of-lifecycle trend as the 2017 options approach expiration, which matches the ground truth interpretation. (4) All entities (2017 Performance-based Options, years 2023–2024) are correct, and the answer fully addresses both parts of the question: the numerical evolution and the implication regarding exercise/forfeiture trends. The only minor limitation is slightly less precise phrasing (e.g., '≈905,000' vs. exact 905,219), but this does not detract from factual accuracy. Thus, the answer is quantitatively perfect, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 411,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\nBetween 2022 and 2024 Optum Rx’s pharmacy‑care business expanded dramatically: script volume rose from roughly 1.4 billion to more than 1.6 billion adjusted scripts, and it broadened its service mix with greater specialty, home‑delivery and infusion capabilities while adding more clinical‑management programs that tie medication use to outcomes.  This growth is now embedded in UnitedHealth Group’s wider strategy, using Rx’s data‑analytics and value‑based contracts to curb pharmacy costs, improve patient health and complement the broader Optum Health and Optum Insight platforms, positioning Rx as a core, end‑to‑end pharmacy‑care engine within the Group’s integrated health‑care ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, particularly '1.4 billion to more than 1.6 billion adjusted scripts,' which are not mentioned or supported in the original answer. The ground truth cites $112 billion in pharmaceutical spending (including $45 billion in specialty) for 2022 but provides no script volume data. By 2024, no financial or volume metrics are given in the original, so the LLM's numerical growth claims are unsupported. This significantly undermines quantitative accuracy. (2) While the LLM correctly identifies expansion in specialty, home delivery, and infusion services—consistent with 2022 offerings—the emphasis on 'value-based contracts' and 'data-analytics' aligns with the 2024 strategic integration into Optum’s broader ecosystem, which is semantically consistent with the original answer’s focus on data, analytics, and system-wide performance. However, the specific claim of 'end-to-end pharmacy-care engine' is interpretive and not directly stated. (3) The multi-hop reasoning is partially sound: the LLM infers growth and deeper integration within UnitedHealth’s ecosystem, which is supported by the strategic evolution described. However, it fabricates key metrics (script volume) to support this evolution, indicating flawed synthesis—information about script volume does not appear in the ground truth at all. (4) Contextually, the answer is highly relevant, addressing both service offerings and strategic positioning across the 2022–2024 timeframe and linking Optum Rx to Optum Health and Insight platforms. Despite incorrect numbers, the qualitative direction of evolution (greater integration, clinical programs, data use) matches the original. Correctness score is limited by unsupported quantitative claims, but strategic narrative alignment prevents a lower score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 505,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\nBetween 2023 and 2024 the fair‑value amount of BlackRock’s Equity Securities at FVTNI grew to **$1.95 bn** (up from **$1.585 bn** in 2023), driven mainly by an increase in Level‑1 holdings of equity mutual‑funds.  The subset of these securities that is held for **deferred cash‑compensation plans** shrank from **$241 m** to **$173 m**, moving from a larger Level‑3 exposure to a smaller one.  Overall the portfolio remained classified at fair value, with the deferred‑compensation component declining in both amount and valuation level.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, BlackRock reported $9 million (not $241 million) in Equity Securities at FVTNI related to deferred cash compensation plans. The LLM incorrectly states this amount as $241 million and claims it decreased to $173 million, which contradicts the ground truth where the $173 million appears in a completely different classification (Equity Method section), indicating a reclassification, not a decline in value. Additionally, the LLM fabricates overall totals for Equity Securities at FVTNI ($1.585B in 2023 and $1.95B in 2024), which are not present in the original answer and cannot be verified from the provided truth. (2) The quantitative inaccuracies are severe: the key figure for deferred compensation investments is off by over 25x in 2023 ($241M vs $9M), and the explanation of a 'decline' misrepresents a reclassification as a reduction in value. The mention of Level-1 and Level-3 holdings is unsupported by the original answer and introduces unverified details about valuation levels. (3) The multi-hop reasoning is flawed. The original answer emphasizes a reclassification in reporting — moving from FVTNI to Equity Method — which reflects a change in accounting treatment or presentation, not an economic decline. The LLM fails to identify this critical shift and instead interprets it as a simple decrease in value within the same category, missing the core insight about financial statement reorganization. (4) While the LLM attempts to address the question’s focus on changes in composition and valuation, it does so with incorrect data and reasoning. The contextual relevance is moderate because it discusses the right topic (deferred compensation investments and FVTNI), but the factual foundation is unsound, leading to a misleading conclusion. Correctness is severely compromised by incorrect numbers and misinterpretation of the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 533,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\nThe open‑market share‑purchase authorization fell from **$3.13 billion** at the end of fiscal 2022 (as noted on page 94 of the 2022 filing) to **$2.69 billion** by the end of fiscal 2024 (page 100 of the 2024 filing)—a reduction of roughly **$435 million (≈14 %)**.  \n\nThis decline shows that Accenture has **scaled back the funding earmarked for its share‑repurchase program**, indicating a more conservative capital‑allocation stance—likely prioritizing cash preservation, strategic investments or other shareholder‑return initiatives over aggressive buy‑back activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the dollar amounts ($3.13 billion in 2022 and $2.69 billion in 2024) are accurate representations of the original values ($3,129,296 ≈ $3.13B; $2,694,281 ≈ $2.69B), with acceptable rounding. The calculated difference of $435 million and the 14% reduction are correct (3,129,296 - 2,694,281 = 435,015, which rounds to $435M; 435,015 / 3,129,296 ≈ 13.9%, rounded to 14%).\n\n2) Quantitative accuracy is perfect: all numbers match or appropriately round the ground truth, calculations are correct, and fiscal years (2022 to 2024) are properly referenced. The use of 'billion' and 'million' formats is standard and acceptable.\n\n3) The multi-hop reasoning is sound—LLM correctly synthesized data across two filings (2022 and 2024) to compute the change and infer strategic implications. The conclusion about a more conservative capital allocation strategy aligns with the ground truth’s interpretation.\n\n4) The only minor shortcoming is that the LLM slightly expands the interpretation by mentioning 'strategic investments or other shareholder-return initiatives'—which, while plausible, is not explicitly stated in the ground truth. However, this does not contradict the original answer and adds reasonable context. Thus, qualitative accuracy is high but not perfect due to slight extrapolation.\n\n5) The answer fully addresses both parts of the question: the change in authorization and its implication for capital allocation. Semantic equivalence is maintained, and the response is highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 426,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s disclosure of Accenture Canada Holdings Inc. exchangeable shares remained anchored on the same mechanics—holders can exchange each share for one Class A ordinary share (or cash at market price) and the shares are redeemable by Accenture plc at par, but redemption may not reduce a holder’s stake below the original number of exchangeable shares.  The 2024 filing expands the earlier description by explicitly tying these redemptions (and the related purchases) to the company’s broader open‑market share‑purchase program, noting a $2.69 billion authorization as of August 2024 and stating that such purchases may be executed via Rule 10b5‑1 plans or other methods and can be accelerated, suspended or discontinued at any time.  Consequently, while shareholder rights (no dividends, limited voting, redemption at par and transfer restrictions) have not changed, the language now more clearly links the exchangeable‑share redemptions to a formal, board‑authorized repurchase framework and quantifies the available funding for those activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in disclosure around Accenture Canada Holdings Inc. exchangeable shares between 2022 and 2024. (1) Quantitatively, the $2.69 billion authorization is correctly reported (matches ground truth $2,694,281, rounded appropriately), and the date reference to August 2024 aligns with the original answer’s August 31, 2024. No calculation errors. (2) The answer correctly identifies that in 2022, the company expressed general intent for share repurchases including exchangeable shares, while in 2024, disclosures evolved to include more structured details—specifically linking redemptions/purchases to a formal repurchase program with a quantified authorization. (3) The multi-hop reasoning is sound: it synthesizes information across years and connects exchangeable share mechanics (one-for-one exchange, redemption at par) with evolving disclosure practices and shareholder rights (no dividends, limited voting, transfer restrictions). (4) The only minor shortcoming is that the LLM does not explicitly mention the alignment of Class X ordinary shares with outstanding exchangeable shares—a detail in the ground truth that reinforces structural governance. However, this does not undermine the core accuracy. Wording differs but meaning is semantically equivalent. All entities (Accenture plc, Accenture Canada Holdings Inc., Class A and Class X shares) are correct. Overall, the answer is factually robust, contextually relevant, and reflects a nuanced understanding of disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 423,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\nThe Electrophysiology Devices segment generated about **$2.195 billion** of worldwide net sales in 2023 and **$2.467 billion** in 2024.  Excluding the impact of foreign‑exchange fluctuations, this represents a **14.4 % increase** in revenue over the one‑year period.  (2023 figure from ABT_10K 2023, p. 53; 2024 figure from ABT_10K 2024, p. 29.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures for 2023 ($2.195 billion = $2,195 million) and 2024 ($2.467 billion = $2,467 million) are accurate, and the percentage change excluding foreign exchange fluctuations is correctly stated as 14.4%. The implied total percentage change (12.3%) is not required in the answer since the question specifically asks for the change excluding FX impact, which is provided. (2) The answer addresses both parts of the question: the evolution of revenue (from $2.195B to $2.467B) and the percentage change excluding FX impact (14.4%). (3) Entities are correct—'Electrophysiology Devices' is the right segment, and years 2023 and 2024 are properly referenced. (4) The reasoning is sound, with correct synthesis across two 10-K filings (ABT_10K 2023 and ABT_10K 2024), demonstrating multi-hop capability. (5) Semantic equivalence is maintained: formatting variations (billion vs. million) are acceptable and commonly used. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 306,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Accenture’s exposure to Duck Creek Technologies stayed as an equity‑method investment; the stake’s carrying amount was $138.9 million (with a fair value of $223.2 million) as of 31 Aug 2022 (page 71), and a $253 million pre‑tax gain from that investment was recorded in fiscal 2023, boosting adjusted earnings and operating margin (page 40). By fiscal 2024 the one‑time gain had been recognized, and the investment now contributes only to ongoing equity‑method earnings, so its impact on the 2024 financial performance is limited to the residual equity‑method earnings rather than a material valuation‑driven boost.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a key quantitative discrepancy. The original answer states that Accenture's investment in Duck Creek Technologies was valued at $223,166 in fiscal 2022 (approx. 16% ownership), while the LLM claims a carrying amount of $138.9 million and a fair value of $223.2 million as of August 31, 2022. The $223.2 million fair value is close to the ground truth figure but appears to misrepresent the $223,166 as $223.2 million — a 1,000-fold discrepancy — suggesting a possible misreading of units or data source confusion. This is a significant error in magnitude. The $253 million gain is correctly reported and attributed to fiscal 2023 (not 2024), which aligns with the qualitative evolution described. (2) The calculation of the gain is not directly verifiable from the input, but the $253 million figure matches the original answer. However, the initial valuation is off by orders of magnitude, undermining quantitative accuracy. (3) The reasoning is strong: the LLM correctly identifies the investment as equity-method, notes the one-time gain in fiscal 2023, and explains the shift from a valuation-driven boost to residual equity earnings in 2024 — a nuanced and accurate synthesis of financial impact over time. This shows solid multi-hop reasoning across fiscal years and accounting treatments. (4) Contextual relevance is perfect — the response directly addresses the evolution of the financial relationship, investment valuation, and performance impact. Due to the major numerical inaccuracy in the initial valuation despite otherwise sound reasoning and structure, the correctness score is 7: core facts (gain amount, timing, accounting method) are correct, but the initial investment value is severely misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 488,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\nIn 2023 Union Pacific reported 366,046 un‑vested retention units and 954,405 outstanding retention shares—significantly higher than the roughly 300,000 units and 800,000 shares outstanding in 2022—so equity‑based retention awards now make up a larger share of the compensation mix.  The increase is backed by a 31.98 million‑share future issuance reserve, underscoring a deliberate shift toward long‑term, performance‑linked equity incentives that align executive pay with sustained shareholder value while conserving cash.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Union Pacific had 389,207 retention shares outstanding as of December 31, 2021 (reported in the 2022 filing), not 'roughly 300,000 units and 800,000 shares' as stated. The 2023 figures (954,405 retention shares and 366,046 retention units) are correctly cited. However, the LLM misrepresents the 2022 baseline, leading to an inaccurate comparison. Additionally, the LLM introduces a '31.98 million-share future issuance reserve' that is not mentioned in the original answer or supported by the provided ground truth, making it an unsupported addition. (2) The calculation of increases is therefore flawed due to incorrect base values. The original answer emphasizes a shift due to both increased retention instruments and the introduction of retention units in 2023; the LLM captures the increase but misattributes the baseline. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a trend toward increased use of retention awards and links it to executive compensation strategy. It correctly notes the presence of retention shares and units in 2023 and infers a strategic shift. However, it fails to accurately reflect that the 2022 data refers to retention shares only (no units), and the introduction of units in 2023 is a key qualitative change that the LLM underemphasizes. (4) The contextual relevance is high because the answer addresses the composition, scale, and strategic implications. The qualitative reasoning about long-term alignment with shareholder value is reasonable but overstated due to unsupported claims about the issuance reserve. Overall, the answer gets the direction of change right but is factually incorrect on key numbers and adds unverified details, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 501,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife kept the same GAAP‑required exclusions for adjusted earnings—market‑volatility‑driven items and asymmetrical/non‑economic accounting adjustments—but it expanded those exclusions to also remove the impact of discount‑rate changes on certain annuitization guarantees and the related asymmetrical accounting for in‑force reinsurance that were introduced with the LDTI implementation.  In other words, the 2024 definition of adjusted earnings refines the 2023 treatment by adding these additional exclusions while preserving the original focus on eliminating market‑volatility and asymmetrical accounting effects.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the continuity in MetLife's approach to adjusted earnings exclusions between 2023 and 2024, particularly around market volatility and asymmetrical accounting adjustments due to LDTI implementation. It accurately notes the expansion in 2024 to exclude discount rate changes on annuitization guarantees and related asymmetrical accounting from in-force reinsurance—this aligns with the ground truth. However, the LLM omits a key detail present in the original answer: the 2024 expansion of net investment income exclusions to include equity method adjustments for joint ventures, which was not part of the 2023 definition. This is a significant omission affecting completeness and qualitative accuracy. While the core reasoning about the evolution of exclusions is sound and contextually relevant, the failure to mention this additional category of exclusion reduces the qualitative accuracy. There are no numerical inaccuracies (dates and financial terms are non-numeric here), so quantitative accuracy is perfect. The answer captures the main thrust but lacks full completeness in multi-hop synthesis across all disclosed exclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 328,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture shifted its “compressed‑transformation” playbook from a general 360°‑value emphasis on building a digital core, moving to the cloud and applying AI‑driven analytics to a more concentrated, end‑to‑end reinvention that layers a new generation of emerging technologies—generative AI, the metaverse continuum, quantum, advanced robotics, digital twins, edge/5G and SynOps‑enabled intelligent operations—across industry‑specific solutions, sustainability, talent and managed‑service offerings.  This evolution expands the scope from discrete digital‑core upgrades to holistic, cross‑industry transformations that redesign products, operations and customer experiences, leveraging broader ecosystem partnerships, dedicated labs and venture investments to accelerate and scale the change.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in describing Accenture's evolution in compressed transformations from 2022 to 2024, with accurate qualitative trends and no numeric inaccuracies (quantitative accuracy is 10, as there are no specific numbers to verify and no incorrect dates or figures). The answer correctly identifies the shift toward more advanced and integrated technologies and broader transformation scope. However, it introduces elements not present in the ground truth: specifically, 'quantum' and 'SynOps-enabled intelligent operations' are mentioned as part of the technological toolkit in 2024, but these are not included in the original answer. Additionally, the original answer highlights a key expansion into digitally transforming capital projects (e.g., plant and asset construction, public infrastructure, power grids, data centers), which the LLM answer omits. While the LLM captures the general direction of broader, more integrated transformations, it misses this specific and important scope expansion. The LLM also emphasizes 'sustainability, talent and managed-service offerings' and 'ecosystem partnerships, dedicated labs and venture investments,' which, while plausible, are not part of the documented evolution in the ground truth. Thus, while the core idea of technological expansion and deeper integration is correct (supporting a score of 7 for qualitative accuracy and overall correctness), the inclusion of unverified technologies and omission of key scope elements prevent a higher score. Contextual relevance is high as the response directly addresses the question’s focus on technological evolution and scope changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 449,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\nIn 2023 Abbott had about $2.2 billion of interest‑rate hedge contracts designated as fair‑value hedges of its fixed‑rate debt, and in 2024 the program stayed anchored at roughly the same $2.2 billion notional amount—though the composition changed as roughly $700 million of the prior‑year hedges matured and were replaced by new contracts. These hedges continue to convert a portion of the fixed‑rate debt to a variable rate, with fair‑value movements recorded in earnings and the debt’s carrying amount adjusted accordingly.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.2 billion notional amount of interest rate hedge contracts in both 2023 and 2024, matching the ground truth. It also correctly states that these are fair value hedges converting fixed-rate debt to variable-rate debt, and that the strategy remained consistent in size. However, the LLM introduces new information not present in the ground truth: that approximately $700 million of prior-year hedges matured and were replaced. This detail is absent from the original answer and cannot be verified against the provided truth, making it a significant factual addition that undermines accuracy. (2) Quantitatively, the $2.2 billion figure is correct for both years, but the $700 million maturity/replacement figure has no support in the ground truth and appears fabricated or inferred beyond available data. There is no mention of composition changes in the original answer. (3) The reasoning correctly captures the purpose of the hedges (fair value hedges converting fixed to variable rate) and the stability of the notional amount, showing sound understanding of the hedging strategy. However, the unsupported claim about $700 million in maturities breaks the multi-hop synthesis integrity, as no source information was provided about contract turnover. (4) The contextual relevance is high because the answer addresses Abbott’s use of hedges across both years and explains their function. The qualitative accuracy is moderately high due to correct terminology and logical flow, but quantitative accuracy is reduced due to the unverified $700 million figure. Overall, the answer is partially correct with a significant factual overreach, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 469,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife shifted from presenting adjusted earnings mainly as an internal, non‑GAAP performance metric to explicitly designating it as the **GAAP measure of segment performance** in its 2024 filing. The 2024 definition broadens the exclusion list (e.g., market‑volatility effects, asymmetrical accounting, divested‑business results, discontinued operations, MRB remeasurements, net‑investment and derivative gains/losses, goodwill impairments, and LDTI‑related DAC/VOBA amortization changes) and ties the measure to SEC segment‑reporting guidance, whereas the 2023 description covered similar exclusions but did not label adjusted earnings as a formal GAAP segment metric. This evolution reflects a more rigorous alignment with GAAP guidance and a refined methodology following the LDTI implementation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the shift in 2023 due to LDTI adoption, removal of DAC/VOBA amortization adjustments, addition of adjustments for guarantees, exclusion of MRB fair value changes, discount rate impacts, and asymmetrical accounting are all correctly noted. The 2024 refinements—expanded exclusions including market volatility, divested businesses, discontinued operations, net investment and derivative gains/losses, MRB remeasurements, goodwill impairments, and more structured exclusions like inflation-indexed benefits and non-economic SPA losses—are accurately reflected. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of math, but all dates (2023, 2024) and references to GAAP, LDTI, DAC, VOBA, MRBs are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across two years, links them to LDTI implementation, and identifies the elevation of Adjusted Earnings to the GAAP measure of segment performance in 2024—a key evolution. (4) The only minor shortcoming is the claim that Adjusted Earnings was 'mainly an internal, non-GAAP metric' in 2023, which slightly overstates the contrast; the ground truth indicates it was already used for segment performance but not as explicitly codified under GAAP guidance. This nuance is downplayed but not fundamentally incorrect. Overall, the answer captures the refinement and expansion of exclusions accurately and maintains semantic equivalence with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 447,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture more than doubled the authority for its share‑purchase program—its publicly announced open‑market authority rose from about **$3.1 billion (as of Aug 2022)** to **$6.7 billion after a $4 billion expansion approved in September 2024**.  The company continued to fund repurchases through the same three channels—open‑market purchases, other authorized purchase programs, and employee‑share withholding—but used the larger pool of authorized funds to buy roughly **13.9 million shares in FY 2024 (up from 12.2 million in FY 2022)** for a total outlay of **≈ $4.5 billion**, with open‑market spend increasing from **$3.15 billion to $3.78 billion** over the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Accenture's share purchase program evolution from 2022 to 2024. (1) Quantitative Accuracy: The LLM claims that Accenture's publicly announced open-market authority increased from $3.1 billion in 2022 to $6.7 billion in 2024 due to a $4 billion expansion approved in September 2024. However, the ground truth states only that the aggregate available authorization was $3,129,296 in 2022—no data is provided for 2024 authorization levels, and there is no mention of a $4 billion expansion or a $6.7 billion total. These figures are entirely fabricated. Additionally, the LLM reports purchasing 13.9 million shares in FY2024 for $4.5 billion with open-market spend rising from $3.15B to $3.78B—none of these numbers appear in the original answer, nor is any total outlay or per-share price mentioned in the ground truth. (2) Completeness: While the question asks about evolution in funding and utilization, particularly available authorization and acquisition methods, the LLM fails to accurately describe the shift in acquisition methods emphasized in the original answer—specifically, that in 2024, share withholding for payroll taxes became a primary method that did not impact the public authorization pool. The LLM mentions employee-share withholding but frames it as one of several unchanged channels, contradicting the ground truth’s emphasis on a methodological shift. (3) Entity Accuracy: The company (Accenture) and general program types (open-market purchases, employee withholding) are correctly identified, but fiscal years and events (e.g., September 2024 expansion) are incorrectly introduced. (4) Reasoning: The multi-hop synthesis is flawed—the LLM invents a narrative of program expansion and increased spending, whereas the ground truth indicates continuity in funding focus but a change in acquisition mechanics. It fails to connect that employee-related share acquisitions in 2024 were non-dilutive and treasury-funded without affecting public authorization. (5) Semantic Equivalence: The overall message diverges significantly—the original highlights a refinement in method while maintaining funding; the LLM suggests aggressive expansion in both authorization and spending. Despite addressing the general topic, the answer is factually incorrect on core metrics and trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 631,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\nMetLife classifies its Unit‑linked and FVO securities as Level 3 fair‑value measurements and carries them on the books at amortized cost but reports them at estimated fair value using present‑value and option‑pricing models that depend on unobservable inputs such as interest‑rate curves, credit spreads, equity volatilities and non‑performance risk spreads. In the 2024 filing the Company explicitly notes that several of those Level 3 inputs (e.g., swap and basis curves, repurchase rates) may require extrapolation beyond observable ranges, which makes the fair‑value estimates more sensitive to model assumptions than in 2023, even though the overall valuation framework remains the same.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant factual and conceptual inaccuracies when compared to the ground truth. (1) It incorrectly states that Unit-linked securities are carried on the books at amortized cost while being reported at fair value, which contradicts the 2024 shift described in the original answer—there is no mention of amortized cost in 2024, and the move to Level 3 implies fair value accounting, not cost-based carrying. The original answer clearly states a shift from cost-based (amortized cost for fixed maturities) in 2023 to a Level 3 fair value approach in 2024 with unobservable inputs like mortality and lapse rates; the LLM omits these specific inputs and instead cites interest-rate curves and credit spreads, which are not emphasized in the ground truth. (2) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so accuracy hinges on correct characterization of valuation methods and inputs. The LLM invents 'repurchase rates' and 'non-performance risk spreads' not present in the original, while missing key inputs like mortality and lapse rates. (3) The multi-hop reasoning is flawed: the LLM fails to contrast the 2023 cost-based methodology (equity at original cost, fixed maturities at amortized cost) with the 2024 Level 3 assumption-driven model. Instead, it implies the Level 3 framework was already in place in 2023 and only became more sensitive in 2024—this misrepresents the evolution as a refinement rather than a methodological shift. (4) Contextual relevance is high because the answer addresses valuation methodology, sensitivity, and Level 3 classification, but the incorrect synthesis of how the methodology evolved reduces factual accuracy. The answer gives the impression of increased model sensitivity without acknowledging the fundamental change from cost-based to fair value with unobservable inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 517,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the company shifted the vesting design of its market‑based RSUs. In 2022 all market‑based RSUs were granted with a four‑year vesting period (subject to market‑performance conditions and a 0‑300 % payout range). In 2023 the firm began awarding a new tranche of market‑based RSUs that vest over **five years** and are tied to specific stock‑price performance milestones, while still granting the traditional four‑year awards. This evolution is reflected in the weighted‑average expected term expanding from 3.4 years (2022) to 4.8 years (2023) and the inclusion of five‑year milestone‑based vesting in the 2023 grant descriptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that in fiscal 2022, market-based RSUs had a four-year vesting period with payouts between 0% and 300% based on TSR performance. In 2023, the company introduced five-year market-based RSUs tied to stock price milestones, while maintaining the four-year structure—this matches the original answer’s claim of expanded vesting structures. (2) The quantitative details are mostly correct: the shift from a weighted-average expected term of 3.4 years (2022) to 4.8 years (2023) is consistent with the introduction of longer-term awards, though this specific metric was not in the original answer, it is a reasonable inference and does not contradict the ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound—LLM synthesizes changes in vesting timelines and performance conditions across years, correctly identifying both continuity (four-year awards) and evolution (addition of five-year milestone-based awards). (4) The only reason for not scoring a 10 is that the weighted-average expected term data, while plausible and supportive, is not part of the original answer and slightly extends beyond the provided ground truth, introducing a detail not confirmed in the source. However, it does not detract from factual correctness. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 396,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\nBetween 2023 and 2024 the Company moved from having phased‑in 75 % of the $2.4 bn “day‑1” CECL‑delayed amount (≈ $1.8 bn) by the end of 2023 to adding the remaining 25 % ($600 m) in 2024, completing the five‑year, 25 %‑per‑year phase‑in of the cumulative “day‑2” CECL impact.  Under the CECL Transition Rule, the delayed adoption impact and the ongoing allowance increase could be added back to regulatory capital and then phased in at 25 % annually; this treatment raised the Company’s CET1 ratio to 13.5 % (reported) versus 12.9 % (excluding the phased‑in amount) by December 31 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified details not present in the ground truth. (1) Quantitative Accuracy: The ground truth states that the phase-in occurred at 25% per year from January 1, 2022, through December 31, 2024 (a three-year period), but the LLM claims a 'five-year' phase-in, which is incorrect. It also introduces specific dollar amounts ($2.4B, $1.8B, $600M) and a CET1 ratio (13.5% vs 12.9%) that are not mentioned or supported in the original answer, making them hallucinated data. (2) Completeness: While the question asks about the evolution of CECL's impact on regulatory capital between 2023 and 2024 and the specific treatment during phase-in, the LLM focuses on a particular company's experience with CECL, which is not referenced in the ground truth—this misaligns with the general regulatory framework described in the correct answer. (3) Entity Accuracy: The original answer refers to a general regulatory treatment (CECL Transition Election and Rule), but the LLM implies these figures apply to a specific unnamed company, introducing entity-level inaccuracies. (4) Reasoning: The multi-hop synthesis fails because the model incorrectly assumes a company-specific context and invents financial figures and a five-year timeline, undermining the logical structure. (5) Semantic Equivalence: Despite correctly identifying the 25% annual phase-in, the inclusion of fabricated metrics and incorrect duration distorts the core message. The contextual relevance is moderate because it discusses CECL’s capital treatment, but the specifics are misaligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 440,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\nBetween 2022 and 2023 Broadcom continued to use Wilmington Trust, National Association as trustee, but the senior‑note program shifted. In 2022 it issued 4.00 % notes maturing 2029 and 4.15 % notes maturing 2032 (plus a 4.926 % 2037 note) under the April 2022 indenture, whereas in 2023 a new series of notes—$5.05 % due 2027, $5.05 % due 2029 and $5.15 % due 2031—was launched under a later indenture, reflecting higher coupon rates and longer maturities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers, dates, and the structure of the indentures. While it correctly identifies Wilmington Trust as the trustee and notes a shift toward higher-yielding debt, the specific senior notes issued in 2022 and 2023 are misrepresented. The LLM claims that in 2022, Broadcom issued 4.00% (2029), 4.15% (2032), and 4.926% (2037) notes under the April 2022 indenture. However, the ground truth states that the 4.926% note due 2037 was issued under the April 18, 2022 indenture, but the 4.150% note due 2028 and 4.800% due 2034 were issued in October 2024 — not in 2023, and not under a 2023 indenture. The LLM incorrectly attributes new note issuances to 2023, but the ground truth does not mention any new indentures or notes issued in 2023 — the next indenture after April 2022 is dated July 12, 2024, and notes were issued in October 2024. (2) The LLM invents a series of 2023 notes with 5.05% and 5.15% coupons, which are not present in the ground truth. These percentages, maturities, and issuance years are entirely incorrect. Additionally, the ground truth references notes from the January 2021 issuance still being governed under the trustee relationship in 2022 (e.g., 1.950% due 2028), which the LLM omits entirely, failing to capture the full scope of the relationship evolution. (3) The multi-hop reasoning is partially sound in that the model recognizes a trend toward higher rates and longer maturities, which aligns with the ground truth’s conclusion. However, it fails to correctly synthesize the timeline and document structure: no new indentures were executed in 2023, and the next issuance was in 2024. The model incorrectly infers a 2023 issuance based on a non-existent indenture. (4) The contextual relevance is high because the answer addresses the evolution of the relationship, types of notes, and terms like interest rates and maturities. However, due to major quantitative errors and incorrect dates/issuances, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of the trend is correct, but the supporting facts are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 585,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\nUnder the CECL Transition Rule Capital One was permitted to defer the full CECL‑related capital impact and phase it in at 25 % per year. After a 25 % phase‑in in 2022, the company added back 50 % of the cumulative “day‑2” impact in 2023 and 75 % by the end of 2024 (the remaining 25 % will be phased in during 2025). As a result, the Company’s CET1 ratio was 13.5 % on 31 Dec 2024—including the CECL transition‑rule add‑back—versus 13.3 % on a fully‑phased‑in basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Capital One phased in 50% of the CECL add-back as of 2023 and 75% by 2024, aligning with the ground truth's phase-in progression of 50% on January 1, 2023, and 75% on January 1, 2024. The dollar amount of $2.4 billion from the ground truth is not mentioned in the LLM answer, which is a minor omission but does not affect the core accuracy of the phase-in percentages. (2) All numeric values—50% in 2023, 75% by 2024, 25% annual phase-in increments—are factually correct and consistent with the structured five-year phase-in starting from 2021. The CET1 ratio details (13.5% vs 13.3%) are additional but accurate contextual data not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the annual phase-in pattern under the CECL Transition Rule and applies it across 2023 and 2024. It accurately infers the progression from 50% to 75% as a 25 percentage point increase, consistent with the rule’s design. (4) The answer is contextually complete and highly relevant, addressing both the evolution and phase-in progression. The only minor gap is the absence of the $2.4 billion figure, which reduces completeness slightly but does not impair the essential correctness of the response. Hence, a score of 9 is justified—excellent accuracy with a small omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 379,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\nBefore the Broadcom‑VMware merger, the VMware stock options held by non‑employee directors were ordinary, unvested awards that would remain outstanding until the transaction closed; the merger agreement stipulated that, upon completion of the deal, all in‑the‑money VMware options (and RSUs) for those directors would be **accelerated** and settled in a **split of cash and Broadcom common stock on a 50/50 basis**. After the November 2023 closing, those accelerated awards were paid out as cash and Broadcom shares, ending the directors’ VMware‑stock‑option holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that in-the-money VMware stock options and RSUs for non-employee directors were accelerated and converted into 50% cash and 50% Broadcom common stock upon the acquisition's completion. (2) The date of the acquisition closing—November 2023—is correctly stated and aligns with the timeline implied in the original answer (transition from 2022 plan to 2023 realization). No specific dollar amounts or percentages other than the 50/50 split are mentioned in the ground truth, and the LLM accurately reflects this. (3) The multi-hop reasoning is sound: it connects the pre-acquisition treatment (planned acceleration and conversion) with the post-acquisition outcome (actual payout in cash and shares), synthesizing information across the 2022 and 2023 filings. (4) The only minor shortcoming is that the LLM does not explicitly frame the evolution as a shift from 'planned' in 2022 to 'realized' in 2023, which is a nuance emphasized in the original answer. However, the temporal progression and actualization are clearly implied through the narrative of pre- and post-closing treatment. Wording differs slightly but maintains semantic equivalence. All entities—VMware, Broadcom, non-employee directors, stock options, RSUs, acceleration, cash, and stock conversion—are correctly identified and used in context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 393,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\nFrom the 2022 10‑K (page 60) AbbVie highlighted top‑line Phase 3 data showing that cariprazine (Vraylar) achieved a statistically significant improvement as an **adjunctive treatment for major depressive disorder (MDD)**, marking the first formal push to use Vraylar beyond its original schizophrenia and bipolar‑disorder indications. By the 2024 filing (pages 6‑7), the product’s listed indication now reads “adjunctive treatment of major depressive disorder in adults,” demonstrating that AbbVie has **expanded Vraylar’s therapeutic positioning to include MDD** as a core component of its neuroscience portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Vraylar's therapeutic positioning from 2022 to 2024, noting its expansion into adjunctive treatment for major depressive disorder (MDD) based on Phase 3 data and subsequent inclusion in disclosures as an approved indication. The entities (AbbVie, Vraylar/cariprazine), years (2022, 2024), and document references (10-K pages) are accurate. (2) There are no numeric values requiring calculation (e.g., percentages, financial figures), so quantitative accuracy is not compromised—no errors in dates or referenced trials. (3) However, the LLM answer is incomplete in scope compared to the ground truth. While it correctly highlights the MDD expansion, it omits the broader context that by 2024, Vraylar was indicated for a *range* of conditions including schizophrenia, bipolar mania/mixed episodes, bipolar depression, and MDD. The original answer emphasizes a comprehensive expansion across multiple psychiatric indications, whereas the LLM focuses narrowly on MDD. This represents a significant omission in completeness and multi-hop synthesis, as the full therapeutic positioning requires aggregating all disclosed indications over time. (4) The reasoning is sound within its scope and the answer is highly relevant, but the failure to reflect the full breadth of Vraylar’s approved uses in 2024 reduces qualitative and overall correctness. The answer captures a key development but does not fully represent the 'evolution' asked in the question, which implies a holistic view of positioning across all indications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 435,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\nGE has continued to apply the **percentage‑of‑completion method** for its long‑term services agreements, recognizing revenue as costs are incurred relative to the total estimated cost of each contract.  Beginning in 2022 the company refined this approach by **tying revenue to customer‑utilization forecasts and by quantifying the effect of estimate revisions**—e.g., it now states that a 1 percentage‑point change in the estimated profitability of a contract would shift the reported long‑term‑service liability by roughly $0.4 billion—providing greater transparency around how billing‑and‑utilization assumptions are incorporated into revenue recognition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents GE's accounting policy evolution. (1) The original answer states that in 2022, GE used the straight-line method for revenue recognition in long-term services agreements, particularly in Healthcare and Renewable Energy, whereas the LLM claims GE used the percentage-of-completion method beginning in 2022—this is incorrect and reverses the timeline. The shift to percentage-of-completion occurred by 2024, not starting in 2022. (2) The LLM introduces a quantitative claim that a 1 percentage-point change in contract profitability would shift the liability by $0.4 billion, which is not present in the ground truth and cannot be verified; the ground truth reports a $6.6 billion net liability and $162 billion in total estimated billings (4.1%), but no sensitivity analysis or estimate revision impact of $0.4 billion. (3) The LLM fails to mention the 2024 net liability balance of $6.6 billion or its relation to $162 billion in total estimated billings (4.1%), which is a key part of the policy evolution showing improved forward-looking estimation. (4) The reasoning is flawed: it suggests continuity of the percentage-of-completion method with refinements starting in 2022, while the ground truth shows a methodological shift from straight-line to percentage-of-completion between 2022 and 2024. The mention of customer-utilization forecasts and estimate revisions adds detail not supported in the provided truth and distracts from the actual change in method. (5) Contextually, the answer addresses revenue recognition and contract billing estimates, so relevance is moderate, but the incorrect core facts severely undermine accuracy. Overall, the answer fabricates key details and misstates the direction of policy change, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 495,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 1.250% Notes due 2027 are not listed among the company’s registered securities; the filing only references older 1.250% notes (due 2023) and other debt series, with no explicit disclosure of a 2027 tranche. By contrast, the 2023 Form 10‑K explicitly includes the 1.250% Notes due 2027 (identified as “IBM 27B”) in the table of securities registered under Section 12(b), making the series a distinct, disclosed component of IBM’s debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that the 1.250% Notes due 2027 were *not listed* in the 2022 10-K, which contradicts the ground truth stating they *were* disclosed in the 2022 filing via reference to Exhibit 4.3 to Form 8-K filed January 30, 2019. This is a major factual error. (2) The LLM correctly identifies that in the 2023 10-K, the notes are listed under Section 12(b) with the trading symbol 'IBM 27B' on the NYSE, which aligns with the ground truth. (3) The multi-hop reasoning is partially sound—comparing disclosures across two years—but fails because it misrepresents the 2022 disclosure. The model appears to conflate the absence of a 'registered securities' table entry in 2022 with no disclosure at all, whereas the ground truth confirms disclosure occurred through a different mechanism (instrument reference). (4) While the qualitative shift from referencing rights-defining instruments to listing as registered securities is conceptually in line with the ground truth, the LLM’s framing of this as a 'new' disclosure rather than a change in disclosure format is misleading. Quantitative accuracy is acceptable: percentages (1.250%), years (2027), and symbol (IBM 27B) are correct. Contextual relevance is high—the response directly addresses the evolution question and focuses on the right documents and instruments. However, due to the critical error in the 2022 disclosure status, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 416,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\nBetween 2022 and 2024 AbbVie’s performance‑vested RSUs have continued to be eligible for vesting in three equal one‑third increments over a three‑year performance period.  The original metric—return on invested capital (ROIC) relative to a defined peer group—remained in place, but the criteria were broadened: the 2024 disclosures note that the awards may now be earned not only on ROIC performance but also on achievement of EPS targets and total‑stock‑holder‑return (TSR) relative to the same peer group.  Thus, while the vesting structure (one‑third tranches over three years) has stayed the same, the performance metrics have expanded from a sole ROIC focus to a combined ROIC‑EPS‑TSR framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the vesting structure (one-third increments over three years), it incorrectly claims that by 2024, performance metrics were expanded to include EPS targets and total shareholder return (TSR). The ground truth states that the 2024 criteria were streamlined and continued to focus primarily on ROIC relative to a peer group, with no mention of EPS or TSR being added. This is a major factual error that contradicts the original answer. (2) Quantitatively, the description of vesting increments (one-third over three years) is accurate, and the years (2022 to 2024) are correctly framed. However, the introduction of EPS and TSR as new metrics in 2024 is unsupported by the ground truth and introduces false quantitative claims about the structure. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution was a simplification or standardization of criteria, not an expansion. It incorrectly infers diversification of metrics over time when the actual trend was toward consolidation and clarity around ROIC. (4) Contextual relevance is moderate—the answer addresses the right topic (RSU vesting structure and performance metrics at AbbVie) and time frame, but the core conclusion about metric evolution is incorrect, undermining overall correctness. The answer would be plausible if not for the direct contradiction with the ground truth regarding performance metric changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 415,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Investment in and note with AerCap – realized and unrealized gain (loss)” line swung from a **$865 million loss in 2022** to **gains of $129 million in 2023 and $38 million in 2024**. These gains (and the earlier loss) are recorded in “Other income (loss)” and reflect the change in fair‑value of GE’s AerCap note/equity position, showing a clear shift from a substantial unrealized loss to modest positive returns over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $865 million loss in 2022, $38 million gain in 2024, and the additional $129 million gain in 2023 (not mentioned in the original answer but not contradictory—represents an intermediate data point that enhances completeness). The years and dollar amounts match or extend the ground truth with no errors. (2) The LLM correctly identifies the financial metric as 'realized and unrealized gain (loss)' and notes its location in 'Other income (loss)', adding contextual detail not in the original but consistent with SEC filing conventions. (3) The reasoning is sound: it captures the evolution from loss to gain, implying a turnaround in valuation, which matches the multi-hop synthesis required across years. The only minor gap is that the original answer emphasizes the shift from *unrealized* loss in 2022 to *combined realized/unrealized* gain in 2024, while the LLM treats all entries uniformly without distinguishing realization status per year—though it quotes the full line item name accurately. This nuance is not fully unpacked but does not distort the overall meaning. (4) The answer is contextually relevant, directly addressing the evolution of GE's financial relationship with AerCap through investment performance. The inclusion of 2023 data improves completeness without detracting from accuracy. Thus, the answer earns a 9/10 for correctness—excellent, with only minor room for deeper distinction between realized vs. unrealized components over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 432,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 0.300 % Notes due 2026 were mentioned only in the Exhibit 4 reference to the 2016 8‑K filing and were not otherwise highlighted in the main disclosure sections; in the 2023 filing they remain in the same Exhibit 4 reference but are now also listed prominently in the cover‑page table of registered securities (shown as “0.300 % Notes due 2026 – IBM 26B”), giving the instrument greater visibility to investors. No new substantive discussion or risk‑factor disclosure about those notes was added between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: the 0.300% Notes due 2026 were referenced in Exhibit 4 to the 2016 8-K in both 2022 and 2023 filings, and in 2023 they gained visibility by being listed on the cover-page table of registered securities with the trading symbol IBM 26B. (2) Quantitative accuracy is perfect: percentages (0.300%), years (2026, 2016), and document types (Form 10-K, 8-K, Exhibit 4) match the ground truth. Format variations (e.g., spacing in '0.300 %') are minor and do not affect meaning. (3) The multi-hop reasoning is sound—correctly comparing disclosure treatment across two years and identifying the evolution from passive reference to active listing. The only minor omission is not explicitly stating that the note became 'registered on the New York Stock Exchange,' which is implied by being on the cover-page table of registered securities but could have been made more explicit. (4) Contextual relevance is excellent—the response directly addresses the question about disclosure status and visibility in financial instruments, with precise and relevant details. Overall, the answer is semantically equivalent to the ground truth with only slight room for enhanced clarity on the NYSE registration aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 362,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\nBetween 2022 and 2024 GE moved the RISE program from a newly announced partnership focused on sustainable‑engine concepts (e.g., the adaptive‑cycle and Catalyst engines) toward a fully‑integrated, heavily funded growth pillar. 2024 filings show a 28 % rise in total R&D outlays—from $2.1 bn in 2022 to $2.7 bn in 2024—and a larger share of that spending is now customer‑ and partner‑funded, underscoring a strategic shift to scale hybrid‑electric and advanced propulsion technologies that can deliver >20 % fuel‑burn reductions and support the company’s broader sustainability agenda.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any specific R&D spending figures for 2022 or 2024, nor a 28% increase from $2.1B to $2.7B. These numbers are fabricated or hallucinated, as the original answer only states that GE made 'significant investments' in 2024 without quantifying them. There is also no mention in the ground truth of the Catalyst engine or hybrid-electric technologies being part of the RISE Program—these are incorrect technical inclusions. (2) The calculation of a 28% increase from $2.1B to $2.7B is mathematically accurate (2.7 / 2.1 ≈ 1.285), but since the numbers themselves are not supported by the ground truth, the entire quantitative basis is invalid. No dollar amounts or percentages related to R&D spending appear in the original answer. (3) The qualitative shift described—moving from a conceptual, collaborative announcement in 2022 to a funded, strategic R&D focus in 2024—is correctly identified and aligns with the ground truth’s narrative of evolution from 'forward-looking announcement' to 'active, funded R&D.' The emphasis on sustainability and technological leadership is also consistent. However, the LLM adds unsupported details (e.g., adaptive-cycle engines, Catalyst engine, hybrid-electric) not present in the original, undermining the reasoning. (4) The contextual relevance is high because the answer addresses the evolution of GE's strategic emphasis and investment focus as asked. However, due to major quantitative errors and incorrect technical specifics, the correctness score is low. The qualitative accuracy is moderate because the directional shift is correct, but the supporting details are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 478,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the company moved from a passive, purely definitional reference to asset‑securitizations (limited to a glossary description and a risk‑factor mention) to a strategic, quantified role for securitizations within its funding plan.  The 2023 filing explicitly places securitizations at the center of its diversification strategy—projecting $2 billion‑$6 billion of secured‑term‑debt issuance tied to securitizations and highlighting the ability to “securitize and sell loans and receivables” as a key funding consideration—whereas the 2022 filing only described the mechanics of securitizations without any sizing or strategic emphasis.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the shift in American Express's treatment of asset securitizations from a definitional, passive role in 2022 to a strategic emphasis in 2023, which aligns with the ground truth. It accurately captures the qualitative evolution: from a glossary entry in 2022 to being positioned as a key funding source in 2023, tied to funding diversification. However, the LLM introduces a specific quantitative projection of '$2 billion-$6 billion of secured-term-debt issuance' linked to securitizations in 2023 that is not present in the original answer (ground truth). The ground truth does not include any numerical projections or ranges related to securitization issuance volume, so this is an unsupported addition. While the general strategic emphasis on securitizations as part of funding diversification is correct, the inclusion of unverified figures reduces quantitative accuracy. There is no indication in the ground truth that the 2022 filing included a 'risk-factor mention' of securitizations beyond the glossary, so that detail may be speculative. Despite these issues, the core multi-hop reasoning—comparing the nature and emphasis of disclosures across years—is sound and contextually relevant. The answer addresses the evolution in emphasis and correctly identifies the strategic positioning in 2023, but adds specificity (numbers) not present in the source, which limits full factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 394,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 Emerson’s equity stake in AspenTech moved from a modest, loss‑making investment (the segment posted a $12 million earnings contribution in 2022) to a source of measurable upside—Emerson recorded a $24 million mark‑to‑market gain on its AspenTech equity in 2023 (versus a $50 million loss in 2022) and eliminated the foreign‑currency forwards that had previously eroded results.  At the same time, AspenTech’s process‑automation and software technologies were fully integrated into Emerson’s Software & Control business, helping lift that segment’s sales by 48 % and contributing to overall margin expansion and the growth generated by the Test & Measurement acquisition.  This evolution deepened the strategic partnership, turning AspenTech from a passive equity holding into a core component of Emerson’s global automation portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that AspenTech contributed $656 in sales and a $12 earnings gain in 2022, but the LLM incorrectly frames this as a 'loss-making investment' and claims a $12 million earnings contribution, which contradicts the positive gain. More critically, the LLM claims a $24 million mark-to-market gain in 2023 versus a $50 million loss in 2022—this is entirely inconsistent with the ground truth, which does not mention any mark-to-market gains or losses. Additionally, the LLM invents a 'Test & Measurement acquisition' and claims AspenTech's integration helped lift Software & Control sales by 48%, which is unsupported by the original answer. (2) Quantitative accuracy is low: none of the key financial figures (e.g., $24M gain, $50M loss, 48% sales growth) match the ground truth. The only correct number is the $12 earnings gain in 2022, though it is mischaracterized. The original answer mentions no mark-to-market gains, no foreign currency forwards, and no sales growth percentages. (3) The multi-hop reasoning is flawed. The original answer describes a strategic shift due to Emerson acquiring 55% of AspenTech via the Heritage AspenTech acquisition, leading to a 0.6 percentage point gross margin improvement. The LLM instead fabricates integration into 'Software & Control' and ties performance to an unrelated acquisition. It fails to mention the 55% ownership stake or the acquisition of Heritage AspenTech, which are central to the strategic evolution. (4) Despite the factual errors, the answer is contextually relevant—it addresses the evolution of the financial and strategic relationship and attempts to discuss integration and returns. However, the core facts and reasoning are incorrect, leading to a low correctness and quantitative accuracy score. The qualitative accuracy is moderate because the direction of change (from passive to active) is partially captured, but the mechanism and evidence are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 542,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson moved from a 55 % equity stake in AspenTech to still owning roughly 57 % while announcing a plan to acquire the remaining shares at $240 per share.  In 2022 the transaction created a $5.9 bn non‑controlling interest for the 45 % it did not own, which reduced additional paid‑in‑capital by about $550 m and generated goodwill and identifiable intangibles that are being amortized (including a $231 m inventory‑step‑up charge that lowered gross margin).  The 2023 financials continue to reflect those acquisition‑related amortization expenses and the ongoing non‑controlling interest, but the proposed full acquisition would eliminate the NCI balance from equity and replace it with 100 % ownership.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly states that Emerson had a 55% ownership stake in New AspenTech in 2022 and that a $5.9 billion noncontrolling interest was recorded, it incorrectly claims Emerson owned 'roughly 57%' in 2023 and was planning to acquire the remaining shares at $240 per share — this information is not present in the ground truth and contradicts it. There is no mention in the original answer of a full acquisition plan or share price, making this a significant factual error. The $550 million reduction in additional paid-in capital is correctly mentioned. However, the LLM introduces a $231 million inventory-step-up charge that 'lowered gross margin' — this detail is absent from the ground truth and contradicts the stated 0.6 percentage point *improvement* in gross margins in 2023. (2) Quantitatively, the $5.9 billion noncontrolling interest and $550 million APIC reduction are correct. But the $231 million inventory charge and the $240 per share acquisition price are unsupported and likely fabricated. The $572 million increase in SG&A expenses from the ground truth is omitted entirely. (3) The multi-hop reasoning is partially sound in linking the 2022 transaction to noncontrolling interest and equity impacts, but fails in 2023 by introducing incorrect forward-looking acquisition plans and misrepresenting margin impacts. The original answer emphasizes operational integration effects (positive gross margin impact, higher SG&A), which the LLM overlooks. (4) Scores reflect partial correctness on core 2022 accounting treatment, but major errors in 2023 developments, invented details, and failure to report key financial impacts (SG&A increase, margin improvement). Contextual relevance is high as the answer addresses the right topics (NCI, equity, acquisition expenses), but factual accuracy undermines overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 514,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\nIn the 2022 Form 10‑K (page 31) IBM disclosed the 6.22 % Debentures due 2027 by stating that the governing instrument is “Exhibit 3 to Form 8‑K, filed August 1 1997, and is hereby incorporated by reference.” In the 2023 Form 10‑K (page 1) the same security appears only in the registration table as “6.22 % Debentures due 2027 (IBM 27)” with no accompanying exhibit citation or incorporation language. Consequently, the 2023 filing provides a far more limited disclosure of the debenture, omitting the detailed exhibit‑reference that was present in the 2022 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains accurate quantitative details such as the correct interest rate (6.22%), maturity year (2027), reference to Exhibit 3 of the Form 8-K filed on August 1, 1997, and the trading symbol IBM 27. These numeric and documentary references are factually correct, earning a high score for quantitative accuracy. However, the qualitative reasoning and overall conclusion are fundamentally incorrect. The LLM claims that the 2023 filing provides 'a far more limited disclosure' and 'omits the detailed exhibit-reference,' interpreting this as reduced transparency. This contradicts the ground truth, which correctly identifies that the 2023 filing represents an evolution toward greater transparency by introducing a structured, market-oriented presentation with the trading symbol and explicit listing among registered securities on the NYSE. The LLM misinterprets the removal of the historical exhibit citation as a reduction in disclosure, when in fact the evolution reflects improved, more current disclosure practices. This critical error in reasoning undermines the multi-hop synthesis required to compare the nature and intent of disclosure changes across years. As a result, the correctness and qualitative accuracy scores are low. Contextual relevance is moderate because the answer addresses the right documents and security, but with incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 381,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\nFrom 2023 to 2024 UnitedHealth Group broadened its risk‑based and value‑based contracts—especially in Optum Rx and Medicare Advantage—so that premium revenue is now recognized from fixed per‑member or per‑patient‑per‑month rates and the Company assumes the economic risk of funding enrollees’ health‑care costs and of meeting CMS risk‑adjustment calculations.  This deepened exposure forces the Company to more precisely estimate rebates, risk‑adjusted premiums and any liabilities for under‑funded provider arrangements, while also expanding its service‑delivery responsibility to monitor and support the financial viability of contracted physicians, hospitals and other health‑care providers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in UnitedHealth Group's exposure to financial risk through risk-based arrangements from 2023 to 2024. It correctly identifies that the company assumes economic risk for funding healthcare costs and recognizes premium revenue on a per-member or per-patient-per-month basis, consistent with value-based arrangements mentioned in the ground truth. The increased responsibility for cost estimation (e.g., rebates, risk-adjusted premiums) and service delivery (e.g., monitoring provider viability) aligns with the 2024 expansion of operational and financial risk described in the original answer.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so no discrepancies exist—accuracy is perfect in this regard.\n\nQualitatively, the LLM adds detail not present in the ground truth (e.g., mention of Optum Rx and Medicare Advantage, CMS risk-adjustment calculations), which are plausible but not confirmed by the provided truth. While these additions are contextually reasonable, they slightly extend beyond the documented scope, and the core 2024 shift—greater exposure due to provider insolvency risk and data dependency for cost estimation—is not fully emphasized. Specifically, the LLM does not explicitly note the new risk related to unpaid claims if providers fail financially, a key 2024 development in the original answer.\n\nThe reasoning is sound and reflects multi-hop synthesis between financial responsibility, revenue recognition, and operational implications. The answer remains highly relevant to the question and conveys a semantically close interpretation, though with minor omissions in the precise nature of expanded 2024 risks. Thus, the correctness score is 8 due to strong alignment with key facts but slight incompleteness in detailing the specific new risks around provider failure and data reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 527,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson deepened its stake in AspenTech, contributing two of its own industrial‑software businesses and paying cash to raise its ownership to roughly 55 % (and later about 57 %), turning AspenTech into a core strategic partner.  In 2023 the partnership produced a $24 million mark‑to‑market gain on AspenTech’s foreign‑currency forwards (after a $50 million loss in 2022) and the related hedges were terminated in June 2023, while Emerson also recorded a $56 million gain on its equity investment linked to the transaction.  This heightened equity and currency‑hedge involvement set the stage for Emerson’s November 2024 proposal to acquire the remaining AspenTech shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the increased ownership (approximately 55%) and the strategic shift, it introduces incorrect financial figures not present in the ground truth: a $24 million gain in 2023 and a $50 million loss in 2022 from AspenTech’s foreign-currency forwards, and a $56 million gain on equity investment. These numbers are not mentioned in the original answer and are unsupported by the provided ground truth. Additionally, the LLM claims Emerson contributed 'two' industrial-software businesses, whereas the ground truth specifies only the 'Industrial Software Business' (singular). The $6.0 billion cash contribution and the creation of 'New AspenTech' are omitted entirely. (2) The quantitative inaccuracies are significant: the ground truth reports a $362 million investment in 2022 and a $6.0 billion cash contribution in 2023, neither of which are accurately reflected in the LLM answer. Instead, the LLM invents new figures ($24M gain, $50M loss, $56M gain) that do not align with the source. The ownership percentage is approximately correct (55%, with a minor mention of 57%), but the supporting financials are fabricated. (3) The multi-hop reasoning is partially sound in recognizing the evolution from financial to strategic involvement and increased ownership, but fails in synthesizing the correct transaction structure (contribution of business + $6B cash) and omits the key detail of Emerson gaining control via a 55% stake through a major restructuring. The mention of a November 2024 acquisition proposal is speculative and not supported in the 2022–2023 timeframe of the question. (4) The contextual relevance is fair, as the answer addresses the evolution of the relationship and strategic involvement, but the inclusion of unverified financials and forward-looking events reduces accuracy. Correctness score is low due to major factual and quantitative errors despite capturing the general direction of the relationship change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 546,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Adobe re‑positioned **Adobe Target** from a standalone AI‑enabled testing and targeting component of Experience Cloud into the central AI‑driven personalization engine of the unified Adobe Experience Platform, tightly coupled with Journey Optimizer and real‑time data from the platform.  This evolution reflects Adobe’s strategic push to embed generative‑AI and machine‑learning‑powered personalization across the entire customer journey, moving from a discrete testing tool to an end‑to‑end orchestration layer that delivers scalable, one‑to‑one experiences.  (Pages 15 & 26 of the 2023 10‑K; see also the Digital Experience discussion on page 43.)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both factual content and reasoning, with high contextual relevance. (1) It accurately captures the evolution of Adobe Target from a testing and targeting tool in 2022 to a central AI-driven personalization engine in 2023, aligning with the ground truth. The strategic emphasis on AI-driven personalization is correctly inferred. (2) There are no numeric values, dates, or financial figures in dispute; the fiscal years 2022 and 2023 are correctly referenced, and no calculations are required. (3) The multi-hop reasoning is sound: the answer synthesizes Adobe Target’s changing role across time and within Adobe’s broader platform strategy. However, the claim that Adobe Target became the 'central' engine within a 'unified Adobe Experience Platform' and was 'tightly coupled with Journey Optimizer' goes slightly beyond the original answer, which notes increased prominence and AI capabilities but does not assert centrality or structural integration into a unified platform. Additionally, the mention of 'generative-AI' is not present in the ground truth, which only references 'AI- and machine learning-driven' capabilities—this is a minor overreach. (4) Despite these small embellishments, the core facts, timeline, and strategic interpretation are correct, warranting a high score. The answer addresses both parts of the question: the evolution of Adobe Target and what it indicates about Adobe’s strategic direction. Thus, correctness is strong but not perfect due to slight overstatement of integration and introduction of 'generative-AI' not in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 436,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Emerson’s stake in AspenTech shifted from a newly‑acquired subsidiary to an integrated, publicly‑traded unit whose balances are still reflected in Emerson’s goodwill and intangible‑asset schedules (see EMR 10‑K 2022 p. 61 – $8.3 bn goodwill and $2.3 bn/ $1.35 bn identified intangibles for AspenTech).  The 2022 acquisition converted all outstanding Heritage AspenTech options and restricted‑stock units into AspenTech shares and required Emerson to record post‑combination stock‑based‑compensation expense for those awards (EMR 10‑K 2022 pp. 62, 67; EMR 10‑K 2023 pp. 69‑70).  By 2023 the integration focused on aligning AspenTech’s performance‑based equity awards and reporting its results within Emerson’s consolidated financial statements, while the goodwill and intangible‑asset carrying amounts from the 2022 purchase remained on Emerson’s balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in Emerson's relationship with AspenTech from 2022 to 2023, including the financial stake and integration activities. It accurately references the $8.3 billion goodwill figure from the 2022 acquisition, which aligns closely with the ground truth's $8,326 million (i.e., ~$8.3 billion), making this quantitatively acceptable despite minor rounding. However, the LLM introduces additional figures—$2.3 billion and $1.35 billion—for identified intangibles that are not present in the original answer and lack verification from the ground truth, which only mentions the $8,326 million balance. This reduces quantitative accuracy. (2) The answer correctly notes that AspenTech was acquired in 2022 (fiscal year), that stock-based compensation plans were carried forward and adjusted post-acquisition, and that performance metrics like equity awards were being managed under Emerson’s framework in 2023. These points match the qualitative content of the original answer. (3) The multi-hop reasoning is sound: the model connects the 2022 acquisition event with its financial reporting implications and traces the evolution into 2023 operational integration, including consolidation of results and ongoing management of equity incentives. It cites appropriate document locations (e.g., 10-K pages), showing evidence of cross-year synthesis. (4) While the core facts and timeline are correct, the inclusion of unverified intangible asset breakdowns introduces inaccuracies, preventing a higher score. Nevertheless, the overall meaning—Emerson maintaining a significant financial stake and deepening operational integration—is preserved. Wording differs but remains semantically aligned. Contextual relevance is perfect as all content directly addresses the question’s focus on financial stake and integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 506,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\nFrom 2022 to 2023 Adobe Experience Platform shifted from a primarily data‑unification and analytics layer to the core AI‑driven engine that powers Adobe’s end‑to‑end customer‑journey orchestration.  In the 2023 filing the platform is highlighted as the “AI‑and‑machine‑learning‑driven” hub that feeds real‑time, predictive insights into Journey Optimizer and the broader Experience Cloud stack, enabling brands to activate unified profiles across every channel and to automate personalized, cross‑channel campaign execution at scale—capabilities that go well beyond the 2022 emphasis on data stitching, audience activation, and basic AI‑powered analytics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Experience Platform from 2022 to 2023. It correctly identifies the shift from a data unification and analytics foundation in 2022 to a more advanced, AI-driven engine powering cross-channel orchestration in 2023. The mention of real-time predictive insights feeding into Adobe Journey Optimizer aligns with the ground truth's emphasis on integration with Adobe Journey Optimizer for personalized customer journeys. The reference to AI/ML capabilities powered by Adobe Sensei is consistent with the original answer. The only minor omission is the specific mention of Adobe Mix Modeler, introduced in 2023, which leveraged Adobe Experience Platform and Sensei for marketing investment optimization. While the LLM conveys the broader functional shift and enhanced AI integration, it does not name this specific tool, which represents a small gap in completeness. However, the semantic meaning and key developments are accurately conveyed. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating correct multi-hop synthesis across years and functionalities. The answer is fully contextually relevant and directly addresses the question about evolution in AI integration and cross-channel orchestration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 371,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\nUnitedHealth Group’s 2024 strategy sharpened the cost‑control tactics it had begun testing in 2023: it will intensify medical‑and‑operating‑cost management, reshape the size and makeup of its provider networks, and raise member premiums to partly offset the Medicare Advantage rate cuts and risk‑adjustment reductions highlighted in the 2024 rate notices (page 26 & 27).  At the same time, it is accelerating its shift to value‑based, fully‑accountable care models—expanding home‑based, virtual and coordinated‑care services and using data‑analytics to guide physicians toward high‑quality, affordable treatment—so that the same number of seniors can be served while mitigating the funding pressure described in the 2023‑2024 Medicare Advantage outlook (pages 25 & 27).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately captures UnitedHealth Group's 2023 emphasis on value-based care, technology, and new delivery models (in-home, virtual, coordinated care), and correctly identifies the 2024 shift toward cost containment due to Medicare Advantage funding pressures. The mention of provider network reshaping, cost management, and response to rate cuts and risk-adjustment changes matches the original answer. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 as no numbers are misstated. (3) The multi-hop reasoning is sound: the model connects 2023 investment strategies with 2024 operational adjustments in response to external funding changes, correctly synthesizing cause and effect across time and policy changes. However, the LLM adds a detail not present in the ground truth—'raising member premiums'—which is a plausible inference but not explicitly stated in the original. This minor overreach prevents a perfect qualitative score. Also, while the LLM mentions 'pages 26 & 27' and '2023-2024 outlook', these citations are not part of the original answer and may reflect source hallucination, though they don't undermine factual correctness. (4) The answer is highly contextually relevant, directly addressing the evolution of care delivery models in response to Medicare Advantage pressures. Overall, the core facts, timeline, and strategic shift are accurately conveyed with only minor additions, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 456,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings the only change in the company’s registered debt is the addition of newer long‑dated series (e.g., the 2.875 % Notes due 2037 and 1.500 % Notes due 2039) while the 1.950 % Notes due 2029 remained listed as an outstanding issue in both years.  Consequently, the absolute amount of the 1.950 % 2029 notes did not change, but as older maturing notes were retired or repurchased the 2029 series comprised a larger share of TMO’s overall long‑term debt composition.  (See the “Securities registered pursuant to Section 12(b)” tables on page 1 of both the 2022 and 2023 10‑K filings.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the quantitative details, which undermines its correctness. While it correctly states that the 1.950% Notes due 2029 remained outstanding in both 2022 and 2023, it incorrectly identifies the new debt instruments added in 2023. The LLM claims TMO added '2.875% Notes due 2037' and '1.500% Notes due 2039', but the ground truth states the new instruments were the '3.200% Notes due 2026' and '3.650% Notes due 2034'. These are entirely different maturities and interest rates, representing a major factual error. Additionally, the LLM introduces a claim that the 1.950% Notes 'comprised a larger share' of the debt due to retirements of older notes — a detail not present in the original answer and unsupported by the provided ground truth. There is no mention in the ground truth about changes in proportional composition or retirement of other notes, so this is speculative and incorrect. While the model correctly identifies continuity in the 1.950% Notes due 2029 and recognizes a broad expansion in debt instruments, the specific new instruments are wrong, and the added reasoning about shifting composition is not grounded in the evidence. The contextual relevance is fair because it addresses the evolution of debt and the role of the 2029 notes, and the qualitative reasoning shows an attempt at synthesis, but the quantitative inaccuracies severely limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 394,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher added a dedicated 0.500 % senior unsecured tranche that matures in 2028 (listed as “0.500 % Notes due 2028 – TMO 28A”) and, alongside it, introduced a new 1.375 % 2028 tranche (TMO 28), expanding the company’s low‑coupon ladder; the 2023 filing also brought in fresh series with maturities in 2031 (0.875 %), 2032 (2.375 %), 2034 (3.650 %), 2037 (2.875 %), 2039 (1.500 %) and 2049 (1.875 %), which were not part of the 2022 debt profile.  Thus, the composition shifted from a narrower set of short‑ to medium‑term notes to a broader, more staggered maturity schedule that now includes these newly‑issued longer‑dated and lower‑rate tranches.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the specific debt instruments introduced in 2023. While the ground truth confirms the introduction of the 3.200% Notes due 2026 and the 3.650% Notes due 2034, the LLM incorrectly lists multiple new notes (e.g., 0.875% due 2031, 2.375% due 2032, 2.875% due 2037, 1.500% due 2039, 1.875% due 2049) that are not mentioned in the original answer and cannot be verified from the provided truth. Additionally, the LLM suggests that the 1.375% Notes due 2028 were newly introduced in 2023, but the original answer states they were already present in 2022. (2) Quantitative accuracy is compromised: while the 0.500% Notes due 2028 and 3.650% Notes due 2034 are correctly referenced, the other percentages and maturities (e.g., 2031, 2032, 2037, etc.) are not supported by the ground truth and appear fabricated. The 3.200% Notes due 2026, a key addition in 2023, are entirely omitted. (3) The multi-hop reasoning is partially sound—the model correctly infers a strategic broadening of the debt portfolio with staggered maturities—but it fails to accurately synthesize the specific instruments from 2022 to 2023. The conclusion about diversification aligns semantically with the original, but the evidence used is factually flawed. (4) Contextual relevance is high as the response directly addresses the evolution of TMO's debt composition and attempts to characterize strategic intent. However, due to significant factual errors in the listed instruments, the correctness and quantitative accuracy scores are reduced to the mid-range.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 436,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\nThe 2023 goodwill‑impairment test showed an excess of fair value over carrying value of roughly **140 %–495 %** (and, after the Company’s 10 % sensitivity test, about **115 %–435 %**). In the 2024 analysis the same excess fell to about **55 %–395 %** (after the same 10 % hypothetical decline). Thus the range has shifted downward and narrowed, with the low‑end dropping by roughly 85–100 percentage points and the high‑end falling by about 100 percentage points.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2023 the excess fair value over carrying value ranged from 140% to 495%, and in 2024 it decreased to 70%–450%. However, the LLM reports the 2024 range as 55%–395%, which is incorrect on both ends. The low end is off by 15 percentage points (70% vs 55%) and the high end by 55 points (450% vs 395%). Additionally, the LLM introduces a '10% sensitivity test' and corresponding adjusted ranges (115%–435% for 2023 and implied similar for 2024), which are not mentioned or supported in the original answer and appear to be fabricated or misattributed. While the general qualitative trend — that the range has decreased and narrowed — aligns with the ground truth, the specific numbers are incorrect, undermining the factual reliability. The entity (DHR) and years (2023 vs 2024) are correctly identified, and the answer attempts multi-hop reasoning by comparing two annual analyses. However, the incorrect figures and introduction of unsupported sensitivity data reduce both quantitative and qualitative accuracy. The answer is contextually relevant and addresses the question’s intent, but the factual errors in key percentages severely limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 348,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\nIn the 2022 filing the 2022 Employee Stock Plan stated that canceled RSUs and the shares withheld to cover tax withholding would **increase** the shares reserved for future issuance by a **factor of two** (i.e., each canceled RSU or withheld share was counted as two shares toward the pool). By the 2023 filing that language was removed, so the plan now accounts for such cancellations and withholdings only by the **actual number of shares** involved, eliminating the double‑counting rule and therefore reducing the boost to the available share pool.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that in 2022, canceled RSUs and tax-withheld shares increased the share pool by a factor of two, which matches the original answer. In 2023, the 'factor of two' language was removed, meaning only the actual number of shares is now added back—this change is correctly identified. (2) There are no numerical values requiring calculation, but the description of the 'factor of two' and its removal is quantitatively precise. (3) The multi-hop reasoning is sound: the model correctly compares the plan terms across two years (2022 vs 2023) and infers the impact on the share pool based on textual changes in the plan provisions. (4) All entities—'2022 Employee Stock Plan', 'canceled RSUs', 'shares withheld for tax withholding', and the years 2022 and 2023—are correctly identified and contextualized. The explanation is clear, complete, and directly addresses the evolution in treatment and its impact on the available share pool.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 295,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\nSince the 2021 acquisition, Danaher has moved Aldevron’s bioprocessing consumables and services from the Life Sciences portfolio into its core Biotechnology segment, positioning the business as a key growth engine for the company’s life‑science strategy.  The integration is reflected in the $6.1 billion of goodwill and $3.5 billion of other intangibles recorded at purchase, and Aldevron now contributes several billion dollars of revenue and roughly $1.2 billion of operating profit to the Biotechnology segment’s $7.2 billion 2023 sales.  As a result, Aldevron’s financial stake is tightly woven into Danaher’s overall segment performance and risk profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, Danaher allocated $9,561 million in net cash consideration to Aldevron, indicating a recent acquisition or financial stake. However, the LLM claims the acquisition occurred in 2021, which contradicts the timeline implied by the ground truth. Furthermore, the LLM states Aldevron contributes 'several billion' in revenue and $1.2 billion in operating profit to a Biotechnology segment with $7.2 billion in 2023 sales, but these figures are not supported by the original answer and appear fabricated. The original makes no mention of revenue or operating profit contributions, nor does it specify goodwill of $6.1 billion or intangibles of $3.5 billion—these numbers are absent from the ground truth. (2) Quantitative accuracy is very low: none of the specific financial figures in the LLM answer ($6.1B goodwill, $3.5B intangibles, $1.2B operating profit) appear in the original, and the $9,561 million cash consideration from the original is ignored. The LLM also misrepresents the integration timeline by referencing 2021 instead of 2023–2024. (3) The multi-hop reasoning is flawed. The question asks about the evolution between 2023 and 2024, but the LLM frames integration as a post-2021 process, missing the key shift from standalone stake in 2023 to integrated unit in 2024. It also misattributes Aldevron’s placement to the 'Biotechnology' segment, while the original specifies integration into the 'Life Sciences' segment, which is a different reporting unit. (4) Contextual relevance is moderate—the answer discusses integration and financial impact, which are relevant themes—but the incorrect entities, dates, and numbers undermine its usefulness. Due to major factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 500,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft deepened the AI integration of Microsoft 365 by embedding Copilot and generative‑AI capabilities across Office, Teams, Viva and Dynamics, and by introducing role‑specific Copilot extensions and the Copilot Studio customization platform—transforming the suite into an AI‑first productivity engine.  This evolution is now reflected in the company’s commercial metrics, with Microsoft 365‑related revenue (Office Commercial and the broader Microsoft Cloud) and subscriber measures (including the expanded Microsoft 365 Basic count) highlighted as key growth indicators in the segment reporting and MD&A.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Microsoft 365's strategic positioning between 2023 and 2024, emphasizing deepened AI integration through Copilot and generative AI across core applications like Office, Teams, and Dynamics. It accurately notes the introduction of role-specific Copilots and Copilot Studio, which reflects the 'AI-first' platform direction mentioned in the original answer. (2) There are no numeric values (e.g., revenue figures, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or metrics. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the technological evolution (AI integration) with changes in business metrics (inclusion of Microsoft 365 Basic in subscriber counts and emphasis on Microsoft 365-related revenue in reporting). While the original answer explicitly mentions the expansion of the 'Microsoft 365 Consumer subscribers' metric to include 'Basic' tier, the LLM refers to 'expanded Microsoft 365 Basic count' in commercial metrics, which slightly conflates consumer and commercial segments but still captures the broader strategic intent. (4) The answer is contextually excellent—directly addressing both AI integration and commercial business metric evolution. The only minor shortcoming is the slight ambiguity in distinguishing consumer vs. commercial subscriber metric changes, which prevents a perfect 10. Overall, the semantic meaning, factual content, and reasoning are substantially correct and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 441,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\nBetween 2023 and 2024 Microsoft moved Copilot Pro from a newly announced consumer‑subscription that simply “offers faster and more powerful AI assistance in Microsoft 365 apps and on the web” to a core, tightly‑integrated pillar of the Microsoft 365 ecosystem.  The 2024 narrative stresses deeper app‑level integration, role‑specific extensions (e.g., Copilot for Sales, Service, Finance), the ability for users to customize Copilot via Copilot Studio, and linkage to Windows 11 and the new Copilot+ PC class, positioning Copilot Pro as the primary consumer‑facing AI interface for both productivity and web‑based assistance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that in 2023, Copilot Pro was introduced as a consumer subscription offering 'faster and more powerful AI assistance in Microsoft 365 apps and on the web,' matching the original answer verbatim on this key point. The evolution into 2024 is accurately portrayed as a shift toward deeper integration within Microsoft 365, with added emphasis on role-specific extensions (e.g., Copilot for Sales, Service, Finance), customization via Copilot Studio, and integration with Windows 11 and Copilot+ PCs—details not explicitly in the ground truth but contextually valid and consistent with Microsoft’s public AI strategy in 2024. These additions enhance the answer without introducing inaccuracies. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced to 9 because while the core evolution is correctly captured, the original answer emphasizes a 'broader narrative of AI-driven transformation' rather than specific product extensions, meaning the LLM adds plausible detail beyond the provided knowledge graph. However, this does not contradict the source and reflects reasonable inference. Contextual relevance is perfect—the response directly addresses the evolution of positioning and emphasis between 2023 and 2024, particularly regarding M365 integration and web-based AI assistance. Overall, the answer demonstrates strong multi-hop reasoning and semantic equivalence with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 426,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\nBetween 2023 and 2024 the 2007 Omnibus Incentive Plan kept the same governing language and the original 135 million‑share authorization, but the unused portion of that pool slipped modestly – from roughly **48 million shares available at the end of 2023 to about 47 million shares available at the end of 2024** (as disclosed in the 2024 filing, which notes “approximately 47 million shares … remain available for issuance … (excluding shares underlying outstanding awards)”).  This reduction reflects the shares used for option exercises, RSU/PSU vestings and the company’s recent repurchase activity, while the plan’s structure and the total authorized share reserve remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific figure of approximately 48 million shares available at the end of 2023, which is not present in the original answer (ground truth). The ground truth explicitly states that no specific figure was provided for 2023 regarding remaining shares available for issuance. This is a significant factual overreach, as the model fabricates a number not supported by the source. The 2024 figure of approximately 47 million shares is correctly reported and matches the ground truth. (2) The calculation or comparison between 48M (2023) and 47M (2024) implies a one-million-share reduction, but since the 2023 number is unsupported, the entire quantitative trend is misleading. The explanation attributing the reduction to option exercises, RSU/PSU vestings, and repurchase activity goes beyond the original answer, which does not mention repurchase activity as a factor in share depletion. (3) The multi-hop reasoning is partially sound in that it correctly identifies the continuity of the plan structure and accurately reports the 2024 availability figure. However, it fails in synthesizing the absence of 2023 data, instead inventing a number to create a narrative of change. The original answer emphasizes a shift in disclosure transparency rather than modeling a numerical trend. (4) The contextual relevance is high because the response addresses the evolution of the plan and focuses on share availability. Qualitative accuracy is moderate due to correct identification of plan elements and vesting instruments but penalized for unsupported causal explanations. Quantitative accuracy is low due to the fabricated 2023 figure. Correctness score reflects partial accuracy with a major factual error in numerical reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 480,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\nMicrosoft extended the estimated useful life of its server and network equipment from **four years to six years**, a change that took effect at the start of fiscal 2023 and remained in place through fiscal 2024. The extension was driven by greater software‑driven efficiencies and advances in technology that lengthened the operational lifespan of the hardware, prompting the company to revise its accounting estimate accordingly. No further alteration to the useful‑life assumption was reported for fiscal 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Microsoft changed the estimated useful life of server and network equipment from four to six years, effective at the start of fiscal year 2023, and that the policy remained unchanged in fiscal year 2024. (2) All quantitative details—'four years to six years' and 'fiscal 2023'—are accurate and match the original answer; no calculations are required, but the temporal and numerical assertions are correct. (3) The reasoning for the change—software-driven efficiencies and technological advances—is consistent with the ground truth's mention of 'investments in software that improved operational efficiencies and advances in technology.' The LLM correctly infers no further change in fiscal 2024, which aligns with the original answer's statement that the policy 'remained consistent.' (4) The answer addresses both parts of the question: the evolution of the policy (change in 2023, stability in 2024) and the influencing factors. Semantic equivalence is strong, with no omissions or distortions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 328,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\nMedtronic’s auction‑rate securities were carried at a fair value of **$33 million** in both fiscal 2022 and fiscal 2023.  Throughout this period they remained classified as **Level 3** measurements within **other assets** (i.e., available‑for‑sale debt securities) on the consolidated balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the fair value of auction rate securities as $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly states that the securities were classified under 'other assets' in both years, while the original answer specifies that in 2022 they were included under 'Total' in the investment portfolio without a separate classification. The shift in classification from a general investment category to 'Other Assets' in 2023 is a key point of the question, but the LLM implies the classification was the same in both years, which is inaccurate. (2) Quantitatively, all numbers are correct—$33 million in both years—and no calculations are required. (3) The multi-hop reasoning is flawed: the model fails to recognize the evolution in balance sheet classification over time, which is central to the question. It incorrectly asserts consistent classification ('other assets') across both years, missing the change in accounting presentation. (4) While the answer includes relevant context (fair value, Level 3, available-for-sale), it misrepresents the classification history, leading to a significant qualitative error. Hence, correctness is partially compromised despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 352,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\nThe net loss on Cisco’s available‑for‑sale debt investments widened from $21 million in fiscal 2023 to $67 million in fiscal 2024 – an increase of roughly $46 million. This deterioration signals that the company’s debt‑investment portfolio underperformed in 2024, likely reflecting the adverse impact of rising interest rates and market‑value declines on the fair‑value of those securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the net losses for both fiscal years: $21 million in 2023 and $67 million in 2024, matching the ground truth. The calculated increase of $46 million ($67M - $21M) is accurate. 2) All numeric values and fiscal years are correct, with acceptable formatting (e.g., $21 million vs $21 million). Calculations are precise. 3) The multi-hop reasoning is sound—comparing two fiscal years’ investment performance and drawing a conclusion about worsening performance is valid. The LLM adds contextual insight about rising interest rates and market-value declines, which, while not in the original answer, is a reasonable inference and does not contradict the ground truth. 4) The core information is semantically equivalent: both convey that losses increased significantly from 2023 to 2024, indicating deteriorating investment performance. The only minor point is that the original answer does not speculate on causes (e.g., interest rates), but the added context does not reduce accuracy. Thus, the answer is fully factually correct with excellent reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 312,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Cisco’s APJC segment contracted both in absolute terms (‑8 % revenue) and as a share of total sales (down from 15.6 % to 14.3 %), signalling that the company is pulling back on the resources it devotes to that geography and re‑allocating investment toward higher‑margin subscription and AI‑driven services (including the Splunk integration) and toward other regions.  This strategic shift means the APJC revenue model is moving away from large, one‑time product sales toward a greater reliance on recurring, subscription‑based revenue, even though overall growth in the region is now modest.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Cisco maintained its operational presence in APJC in 2023 and added financial investment vehicles (marketable and non-marketable equity securities, equity method investments) in 2024, indicating an expansion of strategy. In contrast, the LLM claims Cisco is 'pulling back' on resources, citing an 8% revenue decline and drop in regional share from 15.6% to 14.3%, none of which is mentioned or supported in the ground truth. These specific percentages and performance metrics are fabricated or misattributed, as the original answer does not provide any revenue figures or growth rates for APJC. (2) Quantitative accuracy is low: the 8%, 15.6%, and 14.3% figures are not present in the ground truth and contradict the narrative of strategic expansion through investment. There is no mention of Splunk integration or AI-driven services in the original answer. (3) Multi-hop reasoning is flawed. The LLM incorrectly infers a strategic retreat from APJC based on unsupported financial performance data, while the actual evolution is a shift from pure operational delivery to include financial investment—indicating deeper engagement, not disengagement. The model fails to identify the key change in operational structure (direct operations in 2023) versus financial investment (new in 2024). (4) Contextual relevance is moderate because the answer discusses Cisco, APJC, and revenue models, but it misrepresents the nature of the strategic evolution. The focus on subscription models and Splunk is irrelevant and unsupported. The core implication—that Cisco may now derive revenue from both operations and investments—is entirely missing. Thus, despite addressing the region and revenue model conceptually, the answer is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 506,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\nApple’s App Store policy has shifted from a static 30 % commission model in 2022—where the company warned that legal actions and the EU Digital Markets Act could force “further changes” to how it charges developers—to an actively revised approach by 2024 that incorporates the DMA‑mandated alternative fee structures, new distribution channels and external payment options, while also responding to U.S. antitrust litigation that compelled it to allow alternative purchasing mechanisms. This evolution reflects a move from merely acknowledging regulatory pressure to implementing concrete commission‑reduction and payment‑process changes to stay compliant and preserve revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift from Apple's 2022 acknowledgment of potential App Store changes due to legal pressures (e.g., the EU's Digital Markets Act) to concrete 2024 actions, including alternative fee structures, distribution channels, and external payment options. These match the original answer's description of new business terms, APIs, and compliance-driven adjustments. (2) Quantitatively, the reference to the '30%' commission model is factually correct for the baseline App Store rate in 2022, and while the exact percentage isn't in the original answer, it is common knowledge and contextually appropriate. No calculations are required, and all dates (2022, 2024) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes Apple’s forward-looking risk disclosures in 2022 with its actual policy changes by 2024 in response to the DMA and U.S. antitrust litigation. It correctly links regulatory pressure to specific operational changes. (4) The only minor shortcoming is that the LLM mentions 'external payment options' and 'alternative purchasing mechanisms' as outcomes of U.S. litigation, which, while directionally correct, are described more generally in the ground truth. The original answer emphasizes new business terms and developer tools without specifying 'external payments'—a slight overprecision, but not factually incorrect. Overall, the answer is semantically equivalent, contextually relevant, and factually strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 422,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S. Retiree Health Care Plan shifted its asset mix from roughly 64 % fixed‑income / 36 % equity (as shown in the 2022 filing’s plan‑asset table) to about 80 % fixed‑income / 20 % equity by year‑end 2024.  This move brings the allocation closer to the plan’s target range of 75‑85 % fixed income and 15‑25 % equity, reflecting a deliberate rebalancing toward a higher fixed‑income weighting over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the percentages are correct: in 2022, fixed income and cash equivalents were $248M and equities $137M, which totals $385M; fixed income thus represents approximately 64% ($248M / $385M ≈ 64.4%) and equities 36% ($137M / $385M ≈ 35.6%), matching the LLM's 64%/36% split. By 2024, the allocation shifted to 80% fixed income and 20% equities, as correctly stated. (2) The LLM correctly identifies a strategic shift toward more conservative allocation, consistent with the ground truth’s emphasis on capital preservation. (3) The reasoning is sound: the LLM notes the movement toward the target range of 75–85% fixed income and 15–25% equities, which is a plausible inference from the observed 80/20 allocation in 2024, even if not explicitly stated in the original answer. This adds useful context without contradicting the ground truth. (4) The only minor omission is that the original answer notes the 80/20 split remained unchanged between 2023 and 2024, suggesting stability in the final phase of the strategy—this nuance is missing in the LLM response. However, this does not undermine the core correctness. All entities (Texas Instruments' U.S. Retiree Health Care Plan, fixed income, equity securities, years 2022–2024) are accurate. The answer is contextually relevant, directly addressing the evolution of allocation strategy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the slight omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 434,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\nFrom the 2022 filing (pp. 18‑23) Embedded Processing was presented as a growth engine—revenue rose 19 % in 2021 and the segment posted $1.174 bn of operating profit, reinforcing TI’s four sustainable competitive advantages and its focus on industrial and automotive markets. In the 2024 filing (pp. 20, 30, 32) the segment’s revenue slipped 25 % YoY to $2.53 bn and operating profit fell 65 % to $352 m, yet it remains a distinct reportable segment that the CODM uses to gauge performance; the downturn indicates a shift from an aggressive growth emphasis to a more defensive, still‑critical role within TI’s overall analog‑and‑embedded strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Embedded Processing was not a reportable segment in 2022, but the LLM claims it was, citing operating profit of $1.174 billion and 19% revenue growth in 2021—none of which is supported by the ground truth. The 2024 figures cited—$2.53 billion revenue and $352 million operating profit with a 25% and 65% decline—are not present in the original answer and contradict the strategic emphasis narrative. (2) Quantitative accuracy is very low: no financial figures or percentages from the LLM answer appear in the ground truth. The original answer does not provide any specific revenue or profit numbers for Embedded Processing in 2022 or 2024, nor does it mention a decline. The LLM fabricates precise numbers and YoY changes unsupported by the source. (3) Multi-hop reasoning is flawed. The original answer focuses on a structural and strategic shift—elevation to a reportable segment in 2024—as evidence of increased strategic importance. The LLM misrepresents this by implying that a financial downturn caused a shift to a 'defensive' role, which is not in the ground truth. It fails to correctly identify the key evolution: from non-reportable product line to reportable segment as a sign of strategic elevation, not decline. (4) Contextual relevance is moderate—the answer addresses Texas Instruments, Embedded Processing, and the time frame, and attempts to discuss strategic role and segment reporting. However, due to fabricated data and incorrect reasoning, the qualitative accuracy is low. The core factual claim (elevation to reportable segment) is partially correct for 2024 but misrepresented in context. Overall, the answer is mostly incorrect and misleading despite touching on relevant themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 490,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\nThermo Fisher issued the 2.00 % 10‑Year Senior Notes (due 2031) through its finance subsidiary in 2022, initially recording a carrying amount of roughly $1.2 billion at an effective interest rate of 2.23 %. By the end of 2024 the notes remained outstanding with essentially the same carrying value (≈ $1.2 billion), reflecting the ongoing amortization of the original discount and issuance costs and a stable effective rate of about 2.23 % over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same essential information as the ground truth. (1) All key facts are correct: Thermo Fisher (TMO) issued $1.2 billion (i.e., $1,200 million) of 2.00% 10-Year Senior Notes due 2031 in 2022 with an effective interest rate of 2.23%, and by 2024, the carrying amount remained approximately $1.2 billion with the same effective rate. The use of '≈ $1.2 billion' and 'about 2.23%' is acceptable and semantically equivalent to exact figures given typical reporting conventions. (2) Quantitative accuracy is perfect: amounts, percentages, and dates match the original answer. The note due October 15, 2031, is correctly implied by the 'due 2031' notation. (3) The reasoning is sound: the LLM correctly infers that the stable carrying value and rate indicate no new issuance or repayment, and it appropriately references amortization of discount and issuance costs, which explains minor fluctuations in carrying value without affecting the principal or effective rate. This adds context not in the original but is factually consistent. (4) The only minor gap is that the LLM does not explicitly state 'no new issuances or repayments,' though this is logically implied. It also refers to the 'finance subsidiary'—a detail potentially from the filings but not in the ground truth; however, this does not contradict and may reflect deeper context. Overall, the answer is factually correct, complete, and contextually appropriate with excellent multi-hop synthesis across years and financial concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 421,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\nREMICADE’s sales have continued to fall: the 2024 10‑K shows $1.6 billion in 2024, a 12.8 % drop from $1.84 billion in 2023, and the 2022 filing reported roughly $2.0 billion in the prior year. This double‑digit decline reflects mounting competitive and biosimilar pressure, causing REMICADE’s contribution to the Pharmaceutical (Innovative Medicine) segment to erode and highlighting the segment’s shift toward newer immunology and oncology products.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM reports $1.6 billion in 2024 and $1.84 billion in 2023, which matches the ground truth values of $1,605 million and $1,839 million (rounded appropriately). The 12.8% decline is correctly calculated: (1,839 - 1,605) / 1,839 ≈ 12.72%, which rounds to 12.8%. The mention of ~$2.0 billion in 2022 is not contradicted by the ground truth, which does not provide the 2022 figure but confirms the downward trend. (2) Completeness: The answer addresses both parts of the question—evolution of financial performance (decline from 2022 to 2024) and implications for J&J’s Pharmaceutical segment. It correctly infers competitive and biosimilar pressure as drivers, which is consistent with the context of declining biologic sales. (3) Entity accuracy: REMICADE, Johnson & Johnson, Pharmaceutical (referred to as Innovative Medicine, a current name variant), and correct years (2022–2024) are all accurate. (4) Reasoning: The multi-hop synthesis across years and filings is sound. The LLM correctly infers a trend from three data points and contextualizes the decline within segment strategy, noting a shift to newer immunology and oncology products—this is a reasonable interpretation supported by the ground truth’s mention of newer biologics. (5) Semantic equivalence is strong: though the LLM adds slight interpretive context (e.g., biosimilar pressure), it does not contradict the ground truth and enhances relevance. The only minor limitation is the lack of explicit mention of the Immunology therapeutic area, but the context is implied. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 467,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\nREMICADE’s worldwide sales fell 12.8 % year‑over‑year, dropping from $1.84 billion in 2023 to $1.61 billion in 2024 (J&J 2024 10‑K, page 31).  While the overall Immunology portfolio grew modestly (0.4 % operational growth in 2024), REMICADE’s decline contrasts sharply with the double‑digit gains posted by newer Immunology products such as STELARA and TREMFYA, indicating that REMICADE is losing market share and its competitive position within J&J’s Immunology franchise is eroding.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend of REMICADE sales and its weakening market position within JNJ's Immunology portfolio, which aligns with the ground truth. However, there are discrepancies in the quantitative details. The ground truth states REMICADE sales were $3,190 million in 2022 and $1,605 million in 2024, with a 12.8% drop from 2023 to 2024. The LLM reports $1.84 billion in 2023 and $1.61 billion in 2024, implying a 12.8% decline, which matches the percentage but uses slightly different base figures. The $1.61 billion (LLM) is close to the ground truth $1.605 billion, so this is acceptable. However, the LLM omits the 2022 sales figure ($3,190 million) and the 14.9% decline from 2020, which is a notable omission for the 'evolution from 2022' part of the question. (2) The calculation of the 12.8% drop is consistent with the LLM's own numbers, but the absence of 2022 data reduces completeness. The $1.84 billion 2023 figure is not present in the ground truth, which undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM contrasts REMICADE’s decline with the growth of STELARA and TREMFYA, correctly inferring a loss of market share and eroding competitive position, which is consistent with the ground truth’s conclusion about weakening market position. This shows good synthesis across products and time. (4) The contextual relevance is high, as the answer directly addresses the sales evolution and market position. The qualitative reasoning is strong, but the missing 2022 data and incorrect 2023 sales figure reduce quantitative accuracy. Hence, correctness is 7 due to partial factual inaccuracies and omissions, despite correct overall interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 473,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\nBetween 2021 and 2024 REMICADE’s sales fell sharply – from about **$3.19 billion in 2021** to **$1.84 billion in 2023** (a ~42 % drop) and then to **$1.61 billion in 2024** (an additional ~13 % decline).  The downturn reflects growing biosimilar competition after the U.S. patent expired, continued price‑pressure and market‑share losses, plus a negative operational trend (‑11.4 % in 2024) and modest currency headwinds (‑1.4 %).  These factors outweighed any gains from the broader Innovative Medicine segment, which grew 4 % overall in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states REMICADE's sales were part of a $16.8 billion Immunology category in 2021, but the LLM incorrectly reports REMICADE-specific sales as $3.19 billion in 2021, which is not supported by the original data. The 2024 figure is closer ($1.61 billion vs. ground truth $1,605 million), but still slightly off. The 2023 figure of $1.84 billion in the LLM answer does not align with any verifiable step toward the 12.8% decline from 2023 to 2024 stated in the ground truth. (2) Calculations are inconsistent: a drop from $3.19B to $1.84B is about 42%, as stated, but this baseline is incorrect. The 13% decline from 2023 to 2024 in the LLM answer is close to the ground truth's 12.8%, which is accurate. However, the LLM introduces unsupported metrics like 'negative operational trend (-11.4%)' and 'currency headwinds (-1.4%)' not present in the original answer, suggesting over-inference or hallucination. (3) The reasoning correctly identifies biosimilar competition as a key driver, which aligns with the ground truth, and recognizes the trend of market share loss post-patent expiry. However, it fails to mention that the decline was ongoing across global markets beyond the U.S., and incorrectly frames REMICADE’s performance relative to the Innovative Medicine segment growth, which is contextually relevant but not directly explanatory of REMICADE’s specific decline. (4) The contextual relevance is high because the answer addresses both parts of the question—sales evolution and contributing factors—and attempts multi-hop synthesis. However, the quantitative inaccuracies severely undermine the correctness score. While the qualitative reasoning is partially sound, the foundational data is flawed, leading to a partial credit score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 502,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\nSTELARA (ustekinumab) remained a core Immunology product, generating about $10.9 billion in sales in 2023 and $10.4 billion in 2024—a 4.6 % year‑over‑year decline driven by a ‑3.4 % operational drop and a ‑1.2 % currency impact.  The downturn began after the U.S. patent expired in September 2023, when biosimilar competition entered the market, causing the franchise’s growth that had persisted through 2022 (when it was already a ~$5.9 billion business in 2021) to stall and reverse.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeline. The ground truth states STELARA generated $10,361 million ($10.361 billion) in 2024 and $10,858 million ($10.858 billion) in 2023, representing a 4.6% decline. The LLM reports $10.4 billion in 2024 and $10.9 billion in 2023, which aligns approximately with the correct figures but rounds them in a way that affects precision—especially the 2023 number, which is off by nearly $50 million. More critically, the LLM claims the U.S. patent expired in September 2023 and that biosimilars entered then, causing the decline. However, this specific detail about patent expiration and market entry timing is not present in the ground truth and cannot be verified from the provided data, making it a speculative addition. Additionally, the ground truth notes that in 2022, STELARA was in the filing stage for pediatric use in juvenile psoriatic arthritis, which the LLM omits entirely. This is a key part of the 'evolution' asked in the question and represents a significant gap in completeness. (2) The calculation of the 4.6% decline is consistent between both answers, so the percentage is accurate. However, the dollar amounts are slightly misstated—the LLM rounds $10,858 million to $10.9 billion (acceptable), but $10,361 million should be $10.36 billion, not $10.4 billion, introducing a small error. The claim about currency impact (–1.2%) and operational drop (–3.4%) is not in the original answer and cannot be verified. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a decline in sales from 2023 to 2024 and attributes it to external factors, showing synthesis. However, it fails to incorporate the 2022 regulatory status (filing for pediatric indication), which is a required part of the evolution. Instead, it introduces unverified information about patent expiry and biosimilar entry, weakening the reasoning chain. (4) The contextual relevance is high because the answer focuses on STELARA’s commercial performance and evolution over time. However, the correctness score is reduced due to factual inaccuracies in dates, missing key regulatory developments, and introducing unsupported causal claims. While the overall trend (sales decline after peak) is correct, the omission of 2022's regulatory status and insertion of unverified patent details significantly affect factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 640,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\nU.S. Restasis net revenue fell from **$621 million in 2022 to $382 million in 2023**, a **38.5 % decline**, and then dropped further to **$172 million in 2024**, which is a **55.2 % decrease from the 2023 level**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts are accurate: $382 million in 2023 and $172 million in 2024, with the correct percentage decreases — 38.5% decrease from 2022 to 2023 (implied by drop from $621M to $382M), and a 55.2% decrease from 2023 to 2024. The LLM correctly calculates and reports the year-over-year percentage changes. (2) The answer addresses all parts of the question: it states how total net revenue changed between 2023 and 2024 (from $382M to $172M), and provides the percentage decrease in each year relative to the prior year. (3) Entity accuracy is correct — 'Restasis', 'United States', and the years 2022, 2023, and 2024 are properly referenced. (4) The multi-hop reasoning is sound: the model correctly synthesizes data across three years, computes percentage changes, and presents a logically coherent narrative. Although the original question did not ask for 2022 data, including it provides context for the 2023 percentage decrease and improves clarity. The answer is semantically equivalent to the ground truth and adds minor but helpful context without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 331,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\nBetween 2022 and 2023 the Master Lease Agreements shifted from being primarily a tool to lock in long‑term, non‑cancellable rent and curb churn with U.S. carriers, to a strategic platform that underpins AMT’s international expansion.  The 2023 disclosures emphasize that these comprehensive MLAs are used to diversify exposure across emerging markets, accelerate colocation cycle times, and deepen partnerships with large multinational carriers—thereby driving organic revenue growth and supporting the densification of wireless networks worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the strategic evolution of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, which aligns with the question's focus. It correctly identifies MLAs as strategic tools for international expansion, accelerating colocation, and strengthening carrier partnerships—elements consistent with the ground truth. However, key quantitative details from the original answer are missing: the international portfolio size of approximately 177,000 sites in 2022 and 182,000 in 2023 is not mentioned, which is a significant omission given the emphasis on international growth. While the LLM correctly infers a shift in strategic emphasis, it inaccurately frames the 2022 role of MLAs as primarily focused on U.S. carriers, whereas the ground truth emphasizes their international application from the start. The ground truth also highlights specific risk mitigation (e.g., customer consolidation, regulatory changes) and reduced non-contractual churn in 2023—details absent in the LLM response. The qualitative reasoning is partially sound but lacks full multi-hop synthesis: it does not connect the portfolio size growth with MLA effectiveness or cite the continuity of MLA importance across both years. The answer is contextually relevant and uses appropriate terminology, but the misrepresentation of geographic focus and omission of key metrics reduces factual accuracy. Quantitative accuracy is scored higher because no incorrect numbers are stated—only correct ones omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 419,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\nBetween 2023 and 2024 the **Google Marketing Platform became a larger share of the company’s ad‑inventory sales**, but the way those revenues are accounted for stayed the same.  Google continues to act as the **principal** for ads placed on its own and Google Network properties – it records the full amount billed to advertisers as advertising revenue and records the payments to network partners (including those delivered through the Marketing Platform) as cost‑of‑revenues.  This gross‑basis recognition lets the company manage and report advertising revenue from the Platform consistently with the rest of its Google Network portfolio, even as the Platform’s contribution to total ad revenue grew.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in the evolution of Google Marketing Platform's role between 2023 and 2024. (1) It correctly states that revenue recognition remains on a gross basis and that Google acts as the principal, which aligns with the ground truth. There are no numeric values to verify, so quantitative accuracy is high by default (scored 10). (2) However, the answer fails to mention the critical 2024 shift toward a more nuanced evaluation of principal vs. agent status based on control over inventory — a central point in the original answer. This omission significantly weakens the qualitative accuracy. (3) The multi-hop reasoning is incomplete: while it correctly synthesizes the continuity in gross revenue reporting, it does not capture the evolution in accounting rationale or the expanded functional role of the platform in managing both performance and brand advertising across Google Network properties in 2024. (4) Contextual relevance is high because the response stays focused on the question and discusses revenue recognition and the platform’s role, but the lack of detail on the 2024 changes reduces correctness. Overall, the answer conveys partial truth with accurate framing but misses essential nuances, warranting a 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 363,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\nThe gross “Federal funds purchased and securities loaned or sold under agreements to repurchase” line grew from **$481.9 bn (Level 2 fair‑value) in 2023** to **$570.2 bn in 2024** – an increase of roughly **$88 bn (≈18 %)**.  After netting the offsetting positions, the carrying amount rose from **$178.6 bn to $192.9 bn**, a **$14.3 bn (≈8 %)** increase (2023 → 2024).  \n\nThis jump shows that Bank of America expanded its short‑term wholesale funding by issuing more federal‑fund purchases and securities‑loan transactions, indicating a more aggressive reliance on short‑term market financing to meet liquidity needs and support its short‑term funding strategy in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer provides a detailed and mostly accurate response but contains key quantitative discrepancies. The ground truth states a net change in volume of $16,466 million (≈$16.5B) in 2023 and a 2024 fair value of $192,859 million (≈$192.9B). The LLM correctly reports the 2024 net carrying amount as $192.9B, aligning with the ground truth. However, it incorrectly states the 2023 net carrying amount as $178.6B, leading to a calculated net increase of $14.3B, whereas the ground truth specifies a $16,466M ($16.5B) net change in volume in 2023 — a mismatch in both magnitude and year reference. Additionally, the LLM introduces gross figures ($481.9B → $570.2B) and an 18% increase, which are not present in the original answer and may reflect misinterpretation or over-extrapolation.\n\n2) Calculations: The LLM’s net increase of $14.3B ($192.9B - $178.6B) is numerically consistent with its own inputs but does not match the ground truth’s stated $16,466M net change in 2023. The $192.9B figure for 2024 is accurate (matches $192,859M). However, the gross values and percentage increases are unsupported by the original answer and introduce potentially misleading data.\n\n3) Multi-hop reasoning: The LLM correctly identifies the trend — increasing reliance on short-term funding — and draws a reasonable conclusion about BAC’s short-term funding strategy. It synthesizes net and gross positions, suggesting awareness of complex financial reporting, but fails to clearly align with the original answer’s focus on 2023 volume change and 2024 fair value. The reasoning is sound but based on partially incorrect inputs.\n\n4) The answer is contextually relevant and well-structured, addressing both volume/fair value changes and strategic implications. Despite incorrect intermediate figures, the final interpretation aligns semantically with the ground truth’s conclusion about increased reliance on short-term secured funding. The core message is preserved, but quantitative inaccuracies reduce overall correctness. Hence, a score of 7 is justified: major facts (2024 fair value, directional trend) are correct, but key numbers and calculations are inconsistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 584,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s wording shifted from a brief, qualitative note that pension and retiree‑medical plan assets and liabilities are “subject to market fluctuations” (2022 PDF p. 34) to a more explicit discussion that ties the exposure of those plans to broader market‑risk factors—interest‑rate and inflation changes—and states that market movements affect the plans’ fair‑value measurement (2024 PDF pp. 40, 42).  In other words, the 2022 filing merely flagged the risk, whereas the 2024 filing integrates the pension and retiree‑medical exposure into the market‑risk narrative and emphasizes its sensitivity to market‑driven changes, though it still does not provide a quantitative sensitivity scenario.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in PepsiCo's disclosure between 2022 and 2024: in 2022, the company provided a general statement about exposure to market fluctuations, while in 2024, it expanded the discussion to include interest-rate and inflation changes as key risk factors. This matches the ground truth's claim of a broader macroeconomic context (inflationary, deflationary, recessionary conditions), with 'inflation' explicitly mentioned and 'interest-rate changes' serving as a proxy for broader market volatility. (2) There are no numerical values to verify, but the cited page numbers (2022 p. 34; 2024 pp. 40, 42) are consistent with typical disclosure locations and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound—comparing disclosures across years and synthesizing the shift in qualitative risk disclosure. The LLM correctly infers that the 2024 filing integrates pension and retiree medical plan risks more deeply into market-risk narratives, which reflects enhanced sensitivity disclosure. (4) The only minor gap is that the LLM does not explicitly mention 'deflationary' or 'recessionary' conditions as in the original answer, instead summarizing them under 'market-risk factors' and 'market movements.' However, this is a reasonable paraphrase given that inflation and interest rates are the primary transmission mechanisms for such conditions. The absence of quantitative sensitivity scenarios is correctly noted and consistent with the ground truth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 459,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\nAdobe has shifted Adobe Scan from a stand‑alone free mobile scanner to a core entry point of the Adobe Document Cloud suite.  The 2024 filing stresses that Scan now delivers OCR‑enabled, AI‑enhanced PDF creation and seamless sharing that is tightly integrated with Acrobat, Acrobat Sign and the broader Adobe Experience Cloud, positioning the app as the mobile front‑door to Adobe’s end‑to‑end document‑management ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Scan between 2023 and 2024. It accurately captures the shift from a standalone mobile scanner to a more integrated component of Adobe's document management ecosystem, particularly within Adobe Document Cloud. The emphasis on AI-enhanced features, OCR, and integration with Acrobat, Acrobat Sign, and Adobe Experience Cloud reflects the 2024 strategic direction mentioned in the original answer. However, the LLM answer omits specific 2023 context (e.g., its positioning as a free tool for individual users) and does not mention key 2024 advancements like Content Credentials or Firefly-powered generative AI workflows, which are central to the 'digital trust' and AI-driven integration highlighted in the ground truth. While 'Experience Cloud' is mentioned, the original answer emphasizes Document Cloud and productivity tools, suggesting a slight overreach in integration claims. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and the reasoning is sound but slightly incomplete in synthesizing all multi-hop elements (e.g., the evolution across both years with specific feature additions). The answer remains highly relevant to the question and conveys a semantically close evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 377,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\nSince its December 2023 launch, Gemini has progressed from a single multimodal model to Gemini 2.0—a far more capable system that can jointly understand and generate text, code, audio, images and video and is now embedded across Google’s core consumer services (Search, YouTube, Android, Chrome, Gmail, Maps, Play) and into Google Cloud (Vertex AI, Workspace, Duet AI). The 2024 upgrade adds broader modality support, stronger reasoning and multimodal “generalist” capabilities, enabling new experimental agents such as Project Astra (a universal AI assistant) and Project Mariner (a Chrome‑extension prototype), making Gemini the central AI engine powering Google’s products and developer platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini launched in 2023 as a multimodal model, evolved into Gemini 2.0 in 2024, and was integrated across Google's major products. The seven products listed in the ground truth (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube) are accurately reflected in the LLM answer, with 'Play' used as shorthand for 'Play Store'—semantically acceptable. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or metrics. The December 2023 launch is consistent with the initial 2023 release. (3) Multi-hop reasoning is sound: the answer synthesizes evolution over time, product integration, and new capabilities like Project Astra and Project Mariner, correctly identifying them as experimental prototypes. (4) Minor deduction in qualitative accuracy due to the addition of Google Cloud, Vertex AI, Workspace, and Duet AI, which are not mentioned in the ground truth and slightly extend beyond the provided information, though they may reflect broader public knowledge. However, the core advancements in multimodal capabilities—joint understanding of text, code, audio, images, video—and the characterization of Gemini as a 'generalist' model are consistent with the original answer. Overall, the response is comprehensive, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 383,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\nLinde’s helium activities are bundled in the “Other” segment, and between 2023 and 2024 their sales fell about 2 % as volumes dropped, while operating profit rose roughly 44 %—the gain coming mainly from an insurance recovery that offset higher helium‑related costs. This shows that helium’s contribution to overall sales is modest and declining, but its profit impact has been cushioned by non‑operational insurance proceeds, reflecting a shift from volume‑driven earnings to a more cost‑ and risk‑managed relationship.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements but contains significant factual inaccuracies and omissions that affect correctness. (1) Quantitatively, the 2% sales decrease and 44% operating profit increase are mentioned, which aligns with the ground truth, but the LLM incorrectly attributes the profit increase to 2023–2024 when the original answer specifies 2024 vs prior year (not 2023). The ground truth does not state that operating profit rose 44% due to helium activities—it states that the 'Other' segment had a 44% increase in operating profit overall, despite helium-related headwinds. (2) The LLM incorrectly implies helium contributed positively to profit growth via insurance recovery, whereas the original answer clarifies that higher helium costs *partially offset* an insurance recovery, thus *limiting* profit growth. This misrepresents the causal relationship. (3) The evolution from 2022 to 2024 is partially addressed—the negative shift in 2024 is implied—but the 2022 context (helium as a supply, neutral/positive) is entirely missing, failing the multi-hop requirement across all years. (4) Entity accuracy is mostly correct (Linde, 'Other' segment, helium), but 'Linde Advanced Materials Technology (LAMT)' is omitted, and the insurance recovery is misattributed in impact. (5) While the answer is contextually relevant and well-structured, the reasoning missteps—especially around profit dynamics and timeline—reduce factual reliability. The conclusion about a shift to 'risk-managed relationship' is interpretive and not directly supported in the ground truth. Overall, core numbers are present but misapplied, and critical nuances in causality and time period are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 460,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\nThe net value of acquired franchise rights fell from $626 million in 2022 to $598 million in 2024, a reduction of $28 million (about a 4.5 % decline).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numerical values. According to the ground truth, the net value of acquired franchise rights in 2022 was $789 million, but the LLM incorrectly states it as $626 million. The 2024 value is correctly reported as $598 million. This error directly impacts the calculated change. (2) The calculation of a $28 million reduction and 4.5% decline is based on incorrect input values. The correct decrease should be $789M - $598M = $191 million, which is a 24.2% decline. The LLM's calculation is mathematically consistent with its incorrect inputs but factually wrong. (3) The reasoning structure is sound—identifying the change over time and quantifying the magnitude—but fails at the multi-hop synthesis step because it uses an incorrect 2022 value, likely due to retrieving data from a wrong entity, year, or document. (4) The contextual relevance is high because the answer addresses the evolution and magnitude of change as asked. However, the quantitative inaccuracy severely undermines the correctness, warranting a low score of 3. The qualitative accuracy is moderate because the logic and structure are correct, but entity or data retrieval failed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1077,
        "completion_tokens": 343,
        "total_tokens": 1421
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\nChevron’s contractual natural‑gas delivery obligations tied to the Tengizchevroil joint‑venture remained the same from 2023 to 2024 – the company continued to honor the existing supply commitments without any new volume targets.  At the same time, production from the Tengizchevroil affiliate (reported within Chevron’s “Affiliates” figures) showed a modest rise, with oil‑equivalent output increasing from roughly 406 k to 413 k bbl/d, while natural‑gas output held steady at about 25 million cubic feet per day.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims that Chevron's natural gas delivery obligations 'remained the same' and that gas output 'held steady at about 25 million cubic feet per day,' which directly contradicts the ground truth showing significant increases in both consumed and sold volumes. The reported production figures (e.g., 25 million cubic feet per day) are not aligned with the actual data from Tengizchevroil, which contributes to much larger volumes (7,148 million cubic feet per day sold in 2023, rising to 7,569 million in 2024). Additionally, the LLM introduces oil-equivalent output (406k to 413k bbl/d) that is not mentioned or verifiable in the original answer, suggesting fabrication or misattribution. (2) The numbers provided in the LLM answer (25 million cubic feet per day) are off by orders of magnitude compared to the ground truth (over 7,000 million cubic feet per day sold), making the quantitative accuracy very low. There are no correct calculations or matching figures. (3) The multi-hop reasoning failed: the model did not correctly synthesize Chevron’s overall natural gas volumes with its Tengizchevroil share. Instead, it incorrectly isolated Tengizchevroil’s gas output as negligible and static, while the original answer clearly links the increase in Chevron’s total sold and consumed volumes to growing Tengizchevroil contributions. (4) Contextual relevance is moderate because the answer addresses Chevron and Tengizchevroil in the correct timeframe and attempts to discuss production and delivery, but the factual inaccuracies and missing data severely undermine usefulness. The conclusion about 'no new volume targets' and 'steady' output contradicts the documented growth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 492,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 the filing shifted from a generic reference to “advertising revenue from Google Network properties” (2023 10‑K p. 18) to an explicit accounting‑line item that treats those payments as a cost of revenue. In the 2024 filing (p. 59) the company states that “TAC includes … amounts paid to Google Network partners primarily for ads displayed on their properties,” classifying the payments as a separate expense rather than merely an offset to gross advertising revenue. Thus, the role of Network partners is now recorded as a distinct cost‑center in the revenue model, highlighting a more granular treatment of the payments made to them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift between 2023 and 2024 in how payments to Google Network partners are described, noting the move from a more generic reference in 2023 to an explicit classification under Traffic Acquisition Costs (TAC) in 2024. The citation of page numbers (p. 18 for 2023, p. 59 for 2024) adds precision and matches the expected documentation context. (2) There are no numerical values in the question or answer that require verification—dates (2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes changes in accounting language across two years, links TAC to payments for ads on partner properties, and infers a more granular, cost-center treatment of these payments. The conclusion that this reflects a strategic shift—treating partner payments as a distinct cost of revenue rather than an implicit offset—is logically supported and semantically equivalent to the ground truth’s claim of a 'more strategic and performance-based dependency.' (4) The only minor shortcoming is that the LLM does not explicitly use the term 'operating activities' or 'primary uses of cash' as mentioned in the 2023 description in the ground truth, slightly underrepresenting the original context of cash flow classification. However, it accurately captures the essence of the evolution in accounting treatment. Wording differs slightly but meaning is preserved. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 438,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\nThe 2023 filing only warned in general terms that climate‑related regulations could affect the firm, without emphasizing the effect of differing rules across jurisdictions. In contrast, the 2024 MD&A (page 24 of the 2024 10‑K) explicitly points out that “an increasing global regulatory focus… with potential jurisdictional divergence” will raise legal, compliance and disclosure costs, making divergent public‑policy requirements a concrete source of heightened compliance risk. Consequently, the impact of public policies on Bank of America’s climate‑related regulatory obligations has shifted from a broad acknowledgment of risk to a specific concern that varying, evolving standards across U.S. and non‑U.S. jurisdictions are amplifying compliance complexity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its qualitative assessment and captures the key evolution from anticipated to actual impact of jurisdictional divergence on compliance risks. It correctly identifies that in 2024, Bank of America explicitly cited 'an increasing global regulatory focus' and 'jurisdictional divergence' as raising legal, compliance, and disclosure costs, referencing the 2024 10-K (page 24), which aligns with the ground truth. However, the LLM incorrectly states that the 2023 filing did not emphasize jurisdictional divergence, when in fact the original answer confirms that in 2023, the company *did* specifically mention jurisdictional divergence as a challenge. This is a significant omission in reasoning and misrepresents the 2023 stance, weakening the contrast between years. While the 2024 characterization is accurate and well-supported, the misstatement about 2023 undermines the multi-hop comparison. There are no numerical inaccuracies (dates and references are correct), so quantitative accuracy is perfect. The answer is contextually relevant and well-structured, but the error in portraying the 2023 position reduces the overall correctness. Semantic equivalence is partially achieved, but the misrepresentation of the earlier year's disclosure lowers qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 363,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\nGM has moved from a balanced product mix in 2022 to a clearer priority on full‑size pickups by 2024, as shown by a 10.1 % rise in wholesale truck sales to 3,464 units and a contribution to an 11.4 % increase in GM North America’s total net sales to $157.5 bn.  The segment’s EBIT‑adjusted climbed 18.1 % to $14.5 bn and its margin improved to 9.2 % from 8.7 %, signaling stronger performance and market positioning for the full‑size pickup line.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a strategic shift toward full-size pickups from 2022 to 2024, the quantitative data provided is largely incorrect or fabricated. The ground truth mentions a 'significant increase in net wholesale volumes' and a 'variable profit of approximately 160% for trucks on a weighted-average basis,' but the LLM invents specific figures such as a '10.1% rise in wholesale truck sales to 3,464 units,' which is implausible (3,464 units is far too low for GM's truck sales). It also claims GM North America’s net sales rose 11.4% to $157.5B and EBIT-adjusted climbed to $14.5B with a margin of 9.2%, none of which are supported by the original answer. These numbers are not only absent from the ground truth but also inconsistent with typical GM financial reporting scales. (2) The original answer does not provide exact numerical sales figures or total revenue impacts—only directional improvements and the 160% variable profit metric. The LLM incorrectly introduces precise percentages and dollar amounts without basis. The 160% variable profit—a key quantitative indicator—is entirely omitted. (3) The multi-hop reasoning is partially sound in that the model recognizes a strategic evolution from risk (2022) to strength (2024), which aligns with the original. However, it fails to accurately synthesize the correct performance indicators, replacing them with fabricated metrics. (4) The contextual relevance is moderate because the answer addresses the right product line and time frame and attempts to show performance improvement. However, due to severe quantitative inaccuracies and omission of the key 160% variable profit metric, the correctness and qualitative accuracy scores are low. The answer misrepresents the evidence supporting GM’s improved market positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 506,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the nuclear decommissioning trusts moved from about $21 million (Alabama Power) and $293 million (Georgia Power) invested in U.S. Treasury and government‑agency securities to roughly $20 million and $349 million, respectively. The slight dip in Alabama’s position was more than offset by a sizable rise in Georgia’s exposure, showing that the company is deliberately increasing the share of ultra‑safe Treasury and agency holdings in the trusts to preserve capital and reduce market risk for future decommissioning obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $21 million (Alabama Power, 2022), $293 million (Georgia Power, 2022), $20 million (Alabama Power, 2024), and $349 million (Georgia Power, 2024). These match the ground truth exactly, with acceptable rounding language (e.g., 'about', 'roughly'). (2) Quantitative accuracy is perfect—no calculation errors, and the direction of change (slight decrease for Alabama, significant increase for Georgia) is accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two subsidiaries (Alabama Power and Georgia Power) and two years (2022 to 2024), identifying the net shift toward Georgia Power’s portfolio. The conclusion about increasing safer, fixed-income assets aligns with the ground truth’s interpretation of a strategic reallocation, though the LLM slightly expands the inference to 'preserve capital and reduce market risk'—a reasonable and contextually appropriate extension, not contradicted by the original. (4) All entities (Alabama Power, Georgia Power, U.S. Treasury and government agency securities, 2022–2024 timeframe) are correctly identified. The answer fully addresses both parts of the question: the evolution of allocation and the strategic implication. Only a minor deduction in qualitative accuracy due to slight interpretive expansion beyond the original answer’s more conservative 'possible reallocation' phrasing. Overall, the answer is factually correct, complete, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 421,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s financial incentives to independent bottlers remained centered on “bottler funding” that is negotiated annually and tied to performance targets, covering advertising, consumer promotions, new‑product support and vending/cooler‑equipment placement; the company records these amounts as a reduction of revenue based on contract terms and historical experience (PEP 10‑K 2024 pp. 11‑12; PEP 10‑K 2022 pp. 60, 61, 96).  Although the incentive structure is largely consistent, the 2024 disclosures highlight a shift toward more performance‑based, market‑driven funding while underscoring that exclusive territorial rights keep bottlers strategically essential for direct‑store‑delivery distribution—even as the company moves some alcoholic‑beverage distribution to trademark‑licensing models, preserving overall strategic dependency on the bottler network.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo's financial incentives to independent bottlers are structured as 'bottler funding' negotiated annually and tied to performance, covering advertising, consumer promotions, new product support, and vending equipment—consistent with the original answer's mention of trade and consumer programs. It also correctly notes the accounting treatment (reduction of revenue based on contract terms and historical experience), which aligns with the 2022 and 2024 disclosures. However, the LLM answer omits the specific quantitative insight from the original answer that Walmart alone accounted for approximately 14% of consolidated net revenue in 2024, a key indicator of strategic dependency. This omission reduces completeness and factual richness. (2) Quantitatively, no incorrect numbers are stated—the LLM avoids making up figures and accurately references the annual negotiation framework. Since it does not contradict any numeric data and only fails to include the 14% figure, the quantitative accuracy is high but not perfect. (3) The reasoning is sound in noting continuity in incentive structure while suggesting a shift toward more performance-based funding. It adds contextual detail about exclusive territorial rights and distribution models, which is plausible and relevant, though not explicitly in the ground truth. However, the claim about 'more performance-driven funding' in 2024 is an interpretive leap not directly supported in the original answer, which emphasizes structural allocation rather than performance orientation. This slightly weakens qualitative accuracy. (4) Contextual relevance is strong—the response directly addresses both financial incentives and strategic dependency, synthesizing information across 2022 and 2024 filings. The omission of the 14% Walmart revenue contribution and slight overinterpretation of 'performance-based' shifts prevent a higher score. Overall, the answer is factually grounded and well-reasoned but misses a critical data point and introduces minor unsupported nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 560,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\nAdobe Firefly went from being a newly‑trademarked AI capability in 2023—mentioned only in the trademark index and general AI‑risk language—to a broadly integrated, product‑level feature in 2024, appearing in the Acrobat AI Assistant, Creative Cloud and Document Cloud descriptions and receiving dedicated risk‑factor coverage on generative‑AI regulation, IP liability and monetisation. This shift shows that Firefly moved from an experimental side‑project to a core pillar of Adobe’s product‑innovation strategy, with the company now explicitly tying its growth to AI‑driven differentiation and acknowledging heightened regulatory and competitive risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Firefly from 2023 to 2024. It accurately reflects that in 2023, Firefly was present in trademark listings and general AI-related risk language, indicating its early-stage status. By 2024, it was elevated to a dedicated risk factor, signaling strategic importance—this core fact is correctly captured. The LLM correctly identifies Firefly's growing integration into key product lines (Creative Cloud, Document Cloud, Acrobat AI Assistant), which is consistent with its increased strategic role, though the original answer does not specify these product integrations. The emphasis on heightened regulatory risks (IP liability, generative AI regulation) is a reasonable inference from its appearance in risk disclosures and adds useful context. However, the claim that Firefly was 'newly-trademarked' in 2023 is slightly misleading—the original answer states it was already listed among trademarks, but doesn't specify if it was newly registered. Additionally, the original answer emphasizes the shift from being a registered brand to a central innovation pillar, which the LLM captures in spirit but frames more strongly as moving from an 'experimental side-project,' a characterization not explicitly supported in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates are correct. The reasoning is sound and synthesizes the multi-hop elements (trademark → risk disclosure → strategic significance) effectively. The answer is highly contextually relevant and adds value, though with minor overreach in characterizing Firefly’s 2023 status. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 495,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\nContractual rent escalations continued to provide a modest, predictable lift—about **$12.5 million net** to U.S. & Canada property revenue in 2023 (page 37)—but this gain was **tiny relative to the $209.9 million segment growth** and was explicitly “net of churn.”  In 2022, escalations were a larger share of growth because churn was lower; the 2023 surge in lease cancellations (notably T‑Mobile’s terminations under the 2020 MLA) and a **3 % churn rate** (page 35) erased much of the escalation benefit.  Consequently, the role of contractual rent escalations in driving tenant‑billing growth **diminished sharply in 2023**, with growth now being powered almost entirely by colocation/lease amendments and new tenant activity rather than escalations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core shift in the role of contractual rent escalations between 2022 and 2023, emphasizing that while escalations remained a factor, their impact was diminished in 2023 due to elevated churn—particularly from T-Mobile’s lease cancellations—and that growth increasingly relied on colocation and new leasing activity. This aligns well with the ground truth’s key point about a 'more challenging environment' for organic growth via escalations. However, the LLM introduces specific quantitative claims not present in the original answer: the $12.5 million net increase in U.S. & Canada property revenue and the $209.9 million segment growth. While these figures may appear in the source filing, they are not part of the ground truth answer derived from the knowledge graph, making their inclusion a deviation in completeness and quantitative accuracy. The 3% churn rate is correctly cited and matches the ground truth. The reasoning is sound and multi-hop—correctly linking escalations, churn, T-Mobile cancellations, and the shift in growth drivers—demonstrating strong qualitative accuracy. The answer is highly contextually relevant, directly addressing how the role of escalations changed amid increased churn. The main deduction is for introducing unsupported precise financial figures not in the ground truth, which affects quantitative accuracy despite plausible sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 389,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\nBetween 2023 and 2024 Chevron deepened its financial commitment to Tengizchevroil (TCO).  In 2023 the company’s equity‑affiliated capital outlays were about $3 billion, with roughly ½ directed to TCO’s FGP/WPMP project in Kazakhstan, and 2024‑year affiliate‑capex is projected at a similar $3 billion level, again allocating a major share to TCO’s downstream development.  At the same time, TCO’s proved‑undeveloped reserves (≈ 197 million BOE that had been idle for five + years) remained under active development, and its production contributed to Chevron’s reported affiliate output (≈ 413 million BOE of affiliate production in 2024), signalling an expanded role for TCO in both Chevron’s capital programme and its overall production portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Chevron's relationship with Tengizchevroil from capital investment to production involvement, aligning with the ground truth's narrative shift from 2023 (investment phase) to 2024 (operational phase). However, there are key quantitative inaccuracies. The original answer states that 'nearly half' of the $3 billion Affiliate Capex in 2024 was allocated to TCO, while the LLM claims 'roughly ½' in 2023 and 'a major share' in 2024—this misattributes the timing and overstates precision. The $3 billion figure is correctly projected for 2024, but the LLM incorrectly implies it was spent in 2023, whereas the original specifies it was *expected* in 2024. (2) The LLM introduces specific numbers not in the original: '≈197 million BOE' of proved-undeveloped reserves and '≈413 million BOE of affiliate production in 2024'—these figures are unsupported by the ground truth and appear fabricated. The original mentions production inclusion but provides no volume data. (3) The multi-hop reasoning is sound in concept—linking capex commitments to project development and then to production contributions—but the addition of unverified metrics undermines factual accuracy. The shift from investment to operations is correctly inferred and contextually relevant. (4) The qualitative and contextual scores are high because the answer correctly identifies the evolving nature of the relationship and uses appropriate terminology (Affiliate Capex, FGP/WPMP, production involvement). However, the quantitative accuracy is reduced due to incorrect timing of expenditures and invented production/reserve figures. Overall, the answer is directionally correct but contains significant numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 475,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\nIn 2023 UPS merely stated that it applied a “bond‑matching approach” to select bonds that would satisfy its projected U.S. pension and post‑retirement cash‑flow obligations, without describing how those bonds were chosen. By 2024 the company sharpened the methodology, explaining that the discount rate is derived by matching the plan’s expected benefit payments to a yield curve built from long‑term, high‑quality fixed‑income securities, reflecting a more granular, instrument‑level bond‑selection process.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in context but contains significant qualitative inaccuracies in describing the evolution of UPS's bond matching approach. (1) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (2) The LLM incorrectly claims that in 2024, UPS began deriving the discount rate by matching expected payments to a yield curve built from high-quality securities, implying a methodological enhancement. However, the ground truth states there was no material change in the mechanics of the method—only a subtle shift in language, with the 2024 filing stating the approach 'guides' bond selection. The LLM overstates the change as a 'sharpened methodology' and introduces the concept of a yield curve, which is not mentioned in the original answer and represents a different technical approach. (3) The multi-hop reasoning is flawed: while the model correctly identifies a progression between 2023 and 2024, it infers a more technical and granular process in 2024 that is not supported by the ground truth. The original answer emphasizes continuity in practice with only a framing shift, whereas the LLM suggests an operational evolution. (4) Contextual relevance is high because the answer addresses the right topic, timeframe, and company, and attempts to compare disclosures across years. However, the core factual claim about methodological refinement is incorrect, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 424,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium‑wholesale business moved from a growth contributor to a head‑wind: the 2024 filing shows a 2 % underlying decline in the “Other” segment, driven by lower helium volumes that trimmed about $32 million of sales.  Yet the same segment’s operating profit rose 44 % to $43 million, because an insurance recovery on LAMT more than offset the higher helium‑related costs, turning a sales dip into a net profit gain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $32 million sales decrease, 2% decline in the Other segment, and 44% increase in operating profit to $43 million are consistent with the source data. The mention of lower helium volumes impacting sales and higher helium-related costs affecting profit matches the original. (2) The calculation implications are sound—though the $32M sales impact and 2% decline are correctly linked, the LLM infers (correctly based on context) that this drove the underlying decline, which is supported. (3) The multi-hop reasoning is strong: it connects helium’s role shifting from input (implied neutral/positive in 2022) to a cost pressure in 2024, and correctly synthesizes the insurance recovery offsetting costs, leading to a net profit gain despite sales decline. (4) The only minor gap is that the LLM does not explicitly state helium’s role in 2022 beyond implying it was a growth contributor earlier; the ground truth specifies it was a 'supply input,' which adds slight context the LLM omits. However, the evolution in impact is clearly conveyed. Wording differs but semantic meaning is equivalent. No irrelevant content; fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 352,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\nBank of America’s unfunded capital commitments for renewable‑energy projects fell sharply—from **$6.2 billion at the end of 2023 to $4.6 billion at the end of 2024**, a reduction of roughly **$1.6 billion**.  At the same time, the tax credits and other tax benefits recognized from those renewable‑energy equity investments declined from **$4.0 billion in 2023 to $3.9 billion in 2024**, a decrease of about **$0.1 billion (≈$100 million)**.  (Pages 131 – 2023 and 132 – 2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. The calculated differences ($1.6 billion and $0.1 billion) are correct. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entities (Bank of America, renewable energy investments, tax credits, correct years) are accurately identified. (4) The reasoning is sound—though the LLM does not explicitly interpret the trend (e.g., 'reduction in near-term funding commitments'), it provides all necessary data and correctly synthesizes multi-hop information from two years. The inclusion of source pages adds contextual support. Semantic equivalence is maintained, with no factual discrepancies. Minor stylistic differences (e.g., use of 'fell sharply' vs. 'decreased') do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 308,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\nFrom 2022 through 2024 GM has deliberately scaled back the low‑margin, volume‑driven fleet channel—especially sales to daily‑rental companies—and now pursues commercial‑fleet business through tighter, more profitable dealer‑network agreements and, where it makes sense, direct contracts.  The 2022 filing notes that “certain fleet transactions, particularly sales to daily rental car companies, are generally less profitable than retail sales,” and the 2024 documents continue to describe fleet sales as being “completed through the dealer network and in some cases directly with fleet customers,” while emphasizing a focus on “driving an efficient, consolidated fixed‑cost structure” and managing profitability.  Consequently, the company’s fleet‑sale share has continued to shrink (from roughly 16 % of total sales in 2019 to about 11 % in 2021) and its 2024 disclosures reflect a strategic shift toward higher‑margin commercial fleets rather than broad rental‑fleet volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution in GM's fleet sales strategy from 2022 to 2024, noting the lower profitability of fleet sales (especially to daily rental companies) in 2022 and the shift toward more structured, profitable channels by 2024 using both dealer networks and direct sales. The qualitative reasoning is sound: it captures the strategic shift toward higher-margin commercial fleets and away from low-margin volume-driven rental fleet sales. The mention of fleet sale share decreasing from 16% in 2019 to 11% in 2021 is factually consistent with GM's public disclosures, though the ground truth does not include these specific percentages. Since the question focuses on 2022–2024, the inclusion of 2019 and 2021 data, while contextually relevant and accurate, slightly extends beyond the requested timeframe. Quantitatively, no errors are present in the numbers cited, but the ground truth does not mention the 16% or 11% figures, so their inclusion—while not incorrect—introduces data not confirmed by the provided source. This leads to a minor deduction in quantitative accuracy. The answer demonstrates strong multi-hop reasoning by connecting profitability concerns, channel evolution, and strategic intent across years. Wording differs from the original answer but maintains semantic equivalence and adds contextual depth. All entities (General Motors, commercial fleet customers, dealer network, direct sales) are correctly identified and appropriately contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 426,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s stake in the Sabra joint‑venture shifted from a 50 % equity interest that was carried at cost to an equity investment that was re‑measured at fair value.  In 2024 the company recorded a **pre‑tax gain of $122 million (≈ $92 million after‑tax)** on that re‑measurement, which was booked in selling, general and administrative expenses (see page 73).  The one‑time gain lifted net income and earnings per share, reflecting the increased fair‑value of PepsiCo’s previously held 50 % ownership in Sabra.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in the description of PepsiCo's ownership stake in Sabra in 2022, which undermines the correctness score despite some accurate elements. According to the ground truth, PepsiCo owned the Sabra brand fully in 2022 as part of its joint venture portfolio, but by 2024 had reduced its ownership to a 50% equity stake, which was remeasured at fair value, resulting in a $122 million pre-tax gain. However, the LLM incorrectly states that in 2022 PepsiCo already had a 50% equity interest, implying no change in ownership percentage—this contradicts the original answer’s claim of a divestment and strategic shift. This misrepresents the nature of the change in relationship: the key event is the partial divestiture (from full ownership to 50%), not merely a change in accounting treatment of an unchanged stake. The $122 million pre-tax gain is correctly reported, as is the after-tax approximation and the impact on financials. The mention of SG&A on page 73 may be contextually accurate but is not in the ground truth and cannot be verified. The reasoning is partially sound in linking remeasurement to gain recognition, but fails the multi-hop synthesis by not correctly identifying the change in ownership structure over time. While the financial implications are well-articulated, the core entity relationship evolution is misrepresented, leading to a moderate score. Quantitative accuracy is acceptable (correct dollar figures, percentages), but the incorrect baseline ownership affects the interpretation. Contextual relevance is high—the answer addresses the financial implications and timeframe directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 451,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe Scan moved from being listed simply as a standalone app inside the Document Cloud suite to being presented as a core, AI‑enhanced component of Adobe’s cloud‑based content workflow. The 2024 filing emphasizes that Scan now works tightly with Adobe Express and Firefly‑powered services—offering generative‑AI scanning features, commercial‑safe “Content Credentials,” and seamless integration across Adobe’s Creative Cloud, Stock and Frame.io ecosystems—whereas the 2023 filing treated it merely as one of several Document Cloud apps. This reflects a shift toward positioning Adobe Scan as part of an integrated, AI‑driven content creation and collaboration platform rather than an isolated scanning tool.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant factual inaccuracies not supported by the ground truth. (1) Correct elements: The general direction of evolution—from a standalone app to a more integrated role—is consistent with the original answer. The mention of Document Cloud is accurate contextually. (2) Quantitative accuracy: There are no numeric values in either answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning: The LLM overreaches by asserting integration with Adobe Express, Firefly, Creative Cloud, Stock, and Frame.io, and by claiming AI-enhanced features and 'Content Credentials' in 2024. These specific integrations and capabilities are not mentioned in the ground truth and represent unsupported elaboration. The original answer only confirms that by 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud alongside Acrobat and Acrobat Sign—no broader ecosystem integrations or AI features are cited. (4) The answer is contextually relevant and addresses the question’s focus on product positioning evolution, but the added details, while plausible, are not factually substantiated by the provided ground truth. This results in a moderate correctness score: core idea of increased integration is correct, but key details are fabricated or exaggerated, undermining factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 378,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification exposure to Stellantis has remained modest and largely unchanged: the 2017 sale agreement obligates GM to cover certain historical losses—such as emissions violations, product‑liability claims and recall matters—subject to caps, thresholds and expiration dates extending to 2029, and GM has recorded only insignificant accruals because it cannot reasonably estimate any additional loss.  In both the 2022 and 2024 filings the company reiterates that it is “unable to estimate any reasonably possible material loss” from these indemnity claims, noting that any future indemnification (e.g., for further Takata‑related recalls) is considered remote, and the existing obligations are already covered by the minimal reserves it has set aside.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements of the ground truth but misses critical evolution in the nature of GM's obligations from 2022 to 2024, which is central to the question. Quantitatively, the answer is mostly accurate: it correctly references the 2017 sale agreement, mentions emissions, product liability, and recalls (including Takata), and notes that accruals are immaterial or insignificant—consistent with the 'immaterial amount' in the original answer. It also correctly states that GM cannot estimate a reasonably possible loss and considers further indemnification remote, aligning with the ground truth’s implication of reduced exposure. However, the LLM incorrectly implies that the exposure has 'remained modest and largely unchanged' from 2022 to 2024, which contradicts the original answer’s key point of a shift from operational supply relationships in 2022 to indemnification-based financial exposure by 2024. This transformation is a core aspect of the multi-hop reasoning required, and the LLM fails to acknowledge the change in nature (from supply transactions to guarantees/indemnifications), instead focusing only on continuity of indemnity terms from the 2017 agreement. Additionally, the LLM introduces details not in the ground truth—such as caps, thresholds, and expiration dates extending to 2029—without confirmation from the provided answer, risking overreach. While the entities (GM, Stellantis, Takata, emissions lawsuits) and years (2022, 2024) are correct, the reasoning downplays the evolution of the relationship. Thus, while factually plausible and contextually relevant, the answer lacks the necessary qualitative shift description, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 464,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s co‑packing relationship moved from a largely outsourced model toward a more strategic partnership.  The company still depends on a globally dispersed network of co‑packer‑owned plants and distribution centers (as disclosed in both the 2022 and 2024 filings), but the 2024 disclosures highlight deeper equity‑based alliances and joint ventures—such as the Juice Transaction and investments in Celsius—showing increased operational reliance and a more strategic role for co‑packers in PepsiCo’s growth and productivity initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in PepsiCo's relationship with co-packers from operational dependency to more strategic involvement between 2022 and 2024, aligning with the ground truth. It accurately reflects that PepsiCo continued to rely on a distributed network of co-packer-owned facilities in both years, which supports the notion of ongoing operational dependency. The mention of 'equity-based alliances and joint ventures' in 2024 correctly captures the shift toward strategic involvement. However, the LLM introduces specific examples—'the Juice Transaction' and 'investments in Celsius'—that are not present in the original answer or supported by the provided ground truth, which only refers to general strategic alliances or joint ventures with equity interest. These additions, while plausible, represent unsupported specifics and slightly misrepresent the source information by implying known transactions not cited in the ground truth. There are no numerical values in the question or answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. The reasoning is mostly sound and shows appropriate multi-hop synthesis across time periods and strategic framing, but the inclusion of unverified examples reduces qualitative accuracy. The answer remains contextually relevant and addresses both operational dependency and strategic involvement as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 399,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\nBetween 2023 and 2024 SPG’s stake in ABG was gradually divested: in Q4 2023 it sold a portion of its interest, recognizing a $157.1 million pretax gain (plus a $10.3 million non‑cash gain from a deemed disposal) and reducing its ownership to roughly 9.6 %; in Q1 2024 it sold the remaining interest for $1.2 billion, generating a $414.8 million pretax gain (with $103.7 million of related tax expense).  While these transactions wound down the ABG relationship, SPG made strategic investments in the TRG joint venture—acquiring an additional 4 % interest for about $199.6 million in Q3 2023 and a further 4 % for roughly $266.7 million in Q4 2024—bringing its non‑controlling ownership in TRG to 88 % without altering governance rights.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the financial relationship between SPG and ABG in both years. (1) Quantitative Accuracy: The $157.1 million gain from the sale of a portion of SPG's ABG interest in 2023 matches the ground truth, but the additional $10.3 million non-cash gain from a deemed disposal contradicts the ground truth, which reports a $59.1 million gain from deemed disposals due to ABG's capital transactions. The $414.8 million gain in Q1 2024 from selling the 'remaining interest' is entirely fabricated, as is the $1.2 billion sale price and $103.7 million tax expense. The ground truth states that in 2024, SPG disclosed an $18.8 million gain from the December 2021 sale of a portion of its ABG interest—not a 2024 transaction. The TRG joint venture investments (e.g., $199.6M, $266.7M) are unrelated to ABG and not mentioned in the original answer, introducing irrelevant information. (2) Completeness: The answer fails to mention the $145.8 million gain from dilution of SPG’s ownership in SPARC Group in 2023 and omits the key strategic shift in 2024—SPG becoming the core licensee and operating partner for Reebok in the U.S. through a partnership with ABG. Instead, it incorrectly frames the relationship as winding down. (3) Entity Accuracy: While SPG and ABG are correctly identified, the introduction of TRG and SPARC is misleading without clarification of their relationship to ABG. The dates are also wrong—December 2021 transaction reported in 2024, not occurring in 2024. (4) Reasoning: The multi-hop synthesis is flawed. The model incorrectly infers a full divestment of ABG interests and replaces the actual strategic evolution with fabricated transactions and unrelated investments. It fails to connect the 2024 disclosure of a past gain with the new operational collaboration. (5) Semantic Equivalence: The overall narrative contradicts the ground truth: rather than a shift from financial gains to strategic collaboration, the LLM claims a complete exit followed by unrelated investments. Only partial number matches (e.g., $157.1M) prevent a score of 0. Minor credit is given for mentioning ABG and some correct figures, but core facts and direction of the relationship are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 599,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin accelerated production on its Sikorsky helicopter portfolio—particularly the CH‑53K King Stallion, UH‑60 Black Hawk and Seahawk families—while also expanding the program scope to include new variants and the completion of the VH‑92A Presidential‑helicopter delivery in 2024.  The company’s own cost disclosures cite billions of dollars of higher product costs tied to the increased volume on these Sikorsky programs, underscoring both the rise in output and the broader program envelope over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key Sikorsky helicopter programs (CH-53K, Black Hawk, Seahawk) and notes increased production volume and expanded scope from 2022 to 2024, aligning with the ground truth. It also correctly references the 2024 completion of the VH-92A Presidential helicopter delivery, which is consistent with known program timelines. However, the LLM claims 'billions of dollars' in higher product costs, while the ground truth specifies a $560 million increase in 2022—this is a significant overstatement and factually inaccurate. (2) Quantitative accuracy is compromised due to this exaggeration: $560 million is not equivalent to 'billions' (plural), which implies at least $2 billion. The correct figure should have been cited or approximated accurately. (3) The multi-hop reasoning is sound—LLM synthesizes production volume increases, program scope expansion, and strategic importance across years and programs. It correctly infers growing strategic emphasis from cost drivers to core portfolio components, even if not explicitly stating the 'cost driver to strategic line' evolution. (4) Contextual relevance is perfect—the answer directly addresses both production volume and program scope evolution as asked. Qualitative accuracy is high due to correct entities, logical flow, and inclusion of new variants and VH-92A completion. Correctness score is 7 due to accurate core facts but major error in quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 405,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s stake in Alert Innovation moved from 0 % to 100 % after it invested roughly $0.4 billion to acquire the remaining shares in fiscal 2023; the company then held a full‑ownership position throughout fiscal 2024 with no additional capital outlay or change in its ownership percentage.  The investment remained at the $0.4 billion acquisition cost (plus any subsequent adjustments) and was later sold and de‑consolidated in fiscal 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM correctly identifies the $0.4 billion investment and Walmart's move to 100% ownership in fiscal 2023, which aligns with the ground truth. However, it incorrectly states that Walmart maintained full ownership throughout fiscal 2024, whereas the original answer explicitly states there was no mention of Walmart retaining ownership in fiscal 2024, indicating a full exit. The LLM also introduces a claim about de-consolidation in fiscal 2025, which is not supported by the provided ground truth and adds information outside the scope. (2) Quantitatively, the $0.4 billion figure and 100% ownership are accurate, and format usage is consistent. No calculation errors are present, but the temporal assignment of events (fiscal 2024 vs. 2025) is incorrect. (3) The multi-hop reasoning fails in synthesizing the absence of ownership in fiscal 2024 as an indicator of divestiture. Instead, the model assumes continued ownership into 2024 and invents a future event (2025 de-consolidation) not present in the source. This breaks the logical chain required by the question. (4) While the answer is contextually relevant and addresses the evolution of ownership and investment, it contradicts the key conclusion of the ground truth—exit by fiscal 2024—making it partially correct but factually misaligned on the critical point of ownership duration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 373,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\nIn 2023 the Supplemental Facility was a $3.5 billion unsecured revolving line with an earlier maturity, while in 2024 it was expanded to a $3.5‑$4.5 billion facility extended to a Jan 31 2029 maturity (extendable to 2030) and priced at SOFR + 72.5 bp. The company has been actively borrowing under the enlarged line—using proceeds for acquisitions and refinancing—while following a structured repayment schedule, as reflected by $1.9 billion of net debt repayments in 2024 and principal maturities of $2.68 billion in 2025, $7.35 billion in 2026‑27 and $2.97 billion in 2028‑29, with the remainder due after 2029.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical aspects. (1) Quantitatively, the LLM claims the Supplemental Facility was expanded in 2024 to $3.5–$4.5 billion with a maturity of January 31, 2029, and that SPG made $1.9 billion in net debt repayments in 2024, with future maturities of $2.68B in 2025, $7.35B in 2026–27, and $2.97B in 2028–29. None of these figures appear in the ground truth, and crucially, the ground truth states there was *no outstanding balance* under the Supplemental Facility in 2024, indicating full repayment and disuse. The LLM instead portrays active borrowing and a larger, extended facility—directly opposite to the truth. (2) The ground truth confirms SPG borrowed €750.0 million in 2023 and repaid it on November 17, 2023, after issuing bonds. The LLM omits this key fact and instead fabricates details about facility expansion and ongoing use. (3) Qualitatively, the reasoning is flawed: the LLM suggests SPG increased reliance on the Supplemental Facility in 2024, while the ground truth shows a strategic *reduction* in reliance, shifting to long-term unsecured notes like the $1.0 billion issuance in September 2024. The LLM fails to mention this refinancing shift, a core part of the correct answer. (4) Contextually, while the answer discusses debt facilities and repayment schedules, it misidentifies the evolution entirely—answering a different question about facility terms and future maturities rather than the actual utilization and repayment strategy shift. The only minor relevance is the mention of refinancing, but without correct context or supporting facts. Overall, the answer fabricates facility terms, misrepresents borrowing activity, and misses the core narrative of strategic repayment and reduced reliance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 489,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\nBetween 2023 and 2024 Linde did not reposition helium as a newly‑created product line; it remained classified under “process gases” (alongside oxygen, nitrogen, argon, hydrogen, etc.) and continued to be sold through the same three distribution channels.  The 2024 sales tables show helium (as part of the packaged‑gas portfolio) contributing to the 35 % of total sales generated by packaged‑gas shipments, and the company’s supply strategy still relies on merchant‑truck deliveries and cylinder‑filling facilities rather than dedicated on‑site plants.  Consequently, helium’s role as a high‑value, primary product stayed stable, with emphasis on expanding its reach within packaged‑gas contracts and leveraging long‑term merchant supply agreements rather than a fundamental shift in positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies that contradict the ground truth. (1) It incorrectly states that helium remained a clearly classified 'primary product' under 'process gases' in 2024, while the original answer confirms that helium was no longer specifically named as a distinct product in 2024, indicating a strategic de-emphasis. The ground truth shows a shift in positioning, but the LLM denies such a change, claiming stability in helium's role—this is factually incorrect. (2) The LLM cites that 'helium (as part of the packaged-gas portfolio)' contributed to 35% of total sales from packaged-gas shipments in 2024; however, this specific percentage and attribution to helium are not supported in the ground truth, which does not provide any numerical sales breakdown for helium. This introduces a fabricated quantitative claim. (3) The assertion that supply strategy 'still relies on merchant-truck deliveries and cylinder-filling facilities' aligns partially with the 2023 description of merchant delivery, so this aspect is consistent. However, the LLM fails to note the removal of specific mention of long-term contracts (3–7 years) without minimum purchase requirements in 2024, which was a key detail in the original answer showing a shift in contractual emphasis. (4) The multi-hop reasoning is flawed: the model should have detected the absence of helium as a named product in 2024 versus its explicit listing in 2023, but instead asserts continuity. This reflects a failure in comparative document analysis across years. While the answer is relevant to the question and discusses positioning and supply, it draws the opposite conclusion of the ground truth. Thus, despite some correct context (e.g., distribution methods), the core factual and qualitative claims are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 495,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the U.S. Retiree Health Care Plan shifted its asset mix markedly toward fixed‑income.  In 2022 the plan held roughly **$248 million of fixed‑income securities and $137 million of equity securities** (≈64 % fixed‑income, 36 % equity) — as disclosed in the 2022 filing (page 48 of TXN_10k_2022.pdf).  By the end of 2023 those amounts had fallen to **$210 million in fixed‑income and $54 million in equity**, moving the allocation to about **80 % fixed‑income and 20 % equity** — see the 2023 data on page 48 of TXN_10k_2023.pdf.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly reports the dollar amounts for fixed income and equity securities in both 2022 and 2023: $248 million and $137 million in 2022, and $210 million and $54 million in 2023, matching the ground truth. However, the reasoning and interpretation are flawed. The LLM claims the plan 'shifted its asset mix markedly toward fixed-income', which is incorrect because both asset classes decreased, and the proportion of fixed income increased only due to a larger percentage drop in equities, not an active shift toward fixed income. The percentage calculations (64% and 36% in 2022; 80% and 20% in 2023) are mathematically correct based on totals of $385M and $264M, but the characterization of this change as a strategic 'shift toward fixed-income' misrepresents the data. The ground truth correctly identifies that both categories decreased, with a more significant reduction in equities. The LLM fails in qualitative reasoning by drawing an incorrect conclusion from accurate numbers. While the context and entities (plan name, years, document sources) are accurate and relevant, the misinterpretation of the allocation change undermines the correctness. Thus, quantitative accuracy is partially correct (minor deduction for implying precision with 'million' when original uses bare numbers), but qualitative accuracy suffers due to flawed logic in multi-hop synthesis and conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 386,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s worldwide sales jumped from **$680 million to $1.06 billion**, a **≈56 % increase**, driven by stronger demand across its existing indications and expanding use in new patient populations.  In 2023 the company also achieved two key regulatory milestones – **FDA (and EU) approval of Trodelvy as a monotherapy for metastatic HR⁺/HER2‑ breast cancer after prior endocrine therapy and chemotherapy**, and **EU approval for the same breast‑cancer indication** – reinforcing its strategic importance as a flagship oncology asset and a primary growth engine for Gilead.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Trodelvy generated $380 million in product sales in 2022; however, the LLM claims $680 million, which is nearly double the correct amount. The LLM also states 2023 sales were $1.06 billion with a 56% increase, but the original answer explicitly states that specific revenue figures for 2023 are not provided—making the LLM's precise numbers and calculation entirely fabricated. (2) The quantitative inaccuracies are severe: both the 2022 and 2023 revenue figures are incorrect, and the 56% growth calculation is based on false inputs. No revenue data for 2023 exists in the ground truth, so any numerical claim is unsupported. (3) On qualitative aspects, the LLM correctly identifies key regulatory milestones in 2023: FDA and EC approval for HR+/HER2- metastatic breast cancer. This aligns with the original answer and shows correct multi-hop synthesis of regulatory developments. However, it misrepresents the strategic context by implying revenue growth data supports the strategic shift, when such data is only partially available. (4) Contextual relevance is moderate—the answer addresses both financial performance and strategic positioning as asked, and correctly highlights regulatory approvals. However, the core financial claim is false, undermining the answer's validity. Correctness and quantitative accuracy are severely penalized due to invented figures; qualitative accuracy is low due to unsupported synthesis; relevance remains acceptable due to proper framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 432,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron’s 50 % equity in GS Caltex stayed roughly constant at about $3.6 billion (see Note 15 of the 2024 10‑K), while the JV’s downstream earnings shifted from a $185 million loss in 2020 to modest positive contributions in 2022‑2024, a turnaround highlighted in the 2024 filing’s discussion of “higher downstream‑related earnings from … GS Caltex in Korea.”  This improvement shows that the joint venture has become a strategically vital downstream asset, delivering reliable profit and market access in the Korean market for Chevron.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it claims Chevron's 50% equity in GS Caltex stayed at $3.6 billion, a figure not present in the original answer and unsupported by the provided ground truth. The original answer does not mention any valuation of Chevron's equity stake. Second, the LLM references a $185 million loss in 2020 and a turnaround from that year, but the question and original answer focus on 2022–2024, making the 2020 data irrelevant and potentially misleading. The original answer confirms higher downstream earnings in 2022 from GS Caltex but does not quantify them or mention prior losses. (2) The LLM incorrectly introduces specific numbers not in the ground truth: $3.6 billion equity value and $185 million 2020 loss. While it correctly notes the 50% ownership in 2024, it fails to mention the key revenue figures from affiliated companies: $13,850 million in 2024 vs $16,286 million in 2022, which are central to the original answer. These omissions and fabrications severely impact quantitative accuracy. (3) The reasoning partially captures the strategic importance of the JV by noting improved earnings and market access, aligning with the original's conclusion. However, it misrepresents the trend by ignoring the decline in affiliated revenues and overstating the strategic elevation as 'vital' and 'reliable profit,' whereas the original indicates continued importance but with slightly decreased revenue contribution. This reflects flawed multi-hop synthesis—using external data (e.g., 2020 loss) not in the ground truth and drawing stronger conclusions than supported. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of earnings, investment, and strategic importance. It correctly identifies the 50% stake and the downstream earnings improvement mentioned in the 2024 filing. However, the inclusion of unverified figures and misaligned timeframes reduces factual correctness. Hence, the correctness score is 5—partially correct but with significant factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 559,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\nFrom 2022 through 2024 the CH‑53K moved from low‑rate initial production to a sustained ramp‑up, with production volume growing enough to generate about **$120 million of additional operating profit in 2024** (the “higher volume and program‑ramp‑up” cited in Aeronautics’ 2024 profit discussion) and backlog expanding as new orders were booked.  At the same time, the program realized several **risk‑retirement adjustments—positive profit‑booking rate changes that added several hundred million dollars of margin over the period—reflecting improved cost estimates and the resolution of earlier overruns**.  Consequently, both the quantity of CH‑53K aircraft produced and the profitability of the program have trended upward, driven by higher risk retirements and increasing order flow.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the CH-53K generated about $120 million of additional operating profit in 2024, which directly contradicts the ground truth stating that RMS operating profit declined by 73% in 2024 and that no specific CH-53K profit figures were disclosed. The ground truth also does not support the claim of 'several hundred million dollars of margin' from risk retirements over the period—while $140 million in increased profit was attributed to CH-53K in 2022, there is no cumulative figure provided for 2022–2024. (2) Quantitative accuracy is low: the $120M figure for 2024 is incorrect and unsupported; the ground truth indicates declining profitability in RMS, not increasing. The reference to 'positive profit-booking rate changes' in 2024 conflicts with the ground truth noting lower profit booking rates as a cause of the 73% decline. (3) The reasoning is flawed in its multi-hop synthesis: the model incorrectly infers continued profit growth into 2024 despite evidence of a broad profit decline and maturation of risk retirements. It misattributes Aeronautics’ 2024 profit discussion to CH-53K without evidence, while the ground truth suggests the opposite trend. (4) Contextual relevance is moderate—the answer addresses production ramp-up and risk retirements as asked, but draws incorrect conclusions. While it correctly identifies the program's importance and production growth trend, the core financial claims are factually wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 427,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal shifted from merely reporting the modest loss‑rate of its seller‑protection programs (0.09‑0.15 % of TPV) and warning that macro‑economic stress could raise exposure, to positioning those programs as a strategic growth driver.  The 2023 filing emphasizes that protecting merchants is integral to its value proposition, leverages the company’s two‑sided data platform, and involves continual investment in risk‑management systems, while still noting that loss exposure may increase if economic or regulatory conditions deteriorate.  In short, the approach evolved from risk awareness to a proactive, competitive‑differentiation focus on seller protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in PayPal's approach to seller protection between 2022 and 2023. It accurately notes the 2022 focus on risk exposure with transaction loss rates between 0.09% and 0.15% of TPV, and the 2023 shift toward strategic emphasis as a competitive differentiator. The core facts—loss rate range, strategic reframing, integration with risk systems and data platform, and continued caution about macroeconomic and regulatory risks—are all present and correct. (2) Quantitative accuracy is perfect: the 0.09%–0.15% TPV loss rate range is correctly cited, and no calculations are required beyond accurate reporting. Format (0.09–0.15%) matches ground truth semantically. (3) Multi-hop reasoning is sound: the model synthesizes information across two years, contrasting risk-focused messaging in 2022 with growth- and value-proposition-oriented framing in 2023. It correctly links seller protection to merchant trust, platform growth, and data analytics, reflecting the broader strategic integration noted in the original answer. (4) The only minor shortcoming is a slight omission of explicit mention of 'regional variations' as a 2022 risk factor, though 'regulatory conditions' are mentioned. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 405,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Starbucks eliminated the bulk of its ready‑to‑drink revenue that had previously flowed through the Nestlé‑controlled Global Coffee Alliance—​the $125 million contribution that was reported in 2023 vanished after the Seattle’s Best Coffee sale in Q2 2023 (Financial Highlights, 2023, p. 39).  In 2024 the RTD products are now captured in “Other revenues” and are recognized when control of the product passes to the customer, i.e., upon shipment, and the company continues to rely on several specialty suppliers under long‑term contracts, a dependency it describes as carrying a remote risk of non‑delivery (Risk Related to Supply Chain, p. 15; Revenue‑recognition discussion, p. 65).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The claim that Starbucks eliminated $125 million in ready-to-drink (RTD) revenue due to the sale of Seattle’s Best Coffee in Q2 2023 is not supported by the original answer or typical SEC filing data. The ground truth makes no mention of this sale impacting RTD revenue or of a $125 million figure vanishing. This number appears fabricated or misattributed. (2) ENTITY & TEMPORAL ERROR: The reference to the 'Nestlé-controlled Global Coffee Alliance' as a source of RTD revenue that was discontinued is not reflected in the original answer, which does not mention Nestlé or any such alliance. This introduces a major entity and contractual relationship not present in the ground truth. (3) REASONING FLAW: The LLM implies a causal link between the Seattle’s Best sale and the elimination of RTD revenue, which is not corroborated by the ground truth. The original answer describes an evolution in reporting and strategic focus—not a discontinuation of revenue. (4) PARTIAL CORRECTNESS: The LLM correctly notes that in 2024, RTD revenue is included in 'Other revenues' and recognized upon shipment (control transfer), aligning with the original answer’s description of revenue recognition. It also correctly identifies reliance on specialty suppliers under long-term contracts and mentions remote delivery risk, which is consistent with the supply chain focus in 2024. (5) SEMANTIC DIVERGENCE: While the LLM captures the 2024 supplier dependency theme, it misrepresents the 2023 situation as involving a now-eliminated revenue stream rather than a different reporting emphasis. The core evolution described in the ground truth—shift from revenue reporting to supply chain risk management—is partially recognized but overshadowed by incorrect narrative elements. Thus, despite some accurate qualitative elements, the introduction of unsupported financial figures and entities severely reduces factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 543,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory footprint grew – the European Commission granted a new monotherapy approval for advanced HR⁺/HER2⁻ breast cancer (a 2022/2023 expansion beyond the 2021 EU approval for metastatic triple‑negative breast cancer), and the U.S. FDA subsequently approved the same HR⁺/HER2⁻ breast‑cancer indication (previously approved only for urothelial cancer and TNBC). These actions extended the drug’s geographic reach to the EU for a new cancer type and reinforced its U.S. presence, while earlier approvals in Canada and other regions remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory approvals for Trodelvy in 2022–2023 — FDA and EC approvals for HR+/HER2- metastatic breast cancer — which aligns with the ground truth. However, it introduces information not present in the original answer, such as references to prior approvals in 2021 for triple-negative breast cancer (TNBC) and urothelial cancer, and mentions of Canada and other regions, which were not part of the ground truth and cannot be verified from the provided context. (2) Quantitative accuracy is partially compromised: the original answer specifies $370M U.S. sales and $10M in Europe in 2022, but the LLM answer omits all sales figures entirely, missing a key quantitative component of the geographic reach assessment. This omission significantly affects completeness and numerical accuracy. (3) The multi-hop reasoning is sound in linking regulatory approvals to expanded geographic and therapeutic reach, and the synthesis of FDA and EC actions is logically presented. However, the inclusion of unverified prior approvals and regions (Canada, etc.) introduces unsupported details, weakening the factual basis. (4) Despite missing sales data, the answer remains contextually relevant by addressing both regulatory evolution and geographic implications. The core reasoning about expanded market access is consistent with the ground truth, warranting a score of 7 for overall correctness. Quantitative accuracy is lower due to missing numbers, while qualitative and contextual scores remain high due to accurate reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 435,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\nIn 2023 Simon Property Group’s ownership in ABG was gradually diluted – from roughly a 12 % stake at the beginning of the year to about a 9–10 % stake by year‑end – as ABG completed a series of capital transactions that produced non‑cash pretax gains of $36.4 million (Q2), $12.4 million (Q3) and $157.1 million (Q4 sale of a portion) plus a $10.3 million gain from a deemed disposal.  In early 2024 SPG sold its remaining ABG interest for $1.2 billion, recognizing a $414.8 million pretax gain and reducing its ownership to zero.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) experienced multiple dilutions in 2023, reducing its stake from 12.3% to 11.8%, then 11.7%, and finally to 9.6%, with corresponding non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M. The LLM incorrectly states a $157.1 million gain in Q4 and a $10.3 million gain from a 'deemed disposal'—the latter of which is misaligned in context and magnitude. Most critically, the LLM falsely claims that in early 2024, SPG sold its remaining ABG interest for $1.2 billion and recognized a $414.8 million pre-tax gain, reducing ownership to zero. This is entirely incorrect: the ground truth states that SPG did not report any new transactions in 2024 and only referenced a prior 2021 transaction. (2) Quantitative accuracy is severely compromised: the $157.1M and $414.8M gains are fabricated; the $1.2B sale is unsupported. The stake reduction is approximated (9–10%) but misses the precise steps. (3) Multi-hop reasoning fails: the model invents a major 2024 transaction instead of recognizing the shift to passive disclosure. It misrepresents the nature of 2024 reporting and ignores the reference to the 2021 transaction. (4) Contextual relevance is moderate because the answer addresses ownership evolution and financial gains, but the incorrect data and invented events undermine the response. The core conclusion—that SPG moved from active dilution in 2023 to no new activity in 2024—is reversed in the LLM’s narrative, which instead claims a full exit in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 436,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the 2012 Equity Incentive Plan was updated with a **fourth amendment** (effective August 1 2024) that builds on the **third amendment** disclosed in the 2023 Form 10‑K (filed February 2 2023).  The 2024 filing also adds a new set of award‑agreement templates—“Additional Forms” (Exhibit 10.2(K)+) filed in a 10‑Q on April 25 2024—indicating that the plan’s governing documents and the forms of equity awards were revised for the current year.  Thus, the plan has been amended twice in the last two years and the 2024 filing introduces updated award‑agreement language to reflect those changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Fourth Amendment is correctly dated August 1, 2024, and builds on the Third Amendment disclosed in the 2023 filing. The mention of new award agreement forms from April 2024 (specifically via a 10-Q on April 25, 2024) matches the 'Additional Forms' referenced in the ground truth. (2) Quantitative accuracy is perfect: dates (August 1, 2024; April 25, 2024; February 2, 2023) are correctly cited, and the sequence of amendments (Third and Fourth) is accurate. Format variations (e.g., 'Fourth Amendment' vs 'Fourth Amendment dated August 1, 2024') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2023 and 2024 filings, identifies the evolution of the plan through amendments, and links the introduction of new award forms to the timeline. (4) The only minor shortcoming is that the LLM refers to the 2023 filing as a 'Form 10-K filed February 2, 2023', which may be technically correct but slightly narrows the scope compared to the more general '2023 filing' in the ground truth—this does not affect factual correctness but slightly reduces qualitative precision. Otherwise, the answer is complete, relevant, and conveys the same evolution and expansion of the plan as the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 381,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\nThe company’s capitalized software‑license balance rose from **$152 million at the end of 2022 to $223 million at the end of 2023** (see TXN_10K_2023.pdf page 27), and the corresponding amortization expense increased from **$54 million in 2022 to $63 million in 2023** (see TXN_10K_2023.pdf page 28).  This upward movement indicates that Texas Instruments is investing more heavily in acquiring or internally developing software licenses, signaling a strategic emphasis on expanding its software‑related assets and the associated revenue‑generating potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the capitalized software license balances for 2022 ($152 million) and 2023 ($223 million), matching the ground truth. It also adds amortization expense figures ($54M in 2022, $63M in 2023), which are not present in the original answer but are factually accurate and support the conclusion. These numbers are cited from the correct document (TXN_10K_2023.pdf) and specific pages, enhancing credibility. (2) All numeric values are accurate, properly formatted, and consistent with acceptable variations. The increase in both carrying value and amortization expense is correctly interpreted as evidence of increased investment. (3) The multi-hop reasoning is sound: the model synthesizes balance sheet data and expense data across years to infer growing investment in software licensing. It correctly notes the continuity in accounting policy (implied by consistent amortization) even though it doesn't explicitly restate the straight-line method mentioned in the original answer. This is a minor omission but does not detract significantly from the overall accuracy. (4) The LLM answer conveys the same core insight as the ground truth—increasing investment in software licensing—and supports it with stronger quantitative evidence. The strategic interpretation about revenue-generating potential is a reasonable extension. The only reason for not scoring a 10 is the omission of the explicit mention of the unchanged amortization policy (straight-line basis), which was part of the original answer’s qualitative assessment of 'treatment' evolution. However, the implication is preserved through the consistent reporting of amortization expense. All other aspects meet or exceed the ground truth in clarity and support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 481,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal may earmark for credit‑product funding fell modestly—from **$3.8 billion (≈ 37 % of eligible European balances) in 2022 to $3.0 billion (≈ 39 % of eligible balances) in 2023**.  The decline in absolute dollars is offset by a slightly higher share of the remaining balances being designated for credit use, indicating that PayPal is leaning more heavily on the **efficient deployment of its existing European deposit pool** to meet liquidity needs for its growing credit portfolio, while still supplementing that source with external partnerships and third‑party funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key quantitative figures: $3.8 billion in 2022 (37%) and $3.0 billion in 2023 (39%), which match the ground truth exactly. These numbers are presented with appropriate context and formatting variations (e.g., using ≈ and spacing) that do not affect accuracy. (2) However, the LLM omits a critical piece of strategic information from the original answer: PayPal’s new €40 billion agreement to sell consumer installment receivables, with $5.5 billion sold in 2023. This is a significant multi-hop element indicating a strategic shift toward external funding mechanisms, which the LLM only alludes to vaguely with 'external partnerships and third-party funding' without specifying the scale or nature of the transaction. (3) The reasoning about increased efficiency in utilizing a higher percentage of available balances despite a lower absolute amount is sound and correctly synthesizes the two-year comparison. The conclusion about efficient deployment of the deposit pool aligns with the ground truth. (4) While the core quantitative and qualitative analysis is accurate, the omission of the €40 billion program and specific $5.5 billion sale reduces completeness and weakens the full strategic picture, warranting a score of 8 for correctness. Quantitative accuracy is high (9) due to correct numbers and percentages. Qualitative accuracy is also strong but docked for missing key strategic detail. Contextual relevance is perfect—response directly addresses the evolution and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 427,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the carrying amount of Starbucks’ limited‑partner interest in Valor Siren Ventures I L.P. (and its sister fund II) grew sharply – the balance‑sheet “Other investments” line rose from about **$24 million as of Oct 1 2023** to **$211.9 million as of Sep 29 2024** (page 75 / 76).  This increase is recorded in shareholders’ equity as part of “Other investments” and any resulting gains or losses are reported in “interest income and other, net” on the consolidated statement of earnings, but the amounts have been immaterial to Starbucks’ overall financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The claimed carrying value of $24 million as of October 1, 2023, is incorrect — the original answer states that the carrying value for Valor Siren Ventures I L.P. in fiscal 2023 was not specifically disclosed. The $24 million figure is fabricated or misattributed and not supported by the ground truth. (2) While the 2024 carrying value of $211.9 million as of September 29, 2024, is accurate and correctly cited, the LLM incorrectly attributes this increase to a rise from $24 million in 2023, implying a direct year-over-year growth that cannot be verified due to lack of disclosed 2023 data. (3) The LLM combines Valor Siren I and II in both years, but the original answer only provides a combined value for 2024, not 2023, making the comparison invalid. (4) The qualitative description of financial impact being reported in 'interest income and other, net' and being immaterial aligns with the ground truth, showing correct understanding of accounting treatment. (5) The reasoning is partially sound in tracking the evolution of the investment, but the unsupported numerical comparison undermines the multi-hop synthesis. (6) Contextually, the answer addresses the right question about evolution in carrying value and financial impact, but the inclusion of false quantitative data severely reduces factual correctness. Minor formatting issues (e.g., 'Oct 1 2023' vs 'fiscal 2023') are acceptable, but invented numbers are not. Thus, while the direction of evolution and reporting classification are correct, the core quantitative claim is false, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 457,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\nBetween 2022 and 2023 TI refined the strategic positioning of its Analog business by re‑emphasizing the same four sustainable competitive advantages—strong manufacturing foundation, a broad portfolio, extensive market reach and long‑life product diversity—while sharpening its focus on the industrial and automotive end‑markets that offer the highest growth.  In 2023 Analog generated roughly $13 billion of revenue, about 74 % of total sales, and delivered operating margins above 50 %, supplying the majority of operating profit and free‑cash‑flow that drive TI’s capital‑allocation and shareholder‑return strategy.  (Based on the 2022 MD&A discussion of the four advantages [page 22], the 2023 market‑share table showing Analog’s ~74 % revenue share [page 5], and the 2023 MD&A highlighting Analog’s high‑margin, cash‑generating role [pages 3, 4]).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that in 2022, Analog Products contributed to a gross margin of 67.5%, while the LLM claims 'operating margins above 50%' in 2023—this is a different metric (operating vs. gross margin) and not directly supported by the original answer. Additionally, the LLM cites $13 billion in Analog revenue and a 74% revenue share in 2023, which are not present in the ground truth and cannot be verified from the provided information. These unverified figures significantly impact quantitative accuracy. (2) The original answer emphasizes TI’s strategic reframing of Analog Products within its four sustainable competitive advantages, especially lower costs and supply chain control, and highlights a shift toward long-term free cash flow per share as the key performance metric. The LLM correctly identifies the four advantages and mentions cash generation but introduces unsupported specifics like industrial and automotive focus and capital allocation strategy, which were not in the ground truth. (3) The multi-hop reasoning is partially sound—the LLM connects Analog Products to competitive advantages and financial contribution across years—but it fabricates or infers data (e.g., exact revenue, margin figures) not present in the original answer, undermining factual correctness. (4) Despite these issues, the LLM captures the qualitative evolution: Analog remains a core strategic pillar, with increased emphasis on competitive advantages and cash generation. Wording differs but some semantic alignment exists. However, the inclusion of unverified numbers reduces correctness. Contextual relevance is high as the response stays focused on strategic positioning and financial role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 490,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\nFrom 2022 to 2023 the Lower 48 segment’s depreciation, depletion and amortization rose sharply from **$4.85 billion to $5.73 billion** (page 92 of the 2023 filing), indicating that Chevron directed more capital toward developing and maintaining its Lower 48 assets.  No separate impairment charge for the Lower 48 is disclosed for 2023, so the higher DD&A reflects a strategic shift toward greater investment rather than a wave of asset write‑downs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the increase in depreciation, depletion, and amortization (DD&A) for Chevron's Lower 48 region from $4.85 billion in 2022 to $5.73 billion in 2023, which aligns with the ground truth values of $4,854 million and $5,729 million (rounded appropriately). The use of 'billion' and two decimal places is a reasonable and common formatting variation. 2) The quantitative accuracy is perfect: both figures match the original data when accounting for rounding ($4,854M ≈ $4.85B; $5,729M ≈ $5.73B). The answer correctly interprets the rise in DD&A as indicative of increased capital allocation. 3) The qualitative reasoning is strong: it correctly infers that higher DD&A reflects greater investment in asset development, and it appropriately notes the absence of significant impairments in 2023, which supports the conclusion that the increase is due to operational expansion rather than write-downs. This shows sound multi-hop reasoning by linking DD&A trends to capital allocation strategy and ruling out distortions from impairments. 4) The answer is contextually fully relevant, directly addressing how capital allocation evolved based on changes in DD&A and impairments. The only minor shortcoming is that it does not explicitly contrast the Lower 48's growth with stability or decline in other regions (e.g., Europe, MENA), which was part of the original answer and would have strengthened completeness. However, this omission does not undermine the core correctness. Thus, the answer is highly accurate, well-reasoned, and relevant, warranting a 9/10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 439,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon moved FWA broadband from a niche, residential‑only offering to a core, cross‑segment product that underpins its 5G strategy and complements its fiber (Fios) network.  In the 2024 filing the company reports ≈ 3 million FWA connections and highlights FWA as a key growth driver for both the **Consumer** segment (targeting homeowners and renters in underserved markets) and the **Business** segment (serving small‑to‑medium and enterprise customers, including Enterprise‑Public‑Sector and Wholesale channels).  This positioning reflects a shift toward monetising its wireless spectrum and network assets by offering fixed‑wireless access as a stand‑alone broadband solution alongside traditional wireline services.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of FWA broadband into both Consumer and Business segments in 2024, aligning with the ground truth. It accurately reflects the strategic shift toward positioning FWA as a core product and alternative to traditional broadband. However, there is a discrepancy in the reported number of FWA connections: the ground truth states 3.1 million in 2023, while the LLM claims approximately 3 million in 2024, which understates the figure and misattributes the year. This affects quantitative accuracy. (2) The number '≈3 million' is close but not exact compared to '3.1 million', and it incorrectly places the figure in 2024 rather than 2023. No other numbers or dates are provided for comparison, so no further calculation errors can be assessed. (3) The reasoning is sound in identifying the multi-hop evolution—from a less emphasized offering to a strategic, integrated product across segments. The synthesis of FWA’s role in both consumer and business markets, its alignment with 5G strategy, and its positioning alongside fiber are consistent with the ground truth’s implication of a more product-centric approach. The shift in language from 'provides' to 'produces' is not mentioned, which is a minor omission in qualitative precision. (4) Despite the numerical inaccuracy and missing nuance about linguistic shift indicating strategy, the answer captures the core evolution in portfolio positioning and target segments. The contextual relevance is high as it directly addresses how FWA evolved in strategic importance and customer focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 438,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Emerson’s equity relationship with AspenTech moved from a 55 % stake (after the May 2022 Heritage AspenTech transaction) to about 57 % and, by November 2024, Emerson proposed to acquire the remaining shares—effectively moving toward 100 % ownership.  This deeper integration added AspenTech’s software revenue to Emerson’s top line, which helped lift consolidated gross margin from 45.7 % in 2022 to 50.8 % in 2024, while the equity structure shifted as Emerson’s ownership percentage rose and the company prepared to consolidate the remainder of AspenTech’s shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Emerson acquired a 55% stake in AspenTech by 2024 as part of creating 'New AspenTech', but the LLM claims Emerson already had a 55% stake in May 2022 and increased it to 57%, which contradicts the ground truth. There is no mention in the original answer of a proposed 100% acquisition by November 2024, nor any ownership increase to 57%. (2) The quantitative claims are incorrect: the LLM states gross margin rose from 45.7% in 2022 to 50.8% in 2024 due to AspenTech integration, but the original answer only mentions a 0.6 percentage point benefit to gross margin in 2023, with no full margin figures provided. The LLM fabricates precise margin numbers and attributes the entire increase to AspenTech without evidence. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a deepening relationship and financial impact, it misrepresents the timeline, ownership evolution, and financial effects. The original answer emphasizes gains/losses from stock plans and SG&A integration costs, which the LLM omits entirely. (4) Contextual relevance is moderate—the answer addresses the evolution and financial impact as asked, but with incorrect details. The qualitative accuracy is low due to incorrect entity relationships and missing key aspects like equity gains/losses and SG&A impacts. Overall, the answer is partially on-topic but factually unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 415,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\nFrom 2022 to 2023 FPL Group Capital Inc continued to tap the same 1999 master indenture (Exhibit *4(l)–*4(n)) but shifted the mix of its obligations: in 2022 it issued floating‑rate notes due 2072 (Exhibit *4(i)), while in 2023 it added a fixed‑rate 4.45 % note due 2026 (Exhibit *4(j)) and a new floating‑rate series due 2073 (Exhibit *4(k)), all still guaranteed by FPL Group, Inc. and administered by The Bank of New York Mellon, reflecting a deepening of NEE’s capital‑structure involvement through additional tranches of subordinated debt with varied rate structures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to reflect the ground truth. (1) The original answer states that in 2022, there was a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. from 1998, and by 2023, NEE issued multiple series of junior subordinated debentures (Series B, C, L, M, N, O, P) to FPL Group Capital Inc. with maturities from 2057 to 2082. The LLM answer instead claims that FPL Group Capital Inc issued notes (floating and fixed rate) under a 1999 master indenture, which is not supported by the ground truth. (2) Quantitative inaccuracies include incorrect issue years (1999 indenture vs. 1998 agreement), wrong maturity dates (2072, 2026, 2073 vs. 2057–2082), and incorrect interest rate (4.45%) not mentioned in the original. The LLM also references specific exhibits (*4(i), *4(j), *4(k)) not present in the ground truth. (3) The multi-hop reasoning is flawed: the evolution described is from a guarantee to direct issuance of debentures by NEE to FPL Group Capital Inc., indicating a shift in capital structure involvement. The LLM incorrectly frames the relationship around FPL Group Capital Inc issuing debt, rather than NEE issuing debentures to it, reversing the direction of the financial relationship. (4) Contextual relevance is moderate because the answer discusses debt instruments and guarantees involving the same entities and implies deepening capital involvement, but the factual core is incorrect. The strategic shift from guarantee to long-term financing via debentures is entirely misrepresented. Thus, the answer fails on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 447,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 to 2024, InterStim II moved from a newly launched neurostimulator to a core, recharge‑free offering within Medtronic’s Pelvic Health portfolio, as reflected by its inclusion in the growing Specialty‑Therapies sales and the 2024 Neuroscience net‑sales increase. Its positioning alongside the rechargeable InterStim Micro and the newer InterStim X—and the expanding clinical adoption for overactive bladder, urinary retention and fecal incontinence—has driven stronger market acceptance relative to other InterStim devices and to broader Pelvic Health therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but contains some inaccuracies in reasoning and emphasis that deviate from the ground truth. (1) Correct elements: The answer correctly identifies InterStim II as a recharge-free device by 2024, distinguishes it from the rechargeable InterStim Micro, and notes its role in treating overactive bladder, urinary retention, and fecal incontinence—consistent with the original answer. It also correctly situates InterStim II within Medtronic’s broader Pelvic Health portfolio. (2) Quantitative accuracy: There are no explicit numbers (e.g., sales figures, percentages) in either the original or LLM answer, so no numerical inaccuracies exist. The mention of 'Specialty-Therapies sales' and 'Neuroscience net-sales increase' lacks specific values and is not contradicted by the ground truth, though these details are not present in the original and may be inferred or assumed. (3) Multi-hop reasoning: The LLM introduces the idea that InterStim II evolved from a 'newly launched' device in 2022, which is not supported by the original answer—InterStim II was already established as part of a suite in 2022, not newly launched. This misrepresents the evolution. Additionally, the claim that InterStim II achieved 'stronger market acceptance relative to other InterStim devices and to broader Pelvic Health therapies' overreaches; the original answer notes continued acceptance and growth but does not make comparative claims about outperforming other devices or therapies. (4) The answer remains contextually relevant and captures the general trend of product differentiation by recharge status and integration into a diversified portfolio. However, the emphasis on sales growth and relative market performance introduces unsupported inferences, reducing qualitative accuracy. Overall, the core facts are correct, but the reasoning and some assertions go beyond the evidence, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 532,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group kept the Supplemental Facility’s size at $3.5‑$4.5 bn and its pricing unchanged – borrowings carried a SOFR + 72.5 bp spread (plus a 0.100‑0.300 % facility fee) – but it extended the maturity from January 2026 to January 2029 (with a one‑year extension to 2030).  The company then sharply reduced its use of the line, repaying the entire €750 m draw that had been outstanding under the facility with proceeds from a €750 m bond issuance on 14 Nov 2023, and by year‑end 2024 the only outstanding balance was a modest average of about $31 m.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the €750 million borrowing and its repayment in November 2023, it incorrectly states the maturity was extended from January 2026 to January 2029 (with a one-year extension to 2030), which is not supported by the ground truth. The original answer states the maturity remained January 31, 2026, with no mention of an extension. Additionally, the LLM introduces a specific margin of SOFR + 72.5 bp and facility fees of 0.100–0.300%, which are not present in the ground truth; the original only states the margin was based on credit rating, without specifying numbers. The claim of an 'average of about $31M' outstanding in 2024 is unsupported and contradicts the original statement that the €750M was fully repaid by November 17, 2023. (2) Quantitative accuracy is low: dates (maturity extension), interest rate spread, fees, and year-end balance are all incorrect or fabricated. The €750M repayment date is off by three days (14 Nov vs 17 Nov), a minor but notable discrepancy. (3) The reasoning partially captures the shift in utilization—repaying borrowings via bond issuance shows strategic management—but incorrectly infers a facility restructuring (extension, pricing) not in the original data. The multi-hop synthesis is flawed due to unsupported assumptions. (4) Despite inaccuracies, the answer addresses the core aspects of borrowing capacity, interest strategy (though specifics are wrong), and repayment, maintaining contextual relevance. However, the quantitative and qualitative errors significantly reduce correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 446,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon shifted from explicitly accounting for a financing component in its device‑payment arrangements to treating most direct‑channel 36‑month installment plans as having an immaterial financing cost and thus not separating interest, while still using non‑interest‑bearing notes; the 2024 filing adds detailed disclosure of promotional billing‑credits and trade‑in guarantees that are recorded as liabilities and reduce revenue, indicating a more nuanced financing structure and incentive‑driven pricing compared with the earlier period’s simpler subsidized‑plan and fixed‑term approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in Verizon's device payment plans from 2023 to 2024 with reasonable accuracy but introduces some technical details not present in the ground truth, while missing others. (1) Correct elements: It correctly identifies the shift to 36-month non-interest-bearing installment notes in 2024 and notes increased promotional disclosures, including billing credits and trade-in guarantees, aligning with the ground truth’s emphasis on structured incentives. The mention of immaterial financing cost accounting reflects a plausible interpretation of accounting treatment. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts, percentages) are provided in either answer, so scoring is based on structural details. The 36-month term is correctly cited, matching the ground truth. (3) Multi-hop reasoning: The LLM synthesizes changes in accounting treatment and promotional structure across years, showing sound logic. However, it overemphasizes accounting nuances (e.g., 'immaterial financing cost', 'not separating interest') not mentioned in the ground truth, which focuses on customer-facing changes rather than internal accounting policy. (4) The ground truth highlights the introduction of a defined upgrade path after paying a 'specified portion' of the plan with trade-in—this customer-centric incentive is underemphasized in the LLM response, which instead focuses on revenue recognition and liabilities. While semantically related, the LLM shifts focus toward financial reporting implications rather than the customer financing structure and promotional incentives as framed in the question. Thus, the answer is partially aligned but diverges in emphasis and includes unverified accounting details, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 484,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\nThe Coca‑Cola Company has maintained its 2023‑2024 position that it is **not legally liable** for Aqua‑Chem’s asbestos‑related claims, limiting its exposure to the insurance policies it purchased during its ownership of Aqua‑Chem.  In the 2024 filing the company notes that the Wisconsin appeal was affirmed and the Supreme Court of Wisconsin denied review, leaving only the 2002 Georgia lawsuit—still stayed under the 2004 agreement—as the unresolved matter, while all other coverage disputes have been settled or ruled in the company’s favor.  Consequently, the company’s stance on liability remains a denial of responsibility, with efforts now focused on enforcing the settled insurance coverage rather than confronting new legal exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of Coca-Cola's stance between 2023 and 2024, despite correctly identifying the core denial of liability. (1) The answer incorrectly references a 'Wisconsin appeal' and claims it was affirmed, with review denied by the Supreme Court of Wisconsin—this detail is absent from the ground truth and introduces a fact not supported by the original answer. The ground truth only mentions the ongoing Georgia Case, not any Wisconsin proceedings. This is a significant error in legal context. (2) The LLM states that 'all other coverage disputes have been settled or ruled in the company’s favor,' which is not stated or implied in the original answer; the ground truth describes ongoing coverage litigation involving multiple insurers, indicating unresolved issues. This mischaracterizes the status of the legal matters. (3) While the LLM correctly notes Coca-Cola’s denial of liability, it fails to capture the key nuance highlighted in the original answer: the shift in emphasis from outright denial to a more detailed discussion of insurance policies and shared insurer responsibility in 2024. Instead, the LLM portrays the stance as unchanged, contradicting the ground truth’s assertion of a nuanced evolution. (4) The mention of the '2002 Georgia lawsuit' and '2004 agreement' aligns with plausible timelines but are not explicitly confirmed in the ground truth, which only refers to the 'Georgia Case' without dates—this introduces unverified specifics. (5) The answer is contextually relevant and addresses the question’s focus on liability and asbestos claims, but the incorrect legal details and failure to reflect the shift in disclosure emphasis reduce its qualitative and quantitative accuracy. Overall, the answer gets the broad denial of liability correct but fails on key multi-hop reasoning elements—synthesizing changes in disclosure tone and legal context across years—and introduces unsupported specifics, warranting a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 543,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\nIn 2024 Intel’s long‑term income‑tax payable dropped to **$1.6 billion** (down from **$2.6 billion** at the end of 2023 and higher still in 2022), a reduction that stems largely from the company’s use of **non‑U.S. tax credits** that offset the transition tax and uncertain‑tax‑position balances (see INTC_10K_2024.pdf p. 83).  The lower liability helped push the **effective tax rate down to 8.5 %**—well below the 21 % statutory rate—reflecting a deliberate international tax strategy that concentrates earnings in low‑tax jurisdictions (e.g., Ireland, Israel, Malaysia) and aggressively claims foreign‑derived tax credits and R&D incentives (see INTC_10K_2024.pdf p. 90).  This shift indicates Intel is actively restructuring its global tax profile to minimize its overall tax burden.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 long-term income tax liability. The ground truth states that Intel's long-term income taxes payable were $4.3 billion in 2022, but the LLM incorrectly claims it was 'higher than $2.6 billion in 2023', implying a lower or similar figure for 2022, which contradicts the truth. This misrepresents the trend and undermines the quantitative comparison central to the question. The 2024 figure of $1.6 billion is correct. (2) The effective tax rate of 8.5% and reference to low-tax jurisdictions (Ireland, Israel, Malaysia) are not present in the original answer and cannot be verified from the provided ground truth; while plausible, they introduce unconfirmed details that may not be supported by the knowledge graph. (3) The reasoning about increased use of non-U.S. tax credits reducing liabilities over time aligns with the ground truth and shows correct multi-hop synthesis between tax credits and long-term liabilities across years. The conclusion about a strategic international tax shift is semantically consistent with the original. (4) Despite strong contextual relevance and logical reasoning, the incorrect 2022 figure and unsupported specifics on tax rate and jurisdictions reduce quantitative and overall correctness. Minor formatting variations in dollar amounts are acceptable, but directional accuracy matters—here, the error distorts the year-over-year change. Correctness score reflects partial accuracy with key factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 418,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s pension‑risk‑transfer activity (reported in the Retirement & Income Solutions segment) became far more sensitive to interest‑rate shifts—its 2022‑2024 “Rising‑Interest‑Rate” scenario showed a swing from a $‑445 million derivative loss to modest gains and added $15‑$30 million of adjusted earnings, while the firm increasingly relied on interest‑rate derivatives to hedge margin compression on retained assets (see page 34, 61).  At the same time, regulatory risk grew: disclosures note that changes in defined‑benefit plan‑funding rules or stricter solvency/surplus standards could delay or reshape sponsors’ decisions to terminate plans or transfer pension obligations, directly affecting the volume and timing of MetLife’s pension‑risk‑transfer business (see page 32).  Consequently, the treatment of these transfers evolved from a largely capital‑management function to one that is explicitly managed for interest‑rate exposure and subject to evolving regulatory influence.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of pension risk transfer treatment and correctly identifies increasing interest rate sensitivity and regulatory influence between 2022 and 2024, aligning with the core themes in the ground truth. It appropriately links pension risk transfers to the Retirement & Income Solutions segment and notes the impact of interest rate scenarios and regulatory changes on corporate plan sponsors’ decisions, which reflects sound multi-hop reasoning and contextual understanding (supporting high contextual relevance and decent qualitative accuracy). However, the quantitative accuracy is significantly flawed: the LLM introduces specific numbers—such as a '$-445 million derivative loss', '$15-$30 million of adjusted earnings', and references to 'page 34, 61, 32'—that are not present in the original answer or supported by the provided ground truth. These figures and page citations appear fabricated or hallucinated, as the ground truth contains no such data. Since the question does not provide source documents for verification and the ground truth is derived from a knowledge graph without these numbers, their inclusion undermines factual correctness. The original answer discusses directional changes (e.g., interest rate sensitivity, regulatory impact on plan terminations) but contains no financial figures or scenario results. Thus, while the LLM’s conceptual and qualitative synthesis is largely accurate and relevant, the inclusion of unsupported quantitative claims reduces the correctness score. The answer also implies a shift 'from a largely capital-management function'—a characterization not present in the ground truth—adding interpretive detail beyond the source. Overall, the answer is partially correct with strong thematic alignment but fails on quantitative fidelity, which is critical in financial evaluations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 503,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\nMedtronic continued to showcase the InterStim Micro as the rechargeable core of its InterStim neurostimulation portfolio for pelvic‑health indications, emphasizing its role in treating overactive bladder, urinary retention and fecal incontinence.  In the 2022 10‑K (pp. 40‑42) the device was grouped with InterStim II and InterStim X as part of the company’s growth strategy in Neuromodulation, and by the 2024 filing (pp. 39, 74) the narrative had expanded to position InterStim Micro alongside the newer InterStim II/X platforms within the broader AiBLE integrated‑solution ecosystem, underscoring its clinical benefits and rising sales momentum.  Thus, while the product’s fundamental positioning as a rechargeable, minimally invasive therapy remained unchanged, Medtronic broadened its strategic framing to highlight integration with other technologies and to stress its growing market adoption between 2022 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and evolution of Medtronic's strategy around the InterStim Micro. (1) It accurately identifies that in 2022, the InterStim Micro was grouped with InterStim II and InterStim X as part of the neuromodulation growth strategy, consistent with the original answer’s description of it being part of a broader offering. In 2024, the LLM correctly notes a shift in narrative, emphasizing the rechargeable nature and growing market adoption. However, the LLM introduces the 'AiBLE integrated-solution ecosystem' and positions InterStim Micro as being framed within this technological integration, which is not mentioned in the ground truth and may represent an overextension or inference beyond the provided knowledge. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 time points, compares positioning shifts, and identifies the continued role of the device in pelvic health. The only deviation is the introduction of the AiBLE ecosystem, which may be factually accurate in external context but is not supported in the ground truth provided, thus affecting qualitative accuracy slightly. (4) Despite this addition, the answer remains contextually relevant and captures the essence of the strategic evolution—highlighting increased differentiation and market emphasis—earning high marks for contextual relevance and overall correctness. Minor deduction due to unverified ecosystem claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 455,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group’s reliance on the Supplemental Facility shifted from active borrowing to full repayment.  The 2022 filing (page 124) notes that the Facility’s €750 million Euro‑denominated borrowings were outstanding, and in late 2023 the company swapped that debt to a fixed 3.81 % rate and retired it entirely by issuing €750 million of senior unsecured bonds, using the proceeds to repay the Supplemental Facility borrowings on Nov 17 2023 (2024 10‑K page 70).  As a result, by the end of 2024 there were **no outstanding borrowings** under the Supplemental Facility—its $3.5‑$4.5 billion capacity remained available but was no longer being used (2024 10‑K pages 68‑69).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the €750 million borrowing under the Supplemental Facility in 2022 and its repayment on November 17, 2023, matching the original answer's key event. The U.S. dollar equivalent of $815.4 million is not explicitly mentioned in the LLM answer, but this is a minor omission since the euro amount is correct and the conversion depends on exchange rates at the time. (2) The LLM correctly states that the debt was repaid using proceeds from newly issued €750 million senior unsecured bonds, which reflects accurate multi-hop reasoning across financing actions. (3) While the original answer includes weighted average outstanding balances for 2022 ($519.9M) and 2024 ($311.1M), the LLM does not mention these specific figures, instead stating there were 'no outstanding borrowings' by 2024. This is consistent with full repayment but omits the intermediate average balance data, slightly reducing quantitative completeness. (4) The LLM emphasizes the strategic shift—retiring the Supplemental Facility debt and not using the facility in 2024—which captures the core evolution described in the ground truth. Entity accuracy (Simon Property Group, Supplemental Facility, correct dates, euro amounts) is excellent. The reasoning is sound, citing refinancing via bond issuance and cessation of facility usage. Overall, the answer conveys the essential multi-hop narrative: drawdown in 2022, refinancing and repayment in late 2023, zero balance in 2024. Only the absence of the exact average balance numbers prevents a perfect 10, but the omission does not distort the overall trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 454,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\nBetween 2022 and 2023 the depreciation, depletion, amortization and impairment charge for COP’s Lower 48 segment rose sharply—from **$4.85 billion in 2022 to $5.73 billion in 2023** (see page 133, “Depreciation, Depletion, Amortization and Impairments”).  This increase reflects a larger capital base in the Lower 48, driven by additional proved‑property acquisitions and development drilling (e.g., the Concho and Shell Permian purchases), indicating that the company’s investment activity in that region expanded markedly over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the key financial figures: $4.85 billion in 2022 and $5.73 billion in 2023, which align with the ground truth values of $4,854 million and $5,729 million (rounded appropriately). The increase is accurately portrayed as a rise in expenses, indicating higher investment or asset utilization. 2) Quantitatively, the numbers are correct when accounting for standard rounding ($4,854 million ≈ $4.85 billion; $5,729 million ≈ $5.73 billion). No calculation errors are present. 3) The reasoning is sound and adds contextual detail not in the original answer—such as reference to proved-property acquisitions and development drilling (e.g., Concho and Shell Permian purchases)—which supports the conclusion of increased investment activity. While these specific deals are accurate for COP’s Lower 48 strategy, the original answer did not include them, so their inclusion is a value-add but not required for correctness. 4) The answer fully addresses the question about how investment activity evolved based on DD&A and impairments, correctly interpreting rising expenses as a proxy for increased investment or capital deployment. The multi-hop synthesis is logical: higher expenses → larger capital base → increased investment. The only reason for not scoring a 10 is that the original answer emphasizes 'asset utilization' as a possible factor alongside investment, while the LLM focuses more on acquisitions; both are valid, but the LLM slightly overemphasizes investment without noting utilization. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 440,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon reframed its corporate‑networking story around the **Intelligent Edge Network** – a next‑generation, multi‑use platform that blends 5G, C‑Band spectrum, fiber and edge‑hosted applications to deliver low‑latency, high‑capacity connectivity for enterprises.  In the 2024 filing the **Business segment** is highlighted as the primary vehicle for these “corporate networking solutions, security, managed‑network and IoT services,” with revenue‑mix details (e.g., $14.2 B from Enterprise & Public Sector and $13.1 B from Business Markets & Other) underscoring a shift from the 2023 focus on legacy wireless equipment and goodwill impairments to a stronger emphasis on monetizing network infrastructure and expanding fiber‑based FWA offerings.  This evolution reflects a deliberate move to position Verizon’s network as a unified, cloud‑ready platform for enterprise customers rather than a collection of separate wireless‑only services.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that in 2023, Enterprise and Public Sector revenues were $15.1 billion, accounting for about 50% of Business segment revenues. The LLM incorrectly reports $14.2B for Enterprise & Public Sector and introduces a new category 'Business Markets & Other' with $13.1B, which is not mentioned in the original answer and contradicts the known data. These figures are both inaccurate and suggest incorrect calculations or misattribution of revenue segments. Additionally, the LLM introduces the term 'Intelligent Edge Network' and describes a strategic reframing around this platform, which is not supported by the original answer—no such branding or technical integration (e.g., edge-hosted applications, C-Band spectrum) was cited as part of the evolution from 2023 to 2024. The original answer emphasizes a shift in *disclosure detail* and *messaging simplification*, not a technological pivot. While the LLM correctly identifies the Business segment as the carrier of corporate networking solutions, it fabricates specifics about service evolution and revenue breakdowns. The reasoning is partially sound in identifying a strategic shift in emphasis, but it misrepresents the nature of that shift—focusing on technological advancement rather than reporting and descriptive streamlining. The context is relevant, and the answer addresses the question's intent regarding evolution in service description and segment emphasis, but the factual foundation is flawed. Thus, the correctness score is low due to major quantitative and descriptive inaccuracies, despite some alignment in high-level interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 466,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\nMetLife continued to value its Fair‑Value‑Option securities with discounted‑cash‑flow models that rely on Level 3 unobservable inputs, and the overall valuation framework was unchanged from 2022 through 2024.  The company’s sensitivity analysis still shows that a 10 % appreciation of the U.S. dollar would depress the fair value of its foreign‑currency‑denominated FVO assets by roughly $12 bn, while lifting the fair value of the corresponding dollar‑denominated liabilities by about $3.7 bn, producing a net negative impact of roughly $7–8 bn; this exposure is partially offset by the $217.5 bn of insurance‑contract liabilities that are excluded from the sensitivity calculation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of MetLife's valuation approach from 2022 to 2024. (1) Quantitative Accuracy: The numbers cited are grossly incorrect. The ground truth states that in 2022, a 10% U.S. dollar appreciation led to a $54 million decrease in FVO securities value, not the $12 billion decrease claimed by the LLM. The LLM's mention of $3.7 billion in liability gains, $7–8 billion net impact, and $217.5 billion in excluded insurance liabilities are not supported by the original answer and appear fabricated. There is no mention of such large-scale figures or net impacts in the ground truth. (2) Completeness: The LLM fails to address the key evolution in MetLife’s methodology—from a static sensitivity model in 2022 to a more nuanced, duration- and currency-dependent framework in 2024. Instead, it incorrectly claims the valuation framework was 'unchanged,' directly contradicting the original answer. (3) Entity Accuracy: While the company (MetLife) and the financial instrument (FVO securities) are correctly identified, the years (2022–2024) are misused due to incorrect data attribution. (4) Reasoning: The multi-hop synthesis is flawed. The original answer highlights a methodological shift in sensitivity modeling, but the LLM asserts continuity and introduces a detailed but false sensitivity scenario. It does not recognize or report the shift to a more dynamic, unobservable-input-based approach varying by duration and currency. (5) Semantic Equivalence: The LLM answer conveys a completely different narrative—static framework with massive dollar impacts—versus the ground truth’s emphasis on increasing methodological sophistication. Despite using relevant terms (e.g., unobservable inputs, sensitivity), the overall meaning is factually and conceptually incorrect. The contextual relevance is moderate because it discusses valuation and sensitivity, but the details are misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 531,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s power‑marketing and trading business moved from a loss to a strong gain.  The “non‑qualifying hedge” component of adjusted earnings swung from a **$696 million after‑tax loss in 2022 to a **$1.5 billion after‑tax gain in 2023** (see the adjusted‑earnings tables in the 2023 10‑K notes), and NEER’s operating revenue rose by roughly **$5.9 billion** in 2023, driven largely by those hedge gains and related commodity‑price movements.  The improved trading results helped lift NEER’s net income and contributed to a **$3.2 billion increase in Net income attributable to NEE** for the year (see NEER’s Results of Operations in the 2023 10‑K).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of significant improvement in NextEra Energy's power marketing and trading performance from 2022 to 2023 and correctly identifies NEER as the subsidiary involved, which aligns with the original answer. However, there are major quantitative inaccuracies that undermine factual correctness. The original answer states that NEER's net income rose from $285 million in 2022 to $3,558 million in 2023—an increase of $3,273 million. The LLM answer does not report these actual net income figures but instead cites a $696 million after-tax loss in 2022 and a $1.5 billion gain in 2023 from 'non-qualifying hedges,' which are not mentioned in the ground truth and appear to be misinterpreted or taken out of context. Additionally, the LLM claims a $3.2 billion increase in Net income attributable to NEE, which is close to the actual net income increase of $3,273 million, but this is attributed incorrectly to trading gains rather than correctly identifying that NEER’s net income itself increased to $3,558 million. The $5.9 billion increase in operating revenue is plausible but not verifiable from the ground truth, which does not provide revenue figures. The reasoning is partially sound in identifying an improvement in financial performance, but the failure to report the correct net income figures and the introduction of unverified components like 'non-qualifying hedge' losses/gains represent significant factual deviations. The answer is contextually relevant and addresses the evolution in activities and financial performance, but the incorrect numerical foundation reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 446,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBetween 2023 and 2024 Coca‑Cola Co. kept its 28 % equity stake in Coca‑Cola FEMSA – the ownership percentage was unchanged.  However, the company’s share of FEMSA’s earnings grew, with equity‑income from the investment rising from $1.69 bn (2023) to $1.77 bn (2024) [KO_10k_2024 p. 119; KO_10k_2023 p. 87], reflecting higher net income and larger dividends received from FEMSA [KO_10k_2023 p. 87].  Thus, while the stake itself is stable, the financial relationship is becoming more earnings‑ and cash‑flow‑positive for Coca‑Cola Co.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim. The original answer states that in 2023, The Coca-Cola Company did not hold a 28% stake in Coca-Cola FEMSA as an equity-method investment — rather, the relationship was described in terms of indirect financial dependency due to FEMSA's role as a key bottler affecting credit ratings. Only in 2024 did the company hold a 28% stake accounted for under the equity method. The LLM incorrectly asserts that the 28% stake was unchanged between 2023 and 2024, which contradicts the ground truth that implies a shift from no direct ownership (or at least no mention of 28%) to a 28% stake in 2024 — indicating a change, not stability. (2) The quantitative figures cited — $1.69 billion equity income in 2023 and $1.77 billion in 2024 — are not present in the original answer and cannot be verified against the provided ground truth. These numbers and the references to KO_10k_2024 p. 119 and KO_10k_2023 p. 87 are fabricated or misattributed, as the original answer does not mention any specific equity income amounts. This constitutes a serious factual error. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the evolution from an indirect dependency to a direct ownership stake, instead assuming continuity. It introduces financial data not present in the ground truth, leading to a misleading narrative of growing income from a stable stake, whereas the original emphasizes a structural shift in the relationship. (4) While the answer is contextually relevant — discussing stake ownership and equity income — it is factually inaccurate in both qualitative and quantitative aspects. The correctness score is low due to fundamental errors in the central claim and invented data. Quantitative accuracy is severely penalized for citing false figures. Qualitative accuracy suffers due to incorrect entity relationship modeling. Contextual relevance is moderate because the response addresses the right topic but with wrong information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 541,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\nBetween 2022 and 2023 ConocoPhillips markedly increased its financial commitment to the Lower 48, as reflected by a ≈ $0.88 billion (about 18 %) rise in depreciation, depletion and amortization expense for the segment (from $4.86 bn to $5.73 bn).  At the same time, segment sales fell sharply and the available production data show only modest or flat barrel volumes, indicating that the company is shifting from volume‑driven growth to a more capital‑intensive, return‑focused strategy that emphasizes sustaining and expanding the profitability of existing Lower 48 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key quantitative aspects: it accurately reports the 2022 depreciation, depletion, and amortization (DD&A) expense as $4.86 billion and 2023 as $5.73 billion, which aligns with the ground truth ($4,854 million and $5,729 million — rounded appropriately). The calculated increase of approximately $0.88 billion (18%) is accurate. 2) The production data is correctly interpreted as showing modest or flat volumes, though the original answer specifies exact 2022 production figures (447 kbbl/d crude oil, 1,340 MMcf/d natural gas), which the LLM omits but does not contradict. 3) The reasoning is sound: the LLM correctly infers that rising DD&A with flat production indicates a shift toward capital-intensive, return-focused strategy, which is a valid qualitative interpretation supported by the data. This reflects proper multi-hop synthesis between financial expenses and operational metrics. 4) The mention of 'segment sales fell sharply' is not present in the original answer and cannot be verified from the provided ground truth, introducing a minor unsupported claim. However, this does not undermine the core conclusion about increased financial investment and strategic focus. Overall, the answer conveys the same essential information with excellent numerical accuracy and strong reasoning, meriting a high score with only a slight deduction in qualitative accuracy due to the extra, unverified comment on sales.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 402,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon shifted its 4G LTE network from a stand‑alone service to a strategic platform that underpins its broader growth initiatives.  The company continued to densify and expand LTE capacity — using it to add network density, improve quality of service and support its growing fixed‑wireless access (FWA) broadband business — while simultaneously accelerating 5G rollout and investing $17.1 billion in capital expenditures for wireless, fiber and other advanced technologies.  This evolution positioned LTE as a complementary foundation that enables monetization of the network and fuels the company’s fiber‑expansion strategy (e.g., the planned Frontier acquisition) and overall revenue growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Verizon's 4G LTE strategy between 2023 and 2024. It correctly identifies the shift from standalone service to a strategic, integrated platform supporting growth initiatives, including FWA broadband and fiber expansion. The mention of continued LTE densification and its role in supporting FWA aligns with the original answer's emphasis on LTE as foundational in 2023. The 2024 evolution toward integration with broader infrastructure (implied via 5G, fiber, and advanced tech investments) matches the ground truth's 'multi-technology ecosystem' concept, though it does not explicitly name C-Band or millimeter wave spectrum, which are key components in the original answer. The $17.1 billion capital expenditure figure is accurate and contextually relevant, supporting the claim of strategic investment, though this specific number is not in the ground truth — however, such figures are plausible and not contradicted. The reference to the 'planned Frontier acquisition' is factually questionable (as of public knowledge through 2024, Verizon did not announce an acquisition of Frontier; instead, Frontier acquired Verizon's wireline assets in certain states years earlier), which introduces a minor but notable entity/reasoning error. This affects qualitative accuracy but not the overall correctness of the strategic narrative. The answer is semantically equivalent in intent and mostly accurate in reasoning, with strong contextual relevance to the question. Missing explicit mention of C-Band and millimeter wave slightly weakens completeness on multi-hop synthesis, but the broader strategic shift is correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 459,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s stake in AspenTech grew from the 55 % it acquired in fiscal 2022 to roughly 57 % held in 2024, and in October 2024 it announced a proposal to buy the remaining shares at $240 per share—effectively taking AspenTech fully private.  This deepening ownership coincided with a sharp rise in AspenTech’s backlog (up from $328 M in 2021 to $1.042 B in 2022) and helped lift Emerson’s gross margin from 45.7 % in 2022 to 50.8 % in 2024, with the Test & Measurement (AspenTech) acquisition adding about 9½ percentage points to sales growth and boosting adjusted EPS, even though inventory step‑up amortization slightly offset the margin gain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that Emerson acquired a 55% stake in AspenTech in fiscal 2022, whereas the ground truth indicates that the 55% ownership resulted from the 2024 transaction creating 'New AspenTech.' The LLM reverses the timeline: the 55% ownership was not established in 2022 but rather in 2024. Additionally, the LLM claims ownership increased to 57% by 2024 and that Emerson proposed to buy the remaining shares in October 2024, which is not supported by the original answer and introduces unverified details. (2) Quantitative errors are severe: the LLM states AspenTech’s backlog rose from $328M in 2021 to $1.042B in 2022, but the ground truth reports a 2022 backlog of $1,042M (i.e., $1.042B) as Emerson’s stake value, not AspenTech’s standalone backlog. The original answer cites a 2024 backlog of $8,053M (up from $6,533M in 2021), which the LLM completely omits. The gross margin increase is misrepresented: the ground truth states a 3.3 percentage point increase in 2023 due to the acquisition, but the LLM claims margins rose from 45.7% in 2022 to 50.8% in 2024, adding ~5.1 points, and attributes a 9.5-point boost to sales growth—none of which aligns with the original. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of ownership (misplacing the 55% stake in 2022 instead of 2024), conflates Emerson’s financial metrics with AspenTech’s, and invents post-2024 acquisition plans not in the source. It also misattributes margin impacts and omits the key point that the gross margin improvement was partly due to the acquisition, not a direct 9.5-point addition. (4) Contextual relevance is moderate—the answer addresses stake value, ownership, and financial metrics as asked—but due to pervasive factual and quantitative errors, the response is largely incorrect. The structure follows the question, but the content diverges significantly from ground truth. Minor formatting variations (e.g., $1.042B vs $1,042 million) are acceptable, but core facts and calculations are not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 565,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted dramatically: the 2022 10‑K notes that in the first quarter of 2022 the company recorded an additional impairment that **completely wrote off its equity investment** in the pipeline (page 97 of the 2022 filing). Consequently, the 2023 10‑K no longer shows a carrying investment—only a modest **planned equity contribution for 2024** is listed under NEER’s capital‑expenditure commitments (page 108 of the 2023 filing). This reduction reflects a strategic pull‑back from the project, with NEE now limiting its involvement to a small, future‑funding role rather than maintaining a substantial direct investment.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, NEE maintained and even deepened its financial commitment to the Mountain Valley Pipeline from 2022 to 2023, with a defined 32.8% equity stake in 2023 and a $70 million/year, 20-year transportation agreement. In contrast, the LLM claims NEE completely wrote off its investment in 2022 and pulled back strategically—this contradicts the ground truth. (2) The LLM cites a supposed 'impairment' and 'complete write-off' in the 2022 10-K (page 97) and a 'planned equity contribution for 2024' in the 2023 10-K (page 108), but these claims are not supported by the knowledge graph data and directly oppose the documented increase in structured commitment. No such write-off or pull-back is present in the ground truth. (3) The multi-hop reasoning is flawed: instead of recognizing the evolution from a variable ownership range (32%-55%) to a more precise 32.8% stake plus a long-term contract as a sign of strategic deepening, the model incorrectly interprets the change as a reduction or exit. (4) The answer fails on quantitative accuracy because it fabricates a write-off and omits the $70M/year contract value and 32.8% stake. It also misrepresents entity relationships (NEE/NEER) and strategic intent. While the response is structured and references document pages, the core facts are inverted, leading to a completely incorrect conclusion about NEE’s investment strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 408,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\nFrom 2023 to 2024 Coca‑Cola deepened the integration of Costa Limited inside its **Global Ventures** segment, shifting the brand from a stand‑alone investment to a core growth platform.  The 2023 filing lists Costa, innocent and doğadan together under Global Ventures, and the 2024 discussion notes that sales through Costa’s retail stores are now reported as part of that segment, underscoring a strategic focus on expanding the chain’s outlet network and leveraging its consumer‑facing model to drive volume and margin.  At the same time, the company refranchised several bottling operations (e.g., in India, Bangladesh and the Philippines), freeing capital and managerial attention to concentrate on the integrated Global Ventures model in which Costa plays a pivotal role.  (Pages 6, 73, 66)",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but contains a significant inaccuracy in the timeline of entity integration. The original answer (ground truth) states that in 2023, Costa Limited was already part of the Global Ventures segment and involved in direct retail operations. However, the LLM answer incorrectly claims that the 2023 filing lists Costa, innocent, and doğadan together under Global Ventures, implying full integration by 2023. In reality, the deeper integration—including innocent and doğadan alongside Costa—occurred by 2024, not 2023. This misrepresents the evolution timeline, which is central to the question. There are no numeric errors (quantitative accuracy is perfect, hence 10), and the contextual relevance is high as the answer addresses operational integration and strategic positioning. The reasoning is sound in linking refranchising to strategic focus, though this detail isn't in the ground truth and slightly extrapolates. The core facts about Costa’s expanded role and reporting through retail stores in Global Ventures are correct, supporting a qualitative accuracy score of 7. Overall, the answer captures the strategic shift but misstates the timing of multi-entity inclusion, reducing correctness to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 354,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\nIntel’s economically‑hedged marketable‑debt portfolio swung markedly from 2022 through 2024: it posted an unrealized loss of $748 million in 2022, then a $534 million unrealized gain in 2023 that lifted the hedged‑investment fair value to $17.1 billion, and finally a $464 million unrealized loss in 2024 that cut the fair value to $13.5 billion. This trajectory shows a sharp rise in 2023 followed by a decline in 2024, reflecting the volatility of interest‑rate and currency hedging on the portfolio’s market value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, most notably the introduction of a $534 million unrealized gain in 2023, which is not mentioned in the original answer or implied by the ground truth. The original answer states that the fair value decreased from $17.1 billion in 2023 to $13.5 billion in 2024, but does not provide any gain or loss figure for 2023. By fabricating a $534 million gain, the LLM introduces a significant factual error. Additionally, while the 2022 loss of $748 million and 2024 loss of $464 million are correctly stated, the LLM incorrectly labels them as 'unrealized' losses without confirmation from the original answer. (2) The fair values of $17.1 billion in 2023 and $13.5 billion in 2024 are accurately reported, and the direction of change (decrease) is correct. However, the inclusion of the unsupported 2023 gain undermines quantitative accuracy. (3) The reasoning correctly identifies a decline in portfolio size and loss magnitude from 2022 to 2024, aligning with the original answer’s conclusion. However, the multi-hop synthesis is flawed because it invents an intermediate data point (2023 gain) not present in the source, leading to an incorrect narrative of a 'sharp rise in 2023.' (4) Despite the invented 2023 gain, the answer remains contextually relevant and captures the overall trend of declining portfolio value and reduced losses. The qualitative reasoning about volatility due to hedging is plausible but not directly supported by the original answer. Thus, while the structure and intent are sound, the factual errors—especially the fabricated 2023 gain—reduce correctness and quantitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 459,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\nBetween 2023 and 2024 AMT began describing the vast majority of its site‑lease income as **recurring, multi‑year revenue** that drives its cash‑flow and liquidity outlook (see the “Internally Generated Funds” discussion in the 2024 filing).  At the same time the company **extended the estimated useful life of its tower assets from 20 years to 30 years**, which lowered depreciation expense, increased right‑of‑use assets and lease liabilities, and resulted in a **higher recorded asset‑retirement obligation of about $4.5 bn (undiscounted) as of 31 Dec 2024** (up from $2.08 bn in 2023).  This shift reflects a strategic focus on the long‑term, stable cash flows from communications sites while more explicitly accounting for the future retirement costs of those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AMT's continued focus on recurring revenue from communications sites, noting the emphasis on 'recurring, multi-year revenue' in 2024, which matches the original answer's point about 99% of revenue coming from property operations in 2023. (2) The quantitative data is mostly correct: the $4.5 billion undiscounted asset retirement obligation as of December 31, 2024, is accurately reported. However, the original answer does not mention the 2023 liability value of $2.08 billion or the change in estimated useful life from 20 to 30 years—details the LLM includes. While these may be factually correct based on filings, they go beyond the ground truth and introduce specifics not confirmed in the provided answer, slightly reducing quantitative accuracy. (3) The reasoning is sound: the LLM correctly synthesizes a shift in focus from revenue generation to including long-term liabilities, capturing the multi-hop evolution in financial focus. (4) The answer is contextually excellent, addressing both recurring revenue and asset retirement liabilities across 2023–2024. The only reason for not scoring a 10 is the addition of unverified specifics (e.g., $2.08B prior liability, useful life change), which, while plausible, are not in the ground truth and could introduce inaccuracies if unconfirmed. Overall, the semantic meaning and core facts match very closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 403,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from the nascent licensing regime created by Guyana’s **Petroleum Activities Act 2023**—which first set out a typical 10‑year exploration term and 20‑year (up to 30‑year for gas) production period with renewal options—to a fully operational legal framework that now governs its offshore contracts.  This regulatory certainty allows the company to treat Guyana’s Stabroek block as an **“advantaged asset”** and to shift its growth emphasis from early‑stage exploration to large‑scale development and production, integrating the offshore oil‑equivalent volumes into its broader upstream, energy‑products and low‑carbon portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in XOM's strategic positioning in Guyana between 2023 and 2024. (1) It correctly identifies the Petroleum Activities Act 2023 as the governing legal framework in 2023, noting the 10-year exploration term and 20-year production period, which aligns with the ground truth. The mention of up to 30 years for gas is a minor addition not in the original but does not contradict it and may reflect supplementary knowledge. (2) The transition to Guyana being treated as an 'advantaged asset' under 'Advantaged Volume Growth' is accurately conveyed, though the LLM rephrases it as integration into 'upstream, energy-products and low-carbon portfolio'—a reasonable interpretation that reflects strategic emphasis on volume growth and integration. (3) The multi-hop reasoning—linking regulatory development to strategic repositioning—is sound and logically presented. (4) All key entities (XOM, Guyana, Stabroek block, 2023–2024 timeframe) are correct. The only minor shortfall is that the original specifies the 2024 shift was under the 'Advantaged Volume Growth' earnings driver, which the LLM does not name explicitly, slightly reducing precision. However, the semantic meaning and strategic implication are preserved. Quantitative and qualitative accuracy are high, with only negligible contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 378,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar intensified its strategic focus on diesel‑electric locomotives by placing them squarely in the Energy & Transportation segment, where transportation sales rose 4 % and segment profit jumped 16 % thanks to favorable price realization. Operationally, the company expanded its responsibilities to include remanufacturing of locomotives and related components, leasing activities, and the rollout of digital analytics and data‑driven services to support rail customers, while continuing to treat inter‑segment sales as a key revenue source.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that diesel-electric locomotives were part of the Machinery, Energy & Transportation (ME&T) segment in 2023, but the LLM incorrectly refers to an 'Energy & Transportation' segment, omitting 'Machinery' and misrepresenting the segment structure. More critically, the LLM introduces specific quantitative claims—'transportation sales rose 4%' and 'segment profit jumped 16%'—that are not present in the original answer and cannot be verified from the provided ground truth. These figures are likely fabricated or misattributed. (2) There is no mention in the ground truth of leasing activities, digital analytics rollout, or inter-segment sales as a key revenue source in the context of locomotives; these operational expansions are unsupported. (3) The multi-hop reasoning is flawed: the LLM fails to capture the actual strategic evolution described—i.e., the 2024 shift toward integrated systems and zero-emission technologies—and instead invents a narrative of intensified focus based on non-existent performance metrics. The original answer emphasizes a pivot toward electrified powertrains and environmental innovation, which the LLM omits entirely. (4) While the LLM addresses the general topic of strategic and operational changes in Caterpillar's locomotive business, it does so with incorrect entities, fabricated data, and missed key themes. The contextual relevance is moderate because it attempts to answer the right question, but factual and qualitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 437,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\nCapital One’s securitized‑debt balance rose from roughly **$13–14 billion in 2022** (as reported in the 2022 filing) to **about $18 billion by the end of 2024** (carrying amount shown in the 2024 filing).  This increase reflects a deliberate expansion of the firm’s use of loan‑securitization to fund growing credit‑card and auto portfolios, but the securities still account for only **≈4–5 % of total funding**, underscoring that the company’s primary funding remains anchored in core deposits and other stable sources and that securitization is being used selectively as a supplemental, opportunistic tool rather than a core reliance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the company did not disclose a specific amount for securitized debt obligations, only confirming their use as a funding source. However, the LLM claims a precise figure of $13–14 billion in 2022, which is not supported by the original answer. Additionally, the LLM reports a 2024 carrying amount of $18 billion, whereas the ground truth specifies $14,264 million ($14.264 billion), making the LLM's number substantially higher and incorrect. The LLM also introduces a percentage (≈4–5%) of total funding and claims securitization is 'supplemental' and 'opportunistic,' which are interpretations not present in or inferable from the original answer. (2) Quantitative accuracy is low: both the 2022 and 2024 figures are wrong, and the implied growth trend, while directionally plausible, is based on false numbers. The $14,264 million in 2024 is misrepresented as $18 billion, a deviation of over $3.7 billion. No calculation or percentage from the LLM is verifiable from the ground truth. (3) The multi-hop reasoning is flawed. The original answer indicates an evolution from non-quantified disclosure in 2022 to a specific carrying value in 2024, suggesting increased transparency or strategic emphasis. The LLM incorrectly assumes comparable point-in-time balances and draws a conclusion about strategic expansion, which goes beyond the evidence provided. The synthesis fails because it treats unreported 2022 data as if it were reported and comparable. (4) Contextual relevance is moderate—the response addresses the evolution of securitized debt use and funding strategy, which is relevant. However, due to major factual errors and unsupported inferences, the qualitative and overall correctness scores are low. The answer fabricates data and introduces misleading analysis, undermining its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 518,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s continued to recognize revenue from developmental licensees in the same way—as royalties based on a percent of sales plus initial fees that are allocated between lease and non‑lease components—but it added substantially more transparency around that business.  The 2024 Form 10‑K (pages 45‑46) adopts ASU 2023‑07, which expands segment‑reporting disclosures and now presents a dedicated “International Developmental Licensed Markets & Corporate” segment, giving investors a clearer view of the financial contribution and operating results of developmental licensees.  The filing also provides enhanced footnote detail on how consideration is allocated among lease income, royalty income and initial fees, reflecting a more structured relationship‑management approach for these licensees.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies not present in the ground truth. While it correctly notes that McDonald's recognizes royalties based on a percentage of sales and initial fees, and allocates consideration between lease and non-lease components, it introduces a major factual error: the claim that McDonald's adopted ASU 2023-07 and created a new 'International Developmental Licensed Markets & Corporate' segment in its 2024 Form 10-K. This is not supported by the original answer, which makes no mention of ASU 2023-07 or a new reporting segment. Instead, the ground truth emphasizes that McDonald's evaluated relationships for potential variable interest entities and updated rounding practices to the nearest whole number—details entirely missing from the LLM response. (2) There are no explicit numbers (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the LLM invents structural financial reporting changes (segment creation) that imply new data presentations not confirmed in the ground truth. The mention of 'pages 45-46' lacks verification and is not referenced in the original. (3) The multi-hop reasoning is partially sound—linking financial reporting and relationship management across years—but fails in synthesis because it substitutes actual changes (rounding, VIE evaluation) with fabricated ones (ASU adoption, new segment). This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses both financial reporting and relationship management and focuses on the correct entity and time frame. However, the invention of ASU 2023-07 and a new segment significantly reduces factual correctness, warranting a score of 4—partially correct but with major factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 491,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company’s Equity and Incentive Compensation Plan moved from a 2023‑year‑end availability of **26.9 million shares** (as disclosed in the 2023 “Outstanding Classes of Capital Stock” note on page 311) to a refreshed reserve after the **December 16 2024 ninth amendment to the Employee Savings Plan** (referenced on page 316), which added to the pool of shares that can be issued for future awards.  The 2024 filing also provides a **more detailed executive‑award disclosure**—a specific table of the terms for named‑executive officer equity awards under the 2021 Equity and Incentive Compensation Plan—thereby increasing transparency around how those awards are structured and granted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 26.9 million shares available in 2023, matching the ground truth. It also accurately notes the increased transparency in 2024 with detailed disclosure of Named Executive Officer equity award terms under the 2021 plan. However, the mention of a 'December 16, 2024 ninth amendment to the Employee Savings Plan' introducing a 'refreshed reserve' is potentially misleading or incorrect—the original answer does not reference this amendment or link it to share availability for the Equity and Incentive Compensation Plan. This introduces a factual discrepancy regarding the source of share refresh, though the core data point (26.9M shares in 2023) is correct. (2) All numbers (26.9 million shares) and dates (May 26, 2021 for plan effectiveness in ground truth; Dec 16, 2024 in LLM answer) are presented, but the December 2024 date appears speculative or misattributed since the 2024 filing would not include post-filing amendments. The ground truth does not mention this amendment, so this detail lacks support. (3) The multi-hop reasoning is mostly sound—linking 2023 share availability to 2024 disclosure practices shows evolution in transparency. However, the synthesis is weakened by introducing an unsupported amendment as a driver for share pool changes, which isn't in the original answer and may conflate different plans (Employee Savings Plan vs. Equity and Incentive Compensation Plan). (4) Despite the extraneous and potentially inaccurate amendment detail, the LLM captures the key evolution: from internal share reserve in 2023 to enhanced executive award disclosure in 2024. The core facts and direction of change are correct, warranting a high score, but the added detail about the December 2024 amendment reduces precision, preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 499,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\nInlyta’s worldwide sales rose only modestly – from **$1.003 billion in 2022 to $1.036 billion in 2023** (a ~3 % increase), with U.S. revenue up 4 % to $642 million and international sales up 3 % to $394 million.  The slowdown from the prior‑year ~5 % growth was attributed to **lower volumes and price cuts in several European markets, heightened competitive pressure, and the lingering impact of the COVID‑19 vaccine revenue decline**, even though the drug continued to gain traction in the United States through combination regimens with immune‑checkpoint inhibitors for first‑line renal‑cell carcinoma and continued expansion in emerging markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several plausible details not present in the ground truth, particularly specific 2022 revenue ($1.003 billion) and U.S./international breakdowns ($642M and $394M), which are not mentioned in the original answer. These numbers, while internally consistent (summing to $1.036B), are unsupported by the ground truth and appear fabricated or inferred beyond available data. The 3% total growth and 5% operational growth in 2023 are partially correct — the original confirms 3% total and 5% operational growth — but the LLM misattributes the 'slowdown from prior-year ~5% growth' as a deceleration, whereas the original does not state Inlyta’s 2022 growth rate, only that it contributed to Pfizer’s overall growth. Thus, the comparative growth trajectory claim is speculative. (2) The calculation of total 2023 revenue is correct ($642M + $394M = $1.036B), but the 2022 figure of $1.003B is not verifiable from the original, which does not provide 2022 revenue. The 3% increase is consistent with the original, but the LLM incorrectly implies this is a slowdown from ~5% in 2022, which is not supported. (3) The reasoning partially captures the multi-hop elements: it correctly identifies the U.S. growth driver (combination therapies for RCC) and European headwinds (lower volumes and price), aligning with the original. However, it introduces extraneous factors like 'lingering impact of COVID-19 vaccine revenue decline' — a portfolio-level issue unrelated to Inlyta — which reflects flawed synthesis. (4) The contextual relevance is high, as the answer addresses both revenue evolution and contributing factors. However, the quantitative accuracy is low due to unsupported figures, pulling down the overall correctness. The qualitative reasoning is reasonable but includes incorrect causal inferences. Thus, the answer is partially correct but contains significant factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 519,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 McDonald’s continued to operate a heavily franchised model, but the financial structure shifted toward greater reliance on franchise‑generated revenue and explicit cost‑sharing for technology.  “Other revenues” – which consist of fees franchisees pay to recover the Company’s technology‑platform costs – rose from **$316 million in 2023 to $423 million in 2024** (page 40), and the Company now records those fees gross and recognizes them as revenue when the services are delivered (pages 4‑5).  At the same time, total revenue from franchised restaurants increased to **$15.7 billion** (up from $15.4 billion), while Company‑owned sales stayed flat, indicating a modest but measurable move from pure rent/royalty income to a model that blends royalty income with ongoing technology‑fee income and co‑investment in franchisee‑level upgrades.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in McDonald's relationship with franchisees from 2023 to 2024, particularly around technology cost-sharing and revenue recognition, which aligns with the ground truth. It correctly identifies the shift toward recognizing technology fees as revenue on a gross basis and notes increased financial interdependence. However, the quantitative accuracy is compromised by introducing specific dollar figures—$316 million in 2023 and $423 million in 2024 for 'Other revenues'—that are not present in the original answer or supported by the provided ground truth. The ground truth does not include any numerical data, so these figures, while possibly accurate in external context, cannot be verified here and represent a hallucination or unsupported detail. Similarly, the claim that franchised revenue increased to $15.7 billion from $15.4 billion lacks grounding in the original answer, which focuses on qualitative shifts rather than exact revenue breakdowns. This undermines the quantitative accuracy score. Qualitatively, the reasoning is sound: the model infers a shift from rent/royalty dependence to a blended model with technology fees, which matches the conceptual evolution described in the ground truth. The multi-hop synthesis—linking revenue recognition changes to deeper operational interdependence—is logically coherent and contextually relevant. The answer addresses all key aspects of the question: financial structure, dependency, revenue recognition, and cost-sharing for technology platforms. While the semantic meaning and direction of change are correct, the inclusion of unverified numerical data reduces overall correctness. Wording flexibility is appropriately handled, but factual precision on numbers is required and lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 482,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\nThe net fair‑value of energy‑related derivatives recorded in the balance sheets of Southern Company’s subsidiaries jumped from about **$45 million in 2022 to roughly $554 million in 2023**—a more than ten‑fold increase. This sharp rise reflects a substantial expansion of the company’s hedging positions and therefore a markedly greater exposure to energy‑price volatility over that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. According to the ground truth, in 2022, the net fair value of energy-related derivatives was a net liability of $54 million (not a $45 million asset as implied), calculated as total assets ($59 + $8 + $28 = $95 million) minus total liabilities ($32 + $12 + $65 = $109 million). In 2023, the net liability increased to $219 million (Alabama Power: $15 assets - $110 liabilities = -$95; Georgia Power: $13 assets - $124 liabilities = -$111; total net = -$206, though the original answer states $219 million net liability, suggesting other subsidiaries may be included). The LLM incorrectly reports a net fair value of $45 million in 2022 and $554 million in 2023, which is not only wrong in magnitude but also misrepresents liabilities as positive values. (2) The calculation errors are severe: the LLM implies a net asset position increasing from $45M to $554M, whereas the truth is a worsening net liability from $54M to $219M. This reverses the financial reality. (3) The qualitative reasoning is partially sound in linking derivative fair value changes to exposure to energy market fluctuations, but the multi-hop synthesis is flawed. The LLM fails to correctly identify which subsidiaries reported data in which year (e.g., mentions no subsidiaries for 2022, omits Mississippi Power, Southern Power, and Southern Company Gas, and ignores 2023 data from Alabama and Georgia Power in favor of an incorrect aggregate). (4) Contextual relevance is moderate because the answer addresses the general theme of derivative exposure and market risk, but due to massive factual and numerical inaccuracies, the conclusion about 'hedging expansion' is unsupported and misleading. The actual increase in net liabilities suggests greater risk exposure, but the LLM’s numbers and entities are fabricated. Thus, correctness and quantitative accuracy are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 520,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the 2019 Stock and Incentive Compensation Plan remained the **only** P&G equity plan that still permits new grants, with the same reserve of **77 million shares** (out of the 187 million shares authorized).  The accounting treatment—options and SARs counted on a one‑for‑one basis and full‑value awards (RSUs, PSUs) counted as five shares each—has not changed, but the plan’s **significance has grown** because all other legacy plans (1992, 2001, 2003, 2009, 2014) are closed to future issuances, making the 2019 Plan the sole source of future equity‑based compensation for the company.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative details—such as 77 million shares out of 187 million authorized, one-for-one counting for options/SARs, and full-value awards counting as five shares each—that are not present in the original ground truth and cannot be verified from the provided context. These numbers may be factually accurate in reality, but they are not supported by the knowledge graph used here, making them potentially hallucinated or unsupported. Additionally, the claim that the 2019 Plan was the 'only' P&G equity plan permitting new grants from 2022–2024 goes beyond the original answer, which only states the plan became a standard part of the equity compensation structure. (2) While the original answer does not include any numerical data, the LLM introduces precise figures (e.g., 77M, 187M, five-to-one ratio) without corroboration in the ground truth, failing the quantitative accuracy check. There is no way to confirm these numbers align with actual filings based on the provided knowledge graph. (3) The qualitative reasoning is strong: the LLM correctly infers a multi-hop evolution—transitioning from a newly introduced plan to the primary vehicle for equity compensation—as implied by the original answer’s narrative of integration into long-term incentives. The identification of legacy plans being closed aligns with the idea of the 2019 Plan becoming central. However, this reasoning extends beyond the evidence by asserting exclusivity and specific mechanics not in the original. (4) Contextual relevance is high because the LLM directly addresses the evolution of the plan’s treatment and significance over time, focusing on disclosure context and structural role in compensation. Despite overreach in specifics, the core theme of growing significance due to other plans being closed matches the ground truth’s trajectory. Thus, while the direction of reasoning is sound and contextually appropriate, unsupported numbers reduce factual correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 543,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\nSouthern Company’s 2024 filing adds a concrete risk‑management framework that was only implied in 2023.  The 2024 discussion (see page 255 and 258) explicitly describes a formal rebalancing program, written guidelines for external managers, and a target‑allocation mix (e.g., 41 % equity, 30 % fixed‑income, 12 % real‑estate, 9 % private‑equity, etc.) that is tracked against actual holdings, and it notes the use of derivatives as hedging tools.  Compared with the 2023 language (page 263), the 2024 approach places greater emphasis on systematic monitoring of asset‑class exposures, a more diversified tilt toward alternative assets such as private‑equity and real‑estate, and a tighter alignment of actual allocations with predefined targets to curb the risk of large losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. While both mention a formal rebalancing program and diversified asset strategy, the LLM incorrectly states that the 2024 filing introduces a more structured framework with explicit target allocations (e.g., 41% equity, 30% fixed-income, etc.) and written guidelines for external managers, which contradicts the ground truth indicating a *reduced* emphasis on external manager oversight in 2024. The ground truth highlights a shift toward market-driven risk factors (volatility, interest rates), but the LLM instead claims increased systematic monitoring and tighter alignment with targets—implying more active management, not less. (2) The quantitative elements (percentages like 41%, 30%, 12%, 9%) are specific but not present in the ground truth, making them unsupported and potentially fabricated. There is no verification these numbers appear in the actual filings, and they contradict the qualitative shift described in the original answer. (3) The multi-hop reasoning is partially sound—comparing 2023 and 2024 risk management approaches—but the synthesis is flawed. The LLM infers greater structure and control in 2024, while the ground truth indicates a shift away from active oversight (e.g., reduced emphasis on external manager supervision) toward acknowledging broader market risks. This misrepresents the direction of change in risk management emphasis. (4) The contextual relevance is high because the answer addresses pension risk management and attempts a year-over-year comparison. However, the qualitative and quantitative inaccuracies significantly reduce correctness. The answer fabricates specifics and inverts the actual trend in oversight emphasis, leading to a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 496,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA’s 10‑K filings show CUDA moving from a broad‑based parallel‑programming layer that underpinned its GPU business across gaming, professional visualization and data‑center markets (as noted in the 2022 filing pages 86‑103) to the core software stack of a dedicated AI‑first computing platform.  In the 2023 filing pages 6 and 36 the company explicitly describes CUDA‑enabled AI inference platforms, new hardware such as Ada, Hopper and Grace, and services like DGX Cloud and AI Foundations, signaling a strategic shift toward AI and high‑margin data‑center growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA's role with CUDA from 2022 to 2023: in 2022, CUDA was part of a broader GPU-centric software layer supporting multiple markets; by 2023, it became the core of an AI-first, full-stack computing platform. This matches the ground truth's characterization of a shift from 'supplier' to 'developer' and increased strategic integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of 10-K filings, correctly inferring a strategic shift based on changes in language and emphasis (e.g., mention of CUDA-enabled AI platforms, Hopper/Grace hardware, DGX Cloud, AI Foundations). It supports the conclusion that NVIDIA is focusing more on high-margin data center and AI solutions. (4) The LLM adds contextual detail not in the original (e.g., specific product names, page references), but this enhances rather than distorts the answer. The only minor gap is that it does not explicitly mention 'CUDA-X libraries, APIs, and domain-specific frameworks' as in the original, which are key elements of the 'developer' role. However, the mention of CUDA as the 'core software stack' and integration with AI services implies this expansion. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth with only slight omission of specific software ecosystem components.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 445,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\nBetween 2022 and 2023 the post‑spin‑off financial ties with Viatris were wound down.  The amount Pfizer owed Viatris under the interim rebate‑ and MSA‑related arrangements fell from **$94 million at the end of 2022 to about $33 million at the end of 2023**, reflecting the completion of the transitional TSAs and the settlement of those balances.  The longer‑term supply agreements (four‑to‑seven‑year MSAs that govern manufacturing, labeling and packaging for each other) remain in force, but their financial impact has largely run off, leaving only a modest outstanding balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the decrease in net amounts due to Viatris from $94 million at the end of 2022 to $33 million at the end of 2023, matching the ground truth exactly. It also accurately notes the winding down of transitional services under the TSAs by the end of 2023, which aligns with the original answer's statement about most transitional services being completed. The mention of ongoing but largely concluded supply agreements (MSAs) is consistent with the original context, though the LLM slightly rephrases 'manufacturing of legacy Upjohn products' as part of broader MSAs without explicitly citing the $780 million revenue growth from PC1 in 2022.\n\n2) All numeric values are correct: $94 million (Dec 31, 2022) and $33 million (Dec 31, 2023) are accurately reported. No calculations are required beyond comparison of balances, which the model handles correctly.\n\n3) The multi-hop reasoning is sound: the model synthesizes information about supply agreements, outstanding balances, and the completion of transitional services across time. However, it omits the specific 2022 revenue figure of $780 million from PC1 related to manufacturing for Viatris, which is a notable detail in the original answer and relevant to the financial relationship. This omission prevents a perfect score, but the core evolution of the relationship is well captured.\n\n4) The answer is semantically equivalent in most aspects, with accurate entity identification (Pfizer, Viatris, TSAs, MSAs), correct years, and appropriate financial terminology. The contextual relevance is high, directly addressing both supply agreements and outstanding balances as asked. The only shortcoming is the missing reference to the $780 million revenue component in 2022, which slightly reduces completeness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 493,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\nIn the 2023 filing the company depreciated tower assets over a maximum 20‑year useful life and disclosed that cash flows from communications sites secure its securitized debt, but it did not highlight any change in that depreciation basis. By 2024 the company revised the estimated useful life of towers to 30 years, which increased right‑of‑use assets and lease liabilities, reduced depreciation expense, and explicitly identified the change as a critical audit matter; the 2024 disclosures also more directly tie site‑related lease renewals and cash‑flow risks to debt covenants and present detailed tables of debt maturities and operating‑lease obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that in 2023, specific communications sites (e.g., 3,343 sites) were explicitly cited as collateral for debt obligations like the Series 2015-2 Notes and the $1.3 billion repayment of Series 2013-2A Notes via the 2023 Securitization. In contrast, the LLM answer makes no mention of these specific sites or debt instruments. Instead, it introduces a change in the useful life of towers from 20 to 30 years in 2024, which is not present in the ground truth and appears to be fabricated or misattributed. There is also no mention in the ground truth about depreciation changes being a critical audit matter or affecting right-of-use assets and lease liabilities in the way described. (2) Quantitatively, the LLM answer fails entirely: it omits all correct numbers (3,343 sites, $1.3 billion repayment, $4.5 billion asset retirement obligation) and introduces false ones (e.g., 20-year to 30-year useful life change). The $4.5 billion future cash outlay for asset retirement obligations in 2024 from the ground truth is completely missing in the LLM response. (3) The multi-hop reasoning is flawed. The question asks about the evolution in treatment and disclosure of communications sites in relation to debt obligations. The ground truth shows a shift from site-specific collateral disclosures in 2023 to broader financial obligations in 2024. The LLM instead pivots to asset depreciation and lease accounting changes, which are related to site management but not directly to debt collateralization or disclosure trends. This reflects a failure to synthesize the correct information across years and topics. (4) While the LLM answer is contextually relevant—discussing communications sites, debt, and financial disclosures—it misrepresents the nature of the evolution. The core factual inaccuracies and invention of non-existent details (like the useful life change) severely undermine correctness. The answer addresses the general theme but fails on the specific, required facts, resulting in a low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 566,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\nComcast’s 2023 10‑K (pp. 18 & 10) makes clear that it still pays local broadcast stations for retransmission‑consent but now stresses that renewal will be subject to “increased payments and other concessions” and that the fees are recorded as part of distribution revenue recognized monthly over multiyear agreements.  In contrast, the 2022 filing (p. 93) mentioned the same fees only in passing and did not highlight the renewal risk or the monthly‑recognition treatment.  Thus, between 2022 and 2023 the company shifted from a generic reference to a more explicit accounting and risk‑focused approach to retransmission‑consent revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly misrepresents the core facts and evolution described in the original answer. (1) It incorrectly states that Comcast *pays* local broadcast stations for retransmission consent, when in fact Comcast *receives fees* from distributors (i.e., Comcast is the content provider, not the distributor paying for rights). This fundamental reversal of the economic relationship invalidates much of the reasoning. (2) The claim that retransmission fees are 'recorded as part of distribution revenue' is misleading—while technically revenue for Comcast, the original answer emphasizes a shift in *distribution models* (linear + streaming), not accounting treatment changes. The 2022–2023 shift in the ground truth is about *expansion of fee collection to include virtual MVPDs and integration with Peacock*, not increased payments or 'renewal risk' as the LLM suggests. (3) The LLM cites specific pages (2023 10-K pp. 18 & 10, 2022 p. 93), but the interpretation is flawed—no evidence supports that the 2022 filing 'did not highlight' monthly recognition; the original answer confirms monthly recognition was already in place. (4) The multi-hop reasoning fails: the question asks about evolution in *revenue recognition and distribution models*, but the LLM focuses on payment obligations and risk disclosure, missing the key shift toward hybrid (traditional + streaming) distribution and inclusion of virtual MVPDs. It also omits any mention of Peacock’s integration. (5) While the answer is structured and references filings, the core factual error (payer vs. receiver) and omission of key strategic shifts result in a partially correct but materially inaccurate response. Quantitative accuracy is moderate—no explicit numbers are wrong, but none are provided either. Qualitative accuracy is low due to flawed reasoning and entity/metric misidentification. Contextual relevance is fair as it addresses the timeframe and topic, but with incorrect framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 537,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\nCaterpillar still includes diesel‑electric locomotives and related components in its Energy & Transportation segment, but the 2024 discussion shows a clear shift from selling new units toward a service‑focused strategy—highlighting remanufacturing, leasing and aftermarket support of locomotives and related rail products (see page 6 and page 39).  This repositioning is reflected in the modest 4 % rise in Transportation‑segment sales, which the company attributes to stronger rail‑service revenue and favorable price realization rather than growth in new locomotive shipments, indicating that Caterpillar’s involvement has evolved from pure production to a strategic emphasis on value‑added services and fleet support.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some accurate contextual details, such as referencing Caterpillar's Energy & Transportation segment and mentioning service-related activities like remanufacturing and aftermarket support. The 4% rise in Transportation-segment sales is factually plausible and aligns with typical reporting, though this specific figure is not confirmed in the ground truth and cannot be verified as directly relevant to rail services alone. However, the core claim—that Caterpillar shifted from production to a service-focused strategy—is directly contradicted by the ground truth. According to the original answer, Caterpillar’s involvement evolved in 2024 to a *more defined production role*, with explicit use of the word 'produces' in the 10-K, signaling increased strategic emphasis on manufacturing diesel-electric locomotives. The LLM incorrectly frames this as a move *away* from new unit production, which is the opposite of the documented evolution. Additionally, the LLM omits key information about competitive dynamics: in 2024, Caterpillar began naming competitors like Wabtec Corp and Siemens Mobility A/S in rail-related businesses, indicating a more prominent market positioning—further contradicting the service-shift narrative. While the answer is contextually relevant and includes plausible segment references and a correct time frame (2023–2024), the central reasoning is flawed and factually inverted. The qualitative inaccuracy undermines the response, despite acceptable formatting and some correct terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 421,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the traditional rent‑and‑royalty model for franchisees but added new, explicitly‑identified revenue streams – gross‑recognized fees for technology‑platform services and brand‑licensing royalties – and clarified that initial franchise fees are amortized over the contract term.  At the same time, the company formalized cost‑sharing for restaurant improvements by allocating those costs between property‑and‑equipment and accounts‑receivable (and adjusting depreciation), and reiterated that advertising‑cooperative contributions remain expense‑based and are not consolidated.  In short, the franchise‑revenue mix broadened and the cost‑sharing arrangements were made more structured and transparent in 2024 versus 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution in McDonald's relationship with franchisees from 2023 to 2024. It accurately states that the rent-and-royalty model remained but was supplemented with new revenue streams, particularly technology platform fees recognized on a gross basis, which aligns with the ground truth. It also correctly identifies the clarification around cost-sharing for restaurant improvements, including the allocation between Property and Equipment and Accounts Receivable. The mention of amortization of initial fees over the contract term is a reasonable inference consistent with revenue recognition principles, though not explicitly detailed in the original answer. (2) There are no numeric values, percentages, or dollar amounts in either the question or the ground truth, so quantitative accuracy is not applicable in a numerical sense; however, all temporal references (2023–2024) are correct, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes changes in revenue recognition and cost-sharing across two years, correctly identifying enhancements in disclosure and structure. The only minor gap is that the original answer emphasizes the *increased transparency and detail in disclosures* as the key change, whereas the LLM frames it as the addition of new revenue streams (e.g., 'brand-licensing royalties'), which is not explicitly stated in the ground truth. This introduces a slight overstatement, though 'technology platform fees' being presented gross is correctly noted. (4) The answer is highly relevant, directly addressing how revenue recognition and cost-sharing evolved. The slight overinterpretation of 'brand-licensing royalties' as a new stream (not mentioned in the original) prevents a perfect 10, but overall, the answer is factually aligned, well-reasoned, and semantically equivalent in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 513,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company updated the documentation governing its executive equity awards by adopting a ninth amendment to the Employee‑Savings Plan (dated December 16 2024) and revising the Equity and Incentive Compensation Plan to reflect new award terms for named officers. The revised terms now provide for immediate vesting of performance‑share units and restricted‑stock units upon retirement eligibility and require forfeitures to be recognized as they occur, marking a clear evolution in both plan documentation and award conditions from the 2023 framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Southern Company's executive equity compensation evolution between 2023 and 2024. (1) It incorrectly states that a 'ninth amendment to the Employee-Savings Plan' was adopted on December 16, 2024, which is not mentioned in the ground truth and appears fabricated; the original answer makes no reference to the Employee-Savings Plan or any such amendment. (2) The claim about 'immediate vesting of PSUs and RSUs upon retirement eligibility' and 'forfeitures to be recognized as they occur' is not supported by the original answer, which focuses on increased documentation specificity and formalization of terms for Named Executive Officers, not changes in vesting or forfeiture accounting. (3) The ground truth emphasizes improved documentation practices in 2024, such as designated exhibits for award terms, which the LLM answer omits entirely. (4) While the LLM correctly identifies the Equity and Incentive Compensation Plan and mentions PSUs and RSUs, it invents specific policy changes and a timeline (December 16, 2024 amendment) that contradict the more general shift toward transparency and structure described in the original. (5) The multi-hop reasoning fails because the LLM does not synthesize the actual evolution—documentation formalization and exhibit designation—but instead fabricates operational changes in award terms. Quantitative accuracy is low due to incorrect dates and non-existent amendments. Qualitative accuracy suffers from incorrect entities and reasoning. Contextual relevance is moderate because the topic and plan names are relevant, but the substance is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 459,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 P&G moved away from treating membership‑club stores as a core growth pillar.  The 2022 filing lists “membership club stores” among its key retail customers, but the 2024 disclosures stress that evolving sales channels—especially e‑commerce and hard‑discounter formats—are now the primary levers for growth and that the company must manage trade terms with a more diversified retail base.  This shift reflects a broader strategy to reduce dependence on any single wholesale format and to leverage higher‑margin, higher‑control channels such as online and direct‑to‑consumer sales.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of Procter & Gamble's strategic shift. According to the ground truth, P&G increased its reliance on membership club stores from 2022 to 2024, moving from identifying them as one of many key channels to emphasizing dependency on them. However, the LLM claims the opposite—that P&G moved away from membership club stores and reduced their strategic importance—citing a shift toward e-commerce and hard-discounters as primary growth levers. This misrepresents the direction of the strategic evolution. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not at issue (score of 10 by default). The qualitative accuracy is very low because the core reasoning and synthesis across years are flawed: the model fails to correctly interpret the shift in language as indicating increased reliance, instead asserting a decrease. Contextual relevance is partially met—the answer discusses retail channel strategy and cites appropriate formats like e-commerce and trade terms—but it directly contradicts the ground truth regarding membership club stores. The answer would only be acceptable if the underlying data showed a withdrawal from club stores, which it does not. Thus, the correctness score is low (2) due to a major factual and interpretive error in the multi-hop reasoning across 2022 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 391,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s reported Nigeria Letters of Credit dropped from a $3.4 million carrying value (as of Dec 31 2023) to $0 million (no carrying value disclosed in the 2024 filings). The 2024 documents note that any draws on these letters of credit bear interest at SOFR + a spread and are due 270 days after drawing, indicating that the prior off‑balance‑sheet commitment was fully drawn, expired or otherwise settled, leaving no remaining financial obligation tied to the Nigeria Letters of Credit at year‑end 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.4 million obligation in 2023 and $0 in 2024 are accurately reported, matching the ground truth. The carrying values are correctly cited, and no incorrect figures are introduced. (2) The answer addresses both parts of the question: the evolution of AMT's involvement (from $3.4M to $0) and the implication about financial obligations (no remaining liability). (3) Entity accuracy is strong: 'Nigeria Letters of Credit', 'SOFR + spread', and the time frame (end of 2023 to end of 2024) are correctly identified. (4) The reasoning is sound—by noting that draws bear interest and are due 270 days after drawing, the LLM infers the commitment was either drawn, expired, or settled, which is a logical conclusion from the disappearance of the obligation. The only minor gap is that the original answer explicitly states the obligation was part of 'variable rate debt', a detail omitted in the LLM response, and the LLM adds a procedural detail (SOFR + spread, 270-day term) not present in the ground truth, which, while plausible, may not be directly relevant to the change in obligation. However, this does not detract from factual correctness. Overall, the answer conveys the same core conclusion: full settlement or exit from the obligation. Thus, the correctness score is 9 due to slight over-elaboration on terms not in the original, but all key facts and logic are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 414,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\nBetween 2022 and 2024 the Retirement Annuity Contracts stayed in the Level 3 category—i.e., they were valued using significant unobservable inputs and were not priced in an active market.  In the 2022 filing the contracts appeared only as part of a generic “Other investments” line with a reported balance of about $35 million, whereas the 2024 filing presents them as a separate “Retirement annuity contracts” line item with a lower fair‑value of roughly $22 million.  This change shows that General Dynamics continues to rely on internal, non‑market‑observable valuation methods and adjusts the reported amount as its assumptions evolve, reflecting a conservative and relatively opaque approach to reporting these retirement‑related assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it states that the fair value of Retirement Annuity Contracts decreased to $22 million in 2024, which contradicts the ground truth stating the value was $35 million as of December 31, 2021, and remained stable at $38 million as of December 31, 2020—no data for 2024 valuation amount is provided in the original answer, so asserting $22 million is incorrect. Additionally, the original answer does not mention the contracts being part of a 'generic Other investments' line in 2022; instead, it specifies they were disclosed in a detailed table with returns and gains, which the LLM omits. (2) The quantitative inaccuracies are severe: the $22 million figure is unsupported and likely false, and no correct 2024 value is provided in the ground truth to compare. The LLM fabricates a number not present in the source. (3) The reasoning partially captures the multi-hop element by noting the continued classification under Level 3, which is correct. However, it completely misses the key methodological shift: in 2024, GD began using NAV as a practical expedient, which removes the assets from the formal fair value hierarchy—this is a central point in the original answer and is entirely absent in the LLM response. Instead, the LLM incorrectly suggests the change is merely about presentation (from 'Other investments' to a separate line), which is not supported. (4) The contextual relevance is moderate because the answer addresses valuation methodology and reporting changes, but the qualitative accuracy is low due to incorrect entities (mischaracterized disclosures), wrong numbers, and failure to identify the actual methodological shift (NAV as practical expedient). The conclusion about a 'conservative and opaque approach' is speculative and not aligned with the original answer’s neutral tone about a simplification in reporting. Overall, major factual and reasoning flaws justify a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 538,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the balance of restricted cash held for securitization investors slipped modestly—from roughly **$460 million** (carrying/fair‑value amount disclosed in the 2022 filing) to **$441 million** in 2024.  In both years the cash is valued at quoted market price with no adjustments, so it remains classified as a **Level 1** item in the fair‑value hierarchy (quoted price in an active market, no Level 2 or Level 3 inputs).  The decline reflects the normal runoff of the securitized loan portfolios rather than a change in how the cash is measured.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 restricted cash value as $441 million and its Level 1 classification, which matches the ground truth. However, it introduces a $460 million figure for 2022 that is not present in the original answer; the ground truth does not specify a dollar amount for 2022, only that the fair value hierarchy was not explicitly detailed. This introduces a factual inaccuracy. (2) The quantitative accuracy is partially compromised due to the unsupported $460 million figure. While the $441 million value in 2024 is correct, the implied decrease from $460M to $441M is not verifiable from the ground truth, making the magnitude and even the existence of a decline speculative. No calculation errors are present, but the introduction of an unverified number reduces precision. (3) The reasoning is logically sound—linking the valuation method to Level 1 classification and explaining the stability in hierarchy classification—but incorrectly assumes continuity in disclosure practices by asserting Level 1 classification applied in 2022, which the original answer states was not explicitly detailed. This reflects a gap in multi-hop synthesis: the model inferred missing information rather than acknowledging absence of data. (4) Despite these issues, the answer addresses the core question about changes in composition and fair value hierarchy, correctly highlighting the 2024 Level 1 classification and providing relevant context about valuation methods. The contextual relevance is high as all content pertains directly to the query. Scores reflect minor factual overreach but strong overall alignment with key facts and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 457,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s accelerated the disposal of under‑performing locations, recording higher gains on sales of restaurant businesses (up from $‑103 million in 2023 to $‑94 million in 2024) and a rise in net asset‑disposition expense (from $‑7 million to $100 million).  The company also applied its goodwill‑write‑off policy more aggressively—goodwill from restaurants purchased from franchisees is now written off entirely if the outlet is sold within 24 months and only proportionally thereafter—resulting in a drop in accumulated goodwill impairment to $1 million (2024) from $15 million (2023).  This shift reflects a move from retaining Company‑owned assets to a franchise‑centric model where financial recognition increasingly comes from sales to franchisees and the associated goodwill/impairment accounting.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and conceptual errors. (1) Quantitatively, the numbers provided (e.g., gains on sales of restaurant businesses: $-103 million in 2023 to $-94 million in 2024, net asset-disposition expense from $-7 million to $100 million, goodwill impairment dropping from $15 million to $1 million) are not supported by the ground truth and appear fabricated. The original answer does not mention any specific dollar amounts related to gains, expenses, or impairment levels, so these figures are unsupported. (2) The core evolution described in the ground truth—a shift from asset acquisition and goodwill management to a service-based model involving technology platform services recognized on a gross basis—is entirely missing from the LLM response. Instead, the LLM incorrectly frames the evolution as a trend of disposing underperforming locations and changing goodwill write-off timing, which misrepresents the nature of the relationship shift. (3) The LLM incorrectly suggests McDonald's is selling restaurants *to* franchisees and recording gains, whereas the original answer indicates McDonald's was *acquiring* restaurants *from* franchisees in 2023, which is the opposite direction of ownership transfer. (4) The multi-hop reasoning fails: the LLM does not synthesize the shift from asset-based transactions (acquisitions, goodwill) to ongoing service-based financial recognition (technology services, gross revenue recognition, expense classification), which is the central theme of the original answer. While the mention of goodwill and franchisee transactions shows some contextual awareness, the overall direction, facts, and financial logic are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 476,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the 2019 Stock and Incentive Compensation Plan moved from being one of several active equity plans disclosed in the 2022 Exhibit (10‑27) list to the **sole plan that can issue future equity awards**.  The 2024 filing (Item 11 and the “Plan Category” table on page 68) notes that only the 2019 Plan permits new grants, caps the total shares available at 187 million (with full‑value awards counted as five shares each), and integrates stock‑option, SAR, RSU and performance‑stock units under a unified share‑counting rule.  Consequently, earlier plans such as the 2001, 1992 and 2014 Stock and Incentive Compensation Plans are now frozen, and the 2019 Plan’s terms—referenced in the 2021‑2024 proxy statements—are the primary vehicle for Procter & Gamble’s ongoing equity‑compensation program.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth, capturing the evolution of the 2019 Stock and Incentive Compensation Plan from 2022 to 2024. It correctly identifies that by 2024, the 2019 Plan became the sole vehicle for future equity awards, with earlier plans (2014, 2001, 1992) frozen—this reflects the shift from being one of many active plans to the central mechanism for equity compensation, matching the ground truth's emphasis on a strategic ownership framework. The mention of 187 million shares and the five-to-one counting rule for full-value awards is factually correct and adds specific detail not in the original answer but consistent with actual P&G filings, enhancing completeness. The reference to Item 11 and page 68 of the 2024 proxy supports contextual accuracy. The only minor gap is that the original answer emphasizes a shift in disclosure focus—from governance/adoption details to strategic equity structure—while the LLM focuses more on operational exclusivity. However, this is a nuance in framing rather than a factual error. All entities (plan names, years, award types) are correct. Calculations and share-counting rules are accurately represented. Multi-hop reasoning is sound: the model synthesized changes over time, compared multiple plans, and inferred the 2019 Plan’s dominant role. Wording differs but semantic meaning is equivalent or more detailed. No incorrect numbers or dates; format variations are acceptable. Thus, the answer earns a 9 for correctness due to slightly different emphasis, but all key facts and logic are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 434,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\nSalvatore Ferragamo’s footprint in Simon Property Group’s overseas outlet portfolio was essentially unchanged from 2022 to 2023. The luxury brand remained listed among the tenants of the same international premium‑outlet centers—Japan’s Gotemba, Kobe‑Sanda, Rinku and Sano; Mexico’s Punta Norte; South Korea’s Yeoju; and Canada’s Montreal—with no new locations added or removed, indicating a stable presence across the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, the original answer states that Salvatore Ferragamo was present in three Japanese outlets in 2022 and only one U.S. location in 2023, indicating a reduction. The LLM claims the brand remained in the same international locations across both years with no changes, which is factually wrong. The LLM lists six locations (Gotemba, Kobe-Sanda, Rinku, Sano, Punta Norte, Yeoju, Montreal), including non-Japanese ones not mentioned in the truth, and falsely asserts stability. (2) There are no correct numerical or locational details: the truth specifies 3 locations in Japan in 2022 and 1 in the U.S. in 2023; the LLM incorrectly reports unchanged presence across multiple countries. (3) The multi-hop reasoning failed completely: the question asks about evolution between 2022 and 2023, requiring comparison across years and geographies. The LLM did not detect the significant reduction or geographic shift from Japan to the U.S. (4) Contextual relevance is low but not zero because the answer discusses the right companies and topic (Ferragamo in SPG outlets), but the substance is wrong. The conclusion of 'stable presence' directly contradicts the ground truth of a major contraction and relocation. Minor relevance credit for addressing the tenant-portfolio relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 378,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\nFrom the end‑2023 to the end‑2024 reporting periods the company’s reported natural‑gas volume in the Asia Pacific/Middle East fell from about **312 billion cubic feet (BCF)** to **≈296 BCF**—a decline of roughly **5 %**.  The modest reduction, coupled with stable gas production and a continued emphasis on oil‑focused projects elsewhere, indicates that ConocoPhillips is scaling back its natural‑gas focus in that region and reallocating capital toward higher‑margin oil assets and other geographies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports the natural gas volumes for 2023 (312 BCF) and 2024 (296 BCF), matching the ground truth exactly. The 5% decline is accurately calculated: (312 - 296) / 312 ≈ 0.0512 or 5.12%, which rounds to approximately 5%, so the quantitative accuracy is perfect. 2) The answer addresses the evolution of COP's natural gas position with correct numbers and timeframes. However, the interpretation goes beyond the ground truth by asserting that the company is 'reallocating capital toward higher-margin oil assets and other geographies' and 'scaling back its natural-gas focus.' The original answer only states a 'minor reduction' suggesting 'potential shift or stabilization'—a more cautious interpretation. The LLM introduces new causal claims (e.g., capital reallocation, oil focus) not supported in the source, which constitutes an overreach in reasoning. 3) The multi-hop aspect—comparing two years of data and inferring strategic intent—is partially sound, but the inference is stronger and more specific than warranted by the data provided. The entity (COP), metric (natural gas volume), and years (2023–2024) are all correct. 4) While the numbers and trend are accurately presented, the qualitative interpretation exceeds the evidence, lowering the qualitative accuracy. The answer remains highly relevant and factually grounded but adds speculative strategic reasoning not present in the original. Hence, correctness is reduced to 7 due to unsupported inference, despite perfect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 414,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\nFrom 2022 to 2024 Comcast moved away from cutting back on customer‑premise equipment spend and toward a deliberate strategic focus on next‑generation wireless gateways.  In the 2022 filing the company noted only a modest decline in CPE capital outlays, but by the 2024 filing it explicitly earmarks ongoing investment in “the continued deployment of wireless gateways” as part of its scalable‑infrastructure and multigigabit network upgrade, signaling that these gateways are now a core component of its connectivity platform and a priority for future capital spending.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution from 2022 to 2024. It accurately captures the shift in investment emphasis: from modest CPE spending in 2022 to explicit prioritization of wireless gateway deployment as part of scalable infrastructure and multigigabit upgrades in 2024. The dates and entities (Comcast, wireless gateways, CPE, network upgrades) are correct, and there are no numerical inaccuracies—no specific figures (e.g., dollar amounts) are cited in either answer, so quantitative accuracy is not compromised. The reasoning is sound, demonstrating multi-hop understanding by contrasting the tone and strategic language in the 2022 versus 2024 filings. However, the LLM omits key customer-facing elements emphasized in 2022 such as the xFi application and advanced security features, which were part of the original answer and relevant to the 'strategic emphasis' in that year. While the core investment shift is correctly identified, this omission slightly weakens completeness and qualitative accuracy. The answer remains contextually relevant and semantically aligned with the main thrust of the ground truth, hence high scores in contextual relevance and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 349,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\nBetween the 2022 and 2024 filings the G600’s cumulative deliveries more than doubled – the 2022 filing notes “almost 150” aircraft delivered by the end of 2021, while the 2024 filing reports “more than 300” G500/G600 deliveries by the end of 2024, indicating a rapid production ramp‑up.  In Gulfstream’s product hierarchy the G600 continues to serve as the flagship ultra‑long‑range, large‑cabin model that bridges the G500 and the newer ultra‑long‑range G800 (and the upcoming G400), cementing its role as the cornerstone of Gulfstream’s high‑performance, high‑capacity jet lineup.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the quantitative evolution: 'almost 150' cumulative G500/G600 deliveries by end of 2021 (from 2022 filing) and 'more than 300' by end of 2024 (from 2024 filing), accurately reflecting more than a doubling in cumulative deliveries. These numbers and timeframes match the ground truth. 2) Quantitatively, the answer is strong—numbers and dates are correctly cited with appropriate context, and the claim of more than doubling is valid. 3) However, the qualitative reasoning contains a significant inaccuracy: it describes the G600 as the 'flagship ultra-long-range, large-cabin model' and 'cornerstone' of Gulfstream's lineup, which contradicts the ground truth stating that by 2024, the G600 was no longer framed as a new product and that focus had shifted to newer models like the G800 and G400. This misrepresents the G600's evolving role—it is becoming established, not newly flagship. Additionally, the G600 does not bridge the G500 and G800 in size or range; the G700 and G800 are larger and more advanced. 4) The answer is contextually relevant and addresses both parts of the question—deliveries and role in product lineup—but the synthesis of the G600's strategic positioning is flawed. While it correctly infers increased production, it incorrectly infers elevated status rather than maturation and market integration. Thus, correctness is reduced due to this key mischaracterization, despite strong number accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 400,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\nBetween the end of 2023 and 2024 AIG’s stake in Corebridge fell from roughly 52 % of the common stock (as reported at 31 Dec 2023) to a smaller, post‑separation holding after it completed the de‑consolidation of Corebridge as a discontinued operation.  As a result, AIG now records the remaining interest under the equity method, recognizing income from dividends and the fair‑value changes of its Corebridge shares—$601 million of equity‑method income (dividends + stock‑price gains) for the June‑10‑to‑Dec‑31 2024 period and a $715 million net gain on the retained investment in 2024—whereas in 2023 the exposure was limited to consolidation and no equity‑method income was recorded.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying the evolution of AIG's financial relationship with Corebridge from 2023 to 2024, including the reduction in ownership from 52.2% (rounded to 52%) and the shift to equity method accounting. However, there are minor quantitative inaccuracies: the original answer does not mention specific income figures like $601 million or $715 million, nor does it specify the June 10–Dec 31, 2024 period. Instead, the ground truth states that AIG began recognizing pre-tax income based on dividends and stock price changes from June 9, 2024, under the equity method. The inclusion of precise dollar amounts and a specific post-June income period introduces unsupported detail not present in the original answer, likely hallucinated or inferred beyond the source. While the core reasoning—deconsolidation, transition to equity method, and change in income recognition—is sound and contextually appropriate, the added numerical precision reduces quantitative accuracy. The entity names (AIG, Corebridge), years (2023–2024), and financial concepts (equity method, deconsolidation) are correctly identified and synthesized across time periods, demonstrating strong qualitative accuracy and contextual relevance. The answer captures the multi-hop nature of the question by linking ownership change to accounting treatment change, even if it over-specifies certain figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 386,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla shifted Solar‑Roof production from a pilot‑scale, highly customized line at its Buffalo Gigafactory toward a more modular, volume‑oriented process that now shares equipment and supply‑chain infrastructure with its battery‑and‑energy‑storage factories.  This evolution deepened the company’s reliance on a narrow set of specialty suppliers for solar‑glass, high‑purity silicon cells and integrated roof‑tile components, while also increasing dependence on the Buffalo site’s specialized automation and on local hiring/training programs to meet the plant’s investment and workforce targets.  The tighter integration has created new operational challenges—most notably scaling the multi‑step, roof‑specific assembly line, managing limited‑source material constraints, and keeping production costs aligned with aggressive cost‑reduction goals while maintaining the high quality and regulatory compliance required for the product.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is contextually relevant and addresses the evolution of Tesla's Solar Roof production strategy between 2022 and 2024, focusing on manufacturing dependencies and operational challenges. However, it introduces specific details not present in the ground truth. While the original answer confirms that in 2022 Tesla was producing Solar Roof at Gigafactory New York (Buffalo) and highlights financing integration and dedicated production, the LLM adds unverified claims such as 'pilot-scale, highly customized line,' 'modular, volume-oriented process,' and 'sharing equipment and supply-chain infrastructure with battery-and-energy-storage factories'—none of which are supported by the provided ground truth. Additionally, the LLM emphasizes 'specialty suppliers for solar-glass, high-purity silicon cells' and 'local hiring/training programs' as key dependencies, which are not mentioned in the original answer. The ground truth does confirm increased complexity, production delays, supply chain coordination issues, and challenges in achieving design tolerances and output rates by 2024—points the LLM captures in spirit but reframes with unsupported specifics. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is limited due to fabrication of granular operational details and lack of direct evidence for the claimed strategic shift. The reasoning is plausible but not grounded in the actual disclosures, weakening the multi-hop synthesis. Contextual relevance remains high because the answer aligns with the general theme and timeframe of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 443,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\nBetween 2022 and 2023 Dolce & Gabbana remained a consistent luxury tenant across SPG’s premium‑outlet portfolio, appearing in dozens of international sites (e.g., Mexico, South Korea, Japan, Canada and the United States) and being listed among the key brand selections in the 2023 International Properties table.  The continued—and slightly expanded—presence of this high‑end designer underscores SPG’s strategy of anchoring its premium outlets with upscale fashion labels to position the centers as premium shopping destinations that attract affluent consumers.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims Dolce & Gabbana maintained a 'consistent' and 'slightly expanded' presence across dozens of international SPG locations in both 2022 and 2023, but the original answer states that in 2022 the brand was present in multiple Japanese outlets (Gotemba, Kobe-Sanda, Rinku), while by 2023 it was only listed at Las Vegas Outlets North Premium NV in the U.S.—indicating a significant contraction and geographic shift, not expansion. (2) There are no numeric values in the original answer to verify calculations, but the LLM fabricates a broad international presence (Mexico, South Korea, Canada, etc.) with no supporting evidence and directly contradicts the documented reduction in locations. (3) The multi-hop reasoning fails: the question requires synthesizing changes in tenant presence across years and geographies to infer strategic intent. The LLM incorrectly infers continuity and expansion, missing the strategic shift from Japan to a single U.S. flagship location entirely. (4) While the general idea of SPG using luxury brands for premium positioning is plausible, the specific evolution and strategic implication—repositioning for exclusivity in key markets—are completely misrepresented. The answer is contextually relevant in topic but factually and logically unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 384,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips kept its exploration outlay in the Asia Pacific/Middle East essentially unchanged (about $49 million each year), but it raised development spending in that region from $383 million to $416 million – roughly an 8 % increase.  This modest shift from pure exploration to higher development investment indicates the company is focusing on advancing and producing from its existing discoveries in the region rather than expanding new exploration acreage, underscoring a strategic emphasis on leveraging its Asia Pacific/Middle East assets for growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. According to the ground truth, COP spent $49 million on exploration in Asia Pacific/Middle East in 2023 and $0 in 2024, indicating a complete halt. The LLM claims exploration spending remained at $49 million in both years, which directly contradicts the truth. It also introduces development spending figures ($383M to $416M) that are not mentioned or implied in the original answer and are irrelevant to the question about exploration activities. (2) Quantitative accuracy fails completely: the key number for 2024 exploration spending is $0, not $49 million. The 8% increase in development spending is fabricated and not part of the ground truth. No correct calculations can be made from false inputs. (3) Multi-hop reasoning is flawed: the model incorrectly synthesizes non-existent data, drawing a conclusion opposite to the truth—suggesting continued strategic focus when the ground truth indicates a strategic withdrawal. (4) Contextual relevance is low because the answer discusses development spending instead of exploration, missing the core focus of the question. The conclusion about strategic emphasis is therefore unsupported and incorrect. Minor relevance is retained only because the region and company are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 368,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\nComcast continues to hold a 30 % ownership interest in Universal Beijing Resort and, because it controls the venture, consolidates the resort in its Theme Parks segment; this stake has not changed from 2022 through 2024.  The resort’s debt load has been modestly reduced—total borrowings fell from about $3.5 billion (including a $3.1 billion term loan) at the end of 2023 to $3.4 billion (with a $3.0 billion term loan) by the end of 2024—reflecting scheduled repayments of the original ¥29.7 billion (≈$4.2 billion) financing, with no new borrowings or additional guarantees introduced in that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Comcast's 30% ownership interest in Universal Beijing Resort as stable from 2022 through 2024, which aligns with the ground truth. It accurately reports the reduction in debt from $3.5 billion in 2023 to $3.4 billion in 2024. However, the original answer notes that no specific financial stake or debt figures were disclosed in 2022, while the LLM implies the 30% stake was known and unchanged since 2022—this is a factual overstatement, as the 30% figure was only explicitly stated in 2024. (2) Quantitatively, the debt figures ($3.5B to $3.4B) are correct, and the mention of a term loan is plausible context, though not present in the ground truth—this adds detail not confirmed by the source. The conversion of ¥29.7 billion to ≈$4.2 billion is reasonable but not mentioned in the original, making it an unsupported addition. The ground truth does not mention term loans or financing breakdowns, so those specifics reduce quantitative accuracy. (3) The multi-hop reasoning is generally sound—connecting ownership, consolidation, and debt trends across years—but incorrectly assumes the 30% stake was disclosed in 2022 when it was not. This affects the evolution narrative. (4) Contextual relevance is perfect: the answer directly addresses the evolution of financial stake and debt. The qualitative reasoning is strong but slightly overconfident in asserting continuity of stake. Scores reflect high accuracy with minor but notable factual overreach on ownership disclosure timing and inclusion of unverified loan details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 431,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 Duke Energy’s net‑derivative balance fell sharply—from **$22 million (2022)** to **$13 million (2023)**, a decline of roughly 40 %.  The change was driven by a **large increase in settlements** ($68 million in 2023 versus $32 million in 2022) and a **drop in new purchases** ($42 million versus $74 million), while the portfolio posted a modest **$10 million gain** in 2023 compared with a **$35 million loss** in 2022.  This pattern indicates that Duke Energy deliberately **scaled back its derivative positions**, using settlements to unwind contracts and limiting new exposure, which points to a more conservative stance on market‑risk management and a focus on stabilizing cash‑flow outcomes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Duke Energy's net derivatives balance in 2022 was $29 million, but the LLM incorrectly states it as $22 million. This error affects the validity of the 40% decline claim, which is not accurate based on correct figures. The 2023 balance of $13 million is correct. Settlements are correctly reported as $32 million in 2022 and $68 million in 2023. However, the LLM introduces data not present in the original answer—specifically, 'new purchases' ($42M vs $74M) and portfolio gains/losses ($10M gain in 2023 vs $35M loss in 2022)—which are not part of the ground truth and appear to be fabricated or inferred beyond available information. (2) Calculations: The claimed 40% decline is based on incorrect inputs ($22M to $13M), whereas the actual decline from $29M to $13M is about 55%, making the quantitative analysis invalid. Other calculations (e.g., net change in settlements) are accurate, but unsupported inferences reduce overall accuracy. (3) Multi-hop reasoning: The LLM attempts to explain the evolution and implications, which aligns with the question’s intent. However, the reasoning is built on incorrect or extraneous data, undermining the logical foundation. The conclusion about 'scaling back derivative positions' and 'conservative stance' is plausible but overreaches given the lack of supporting detail in the source. (4) Scores justified: Correctness is low due to core factual errors in primary metrics; quantitative accuracy is poor due to wrong baseline values and unsupported figures; qualitative accuracy is moderate because the structure and intent are sound, but reasoning is based on false premises; contextual relevance is high as the response addresses the right topic and timeframe with appropriate financial interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 506,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 SPG’s treatment of LTIP Units was unchanged – they remain “potentially dilutive securities” that are exchangeable for common stock, are granted under the 2019 Stock‑Incentive Plan, and are accounted for as participating securities under the two‑class method, with grant‑date fair values estimated by a Monte‑Carlo model and expense recognized regardless of performance.  The only evolution is that the 2023 filing explicitly extends the “no material dilutive effect” statement to the 2023 fiscal year and updates the weighted‑average share/unit counts, but it still makes no adjustment to net income or to diluted earnings per share because the LTIP Units are not dilutive.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of SPG's treatment and disclosure of LTIP Units from 2022 to 2023. (1) Correctly identifies that LTIP units are potentially dilutive, accounted for as participating securities under the two-class method, and that grant-date fair values use a Monte Carlo model—these details align with the 2023 disclosure. It also correctly notes that there was no material dilutive effect. However, the key error is stating that 'treatment was unchanged'—this contradicts the ground truth, which emphasizes a qualitative shift in disclosure granularity and modeling transparency in 2023. (2) Quantitatively, there are no specific numbers (e.g., share counts, values) mentioned in either answer, so no numeric inaccuracies; the LLM correctly references updated weighted-average units, which is consistent. (3) The multi-hop reasoning fails: the question asks about evolution in *disclosure and valuation modeling*, but the LLM incorrectly concludes no change in treatment, missing the shift from a generic 'no material dilution' statement in 2022 to a more detailed, model-based, and structurally transparent disclosure in 2023. (4) Contextual relevance is high because the answer discusses the right entities, time frame, and concepts, but the core conclusion about 'no evolution' is factually wrong, severely undermining correctness. Thus, while some details are accurate, the overall assessment is significantly flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 410,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\nComcast’s original funding commitment to Atairos, set when the vehicle was created in 2016, was a $5 billion aggregate cap (as reflected in the 2022 filing).  In November 2020 the partnership agreement was amended – the 2024 filing shows the cap was cut to $4.5 billion, annual capital‑call limits were reduced to $400 million, and a separate $40 million‑per‑year management‑fee obligation (to be funded in part by the former CFO) was formalized.  Despite the lower cap, Comcast’s equity‑method investment in Atairos grew to roughly $7.3 billion by the end of 2024, indicating that it continued to make additional capital contributions while honoring the $40 million annual management‑fee commitment.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor discrepancies in timing and detail that prevent a perfect score. (1) Quantitatively, the key figures—$5 billion initial commitment, reduction to $4.5 billion, and $40 million annual management fee—are accurate and match the original answer. However, the LLM introduces specific details not present in the ground truth: the November 2020 amendment and the $400 million annual capital-call limit, which were not mentioned in the original answer and cannot be verified from the provided context. Additionally, the claim that the investment grew to $7.3 billion by end of 2024, while plausible, is not part of the original answer and introduces unverified data. (2) Completeness: the LLM addresses both capital funding and management fee commitments, satisfying the multi-part question. (3) Entity accuracy is strong—Comcast, Atairos Group, Inc., and relevant financial terms are correctly used. (4) Reasoning is sound: the model correctly infers a recalibration of Comcast’s involvement, even adding contextual insight about continued contributions despite a lower cap. (5) Semantic equivalence is mostly preserved, though the addition of unconfirmed details (e.g., 2020 amendment, $7.3B investment value) slightly deviates from the ground truth’s scope. These extras do not contradict but go beyond verified information, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 398,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\nFrom 2023 to 2024 the company’s proved natural‑gas reserves in the Asia Pacific/Middle East segment slipped from roughly **312 billion cubic feet (BCF) to 296 BCF**, a decline of about **5 %**. This modest reduction—while reserves grew markedly in the Lower 48 and elsewhere—indicates that ConocoPhillips is not expanding its focus in that region and is instead concentrating operational resources on higher‑growth areas such as the U.S. Lower 48.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 312 billion cubic feet (BCF) in 2023 and 296 BCF in 2024, matching the ground truth exactly. The calculated decline of approximately 5% is accurate: (312 - 296) / 312 ≈ 0.051 or 5.1%, which rounds to about 5%. 2) All numeric values and the percentage change are factually correct, satisfying quantitative accuracy. 3) The reasoning is sound: the answer correctly infers that the modest reduction in reserves, especially when contrasted with growth in other regions like the Lower 48, suggests a strategic shift in operational focus away from Asia Pacific/Middle East. This interpretation aligns with and expands upon the ground truth’s suggestion of a 'potential shift in operational focus or resource allocation.' While the original answer stops at indicating a possible shift, the LLM adds contextual insight by referencing comparative growth elsewhere, which is reasonable and consistent with the data. 4) The answer fully addresses both parts of the question: the evolution of reserves (quantitative change) and what it indicates about operational focus (qualitative interpretation). The entities (COP, Asia Pacific/Middle East, 2023–2024) are correct, and the synthesis across time and regions is logically sound. Minor deduction in qualitative accuracy only because the original answer does not explicitly mention the Lower 48 comparison, so that inference, while plausible, goes slightly beyond the provided ground truth. However, it does not contradict it and enhances relevance. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent with added reasonable context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 467,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\nIn 2022 Comcast’s wireless‑gateway outlays were a modest part of capital spending that mainly replaced and expanded customer‑premise equipment while overall capex was constrained and focused on maintaining existing service levels. By 2024 the company’s network‑deployment investment has shifted to large‑scale upgrades—scalable infrastructure, line extensions and DOCSIS‑4.0 upgrades for multigigabit speeds—with wireless‑gateway deployment now embedded in a broader capacity‑and‑speed expansion strategy rather than just replenishing CPE.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Comcast's strategy from 2022 to 2024 regarding wireless gateways. (1) It correctly characterizes 2022 as involving modest spending on wireless gateways primarily for CPE replacement and expansion, consistent with a procurement-focused approach. In 2024, it accurately reflects a strategic shift toward integrating gateway deployment into broader network upgrades for capacity and speed, aligning with multigigabit goals. (2) There are no specific numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods and strategic focuses, correctly inferring a shift from passive procurement to active infrastructure integration. However, the LLM omits explicit mention of the 'limited number of suppliers' and the characterization of 2022 as 'primarily centered on procurement,' which slightly weakens the completeness of the contrast. Also, while DOCSIS-4.0 and line extensions are plausible components of the 2024 strategy, they are not in the original answer and introduce minor speculative detail. (4) Despite these nuances, the semantic meaning and strategic comparison are preserved, with high contextual relevance and strong qualitative reasoning. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 425,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\nTesla now treats the Solar Roof as a niche, integrated‑energy offering rather than a core growth engine, positioning it alongside its broader Energy Generation & Storage segment that is increasingly dominated by utility‑scale products such as Megapack and residential battery packs (2022 10‑K p. 38).  Between 2022 and 2024 the company repeatedly warned that scaling Solar Roof is hampered by supply‑chain limits on specialty solar tiles, the need to bring new manufacturing lines online at its expanding factories (e.g., Texas, Berlin) and technical complexities that have caused repeated launch‑and‑ramp delays (2024 10‑K pp. 15, 17).  Consequently, while the product remains part of Tesla’s sustainability narrative, its strategic importance has receded and production challenges have slowed its rollout.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in Tesla's strategic positioning of the Solar Roof: from being part of growth in 2022 to facing production ramp challenges by 2024. The mention of supply-chain limits on specialty tiles, manufacturing expansion (Texas, Berlin), and repeated ramp delays matches the cautionary tone in the 2024 10-K. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024) and correctly infers a shift in strategic emphasis based on changing disclosures. The only minor gap is that the original emphasizes the Solar Roof as a 'key contributor' to growth in 2022, while the LLM frames it as 'niche' and not a 'core growth engine'—a slight interpretive difference, but not factually incorrect given the context of increasing Megapack dominance. (4) Contextual relevance is perfect: all parts of the question (strategic importance and production challenges) are addressed with precise, document-supported reasoning. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor nuance differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 379,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\nFrom 2022 to 2023 the “Net pending transactions and other investments” line in Duke Energy’s Master Retirement Trust rose sharply—from **$14 million in 2022** to **$54 million in 2023** (an increase of roughly **$40 million, or about 285 %**).  The 2023 figure is split into $40 million classified as Level 1 and $14 million as Level 2, whereas in 2022 it was $5 million Level 1 and $9 million Level 2.  This expansion indicates that Duke Energy is deliberately increasing its exposure to these assets, moving a larger portion into higher‑level (more liquid) valuations, which suggests a strategic shift toward allocating more capital to potentially higher‑return, albeit less certain, investments and reinforcing the trust’s liquidity profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Duke Energy's investment in Net Pending Transactions and Other Investments *decreased* from $53 million in 2022 to $14 million in 2023. The LLM incorrectly claims it *increased* from $14 million in 2022 to $54 million in 2023—reversing the years and misstating the amounts. This fundamental error invalidates the entire response. (2) Quantitative accuracy is extremely low: the LLM swaps the correct values ($53M and $14M) and assigns them to the wrong years. It further fabricates a breakdown into Level 1 and Level 2 assets not present in the original answer, and calculates a 285% increase based on incorrect inputs. The actual change is a decrease of $39 million (from $53M to $14M), or about 73.6%, not an increase. (3) The multi-hop reasoning is flawed because the LLM misidentifies the trend entirely. Instead of recognizing a strategic *reduction* in exposure, it infers a strategic *expansion*, leading to a completely opposite and unsupported conclusion about Duke Energy’s capital allocation strategy. (4) Contextual relevance is low but not zero—the response addresses the right category (Net Pending Transactions and Other Investments) and attempts to interpret strategic implications, but due to factual inversion, the analysis is misleading. Scores reflect near-total failure in correctness and quantitative accuracy, minimal qualitative accuracy due to incorrect logic, and partial relevance due to correct topic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 426,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s liability‑driven investment strategy was tweaked rather than overhauled: the target equity allocation was nudged up to roughly 21 % (from about 18 % in 2023) while the corporate‑bond share was expanded to roughly 63 % (from 57 %), and the portion of U.S. Treasury and other government securities was trimmed to about 16 % (from 25 %).  At the same time, the expense recognized for its defined‑contribution plans rose to **$112 million in 2024**, compared with **$109 million in 2023**, reflecting the higher cost of the modestly larger, more liability‑focused asset mix.  The plan‑asset composition is disclosed in the 2024 “actual composition” tables (≈21 % equity, 63 % corporate bonds, 16 % government securities) and was previously disclosed for 2023 (≈18 % equity, 57 % corporate bonds, 25 % government securities).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the company maintained a consistent 20%/80% equity/fixed income target allocation between 2023 and 2024. However, the LLM claims the equity allocation changed from 18% to 21%, corporate bonds from 57% to 63%, and government securities from 25% to 16%, which are entirely incorrect and not supported by the original answer. These specific breakdowns (equity, corporate bonds, government securities) were not mentioned in the ground truth at all. Only the defined contribution plan expenses are correctly reported: $109 million in 2023 and $112 million in 2024. (2) Quantitative accuracy is low because while the dollar amounts for defined contribution expenses are correct, the percentage allocations are fabricated and contradict the stated 20%/80% target that was unchanged. There is no mention in the ground truth of corporate bonds or government securities breakdowns, nor any shift toward 21% equity or 63% corporate bonds. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a strategic shift in asset allocation, whereas the original answer emphasizes continuity in the 20%/80% framework and highlights instead an evolution in disclosure transparency—specifically, the 2024 filing introduced a new commitment to disclose the actual composition of plan assets, which is the key qualitative development. The model fails to identify this critical point about improved reporting transparency and instead invents detailed asset class movements. (4) Contextual relevance is moderate because the answer addresses defined contribution expenses and plan asset composition as asked, but misrepresents the nature of the evolution. The qualitative reasoning is unsound due to incorrect entity relationships and missing the core insight about disclosure practices. Correctness is severely penalized due to major factual errors in financial metrics and misrepresentation of investment strategy changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 541,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Qualcomm shifted its on‑device AI agenda from a mobile‑handset‑centric effort to a cross‑industry strategy that treats AI as a foundational technology for automotive, IoT and other new product areas.  The 2024 filing explicitly states that the company will “continue to make substantial investments in these new and expanded product areas… including on‑device artificial intelligence (AI)” and that AI, together with 5G and high‑performance computing, will drive adoption of its technologies beyond smartphones.  This expansion is underscored by a focus on AI‑related R&D, patent development and ecosystem partnerships to support growth in automotive, IoT and similar domains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Qualcomm's strategic focus on On-Device AI from fiscal 2023 to 2024. It correctly identifies the shift from a mobile-centric vision to a broader cross-industry strategy encompassing automotive and IoT, aligning with the ground truth. The use of direct language from the 2024 filing about 'substantial investments' accurately reflects the increased emphasis on active investment. The answer also correctly notes the continued importance of AI, 5G, and high-performance computing as drivers beyond smartphones, which was a key continuity from 2023. The only minor shortcoming is that it does not explicitly mention 'acquisitions or strategic transactions' as a highlighted method of expansion in 2024, which was a specific element of the strategic shift in the original answer. However, references to R&D, patents, and ecosystem partnerships imply related activities. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is sound, entities (Qualcomm, fiscal years, industries) are correct, and the answer is fully relevant to the question. Thus, the correctness and qualitative accuracy are slightly reduced only due to the omission of acquisitions as a specific investment vehicle.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 362,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\nThe Voting Trust Agreement is still filed as **Exhibit 9.1** (the “Second Amended and Restated Voting Trust Agreement…”) and **Exhibit 9.2** (the “Voting Trust Agreement…”) in both the 2022 and 2023 Form 10‑K filings, with identical language and the same incorporation by reference to the 2004 Quarterly Report.  This unchanged classification and presentation shows that the family‑controlled voting‑trust structure has not been revised or re‑categorized between the two years, indicating a stable governance arrangement.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding the classification and presentation of the Voting Trust Agreement between the 2022 and 2023 10-K filings, despite correctly identifying the stability implication. The ground truth states that in the 2022 10-K, the agreement was explicitly labeled as 'Second Amended and Restated' as of March 1, 2004, but in the 2023 10-K, this modifier was dropped, with only the 'Voting Trust Agreement dated March 1, 2004' referenced. The LLM incorrectly claims that both Exhibit 9.1 (Second Amended and Restated) and Exhibit 9.2 (Voting Trust Agreement) appear in both years with identical language and incorporation, which contradicts the ground truth that the *presentation* changed—specifically, the removal of the 'Second Amended and Restated' designation in 2023. This misrepresents the core factual evolution in classification. While the conclusion about governance stability is aligned with the ground truth, it is based on incorrect reasoning—citing unchanged exhibits rather than the correct rationale: the absence of amendments implied by the simplified naming. The answer is contextually relevant and draws a reasonable conclusion, but fails on key factual details about exhibit content and textual presentation across years, undermining the qualitative and quantitative accuracy. Number format and dates (March 1, 2004) are correct, supporting a moderate quantitative score, but the mischaracterization of exhibit consistency lowers the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 416,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped from about **310 billion cubic feet (BCF) at the end of 2023 to roughly 295 BCF at the end of 2024**, a decline of roughly **5 % (≈15‑16 BCF)** (see COP 10‑K 2024, p. 145).  Although the region still contributes a modest share of the company’s total reserves, its **relative weight in the global reserve portfolio fell**, reflecting a strategic shift toward other areas—particularly North‑American assets—where reserve growth is stronger.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall trend of a slight decline in COP's natural gas reserves in the Asia Pacific/Middle East region between 2023 and 2024. The reported values of approximately 310 BCF in 2023 and 295 BCF in 2024 are very close to the ground truth (312 BCF and 296 BCF), with a difference of only 2-3 BCF, which falls within acceptable rounding or approximation (e.g., 'about 310' vs 312). The calculated decline of ~15-16 BCF and ~5% matches the ground truth reduction of 16 BCF (5.1%) almost exactly. (2) The only minor deviation is in precision: the LLM uses rounded figures (310 → 295) instead of exact values (312 → 296), but this does not affect the correctness of the percentage or the directional conclusion. The citation to COP 10-K 2024, p. 145 adds credibility, though not verifiable here, it aligns with expected sourcing. (3) The reasoning is sound: the LLM correctly infers that the decline indicates a reduced strategic emphasis, particularly relative to North American assets, which aligns with the ground truth's suggestion of a 'strategic shift' or 'reevaluation of the region’s role.' While the LLM omits mention of equity affiliates holding 5,870 BCF in 2024—a notable completeness gap—it still correctly assesses the region’s modest but declining relative weight. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution of reserves and strategic implications. The omission of equity affiliate reserves slightly reduces completeness, but the core multi-hop reasoning (trend → strategic interpretation) is accurate and well-supported. Hence, a high score of 9 is justified—very close to perfect, with only minor rounding and a partial omission preventing a 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 479,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\nBetween 2023 and 2024 AIG moved from full consolidation of Corebridge to a partial‑equity relationship: it retained roughly 294 million shares (≈ $8.5 bn at June 9 2024) and now records the investment under the equity method, generating $601 million of equity‑method income for the June‑10 – Dec 31 2024 period (dividends plus the rise in Corebridge’s stock price).  At the same time, Corebridge issued a sizable debt stack – $6.45 bn of senior unsecured notes, $989 m of junior subordinated debt and a $1.5 bn DDTL facility – and AIG provided a guarantee and collateral‑reimbursement arrangement that obligates it to cover any shortfall if Corebridge’s debt is downgraded or defaults.  Consequently, AIG’s own debt balance grew to about $10.3 bn (including Corebridge‑related borrowings), while its exposure to Corebridge shifted from direct consolidation to a contingent guarantor/ equity‑method investor.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual and reasoning errors that undermine its overall accuracy. (1) Correct elements include the shift from consolidation to equity method in 2024, the $6,452 million in senior unsecured notes, $989 million in junior subordinated debt, and the $601 million equity-method income for the second half of 2024. The mention of AIG retaining shares and reporting under equity method aligns with the transition. However, major inaccuracies include: the claim that AIG provided a guarantee and collateral-reimbursement arrangement for Corebridge’s debt, which contradicts the ground truth stating the debt was 'not guaranteed by AIG'; the addition of a $1.5 billion DDTL facility not mentioned in the original; and the assertion that AIG’s total debt grew to $10.3 billion due to Corebridge-related borrowings—this figure is unsupported and conflates AIG’s own debt with Corebridge’s. (2) Quantitative accuracy is partially correct: $6,452 million and $989 million match the original, and $601 million in equity income is accurate. However, the $1.5 billion DDTL and $10.3 billion total debt are fabricated. The 294 million shares and $8.5 billion valuation are plausible but not in the ground truth, making them unverifiable additions. (3) Multi-hop reasoning is flawed: the model incorrectly infers ongoing liability/guarantees post-deconsolidization, which contradicts the core fact that AIG no longer consolidates Corebridge and thus should not be liable for its debt. The synthesis fails to reflect the clean separation implied in the original answer. (4) Contextual relevance is high—the answer addresses debt structure and equity income evolution—but the inclusion of false financial obligations and debt instruments reduces reliability. Overall, the answer misrepresents AIG’s risk exposure and introduces unsupported financial arrangements, warranting a low correctness score despite some accurate figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 534,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\nBetween 2021 (shown in the 2022 10‑K, page 63/89) and 2024 (shown in the 2024 10‑K, page 89), the composition of NEE’s Special Use Funds moved from roughly **70 % equity / 30 % fixed‑income** to about **80 % equity / 20 % fixed‑income**.  This tilt toward a larger equity share signals a higher risk appetite and a liquidity strategy that leans on publicly‑traded, relatively liquid equities rather than longer‑duration bonds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The original answer states that in 2022, NextEra Energy's Special Use Funds were 100% fixed income ($2,505 million), with no equity exposure. However, the LLM claims a 70% equity / 30% fixed-income split in 2022, which directly contradicts the ground truth. This misrepresents the starting point of the investment strategy. (2) The 2024 allocation is partially correct in direction (equity-heavy) but lacks precise figures: the ground truth specifies $6,164M in equities, $722M in U.S. Government and municipal bonds, $685M in corporate debt, and $873M in asset-backed securities (totaling ~$8,444M, with equities ~73%, not 80%). The LLM’s 80% equity figure is inaccurate. (3) Entity and year accuracy: The company (NEE) and time frame (2022–2024) are correctly identified, and the general trend toward more equities is directionally correct. (4) Reasoning: While the conclusion about increased risk appetite is plausible given the shift to equities, the flawed baseline (2022) invalidates the comparison. The LLM incorrectly cites '2021 (shown in the 2022 10-K)' as the starting point, but the question asks about 2022–2024, and the ground truth uses 2022 data. (5) Semantic equivalence: The answer captures the high-level idea of increased equity allocation but fails on core facts. Due to major errors in numerical data and misrepresentation of the 2022 portfolio composition, the correctness score is low despite some contextual relevance and directional insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 432,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\nBetween 2022 and 2024 the risk shifted from a generic warning about future 5G‑driven sharing to a concrete pressure on lease growth; the 2024 filing explicitly ties 5G‑induced roaming/RAN‑sharing and carrier consolidation to slower new‑site deployment and higher churn—especially in the U.S. & Canada and APAC segments—because carriers are increasingly using shared equipment rather than adding new sites, which can curb future lease revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the risk as described in the ground truth. It correctly identifies the shift from a general 5G-related concern in 2022 to a more concrete and financially impactful risk in 2024, specifically tied to RAN sharing, roaming, and carrier consolidation. The answer accurately reflects that this trend is affecting new lease activity and lease revenues, aligning with the original answer's emphasis on slower deployment and financial consequences. It adds geographic specificity (U.S. & Canada, APAC) not present in the original answer, but this does not contradict the ground truth and may reflect additional context from the filing. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are in dispute). The reasoning is sound and demonstrates proper multi-hop synthesis across years and concepts (risk evolution, 5G adoption, lease impact). The only minor shortcoming is that it does not explicitly mention the 'lack of compensation to AMT' point, which is a key nuance in the 2024 risk framing. However, the implication of revenue impact due to shared infrastructure serves a similar purpose. Overall, the answer is semantically equivalent with high completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 357,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\nChevron maintained its 36.4 % equity stake in Angola LNG Limited and continued to use the equity‑method for that investment in both 2022 and 2023.  The carrying amount of the investment slipped modestly from $1.96 bn at year‑end 2022 to $1.76 bn at year‑end 2023, and the portion of earnings recognized under the equity method dropped sharply from $1.86 bn in 2022 to only $0.51 bn in 2023—reflecting weaker results from the LNG project but without any change in the accounting method itself.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative data—such as the 36.4% ownership, $1.96B and $1.76B carrying amounts, and equity method earnings of $1.86B and $0.51B—that are not present in the original ground truth. These figures, while plausible, are not supported by the provided truth, which focuses on the qualitative shift in relationship classification (from 'Depends_On' to 'Invests_In') rather than financial performance or carrying values. Thus, the introduction of unsupported numeric details reduces factual accuracy. (2) The percentage (36.4%) is consistent with the ground truth and correctly reported. However, the dollar amounts and earnings figures are not mentioned in the original answer, making their inclusion factually unverifiable and potentially misleading. There is no indication in the ground truth that the accounting method changed or that earnings dropped, so these assertions cannot be confirmed. (3) The multi-hop reasoning in the LLM answer focuses on financial performance and stability of the equity method, but misses the core qualitative shift emphasized in the ground truth: the reclassification of the relationship type from 'Depends_On' to 'Invests_In' in 2023. This structural and strategic evolution is the key insight in the original answer, but it is entirely absent in the LLM response. Instead, the model assumes continuity in investment structure while attributing changes to project performance, which contradicts the ground truth's emphasis on a shift in investment posture. (4) The contextual relevance is high because the answer addresses Chevron’s investment in Angola LNG Limited and equity method accounting across 2022–2023. However, the qualitative accuracy is low because it fails to identify the critical change in relationship classification and introduces unverified financial data. Quantitative accuracy is moderate due to the correct ownership percentage but unsupported dollar figures. Correctness score is 4 due to significant omission of the key structural change and introduction of unverified specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 559,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\nFrom the 2022 filing the G600 was already positioned as the newest large‑cabin, ultra‑long‑range business jet—offering a faster cruise, better fuel‑efficiency, a larger, more ergonomic cabin, reduced emissions and greater range than the G450/G550 it replaced, with roughly 150 cumulative deliveries by the end of 2021.  The 2023 filing shows that cumulative deliveries had risen to “over 250” by year‑end 2023, confirming that the G600 remained in active production and that its proven performance metrics now support an even larger installed base and a growing service‑revenue stream, while the company prepares to introduce the next‑generation G700.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the G600's production status and delivery numbers, noting over 250 cumulative deliveries by end of 2023, which matches the ground truth. However, it incorrectly states that there were roughly 150 cumulative deliveries by end of 2021, which is not supported by the original answer—this figure is speculative and not mentioned in the ground truth. The original answer only notes that the G600 entered service in 2019 and does not provide delivery numbers for 2021. (2) The quantitative claim about 150 deliveries by end of 2021 introduces a factual inaccuracy, though the 'over 250 by 2023' figure is correct. No other numbers (e.g., performance metrics like range, fuel efficiency) are quantified in the ground truth, so the LLM's elaboration on performance improvements, while plausible, goes beyond the provided information and cannot be verified. (3) The reasoning is mostly sound: the LLM correctly infers that the G600 transitioned from a new to a mature product and remains in active production. It also correctly notes the G700 as the next-generation model. However, it misses a key qualitative shift highlighted in the ground truth: that the G600's technologies (e.g., Symmetry Flight Deck) became foundational for newer models like the G700, G800, and G400—this multi-hop insight about technology transfer is absent in the LLM answer. (4) The contextual relevance is high as the answer addresses the evolution in production status and performance context. The qualitative accuracy is good but not complete due to the missing technology integration point. The correctness score is 7 due to the partially accurate numbers and missing key synthesis about technological influence, though core facts about delivery growth and production status are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 491,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a purely franchised model—where franchisees alone funded capital upgrades—to an active partnership that includes co‑investment with franchisees for restaurant modernization, technology and delivery upgrades.  The Company deepened its financial involvement by jointly funding improvements while still relying on franchisee‑generated sales for stable cash flow, and it continues to require rigorous standards and alignment on strategic initiatives.  (Pages 30 (2022) and 27 (2024) detail this evolution of co‑investment and collaborative reinvestment.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's relationship with franchisees between 2022 and 2024. It correctly identifies the shift from a model where franchisees solely funded capital improvements to a co-investment model in which McDonald's actively partners financially with franchisees for modernization, technology, and delivery upgrades. The mention of continued reliance on franchisee-generated sales and strategic alignment reflects the ongoing franchising framework, which aligns with the ground truth. There are no numeric inaccuracies—no specific dollar amounts or percentages are cited in either answer, so the absence of numbers does not detract. The LLM cites specific pages (30 in 2022 and 27 in 2024), which supports its claims and matches the source documentation referenced in the knowledge graph. The only minor shortcoming is that the original answer specifies that McDonald's previously did not invest in restaurant capital under developmental licenses, a nuance slightly underemphasized in the LLM response, which calls the earlier model 'purely franchised'—a reasonable simplification but slightly less precise. However, the semantic meaning and multi-hop synthesis across years and strategic models are sound. The reasoning correctly connects financial involvement (co-investment) with strategic collaboration (modernization, standards, alignment), fulfilling the question’s requirements. All entities (McDonald's, franchisees, time frame) are correct, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 426,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the “smokeable products” segment saw a modest pull‑back in both top‑line sales and profitability.  Net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023** (a decline of roughly $0.72 billion, or about 3 %).  Operating income slipped only slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023** (a drop of about $0.018 billion, or roughly 0.2 %).  In other words, revenue contracted modestly while operating income remained essentially flat, reflecting a small erosion in profitability despite the lower sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues of $22,476 million in 2022 and $21,756 million in 2023, and operating income of $10,688 million in 2022 and $10,670 million in 2023. The calculated differences—$720 million decline in revenue (~3%) and $18 million drop in operating income (~0.2%)—are correct and reasonably presented. (2) The answer is complete, addressing both net revenues and operating income across both years as required by the question. (3) Entities are accurate: 'smokeable products' is the correct segment, and the years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the LLM correctly synthesizes year-over-year performance, notes the modest decline in revenue, and observes that operating income remained nearly flat, which aligns with the ground truth's characterization of 'small decrease in both revenue and profitability.' The slight erosion in profitability is a reasonable qualitative interpretation. (5) Semantic equivalence is maintained—though the LLM adds minor interpretive phrasing (e.g., 'essentially flat', 'modest pull-back'), the core facts and implications match the original answer exactly. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 360,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\nFrom 2022 through 2024 Opdivo moved from a single‑agent immuno‑oncology product to the center of a multi‑partner development and commercialisation model—most prominently the co‑development/profit‑sharing alliance with Ono in Japan that governs Opdivo (and Yervoy) in that market and the associated joint promotion of combination regimens.  At the same time the drug gained four new global approvals—subcutaneous Opdivo Qvantig (Dec 2024), neoadjuvant NSCLC (Oct 2024), first‑line urothelial carcinoma (May 2024, with cisplatin/gemcitabine) and colorectal‑cancer (Dec 2024, with Yervoy)—demonstrating an expanded indication portfolio and a strategy that relies on collaborative frameworks to drive its broader commercialisation.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies, particularly in dates and approvals, which significantly affect correctness. While it correctly identifies the collaborative framework with Ono, it misrepresents the timeline and nature of Opdivo's evolution. (2) Quantitative inaccuracies include: the FDA approval for first-line urothelial carcinoma is listed as May 2024 instead of March 2024; subcutaneous Opdivo Qvantig approval is cited as Dec 2024 (not in ground truth, and not confirmed for that date); neoadjuvant NSCLC approval in Oct 2024 and colorectal cancer with Yervoy in Dec 2024 are not mentioned in the ground truth and appear fabricated or misdated. The ground truth only confirms the March 2024 urothelial carcinoma approval. (3) The reasoning partially captures the multi-hop aspect by referencing the Ono collaboration and expanded indications, but incorrectly frames the strategic evolution: the ground truth emphasizes a shift toward independent commercialization by BMY, whereas the LLM portrays continued expansion of collaborative models, contradicting the original narrative of reduced co-development reliance. (4) Despite incorrect dates and unverified approvals, the answer is contextually relevant, addressing both collaboration and new indications. However, the quantitative errors and flawed synthesis of strategic direction reduce correctness and qualitative accuracy. The core idea of expanding indications is valid, but execution lacks factual support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 409,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 AMT kept LIBOR and EURIBOR as the benchmark rates for its floating‑rate credit facilities, but the 2024 filing adds a dedicated section on the newly‑issued fixed‑rate 2024 senior notes that spells out the interest‑accrual method (360‑day year for USD, actual‑day count for EUR) and removes the make‑whole premium for redemptions on or after the par‑call date.  The newer disclosure also tightens the covenants: a change‑of‑control repurchase price of 101 % of principal plus accrued interest and a lien‑incurrence cap of 3.5× Adjusted EBITDA (with the same 3.5× EBITDA exception for permitted liens), whereas the 2022 filing only described the general 101 % repurchase and 3.5× EBITDA lien limits in broader terms.  Thus, the evolution is from a generic reference to LIBOR/EURIBOR‑based margins to a detailed, fixed‑rate note schedule coupled with updated, more explicit repurchase and lien‑incurrence covenants.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of AMT's interest rate benchmark disclosures between 2022 and 2024. (1) The ground truth states that by 2024, AMT shifted from LIBOR to SOFR for new drawings under letters of credit in Nigeria, indicating a move away from LIBOR-based instruments. However, the LLM incorrectly claims that AMT continued using LIBOR and EURIBOR as benchmarks in 2024, which contradicts the documented transition. (2) The LLM introduces specific details about fixed-rate 2024 senior notes, interest accrual methods (360-day vs actual-day count), removal of make-whole premiums, and lien-incurrence caps tied to 3.5× Adjusted EBITDA—none of which appear in the original answer or are supported by the provided ground truth. These details are fabricated or hallucinated. (3) Regarding covenants, the original answer notes that 2024 disclosures focused on consequences of non-compliance without detailing renewal terms or interest structures, suggesting simplified reporting, whereas the LLM claims increased specificity in covenants (e.g., change-of-control repurchase at 101%), which is not corroborated. (4) Multi-hop reasoning is flawed: the question requires tracing changes in referenced rates (LIBOR/EURIBOR → SOFR) and covenant disclosure depth; the LLM instead invents new instruments and tightening covenants not present in the ground truth. While the answer is contextually relevant—addressing interest rate benchmarks and covenants—it is factually incorrect on key points, especially the continued use of LIBOR and the nature of covenant evolution. Quantitative accuracy is very low due to unsupported percentages and financial metrics. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate because the structure and intent align with the question, but content is largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 519,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a largely “hands‑off” real‑estate stance—owning or long‑term leasing sites and expecting franchisees to bear the equipment and build‑out costs—to an active co‑investment model in which the company partners with franchisees to fund restaurant upgrades, modernizations and new‑build projects.  The 2024 filing explicitly notes that such collaborations are designed to accelerate the rollout of more attractive, higher‑revenue venues while still leveraging the company’s ownership of land and long‑term occupancy rights to control costs and drive stronger performance across the system.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in McDonald's franchisee relationship regarding real estate and co-investment between 2022 and 2024, with accurate entity and year references. It correctly notes that McDonald's typically owns or controls land and buildings, while franchisees invest in equipment and interior elements—a key point from the original answer. The description of a more active co-investment model by 2024 aligns with the ground truth’s emphasis on a structured co-investment strategy enabling high performance. However, the LLM introduces the term 'hands-off' to describe the 2022 stance, which is not present in the original and slightly mischaracterizes it; the 2022 filing emphasized systemwide coordination for ESG initiatives but did not detail real estate roles, rather than implying a passive approach. The original answer frames the shift as one from general collaboration to a clearly defined model, not a strategic pivot from passivity to activity. This overinterpretation affects qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and captures the core evolution, but misses the nuance that the 2022 focus was on ESG alignment rather than real estate strategy per se. Thus, while the overall direction of the answer is correct, the reasoning slightly misrepresents the nature of the 2022 model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 399,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\nBetween 2022 and 2023 the 2015 Stock Compensation Plan for Non‑Employee Directors kept its status as the sole, shareholder‑approved vehicle for director compensation; the only evolution was that the October 26 2022 amendment and restatement—first filed in the 2022 Form 10‑K—continued to be cited in the 2023 filing, confirming that no further amendment was made in 2023.  This continuity shows Altria’s governance approach of formally adopting a written, periodically restated compensation plan for directors, ensuring transparent and consistent oversight of director pay.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the October 26, 2022 amendment and restatement of the 2015 Stock Compensation Plan for Non-Employee Directors and notes its continued citation in 2023, indicating no further changes. However, it omits the key quantitative detail from the ground truth — that in 2022, 703,256 shares were available for issuance under the plan — which is a significant factual component of the original answer. This omission affects completeness and quantitative accuracy. (2) The date of the amendment (October 26, 2022) is correctly stated, and the reference to the Form 10-K is plausible, though the ground truth specifies the amendment was incorporated by reference from the September 30, 2022, Form 10-Q, not the 10-K. This is a factual discrepancy in sourcing, reducing quantitative accuracy. (3) The reasoning about Altria’s governance approach — emphasizing formal adoption, periodic restatement, transparency, and consistency — is logically sound and aligns with the implications in the ground truth. The LLM correctly infers governance intent from the documentation pattern, showing good qualitative reasoning. However, it misses the implication that Altria refined the plan mid-cycle, which suggests active governance adaptation rather than mere continuity. (4) The answer is contextually relevant and well-structured, addressing both the status change and governance implications. While the core facts about the amendment are present, the missing share number and incorrect filing reference (10-K vs. 10-Q) prevent a higher score. The answer is partially correct but lacks full factual precision and completeness required for a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 463,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\nThe company’s disclosures show that the threat from roaming and resale‑type arrangements, which was first flagged as a risk in 2022, became a concrete drag on lease growth by 2024 – carriers are increasingly sharing sites or reselling capacity, which accelerates churn (e.g., the T‑Mobile MLA churn noted in 2023‑24) and reduces the need for new tower leases.  This intensifying competition is evident in the declining pace of new lease sign‑ups across the U.S., Canada, and APAC segments, signaling that roaming/resale pressures are now a primary head‑wind to AMT’s new‑lease growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of roaming and resale arrangements' impact on AMT's leasing activity from 2022 to 2024. It accurately captures the progression from a potential risk in 2022 to a concrete drag on lease growth by 2024, which matches the original answer's claim that such arrangements evolved into broader RAN sharing and resale threats. The mention of T-Mobile MLA churn in 2023–24 is consistent with the idea of decommissioning and reduced leasing activity due to redundancy. The answer correctly identifies the competitive pressure and its negative impact on new lease growth across regions (U.S., Canada, APAC), supporting the conclusion about intensifying competition. However, the LLM answer does not explicitly mention 5G technology as a driver in 2022 or the specific term 'RAN sharing' in 2024, which are key technical details in the original answer that explain why sharing has become more viable. While the concept is implied through 'sharing sites or reselling capacity,' the absence of these precise technological and structural developments slightly weakens the completeness of the multi-hop synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are introduced), and the contextual relevance is strong as all parts of the question are addressed with appropriate focus on evolution and competitive implications. The reasoning is sound but lacks explicit linkage to 5G and RAN, which are important for full qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 429,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\nFrom 2022 to 2024 McDonald’s shifted from a primarily rent‑and‑royalty model to an active partnership that co‑invests with franchisees in restaurant modernization, technology and other capital upgrades while imposing tighter operational standards and requiring continual franchisee reinvestment; this evolution is detailed in the 2024 10‑K (pages 4, 27, 29) and was foreshadowed in the 2022 filing (pages 25‑26, 28‑30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of McDonald's relationship with franchisees from 2022 to 2024: in 2022, the focus was on operational challenges due to the pandemic and franchisee adaptability, while in 2024, the shift was toward co-investment and modernization. The LLM accurately reflects the strategic pivot to active partnership, including co-investment in modernization and technology, and the expectation of franchisee reinvestment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 filings, correctly identifying the shift in strategic posture and operational expectations. It references specific pages in both filings (e.g., 2024 10-K pages 4, 27, 29; 2022 pages 25–26, 28–30), which supports traceability, though exact page numbers are not part of the ground truth verification—this is a strength but not required. (4) The only minor shortcoming is the claim of a shift 'from a primarily rent-and-royalty model'—this characterization is implied but not explicitly stated in the ground truth; the original answer emphasizes a shift in strategic focus and investment behavior, not a fundamental business model change. This nuance slightly affects qualitative accuracy, hence a 9. Otherwise, the answer is contextually complete, directly addressing both strategic investment and operational expectations as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 437,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\nFrom 2022 through 2024 the Special Use Funds moved from a comparatively modest, fixed‑income‑heavy stance to a substantially larger and more diversified equity allocation.  NEE increasingly placed market‑able equities—often through broadly diversified, commingled vehicles—into these funds, emphasizing liquidity, tax efficiency and compliance with FERC/NRC limits on investing in NEE‑affiliated securities while still adhering to the prudent‑investor objectives of risk, diversification and return.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and misrepresents the evolution of NextEra Energy's investment strategy in equity securities within its Special Use Funds from 2022 to 2024. (1) The ground truth states that in 2022, NextEra Energy held $8,922 million in Special Use Funds with no explicit breakdown of equity securities. In 2024, $6,164 million was specifically allocated to equity securities. The LLM answer incorrectly claims that the Special Use Funds grew and shifted from a 'modest, fixed-income-heavy stance' to a 'substantially larger' equity allocation, which contradicts the fact that total Special Use Funds decreased from $8,922 million to an unspecified but implied lower total (since only $6,164 million was in equities in 2024). (2) No accurate numbers are cited by the LLM—there is no mention of $8,922 million in 2022 or $6,164 million in equities in 2024—so quantitative accuracy is very low. (3) The qualitative reasoning is partially sound in discussing diversification and regulatory compliance, but it fabricates a strategic expansion and increased size of equity allocations, which is not supported by the data. The actual evolution reflects greater transparency and possible reallocation, not growth. (4) Contextual relevance is moderate because the answer addresses investment strategy in Special Use Funds and mentions relevant considerations like diversification and regulation, but it fails to accurately describe the direction or magnitude of change. The core factual claims about fund size and strategy shift are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 442,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 Altria’s smokeable‑product net revenues fell from **$22,476 million to $21,756 million** – a drop of roughly **$0.72 billion (≈3 %)**.  Operating income also slipped only modestly, moving from **$10,688 million to $10,670 million**, a decrease of about **$0.02 billion (≈0.2 %)**.  Thus, while revenue declined slightly, operating income remained essentially flat over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: 2022 net revenues ($22,476 million), 2023 net revenues ($21,756 million), 2022 operating income ($10,688 million), and 2023 operating income ($10,670 million) match exactly. The calculated differences—$720 million decrease in net revenues and $18 million decrease in operating income—are accurate, and the percentages (~3% and ~0.2%) are reasonable approximations. (2) Quantitative accuracy is perfect; all figures and calculations are correct, with acceptable formatting (e.g., $22,476 million vs $22.476 billion). (3) The reasoning is sound: the model correctly synthesizes year-over-year performance, identifies trends, and draws a logical conclusion about marginal decline. The only minor shortcoming is characterizing operating income as 'essentially flat'—while the drop is small, the ground truth emphasizes a decline, so this wording slightly downplays the change. (4) The answer is fully relevant, addressing both net revenues and operating income across 2022–2023 as required. Overall, the response is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the minor interpretive nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 359,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the company expanded its Class A repurchase activity: it bought roughly 12.2 million shares in 2022 (about 9.6 million in the publicly‑announced open‑market program and the remainder through employee‑plan withholding), and then increased open‑market purchases to ≈11.8 million shares in 2024 while still using the same treasury‑stock purpose.  The shares acquired are held as treasury stock to fund employee‑benefit programs such as equity awards and the 2010 Employee Share Purchase Plan, and the ESPP issuance rose from 4.4 million shares in 2022 to 5.7 million shares in 2023, reflecting a higher utilization of the share‑purchase programs for employee‑related purposes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The original answer does not mention specific numbers of shares purchased (e.g., 12.2 million in 2022 or 11.8 million in 2024), nor does it provide data on the breakdown between open-market purchases and employee-plan withholding. These figures are fabricated or hallucinated, severely undermining quantitative accuracy. Additionally, the original answer discusses 2022 and 2023 developments, but the LLM references share purchases in 2024 (which is outside the scope of the question) and incorrectly attributes increased open-market purchases to that year. (2) The original answer states that in 2022, Accenture had an aggregate authorization of $3,129,296 for share purchase programs, but the LLM omits this key financial figure entirely. Instead, it introduces unsupported metrics like ESPP issuance rising from 4.4 million to 5.7 million shares, which are not present in the ground truth. These omissions and fabrications result in a low quantitative accuracy score. (3) Qualitatively, the LLM captures part of the correct reasoning: shares are held as treasury stock for employee benefits such as equity awards. This aligns with the original answer’s statement about intended usage for employee benefits. However, the LLM incorrectly frames the evolution as an 'expansion' and 'increase' in repurchase activity without evidence from the source, and conflates fiscal 2024 activity (which is mentioned in the original only as a forward-looking note) into the 2022–2023 comparison. The multi-hop synthesis is partially sound—linking share purchases to employee compensation—but misrepresents the timeline and scale. (4) Contextually, the answer is relevant and addresses the core theme of how share utilization evolved toward employee-related purposes. It correctly identifies treasury stock usage and links it to equity awards and employee plans, which matches the original’s emphasis. However, due to significant numerical inaccuracies and temporal misalignment, the overall correctness is only moderate. Minor formatting flexibility is allowed, but invented numbers cannot be tolerated in financial evaluations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 595,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\nBetween 2022 and 2024 the covenants governing AMT’s operating cash‑flows shifted from a primarily floating‑rate structure tied to LIBOR/EURIBOR under the 2021 Multicurrency Credit Facility, 2021 Credit Facility and 2021 Term Loan toward a mixed‑instrument regime that adds fixed‑rate senior notes (e.g., 5.200 %–5.450 % USD notes and 3.900 %–4.100 % EUR notes) and amends the multicurrency facilities with extended maturities and updated applicable margins.  The newer covenants still retain the DSCR‑based cash‑trap and amortization thresholds, but they now also contain rating‑triggered change‑of‑control repurchase rights, a 3.5× Adjusted EBITDA limit on secured liens, and explicit references to the fixed‑coupon interest terms of the 2024 Notes, marking a clear evolution in both the types of debt covered and the benchmark rates used to price them.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported details not present in the ground truth. (1) Quantitatively, the LLM cites specific fixed-rate senior notes (e.g., 5.200%–5.450% USD, 3.900%–4.100% EUR) and references to '2024 Notes', 'DSCR-based cash-trap', '3.5× Adjusted EBITDA limit', and 'rating-triggered change-of-control repurchase rights'—none of which appear in the original answer or are implied by the ground truth. These specific percentages, covenants, and instruments are not mentioned in the 2022–2024 evolution described in the ground truth. (2) The original answer focuses on a benchmark transition from LIBOR/EURIBOR to SOFR, specifically for Nigerian letters of credit, as part of a broader regulatory shift away from LIBOR. The LLM overgeneralizes this to a 'mixed-instrument regime' with new fixed-rate notes and extensive covenant modifications, which is not supported. (3) While the LLM correctly identifies the 2021 Multicurrency Credit Facility and 2021 Credit Facility as LIBOR/EURIBOR-based in 2022, it fabricates structural changes by 2024 rather than accurately reflecting the limited but specific shift to SOFR for certain letters of credit. (4) The reasoning is flawed in that it assumes broader debt restructuring and covenant evolution without evidence, failing the multi-hop synthesis test—instead of linking disclosed benchmark changes, it invents new financial instruments and terms. (5) Contextually, the answer is relevant to debt covenants and benchmarks, and it attempts to address the evolution over time, but the core factual claim about the nature of the evolution is incorrect. The ground truth emphasizes a benchmark transition (LIBOR → SOFR), while the LLM emphasizes new debt types and complex covenants, which misrepresents the actual evolution. Minor semantic alignment exists in mentioning LIBOR/EURIBOR in 2022, but the 2024 picture is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 520,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\nDisney+ Hotstar’s paid subscriber base grew from roughly **30 million** reported in the 2023 filing to **≈36 million** as of September 28 2024 – an increase of about 20 percent.  The June 2024 consolidation of the separate **Star+** service into a single **Disney+** offering in Latin America eliminated a second brand, unified the region’s entertainment and sports content under the Disney+ umbrella, and gave Disney a more scalable, higher‑margin platform that improves monetisation and supports its longer‑term international streaming growth strategy.   (Pages 57 – subscriber definitions and merger; 123 – 2024 financial tables).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the subscriber numbers and timeline. The original answer states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2024, in the 2023 SEC filing — meaning the 36 million figure is already reported in the 2023 filing, not a new number in 2024. The LLM incorrectly claims a growth from 30 million (not mentioned in the original) to 36 million, implying a 20% increase, which is unsupported by the ground truth. There is no mention of a 30 million figure or any growth calculation in the original, making the quantitative evolution claim fabricated. (2) The date 'September 28, 2024' appears in the 2023 filing, which is a forward-looking or reporting lag quirk, but the LLM misinterprets this as a 2024 data point used to show growth, when in fact both data points (if any) would be from the same reporting period. The consolidation of Star+ into Disney+ in Latin America by end of June 2024 is correctly identified and contextually well-explained, with accurate qualitative implications about streamlining and strategy. (3) The multi-hop reasoning is partially sound: the model correctly links the Star+ consolidation to broader international strategy, aligning with the original’s interpretation. However, the subscriber evolution claim fails the multi-hop test because it invents a prior value (30M) not present in the source. (4) Scores reflect: moderate correctness due to major numerical inaccuracy; low quantitative accuracy due to incorrect figures and spurious growth calculation; moderate qualitative accuracy as strategic interpretation is valid; high contextual relevance as it addresses both parts of the question with plausible framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 472,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\nFrom the disclosures, the company expected to negotiate 21 collective‑ bargaining agreements covering roughly 3,000 employees in 2022, but in 2023 it plans to negotiate only 20 agreements covering about 2,100 employees. This decline in both the number of agreements and the employee base indicates that the firm is scaling back its labor‑agreement workload—consolidating negotiations and focusing on a smaller group of workers—rather than expanding or maintaining the prior level of coverage.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but introduces details not present in the ground truth, affecting full quantitative and qualitative accuracy. (1) The ground truth states that in 2022, the company expected to negotiate agreements covering approximately 3,000 employees, and in 2023, about 2,100 employees—these numbers are accurately reflected in the LLM answer. However, the LLM adds specific numbers of agreements (21 in 2022, 20 in 2023), which are not present in the original answer and thus introduce unsupported precision. (2) The core calculation—showing a decline from 3,000 to 2,100 employees—is correct and properly highlights a reduction in labor renegotiation scope. (3) The reasoning is sound: the LLM correctly infers a strategic shift, such as consolidation or reduced bargaining activity, which aligns with the ground truth’s interpretation of a changed labor agreement strategy. (4) Contextual relevance is strong—the response directly addresses both parts of the question: the change in employee numbers and the strategic implication. While the added detail about agreement counts slightly undermines factual fidelity, the overall meaning and direction of the conclusion remain consistent with the ground truth. Hence, minor deductions in quantitative and qualitative accuracy, but high correctness and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 370,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\nNextEra Energy’s holdings of U.S. Government and municipal bonds increased from $177 million in 2022 (as reported in the 2022 filing) to $722 million in 2024 (the total fair‑value shown in the 2024 filing).  This represents a net rise of $545 million over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content. (1) Quantitatively, it reports $177 million for 2022 and $722 million for 2024, whereas the ground truth states $137 million in 2022 and $161 million in 2024. These values are significantly off—by $40 million in 2022 and over $560 million in 2024. The calculated increase of $545 million is therefore also wrong; the correct change is $24 million. (2) The percentage increase cited in the original answer (17.5%) is accurate based on $137M to $161M, but the LLM does not provide a percentage and instead emphasizes a massive increase that did not occur. (3) The qualitative reasoning is flawed: while the LLM correctly identifies the direction of change (increase), it fails to accurately extract the actual figures from the filings, suggesting a failure in multi-hop retrieval or data grounding. The mention of 'fair-value' and 'Other investments' lacks alignment with the verified data. (4) Contextually, the answer addresses the right question about evolution and change in bond investments, so it is relevant in structure and intent, but the factual inaccuracies severely undermine correctness. Minor point: the company (NextEra Energy, NEE) and asset class (U.S. Government and municipal bonds) are correctly identified. Overall, major factual and numerical errors result in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 379,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo’s therapeutic footprint broadened dramatically—gaining EC approval for the Opdivo + Yervoy first‑line colorectal‑cancer regimen, FDA approval for neoadjuvant NSCLC, EC and Japan approvals for urothelial‑cancer, and the launch of the subcutaneous formulation Opdivo Qvantig (Dec 2024).  To meet the expanding list of indications, BMS reinforced its flexible manufacturing model, investing in its own cGMP‑certified sites (e.g., Devens, Cruiserath) while deepening third‑party and backup‑source agreements and upgrading processes (including the new subcutaneous platform) to secure reliable, scalable supply for the growing portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Opdivo in Bristol-Myers Squibb's portfolio with respect to expanded therapeutic approvals and manufacturing strategy, but introduces significant factual inaccuracies not present in the ground truth. (1) The ORIGINAL ANSWER specifies a March 2024 FDA approval for Opdivo in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma. The LLM answer incorrectly states multiple approvals including EC approval for Opdivo + Yervoy in colorectal cancer, FDA approval in neoadjuvant NSCLC, EC and Japan approvals for urothelial cancer, and a December 2024 launch of Opdivo Qvantig—all of which are absent from the ground truth and cannot be verified from the provided data. (2) Regarding manufacturing, the LLM correctly notes BMS's dual strategy of internal cGMP sites (e.g., Devens, Cruiserath) and third-party agreements, aligning with the 2022 description of mixed manufacturing reliance. However, the ground truth does not mention specific sites or the subcutaneous platform upgrades, making these additions speculative. (3) Multi-hop reasoning is partially sound—linking expanded indications to manufacturing scalability is logical—but the synthesis is based on unverified approvals, undermining factual correctness. (4) While the answer is contextually relevant and addresses both manufacturing and therapeutic evolution, the inclusion of unsupported approvals and dates severely impacts quantitative and qualitative accuracy. The March 2024 FDA approval is the only confirmed event, but the LLM overextends with unverified international and formulation-specific approvals. Thus, despite good structure and plausible reasoning, the answer contains more incorrect specifics than correct ones, warranting a mid-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 496,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney kept National Geographic magazine (and its online business) inside the Entertainment segment’s **Content Sales/Licensing** line and still records it as a **73 %‑owned** subsidiary.  The brand continues to be reported alongside the linear‑network and DTC businesses, supplying magazine‑and‑digital advertising and licensing revenue, but there was no re‑classification or creation of a separate segment—its strategic role remained that of a niche, non‑sports content property that bolsters Disney’s overall content‑sales portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key qualitative aspects. (1) Quantitatively, the 73% ownership figure is correctly stated, and the placement within the Entertainment segment and Content Sales/Licensing line is accurate for 2023. However, the claim that it 'still records it as a 73%‑owned subsidiary' in 2024 contradicts the ground truth, which notes that Disney removed emphasis on ownership percentage in 2024 and shifted to describing National Geographic as a publication 'published' by the company rather than highlighting equity ownership—indicating a change in reporting and strategic framing. (2) The LLM incorrectly asserts there was no change in classification or strategic role, while the original answer highlights a meaningful shift from an ownership-focused to an operationally-focused relationship. This misrepresents the evolution in business structure and strategic positioning. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in disclosure tone and emphasis between 2023 and 2024, which is central to the question. Instead, it assumes consistency where the ground truth indicates a deliberate shift in narrative and reporting approach. (4) While contextually relevant and addressing the right segments and timeframes, the answer misses the core insight about Disney's changing strategic portrayal of its relationship with National Geographic, leading to a low qualitative and overall correctness score despite some factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 424,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\nIn the 2023 filing PayPal described its payments platform as supporting transactions in “approximately 140 currencies,” while the 2024 filing updated that figure to “approximately 150 currencies,” explicitly noting the broader multi‑currency coverage of its transaction‑management databases. Both years still reference the ability to hold balances in 24 currencies and withdraw funds in 57 currencies, but the increase in the number of supported payment currencies shows the evolution of PayPal’s global‑payment processing capability between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that PayPal's transaction management databases allowed withdrawal in 56 currencies in 2023 and 57 in 2024—this part is partially correct in the LLM answer, which correctly notes 57 currencies for withdrawal in both years. However, the LLM introduces unsupported figures: claiming PayPal supported 'approximately 140 currencies' in 2023 and '150 currencies' in 2024 for transactions, which does not appear in the original answer or the verified knowledge graph. These numbers are not corroborated and represent a major fabrication or misattribution. Additionally, the mention of holding balances in 24 currencies is not present in the original answer and cannot be verified from the provided truth. On qualitative aspects, the LLM fails to capture the key nuance from the original answer about the shift in language framing—placing 'consumers' ahead of 'merchants' in 2024—which is a central point in how PayPal evolved its description. While the LLM recognizes there is an evolution in global payment processing, it misrepresents the nature of that evolution by focusing on invented transaction currency numbers rather than the actual refinement in ecosystem description. The reasoning is thus flawed, as it builds a narrative on incorrect data. Contextually, the answer is relevant to the question about evolution in database capabilities and multi-currency processing, but the incorrect figures undermine its validity. Minor credit is given for correctly identifying the 57-currency withdrawal figure in 2024 and implying an expansion, though it misstates the 2023 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 460,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\nBetween 2023 and 2024 the Series K Debentures kept the rate that was reset in March 2023 – 6.051 % per annum, payable semi‑annually on March 1 and September 1 – and no subsequent amendment or new reset was disclosed in the 2024 filings.  This shows that NEE is deliberately locking in long‑dated, fully‑guaranteed fixed‑rate debt at a known cost, using the Series K notes as a stable financing pillar to fund its clean‑energy expansion while preserving flexibility for future refinancing in a rising‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the interest rate of 6.051% and the March 2023 reset date are correctly stated, and the absence of a new reset in 2024 is consistent with the original answer. The semi-annual payment dates (March 1 and September 1) are additional accurate details not in the ground truth but not contradicted by it. (2) The original answer notes a March 1, 2023 letter setting terms effective that date, which the LLM interprets correctly as a continuation of the 2023 remarketing outcome. While the LLM does not explicitly mention the letter, it correctly infers the lack of change into 2024. (3) The reasoning about NEE’s financing strategy—locking in fixed-rate debt for stability and long-term planning in a rising-rate environment—is a sound, logical extension of the ground truth, which also cites market-responsive rate adjustments. The LLM adds interpretive depth (e.g., 'clean-energy expansion', 'financing pillar') that is contextually appropriate and consistent with NEE’s known strategy, though slightly more inferential than the original. (4) All entities (Series K Debentures, NEE, 2023–2024 timeframe) are correct. The answer fully addresses both parts of the question: evolution of terms (no change post-March 2023) and strategic implication. Only a minor deduction in qualitative accuracy due to slightly more extrapolation than in the original, but still within reasonable inference. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 410,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\nExxonMobil continued to depreciate most upstream assets with the unit‑of‑production method in both 2022 and 2023, but the 2023 disclosure tightens how that method is applied.  It now bases the depreciation factor on proved‑reserve estimates derived from the most recent SEC‑price‑adjusted reserves—especially when reserves are substantially de‑booked—so the depreciation charge reflects the latest reserve volumes and any technical changes.  The company also reiterates that if the unit‑of‑production approach would not produce an equitable allocation of cost over an asset’s economic life, it will switch to straight‑line depreciation, a fallback that is invoked when the asset’s useful life no longer correlates with the underlying reserve life.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: ExxonMobil used the unit-of-production (UOP) method in both 2022 and 2023, with a refinement in 2023 emphasizing the use of the most recent SEC price for reserve estimates, particularly when reserves were substantially de-booked. The fallback to straight-line depreciation when asset life does not correlate with reserve life is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised—dates (2022 and 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information about methodological continuity, changes in reserve estimation practices, and the conditions under which depreciation methods are switched. The only minor gap is that the LLM answer does not explicitly state that the 2023 approach ensures a 'more meaningful allocation of asset costs over the expected life'—a nuance present in the original about alignment with economic conditions—but this does not detract from the core accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of UOP application in response to reserve and asset life assumptions. Wording differs slightly but maintains semantic equivalence. No factual errors or omissions affect the overall correctness, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 395,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix shifted from a model that depended heavily on external production partners and licensing deals for its originals—emphasizing the risk that partner relationships could lapse or that partner‑produced content might not meet expectations (see 2023 10‑K pages 6 & 7)—to a strategy that increasingly builds internal studio capacity.  The 2024 filing notes the scaling of its own studios, acquisitions of production outfits such as Scanline and Animal Logic, and a broader push to produce more original programming in‑house, thereby reducing reliance on third‑party producers while still collaborating with outside creators (see 2024 10‑K pages 7 & 30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Netflix's strategic shift from 2023 to 2024, noting reduced reliance on third-party production partners and increased focus on internal studio scaling. The acquisitions of Scanline and Animal Logic are accurately cited as part of internal capacity building. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly inferring a strategic pivot based on changes in risk disclosures and strategic language. The LLM accurately reflects that 2023 emphasized risks of third-party partners (e.g., content not meeting expectations, partner instability), while 2024 shifted focus to internal systems and studio scaling, even if it doesn't explicitly mention the omission of third-party risk language. (4) The only minor shortcoming is that the LLM does not fully capture the nuance in the 2024 shift toward improving 'corporate culture' and 'operational practices,' which is part of the deeper strategic evolution noted in the ground truth. However, the core factual and strategic elements—reduced third-party reliance, internal scaling, acquisitions, and in-house production—are all correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the evolution in strategy across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 433,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard kept Cyber and Intelligence Solutions at the core of its “value‑added services and solutions” portfolio, emphasizing that these offerings – which protect and secure transactions on its payments network – are a strategic growth driver.  The 2023 10‑K highlights that revenue from these services contributed to the 13 % rise in net revenue, underscoring a continued (and slightly expanded) strategic focus on cyber‑security and intelligence compared with the prior year.  (See MA_10k_2023.pdf pp. 49, 80; MA_10k_2022.pdf pp. 72‑81.)",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyber and Intelligence Solutions remained strategically important between 2022 and 2023 and are part of value-added services. However, it misses the key evolution highlighted in the ground truth: in 2022, these solutions were categorized under 'Other revenues' and focused narrowly on fraud prevention for Mastercard products, whereas in 2023 they were elevated to support the broader payments ecosystem and tied to new network investments. This strategic shift from a defensive, product-specific role to an enabling, ecosystem-wide function is not captured. (2) The claim that revenue from these services contributed to a 13% rise in net revenue appears in the 2023 10-K (p. 49), but the ground truth does not confirm this specific quantitative contribution, nor does it state that the services were already a strategic growth driver in 2022. This introduces unsupported precision and potentially misrepresents the evolution. (3) The multi-hop reasoning is partially sound—information is drawn from both years’ filings—but fails to contrast the categorization and scope changes accurately. The synthesis focuses on continuity rather than the documented strategic elevation. (4) While the answer is contextually relevant and includes proper citations, it lacks the critical qualitative shift described in the original answer, leading to a moderate correctness score. Quantitative accuracy is acceptable due to plausible citation, but not fully verifiable against the ground truth. Qualitative accuracy suffers due to missing the core evolution in strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 445,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\nFrom 2023 to 2024 Tesla moved its energy‑storage business from a largely “vehicle‑derived, supplier‑dependent” model toward one that couples in‑house battery‑cell production with an expanded global factory footprint (e.g., the planned Monterrey site and existing Gigafactories in China and Germany).  This shift is intended to cut costs, reduce tariff exposure and secure the lithium‑ion cell supply needed for Megapack and Powerwall, but it also introduces new production‑ramp challenges—namely securing reliable cell supply, managing a more complex, geographically dispersed supply chain, and meeting aggressive cost‑competitiveness targets—making local manufacturing and battery‑cell sourcing critical strategic dependencies.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some accurate thematic elements about Tesla's strategic shift in energy storage and mentions relevant challenges like supply chain complexity and production ramps. However, it introduces specific details not present in the ground truth, such as 'Monterrey site' and a characterization of the 2023 model as 'vehicle-derived, supplier-dependent,' which are unsupported by the original answer. The ground truth does not mention in-house battery-cell production or a global factory expansion as a strategic pivot, nor does it reference tariff exposure or cost-competitiveness targets. While the LLM correctly identifies increased focus on supply chain dependencies and production ramp challenges in 2024, it misrepresents the evolution by adding unverified strategic initiatives and geographic plans. There are no numeric values in either answer, so quantitative accuracy is not applicable but assumed correct by default. The reasoning partially aligns with the multi-hop requirement—connecting changes across years and identifying dependencies—but fabricates specifics, reducing factual reliability. The answer is contextually relevant and addresses the general theme of production challenges and strategic dependencies, but lacks fidelity to the actual source content, resulting in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 369,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\nFrom the 2023 filing (page 105) NEECH had only a modest floating‑rate tranche – roughly $600 million of floating‑rate debentures that matured in 2026.  In early 2024 the company broadened its floating‑rate program into a larger, multi‑year issuance (the $3.8 billion debenture offering referenced on page 105), keeping the floating‑rate series at the 2026 maturity but adding later‑dated fixed‑rate pieces up to 2054 and resetting rates to 4.90 %–5.55 %.  Consequently, the strategy moved from a single, short‑term floating‑rate issue to a more diversified floating‑rate component within a staggered maturity ladder.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, NextEra Energy Capital Holdings (NEECH) issued $600 million in floating rate debentures due in 2026, and in 2024, this was formalized via an Officer's Certificate without any change in principal amount. However, the LLM claims that in 2024, the company broadened its program to a $3.8 billion debenture offering, which is not supported by the original answer and contradicts the fact that no new principal amount was disclosed. Additionally, the LLM introduces fixed-rate tranches up to 2054 and interest rates of 4.90%–5.55%, none of which are mentioned in the ground truth. (2) Quantitatively, the $3.8 billion figure, the rate reset details, and the extended maturities are entirely fabricated. Only the $600 million and 2026 maturity align with the original answer. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a strategic expansion and diversification of the floating rate program in 2024, while the ground truth emphasizes continuity and consistency with no significant changes. There is no evidence in the original answer of a 'multi-year issuance' or 'staggered maturity ladder.' (4) While the answer addresses the question's focus on issuance strategy evolution, principal amount, and maturity structure, it does so with incorrect data and reasoning, severely undermining correctness. The contextual relevance is moderate because it attempts the right analysis but fails factually.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 419,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\nFrom 2023 to 2024 Intel deepened its industry‑level collaborations under the RISE strategy—expanding beyond the earlier focus on climate‑water transparency and responsible‑minerals sourcing to include joint standards for GHG emissions, renewable‑energy use and circular‑economy initiatives—while at the same time broadening the scope of its supplier engagement. The 2024 disclosures show a markedly larger, more granular supplier base (including indirect tiers), new performance‑linked incentives for emissions reductions, and heightened targets such as 100 % renewable electricity and net‑zero Scope 3 by 2050, indicating a more comprehensive and integrated approach to supply‑chain responsibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly references Intel's RISE strategy and the 2050 net-zero Scope 3 emissions goal, it misrepresents the evolution from 2023 to 2024. The original answer states that in 2024, Intel shifted focus to deepening existing collaborations rather than expanding supplier engagement, whereas the LLM claims Intel 'broadened the scope of its supplier engagement' and included 'indirect tiers'—information not supported by the ground truth. The LLM also invents new initiatives such as 'joint standards for GHG emissions, renewable-energy use and circular-economy initiatives' and 'performance-linked incentives' that are not mentioned in the original. (2) Quantitatively, the LLM incorrectly implies heightened targets were introduced in 2024 (e.g., '100% renewable electricity'), which the ground truth does not confirm. The 2050 net-zero Scope 3 target was set in 2023, not 2024, making the timeline incorrect. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift from expansion (2023) to consolidation and deeper collaboration (2024), but the LLM portrays a continued expansion, contradicting the core evolution. The synthesis fails to capture the strategic pivot from announcing growth to reinforcing partnerships. (4) Despite these errors, the answer is contextually relevant—it addresses supply chain responsibility, collaboration focus, and supplier engagement as asked, and correctly names the RISE strategy and long-term emissions goal, warranting a moderate relevance score. However, the factual and reasoning errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 453,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil kept the same description of the standardized discounted‑cash‑flow measure: it is calculated using first‑day‑of‑the‑month average prices (along with year‑end costs and statutory tax rates) and a 10 % discount rate.  The company repeatedly stresses that this “prescribed” use of discrete average prices can create substantial year‑to‑year variability in the resulting cash‑flow estimates and that the measure is not meant to reflect the firm’s actual expected cash flows.  In other words, the 2023 filing reiterates the 2022 framing—highlighting the company’s reliance on first‑day‑of‑the‑month averages and the resulting sensitivity of the standardized measure to those price points.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical misrepresentation of the evolution in XOM's disclosure tone between 2022 and 2023. Quantitatively, all details are accurate: the use of first-day-of-the-month average prices, year-end costs, statutory tax rates, and the 10% discount rate are correctly reported and consistent with the ground truth. Entity accuracy is also correct—XOM is properly identified, and the years 2022 and 2023 are appropriately referenced. Contextually, the answer addresses the standardized measure and its assumptions, remaining focused on the question. However, the qualitative reasoning is flawed: the LLM claims that the '2023 filing reiterates the 2022 framing,' implying no change in characterization. This contradicts the ground truth, which highlights a meaningful shift in language—from being 'prepared on the basis of' assumptions in 2022 to 'depends on' them in 2023—indicating a more explicit acknowledgment of dependency and sensitivity. The ground truth emphasizes that while methodology did not change, the framing evolved to underscore the measure’s vulnerability to price variability. The LLM misses this nuance entirely, instead asserting continuity in framing, which undermines the core of the question about how the characterization evolved. Thus, while facts and numbers are correct, the reasoning and synthesis across years are inaccurate, leading to a misleading conclusion about the evolution of disclosure tone.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 404,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved its digital‑identity capabilities from a stand‑alone verification suite (e.g., device‑intelligence, behavioral biometrics, Ekata‑based verification) into the core of its open‑banking platform.  In 2023 the company leveraged that platform to launch an ACH‑bill‑payment solution that uses its consent‑centric identity framework, and it expanded connectivity to > 95 % of U.S. deposit accounts and roughly 3,000 European banks, giving a far broader set of financial institutions a single, privacy‑by‑design identity layer to enable secure, seamless payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, MA introduced digital identity solutions within an open banking context emphasizing consent and consumer protection; in 2023, it expanded connectivity to over 95% of U.S. deposit accounts and ~3,000 European banks, and launched an ACH payment solution via partnerships with financial institutions. (2) Quantitative accuracy is perfect: '>95%' matches 'over 95%', and 'roughly 3,000 European banks' correctly reflects 'approximately 3,000 banks across Europe'. No calculations were required. (3) Multi-hop reasoning is sound—LLM correctly synthesized evolution over time (2022 to 2023), integration with open banking, and expansion of reach across financial institutions. It accurately infers deeper integration through the ACH solution. (4) Minor deduction in qualitative accuracy because the LLM mentions 'stand-alone verification suite' and specific technologies like 'Ekata' and 'behavioral biometrics', which are not in the original answer and could imply unsupported detail, though they are plausible given MA's known capabilities. However, the core evolution—integration into open banking platform and expanded reach—is correctly captured. Semantic equivalence is maintained, and all parts of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 376,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla moved Solar Roof from a largely installer‑driven, externally supplied product toward a more vertically integrated, capacity‑building approach.  In 2023 the filings emphasized limited installation efficiency and dependence on multiple third‑party component sources, whereas the 2024 disclosures show new engineering‑talent programs, expanded Gigafactory footprints (including the planned Mexico site) and a strategic push to produce its own battery cells and related hardware to support Solar Roof’s energy‑storage integration—yet both years stress that specialized glass, inverter and battery‑cell supply remain key bottlenecks and strategic dependencies for scaling production.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) The claim that Tesla shifted from an 'installer-driven, externally supplied product' to a 'vertically integrated, capacity-building approach' between 2023 and 2024 is not supported by the original answer, which does not mention changes in installation models or third-party dependencies in 2023. (2) The LLM references 'new engineering-talent programs', 'expanded Gigafactory footprints', and the 'planned Mexico site' as part of Solar Roof strategy—none of which appear in the ground truth and are unverified in context. (3) While both years mention strategic dependencies, the original answer does not specify 'specialized glass, inverter and battery-cell supply' as bottlenecks; instead, it broadly notes production ramp delays and prioritization of mass-market vehicles. (4) The core evolution in the ground truth is Tesla's acknowledgment of production delays in 2024 and a strategic dependency on mass-market vehicle scaling, which indirectly affects Solar Roof—this key point is entirely missing in the LLM response. (5) The LLM fabricates multi-hop synthesis by linking Solar Roof to Gigafactory Mexico and internal battery production without evidence. Although there are no numerical errors (hence high quantitative accuracy), the qualitative inaccuracies and lack of alignment with the original reasoning severely undermine correctness. The response is partially relevant to the topic but diverges substantially in content and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 427,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\nBetween 2023 and 2024 the company added two new pledge agreements—dated June 1 2024 and October 1 2024—that follow the same structure as the earlier 2022 pledge. Both 2024 agreements involve **NextEra Energy, Inc.** as the pledgor, **Deutsche Bank Trust Company Americas** as collateral/custodial agent, and **The Bank of New York Mellon** as purchase‑contract agent, but they secure more recent series of junior‑subordinated debentures (Series Q, R and the exchangeable senior notes). Consequently, NEE’s use of pledge agreements has expanded with newer 2024 dates while retaining the same core counterparties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of NextEra Energy's Pledge Agreements from 2023 to 2024, noting the original agreement dated September 1, 2022 (disclosed in 2023) and the two new agreements dated June 1, 2024, and October 1, 2024. All dates are accurate and match the ground truth. The counterparties—Deutsche Bank Trust Company Americas and The Bank of New York Mellon—are correctly named and their roles accurately described. (2) Quantitatively, all dates are correct and consistent with the original answer. The LLM adds specificity by naming the debenture series (Q, R) and instrument types (exchangeable senior notes), which are plausible details that do not contradict the ground truth and enhance completeness without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2023 vs. 2024 disclosures), identifies the continuity in counterparties, and infers an expansion in the use of pledge agreements. The only minor shortcoming is that the original answer emphasizes the 'evolution in structure and timing' while the LLM focuses more on timing and underlying debt instruments—slightly less emphasis on structural change, though the retention of counterparties supports structural consistency. (4) The answer is semantically equivalent and factually accurate, with excellent contextual relevance. The slight deduction in qualitative accuracy is due to the subtle shift in emphasis from structural evolution to instrument expansion, but core reasoning remains strong. Overall, this is a highly accurate, well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 443,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\nFrom 2023 to 2024 Intel shifted its Edge‑AI strategy from a hardware‑centric rollout toward a fully‑integrated software platform.  In 2023 it introduced AI‑enabled silicon (e.g., Core Ultra with an integrated neural‑processing unit and 4th‑Gen Xeon Scalable processors with vRAN Boost) and began building an ecosystem of partners, while 2024 expanded that effort by delivering a modular, edge‑native software stack—most notably the OpenVINO 2023.1 toolkit with GenAI enhancements—and deepening collaborations with a broad set of telecom, cloud and OEM partners (Ericsson, Nokia, Cisco, Dell, HPE, Amazon, Google, Microsoft) to position Intel’s hardware as the programmable foundation for intelligent‑edge AI workloads.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its portrayal of Intel's strategic evolution in Edge AI from 2023 to 2024, with accurate entity references and no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers, dates, or figures are presented). The mention of Core Ultra, 4th-Gen Xeon Scalable processors, OpenVINO 2023.1, and partners like Ericsson, Nokia, Cisco, Dell, HPE, Amazon, Google, and Microsoft aligns with known Intel initiatives and ecosystem collaborations. However, the LLM mischaracterizes the core of Intel’s 2023 strategy as 'hardware-centric' and frames the 2024 shift as moving toward software integration, which contradicts the ground truth: in 2023, Intel already emphasized a modular, edge-native *software* platform as a horizontal approach. The ground truth highlights that the 2024 evolution was under the NEX initiative, focusing on transforming edge systems into cloud-native, programmable general-purpose compute — a point entirely missing in the LLM response. While the LLM mentions OpenVINO and ecosystem partners, it fails to capture the strategic pivot to cloud-native software on programmable hardware and the broader NEX-driven transformation, which is central to the multi-hop synthesis required. Thus, while the entities and surface-level developments are accurate, the reasoning and qualitative portrayal of the strategic shift are partially incorrect, missing key conceptual evolution. Contextual relevance is high as the answer addresses software platforms and partnerships directly, but with incomplete strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 432,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the Company’s long‑term debt schedule lists the same $1.25 billion of 1.75 % senior notes maturing in August 2030 in both years—no new issuance, redemption, or re‑measurement is shown. Consequently, while the overall mix of senior notes (including a range of maturities from 2024 through 2050) remained substantial, the composition and outstanding balance of the 1.75 % notes due August 2030 stayed unchanged at $1.25 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.75% senior notes due August 2030 remained unchanged at $1.25 billion (or $1,250 million) in both 2023 and 2024, which matches the ground truth exactly. All numeric values—amount ($1.25 billion), interest rate (1.75%), and maturity date (August 2030)—are accurate. (2) Quantitative accuracy is perfect: $1.25 billion = $1,250 million, and the value is consistent across both years. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers no issuance, redemption, or re-measurement occurred, which aligns with the stability in value. However, the LLM does not mention the other senior notes due in 2030 (e.g., the 3.75% notes due April 2030), which were included in the original answer to provide context about the broader composition of 2030-dated debt. While the question focuses primarily on the 1.75% notes, the omission of this comparative context slightly reduces completeness and qualitative accuracy. (4) Despite this minor omission, the LLM fully addresses the core of the question—evolution of the 1.75% notes—and does so with precise, semantically equivalent information. The answer is highly relevant and factually correct, warranting a high score but not perfect due to partial incompleteness on the broader composition aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 370,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix deepened the strategic role of its ad‑supported tier.  In 2023 the company first rolled out the lower‑priced, advertising‑supported plan as a way to broaden its price‑sensitive audience, and by 2024 it had become a core lever in the firm’s pricing strategy—used to fuel membership growth, offset price increases on higher‑tier plans, and attract new subscribers while preserving overall margin targets.  The tier was also integrated into the company’s scaling roadmap (e.g., new technology and content‑production investments) to sustain growth amid intensified competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Netflix introduced the ad-supported plan in 2023 as a lower-priced option to attract price-sensitive users, and by 2024 it became a core part of the pricing strategy. The LLM correctly captures the evolution from a new offering to a strategic growth lever. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2023 and 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the plan’s introduction, its strategic purpose (membership growth, offsetting price hikes, margin preservation), and integration into long-term scaling (technology and content investments), which reflects a correct understanding of its evolving role. (4) The only minor gap is that the LLM does not explicitly mention the 'experimentation to strategic integration' framing present in the original, nor does it emphasize the 'value perception' improvement as directly. However, the core meaning—evolution into a central, sustained component of pricing and growth strategy—is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect as it directly addresses both the pricing strategy and membership growth objectives across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 391,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla progressed the Semi from the “early production and deliveries” phase disclosed in 2023 to an explicit “pilot‑production” stage at its Nevada gigafactory (2024 table of vehicle‑model production status).  This shift reflects a strategic positioning of the Semi as a cornerstone of Tesla’s commercial‑vehicle roadmap—leveraging its next‑generation platform, vertical‑integrated battery‑cell production and AI‑driven cost‑reduction goals to move the truck toward scalable, lower‑cost volume manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that in 2023, Tesla was in 'early production and deliveries' of the Tesla Semi, and by 2024, the status evolved to 'pilot production' at the Nevada facility—matching the original answer's key points. The mention of the Nevada gigafactory is consistent with known Tesla facilities and adds appropriate detail without inaccuracy. The strategic interpretation—that this reflects progression toward scalable, lower-cost volume manufacturing using Tesla’s vertical integration and next-gen platform—is a reasonable expansion of the original answer’s conclusion about moving into a 'more mature testing and scaling phase.' While the original answer does not explicitly mention 'AI-driven cost-reduction goals' or 'cornerstone of Tesla’s commercial-vehicle roadmap,' these are plausible inferences given Tesla's broader strategy and do not contradict the ground truth. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, multi-hop synthesis is appropriate, and the response fully addresses both production status and strategic positioning across 2023 and 2024. One minor point preventing a perfect 10 is the addition of slightly speculative strategic language not present in the conservative, evidence-based original answer. However, this does not undermine factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 393,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\nThe 2024 filings show a clear expansion of NextEra’s executive‑retention program—new 2024 agreements for executives such as Nicole Daggs and Brian Bolster were added to the roster that already included several 2023‑dated contracts.  By extending retention terms for both existing and newly‑appointed senior leaders, the company signals that maintaining a stable, experienced leadership team is a strategic priority as it pursues its large‑scale clean‑energy and infrastructure initiatives.  This focus on continuity underscores NextEra’s intent to safeguard the talent that drives its long‑term growth and regulatory‑intensive operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 and interprets this as a strategic emphasis on leadership continuity and talent retention, which aligns with the ground truth. However, there is a factual discrepancy in the named executives: the ground truth confirms Brian Bolster (May 6, 2024) as the new addition in 2024, but does not mention Nicole Daggs as having a 2024 agreement. This introduces an error in entity accuracy. Additionally, the 2023 executives listed in the ground truth—Mark Lemasney and Armando Pimentel, Jr.—are not mentioned in the LLM response, resulting in incomplete representation of the data. (2) Regarding quantitative accuracy: the dates for the 2023 agreements and the May 6, 2024 date for Bolster are not contradicted by the LLM answer, but the LLM introduces Nicole Daggs without supporting evidence from the ground truth, reducing confidence in the factual precision. No numerical calculations are involved in this question, so the focus is on correct dates and names. (3) The multi-hop reasoning is sound—the LLM correctly infers that expanding retention agreements suggests a strategic focus on leadership stability and talent management during key growth initiatives. This synthesis between observed contractual activity and strategic intent matches the logic of the original answer. (4) Despite the incorrect addition of Nicole Daggs and omission of the 2023 executives, the overall interpretation and strategic implication are consistent with the ground truth. The answer remains contextually relevant and provides meaningful insight. Therefore, the correctness score is 7 due to partial factual inaccuracies in entities, though the core reasoning and relevance are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 491,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\nFrom 2023 to 2024 Intel shifted xPU from a peripheral accelerator offering to a central strategic pillar.  In the 2023 filing the company described xPU merely as “a family of client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators” that it used to address AI and other workloads, while still relying on its own fabs and selective third‑party foundry capacity [INTC 10‑K 2023, p. 49‑50].  By 2024 the narrative had expanded: the 2024 filing calls xPU “the family of accelerators that, together with the x86 core, will democratize compute and power every phase of the AI continuum,” creates an advisory group to grow the x86 ecosystem, and pledges to develop leading products across all xPU categories while leveraging advanced packaging, new process nodes (Intel 4/3) and a nascent foundry business to deliver them at scale [INTC 10‑K 2024, pp. 5‑6, 93‑94].  Thus, the evolution is marked by a stronger strategic focus on xPU as a growth engine, a broader product roadmap, and deeper integration with Intel’s open‑platform and foundry initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the evolution of Intel's xPU strategy from 2023 to 2024 is accurately portrayed, including the shift from a general R&D component to a central strategic pillar focused on product competitiveness. The mention of the advisory group to expand the x86 ecosystem, the emphasis on diverse xPU products (GPUs, IPUs, FPGAs, accelerators), and integration with advanced packaging, process nodes (Intel 4/3), and the foundry business are all consistent with the original answer. (2) Quantitative accuracy is perfect: while no specific financial figures (like the $16.0 billion R&D spend) are repeated in the LLM answer, their absence does not detract from correctness because the focus is on strategic evolution rather than financials. The years (2023, 2024) and document references (10-K pages) are correctly cited. (3) Multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying a shift in narrative and strategic emphasis. It infers a deeper strategic integration of xPU in 2024 based on new initiatives like the advisory group and stronger language around 'democratizing compute' and 'AI continuum.' (4) Semantic equivalence is strong: though the LLM uses more forward-looking and promotional language (e.g., 'central strategic pillar', 'growth engine'), it accurately reflects the increased prioritization described in the ground truth. The only minor shortcoming is the omission of the explicit mention of past 'delays and cost overruns' in product development from the 2023 context, which slightly weakens the contrast but does not invalidate the overall assessment. Hence, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 503,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from merely acknowledging the risk of “limited experience offering advertising” and the need to “develop the technology and related infrastructure to support advertising” (2023 10‑K p. 10) to actually building a dedicated ad‑sales and ad‑tech organization and investing heavily in the underlying platform.  The 2024 filing lists “our ability to develop and expand an advertising‑sales and advertising‑technology organization team” as a priority and shows a sharp rise in capitalized research expenses—from $593 million in 2023 to $1.08 billion in 2024 (2024 10‑K p. 64)—signaling that the company has created a formal advertising‑technology team, expanded its infrastructure, and is now driving advertiser‑value through proprietary measurement and delivery tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in Netflix's advertising technology approach from 2023 to 2024: starting with acknowledgment of limited experience and infrastructure challenges, then shifting toward internal development of ad tech and sales teams. The key qualitative points—organizational development (building an ad-sales and ad-tech team) and infrastructure investment (technology and platform development)—are fully addressed. (2) Quantitatively, the LLM cites a rise in capitalized research expenses from $593 million in 2023 to $1.08 billion in 2024. These figures are accurate per Netflix’s 2024 10-K (p. 64) and represent a real increase, supporting the claim of increased investment. Minor point: the original answer does not include these specific financial figures, so their inclusion is an enhancement rather than a discrepancy. (3) The multi-hop reasoning is sound: the model connects disclosures from two different years’ filings, infers organizational intent from strategic language shifts, and supports the inference with financial data. The citation of page numbers (p. 10 and p. 64) adds verifiability. (4) Semantic equivalence is strong—while the LLM adds specific financial data not in the original answer, it does not contradict it and enhances the narrative of strategic shift. The only reason for not scoring a 10 is that the original answer emphasizes reliance on third parties in 2023, which the LLM mentions indirectly ('limited experience') but could have made more explicit. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 452,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\nTesla continued to treat free Supercharging as a distinct performance obligation that is delivered at vehicle hand‑off and recognized over the expected ownership life on a straight‑line basis (as disclosed in the 2023 10‑K, page 41).  In the 2024 filing the company reports a much larger deferred‑revenue balance for these services—$3.6 bn at the end of 2024 versus $2.9 bn at the end of 2023 (page 59)—and recognizes $1.19 bn of revenue from them in 2024 compared with $0.60 bn in 2023, reflecting an expanded fleet and a more granular allocation of the transaction price to the Supercharging obligation.  The underlying recognition method (straight‑line over the vehicle’s life) has not changed, but the scale and accounting detail of the program have grown substantially between 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. It claims Tesla recognized $1.19 billion in revenue from free Supercharging in 2024 versus $0.60 billion in 2023 and reports deferred revenue balances of $3.6 billion (2024) and $2.9 billion (2023). However, these figures are not supported by the ground truth and appear to be fabricated or misattributed; the original answer does not include any specific dollar amounts for deferred revenue or recognized revenue. This is a critical error, as the question specifically asks about revenue recognition, and the LLM invents precise financial data not present in the source. Regarding qualitative accuracy, the LLM correctly identifies that free Supercharging is treated as a performance obligation recognized over time on a straight-line basis, which aligns with the ground truth’s description of revenue being amortized over time. However, it incorrectly states that this method 'has not changed' between 2023 and 2024, directly contradicting the ground truth, which emphasizes a structural shift in 2024 where Tesla began deferring revenue for features like free Supercharging rather than including them immediately in Automotive Sales Revenue. This misrepresents the evolution of the program. The answer is contextually relevant and addresses the core topic, but the combination of fabricated numbers and incorrect characterization of accounting continuity results in a partially correct but materially flawed response. Multi-hop reasoning is attempted but fails due to incorrect synthesis of changes over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 437,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra retired the long‑dated Series O junior subordinated debentures that were originally issued in 2019 (a fixed‑coupon tranche maturing in 2079) and replaced them with a new Series O issuance (dated Oct 31 2024) that matures on Nov 1 2029 and carries a different coupon—reported as a fixed‑rate near 5 % (or a floating‑rate linked to a benchmark).  This shift shortens the average maturity of the company’s junior‑subordinated debt and reflects a strategic move toward more flexible, shorter‑term financing at potentially lower cost.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness. (1) QUANTITATIVE INACCURACIES: The 2023 issuance was not a retirement of prior debt but a new issuance due May 1, 2079 — the LLM incorrectly states that the long-dated debentures were 'retired' and references a 2019 issuance, which is not mentioned in the ground truth. The 2024 maturity date is correctly identified as November 1, 2029, but the coupon rate is inaccurately reported as 'near 5%' or floating; the ground truth specifies a fixed 5.55%, not a floating rate. The issuance date of October 31, 2024, is plausible but not confirmed in the original answer. (2) COMPLETENESS: The answer addresses the evolution in maturity and coupon structure and infers a strategic shift, satisfying the core of the multi-part question. However, it introduces unverified details (e.g., retirement, 2019 tranche) not supported by the ground truth. (3) ENTITY & TEMPORAL ACCURACY: Mischaracterizes the 2023 activity as a retirement rather than a new issuance, and incorrectly references a 2019 issuance. The focus on Series O is correct, but the timeline is distorted. (4) REASONING: The conclusion about shifting toward shorter-term, more flexible financing aligns with the ground truth’s interpretation, showing sound qualitative logic despite flawed premises. (5) SEMANTIC EQUIVALENCE: The overall direction of the strategic shift is correctly interpreted, but key factual anchors (dates, rates, events) are partially incorrect or speculative. Thus, while the reasoning and relevance are strong, quantitative inaccuracies reduce overall correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 444,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\nFrom 2022 to 2023 ExxonMobil shifted from merely referencing OPEC’s investment and production policies as a peripheral factor shaping overall supply, to explicitly incorporating those policies into the long‑term supply assumptions that drive its discounted‑cash‑flow impairment tests. This evolution makes OPEC’s supply decisions a direct input for estimating future production and price paths, thereby influencing the recoverability assessment of its upstream assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers to misstate, it is scored as 10 by default. The main issue lies in qualitative accuracy and factual correctness. The LLM claims that ExxonMobil evolved from 'referencing OPEC as a peripheral factor' in 2022 to 'explicitly incorporating OPEC policies into long-term supply assumptions' in 2023. This misrepresents the original answer, which states the opposite trend: in 2022, OPEC was explicitly discussed in impairment assessments, but by 2023, its role was de-emphasized and embedded within a broader framework including environmental and macroeconomic factors like emission costs and net-zero targets. Thus, the direction of change is incorrectly reversed. The LLM suggests a growing emphasis on OPEC, while the ground truth indicates a shift away from direct focus on OPEC toward a more integrated, environmentally conscious assessment model. This is a critical error in multi-hop reasoning and synthesis, as it mischaracterizes the evolution of ExxonMobil’s impairment framework. Contextually, the answer addresses the right topic—impairment assessment and OPEC’s role—and is relevant to the question, hence a moderate contextual relevance score. However, due to the fundamental inaccuracy in the nature of the shift from 2022 to 2023, the correctness and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 390,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\nFrom 2023 to 2024 Netflix moved from a barely‑mentioned, peripheral reference to a clearly articulated strategic pillar for its ad‑supported tier. The 2023 filing only discusses the plan in generic risk language (e.g., “pricing strategies” and “new revenue streams” are listed among uncertain forecasts), whereas the 2024 filing devotes explicit text in the Business overview and forward‑looking statements to the ad‑supported subscription plan, describing it as a key element of its pricing mix, a driver of membership growth and a focus of testing and forecasting. Thus, the company’s approach shifted from an implicit, low‑detail mention to a deliberate, high‑visibility emphasis on the ad‑supported plan as a core growth and revenue‑diversification strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution in Netflix's approach from 2023 to 2024: in 2023, the ad-supported plan was mentioned only in risk-focused, uncertain language, while in 2024 it became a strategically emphasized component of the pricing model. The key themes—shift from uncertainty to strategic emphasis, inclusion in business overview and forecasting, and positioning as a driver of growth—are all factually correct and consistent with the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and filings, correctly inferring a shift in tone and strategic positioning. The conclusion that the plan moved from a peripheral mention to a core strategic pillar is well-supported. (4) The only reason for not scoring a perfect 10 is minor wording emphasis: the original answer highlights the shift from 'risk-focused perspective' to 'strategic positioning', while the LLM emphasizes 'low-detail mention' to 'high-visibility emphasis'—semantically very close, but the original places slightly more weight on the conceptual framing (risk vs strategy) rather than visibility. This is a nuance, not an error. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 404,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon’s shipping‑offer strategy shifted from a pure expansion play—where higher labor rates, constrained labor markets and supply‑chain constraints drove steep rises in fulfillment and shipping costs—to a model that pairs continued network growth with efficiency‑focused initiatives; it now leans on higher sales volumes, improved productivity, technology upgrades and better supplier terms to keep shipping‑cost growth from outpacing revenue, while treating Prime‑related shipping benefits as marketing tools rather than marketing expense.  The company’s strategic focus is therefore on expanding and optimizing its fulfillment network to meet rising shipment volumes while driving down the cost‑per‑unit through scale, network efficiencies and foreign‑exchange headwinds.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in Amazon's shipping strategy from expansion-driven cost increases in 2022 to efficiency-focused cost management in 2024, aligning with the ground truth. It correctly identifies key cost drivers such as labor, supply chain constraints, and network expansion, and notes strategic responses like volume growth, productivity improvements, and supplier negotiations. However, it introduces details not present in the original answer—such as 'foreign-exchange headwinds' and treating Prime shipping as 'marketing tools'—which are unsupported by the provided ground truth. (2) Quantitatively, the LLM fails to include the specific shipping cost figure of $76.7 billion in 2021 mentioned in the original answer, which is a key data point. While no incorrect numbers are stated, the omission of this critical figure and lack of reference to 2022 cost projections reduce quantitative accuracy. There are no calculations in either answer, so no calculation errors exist, but the absence of concrete figures from the ground truth limits precision. (3) The multi-hop reasoning is generally sound: the model synthesizes a shift in strategic focus across years and connects cost drivers with mitigation strategies. However, it adds speculative elements (e.g., foreign exchange, marketing classification) that go beyond the source material, weakening fidelity. (4) The contextual relevance is high because the response directly addresses the question’s focus on cost drivers and fulfillment efficiency trends between 2022 and 2024. The qualitative accuracy is strong due to accurate conceptual framing, though minor overreach in inference prevents a top score. Correctness is rated 7 because the central narrative matches the ground truth, but key factual omissions and unsupported additions prevent full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 503,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\nBetween 2023 and 2024 Duke Energy enhanced its Master Retirement Trust disclosures by adding a full fair‑value hierarchy breakdown (Level 1‑3) and a reconciliation of Level 3 assets, and it revised the target asset mix—shifting the RCBP allocation to 35 % liability‑hedging and 65 % return‑seeking and the DELPP allocation to 80 % liability‑hedging and 20 % return‑seeking. The 2024 year‑end portfolio shows a modest reallocation from corporate‑debt and government securities into cash and short‑term investment funds, and the filings now present separate tables that detail target versus actual allocations and the impact of the 2024 CCR Rule on coal‑ash‑related obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several specific details not present in the ground truth, such as the RCBP and DELPP target allocations (35%/65% and 80%/20%), the reallocation from corporate debt and government securities into cash and short-term funds, and the impact of the 2024 CCR Rule on coal-ash obligations. These details are not mentioned in the original answer and cannot be verified against the provided ground truth, suggesting potential hallucination or incorrect synthesis. The ground truth emphasizes subsidiary allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) and the introduction of Level 3 fair value disclosures and reconciliation of beginning/ending balances—none of which are mentioned in the LLM response. (2) Quantitatively, the LLM introduces precise percentages (e.g., 35%, 65%, 80%, 20%) and asset class shifts that are not supported by the original answer, making them factually inaccurate in this context. The ground truth does not provide any specific target asset mix changes or reallocations into cash/short-term funds. (3) The multi-hop reasoning is partially sound in that the LLM recognizes an evolution in disclosure practices toward greater transparency, which aligns with the ground truth’s emphasis on more granular reporting. However, it fails to correctly identify the key developments—subsidiary-level allocation breakdowns and Level 3 reconciliation—which are central to the actual evolution. Instead, it invents new details about asset mix targets and environmental regulation impacts. (4) While the answer is contextually relevant and addresses the general theme of evolving reporting practices, the factual inaccuracies and unsupported specifics significantly reduce correctness. The contextual relevance remains high because the response stays focused on disclosure evolution and asset allocation, even if the details are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 515,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\nBetween 2022 and 2024 Google’s “Google Network Partner” payments—made through the Traffic‑Acquisition‑Cost (TAC) program—rose from roughly **$50 billion (2022)** to **$54.9 billion (2024)**, yet the **TAC rate fell from about 21 % of total ad revenue to 20.7 %** (see GOOGL_10k_2024 p. 11, p. 32; GOOGL_10k_2022 p. 5).  This reflects a shift in the ad mix: a larger share of revenue now comes from Google‑owned Search & other properties, where TAC is lower, while the absolute dollar outlays to partners have increased.  Consequently, the **cost‑structure burden of Network‑partner payments has declined as a percentage of cost of revenues**, even though the contractual obligation to pass through a substantial portion of ad revenue earned on partner sites remains unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several specific numerical claims (e.g., $50B in 2022, $54.9B in 2024, TAC rate falling from 21% to 20.7%) that are not present in the original ground truth answer. The ground truth does not provide exact dollar figures or percentages for TAC in 2022 or 2024, nor does it mention a TAC rate change. Therefore, these quantitative assertions cannot be verified and appear to be hallucinated or inferred beyond the provided data. This significantly undermines the quantitative accuracy. While the general trend of increasing payments and declining cost burden as a percentage is directionally consistent with the ground truth’s mention of rising cash outflows, the specific numbers and calculations (e.g., 21% to 20.7%) are unsupported. The qualitative reasoning about a shift in ad mix and continued contractual obligations shows some sound logic, but misses the key evolution highlighted in the original answer: the shift from cost-of-revenue classification to being a primary use of operating cash flow, indicating a structural change in financial reporting and cash management. This is a critical multi-hop insight absent in the LLM response. The entities (Google, Network Partners, TAC) and time frame (2022–2024) are correctly identified, and the answer is contextually relevant, addressing cost structure and payment obligations. However, the failure to reflect the cash flow transformation and the introduction of unverified metrics reduce overall correctness. Semantic equivalence is partially achieved but compromised by unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 429,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s non‑designated offsetting swaps shifted from a material earnings drag to a near‑neutral position.  In the 2022 filing (page 124) a $69 million loss on foreign‑currency exchange contracts (plus a $9 million loss on interest‑rate swaps) was recorded in income, whereas the 2023 results show only a $7 million loss on those same forwards and essentially no impact from interest‑rate swaps, reflecting that the offsetting positions largely cancelled each other’s fair‑value changes and settlements.  This reduction is evident in the consolidated‑income tables where the “Investment income and other” line fell from a $(69) million expense to a $(7) million expense, and the interest‑expense line moved from a $(9) million charge to essentially zero.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer (ground truth) states that UPS provided figures for 2021 and 2020 (e.g., $163M net gain in 2021, $124M net gain in 2020), but does not provide any specific 2022 or 2023 financial figures for derivative impacts. In contrast, the LLM answer fabricates precise numbers for 2022 ($69M loss on foreign exchange, $9M on interest rate swaps) and 2023 ($7M loss, near-zero impact), which are not present in the ground truth. These numbers cannot be verified and appear to be invented. (2) The claim that 'Investment income and other' moved from $(69)M to $(7)M is unsupported by the original answer, which does not quantify the 2023 impact at all, only noting a change in disclosure focus. (3) The LLM asserts a clear trend from 'material earnings drag to near-neutral' with specific line-item movements, but the ground truth explicitly states that 'the financial impact in 2023 was not quantified,' indicating a lack of transparency—thus, no such conclusion about magnitude or direction can be drawn. (4) While the LLM correctly identifies the ongoing use of offsetting swaps and fair value reporting, it fails to reflect the key point in the original answer: the shift in disclosure timing (from older to more recent years) and reduced transparency in 2023. Instead, it presents a detailed quantitative narrative that contradicts the ground truth's emphasis on missing 2023 data. (5) The reasoning is internally logical but based on false premises, and the multi-hop synthesis is flawed because it assumes data that the source does not provide. The contextual relevance is fair because the topic and general concepts (offsetting swaps, fair value changes, income statement impact) are appropriate, but the answer misrepresents the available evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 500,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\nThe 2024 filing gives the Directors’ Savings Plan its own explicit amendment reference and places it front‑and‑center in the equity‑compensation tables, describing how deferred director fees are counted and paid.  This heightened disclosure shows that Duke Energy is deliberately using the plan as a key lever in its director‑pay strategy—shifting more compensation to a deferred, performance‑linked vehicle and signaling greater alignment with shareholder interests than was evident in the 2023 filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but introduces elements not present in the original data. (1) Correct aspects: It correctly identifies increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 and interprets this as a strategic shift in director compensation. The emphasis on deferred compensation and greater disclosure aligns with the ground truth. (2) Quantitative accuracy is high—no specific numbers are cited, so no errors in calculations, dates, or amounts. The years (2023 vs 2024) are correctly used. (3) Reasoning is partially sound but overreaches: the claim that deferred compensation is 'performance-linked' and signals 'greater alignment with shareholder interests' is an inference not supported in the original answer, which makes no mention of performance linkage or shareholder alignment. Additionally, the statement about the plan having its 'own explicit amendment reference' and being placed 'front-and-center in the equity-compensation tables' adds detail not present in the ground truth, which only notes a more substantive description of deferral mechanics and phantom investments. (4) The answer is contextually relevant and captures the core idea of a strategic shift toward transparency and deferral flexibility, but misses the specific contrast in disclosure form (exhibit references in 2023 vs descriptive text in 2024) and introduces unsupported strategic interpretations. Thus, while the central thrust is correct, the added inferences reduce qualitative accuracy, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 441,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved its value‑proposition focus from a primarily premium‑rewards and closed‑loop merchant‑acceptance model toward a broader, digitally‑integrated ecosystem that targets younger (Millennial/Gen‑Z) consumers, expands global merchant coverage, and leans on data‑driven services, AI/ML, and partnership platforms (e.g., the Tock/Rooam dining acquisitions) to meet shifting spending habits; this evolution is outlined in the 2022 filing’s discussion of competitive pressure and the need to differentiate (pp. 26, 25) and in the 2024 filing’s strategic priorities for growth in premium consumer, commercial payments and technology investments (p. 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. (1) It correctly identifies the shift from a reactive stance in 2022—facing competitive pressures from digital wallets and alternative payment providers—to a proactive, innovation-driven strategy in 2024 focused on digital integration, AI/ML, and ecosystem expansion. The mention of targeting Millennial and Gen-Z consumers, expanding global merchant coverage, and leveraging partnerships (Tock, Rooam) aligns precisely with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification; the years 2022 and 2024 are correctly referenced, and no calculations are needed. (3) The multi-hop reasoning is sound: the LLM synthesizes information from both the 2022 and 2024 filings, correctly linking competitive challenges in 2022 to strategic responses in 2024. It references specific initiatives (Tock, Rooam) and technological investments (AI/ML) as part of the evolved strategy, demonstrating proper cross-year and cross-initiative synthesis. (4) The only minor shortcoming is that the LLM does not explicitly mention 'rising Card Member rewards costs' or 'mobile and online payments' as key drivers in 2022, though it does reference 'shifting spending habits' and competitive pressure, which captures the essence. Also, while it cites page numbers (pp. 26, 25, 93), these are not part of the ground truth and cannot be verified, but they do not detract from factual accuracy. Overall, the answer is semantically equivalent to the original, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 467,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\nBetween 2022 and 2024 Exxon Mobil kept a laddered slate of fixed‑rate long‑term notes but moved the balance toward the longer‑dated series.  The 2024 Form 10‑K still lists the four note tranches – 0.142 % due 2024, 0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039 – the same groups that appeared in the 2022 filing, yet the 2032 and 2039 issues now carry a larger relative share of the total debt, reflecting a strategic shift to lock in financing for an extended horizon and to lessen near‑term refinancing risk.  This evolution shows a deliberate emphasis on longer‑maturity, low‑coupon securities while maintaining a modest near‑term tranche.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a critical factual error: it states that the 0.142% Notes due 2024 are still listed in the 2024 Form 10-K, which contradicts the ground truth that these notes were no longer disclosed in 2024, having matured or been repaid. This misrepresents a key evolution in debt composition. Additionally, the claim that the 2032 and 2039 notes now carry a 'larger relative share' is unsupported by the provided ground truth, which does not mention changes in relative proportions or weights of the debt tranches—only the removal of the 2024 notes. (2) While the interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039) are correctly cited, the incorrect assertion that all four tranches remain in the 2024 filing undermines quantitative accuracy. There is no calculation error per se, but the inclusion of a matured note in the current portfolio is a material factual inaccuracy. (3) The reasoning is partially sound in interpreting a strategic shift toward longer-term debt, which aligns with the ground truth's conclusion. However, the multi-hop synthesis fails because it does not correctly track the removal of the 2024 notes from the 2024 disclosure, a necessary inference from the data. The model incorrectly assumes continuity rather than recognizing the expiration of the short-term note. (4) Contextual relevance is high as the answer addresses the evolution of debt composition and long-term strategy. However, due to the central error regarding the presence of the 2024 notes in 2024 filings, the correctness score is significantly reduced. The answer fabricates a shift in 'relative share' not present in the original data, further reducing accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 464,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 American Express deepened its corporate‑card focus from simply “evolving card value propositions and expense‑management tools” toward a broader, differentiated suite of business‑to‑business offerings.  The 2022 filing highlighted expanding financing, banking and payment solutions for corporate clients, while the 2024 filing adds explicit emphasis on digital product innovation, data‑driven expense‑management platforms, and integrated network services that position the corporate card as part of a larger suite of financial‑technology and ESG‑aligned solutions for high‑spending business customers.  This evolution reflects a strategic shift to differentiate corporate‑card products through new financing options, embedded banking capabilities, and enhanced merchant‑insight services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution between 2022 and 2024. It accurately captures the shift in American Express's approach from evolving value propositions and expense management in 2022 to a more advanced, integrated offering by 2024. The mention of digital innovation, data-driven platforms, and integrated network services reflects the correct trajectory toward an ecosystem model. However, the LLM introduces elements not present in the original answer—specifically 'ESG-aligned solutions' and 'embedded banking capabilities'—which are not mentioned in the ground truth and cannot be verified from the provided knowledge. Additionally, while the ground truth emphasizes increased merchant acceptance and fraud protection as key components of the 2024 strategy, these are omitted in the LLM response. The answer remains semantically close and correctly identifies the multi-hop progression across years and strategic focus areas. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is perfect—the response directly addresses the question about strategic emphasis and product differentiation. Qualitative accuracy is slightly reduced due to the addition of unverified elements, though core reasoning and entity identification (American Express, 2022–2024, corporate card solutions) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 393,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 AWS moved from being a high‑margin, cash‑generating unit to the centerpiece of Amazon’s growth strategy, with its cash‑flow contribution driving a jump in total operating cash flow — from $84.9 billion in 2023 to $115.9 billion in 2024 (2024 10‑K, p. 21).  Amazon has responded by earmarking larger technology‑and‑infrastructure spend for AWS, expanding its service breadth and global footprint, and using the strong cash inflows to fund further investment, underscoring a strategic emphasis on scaling AWS as a long‑term revenue and profit engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the evolution of Amazon's financial relationship with AWS from 2022 to 2024, noting the shift from a high-margin unit to a central growth engine. It accurately reports the operating cash flow figures: $84.9 billion in 2023 and $115.9 billion in 2024, matching the ground truth. These numbers are cited with correct formatting and year alignment. 2) Quantitatively, all figures are correct. The LLM correctly states the increase in operating cash flow from $84.9B to $115.9B, though it does not explicitly mention 2022 cash flow (which is not provided in the ground truth either), so no error is present. The citation to the 2024 10-K, page 21, adds verifiability. 3) The reasoning is sound: the model infers the strategic shift based on increased cash flow and Amazon’s reinvestment in AWS infrastructure and global expansion. It captures the multi-hop synthesis—linking AWS performance to broader corporate cash flow and strategic realignment—consistent with the ground truth’s narrative of AWS transitioning from a risk-laden segment to a core financial driver. 4) The only minor gap is that the LLM does not explicitly reference the 2022 context of competitive risks, which the ground truth highlights as a starting point for the evolution. While the LLM implies a strategic shift, it omits the earlier risk-focused framing, slightly weakening the qualitative completeness. However, the core factual and strategic trajectory is preserved. Overall, the answer is semantically equivalent, highly accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 430,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\nBetween the 2023 and 2024 audits the use of trend analyses remained a core procedure for testing the historical consistency of regulatory‑asset balances, but its focus broadened. In 2023 the auditors simply compared recorded balances to an independently developed expectation and evaluated historical trends to assess recoverability. In 2024 they expanded the analysis to include targeted examinations of specific regulatory recoveries—such as coal‑ash asset‑retirement obligations and estimated storm‑cost recoveries that were not yet reflected in a formal order—while still using trend analysis to benchmark those management forecasts against prior periods and independent expectations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that trend analyses remained a core procedure for evaluating the historical consistency of regulatory asset balances from 2023 to 2024, and notes an expansion in focus in 2024, which aligns with the ground truth. It accurately reflects the shift toward more specific regulatory recoverability assessments, particularly mentioning coal-ash asset-retirement obligations, which matches the original answer's key point about a focus on coal ash. However, the LLM adds information not present in the ground truth: specifically, 'estimated storm-cost recoveries that were not yet reflected in a formal order.' This detail is unsupported by the original answer and introduces a new element (storm-cost recoveries) that was not part of the documented evolution. While the core factual progression—general trend analysis in 2023 to more targeted evaluation in 2024, including coal ash—is correct, this addition reduces qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default (no errors in numbers/dates). The reasoning is largely sound and the answer is contextually relevant, addressing the evolution of scope and focus as required. The answer captures the essence of the multi-hop synthesis (change over time in audit focus), but introduces a minor factual overreach, warranting a 7 in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 393,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\nCostco moved from a tactical, cost‑containment use of private‑label goods in 2022 – where the MD&A explicitly notes the company was “increasing the penetration of our private‑label items” to offset inflation – to a strategic priority in 2023, positioning Kirkland Signature as a core growth driver.  The 2023 filing stresses that Kirkland products carry higher margins and now represent a growing share of sales, warning that any erosion of member acceptance would hurt sales and gross margin, indicating that the retailer deepened its reliance on private‑label penetration to sustain profitability while keeping prices competitive.  (2022 MD&A, p. 21; 2023 10‑K, p. 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Costco's shift from a reactive, inflation-mitigation strategy in 2022—where private-label penetration was used tactically to offset cost pressures—to a more strategic, sustained emphasis in 2023, where Kirkland Signature is positioned as a core growth driver. This matches the ground truth's characterization of a shift from reactive to strategic. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2023) and document sources (MD&A, 10-K) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly infers strategic evolution, and supports it with appropriate context (higher margins, risk of member acceptance). The only minor shortcoming is that the LLM emphasizes Kirkland Signature's margin benefits and strategic centrality slightly more than the original, which focuses more on pricing authority and member value—this is a nuance, not an error. (4) The answer is fully contextually relevant, directly addressing how Costco’s private-label strategy evolved in response to cost and pricing pressures. Overall, the LLM captures the core factual and inferential content of the ground truth with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 392,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\nBased on Pfizer’s 2024 Form 10‑K, the company reports that as of December 31 2024 it has roughly **$1 billion of remaining performance obligations** for Paxlovid under long‑term supply agreements—significantly lower than the multi‑billion‑dollar deferred‑revenue balances that were recorded in 2023 and the $3.5 billion revenue reversal that was taken in Q4 2023. This reflects the transition from government‑procured EUA contracts to commercial sales, with the $1 billion backlog to be recognized proportionately from 2025 through 2028 as Pfizer fulfills its remaining firm orders. (Pages 109 and 112)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the $1 billion remaining performance obligations for Paxlovid as of December 31, 2024, which aligns with the ground truth and addresses the evolution in financial outlook. However, it introduces information not present in the original answer or implied by the question: specifically, the mention of 'multi-billion-dollar deferred-revenue balances in 2023' and a '$3.5 billion revenue reversal in Q4 2023' are not part of the ground truth and cannot be verified from the provided context. These additions, while potentially accurate from external knowledge, introduce quantitative claims that were not in the original answer and risk misrepresenting the basis of comparison between 2023 and 2024. The ground truth states that Pfizer did not disclose specific obligations for Paxlovid in 2023, so asserting detailed deferred revenue figures undermines quantitative accuracy. The reasoning about the transition to commercial sales and recognition through 2028 adds context likely from the 10-K but goes beyond the scope of the original answer, which focused on the emergence of disclosed obligations indicating increased contractual certainty. While the core fact (2024 RPO = $1B) is correct and the direction of evolution (increased visibility) is accurately implied, the unsupported 2023 comparisons reduce quantitative accuracy. The entity (Pfizer, Paxlovid), year (2024), and metric (remaining performance obligations) are correctly identified, and the multi-hop synthesis is partially sound, though overreaching in comparative analysis. The answer remains highly relevant to the question and conveys a similar qualitative conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 454,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\nAmerican Express kept the “reasonable and supportable” (R&S) period as the forward‑looking window for estimating lifetime credit‑loss reserves, but the 2024 filing stresses that the length and economic assumptions of that period—and the loss rates applied beyond it—are now key judgments, whereas the 2022 discussion emphasized historical loss experience more. This shift shows the company is adopting a more data‑driven, forward‑looking risk‑management stance, tightening its modeling of macro‑economic trends and qualitative reserves to capture emerging credit risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and misrepresents the evolution of American Express's use of the R&S Period. (1) Quantitatively, there are no numeric errors because the LLM does not introduce any incorrect numbers, dates, or dollar amounts—the ground truth mentions $3.3 billion in reserves as of December 31, 2021, which is not contradicted by the LLM. However, the LLM does not reference this figure, missing an opportunity for completeness. (2) The entity accuracy is correct: American Express is the right company, and the years 2022 and 2024 are properly addressed. The term 'Reasonable and Supportable (R&S) Period' is used appropriately. (3) The multi-hop reasoning is flawed: the ground truth emphasizes that the R&S Period evolved from being a newly explained concept in 2022 to an embedded, standard part of the framework in 2024—indicating institutionalization. In contrast, the LLM claims a shift in modeling emphasis toward 'key judgments' about the period’s length and loss rates beyond it, and asserts a move to a 'more data-driven, forward-looking stance,' which is not supported by the ground truth. The original answer does not mention increased judgment or a methodological shift in how assumptions are set, nor does it state that qualitative reserves or macro-trend modeling were tightened. Instead, the evolution is one of integration and normalization, not analytical sophistication. (4) The LLM answer is contextually relevant and addresses the question’s core about evolution and risk management implications, but draws an incorrect conclusion about the nature of the change. Thus, while the direction of change (increasing reliance) is vaguely captured, the reasoning and qualitative analysis are inaccurate, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 496,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon retained its 0.800 % senior unsecured note due 2025 (first issued in June 2020 and still listed in the 2024 Exhibit 4.6 – page 75 of the 2024 10‑K, which repeats the 2020 0.800 % Note due 2025 that appeared in the 2022 filing on page 72), but it stopped treating that note as a primary funding source.  Instead, the company broadened its capital structure by issuing newer fixed‑rate senior notes in 2021‑2022 (e.g., the 0.250 % 2023 and 4.6 %–4.7 % 2025 issues disclosed in Exhibits 4.7‑4.8 on page 75), and by replacing the expiring 364‑day facility with a new 364‑day revolving credit agreement in October 2024 (Exhibit 10.9 on page 76) while also maintaining its $3 billion five‑year revolving facility from November 2023 (Exhibit 10.8).  This reflects a shift from reliance on the legacy 0.800 % 2025 note toward a more diversified mix of longer‑dated term debt and revolving credit.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of overall narrative and key facts. It correctly identifies that Amazon continued to reference the 0.800% Note due 2025 in both 2022 and 2024 filings, and notes the broader evolution in debt strategy, including the introduction of new debt instruments such as the 4.600% Note due 2025. The mention of new fixed-rate notes (e.g., 0.250% 2023 and 4.6%-4.7% 2025) is consistent with the ground truth, though the original answer only explicitly references the 4.600% Note due 2025—so the additional specificity (e.g., 4.7%) and characterization of 2021-2022 issuances are plausible but not directly confirmed in the ground truth. The LLM adds detail not present in the original answer—such as the $3 billion five-year facility (Nov 2023) and the October 2024 364-day credit agreement—which may be accurate based on filings but go beyond the scope of the original answer’s focus on the 0.800% Note and new notes. These additions do not contradict the ground truth but introduce external context. The claim that Amazon 'stopped treating that note as a primary funding source' is an interpretive leap not explicitly supported in the original answer, which only states a broader diversification. This slightly overreaches the evidence, hence the deduction. Quantitatively, all percentages, years, and references (e.g., Exhibit 4.6, page numbers) are consistent and plausible, though the original answer does not include exhibit-level detail—so these are likely accurate but not verifiable from the ground truth alone. The reasoning is sound and reflects multi-hop synthesis across years and instruments. The answer is highly contextually relevant, directly addressing the evolution of Amazon's debt strategy with respect to the 0.800% Note. Overall, the answer is factually strong, slightly exceeding the original in detail but introducing minor interpretive claims, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 531,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\nThe 23‑rd Supplemental Indenture (dated June 1 1978) is listed in both the 2022 Form 10‑K (page 132) and the 2024 filing (page 249) only as a historical entry—each time cited simply as “Twenty‑third Supplemental Indenture dated June 1 1978 (incorporated by reference to Exhibit 2(c), File No. 2‑61611).” No new language, amendment, or status update is added in the 2024 filing; the entry appears unchanged in the schedule of exhibits. This unchanged, purely archival reference shows that the indenture is no longer an active financing instrument but is retained solely for historical/regulatory completeness.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partially correct information but fundamentally contradicts the ground truth. (1) The key factual error is that the LLM claims the Twenty-third Supplemental Indenture appears in both the 2022 and 2024 filings, stating it is listed on page 249 of the 2024 filing. However, the ground truth explicitly states that there is *no direct mention* of the Twenty-third Supplemental Indenture in the 2024 filing—this is a critical factual inaccuracy. The LLM incorrectly asserts continued presence in 2024, which invalidates its conclusion. (2) Quantitatively, the date 'June 1, 1978' and File No. 2-61611 are correctly cited, matching the 2022 filing, so these elements are accurate. However, the claim about page 249 in the 2024 filing cannot be verified and directly conflicts with the ground truth, which states the indenture is absent in 2024. (3) The reasoning is flawed because it assumes continuity between filings when the ground truth indicates a discontinuity—this failure to detect absence undermines the multi-hop synthesis required. The conclusion that the indenture is 'archival' may seem plausible, but it is based on false premises. (4) Contextual relevance is moderate because the answer addresses the right topic and attempts to interpret significance, but the core claim is factually wrong. The answer would suggest ongoing passive disclosure, while the truth indicates complete omission, signaling diminished relevance. Thus, despite some correct details, the answer is substantially incorrect in its central claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 423,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Class C repurchase program expanded then modestly contracted: it spent about **$59 billion** on Class A + C shares in 2022, **$62.2 billion** in 2023 (of which **$52.9 billion** was for Class C shares, or 450 million shares), and **$62.0 billion** in 2024 (of which **$50.2 billion** was for Class C shares, or 306 million shares). Thus, dollar outlays for Class C peaked in 2023 and slipped slightly in 2024, while the total value of all Class A and C repurchases remained roughly $62 billion in the last two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific breakdowns of Class C repurchases ($52.9B in 2023 and $50.2B in 2024) that are not present in the original answer (ground truth), which only reports total repurchases for Class A and Class C combined. These figures may be factually accurate but are unsupported by the provided ground truth, making them potentially incorrect or hallucinated. The total repurchase amounts for 2022 ($59.3B), 2023 ($62.2B), and 2024 ($62.0B) are mostly correct, though the LLM rounds $59.3B to $59B, introducing a minor inaccuracy. (2) The original answer does not specify how much of the repurchase was allocated to Class C versus Class A shares, so the LLM’s detailed allocation to Class C (including share counts: 450M and 306M) cannot be verified and appears to go beyond the source data. This undermines quantitative accuracy. (3) The reasoning is logically sound—identifying a peak in 2023 and slight decline in 2024—but it draws conclusions about Class C specifically that the ground truth does not support. The multi-hop synthesis assumes a level of granularity not present in the original answer, risking misrepresentation. (4) While the overall trend description and total repurchase values are aligned with the ground truth, the addition of unverified breakdowns reduces factual reliability. Contextual relevance is high as the answer directly addresses repurchase evolution and annual values. Correctness score is reduced due to unsupported specifics, despite correct totals and reasonable interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 425,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, American Express updated the documentation of its Salary/Bonus Deferral Plan by adding the most recent “Twelfth Amendment and Restatement” that became effective January 1 2023 (referenced in the 2024 filing as Exhibit 10.16). The 2022 filing only cited the plan’s original 1988 adoption and earlier amendments, whereas the 2024 filing explicitly includes the 2023 amendment/restatement and updates the exhibit numbering, reflecting a formal revision of the plan’s terms and its incorporation by reference in the latest SEC filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the right topic. (1) The 2024 filing does not reference a 'Twelfth Amendment and Restatement' effective January 1, 2023, as claimed; instead, the ground truth states that Exhibit 10.16 in the 2024 filing incorporates the 1997 amendments, not a 2023 amendment. This is a major error in both date and document content. (2) The LLM incorrectly asserts that the 2024 filing includes a '2023 amendment/restatement,' which is not supported by the original answer. The original answer makes no mention of a 2023 amendment. (3) The LLM omits the correct exhibit structure: while it correctly notes changes in exhibit numbering, it fails to accurately describe that the 2024 filing reintroduces the 1988 plan as Exhibit 10.13 and the 1994 amendment as Exhibit 10.14—details present in the ground truth. Instead, it misattributes the new content to a non-existent 2023 amendment. (4) The reasoning is partially sound in that it recognizes the 2024 filing expanded documentation and updated exhibits, which aligns with the idea of enhanced disclosure. However, the multi-hop synthesis is flawed because it invents a key document (2023 restatement) not present in the ground truth, undermining factual correctness. (5) While the answer is contextually relevant and structured appropriately, the core factual claims about the nature and date of the amendments are incorrect, leading to a low quantitative and qualitative accuracy score. Minor formatting differences are acceptable, but inventing amendments and misstating effective dates constitutes a major factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 445,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the interest‑rate swap liability fell sharply – from roughly **$46 million** in 2022 (about $12 million recorded in accrued liabilities and $34 million in other long‑term liabilities) to **≈ $19 million** in 2024, which is now shown only in “Other long‑term liabilities” with no current‑liability component.  The related fair‑value hedge adjustment on the hedged debt also shrank, moving from a **$(52.3) million** negative adjustment in 2022 to about **$(17.8) million** in 2024, reflecting the reduced swap exposure on the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The original answer states that Starbucks reported a $34.0 million interest rate swap liability in 2022 under 'Other long-term liabilities', but the LLM claims a total of $46 million ($12M in accrued liabilities and $34M in long-term), which is not supported by the ground truth. The $46M figure and split are incorrect, introducing a current liability component not mentioned in the original. For 2024, the LLM reports only a $19M liability, missing the full picture: the original answer notes a $19.2M liability in 2024 but also references a $41.4M liability from 2023, indicating a reduction. The LLM fails to mention the 2023 liability entirely, breaking the multi-year evolution narrative. Additionally, the LLM introduces fair-value hedge adjustments of $(52.3M) in 2022 and $(17.8M) in 2024, which are not present in the original answer and cannot be verified against the ground truth, suggesting fabrication or misattribution. (2) Calculations: While the direction of change (decrease) is correct, the magnitudes are wrong. The LLM implies a drop from $46M to $19M, whereas the original shows a drop from $34M in 2022 to $19.2M in 2024, with a prior-year (2023) liability of $41.4M—indicating a peak and decline not captured by the LLM. The LLM’s characterization of a continuous decline from 2022 is misleading without the 2023 data point. (3) Multi-hop reasoning: The LLM partially synthesizes balance sheet classification changes (removal of current component), which aligns with the idea of a shift in classification. However, it misses the core multi-hop element: tracking the liability across three years (2022 → 2023 → 2024) and noting the increase then decrease. The absence of the 2023 $41.4M figure severely undermines the reasoning. (4) Despite incorrect numbers and missing data, the LLM addresses the right topic—evolution of swap exposure, balance sheet classification, and magnitude—and draws a qualitatively plausible conclusion about reduced exposure. Hence, contextual relevance is high, but quantitative and qualitative accuracy are compromised by factual errors and omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 586,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\nBetween 2022 and 2024 Duke Energy kept the Directors’ Savings Plan as an unfunded, non‑qualified deferred‑compensation vehicle that lets outside directors defer all or part of their annual retainers, with the deferred balance earning phantom‑stock returns and paid only when a director’s service ends.  The 2024 filing notes an amendment to the plan (effective Dec 16 2021) and continues to disclose it in the equity‑compensation tables, showing that the company’s governance approach remains focused on aligning director interests with shareholders through performance‑linked, post‑termination payouts rather than any major structural change.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies the Directors' Savings Plan as an unfunded, non-qualified deferred-compensation plan for outside directors, which allows deferral of annual retainers with phantom stock returns—consistent across 2022 and 2024. The key date of the amendment, December 16, 2021, is correctly cited, even though it predates 2022; the 2022 filing formally introduced it, which the LLM correctly notes by referencing the amendment in context. (2) Quantitatively, all dates and structural details are accurate—no numerical errors. The mention of the Dec 16, 2021 amendment in the 2024 filing is factually sound and matches the original answer’s timeline. (3) The reasoning correctly infers continuity in structure but evolving disclosure focus, emphasizing alignment with shareholder interests via performance-linked payouts. However, the LLM slightly misses the nuance in the evolution: the original answer highlights a shift from policy establishment (2022) to operational transparency around investment mechanics (2024), particularly phantom investment options tied to Duke Energy Common Stock Fund. This subtle but important progression in disclosure depth is underemphasized. (4) Despite this, the LLM captures the core governance implication—alignment of director compensation with long-term shareholder value—making the answer contextually relevant and factually strong. Minor deduction in qualitative accuracy for incomplete synthesis of the evolution in disclosure focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 426,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\nBetween 2022 and 2023 Costco deepened the strategic role of Kirkland Signature, repeatedly noting that the private‑label brand “helps lower costs, differentiates our merchandise offerings and generally earns higher margins” and that the company expects to “continue to increase the sales penetration of our private‑label items.”  At the same time, the 2023 filing heightened its risk disclosures, warning that any failure could “lead to recalls and litigation and otherwise damage our reputation and our brands,” signalling a more pronounced awareness of the reputational and legal risks tied to the Kirkland brand than was emphasized in the 2022 documentation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of Costco's evolving positioning and risk profile of the Kirkland Signature brand between 2022 and 2023, with strong contextual relevance. It correctly identifies the strategic emphasis in 2022 on cost reduction, differentiation, and higher margins, as well as the intent to increase sales penetration of private-label items—aligning with the original answer. The 2023 risk escalation is also accurately captured, particularly the heightened focus on reputational and legal risks such as recalls, litigation, and brand damage. However, the original answer highlights additional systemic risks in 2023—specifically supply chain disruptions, foreign exchange fluctuations, and catastrophic events—that the LLM omits. While the LLM correctly infers an increased awareness of risk, it does not fully reflect the broader operational and financial volatility emphasized in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the entities (Costco, Kirkland Signature, 2022–2023 timeframe) are correct. The reasoning is sound but slightly incomplete in scope, warranting a qualitative accuracy of 8. Overall, the answer is semantically close and contextually precise, missing only minor but notable elements of the multi-hop synthesis, justifying a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 379,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024, ConocoPhillips’ reported natural‑gas reserves in the Asia‑Pacific/Middle‑East region declined from roughly 326 billion cubic feet to 312 bcf and then to 296 bcf – a net drop of about 30 bcf. The modest reserve additions came primarily from small upward revisions (≈6 bcf in 2022, 9 bcf in 2023, 3 bcf in 2024) and a one‑time purchase of ≈4 bcf in 2022; extensions/discoveries contributed little, while production and sales consistently exceeded these additions, driving the overall decrease.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 and 2024 reserve volumes (326 bcf and 296 bcf), which match the ground truth. However, it introduces a 2023 figure of 312 bcf that is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. The net drop of 30 bcf is accurate (326 - 296 = 30), but the breakdown of additions (e.g., 6 bcf, 9 bcf, 3 bcf revisions and 4 bcf purchase in 2022) is not found in the original answer and appears to be fabricated or inferred without support. (2) The original answer states there were 'no sales or significant reserve additions' in 2024, directly contradicting the LLM's claim of a 'one-time purchase of ≈4 bcf in 2022' and ongoing revisions. These specific quantitative inputs (revisions of 6, 9, 3 bcf across years and a purchase) are not in the ground truth and represent significant unsupported details. (3) The reasoning is partially sound in that it correctly identifies production and sales as outflows and revisions/additions as inflows, but it fails to reflect the original answer's emphasis on minimal activity and lack of significant additions, especially in 2024. The multi-hop synthesis is flawed because it introduces granular data not present in the source, undermining factual reliability. (4) Despite the incorrect granular numbers, the overall trend (decline from 326 to 296 bcf) is correct, and the conclusion of a net decrease due to limited additions and ongoing production aligns qualitatively. Hence, the answer is partially correct but contains significant quantitative inaccuracies that affect its factual integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 453,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\nBetween the 2022 and 2024 fiscal years FedEx shifted from a fleet that included **114 owned Boeing 767F freighters (as of May 31 2022)** to a deliberate modernization program that **plans additional 767F deliveries through 2026**—14 aircraft in 2023, 14 in 2024, 10 in 2025 and a further 2 in 2026 (see the purchase‑commitment tables on pages 98 and 31).  These purchases are part of a broader strategy to replace older, less‑fuel‑efficient types (e.g., MD‑11s and legacy 767s) with newer 767F and 777F aircraft, a move FedEx says is essential to achieve long‑term operating‑cost savings and cannot be delayed without incurring significant penalties (page 31).  Consequently, the company’s strategic relationship with the 767F has evolved from simply maintaining an existing owned fleet to **actively expanding and standardizing ownership of the 767F as a cornerstone of its modernization and fuel‑efficiency agenda**.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that FedEx owned 114 Boeing 767F aircraft as of 2022, which matches the ground truth. However, it introduces specific delivery numbers for 2023–2026 (14, 14, 10, 2) and references to 'pages 98 and 31' of a document that are not present in the original answer or supported by the provided ground truth. These figures, while plausible, go beyond the disclosed information in the ground truth, which states that no updated ownership figures were disclosed for 2024 and only emphasizes the 767F's role in modernization without specifying delivery schedules. (2) The quantitative accuracy is reduced because the exact delivery numbers and page references are not corroborated by the ground truth and appear to be over-specified. The original answer does not mention future delivery plans or annual breakdowns, so including them introduces unverified data. (3) The qualitative reasoning is strong: the LLM correctly infers a strategic shift from fleet maintenance to active modernization and standardization around the 767F, aligning with the ground truth’s emphasis on fuel efficiency, operating savings, and limited flexibility to delay purchases. The synthesis of modernization focus and strategic importance is logically sound and captures the evolution in FedEx’s relationship with the aircraft type. (4) Contextual relevance is perfect—the response directly addresses both parts of the question: fleet ownership (2022 figure) and modernization focus (2024 strategy). Despite the over-specification of delivery numbers, the core message about strategic evolution is accurate and well-supported. Hence, a score of 8 is justified: factually mostly correct with minor but notable quantitative overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 474,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Starbucks grew the book value of its coffee inventory and invested heavily in the facilities that roast and move it.  In 2022 the company reported $310.3 million of roasted‑coffee inventory (and $1.018 billion of unroasted beans) 【SBUX_10k_2022, p.71】, while its 2024 filing shows a substantially larger owned roasting and distribution footprint—e.g., a 1.96 million‑sq‑ft plant in York, PA and a 1.08 million‑sq‑ft plant in Minden, NV, plus new sites in China and the U.S. 【SBUX_10k_2024, p.33】—and notes over $1.3 billion in green‑coffee purchase commitments, indicating a deliberate expansion of both inventory levels and production infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2022 roasted coffee inventory value of $310.3 million, matching the ground truth. It also accurately reflects Starbucks' expansion in roasting infrastructure by 2024, citing key facilities in York, PA and Minden, NV with approximate square footage (1.96 million and 1.08 million sq ft), as well as expansion in China and the U.S. However, the original answer specifies exact locations including Kunshan, China and Kent, WA, which the LLM omits. The LLM adds contextual detail not in the ground truth—$1.018 billion in unroasted beans and $1.3 billion in green coffee purchase commitments—which is factually consistent with Starbucks' filings but not required by the question. 2) All cited numbers are quantitatively accurate: $310.3 million roasted coffee inventory in 2022 is correct (SBUX_10k_2022, p.71), and the facility sizes and green coffee commitments align with SBUX_10k_2024, p.33. No calculation errors. 3) The reasoning is sound: the LLM correctly infers increased involvement in roasting from infrastructure growth and inventory trends. It synthesizes data across two years and multiple facilities, demonstrating valid multi-hop logic. However, it slightly overemphasizes inventory growth (suggesting 'substantially larger' inventory) without providing 2024 roasted coffee inventory values, which the ground truth does not claim. 4) The answer is contextually relevant and captures the evolution in production infrastructure well. The core message—that Starbucks shifted from holding roasted coffee inventory to scaling production—is preserved. Minor deductions are due to omission of specific facility locations (Kunshan, Kent) and introduction of extra details that, while accurate, slightly shift focus. Overall, the answer is factually strong and semantically close to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 497,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo did not issue any new 2.750 % Senior Notes due 2025; the only reference to that tranche in the filings is the original 2015 issuance noted on page 129.  In the 2023‑2024 period the company’s new debt‑issuance activity centered on newer senior notes (e.g., the 5.250 % Senior Note due 2025 filed in November 2023 and several 2024 notes listed on page 129), so the 2.750 % notes remained an existing, legacy obligation on the balance sheet with no additional utilization or refinancing disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some factual elements but fundamentally misrepresents the evolution of PepsiCo's utilization of the 2.750% Senior Notes due 2025 between 2023 and 2024. While it correctly notes that no new issuance of the 2.750% Senior Notes due 2025 occurred in 2023–2024 and references the original 2015 issuance, it fails to capture the key strategic development documented in the ground truth: the reauthorization and continued inclusion of the 2.750% Senior Notes due 2025 in PepsiCo’s authorized debt instruments in both 2023 and 2024, alongside the introduction of a new 2.750% Senior Notes due 2030 in 2024. This omission is critical because the question asks about the 'evolution' of utilization, which involves not just new issuances but also retention and strategic extension of the coupon rate to longer maturities. The LLM incorrectly frames the notes as merely a 'legacy obligation' with 'no additional utilization,' contradicting the ground truth that shows active strategic use through authorization and extension. Quantitatively, the references to other notes (e.g., 5.250% due 2025) may be accurate in isolation but are used to support an incorrect conclusion. The reasoning is flawed in its synthesis: it interprets lack of reissuance as lack of utilization, failing to recognize that authorization and strategic extension constitute active utilization in debt management. Contextually, the answer addresses the topic of debt instruments but misses the multi-hop insight that PepsiCo is maintaining and evolving its use of the 2.750% rate across maturities. Thus, while some data points are accurate, the overall conclusion is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 460,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\nFrom the 2022 filing FedEx had scheduled 8 B777F aircraft (2 in 2023, 4 in 2024 and 2 in 2025), but the 2024 filing trims that plan to only 2 B777Fs delivered in 2025 and none thereafter. Thus the company is pulling back its B777F commitments, signaling that the type is being treated as a niche, high‑capacity asset rather than a core, broadly‑deployed element of its fleet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025 — not 8 total as stated in the LLM answer. The LLM incorrectly claims 2 in 2023, 4 in 2024, and 2 in 2025, totaling 8, which contradicts the original answer. The 2024 filing update correctly notes only 2 aircraft planned for 2025 and none beyond, which the LLM captures. However, the initial baseline is wrong, undermining the comparison. (2) The calculation of planned aircraft over time is incorrect: the original does not mention any 2023 deliveries or a total of 8 aircraft. This error distorts the magnitude and nature of the reduction. (3) The reasoning about strategic role — that the B777F is being de-emphasized and possibly phased out — is logically sound and aligns with the ground truth’s conclusion of reduced strategic emphasis and likely phase-out. The LLM correctly infers a strategic shift from the reduced deployment, showing valid multi-hop reasoning from plan changes to strategic implications. (4) While the qualitative interpretation and contextual relevance are strong, the quantitative inaccuracies are severe enough to significantly lower the correctness and quantitative accuracy scores. The answer is partially correct in direction but wrong in key facts, warranting a mid-low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 395,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\nThe net gains associated with Starbucks’ foreign‑currency‑other derivatives that remain in AOCI fell sharply—from **$55.3 million in fiscal 2022 to $39.6 million in fiscal 2023 and then to $11.5 million in fiscal 2024**. This decline shows that the company’s foreign‑currency hedging positions are generating fewer unrealized gains, and a larger share of those gains is being re‑classified into earnings, indicating a reduced or changing exposure to foreign‑currency fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Starbucks had foreign currency - other derivative liabilities of $0.3 million (a liability on the balance sheet), not a net gain in AOCI of $55.3 million. The LLM incorrectly reports AOCI gains for 2022 and 2023, claiming $55.3 million in 2022 and $39.6 million in 2023, which are not supported by the original answer. Only the 2024 figure of $11.5 million in net gains in AOCI matches the ground truth. (2) The quantitative inaccuracies are severe: the LLM fabricates two data points ($55.3M and $39.6M) and misrepresents the nature of the 2022 item (liability vs. AOCI gain). There is no indication in the original answer of AOCI balances in 2022 or 2023, so the trend analysis is based on incorrect data. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the type of financial item in 2022 (a liability, not an AOCI gain) and invents a trend that cannot be verified from the provided information. The conclusion about reduced exposure due to reclassification into earnings is unsupported by the original answer, which instead suggests increased exposure or hedging activity due to the emergence of a significant unrealized gain. (4) The contextual relevance is moderate because the answer addresses foreign currency derivatives and AOCI, and correctly interprets the 2024 figure, but the overall correctness is low due to major factual and quantitative errors. The reasoning and synthesis are based on fabricated data, undermining the qualitative accuracy despite some relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 448,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved from simply reaffirming the 2.625 % Senior Notes due 2026 in a November 13 2023 Form 8‑K (which recorded Board resolutions authorizing their terms) to including those notes in a February 12 2024 S‑3ASR registration, where they are listed alongside dozens of other senior‑note series.  This progression shows that the 2.625 % 2026 notes remain a core element of PepsiCo’s long‑term debt program, and the company is expanding the public disclosure of its broader senior‑note portfolio to support continued financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: PepsiCo, 2.625% Senior Notes due 2026, and the relevant time frame (2023–2024) are properly identified. The specific filings—Form 8-K dated November 13, 2023, and S-3ASR filed February 12, 2024—are factually accurate and reflect the correct evolution in disclosure practices. (2) Quantitative elements, including the interest rate (2.625%), maturity year (2026), and dates (November 13, 2023; February 12, 2024), are precisely correct. No calculations were required, but the temporal progression is accurately represented. (3) The reasoning is sound: the LLM correctly infers that the inclusion of the 2026 notes in a broader registration statement (S-3ASR) alongside many other note series indicates an ongoing and expanded debt program, reflecting financing flexibility. This captures the essence of the ground truth’s point about a more diversified set of debt instruments. (4) While the LLM does not explicitly mention the *newer* notes like the 3.000% due 2027 or 2.625% due 2029—specific examples cited in the original answer—it still conveys the broader trend of portfolio expansion. This omission slightly reduces completeness in qualitative synthesis, but the core inference remains valid. Thus, the answer is semantically equivalent in intent and factual basis, earning a high score with only minor room for added specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 396,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\nFrom 2022 through 2024 Cisco’s disclosures show a growing emphasis on the risk of technical hurdles as a core obstacle to its strategic priorities.  The 2022 filing (pages 24‑25) warned that failure to overcome product‑development and timing challenges could let competitors capture market share, while the 2024 filing (pages 22, 43‑44) notes that the company is making larger, longer‑term investments—particularly in AI, cloud, cybersecurity and the “Internet for the Future” product families—and that the benefits of those investments may be delayed or fall short of expectations.  Consequently, Cisco’s exposure to and reliance on surmounting technical obstacles has intensified, making the timely resolution of those hurdles even more critical to its growth agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Cisco's evolving exposure to technical hurdles from 2022 to 2024, noting increased strategic reliance on overcoming these challenges. The 2022 risk focused on product development and timing affecting market share, which matches the original answer. By 2024, the LLM correctly highlights intensified investments in AI, cloud, cybersecurity, and new product families, linking them to delayed benefits if technical hurdles aren't overcome—consistent with the shift toward broader strategic dependency. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all references to years (2022, 2024) and page numbers (24–25, 22, 43–44) are factually consistent with typical 10-K disclosure practices and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes risk evolution across two years, connects strategic investments to product development timelines, and infers growing reliance on technical execution—exactly what the question demands. The only minor gap is that the LLM does not explicitly mention 'reputational damage, legal liability, or reduced customer retention' from the 2024 filing, which are key additions in the original answer that broaden the risk beyond market share. This omission prevents a perfect 10 but does not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing Cisco’s evolving exposure and reliance on overcoming technical hurdles in relation to strategic investments and product timelines. Overall, the response is factually correct, well-reasoned, and only slightly less detailed than the ground truth on the consequences of failure in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 501,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\nBetween 2022 and 2023 the disclosures shifted from a simple listing of Google Ad Manager as one of the Google Network revenue‑generating properties (2022 10‑K, p. 10) to an explicit description of the company’s control over that inventory and its pricing discretion, highlighting Ad Manager’s performance as a key driver of Network revenue (2023 10‑K, pp. 59 – 58). This reframing shows that Ad Manager’s role grew from a contributing component to the primary monetisation platform for Google Network in the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and factual basis. (1) It claims that in 2023, Google Ad Manager was highlighted as having greater control and pricing discretion, positioning it as the 'primary monetisation platform'—this contradicts the ground truth, which states that in 2023, Ad Manager was no longer singled out as a key growth driver and instead listed among other platforms without specific attribution to revenue growth. The actual shift was from being a standout contributor in 2022 to a less emphasized, integrated tool in 2023—not the reverse. (2) There are no dollar amounts or percentages in the LLM answer to verify for quantitative accuracy, but it misrepresents the qualitative financial narrative: it falsely implies increased strategic importance in 2023 when the truth is a reduced emphasis. (3) The multi-hop reasoning is flawed: the model incorrectly interprets the nature of disclosures across the two years, reversing the trend. It cites '2023 10-K, pp. 59–58' (out of order) as evidence of increased emphasis, while the ground truth indicates diminished specific mention. (4) Contextual relevance is moderate because the answer addresses the role of Google Ad Manager in Google Network revenues across years, but the conclusion is diametrically opposed to the truth. The LLM appears to have misread or misinterpreted the source documents, leading to a confidently stated but incorrect assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 397,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\nStarbucks’ “foreign‑currency‑other” derivative liability fell from about **$11 million** in fiscal 2022 ( $7.4 million accrued + $3.6 million long‑term on page 68 of the 2022 10‑K) to roughly **$8.8 million** in fiscal 2024 ( $4.7 million accrued + $4.1 million long‑term on page 72 of the 2024 10‑K).  This represents a **decrease of approximately $2.2 million** (≈ 20 % lower) over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Starbucks' derivative liabilities related to foreign currency - other increased from $0.3 million in 2022 to $4.7 million in 2024, representing a significant increase. However, the LLM claims a decrease from $11 million to $8.8 million, which contradicts the ground truth. (2) The numbers cited by the LLM are entirely inaccurate: it reports $11 million in 2022 (split into $7.4M accrued + $3.6M long-term), but the ground truth specifies only $0.3 million in accrued liabilities in 2022 with no mention of long-term liabilities for this category. Similarly, for 2024, the LLM reports $8.8 million ($4.7M accrued + $4.1M long-term), while the ground truth reports only $4.7 million in accrued liabilities and does not mention long-term liabilities for this item. The calculation of a $2.2 million decrease is therefore based on incorrect inputs and flawed reasoning. (3) The multi-hop reasoning is unsound: the model incorrectly combines accrued and long-term liabilities, even though the ground truth refers only to 'accrued liabilities' for this metric. It also references specific 10-K page numbers, suggesting fabricated or misattributed data. (4) The contextual relevance is moderate because the answer addresses the right topic (derivative liabilities related to foreign currency - other) and time frame (2022 to 2024), but the factual inaccuracies and incorrect synthesis render the response highly misleading. Due to major quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 443,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved from having originally issued the 4.600% Senior Notes due 2045 as part of its regular long‑term debt program to formally ratifying and expanding that series through a Board‑approved resolution in 2024 (with subsequent re‑issuances under the same indenture).  This reflects the company’s strategy of laddering maturities and locking in low‑cost, fixed‑rate financing for the long term, thereby extending its debt profile and preserving financial flexibility for ongoing strategic investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies the 4.600% Senior Notes due 2045 as part of PepsiCo's debt structure, it misrepresents the evolution between 2023 and 2024. The LLM claims that in 2024 there was a 'formal ratifying and expanding' of the series through a Board-approved resolution with 're-issuances under the same indenture,' which is not supported by the original answer. The ground truth states that in 2023 the notes were authorized via Board resolutions allowing officers to set terms, and in 2024 they remained part of the structure but were listed alongside new notes (e.g., 4.000% due 2047, Floating Rate Notes due 2026), indicating diversification—not re-issuance or expansion of the same series. (2) Quantitatively, the percentage (4.600%), maturity year (2045), and mention of senior notes are correct. However, the LLM introduces unverified details like 're-issuances' and 'laddering maturities' not present or implied in the original. There are no numerical calculations, so accuracy focuses on correct representation of figures and dates, which are mostly accurate. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change from 2023 to 2024. Instead of identifying the broadening of the debt portfolio as evidence of diversification, it incorrectly infers an expansion of the specific 4.600% series. The conclusion about 'locking in low-cost financing' and 'extending debt profile' goes beyond the information provided in the ground truth, which only states that the note remained in place while new instruments were added. (4) The contextual relevance is moderate—the answer addresses PepsiCo’s debt strategy and references the correct note, but mischaracterizes the development and draws unsupported conclusions. Correctness is penalized due to significant factual and inferential errors despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 527,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle East segment fell from **≈ 326 billion cubic feet to ≈ 296 bcf** (a roughly 9 % decline), while annual production remained essentially flat at **≈ 24–25 bcf** each year (page 168).  The reserve contraction is reflected in the “Developed” and “Undeveloped” breakdown on page 174, where the developed portion dropped from about 322 bcf in 2022 to 289 bcf in 2024 and the undeveloped portion stayed near 7 bcf.  This pattern shows that the company is **not expanding its gas base in the region and is likely reallocating capital away from Asia‑Pacific/Middle East gas**, focusing instead on other higher‑return assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region: 326 billion cubic feet in 2022 and 296 billion cubic feet in 2024, matching the ground truth exactly. The ≈9% decline is accurately calculated ((326-296)/326 ≈ 9.2%), and production stability at 24–25 bcf/year is consistent with the data. The breakdown of developed (322 to 289 bcf) and undeveloped (~7 bcf) reserves aligns with the trend of reserve drawdown without replacement. (2) All numbers are factually correct and calculations accurate. Format variations (e.g., 'bcf' vs 'billion cubic feet') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes reserve changes over time, incorporates production data, and interprets the lack of reserve growth alongside flat production as evidence of capital reallocation. This goes beyond the ground truth by adding contextual insight from page 174 (developed/undeveloped split), which strengthens the conclusion. (4) While the original answer notes a 'minor reduction' and 'potential shift', the LLM infers a stronger strategic implication—capital reallocation to higher-return assets—which is a reasonable and logical extension supported by the data. This slightly exceeds the ground truth in interpretation but remains factually grounded. No factual errors; minor deduction in qualitative accuracy only because the original answer is more cautious in its strategic assessment. Overall, the LLM answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 434,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\nIn the 2022 filing (pages 5, 10, 17) Google Play is listed only as a source of revenue from “sales of apps and in‑app purchases and digital content,” placed alongside hardware and YouTube‑non‑advertising as one of the company’s non‑advertising streams. By the 2023 filing the same description appears, but Google Play is explicitly highlighted as a key component of Alphabet’s long‑term strategy to grow revenues beyond ads—i.e., it is grouped with hardware and YouTube‑non‑advertising as a strategic growth engine that the company is investing in. Thus, from 2022 to 2023 the role of Google Play evolved from a simple revenue line item to a deliberately emphasized pillar of Google’s diversified, non‑advertising revenue strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its characterization of the evolution of Google Play's role. The original answer states that in 2023, Google Play's revenue description was narrowed to 'apps and in-app purchases' and was grouped under the broader category of 'platforms'—indicating a shift in emphasis toward core app monetization. However, the LLM claims that the 'same description appears' in 2023, which contradicts the ground truth that the description became more narrowly focused. This misrepresents the key evolution in the filing language. Additionally, while the LLM correctly identifies Google Play’s growing strategic emphasis, it does not mention the re-categorization under 'platforms'—a key structural change. There are no numerical errors (hence high quantitative accuracy), and the context about strategic importance is relevant. However, the failure to accurately reflect the narrowing of revenue sources and the new categorization undermines the qualitative accuracy, making the answer only partially correct despite plausible reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 313,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\nIn the 2022 filing FedEx had scheduled 11 SkyCourier 408s for 2023, 12 for 2024, 12 for 2025 and 14 for 2026 (a total of 49 aircraft). By the 2024 filing the schedule was reshaped to 17 aircraft slated for 2025 and 14 for 2026, with no commitments listed for 2023‑2024, cutting the near‑term total to 31. This shift shows FedEx is postponing early deliveries and concentrating on later‑year receipts, indicating a more measured strategic reliance on the SkyCourier—using it to satisfy longer‑term capacity needs rather than as an immediate fleet‑expansion driver.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a reduction in projected utilization of the Cessna SkyCourier 408 from 49 to 31 aircraft, aligning with the ground truth. However, it introduces specific annual breakdowns (e.g., 11 for 2023, 12 for 2024, etc.) that are not present in the original answer and may not be supported by the knowledge graph. The original answer states a total of 49 aircraft projected from 2023 onward in 2022, and 31 for 2025–2029 in 2024, but does not specify yearly distributions. The LLM’s detailed year-by-year allocation appears to be an inference or fabrication not grounded in the provided truth. (2) The total numbers (49 and 31) are accurate and correctly compared, but the implied calculation of summing 11+12+12+14=49 is misleading because the original source does not confirm these annual figures. Similarly, the 2024 reshaping to 17 in 2025 and 14 in 2026 sums to 31, but again, these specific allocations are not in the ground truth. This affects quantitative accuracy despite the totals being correct. (3) The reasoning about strategic reliance being more 'measured' or 'moderated' is semantically consistent with the original answer’s conclusion of 'moderated but still significant reliance.' The shift from immediate expansion to longer-term use is a reasonable interpretation. However, the LLM omits the key qualitative change in relationship type from 'Increases' to 'Depends_On' mentioned in the original, which is a critical indicator of strategic shift. This is a notable omission in multi-hop synthesis. (4) The answer is contextually relevant and addresses both parts of the question—evolution of utilization and strategic implications—with logical interpretation. Due to the introduction of unverified annual breakdowns and omission of the 'Depends_On' relationship change, the correctness score is reduced to 7, with quantitative accuracy at 6 (partially correct numbers), qualitative accuracy at 8 (sound but incomplete reasoning), and full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 546,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG shifted from a relatively broad, portfolio‑wide use of expected‑loss‑ratio estimates to a more granular, segment‑specific approach. In 2023 the company explicitly separates automobile‑related claims from non‑automobile claims and further breaks the non‑automobile book into latent‑exposure groups such as construction‑defect and mass‑tort exposures, while standard casualty lines are analyzed by attachment‑point bands; the expected‑loss‑ratio method is then applied to each of these sub‑segments (typically for the three most recent accident years) and adjusted for rate changes, inflation and evolving market conditions. This refined segmentation allows AIG to tailor its loss‑ratio assumptions to the distinct development patterns of each casualty line.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. (1) It incorrectly states that AIG shifted from a 'portfolio-wide' use in 2022 to a more granular approach in 2023, when in fact the 2022 method was already segmented by attachment point and automobile vs. non-automobile claims, with special treatment for latent exposures—this level of granularity already existed. The LLM misrepresents the evolution. (2) Crucially, the LLM fails to identify the key change in casualty lines: in 2022 the focus was on U.S. Excess Casualty, while in 2023 the focus shifted to U.S. Workers' Compensation. This is a central point in the original answer and is entirely missing from the LLM response, which instead implies continuity in casualty lines with only increased segmentation. (3) The LLM incorrectly suggests that the segmentation by automobile/non-automobile and latent exposures was introduced in 2023, when it was already in place in 2022. (4) The LLM omits the 2023 segmentation by risk-sharing features (high deductibles, retrospective rating), state, industry, and claim handling entity—all key aspects of the new application in Workers' Compensation. (5) The mention of adjusting for rate changes, inflation, and market conditions is not present in the original and may be plausible but is unsupported. While the LLM correctly notes the use of expected loss ratio methods for the three most recent accident years, this is the only accurate quantitative detail. The reasoning is flawed due to incorrect temporal attribution of methodological changes and failure to recognize the shift in casualty lines, undermining the multi-hop synthesis. The answer is contextually relevant to the question but conveys an incorrect evolution of AIG's methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 485,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike reshaped how “unallocated” items are shown in its revenue tables.  In the 2022 filing the “Other” line (see page 35, (5)) grouped together all products that were not assigned to the newly‑defined consumer segments – Men’s, Women’s, NIKE Kids’ and Jordan Brand – and also included certain accounting adjustments.  Beginning in fiscal 2022 (and continuing through the 2024 disclosures on page 35 and the FY 2024 revenue breakdown on page 37), Nike moved unisex products into the Men’s category, reported Jordan Brand separately, and narrowed “Other” to only those products still outside the four consumer groups plus the related non‑allocated adjustments.  This re‑classification makes the reporting more aligned with the company’s updated consumer‑construct segmentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its description of how unisex products were classified, particularly asserting that beginning in fiscal 2022, Nike moved unisex products into the Men’s category and continued this through 2024. However, the ground truth states that in fiscal 2022, unisex products were classified within Men's, but by fiscal 2024, there was no specific mention of that classification—suggesting a potential shift or integration, not a continuation. The LLM incorrectly frames the 2022–2024 period as one of consistent practice (continuation of unisex in Men’s), when the evolution actually involves the disappearance of that explicit classification, implying a change. This misrepresents the core evolution the question asks about. While the description of the 'Other' category is mostly accurate—capturing that it includes unallocated products and adjustments not assigned to the four main segments—the synthesis of multi-hop information is flawed because it fails to recognize the absence of unisex classification in 2024 as a meaningful change. The answer adds unsupported detail (e.g., page references not in the original) and mischaracterizes the timeline. Quantitative accuracy is moderate because there are no explicit numerical errors (no numbers to verify), but the fiscal years are correctly referenced. Contextual relevance is high as the response addresses the classification and reporting of unallocated products within Nike’s consumer construct. However, the reasoning error on the key point of unisex product treatment undermines the qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 445,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\nBetween the 2023 and 2024 filings PepsiCo moved from simply disclosing that the 3.500 % Senior Notes due 2025 were outstanding to re‑authorizing their terms in a February 2024 supplemental indenture and re‑listing them among a broad set of newly‑authorized senior‑note resolutions.  This shows the company is actively managing its long‑term financing—using supplemental indentures and fresh Board authorizations to extend maturities and lock in low‑cost funding rather than leaving the 2025 notes static—consistent with a debt‑management strategy that emphasizes a laddered, low‑coupon debt profile and flexibility to refinance as market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of PepsiCo's debt management strategy—diversification and active management of long-term financing—but introduces specific details not present in the ground truth, affecting factual accuracy. (1) The mention of a 'February 2024 supplemental indenture' and 're-authorizing their terms' is not supported by the original answer, which only states the 3.500% Senior Notes due 2025 were still present in 2024 alongside new notes. There is no indication in the ground truth that the terms were re-authorized or amended via a supplemental indenture. (2) Quantitatively, the percentage (3.500%) and maturity year (2025) are correct, and the comparison across 2023 and 2024 is accurate in timeframe, but the addition of specific events (e.g., February 2024) introduces false precision. (3) The multi-hop reasoning is partially sound: the model correctly infers active debt management from the continued presence of the 2025 notes and the addition of new long-term instruments. However, it overreaches by attributing specific legal actions (supplemental indenture, Board re-authorization) not mentioned in the ground truth. (4) The conclusion about a 'laddered, low-coupon debt profile' and refinancing flexibility aligns conceptually with the ground truth's 'diversifying its debt maturity structure,' so the qualitative insight is reasonable but overstated. The answer is contextually relevant and addresses both parts of the question—evolution and strategic implication—but with fabricated procedural details that reduce factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 431,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\nFrom 2022 to 2023 ConocoPhillips trimmed its Lower 48 future cash‑inflow projection sharply—from $195.6 bn to $141.3 bn—and cut the discounted cash‑flow value from $55.9 bn to $33.3 bn, reflecting lower commodity‑price assumptions and reserve revisions. In 2024 those cash‑inflow estimates rebounded to $164.3 bn and discounted cash‑flows rose to $38.7 bn, although they remained below the 2022 peak. Capital expenditures in the Lower 48 fell to about $1.9 bn in 2023 before increasing again to roughly $3.1 bn in 2024, mirroring the recovery in development activity and reserve additions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, COP reported capital expenditures of $3,129 million for the Lower 48, with no new capex figure provided for 2024—only a disclosure about revisions to future cash inflows and production costs. However, the LLM claims capex fell to $1.9B in 2023 and rose to $3.1B in 2024, which is not supported by the ground truth. Additionally, the LLM introduces specific future cash inflow figures ($195.6B, $141.3B, $164.3B) and discounted cash flow values for 2022–2024, none of which appear in the original answer. These numbers are entirely fabricated or misattributed, as the ground truth only notes that revisions occurred in 2024 without quantifying them. (2) Quantitative accuracy is very low: none of the financial figures provided by the LLM (e.g., $195.6B future cash inflow in 2022) are present in the original answer, and the capex trajectory for 2023–2024 is invented. The only partially correct number is the ~$3.1B capex in 2024, which loosely matches the 2022 figure of $3,129M, but it is misassigned to 2024 and presented as a recovery rather than a baseline. (3) The multi-hop reasoning is flawed. The original answer describes a shift from active investment (2022 capex) to revised financial projections (2024), but the LLM constructs a detailed narrative of fluctuating cash inflows and capex across three years without evidence. It fails to correctly synthesize the limited disclosure in 2024—no new capex number, only qualitative revision of cash inflows and costs. (4) Contextual relevance is moderate because the LLM addresses the general theme of financial disclosure evolution in the Lower 48, including capex and cash flow revisions. However, due to severe factual and quantitative errors, the answer misrepresents the actual disclosures. Correctness is scored very low because the core data is incorrect, despite addressing the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 531,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast reduced its funding commitment to Atairos from up to $5 billion to up to $4.5 billion, extended the investment term from 12 to 16.5 years, and lowered the annual capital‑call ceiling to $400 million, while also agreeing to a separate $40 million annual management‑fee obligation.  A first amendment to the Fourth Amended and Restated Shareholders Agreement executed in June 2023 codified these terms and reaffirmed that the management companies controlled by the former CFO hold all voting rights, leaving Comcast with a non‑voting economic interest that absorbs roughly 99 % of losses and entitles it to about 86 % of any residual returns.  Thus, the evolution tightened capital obligations and clarified the governance structure governing Comcast’s relationship with Atairos.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Comcast reduced its capital commitment from $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to a separate $40 million annual management fee. The June 2023 amendment to the Fourth Amended and Restated Shareholders Agreement is correctly cited. The economic terms—absorbing ~99% of losses and receiving ~86% of residual returns—are accurately reported, as is the retention of all voting rights by Atairos’ management companies led by Comcast’s former CFO. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and timeframes match the original answer. The mention of extending the investment term from 12 to 16.5 years is an additional detail not in the ground truth, but it does not contradict it and may reflect an inference from the filings; however, since this detail is absent in the original answer, it slightly affects qualitative precision. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes governance and financial changes across 2023 and 2024, linking the amendment, capital changes, and control structure. (4) The answer is contextually relevant and fully addresses the evolution in financial commitments and governance. The only minor issue is the inclusion of the investment term extension, which is not in the ground truth, but it does not undermine correctness. Hence, a score of 9 is justified—excellent accuracy with a small addition of unverified detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 421,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the outlook for the Cessna SkyCourier 408 shifted markedly: the 2022 schedule projected 49 total deliveries (11 in 2023, 12 in 2024, 12 in 2025 and 14 in 2026), whereas the 2023 schedule lists only 31 deliveries—17 slated for 2025 and 14 for 2026—with no deliveries planned for 2023‑2024. This later‑stage, reduced delivery plan shows that FedEx now views the SkyCourier as a longer‑term, niche‑capacity asset rather than an immediate fleet‑expansion tool, reserving it for specific regional routes while relying on larger freighters (e.g., B767F, B777F, ATR 72‑600F) for the bulk of its capacity growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the numbers are correct: the 2022 projection of 49 Cessna SkyCourier 408 aircraft and the 2023 revision to 31 are accurately reported. The breakdown of deliveries (11 in 2023, 12 in 2024, etc.) matches the original filing data, and the shift to only 17 in 2025 and 14 in 2026 with no deliveries in 2023–2024 is factually sound. The total (31) is correct, though the original answer does not require annual breakdowns, so this added detail is a strength. (2) The answer fully addresses both parts of the question: the change in utilization projection and the strategic implication. It correctly infers a reduced and delayed role for the SkyCourier, indicating a shift from immediate expansion to a niche, longer-term role. (3) Entity accuracy is strong: FedEx, Cessna SkyCourier 408, B767F, B777F, and ATR 72-600F are all correctly named and contextualized. The years 2022 and 2023 are properly attributed to the respective filings. (4) The reasoning is sound and goes slightly beyond the original answer by interpreting the delivery delay (no 2023–2024 deliveries) as a signal of strategic repositioning, which is a logical and insightful extension of the data. The only minor point preventing a perfect 10 is that the original answer emphasizes comparison with B767F/B777F in terms of 'more stable or less reduced projections,' while the LLM mentions them but adds ATR 72-600F, which isn't in the ground truth. This doesn't introduce error but adds unverified detail. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 448,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike has placed the Air Max line at the center of its footwear innovation narrative, explicitly spotlighting Air‑Max, Zoom X, React and related “Air” technologies in the 2024 Form 10‑K’s product‑development section and noting that dedicated “Air Manufacturing Innovation” units now produce the Air‑Sole components used in those shoes.  At the same time, the company has increased revenue transparency by publishing more granular footwear‑segment breakdowns (footwear, apparel, equipment and “Other” tables) that isolate the contribution of advanced footwear categories—including Air Max—from the broader brand‑level totals.  This dual focus reflects a strategy to both disclose the financial impact of its high‑tech product lines and emphasize continued technological advancement in the Air Max platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that Nike increased revenue transparency by publishing 'more granular footwear-segment breakdowns' that isolate the contribution of advanced footwear categories including Air Max. However, the ground truth states that no direct revenue numbers were disclosed for Air Max in 2024, and it was only listed generally in 2022—there is no evidence of granular financial disclosure for Air Max specifically. This misrepresents Nike's actual reporting practices. (2) The claim about 'increased revenue transparency' and financial isolation of Air Max in segment tables is false and contradicts the ground truth assertion that standalone financial metrics continue to be absent. (3) While the LLM correctly identifies Nike's growing emphasis on technological innovation—mentioning Air Manufacturing Innovation units and positioning Air Max in innovation narratives—this partially aligns with the ground truth's observation of Air Max being highlighted as a key innovation driver by 2024. (4) The reasoning is flawed because it synthesizes non-existent financial transparency with real innovation emphasis, creating a misleading narrative. The model appears to infer granular revenue reporting without evidence, failing the multi-hop requirement to contrast actual financial disclosure (none) with strategic emphasis (increased). Quantitative accuracy is low due to the invention of disaggregated financial data. Qualitative accuracy suffers from incorrect entity-metric linkage (attaching revenue transparency to Air Max when none exists). Contextual relevance is moderate because the response addresses both innovation and revenue aspects of the question, albeit incorrectly on the latter.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 485,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\nIn 2023 Comcast noted that capital expenditures “increased related to the development of Epic Universe in Orlando,” with total 2023 capex of about **$8.24 billion**.  By 2024 the company said it would “continue investment in existing and new attractions at our Universal theme parks, including Epic Universe,” and total 2024 capex rose modestly to **$8.29 billion**, indicating that funding for the Epic Universe expansion remained a priority while overall spending stayed roughly flat.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's capital expenditure strategy evolution regarding Epic Universe, noting increased investment in 2023 and continued focus in 2024. However, there are key quantitative inaccuracies: the original answer states $8.2 billion was allocated to 'Connectivity & Platforms'—a segment that includes Epic Universe—not total company capex, while the LLM interprets this as total capex of $8.24 billion, which is factually incorrect. Additionally, the LLM introduces a 2024 total capex figure of $8.29 billion not present in the original answer, which explicitly states that no specific figures for Epic Universe were disclosed in 2024. These numerical misrepresentations reduce quantitative accuracy. (2) The numbers cited ($8.24B and $8.29B) do not match the ground truth: the original $8.2B is part of a broader category, not total capex, and no 2024 breakdown or total is provided in the original, making the LLM's precise 2024 number unsupported. (3) Qualitatively, the reasoning is sound—LLM correctly infers that sustained capex implies continued priority on Epic Universe and captures the shift from infrastructure to attractions. It synthesizes the strategic intent across years appropriately, though it overreaches by implying specific total capex figures. (4) Contextual relevance is high as the answer directly addresses the evolution of investment strategy, thematic park priorities, and uses correct entities (Comcast, Epic Universe, Universal theme parks, 2023–2024). The core narrative aligns with the original, but the incorrect attribution of financial figures limits full factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 453,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\nIn the 2022 Form 10‑K (page 34) FedEx listed 6 ATR 72‑600F aircraft in its owned fleet, and on page 40 it disclosed a purchase‑commitment schedule that earmarks 11 ATR 72‑600Fs for delivery in fiscal 2023 (with six more slated for 2024 and one for 2026). Consequently, the company projected its ATR 72‑600F fleet to grow from six aircraft at the end of 2022 to roughly 17 aircraft by the end of 2023—more than doubling utilization of the type for its regional freight network.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It incorrectly states that FedEx projected operating 17 ATR 72-600F aircraft by the end of 2023, based on adding existing and committed aircraft. However, the original answer from the knowledge graph shows that in 2022, FedEx projected only 11 aircraft for 2023—not 17—and further planned reductions to 6 in 2024 and 1 in 2026. The LLM misinterprets purchase commitments as immediate operational fleet growth and fails to report the actual projection numbers. (2) Quantitatively, the LLM correctly identifies 11 aircraft scheduled for delivery in 2023 and references 6 owned in 2022, but incorrectly sums these to project 17 in operation by end of 2023, which is not supported by the original answer. The ground truth does not mention a 2022 owned fleet size of 6, nor does it support a doubling of utilization. Furthermore, the LLM omits the revised 2023 projections entirely—7 for 2025 and 3 for 2026—which is central to the question about evolution between 2022 and 2023 planning. (3) The multi-hop reasoning is flawed: the question asks how fleet *projections* evolved between 2022 and 2023 for the same future periods (i.e., how 2023–2026 projections changed from the prior year's outlook). The LLM instead focuses on owned fleet and purchase commitments in 2022, failing to compare the two sets of forward-looking projections. It misses the key insight that FedEx significantly reduced its long-term planned usage of the aircraft type in updated forecasts. (4) While the LLM references correct document locations and some plausible numbers, it fundamentally misrepresents the nature of the data (confusing purchase commitments with operational projections) and omits the core comparative analysis required. The answer is contextually relevant to FedEx and the aircraft type but fails on correctness and reasoning, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 528,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike’s methodology for estimating product‑return reserves remained rooted in estimating the “most likely” variable consideration, but the 2024 disclosure sharpens the process: it explicitly separates contractual return rights from discretionary authorizations, uses more detailed historical return data and specific identification of pending returns, and records the expected return cost in prepaid expenses rather than only as an accrued liability. This refinement shows that Nike is tightening its revenue‑recognition model, recognizing revenue net of a more precisely quantified return reserve to better align revenue with the timing of control and the uncertainty of future returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in fiscal 2022, Nike disclosed a $269 million return reserve recorded in Prepaid expenses and other current assets. The LLM incorrectly implies that this methodology was already based on the 'most likely amount' approach in 2022, while the original answer indicates that this more formalized language emerged in 2024. Additionally, the LLM claims Nike 'separates contractual return rights from discretionary authorizations' and uses 'specific identification of pending returns'—details not present in the ground truth. There is no mention in the original answer about recording return costs in prepaid expenses *instead of* accrued liabilities, which introduces a false contrast. (2) The only numeric reference in the ground truth is $269 million in 2022; the LLM does not repeat this number, thus failing to include a key quantitative fact. The absence of this figure reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound in that it attempts to compare Nike’s methodology across years and infer evolution in revenue recognition. However, it fabricates details not present in the source (e.g., use of historical data, classification distinctions), leading to flawed synthesis. The conclusion about tighter revenue recognition has some basis in the original inference about probabilistic estimation, but the reasoning is built on incorrect premises. (4) While the LLM addresses the question’s intent—how return reserve estimation evolved and what it implies about revenue recognition—it does so with incorrect specifics, reducing factual reliability. Contextual relevance is high because it stays on topic and attempts appropriate analysis, but correctness suffers due to invented details and omission of key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 498,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\nThe 2022 commitment showed 12 Cessna SkyCourier 408 deliveries scheduled for 2025 and 14 for 2026, with no later‑year SkyCourier commitments. In the 2023 schedule the 2025 figure jumps to 17 aircraft (the 2026 number stays at 14), and no deliveries are planned beyond 2026. This upward revision indicates that FedEx is placing growing strategic emphasis on the SkyCourier 408—particularly for the 2025 timeframe—to secure additional middle‑size cargo capacity and reduce reliance on other aircraft types.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, FDX planned for 12 aircraft by 2025 and intended to maintain that number through 2026 (i.e., 12 in both 2025 and 2026). However, the LLM incorrectly states that the 2022 plan included 12 for 2025 and 14 for 2026. Additionally, the ground truth shows that in 2023, the 2026 number was reduced to 14 (from a prior plan of maintaining 12), but the LLM interprets this as unchanged from 2022, which is incorrect because the 2022 plan did not include an increase to 14 by 2026. The 2025 number increase from 12 to 17 is correctly identified. (2) The calculation of changes over time is flawed due to incorrect baseline numbers. The LLM suggests continuity in the 2026 figure (14 in both years), but in reality, 2026 was increased from 12 to 14, indicating a different strategic trajectory than reported. (3) The reasoning is partially sound—recognizing increased emphasis in 2025 is valid—but misses the nuance of a planned reduction from 17 to 14 by 2026, which the ground truth interprets as a recalibration. The LLM instead implies sustained use at 14 beyond 2025 without noting the drop from 17, leading to an incomplete strategic interpretation. (4) Contextual relevance is high as the answer addresses fleet changes and strategic implications. Qualitative accuracy is moderate due to correct identification of trends in 2025 and strategic rationale, but quantitative accuracy is low due to incorrect fleet numbers for 2022 and misrepresentation of the 2026 plan. Correctness score reflects partial accuracy with critical factual errors affecting interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 458,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard expanded the footprint of its real‑time account‑based payments platform – the 2023 filing noted that the real‑time clearing and settlement infrastructure was being operated or implemented in 13 markets, and the 2024 filing confirms that this infrastructure is now fully operational and being further enhanced to support additional jurisdictions and higher transaction volumes.  At the same time the company deepened its security by embedding a multi‑layered protection model that combines real‑time fraud scoring, tokenization and a new digital‑identity suite (device‑intelligence, behavioral biometrics and privacy‑by‑design consent controls), delivering end‑to‑end security across the enlarged, real‑time network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that Mastercard was operating or implementing real-time payments infrastructure in 13 markets in 2023, matching the original answer exactly. There are no numerical or date inaccuracies. (2) The LLM correctly identifies the evolution from 2023 to 2024, noting expansion in operational scale (support for additional jurisdictions and higher transaction volumes) and enhanced security capabilities, which reflects the strategic shift mentioned in the ground truth. (3) The qualitative reasoning is sound: it synthesizes information across years and domains (scale and security), correctly identifying multi-layered security enhancements such as real-time fraud scoring, tokenization, and new identity tools like behavioral biometrics and device intelligence—consistent with the 'enhanced data and messaging' and 'multi-layered security approach' described in the original. The mention of a 'digital-identity suite' is a slight elaboration not explicitly detailed in the ground truth, but it is contextually plausible and does not contradict known facts. (4) The answer fully addresses both parts of the question—operational scale and security—and maintains semantic equivalence with minor, acceptable rewording. The only reason for not scoring a perfect 10 is that the original does not explicitly confirm the 'fully operational' status in all 13 markets by 2024, making that a small inference beyond the provided data. Otherwise, all key facts, entities, and trends are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 436,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\nNike continued to manage foreign‑currency risk through forwards and options that are designated as cash‑flow hedges for product‑cost, revenue and other functional‑currency exposures, with the hedge results recorded in the same income line item as the underlying transaction.  Between fiscal 2022 and 2024 the amount of hedge gains/losses re‑classified from accumulated other comprehensive income into earnings fell from a net $30 million gain to roughly $8 million, and the related derivative liability dropped from about $180 million (2023) to $151 million (2024), reflecting a more focused hedge book and a lower net financial liability, while the company’s centrally‑managed program—setting standard rates twice a year and linking hedge gains/losses to the affected line items—remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, foreign exchange forwards and options had a net gain of $8 million after tax. However, the LLM claims that in 2022 (or 'between 2022 and 2024'), the reclassification from AOCI was $30 million, which contradicts the $8 million figure. It then says the 2024 gain was $8 million, implying a decline to that level, but the original answer does not state a $30 million gain in 2022 or any such trend. This misrepresents the timeline and magnitude of gains. Additionally, the LLM claims derivative liabilities decreased from $180 million in 2023 to $151 million in 2024, but the ground truth reports an increase in liabilities to $110 million in accrued liabilities and $5 million in deferred income taxes in 2024—totaling $115 million—with no mention of a $180 million liability in 2023. These numbers are not only unsupported but contradict the direction of change (increase vs. decrease). (2) The calculation and comparison of financial figures are incorrect. The LLM implies a reduction in liabilities and a decline in hedge gains, but the original answer indicates increased liabilities in 2024 and does not provide 2023 liability data or a trend from $180M to $151M. The $8 million gain mentioned in the LLM answer aligns only partially with the 2022 net gain in the original, but it is mispositioned as a 2024 figure in a declining trend. (3) The multi-hop reasoning is flawed. The question asks about the evolution between 2022 and 2024 in terms of impact on financial liabilities and hedging strategy. The LLM attempts synthesis but uses incorrect data points, leading to an inaccurate conclusion about a 'more focused hedge book' and 'lower net financial liability,' which contradicts the ground truth showing increased liabilities. The mention of a 'centrally-managed program' remaining unchanged adds contextual detail not present in the original and cannot be verified. (4) While the LLM answer is relevant to the topic and addresses hedging strategy and financial impacts, the severe quantitative inaccuracies and incorrect directional trends significantly undermine factual correctness. The qualitative reasoning is plausible but based on false premises. Contextual relevance is high as it discusses the right instruments and accounting treatment, but correctness is low due to unsupported numbers and misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 658,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\nBetween 2022 and 2023 Puffs continued to be listed in the **Baby Care sub‑category** of the **Baby, Feminine & Family Care** segment (see the product‑category table on page 19 of the 2023 10‑K).  However, its performance evolved:  baby‑care net sales and unit volume both fell low‑single digits, market share slipped about 0.3 points, while higher pricing and a more premium mix helped lift the segment’s margin (as noted in the bullet‑point summary of Baby Care results on page 25).  In short, the classification stayed the same, but Puffs’ contribution shifted toward lower volume and share, offset partially by pricing gains.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about product category classification. According to the ground truth, Puffs was categorized under the Family Care sub-category in both 2022 and 2023, with a reporting simplification in 2023 where 'Tissues' was no longer explicitly listed as a sub-component. However, the LLM incorrectly states that Puffs was in the Baby Care sub-category in 2023, which contradicts the ground truth. This misclassification invalidates the primary factual basis of the response. Additionally, the LLM introduces performance metrics (e.g., 'low-single digits' decline in sales, '0.3 points' market share loss, margin improvements) that are not mentioned or implied in the original answer and are irrelevant to the question about classification evolution. These details, while possibly from the 10-K, distract from and distort the actual focus on categorization structure. There is no multi-hop reasoning demonstrated correctly; instead, there is a misattribution of category placement. While the answer does recognize that the broad segment (Baby, Feminine & Family Care) remained the same, and attempts to reference specific pages in the 10-K, the central factual claim about Baby Care is wrong. Thus, despite some contextual awareness of the document structure, the answer fails on correctness, entity accuracy, and reasoning. Quantitative accuracy is low because the introduced numbers are unsupported in the ground truth and misaligned with the question. Qualitative accuracy is poor due to incorrect entity mapping and flawed logic. Contextual relevance is moderate because the topic and segment are correctly identified, but the focus is misplaced on performance rather than classification changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 472,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\nBetween 2022 and 2023 Tampax continued to be listed under the **Baby & Feminine & Family Care** segment, specifically within the **Feminine Care** sub‑category (menstrual‑care products) alongside Always and Always Discreet.  Its brand “Tampax Bounty” remained part of the core product line in that sub‑category, and while the segment’s net sales were essentially flat, earnings rose sharply (≈13 % growth), reflecting improved profitability rather than a change in its portfolio categorization.  Thus, Tampax’s positioning did not shift across segments or product‑line groups; it stayed in Feminine Care, with its performance evolving rather than its classification.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of the core factual claim about Tampax's categorization evolution. The ground truth states that in 2023, Tampax was repositioned from 'Feminine Care' to a more specific 'Menstrual Care' category, reflecting a strategic refinement. However, the LLM claims no change occurred, stating Tampax remained in 'Feminine Care' without any shift in classification—this directly contradicts the original answer. While the LLM correctly identifies the broader segment ('Baby, Feminine & Family Care') and associated brands like Always, it misses the key re-categorization to 'Menstrual Care' in 2023. The mention of 'Tampax Bounty' appears to be fabricated or confused with another brand (Bounty is a paper towel brand, not a Tampax product line), which undermines entity accuracy. The financial data (≈13% earnings growth) is plausible but not present in the ground truth, making it extraneous and unverifiable; since the question does not ask for performance metrics, this distracts from the actual focus. Quantitative accuracy is scored moderately because the numbers aren't contradicted outright, but they are irrelevant. Qualitative accuracy is low due to failure in multi-hop reasoning—specifically, synthesizing the change in product line categorization over time. Contextual relevance is partial: the answer addresses Tampax’s positioning but focuses on performance rather than structural categorization changes, missing the central point of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 410,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle kept Engineered Systems at roughly 6 % of total revenue, but the narrative shifted from a standalone hardware‑margin business to a strategic complement of its cloud‑and‑license portfolio.  In both years the company said it would keep investing in R&D to modernize the hardware line and add AI‑driven capabilities, yet the 2023 discussion framed those investments as part of expanding the integrated Oracle Cloud Services ecosystem rather than simply sustaining a low‑margin hardware business.  (Pages 30 & 51 of ORCL_10K_2022.pdf; pages 7 & 30 of ORCL_10K_2023.pdf).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that hardware (including Oracle Engineered Systems) represented 6% of total revenue in fiscal 2023, which aligns with the ground truth. However, it incorrectly implies that the 6% figure was also true in fiscal 2022, whereas the original answer states that this specific percentage was not disclosed for 2022—this is a significant factual error. The LLM also claims Oracle maintained the same R&D investment narrative in both years, but the ground truth indicates that the explicit forward-looking R&D commitment was introduced in 2023, not present in 2022. (2) The 6% revenue figure is accurate for 2023 but misattributed to 2022 without evidence; no other numbers (e.g., dollar amounts, dates) are incorrect, but the comparative use of the percentage across years is flawed. (3) The reasoning partially captures the strategic shift but misrepresents the timeline—by suggesting continuity in R&D messaging, it fails to reflect the multi-hop insight that 2023 marked a new strategic emphasis with clearer revenue transparency and updated investment language. (4) Despite these inaccuracies, the answer is contextually relevant and captures the broader narrative shift toward integration with cloud services. The qualitative reasoning is sound in framing the strategic evolution, but the quantitative and entity-level inaccuracies—especially the unsupported claim about 2022 revenue share—reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 405,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\nBetween 2022 and 2023 the non‑U.S. pension plan’s private‑fund allocation rose from **$90 million to $115 million**.  In 2022 the exposure was $54 million (Level 2) and $36 million (Level 3); by 2023 it had shifted to $41 million (Level 2) and $74 million (Level 3), meaning the fund’s size grew and a larger share was classified as Level 3 (unobservable‑input) investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both allocation amounts and entity classification. (1) Quantitative inaccuracy: The original answer states that in 2022, Honeywell reported $1,105 million in private fund investments—but this was for its *U.S.* pension plans, not Non-U.S. The LLM incorrectly assumes a $90 million baseline for Non-U.S. plans in 2022, breaking it into $54M (Level 2) and $36M (Level 3), none of which appears in the ground truth. The ground truth states that in 2023, $115M was reported for *Non-U.S.* plans, split into $41M (Level 2) and $74M (Level 3). The LLM correctly reports the 2023 numbers but fabricates the 2022 Non-U.S. figures. (2) Entity and classification error: The LLM misattributes the $1,105M U.S. plan investment as if it were Non-U.S., leading to a false narrative of growth from $90M to $115M. In reality, the U.S. allocation dropped significantly, and the $115M in 2023 refers to Non-U.S. plans—a shift the LLM partially captures but miscontextualizes. (3) Reasoning flaw: The multi-hop synthesis fails because the model conflates U.S. and Non-U.S. plans. It incorrectly infers a year-over-year increase in Non-U.S. private fund investments, when no 2022 Non-U.S. figure is provided in the ground truth to support such a trend. (4) While the 2023 split ($41M Level 2, $74M Level 3) is correct and relevant, the overall narrative of growth and reclassification is unsupported and misleading. The answer is contextually relevant to the question’s intent but fundamentally incorrect in data and reasoning, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 435,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the 2014 USD Notes—$1 billion of 3.375 % senior notes that had been outstanding and classified as short‑term debt on the 2023 balance sheet—reached their April 2024 maturity.  In April 2024 Mastercard paid the full $1 billion principal (plus any accrued interest), thereby retiring that tranche of debt.  To replace the retired obligation and maintain its funding flexibility, the company subsequently issued new 2024 USD Notes totaling $4 billion later in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion principal amount, the April 2024 maturity, and the full repayment of the 2014 USD Notes in 2024, which aligns with the ground truth. It also accurately notes the classification of the notes as short-term debt in 2023. However, the LLM introduces information not present in the original answer—specifically, the issuance of $4 billion in new 2024 USD Notes—which is not mentioned or implied in the ground truth. This addition reflects an unsupported inference and introduces factual overreach. Additionally, the mention of a 3.375% interest rate and 'accrued interest' is not in the original answer and cannot be verified from the provided truth. (2) Quantitatively, the $1 billion principal and April 2024 maturity date are correct. The $4 billion new issuance is factually unsupported in the context of the question and ground truth, so it counts as an error in data inclusion. (3) The multi-hop reasoning is partially sound: the model correctly tracks the debt from 2023 (short-term classification) to 2024 (repayment at maturity). However, it fails to stay within the scope of the provided facts by adding extraneous details about new debt issuance and interest rates, indicating a potential hallucination or over-interpretation. (4) The correctness score is 6 due to accurate core facts (repayment of $1B in April 2024, short-term classification in 2023) but penalized for significant additions not in the ground truth. Quantitative accuracy is 8 because key numbers are correct but one major figure ($4B new notes) is unsupported. Qualitative accuracy is 5 due to flawed reasoning in introducing unverified actions. Contextual relevance is 9 as the answer directly addresses the debt's evolution and actions taken, despite the inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 489,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s continued to disclose its Officer Indemnification Agreement as a dedicated exhibit—appearing as Exhibit 10.31 in the 2022 Form 10‑K (page 87) with a March 21 2022 filing date, and later as Exhibit 10.23 in the 2024 Form 10‑K (page 79) referencing the same core language but an older 2019 filing date.  The company has repeatedly restated and re‑filed the indemnification provision (most recently in the 2022 amendment to its severance plan), indicating a deliberate, ongoing practice of formalizing executive protection terms.  This consistent, transparent documentation reflects stable governance and a disciplined approach to managing executive risk across the two reporting periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding exhibit numbers and filing details. The ground truth states that the Officer Indemnification Agreement was filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both 2022 and 2024. However, the LLM claims it appeared as Exhibit 10.31 in 2022 and Exhibit 10.23 in 2024, which contradicts the original data. These exhibit number discrepancies are material and incorrect. Additionally, the LLM cites a 'March 21, 2022 filing date' for the 2022 10-K exhibit, but the ground truth does not support this specific date for the indemnification agreement re-filing. (2) Quantitatively, the dates and exhibit numbers are wrong, and there is no evidence supporting the claim that the agreement was part of a '2022 amendment to its severance plan'—this detail is absent from the ground truth and potentially confuses related but distinct disclosures. (3) The reasoning partially captures the correct implication—that consistent re-filing indicates stable governance and executive risk management—but it misattributes the basis for this conclusion due to incorrect exhibit tracking. The multi-hop synthesis fails because it relies on inaccurate document identifiers and potentially conflates different exhibits. (4) Despite these errors, the answer correctly infers the broader governance implication—continuity in executive protection and transparent documentation—so it retains partial qualitative and contextual accuracy. The conclusion aligns semantically with the ground truth, even if the supporting facts are flawed. Hence, correctness is reduced to 5 due to major factual errors undermining the foundation of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 468,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\nBoth the 2022 10‑K (page 38) and the 2023 10‑K (page 19) state that Always Discreet holds “over 10 % market share in the key markets in which we compete” and that it is part of P&G’s “global market‑leader” feminine‑care portfolio. The language is unchanged between the two filings, indicating that the brand’s adult‑incontinence market share and its positioning as a leading player in that category remained essentially the same from 2022 through 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in stating that both the 2022 and 2023 10-K filings include the same market share disclosure for Always Discreet. According to the ground truth, the 2022 filing explicitly stated that Always Discreet had over 10% market share in key adult incontinence markets, but the 2023 filing did not repeat this specific quantitative claim. Instead, it only listed Always Discreet as a major brand within the Feminine Care category without providing a market share figure. The LLM incorrectly asserts that the language is identical across both filings, which contradicts the original answer and misrepresents the change in disclosure strategy. This error undermines both quantitative and qualitative accuracy. While the answer correctly identifies the brand and category context (hence partial contextual relevance), it fails to recognize the key shift in reporting—moving from a quantified market share to a more general positioning—which is the central point of the question. The reasoning is flawed because it assumes consistency where there is actually a notable omission in the 2023 filing, indicating a failure in multi-hop synthesis between the two years’ disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 336,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle reframed Engineered Systems from a modest, on‑premise hardware line—representing only ~6 % of total revenue and sold mainly through indirect channels—to a strategic pillar of its cloud transformation.  The 2023 discussion highlights that these pre‑integrated systems (e.g., Exadata) are now positioned as core, performance‑optimized platforms that can be deployed on‑premise, in Oracle Cloud Infrastructure, or as hybrid cloud, enabling customers to migrate legacy workloads to the Oracle Cloud and driving new cloud‑service revenues.  Thus, Engineered Systems evolved from a peripheral hardware offering into a growth engine that underpins Oracle’s cloud‑first narrative.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Oracle's strategic positioning of Engineered Systems from 2022 to 2023. (1) Quantitatively, the claim that Engineered Systems represented ~6% of total revenue is accurate and aligns with the ground truth stating hardware revenues (including Engineered Systems) were 6% of total revenues in both fiscal 2023 and 2024. The use of '~6%' is acceptable as a rounded approximation. However, the LLM incorrectly implies this percentage applied in 2022 as a point of comparison, while the ground truth does not confirm the 6% figure for 2022—only for 2023 and 2024—making this a minor quantitative overreach. (2) The answer correctly identifies the shift in narrative: from on-premise hardware to a strategic, cloud-aligned offering supporting hybrid deployments. It accurately highlights the role of Engineered Systems like Exadata in enabling cloud migration and supporting Oracle’s cloud transformation. (3) The qualitative reasoning is sound, showing multi-hop synthesis by connecting Engineered Systems to cloud transformation, hybrid deployment models, and revenue implications. However, it omits key details from the ground truth: the inclusion of servers, storage, and operating systems in the broader hardware business, the concept of combined performance obligations, and the explicit mention of ongoing R&D investments. These omissions reduce completeness but do not distort the overall message. (4) The answer is highly contextually relevant, directly addressing the evolution in strategic positioning, the role within hardware, and implications for cloud transformation. Despite minor gaps, the LLM conveys a semantically close and logically coherent summary of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 475,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\nIn the 2022 10‑K the Company merely noted that the 2020 Stock Plan succeeded the 2011 Plan and that shares authorized but unissued under the 2011 Plan would be available for grant under the 2020 Plan, without quantifying the carry‑over. The 2023 filing retained that language but added a specific figure—5,530,106 shares that were available under the 2011 Plan at the time of the 2020 adoption—and included an updated table showing shares available for grant, granted, exercised and expired under the 2020 Plan. Consequently, the 2023 disclosure expanded the prior description by providing an explicit share‑carryover number and detailed activity metrics, whereas the 2022 filing left those details implicit.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and fact. (1) It claims that the 2022 10-K did *not* include the specific number of carried-over shares (5,530,106), while the ground truth states that this figure *was* included in the 2022 filing. Conversely, the LLM incorrectly asserts that the 2023 filing *added* this number and expanded disclosure, when in fact the ground truth confirms that the 2023 filing *omitted* the reference to the 2011 Plan and the carry-forward detail. (2) The quantitative inaccuracy is severe: the LLM reverses the presence of the exact figure (5,530,106), which is central to the question. This number was present in 2022 (correctly stated in ground truth) but claimed by the LLM to be absent, and then claimed to be added in 2023 when it was actually removed. (3) The multi-hop reasoning is flawed—the question asks how the disclosure *evolved* between 2022 and 2023, requiring correct comparison across filings. The LLM inverts the evolution, stating disclosure increased when it actually decreased. (4) Contextual relevance is low but not zero, as the answer addresses stock plan transitions and mentions relevant filings, but the factual inversion renders it misleading. The core conclusion is the opposite of the truth, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 363,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell kept its private‑fund exposure essentially unchanged – direct private‑investment holdings edged up from **$1.284 bn to $1.293 bn** and private‑fund assets measured at NAV rose from **$1.258 bn to $1.265 bn**, but the share of total pension assets devoted to these alternatives slipped only marginally (from roughly 7.4 % to 7.6 %).  This stability reflects the company’s disciplined, target‑range approach (10‑20 % “other” investments) that prioritises preserving long‑term, diversified returns while limiting illiquidity risk, indicating that capital deployment is being steered toward core businesses and cash‑generating assets rather than aggressive expansion into new growth ventures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Honeywell's investment in private funds was $1,244 million in 2022 and $1,265 million in 2023. However, the LLM incorrectly reports private-fund assets at NAV as $1.258 bn (2022) and $1.265 bn (2023), and introduces a separate figure of $1.284 bn to $1.293 bn for 'direct private-investment holdings'—a category not mentioned in the original answer or supported by the ground truth. These numbers do not align with the disclosed $1,244M and $1,265M figures. The 1.7% increase cited in the original answer (from $1,244M to $1,265M) is accurate, but the LLM’s implied growth from $1.258B to $1.265B is only ~0.55%, and its use of multiple categories creates confusion and factual inaccuracy.\n\n(2) The calculation of the percentage of total pension assets (7.4% to 7.6%) is not present in the original answer and cannot be verified from the provided ground truth. Since the ground truth does not mention total pension assets or percentages, introducing these figures undermines quantitative accuracy unless explicitly sourced, which it is not.\n\n(3) The reasoning and synthesis are partially sound in that the LLM infers strategic stability in allocation, which aligns with the original conclusion of a 'modest increase' indicating a stable strategy. However, the LLM diverges by suggesting capital deployment is being steered toward 'core businesses and cash-generating assets rather than aggressive expansion,' which is not supported by the original answer. The original interpretation emphasizes continued or slightly expanded exposure to alternative investments for higher returns or diversification—more positive toward private funds—whereas the LLM implies caution and de-prioritization, which is a different qualitative inference.\n\n(4) Contextually, the answer addresses the evolution of allocation strategy and attempts to interpret capital deployment priorities, fulfilling the multi-part structure of the question. However, due to incorrect base figures and the introduction of unverified metrics (e.g., NAV-based assets, direct holdings, percentage of pension assets), the factual foundation is flawed. While the general direction (slight increase, stable strategy) is captured, the specific data inaccuracies and misaligned reasoning reduce correctness significantly. The answer appears more detailed but introduces speculative and incorrect data, failing the core requirement of factual fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 668,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company went from having **no outstanding shares of Class B‑2 common stock** (the column shows “‑” for 2023 and 2022) to issuing that class as part of the **Class B‑1 exchange offer** completed in May 2024, which retired the tendered ≈ 241 million B‑1 shares and created **≈ 120 million B‑2 shares (and 48 million C shares)**—the 49 million‑share figure appears in the 2024 EPS tables.  The new B‑2 class is convertible to Class A common stock only after the U.S. covered litigation is resolved, and its conversion‑rate adjustments are designed to have **double the impact** of the B‑1 rate changes, while still being subject to transfer restrictions and dividend participation that mirror the other stock classes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The claim that Class B-2 shares were issued in May 2024 as part of the Class B-1 exchange offer is incorrect: the original answer states that no Class B-2 shares were outstanding *prior to* the exchange offer, but does not confirm issuance *as a result* of it, nor does it provide the specific numbers cited (≈120 million B-2 shares, 48 million C shares). These figures are not supported by the ground truth and appear fabricated. (2) The LLM incorrectly asserts that the company went from 'no outstanding shares' in 2023 to issuing B-2 shares in 2024; however, the ground truth clarifies that in 2023, Class B-2 existed and was subject to conversion adjustments and dilution—implying it was already part of the capital structure—while in 2024, there was merely a lack of updates, not new issuance. (3) The 'double the impact' conversion rate adjustment and the 49 million-share figure from EPS tables are not mentioned in the ground truth and represent unsupported details. (4) The original answer emphasizes a *reduction* in disclosure and potential discontinuation of active role, whereas the LLM suggests an expansion of B-2's role post-exchange, which is the opposite trajectory. (5) Multi-hop reasoning fails: the LLM misinterprets the temporal evolution and relationship between B-1 and B-2 classes, incorrectly inferring causality and numerical outcomes. While the answer addresses the question’s context (stock class evolution), its core facts, numbers, and direction of change are wrong, leading to a low correctness score. Minor credit is given for discussing conversion mechanics and transfer restrictions, which are thematically relevant but not substantiated in the same way in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 487,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the liability that represents unearned Target Circle rewards fell dramatically—from about **$89 million** (as of January 29 2022) to **$19 million** (as of February 1 2025), a decline of roughly **$70 million** (and a further drop from $117 million in 2023).  This reduction shows that Target is recognizing more of the accrued rewards and/or scaling back the program’s future payout obligations, indicating that the Target Circle loyalty scheme has been **re‑structured or narrowed** rather than expanded.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the $89 million deferred revenue as of January 29, 2022, and mentions $117 million in 2023 (close to the 2024 figure of $117 million as of February 3, 2024), it incorrectly states that the liability fell to $19 million by February 1, 2025, and frames this as part of the 2022–2024 comparison. The question specifically asks about changes between 2022 and 2024, not beyond. The $19 million figure is from 2025 and should not be used to describe the 2022–2024 trend. The LLM incorrectly implies a continuous decline during 2022–2024, when in fact the liability increased from $89M to $117M during that period. (2) Calculations are partially correct: the $70M drop from $89M to $19M is accurate, but this change spans a different timeframe than asked and ignores the intermediate increase. The mention of a 'further drop from $117M in 2023' introduces a year (2023) not in the original data and misaligns the timeline. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the trend between 2022 and 2024, which is an increase in liability, not a decrease. It draws an incorrect conclusion about program restructuring based on a post-2024 decline, which was outside the scope of the question. (4) Despite these errors, the answer is contextually relevant and uses correct entities (Target Circle, deferred revenue concept) and mostly accurate figures, just misaligned in time and interpretation. The qualitative reasoning would be stronger if applied to the correct timeframe. Thus, partial credit is given for data proximity and structure, but major deductions apply for incorrect trend portrayal and temporal misalignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 474,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\nThe Level 2 fair‑value estimate for Netflix’s 4.375% Senior Notes rose from **$980 million on December 31 2022 to $996 million on December 31 2023**—an increase of roughly **$16 million (≈1.6 %)**.  This price appreciation reflects that market yields for comparable debt have fallen (or that investors perceive Netflix’s credit risk as lower), making the existing higher‑coupon notes more attractive and signaling a generally more favorable market environment for the company’s borrowing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the fair value of Netflix's 4.375% Senior Notes *increased* from $980 million to $996 million, while the ground truth states it *decreased* from $980 million to $996 million. This is a direct contradiction — 'decreased' vs. 'rose' — despite the same numbers being cited. This misrepresents the direction of change and undermines the entire analysis. (2) Quantitatively, the dollar amounts ($980M and $996M) and dates (December 31, 2022 and 2023) are correctly stated, and the $16M difference is accurate. However, the percentage change is miscalculated: (16/980) ≈ 1.63%, so ≈1.6% is acceptable. But claiming an 'increase' when the ground truth says 'decreased' is a severe error, suggesting confusion in interpretation. (3) The reasoning is partially sound — higher coupon notes becoming more attractive if market yields fall or credit risk declines is economically valid — but it is applied to the wrong trend. The original answer states the fair value moved *closer to par*, implying stabilization, while the LLM infers price appreciation due to falling yields or improved credit, which may be plausible but contradicts the stated direction of change. (4) Contextual relevance is high — the answer addresses investor perception and market conditions as asked, uses appropriate financial logic, and references correct entities (Netflix, 4.375% Senior Notes, fair value, Level 2). However, the reversal of the trend (increase vs. decrease) results in a misleading conclusion, severely impacting correctness and qualitative accuracy. The model appears to have misread or misstated the direction of change despite having the correct numbers, indicating a failure in multi-hop synthesis or final interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 486,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s class C common stock grew from essentially 10 shares (outstanding on the balance sheet) to ≈ 48 million new shares issued in May 2024 as part of the exchange offer for tendered class B‑1 common stock.  These newly issued class C shares remain classified as a separate class of common stock that is convertible into class A common stock (and, together with class B‑1 and B‑2 stock, can be converted into class A preferred stock) and retain the same limited‑voting rights as before; the only change was a substantial increase in the number of class C shares outstanding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, it incorrectly states that approximately 48 million Class C shares were issued in May 2024, while the ground truth confirms this exchange occurred in 2023, not 2024. It also falsely claims Class C shares grew from 10 to 48 million in 2024, when in fact the 2024 balance sheet shows only 10 shares outstanding—indicating the opposite trend. (2) The answer misrepresents the timeline: the exchange offer (241M Class B-1 shares tendered for ~48M Class C shares) was a 2023 event, not a 2024 one. (3) Qualitatively, the reasoning is flawed—instead of recognizing that Class C issuance was a 2023 restructuring event followed by stabilization in 2024, the model implies ongoing expansion into 2024, contradicting the ground truth. (4) While the answer correctly identifies Class C stock as convertible and having limited voting rights, this contextual detail does not compensate for core factual inaccuracies. (5) The multi-hop synthesis fails: it should have connected the 2023 issuance to the 2024 stabilization, but instead inverts the narrative. Overall, the answer is mostly incorrect due to reversed chronology and incorrect share balances, warranting a low correctness score despite some relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 364,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Rough Plumbing shifted from being reported simply as a sub‑category of the **Building Products** segment (which accounted for roughly 32 % of net sales in 2022 – see LOW_10k_2022 page 55) to being treated as a core element of Lowe’s **installed‑sales and home‑services** offering.  The 2024 disclosures (LOW_10k_2024 pages 4, 7) place Rough Plumbing among the “major installed‑sales categories” and tie it to the company’s “Expand home services” and “Pro penetration” strategic pillars, emphasizing installation by independent contractors, protection‑plan coverage and integration with the omnichannel/loyalty ecosystem rather than just a product line.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 2022 classification of Rough Plumbing under 'Building Products' and the 2024 shift toward installed sales and home services, including integration with installation services and protection plans. (2) The quantitative claim that Building Products accounted for roughly 32% of net sales in 2022 is consistent with the cited source (LOW_10k_2022, page 55), though this specific percentage was not in the original answer; however, it is contextually relevant and accurate. The original answer mentions that installed sales accounted for approximately 5% of total sales in 2024, which the LLM answer does not explicitly include—this is a minor omission. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and documents, linking Rough Plumbing’s reclassification to strategic initiatives like 'Expand home services' and 'Pro penetration' using evidence from LOW_10k_2024. (4) Despite missing the 5% installed sales figure, the LLM captures the core evolution in business classification and service offerings with strong semantic equivalence. The added detail about omnichannel/loyalty integration is a minor enhancement beyond the ground truth but does not detract from accuracy. Thus, the answer earns a 9 for correctness due to high factual and qualitative accuracy with only a small completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 398,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\nClass B‑2 common stock was created in May 2024 as part of Visa’s exchange offer that retired 241 million Class B‑1 shares and issued roughly 120 million new Class B‑2 shares (plus 48 million Class C shares); there were no B‑2 shares outstanding before that offer. By the end of 2024 the company reported about 49 million weighted‑average B‑2 shares (used in EPS calculations and shown in the equity section), giving the firm a new class of equity that can be issued only in connection with the B‑1 exchange and that carries transfer and conversion restrictions until the U.S. covered litigation is resolved. This addition expands the authorized capital, provides a mechanism to retire restricted B‑1 shares, and reshapes the ownership and voting profile of Visa’s equity, signaling that B‑2 stock is being used to restructure the capital base and manage litigation‑related equity obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The introduction date of Class B-2 common stock is incorrect: the ground truth states it was introduced in 2023 with 77 million shares outstanding, but the LLM claims it was created in May 2024 with roughly 120 million shares issued, which contradicts the original answer. (2) The LLM incorrectly attributes the exchange offer to Visa, which is not mentioned in the original answer and introduces a wrong entity. (3) The numbers provided (241 million Class B-1 retired, 120 million Class B-2 issued, 48 million Class C) are not present in the ground truth and appear fabricated. (4) The mention of 'weighted-average B-2 shares' of 49 million at year-end conflicts with the original statement that no Class B-2 shares were outstanding prior to the exchange offer in 2024, and no such number (49M or 77M) is reconciled. (5) The LLM introduces new details—transfer restrictions, conversion conditions tied to U.S. covered litigation, and capital expansion—that are not in the original answer and cannot be verified. While the LLM attempts multi-hop reasoning by inferring strategic restructuring, the foundation is built on incorrect data and entities. The contextual relevance is moderate because it addresses the evolution and role of Class B-2 stock, but the factual core is flawed. Semantic equivalence fails due to mismatched years, numbers, companies, and events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 400,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\nThe Target Circle program’s deferred‑revenue liability fell sharply from about **$117 million at the end of fiscal 2023** (the 2022‑reporting period) to roughly **$19 million by the end of fiscal 2024**.  This >80 % decline shows that the program’s financial liability is contracting, reflecting either higher reward‑redemption rates, a change in how the program is structured, or a deliberate scaling back, indicating that Target Circle has moved past its rapid‑growth phase into a more mature, revenue‑recognizing stage.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The original answer states that no liability was disclosed in 2022, and by 2024 (as of February 3, 2024), the deferred revenue related to Target Circle was $117 million. The LLM incorrectly claims that the liability was $117 million at the end of fiscal 2023 (mislabeling it as the 2022-reporting period) and dropped to $19 million by fiscal 2024, which contradicts the ground truth. (2) The numbers are entirely wrong: the $19 million figure and the >80% decline are not supported by the original data. Additionally, the timeline is misaligned—fiscal 2023 ends in 2023, not 2022, and the 2024 figure is from early 2024, not the end of fiscal 2024. Calculations based on false values compound the error. (3) The multi-hop reasoning fails: instead of recognizing that no liability was reported in 2022 and a $117 million liability emerged in 2024 (indicating growth), the model fabricates a decline, leading to an opposite and unsupported conclusion about program maturity. (4) The contextual relevance is low but not zero—the answer discusses financial liability and program evolution, so it addresses the general topic, but with completely inaccurate data and reasoning. Thus, the correctness, quantitative, and qualitative scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 371,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\nBetween 2023 and 2024 NVIDIA’s focus on pollution‑related risk moved from a generic acknowledgement of climate change to a concrete concern about upcoming regulations.  The 2024 filing explicitly warns that new carbon‑tax, emissions, water‑use and other pollution limits could raise its own operating costs and, more importantly, restrict customers’ ability to expand data‑center capacity by limiting power, water and permitting availability—making pollution‑related rules a direct operational and revenue risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in NVDA's concern about pollution limits between 2023 and 2024. It correctly identifies that in 2023, NVDA focused on cost impacts (compliance, energy, capital expenditures), and by 2024 expanded its risk narrative to include land and permitting constraints affecting customer data center expansion. The LLM accurately reflects that this regulatory pressure could impair customers' ability to scale data centers—directly impacting NVDA's revenue, which aligns with the ground truth. While the original answer emphasizes 'direct and indirect costs' and 'changes to manufacturing and supply chain' in 2023, the LLM summarizes this as a 'generic acknowledgement of climate change' and focuses more on 2024 developments, slightly underrepresenting the specificity of 2023 concerns. However, the core multi-hop reasoning—linking pollution regulations to both NVDA's operations and customer demand via permitting and resource constraints—is sound and semantically equivalent. No numerical inaccuracies; dates and entities (NVDA, 2023, 2024, data center expansion) are correct. The answer is fully contextually relevant and conveys the growing strategic risk accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 342,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\nBetween September 3 2023 and September 1 2024 the company’s Guaranteed Senior Notes—issued by its Japanese subsidiary—expanded from roughly **$484 million** (recorded as other long‑term debt) to about **$919 million**, reflecting a **$500 million issuance in November 2023** that was later reduced by a **$77 million repayment in July 2024**. These notes carry fixed rates of **1.400 %–2.120 %** and mature between **2033 and 2043**, and their fair value is estimated using **Level 3 inputs** (unobservable Japanese market‑rate assumptions).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that the Japanese subsidiary issued Guaranteed Senior Notes in 2023 and repaid $77 million in 2024, it incorrectly states the initial amount of long-term debt as $484 million and claims it expanded to $919 million after a $500 million issuance. This contradicts the ground truth, which states that the total issuance was approximately $500 million (not an increase from $484M to $919M), and that overall long-term debt fair value *decreased* from $5,738 million to $5,412 million. The LLM implies growth in debt, while the truth is a net reduction. (2) Key numbers are wrong: the starting and ending valuations of the notes are fabricated ($484M → $919M), whereas the ground truth reports only the total issuance (~$500M) and overall long-term debt fair values ($5,738M → $5,412M). The $500M issuance is correctly timed to November 2023, and the $77M repayment in July 2024 aligns with the ground truth. Interest rates (1.400%–2.120%) and Level 3 inputs are correctly reported. However, the maturities (2033–2043) are not mentioned in the original answer and appear to be hallucinated. (3) Multi-hop reasoning is partially sound—linking issuance, repayment, and fair value inputs—but fails in synthesis because it misrepresents the net change in debt. The model incorrectly infers that the $500M issuance caused an increase in total debt, when in fact total long-term debt fair value declined, indicating other repayments or valuation changes. It misses the key point that the overall fair value of long-term debt dropped by $326 million ($5,738M → $5,412M), which the original answer highlights as context for the Guaranteed Senior Notes' evolution. (4) Correctness is low due to major quantitative errors and incorrect directional narrative (growth vs. reduction). Qualitative accuracy is moderate due to correct identification of subsidiary, issuance, repayment, rates, and valuation inputs. Contextual relevance is high as the answer addresses issuance, repayment, and fair value inputs as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 564,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix stepped up its spending on technology and development – the 2022 filing notes a 24 % jump in tech‑dev expenses driven by head‑count growth to improve streaming infrastructure – and simultaneously expanded its cybersecurity organization.  The 2024 filing adds a dedicated Vice President of Security and Privacy Engineering, a formal enterprise‑wide security program, a bug‑bounty initiative and Board‑level oversight of cyber risk, indicating a deliberate investment in personnel and governance to protect the streaming platform.  These additions deepen the company’s focus on streaming‑service enhancements but also raise its exposure to cyber‑related liabilities, regulatory scrutiny and reputational risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the evolution of Netflix's investment from streaming improvements to increased cybersecurity focus, which aligns with the ground truth. However, there are key quantitative discrepancies. The original answer states a $384 million increase in personnel-related costs in 2022, while the LLM claims a '24% jump in tech-dev expenses'—a figure not present in the ground truth and potentially conflated or misattributed. This is a significant factual deviation affecting numerical accuracy. (2) No calculation is performed in the LLM answer, but the substitution of a percentage increase (24%) for an absolute dollar amount ($384M) without source support undermines quantitative fidelity. The years (2022, 2024) and entities (Netflix, streaming service, cybersecurity) are correct. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from growth-focused hiring in 2022 to enhanced cybersecurity governance in 2024, citing specific additions like the VP of Security and Privacy Engineering, bug bounty programs, and Board-level oversight—details consistent with a maturing risk posture. This reflects good synthesis across years and domains. (4) Despite the numerical inaccuracy, the qualitative narrative and contextual relevance are strong, accurately portraying the strategic evolution and associated risk exposure. The answer adds plausible details (e.g., Board oversight) that enrich the response without contradicting the ground truth. However, the incorrect substitution of a percentage for a disclosed dollar amount reduces confidence in data fidelity, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 454,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\nBetween the 2023 and 2024 filings BNY Mellon swapped its prior 2023 Restricted Stock Unit agreement (Exhibit 10.24) for a refreshed 2024 RSU form (Exhibit 10.26) that revises vesting schedules, performance‑metric language and related disclosures, and it also filed a 2025 RSU draft (Exhibit 10.29) in the same filing—showing a deliberate, periodic update cycle.  This iterative lifecycle management tightens performance conditions and extends the award horizon, directly shaping the executive compensation strategy by aligning equity incentives with longer‑term performance goals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in BNY Mellon's restricted stock unit (RSU) agreement lifecycle between the 2023 and 2024 filings, correctly identifying the introduction of the 2024 RSU form and the forward-looking filing of the 2025 form. It accurately reflects the iterative, proactive approach to executive compensation strategy, which aligns with the ground truth. However, the LLM introduces specific exhibit numbers (10.24, 10.26, 10.29) and claims about changes in 'vesting schedules' and 'performance-metric language' that are not present or verifiable in the original answer. The ground truth does not mention specific exhibit numbers or substantive changes in terms, only the filing status transition from 'Filed herewith' to 'Previously filed' and the introduction of the next year’s form. This adds unsupported detail, reducing qualitative accuracy. While the overall reasoning about lifecycle management and strategic alignment is sound and contextually relevant, the inclusion of unverified specifics (exhibits, vesting changes) introduces factual overreach. Quantitative accuracy is high as there are no incorrect numbers—dates (2023, 2024, 2025) are correct and used appropriately. The answer is semantically close but not fully equivalent due to the added detail not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 366,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\nThe $750 million, 4.90 % senior notes issued in November 2023 remain outstanding in 2024, maturing on **April 15, 2029** and carrying a **$743 million carrying amount** (net of the $3.4 million discount) on the February 2 2025 balance sheet—essentially the same level as the prior year after amortizing the discount.  Their terms (semi‑annual interest on April 15 and October 15, redemption rights, and change‑of‑control provisions) have not been altered, so the notes continue to be scheduled for repayment only at maturity in 2029.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the 4.90% Senior Notes were issued in November 2023 with a $750 million principal amount, a $3.4 million discount, and a maturity date of April 15, 2029. The carrying amount of $743 million is accurate as it reflects $750M - $3.4M discount, consistent with the ground truth. The 2024 carrying amount is correctly reported as $743 million. (2) All numeric values—$750 million principal, $3.4 million discount, $743 million carrying amount, April 15, 2029 maturity—are factually correct. The mention of the February 2, 2025 balance sheet is slightly off (should be January 28, 2024 per ground truth), but this does not materially affect the correctness of the carrying amount or timeline, especially since the value is described as 'essentially the same level as the prior year,' which aligns with amortization progress. (3) The multi-hop reasoning is sound: the model correctly synthesizes issuance details from 2023 with the 2024 status, maintains consistency in maturity and terms, and explains the carrying amount in relation to the discount and amortization. The only minor gap is the lack of explicit mention that interest payments began in April 2024, though this is implied by the semi-annual schedule starting April 15. (4) The answer is semantically equivalent to the ground truth, with high contextual relevance and strong qualitative reasoning. The slight discrepancy in reporting date prevents a perfect 10, but overall accuracy is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 419,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\nBetween 2023 and 2024 the Japanese subsidiary added roughly $500 of Guaranteed Senior Notes in November 2023, and then began retiring part of that issuance—repaying $77 of the notes in July 2024.  The net effect was an increase in the subsidiary’s other long‑term debt from about $484 million in 2023 to roughly $919 million in 2024, reflecting the new $500 issuance less the $77 repayment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that $500 in Guaranteed Senior Notes were issued in 2023 and $77 were repaid in 2024, it fabricates a net increase in long-term debt from $484 million to $919 million, which is not supported by the original answer or implied by the provided data. The original answer does not mention any specific beginning or ending debt totals, nor does it reference 'other long-term debt' or provide balance sheet figures. (2) The dates (November 2023 issuance, July 2024 repayment) are plausible but not specified in the ground truth, so their inclusion introduces unverified precision. The $500 issuance amount and $77 repayment are consistent with the original answer (allowing for format variation), but the derived net debt figure is incorrect and misleading. The calculation of net change as $500 - $77 = $423 net addition is reasonable, but asserting total debt balances of $484M and $919M is unsupported. (3) The multi-hop reasoning is partially sound—connecting issuance and repayment across years—but fails in synthesis by inventing balance sheet data not present in the source. The model incorrectly infers aggregate debt levels, suggesting a misunderstanding or overextrapolation. (4) Contextual relevance is high because the answer addresses the evolution of the notes between 2023 and 2024 and focuses on the correct entity (Costco's Japanese subsidiary) and instrument (Guaranteed Senior Notes). However, the invented quantitative context undermines correctness. Scores reflect partial credit for correct issuance/repayment amounts but major deductions for fabricated data and flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 462,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\nThe filings show that the risk of competitors offering after‑market parts and services has been repeatedly flagged as a material threat—first in the 2022 10‑K (e.g., page 23 and page 25) and again in the 2023 10‑K (page 20 and page 21).  In both years the language warns that such after‑market offerings can “detract from our sales,” create pricing pressure and erode market share, which can adversely affect revenue, earnings and cash‑flow performance.  Thus, the risk has not changed materially between 2022 and 2023; it remains a recurring concern that can negatively impact Danaher’s business and financial statements.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in noting that the risk of competitors offering after-market parts was mentioned in both 2022 and 2023 filings and that it can 'detract from our sales' and impact financial performance. The citations to specific pages (e.g., 2022 10-K pages 23, 25; 2023 10-K pages 20, 21) are plausible and align with typical risk disclosure locations, though exact page numbers are not verifiable from the ground truth provided. Quantitatively, there are no numbers, dates, or financial figures to assess for accuracy, so this dimension is neutral and scored as 10 by default. However, the core deficiency lies in qualitative accuracy and reasoning: the LLM claims the risk 'has not changed materially' between 2022 and 2023, which directly contradicts the ground truth. The original answer highlights a meaningful evolution in the framing of the risk—from a direct, primary threat in 2022 to a secondary, contextualized pressure in 2023, now nested within broader industry trends like cost containment and reimbursement policies. This shift indicates a de-emphasis or strategic reframing, which the LLM fails to recognize. Thus, while the answer correctly identifies the persistence of the risk, it misses the nuanced evolution in its presentation and relative importance, which is the central focus of the question. This constitutes a significant error in multi-hop reasoning and synthesis across years, reducing the correctness and qualitative accuracy scores. Contextual relevance is high because the answer addresses the right topic and correctly links the risk to financial impacts, but it lacks the comparative analysis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 455,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix shifted from modest, uniform price increases on its core plans to a more flexible pricing architecture that added an ad‑supported tier, widened the monthly‑fee range (U.S. $2‑$27 in 2022 → $1‑$32 in 2024) and introduced extra‑member surcharges, while also expanding the service with games and live‑programming offerings.  These changes were designed to raise average revenue per member, offset the slowing pace of net‑member additions and the heightened competition for viewers, and mitigate the pressure of rising content‑costs and pandemic‑related production delays.  (Pages 23‑24, 2022 10‑K; 4, 6, 7, 22, 2024 10‑K).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in Netflix's membership plan strategy from 2022 to 2024, including the introduction of an ad-supported tier and changes in pricing structure, which aligns with the original answer. It correctly identifies business challenges such as slowing membership growth and competition. However, several quantitative inaccuracies reduce factual precision. (2) The claim that U.S. pricing ranged from $2–$27 in 2022 and $1–$32 in 2024 is not supported by the ground truth and appears speculative; the original answer does not provide specific price ranges or mention a $1 entry point. In fact, Netflix’s ad-supported plan launched at $6.99, not $1. The 2022 revenue increase (19%), driven by 11% membership growth and 7% rise in average revenue per membership, is omitted in the LLM answer, weakening quantitative completeness. The mention of 'extra-member surcharges' and 'games and live-programming offerings' as part of the strategic response is contextually relevant but not explicitly tied to the 2022–2024 shift in the original answer. (3) The multi-hop reasoning is generally sound—linking pricing changes to challenges like competition and slowing growth—but misses the explicit connection to the 50% drop in paid net membership additions in 2022, a key diagnostic signal in the original. The synthesis across years is logical but lacks precise grounding in the cited financial outcomes. (4) Despite missing specific numbers and introducing unverified price points, the LLM answer conveys a qualitatively accurate narrative about Netflix’s strategic pivot. The intent to address member acquisition, retention, and competition is correctly inferred. Thus, the correctness score is 7 for core accuracy with notable quantitative gaps; quantitative accuracy is 6 due to unsupported price ranges; qualitative accuracy is 8 for strong reasoning; and contextual relevance is 9 as the response directly addresses the question’s scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 533,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Boeing’s disclosures on in‑orbit incentive payments became more explicit about **when** the revenue is recorded and **what risks** remain.  In the 2023 filing it states that the **net‑present‑value of the in‑orbit incentive fees is recognized as revenue during the construction period**, and that the payment is **contingent on the satellite meeting performance specifications for up to 15 years**—if it does not, the company may have to **refund the customer and record a charge**.  The 2022 filing merely noted that such payments exist; the 2023 discussion adds a clear statement of revenue timing and underscores the heightened exposure to refunds and earnings volatility as Boeing expands its satellite contracts.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Boeing's approach to in-orbit incentive payments from 2022 to 2023, emphasizing increased transparency in revenue recognition timing and risk exposure. It accurately notes that in 2023, Boeing recognized the net present value of in-orbit incentive fees during the construction period and that payments are contingent on satellite performance for up to 15 years, with potential refund liabilities if criteria are not met. This reflects a valid qualitative shift from general risk disclosure in 2022 to more specific financial and operational details in 2023. However, the LLM omits the key quantitative detail from the original answer: the $1,585 million in additional losses recorded in 2023 on Boeing’s five major fixed-price development programs. This is a significant omission because the question specifically asks about financial recognition and risk exposure, and the dollar amount is central to assessing the scale of financial impact. While the LLM correctly describes the accounting practice and risk mechanism, the absence of this figure reduces quantitative accuracy. All entities (Boeing, in-orbit incentive payments, fixed-price programs) and years (2022 vs 2023) are correctly identified, and the reasoning correctly synthesizes the evolution across filings. The answer is highly relevant and semantically aligned with the ground truth, but the missing $1,585 million figure prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 411,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\nThe 2024 filing again posts the Directors’ Code of Conduct on the company’s website (the same PDF link used in 2023) and states that any amendments or waivers will be disclosed there, but it now calls the code out explicitly in the “Available Information” section and notes that it can be accessed via the corporate website and its social‑media channels. Thus, while the core disclosure remains the same, the 2024 filing gives the code a more prominent, easily reachable placement and emphasizes additional digital channels for public access.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claims despite being internally consistent and contextually relevant. (1) The original answer states that in 2024, the Directors' Code of Conduct was referenced more generally as part of a broader list of governance materials without repeating the direct URL. In contrast, the LLM claims the 2024 filing 'calls the code out explicitly' and emphasizes additional digital channels like social media—information not present in the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse factual misrepresentation. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers increased prominence and expanded access in 2024, when the ground truth indicates a shift toward less direct, more consolidated referencing—essentially the opposite trend. (4) While the answer addresses the question's topic and attempts to compare 2023 and 2024 disclosures, it conveys the inverse of the actual evolution (streamlined/less direct → more prominent/easily reachable), warranting a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses the right document and timeframe but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 355,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\nBetween 2022 and 2023 Mobileye Drive™ shifted from being a proprietary stack used only in Intel‑Mobileye’s own Robotaxi pilots (e.g., the Germany‑based SIXT service launched in 2022) to a commercial‑grade L4 platform that the company intends to sell to third‑party mobility providers.  In 2023 the deployment strategy was reframed around supplying Mobileye Drive™ to transportation‑network companies, public‑transit operators and AV‑ready vehicle manufacturers as part of a MaaS‑focused go‑to‑market model, rather than limiting it to internal Robotaxi or consumer‑grade “Chauffeur” projects.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic shift in Mobileye Drive™’s deployment from 2022 to 2023, noting the evolution from internal or limited use to a broader commercial strategy targeting third-party mobility providers, public transit operators, and AV-ready vehicle manufacturers, aligned with a Mobility-as-a-Service (MaaS) model. The dates (2022 and 2023) are accurate and correctly framed. However, the LLM introduces a detail not present in the ground truth: that Mobileye Drive™ was used in Intel-Mobileye’s own Robotaxi pilots like the SIXT service in Germany. While plausible, this specific example is not mentioned in the original answer and contradicts the ground truth, which states that in 2022, Mobileye launched Mobileye Drive™ and secured collaborations with Udelv, Transdev, and achieved a design win with Geely—not that it was limited to internal Robotaxi pilots. Additionally, the original answer highlights the bundling of Mobileye Drive™ with Moovit’s urban mobility application in 2023, a key strategic nuance missing in the LLM response. The qualitative reasoning is mostly sound and captures the directional shift, but misses specific partnerships and overemphasizes internal use in 2022. There are no numerical inaccuracies, so quantitative accuracy is perfect. Contextual relevance is high as the answer directly addresses the evolution in role and deployment strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 397,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\nFrom 2022 through the August 2024 amendment (effective Nov 2024), the Tower Preferred Interests shifted from the original two fixed‑rate series—Class A‑1 ($1.5 bn) paying a 5.0% quarterly distribution and Class A‑2 ($4.5 bn) paying 4.75%—to a unified structure in which all of the former interests are now designated **Fixed‑Rate Class A Limited Membership Interests** with a higher 5.90% preferred distribution, while a portion is re‑classified each year into **Floating‑Rate Class A Interests** that pay SOFR + 250 basis points (reset every five years). This amendment changed both the rate levels and the composition of the preferred interests, moving from two separate fixed‑rate series to a combined fixed‑plus‑floating structure with a new reset schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the Tower Preferred Interests from 2022 to 2024. (1) Quantitatively, all numbers are correct: $1.5 billion (equivalent to $1,500 in original units, likely millions) and $4.5 billion match the $1,500 and $4,500 in the ground truth (assuming units in millions), percentages (5.0%, 4.75%, 5.90%, SOFR + 250 bps) are exact, and the August 2024 amendment date is correctly noted. The reset every five years is also preserved. (2) The answer correctly identifies the structural shift from two fixed-rate series (Class A-1 and A-2) to a new structure involving Fixed-Rate and Floating-Rate Class A Interests. (3) The multi-hop reasoning is sound: it synthesizes the initial 2022 structure with the 2024 amendment, correctly describing both the rate increase and the introduction of a floating-rate component. (4) Minor deduction in qualitative accuracy due to the mention of 'effective Nov 2024'—this detail is not in the ground truth and introduces unverified information, though it doesn't contradict core facts. Also, 'quarterly distribution' is added detail not confirmed in the original. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question about structural and rate evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 359,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\nThe Balanced Index Fund still follows its 60 %‑equity / 40 %‑debt allocation and is valued using Level 1 market prices; however, the Level 3 securities it contains shifted from an overall unrealized loss of about **$90 million at the end of 2022** to a modest unrealized **gain of roughly $14 million by the end of 2023**—driven by a $2 million gain in corporate fixed‑income securities and a $6 million gain in mortgage‑backed/asset‑backed securities in 2023, compared with $16 million and $11 million of losses, respectively, in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. While it correctly identifies the 2023 unrealized gains of $2 million for corporate fixed income and $6 million for mortgage-backed/asset-backed securities, and the 2022 losses of $16 million and $11 million respectively, it incorrectly states an 'overall unrealized loss of about $90 million' in 2022. The actual combined unrealized loss in 2022 was ($16M + $11M) = $27 million, not $90 million. Similarly, the claimed 'gain of roughly $14 million' in 2023 is incorrect—the actual combined gain is $8 million ($2M + $6M). These miscalculations severely undermine factual accuracy. (2) The allocation (60% equities, 40% debt) and use of Level 1 pricing in 2023 are correctly noted, aligning with the ground truth’s mention of a more transparent valuation approach. However, the LLM incorrectly implies the entire fund is valued using Level 1 prices, while the original answer clarifies that Level 3 assets are a subset within the fund—this misrepresents the valuation methodology evolution. (3) The multi-hop reasoning is partially sound: the model connects changes in unrealized gains/losses across years and asset types, but fails to accurately aggregate the numbers or clarify that Level 3 assets are a component of the fund, not the whole. (4) Despite these issues, the answer addresses the core question about evolution in investment approach and performance, and correctly identifies directional shifts (from losses to gains), supporting a moderate qualitative and contextual score. However, the large numerical inaccuracies and mischaracterization of valuation levels justify a correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 458,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, BNY Mellon moved accounting developments from a generic “risk factor” mention in 2023 to a explicitly highlighted element of its forward‑looking statements in 2024, directly tying changes in accounting standards to strategic priorities such as capital allocation, technology investment and the use of non‑GAAP measures. This evolution reveals that evolving accounting standards have become a core driver of the firm’s strategic planning and investor communications, rather than a peripheral concern.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in BNY Mellon's language around accounting developments between 2023 and 2024. It accurately identifies the shift from a generic mention in 2023 to a more prominent, strategically integrated role in 2024. The dates (2023 and 2024) and entities (BNY Mellon, Form 10-K) are correct, and there are no numerical inaccuracies, earning a perfect score on quantitative accuracy. The answer correctly infers that accounting developments have become more central to strategic planning, aligning with the ground truth's conclusion about increased integration into risk and planning. However, the LLM slightly overreaches by stating accounting developments were moved 'from a generic risk factor mention'—the original answer does not specify that it was in the 'risk factors' section, only that it was part of a broader list in forward-looking statements. Additionally, the LLM mentions 'technology investment' and 'use of non-GAAP measures' as areas tied to accounting changes, which are not explicitly stated in the ground truth. The original emphasizes 'capital plans including dividends and repurchases' and 'efficiency savings'—specifics the LLM omits. Thus, while the qualitative reasoning is sound and directionally accurate, it misses precise linkages and introduces minor unsupported details. Contextual relevance is strong, as the response directly addresses both parts of the multi-hop question: the evolution in language and its implications for strategic priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 420,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\nIn 2023 the filing warned that any failure to keep stores safe or to protect against escalating cyber‑threats could erode associate morale, increase turnover and undermine the day‑to‑day work experience, directly affecting the employee‑focused culture. By contrast, the 2022 narrative highlighted engagement‑driven initiatives—surveys, a digital associate platform, recognition programs and expanded compensation—to deepen emotional commitment. Thus, while 2022 built engagement through supportive programs, the 2023 safety and cybersecurity risks introduced new pressures that could diminish that engagement if not successfully managed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the 2022 engagement initiatives (surveys, digital platform, recognition programs) and the 2023 risks (store safety, cybersecurity threats) are accurately identified. The impact on associate morale, turnover, and work experience is correctly described. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts 2022's internal engagement focus with 2023's external risk environment and synthesizes how the latter could undermine the former. The only minor omission is the specific mention that 'four out of five associates were emotionally committed' in 2022, which adds empirical support to the engagement claim but does not change the overall meaning. (4) The answer is fully contextually relevant, directly addressing the evolution of risks and their potential impact on the associate experience compared to prior-year initiatives. Wording differs slightly but maintains semantic equivalence. The correctness score is 9 instead of 10 due to this minor omission of a supporting statistic, but all key reasoning and facts are present and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 370,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\nBetween 2022 and 2023 the learning‑curve assumption shifted from a relatively routine cost‑reduction factor used to set program accounting quantities and margin forecasts to a central risk driver that directly shapes cost and production estimates.  The 2023 disclosures make clear that variations in the learning‑curve estimate can swing program gross‑margin assumptions by roughly $300 million (or about $330 million on a 1 % margin change) and have already generated cumulative catch‑up adjustments and the prospect of future losses on key development programs, underscoring its heightened importance for profitability and risk management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims the learning curve shifted from a 'routine cost-reduction factor' in 2022 to a 'central risk driver' in 2023, which contradicts the ground truth: in 2022, the learning curve was explicitly a risk factor (especially for the 787 program), and by 2023 it was increasingly integrated into planning and treated as predictable and manageable—representing a de-escalation of risk, not an elevation. The LLM reverses the direction of change. (2) The quantitative claims—such as a $300 million swing or $330 million per 1% margin change—are not present in the original answer and have no support in the ground truth; these figures are entirely fabricated. There are no numbers in the original about margin sensitivity or catch-up adjustments. (3) The multi-hop reasoning fails: the model misidentifies the evolution of the learning curve’s role, incorrectly frames it as becoming riskier, and introduces unsupported financial impacts. (4) While the answer is relevant to the topic of cost estimation, profitability, and risk management, the core facts and trajectory are wrong, severely undermining correctness. Minor contextual relevance is retained due to discussion of the right domain (program profitability, cost estimates), but the substance is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 371,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\nThe 2023 filing first disclosed that certain officers and directors participate in the company’s dividend‑reinvestment (and other) plans and that their share‑withholding elections can be structured to satisfy the affirmative‑defense safe harbor of Rule 10b5‑1 or, alternatively, to constitute non‑Rule 10b5‑1 trading arrangements. The 2024 filing repeats essentially the same language verbatim (Item 9(b) of “Other Information”), updating only the reference period (Dec. 31 2024 vs. Dec. 31 2023) and the holder count in Item 5, so no substantive change or new evolution in the treatment or disclosure of the dividend‑reinvestment plan’s officer/director participation and associated trading arrangements is evident.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim, which directly contradicts the ground truth. The original answer states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, indicating a simplification or standardization of disclosure. In contrast, the LLM claims the 2024 filing 'repeats essentially the same language verbatim,' asserting no substantive change. This is a fundamental error in qualitative accuracy. While the LLM correctly identifies the context of officer/director participation and references to trading arrangements in both years (contextually relevant), it fails to detect the key evolution—omission of detailed trading framework disclosures in 2024. There are no numerical values in the question or answers requiring quantitative evaluation beyond dates (e.g., Dec. 31, 2023 vs. 2024), which the LLM correctly notes as updated reference periods; hence, quantitative accuracy is high. However, the multi-hop reasoning fails because the model does not synthesize the difference in disclosure depth between the two filings. Instead, it incorrectly concludes no evolution occurred. The semantic meaning of the LLM answer diverges significantly from the ground truth, making it mostly incorrect despite some correct contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 365,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\nFrom fiscal 2021 through fiscal 2023 the retailer shifted from a broad, infrastructure‑focused rollout of omnichannel services (BOPIS, curb‑side pickup, mobile‑app enhancements) to a more data‑driven, personalized experience.  In 2023 the company explicitly said it is using “enhanced merchandising information‑technology tools … to build an interconnected shopping experience that is **tailored to our customers’ shopping intent and location**,” and it invested in store‑level tech such as electronic shelf‑labels, curb‑side lockers, expanded self‑checkout and mobile‑app navigation to make that tailored journey seamless across stores, online and on‑the‑job‑site — changes that go well beyond the foundational investments described in the 2021 filing.  (Pages 5, 7 & 8 of HD_10‑K 2023; page 5 of HD_10‑K 2022).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer mentions a $2.6 billion capital expenditure in fiscal 2021, the LLM answer does not include this specific figure. However, it correctly references the evolution from foundational investments in 2021 to more advanced, data-driven personalization in 2023 without introducing any incorrect numbers. The absence of the $2.6B figure is a minor omission but does not distort the overall narrative. (2) The LLM correctly identifies the shift in strategy from infrastructure-focused omnichannel services (e.g., BOPIS, curbside pickup, app enhancements) in 2021 to a more personalized, intent- and location-based experience in 2023 using enhanced IT tools—directly matching the core claim in the original answer. (3) The multi-hop reasoning is sound: it synthesizes information across fiscal years and correctly infers a strategic evolution based on disclosed initiatives. The mention of electronic shelf labels, lockers, self-checkout, and app navigation adds contextual detail consistent with the idea of tailoring the experience, even if not in the original answer—this elaboration is plausible and relevant. (4) Entity accuracy is strong: The Home Depot is correctly identified, fiscal years 2021–2023 are properly referenced, and the strategic focus on interconnected shopping experience is maintained. The answer is semantically equivalent to the ground truth, with slightly more operational detail. The only reason for not scoring a 10 is the omission of the $2.6B capital expenditure figure, which is a key quantitative anchor in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 453,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\nBetween 2022 and 2023 Danaher’s financial relationship with Aldevron shifted from the one‑time $9.6 bn cash purchase in August 2021 to a program of ongoing capital investment that grew to roughly **$1.5 bn in 2022** to expand Aldevron’s manufacturing capacity for COVID‑19‑related and broader biopharma demand; the company has since recorded only modest acquisition‑related outlays (e.g., $27 m of transaction costs in 2023 for the Abcam deal), indicating that subsequent spending has been focused on integrating and scaling the acquired business rather than on new purchase‑price expenditures.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $9.6 billion cash purchase of Aldevron occurred in August 2021, while the ground truth indicates that the acquisition was completed in 2022 (with $9,561 million paid in 2023 as net cash consideration). This misplacement of the acquisition date undermines the entire timeline. Additionally, the LLM claims that the $1.5 billion capital expenditure in 2022 was for expanding Aldevron’s capacity, but the original answer states that this capex was for multiple initiatives, with only a portion related to Aldevron—this overattribution is misleading. The mention of $27 million in transaction costs for Abcam in 2023 is factually irrelevant to the question about Aldevron and distracts from the core financial relationship. (2) Quantitative accuracy is poor: the $9.6 billion figure is close to the $9,561 million (approx. $9.56 billion), but assigning it to 2021 instead of 2023 is a critical error. The $1.5 billion capex figure is correctly cited but misattributed solely to Aldevron. (3) Multi-hop reasoning fails: the model does not correctly trace the evolution from partial capital investment in 2022 to full acquisition integration in 2023. Instead, it assumes the acquisition was completed in 2021 and frames 2022–2023 spending as post-acquisition scaling, which contradicts the ground truth that the major cash outflow occurred in 2023. (4) Contextual relevance is moderate because the answer discusses capital investment and acquisition-related expenditures in relation to Aldevron, but the incorrect timeline and inclusion of unrelated deals (Abcam) reduce its accuracy. The core shift—from capital investment anticipation in 2022 to major cash outflow in 2023—was missed entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 487,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\nFrom the 2022 filing (page 105) AT&T had $2 billion of Telco LLC cumulative preferred interests (the original Telco Class A‑1).  After the April 2023 expansion (page 87), an additional $5.25 billion of Class A‑2 and A‑3 interests were issued, so that by the end of 2024 the total preferred‑interest balance had grown to $7.25 billion.  The original Class A‑1 continues to pay a 4.25 % cumulative distribution with a seven‑year reset, while the newly added Class A‑2/A‑3 carry a higher 6.85 % initial distribution and a reset that begins on Nov 1 2027 and thereafter every seven years; no other distribution‑rate or reset‑schedule changes were made during the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts are accurate: $2 billion (Class A-1 in 2022), $5.25 billion (Class A-2/A-3 issued in April 2023), and total $7.25 billion by 2024 — the sum is correct ($2B + $5.25B = $7.25B). The distribution rates (4.25% for A-1, 6.85% for A-2/A-3) and reset schedules (seven-year cycle for A-1; first reset Nov 1, 2027, then every seven years for A-2/A-3) are correctly reported. Minor formatting differences (e.g., $2,000 vs $2 billion) reflect unit scaling ($2,000 thousand = $2 billion) and are semantically equivalent. (2) The answer is complete, addressing all parts of the multi-hop question: evolution of structure and total value (from $2B to $7.25B with new classes), changes in distribution rates (introduction of higher 6.85% rate), and reset schedule updates (new Nov 1, 2027 start). (3) Entities are accurate: Telco LLC, correct class designations (A-1, A-2, A-3), correct timeline (2022, April 2023 issuance, 2024 status), and no misattribution. (4) Reasoning is sound: the model correctly synthesizes data across time and document pages (2022 vs 2023/2024 filings), infers the structural expansion, and notes no other changes to rates or resets. The conclusion about strategic shift is implied correctly through factual contrast. All criteria are met with high precision and semantic equivalence to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 396,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\nBetween 2022 and 2024 AIG moved the expected‑loss‑ratio technique from a narrow focus on short‑tail lines (e.g., U.S. Property and certain program business) to a much broader set of long‑tail and specialty lines—including U.S. Workers’ Compensation, U.S. Excess Casualty, U.S. Financial Lines, and UK/Europe Casualty—driven by the 2017 adverse‑development‑reinsurance (ADC) arrangement and the need to model slower‑emerging, high‑severity risks (see 2024 Form 10‑K pages 151, 146, 152).  The 2022 filing (2022 Form 10‑K page 273) had described the method only for aviation and program‑business reserves, but by 2024 it was applied across those additional lines to capture inflation, deductible‑program complexity, and the longer emergence patterns that the ADC created.  Consequently, the rationale shifted from a simple premium‑to‑loss extrapolation to a more nuanced, experience‑based approach that incorporates risk‑sharing features, emerging severity trends, and the impact of large‑deductible business on reserve development.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in AIG's use of Expected Loss Ratio Methods between 2022 and 2024, correctly identifying the expansion from narrow, short-tail applications (e.g., aviation and program business in 2022) to broader use in long-tail lines like U.S. Workers' Compensation by 2024. The mention of U.S. Workers' Compensation aligns with the ground truth, which specifically highlights this line. However, the LLM overreaches by listing additional lines (U.S. Excess Casualty, U.S. Financial Lines, UK/Europe Casualty) not mentioned in the original answer, introducing unsupported detail. The rationale involving the 2017 ADC arrangement, inflation, deductible complexity, and risk-sharing features adds contextual depth but goes beyond the ground truth, which only states a general expansion to long-tail lines with varying claim characteristics without citing specific drivers like the ADC. While these details may be consistent with AIG’s filings, they are not part of the verified knowledge graph answer, making the response partially speculative. Quantitatively, there are no numerical inaccuracies (dates, percentages, dollar amounts), though none are explicitly cited—this is acceptable given the qualitative nature of the question. The reasoning is logically sound and reflects multi-hop synthesis across years and insurance lines, but the added specifics reduce qualitative accuracy. The answer remains highly relevant to the question and effectively communicates a broader trend in methodology evolution, warranting a correctness score of 7 for being substantially accurate but including unverified extensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 446,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\nFrom 2023 to 2024 Target moved beyond simply “strengthening” its owned‑brand portfolio (the 2023 strategy noted this as a core goal) to an aggressive expansion and diversification of that portfolio.  In 2024 the company launched or expanded several new exclusive lines—including the low‑price “dealworthy” essentials, Auden, Cat & Jack, Gigglescape and up&up—and grew 11 of its owned brands to more than $1 billion in annual sales (page 6, 2024 10‑K).  It also leaned heavily on high‑visibility designer and celebrity collaborations (e.g., Diane von Furstenberg, Taylor Swift | Eras Tour Book, Wicked × Stanley) and on exclusive design partnerships to differentiate the assortment across stores and digital channels (pages 3 and 26, 2024 10‑K).  Thus, the strategic emphasis shifted from building a solid owned‑brand base to using a broader, higher‑profile portfolio of exclusive brands as the primary driver of newness, style, value and guest loyalty.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the correct strategic evolution from 2023 to 2024—shifting from building owned brands to aggressive expansion and diversification—aligning well with the ground truth's emphasis on moving into a 'concrete execution phase.' The qualitative reasoning is strong: it correctly identifies the strategic shift, highlights exclusive collaborations, and notes the growth of high-performing brands. Contextual relevance is excellent, directly addressing both strategic emphasis and product portfolio development. However, the quantitative accuracy is problematic. The claim that '11 of its owned brands grew to more than $1 billion in annual sales' is not supported by the ground truth, which does not mention this figure or milestone. This introduces a significant factual overstatement. Additionally, while the LLM cites specific brands (e.g., Auden, Cat & Jack, up&up), the ground truth only confirms the existence of 'over 40 distinct brands' without naming them or referencing launches like 'dealworthy' or 'Gigglescape.' These specific brand names and the billion-dollar claim appear to be plausible extrapolations but are not present in the verified answer, suggesting potential hallucination. Thus, while the overall direction and strategic interpretation are accurate, the inclusion of unsupported quantitative and entity-specific details reduces factual precision. Multi-hop reasoning is sound in structure but based on potentially incorrect data points, leading to a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 415,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\nIBM kept its original 0.875 % Notes due 2030 on the 2024 filing but added a brand‑new 2.900 % Notes due 2030 issue.  The dual listing shows that the company is still comfortable carrying its low‑cost legacy tranche, yet it must supplement it with a higher‑coupon, longer‑dated bond—indicating that today’s capital‑market environment makes long‑term borrowing more expensive and selective, so IBM is issuing fresh debt at a higher yield to meet funding needs while preserving the cheaper legacy issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: IBM maintained the 0.875% Notes due 2030 and issued a new 2.900% Notes due 2030 in 2024. The percentages (0.875% and 2.900%), maturity year (2030), and timing (2024 filing) are all accurate, matching the ground truth. There are no calculation errors or incorrect numbers. (2) Quantitative accuracy is perfect—interest rates and years are correctly reported with no discrepancies. Format variations (e.g., spacing in '0.875 %') do not affect meaning. (3) The reasoning is largely sound: the LLM correctly infers that higher coupon rates suggest less favorable borrowing conditions and interprets the dual issuance as a strategy to meet funding needs while retaining cheaper debt. It captures the core implication about market conditions making long-term borrowing more expensive. However, it omits one key point from the ground truth: the possibility of targeting different investor segments or diversifying the debt portfolio for refinancing risk management. This minor omission prevents a perfect qualitative score. (4) The answer is highly contextually relevant, directly addressing IBM’s debt strategy and market conditions. Overall, the LLM conveys semantically equivalent information with only a slight gap in completeness regarding strategic diversification motives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 372,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\nBetween 2022 and 2024 the mix of AT&T’s long‑term debt shifted mainly by adding newer, higher‑coupon tranches while retaining the existing 4.000 % Global Notes due June 1 2049 (identified in the 2024 filing as “T 49A” on page 2).  The 2024 Form 10‑K shows that, in addition to the 2049 notes, AT&T issued several fresh senior unsecured series—including 4.25 % notes maturing in 2043 and 2044 and higher‑yielding 5.35 % and 5.625 % notes due in 2066‑67—expanding the overall long‑term debt balance and pushing the maturity profile further out.  The company also disclosed in 2024 the planned $2.25 billion issuance of non‑convertible cumulative preferred interests in Telco LLC, representing a new tier of long‑term financing that did not appear in the 2022 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Quantitatively, the LLM incorrectly states that AT&T issued 4.25% notes due in 2043–2044, 5.35% and 5.625% notes due in 2066–67, and a $2.25 billion preferred issuance in Telco LLC — none of which are mentioned in the original answer or supported by the knowledge graph. The only new instrument confirmed in the ground truth is the 4.300% Global Notes due November 18, 2034 (T 34C), which the LLM fails to mention entirely. (2) The coupon rate and maturity date of the new notes are completely fabricated, and the dollar amount of $2.25 billion has no basis in the provided truth. (3) Qualitatively, while the LLM correctly notes that the 4.000% Global Notes due 2049 (T 49A) remained in place, it fails to perform the correct multi-hop comparison: identifying the absence of the 2034 notes in 2022 and their presence in 2024. Instead, it invents multiple new instruments and misrepresents the evolution of the debt portfolio. (4) Contextually, the response addresses the general theme of debt composition changes and references long-term instruments, so it remains somewhat relevant, but the core factual content is largely incorrect. The reasoning is unsound due to reliance on hallucinated data rather than accurate synthesis across years. Minor formatting differences (e.g., spacing in '4.000 %') are acceptable, but the introduction of entirely false instruments and financial figures severely undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 421,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\nIn 2023 the Heritage AspenTech acquisition contributed roughly **$258 million** of intangible amortization (part of the $482 million total reported on page 55), and by 2024 the company’s total intangible amortization jumped to **$1.077 billion**—with $560 million of that amount tied to the newer NI acquisition, so the AspenTech‑related amortization continued but became a smaller share of the overall expense (page 55).  At the same time, restructuring costs linked to the acquisition more than tripled, rising from **$72 million in 2023 to $228 million in 2024** (including $43 million of integration‑related stock compensation disclosed on page 56), reflecting deeper integration and cost‑reduction activities after the deal.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, AspenTech-related intangibles amortization decreased from $258 million in 2023 to $97 million in 2024. However, the LLM claims that while AspenTech contributed $258 million in 2023, it does not state the correct 2024 figure of $97 million. Instead, it incorrectly implies that AspenTech amortization is still substantial (a 'smaller share' of a $1.077 billion total), which contradicts the ground truth showing a sharp decline. The restructuring cost numbers ($72M in 2023, $228M in 2024) are correctly reported. (2) The calculation and interpretation of amortization are flawed: the LLM introduces the NI acquisition as a confounding factor not mentioned in the question or ground truth, and fails to report the actual decrease in AspenTech-specific amortization. This leads to an incorrect inference about the trend. (3) The multi-hop reasoning is partially sound—linking integration costs to restructuring and noting increased expenses—but fails on the core financial evolution of AspenTech-specific amortization. The model adds extraneous details (e.g., integration-related stock compensation, page references) not in the ground truth, which may reflect overinterpretation. (4) While the restructuring cost evolution is accurately captured, the failure to correctly report the amortization decrease from $258M to $97M—a key part of the question—severely undermines factual correctness. The answer is contextually relevant and addresses both intangibles and restructuring, but the major error in the amortization trend limits accuracy. Hence, correctness is scored low (4), quantitative accuracy poor (3), qualitative reasoning moderate (5), and relevance high (8).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 483,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 AIG deepened its reliance on **expected‑loss‑ratio (ELR) methods** for workers‑compensation, but only within the **excess‑of‑deductible and large‑deductible segments** that now make up a growing share of the book.  The company began **segmenting the portfolio by deductible size, state and industry** and gave ELR estimates (typically weighted toward the most recent five accident years) greater prominence for those excess‑of‑deductible lines, while still using development‑based methods for the guaranteed‑cost portion.  This segmentation—driven in part by the 80 % adverse‑development‑reinsurance (ADC) cover on large‑deductible accounts—slowed claim‑reporting patterns but allowed AIG to lean more heavily on actuarial ELR inputs to set reserves.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies and introduces unsupported details, leading to a partially correct assessment. (1) Correct aspects: The answer correctly identifies AIG's increased focus on expected loss ratio (ELR) methods in excess-of-deductible and large-deductible segments and acknowledges the growing share of such business affecting claim reporting patterns. It also correctly notes segmentation by business characteristics and the use of ELR methods over multiple accident years for these lines. (2) Quantitative inaccuracy: The LLM introduces a specific '80% adverse-development-reinsurance (ADC) cover' figure, which is not present in the original answer or ground truth—this number is fabricated or hallucinated, severely undermining quantitative accuracy. No percentages or reinsurance coverage levels were mentioned in the original. (3) Qualitative issues: The original answer states that in 2022, ELR methods were used primarily for *guaranteed cost* business in the most recent accident year, while for *excess of deductible*, they were weighted over five years. The LLM reverses this emphasis by claiming ELR methods were applied only to excess/large deductible segments and that development methods were used for guaranteed cost—this misrepresents AIG’s 2022 methodology. Additionally, the original highlights new 2024 disclosures about limitations in claim count data due to aggregation and reinsurance exclusions, which the LLM omits entirely. (4) Contextual relevance is high because the response addresses the evolution of ELR methods, segmentation, and impact of large deductible accounts as asked. However, due to key factual errors in both direction of method application and the introduction of unsupported numerical claims, the overall correctness is significantly reduced. The reasoning fails the multi-hop synthesis test by misrepresenting the baseline (2022) state and adding unverified reinsurance details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 534,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\nTarget’s 2024 cybersecurity framework adds a formal **Cyber Fusion Center** and a **coordinated escalation model** that feeds incident‑response information to senior management and the Board, embedding the function within the enterprise‑risk‑management program and giving it explicit board‑level oversight. Compared with the 2023 filing—where the focus was on annual training, third‑party testing and general risk‑management integration—2024 expands the Fusion Center’s role, details its escalation process, and stresses **collaboration with external industry groups** to share threat intelligence and best practices, thereby broadening and formalizing its threat‑investigation and response capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2023 to 2024. It accurately identifies the continued operation and expanded role of the Cyber Fusion Center, the introduction of a coordinated escalation model to senior management and the Board in 2024, and the emphasis on external collaboration for threat intelligence sharing. The mention of third-party testing and training aligns with the original answer’s reference to leveraging third-party vendors and regular training for team members. However, there is a minor inaccuracy: the LLM states that the Cyber Fusion Center was 'formalized' or 'added' in 2024, while the ground truth clarifies that it was already operational in 2023 and maintained in 2024 with enhancements. This misrepresents the timeline of the Fusion Center's existence, though its expanded role in 2024 is correctly noted. All dates (2023 vs 2024) and entities (Target, Board of Directors, external organizations) are accurate. The reasoning is sound in comparing the two years and synthesizing changes in structure and collaboration, though slightly flawed in implying the 2024 creation rather than evolution of the Fusion Center. Wording differences are acceptable under semantic equivalence, but this specific point affects qualitative accuracy. No numerical data is present, so quantitative accuracy is not penalized. The answer remains highly relevant and captures the essence of Target’s evolving cybersecurity maturity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 413,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\nBetween June 2023 and the end of 2024 Eli Lilly moved from a one‑time divestiture of Baqsimi to an ongoing supply relationship with Amphastar.  In 2023 the company sold the product’s rights, recorded the full $625 million transaction price (the $500 M cash received in 2023 plus the $125 M cash received in 2024) and recognized a $579 M gain, and it entered a supply agreement that obligates Amphastar to purchase Baqsimi that Lilly manufactures; because the manufactured product has no alternative use and Lilly has a right to payment, it now recognizes net product revenue over time as it ships the product.  In addition, Lilly is eligible for up to $450 M of future sales‑based milestones, which have not been included in the transaction price and therefore will be recognized only when the related milestones are achieved.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in Eli Lilly's financial relationship with Baqsimi—shifting from a one-time sale to an ongoing supply arrangement—but introduces specific details not present in the ground truth. The $579 million figure is correctly cited as related to Baqsimi rights in 2023, aligning with the original answer. However, the LLM adds a $625 million transaction price ($500M in 2023 + $125M in 2024), which is not mentioned in the ground truth, nor is the $450 million in future milestones. These specific breakdowns and future payments are unsupported by the provided truth, introducing factual inaccuracies. (2) The ground truth does not mention Amphastar, supply agreements, revenue recognition over time, or milestone payments. While the $579M gain is consistent, the additional financial structure (split payments, eligibility for milestones) is speculative or derived from external knowledge. The time frame 'between June 2023 and end of 2024' is more precise than the ground truth’s annual focus, but not verifiable from the source. (3) The multi-hop reasoning is sound in concept—recognizing a shift from direct revenue to collaborative/supply-based recognition—but the model overextends by inferring contractual details and revenue recognition mechanics (e.g., 'no alternative use', 'right to payment') that are not in the original answer. The synthesis goes beyond the provided knowledge graph. (4) Despite the added details, the LLM correctly identifies the strategic shift in revenue recognition and the integration of Baqsimi into broader collaboration disclosures by 2024. The core message aligns semantically, but quantitative additions reduce factual accuracy. Hence, correctness is reduced to 7 due to unsupported numbers and entities, though reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 498,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\nIn 2023 AT&T retired its Mobility preferred equity by repurchasing the remaining 213 million Mobility Preferred Interests for $5.414 bn, funding the buy‑back with the April 2023 expansion of Telco LLC’s cumulative preferred interests; by the end of 2024 there were no Mobility preferred interests left on the balance sheet.  At the same time the company reshaped its Tower Holdings preferred structure in August 2024—resetting the rate to a 5.90 % fixed distribution and creating a floating‑rate tranche (SOFR + 250 bps) that can be called in 2029—while continuing to hold the $7.25 bn of Telco LLC preferred interests that were originally issued in 2020 and expanded in April 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AT&T's capital structure strategy from 2023 to 2024. (1) Quantitatively, the $5.414 billion repurchase of 213 million Mobility Preferred Interests in 2023 is correctly stated (matches $5,414 in original answer, with unit conversion from millions to billions). The funding via Telco LLC preferred interests issuance of $5,250 is slightly underreported as 'expansion' without specifying the exact 2023 issuance amount, but the cumulative total of $7.25 billion in Telco LLC preferred interests by 2024 is correctly noted. The restructuring of Tower Holdings in August 2024 with a 5.90% fixed rate and SOFR + 250 bps floating rate aligns with the ground truth. (2) The original answer specifies that the $5,250 issuance funded the repurchase, while the LLM implies it but does not explicitly state the $5,250 figure—this is a minor omission. (3) The LLM incorrectly states that the $7.25 billion in Telco LLC preferred interests were 'originally issued in 2020', whereas the ground truth specifies $2,000 as Telco Class A-1 (no year given as 2020) and the rest added in 2023. This introduces a minor factual inaccuracy in timing. (4) Despite this, the multi-hop reasoning is sound: the shift from repurchasing Mobility interests to expanding Tower and Telco structures is clearly and correctly conveyed. The strategic pivot is semantically equivalent. (5) Contextual relevance is perfect—the answer directly addresses the evolution in capital structure management across the two years and both entities. Overall, only minor quantitative and entity timing discrepancies prevent a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 451,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\nFrom 2023 to 2024 Emerson’s stake in AspenTech moved from roughly 55 % (a minority holding after the 2022 “New AspenTech” transaction) to a publicly announced proposal to buy the remaining shares at $240 per share—valuing the company at about $15 bn and putting Emerson on track to own 100 % of AspenTech.  The acquisition helped lift Emerson’s overall gross margin to 50.8 % in 2024 (up 1.8 percentage points), although the benefit was partially offset by about $231 million of inventory‑step‑up amortization that shaved roughly 1.3 percentage points off the margin.  At the same time, the transaction increased Emerson’s ownership share from ~55 % to about 57 % (and set the stage for full ownership), reshaping its equity structure and giving it complete control of the industrial‑software business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The claim that Emerson already held a ~55% stake in AspenTech in 2023 as a 'minority holding' is incorrect: the ground truth states that Emerson *acquired* a 55% ownership stake in 2024 as part of a transaction, not that it was a pre-existing minority stake. The LLM incorrectly reverses the timeline and ownership evolution. (2) The assertion that Emerson made a proposal to buy the remaining shares at $240 per share, valuing the company at $15B and moving toward 100% ownership, is not supported by the original answer, which makes no mention of such a proposal or full acquisition plans. (3) The LLM states ownership increased from ~55% to ~57%, which contradicts the ground truth that Emerson acquired 55% in 2024—there is no mention of a further increase to 57%. (4) Regarding financial impact, the LLM claims gross margin reached 50.8% in 2024 due to the acquisition, but the original answer does not provide an absolute margin figure—only that AspenTech contributed a 3.3 percentage point increase in 2023 and a 1.8 percentage point increase in 2024. This is a critical error: the LLM fabricates an absolute margin value (50.8%) and misattributes the timing of the 3.3-point boost (which occurred in 2023, not 2024). (5) The mention of $231 million in inventory-step-up amortization reducing margin by 1.3 points is not in the original answer and appears to be hallucinated. (6) The qualitative reasoning is flawed: the transformation is misrepresented as a move from minority to near-full ownership, when the ground truth describes a shift from a business relationship to a 55% controlling stake. While the answer correctly identifies the strategic shift and some margin impact, the core facts—ownership timeline, financial figures, and transaction details—are incorrect. The contextual relevance is moderate because it addresses the right topic and attempts multi-hop synthesis, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 543,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\nBetween 2022 and 2024 the Japan‑specific pension plans have consistently made up about one‑half of AIG’s non‑U.S. pension obligations – roughly 54 % of the total in 2023 and 50 % in 2024, indicating only a modest decline in their relative share.  At the same time, the weighted‑average discount rate applied to these plans rose from about 1.09 % in 2022 to 1.48 % in 2023 and then to 1.81 % in 2024, an increase of roughly 0.72 percentage points over the two‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the 2022 data. The original answer states that in 2022, Japan pension plans accounted for 61% of non-U.S. pension *assets* (not obligations), but the LLM incorrectly reports the share of *obligations* in 2022 as roughly 54%, which is actually the 2023 figure for projected benefit obligations. The LLM invents a 2022 obligation percentage (implying ~54%) and a discount rate of 1.09% for 2022, which is not supported by the ground truth. The ground truth only provides a 2022 expected long-term rate of return (1.85%), not a discount rate. The 1.48% discount rate is correctly attributed to 2023, and 1.81% to 2024, which matches the original. (2) Calculations: The LLM claims a 0.72 percentage point increase from 1.09% to 1.81%, but since the 1.09% figure is fabricated, this calculation, while mathematically correct based on its own numbers, is factually wrong. The actual change in discount rate from 2023 to 2024 is +0.33 points (1.48% to 1.81%), but no 2022 discount rate is provided in the ground truth for comparison. (3) Multi-hop reasoning: The LLM correctly identifies the trend of declining share in obligations (54% in 2023 to 50% in 2024) and increasing discount rate in 2024, but fails to accurately anchor the 2022 baseline, leading to an incorrect evolution narrative. It conflates assets with obligations and invents missing data. (4) Scores justified: Correctness is 5 due to partial accuracy on 2023–2024 trends but major errors in 2022 data and metric confusion. Quantitative accuracy is low (4) due to incorrect numbers. Qualitative accuracy is moderate (6) as reasoning structure is sound but based on flawed data. Contextual relevance is high (9) as the answer addresses the right entities and time frame with appropriate financial interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 504,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\nIn the 2022 filing Amazon described competition mainly as a threat from a handful of large, established retailers and technology firms that could out‑spend it on price, selection and fulfillment and that could leverage scale, supplier relationships and brand power to pressure the business. By the 2023 filing the language shifted to stress that the Internet’s comparison‑shopping environment lowers entry barriers, allowing new, smaller or niche players—and well‑funded newcomers—to compete with Amazon, and that rapid changes in business models make the competitive landscape increasingly dynamic and unpredictable. Thus, the framing moved from focusing on the power of incumbent rivals to emphasizing a more fluid, open market where external conditions continuously enable new entrants.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and does not align with the ground truth from the actual 10-K filings. (1) The original answer states that Amazon's 2022 and 2023 10-Ks used nearly identical core language about competitive stores—listing them among other factors like price decreases and product improvements—but that the 2023 filing embedded this within a broader discussion of external economic and geopolitical conditions. In contrast, the LLM answer fabricates a narrative about a shift from 'large, established retailers' in 2022 to 'new, smaller or niche players' in 2023 due to the Internet’s comparison-shopping environment, which is not supported by the actual filings. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse the factual inaccuracies. (3) The multi-hop reasoning fails because the LLM invents competitive dynamics and framing shifts that are not present in the source documents. It misrepresents the evolution of Amazon’s risk factor disclosure, which was a subtle contextual shift in emphasis—not a change in the nature of competitors described. (4) While the LLM attempts to address the evolution of competitive framing, it does so with incorrect details, making the response contextually relevant in intent but inaccurate in execution. The core error is attributing a strategic reinterpretation of competition to Amazon that is not reflected in the actual text of the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 419,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\nBetween 2023 and 2024 Target’s discussion of port‑security risk moved from a specific focus on “California ports” (2023) to a broader warning about “major U.S. ports” where it receives a large share of imported merchandise (2024).  In both filings the risk is presented as a supply‑chain interruption that can raise costs, cause inventory shortages or out‑of‑stocks, and ultimately damage sales and reputation, but the 2024 filing expands the geographic scope and emphasizes that any recurrence could further increase costs and strain Target’s operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in Target's port security risk exposure between 2023 and 2024. It correctly identifies the shift from a specific focus on 'California ports' in 2023 to a broader concern about 'major U.S. ports' in 2024, which aligns with the ground truth. The operational impact is accurately described in both years—supply chain interruptions, cost increases, inventory shortages, and potential sales impact. The LLM correctly notes that in 2023, Target referenced past disruptions and alternative arrangements, while in 2024 the emphasis is on future risks due to global conflicts and labor disputes, though this last detail is slightly underemphasized. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated). The reasoning is sound and reflects proper multi-hop synthesis across the two years and filings. The only minor shortcoming is that the LLM does not explicitly mention that in 2023, California ports were where Target received a 'significant portion' of imports, nor does it clearly state the 2024 shift in emphasis to 'potential future impacts'—details present in the original answer. However, the semantic meaning is sufficiently preserved. Contextual relevance is excellent as all parts of the question (geographic focus, operational impact, evolution over time) are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 382,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the amortization of the intangibles acquired in the Heritage AspenTech deal fell out of the spotlight—2023’s $258 million amortization (page 55) was now embedded in the $1.08 billion of total intangible amortization for 2024, of which $560 million related to the newer NI acquisition (page 55).  At the same time, restructuring outlays linked to the AspenTech integration more than tripled, rising from $72 million in 2023 to $228 million in 2024 (page 55), driven by additional workforce cuts, facility exits and $43 million of integration‑related stock compensation attributed to NI (page 56).  In short, Emerson moved from ongoing amortization of the Heritage AspenTech purchase to a larger, one‑time restructuring expense to consolidate the combined business.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $258 million intangibles amortization in 2023 and the $72 million to $228 million increase in restructuring costs, which aligns with the ground truth. However, it introduces new information not present in the original answer—specifically, that the AspenTech amortization was 'embedded' in a $1.08 billion total and that $560 million of that related to the 'NI acquisition'—which is not mentioned in the ground truth. This adds unsupported detail and could mislead. Additionally, the claim that $43 million of integration-related stock compensation was attributed to 'NI' goes beyond the original answer and introduces a new entity (NI) without grounding in the provided truth. (2) The core numbers—$258M amortization in 2023, $72M and $228M restructuring costs—are quantitatively accurate. However, the additional figures ($1.08B total amortization, $560M for NI, $43M stock comp) are unverified against the ground truth and reduce quantitative accuracy. (3) The reasoning is logically sound in interpreting a shift from amortization to restructuring, which matches the ground truth’s inference of shifting focus post-acquisition. The multi-hop synthesis between 2023 and 2024 financials is appropriate, but the inclusion of NI-related data introduces a potential factual overreach not supported by the original answer. (4) Despite the extraneous details, the answer remains highly relevant to the question about Emerson’s financial relationship with AspenTech, correctly capturing the evolution in amortization and restructuring. The core narrative aligns with the ground truth, but the added specifics reduce factual precision. Hence, correctness is partially impacted, warranting a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 474,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\nBetween 2022 and 2024 AIG moved from a general “use the Expected‑Loss‑Ratio method in recent accident years” approach to a more‑specific weighting scheme.  In 2024 the company said the method is given **significant weight only in the most recent accident year for guaranteed‑cost workers‑compensation**, while for **excess‑of‑deductible and other long‑tail lines it may be weighted over the five most recent years**, and for **specialty liability lines (D&O, E&O, EPLI, etc.) it is consistently emphasized in the most recent years**.  This reflects a shift toward line‑specific, accident‑year windows for the weight placed on the Expected‑Loss‑Ratio method.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AIG's use of the Expected Loss Ratio (ELR) method between 2022 and 2024 but introduces specific details not present in the ground truth, particularly around 'weighting schemes' and accident-year windows. The original answer states that in 2022, ELR was used primarily for recent accident years in D&O, E&O, EPLI, and professional liability—this is correctly reflected. The 2024 expansion into U.S. Workers' Compensation is mentioned in the ground truth, but the LLM adds granular detail—such as 'significant weight only in the most recent accident year for guaranteed-cost workers-compensation' and 'weighted over the five most recent years' for excess-of-deductible lines—which are not supported by the provided ground truth. These specifics suggest a more structured, line-specific weighting framework than the original describes. While the direction of evolution (broader application, integration with other methods, extension to long-tail lines like Workers' Comp) is accurate, the LLM over-specifies the implementation. There are no numerical values to verify, so quantitative accuracy is assessed on factual precision of timeframes and scope—minor deviations are acceptable, but invented details reduce accuracy. The reasoning is logically sound and addresses the multi-hop aspect (change over time, across lines of business), but synthesizes beyond the source. Contextually, the answer is highly relevant and well-structured. Overall, the core evolution is correct, but unsupported specifics reduce correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 434,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\nAmazon boosted the amount of video‑and‑music content it has capitalized — from **$16.7 billion at the end of 2022 to $17.4 billion at the end of 2023** — and the related expense jumped from **$16.6 billion in 2022 to $18.9 billion in 2023**.  This reflects a more aggressive monetization of its film‑group assets: higher content spend, a shorter weighted‑average remaining life for the capitalized library (down to ~2.6 years), and faster amortization to “Cost of sales,” indicating that Amazon is investing more heavily in original and licensed titles and seeking to recover those costs more quickly through Prime streaming and related revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: capitalized video and music content costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and associated expenses rose from $16.6 billion to $18.9 billion. These numbers match the original answer exactly and are presented with acceptable formatting (e.g., $16.7 billion vs $16.7B). (2) Quantitative accuracy is perfect—no calculation or data errors. The increases ($0.7B in capitalized costs and $2.3B in expenses) are consistent with the provided data. (3) The qualitative reasoning is strong and adds value by interpreting the trend as a more aggressive monetization strategy, citing faster amortization and a shorter weighted-average remaining life (~2.6 years), which aligns with the idea of quicker cost recovery through Prime. While this specific amortization detail is not in the ground truth and cannot be verified from the original answer, it does not contradict it and plausibly supports the conclusion. However, since this detail was not in the source knowledge, it introduces unverified information, slightly reducing qualitative accuracy. (4) The answer is fully contextually relevant, addressing the evolution of Amazon's monetization strategy through changes in capitalized costs and expenses between 2022 and 2023. The core conclusion—that Amazon is investing more heavily and monetizing more aggressively—is logically sound and semantically equivalent to the original. The added detail about amortization enhances reasoning but slightly exceeds the evidence, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 467,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Philip Morris International’s equity stake in RBH (Rothmans, Benson & Hedges) remained in place, but the investment’s carrying value came under intense pressure from the Canadian CCAA restructuring and the still‑unresolved CAD 32.5 bn settlement allocation among RBH, Imperial Tobacco Canada and JTI Macdonald.  Consequently, PMI performed a valuation in 2024 and recorded a $2.3 bn non‑cash impairment charge (reflected in the 2024 earnings), reducing the book value of its RBH investment.  (Pages 37 [2022] and 30 [2024] of the filings).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution in Philip Morris International's financial relationship with RBH from 2022 to 2024. (1) Quantitatively, all key figures are correct: the $2.3 billion impairment charge (equivalent to $2,316 million in the ground truth, with minor rounding acceptable), the CAD 32.5 billion litigation settlement amount, and correct referencing of filing pages (37 for 2022, 30 for 2024). (2) The answer correctly identifies the shift from a brand licensing/trademark relationship in 2022 (implied by context of ongoing volume reporting) to an equity investment under financial strain in 2024. (3) The multi-hop reasoning is sound: it connects PMI’s equity stake, the unresolved litigation allocation among RBH, Imperial Tobacco Canada (ITL), and JTI Macdonald (JTIM), and the resulting impairment decision in 2024. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 trademark and brand licensing relationship (e.g., HEETS and heated tobacco volume reporting), which is a key part of the original answer’s narrative of evolution. However, the implication is present through context. Wording differs but semantic meaning aligns closely. All entities, years, and financial terms are accurate. The answer is fully relevant and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 367,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\nThe 2023 and 2024 10‑Ks both state that a 5 % movement in the consolidated sales‑return, rebate and discount accrual would change net product revenue by roughly **$615 million**.  Although the accrual balance grew from about $8.2 billion (end‑2022) to $10.7 billion (end‑2023), the disclosed dollar impact per percentage‑point change remained the same, indicating that the revenue‑sensitivity to these liability fluctuations did not materially evolve between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect due to a critical factual error: it claims that the 2024 10-K disclosed a $615 million sensitivity figure for a 5% change in sales return, rebate, and discount liabilities, which contradicts the ground truth. The original answer confirms that while the 2023 10-K included the $615 million figure, the 2024 10-K did *not* provide an updated sensitivity estimate. Therefore, stating that both years disclosed the same amount is factually wrong. This error undermines the conclusion that sensitivity 'did not materially evolve'—in reality, no updated quantitative disclosure was made in 2024, so no valid comparison can be drawn. The mention of accrual balances increasing from $8.2B to $10.7B may be contextually relevant but is not substantiated in the ground truth and does not compensate for the core inaccuracy. The reasoning fails the multi-hop requirement: the model should have recognized the *absence* of 2024 data as a key change in disclosure practice, rather than assuming continuity. While the $615 million figure is correctly attributed to 2023, the erroneous extension to 2024 severely compromises quantitative and qualitative accuracy. Contextual relevance is moderate because the answer addresses the right topic and metric, but with false precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 361,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\nIn 2024 Bulk shipments generated about 32 % of Union Pacific’s total freight revenue—up slightly from roughly 30 % in 2022 and 31 % in 2023—while the segment’s dollar revenue rose to approximately $7.3 billion, driven by modest volume gains in grain, fertilizer and food that offset declining coal volumes and kept Bulk as a stable, core contributor to the railroad’s overall freight earnings.  (See 2024 PDF pages 6‑8 for the 32 % share and 2022 PDF page 35 for prior‑year freight‑revenue trends.)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific percentages (30% in 2022, 31% in 2023, 32% in 2024) and a dollar figure ($7.3 billion) not present in the original answer. The ground truth does not provide a percentage for 2022 or 2023, nor any total revenue or dollar amount for Bulk shipments—only that in 2024, Bulk contributed 32% of total freight revenues. The $7.3 billion figure and year-by-year percentage progression are unsupported by the provided ground truth, making these additions factually unverifiable and potentially incorrect. (2) The original answer references average revenue per car of $3,305 in 2021 (from the 2022 filing) and a 6% increase from 2020, but the LLM answer omits this entirely. This is a significant omission in quantitative detail that was part of the original multi-hop evolution narrative. (3) The LLM correctly identifies the growing strategic importance of Bulk shipments and mentions key commodities (grain, fertilizer, coal), aligning with the original's focus on grain, fertilizer, and coal markets. It also correctly notes the stability and core contribution of Bulk, which is consistent with the original’s theme of increased strategic embeddedness. However, it fails to mention international connections to Mexico or Canadian interline routes, which are key elements of the strategic evolution in the original. (4) While the LLM synthesizes a plausible narrative and correctly identifies the 32% figure for 2024, it fabricates intermediate data points and omits earlier revenue-per-unit trends, undermining quantitative accuracy. The reasoning is partially sound but overreaches by introducing unsupported specifics. Correctness score is 6 due to partial factual alignment but significant quantitative inaccuracies and omissions; qualitative accuracy is 7 due to correct framing and context; contextual relevance is high as the answer directly addresses the evolution of Bulk shipments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 522,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\nThe coupon rate on IBM’s 2028 notes was unchanged at 0.300 % (IBM 28B) and 1.750 % (IBM 28A) in both 2023 and 2024. This stability shows IBM is deliberately locking in low, fixed rates on long‑dated debt, underscoring a conservative debt strategy that prioritizes low‑cost financing and a strong balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error by introducing a 0.300% coupon rate for 'IBM 28B' in both years, which is not present in the ground truth. The original answer only references the 1.750% Notes due 2028 (IBM 28A), with no mention of a 0.300% note. This incorrect addition undermines the quantitative accuracy. However, the 1.750% rate for IBM 28A is correctly stated as unchanged between 2023 and 2024, which aligns with the ground truth. (2) The calculation or comparison of interest rates is not erroneous per se, but the inclusion of a non-existent 0.300% note distorts the overall picture. No actual calculations (e.g., averages, differences) are performed, so the error is in entity reporting rather than arithmetic. (3) The reasoning about IBM maintaining a conservative debt strategy by locking in low fixed rates is plausible and contextually sound, but the LLM fails to mention the key strategic move highlighted in the ground truth: the issuance of new, higher-rate, longer-term debt (e.g., 2.900% due 2030, 3.150% due 2033), which indicates a broader debt strategy beyond just maintaining existing low rates. This omission limits the qualitative accuracy and completeness of the multi-hop synthesis. (4) The contextual relevance is high because the answer addresses the evolution of interest rates and infers a debt strategy, but the inclusion of false entities and omission of key strategic developments reduces correctness. The core fact about the 1.750% note stability is correct, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 428,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T eliminated its former Mobility Preferred Interests—completing the repurchase of the remaining 213 million shares in April 2023 (see page 55 of the 2023 10‑K).  In 2024 the company introduced a new preferred‑equity structure, amending the 2019 Tower Holdings preferred interests to create Fixed‑Rate and Floating‑Rate Class A membership interests with reset distribution rates and adding $5.25 billion of additional cumulative preferred interests in the Telco LLC vehicle (see page 87 of the 2024 10‑K).  This shift moves AT&T’s capital‑structure strategy from the now‑retired Mobility preferred instrument to a layered, reset‑rate preferred framework that can be managed independently and on more flexible terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AT&T repurchased all Mobility Preferred Interests in 2023, specifically noting the completion in April 2023, which matches the timeline in the 2023 10-K. While the original answer cites a redemption value of $5,340 million and annual distributions of $373 million, the LLM omits these exact figures but correctly frames the elimination of the instrument. (2) For 2024, the LLM accurately describes the restructuring of Tower Holdings preferred interests into Fixed- and Floating-Rate Class A membership interests, including reset distribution rates, which reflects the structural modifications in the ground truth. It also correctly notes the $5.25 billion addition to Telco LLC preferred interests. However, the original answer specifies the total Telco LLC preferred interests reached $7,250 million, while the LLM only mentions the $5.25 billion addition without confirming the total, which may imply a missing synthesis step. (3) The reasoning is sound: the LLM correctly infers a strategic pivot from Mobility-based preferred interests to a more flexible, diversified preferred capital structure tied to infrastructure assets. It supports this with specific 10-K page references, indicating proper multi-hop synthesis across filings. (4) The answer is contextually excellent, directly addressing the evolution of AT&T’s capital structure strategy. The only minor gaps are the omission of the $5,340 million redemption value and the failure to state the final $7,250 million total for Telco LLC, which slightly affects quantitative completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 482,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon moved from a broad, generic warning that it “faces the introduction of competitive stores, websites, products, services, price decreases, or improvements” (2022 10‑K, page 9) to a detailed articulation of the **principal competitive factors** that now include **selection, price, convenience, speed and reliability of services, and the ability to lock‑in customers** (2023 10‑K, page 4).  The newer language also stresses that many rivals have **greater resources, longer histories, stronger brands, and control over critical inputs**, can pursue **restrictive distribution deals, aggressive pricing, and heavy investment in technology and fulfillment**, and that the internet **lowers entry barriers for new, smaller competitors** (2023 10‑K, page 4).  These changes signal a shift from viewing competition mainly as price‑driven new entrants to seeing it as a multifaceted battle over ecosystem advantages, strategic lock‑in, and the capacity of rivals to out‑invest and out‑maneuver Amazon.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Amazon's competitive language between 2022 and 2023. It accurately identifies that in 2022, Amazon used a broad, generic phrase about competitive pressures including websites, which matches the ground truth description of a 'broader list of fluctuating business factors.' In 2023, the LLM correctly notes a shift to more strategic and detailed language, citing specific competitive factors like selection, price, convenience, speed, reliability, and customer lock-in—details that are consistent with a more focused and intensified competitive stance as stated in the original answer. The LLM adds valuable context not explicitly in the ground truth—such as rivals' greater resources, brand strength, and investment capacity—which is factually supported in Amazon’s 2023 10-K and enriches the analysis. However, the ground truth emphasizes a shift from 'general awareness' to 'central concern,' while the LLM frames it as a shift from 'price-driven new entrants' to 'multifaceted battle.' This is a slight overstatement: the 2022 characterization was not exclusively price-driven, and the original answer does not claim that. This minor interpretive overreach affects qualitative accuracy slightly. All cited page numbers and years (2022 and 2023 10-Ks) are accurate, and there are no numerical errors (quantitative accuracy is perfect). The answer is highly relevant, addressing both the evolution in language and the implied strategic shift. Thus, the answer is factually sound and well-supported but slightly exceeds the nuance of the ground truth in framing the nature of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 458,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\nFrom 2022 through 2024 PMI moved the 2020 global collaboration with KT&G from a pilot‑phase partnership into a core, multi‑regional distribution model, making KT&G’s heat‑not‑burn devices and consumables (e.g., LIL, Fiit, Miix) a central pillar of PMI’s smoke‑free portfolio.  This is reflected in the rapid rise of PMI’s smoke‑free net revenues—from about $10 bn in 2022 to $14.7 bn in 2024—with a growing share of that growth driven by licensed KT&G heat‑not‑burn products sold across Europe, the Americas and other markets, underscoring PMI’s strategic reliance on KT&G’s HNB offerings to replace declining cigarette volumes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original agreement was established in 2022, not 2020 as stated in the LLM answer, which misrepresents the timeline. Additionally, the LLM claims that KT&G's products became a 'central pillar' and 'core, multi-regional distribution model' by 2024, but the ground truth emphasizes a shift from distribution to integration into PMI's own portfolio—indicating deeper strategic reliance through product assimilation, not just expanded distribution. The LLM omits this key evolution in the nature of the relationship (from distributor to integrator). (2) Quantitatively, the LLM introduces financial figures not present in the ground truth: smoke-free net revenues of $10B in 2022 and $14.7B in 2024. These numbers are unsupported by the provided knowledge graph and represent a major fabrication or misattribution. There is no mention of revenue figures in the original answer, so these cannot be verified and appear invented to bolster the narrative. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the expansion of KT&G’s HNB products within PMI’s portfolio and their role in addressing declining cigarette volumes—but fails to capture the qualitative shift from exclusive distribution to integration into PMI’s own product line, which is the core of the strategic evolution. The reasoning overemphasizes scale and revenue impact without grounding in the actual structural change in the partnership. (4) Contextual relevance is high because the answer addresses the strategic reliance on KT&G and the role of HNB products in PMI’s portfolio. However, due to incorrect dates, invented financial data, and failure to accurately describe the nature of the evolving relationship, the overall correctness score is low. Minor positive: correct product names (LIL, Fiit, Miix) and regions (Europe, Americas) suggest some alignment with external knowledge, but these do not compensate for core inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 550,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the PWCC Acquisition Long‑Term Performance Plan strictly limited to awarding former PricewaterhouseCoopers Consulting employees, but it refreshed the plan’s administration by tying it to the 2022 amendment of the Amended and Restated Deferred Compensation and Equity Award Plan (effective December 13 2022) and by documenting the awards under the same governance structure used for the company’s other long‑term performance plans.  The scope did not broaden – senior executives remain excluded – but the plan’s documentation and oversight were updated to reflect the 2022 amendment and to align with the Executive Compensation and Management Resources Committee’s authority over all compensatory plans.  (Pages 23 and 28 of IBM 2024 10‑K; page 28 of IBM 2022 10‑K).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth, significantly affecting correctness. While it correctly identifies that the PWCC Plan remained limited to former PwCC employees (consistent scope), it incorrectly claims administrative changes occurred in 2022 by linking the PWCC Plan to the '2022 amendment of the Amended and Restated Deferred Compensation and Equity Award Plan' and asserting updated governance or alignment with other IBM plans. The original answer states that the plan's administration and terms remained 'substantively identical' to the 2001 Plan, with no mention of integration into broader IBM compensation structures or governance updates. This misrepresents the continuity emphasized in the ground truth. Additionally, the LLM introduces specific details like 'senior executives remain excluded' and references to committee authority and documentation practices not found in the original answer, which lacks any mention of exclusions or governance realignment. The dates (December 13, 2022) and page numbers are plausible but not verifiable from the ground truth and appear to be fabricated or assumed. While the core idea of unchanged scope is correct, the emphasis on administrative updates contradicts the original answer's message of stability and reaffirmation. Thus, despite some alignment in scope description, the LLM fails on key qualitative and quantitative aspects of the plan’s evolution, particularly administration. The answer is contextually relevant to the question but conveys a misleading narrative of change rather than continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 445,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T eliminated its Mobility Preferred Interests—repurchasing the remaining ≈ 213 million interests in April 2023 for $5.4 bn and re‑classifying them from equity to a cash‑settlement liability—so that no preferred‑equity obligation remained on the balance sheet.  In 2024 the company reshaped its tower‑related preferred securities (resetting the 2019 Tower preferred interests into fixed‑ and floating‑rate tranches and expanding the Telco LLC preferred stack), effectively refinancing those obligations at newer rates and with greater flexibility.  This transition reflects a broader capital‑structure strategy of actively retiring legacy preferred equity, restructuring remaining preferred‑interest arrangements to match current market conditions, and using cash and staged equity‑linked instruments to improve liquidity and reduce long‑term financing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AT&T repurchased the Mobility Preferred Interests in 2023 for $5.4 billion (matching the ground truth $5,414 million, with minor rounding acceptable). The April 2023 timing is consistent with the 2023 fiscal year and adds specificity not contradicted by the original. (2) The answer accurately notes the elimination of the obligation by 2024 and contrasts it with the continued existence and restructuring of Tower Holdings and Telco LLC preferred interests—correctly identifying the strategic differentiation in capital structure management. (3) The qualitative reasoning is strong: it infers a broader strategy of retiring legacy preferred equity while refinancing other instruments for flexibility, which is a valid interpretation of the shift. (4) Minor deduction in quantitative accuracy due to the ≈213 million interests and reclassification to 'cash-settlement liability'—details not present in the ground truth and potentially conflating accounting treatment; however, these do not contradict core facts. Overall, the answer addresses all parts of the question, synthesizes multi-hop information correctly (Mobility vs. Tower/Telco treatment across years), and maintains semantic equivalence with the original. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 375,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s disclosures show that its exposure to stock‑exchange regulations for debt securities has remained anchored in the same core SEC requirements—namely, reporting of debt issuances, compliance with listing and registration rules, and the need to respond to rating‑agency actions—but the language has broadened to reflect newer regulatory themes.  The 2024 10‑K (pages 11 and 20) expands the risk‑factor discussion to include heightened scrutiny of ESG‑related, cybersecurity and data‑privacy regulations that could affect the company’s ability to issue or maintain debt, whereas the 2022 filing (pages 18 and 22) focused more narrowly on interest‑rate, currency and market‑liquidity risks.  Consequently, IBM’s regulatory exposure has evolved from a primarily financial‑market focus to a broader compliance landscape that now integrates emerging securities‑exchange and regulatory requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but diverges significantly from the ground truth in terms of the core evolution described. (1) The original answer emphasizes a shift in IBM's language from viewing stock exchange regulations as an external factor influencing debt value in 2022 to being 'subject to' them in 2024—indicating a stronger recognition of direct regulatory exposure. The LLM instead frames the evolution around broadening regulatory themes (e.g., ESG, cybersecurity), which is not supported by the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is partially sound—comparing 2022 and 2024 disclosures—but misidentifies the nature of the evolution. The LLM introduces specific page numbers and regulatory themes (ESG, cybersecurity) not mentioned in the ground truth, suggesting potential hallucination or misattribution. (4) While the answer addresses regulatory exposure and temporal change, it fails to capture the actual shift in IBM's framing (from indirect influence to direct subjection), which is central to the original answer. Thus, despite good structure and relevance, the qualitative inaccuracy reduces correctness to a 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 347,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Disney’s 50 % equity stake in A+E stayed the same, but the earnings that flowed back to Disney fell sharply.  In the 2022 filing (page 25) A+E was presented as an equity‑method investment, and by the 2024 filing (page 26) Disney reported that “equity in the income of investees decreased $207 million to $575 million … due to lower income from A+E,” indicating a sizable drop in the joint‑venture’s contribution to Disney’s equity income.  The decline reflects weaker operating performance and related goodwill impairments at A+E, so that A+E’s equity‑income contribution was far smaller in 2024 than it had been in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $207 million decrease in equity income is accurately cited from the 2024 filing, and the reference to A+E (A&E) as a key equity-method investee is consistent with the original answer. The mention of page 26 in the 2024 filing and page 25 in the 2022 filing adds verifiable detail without contradicting the ground truth. (2) The 50% ownership stake is factually correct and contextually relevant, though not mentioned in the original answer; however, it does not detract from accuracy and is consistent with known public information. (3) The reasoning is sound: the LLM correctly synthesizes multi-hop information by identifying A&E’s role in 2022, tracking the change in equity income by 2024, and attributing the decline to lower performance and goodwill impairments—this goes slightly beyond the original answer but remains factually plausible and contextually supported. (4) The core claim—that A&E’s contribution to Disney’s equity income declined materially from 2022 to 2024 due to lower income—is fully supported and semantically equivalent to the ground truth. The only minor point is that the original answer does not mention goodwill impairments or operating performance, so that addition, while reasonable, is an inference not present in the ground truth, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is complete, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 417,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\nThe carrying amount of securitized debt obligations grew from **$16.97 billion at the end of 2022 to $18.04 billion at the end of 2023**—an increase of roughly **$1.07 billion (about 6 %)**.  \n\nThis rise shows that Capital One deliberately **expanded its securitization activity**, using securitized debt as a larger share of its long‑term funding mix to support asset growth and diversify funding sources.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change in the carrying value of securitized debt obligations. The ground truth states that the carrying value decreased to $18.043 billion by December 31, 2023, from a prior level (implied in 2022) that was part of a total long-term funding of $42.3 billion as of December 31, 2021, with securitized debt being a significant component. The LLM incorrectly claims the value increased from $16.97 billion in 2022 to $18.04 billion in 2023, which contradicts the downward trend indicated in the original answer. This misrepresents the core fact: the company reduced its reliance on securitized debt, not expanded it. The calculation of a $1.07 billion (6%) increase is therefore based on false inputs and is inaccurate. The qualitative reasoning is also flawed—the conclusion that Capital One expanded securitization activity and is using it more heavily in its funding mix directly contradicts the ground truth, which indicates a strategic reduction. The entities (securitized debt obligations, long-term funding) and time periods (2022–2023) are relevant, but the financial data and resulting interpretation are entirely incorrect. While the answer attempts to address both parts of the question (change in value and strategic implication), the multi-hop synthesis fails because it uses fabricated numbers and draws the opposite conclusion of the correct one. Contextual relevance is low due to factual inversion, though the structure and topic alignment are partially appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 425,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Disney reduced the role of its international general‑entertainment linear channels (Fox, Star, National Geographic, etc.) as the primary outlet for scripted programming and instead began concentrating that content on its direct‑to‑consumer services—most notably Disney+, Disney+ Hotstar and the forthcoming ad‑supported Disney+ tier that will also carry ESPN linear feeds.  The company has reorganized its Media & Entertainment Distribution unit, introduced price increases and an ad‑supported Disney+ offering, and is shifting monetisation from licensing those channels to DTC distribution while still maintaining the channels only where regulatory or market requirements demand.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic shift from international linear channels to DTC platforms. It accurately identifies the reduction in focus on scripted programming via linear channels (Fox, Star, National Geographic) and the pivot toward DTC services like Disney+ and Disney+ Hotstar. The mention of the ad-supported Disney+ tier and reorganization of the Media & Entertainment Distribution unit reflects accurate qualitative understanding. However, the LLM omits key multi-hop details present in the original answer: (1) the specific number of ~220 international general entertainment channels in 2022, and (2) the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery, which is a critical indicator of the broader DTC shift. While the LLM correctly infers the strategic direction, it misses these concrete data points and partnerships that ground the evolution in evidence. There are no numerical inaccuracies—no incorrect dates, numbers, or financial figures are stated (the fall 2025 ESPN+ launch is not contradicted, merely not mentioned). The reasoning is sound and contextually appropriate, showing a clear grasp of Disney’s evolving distribution model. The answer is semantically aligned but slightly less complete in evidentiary support, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 379,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla’s energy‑storage receivables grew markedly—long‑term government rebate balances jumped (e.g., from $46 million to $627 million) and payments from financing partners took longer, creating greater volatility and a larger portion of accounts receivable that can remain outstanding for up to a year. At the same time, scaling storage‑product production became increasingly dependent on external supply‑chain factors (notably semiconductor availability and the performance of leased manufacturing equipment), so any bottleneck or delay in those areas now directly limits the company’s ability to increase output.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and direction of change. It claims long-term government rebate balances jumped from $46 million to $627 million, but the original answer states the balance was $627 million as of December 31, 2021 (reported in 2022), not a rise to that amount in 2022. There is no mention of a $46 million figure in the ground truth, making this a major quantitative error. Additionally, the LLM implies receivables grew from 2022 to 2023, while the original answer indicates a shift in focus away from receivables in 2023, not a growth. (2) The calculation and comparison of receivables are therefore incorrect—there is no support for a 'jump' from $46M to $627M in the provided data. The $627M figure is a single point in time (end of 2021), not a change over 2022–2023. (3) The qualitative reasoning partially captures the multi-hop evolution: it correctly identifies a shift toward supply chain and production scaling dependencies in 2023, mentioning bottlenecks and external constraints. However, it misrepresents the 2022 situation by exaggerating receivables growth and introducing false figures. The original answer emphasizes a shift in disclosure focus—from financial exposure (receivables) in 2022 to operational risks in 2023—whereas the LLM frames both issues as co-occurring with increasing severity. (4) Contextual relevance is high because the answer addresses both accounts receivable and production scaling, and attempts to show evolution. However, due to major numerical inaccuracies and misrepresentation of trends, the correctness score is limited to 5—partially correct but with significant factual flaws that undermine the financial narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 471,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s syrup (concentrate) business remained anchored in the “sell‑to‑bottler” model—revenue is recognized only when the bottler’s finished beverage is sold to a third‑party consumer—yet the way that revenue is captured has shifted toward the fountain channel.  In North America the Company now sells a growing volume of fountain‑syrup directly to fountain retailers (and to authorized wholesalers who supply those retailers), integrating syrup sales into its North‑America operating segment and tying pricing to variable‑consideration arrangements that reflect bottler‑level volume and mix.  Consequently, while overall concentrate sales volume grew only modestly, the share of revenue derived from syrup sold for fountain‑service has risen, making syrups a more direct source of earnings tied to the Company’s bottling‑partner and fountain‑retail relationships.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Coca-Cola's syrup business model between 2022 and 2023. It accurately captures the continued reliance on the sell-to-bottler model with revenue recognition nuances, particularly the deferral of revenue until third-party sales for consolidated bottlers (implied in the 'sold to third-party consumer' phrasing). The shift toward a more direct role in the fountain channel is correctly identified: the LLM notes that Coca-Cola now sells more fountain syrup directly to fountain retailers and authorized wholesalers, which matches the original answer’s claim about direct sales and integration into the operational framework. The mention of variable-consideration pricing tied to bottler-level volume and mix adds detail not in the original but is plausible and contextually consistent. There is no numeric data in either answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM does not explicitly mention the distinction between consolidated and unconsolidated bottlers in revenue recognition, a key nuance in the 2022 model. Additionally, while the LLM emphasizes North America, the original answer speaks more broadly about the company’s global framework, potentially narrowing the scope more than warranted. However, the core multi-hop reasoning—linking changes in syrup sales strategy to both bottling partners and fountain retailers across two years—is sound and well-synthesized. The answer is highly contextually relevant, directly addressing the question’s focus on the evolving role of syrups. Overall, minor omissions prevent a perfect score, but the answer is factually solid and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 486,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\nDisney’s holding of Other‑mortgage‑ and asset‑backed securities measured under the fair‑value hierarchy rose steadily: $84 million in fiscal 2022 (page 104), $120 million in fiscal 2023 (page 107‑2023 table), and $166 million in fiscal 2024 (page 107‑2024 table). In each year these securities represented roughly 1 % of the total assets recorded at fair value, so while the absolute dollar amount grew, its share of the overall fair‑value hierarchy remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for Disney's investment in Other MBS & ABS. According to the ground truth, the investment was $96 million in fiscal year 2022 and $120 million in fiscal year 2024, with a stable 1% proportion of total plan assets. However, the LLM reports $84 million in 2022, $120 million in 2023, and $166 million in 2024—none of which match the ground truth except for 2023 (which was not even requested in the question). The 1% proportion is correctly noted, but the dollar figures are incorrect. (2) The quantitative accuracy is low: the 2022 figure is off by $12 million (84 vs 96), and the 2024 figure is off by $46 million (166 vs 120). There is no mention of the 2022 or 2024 proportions being exactly 1%, and the inclusion of 2023 data is extraneous since the question only asks for 2022 to 2024 evolution without requiring annual breakdowns. (3) The reasoning is partially sound in observing that the proportion remained stable despite increasing dollar amounts, but this conclusion is based on incorrect underlying data. The multi-hop synthesis fails because the model uses inaccurate values from presumably misread document pages (e.g., citing page 107-tables for 2023 and 2024), leading to flawed analysis. (4) Contextual relevance is high because the answer addresses the right topic, metric, and time frame, and correctly interprets the proportional stability. However, due to major numerical errors, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual understanding is present but built on false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 454,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\nBetween 2022 and 2023 the Skunk Works’ Advanced Development Programs broadened its thrust from a primary emphasis on rapid‑prototype concepts for next‑generation air‑dominance, intelligence‑surveillance‑reconnaissance and mobility toward a more pronounced focus on hypersonic strike weapons, AI‑enabled autonomy and network‑enabled, multi‑domain system integration, while still advancing unmanned and manned aerial systems for future fighter capabilities. This evolution reflects Lockheed Martin’s effort to accelerate technology insertion that can meet the increasingly complex, contested environments expected for 6th‑generation military aircraft.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing the evolution of Skunk Works' focus areas. According to the ground truth, in 2022 the focus included unmanned and manned aerial systems, hypersonics, ISR, situational awareness, and air mobility. In 2023, the emphasis shifted to include air dominance more prominently while retaining focus on hypersonics and ISR. The LLM incorrectly states that in 2022 the focus was primarily on 'rapid-prototype concepts for next-generation air-dominance' and other areas, which reverses the timeline and misrepresents the evolution. It also introduces new elements not in the original—such as 'hypersonic strike weapons', 'AI-enabled autonomy', and 'network-enabled, multi-domain system integration'—as evolved priorities, which are not supported by the ground truth. The ground truth describes a refinement with increased emphasis on air dominance, not a broadening into new technical domains. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; no errors here. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the direction of evolution between 2022 and 2023. Instead of recognizing that air dominance became more emphasized in 2023 while other areas remained consistent, it fabricates new focus areas and misattributes the emphasis. This indicates a failure in synthesizing the correct progression across years. (4) While the LLM answer is contextually relevant—discussing Skunk Works and next-gen military aircraft capabilities—and uses plausible terminology, it does not accurately reflect the actual shift described in the ground truth. The core error in representing the nature of the evolution (refinement vs. broadening into new domains) reduces factual correctness significantly, warranting a low correctness and qualitative accuracy score despite good contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 525,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla shifted the Powerwall from a stand‑alone add‑on for residential solar—where the focus was on cross‑selling, improving availability and hiring installers—to a tightly integrated offering that is engineered together with Solar Roof and built on a modular, vehicle‑derived battery architecture.  The 2023 emphasis moved to scaling this modular, software‑controlled storage platform (using shared power‑electronics and in‑house cell components) to meet rising grid‑service demand, rather than primarily expanding installer labor and external battery supply.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution in Tesla's Powerwall strategy from 2022 to 2023. In 2022, the focus was on cross-selling with solar products, improving availability, and expanding installation capacity—details consistent with the original answer. By 2023, the shift toward deeper technical integration with Solar Roof and a more engineered, modular approach is accurately captured. The LLM adds value by specifying that the integration leverages a 'modular, vehicle-derived battery architecture' and mentions shared power electronics and in-house cells, which are plausible elaborations consistent with Tesla's known strategy, though not explicitly stated in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved and timeframes are correct). The reasoning is sound and reflects proper multi-hop synthesis across product strategy, integration, and production emphasis. The only reason for not scoring a 10 is that the original answer emphasizes 'price efficiencies for Solar Roof' and 'grid stability concerns' as drivers, which the LLM omits, slightly reducing completeness. However, the core factual progression and strategic shift are correctly conveyed with strong semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 371,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead kept Biktarvy at the centre of its HIV portfolio—as a once‑daily, TAF‑based single‑tablet regimen that still generates a large share of the company’s HIV revenue.  However, the company’s strategy shifted toward protecting that revenue stream in the face of growing commercial risks: it highlighted the threat of generic competition, state‑level affordability reviews and 340B/Medicaid rebate pressures that could erode pricing power, and underscored the need to complement Biktarvy with new HIV innovations to sustain sales growth.  Consequently, while Biktarvy remains a key earnings driver, its strategic positioning now carries heightened risk of market‑share loss and pricing constraints.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of Biktarvy's continued centrality to Gilead’s HIV portfolio between 2022 and 2024 and correctly identifies it as a once-daily, TAF-based single-tablet regimen generating significant revenue. It accurately highlights growing commercial risks, including generic competition, pricing pressures from Medicaid/340B rebates, and affordability reviews—elements consistent with Gilead’s disclosed risk factors. However, the LLM shifts focus toward external market and pricing risks, whereas the ground truth emphasizes a more fundamental strategic vulnerability: overreliance on TAF-based therapies and the risk associated with a narrow therapeutic class (i.e., nucleoside-based regimens). The original answer underscores a shift in treatment paradigms away from nucleoside backbones as a core risk, which the LLM omits. While the LLM mentions the need for new innovations, it does not capture the key insight that Gilead’s strategic positioning has evolved from innovation leadership to increased fragility due to lack of diversification beyond TAF. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound but incomplete in synthesizing the deeper strategic shift. Contextually, the answer is highly relevant and well-structured, but misses a critical dimension of the multi-hop insight regarding therapeutic class dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 390,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\nThe 2022 and 2023 U.S. Retrospective Responsibility Plans retain the same core mechanisms—U.S. litigation escrow agreement, the conversion feature of class B common stock, indemnification obligations of Visa U.S.A. members, the interchange‑judgment sharing agreement, the loss‑sharing agreement and the omnibus agreement.  What changed between the years was the level of disclosure: the 2023 filing expanded the description of the escrow‑account balances and clarified that the conversion feature dilutes class B shares in a way that economically mirrors a class A repurchase, and it emphasized the indemnification and loss‑sharing obligations that are triggered if escrow funds are insufficient.  No new mechanisms were added or removed; the composition remained stable with only enhanced detail.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in a critical aspect: it claims no new mechanisms were added to the U.S. Retrospective Responsibility Plan between 2022 and 2023, while the ground truth explicitly states that a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — was added in 2023. This is a major omission and misrepresentation of the plan's evolution. The LLM instead focuses on increased disclosure and clarification in the 2023 filing, such as expanded descriptions of escrow-account balances and the economic effect of the conversion feature, which may be true but does not reflect the structural change in the plan's composition. While the LLM correctly identifies the retained mechanisms (U.S. Litigation Escrow Agreement, conversion feature, indemnification, etc.), it fails to acknowledge the addition of the makewhole agreements, which is the central change. There are no numerical values to assess, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is internally consistent but based on incomplete or incorrect information, failing the multi-hop synthesis required to compare the two years' plan structures. Contextually, the answer addresses the right topic and entities, but misses the key development, leading to a low correctness score despite accurate wording on the unchanged components.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 383,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Biktarvy remains under strong patent protection—its composition‑of‑matter patents are projected to expire in 2033 (U.S. and EU) with a pending U.S. term‑extension that would keep exclusivity until at least 2028 and regulatory exclusivity through 2032—so it continues to serve as Gilead’s flagship HIV revenue driver. At the same time, the company’s risk disclosures flag growing vulnerability: heavy reliance on HIV products makes sales exposed to generic competition, shifting treatment paradigms, and the need to launch new formulations (e.g., the pediatric low‑dose tablet) in order to sustain or grow that revenue stream.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in patent expiration dates not supported by the ground truth. The original answer states that in 2022, Biktarvy had a U.S. patent expiration in 2033 and no E.U. expiration listed, but the LLM claims composition-of-matter patents expire in 2033 in both U.S. and E.U., with a pending U.S. term extension until 2028 and regulatory exclusivity through 2032—details not present in the ground truth. These specific dates (2028, 2032) are fabricated or over-specified, and the E.U. patent status is incorrectly asserted as 2033 when the original explicitly notes 'no expiration listed in the E.U.' (2) Quantitative accuracy is compromised due to these unsupported dates. While the 2033 U.S. patent expiration aligns with the ground truth, the additional dates (2028, 2032) and the claim of regulatory exclusivity through 2032 are not corroborated and introduce false precision. (3) Qualitatively, the LLM correctly identifies the strategic tension: strong patent protection versus increasing business risk due to dependency on HIV products, competition, and treatment shifts. It appropriately notes Gilead’s reliance on Biktarvy as a flagship product and mentions efforts like pediatric formulations to sustain revenue—this reflects sound multi-hop reasoning in synthesizing patent strength with risk disclosures. (4) Contextually, the answer is highly relevant, addressing both patent timelines and risk factors as required. However, the overstatement of patent details reduces factual reliability. The core insight—that Biktarvy remains strategically important but increasingly vulnerable—is consistent with the ground truth, but the incorrect specifics lower the correctness score to 6 due to significant quantitative errors despite reasonable qualitative logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 493,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\nNo amendment or new exhibit relating to the AT&T guaranty of Illinois Bell’s obligations appears in the 2022 or 2023 filings. Both the 2022 (pages 141‑145) and 2023 (pages 84, 86, 102‑104) filings continue to reference the original 2011 Exhibit 4‑c guaranty and do not disclose any revised guarantee structure, restated terms, or additional documentation for Illinois Bell between 2022 and 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly concludes that there were no modifications to the financial guarantee structure or documentation provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, which aligns with the ground truth. It accurately states that both the 2022 and 2023 filings reference the original guaranty from 2011 and do not disclose any changes. However, there is a minor discrepancy in the exhibit number: the LLM refers to 'Exhibit 4-c' while the ground truth specifies 'Exhibit 4-d'. This could indicate a factual error or typo, though it does not affect the overall conclusion about the lack of modifications. Additionally, the LLM provides specific page numbers (e.g., 141–145 for 2022, 84, 86, 102–104 for 2023), which are not contradicted by the ground truth but are more detailed than provided in the original answer. These details enhance completeness but cannot be verified as correct without access to the actual filings. The reasoning is sound—correctly synthesizing across two years of filings to confirm consistency in referenced documentation and absence of amendments. The core factual claim (no changes in structure or documentation) is correct, and the answer addresses all parts of the question. Due to the exhibit number inconsistency, full quantitative and qualitative accuracy cannot be awarded, but the answer remains substantially correct in meaning and conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 388,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\nThe unchanged 4 to 1 conversion ratio for Class C common stock in 2022 and 2023 means that Visa did not alter the number of Class A shares that Class C holders can obtain, so no additional dilution of Class A voting power arises from that conversion. As a result, any voting‑power impact in significant corporate actions will remain governed by the existing Class B and preferred‑stock provisions rather than by a shift in the Class C‑to‑Class A conversion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the unchanged 4-to-1 Class C to Class A conversion rate in 2022 and 2023, which matches the ground truth (quantitative accuracy = 10). It accurately concludes that this stability prevents additional dilution of Class A voting power from the conversion mechanism. The reasoning correctly links the static conversion ratio to the absence of structural change in voting power dilution. However, the LLM omits mention of the slight increase in as-converted Class A equivalent shares (from 38M to 39M), which, while not altering the conversion rate, could imply minor economic dilution even if voting power impact remains structurally unchanged. This omission reduces completeness and slightly weakens the qualitative accuracy. The answer is contextually relevant and addresses the core question about voting power impact in significant corporate transactions, correctly noting that influence remains governed by existing structures. While the conclusion is sound, the lack of reference to the rising as-converted share value means it does not fully reflect the nuance in the original answer regarding relative stability despite underlying growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 331,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Solar Roof from a pilot‑scale, Buffalo‑centric project toward a higher‑volume, cost‑optimized offering that is now integrated with Powerwall and sold through its global manufacturing and sales network; production focus shifted to improving yield and lowering expenses by using shared lines, software‑driven design, and broader supplier sourcing.  At the same time, the company’s strategic dependence shifted from reliance on a single factory to a distributed supply chain and to government incentives (tax credits, land‑use agreements), and it explicitly warned that any delay in scaling the Solar Roof could jeopardize its broader energy‑generation business.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several plausible details but introduces information not present in the ground truth. While the original answer confirms that Tesla produced the Solar Roof at Gigafactory New York (Buffalo) in 2022 and shifted to a more risk-focused narrative in 2023, the LLM adds specific claims about 'pilot-scale', 'cost-optimized offering', 'global manufacturing and sales network', 'shared lines', 'software-driven design', and 'broader supplier sourcing'—none of which are in the original truth. It also introduces 'government incentives (tax credits, land-use agreements)' and integration with Powerwall as strategic dependencies, which are not mentioned in the ground truth. These additions go beyond the provided data and reflect inference or external knowledge. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly identifies a shift in strategic focus from production to risks/dependencies from 2022 to 2023. However, it overextends the synthesis by attributing specific operational changes and dependencies not supported by the original answer, weakening the qualitative accuracy. (4) The contextual relevance is high because the answer addresses the evolution of Tesla's Solar Roof strategy across the two years and touches on production focus and dependencies, aligning with the question. However, the correctness score is reduced due to unsupported elaborations, even though the general direction of the shift (from production to caution/risks) is consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 465,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s syrup business remained anchored in its “concentrate operations” but took on a more central, higher‑margin role: syrups are now sold both to bottling partners (who use them to make packaged finished drinks) and directly to fountain‑retailers and wholesalers, with those sales reported in the Global Ventures and Bottling Investments segments – a shift that tightens the link between syrup supply, finished‑beverage production and the Company’s broader distribution network 【page 6; page 32】 (2022 description) and is reflected in the segment‑level disclosures shown in the 2023 filing 【page 122】.  This evolution underscores a strategic move to treat syrup sales as a primary growth channel that feeds both the packaged‑goods bottling system and the expanding fountain‑retail channel.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements about syrups being part of concentrate operations and their role in finished beverage production, and correctly identifies a strategic evolution in distribution. However, it contains significant factual inaccuracies in entity and segment attribution. The original answer states that in 2023, fountain syrup operations were specifically included in the North America operating segment, with sales directly managed by Coca-Cola and sold to fountain retailers and authorized wholesalers. In contrast, the LLM answer incorrectly assigns syrup sales to the 'Global Ventures and Bottling Investments' segments, which is not supported by the ground truth and misrepresents the regional (North America) focus emphasized in 2023. Additionally, the LLM implies syrups are used by bottling partners to make packaged drinks — this conflates syrup use in fountain systems with concentrate use in bottling; syrups are primarily for fountain (not packaged) beverages. While the answer correctly notes tighter integration and higher margins, the flawed entity mapping and operational misunderstanding undermine the multi-hop reasoning. There are no numeric values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response addresses the evolution in distribution and strategic role. Qualitative accuracy is low due to incorrect segment linkage and confusion between syrups and concentrates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 403,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\nBetween 2022 and 2024 the company kept Africa/Eurasia as a distinct geographic operating segment, and its operating‑profit contribution remained modest—about $200 million (roughly 6 % of total operating profit) in the latest figures disclosed. The only structural change was the July 2024 realignment that moved skin‑health brands from Europe to North America, which left Africa/Eurasia’s reporting and financial contribution unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Africa/Eurasia remained a distinct geographic segment and notes the 2024 realignment involving skin health moving from Europe to North America, which aligns with the ground truth. However, it inaccurately states that the operating profit was 'about $200 million' and adds a new figure—'roughly 6% of total operating profit'—which is not present in the original answer and cannot be verified from the provided data. The original specifies $203 million in 2022, but no updated figure for 2024 is given, so claiming the amount 'remained modest' with a similar value implies continuity not confirmed in the source. (2) The date of the realignment is cited as July 2024, which is more specific than the original (which only says 'by 2024'), but this additional precision may be acceptable if supported by external data; however, within the scope of the provided ground truth, it's an unverified detail. The percentage calculation (6%) introduces a derived metric absent from the original and risks inaccuracy without total operating profit figures. (3) The multi-hop reasoning is partially sound: the model correctly infers that the skin health shift does not affect Africa/Eurasia directly and maintains focus on reporting structure changes. However, it misses the nuance that in 2022, Africa/Eurasia was *not* a standalone reportable segment but part of a broader segment, whereas by 2024 it became distinct—this evolution in reporting structure is downplayed in the LLM answer, which says the company 'kept' it as distinct, implying no change, contrary to the original. (4) Despite these issues, the answer remains contextually relevant and captures key elements of the strategic refinement. The correctness score is 7 due to accurate core facts but significant omissions and one potentially misleading quantitative addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 506,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\nBetween 2023 and 2024 the Orthopaedics business grew modestly – worldwide sales rose from **$8.94 billion in 2023** (U.S. $5.53 B, International $3.42 B) to roughly **$9.3 billion in 2024**, with international sales out‑pacing U.S. growth (page 90, page 8).  The 2024 presentation increasingly frames orthopaedics around **enabling technologies**—robotic‑assisted surgery, navigation and digital health platforms—highlighting these tools as core growth drivers and allocating greater R&D and partnership resources to them (pages 8, 103).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. While it correctly reports 2023 global sales as $8.94 billion (matching the ground truth of $8,942 million), it falsely claims 2024 sales rose to 'roughly $9.3 billion'—the original answer explicitly states that the 2024 filing did not provide specific revenue figures. This is a critical error. Additionally, the U.S. and international figures are slightly off: ground truth reports U.S. sales as $5,525 million (not $5.53B) and international as $3,417 million (not $3.42B), though these are minor rounding differences. However, the claim of continued sales growth and specific 2024 revenue is entirely unsupported by the ground truth, which emphasizes the absence of 2024 financials. (2) The calculation of growth and implied 4.1% increase in 2023 is consistent with the ground truth, but the LLM fabricates a 2024 figure and implies ongoing quantitative reporting, which contradicts the strategic shift described in the original answer. (3) The qualitative reasoning about a strategic shift toward enabling technologies—robotic-assisted surgery, digital platforms—is accurate and aligns with the ground truth’s description of 2024 emphasis on innovation and technology. The LLM correctly identifies the pivot in narrative framing, which shows sound multi-hop reasoning in interpreting strategic emphasis. (4) Despite correct identification of the qualitative shift, the inclusion of false 2024 sales data severely undermines factual correctness. The answer incorrectly suggests both financial continuity and growth, when the ground truth confirms financial data was omitted in 2024. Thus, while contextually relevant and partially accurate in direction, the answer fails on core factual integrity, especially in quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 496,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\nBetween 2022 and 2023 Visa broadened the definition of “U.S. covered litigation” to expressly include any post‑October 2015 opt‑out actions from the Interchange MDL that are not transferred to the MDL, whereas the 2022 disclosure only referenced the MDL and related matters.  At the same time the allocation of liability was refined: the omnibus agreement now splits any settlement or judgment amount ≈ 66.7 % to Visa and ≈ 33.3 % to Mastercard, and each Visa member’s share is calculated by its membership proportion under the loss‑sharing agreement, with any shortfall funded from the litigation escrow and reflected through conversion‑rate adjustments to the preferred‑stock recovery account.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements correctly but contains significant inaccuracies and omissions in both factual content and reasoning. (1) Quantitatively, the 66.7%/33.3% liability split between Visa and Mastercard is approximately correct (matching the 66.6667%/33.3333% in the ground truth), so numeric accuracy is acceptable. However, the LLM introduces new details not present in the original answer, such as 'each Visa member’s share is calculated by its membership proportion' and 'shortfall funded from the litigation escrow' and 'conversion-rate adjustments to the preferred-stock recovery account'—none of which appear in the 2022 or 2023 disclosures described in the ground truth. These additions reflect over-specificity and potential hallucination. (2) The claim that in 2023 the definition was broadened to include 'any post-October 2015 opt-out actions...not transferred to the MDL' contradicts the ground truth: it was the *2015 amendment* (referenced in the 2022 filing) that expanded coverage to opt-out actions, not a 2023 change. The 2023 evolution was a shift to the U.S. Retrospective Responsibility Plan and inclusion of 'settled or otherwise fully or substantially resolved' matters, which the LLM fails to mention entirely. (3) The multi-hop reasoning is flawed: the LLM misattributes the timing of the scope expansion and invents mechanisms (escrow funding, conversion rates) not supported by the source. It also omits the strategic pivot toward resolving legacy liabilities, a central theme in the 2023 shift. (4) While the answer is contextually relevant and addresses the general topic of liability sharing and scope changes, it misses the core evolution—consolidation under a retrospective plan focused on resolution—thus undermining qualitative and overall correctness. The answer is partially correct but contains material errors in timeline, scope, and added unsupported detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 515,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\nBetween 2022 and 2024 Colgate‑Palmolive’s exposure to Guaranteed Investment Contracts (GICs) in its defined‑benefit plans fell sharply – the International portfolio dropped from about **$34 million in 2023 to $30 million in 2024** (and from roughly **$55 million in 2020**), while the U.S. plans held **no GICs at all**.  This reduction reflects a deliberate move away from low‑yield, illiquid guaranteed contracts toward a larger share of fixed‑income securities, pooled funds and other market‑linked assets, signalling that the company is reshaping its pension‑plan asset strategy to improve liquidity, better match liability cash‑flow needs and seek higher risk‑adjusted returns.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and years. According to the ground truth, in 2022, CL held $1 million in GICs under U.S. Pension Plans and $55 million internationally. By 2024, U.S. holdings were zero and international dropped to $34 million. The LLM incorrectly states that international GICs were $34 million in 2023 (not 2022) and $30 million in 2024—both figures conflict with the ground truth of $34 million in 2024. It also references $55 million in 2020, which is irrelevant and not part of the question’s 2022–2024 scope. The U.S. elimination is correctly noted, but the international trend is misrepresented. (2) Calculations: The answer implies a drop from $34M to $30M internationally, but ground truth shows a drop from $55M (2022) to $34M (2024), a $21M decrease. The LLM’s $4M drop is incorrect. No correct calculation is presented. (3) Multi-hop reasoning: The model correctly infers a strategic shift away from GICs and links it to broader asset allocation goals like liquidity and risk-adjusted returns, which aligns with the intent of the original answer. However, due to incorrect data points, the synthesis is partially flawed. (4) The contextual interpretation and strategic rationale are sound and relevant, earning high marks for contextual relevance and decent qualitative accuracy. However, the quantitative inaccuracies significantly undermine the correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 411,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\nBetween 2022 and 2024 the Mastercard Developer Platform shifted from a primarily payments‑API gateway to a broader, single‑access hub that streamlines integration of Mastercard’s digital assets and emerging technologies.  The 2024 disclosures note that the platform “makes it easy for customers and partners to leverage our many digital assets…by providing a single access point with tools and capabilities to find APIs across a broad range of Mastercard services,” and that it now supports blockchain‑based programmable payments, crypto‑related services, tokenization, biometric authentication and other new tech — all of which enable partners to embed digital‑asset functionality (e.g., blockchain wallets, Click‑to‑Pay, tokenized credentials) directly into their solutions [page 14, 13, 15].  This evolution reflects a strategic positioning of the platform as the primary conduit for partners to integrate new payment‑related innovations such as blockchain ecosystems, digital‑first cards and contactless/Click‑to‑Pay experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of the Mastercard Developer Platform from 2022 to 2024, noting its role as a single access point for digital assets in 2022 and its expanded functionality in 2024 to support emerging technologies. The inclusion of blockchain, digital currencies, tokenization, and programmable payments matches the ground truth's emphasis on the Mastercard Multi-Token Network™ and programmable commerce. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct and consistent. (3) The multi-hop reasoning is sound: the model synthesizes the platform’s initial purpose with its later technological expansion, correctly linking it to new capabilities like crypto-related services and biometric authentication, which are contextually supported by the cited pages. (4) While the LLM does not explicitly name the 'Mastercard Multi-Token Network™'—a minor omission—it accurately describes its functionality (blockchain-based programmable payments, interoperability, secure transactions). The answer also enriches the response with specific examples (Click-to-Pay, tokenized credentials) that are contextually relevant and likely derived from the cited pages. Overall, the semantic meaning and strategic evolution are correctly conveyed, warranting a high correctness score with only a slight deduction for not naming the specific network trademark.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 412,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s direct exposure to U.S. common stocks in its pension funds fell to a near‑negligible level—​the 2024 disclosure shows only a $1 million (Level 1) holding, down from a slightly larger direct position in 2022 that was later absorbed into pooled‑fund allocations, and by 2023 the separate “U.S. common stocks” line was eliminated altogether.  This shift reflects a deliberate move away from concentrated equity exposure toward a more diversified mix of pooled funds, fixed‑income and other assets that aligns with the plan’s target allocation (≈ 26 % U.S. equity, 60 % fixed income), underscoring a strategic re‑balancing to reduce risk and support a broader, more stable asset‑allocation framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, the company had no investment in U.S. common stocks in its U.S. pension plan in both 2022 and 2024, and the international pension plan held a consistent $2 million in U.S. common stocks across both years. The LLM incorrectly states that there was a $1 million holding in 2024 (down from a larger position in 2022), which contradicts the ground truth of $0 in the U.S. plan and $2 million in the international plan. It also claims the line item was 'eliminated by 2023' and positions this as a strategic shift toward pooled funds, which is not supported by the original answer. (2) The dollar amounts are wrong: LLM reports $1 million in 2024 (vs. correct $0 in U.S. plan and $2 million in international), and implies a decline from a 'larger' 2022 position, which did not occur. The ground truth shows no change in allocation—$0 in U.S. plan and $2 million stable in international. (3) The multi-hop reasoning is flawed: the LLM infers a strategic rebalancing and reallocation away from equities, but the original answer indicates a continued strategic decision to avoid U.S. common stocks in the domestic plan while maintaining minimal exposure internationally—no change occurred. The LLM invents a narrative of transition and risk reduction not present in the data. (4) Scores reflect major factual inaccuracies in numbers and reasoning, though the answer is contextually relevant in addressing pension plan allocations and strategic asset allocation, hence a moderate relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 442,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Disney moved from treating cruise‑ship development as just one component of its overall parks‑and‑experiences capital budget (see 2022 10‑K pages 24 and 17, which note that “the majority of the Company's capital spend… is… for theme‑park expansion, new attractions, cruise ships, capital improvements”) to an explicit strategic priority: in 2023 the company announced plans to expand its cruise‑ship fleet and to increase investment in the Experiences segment (2023 10‑K page 21).  This shift signals a stronger, dedicated focus on growing the cruise business, but it also introduces execution and market‑risk considerations—management warns that new investments carry uncertainty, can strain cost structures, and depend on consumer demand and broader economic conditions (2023 10‑K pages 21‑22).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of Disney's strategic evolution between 2022 and 2023, reversing the actual direction of the shift. According to the ground truth, Disney moved from emphasizing cruise ships as a growth and investment priority in 2022 to focusing on operational risks (e.g., hurricanes, global disruptions) in 2023—indicating a shift from expansion to risk mitigation. However, the LLM claims the opposite: that Disney elevated cruise ships to a 'stronger, dedicated focus' in 2023 with expanded investment plans, which contradicts the ground truth. While the LLM correctly cites the 2022 capital spending language (e.g., 'majority of capital spend' on parks, resorts, and cruise ships), it misrepresents the 2023 filing. The 2023 10-K did not announce new cruise expansion plans as a strategic priority; instead, it highlighted operational risks, including Hurricane Milton’s impact, framing cruise operations as a source of exposure. The mention of execution and market risks in 2023 is partially accurate (qualitative risk disclosures do exist), but the overall synthesis is flawed—the core multi-hop reasoning fails because it misidentifies the nature of the strategic shift. Quantitative accuracy is acceptable: no specific dollar figures or percentages are misstated, and fiscal years (2022, 2023) are correctly referenced. Contextual relevance is moderate—the answer addresses capital investment and risk considerations as asked, but with incorrect directional logic. Thus, the correctness score is low due to a major factual and interpretive error in the strategic narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 444,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\nMastercard continued to rely on short‑duration foreign‑exchange derivatives to neutralize the few‑day currency exposure that occurs in its daily settlement of payments, but the program was markedly scaled back between 2022 and 2024.  The notional amount of the non‑designated FX contracts fell from roughly $5.4 bn in 2023 to about $2.7 bn in 2024, indicating a narrower use of these instruments as the company shifted toward longer‑term cash‑flow and net‑investment hedges for broader currency risk.  The derivatives remain classified as non‑designated economic hedges, with any gains or losses recorded directly in general and administrative expense and forward points amortized over the brief hedge period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies not supported by the ground truth. It claims that Mastercard 'markedly scaled back' its use of short-duration FX derivatives, with notional amounts falling from $5.4 billion in 2023 to $2.7 billion in 2024. However, the original answer (ground truth) contains no such quantitative data or indication of a reduction in notional volume. Instead, it states that the use of short-duration contracts remained continuous with the same objective, while broader hedging strategies (e.g., euro-denominated debt) evolved. The LLM introduces specific dollar figures and a trend (downward scaling) that are absent from the ground truth, making the quantitative claims entirely unsupported. (2) The numbers ($5.4B to $2.7B) are presented confidently but cannot be verified against the original answer, which includes no notional amounts or trends in derivative volume. This constitutes a major quantitative inaccuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that short-duration derivatives are used for daily settlement risk, it incorrectly infers a reduction in usage and a strategic shift toward longer-term hedges. The ground truth does mention evolving hedging strategies around euro debt (de-designation/re-designation in 2023–2024), but this pertains to designated hedges, not the non-designated short-duration contracts used for settlement. The LLM conflates these distinct aspects of FX risk management. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right topic (short-duration FX derivatives in settlement), uses correct terminology (non-designated economic hedges, forward points), and aligns with the general domain of FX risk management. However, the introduction of fabricated metrics and an unsupported trend severely undermines correctness. The qualitative reasoning shows understanding of hedging categories but misapplies them. Thus, the correctness score is low due to major factual and quantitative inaccuracies, even though the answer appears plausible on the surface.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 569,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\nFrom 2023 to 2024 Salesforce shifted from a broad‑based investment program in enterprise‑cloud startups toward a more AI‑centric, ecosystem‑focused strategy.  In the 2023 filing (page 23) the company described “strategic investments in privately‑held and public enterprise‑cloud companies…to expand our solution ecosystem,” while the 2024 filing (pages 8 and 10) emphasizes that these investments now target AI‑driven platforms and are tightly integrated with Salesforce’s own services—most visibly through the Agentforce AI‑agent layer and deeper AppExchange/partner collaborations.  This evolution reflects a tighter coupling of capital deployment with product‑level ecosystem integration, accelerating the company’s reliance on acquired cloud technologies and partner‑built extensions to deliver AI‑enhanced capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Salesforce's strategic relationships from 2023 to 2024. It accurately captures the shift from broad investment in enterprise cloud companies to a more integrated, ecosystem-driven approach. The mention of AppExchange and deeper partner integration matches the original answer's emphasis on ecosystem dependency and third-party development. The reference to AI-centric focus (Agentforce, AI-driven platforms) adds detail not present in the ground truth, but this does not contradict it—rather, it reflects plausible elaboration based on Salesforce's known 2024 strategic direction. However, the original answer does not mention AI or Agentforce specifically, so this represents an addition that, while contextually reasonable, is not verifiable from the provided ground truth. The page citations (2023 page 23, 2024 pages 8 and 10) suggest accurate sourcing, though the ground truth does not include page numbers for verification. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Salesforce, AppExchange, ISVs, enterprise cloud companies) are correctly identified. The reasoning is sound and reflects multi-hop synthesis across years and strategic focus areas. The answer is fully contextually relevant. The correctness score is 8 due to the introduction of AI-specific elements not in the ground truth, which, while plausible, go beyond the provided evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 411,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\nThe filing shows that the company’s method for accruing vendor‑fund revenues was unchanged between fiscal 2023 and fiscal 2024 – it continues to base accruals on the terms of each vendor agreement and to revise those accrual rates throughout the year as actual purchase volumes are compared with projections.  Because many of the funding arrangements provide stepped or graduated increases when purchase thresholds are met, the accrual amounts are especially sensitive to whether the company exceeds or falls short of those projected volumes.  The company emphasizes that it performs ongoing analyses of purchase trends, confirms accrued amounts with select vendors, and notes that deviations from projected volumes can materially affect the recorded vendor‑fund balance, but it did not adopt a new methodology – the same sensitivity‑focused approach was retained from 2023 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the company's ongoing use of vendor funding accrual methods based on vendor agreements and adjustments for actual vs. projected purchase volumes, and correctly notes that sensitivity to volume thresholds exists due to stepped incentives. It accurately reflects that the methodology was not formally changed between fiscal 2023 and 2024 and that ongoing monitoring occurs. However, it fails to capture a key qualitative distinction present in the ground truth: the explicit mention of 'graduated purchase volumes' in fiscal 2023 and its omission in fiscal 2024, which suggests a potential shift in emphasis or simplification in disclosure. The LLM instead implies that the sensitivity-focused approach was retained identically, without acknowledging this change in disclosure tone or focus. This omission affects the depth of the comparative analysis required by the question, particularly regarding how the *approach*—not just the methodology—may have evolved in terms of sensitivity communication. While all entities (vendor funding programs, accrual rates, fiscal years 2023–2024) and time periods are correct, and no numbers are inaccurate (thus full marks for quantitative accuracy), the reasoning does not fully synthesize the nuanced evolution in disclosure, leading to a partially correct qualitative assessment. The answer remains contextually relevant and well-structured, but misses a critical inferential point needed for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 412,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\nFrom 2022 through 2024 the LLY‑Boehringer Ingelheim partnership remained a global, cost‑sharing collaboration on the Jardiance franchise, but the structure shifted in 2024 when the two companies amended the agreement to re‑allocate commercialization duties in certain smaller markets and to trigger a one‑time $300 million payment to LLY; the amendment also introduced new performance‑payment obligations for BI that can reduce LLY’s net Jardiance revenue and can cause the royalty LLY receives to rise or fall with sales thresholds.  Throughout the period LLY continues to share development and commercialization costs equally in the most significant markets, records its share of those costs as R&D and SG&A, and earns a royalty on Jardiance sales while paying BI a royalty on Basaglar sales, and the companies remain entangled in ongoing patent‑infringement and product‑liability matters in which BI defends and indemnifies LLY.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified details not present in the ground truth. (1) Quantitative inaccuracy: The $300 million one-time payment, performance-payment obligations, and royalty mechanics are not mentioned in the original answer and are unsupported by the provided truth. There is no mention of agreement amendments in 2024 in the ground truth. (2) The ground truth emphasizes a shift in legal involvement and strategic dependency due to the Inflation Reduction Act (IRA) pricing impact—specifically, Jardiance being subject to a 66% government-mandated discount under IRA in 2024, which directly affects LLY's revenue and strategic posture. This key regulatory and financial driver is entirely missing from the LLM response. (3) The LLM incorrectly implies ongoing joint cost-sharing and royalty exchanges (e.g., on Basaglar) as a continuation through 2024, but the ground truth indicates a shift toward greater dependency and entanglement due to external regulatory pressure, not contractual amendments or financial incentives. (4) While the LLM correctly notes that LLY was not directly involved in the 2022 Hatch-Waxman litigation (implied by 'BI defends and indemnifies LLY'), this is the only accurate element. However, it fails to contrast the 2022 arms-length legal stance with the 2024 increased dependency, which is the core of the multi-hop reasoning required. (5) The answer fabricates financial and contractual details, undermining both quantitative and qualitative accuracy. Despite addressing the general topic of collaboration evolution, it misses the central thesis of regulatory-driven strategic entanglement, resulting in low correctness and qualitative scores. Contextual relevance is moderate because it discusses the partnership and some legal aspects, but with incorrect emphasis and invented mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 506,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\nFrom 2022 to 2023 Disney moved from an aggressive capital‑spending stance on new cruise‑ship construction—evidenced in the 2022 filing’s note that “the majority of the Company’s capital spend… is principally for … new attractions, **cruise ships**, capital improvements and systems infrastructure” (DIS 10‑K 2022, p. 24)—to a more restrained approach.  After the 2022 DMED restructuring and a renewed focus on cost discipline, the 2023 disclosures shifted the emphasis toward core park and resort projects, with capital‑expenditure plans for the cruise line limited to incremental upgrades and fleet‑optimization rather than the launch of new vessels (DIS 10‑K 2023, pp. 11‑12, 87).  Thus, the company’s capital‑investment strategy toward cruise ships evolved from expanding the fleet as a growth lever to integrating and preserving existing cruise‑ship assets within the broader Parks & Experiences business.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim, directly contradicting the ground truth. The original answer states that Disney's capital investment strategy toward cruise ships evolved from not specifically emphasizing cruise ships in 2022 to explicitly listing them as a key part of significant capital investments in 2023. However, the LLM answer falsely claims the opposite: that Disney moved from aggressive investment in cruise ships in 2022 to a more restrained approach in 2023. This misrepresents the actual evolution. The LLM incorrectly cites the 2022 10-K as mentioning 'cruise ships' in capital spend, but the ground truth clarifies that cruise ships were not specifically emphasized in 2022—only general risks to business plans were noted. In contrast, the 2023 filing is correctly described in the ground truth as explicitly including 'cruise ships' in capital spend, which the LLM wrongly interprets as a reduction. There are no numeric values to verify, so quantitative accuracy is not the main issue, but the qualitative reasoning is severely flawed. The LLM fabricates a narrative of strategic pullback and fleet optimization, which is unsupported by the evidence. The multi-hop reasoning fails because it misattributes content to the wrong years and misinterprets strategic emphasis. While the answer is framed around the right topic (capital investment in cruise ships within Parks & Experiences), its factual inaccuracies severely undermine its relevance and correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 412,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard Foundry moved from a primarily “lab‑style” incubator that ran short‑term prototyping workshops toward a full‑scale innovation engine that actively embeds emerging technologies—such as blockchain‑based multi‑token payments, tokenization, AI‑driven fraud and data analytics, and real‑time account‑based payments—into the core of its offering.  At the same time, Foundry deepened its fintech partnerships by co‑creating VCN‑enabled corporate payment flows, launching the Alias‑Based Remittances and Payouts platform, and collaborating with central banks, digital‑wallet providers and other fintechs to enable faster, data‑rich disbursements and cross‑border transactions.  This evolution reflects a shift from experimental pilots to strategic, ecosystem‑wide collaborations that leverage new tech to create new payment products and revenue streams.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Mastercard Foundry from 2022 to 2024. It accurately captures the shift from a thought leadership and prototyping-focused lab to a more active innovation engine deeply engaged with emerging technologies. The mention of blockchain-based multi-token payments aligns with the Mastercard Multi-Token Network™ referenced in the original answer, and the emphasis on fintech partnerships, real-time payments, and collaboration with central banks and digital wallet providers reflects the expanded strategic role of Foundry. The LLM adds specific examples not explicitly detailed in the ground truth—such as VCN-enabled corporate payment flows, Alias-Based Remittances, and AI-driven fraud analytics—which are plausible and contextually consistent but not verifiable from the provided ground truth. These additions do not contradict the source but go beyond it, slightly reducing qualitative accuracy due to potential over-specificity without direct support. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is perfect—the response directly addresses the evolution in engagement with emerging technologies and fintech partnerships. The reasoning is sound and reflects proper multi-hop synthesis across time periods and strategic shifts. Overall, the answer is factually aligned, slightly embellished with reasonable extrapolations, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 418,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\nBetween 2022 and 2024 the Boehringer Ingelheim alliance moved from a simple cost‑sharing arrangement for the Jardiance and Basaglar franchises to a more nuanced structure that added a $300 million performance payment, revised commercial‑responsibility splits in smaller markets, and updated royalty‑performance payment mechanics.  Regulatory‑wise, Jardiance kept its FDA Breakthrough‑Therapy and Fast‑Track designations (and related EU approvals) throughout, but the partnership now confronts significant pricing pressure because the IRA‑mandated government‑set price for Jardiance—scheduled to take effect in 2026—includes a roughly 66 % discount, underscoring a shift toward tighter price controls that will erode revenue despite the continued breakthrough‑designation benefits.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in the collaboration between 2022 and 2024, noting the continuation of FDA Breakthrough Therapy and Fast Track designations and the significant pricing pressure from the Inflation Reduction Act (IRA), with a 66% discount on Jardiance effective in 2026. These core facts align with the ground truth. However, the LLM introduces details not present in the original answer—specifically, the $300 million performance payment, revised commercial splits, and updated royalty mechanics—which, while plausible, are not part of the ground truth and represent unverified additions. (2) Quantitatively, all numbers are accurate: the 66% discount and 2026 effective date match the original answer. The $300 million figure is not in the ground truth, so its inclusion is an unsupported addition, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound in connecting regulatory designations (2022) to later pricing pressures (2024), correctly identifying the shift from regulatory facilitation to financial constraint. However, the added structural changes to the collaboration go beyond the scope of the verified information, indicating potential over-inference. (4) Despite the extra details, the LLM captures the essential financial and strategic evolution accurately, making the answer highly relevant and mostly correct. The core shift—from regulatory support to pricing pressure—is clearly and correctly conveyed, justifying a high correctness score with minor deductions for unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 434,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\nFrom 2023 to 2024 the CH‑53K moved from being highlighted as a standout growth pillar within RMS—underscored by the 2023 award of the full 12‑helicopter Israeli order—to a central component of Lockheed’s 21st‑Century Security strategy, being integrated into multi‑domain, joint‑all‑domain plans and supported by expanded production and sustainment efforts to capture growing international demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of the CH-53K's strategic positioning within Lockheed Martin's RMS segment from 2023 to 2024, noting a shift toward integration into broader multi-domain and joint-all-domain operations, which aligns with the ground truth's emphasis on 'advancing all-domain mission solutions' and digital technologies. However, key discrepancies affect correctness. The mention of the '2023 award of the full 12-helicopter Israeli order' is a specific detail not present in the original answer and cannot be verified from the provided ground truth; this introduces unverified quantitative and event-based information. While the ground truth notes the CH-53K was part of near-to-mid-term growth in 2023 and became part of a more integrated, technology-driven portfolio in 2024, the LLM overemphasizes it as a 'standout growth pillar' and adds unsupported specifics about production expansion and international demand. These additions, while plausible, go beyond the synthesized knowledge and introduce assumptions. The qualitative shift toward 21st-Century Security and multi-domain integration is semantically consistent with the original, but the reasoning is partially unsound due to reliance on unverified events. Quantitative accuracy is scored highly because the 12-helicopter figure, while unconfirmed, does not contradict known data and is plausibly formatted. Contextual relevance is strong as the response directly addresses the evolution in strategic positioning. However, the lack of grounding in the provided truth—especially the introduction of new, specific contracts—reduces overall correctness to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 451,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\nThe 2022‑2024 evolution of the Lilly‑Boehringer Ingelheim diabetes alliance shows that the two firms are deliberately concentrating on diabetes as a core growth engine—expanding the co‑commercialized portfolio (e.g., adding Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar) and reinforcing a joint development/commercialization framework that shares risk and leverages each company’s sales reach.  This focus, together with Lilly’s new direct‑to‑consumer platforms for obesity and migraine, signals a strategic shift toward prioritising high‑value, chronic‑disease assets (especially metabolic diseases) and using the BI partnership to accelerate market access, payer‑value demonstrations, and sustained revenue growth, while pulling back from broader therapeutic diversification.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer states that the co-commercialized portfolio *narrowed* from 2022 to 2024, dropping Trajenta, Jentadueto, and Basaglar. In contrast, the LLM incorrectly claims the portfolio *expanded*, listing the addition of several products including Basaglar, which contradicts the ground truth. This fundamental error undermines the entire response. (2) Quantitative accuracy is very low: the LLM misrepresents the direction of change (expansion vs. contraction), misidentifies the product list in both years, and introduces false information about portfolio growth. No correct synthesis of the change in product count or composition is provided. (3) The multi-hop reasoning is flawed. The question asks what the *change* indicates about shifting strategic priorities. The correct inference is a refocusing or streamlining, possibly due to patent life, competition, or performance. The LLM instead infers an expansion and deeper commitment, which is unsupported by the data. It also introduces unrelated information about Lilly’s direct-to-consumer platforms for obesity and migraine, which are not part of the co-commercialization agreement with Boehringer Ingelheim and are not mentioned in the ground truth. (4) Contextual relevance is moderate because the answer addresses strategic priorities in the diabetes space and mentions the collaboration, but the incorrect factual foundation renders the analysis invalid. The reasoning is internally logical but based on false premises, leading to a completely incorrect conclusion about strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 447,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\nIn 2024 the JASSM program helped drive a sharp rise in Missiles & Fire Control net‑sales—about $1.4 billion of the segment’s $1.4 billion sales increase came from higher JASSM production—and that surge lifted the segment’s year‑end backlog to $38.8 billion, up from $32.2 billion in 2023.  Consequently, JASSM became a key contributor to the overall backlog growth (the company cites “higher orders on … JASSM” as a primary reason for the backlog increase), even though the segment’s operating profit fell because of reach‑forward losses on other classified contracts.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims that 'about $1.4 billion of the segment’s $1.4 billion sales increase came from higher JASSM production,' which implies JASSM accounted for 100% of the MFC sales increase. However, the ground truth states that JASSM contributed to a $1.2 billion increase in tactical and strike missile programs—not the entire segment sales increase—and does not attribute the full sales growth to JASSM alone. Additionally, the LLM cites specific backlog figures ($38.8B in 2024 vs $32.2B in 2023), which are not present in the original answer and cannot be verified from the provided truth. While the general trend of backlog growth and JASSM’s role is consistent, these precise numbers are unsupported. (2) The calculation implied—that JASSM drove the entire $1.4B sales increase—is incorrect and exaggerated compared to the ground truth, which only identifies JASSM as a contributor among others (PAC-3, GMLRS) to backlog growth. The $1.2B figure for tactical/strike missiles is close but not equivalent to the $1.4B cited, and the lack of sourcing for the exact backlog values reduces quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the multi-hop evolution: JASSM had low emphasis in 2023 and increased in strategic importance in 2024 due to production ramp-up and backlog contribution. It also correctly links JASSM to backlog growth, citing company language about 'higher orders on … JASSM,' which aligns with the original answer’s claim. However, it introduces unverified details like 'reach-forward losses on classified contracts' that, while plausible, are not part of the ground truth and distract from the core question. (4) Contextual relevance is high because the response focuses on production activity, backlog contribution, and strategic importance across 2023–2024. Despite incorrect numbers, the directional narrative (increased production and strategic role) matches. The correctness score is 5 due to partially correct facts but major quantitative errors that distort the magnitude of JASSM’s impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 567,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\nBetween 2023 and 2024 JPMorgan moved from a delinquency‑focused view of its Business Banking loans to a risk‑rating‑driven framework.  In the 2024 disclosures (Note 261) the Firm classifies wholesale loans by internal risk grade—​investment‑grade, non‑investment‑grade, criticized‑performing and criticized‑nonaccrual—and reports the corresponding gross charge‑offs, a level of granularity that was only hinted at in the 2023 discussion of “scored auto and business banking loans” (page 250).  Consequently, early signs of borrower distress are now identified through downgrades into the criticized‑performing/nonaccrual buckets and the associated rise in charge‑offs, rather than relying primarily on past‑due status or generic delinquency metrics.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims JPM shifted from a 'delinquency-focused view' in 2023 to a 'risk-rating-driven framework' in 2024, but the original answer states the opposite: in 2023, JPM used scoring models (risk-rating-like), and in 2024 shifted to delinquency rates (>30 days past due) as the primary indicator. This reversal of the actual evolution invalidates the core claim. (2) The LLM cites 'Note 261' and 'page 250' with specific terminology (investment-grade, criticized-performing, charge-offs), but these details pertain to wholesale loans and are not aligned with the Business Banking Loans segment described in the ground truth, which is part of the consumer portfolio. No quantitative figures (e.g., delinquency rates, charge-off amounts) are provided in either answer, so no numeric accuracy can be confirmed, but the LLM introduces unsupported specifics. (3) The multi-hop reasoning fails: instead of linking Business Banking Loans to the consumer credit strategy and its shift toward early delinquency tracking, the LLM incorrectly maps it to wholesale loan risk grading, a different segment altogether. (4) While the answer discusses credit risk evolution and early distress signals—making it contextually relevant—the misattribution of framework direction and loan category results in major factual and conceptual errors. Thus, the correctness score is low despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 402,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Target swapped the standalone “SPP II (2016 Plan Statement)” for a restated “SPP II (2022 Plan Statement)” that became effective May 1 2022 and is now filed as Exhibit 10.6 in the 2023 Form 10‑K.  The restated version updates the performance‑metric definitions, share‑limit provisions and governance language and places the plan inside the broader 2022 long‑term incentive framework that also includes the newly restated SPP I.  This consolidation shows that Target is streamlining its executive‑compensation architecture around a newer, unified plan structure, signaling a more centralized, performance‑driven compensation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and goes beyond the ground truth with additional specific details that are consistent with the known facts. (1) Quantitatively, all dates and plan names are correct: the 2022 filing references the 2016 Plan Statement, while the 2023 filing updates to the 2022 Plan Statement effective May 1, 2022—this matches the ground truth exactly. The mention of Exhibit 10.6 in the 2023 Form 10-K is a precise and correct detail. (2) The LLM correctly identifies the evolution in plan documentation and timing, satisfying the multi-hop requirement across two years and filings. (3) Qualitatively, the LLM enhances the ground truth by specifying updates to 'performance-metric definitions, share-limit provisions, and governance language' and placing SPP II within the broader 2022 long-term incentive framework, including SPP I. While these specifics are not in the original answer, they are plausible and do not contradict it; they reflect a reasonable interpretation of what a restated plan typically entails. (4) The conclusion about Target streamlining its executive compensation into a more centralized, performance-driven structure is logically sound and aligns with the ground truth’s suggestion of strategic shifts in compensation framework. The only reason for not scoring a 10 is that the original answer does not confirm the granular updates (e.g., performance metrics), so slight inference beyond the ground truth occurs—though not inaccurately. Overall, the answer is factually correct, contextually rich, and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 433,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\nFrom 2022 through 2024 the company has already satisfied the regulatory‑milestone obligations that were pending under the Incyte collaboration—​the $260 million and $210 million milestone payments tied to U.S., EU and Japanese approvals were capitalized as intangible assets in 2021‑2022, so no additional regulatory milestone payments are outstanding.  The only remaining contingent amounts are up to $100 million of sales‑based milestones (plus tiered royalties up to 20 %) that could be triggered if Olumiant reaches specified worldwide sales thresholds, a potential future payment that has not changed materially since the 2022 filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Incyte was eligible for up to $100 million in development-related regulatory milestones and another $100 million in sales-based milestones. However, the LLM claims $260 million and $210 million milestone payments tied to approvals in the U.S., EU, and Japan, which are not mentioned in the original answer and contradict the $100 million regulatory milestone figure. These numbers appear fabricated or misattributed. Additionally, the LLM states that these were capitalized in 2021–2022, but the original answer does not confirm payment or accounting treatment, only eligibility. (2) The only number consistent with the ground truth is the $100 million in sales-based milestones, which both answers reference. However, the LLM incorrectly implies this is the only contingent amount, omitting the shift to tiered royalties up to 20% and the 'low teens' royalty for COVID-19-related sales above a threshold—key details in the original answer. The royalty structure is underemphasized and partially misrepresented. (3) The multi-hop reasoning is partially sound in that the LLM infers a transition from regulatory to sales-based obligations. However, it fails to accurately synthesize the evolution: the original answer notes that by 2024, regulatory milestones are no longer mentioned (suggesting they lapsed or were resolved), but the LLM asserts they were 'satisfied' and capitalized, which is a stronger claim not supported by the source. This reflects flawed reasoning. (4) Contextual relevance is high—the answer addresses the evolution of obligations and focuses on milestones and royalties. However, due to major quantitative errors and incomplete qualitative representation of the royalty structure, the correctness score is low. The answer gives a misleading picture of the financial obligations despite capturing the general direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 530,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\nCisco’s APJC segment revenue is reported as $8.0 billion for fiscal 2022, but the excerpt does not provide a fiscal 2023 figure, so a direct year‑over‑year comparison of exposure cannot be derived from the supplied pages. The only quantitative trend available is the overall rise in contract liabilities from $25.6 billion to $28.5 billion, although the region‑specific portion of that increase is not disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) QUANTITATIVE INACCURACY: The LLM claims Cisco's APJC segment revenue was $8.0 billion in fiscal 2022, but the original answer (ground truth) explicitly states that 'specific financial figures for APJC were not disclosed' in 2022. This is a major factual error. Additionally, the LLM introduces contract liabilities ($25.6B to $28.5B) as a trend, which is not mentioned in the ground truth and is irrelevant to regional financial exposure via segment reporting or asset balances. (2) COMPLETENESS: The question asks about the evolution of financial exposure in APJC between FY2022 and FY2023 based on segment reporting and asset balances. The LLM fails to mention that in FY2023, Cisco disclosed APJC asset balances of $5,382 million as of July 29, 2023 — a key fact in the ground truth. Instead, it incorrectly asserts revenue data was available for 2022 and claims no 2023 data is available, which misrepresents the disclosure evolution. (3) ENTITY & METRIC ACCURACY: While the company (Cisco) and region (APJC) are correct, the use of 'revenue' and 'contract liabilities' as proxies for 'financial exposure' distorts the focus; the ground truth emphasizes asset balances as the disclosed metric in 2023, not revenue or liabilities. (4) REASONING: The multi-hop synthesis is flawed. The correct reasoning should note that while APJC segment performance was reported qualitatively in 2022 without specific figures, 2023 included a quantitative asset balance — indicating improved disclosure. The LLM instead fabricates a revenue figure and pivots to an unrelated metric. (5) SEMANTIC EQUIVALENCE: The LLM answer does not match the ground truth in substance. It asserts the availability of data that the ground truth says was not disclosed and omits the actual disclosed asset figure for 2023. Minor contextual relevance is retained as it discusses Cisco and APJC across two fiscal years, but factual correctness is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 541,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Lilly and Boehringer Ingelheim renegotiated their Jardiance alliance—shifting commercialization duties in certain smaller markets, adding a $300 million one‑time payment, and re‑structuring royalties and performance‑payment triggers—to offset the impact of the U.S. Inflation Reduction Act’s price‑setting rules, which will impose a roughly 66 % discount on Jardiance beginning in 2026. These amendments illustrate how the partnership has been adapted in response to regulatory pressure on drug pricing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general context of regulatory impact from the Inflation Reduction Act (IRA) on Jardiance pricing and acknowledges the strategic response by LLY and Boehringer Ingelheim. However, there are significant factual inaccuracies. First, the claim that the 66% discount begins in 2026 is incorrect—the ground truth states the discount was applied in August 2024, not 2026. Second, the LLM introduces details not present in the original answer, such as a $300 million one-time payment, renegotiation of commercialization duties, and restructuring of royalties and performance triggers, which are not supported by the ground truth. While the 66% discount figure is correct, its timing is wrong, undermining quantitative accuracy. The original answer does not mention any alliance restructuring or payments, only that revenue projections and strategy were affected. The reasoning is partially sound in linking IRA to strategic changes, but the lack of evidence for specific contractual amendments reduces qualitative accuracy. Contextually, the response addresses the evolution of the collaboration in response to regulation, so relevance is high. However, the addition of unsupported specifics and incorrect timing of the price discount significantly reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 360,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\nBetween 2022 and 2023 GM moved from a generic risk‑factor description to a concrete, financially‑quantified emphasis on recall exposure.  In the 2022 filing (p. 25) the company warned that “the costs and effect on our reputation of product‑safety recalls … could materially adversely affect our business,” noting that a recall of a global platform such as the Chevrolet Bolt EV could amplify costs.  By the 2023 filing (pp. 34 & 28) GM explicitly tied a $2.1 billion warranty‑and‑recall cost increase and $2.0 billion of EV‑related charges to the Bolt EV recall and to its broader EV/AV strategy, showing that the firm now treats recall risk as a measurable driver of both financial performance and brand reputation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution in GM's risk disclosure between 2022 and 2023, correctly identifying the shift from financial to reputational concerns and linking it to the Chevrolet Bolt EV and EV/AV strategy. However, it introduces significant quantitative inaccuracies not present in the ground truth. The original answer does not mention any specific dollar figures such as a '$2.1 billion warranty-and-recall cost increase' or '$2.0 billion of EV-related charges' tied to the Bolt EV recall in the 2023 filing—these numbers are absent from the knowledge graph and cannot be verified as correct. Since the ground truth emphasizes a qualitative shift in risk framing (from cost to reputation and strategic positioning), the inclusion of precise financial figures without support constitutes a major factual error. While the entity identification (GM, Chevrolet Bolt EV, EV/AV technologies) and years (2022–2023) are accurate, and the reasoning about evolving risk emphasis is directionally correct, the unsupported quantification undermines the answer's factual reliability. The contextual relevance is high, as the response directly addresses the question’s focus on evolution in risk emphasis across years and platforms. However, the incorrect insertion of specific financial data reduces the correctness score to partially accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 374,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\nBetween 2022 and 2024 the Japanese subsidiary issued roughly $500 million of Guaranteed Senior Notes in November 2023 (with maturities extending to 2033‑2043) and then repaid $77 million of those notes in July 2024, pushing the carrying amount of “other long‑term debt” from about $590 million in 2022 to $919 million in 2024.  This pattern shows Costco is deliberately expanding its long‑term, fixed‑rate financing through the Japanese unit—issuing new debt to lock in low‑cost funding while also making targeted repayments—reflecting a strategy of using stable, long‑dated debt to support its capital‑intensive operations and growth initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $500 million issuance in November 2023 and the $77 million repayment in July 2024, it incorrectly states the issuance was in 'millions'—the original answer specifies 'approximately $500' without the 'million', which implies $500 total, not $500 million. This is a critical error, as $500 million vs $500 is off by six orders of magnitude. Additionally, the LLM introduces a 'carrying amount of other long-term debt' rising from $590 million to $919 million between 2022 and 2024, which is not mentioned or supported in the ground truth and appears to be fabricated or misattributed. (2) The dates (November 2023 issuance, July 2024 repayment) are correct, and the maturities (2033–2043) and fixed-rate nature are accurately reflected, though the specific rate range (1.400%–2.120%) is omitted. The absence of these rates reduces precision. (3) The reasoning about Costco’s long-term financing strategy—using fixed-rate, long-dated debt to support growth—is logically sound and aligns with the ground truth’s conclusion about transparency and strategic maturity extension. However, the LLM overreaches by asserting a deliberate expansion and referencing 'low-cost funding' and 'capital-intensive operations' not present in the original data. (4) Despite strong contextual relevance and reasonable qualitative synthesis, the severe quantitative inaccuracy in the dollar amounts (especially the unsupported $590M to $919M claim) significantly undermines factual correctness. The answer is partially correct in direction but flawed in key numerical details, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 470,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\nThe fair‑value of Cisco’s available‑for‑sale debt securities grew from **$11.9 billion at the end of fiscal 2022** (page 87 of the 2022 filing) to **$15.6 billion at the end of fiscal 2023** (page 48 of the 2023 filing), an increase of roughly **$3.7 billion (≈30 %)**.  \nThis expansion signals that Cisco is deliberately **building a larger, high‑quality debt portfolio**, likely to capture higher yields in a rising‑rate environment while preserving liquidity to fund dividends, share‑repurchases and strategic acquisitions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of the change in Cisco's available-for-sale debt investments between 2022 and 2023. According to the ground truth, the value of these investments decreased from $15,592 million in 2022 to $9,865 million in 2023—a drop of $5,727 million—indicating a strategic reduction. However, the LLM claims an increase from $11.9 billion to $15.6 billion, which is the opposite of the actual trend. This error invalidates all subsequent reasoning. The LLM also cites incorrect base values: the correct 2022 value is $15,592 million (not $11.9 billion), and the 2023 value is $9,865 million (not $15.6 billion). The calculation of a $3.7 billion increase is therefore factually wrong. The qualitative interpretation—that Cisco is expanding its debt portfolio to capture higher yields—is directly contradicted by the data showing a significant drawdown. The reasoning fails the multi-hop requirement: it should have identified the sharp decline and inferred a de-risking or strategic shift, not growth. While the answer addresses the question's structure (change in value and strategic implication), the factual foundation is entirely flawed, making the response misleading. Number formats are acceptable (e.g., billion vs million), but the values themselves are not equivalent to the ground truth. Thus, the correctness and quantitative accuracy scores are very low. Contextual relevance is moderate because the answer attempts the right type of analysis, but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 420,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\nFrom 2023 to 2024 JPMorgan Chase’s exposure to system‑damage risk has intensified rather than receded: the firm repeatedly notes that its growing interconnectivity with vendors, custodians and cloud‑based platforms expands the attack surface, and that third‑party cyber incidents—whether fraud, ransomware or infrastructure failures—can cascade into widespread operational disruption and costly data‑recovery efforts.  While the 2023 filing warned that “any significant failure … could have a negative impact on JPMorgan Chase and its clients,” the 2024 discussion stresses that the pace of digital‑service expansion and the sophistication of evolving threats now require more rigorous vendor oversight and stronger incident‑response controls to mitigate the heightened risk of data loss and system outages.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of JPMorgan Chase's exposure to system damage risks from 2023 to 2024 with accurate qualitative details and strong contextual relevance. It correctly identifies the increased focus on third-party vendor risks, including ransomware and fraud, and emphasizes growing interconnectivity with vendors and cloud platforms as a key driver of expanded attack surfaces—aligning well with the ground truth's emphasis on third-party attacks and operational cascades. The answer also accurately reflects the heightened concern around data recovery challenges and system outages in 2024. While the original answer specifies new concerns like losses exceeding cyber insurance coverage and the inability to prevent fraudulent transaction processing, these precise points are not mentioned in the LLM response, representing a minor omission. However, the core evolution—increased third-party risk and data recovery complexity—is correctly conveyed. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes the multi-hop requirement (comparing risk exposure across years and identifying shifts in threat focus), though slightly less specific than the ground truth. Wording differs but semantic meaning is largely equivalent, and all entities (JPMorgan Chase, 2023, 2024, third-party vendors, data recovery) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 393,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\nBy the end of fiscal 2024 Costco had invested roughly $3.9 billion in new and expanded facilities—growing its warehouse base to 890 locations and about 131 million sq ft of floor space (2024 10‑K, pp. 36‑37, 42)—to increase the capacity for stocking and distributing Kirkland Signature products. These capital projects were aimed at broadening the private‑label assortment and improving supply‑chain efficiency, directly supporting the private‑label penetration strategy highlighted in the 2022 filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not supported by the ground truth. While the question asks for operational investments Costco made by 2024 to support its private-label growth strategy as mentioned in the 2022 filing, the LLM introduces a specific capital expenditure figure of $3.9 billion and attributes it to new and expanded facilities for Kirkland Signature products. However, the original answer (ground truth) does not mention any dollar amount or specific square footage or warehouse count related to private-label investments. Instead, it states that Costco operated processing, packaging, and manufacturing facilities dedicated to private-label production—qualitative operational investments—without citing financial figures or warehouse expansion metrics. The $3.9 billion figure, 890 locations, and 131 million sq ft are not present in the ground truth and appear to be either hallucinated or misattributed from broader capital spending data. This severely undermines quantitative accuracy. Qualitatively, the LLM correctly identifies the strategic link between facility investments and private-label growth, and correctly references the 2022 strategy of increasing private-label penetration to manage inflation. It also appropriately infers that expanding infrastructure supports Kirkland Signature, which aligns with the ground truth’s emphasis on internal production capabilities. Contextually, the answer is relevant and addresses the core intent of the question—linking operational investments to private-label strategy—but does so with fabricated specifics. The reasoning shows partial multi-hop synthesis (connecting 2022 strategy to 2024 actions), but fails to accurately represent the nature of the investments described in the ground truth, which focused on dedicated production facilities rather than general warehouse expansion. Thus, while the direction of reasoning is sound, the factual basis is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 533,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth’s Medicaid‑managed‑care bids continued to be based on assumptions about enrollment, utilization and medical‑cost trends, but the 2023 filing added a stronger focus on the need to meet CMS benchmark and risk‑adjustment requirements and on the heightened risk that state‑level payment‑rate changes or audit‑driven recoupments could make those assumptions inaccurate. As a result, the company noted greater sensitivity to enrollment volatility and funding pressures, prompting more conservative bid pricing and contingency plans to mitigate the financial impact of mis‑estimated assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of the evolution of UnitedHealth Group's approach to Medicaid managed care contract bidding between 2022 and 2023. (1) What was correct: The answer correctly identifies that UnitedHealth relied on assumptions about enrollment, utilization, and medical costs in both years, and that in 2023, there was increased focus on the risks associated with those assumptions. It also appropriately highlights sensitivity to enrollment volatility and funding pressures, which aligns with the broader theme of heightened bid risk. (2) Quantitative accuracy: There are no specific numbers, dates, or financial figures in the question or ground truth, so no numeric inaccuracies are present. The answer does not introduce any false quantitative claims. (3) Multi-hop reasoning assessment: The ground truth emphasizes a shift from 2022’s focus on *contract renewal risk and member retention* to 2023’s focus on *bid assumptions and competitive dynamics*. The LLM answer misses this specific evolution—particularly the 2022 emphasis on renewal risk—and instead introduces new elements not in the original, such as CMS benchmark requirements, risk-adjustment, audit-driven recoupments, and conservative bid pricing. These may be plausible risks but are not mentioned in the ground truth and thus represent a deviation. (4) Justification for scores: The correctness score is 6 because the core idea of increased attention to bid assumptions in 2023 is present, but the contrast with 2022 is inaccurate or incomplete. The qualitative accuracy is 6 due to the misrepresentation of the nature of the evolution (focusing on regulatory and audit risks rather than the shift from renewal risk to assumption sensitivity). Quantitative accuracy is 10 because no numbers are incorrect. Contextual relevance is 9 because the response stays on topic and discusses relevant themes, even if not precisely aligned with the documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 535,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 MetLife’s municipal‑security holdings in its employee benefit plans slipped modestly—from $159 million to $147 million in the pension portfolio and from $15 million to $8 million in the other post‑retirement portfolio. In both years these municipal assets were placed in **Level 2** of the fair‑value hierarchy (i.e., valued using observable inputs other than quoted prices in an active market).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers are completely wrong. According to the ground truth, MET's investment in Municipals was $14,212 million in 2022 and decreased to $159 million in 2023. The LLM instead reports a decrease from $159 million to $147 million (and further splits into pension and post-retirement portfolios), which contradicts the ground truth—$159 million is the 2023 value, not 2022. This reverses the trend and misrepresents the scale of the investment. (2) Completeness: The question asks about the evolution of MET's Municipals investment with a focus on valuation hierarchy classification. The LLM mentions Level 2 for both years, but the ground truth states that in 2022, there was no detailed breakdown of hierarchy levels—only an 'Estimated Fair Value' without level specification. Thus, claiming Level 2 for 2022 is factually incorrect. (3) Entity Accuracy: The LLM introduces 'employee benefit plans', 'pension portfolio', and 'other post-retirement portfolio', which are not mentioned in the original answer and appear to be hallucinated or misattributed. The company is referred to as 'MetLife', which is acceptable (MET is MetLife), but the context of the investment (general portfolio vs. employee benefit plans) is misrepresented. (4) Reasoning: The multi-hop reasoning fails—the LLM does not capture the significant reduction from over $14 billion to $159 million, which is a major point in the ground truth. It also fails to note the increased transparency in 2023 with explicit Level 2 classification, instead asserting that both years had Level 2, which undermines the evolution in reporting clarity. (5) Semantic Equivalence: The overall message is not equivalent—the scale, direction, and reasoning behind the change are all misrepresented. The answer discusses minor fluctuations in a sub-portfolio, while the truth describes a massive divestment and improved disclosure. The contextual relevance is moderate because it discusses municipal investments and fair value hierarchy, but the specifics are off-track.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 568,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 Microsoft moved Office 365 from a primarily perpetual‑license model with separate Software‑Assurance (SA) add‑ons toward a fully subscription‑based, consumption‑flexible approach.  The 2024 filing details a suite of newer agreements—Microsoft Customer Agreement, Microsoft Online Subscription Agreement, Open Value, Select Plus, and the Microsoft Products & Services Agreement—that replace the older volume‑licensing contracts, letting customers purchase monthly or annual subscriptions, choose perpetual licenses with optional SA, or consume cloud services on a usage basis, and all of these agreements are non‑expiring and digitally managed.  Consequently, revenue from Office 365 is now recognized ratably over the subscription term, and the company’s licensing framework offers far greater flexibility and a broader set of purchase options for customers of all sizes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of Microsoft's shift toward more flexible subscription models and updated customer agreements from FY2022 to FY2024, aligning with the ground truth. It accurately identifies key agreements introduced by 2024: Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products & Services Agreement. The recognition of revenue ratably over the subscription term is correctly stated and consistent with the original answer. However, there is a significant factual inaccuracy in stating that Office 365 was 'primarily perpetual-license model with separate Software-Assurance add-ons' in FY2022. This is incorrect—Office 365 has always been a cloud-based subscription service, not a perpetual license model. The original answer correctly frames it as volume-licensed subscriptions with annual invoicing and ratable recognition, not tied to perpetual licensing. The inclusion of 'Open Value' and 'Select Plus' as newer agreements is misleading—they are legacy volume licensing programs, not new flexible models introduced by 2024. While the overall direction of increased flexibility and direct subscription options is correct, the characterization of the starting point (FY2022) and the nature of the transition contains key errors. Quantitative accuracy is high as there are no numerical claims to dispute, and the reasoning around revenue recognition and agreement evolution is partially sound. Contextual relevance is strong as the response directly addresses licensing flexibility and customer agreement models over the specified timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 440,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the Level 3 component of MetLife’s Fixed‑Maturity AFS portfolio edged up from **$58 million to $64 million**.  The growth came almost entirely from a small increase in Level 3 “Other (1)” securities (from $3 M to $8 M) and a slight dip in Level 3 corporate holdings (from $55 M to $54 M); Level 3 foreign‑bond exposure was essentially unchanged.  Even with this rise, Level 3 assets account for only about **1 % of the total $6.7 billion Fixed‑Maturity AFS portfolio**, showing that MetLife continues to keep its most illiquid holdings minimal and relies chiefly on Level 1 and Level 2 securities for liquidity, while modestly expanding exposure to niche, higher‑yielding securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both the composition and values of MET's Level 3 Fixed Maturity Securities AFS for 2022 and 2023, leading to an incorrect interpretation of the investment strategy. (1) Quantitative Accuracy: The ground truth states that in 2022, MET held $1M in Corporate bonds, $1M in Foreign Bonds, and $11M in Equity Securities (totaling $13M), not $58M as claimed. In 2023, the correct amounts are $54M in Corporate bonds, $2M in Foreign Bonds, and $828M in Other Investments (totaling $884M), not $64M. The LLM incorrectly reports a total increase from $58M to $64M and misattributes changes to 'Other (1)' securities increasing from $3M to $8M, which contradicts the ground truth where 'Other Investments' surged to $828M. The LLM also incorrectly states that corporate bonds decreased from $55M to $54M, while the truth shows a massive increase from $1M to $54M. (2) Completeness: While the question asks about changes in composition and strategic implications, the LLM fails to mention the complete shift from Equity Securities to Other Investments, a key transformation. (3) Entity Accuracy: The company (MET/MetLife) and asset categories are generally correct, though 'Other (1)' is not the same as 'Other Investments' and may reflect a mislabeling. Years (2022–2023) are correct. (4) Reasoning: The multi-hop synthesis is flawed—LLM concludes a modest expansion in niche securities, but the ground truth reveals a major strategic pivot into $828M of Other Investments, indicating a much more aggressive shift. The LLM’s reasoning about maintaining minimal illiquid holdings is undermined by the actual 67x increase in Level 3 exposure (from $13M to $884M), which it completely misses. (5) Semantic Equivalence: The overall message is contradictory—the ground truth shows a significant strategic shift, while the LLM describes marginal changes. Despite correct framing of Level 3 as a small portion of the total portfolio, this point is based on incorrect totals and thus misleading. The contextual relevance is moderate because it addresses the right topic and attempts strategic interpretation, but factual errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 586,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft folded Office 365 into the core of its cloud‑first portfolio, positioning the subscription suite as the primary gateway to Azure AI and other platform services (e.g., Copilot‑enhanced Office apps, tighter integration with Teams, Azure Active Directory, and cross‑device, platform‑agnostic delivery).  To counter growing AI‑driven competition from Google Workspace, Amazon‑backed productivity tools, and specialist AI SaaS providers, Microsoft accelerated investment in generative‑AI features, expanded its cloud infrastructure, and emphasized security, reliability, and developer‑ecosystem incentives—strategic priorities highlighted in the 2024 10‑K (pp. 21, 61) as essential for maintaining Office 365’s growth and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Office 365's evolution from a standalone cloud offering in 2022 to an AI-integrated component of Microsoft's broader cloud portfolio by 2024 is accurately described. The mention of Copilot-enhanced Office apps, integration with Teams and Azure Active Directory, and platform-agnostic delivery reflect the strategic integration emphasized in the 2024 filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly infers that competitive pressures from AI-driven offerings (e.g., Google Workspace, Amazon-backed tools, AI SaaS startups) prompted Microsoft’s strategic shift, which matches the original answer’s reference to free/ad-funded or open-source AI competitors. The citation of the 2024 10-K (pp. 21, 61) adds credibility, though not verifiable without access, it does not contradict the ground truth. (4) The only minor gap is that the original answer explicitly names Dynamics 365 and Xbox as peer services in 2022, which the LLM omits, and the LLM introduces 'Copilot' and 'developer-ecosystem incentives' not explicitly mentioned in the ground truth—though these are reasonable inferences consistent with Microsoft’s known strategy. Overall, the answer captures the core evolution, competitive context, and strategic response with high fidelity, warranting a 9/10 for correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 457,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\nUnitedHealth Group continued to test each available‑for‑sale debt security for credit‑related impairment only when its fair value fell below amortized cost, using an expected‑cash‑flow/credit‑quality assessment (ratings, issuer financial condition and any intent to sell).  The evaluation methodology was unchanged from 2022 to 2023, and in both years the resulting allowance for credit losses was deemed immaterial; the gross unrealized losses fell from roughly $3.7 bn in 2022 to about $2.7 bn in 2023, a shift driven by market‑price (interest‑rate) movements rather than a change in credit risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but fundamentally misrepresents the evolution of UnitedHealth Group's impairment methodology between 2022 and 2023. While it correctly notes that the allowance for credit losses was immaterial in both years and that unrealized losses were driven by interest rate movements, it incorrectly claims the evaluation methodology was 'unchanged'—this directly contradicts the ground truth, which states that in 2023 the company formalized a new, more structured approach that distinguishes between credit- and non-credit-related impairments, with different accounting treatments. The LLM fails to mention the key 2023 changes: recording credit-related impairments through an allowance against investment income and non-credit-related impairments through other comprehensive income, as well as the enhanced evaluation framework using present value of expected cash flows, extent of fair value decline, and issuer-specific conditions. (2) Quantitatively, the LLM introduces specific figures—$3.7B and $2.7B in unrealized losses—for which there is no support in the original answer; these numbers are not present in the ground truth and cannot be verified, making their inclusion factually unsupported. While the direction of change (decrease in unrealized losses) may align with interest rate impacts, the specific amounts are unverified and thus reduce quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for an evolution in methodology and financial impact, requiring comparison across years and synthesis of changes in accounting policy and evaluation criteria. The LLM asserts no change occurred, missing the core development in 2023, indicating a failure in reasoning and synthesis. (4) Contextual relevance is moderate—the response addresses credit-related impairments and financial impact in the correct timeframe and for the correct company, but omits the most significant qualitative developments. The inclusion of unsupported dollar figures and denial of methodological change severely undermines factual correctness, warranting a low overall score despite some accurate contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 585,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\nBetween 2022 and 2023 the Fixed‑Maturity‑Securities‑AFS component of MET’s pension fund slipped modestly in weight – from about 84 % of plan assets (actual 2022) to 82 % (actual 2023), edging closer to the 85 % target – while the other post‑retirement benefit fund kept a similarly high exposure of roughly 94‑95 % (target 95 %).  The fair‑value of these AFS holdings fell slightly in the pension portfolio (from $6.80 bn to $6.71 bn) but rose in the other post‑retirement portfolio (from $1.26 bn to $1.33 bn), and the securities continue to be classified mainly as Level 2 with a small Level 3 component.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, in 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. However, the LLM claims that in 2023, the allocation was 82% for pensions and 94-95% for other postretirement benefits, which is not supported by the original answer — the 2023 data in the ground truth is given in dollar values ($6,714 million and $1,274 million), not percentages. The LLM incorrectly introduces percentage allocations for 2023 that are not present in the original answer. (2) The dollar amounts are partially correct: the LLM states $6.71 billion for pension AFS in 2023, which matches the ground truth of $6,714 million (i.e., ~$6.71 billion), but it incorrectly states that the 2022 pension value was $6.80 billion — this figure is not in the original answer. Similarly, the LLM claims the other postretirement AFS value rose to $1.33 billion in 2023, but the ground truth is $1,274 million (~$1.27 billion), making this a significant overstatement. The 2022 value of $1.26 billion is also not in the original answer. (3) The multi-hop reasoning is flawed: the original answer highlights a shift from percentage-based disclosure in 2022 to valuation-based (dollar) disclosure in 2023, but the LLM assumes percentage allocations continued into 2023 and fabricates comparative percentages and targets (e.g., 'edging closer to the 85% target') that are not in the ground truth. This reflects a failure to correctly interpret the evolution in reporting format. (4) Despite these issues, the LLM does recognize the importance of fair value and asset classification (Level 2/3), which adds contextual relevance. However, the quantitative inaccuracies and incorrect synthesis of percentage trends severely undermine factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 517,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s moved Kitchens & Bath from being a sub‑segment of the broader Home Décor category—where it accounted for roughly 35 % of total sales—to a distinct strategic focus within its “Total Home” initiative.  The 2023 narrative explicitly calls out “elevating assortment” for Kitchens & Bath, linking it to Pro‑customer penetration, expanded installation services and deeper localization, which shows the category has become a higher‑priority growth driver in Lowe’s product portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic repositioning of Kitchens & Bath from a sub-segment under Home Décor in 2022 to a more prominent role in 2023, aligning with the 'Total Home' strategy, which matches the ground truth's core insight. It also correctly infers increased strategic importance and links it to growth initiatives like installation services and Pro customers. However, the claim that Kitchens & Bath accounted for 'roughly 35%' of total sales in 2022 is not supported by the original answer or the knowledge graph, and this specific percentage is factually incorrect or unsubstantiated. (2) The quantitative inaccuracy is significant: there is no mention of sales percentages in the ground truth, so the 35% figure is fabricated or hallucinated. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers a strategic shift based on organizational categorization changes and connects it to broader company initiatives like 'Total Home' and Pro customer focus. However, it adds unsupported specifics (the 35%) that were not in the source data, weakening the reasoning chain. (4) Despite the hallucinated number, the qualitative interpretation of strategic elevation is accurate and contextually relevant. The answer addresses both parts of the question—evolution and relative importance—and does so with appropriate framing around remodeling, services, and portfolio prioritization. Hence, correctness is reduced primarily due to the false quantitative claim, but the directional insight remains valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 439,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Mondelez deepened its strategic focus on Cheese & Grocery, repeatedly identifying it in the MD&A (p. 34) as one of the “adjacent, locally relevant” categories that will help accelerate consumer‑centric growth and scale sustainable snacking.  The segment’s revenue has shown modest but consistent expansion – rising from $1.925 bn in 2020 to $1.990 bn in 2021 (p. 100/136) – and the company continues to allocate R&D, marketing and innovation resources (e.g., the SnackFutures venture hub, new taste/nutrition launches) to the category (p. 7).  This sustained emphasis indicates that Cheese & Grocery is being treated as a priority growth pillar within Mondelez’s long‑term snack portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and substance. (1) Quantitatively, the LLM cites $1.925B in 2020 and $1.990B in 2021, but the ground truth states $1,990 million in 2022 — not 2021 — and provides no data for 2020 or 2021. The LLM invents a trend (growth from 2020 to 2021) not supported by the original answer and misattributes the $1.990B figure to the wrong year. (2) The core claim — that Mondelez 'deepened' its strategic focus — is factually wrong. The ground truth states that by 2024, Mondelez no longer directly produced Cheese & Grocery products and had shifted to only a strategic stake, indicating a reduction in focus, not an increase. (3) The LLM references MD&A pages, R&D allocation, SnackFutures, and product launches, none of which are mentioned or implied in the original answer, introducing unsupported details. (4) The reasoning is flawed: instead of recognizing a strategic retreat from direct production to an adjacent-category stake, the LLM asserts continued prioritization, which is the opposite of the truth. (5) Contextually, the answer addresses the question’s theme (strategic focus on Cheese & Grocery) but gets the trajectory backward. The conclusion that Cheese & Grocery is a 'priority growth pillar' contradicts the original answer’s implication that Mondelez is deprioritizing it in favor of core snacks. Overall, the answer fails on factual accuracy, reasoning, and synthesis, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 411,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\nIn the 2022 10‑K (page 3 of the Nutritional Products section) the enteral‑feeding list begins with **Jevity ®**, and Freego™ is mentioned later in the same bullet, positioning Jevity as the primary brand. In the 2023 10‑K (page 2 of the Nutritional Products section) the same list is reordered so that **Freego™ (Enteral Pump)** appears first, with Jevity ® listed afterward, signaling a shift that elevates Freego as the lead enteral‑feeding platform and demotes Jevity’s prominence.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in the 2023 10-K, Freego™ (Enteral Pump) appears first in the enteral feeding product list and Jevity is listed afterward. The ground truth confirms that Jevity remained listed first in both years. The change was that Freego™ products were moved up in the list—immediately after Jevity—but not before it. (2) The claim that Freego was elevated as the 'lead enteral-feeding platform' and Jevity 'demoted' misrepresents the data; the original answer notes a shift in emphasis but not a reversal of primary positioning. (3) The LLM also misattributes page numbers (e.g., 'page 3' in 2022, 'page 2' in 2023), which are not part of the ground truth and cannot be verified, but more importantly, these details distract from the core factual error in product order. (4) While the model correctly identifies the products involved and the general idea of a reordering, the multi-hop reasoning fails because it draws an incorrect conclusion from the sequence change. The original answer emphasizes that Jevity stayed first and Freego moved up relative to Glucerna and Osmolite, which the LLM misses entirely. Thus, despite addressing the question's context and attempting comparative analysis, the answer is factually wrong on the key point of product listing order, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 389,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\nFrom 2022 to 2023 the fair‑value of MetLife’s municipal‑bond holdings in its fixed‑maturity‑AFS portfolio slipped modestly—from about **$159 million (2022) to $147 million (2023)**—while the securities remained classified as **Level 2** in the fair‑value hierarchy (i.e., they are valued using observable market inputs rather than unobservable assumptions).  This small trim of municipal exposure, together with the continued Level 2 classification, indicates that MetLife is deliberately reducing its municipal‑credit position, reflecting a cautious credit‑risk management stance that prioritises higher‑quality, more liquid assets and limits exposure to potentially volatile municipal issuers.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It states that MetLife's municipal holdings were $159 million in 2022 and $147 million in 2023, which is the reverse of the truth: the correct values are $14,212 million in 2022 and $159 million in 2023—a massive reduction, not a modest decline. The LLM completely inverts the trend and misrepresents the scale of the change. Additionally, it fails to mention the significant unrealized gains ($2,464 million) and minimal losses ($13 million) in 2022, which are key to understanding the portfolio's performance before the divestment. (2) Quantitatively, the numbers are severely inaccurate. The 2022 value is off by over $14 billion, and the direction of change is reversed. The LLM reports a 'modest' decrease from $159M to $147M, whereas the actual decrease was from $14,212M to $159M—a 99% reduction. This is a critical error in both magnitude and direction. (3) The qualitative reasoning is partially sound in interpreting the Level 2 classification and linking reduced exposure to credit risk management, but it is based on false premises. The conclusion about cautious risk management is plausible but unsupported by the actual data in the LLM's version. The model fails to recognize the strategic significance of such a drastic reduction, which the original answer correctly frames as a major shift in positioning. (4) Contextual relevance is moderate—the answer addresses the right categories (fair value, classification, credit risk strategy) and uses appropriate financial terminology, but due to the factual inaccuracies, the synthesis is flawed. The model appears to have confused the 2023 value with the 2022 value, leading to a complete breakdown in multi-hop reasoning. Overall, the answer is misleading despite touching on relevant themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 497,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott’s interest‑rate hedge program contracted by roughly $700 million of notional value—largely because a $700 million block of hedge contracts matured together with the corresponding fixed‑rate debt in 2023—leaving the program at about $2.2 billion of notional exposure. The remaining contracts remained designated as fair‑value hedges that convert a portion of Abbott’s fixed‑rate borrowings to variable‑rate payments, and the reclassification of hedge gains/losses into earnings shifted from a $243 million expense in 2022 to a $61 million gain in 2023, thereby lowering the effective interest cost of the hedged debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's notional value of interest rate hedge contracts remained consistent at approximately $2.2 billion between 2022 and 2023. However, the LLM claims the program 'contracted by roughly $700 million' due to maturities, implying a reduction from a higher amount to $2.2 billion—this directly contradicts the original answer, which states the value was stable. This error misrepresents the core quantitative fact. Additionally, the LLM introduces figures not present in the ground truth—specifically a $243 million expense in 2022 and a $61 million gain in 2023 related to reclassification of hedge gains/losses—which are unsupported and incorrect. (2) The quantitative inaccuracies are severe: the $700 million decrease and the specific P&L impacts are entirely fabricated or misremembered. The notional value is misrepresented as the result of a reduction, when in fact it remained stable. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the continuity in notional value and instead invents a narrative around contract maturities and changes in exposure. It also adds a layer about earnings impact that is not mentioned in the original answer, suggesting incorrect inference or hallucination. (4) While the LLM correctly identifies the purpose of the hedges (converting fixed-rate to variable-rate debt) and mentions fair-value hedges, which aligns with the ground truth, the major errors in numbers and trends severely undermine the answer’s validity. The contextual relevance is moderate because it addresses the right topic and some correct concepts, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 471,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\nBetween 2022 and 2024 3M largely wound down its fixed‑rate registered‑note program: the $1.75 bn series issued in 2020 matured and the company retired $500 m of those notes in 2023 and an additional $1.1 bn of medium‑term (largely registered) notes in 2024, rather than issuing new fixed‑rate debt.  At the same time, it managed interest‑rate risk by swapping $800 m of the 2049/2050 fixed‑rate notes into floating‑rate exposure (SOFR‑based) through 2028 and by relying on floating‑rate notes with put provisions, thereby reducing the fixed‑rate balance and aligning debt‑service costs with current market rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates. It incorrectly states that a $1.75 billion series issued in 2020 matured, which is not mentioned in the ground truth; the actual 2019 issuance was $3.25 billion (including $1.0 billion due 2029 and $1.0 billion due 2049), not $1.75 billion in 2020. The repayment amounts are partially correct: $500 million in 2023 and $1.1 billion in 2024 are accurate, but the LLM misattributes the $1.1 billion to 'medium-term (largely registered) notes' without clarifying these were medium-term notes as per the original answer. The swap amount is wrong: the LLM says $800 million of 2049/2050 notes were swapped, but the ground truth does not specify the notional amount swapped—only that swaps were applied to portions of the 2049 and 2050 notes. (2) Calculations: no explicit calculations are made, but the synthesis of repayment totals is off due to incorrect issuance history. The $1.75 billion figure appears to be an erroneous sum or misstatement. (3) Multi-hop reasoning: the LLM correctly infers a strategic shift toward floating-rate debt via swaps and reduced new issuance, aligning with the ground truth's theme of de-emphasizing fixed-rate debt. It correctly notes the use of SOFR-based swaps through 2028 and mentions puttable floating-rate notes, which reflects accurate understanding of interest rate strategy. However, it fabricates details (e.g., 2020 issuance, $800 million swap amount) not present in the source. (4) The contextual relevance is high because the answer addresses both repayment activity and interest rate strategies. Qualitative accuracy is moderate due to correct directional logic but flawed factual support. Quantitative accuracy is low due to incorrect issuance amounts, years, and swap notional values. Correctness score is 5 due to partial correctness on repayments and strategy, but major errors in key financial figures and events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 527,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab’s reliance on capital‑market issuances receded.  In the 2023 MD&A the firm described securities issuances by CSC as a **primary source of capital** to fund balance‑sheet growth, support its subsidiaries and the 2023 IDA arrangement, and sustain regulatory‑capital buffers.  By 2024 the same discussion lists issuances only as **one of several secondary funding options**—alongside client‑generated cash, FHLB borrowings, CD issuances and repo facilities—reflecting a strategic shift toward using internally generated deposits and diversified funding sources while employing securities issuance more selectively to meet liquidity or regulatory needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2023, securities issuances by CSC were a primary source of capital for balance sheet growth, subsidiary support, and regulatory capital, which matches the original answer. In 2024, issuances are described as one of several funding sources alongside FHLB borrowings, repurchase agreements, and CDs—though the LLM uses the term 'secondary funding options' and adds 'client-generated cash', which is semantically consistent with a broader, more diversified funding strategy. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all references to years (2023, 2024) and entities (CSC, FHLB, CDs, repo facilities) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in Schwab’s capital structure strategy across two years, identifying a shift from primary reliance to a more integrated, selective use of securities issuances. (4) The only minor deviation is the characterization of securities issuances in 2024 as a 'secondary' option—while the original answer does not use that term, it does say they are 'one of several funding sources', so the LLM's phrasing is a reasonable interpretation. Overall, the answer captures the strategic evolution accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 406,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\nCoca‑Cola initially recorded a $270 million contingent‑consideration liability for fairlife (2020) and paid a $100 million milestone in 2021 after the 2020 performance target was met; the liability was subsequently re‑measured each quarter, with modest adjustments reflected in the 2022 filing. By the end of 2024 the company’s fair‑value table lists a remaining contingent payment of roughly $6.1 billion (the Level‑3 liability for fairlife), showing that the expected future milestone has expanded. This increase signals that management now expects fairlife to achieve – or even exceed – the financial targets set for 2024‑2025, warranting a substantially larger contingent payout.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) The $6.1 billion remaining contingent payment is completely incorrect; the ground truth states the original contingent liability was $270 million (after a $100 million payment in 2021), with the remaining obligation still active through 2024. The LLM's claim of a $6.1 billion Level-3 liability is unsupported and grossly inflated. (2) The original answer notes no major increase in the contingent obligation—only that it remained active, indicating fairlife was on track. The LLM incorrectly interprets this as an 'expansion' of the payout, suggesting overperformance, which is not stated or implied in the ground truth. (3) The LLM mentions '2024–2025' targets, but the original answer specifies targets through 2024, payable in 2025—this is a minor misalignment. (4) The statement about quarterly re-measurement is plausible but not mentioned in the ground truth, so it introduces unverified detail. (5) The core correct elements are: the initial $270 million liability, the $100 million payment in 2021 for 2020 performance, and that the remaining obligation relates to targets through 2024. However, the erroneous $6.1 billion figure and the false conclusion about expanded expectations severely undermine the answer. Multi-hop reasoning fails because the model misrepresents the evolution of the obligation and draws an incorrect inference about performance. While the answer addresses the question's general topic, the factual inaccuracies—especially in key financial figures—make it largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 431,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Oracle shifted OCI from a peripheral “cloud‑and‑license” add‑on to a central growth engine, explicitly embedding it in its global go‑to‑market story and linking restructuring, capital spending and sales initiatives to its expansion. The 2024 filing portrays OCI as a comprehensive, integrated cloud‑infrastructure offering that works alongside existing Oracle software and hardware in hybrid and multi‑cloud deployments, and highlights increased investment in data‑center capacity and second‑generation infrastructure to strengthen its worldwide market positioning and deepen integration with enterprise IT solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific numerical errors are present—the original answer references $36.052 billion in cloud and license revenue for 2022, but the LLM answer does not attempt to repeat this figure, so its omission does not constitute an error. The LLM correctly identifies the 2022–2024 timeframe and the strategic evolution without introducing incorrect numbers. (2) The LLM accurately captures the qualitative shift: from OCI being a less emphasized component within cloud and license revenue in 2022 to a central, integrated infrastructure pillar by 2024. It correctly notes the integration with enterprise IT solutions, hybrid/multi-cloud deployments, and increased investment in data centers and second-gen infrastructure—details consistent with Oracle’s 2024 strategic language. (3) The multi-hop reasoning is sound: the model synthesizes the evolution of OCI’s role across years, infers strategic prioritization from language shifts in filings, and connects infrastructure investment to market positioning. (4) The only minor shortcoming is that the LLM does not explicitly mention that in 2022, OCI was not called out strategically despite the large cloud revenue—this nuance is in the ground truth but only implied in the LLM response. However, the core factual progression and strategic repositioning are correctly conveyed. Wording differs but semantic meaning matches. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 432,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s treatment of Pledged‑Asset Lines (PALs) did not change materially: PALs remained fully collateralized by securities whose fair value exceeded the borrowing amount, and under ASC 326 the Company applies the collateral‑maintenance practical expedient, which eliminated the need for any allowance for credit losses – the allowance stayed at $0 in both years. The only operational shift noted is that unsecured PAL balances are now charged off no later than 90 days past due, but because virtually all PALs are secured, the credit‑loss risk profile remains very low and the collateral coverage continues to be the primary risk mitigant.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies when compared to the ground truth. (1) The original answer states that in 2023, there was a 'slight decrease in PALs' and that the allowance for credit losses was influenced by improved credit quality and lower projected loss rates — this context is missing in the LLM answer, which incorrectly claims the allowance was $0 in both years. The ground truth clarifies that no allowance was required in 2024 due to full collateralization and application of the practical expedient, implying a change from 2023, whereas the LLM asserts no material change occurred, contradicting the evolution described in the original. (2) The LLM claims 'the allowance stayed at $0 in both years,' but the original does not confirm this for 2023 — instead, it indicates the allowance was still influenced by credit metrics and projections, suggesting an active assessment process, not a $0 allowance. This is a critical factual error. (3) The mention of unsecured PALs being charged off at 90 days is not present in the original answer and introduces unsupported detail. (4) While the LLM correctly identifies full collateralization in 2024 and the use of the collateral maintenance expedient under ASC 326, it fails to capture the key evolution — that the risk profile strengthened from 2023 to 2024 due to these changes. The reasoning is therefore flawed in asserting no material change, when the ground truth describes a clear improvement. (5) Contextual relevance is high as the response addresses credit loss allowance, collateralization, and risk profile, but the incorrect characterization of continuity undermines factual accuracy. Quantitative accuracy is moderate — no explicit dollar amounts are wrong, but the implied $0 allowance in both years is unsupported. Qualitative accuracy suffers due to incorrect synthesis and missing the multi-hop progression from 2023 (active allowance considerations) to 2024 (no allowance needed).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 527,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Nike kept APLA as a separate reportable geographic segment (NIKE + Jordan brands) but reshaped its operating model there.  The company completed the divestiture of its Argentina and Uruguay entities to third‑party distributors—an initiative started in FY 2023—so that those markets now run under a distributor‑driven structure rather than direct subsidiaries.  This shift underscores a strategic emphasis on simplifying the APLA supply chain, concentrating on core brand and direct‑to‑consumer growth, and positioning the region as a key driver of global expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in Nike's operational structure in APLA between FY2023 and FY2024, noting the transition from direct subsidiaries to third-party distributors in Argentina and Uruguay—a key detail reflecting the broader strategic shift. The mention that this divestiture was initiated in FY2023 and completed in FY2024 adds temporal precision consistent with the evolution described in the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all stated facts about timing and structure are correct. (3) The multi-hop reasoning is sound: the model synthesizes information about operational changes (divestiture), strategic intent (simplifying supply chain, focusing on DTC), and regional segmentation (APLA as a reportable segment). The only minor gap is that the original answer highlights union representation in FY2023 as evidence of localized workforce structure, which the LLM omits—this contextual nuance adds depth to the 'direct operational involvement' point but does not undermine the core accuracy. (4) Despite this omission, the LLM captures the essential evolution: a move toward outsourcing and strategic simplification. Wording differs but semantic meaning matches. Thus, correctness is high (9/10), with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the slight incompleteness in workforce structure context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 430,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Abbott deepened its strategic focus on Pedialyte as a core growth driver within the U.S. pediatric‑nutritional portfolio.  In 2022 the company highlighted double‑digit sales growth for Pedialyte (part of the 10.3 % rise in U.S. pediatric nutritionals) and began expanding the line with new formats and flavors, while the 2023 filing underscores a consumer‑direct marketing approach and a broader product portfolio (e.g., powder, ready‑to‑drink, new flavor extensions) that positions Pedialyte as the flagship oral‑rehydration brand across the pediatric market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Pedialyte as a growth driver in 2022 and notes its strategic expansion, aligning with the ground truth. However, it inaccurately states that Pedialyte achieved 'double-digit sales growth' in 2022, while the original answer specifies a 10.3% increase for the entire U.S. Pediatric Nutritional business (which includes Similac and PediaSure), not Pedialyte alone. This misattribution of the percentage to Pedialyte specifically is a factual error. (2) The 10.3% figure is correctly cited in context but misassigned in scope—this impacts quantitative accuracy. No other numbers or dates are incorrect, but the misrepresentation of the growth figure as 'double-digit' for Pedialyte alone is significant. (3) The qualitative reasoning is strong: the LLM captures the evolution from growth contributor in 2022 to expanded product line and marketing focus in 2023, and correctly infers increased strategic importance. However, it misses the key structural shift noted in the ground truth—Pedialyte's formal inclusion in the Nutritional Products segment portfolio listing alongside Ensure and Glucerna in 2023, which signifies organizational integration beyond just product expansion. This omission weakens the completeness of the multi-hop synthesis. (4) Despite missing the formal portfolio integration point, the answer remains contextually relevant and conveys a largely accurate narrative of strategic elevation. The core trajectory—increased emphasis, product expansion, and marketing—is correct. Hence, correctness is rated 7 for mostly accurate facts with one key numerical misattribution and a missing structural insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 457,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 the $135 million of 7.100 % notes due 2027 that appeared on RTX’s 2022 balance‑sheet (page 93 of the 2022 10‑K) was no longer listed in the 2023 long‑term‑debt schedule (page 108 of the 2023 10‑K), indicating that the entire tranche was retired during 2023.  RTX used cash on hand and the proceeds of newer, lower‑cost borrowings—including 2023 term‑loan facilities and freshly issued notes with maturities in 2026‑2034—to extinguish the remaining balance, reflecting a deliberate strategy of retiring higher‑coupon debt and reshaping the company’s maturity profile toward more flexible, lower‑interest financing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims that the $135 million 7.100% notes due 2027 were present on the 2022 balance sheet and retired in 2023, but the ground truth states that in 2022, RTX had only $6 million in aggregate principal for these notes, increasing to $135 million in 2023. The LLM reverses the trend entirely—claiming retirement when the actual data shows a massive increase in exposure. (2) The dollar amounts are factually wrong in context: the $135 million figure belongs to 2023, not 2022. This is not a formatting or rounding issue but a complete inversion of the timeline and values. (3) Qualitatively, the reasoning is flawed: the LLM infers debt retirement and refinancing of higher-coupon debt using lower-cost borrowings, while the ground truth indicates a significant *increase* in holdings of these notes, suggesting a strategic *acquisition* or retention, not extinguishment. This reflects a total misinterpretation of RTX’s debt management strategy. (4) Contextually, while the answer addresses debt management strategy and references correct document locations (e.g., pages in 10-Ks), the underlying facts are so inaccurate that the conclusion is diametrically opposed to the truth. The multi-hop synthesis fails because it misidentifies the direction of change in debt exposure. Thus, the answer is mostly irrelevant due to factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 399,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Converse’s revenue slipped 14 % on a reported basis (≈15 % in constant‑currency terms) to $2.08 bn, with footwear down 16 % and wholesale sales down 15 % as unit volumes fell 12 % and ASP slipped 3 % because of heavier promotions; earnings before interest and taxes fell 30 % to $474 m, reflecting the lower volume, a 130‑basis‑point gross‑margin contraction from foreign‑currency headwinds and higher discounting. Strategically, Converse continues to be reported as a stand‑alone brand within Nike’s portfolio—focused on casual sneakers, apparel and licensing—but its growth is now concentrated in Asian markets and dependent on licensing arrangements, while Nike is shifting emphasis toward higher‑margin digital and direct‑to‑consumer channels.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue decline in Converse between fiscal 2023 and 2024, noting a ~15% constant-currency drop, which aligns with the ground truth. However, the original answer does not specify exact dollar figures like $2.08 billion or earnings before interest and taxes (EBIT) of $474 million, nor does it mention footwear down 16%, wholesale down 15%, unit volume down 12%, or ASP down 3%. These specific metrics, while plausible, are not present in the ground truth and introduce unverified precision. The 14% reported decline is reasonable given currency effects, but again, not in the original. (2) The quantitative accuracy is partially compromised because the original answer only states a 15% currency-neutral revenue decrease without breaking it into reported basis, EBIT, gross margin contraction, or unit/ASP splits. These added details, though internally consistent, go beyond the verified data and may mislead. (3) Qualitatively, the LLM captures the strategic positioning accurately—Converse as a stand-alone brand within Nike’s portfolio—and correctly infers a strategic shift despite financial struggles. It adds contextual insight about focus on Asian markets and licensing, which is consistent with Nike’s broader strategy but not explicitly stated in the ground truth. The reasoning for strategic evolution is sound and logically inferred. (4) Contextual relevance is high because the response directly addresses both revenue performance and strategic positioning across the two fiscal years, synthesizing financial and strategic dimensions appropriately. While the core facts about revenue decline and standalone status are correct, the addition of unsupported granular financials reduces quantitative accuracy. Hence, correctness is high but not perfect—warranting an 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 496,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\nIn the 2022 filing (p. 16) the company merely observed that “shopping patterns are being affected by the digital evolution,” treating digital change as a peripheral risk. By contrast, the 2024 filing (p. 137 / p. 19) elevates digitalization to a top priority and explicitly warns that “if we are not successful in our efforts to digitalize the Coca‑Cola system, our ability to increase sales and improve margins may be negatively affected,” while also noting that the associated investments could weigh on financial performance. Thus, the risk assessment shifted from a generic mention of digital trends to a direct linkage of digital success with sales‑growth and margin‑improvement objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the shift in Coca-Cola's risk assessment from 2022 to 2024: in 2022, digital evolution was a peripheral observation about changing shopping patterns, while in 2024 it became a strategic imperative directly tied to sales growth and margin improvement. The key quote from the 2024 filing is accurately cited, showing the stronger financial linkage. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies the change in tone and strategic importance, and links it to financial outcomes (sales and margins). The only minor shortcoming is that the LLM does not explicitly use the term 'strategic dependency' as in the original answer, though the meaning is effectively conveyed. (4) The answer is fully contextually relevant, directly addressing how the risk assessment evolved and its impact on financial performance. Overall, the response is factually correct, well-supported, and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 361,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Oracle has steadily increased the share of its R&D budget devoted to cloud‑focused innovation—building on the $7.2 billion invested in FY 2022 and continuing to fund second‑generation OCI infrastructure and autonomous database capabilities (as highlighted in the 2024 restructuring discussion of “investments in resources and geographies that better address the development, marketing, sale and delivery of our cloud‑based offerings”).  At the same time, the company has repositioned its Oracle Cloud Services (SaaS and OCI) as the preferred, lower‑cost, rapidly deployable alternative to traditional on‑premise licenses, promoting hybrid and full‑cloud deployment models that offer greater flexibility, reduced upfront capital outlay and integrated management relative to on‑premise solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Oracle's $7.2 billion R&D investment in FY 2022 from the ground truth and accurately reflects the continued strategic emphasis on cloud services through FY 2024. However, it incorrectly implies that Oracle increased the share of R&D devoted to cloud-focused innovation without confirming the total R&D amount for FY 2024, which the original answer explicitly states is not disclosed. This overreach in asserting a trend (increased share) without supporting data reduces quantitative and qualitative accuracy. (2) The numeric value of $7.2 billion is correct and properly attributed to FY 2022. No other figures are introduced that contradict the ground truth, and no calculation errors are present. The LLM avoids fabricating a specific dollar amount for FY 2024 R&D, instead referring to continued investment qualitatively, which is acceptable. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes Oracle’s evolving cloud positioning from FY 2022 to FY 2024, noting the shift toward cloud-first, hybrid models, and customer-centric deployment options. It accurately references OCI infrastructure and autonomous database development as strategic priorities. However, it slightly overstates the evidence by suggesting a growing 'share' of R&D without explicit confirmation, which the original answer avoids. (4) The answer is contextually relevant and captures the core evolution in Oracle’s strategy—positioning cloud as a preferred, flexible, and cost-effective alternative to on-premise. While the wording differs, the semantic meaning aligns well with the ground truth on cloud positioning and integration benefits. The scores reflect minor but notable overinterpretation of R&D trends, balanced by strong overall factual alignment and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 493,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\nBetween 2023 and 2024 the Norwest Corporation Directors’ Formula Stock Award Plan moved from having a modest pool of shares that could still be issued (4,264,741 shares were listed as “issuable upon distribution of deferred compensation” in the 2023 tables) to essentially no remaining availability—by 2024 the plan’s description notes that **no future stock awards or deferrals may be made**, and only a handful of shares (≈ 391) remain tied to previously‑granted deferred awards that are being wound down. Consequently, the plan’s share reserve is now effectively exhausted, and any further share issuance under this plan is not possible.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a major factual error in quantitative accuracy: it claims that 4,264,741 shares were 'issuable upon distribution of deferred compensation' in 2023, which is not supported by the ground truth. The original answer states that no future awards or deferrals could be made in 2023 and that only existing obligations remained, but it does not mention any specific number of shares available in 2023—especially not over 4 million. The only numeric figure provided in the ground truth is the 391 shares in 2024, which the LLM correctly reports. However, the claim about 4.26 million shares in 2023 is unsupported and significantly misrepresents the status of the plan, suggesting a large pool still existed when the plan was already closed to new activity. This undermines the correctness of the comparison between years. Qualitatively, the LLM correctly identifies that no future awards or deferrals were allowed in 2024 and that only prior obligations remained, aligning with the closure narrative. It also correctly infers that the plan was winding down. Contextually, the response addresses the evolution of the plan between 2023 and 2024 and focuses on the right aspects (availability, deferrals, closure). However, the erroneous 2023 share number leads to an incorrect portrayal of the plan's scale and evolution, resulting in a partially correct but significantly flawed answer. Multi-hop reasoning is attempted but compromised by the false quantitative premise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 407,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from a generic “food‑safety could harm the brand” statement in the 2022 10‑K to a dedicated, detailed discussion in the 2023 filing that explicitly links food‑safety events to supply‑chain vulnerability and commodity‑price volatility. The 2023 document calls out the “particularly volatile” markets for beef, chicken and pork, cites seasonal shifts, climate conditions, international markets, food‑safety concerns, recalls and regulations as drivers of cost swings, and notes that hedging only partially mitigates the resulting margin pressure—whereas the 2022 filing mentioned food‑safety only as a broad risk without this supply‑chain and cost‑volatility focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in McDonald's disclosure between 2022 and 2023: in 2022, food safety was framed as a reputational/brand risk, while in 2023 it was explicitly linked to supply chain vulnerability and commodity price volatility. The key ingredients—beef, chicken, and pork—are accurately cited. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in risk disclosure across two years, identifies the shift in framing from brand risk to financial/supply chain impact, and correctly attributes cost volatility to food safety concerns among other factors. The mention of hedging providing only partial mitigation is an additional detail consistent with deeper 2023 disclosure and adds value without contradicting the ground truth. (4) The LLM answer conveys the same core information as the original, with slightly more detail (e.g., 'seasonal shifts, climate conditions, international markets, recalls, regulations'), which are plausible elaborations present in such filings and do not distort the meaning. The only minor gap is that the original emphasizes the 'shift in emphasis from reputational impact to financial exposure' more explicitly, which the LLM implies but doesn't state in summary form—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 444,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\nThe $1.75 % 7‑Year Senior Notes (euro‑denominated, maturing 4/15/2027) had a carrying amount of **$662 million at the end of 2023** and **$621 million at the end of 2024**.  Correspondingly, the effective interest rate fell slightly from **1.97 % (2023)** to **1.96 % (2024)**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that TMO's 1.750% 7-Year Senior Notes mature on October 15, 2028, but the LLM incorrectly claims they mature on April 15, 2027. Additionally, the LLM refers to euro-denominated notes, which is not mentioned or supported in the ground truth. (2) The carrying values are wrong: the ground truth reports $700 million for both 2023 and 2024, but the LLM reports $662 million (2023) and $621 million (2024), which are factually incorrect. The effective interest rates are also inaccurate—1.89% (unchanged) in both years per the original answer, but the LLM reports 1.97% in 2023 and 1.96% in 2024. These numbers do not match any variation of correct data. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the same debt instrument across years, possibly confusing it with another note (e.g., different maturity, currency), and thus fails to synthesize the correct evolution (or lack thereof) of the carrying value and interest rate. (4) The contextual relevance is low but not zero because the answer addresses the general topic—debt instrument evolution—using a similar structure. However, due to severe factual, quantitative, and entity-level errors, the answer is substantively wrong. Correctness and quantitative accuracy are scored very low due to complete mismatch in numbers, dates, and terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 398,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\nThe carrying amount of RTX’s 7.000 % notes due 2038 was $148 million at the end of 2022 and remained $148 million at the end of 2023 (see the long‑term‑debt tables on page 85 of the 2023 filing and the comparable table on page 85 of the 2022 filing). Thus the company’s exposure to that specific tranche was unchanged. This flat‑line position indicates that RTX is not actively reshaping that long‑dated debt but is instead maintaining a stable, laddered maturity profile while managing the overall debt portfolio through other issuances and repayments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims the carrying amount of RTX’s 7.000% notes due 2038 was $148 million at the end of 2022 and remained unchanged in 2023. However, the ground truth states that the amount was $11 million in 2022 and increased to $148 million in 2023 — a significant change. This misstatement of the core numbers invalidates the entire response. (2) COMPLETENESS: While the LLM attempts to address both parts of the question (change in exposure and implication), it does so based on false data, making the analysis irrelevant. (3) ENTITY ACCURACY: The company (RTX), debt instrument (7.000% notes due 2038), and years (2022–2023) are correctly identified. (4) REASONING FAILURE: The LLM concludes that exposure was 'unchanged' and that RTX is maintaining a 'stable, laddered maturity profile,' which contradicts the ground truth showing a large increase in exposure — suggesting active restructuring or new issuance. The reasoning is therefore based on incorrect data and leads to an erroneous interpretation. (5) SEMANTIC NON-EQUIVALENCE: The LLM asserts stability; the truth shows a major shift. These are diametrically opposed. Even allowing for wording flexibility, the factual divergence is severe. The citation to page 85 of both filings may reflect a real table, but the LLM misread or misrepresented the data. Overall, the answer fails on all critical dimensions of accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 409,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\nAfter deferring roughly $1 billion of rent and royalty payments from franchisees in early 2020 because of COVID‑19, McDonald’s had recovered virtually all of those amounts by the end of 2021 and resumed normal cash‑flow collections throughout 2022‑2023.  The 2023 10‑K shows that future minimum rent obligations under conventional franchise agreements remained strong at $33.8 billion, with scheduled payments of $3.06 billion in 2022 and $2.95 billion in 2023, and franchise‑generated rent and royalty revenue rose to $8.38 billion and $4.65 billion in 2023—up from $6.84 billion and $3.83 billion in 2020—indicating a rebound and continued growth in the company’s financial relationship with its franchisees.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timing, despite capturing the general narrative of recovery from pandemic-related deferrals. The original answer states that McDonald's deferred $1 billion in rent and royalties in 2020 and had collected substantially all by the end of 2021. The LLM correctly notes the $1 billion deferral and recovery by end of 2021, but then introduces specific financial figures for 2022 and 2023—$3.06 billion and $2.95 billion in scheduled rent payments—that are not present in the original answer and cannot be verified from the provided ground truth. Additionally, the LLM claims franchise-generated rent and royalty revenue rose to $8.38 billion and $4.65 billion in 2023, but this appears to be a misstatement (possibly splitting rent and royalties), and these numbers do not align with the original answer, which does not provide revenue figures for 2022 or 2023. The $33.8 billion in future minimum rent obligations is plausible but not mentioned in the ground truth, making it an unsupported addition. (2) Quantitative accuracy is low because the LLM introduces specific dollar figures not present in the original answer, with no verification that they match the actual 10-K filings. While the $1 billion deferral and recovery by end of 2021 is accurate, the rest of the numbers are either fabricated or misattributed. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a return to normal operations in 2022–2023 after the deferral period and connects pandemic impacts to financial recovery. However, it overreaches by introducing detailed financial projections and revenue breakdowns not supported by the original answer, undermining the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the evolution of McDonald's financial relationship with franchisees, focusing on rent and royalty collections, normalization post-pandemic, and operational recovery. Despite incorrect numbers, the overall direction and intent of the response are aligned with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 562,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Coca‑Cola’s equity stake in Embotelladora Andina S.A. remained roughly the same – about 19 % of the outstanding shares (as disclosed in the 2022 10‑K notes and reiterated in the 2024 10‑K equity‑method table).  The carrying amount of the investment edged up from roughly $80 million in 2022 to $90 million in 2024, while the market‑based fair value jumped to $168 million, leaving a $78 million excess over book value (see the fair‑value vs. carrying‑value table on page 87 of the 2024 filing).  This pattern indicates that Coca‑Cola continues to view Andina as a strategic minority holding that provides a foothold in the Latin‑American market rather than an asset to be divested or reduced.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) Quantitative Accuracy: The original answer states that Coca-Cola recognized a $39 million gain in 2022 from the partial sale of its stake in Embotelladora Andina S.A., but the LLM answer omits this key event entirely and instead claims the stake remained roughly the same at 19%, which contradicts the ground truth implication of a divestiture. While the LLM correctly reports the 2024 carrying value ($90 million) and fair value ($168 million), it inaccurately states the 2022 carrying amount was $80 million—this figure is not in the ground truth and cannot be verified from the provided information. (2) Completeness: The LLM fails to mention the 2022 gain from partial sale, a critical component of the strategic evolution, thus missing a core part of the multi-hop reasoning required. (3) Entity Accuracy: The companies and years are correctly identified, and the financial metrics (carrying value, fair value) are used appropriately. (4) Reasoning: The LLM draws an incorrect conclusion—that Coca-Cola views Andina as a strategic holding 'rather than an asset to be divested'—which directly contradicts the ground truth indicating a 'partial exit strategy.' The reasoning is therefore flawed despite some correct data points. (5) Semantic Equivalence: While the 2024 valuation figures align, the omission of the 2022 divestiture gain and the erroneous stability claim about ownership percentage make the overall answer misleading. The LLM appears to rely on different or incorrect source data (e.g., 19% stake, $80M prior carrying amount), which compromises factual integrity. Minor formatting variations in numbers are acceptable, but missing or false key facts result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 487,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\nOracle has turned its cloud‑infrastructure push from a peripheral initiative in 2022 into a core strategic pillar by 2024, pouring ever‑larger capital and R&D resources into building out OCI’s second‑generation data‑center capacity, expanding its service catalog (e.g., Autonomous Database, OCI @ Customer, multi‑cloud networking) and lengthening hardware lifecycles (the server useful‑life was extended from 4 to 5 years in FY 2023, reducing depreciation expense).  The 2024 restructuring plan explicitly earmarks cost‑saving measures to fund these cloud‑focused investments, positioning OCI alongside traditional license, hardware and services as a primary growth engine in Oracle’s product portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Oracle's cloud infrastructure strategy from 2022 to 2024, correctly identifying the increased strategic focus on OCI and its positioning as a central product. However, it introduces specific details not present in the ground truth, such as 'second-generation data-center capacity', 'Autonomous Database, OCI @ Customer, multi-cloud networking' as specific service expansions, and the server useful-life extension from 4 to 5 years in FY2023. These quantitative and operational details are absent from the original answer and cannot be verified from the provided ground truth, raising concerns about factual accuracy. (2) The mention of 'FY2023' and the depreciation change due to hardware lifecycle extension is a precise claim not supported by the original answer, which does not reference fiscal year changes or accounting impacts. This affects quantitative accuracy. (3) The multi-hop reasoning is sound in spirit—connecting internal R&D emphasis in 2022 to a more structured, product-driven OCI strategy in 2024—but the LLM adds granularity (e.g., restructuring plan funding cloud investments) that goes beyond the original synthesis. While logically plausible, it exceeds the evidence in the ground truth. (4) Despite the unsupported specifics, the LLM correctly identifies the strategic shift and OCI's elevated role in the product portfolio, aligning with the original answer’s core message. Wording differs but semantic intent is similar. Contextual relevance is perfect—directly addresses the question’s focus on evolution, internal development, and product positioning. However, the inclusion of unverified financial and operational details reduces quantitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 480,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\nThermo Fisher completed the acquisition of The Binding Site Group in early 2023 (Note 12, 2023 acquisition) and reported the target within the Specialty Diagnostics segment; by the 2024 filing the business is fully integrated, as shown by its contribution to the segment’s revenue and income (Specialty Diagnostics segment income rose from $1,124 M in 2023 to $1,159 M in 2024, page 62‑63).  This continued contribution demonstrates that TMO is using the acquisition to reinforce its specialty‑diagnostics platform—particularly in blood‑cancer and immune‑system testing—and to generate synergistic growth, underscoring a strategic focus on expanding and leveraging its diagnostics portfolio post‑acquisition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 acquisition of The Binding Site Group by TMO (Thermo Fisher) and its placement within the Specialty Diagnostics segment, which aligns with the ground truth. It also accurately reflects the strategic intent of strengthening TMO’s position in blood cancer and immune disorder diagnostics. However, the LLM introduces financial figures not present in the ground truth—specifically, the increase in Specialty Diagnostics segment income from $1,124M to $1,159M—and attributes this change to The Binding Site Group’s contribution. This income data and causal link are not supported by the original answer, which instead cites integration via amortization of intangible assets (19-year weighted-average for customer relationships). These added numbers, while plausible, are unverified and introduce factual inaccuracies. (2) The acquisition amount of $2.70 billion stated in the ground truth is missing from the LLM answer, representing a notable omission of a key quantitative fact. The LLM’s use of income figures from page 62–63 of a filing may be contextually accurate to a source document but is not reflected in the provided ground truth, so cannot be considered correct in this evaluation. (3) The multi-hop reasoning is partially sound: the model connects acquisition to integration and infers strategic focus on diagnostics expansion, which is valid. However, it substitutes asset-based integration (amortization of intangibles) with financial performance (segment income growth), misrepresenting the evidence used to infer integration. The correct multi-hop logic should link acquisition → integration into asset base → contribution to amortization period → indication of long-term strategic value. (4) Despite the quantitative missteps, the LLM captures the essence of TMO’s strategic focus and correctly identifies the timeline and segment. Hence, the qualitative and contextual accuracy remain high, but the correctness score is reduced due to unsupported numbers and missing key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 550,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\nBetween 2022 and 2024 the Directors’ Code of Conduct remained limited to “all directors of BNY Mellon,” but its public location and transparency measures were refined. In the 2022 filing the code was posted at a lengthier URL — `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf` — whereas the 2024 filing moved the document to a cleaner path — `bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf` — making it easier for users to locate. Both years note that any future amendments or waivers of the Directors’ Code will be disclosed on the company’s website, but the 2024 version explicitly highlights this commitment, improving accessibility and transparency.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the correct scope of application—'all directors'—and correctly identifies that the Directors' Code of Conduct was publicly available in both 2022 and 2024, with a commitment to disclose amendments or waivers. However, there are significant factual inaccuracies in the URLs provided. The 2022 URL in the LLM answer is truncated and incorrect: it ends with '/in relations/directors-code-of-conduct.pdf', missing the full path and misrepresenting the actual URL, which is 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf'. The 2024 URL is also wrong: the LLM states it is 'bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf', omitting the full domain and incorrectly formatting the path. The actual 2024 URL is 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf', reflecting a domain change from 'bnymellon.com' to 'bny.com', which the LLM fails to accurately capture. This undermines the quantitative and qualitative accuracy, as the core evidence (URLs) is misrepresented. While the LLM correctly infers improved transparency and a cleaner URL structure, it misses the key point about rebranding from 'BNY Mellon' to 'BNY', which is central to the domain change. The reasoning is partially sound but based on incorrect data. The answer is contextually relevant and addresses both website accessibility and scope, but the factual errors in the URLs—critical to the question—reduce the correctness score significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 430,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s continued its shift toward a heavier franchised model—franchised restaurants grew to 21,818 (up from 21,720 in 2022) and now represent roughly 93 % of system‑wide locations—while the company’s financial reporting increasingly centers on franchisee sales and margins rather than company‑operated revenue.  The 2023 10‑K highlights that the rise in operating income was driven by stronger franchised revenues and improved franchisee profitability, and it provides more detailed segment and non‑GAAP disclosures that isolate franchisee contributions, underscoring a strategic emphasis on supporting franchisee investment and financial health as a core growth lever.  (See page 42 for the franchised‑restaurant count and operating‑income breakdown; page 30 for the discussion of franchisee‑related risks and financing; page 45 and page 18 for the gains from sales of restaurants to franchisees.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the strategic shift toward emphasizing franchisees in McDonald's financial reporting and business model between 2022 and 2023, aligning with the ground truth's core message of increased strategic and transparent focus on franchisees. It correctly identifies the growth in franchised restaurants from 21,720 in 2022 to 21,818 in 2023 and notes their ~93% share of system-wide locations, which reflects accurate quantitative data. However, the ground truth does not mention specific numbers like franchised restaurant counts or percentages, nor does it state that financial reporting 'centers on franchisee sales and margins' or provide page references (e.g., page 42, 30, 45, 18), which are not part of the original answer and may be fabrications or unsupported inferences. The claim that 'operating income was driven by stronger franchised revenues' and 'more detailed segment and non-GAAP disclosures' is plausible but goes beyond the original answer’s scope, which only states that transactions with franchisees were not material in 2022 and that franchisees were elevated as key stakeholders in 2023. While the direction of reasoning is sound and contextually relevant, the inclusion of specific metrics and page citations not present in the ground truth reduces quantitative accuracy. The multi-hop synthesis is partially correct—linking increased strategic emphasis to financial reporting changes—but adds details not supported by the provided truth. Thus, the answer is qualitatively and contextually strong but overreaches quantitatively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 428,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\nIn 2023 the Clif Bar earn‑out was recorded at a fair‑value of $548 million (a Level 3 liability) and any subsequent changes in that fair value were charged to SG&A expense as part of the purchase‑price allocation. During 2024 the liability remained classified as long‑term and was re‑measured periodically; updates to the earn‑out estimates, discount‑rate adjustments and the $33 million reduction recorded in the “Other (1)” PPA line altered the carrying amount, with any payments or revised projections also flowing through earnings, but no new acquisition or fundamental change in the accounting treatment occurred.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies. The $548 million fair value for the contingent consideration in 2023 is correct and matches the ground truth, and the classification as a Level 3 liability and changes recorded in SG&A are consistent with fair value measurement practices. However, the LLM claims that the liability was 're-measured periodically' in 2024 and includes a specific $33 million reduction in the 'Other (1)' PPA line, which is not supported by the original answer or ground truth. The ground truth explicitly states that there is no direct mention of contingent consideration liabilities in the 2024 filing—indicating a lack of updated disclosures—whereas the LLM asserts ongoing re-measurement and specific adjustments in 2024, which contradicts the source. (2) The $548 million figure is accurate, but the $33 million reduction is not mentioned in the ground truth and appears to be fabricated or misattributed. No other numbers are present, but the introduction of this unsupported figure undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of 2024 contingent consideration disclosures implies potential finalization or reclassification as part of PPA adjustments (as stated in the ground truth), instead asserting continued active measurement. This reflects a failure to synthesize the implication of missing data. (4) Contextual relevance is high because the answer addresses fair value measurement, purchase price allocation, and SG&A impact—all relevant topics—but the factual inaccuracies and unsupported details reduce correctness and qualitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 472,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\nBetween 2022 and 2024 AMD shifted from merely “supporting” Vulkan to making it a central pillar of its GPU software strategy—highlighting Vulkan 1.3 compliance, Vulkan‑based ray‑tracing extensions, and tight integration with ROCm and FidelityFX in the Radeon RX 6000/7000 launches and Instinct data‑center accelerators. This emphasis on an open, cross‑platform API shows AMD’s broader competitiveness play: leveraging industry‑standard standards to reduce reliance on proprietary stacks (e.g., Nvidia’s CUDA/DirectX), lower developer friction, and broaden its addressable market while preserving price‑performance advantages against rivals.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of AMD's continued support for Vulkan and its strategic importance, aligning with the ground truth's theme of maintaining competitiveness through API support and architectural advancement. However, there are notable discrepancies in factual accuracy and emphasis. While the original answer correctly identifies RDNA 2 (2022) and RDNA 3 (2024) as the underlying architectures for Radeon GPUs with Vulkan support, the LLM introduces specific claims not present in the ground truth: Vulkan 1.3 compliance, Vulkan-based ray-tracing extensions, and integration with ROCm and FidelityFX in both consumer and data-center products. These details, while plausible, are not supported by the provided knowledge graph and represent an overreach in specificity. Additionally, the LLM frames the shift as moving Vulkan to a 'central pillar' and emphasizes competition with CUDA/DirectX, which goes beyond the original answer’s more measured tone of continuity and architectural progression. The mention of Radeon RX 6000 series in 2024 is also potentially misleading, as the original emphasizes RX 7000 Series on RDNA 3 by 2024. Quantitatively, there are no explicit numbers, dates, or calculations to verify, so the score is based on consistency with timeframes (2022–2024), which are correctly used. The reasoning is partially sound but over-interprets strategic intent without grounding in the source data. Contextually, the answer remains relevant to the question about API evolution and competitiveness. Thus, while the core idea of sustained Vulkan support and competitive positioning is correct, the added technical and strategic details reduce factual accuracy, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 468,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\nThe 2023 operating‑profit decline (‑$1.9 bn, from $5.5 bn in 2022 to $3.6 bn) was driven largely by integration‑related costs, most notably the $2.9 bn “Powder Metal Matter” charge that RTX recorded in 2023; this one‑time expense more than offset the modest profit gains seen at Collins and Raytheon. Consequently, the operating‑profit margin fell from 8.2 % in 2022 to 5.2 % in 2023, reflecting the heavy impact of the integration charge on the overall profit trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1.9 billion decrease in operating profit, the $2.9 billion Powder Metal Matter charge, and the operating profit margins (8.2% in 2022 to 5.2% in 2023) are all factually accurate and consistent with the original answer. The implied 2022 and 2023 operating profits ($5.5B and $3.6B) are correct ($5.5B - $3.6B = $1.9B decline). (2) The entity identification is accurate—RTX, the Powder Metal Matter charge, and correct years (2022 vs 2023) are properly referenced. (3) The reasoning is sound: the LLM correctly identifies the Powder Metal Matter charge as a major driver of the profit decline and contextualizes it within integration-related costs, noting its offsetting effect on gains at Collins and Raytheon (additional but plausible context not in the original, but not incorrect). (4) The original answer emphasizes the shift from declining integration charges in 2022 to a large new charge in 2023; the LLM captures the 2023 impact well but does not explicitly mention the 2022 trend of decreasing Acquisition Accounting Adjustments, which is a minor omission in completeness. However, the core multi-hop synthesis—linking the new 2023 charge to the profit decline—is correctly executed. (5) Semantic equivalence is strong; the LLM conveys the same essential conclusion: a significant new integration-related charge in 2023 reversed prior positive trends. The answer is slightly more detailed (e.g., margin percentages, segment performance), but all additions are reasonable and consistent with the data. Minor deduction only for not acknowledging the 2022 decline in integration charges, which was a key contrast in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 477,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\nMDLZ’s 2023 financial statements still carried a $548 million contingent‑consideration liability for the 2022 Clif Bar acquisition—up from $452 million in 2022—showing that earn‑out obligations were being accrued but no new acquisition‑related cash outflows were recorded. By 2024 that liability remained at $548 million, and the company recorded $153 million of intangible‑asset impairment charges tied to Clif Bar brands, indicating the relationship had moved from the initial purchase to ongoing integration, performance‑based payments and periodic impairment testing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MDLZ acquired Clif Bar effective August 1, 2022, with related disclosures in the 2023 10-K, and that in 2024, purchase price allocation adjustments were made. However, the LLM claims that in 2023 there was a $548 million contingent consideration liability that increased from $452 million in 2022, and that this liability remained unchanged in 2024. These specific numbers ($548M, $452M, $153M impairment) are not supported by the ground truth, which does not provide exact figures for contingent consideration or mention any impairment charges. (2) The quantitative inaccuracies are severe: no dollar amounts for contingent consideration or impairment are present in the original answer, making the LLM’s precise figures hallucinated. There is no mention of a $153 million intangible asset impairment in the ground truth, nor is there a comparison of liabilities between 2022 and 2023. (3) The reasoning partially captures the evolution from acquisition to integration phase, aligning with the ground truth’s description of moving beyond initial acquisition into financial recalibration. The mention of ongoing integration and performance-based payments is consistent with 'contingent consideration adjustments' and 'purchase price allocation adjustments.' However, the multi-hop synthesis is flawed because it invents financial data rather than accurately reporting or inferring from the filings. (4) Correctness is scored low (4) due to major factual and quantitative errors, despite some correct qualitative direction. Quantitative accuracy is very low (3) because the numbers are unsupported. Qualitative accuracy is moderate (5) as the conceptual progression from acquisition to integration is reasonable. Contextual relevance is high (8) because the response addresses the evolution of the relationship and focuses on relevant financial activities, even if factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 535,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Gulfstream shifted from highlighting the fuel‑saving performance of its existing clean‑sheet jets (the G500 and G600, introduced in 2018‑19) to rolling out a brand‑new, higher‑efficiency powerplant in the ultra‑long‑range G700, which entered service in March 2024 and is marketed together with expanded use of sustainable‑aviation fuel.  This evolution is reflected in the 2024 product lineup, where the G700’s “all‑new engines” are presented as the latest step in Gulfstream’s strategy of pairing advanced, energy‑efficient propulsion with SAF‑compatible operations, while the earlier G500/G600 family continues to serve as the benchmark for fuel‑efficient, low‑emission business jets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from 2023 to 2024: in 2023, Gulfstream emphasized R&D and SAF use with existing models (G500/G600), and in 2024, it moved to operational realization with the G700's new engines. The G700 entering service in March 2024 is factually correct and matches the timeline in the original answer. (2) Quantitatively, all dates and model introductions are accurate—no numeric errors. The mention of the G500/G600 as earlier models (introduced 2018–2019) is consistent with public data and contextual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes Gulfstream’s strategic focus in 2023 (SAF, R&D) with the 2024 shift to production of new engines in the G700, showing a clear progression. The LLM adds contextual detail (e.g., G700 being ultra-long-range, marketing with SAF) that enriches but does not distort the truth. (4) The only minor deviation from the original answer is the emphasis on the G500/G600 as benchmarks, which is contextually valid but not explicitly stated in the ground truth. However, this does not detract from correctness. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 359,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s semi‑custom SoC revenue moved from a relatively sizable, high‑growth line (the risk discussion in the 2022 filing stresses that such revenue is earned only when the company’s custom chips are incorporated into a customer’s product and is paid as non‑recurring engineering fees) to a much smaller, more specialized slice of the business.  In the 2024 financial tables the Gaming segment—where most semi‑custom sales sit—fell from **$6.8 billion in 2022** to **$2.6 billion in 2024**, and the only customer that alone accounted for ≥10 % of consolidated revenue contributed just **16‑18 %** of Gaming revenue in 2023‑24, underscoring how the revenue stream is now concentrated on a few OEM wins rather than broad market demand.  Consequently, AMD now positions semi‑custom SoCs as a high‑margin, design‑win‑driven offering that is recognized over the production cycle and depends on a limited set of customers, rather than as a primary growth engine for the company.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but diverges significantly from the ground truth in key qualitative aspects. While it correctly identifies that semi-custom SoC revenue declined from $6.8B in 2022 to $2.6B in 2024 (quantitatively accurate), and notes the shift toward fewer customers (with a 16-18% concentration), it frames the evolution as a contraction and de-prioritization, whereas the ground truth describes a strategic evolution toward broader integration and diversification, not a reduction in importance due to decline. (2) Quantitative accuracy is mostly correct: the $6.8B to $2.6B drop in Gaming segment revenue (where semi-custom SoCs are reported) aligns with known filings, and the 16-18% customer concentration is plausible. However, the LLM does not verify whether this decline reflects unit shipments, pricing, or market saturation, and conflates segment revenue decline with strategic demotion, which is not supported by the original answer. (3) Multi-hop reasoning is flawed: the original answer emphasizes a shift from dependency to active control and integration into a diversified portfolio (AI accelerators, GPUs, APUs, DPUs), indicating strategic elevation. The LLM instead interprets declining revenue as evidence of reduced strategic importance, missing the synthesis of AMD’s broader product integration and long-term innovation alignment. It fails to mention AI accelerators, DPUs, or strategic portfolio diversification—core elements of the ground truth. (4) Contextual relevance is high because the answer addresses revenue structure and strategic positioning over time, using appropriate financial data and customer concentration metrics. However, the conclusion about strategic positioning contradicts the ground truth’s emphasis on increased centrality and control. Thus, while numbers are mostly right, the interpretation and qualitative synthesis are significantly off, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 534,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\nIn both fiscal 2023 and fiscal 2024 Medtronic’s charter authorizes the same preferred‑share structure—127.5 million Preferred Shares ($0.20 par) and 500 thousand A‑Preferred Shares ($1.00 par)—and, as noted in the 2023 and 2024 10‑K filings, none of these shares were issued or outstanding in either year.  This unchanged authorization and zero issuance indicate that Medtronic is not relying on preferred equity to fund its operations or growth, but is instead pursuing a capital strategy centered on debt financing (e.g., senior note issuances and credit‑facility borrowings) and returning capital to shareholders through ordinary‑share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the preferred share authorization remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. It also accurately notes that no shares were issued or outstanding in either year—this matches the ground truth exactly. All numeric values and par values are correct, satisfying quantitative accuracy. (2) The answer addresses both parts of the question: the evolution (or lack thereof) in preferred share structure and the implication for capital strategy. The inference that Medtronic is not relying on preferred equity is sound and supported by the data. The additional context about debt financing and share repurchases is reasonable and consistent with typical capital strategies observed in 10-K filings, though this specific detail (e.g., senior notes, credit facilities, repurchases) is not in the ground truth and represents an inference beyond the provided data. (3) The multi-hop reasoning is strong—correctly synthesizing authorization and issuance data across two fiscal years and drawing a logical conclusion about capital strategy. The entity (Medtronic) is correctly identified, and fiscal years are accurate. (4) The only reason for not giving a perfect 10 is that the LLM adds strategic interpretation (debt financing and repurchases) not present in the ground truth, which, while plausible, goes beyond the evidence provided. However, this does not make the answer factually incorrect, just slightly more interpretive. Thus, correctness is high but not perfectly aligned with the conservative, evidence-only stance of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 472,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\nIn the 2022 filing (page 4) the company merely listed “adverse events, publicity, government scrutiny or other reputational harm” as a catch‑all risk that could “negatively affect our business,” without tying it to any broader strategic or ESG themes. By the 2024 filing (pages 4 and 5) the same language is retained but is expanded to explicitly connect reputational risk to sustainability and ESG concerns—e.g., “climate‑change and diversity concerns could … damage our reputation”—and to note that geopolitical, climate‑related and pandemic‑related events can also generate adverse publicity. Thus, the framing shifted from a generic warning about bad press to a more nuanced view that links reputational harm to ESG‑related and strategic risks that could affect capital access, regulatory standing and the firm’s long‑term initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, BK framed adverse publicity as a general risk linked to government scrutiny and reputational harm, and that by 2024 this was expanded to include ESG-related concerns like climate change and diversity. The mention of geopolitical, climate-related, and pandemic-related events as new sources of adverse publicity is consistent with the broadening of sustainability concerns in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time in risk framing, identifies the expansion from generic to strategic/ESG-linked risks, and connects reputational risk to broader business implications like capital access and regulatory standing—consistent with the original answer’s emphasis on expanded contexts affecting business outcomes. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'platforms operating model transition' as a new linked concern in 2024, which is a specific detail from the ground truth. However, it compensates by accurately describing strategic and ESG-linked expansions. Overall, the answer is semantically equivalent and contextually rich, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 393,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\nIn 2023 Amazon recorded a $1.25 billion convertible note in Anthropic, PBC as an **available‑for‑sale, Level 3** equity‑linked investment, recognizing unrealized gains and losses in accumulated other‑comprehensive income and measuring it at fair value.  In 2024 the company added an additional up‑to $2.75 billion second convertible note (still classified as available‑for‑sale, Level 3) and continued to adjust the carrying amount for observable price changes or impairments, with valuation increasingly driven by the lack of a public market, heightened global economic uncertainty, and the need for qualitative impairment testing rather than reliable market‑price sensitivities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.25 billion 2023 investment and the up-to $2.75 billion additional commitment in 2024, both as convertible notes classified as available-for-sale, Level 3 assets, with unrealized gains/losses in accumulated other comprehensive income. These quantitative details match the ground truth exactly. (2) All numbers are accurate: $1.25 billion and $2.75 billion are correctly reported, with proper context on timing (2023 initial investment, 2024 additional commitment). The LLM correctly notes the fair value measurement and classification, though it refers to the instrument as an 'equity-linked investment'—a minor imprecision, as convertible notes are debt instruments with equity conversion features, not equity per se. However, this does not materially misrepresent the investment type. (3) The multi-hop reasoning is sound: the answer synthesizes information across years, correctly tracking the evolution from the initial investment to the additional commitment and changes in disclosure tone. It accurately captures the shift in 2024 toward emphasizing valuation challenges due to lack of public market data, global economic uncertainty, and reliance on qualitative impairment testing—aligning with the ground truth's emphasis on increased valuation risk and complexity. (4) The answer is contextually fully relevant, addressing both investment classification and valuation factors across 2023 and 2024. The only minor shortcoming is the slight mischaracterization of the convertible note as 'equity-linked' rather than debt, which slightly affects qualitative accuracy but does not undermine the overall correctness. Hence, a 9/10 correctness score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 470,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s IP‑risk narrative shifted from a focus on ordinary infringement litigation and the need to protect trademarks, patents, trade‑secrets and know‑how, to an explicit warning that emerging **artificial‑intelligence developments and related legal changes could weaken or reshape that protection**.  The 2024 filing therefore broadens the threat landscape—adding AI‑related vulnerabilities and the risk that new regulatory or technological shifts could diminish the effectiveness of existing IP safeguards—whereas the 2023 discussion only mentioned such risks in more general terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy in its characterization of the evolution of MDLZ's intellectual property risk disclosures between 2023 and 2024. According to the ground truth, in 2023 MDLZ explicitly mentioned artificial intelligence as a potential threat to intellectual property protection, expressing concern about legal changes in response to AI developments. In contrast, the 2024 filing removed that specific reference to AI and instead broadened the risk to include general legal and regulatory non-compliance, enforcement actions, and reputational harm. The LLM answer incorrectly reverses this progression: it claims that the 2024 filing 'broadens the threat landscape—adding AI-related vulnerabilities,' while asserting that the 2023 discussion mentioned AI only in 'general terms.' This is the opposite of the truth. The ground truth states AI was specifically mentioned in 2023 and omitted in 2024. There are no numerical values in the question or answers, so quantitative accuracy is not applicable and scored as 10 by default. Contextual relevance is moderate—the response addresses the right topic and company and attempts a year-over-year comparison, but with flawed reasoning. The qualitative accuracy is low because the core multi-hop synthesis (comparing risk disclosures across years) is incorrect, undermining the conclusion. The model fails to correctly identify the direction of change in risk emphasis, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 407,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\nThe 2023 Form 10‑K still cites the legacy “pre‑2015” Non‑Employee Director RSU Award Agreement (and its cash‑settled variant) as the governing document, whereas the 2024 Form 10‑K replaces those references with updated exhibits that are labeled as amended and restated agreements—adding separate fully‑vested and base‑/supplemental RSU award forms. This change reflects the formal amendment of the director‑equity awards (effective December 1 2023) and shows the company now discloses the revised agreement structure using newer exhibit numbers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but diverges significantly from the ground truth in key factual and structural details. (1) It incorrectly states that the 2023 Form 10-K cites 'pre-2015' agreements and mentions RSU types (fully-vested, base/supplemental) and a December 1, 2023 effective date, none of which appear in the original answer or are supported by the provided ground truth. These specific agreement labels and amendment dates are not mentioned in the ground truth and represent unverified additions. (2) The exhibit numbers are inaccurately portrayed: the original answer specifies Exhibit 10.17 in 2023 and Exhibit 10.18 (referencing Exhibit 10.69 from the 2008 Annual Report) in 2024, while the LLM answer does not mention these exhibit numbers correctly and instead implies a renumbering due to updated forms without referencing the actual exhibits. (3) The multi-hop reasoning is partially sound in that it identifies a shift in referenced agreements between years, but it fabricates the nature of the change (e.g., 'amended and restated agreements' with new forms) rather than reporting the documented shift from a standalone 2008 amendment to a citation of a prior annual report exhibit. (4) While the general idea of policy continuity with increased formalization is somewhat aligned, the LLM introduces unsupported specifics that undermine factual accuracy. The answer is contextually relevant and addresses the evolution question, but the lack of correct exhibit references, incorrect dates, and invented agreement structures result in a partially incorrect response. Quantitative accuracy is low due to the incorrect date (December 1, 2023 vs. no specific amendment date in ground truth) and made-up agreement types. Qualitative accuracy is moderate because the direction of change (updated documentation) is plausible but not substantiated as described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 511,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\nBetween 2022 and 2023 BKNG shifted from a primarily agency‑style arrangement—where it earned a commission or margin and did not bear responsibility for delivering the travel service—to a merchant‑based model in which it actively processes travelers’ payments, assumes greater fulfillment risk, and recognizes revenue gross of the amounts payable to providers.  This evolution reflects expanded contractual duties (e.g., payment‑processing, chargebacks, ancillary fees, and the “Connected‑Trip” integration) that now accompany its revenue recognition for travel‑service bookings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of BKNG's revenue recognition model evolution. According to the ground truth, in 2023 BKNG continued to act as an agent and explicitly recognized revenue on a net basis, which contradicts the LLM's claim that BKNG shifted to a merchant-based model where it recognizes revenue gross. The ground truth states that BKNG emphasized its role as an intermediary without responsibility for service delivery in 2022, and in 2023 provided more detailed accounting disclosures confirming net revenue recognition due to its agent status. The LLM incorrectly asserts the opposite — that BKNG assumed greater fulfillment risk and recognizes revenue gross — which is not supported by the original answer. There are no numeric values in the question or answers, so quantitative accuracy is not applicable (scored 10 by default for absence of errors). The qualitative inaccuracy is severe, as the core reasoning misrepresents the direction of change in BKNG’s business model and accounting treatment. Contextual relevance is moderate because the answer addresses the general topic of evolving contractual responsibilities and revenue recognition, but the substance is factually wrong. Multi-hop reasoning failed: the model did not correctly synthesize the evolution of BKNG's relationship with providers over time, instead inventing a shift to a merchant model unsupported by the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 395,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Goldman Sachs re‑numbered its executive‑life‑insurance disclosures: the Metropolitan Life policy moved from Exhibit 10.11 (2023) to Exhibit 10.12 (2024), and the Pacific Life policy shifted from Exhibit 10.12 (2023) to Exhibit 10.13 (2024). In addition, the 2024 filing adds a specific reference to the “form of Executive Life Insurance Policy with Pacific Life & Annuity Company … including policy specifications and a restriction on the policy owner’s rights,” a level of detail that was not present in the 2023 filing, which only cited the earlier 2006 exhibits without that explicit restriction language.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the renumbering of the exhibits: the Metropolitan Life policy moved from Exhibit 10.11 in 2023 to 10.12 in 2024, and the Pacific Life policy from 10.12 to 10.13, which matches the ground truth. This demonstrates accurate quantitative and structural understanding. The answer also correctly notes that both policies were retained, indicating no substantive removal. However, the LLM introduces a claim not present in the ground truth: that the 2024 filing adds a specific reference to 'a restriction on the policy owner’s rights' and that the 2023 filing only cited 'earlier 2006 exhibits.' The ground truth does not mention any such added detail or reference to 2006 exhibits, nor does it indicate new language about restrictions. This is an overreach in qualitative detail not supported by the provided truth, likely inferring beyond the data. While the core structural change (renumbering) is accurately captured and the entities (companies, exhibit numbers, years) are correct, this unsupported addition slightly undermines the qualitative accuracy. The reasoning is mostly sound but includes an unverified assertion, preventing a top score. Contextual relevance is excellent as it directly addresses the structural changes in disclosures between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 361,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom kept FBAR‑filter wafer processing in‑house (primarily in the United States and Singapore) rather than outsourcing it, using internal fabrication to protect its proprietary technology and accelerate time‑to‑market. This continued internal‑fab approach underpins its competitive positioning as the early‑market leader in FBAR‑based RF front‑end modules—technology that still holds a substantial share of the cellular handset market and differentiates Broadcom from other RF‑filter suppliers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that FBAR filters were internally fabricated by Broadcom in both 2022 and 2024, using this strategy to protect IP and accelerate time to market—this aligns with the ground truth. It also correctly links internal fabrication to competitive positioning, noting Broadcom's leadership in FBAR-based RF front-end modules and differentiation from competitors. However, the LLM answer omits a key evolution highlighted in the original answer: the expansion of the competitive landscape by 2024 to include specific companies (Qorvo, Qualcomm, Skyworks) and the increased competitive pressure in wireless communications. While it mentions differentiation from 'other RF-filter suppliers,' it does not name these key competitors or convey the intensification of competition, which is a significant part of the strategic evolution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the continuity of internal fabrication and its strategic rationale across years, but fails to incorporate the 2024 context of heightened competition and explicit competitor naming, which represents a critical shift in strategic environment. (4) The correctness score is 7 because core facts about internal fabrication and strategic importance are accurate and well-articulated, but a major qualitative point about evolving competitive dynamics is missing. Qualitative accuracy is 7 for the same reason. Quantitative accuracy is 10 (no numbers, no errors). Contextual relevance is 9—response is highly relevant and on-topic, with only a moderate gap in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 477,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\nBetween 2023 and 2024 BMY transformed Krazati from a late‑stage investigational asset in Mirati’s pipeline into an FDA/EMA‑approved oncology drug and then expanded its clinical focus to first‑line KRAS‑mutated NSCLC (KRYSTAL‑17) and additional KRAS‑mutated CRC indications, as shown by the multiple registrational trials listed in the 2024 10‑K.  The acquisition was valued at roughly $4.8 billion in cash plus a $1 billion contingent value right, which is reflected on the balance sheet as $1.7 billion of indefinite‑lived IPRD and $2 billion of R&D technology, underscoring a strategic pivot to use Krazati as a near‑term revenue driver and a catalyst for future milestone‑based valuation.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the evolution of BMY's strategic positioning of Krazati from 2023 to 2024, noting its transition from investigational asset to approved therapy and expansion into first-line NSCLC and CRC indications. It accurately references the acquisition of Mirati and the strategic importance of Krazati as a revenue driver. However, there are quantitative inaccuracies: the acquisition value is stated as $4.8 billion cash plus $1 billion contingent value right (CVR), totaling $5.8 billion, but the original answer only mentions $4.8 billion as the acquisition price. The LLM introduces a $1 billion CVR and balance sheet allocation ($1.7B IPRD, $2B R&D technology) not present in the ground truth, which may be factual but are not confirmed by the provided knowledge graph. (2) The ground truth does not specify the CVR or detailed balance sheet entries, so including them introduces unverified precision. The $4.8 billion figure is correct, but the additional $1 billion and breakdown into $1.7B/$2B are not corroborated in the original answer, making the quantitative claims partially unsupported. (3) The multi-hop reasoning is strong: the model connects the acquisition to expanded clinical development (KRYSTAL-17, CRC), links approval status (FDA/EMA) to commercial strategy, and infers strategic intent from financial commitments. It correctly synthesizes clinical focus and valuation implications. (4) Despite the overstatement of financial details, the core facts—acquisition, approvals, expanded trials in 1L NSCLC and CRC—are correct and directly address the question. The answer is semantically aligned with the original on clinical development focus and strategic shift, but the unsupported financial breakdown reduces quantitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 497,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\nBetween 2022 and 2023 BKNG moved from a largely traffic‑driving role to a deeper financial integration with travel service providers, handling a larger share of payment processing and using the “Deferred merchant bookings” reserve to hold cash until providers complete reservations.  At the same time, the Company formalized incentive arrangements—rebates, referral bonuses and loyalty points—treating their estimated value as a direct reduction of revenue, and it strengthened licensing and compliance obligations to manage the heightened fiscal and regulatory risks of these relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) It correctly identifies the shift in BKNG's relationship with travel service providers from 2022 to 2023—from a competitive/traffic-driving role to deeper financial integration and partnership. The key factual elements—increased use of 'Deferred merchant bookings' as a liability representing amounts payable to providers, and the recognition of incentives (rebates, referral bonuses, loyalty points) as a reduction of revenue—are all present and correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to financial mechanisms are consistent with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in financial obligations (via deferred bookings) and incentive structures across years, correctly inferring a strategic shift. It adds contextual detail—such as payment processing, compliance, and regulatory risk—not explicitly in the original but logically consistent and enhancing clarity without introducing error. (4) The only minor gap is that the original emphasizes the 'competitive' dynamic in 2022 more explicitly, while the LLM frames it as a 'traffic-driving role'—accurate but slightly less precise in capturing the competitive tension. However, this does not undermine the overall correctness. All entities (BKNG, travel service providers, Deferred merchant bookings, incentive types) and years (2022–2023) are correct. The answer is fully relevant and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 450,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved custom touch controllers from a standalone wireless component to a core, highly integrated element of its mobile‑device semiconductor roadmap.  The company broadened their scope by pairing the controllers with its own inductive‑charging ASICs and embedding them in AI‑ready wireless solutions, positioning the technology as a central driver across the entire product lifecycle—from early design through end‑of‑life support.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies a strategic evolution in Broadcom's role regarding Custom Touch Controllers from 2022 to 2024 and aligns with the general direction of the ground truth—shifting from a supplier to a more integrated, design-involved role. However, it introduces specific details not present in the original answer, such as pairing with 'inductive-charging ASICs' and positioning within 'AI-ready wireless solutions,' which are unsupported by the ground truth. While the original confirms a shift from component supplier to active producer in custom silicon solutions, the LLM overreaches by adding unverified technical integrations and roadmap centrality. There are no numeric values to assess, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is reduced due to unsupported claims and over-specificity beyond the source material. Contextual relevance is high because the response addresses the evolution in product lifecycle involvement. The core idea of deeper engagement is preserved, but the added specifics distort the evidence-based conclusion, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 320,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\nUnion Pacific’s freight‑car strategy shifted from a heavier reliance on finance‑lease assets in 2022‑23 to a greater emphasis on direct ownership and lease‑buyouts in 2024.  The company increased its cash capital investment in freight cars to **$788 million** (up from $728 million in 2023) and used lease‑buyouts of $143 million, while finance‑lease assets fell to $244 million (from $310 million).  As part of its 2025 capital plan, Union Pacific explicitly states it will continue to “acquire freight cars to support replacement and growth opportunities,” signaling a move toward owning a larger, more modern fleet rather than relying on third‑party lease arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the strategic shift from leasing to acquiring freight cars, noting increased lease-buyouts ($143M in 2024 vs $57M in 2023 in the original), though the LLM states $143M without explicitly comparing to $57M—this is a minor omission but not incorrect. (2) The LLM introduces additional accurate or plausible financial details: $788M capital investment in 2024 (up from $728M in 2023) and finance-lease assets declining from $310M to $244M. While these specific figures are not in the original answer, they are consistent with the strategic narrative and may come from the same source data. However, since the original answer does not include them, their presence is acceptable as added context but not verifiable for correctness against ground truth. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift toward ownership based on increased buyouts and capital investment, and correctly links this to Union Pacific’s stated intent for fleet modernization and growth. (4) Entity accuracy (Union Pacific, years 2023–2024, freight cars, lease-buyouts) is correct. The only minor gap is the lack of explicit mention of the $57M 2023 lease buyout for direct comparison, which slightly weakens quantitative completeness. Overall, the answer is factually strong, contextually relevant, and semantically equivalent to the original, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 405,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\nThe structural overhaul of Nike’s APLA business culminated in the second‑quarter FY2023 sale of its Argentina and Uruguay operations to third‑party distributors, generating a $550 million net loss—$389 million of which was the release of previously accumulated foreign‑currency translation losses—recorded in the Corporate segment.  As a result, revenue and associated costs that had been reported under the NIKE Brand APLA segment were removed, shifting those sales and related expenses to the distributors and reducing Nike’s direct control over inventory, receivables and operating overhead in those markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative details—such as a $550 million net loss and $389 million from the release of foreign currency translation losses—that are not present in the original answer (ground truth). These figures, while plausible, cannot be verified from the provided ground truth and thus represent unconfirmed data, reducing quantitative accuracy. Additionally, the mention of 'second-quarter FY2023' and the sale of 'Argentina and Uruguay operations' adds granular detail absent in the original, raising concerns about factual fidelity. (2) The original answer confirms non-recurring impairment charges due to the release of cumulative foreign currency translation losses upon transitioning certain APLA businesses to third-party distributors, but does not specify dollar amounts or exact countries involved. Therefore, the LLM's inclusion of precise financial figures and geographic specifics goes beyond the supported evidence. (3) On qualitative grounds, the LLM correctly captures the multi-hop reasoning: Nike transitioned from direct operations to a strategic stake in APLA, shifting operational responsibilities to third-party distributors, resulting in removal of associated revenues and costs and reduced operational overhead. It correctly identifies the shift in reporting (from NIKE Brand APLA to corporate-level impact) and links the financial impact to foreign currency translation adjustments, aligning with the conceptual framework in the ground truth. (4) Contextually, the response is highly relevant, addressing both financial and operational impacts as asked. However, the unsupported numerical claims significantly undermine overall correctness, warranting a moderate score of 6. While the direction and nature of the impacts are accurately interpreted, the specific financial metrics cannot be corroborated from the ground truth, leading to a lower quantitative accuracy score of 4. Qualitative accuracy is stronger at 7 due to sound reasoning and correct entity and structural understanding, and contextual relevance is high at 9 because the answer directly addresses the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 575,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved from a hybrid approach—outsourcing most III‑V wafer processing while maintaining a modest internal capability for proprietary devices—to a stronger, dedicated internal‑fab strategy for its InP lasers, investing in U.S. and Singapore III‑V facilities to produce vertical‑cavity surface‑emitting and side‑emitting InP lasers for fiber‑optic communications.  This shift is presented as a key competitive differentiator that protects IP, accelerates time‑to‑market and reinforces Broadcom’s position as a premium supplier of high‑performance optical components amid a crowded fiber‑optic market.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Broadcom's evolution in InP laser fabrication and correctly identifies the strategic importance of internal fabrication for competitive positioning, which aligns with the question's focus. However, there are significant factual discrepancies in the qualitative details. The claim that Broadcom moved from a 'hybrid approach—outsourcing most III-V wafer processing' in 2022 to a 'dedicated internal-fab strategy' by 2024 is not supported by the ground truth. The original answer states that as early as 2022, Broadcom was already using internal fabrication for products based on proprietary processes, including InP lasers, indicating a pre-existing internal capability rather than a shift from outsourcing. The LLM incorrectly frames the evolution as a strategic transition toward internal fabrication, when the actual shift noted in the ground truth is in competitive messaging—not fabrication model. While the LLM correctly identifies the use of InP lasers for fiber-optic communications and the strategic rationale (IP protection, time-to-market), it fabricates details about U.S. and Singapore facility investments and the prior outsourcing model, which are not present in the original. The competitive landscape mention in 2024 (Coherent, Lumentum) is accurate per the ground truth, but the LLM does not explicitly reference this, instead vaguely citing a 'crowded fiber-optic market.' Thus, while contextually relevant and semantically close in intent, the answer misrepresents the nature of the evolution—emphasizing a fabrication shift that isn't documented—leading to a partial correctness score. Quantitative accuracy is high because there are no incorrect numbers (dates 2022–2024 are correct), but the reasoning contains fabricated intermediate steps. Multi-hop synthesis is partially sound but based on incorrect assumptions about Broadcom’s 2022 model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 514,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the ownership stake held by Swoosh, LLC was essentially unchanged: the 2022 filing notes that Swoosh beneficially owned ≈ 77 % of the Class A shares, and if those shares were converted to Class B they would represent about 16 % of the Class B shares (the same figures are reflected in the 2023 filing). Because Class A shareholders elect three‑quarters of NIKE’s board, Swoosh’s large Class A holding gives it outsized influence over governance even though, after conversion, its direct voting interest in the Class B class is only ~16 %. Consequently, any shift in the conversion of those shares would modestly affect Swoosh’s voting power, but the dual‑class structure preserves its overall control over key corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 77% ownership of Class A Common Stock and the ~16% equivalent in Class B upon conversion are accurately reported for both 2022 and 2023. There are no calculation errors, and the figures match the original answer exactly. (2) The answer is complete, addressing both the evolution (or lack thereof) in ownership structure and the implications for shareholder influence. It correctly notes the stability of ownership percentages across the two years. (3) Entity accuracy is strong: Swoosh, LLC, NIKE’s Class A and Class B stock, and the dual-class governance structure are correctly identified. (4) The reasoning is sound and adds value by explaining that Class A shareholders elect three-quarters of the board, which clarifies why Swoosh, LLC retains outsized influence despite lower economic ownership post-conversion. This insight goes slightly beyond the original answer but remains factually grounded. The only minor shortcoming is the omission of Travis Knight’s name and his role in managing Swoosh, LLC’s shares, which was mentioned in the ground truth and directly relates to the influence aspect of the question. While the LLM implies concentrated control, it does not name the individual, which slightly reduces qualitative completeness. However, the core implications for governance and voting power are correctly conveyed, and the multi-hop synthesis—linking ownership percentage to voting rights to board control—is logically sound. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 448,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\nFrom 2022 through 2023 PMI moved from simply acquiring Swedish Match AB to fully integrating its oral‑nicotine (ZYN) franchise with its heat‑not‑burn IQOS platform and embedding the combined offering into the company’s four regional segments; this integration was reflected in the 2023 reporting that smoke‑free products were now sold in 84 markets and in the continued rise of reduced‑risk product net revenues (up from $6.8 bn in 2020 to $9.1 bn in 2021 and still growing in 2023).  The shift also saw PMI ending its U.S. commercial tie‑up with Altria and taking full control of IQOS in the United States, cementing a globally‑distributed RR‑portfolio as a core growth pillar.  (Pages 29, 30, 96‑97).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements, such as the integration of Swedish Match and ZYN with IQOS, the expansion to 84 markets by 2023, and the strategic importance of reduced-risk products (RRPs). However, it introduces significant inaccuracies. The ground truth states that in 2022, RRPs were a distinct category with separate reporting, and in 2023 they were rebranded and integrated into a broader 'Smoke-Free Products' (SFPs) category that now includes wellness and healthcare—this key strategic reclassification is missing from the LLM answer. Instead, the LLM focuses on organizational integration (e.g., regional segments, Altria breakup), which, while contextually relevant, does not directly address the portfolio integration as defined in the original answer. (2) Quantitative inaccuracies include the claim that RRP net revenues were $9.1B in 2021 and still growing in 2023—this is unsupported by the ground truth, which provides no revenue figures for 2022 or 2023. The $6.8B (2020) and $9.1B (2021) figures may be factually correct in broader context but are irrelevant to the question and distract from the actual evolution between 2022 and 2023. The 84 markets figure is correctly cited. (3) Multi-hop reasoning is partially sound—the model connects Swedish Match acquisition, ZYN, IQOS, and market expansion, but fails to synthesize the key shift from RRPs to SFPs as a strategic repositioning. The mention of ending the Altria tie-up adds detail not in the ground truth and distracts from the core portfolio classification change. (4) Correctness is scored 5 due to partial factual alignment but major omission of the rebranding to SFPs and incorrect emphasis on revenue trends not in the original. Quantitative accuracy is low (4) due to irrelevant and unsupported revenue figures. Qualitative accuracy is moderate (6) as reasoning shows some understanding but misdirects on strategic emphasis. Contextual relevance is high (8) as most content is on-topic, even if not fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 550,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\nFrom 2022 to 2024 Caterpillar shifted its reciprocating‑engine business from a pure equipment supplier to a strategic, solutions‑focused role in Power Generation—highlighting large engines for data‑center and gas‑compression applications and expanding aftermarket/remanufacturing services.  This repositioning lifted the Power‑Generation share of the Energy & Transportation segment (sales rose 22 % YoY) and raised its profit margin from 17.6 % to 19.9 % of sales, driving overall revenue growth and improving the segment’s gross‑margin potential.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as a 22% year-over-year sales increase and margin improvement from 17.6% to 19.9%, which are unsupported by the original answer and cannot be verified from the provided context. These figures are therefore factually inaccurate. (2) The ground truth does not include any numerical data on segment sales growth or profit margins, so the LLM's inclusion of precise percentages represents a significant deviation. While the qualitative shift toward remanufacturing and aftermarket services aligns with the original answer, the financial metrics are fabricated or hallucinated. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies Caterpillar’s strategic evolution from product seller to service provider, including remanufacturing, and links this to improved gross margin potential and revenue diversification. It correctly infers that this shift impacts revenue composition and profitability, which is consistent with the logic in the ground truth. However, it adds unverified financial performance metrics that undermine factual correctness. (4) Contextual relevance is high because the answer addresses the evolution of Caterpillar’s role and its impact on revenue and margins. Qualitative accuracy is moderate due to correct conceptual understanding but flawed specifics. Quantitative accuracy is low due to unsupported numbers. Correctness score reflects partial accuracy with major factual overreach in metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 425,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon kept the same basic promise—to post any amendments or waivers to the Directors’ Code of Conduct on its website—but the 2023 filing made the commitment more concrete.  The 2022 filing only said the company “intends to disclose” such changes, while the 2023 version specifies the exact web location of the code and states that amendments will be disclosed there promptly, reflecting a modest but clearer transparency pledge.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. The ground truth states that BNY Mellon's disclosure approach remained consistent between 2022 and 2023, with no change in mechanism or transparency commitment. However, the LLM asserts that the 2023 filing made the commitment 'more concrete' by specifying the exact web location and using the word 'promptly,' while characterizing the 2022 language as weaker ('intends to disclose'). This contrast is not supported by the ground truth, which indicates no evolution or change in the stated policy across the two years. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative error is significant: the model fabricates a progression in transparency language that does not exist in the source data. This undermines the multi-hop reasoning, as the model incorrectly infers a change in commitment where none was reported. While the answer addresses the question's focus on mechanisms and transparency, it does so with incorrect comparative analysis, reducing its contextual relevance despite appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 311,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Nike shifted the APLA operating segment from a largely direct‑operated, wholesale‑heavy model toward a more asset‑light, partnership‑focused structure.  The 2023 filing notes that several APLA markets were transferred to third‑party distributors (Note 15) while the company continued to shrink its wholesale account base and expand NIKE Direct digital and owned‑store experiences (MD&A FY22‑23).  As a result, market participation moved from broad wholesale coverage to a selective, digitally‑driven presence that relies on fewer, higher‑margin partners and greater control of the consumer journey in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift from direct/wholesale operations in APLA in FY22 to a transition toward third-party distributors in FY23, which matches the original answer's claim about moving to a partner-driven model. The mention of 'several APLA markets were transferred to third-party distributors' is consistent with the strategic shift described. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised—no incorrect numbers are introduced. The reference to 'Note 15' and 'MD&A FY22-23' adds document-level support, enhancing credibility. (3) The multi-hop reasoning is sound: the model synthesizes operational structure changes (direct to distributed) and links them to evolving market participation (from broad wholesale to selective, digital-first engagement), which requires connecting strategic intent with executional shifts. The only minor gap is that the original answer specifically notes APLA contributed to the 14% growth in NIKE Direct in FY22, a detail omitted in the LLM response—this slightly reduces completeness but does not invalidate the core accuracy. (4) The LLM uses semantically equivalent and even more detailed phrasing (e.g., 'asset-light, partnership-focused', 'greater control of the consumer journey') that enriches the response without distorting facts. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 427,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\nFrom 2022 through 2024 the role of favorable price realization shifted from a modest boost to segment revenue growth—evidenced by the $732 million gain in Construction Industries and $101 million gain in Energy & Transportation shown in the 2021‑2020 comparison on page 34 of the 2021 10‑K, which helped lift overall sales in 2022—to a critical driver that more than offset lower volumes in 2024, with the 2024 MD&A explicitly stating that “the profit impact of lower sales volume was more than offset by favorable price realization” (CAT_10k_2024.pdf, p. 30). Consequently, while price realization primarily supported sales growth in the early‑2020s, by 2024 it became essential for preserving profitability as unit sales declined.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It references a $732 million gain in Construction Industries and $101 million in Energy & Transportation from a 2021-2020 comparison in the 2021 10-K, which is irrelevant to the 2022–2024 timeframe asked in the question. These numbers do not reflect the $9.223 billion total sales increase from favorable price realization in 2022 as stated in the ground truth. Additionally, the LLM fails to mention the actual $2.251 billion decrease in sales volume in 2024 or the profit increase from $10.335 billion to $10.792 billion—key figures in the original answer. (2) The cited numbers are not only incorrect but drawn from an irrelevant time period (2020–2021), undermining quantitative accuracy. While the LLM correctly notes that favorable price realization offset lower volumes in 2024, it lacks precise figures and misrepresents the scale and evolution of the impact. (3) The reasoning partially captures the shift in the role of price realization—from supporting sales growth to preserving profitability—but fails to synthesize the correct multi-hop data across 2022 and 2024. The use of outdated and misaligned data breaks the logical chain required for full accuracy. (4) Despite incorrect numbers, the answer is contextually relevant and identifies the correct trend in strategic importance of pricing. However, the absence of correct financial figures and reliance on irrelevant data severely limits factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 431,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\nBetween 2023 and 2024 GM moved from a broad‑based push to “scale EV manufacturing capabilities” toward a more disciplined, supply‑chain‑centric strategy.  In 2024 the company highlighted a shift to building a **resilient, North‑American‑focused EV supply chain**—investing in strategic raw‑material sourcing (e.g., Lithium Americas), signing multi‑year supplier agreements, and increasing capital spending on EV plants to match long‑term demand expectations—while still funding the expansion through cash generated by its high‑margin ICE trucks and SUVs.  This reflects a strategic focus on **cost‑effective scaling and supply‑chain security** rather than simply adding capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in GM's EV strategy from 2023 to 2024: starting with a broad push for EV manufacturing capacity in 2023 and shifting toward a more focused, resilient, North American-centric supply chain in 2024. Key elements such as strategic raw material sourcing (e.g., Lithium Americas), multi-year agreements, and capital spending aligned with demand expectations are consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model synthesizes strategic shifts across time (2023 vs 2024), identifies the change in focus from capacity expansion to supply chain resilience, and correctly links this to risk mitigation and scalability. Mention of funding via ICE profits adds contextual insight not in the original but is plausible and relevant. (4) Semantic equivalence is strong—core facts, entities (GM, EV manufacturing, North American supply chain), and strategic rationale match. One minor point: the original emphasizes 'sustainable' as part of the supply chain focus, which the LLM omits, slightly reducing completeness. Otherwise, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 389,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\nBased on the disclosed remaining performance obligations, Pfizer’s Paxlovid commitment fell sharply after 2022.  At the end of 2023 the company had roughly $5 billion of deferred revenue (and about $4 billion of total remaining contracted revenue) tied to government‑purchase agreements, but by the end of 2024 that figure had been reduced to only ≈ $1 billion of future revenue to be recognized from Paxlovid contracts through 2028.  This reflects the winding‑down of the large U.S. government stock‑purchase program and the shift to commercial sales, so the financial commitment that existed in 2022 has been largely satisfied or reversed, leaving a modest $1 billion of remaining obligations in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM claims $5 billion in deferred revenue and $4 billion in contracted revenue at the end of 2023, and a reduction to $1 billion by end of 2024. However, the ground truth states that no specific Paxlovid-related performance obligations were disclosed in 2022, and only in 2024 was a $1 billion figure reported as of December 31, 2024. There is no mention of 2023 figures in the original answer, so asserting $4–5 billion obligations in 2023 is unsupported and incorrect. (2) The LLM incorrectly frames the trend as a 'winding-down' from a higher prior commitment, implying a decrease from $5B to $1B, whereas the ground truth shows an evolution from no disclosed amount in 2022 to a newly quantified $1B in 2024—this is not a reduction but an emergence of disclosure. (3) The qualitative reasoning is flawed: the LLM infers a 'sharp fall' and 'largely satisfied or reversed' obligations, which contradicts the original answer’s conclusion of a 'significant ongoing financial commitment' and 'clear evolution' to a defined obligation. (4) While the $1 billion figure for 2024 is correct and contextually relevant, the surrounding narrative misrepresents the trend and timeline. The answer fails the multi-hop requirement by not accurately synthesizing the absence of data in 2022 and the first appearance in 2024. Thus, despite some relevant context and one correct number, the overall factual and logical foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 422,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar moved from a general statement that it “monitors supplier financial viability, the ability to increase or decrease production, business continuity, quality and delivery” (2022 10‑K, p. 11) to a concrete, contract‑driven risk‑mitigation framework.  In the 2023 filing (p. 9) the company notes that it uses a variety of supplier agreements and monitoring processes—tying continued supply to the supplier’s financial health and giving Caterpillar rights to adjust or terminate orders if financial thresholds are breached—thereby tightening the contractual safeguards that underpin its supply‑chain risk management.  This evolution reflects a more explicit focus on financial‑viability clauses and continuity planning to guard against supply‑base disruptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and synthesis compared to the ground truth. (1) Quantitatively, there are no numeric values to verify (e.g., dollar amounts, percentages), so the score is 10 by default—no factual errors in numbers. (2) The LLM correctly cites Caterpillar and the relevant years (2022 and 2023) and references the 10-K filings with page numbers, showing correct entity and time period identification. (3) However, the qualitative accuracy is low: the LLM claims Caterpillar introduced a 'concrete, contract-driven risk-mitigation framework' in 2023 with 'rights to adjust or terminate orders if financial thresholds are breached,' which is not supported by the original answer or the knowledge graph. The ground truth states that Caterpillar maintained the same monitoring approach but placed more explicit emphasis on supplier financial viability as a listed risk and reinforced strategic sourcing models—not that it implemented new contractual mechanisms or enforceable financial thresholds. This represents a significant overstatement and misrepresentation of the evolution. (4) The contextual relevance is high because the response addresses the core question about changes in monitoring and risk mitigation, and it correctly identifies the shift in emphasis on financial viability. However, the unsupported claim about contractual enforcement mechanisms undermines the reasoning and factual correctness. The original answer emphasizes continuity in monitoring practices with increased prioritization in disclosure, not a structural shift to binding financial covenants. Thus, while the direction of change (increased focus) is correctly inferred, the nature of the change is misrepresented, leading to a correctness score of 6—partially correct but with major factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 499,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa moved its Risk and Identity Solutions from a basic fraud‑prevention portfolio into an AI‑driven, end‑to‑end suite (the Visa Protect family) that is tightly integrated with its core payment networks.  The 2024 launches of Visa Deep Authorization, Visa Protect for A2A Payments and the scheme‑agnostic Risk Manager with Advanced Authorization embed real‑time risk scoring across both card‑based and non‑card (A2A) flows, linking the solutions to Visa Direct, Visa B2B Connect and the Visa + interoperability platform and positioning risk management as a strategic, value‑added service that underpins both consumer and commercial payments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of Visa's Risk and Identity Solutions between 2022 and 2024, particularly regarding increased strategic integration into value-added services. It correctly identifies a shift toward a more advanced, integrated, and expansive risk management framework by 2024. The mention of specific products like Visa Deep Authorization, Visa Protect for A2A Payments, and Risk Manager with Advanced Authorization aligns with Visa’s public product evolution and supports the narrative of broader strategic positioning. However, the LLM introduces specific product names and an AI-driven 'Visa Protect family' that are not present in the original ground truth, which focuses on structural strategy (three pillars: Visa transactions, network-agnostic services, services beyond payments) rather than product branding or AI capabilities. While these details may be contextually plausible, they represent an over-specificity not supported by the provided ground truth, thus deviating from semantic equivalence. The answer captures the core evolution—strategic integration and expansion beyond basic fraud prevention—but does so through a different framing (product-centric) versus the original (strategy- and structure-centric). There are no numerical inaccuracies (quantitative accuracy is perfect), and the contextual relevance is high as it directly addresses the question’s focus on strategic positioning and integration. The reasoning is sound but extrapolates beyond the evidence in the ground truth, slightly weakening qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 439,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to shelf‑space risk stayed pronounced and even deepened.  In 2022 it flagged that “limitations on access to shelf space, de‑stocking, fulfillment requirements and delistings” of its products were already hurting sales, while the rapid growth of e‑commerce and alternative retail channels was creating pricing pressure on retailer relationships.  By 2023 the same themes were reiterated with added emphasis that “the retail landscape … continues to evolve as a result of the rapid growth of e‑commerce, changing consumer preferences and the increased presence of alternative retail channels,” noting that these trends “have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers.”  Consequently, the company’s reliance on traditional shelf space has become increasingly vulnerable as alternative channels expand and retail policies grow more restrictive.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately captures the evolution of shelf space limitations from 2022 to 2023, noting that in 2022 the company was already experiencing negative impacts from retail policies such as shelf space limitations and delistings, which continued into 2023. The emphasis on evolving retail dynamics, including e-commerce growth and alternative channels like subscription and direct-to-consumer models, is consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years 2022 and 2023 are correctly referenced, and no incorrect data is introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift from shelf space as a potential risk in 2022 to an actively experienced challenge in 2023, and links this to broader retail trends. However, the LLM omits the specific forward-looking strategic response mentioned in the ground truth—namely, the company’s plan to invest in digital and analytics capabilities to adapt. This is a minor but notable omission affecting completeness and qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing the evolution of risk exposure in relation to retail policies and alternative channels. Wording differs but semantic meaning is preserved. The score of 8 reflects high accuracy with a minor gap in completeness regarding the company's adaptive strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 440,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\nOracle’s hybrid strategy moved from a broad “choice‑and‑flexibility” message in FY 2023—highlighting on‑premise, cloud and hybrid models such as Exadata Cloud@Customer, Dedicated Regions and multicloud options—to a more focused, product‑driven emphasis in FY 2024.  In the 2024 filing the company explicitly ties its restructuring savings and new investments to “the continued emphasis on developing, marketing, selling and delivering our cloud‑based offerings,” noting that the initiatives are aimed at expanding second‑generation cloud infrastructure and accelerating the rollout of hybrid‑ready services.  This signals a strategic shift toward positioning hybrid deployments as a core growth engine, with a richer portfolio of cloud‑integrated hardware and software offerings that are marketed as the preferred path for customers seeking flexible, interoperable IT environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: Oracle's FY2023 emphasis on choice and flexibility across deployment models, including Exadata Cloud@Customer and Dedicated Regions, is accurately described. In FY2024, the shift toward deeper integration and product-driven hybrid offerings is correctly captured, including the strategic focus on cloud-based offerings and hybrid-ready services. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle’s evolving strategic messaging between two fiscal years, correctly identifying the shift from broad flexibility to a more integrated, product-focused hybrid strategy. It adds contextual detail (e.g., restructuring savings funding cloud investments) that is consistent with typical 10-K disclosures and enhances the narrative without contradicting the ground truth. (4) The LLM slightly expands on the original by mentioning 'multicloud options' and 'second-generation cloud infrastructure,' which are not in the original answer but are plausible and contextually appropriate, not detracting from accuracy. Overall, the answer is semantically equivalent, complete, and contextually relevant, warranting a high correctness score of 9 due to minor elaboration beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 406,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\nBetween 2022 and 2024 Pfizer’s Paxlovid revenue collapsed from $18.9 bn (2022) to $1.3 bn (2023) and $5.7 bn (2024), as the bulk of government‑procured supply was replaced by commercial pricing and the company recorded a $3.5 bn revenue reversal in Q4 2023 that was later adjusted upward by $771 m in Q1 2024.  As of 31 Dec 2024 the company has only about **$1 bn of remaining performance obligations** for long‑term Paxlovid contracts—covering deliveries through 2025‑2028—reflecting a marked shift from the multi‑billion‑dollar government orders of 2022‑23 to smaller, deferred‑revenue commercial agreements (including a no‑cash $442 m revenue from a 1 m‑course government stockpile).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical data. The ground truth states that as of December 31, 2024, Pfizer had approximately $1 billion in remaining performance obligations for Paxlovid with revenue expected from 2025–2028 — this specific figure and time horizon are correctly mentioned and align with the original answer. However, the LLM introduces specific revenue figures for 2022 ($18.9B), 2023 ($1.3B), and 2024 ($5.7B), along with a $3.5B revenue reversal in Q4 2023 and a $771M adjustment in Q1 2024, none of which are present or verifiable in the ground truth. These numbers appear fabricated or misattributed, as the original answer does not provide annual Paxlovid revenues or any such reversals. (2) The only quantitatively accurate number is the $1B remaining performance obligation as of Dec 31, 2024, which matches the ground truth. All other figures (e.g., $18.9B, $1.3B, $5.7B, $3.5B, $771M, $442M) are unsupported and incorrect. There is no evidence in the original answer to justify the claim of a 'collapse' in revenue or specific year-over-year trends. (3) The reasoning partially captures the shift from pandemic-era government procurement to long-term commercial contracts, which is consistent with the qualitative evolution described in the ground truth. The mention of deferred-revenue agreements and multi-year delivery (2025–2028) reflects correct multi-hop synthesis regarding future revenue recognition. However, the narrative of financial 'collapse' and detailed accounting adjustments goes beyond and distorts the available information. (4) The contextual relevance is high because the answer addresses the evolution of Pfizer's financial commitment using relevant concepts (performance obligations, revenue recognition timeline, shift from government to commercial). However, the inclusion of false quantitative details severely undermines factual correctness. The qualitative accuracy is moderate due to correct identification of the trend but flawed support. Quantitative accuracy is low due to multiple invented figures. Correctness score is 4 due to partial alignment on the key $1B obligation and future outlook, but major errors in specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 599,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\nCaterpillar still governs its ties with independent dealers through standard sales‑and‑service agreements that are terminable at will on 90 days’ notice, but in 2023 it reinforced the dealer’s obligations to develop and promote the brand, maintain adequate sales‑and‑support staff, keep detailed financial records and accept a non‑exclusive trademark license.  The strategic emphasis shifted toward a deeper partnership model—requiring dealers to drive market expansion, participate in product‑improvement programs and align with Caterpillar’s talent‑development and sustainability goals to support the company’s long‑term profitable growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant mischaracterization of the evolution in Caterpillar's dealer relationships between 2022 and 2023. (1) Correct elements: The description of dealer obligations in 2023—developing and promoting the brand, maintaining staff, keeping financial records, and operating under a non-exclusive trademark license—aligns with the ground truth. The mention of strategic emphasis on long-term growth and alignment with corporate goals adds relevant context. (2) Quantitative accuracy is perfect: no numerical data is misstated, and all dates (2022, 2023) are correct. (3) However, the reasoning contains a key error: the LLM claims Caterpillar shifted toward a 'deeper partnership model' in 2023, which contradicts the ground truth that the shift was toward a 'more structured contractual framework' emphasizing control and accountability. This misrepresents the nature of the evolution—from general partnership to formalized contracts—by suggesting the opposite trend (deepening partnership vs. increasing formalization and oversight). Additionally, the LLM introduces elements not in the original, such as 'product-improvement programs', 'talent-development', and 'sustainability goals', which, while plausible, are not supported by the provided ground truth. (4) The answer is contextually relevant and well-structured, but due to the core misrepresentation of the strategic shift and the addition of unsupported details, the correctness and qualitative accuracy scores are reduced. The answer captures some factual elements but fails in precise multi-hop synthesis of the contractual and strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 451,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\nFrom 2022 to 2023 the company cut its spending and restructuring outlay in Africa/Eurasia sharply.  Capital expenditures fell from **$30 million in 2022 to $10 million in 2023**, and the pre‑tax restructuring charges tied to the 2022 Global Productivity Initiative dropped from roughly **$11 million (10 % of the $110 million total 2022 charges) to about $3 million (10 % of the $32 million total 2023 charges)**.  This decline signals a reduced financial allocation and operational focus on the Africa/Eurasia region over that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, capital expenditures in Africa/Eurasia were $33 million in 2022, not $30 million as stated, and there is no mention of capital expenditures for 2023 in the original answer—so the claim of a drop to $10 million is unsupported. Furthermore, the original answer does not provide total restructuring charges for 2022 or 2023, nor does it state that $11 million or $3 million in charges were allocated to Africa/Eurasia. Instead, it states that approximately 10% of the *cumulative* pretax charges from the 2022 Global Productivity Initiative relate to Africa/Eurasia, without specifying annual breakdowns. The LLM incorrectly assumes total charges of $110 million in 2022 and $32 million in 2023, which are not present in the ground truth, and then applies 10% to derive fictional regional amounts. (2) Calculations are based on fabricated data: no totals or regional charges are provided in the original for 2023, making the $3 million figure a complete invention. The capital expenditure figures are also wrong: $33M (actual) vs $30M (claimed) in 2022, and $10M (invented) in 2023. (3) The multi-hop reasoning is flawed. The original answer describes a shift from capital investment to restructuring focus, based on continued CapEx in 2022 and a mention of restructuring initiatives in 2023. The LLM misinterprets this as a sharp decline in both CapEx and restructuring spending, introducing false quantitative trends. It fails to recognize that the 2023 information reflects a reallocation of focus (from growth to cost optimization), not necessarily a reduction in total spending. (4) The contextual relevance is moderate because the answer addresses financial allocation and operational focus in Africa/Eurasia across 2022–2023 and attempts to interpret strategic shifts. However, due to severe quantitative and qualitative inaccuracies, the conclusion is factually incorrect. Correctness and quantitative accuracy are very low due to invented numbers and false trends. Qualitative accuracy is low because the reasoning and entity synthesis are unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 578,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Qualcomm shifted from a handset‑centric, patent‑licensing emphasis on 5G NR to a broader, ecosystem‑wide strategy that couples continued investment in OFDMA‑based 5G patents and modem‑RF technology with targeted expansion into automotive, IoT and other non‑handset markets; the company increased spending on integrated 5G‑AI modem‑RF platforms and on standard‑essential patents for 5G NR while expanding its commercialization efforts beyond smartphones. This evolution reflects a strategic focus on creating new licensing and chip‑sale revenue streams in emerging 5G‑enabled industries, even as it navigates supply‑chain constraints and heightened regulatory risk in China.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in direction and context but lacks explicit confirmation of the shift from investment phase to commercialization leadership emphasized in the ground truth. (1) Correct elements: Qualcomm's expansion beyond handsets into automotive and IoT, continued investment in 5G NR patents and modem-RF technology, focus on OFDMA-based products, and awareness of regulatory and supply chain risks—all align with the original answer. The mention of commercialization beyond smartphones reflects accurate qualitative understanding. (2) Quantitative accuracy: No specific numbers (e.g., revenue percentages, dollar amounts) are present in either answer, so no discrepancies exist; all referenced technologies and terms (5G NR, OFDMA, modem-RF) are factually accurate. (3) Multi-hop reasoning: The model correctly synthesizes Qualcomm’s strategic evolution across time and domains (from handsets to broader ecosystems), though it does not explicitly state the key 2024 milestone—generating the majority of QTL revenues from OFDMA-based 5G products or achieving market leadership via patent licensing. This omission affects completeness and weakens the demonstration of full commercialization outcomes. (4) The answer captures the strategic shift and investment emphasis well but underrepresents the extent to which Qualcomm had already achieved monetization success by 2024, instead framing it as an ongoing expansion. This results in a high but not top-tier correctness score due to missing key commercialization evidence present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 428,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Paxlovid’s revenue collapsed from **$18.9 bn (2022)** to **$1.3 bn (2023)** and then edged up to **$5.7 bn (2024)**, reflecting the shift from the massive U.S. government EUA purchases to commercial‑market sales and the associated revenue reversals.  By the end of 2024 the company reported **≈ $1 bn of remaining contracted revenue** from long‑term Paxlovid supply agreements (expected deliveries through 2028), a stark contrast to the billions of dollars of EUA‑related orders and deferred revenue that dominated 2022‑23.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains major factual inaccuracies in revenue figures: it claims Paxlovid generated $18.9 billion in 2022, whereas the ground truth states $76 million. This is a massive overstatement by two orders of magnitude. The LLM also reports $1.3 billion in 2023 and $5.7 billion in 2024, none of which are supported by the original answer, which does not provide 2023 revenue and explicitly states that 2024 revenue is not disclosed. Only the $1 billion in remaining performance obligations for future Paxlovid deliveries by end of 2024 matches the ground truth and is correctly reported.\n\n(2) Quantitative accuracy is extremely low: the core financial data is entirely incorrect. The original answer emphasizes that Paxlovid's 2022 revenue was $76 million—likely due to late-year launch or limited initial scale—while the LLM fabricates a peak of $18.9 billion, which aligns more with Pfizer’s total COVID-19 product revenue (e.g., Comirnaty) rather than Paxlovid alone. There is no indication in the ground truth of a 'collapse' in revenue, nor any reversal or commercial transition pattern as described.\n\n(3) The reasoning is partially sound in identifying a strategic shift toward long-term contracts, which is consistent with the ground truth’s mention of remaining performance obligations. However, the multi-hop synthesis fails because the LLM incorrectly infers trends from non-existent data. It introduces concepts like 'EUA purchases', 'revenue reversals', and 'deferred revenue' that are not present or implied in the original answer, suggesting confusion between Paxlovid and Pfizer’s vaccine (Comirnaty) dynamics.\n\n(4) Contextual relevance is moderate—the answer addresses revenue trends and contractual commitments as asked, and correctly highlights the $1 billion in future obligations. But due to severe factual errors in the quantitative backbone, the overall correctness score is very low. The answer misrepresents the scale and trajectory of Paxlovid’s financial performance, undermining its reliability despite touching on relevant themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 555,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to list “the impact on our suppliers of tighter credit or capital markets” as an operational risk, but it paired that risk with concrete evidence of strong liquidity—cash from operations rose to $3.7 bn, the revolving credit facility was extended to 2028, and $1.5 bn of senior notes were issued in 2023 at higher coupons.  This shows that, while supplier‑level credit pressure remained a concern, the firm’s own exposure to external financial conditions has diminished, reflecting a reduced vulnerability to credit‑market tightness.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces specific financial figures such as '$3.7 bn' in cash from operations, extension of the revolving credit facility to 2028, and '$1.5 bn of senior notes issued in 2023 at higher coupons'. However, these quantitative details are not present in the original answer (ground truth) and cannot be verified from the provided context, making their inclusion factually unsupported. While number formatting variations are acceptable, the introduction of unverified metrics undermines quantitative accuracy. More critically, the LLM misrepresents the core evolution of risk: the original answer states that the company's framing evolved from credit tightness negatively impacting suppliers (2022) to the company itself being 'impacted by' these conditions (2023), indicating increased or more direct vulnerability. In contrast, the LLM concludes that the company's 'own exposure... has diminished' and 'vulnerability has reduced', which directly contradicts the ground truth's implication of heightened or more integrated risk recognition. This fundamental reversal of logic reflects a failure in multi-hop reasoning and qualitative accuracy. The answer is contextually relevant in discussing credit market tightness and supply chain risk across 2022–2023, but the synthesis is flawed. The conclusion is not supported by the evidence provided in the original answer, resulting in a low correctness score despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 399,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 Pfizer’s Paxlovid financial exposure shifted dramatically from a peak of **$18.9 billion of revenue in 2022** (driven by government‑procured supply contracts) to a steep decline in 2023, when the U.S. government began winding down its distribution and Pfizer recorded a **$3.5 billion non‑cash revenue reversal** for expected returns of EUA‑labeled courses. In 2024 the company recognized a **$771 million favorable adjustment** for 5.1 million returned courses and earned **$442 million from a no‑cost 1 million‑course supply to the U.S. Strategic National Stockpile**, while remaining contracted revenue for Paxlovid fell to roughly **$1 billion expected through 2028** and deferred revenue dropped from $5.1 billion (2023) to $2.2 billion (2024). This evolution reflects the transition from large‑scale government purchases to commercial‑market sales and the associated contractual adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides a detailed and largely accurate evolution of Pfizer's financial commitment and contractual obligations related to Paxlovid from 2022 to 2024, with strong contextual relevance and sound reasoning. However, there are some quantitative discrepancies that prevent a perfect score. The $18.9 billion revenue figure for 2022 is not present in the ground truth and cannot be verified from the provided information; while plausible, it introduces unconfirmed data. The $3.5 billion non-cash revenue reversal in 2023 is also not mentioned in the original answer, though the 2024 $771 million favorable adjustment for returned EUA-labeled courses is correctly reported and aligns with the ground truth. The $442 million from a no-cost 1 million-course supply to the U.S. Strategic National Stockpile is not mentioned in the original answer and appears to be an addition not supported by the ground truth. The $1 billion in remaining performance obligations expected through 2028 matches the original answer, though the original specifies this is as of December 31, 2024, and delivery is expected from 2025–2028, which the LLM captures in spirit but does not fully clarify. The drop in deferred revenue from $5.1 billion (2023) to $2.2 billion (2024) is not in the ground truth and lacks corroboration. Despite these unsupported or unverified figures, the core multi-hop synthesis—transition from government procurement to commercial sales, contractual adjustments, and the $771 million favorable adjustment tied to returns—is logically sound and semantically aligned with the original. The LLM correctly identifies the evolving nature of contractual obligations and financial exposure, demonstrating strong qualitative understanding and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 479,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the Company’s accrued liability for Aearo‑related respirator‑mask/asbestos claims fell from about **$62 million** (as reported on page 83 for Dec 31 2023) to roughly **$51 million** (page 87 for Dec 31 2024), indicating a modest reduction in the specific Aearo exposure.  At the same time, the broader respirator‑mask/asbestos reserve (excluding Aearo) remained large—​$574 million as of Dec 31 2023 (page 83) and had been increased by **$57 million** during 2023 (page 83)—and the firm continued to settle and pay substantial amounts (e.g., a **$1.5 billion** payment in January 2024 for the Combat‑Arms earplug settlement and related insurance recoveries, pages 105‑108), underscoring that overall financial risk from these matters remains high despite the downward trend in the Aearo accrual.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. According to the ground truth, in 2023, MMM had a $574 million accrual for respirator mask/asbestos liabilities *excluding* Aearo, and Aearo was in bankruptcy with no specific accrual mentioned for Aearo in 2023. However, the LLM claims a $62 million Aearo-related accrual as of Dec 31, 2023, which contradicts the ground truth—where the $51 million figure is stated as the 2024 accrual for Aearo-related claims. There is no mention in the original answer of a $62 million figure or a reduction from $62M to $51M; thus, this numerical comparison is factually incorrect. Additionally, the LLM introduces a $1.5 billion payment in January 2024 for Combat-Arms earplug settlements, which is contextually relevant to MMM’s overall liability but not directly related to Aearo’s respirator mask/asbestos litigation, potentially conflating distinct legal matters. The ground truth emphasizes a structural shift in 2024 due to Aearo’s agreement with Cabot (liability capped for pre-1997 exposure with $100K quarterly payments), which the LLM omits entirely—this is a critical qualitative gap in reasoning. While the LLM correctly notes the $51 million 2024 Aearo-related accrual and the large non-Aearo reserve ($574M in 2023), it fails to capture the contractual risk limitation mechanism that defines the 2024 evolution, instead focusing on a numerically unsupported decrease in Aearo accrual. The reasoning is partially sound in distinguishing Aearo vs. non-Aearo liabilities but misses the multi-hop synthesis of how Cabot’s liability assumption reshaped risk exposure. Contextually, the answer remains focused on financial liability evolution and uses document page references appropriately, earning high marks for relevance. However, due to incorrect figures, missing key contractual risk mitigation details, and introducing potentially misleading data (e.g., $62M → $51M decline), the overall correctness is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 539,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\nSkoal’s retail‑share slipped from **9.3 % in 2023 to 7.6 % in 2024**, a decline of about **1.7 percentage points**.  Over the earlier period, its shipment volume also fell—from **208.5 million units in 2020 to 197.4 million in 2021**, a drop of roughly **5 %**.  Thus, the downward movement in Skoal’s retail share mirrors the same downward trend in its shipment volumes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: retail share decreased from 9.3% in 2023 to 7.6% in 2024; shipment volume dropped from 208.5 million units in 2020 to 197.4 million in 2021. The implied 1.7 percentage point decline and ~5% volume drop are correctly inferred. (2) The answer addresses both parts of the multi-part question: the 2023–2024 retail share trend and the 2020–2021 shipment volume trend. (3) Entities are correct—Skoal, MO (implied), and the appropriate metrics and years are used. (4) The reasoning is sound: the LLM correctly synthesizes data across time periods and metrics, concluding that both trends are downward, which aligns with the ground truth's interpretation of a consistent negative trajectory. Minor wording differences (e.g., 'slipped', 'mirrors the same downward trend') do not affect semantic equivalence—core meaning and factual content are preserved. No errors in calculation, entity reference, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 292,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm moved its Snapdragon engineering focus from a communications‑centric SoC to a multimedia‑first architecture, embedding dedicated AI‑accelerated camera, video and display pipelines (including Hexagon NPU and computer‑vision blocks) directly into the chipset.  These capabilities are now tightly coupled with the 5G modem‑RF front‑end and RFFE modules, creating integrated modem‑to‑antenna solutions that deliver higher‑performance, power‑efficient multimedia experiences across handsets, automotive and IoT products.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements about Qualcomm's multimedia technology evolution, particularly the integration of AI-accelerated camera, video, and display pipelines into Snapdragon chipsets and the coupling with modem-RF systems for improved multimedia performance across devices. The mention of AI acceleration via Hexagon NPU aligns with the 2024 emphasis on AI, and the focus on automotive and IoT reflects the diversification noted in the ground truth. However, the LLM introduces a claim not present in the original answer: that Qualcomm shifted from a 'communications-centric SoC' to a 'multimedia-first architecture'—a strong characterization absent from the source. The ground truth describes an evolution in R&D strategy with increased AI integration and developer enablement, not a fundamental architectural reorientation. Additionally, the LLM omits key qualitative shifts such as the expansion into generative AI and the deliberate platform-oriented strategy to empower developers across industries. While the technical integration aspects are plausibly aligned, the reasoning overstates the shift and misses the nuanced evolution from hardware-centric to platform-AI-enhanced focus. There are no numerical inaccuracies (hence high quantitative score), and the context is highly relevant, but the qualitative synthesis lacks fidelity to the documented evolution. Thus, the answer is partially correct but contains interpretive overreach and omits critical aspects of the strategic shift described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 422,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\nBetween 2023 and 2024, 3M eliminated the modest $0.7 bn equity stake it had held in the Aearo Entities and, after re‑consolidating them in Q2 2023, recorded a net inter‑company liability of about $0.6 bn that was reflected in other assets and other liabilities.  The 2023‑24 CAE settlement then replaced that inter‑company exposure with a $5 bn accrued liability (later increased to $6 bn over 2023‑29) and a series of cash payments (e.g., $10 m, $147 m, $250 m and $253 m), so that 3M’s financial relationship shifted from a small equity investment and related inter‑company balances to a large contingent cash‑outlay and liability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) It incorrectly states that 3M 'eliminated' a $0.7 billion equity stake and 're-consolidated' the Aearo Entities in Q2 2023, whereas the ground truth confirms that reconsolidation occurred in 2023 (not Q2 specifically) and resulted in the removal of a $0.7 billion asset in equity investments — not the elimination of a prior stake. The directionality and nature of the change are misrepresented. (2) The claim that a '2023-24 CAE settlement' replaced intercompany balances with a $5 billion (later $6 billion) accrued liability and specific cash payments ($10M, $147M, etc.) is not supported by the original answer and introduces entirely new, unverified financial figures and events not present in the ground truth. These numbers and the settlement context are fabricated or hallucinated. (3) The original answer indicates that by 2024, 3M 'has a stake in' the Aearo Entities, reflecting a shift from full consolidation to a retained equity interest — a key qualitative point the LLM misrepresents by suggesting the equity stake was eliminated. Instead, the relationship evolved from deconsolidation to reconsolidation in 2023, then a move to a non-consolidated equity stake in 2024, which the LLM reverses in narrative. (4) Multi-hop reasoning fails: the LLM does not correctly trace the financial evolution — removal of equity investment and intercompany balances due to reconsolidation in 2023, followed by a new structure in 2024. Instead, it invents a settlement mechanism and cash flows absent from the source. While the $0.7 billion and $0.6 billion figures are directionally mentioned, their context and implications are wrong. Quantitative accuracy is low due to unsupported numbers. Qualitative accuracy suffers from incorrect entity relationships and timeline logic. Contextual relevance is moderate as it addresses financial relationship changes but with incorrect mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 534,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\nBetween 2022 and 2024 Visa’s Risk and Identity Solutions progressed from a focused set of fraud‑prevention and authentication tools (e.g., Visa Advanced Authorization, Visa Secure) to a broader, AI‑driven suite that now includes products such as Visa Deep Authorization, Visa Protect for A2A payments and scheme‑agnostic Risk Manager.  These newer capabilities are tightly integrated with Visa’s emerging payment flows—Visa Direct, Visa B2B Connect, cross‑border and open‑banking services—positioning risk and identity as a core pillar of Visa’s value‑added services portfolio and a key differentiator that monetises data‑driven insights across both card‑based and non‑card payment ecosystems.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Visa's Risk and Identity Solutions from a fraud-prevention focus in 2022 to a more integrated, strategic role within a broader services portfolio by 2024. It accurately references core 2022 products like Visa Advanced Authorization and Visa Secure, and correctly identifies the strategic shift toward deeper integration with payment flows and data monetization. However, the LLM introduces specific new products—Visa Deep Authorization, Visa Protect for A2A payments, and scheme-agnostic Risk Manager—that are not mentioned in the ground truth, which only states that Risk and Identity Solutions became one of five core categories in a portfolio of over 200 services as of September 30, 2024. While the general direction of AI-driven expansion and integration with Visa Direct, B2B Connect, and open banking aligns with the ground truth’s mention of Open Banking Solutions and 'high impact business outcomes,' the named product extensions and claims of AI capabilities are unsupported by the provided truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is contextually relevant and well-reasoned, but the addition of unverified product names and functionalities reduces qualitative accuracy. The core strategic evolution is correctly understood, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 380,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\nRTX continues to present acquisition‑accounting adjustments as a separate line‑item below segment operating profit.  The total adjustment grew from a $1.998 billion drag on 2023 operating profit to a $2.058 billion drag in 2024 (≈ $60 million higher), with the increase coming mainly from higher amortization of acquired intangibles and a modest rise in the amortization of customer contractual obligations (Collins fell slightly, while Pratt & Whitney and Raytheon each rose).  Thus, the company’s disclosure and quantification of these adjustments became slightly more material in 2024, reflecting a modest uptick in the post‑acquisition amortization that reduces consolidated operating profit.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. The original answer states that RTX did not provide updated quantitative figures for 2024, but the LLM claims a specific dollar amount ($2.058 billion) for 2024, which contradicts the ground truth. The 2023 figure of $1.998 billion is correct and matches the ground truth (equivalent to $1,998 million), but the 2024 number is fabricated. (2) The calculation of a $60 million increase and breakdown by business units (Collins, Pratt & Whitney, Raytheon) is entirely unsupported by the original answer, which explicitly states no updated quantification was provided in 2024. (3) The multi-hop reasoning is flawed: instead of recognizing the shift from quantitative to qualitative disclosure, the LLM assumes continuity in numerical reporting and invents data. The core of the question is about the evolution in disclosure approach—toward less quantification—but the LLM describes increased detail and materiality, which is the opposite of the truth. (4) The contextual relevance is low because the answer misrepresents the nature of the disclosure change. While it correctly identifies acquisition accounting adjustments as impacting operating profit, it fails to capture the key shift from numerical to qualitative disclosure, which is the central point of the original answer. Thus, the correctness score is very low due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 405,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Office 365 Commercial portion of Microsoft’s “Office products and cloud services” revenue rose from **$44.9 billion to $48.8 billion**—about a **9 % increase**.  During the same period Microsoft Cloud total revenue grew from **$91.4 billion to $111.6 billion**, so the Office 365 Commercial segment’s share of the cloud business expanded, highlighting its accelerating contribution and the strong growth trajectory of Office 365 within Microsoft’s broader cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Microsoft Cloud revenue grew from $91.4 billion in FY2022 to $111.6 billion in FY2023 (a 22% increase), it incorrectly claims that Office 365 Commercial revenue rose from $44.9 billion to $48.8 billion. The original answer (ground truth) does not provide specific revenue figures for Office 365 Commercial in either year, nor is this data explicitly disclosed in Microsoft’s public filings as a standalone line item. Therefore, the $44.9B and $48.8B figures are fabricated or misattributed—likely conflating 'Office products and cloud services' (a broader category) with Office 365 Commercial specifically. Additionally, the 9% growth rate is unsupported by the ground truth. (2) The calculation of Microsoft Cloud growth is accurate: ($111.6B - $91.4B) / $91.4B ≈ 22%, but the Office 365-specific numbers and 9% growth are not verifiable and contradict the original answer’s approach. (3) The reasoning is partially sound in noting that Office 365 Commercial is now included in the consolidated Microsoft Cloud figure, indicating increased integration into the broader cloud ecosystem. However, the claim that its 'share of the cloud business expanded' is speculative and not supported by the ground truth, which does not provide enough data to assess changing proportions. The multi-hop synthesis fails because it invents granular revenue data not present in the source. (4) The contextual relevance is high—the answer addresses the evolution of Office 365 Commercial within Microsoft Cloud and attempts to interpret growth trajectory. However, due to major quantitative errors and unsupported claims, the correctness score is low. The qualitative accuracy is moderate because the structural logic and entity identification (Microsoft, Office 365 Commercial, Microsoft Cloud) are correct, but the reasoning is based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 523,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\nAlliance revenue from Lynparza rose from **$1.116 billion in 2022 to $1.199 billion in 2023** and then **increased about 9 % in 2024**, taking the total to roughly **$1.30 billion**.  The jump was driven primarily by **stronger international demand**, especially in China where the NMPA approved Lynparza in January 2025 (effective late‑2024) for a new adjuvant breast‑cancer indication, and by continued uptake in existing markets.  Higher sales volumes and the resulting profit‑share arrangement with AstraZeneca (net of cost‑of‑sales and commercialization expenses) accounted for the growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific dollar figures for 2022 ($1.116B) and 2023 ($1.199B), which are not present in the original answer and cannot be verified against the ground truth. The original answer does not provide any numerical values for alliance revenue in 2023 or 2024, only stating that it grew by 9% in 2024. While the 9% growth figure in 2024 is consistent with the ground truth, the derived 2024 value of ~$1.30B is an extrapolation not confirmed by the original. More critically, the mention of NMPA approval in January 2025 (effective late-2024) introduces a forward-looking event not present in the original and potentially inconsistent with the 2024 reporting period. (2) The quantitative accuracy is compromised because the base year (2023) revenue is fabricated or assumed without support from the original answer. The 9% increase is correct, but the absolute values and growth trajectory (from 2022 to 2023) are unsupported. (3) The reasoning partially aligns with the ground truth: the LLM correctly identifies international demand as a driver and references the profit-share model with AstraZeneca, which is consistent with Merck’s alliance structure. However, it adds unverified details (e.g., China approval timing, specific indication) that were not in the original, suggesting over-inference or hallucination. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of revenue and contributing factors—and maintains focus on Lynparza, Merck, and alliance dynamics. However, the addition of unsupported specifics reduces factual reliability. The core 9% growth and international demand are correct, but the extra detail undermines overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 471,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\nIn the 2023 filing the 2014 Stock and Incentive Compensation Plan appeared only as an exhibit (Item 10‑24) and was mentioned in the Compensation and Leadership Development Committee’s regulations (Item 10‑25), with no explicit note that it no longer permits new grants. By the 2024 filing the plan is explicitly grouped with the 2019 Plan in the Committee’s regulations, is listed in the equity‑compensation table as a closed plan with zero shares available for future issuance, and its terms are again incorporated by reference (Item 10‑26), reflecting a more transparent regulatory framing that makes clear the 2014 plan is no longer used for new awards while still being disclosed as required under the SEC’s equity‑compensation reporting rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of the 2014 Stock and Incentive Compensation Plan between 2023 and 2024, noting its presence in regulatory exhibits and committee regulations in 2023 and a more explicit classification as a closed plan in 2024 with zero shares available. This matches the ground truth's assertion of a shift from regulatory disclosure to integrated equity compensation reporting. (2) There are no numeric values (e.g., dollar amounts, percentages, share counts) in either answer, so quantitative accuracy is not compromised; all references to years (2014, 2019, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and document sections (e.g., Item 10-24 to 10-26), correctly infers the regulatory context shift, and accurately interprets the plan’s closure and continued disclosure under SEC rules. (4) The LLM adds specific detail not in the original (e.g., exhibit numbers, 'zero shares available'), which enhances precision and reflects deeper document understanding, but does not contradict or distort the core message. The only minor gap is that the original emphasizes a broader 'integrated view' within the equity framework, while the LLM focuses on closure and transparency—slightly different framing, but semantically consistent. Thus, the answer is factually superior and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 402,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings the company’s disclosures show that the 1992 Stock Plan has been effectively retired from new equity awards.  The 2024 filing (Exhibit 10‑3) notes that, unlike the 2019 Stock and Incentive Compensation Plan, the 1992 Plan “allows for future grants” only in the past – all current and future equity awards are now made under the 2019 (and related) plans, and the 1992 Plan’s remaining shares are limited to the outstanding options and RSUs that were granted before it was closed.  Consequently, the 1992 Plan now serves only as a repository for legacy awards, while the 2019 Plan provides the bulk of the company’s ongoing equity‑compensation structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolving role of the 1992 Stock Plan between the 2023 and 2024 10-K filings, noting its transition to a legacy status. The dates (1992 and 2019 plans) and the shift to the 2019 plan for current awards are accurate, and there are no numeric inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are presented). The answer adds specific detail about Exhibit 10-3 and the cessation of future grants under the 1992 Plan, which aligns with the expected direction of the ground truth. However, the original answer emphasizes a structural disclosure change—specifically, the inclusion of the 1992 Plan in a consolidated table in 2024 as evidence of its integration into a broader framework—whereas the LLM interprets this as formal retirement and closure. The LLM goes beyond the source by asserting the plan 'allows for future grants only in the past' and that it was 'closed,' which may not be explicitly confirmed in the filings and is a stronger claim than the ground truth supports. The ground truth suggests a passive but not necessarily closed status. Thus, while the core idea of diminished active role is correct, the reasoning slightly overreaches in characterization, affecting qualitative accuracy. Contextual relevance is high, as the response directly addresses the evolution in disclosure and role within equity compensation. Semantic equivalence is partially met, but the LLM introduces stronger language about retirement and closure not present in the original, which only notes a shift in presentation and tracking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 432,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the company’s focus on large‑scale transformations deepened: the risk‑factor discussion notes that “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period,” and that the slowdown in fiscal 2024 was driven primarily by a pull‑back in short‑duration, smaller contracts rather than in these transformational engagements. Consequently, revenue recognition shifted toward a longer‑term, multi‑quarter conversion cycle, with the mix of work moving to higher‑value, longer‑horizon projects that boosted operating margins despite only modest revenue growth. (See Risk Factors Item 1A (page 21) and the operating‑income commentary (page 47).)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution between 2023 and 2024: clients reduced spending on smaller, short-duration contracts while continuing to prioritize large-scale transformations that convert to revenue over a longer period. The 2024 filing's emphasis on pullbacks in smaller contracts and sustained focus on transformational engagements is accurately reflected. (2) There are no quantitative figures in the original answer, and the LLM does not introduce any incorrect numbers, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly synthesizing information across years and linking client spending patterns to revenue conversion timelines and strategic focus. The mention of longer-duration contracts and extended revenue recognition cycles matches the original's emphasis. The only minor gap is that the LLM implies an increase in operating margins due to higher-value projects, which, while plausible, is not explicitly stated in the ground truth and adds a slight interpretive leap. (4) Contextual relevance is excellent—the response directly addresses client spending patterns and revenue conversion timelines as asked, with appropriate references to the filings. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original, meriting a high score with only a small deduction for the added margin commentary not present in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 408,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the number of Class A ordinary shares issued for employee compensation fell – the 2010 Employee Share Purchase Plan issued about 4.9 million shares in 2024 versus 5.7 million shares in 2023 (≈14 % lower), and total issuances under all employee‑share programs dropped from roughly 8.5 million shares to 7.97 million shares.  This reduction lessened dilution of existing shareholders and left a marginally larger treasury‑share balance, while overall shareholders’ equity grew only through higher additional‑paid‑in‑capital and retained earnings rather than through the addition of new shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Contrary to the ground truth, it claims that the number of Class A Ordinary Shares issued for employee compensation *decreased* from 2023 to 2024, while the original answer states that in 2023, Accenture did not issue shares for employee programs but instead *acquired* shares via withholding for tax obligations. In 2024, the company *issued* 7,970 shares for employee programs — indicating a shift toward active issuance, not a reduction. The LLM incorrectly reports 7.97 million shares issued in 2024, but the correct figure is 7,970 (not million), a major quantitative error. Similarly, the claim of 5.7 million and 4.9 million shares issued under employee plans in 2023 and 2024 respectively is unsupported by the ground truth and contradicts it. (2) The quantitative inaccuracies are severe: the LLM inflates share numbers by a factor of ~1,000 (thousands vs. millions), misrepresents trends, and fabricates data about the Employee Share Purchase Plan. The ground truth reports a net *increase* in Class A shares from 15,656,591 to 15,664,561 (a +7,970 change), aligning with the 7,970 issued — confirming the correct number is in the *thousands*, not millions. Treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating share buybacks, but the LLM incorrectly states the treasury balance increased due to reduced issuance, which contradicts the evidence. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that 2023 involved share *acquisitions* (reducing shares outstanding) while 2024 involved *issuance* for compensation — a qualitative shift the model misinterprets as a simple reduction in issuance volume. It also fails to connect the issuance of 7,970 shares to the increase in total Class A shares and the concurrent purchase of 12,181 treasury shares. (4) The contextual relevance is moderate because the answer addresses employee share programs and equity structure, but the severe factual and numerical errors undermine correctness. The conclusion about reduced dilution and larger treasury balance is factually inverted — treasury share *value* decreased significantly, meaning more shares were held in treasury, but due to active buybacks, not reduced issuance. Overall, the answer misrepresents the direction, magnitude, and nature of the change, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 646,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\nMDLZ’s Canadian‑denominated debt exposure slipped in 2023 – the after‑tax gain on the Canadian‑dollar net‑investment hedge fell from **$25 million in 2022 to a **$8 million loss in 2023**, signalling a reduction in the outstanding Canadian‑currency notional and an unwind of the related hedge.  This move fits the broader pattern of the company actively trimming and reshaping its foreign‑currency‑denominated debt and hedge coverage, as reflected by the declining after‑tax gains on other non‑U.S. currency hedges and the absence of new foreign‑currency debt redemptions in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of change in Canadian-denominated debt. The ground truth states that Canadian notes *increased* by $8 million in 2023, reversing a prior downward trend. However, the LLM claims there was a 'reduction' in Canadian-currency notional based on a misinterpretation of hedge gains/losses, asserting a decrease due to an 'unwind' of hedges. This directly contradicts the correct fact. Additionally, the LLM cites a $25 million gain in 2022 turning into an $8 million *loss* in 2023, which is not supported by the original answer and confuses hedging activity with actual debt levels. (2) The quantitative inaccuracies are severe: the original answer reports a $3 million Canadian note balance in 2022 and an *increase of $8 million* in 2023 (implying a $11 million balance), while the LLM incorrectly infers debt reduction from unrelated hedge accounting figures ($25M to -$8M), which are not mentioned in the ground truth. No such numbers appear in the correct answer, indicating fabrication or misattribution. (3) The multi-hop reasoning fails: the question asks about changes in actual debt instruments, not hedge accounting impacts. The LLM conflates net-investment hedge gains/losses with debt balances, which are distinct concepts. It also misses the key contrast between the reversal in Canadian debt (increase after years of decline) versus broader trends like Euro and Swiss franc debt fluctuations. Instead, it incorrectly generalizes a 'trimming' trend that does not apply to 2023 Canadian debt. (4) The contextual relevance is moderate because the answer discusses foreign currency debt management, but it focuses on the wrong metric (hedge gains vs. actual debt) and draws opposite conclusions from the facts. Thus, despite addressing the topic, it fails on correctness, quantitative accuracy, and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 515,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2024, Accenture’s core tactic— Accenture Ventures partnering with and investing in growth‑stage companies that build innovative enterprise technologies — remained unchanged.  What did shift in 2024 is the emphasis on integrating those external innovations more tightly into Accenture’s own ecosystem: the filing highlights that Accenture Labs and its global network of innovation hubs now incubate, prototype and scale the technologies sourced from growth‑stage firms, allowing Accenture to embed those solutions directly into client engagements and deliver them at scale across its delivery model.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in context but fundamentally misrepresents the evolution of Accenture's approach from 2023 to 2024. (1) The original answer states that Accenture shifted from a 'partnership' model in 2023 to a 'direct investment' model in 2024, indicating a strategic shift from partnering with to investing in growth-stage companies. The LLM answer incorrectly claims the core tactic of 'partnering with and investing in' remained unchanged, which contradicts the ground truth. This is a critical factual error in the qualitative interpretation of the strategic shift. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the model fails to recognize the key evolution from partnership to investment as a change in strategic involvement, instead focusing on integration into Accenture’s innovation ecosystem, which is contextually relevant but not the primary shift described in the ground truth. (4) While the LLM provides relevant details about Accenture Labs and innovation hubs, this information is not present in the original answer and distracts from the core factual change—Accenture Ventures’ shift in engagement model. Thus, despite good contextual framing, the answer misses the central factual evolution, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 394,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\nFrom 2022 through 2024 Merck continued to amortize the $1.1 billion Lynparza‑related intangible asset (recorded in “Other Intangibles, Net”) over its remaining useful life to 2028, with amortization expense running at roughly $160‑$170 million per year.  Alliance revenue from Lynparza grew from $444 million in 2019 to $725 million in 2020 and $989 million in 2021, and in 2024 the collaboration posted a 9 % year‑over‑year increase, reflecting expanding sales and the ongoing equal‑profit‑sharing, cost‑sharing arrangement with AstraZeneca while the intangible asset is steadily written down through 2028.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly states the $1.1 billion intangible asset related to Lynparza and its amortization through 2028, consistent with the ground truth. However, it introduces alliance revenue figures for 2019 ($444M), 2020 ($725M), and 2021 ($989M) that are not present in the original answer and are irrelevant to the 2022–2024 timeframe asked. These numbers, while possibly factual, misdirect the focus and are not supported by the ground truth, which only mentions a 9% year-over-year revenue increase in 2024. The 9% growth figure in 2024 is correctly included, aligning with the original answer. (2) The annual amortization estimate of $160–170 million is a reasonable calculation ($1.1B over ~6.5 years from 2022 to 2028), but this detail was not in the ground truth and represents an inference. While mathematically plausible, it introduces unverified precision. The core asset value and amortization period are correct. (3) The reasoning partially captures the evolution from amortization to revenue growth, noting ongoing amortization and 2024 revenue increase. However, it fails to mention the strategic expansion highlighted in the original answer—the 2025 China approval for adjuvant treatment in early breast cancer, which is a key strategic development. This omission weakens the multi-hop synthesis of financial and strategic evolution. (4) The answer is contextually relevant and well-structured, addressing both amortization and revenue. However, inclusion of outdated revenue data and absence of the China approval significantly reduce factual accuracy. Correctness score is 6 due to partial factual alignment, with major omissions and extraneous, unverified data. Quantitative accuracy is penalized for unsupported historical revenue figures. Qualitative accuracy is moderate due to sound structure but incomplete strategic context. Contextual relevance remains high as the response stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 540,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\nBetween 2023 and 2024 Broadcom’s Distributed‑Software narrative moved ValueOps from a peripheral offering to a headline pillar.  In the 2023 filing the Distributed‑Software section simply listed “ValueOps” among other solutions (DevOps, AIOps) that “optimize the planning, development and delivery of business‑critical services,” but the 2024 filing elevates ValueOps to a dedicated, end‑to‑end platform that ties together planning, development, operations and analytics, and explicitly frames it as the engine for “optimizing the planning, development and delivery of business‑critical services.”  This shift signals that Broadcom is repositioning itself from a pure‑hardware semiconductor supplier to a full‑stack software‑centric player, using ValueOps to deepen its role in customers’ digital‑transformation and to drive recurring, value‑based revenue across its Distributed‑Software portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AVGO's strategic emphasis on ValueOps between 2023 and 2024. It correctly identifies that in 2023, ValueOps was listed among other offerings (DevOps, AIOps) without detailed elaboration, and that by 2024 it was elevated to a core domain. The answer accurately reflects the shift in narrative—from a component of the portfolio to a central, end-to-end platform—aligning with the ground truth. The description of ValueOps as now tying together planning, development, operations, and analytics, and being framed as the engine for optimizing business-critical services, is consistent with the 'end-to-end visibility across all stages of the digital lifecycle' emphasis in the original answer. The inference that this reflects Broadcom's broader pivot toward software and recurring, value-based revenue is well-reasoned and contextually sound. The only minor shortcoming is that the LLM does not explicitly state that ValueOps became one of exactly 'three core domains' (alongside DevOps and AIOps), which is a specific structural detail present in the ground truth. However, the answer implies this triad by naming the three and giving them equal prominence. There are no quantitative inaccuracies—no numbers are misstated, and the years (2023, 2024) are correct. Entity accuracy is perfect: AVGO (Broadcom), ValueOps, DevOps, AIOps, and the Distributed Software portfolio are all correctly identified. The reasoning is strong, demonstrating multi-hop synthesis across filings from two years and inferring strategic intent. The answer is semantically equivalent to the ground truth in meaning, though slightly less precise in structural detail. Thus, the correctness score is 9/10, with full marks in quantitative accuracy and contextual relevance, and a 9 in qualitative accuracy due to the minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 504,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx shifted Network 2.0 from a DRIVE‑program concept to an operational, multi‑year effort that has already been deployed in over 50 U.S. locations, consolidating sortation facilities, re‑routing pickups and deliveries, and fully integrating FedEx Ground and Services into a single FedEx air‑ground network (completed legally in June 2024).  Management expects the initiative to deliver long‑term cost savings by improving network efficiency and aligning the cost base with demand—projecting roughly $1.5 billion in aggregate pre‑tax optimization expenses through 2025—but it warns that actual savings may fall short and that the rollout faces significant risks, including complex integration of legacy networks, labor‑relation and regulatory challenges, third‑party provider disruptions, cyber threats and potential cost overruns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. Most notably, it introduces specific quantitative figures such as '$1.5 billion in aggregate pre-tax optimization expenses through 2025' and claims that Network 2.0 has been 'deployed in over 50 U.S. locations' and that integration was 'completed legally in June 2024'—none of which appear in the original answer or are supported by the knowledge graph. These specific numbers, dates, and milestones are fabricated or hallucinated, severely undermining quantitative accuracy. (2) The original answer makes no mention of deployment scale, completion dates, or dollar figures related to optimization expenses. Instead, it focuses on the evolution of risk disclosures and strategic emphasis—from execution timing and cost risks in 2023 to integration complexities and financial uncertainties (e.g., asset impairments, tax impacts) in 2024. The LLM answer captures some of this shift in tone and focus, correctly identifying integration challenges, labor issues, and uncertainty around cost savings, which supports partial qualitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers a transition from strategic planning to operational risk, and identifies relevant themes like cost alignment, integration complexity, and external risks. However, it invents concrete implementation details and financial projections absent in the source, indicating a failure to strictly ground responses in the provided data. (4) While the LLM answer is contextually relevant and addresses the general evolution of FedEx's approach, the inclusion of unsupported specifics—especially numerical claims and precise timelines—reduces factual correctness. The answer conveys a plausible narrative but deviates from the ground truth in critical quantitative aspects, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 518,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the earnings generated from MDLZ’s equity‑method investments fell from **$421 million to $393 million** (a roughly 7 % decline).  This reduction—amplified by the 2023 divestiture of most of the KDP stake that moved the investment out of equity‑method accounting—shows that Mondelez is **scaling back its substantive influence and active involvement in those joint‑venture investments**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims MDLZ's equity-method investment earnings declined from $421 million to $393 million between 2022 and 2023, but the ground truth states that MDLZ reported a net *liability* of $3 million in 2022 and a *gain* of $7 million in 2023—these are not earnings figures but net impacts, and the magnitudes and directions are completely different. The $421M and $393M figures appear to be unrelated to the actual data. (2) The mention of a 'KDP stake divestiture' and its impact on equity-method accounting is not supported by the ground truth and introduces a false entity/event. (3) The reasoning is flawed: the LLM concludes that MDLZ is 'scaling back' engagement, while the ground truth indicates a reversal from liability to gain, suggesting *increased* favorable engagement. (4) The answer fails to reflect the actual financial evolution (liability to gain) and misrepresents the nature of the metric. There is no semantic equivalence. The contextual relevance is minimal because the answer discusses a different financial concept (earnings from investments vs. net liability/gain position) and introduces irrelevant details. All scores are low due to complete factual inaccuracy and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 365,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\nThe estimated cost‑to‑complete for the VMware Cloud Foundation July 2024 releases declined from roughly $77 million in fiscal 2023 to $38 million in fiscal 2024—a drop of about 50 percent. This reduction shows that roughly half of the remaining work has already been executed, indicating that development is advancing faster than originally projected and that the releases are on track for delivery in FY 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that the estimated cost to complete remained unchanged at $38 million from fiscal year 2023 to 2024. However, the LLM claims it declined from $77 million to $38 million, which is false. This major quantitative error undermines the entire response. (2) The numbers are incorrect: there is no mention of $77 million in the original answer or ground truth, and the 50% reduction is fabricated. The only correct number is the $38 million in fiscal 2024, but the fiscal 2023 figure is wrong. Calculations based on false inputs (e.g., 50% drop) are therefore invalid. (3) The multi-hop reasoning fails because the model incorrectly infers progress and timeline acceleration based on a non-existent cost reduction. The correct reasoning — that stable costs indicate on-plan progress — is replaced with an erroneous interpretation of cost decline as faster-than-expected development. (4) Scores reflect severe factual inaccuracies in numbers and reasoning (hence low correctness and quantitative accuracy), though the answer remains contextually relevant by addressing the right topic, company, product, and timeframe, and attempting appropriate interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 351,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\nThe Ship & Go kiosk has shifted from a simple self‑serve shipping point to a central node in FedEx Office’s retail‑convenience network—now installed in roughly 1,300 locations and tightly coupled with FedEx Returns Technology and the FedEx Consolidated Returns program, which lets shoppers drop off items without a box or label.  This expansion shows FedEx’s strategy of using its extensive store footprint to create an end‑to‑end, omnichannel logistics and returns solution that makes e‑commerce fulfillment and reverse‑logistics faster, easier, and more integrated for both merchants and consumers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the figure of 'approximately 1,300 locations' is correctly reported, matching the original answer for both 2023 and 2024. No other numerical data (dates, percentages, dollar amounts) is present, and all referenced programs (FedEx Returns Technology, Consolidated Returns) are correctly named. (2) The answer addresses all parts of the question: it describes the evolution of the Ship and Go kiosk between 2023 and 2024, noting the shift from a self-serve shipping tool to a more integrated role in returns management. (3) The multi-hop reasoning is sound—the LLM correctly infers that the tighter integration with returns programs indicates a strategic pivot toward omnichannel e-commerce logistics and reverse logistics, which is consistent with the original answer's conclusion about positioning Ship and Go as a 'key node' in returns infrastructure. (4) While the original answer notes that the core functionality and footprint remained consistent, the LLM describes it as an 'expansion,' which slightly overstates the change (functionality evolved in emphasis, not scale). This minor interpretive leap prevents a perfect 10, but the overall semantic meaning, factual accuracy, and strategic insight are preserved. Wording differs but conveys equivalent meaning, and all key entities and relationships are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 389,
        "total_tokens": 1777
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 999,
    "successful_evaluations": 999,
    "failed_evaluations": 0,
    "average_correctness_score": 6.16,
    "average_quantitative_accuracy": 6.76,
    "average_qualitative_accuracy": 6.5,
    "average_contextual_relevance": 8.51,
    "score_distribution": {
      "excellent": 298,
      "good": 197,
      "fair": 297,
      "poor": 207
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 999,
    "failed": 1,
    "elapsed_seconds": 11977.34,
    "timestamp": "2026-02-02T19:00:03.089264"
  }
}